fluorodeoxyglucose f18 has been researched along with Sensitivity and Specificity in 4127 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 261 (6.32) | 18.2507 |
| 2000's | 1795 (43.49) | 29.6817 |
| 2010's | 1792 (43.42) | 24.3611 |
| 2020's | 279 (6.76) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, EN; Chen, WC; Liu, ZQ; OuYang, PY; Wu, YS; Xiao, SM; Xie, FY; Yang, SS; Zhang, BY; Zhang, J; Zhang, X | 1 |
| Abrar, DB; Antoch, G; Bittner, AK; Breuckmann, K; Bruckmann, NM; Buchbender, C; Dietzel, F; Fendler, WP; Häberle, L; Herrmann, K; Hoffmann, O; Ingenwerth, M; Kirchner, J; Mohrmann, S; Morawitz, J; Ruckhäberle, E; Sawicki, LM; Ullrich, T; Umutlu, L | 1 |
| Grünig, H; Holzmann, D; Huellner, MW; Husmann, L; Mader, CE; Maurer, A; Meerwein, CM; Messerli, M; Mühlematter, UJ; Rupp, NJ; Skawran, S; Soyka, MB | 1 |
| Akl, P; Buvat, I; Duboucher, C; Lacroix, M; Soussan, M; Wallis, D | 1 |
| Chen, L; Du, F; Gao, MJ; Hu, JB; Huang, ZK; Liu, Y; Lou, C; Zhou, J | 1 |
| Li, G; Wang, Z; Wu, Y; Zhang, B; Zhou, Z | 1 |
| Borello, A; Ferrero, A; Guerra, M; Langella, S; Lo Tesoriere, R; Russolillo, N | 1 |
| Arora, K; Barry, CE; Cai, Y; Chen, RY; Dawson, R; Diacon, AH; Gao, J; Goldfeder, LC; Jin, X; Liu, X; Malherbe, ST; Pan, S; Qu, Y; Smith, B; Tameris, M; Thienemann, F; Vincent, J; Walzl, G; Wang, J; Wilkinson, RJ; Yu, X; Zhang, R; Zhu, H | 1 |
| Ahmed, MM; Baker, A; Fagiry, R; Ibrahim, N; Mahmood, S; Mair, M; Menon, I; Vaidhyanath, R | 1 |
| Akazawa, Y; Hiramatsu, K; Matsuda, H; Naito, T; Nakamoto, Y; Nosaka, T; Ofuji, K; Ohtani, M; Ozaki, Y; Saito, Y; Takahashi, K | 1 |
| Gao, C; Liu, H; Zou, Q | 1 |
| Jeong, JH; Kim, K; Kim, SJ | 1 |
| Eberhard, N; Gruenig, H; Hasse, B; Huellner, MW; Husmann, L; Mestres, CA; Rancic, Z | 1 |
| Huang, Y; Lai, B; Zheng, S | 1 |
| Choi, YJ; Kang, T; Kim, H; Kim, IJ; Kim, K; Pak, K; Seol, YM | 1 |
| Bulloch, G; Chatterjee, R; Donnan, L; Guo, A; MacManus, M; Seth, I; Seth, N; Siu, AHY | 1 |
| Bhatnagar, R; Bodtger, U; Fjaellegaard, K; Frost Clementsen, P; Gerke, O; Koefod Petersen, J; Laursen, CB; Malene Fischer, B; Porcel, JM; Reuter, S | 1 |
| Alavi, A; Baun, C; Duvnjak, S; Falch, K; Gerke, O; Hansen, JA; Hildebrandt, MG; Høilund-Carlsen, PF; Naghavi-Behzad, M | 1 |
| Guzmán Pérez-Carrillo, GJ; Ivanidze, J | 1 |
| Banerjee, A; Benedetto, V; Brindle, L; Callister, MEJ; Clegg, A; Cook, A; Cozens, K; Crosbie, PA; Dizdarevic, S; Eaton, R; Eichhorst, K; Frew, A; George, S; Gilbert, FJ; Gleeson, FV; Groves, AM; Han, S; Harris, S; Hill, J; Jones, J; Kankam, O; Karunasaagarar, K; Kurban, L; Little, L; Madden, J; McClement, C; Miles, KA; Moate, P; Peebles, C; Pike, L; Poon, FW; Qureshi, NR; Rintoul, RC; Shah, A; Sinclair, D; Tzelis, D; Vale, L; Weir-McCall, JR | 1 |
| Chen, S; Cheng, W; Li, L; Wang, H; Wu, J; Wu, S; Yin, Y | 1 |
| Huang, R; Huang, S; Qi, Z; Su, M | 1 |
| Anten, MHME; Broen, MPG; Geitenbeek, RTJ; Graven, LH; Martin, E; Taal, W; van der Pol, JAJ; Verhoef, C | 1 |
| Bergamini, A; Bettinardi, V; Bezzi, C; Bocciolone, L; Candiani, M; Candotti, G; De Cobelli, F; Fallanca, F; Gianolli, L; Gnasso, C; Ironi, G; Mangili, G; Mapelli, P; Picchio, M; Rancoita, PMV; Sant'Angelo, M; Scifo, P; Taccagni, GL | 1 |
| Gambhir, S; Hassan, A; Ora, M; Saini, VK; Singh, AK | 1 |
| Goi, T; Kurebayashi, H; Morikawa, M; Okazawa, H; Sawai, K; Seto, S; Tsujikawa, T | 1 |
| Evans, J; Hardman, J; McLaren, O; Williams, R; Zhu, Y | 1 |
| Bertolaso, P; Bladou, F; Brouste, V; Cabart, M; Cazeau, AL; de Clermont-Gallerande, H; Gross-Goupil, M; Lefort, F | 1 |
| Doi, H; Hume, WE; Ishii, A; Mawatari, A; Nakatani, Y; Nozaki, S; Tanaka, M; Tsuyuguchi, N; Wada, Y; Watanabe, Y | 1 |
| Andersen, JAS; Bastholt, L; Gerke, O; Grupe, P; Hess, S; Hildebrandt, MG; Holdgaard, PC; Spatzek, AD; Vilstrup, MH | 1 |
| Atilgan, HI; Yalcin, H | 1 |
| Kim, SJ; Lee, SW | 3 |
| Hu, S; Ni, J; Xu, H; Yin, Q; Zhong, Y | 1 |
| Anderson, MA; Blaszkowsky, LS; Caravan, P; Catalano, OA; Clark, JW; Crafa, F; Cusack, JC; Esfahani, SA; Ferrone, CR; Franses, JW; Furtado, FS; Goyal, L; Hahn, PF; Hong, TS; Kilcoyne, A; Mahmood, U; Mojtahed, A; Qadan, M; Rosen, BR; Ryan, DP; Striar, RM; Tanabe, KK; Vangel, M; Weekes, CD; Wo, JY; Wu, MZ | 1 |
| Li, L; Li, Y; Xiao, L | 1 |
| Alkhoder, S; Benali, K; Brochet, E; Deschamps, L; Driss, AB; Ehmer, C; Hyafil, F; Males, L; Mikail, N; Ou, P; Raffoul, R; Rossi, A; Rouzet, F; Saker, L | 1 |
| Chen, L; Shah, A; Sonbol, M; Yang, M | 1 |
| Subramaniam, RM | 1 |
| Antic, S; Chen, H; Cords, AJ; Eisenberg, R; Grogan, EL; Helton, JE; Manning, HC; Massion, PP; Muterspaugh, A; Paez, R; Shah, C; Walker, RC | 1 |
| Garland-Kledzik, M; Hamilton, O; Likar, C; Thomay, A; Williams, A | 1 |
| Li, L; Li, Q; Ren, Y; Su, M; Sun, X; Tian, R; Wang, H; Wu, T; Zou, K | 1 |
| Fukui, M; Hattori, A; Matsunaga, T; Nomura, K; Suzuki, K; Takamochi, K | 1 |
| Chen, W; Nie, X; Niu, J; Sun, J; Zeng, J; Zhou, J | 1 |
| Aitken, M; Balter, M; Chan, MV; Farrell, A; Hanneman, K; Islam, N; Iwanochko, M; McInnes, MDF; Metser, U; Moayedi, Y; Thavendiranathan, P; Urzua Fresno, C; Veit-Haibach, P | 1 |
| Denecke, T; Henkelmann, J; Henkelmann, R; Purz, S; Roth, A; Sabri, O; Zajonz, D | 1 |
| Jeong, SY; Kim, SJ; Lee, SW; Shim, SR | 1 |
| Adlouni, M; Ahmed, AI; Al-Mallah, MH; Alnabelsi, T; Chinnadurai, P; Rahimi, M | 1 |
| Kim, SJ; Shim, SR | 1 |
| Dasgupta, P; Ghose, A; Hayes, JDB; Kandala, A; Omorphos, NP; Sharma, A; Vasdev, N | 1 |
| Mesquita, CT; Rezende, MF | 1 |
| Hermans, JJ; Litjens, G; Prokop, M; van Geenen, EJM; van Laarhoven, CJHM | 1 |
| Bund, C; Chibbaro, S; Kremer, S; Lersy, F; Namer, IJ | 1 |
| Chen, Y; Li, S; Shao, X; Shi, G; Wang, J; Wang, Y; Wu, Z; Yang, M; Yang, X; Zhang, F; Zhang, S | 1 |
| Azevedo, EC; Baik, FM; Castillo, J; Chin, FT; Colevas, AD; Duan, H; Ferri, V; Freeman, L; Hom, M; Iagaru, A; Kaplan, MJ; Koran, ME; Lee, YJ; Martin, BA; Raymundo, RC; Rosenthal, EL; Shen, B; Valencia, A; van den Berg, NS; Zhou, Q | 1 |
| Amin, AA; Elahmadawy, MA; Heikal, SY; Shalash, AM; Youssef, AA | 1 |
| Liu, X; Lu, L; Ren, Y; Wang, J; Yang, X | 1 |
| Han, Y; Huang, L; Liu, J; Tian, X | 1 |
| de Andrés Gómez, A; Ferrer Rebolleda, J; Fuster Diana, CA; García García, JÁ; García-Vilanova Comas, A; Sánchez Jurado, R; Villalba Ferrer, F | 1 |
| Debruyn, E; Gilbert, FJ; Gleeson, FV; Harris, S; Qureshi, NR; Rintoul, RC; Weir-McCall, JR | 1 |
| Hanaoka, K; Ishii, K; Kaida, H; Kimura, Y; Kitajima, K; Nagaoka, T; Nemoto, M; Tanaka, A; Tsuchitani, T; Yamada, T | 1 |
| Afzal, Z; Ashcroft, J; Cheow, H; Davies, J; De Paepe, KN; Joshi, H; Meyer, J; Powar, M; Rooney, S; Simillis, C; Wheeler, J | 1 |
| Agrawal, A; Bedmutha, AS; Choudhury, S; Goel, M; Patkar, S; Purandare, NC; Puranik, AD; Ramadwar, M; Rangarajan, V; Shah, S | 1 |
| Pereira, M; Punatar, CB; Sagade, SN; Singh, N | 1 |
| Guo, H; Liu, S; Ma, S; Wang, L; Xu, S; Yao, S; Zhang, Z | 1 |
| Arnold, A; Hohmann, J; Weber, P | 1 |
| Dollinger, M; Habicher, W; Schicho, A; Schleder, S; Schreyer, AG; Stroszczynski, C; Strotzer, Q; Wendl, C | 1 |
| Chaushu, H; Even-Sapir, E; Gutfeld, O; Holan, A; Horowitz, G; Kampel, L; Muhanna, N; Nachalon, Y; Nard-Carmel, N; Oestraicher, Y; Ospovat, I; Oz, YN; Shapira, U; Ungar, O; Warshavsky, A | 1 |
| Chen, CY; Fan, W; Guo, ZX; He, Y; Li, A; Li, J; Lin, QG; Liu, ZQ; OuYang, PY; Peng, QH; Wu, YS; Xiao, SM; Xie, CM; Xie, FY; Xu, SK; Yang, SS; Yao, WY; Zhang, BY; Zhang, X | 1 |
| Artiko, V; Odalovic, S; Petrovic, J; Popovic, M; Rankovic, N; Sobic Saranovic, D; Stojiljkovic, M; Veljkovic, M | 1 |
| Adhaduk, M; Ashwath, M; Khalid, MU; Liu, K; Mansour, S; Paudel, B | 1 |
| Erdogan, ST; Flygare, L; Söderkvist, K | 1 |
| Albrecht-Beste, E; Aleksyniene, R; Andersen, FL; Fischer, BM; Korsholm, K; Vadstrup, ES | 1 |
| Ruan, D; Sun, L | 1 |
| Budde, RPJ; Caliskan, K; Damman, K; Glaudemans, AWJM; Manintveld, OC; Mecozzi, G; Sinha, B; Slart, RHJA; Ten Hove, D; Wahadat, AR; Witteveen, H; Wouthuyzen-Bakker, M | 1 |
| Chang, CW; Chang, WY; Chen, LY; Huang, YT; Huang, YY; Ou, YC; Peng, NJ; Tseng, NC | 1 |
| Arikan, AE; Capkinoglu, E; Dulgeroglu, O; Kara, H; Uras, C | 1 |
| Liang, Z; Liu, W; Mo, Y; Zeng, X; Zhang, C | 1 |
| Baumgartner, M; Breit, HC; Bremerich, J; Jaeger, PF; Maier-Hein, KH; Sauter, AW; Sommer, G; Stieltjes, B; Thaiss, W; Weikert, T; Winkel, DJ; Yang, S | 1 |
| Akkus Gunduz, P; Araz, M; Erden, GA; Kir, KM; Kucuk, NO; Kuru Oz, D; Ozkan, E; Soydal, C; Yavuz, Y | 1 |
| Baixeras, N; Pudis, M; Suárez-Piñera, M; Torró, CM; Vilariño, N | 1 |
| Cao, C; Chen, S; Chen, X; Fang, Y; Huang, S; Qiang, M; Tao, C; Wang, L; Xu, Y | 1 |
| Lei, Y; Li, X; Liu, J; Wan, Q; Xia, X; Xie, X; Zou, Q | 1 |
| Berends, AMA; Brouwers, AH; Kerstens, MN; Links, TP; Schaafsma, M | 1 |
| Kim, SJ; Ko, WS | 2 |
| Abougabal, AM; El-Noueam, K; Ettaby, A; Fadel, S; Soliman, H | 1 |
| Alpoim, T; Cristo Santos, J; Duarte, H; Henriques Abreu, M; Henriques Abreu, P; Próspero, I; Seoane Santos, M; Sousa, S | 1 |
| Chen, Y; Guo, L; Ren, Q; Shao, X; Xu, X | 1 |
| Chen, L; Li, J; Xiao, Y; Xie, R; Yang, C; Zha, Y | 1 |
| Coskun, G; Hasbek, Z; Karabacak, U; Karadayi, K; Mollaoglu, MC; Turkan, H | 1 |
| Bartolomei, M; Bianchini, C; Bonsembiante, A; Caracciolo, M; Carandina, I; Ciorba, A; Cittanti, C; Corazzi, V; Migliorelli, A; Ortolan, N; Panareo, S; Pelucchi, S; Uccelli, L; Urso, L | 1 |
| Atay, LO; Aydos, U; Cebeci, S; Duzlu, M; Pula, D; Yeniceri, A; Yilmaz, M | 1 |
| Groheux, D | 1 |
| Evangelista, L; Filippi, L; Schillaci, O; Urso, L | 1 |
| Au Yong, TK; Chan, TK; Chu, KS; Kung, BT; Lau, JHY; Li, WI | 1 |
| Guan, L; Li, X; Ma, Y; Mu, Y; Yang, Y; Zhang, J | 1 |
| Abbey, L; Abdelghany, TM; Abdellatif, MH; Abdelmohsen, UR; Abduljaleel Alzawar, NS; Abid, MF; Abu Kasim, AFB; Abu Saad, H; Adolpho, LF; Agostini, F; Agrizii, AP; Ahmed, S; Akce, M; Åkesson, D; Al-Awaadh, AM; Al-Mutar, DMK; Al-Odayni, AB; Al-Rajhi, AMH; Alaaeldin, R; Alam, M; Alam, MM; Alanazi, MA; Alattar, H; Alawlaqi, MM; Aldebis, HK; Algehainy, NA; Almeida, AA; Aloisi, F; Alrahlah, A; Alsenani, F; Alshabib, A; Altemani, FH; Althagafi, A; Amari, A; Andronesi, AG; Antonyuk, M; Arantes, TD; Araújo, R; Arrotti, S; Asakura, T; Asib, N; Atlaskin, AA; Aung, MS; Axiaq, A; Azekawa, S; Bacon, S; Bagalagel, A; Balbinot, GS; Barnet, LS; Baroyi, SAHM; Barreto, F; Barth, Y; Barysheva, AV; Bassa, E; Basu, R; Basu, S; Bates, C; Bautista, LS; Beitl, K; Beloti, MM; Benatti, G; Benavent-Celma, C; Bentaher, A; Bergsland, N; Bernardino, AF; Bernhardt, A; Bhandari, RK; Bhaskaran, K; Bhate, K; Bhattacharjee, A; Bian, X; Bien, EM; Birch, M; Bishara, K; Biswas, JP; Bleha, R; Bocale, R; Bona, S; Boriani, G; Bouyssi, A; Bradley, D; Bravo-Sánchez, MG; Bressan, GC; Brik, A; Brizuela, A; Brockbank, KGM; Buchner, F; Bunc, M; Buscombe, JR; Butler, AJ; Buzaleh, AM; Buzin, MI; Cabrera-Capetillo, CA; Calvo, AM; Camerota, A; Campagna, G; Campisi, M; Cano, K; Cao, HST; Cardellini, S; Carvalho, AP; Carvalho, BCR; Castillo-Baltazar, OS; Cataldo, P; Chai, P; Chakraborty, S; Chalo, DM; Chan, MY; Chander, S; Changbunjong, T; Chappuis, CJF; Chee, RCH; Chen, C; Chen, CJ; Chen, E; Chen, M; Chen, X; Chen, Y; Cheng, HT; Cheng, MC; Cheow, HK; Chi, Y; Chirikova, NK; Chiu, SH; Cho, G; Cho, HR; Cho, S; Cho, SJ; Choe, A; Choe, YH; Chun, BS; Chun, Z; Cinque, A; Ciopec, M; Cladas, Y; Cleary, SP; Clermont, O; Cléroux, M; Cockburn, J; Collares, FM; Colombini-Ishikiriama, BL; Conn, BN; Cortina, JL; Cox, DRA; Crini, G; Croker, R; Cursaru, DL; Curtis, HJ; da Silva, KJG; Dalla Costa, T; Davy, S; de Araújo, BV; de Cassia Ribeiro Gonçalves, R; de Gaetano, F; de Gregorio, C; de Oliveira, MG; De Vera, MAT; de Vos, M; de-la-Fuente, I; Dell'Oca, I; Delles, M; Déméautis, T; Dempster, M; Deng, YH; Denisenko, Y; Descombes, C; Desideri, G; Devarbhavi, H; Devouassoux, G; Di Bella, G; Di Marco, F; Diao, Y; Dias, BB; Dilgin, Y; Dimopoulou, I; Dionísio, TJ; Dobrovic, A; Dokin, ES; Dolby, T; Dong, X; Dong, Y; Dou, SX; Douglas, IJ; Dousset, S; Du, Z; Duan, M; Duan, SB; Duke-Williams, O; Duteanu, N; Dutertre, S; Dutta, S; Dwyer, MG; Ebenbauer, J; Eggo, RM; El-Mordy, FMA; Elbhnsawi, NA; Elrehany, MA; Elshewemi, SS; Elwakil, BH; Emadzadeh, D; Eraso, E; Ermolenko, E; Erten, K; Ettorre, E; Evans, D; Evans, SJ; Faheem, M; Fallanza, M; Faramarzi, M; Faria, FAC; Faro, DC; Fatma, YS; Fazil, S; Feng, Y; Ferguson, J; Fernandes, MH; Fernández-Domínguez, M; Ferrari, LAL; Ferraz, EP; Ferreira, LC; Ferri, C; Fikry, M; Floris, M; Forbes, H; Fotouh, B; Franke, K; Freitas, AC; Freitas, GP; Frieboes, HB; Fu, B; Fu, Y; Fukina, DG; Fukuda, DH; Fukunaga, K; Fulham, GJ; Furlan, L; Furtado Mesa, M; Furtunescu, FL; Gabbieri, D; Ganash, M; Gebers, JC; Gehman, V; Ghaedi, A; Ghazali, NSM; Ghebrekristos, Y; Gil, J; Gilbert, NM; Gimenes, R; Giordano, L; Glehen, O; Godeau, C; Goh, SK; Goldacre, B; Gomes, AM; Gomes, MPO; Gomes, PS; Gomes, RMODS; Gómez-Coma, L; Grenho, L; Gu, Q; Gu, T; Gu, YC; Guiducci, V; Guillemin, JP; Guo, W; Guo, YW; Gur, E; Guridi, A; Guzmán-López, A; Gvozdenko, T; H Elmaidomy, A; Hagar, M; Haider, S; Han, JM; Hanratty, J; Hans, R; Haque, N; Harharah, HN; Harharah, RH; Harper, S; Hasegawa, N; Hassanin, AH; Hastuti, YP; Hatem, AE; He, R; He, Y; Heinemann, C; Heinmaa, I; Heinzl, F; Helfer, VE; Hester, F; Hickman, G; Hill, MA; Hill, WG; Hintze, V; Ho, JSY; Ho, LY; Hoang, T; Holzer, I; Houbraken, J; Hsu, CN; Hu, J; Hu, X; Hu, Y; Hua, T; Huang, Z; Hulme, WJ; Hunter, A; Ianăşi, C; Ibañez, R; Iezzi, R; Iliuță, L; Im, YM; Imran, M; Inglesby, P; Inguimbert, N; Iqbal, A; Izawa, N; Jahaj, E; Jain, S; Jakimovski, D; Jalal, MM; Jaroszuk-Ściseł, J; Jasim, DJ; Jauregizar, N; Javle, MM; Jędryczka, M; Ji, H; Jiang, Y; Jin, J; Johnson, NT; Joshi, S; Jullok, N; Kachapulula, PW; Kaczmarek, J; Kaczmarek-Szczepańska, B; Kadota, K; Kaji, M; Kakeji, Y; Kakizoe, S; Kakudidi, E; Kalitukha, L; Kamata, H; Kang, YJ; Kapinos, AA; Karakaya, S; Kashchenko, NI; Kasyanov, S; Kataky, R; Katati, B; Kato, G; Katsina, AU; Kaya, A; Kaya, H; Kazarina, OV; Ke, Y; Keenan, C; Keilson, JM; Keshavan, A; Keskinidou, C; Khalifa, MA; Khan, R; Khan, S; Kim, D; Kim, K; Kim, MS; Kim, SM; Kim, WH; Kim, Y; Kim, YJ; Kishimura, H; Kitagawa, RR; Klemenkova, ZS; Kloss, F; Kobayashi, N; Kohlhoff, M; Kong, WKF; Konsek, H; Kornaros, M; Kotanidou, A; Kovacs, S; Kraska, J; Kruppke, B; Kumagai, Y; Kumar, S; Kumari, R; Kuruva, V; Kuster, RM; Kusumoto, T; Kutyła, M; Kwon, JH; Kwon, SH; Kwong, KY; Kyser, AJ; Lackner, M; Lass-Flörl, C; Lauri, C; Lavandera, JV; Lee, BH; Lee, ECY; Lee, HJ; Lee, J; Lee, PS; Lee, S; Lee, SE; Lee, SY; Lefort, F; Leite, JPV; Leo, G; Leonard, R; Leow, AST; Lepori, N; Leyden, K; Leys, L; Ležaić, L; Li, D; Li, H; Li, J; Li, S; Li, TYW; Li, X; Li, XH; Li, Y; Li, Z; Li, ZH; Liao, S; Liaqat, K; Lim, H; Lin, BS; Lin, MY; Lin, NH; Lin, X; Lin, Y; Liu, C; Liu, H; Liu, HK; Liu, HX; Liu, P; Liu, R; Liu, T; Liu, X; Liu, Y; Lock, GA; Lokaj, G; Lopes, HB; Losi, V; Lotsios, NS; Low, KE; Lu, Z; Luhana, S; Luo, X; Luo, XQ; Lutz, MB; Lysova, AA; Lyssenko, KA; Macit, M; MacIver, B; MacKenna, B; Magalhães, GAP; Magnavacchi, P; Mahadevan, J; Mahboubi, A; Maher, SA; Mahipal, A; Mahmoud, MY; Maithel, SK; Makhtar, MMZ; Makurat-Kasprolewicz, B; Malysheva, YB; Mansourizadeh, A; Marek, EJ; Maresca-Fichter, H; Martin, JT; Maslov, AA; Mastora, Z; Mastroiacovo, D; Mastropetros, SG; Matei, D; Mathur, R; Matos, AO; Matsuda, Y; Maurya, SK; Mayor, Á; Mayrhofer, D; Mazzuco, AC; McCaffrey, J; McClure, T; McDonald, HI; Mchunu, NP; McLaggan, D; Mehrkar, A; Meilik, B; Melito, VA; Mellem, J; Mengozzi, A; Menotti, J; Mesquita, V; Miao, Z; Mihai, S; Miller, S; Minassian, C; Mirabile, A; Mitra, S; Mladin, G; Mo, Z; Moawad, H; Mohamed, EM; Mohammed, TJ; Mohanlall, V; Mohyeldin, RH; Moldovan, H; Monneret, G; Monopoli, DE; Monte, IP; Monteiro, JRB; Morgante, V; Mori, M; Morin-Crini, N; Morita, A; Morton, CE; Mrak, M; Muhammed, AP; Mulick, A; Muralidharan, V; Murthy, P; Muselli, M; Mustafa, S; Mysore Visweswariah, A; Nagao, G; Naicker, S; Nakagawara, K; Namgoong, B; Namkoong, H; Namukobe, J; Nasir, AA; Nasreen, SA; Natarajan, P; Nchiozem-Ngnitedem, VA; Necozione, S; Negrea, A; Negrea, P; Ngubane, S; Nguyen, TT; Nicke, A; Nightingale, E; Nistor, CL; Nitsch, D; Njapau, H; Noman, M; Novgorodtseva, T; Nowak, A; O'Connor, SR; Ofoe, R; Oh, K; Oh, TH; Oki, E; Olama, ZA; Olennikov, DN; Oliveira, GM; Omar, D; Ong, SJ; Orfanos, SE; Origa-Oryem, H; Orita, H; Ortiz, I; Ota, M; Ott, J; Otvagina, KV; Pacheco, N; Pacheco, RR; Padmanabhan, D; Pagan, JD; Pagnotta, PA; Palangi, V; Palanisamy, G; Palanisamy, K; Palanisamy, S; Pan, SG; Panaitescu, E; Pang, X; Panoutsakopoulos, V; Parera, VE; Park, JI; Park, JS; Park, SW; Park, Y; Park, YS; Parkash, O; Parry, J; Parry, JP; Paul, SK; Pavšič, N; Pałubicka, A; Persat, F; Petriz-Prieto, MA; Petukhov, AN; Pham, T; Pillay, S; Poh, KK; Ponomarev, II; Pontons-Melo, JC; Posa, A; Powell, E; Priya, AK; Punekar, R; Puppin Rontani, RM; Purushottam, M; Pusphanathan, K; Qi, JY; Qin, J; Qin, Z; Qiu, B; Qiu, X; Quattrini, G; Quindós, G; Qureshi, F; Rabbany, MA; Rac-Albu, M; Rac-Albu, ME; Rădulescu, BC; Rafatullah, M; Rajab, TK; Rajna, S; Ramanathan, M; Rao, D; Raviglione, D; Razorenov, DY; Redd, MJ; Rehman, W; Reig, M; Rentsch, CT; Ribeiro, LMS; Robles, D; Rocchi, S; Rocha, FG; Rodrigues, C; Rodrigues, LA; Rodrigues, RP; Roh, GH; Ronowska, A; Root, A; Rosa, AL; Rossi, R; Roy, S; Roy, VC; Rupji, M; Saber, EA; Sadarat, F; Saed, Y; Saeed, WS; Saeki, H; Saha, B; Saiwichai, T; Sakowicz-Burkiewicz, M; Sampedro, T; Sands, K; Santos, CF; Sari, M; Sathi, FA; Sauro, S; Sazanova, TS; Scafa-Udriște, A; Schoustra, SE; Schultze, A; Seo, DJ; Sevillano, E; Sezmis, G; Sgura, FA; Shah, NNAK; Shani, N; Shankarappa, B; Sharkey, LM; Sharma, VK; Sharp, C; Shehata, N; Shelton, N; Shieh, PB; Shimokawa, M; Shin, J; Shin, SH; Shin, YN; Shin, YR; Shipilova, A; Shoparwe, NF; Shukor, H; Sia, CH; Siddiqui, MH; Siddiqui, MR; Siena, V; Signore, A; Silwane, B; Siqueira-Sandrin, VS; Siregar, A; Sirignano, P; Sit, NW; Skidmore, S; Skupov, KM; Smeeth, L; Smoczer, C; Smolyanskiy, E; Sohn, H; Solodeev, I; Solovyev, A; Şomoghi, R; Song, F; Song, H; Song, Z; Souf, YM; Sousa, SC; Souza, MT; Steinbach-Rankins, JM; Stockton, J; Stout, JR; Su, K; Su, MZ; Suarez-Lopez, YA; Sukkurd, R; Sultanov, R; Sun, Y; Sun, Z; Supernak, M; Supriyono, E; Suroshe, SS; Suvorov, SS; Svera M Ianăşi, P; Switchenko, JM; Syarif, NY; Synytsya, A; Taherzadeh, MJ; Tain, YL; Tamburino, C; Tammam, OY; Tan, BYQ; Tan, H; Tan, S; Tanaka, H; Tang, R; Tang, X; Tang, Z; Taurino, M; Tazare, J; Teresi, L; Testro, A; Thanasoponkul, W; Thangarasu, S; Thavaselvam, D; Theodoro, RC; Theron, G; Thomas, RH; Thomson, JJ; Tian, X; Tian, Y; Tomaszewski, CA; Tomlinson, LA; Torres, CMME; Tóth, M; Trecourt, A; Trevisani, F; Trimarchi, G; Tristán, C; Truong, VK; Tsigkou, K; Tsutsumi, S; Ubukata, Y; Uehara, H; Uwamino, Y; Vahedi-Shahandashti, R; Valberg, SJ; Valderrama, C; Valdovinos-García, EM; Valsecchi, D; van Diepeningen, AD; van West, P; Vargas-Osuna, E; Vassall, M; Vassilaki, N; Vassiliou, AG; Vecino, X; Velez-Irizarry, D; Venkatesh, YN; Vignali, L; Virdis, A; Viswanath, B; Voisin, AS; Volkova, YA; Vorotyntsev, AV; Vorotyntsev, IV; Vtyurina, ES; Vu, DH; Waldridge, B; Walker, AJ; Wallon, M; Wang, B; Wang, G; Wang, H; Wang, J; Wang, LJ; Wang, S; Wang, T; Wang, X; Wang, Z; Warren, RM; Warren-Gash, C; Wei, SH; Weinstock-Guttman, B; Wekwejt, M; Wessjohann, LA; Wiesmann, HP; Williams, ZJ; Williamson, EJ; Wilson, M; Wing, K; Wong, AY; Wong, BKL; Woodward, S; Wozniak, KL; Wu, C; Wu, K; Wu, S; Wu, Y; Xiang, D; Xie, H; Xiong, X; Xu, C; Xu, H; Xu, J; Xu, WH; Xu, Y; Xun, T; Yamaguchi, S; Yan, P; Yan, W; Yan, Z; Yang, B; Yang, F; Yang, L; Yao, XB; Yasui, H; Yenesew, A; Yeo, LLL; Yeo, TC; Yi, S; Yin, F; Yip, JWL; Yoon, SH; Yoon, SJ; Yoshida, M; Yoshizumi, T; Young, LA; Yu, C; Yu, DD; Yu, F; Yu, H; Yu, JD; Yu, NJ; Yu, X; Yuan, Y; Yurenko, A; Yusof, YA; Zahedipoor, A; Zahran, EM; Zainuddin, NI; Zanatta, AC; Zanotto, ED; Zanozin, ID; Zavascki, AP; Zenke, M; Zhang, F; Zhang, G; Zhang, H; Zhang, J; Zhang, L; Zhang, MX; Zhang, NY; Zhang, Q; Zhang, W; Zhang, X; Zhang, XM; Zhao, F; Zhao, Q; Zhao, R; Zhao, Y; Zheng, J; Zheng, S; Zhou, L; Zhou, X; Zhu, H; Zivadinov, R; Žižek, D; Zuccoli, JR; Zwaan, BJ | 1 |
| Chen, C; Guo, P; Li, X; Sun, Q; Wang, L; Zhang, Y | 1 |
| Aigner, C; Darwiche, K; Eberhard, W; Hautzel, H; Herrmann, K; Hockmann, J; Plönes, T; Stuschke, M | 1 |
| Ae, K; Ariga, A; Hayakawa, K; Kurosawa, N; Matsumoto, S; Minami, Y; Saito, M; Tanizawa, T; Terauchi, T; Yamashita, K | 1 |
| Alemán, C; Montoro, B; Persiva, O; Sánchez, L; Sansano, I; Simó, M; Vázquez, A | 1 |
| Fijuth, J; Foks, M; Gottwald, L; Kalita, K; Kosinska, M; Kuncman, L; Misiewicz, P | 1 |
| Gao, Y; Gauci, CM; Kim, TJ; Perera, DS | 1 |
| Kohan, A; Mesci, A; Metser, U; Mirshahvalad, SA; Murad, V; Ortega, C; Veit-Haibach, P | 1 |
| Dehner, LP; Frederickson, N; Hagedorn, KN; Lucas, JT; Mallinger, P; Messinger, YH; Mize, WA; Nelson, AT; Schultz, KAP; Shulkin, BL; Towbin, AJ | 1 |
| Beer, AJ; Beer, M; Böhm, F; Deininger, K; Hoffmann, TK; Lingl, JP; Schuler, PJ; Thaiss, W | 1 |
| Deng, Y; Wang, H; Xie, H; Zhang, W | 1 |
| Agrawal, A; Bakshi, G; Choudhury, S; Ghosh, S; Joshi, A; Maitre, P; Menon, S; Murthy, V; Norohna, V; Pal, M; Prabhash, K; Prakash, G; Purandare, N; Puranik, A; Rangarajan, V; Shah, S | 1 |
| Kuribayashi, A; Miura, M; Nakamura, S; Wamasing, N; Watanabe, H | 1 |
| Chen, KC; Chiu, YJ; Chu, PY; Li, CY; Wang, TH | 1 |
| Adhaduk, M; Ashwath, M; Delcour, K; Gebska, MA; Giudici, M; Liu, K; Paudel, B; Samuelson, RJ | 1 |
| Alt, V; Bundschuh, RA; Dierks, A; Lang, S; Lapa, C; Rischpler, C; Wassilew, G | 1 |
| Auernhammer, CJ; Bartenstein, P; Cyran, CC; Ebner, R; Fabritius, MP; Grawe, F; Hinterberger, A; Ingenerf, M; Knösel, T; Kunz, WG; Lohse, A; Mansournia, S; Ricke, J; Rübenthaler, J; Schmid-Tannwald, C; Schnitzer, ML; Sheikh, GT; Soltani, V; Spitzweg, C; Winkelmann, M | 1 |
| Battistella, P; Kucharczak, F; Mariano-Goulart, D; Paunet, T; Sagnes, J | 1 |
| Bhalla, D; Jana, M; Kandasamy, D | 1 |
| Aziz, A; Bhosale, P; Frumovitz, M; Gonzales, NR; Jhingran, A; Morani, AC; Ramalingam, P; Salvo, G; Sun, J | 1 |
| Abbas, LA; Haidar, H; Hajeer, S; Majzoub, RE | 1 |
| Rasheed, N; Razi, M | 1 |
| Avsar, G; Bayar, S; Cetindag, Ö; Deryol, R; Eroglu, A; Ertekin, SÇ; Hakseven, M; Karasoy, D | 1 |
| Asel, C; Bauer, B; Gabriel, M; Poier-Fabian, N; Rubicz, N; Zwittag, P | 1 |
| Benz, DC; Buechel, RR; Fuchs, TA; Gaemperli, O; Giannopoulos, AA; Gräni, C; Grossmann, M; Kaufmann, PA; Markendorf, S; Messerli, M; Patriki, D; Pazhenkottil, AP | 1 |
| Kleiner, S; Weber, W | 1 |
| Aschwanden, M; Berger, CT; Daikeler, T; Imfeld, S; Rottenburger, C; Schegk, E; Staub, D | 1 |
| Chapiro, J; Pucar, D; Saperstein, L; Savic, LJ; Schobert, I | 1 |
| Wan, DQ | 1 |
| Amitai, A; Baruch, Y; Bernstine, H; Cohen, N; Domachevsky, L; Frenkel Rutenberg, T; Ohana, N; Shemesh, S | 1 |
| Arunsingh, M; Dyker, KE; Prestwich, RJD; Scarsbrook, AF; Vaidyanathan, S; Zhong, J | 1 |
| Amitay-Laish, I; Bairey, O; Barzilai, A; Even-Sapir, E; Feinmesser, M; Feuerman, H; Hodak, E; Mimouni, D; Snast, I | 1 |
| Harlos, C; MacCrostie, P; Mason, W; Metser, U; Poon, R | 1 |
| Jiang, B; Shi, H; Teng, X; Wang, S; Yang, F | 1 |
| Chien, KL; Huang, CK; Huang, JY; Ruan, SY | 1 |
| Cheng, SH; Hou, B; Hu, Y; Huo, L; Jin, ZY; Liu, D; Xing, H; Xue, HD | 1 |
| Kim, BS; Kim, D; Lee, WJ; Woo, SH; Yoon, HJ | 1 |
| Agrawal, A; Choudhury, S; Mittal, N; Mohite, A; Purandare, N; Puranik, A; Rangarajan, V; Shah, S | 1 |
| Albano, D; Bertagna, F; Giubbini, R; Mattia, B | 1 |
| Fan, YZ; Rao, MH; Xiong, YL; Yan, QB; Yuan, GB; Zheng, CX | 1 |
| Budak, E; Yanarateş, A | 1 |
| Amaro, E; Felício, AC; Ferrari, BL; Gamarra, LF; Lacerda, SS; Mamani, JB; Neto, GCC; Nucci, MP | 1 |
| Lijun, Z; Xiao-Xue, W; Xinyue, H | 1 |
| Nagai, T; Nagoshi, T; Tanaka, TD; Yoshimura, M | 1 |
| Jiang, Y; Li, L; Li, M; Wu, W; Zhang, P | 1 |
| Nayak, GK; Shepherd, TM | 1 |
| Gormsen, LC; Hansen, IT; Hauge, EM; Keller, KK; Nielsen, BD; Therkildsen, P | 1 |
| Brauer, T; Hoberück, S; Hoffmann, RT; Kotzerke, J; Platzek, I; Winzer, R; Zöphel, K | 1 |
| Bassett, R; Bhosale, P; Devine, C; Ganeshan, D; Kuchana, V; Virarkar, M | 1 |
| Calderoni, L; Castellucci, P; Fanti, S; Telo, S; Vichi, S; Zagni, F | 1 |
| Abu-Hijleh, HA; Abualruz, A; Aldahamsheh, OO; Thalib, L; Younis, MH | 1 |
| Alsayed, Y; Edesa, W; Hussein, M; Kandeel, AA; Younis, J; Zidan, L | 1 |
| Alavi, A; Bassetti, M; Cadeo, B; Carnelutti, A; Di Gregorio, F; Melchioretto, G; Merelli, M; Muser, D; Righi, E | 1 |
| Aikata, H; Akagi, M; Awai, K; Chayama, K; Fujino, H; Hiramatsu, A; Imamura, M; Kawaoka, T; Kobayashi, T; Kodama, K; Morio, K; Murakami, E; Nakahara, T; Nakamura, Y; Namba, M; Ohdan, H; Ohya, K; Tsuge, M; Uchikawa, S; Yamauchi, M | 1 |
| Gajjala, SR; Hulikal, N; Kadiyala, S; Kalawat, T; Kottu, R | 1 |
| Büyükşimşek, M; Güney, İB; Kolsuz, İ; Mirili, C; Oğul, A; Paydaş, S; Tohumcuoğlu, M; Yetişir, AE | 1 |
| Braren, R; Heid, I; Hörl, M; Kaissis, GA; Lohöfer, FK; Munoz-Alvarez, KA; Paprottka, P; Rummeny, EJ; Schwaiger, M; Steiger, K; Weichert, W | 1 |
| Casali, M; Cecchin, D; Evangelista, L; Fraia, AS; Giraudo, C; Lupi, A; Quaia, E | 1 |
| Jeavons, S; Law, P; McGill, G; Miles, KA; Ngai, S; O'Mahoney, E; Oh, G; Yu, C | 1 |
| Corneli, M; Daquarti, GJ; Gobbo, MY; Grymberg, L; Masoli, OH; Meretta, AH; Nacinovich, F; Pérez Baliño, N; Ronderos, R; Rosa, D | 1 |
| Fei, J; Guo, C; Niu, L; Wang, D; Zhang, J; Zheng, D | 1 |
| Chankowsky, J; Hirsh, V; Khokhar, RA; Kovacina, B; McDougall, CC; Nair, JKR; Probst, S; Raidu, BVS; Sabri, A; Saeed, UA; Taylor, J; Van Kempen, LC | 1 |
| Kim, SJ; Lee, JS | 1 |
| Altmayer, S; Basso Dias, A; de Souza Santos, F; Henz Concatto, N; Hochhegger, B; Hoefel Paes, J; Machado Medeiros, T; Mattiello, R; Mohammed, TL; Verma, N; Watte, G; Zanon, M | 1 |
| Budiawan, H; Hutomo, F; Mulyanto, ID; Yudistiro, R | 1 |
| Gormsen, LC; Nielsen, BD | 1 |
| Betrains, A; Blockmans, D | 1 |
| Brodersen, JB; Hess, S | 1 |
| Basu, S; Kalshetty, A | 1 |
| Hess, S | 1 |
| Scholtens, AM | 1 |
| Kwee, RM; Kwee, TC | 2 |
| Al Najafi, M; Dey, AK; Mehta, NN; Reddy, AS; Uceda, DE | 1 |
| Kircher, M; Lapa, C | 1 |
| Alavi, A; Bisson, G; Chandra Khangembam, B; Deogaonkar, V; Kumar, R; Seraj, SM; Vangu, MD | 1 |
| Altun, E; Basch, EM; Bjurlin, MA; Chen, RC; David, GU; Deal, AM; Eulitt, PJ; Godley, PA; Kim, WY; Lee, JK; Lin, W; Milowsky, MI; Nielsen, ME; Pruthi, RS; Ramirez, J; Rathmell, WK; Rose, TL; Sheikh, A; Smith, AB; Wallen, EM; Whang, YE; Wong, TZ; Woods, ME | 1 |
| Chen, Y; Fu, Z; Ge, B; Li, M; Li, Y; Que, R; Tao, Z | 1 |
| Andreu-Arasa, VC; Fujima, N; Meibom, SK; Mercier, GA; Sakai, O; Truong, MT | 1 |
| Evangelista, L; Fiordoro, S; Mansi, L; Porcaro, F; Sicignano, M; Spadafora, M | 1 |
| Dalci, K; Guney, IB; Kucuker, KA; Teke, ZT | 1 |
| Guney, IB; Kucuker, KA; Teke, Z; Yalav, O | 1 |
| Li, J; Pang, X; Song, F; Wei, Z; Zhang, X; Zhou, H | 1 |
| Du, G; Fu, Z; Liu, L; Xue, M | 1 |
| Hu, B; Hu, T; Li, Y; Teng, L; Yao, Z; Zhang, Z; Zhao, Y | 1 |
| Aggarwal, A; Goel, S; Gupta, M; Iqbal, A; Rao, A; Singh, S | 1 |
| Anagnostopoulos, A; Burger, IA; Eberhard, N; Hasse, B; Huellner, MW; Husmann, L; Kaelin, MB; Kudura, K; Ledergerber, B; Mestres, CA; Rancic, Z | 1 |
| Baynosa, J; Cheng, D; De Guzman, MD; Doyle, GM; Jones, MS; Kirgan, D; McNicoll, CF; Rivera, MR; St Hill, CR | 1 |
| Kim, DH; Kim, SJ | 1 |
| Atun, R; Hricak, H; Scott, AM; Vargas, HA; Ward, ZJ; Woo, S | 1 |
| Artiko, VM; Beatovic, S; Grozdic Milojevic, I; Nikitovic, M; Paripovic, L; Saponjski, J; Saranovic, D; Sobic Saranovic, DP | 1 |
| Buck, A; Delso, G; Huellner, M; Kaushik, S; Kemp, B; Sekine, T; Ter Voert, EEGW; Veit-Haibach, P; Warnock, G; Wiesinger, F | 1 |
| Huo, L; Wang, X | 1 |
| Boura, J; LeRose, CC; Ramirez, CA | 1 |
| Alexiou, G; Argyropoulou, MI; Naka, C; Tsili, AC | 1 |
| Birchall, J; Breik, O; Jones, K; Kumar, A; Laugharne, D; Mortimore, S | 1 |
| Andreu-Arasa, VC; Fujima, N; Meibom, SK; Mercier, GA; Sakai, O; Salama, AR; Truong, MT | 1 |
| Akatli, A; Akyol, H; Asik, M; Balci, TA; Comak, A; Elmali, F; Kekilli, E; Koroglu, R; Kuslu, D; Simsek, FS; Ulutas, H; Yalcin, NC | 1 |
| Cheon, GJ; Choi, SH; Hwang, I; Kang, KM; Kim, JH; Lee, EK; Lee, JY; Pak, K; Park, J; Ryoo, I; Sohn, CH; Yoo, RE; Yun, TJ | 1 |
| Wu, Q; Xie, X; Zhong, L | 1 |
| He, H; Lu, RC; She, B; Shi, H; Wang, SB; Xie, R; Xv, DD; Yang, ZH | 1 |
| Earls, P; Emmett, L; Gallagher, R; Ho, B; Lee, J; Matthews, T; Tang, R | 1 |
| Liu, Y; Luo, H; Zhang, J; Zhang, X | 1 |
| Borra, RJH; Damman, K; Gheysens, O; Glaudemans, AWJM; Mecozzi, G; Postma, DF; Sinha, B; Slart, RHJA; Ten Hove, D; Treglia, G; van Geel, PP; Wouthuyzen-Bakker, M | 1 |
| Aslanidi, IP; Firsova, MV; Mendeleeva, LP; Mukhortova, OV; Savchenko, VG; Solovev, MV | 1 |
| El Ghannudi, S; Imperiale, A; Martinez, M; Ohlmann, P; Poindron, V; Schindler, TH | 1 |
| Ahmed, G; El Semary, SF; Kenaai, NE; Nagy, N; Omar, W; Rahman, HA; Zaky, I | 1 |
| Bendifallah, S; Body, G; Bricou, A; Collinet, P; Delvallée, J; Huchon, C; Lavoue, V; Ouldamer, L; Rossard, L; Touboul, C | 1 |
| Donswijk, ML; Einerhand, SMH; Hendricksen, K; Mertens, LS; van der Poel, HG; van Gennep, EJ; van Rhijn, BWG | 1 |
| Andersen, TL; Dahlsgaard-Wallenius, SE; Gerke, O; Hildebrandt, MG; Høilund-Carlsen, PF; Johansen, A; Morsing, A; Petersen, H; Vilstrup, MH | 1 |
| Ambrosini, V; Calabrò, D; Telo, S | 1 |
| Iagaru, A; Moradi, F | 1 |
| Calais, J; Mona, CE | 1 |
| Beckers, M; Le Gal, G; Le Roux, PY; Lecumberri, R; Robin, P; Rondina, M; Salaun, PY; van Es, N | 1 |
| Abe, H; Aikou, S; Fukayama, M; Jinbo, K; Kawasaki, K; Koyama, K; Momose, T; Mori, K; Nishida, M; Nomura, S; Okumura, Y; Onoyama, H; Seto, Y; Takahashi, M; Urabe, M; Ushiku, T; Yagi, K; Yamashita, H; Yoshimura, S | 1 |
| Ae, R; Hamaguchi, T; Harada, M; Iwasaki, Y; Mizusawa, H; Murai, H; Murayama, S; Nakamura, Y; Sakai, K; Sanjo, N; Satoh, K; Takao, M; Tsukamoto, T; Yamada, M | 1 |
| Huang, X; Li, J; Xiong, Y; Yang, J | 1 |
| Asenov, YN; Dineva, SE; Grudeva, VV; Hadzhiyska, VH; Ilcheva, MG; Mladenov, KB; Nikolova, PN; Veneva, S | 1 |
| Kim, HW; Lee, HE; Lee, S; Oh, K; Yoo, SK; Yun, M | 1 |
| Akdemir, ÜÖ; Ataş, N; Avanoğlu Güler, A; Karadeniz, H; Taner, ME | 1 |
| Henkelmann, J; Heyde, CE; Spiegl, UJA; Voelker, A; von der Hoeh, N | 1 |
| Bille, C; Braad, PE; Christensen, IY; Ewertz, M; Gerke, O; Hildebrandt, MG; Jensen, JD; Jylling, AMB; Larsen, LB; Søe, KL; Vogsen, M | 1 |
| Endoh, H; Ichikawa, A; Nishizawa, N; Oriuchi, N; Satoh, Y; Shiozawa, S; Yamamoto, R | 1 |
| Choyke, P; Dew, A; Hill, E; Kazandjian, D; Lindenberg, L; Mena, E; Morrison, C | 1 |
| Kamiya, T; Murakami, S; Naka, S; Shimamoto, H; Watabe, T | 1 |
| Baba, S; Hiwatashi, A; Iihara, K; Ishimatsu, K; Iwaki, T; Kamei, R; Kikuchi, K; Kikuchi, Y; Kitamura, Y; Momosaka, D; Mukae, N; Nakayama, T; Sagiyama, K; Suzuki, SO; Togao, O; Yamashita, K | 1 |
| Aggarwal, A; Durga, G; Goel, S; Gupta, M; Gupta, N; Iqbal, SA; Singh, S; Talwar, V | 1 |
| Bassett, RL; Le, VT; Whitman, GJ; Wong, FC | 1 |
| Kim, K; Kim, SJ | 3 |
| Abecasis, N; Brandão, F; Cabral, F; Casaca, R; Cruz, A; Fonseca, R; Monteiro, C; Pedro, C; Pinto, I; Ramos, P; Ratão, P; Salgado, L | 1 |
| Abdelhafez, YG; Badawi, RD; Nardo, L; Spencer, BA | 1 |
| Baker, SL; Boxer, A; DeCarli, C; Edwards, L; Gorno-Tempini, M; Grinberg, LT; Hepker, M; Huang, E; Hwang, JL; Iaccarino, L; Jagust, WJ; Janabi, M; La Joie, R; Lesman-Segev, OH; Lobach, I; Miller, BL; Olichney, J; Pham, J; Rabinovici, GD; Rosen, HJ; Seeley, WW; Seo, SW; Spina, S | 1 |
| Cheon, M; Choi, JY; Hyun, SH; Kim, BT; Lee, KH; Park, YJ; Um, SW; Won, HH; Yoo, J; Zo, JI | 1 |
| Flavell, RR; Ha, PK; Strohl, MP; Yom, SS | 1 |
| Herscovitch, P | 1 |
| Han, J; Li, F; Li, X; Li, Y; Qu, L | 1 |
| Atkins, A; Betzer, O; Motiei, M; Popovtzer, A; Popovtzer, R; Rahimipour, S; Sadan, T; Tzror-Azankot, C | 1 |
| Danilenko, VV; Kmetyuk, YV; Solodyannikova, OI; Sukach, GG | 1 |
| Feng, Z; Jiang, L; Li, P; Shao, H; Shi, X; Wang, X | 1 |
| Li, W; Meng, Z; Yin, L | 1 |
| Bai, Y; El Fakhri, G; Fu, F; Gao, Y; Li, X; Shao, F; Wang, M; Wang, Z; Wei, W; Wu, Y; Xu, J; Zhang, W | 1 |
| Dieng, M; Einstein, AJ; Emmett, L; Khanna, N; Lord, SJ; Menzies, AM; Morton, RL; Nguyen, M; Nieweg, OE; Nijhuis, AAG; Saw, RPM; Thompson, JF; Turner, RM; Zeng, J | 1 |
| Arpin, L; Beaudoin, JF; Bouchard, J; Cadorette, J; Fontaine, R; Gaudin, É; Koua, K; Lecomte, R; Leroux, JD; Paillé, M; Paulin, C; Pepin, CM; Thibaudeau, C; Toussaint, M; Viscogliosi, N | 1 |
| Biondetti, P; Canamaque, LG; Catalano, OA; Digumarthy, SR; Furtado, FS; Groshar, D; Lahoud, RM; Mahmood, U; Rosen, BR; Shepard, JO; Umutlu, L; Vangel, MG; Zhang, EW | 1 |
| Song, BI | 1 |
| Han, S; Kim, TH; Kim, YI; Ryu, JS; Woo, S | 1 |
| Chen, B; Gao, S; Ji, B; Liu, D; Wang, X; Zhang, H | 1 |
| Alberts, I; Ashar-Oromieh, A; Bohn, KP; Mingels, C; Prenosil, G; Rominger, A; Sachpekidis, C; Shi, K; Viscione, M | 1 |
| Agrawal, A; Jiwnani, S; Karimundackal, G; Kumar, R; Mathew, B; Prabhash, K; Prakash Agarwal, J; Pramesh, CS; Purandare, NC; Puranik, A; Rangarajan, V; Shah, S; Tandon, S | 1 |
| Al-Yousef, A; Arakelyan, VS; Aslanidis, IP; Belov, YV; Ekaeva, IV; Garmanov, SV; Golukhova, EZ; Kosenkov, AN; Mironenko, VA; Mukhortova, OV; Popov, DA; Pursanova, DM; Shurupova, IV; Vinokurov, IA | 1 |
| Aune, G; Hagen, B; Nordskar, NJ; Ogarkov, A; Salvesen, Ø; Vesterfjell, EV | 1 |
| Demirbas, S; Korkmaz, C; Vatansev, H | 1 |
| Datta-Gupta, S; Garg, P; Kumar, R; Sharma, A; Sharma, R | 1 |
| Aryal, A; Gamanagatti, S; Khan, SA; Kumar, VS; Shamim, SA | 1 |
| Caforio, ALP; Grabowski, M; Kobylecka, M; Królicki, L; Maksimović, R; Marcolongo, R; Opolski, G; Ozierański, K; Ristić, AD; Seferović, PM; Šobić-Šaranović, D; Tymińska, A | 1 |
| Arihiro, K; Emi, A; Kadoya, T; Kimura, Y; Masumoto, N; Okada, M; Sasada, S | 1 |
| Broglie, MA; Hüllner, MW; Morand, GB; Rupp, NJ; Stadler, TM | 1 |
| Agrawal, K; Panda, RA; Parida, GK | 1 |
| Aras, O; Sayman, HB | 1 |
| Cao, C; Chen, X; Hu, Q; Hua, Y; Huang, S; Jiang, F; Jin, Q; Jin, T; Piao, Y; Xu, Y | 1 |
| Girgin, RB; Gungor, S | 1 |
| Ma, C; Xu, BX; Yu, BX; Zhang, WH | 1 |
| Amorim, BJ; Bernstine, H; Blaszkowsky, LS; Canamaque, LG; Caravan, P; Catalano, OA; Catana, C; Domachevsky, L; Ferrone, CR; Groshar, D; Ken, H; Mahmood, U; O'Shea, A; Parente, CA; Salvatore, M; Soricelli, A; Umutlu, L; Zhang, C | 1 |
| Bo, X; Chen, L; Liu, G; Liu, H; Pang, L; Shi, H; Wang, C; Wang, J; Wang, Y; Yu, H | 1 |
| Dierckx, RAJO; Glaudemans, AWJM; Kwee, TC; Londema, M; Nijsten, MWN; Pijl, JP; Pillay, J; Slart, RHJA; van der Voort, PHJ | 1 |
| Adlerstein L, I; Barahona Z, D; Faure R, MI | 1 |
| Karsten, E; Laurent, R; Little, CB; Nguyen, K; Sammel, AM; Smith, S; Xue, M | 1 |
| Bekers, EM; Donswijk, ML; Lahaye, MJ; Mertens, LS; Stokkel, LE; Stokkel, MPM; van Rhijn, BWG | 1 |
| Bley, TA; Brands, RC; Brumberg, J; Buck, AK; Dierks, A; Hartmann, S; Haug, L; Herterich, T; Kertels, O; Kübler, AC; Lapa, C; Linz, C; Müller-Richter, U | 1 |
| Feng, W; Gao, Y; Lei, JQ; Lu, XR; Qu, MM; Zhai, YN | 1 |
| Gupta, T; Kannan, S; Manjali, JJ; Purandare, N; Rangarajan, V | 1 |
| Amthauer, H; Bluemel, S; Böhmer, D; Frost, N; Furth, C; Michaels, L; Neudecker, J; Ochsenreither, S; Penzkofer, T; Rogasch, JMM; Rückert, JC; Temmesfeld-Wollbrück, B; von Laffert, M | 1 |
| Chae, YS; Jeong, SY; Jung, JH; Kim, HJ; Kim, WH; Kim, WW; Lee, J; Lee, RK; Lee, SJ; Lee, SW; Park, CS; Park, HY; Park, JY | 1 |
| Aher, PY; Graham, MM; Maheshwarappa, RP; Mishra, P; Ora, M; Priya, S; Soni, N | 1 |
| Guenette, JP | 1 |
| De Spiegeleer, B; Juanito, G; Lawal, I; Maes, A; Sathekge, M; Van de Wiele, C; Vander, BK | 1 |
| Castiñeira-Mourenza, JA; Martínez-Pías, E; Prieto-González, AJ; Rodríguez-Osorio, X | 1 |
| Hamada, K; Hashimoto, K; Honda, M; Kawamura, H; Nakayama, Y; Saginoya, T; Takada, T; Takano, Y; Todate, Y; Yamaguchi, H | 1 |
| Cohen, D; Even-Sapir, E; Hazut Krauthammer, S; Levine, C | 1 |
| Kojima, I; Kouketsu, A; Kumamoto, H; Miyashita, H; Mori, S; Murata, T; Nagai, H; Nogami, S; Sakamoto, M; Takahashi, T; Yamauchi, K | 1 |
| Mahmoodi, Z; Salarzaei, M; Sheikh, M | 1 |
| Chen, B; Gao, F; Li, C; Li, Z; Shi, L; Sun, W; Wang, P | 1 |
| Choi, YY; Kim, TY; Lee, JY; Lee, YJ; Park, DW; Tae, K | 1 |
| Agazzi, GM; Albano, D; Bertagna, F; Bosio, P; Farina, D; Giubbini, R; Grammatica, A; Lancini, D; Maroldi, R; Nicolai, P; Piazza, C; Ravanelli, M; Squassina, G; Zigliani, A | 1 |
| Blum, S; Fritzmann, J; Hoberück, S; Hoffmann, RT; Kotzerke, J; Kühn, JP; Laniado, M; Michler, E; Nebelung, H; Platzek, I; Plodeck, V; Radosa, CG; Streitzig, J; Weitz, J; Zöphel, K | 1 |
| Avramovic, N; Dell'aquila, AM; Kokalova, A; Martens, S; Sindermann, JR; Wenning, C | 1 |
| Barkhof, F; Croon, PM; Danfors, T; Egger, K; Fällmar, D; Haller, S; Kellner, E; Kilander, L; Larsson, EM; Lilja, J; Ossenkoppele, R; Tolboom, N; van Berckel, BNM; Verfaillie, SCJ | 1 |
| Han, YJ; Li, HS; Li, YC; Mohammed Shah Alam, MS; Ren, YY; Wang, QS; Wang, Z; Wu, HB; Zhou, WL | 1 |
| Barton, H; Charles-Edwards, E; Chevassut, T; Dizdarevic, S; Teagle, AR | 1 |
| Dhawan, V; Eidelberg, D; Grmek, M; Jensterle, L; Ma, Y; Peng, S; Pirtošek, Z; Tomše, P; Trošt, M; Zaletel, K | 1 |
| Antunovic, L; Castiglioni, I; Chiti, A; Gallivanone, F; Kirienko, M; Leonardi, L; Sollini, M; Testanera, G; Veronesi, G; Voulaz, E | 1 |
| Jin, G; Li, Y; Su, D | 1 |
| Bremicker, K; Exner, M; Höhn, AK; Meyer, HJ; Purz, S; Schob, S; Stumpp, P; Surov, A | 1 |
| Choi, EK; Kang, BJ; Kim, SH; O, JH; Park, SY; Yoo, IR | 1 |
| Ansquer, C; Archange, C; Baumstarck, K; Brunaud, L; Guerin, C; Haissaguerre, M; Hindié, E; Houzard, C; Huglo, D; Lifante, JC; Loundou, A; Mirallié, E; Olivier, P; Pattou, F; Sebag, F; Tabarin, A; Taïeb, D | 1 |
| Agrawal, A; Engineer, R; Guruchannabasavaiah, B; Ostwal, V; Rangarajan, V; Saklani, A; Vallam, KC | 1 |
| Aubier, M; Borie, R; Crestani, B; Debray, MP; Dieudonné, A; Justet, A; Laurent-Bellue, A; Lebtahi, R; Thabut, G | 1 |
| Habu, M; Joujima, T; Kawanabe, N; Kito, S; Kito-Shingaki, A; Kodama, M; Koga, H; Kokuryo, S; Matsumoto-Takeda, S; Miyamoto, I; Morimoto, Y; Nishimura, S; Oda, M; Osawa, K; Sasaguri, M; Tanaka, T; Uehara, M; Wakasugi-Sato, N; Yamamoto, N; Yoshiga, D | 1 |
| Kuang, A; Ma, H; Pang, F; Ren, P; Shen, G | 1 |
| Castelijns, JA; de Bree, R; de Graaf, P; de Jong, MC; Hoekstra, OS; Jagesar, VA; Noij, DP | 1 |
| Avramovic, N; Dell'Aquila, AM; Milankovic, D; Sindermann, JR; Vrachimis, A; Weckesser, M; Wenning, C | 1 |
| Farahani, ZA; Hess, S; Tind, S; Vestergaard, S | 1 |
| Bang, YJ; Cheon, GJ; Ha, S; Kim, TY; Kim, WH; Kwon, HW; Oh, DY; Park, S | 1 |
| Baghel, V; Bal, C; Bansal, A; Kumar, P; Tripathi, M | 1 |
| Kim, J; Kim, SE; Lee, JS; Lee, WW; Song, YS | 1 |
| Honda, H; Hong, S; Kamei, R; Kawanami, S; Matsumoto, Y; Sagiyama, K; Watanabe, Y | 1 |
| Aydin, S | 1 |
| Higashi, K; Ishigaki, Y; Nakamura, Y; Oguchi, M; Shimasaki, M; Takegami, T; Ueda, Y; Watanabe, N | 1 |
| Beiderwellen, K; Deuschl, C; Forsting, M; Grüneisen, J; Herrmann, K; Heusch, P; Kirchner, J; Lauenstein, TC; Sawicki, LM; Umutlu, L | 1 |
| An, MS; Bae, KB; Baik, H; Hong, KH; Kim, KH; Lee, SM; Oh, MK; Seo, SH | 1 |
| Bhasin, DK; Das, A; Gupta, R; Mittal, BR; Nada, R; Rana, SS; Santhosh, S | 1 |
| Cakmakcilar, A; Ciftci, E; Erturk, SA; Turgut, B | 1 |
| Hadžihasanović, B; Kristić, S; Vegar Zubović, S | 1 |
| Abouzied, ME; AlQahtani, M; Alsugair, A; Aras, O; Demirkaya, O | 1 |
| An, YS; Han, SU; Lee, D; Lee, JH; Lee, KM; Lee, SJ; Park, S; Yoon, JK | 1 |
| Kan, Y; Wang, W; Yang, J; Yuan, L | 1 |
| Chang, YC; Chen, JS; Chen, SH; Chen, TC; Chou, WC; Hsieh, CH; Hsu, JT; Hwang, TL; Tseng, JH; Yeh, CN; Yeh, TS; Yen, TC | 1 |
| Sabour, S | 1 |
| Baldassari, MP; Barbosa, EM; Connolly, C; Delikatny, EJ; Deshpande, C; Drebin, J; Dunbar, A; Keating, J; Kucharczuk, JC; Kularatne, SA; Low, P; Mizelle, J; Newton, AD; Okusanya, O; Predina, JD; Singhal, S; Xia, L | 1 |
| Frary, EC; Gerke, O; Hess, S; Laustrup, H | 1 |
| Bell, C; Bjerggaard Jensen, J; Bouchelouche, K; Høyer, S; Ipsen, P; Vind-Kezunovic, S | 1 |
| Falcoz, PE; Filosso, PL; Guerrera, F; Massard, G; Nigra, V; Oliaro, A; Renaud, S; Ruffini, E; Santelmo, N; Schaeffer, M; Solidoro, P | 1 |
| Argon, AM; Avci, NC; Yararbas, U; Yeniay, L | 1 |
| Chen, J; Geng, Q; Hou, Q; Huang, W; Liu, Y; Luo, J; Nie, Z; Xie, N; Yang, F; Zhou, Y | 1 |
| Carp, L; Helsen, N; Roothans, D; Stroobants, S; Van Den Heuvel, B; Van den Weyngaert, D; Van den Wyngaert, T | 1 |
| Ai, L; Chen, Q; Dai, J; Fan, D; Jiang, T; Lin, S; Qiao, Z; Wang, K; Zhao, X | 1 |
| Macbeth, F; Treasure, T | 1 |
| Kishida, Y; Koyama, H; Miyazaki, M; Ohno, Y; Seki, S; Yoshikawa, T; Yui, M | 1 |
| Fujino, K; Kaneda, H; Kimura, M; Kusunoki, S; Ota, T; Takeda, S; Terao, Y; Ujihira, T | 1 |
| Chen, M; Chen, S; Harmon, S; Jeraj, R; Li, X; Li, Y; Perk, T | 1 |
| Carp, L; De Bree, R; Debruyne, PR; Hakim, S; Helsen, N; Hoekstra, OS; Hutsebaut, I; Lenssen, O; Maes, ALM; Martens, MJ; Meersschout, SAE; Stroobants, S; Van den Weyngaert, D; Van den Wyngaert, T; van Dinther, J; Van Laer, CG; Vermorken, JB | 1 |
| Bukawa, H; Hasegawa, S; Ishibashi-Kanno, N; Uchida, F; Yamagata, K; Yanagawa, T | 1 |
| Marcus, C; Subramaniam, RM | 1 |
| Balachandran, A; Bhosale, P; Katz, M; Rayamajhi, S; Reddy, A; Rohren, E | 1 |
| Inui, Y; Ito, K; Kato, T | 1 |
| Buda, A; Crivellaro, C; De Ponti, E; Di Martino, G; Elisei, F; Guerra, L; Guglielmo, P; La Manna, M; Landoni, C; Magni, S | 1 |
| Bisdas, S; Rice, L | 1 |
| Ahonen, AA; Hippeläinen, ET; Loimaala, AJ; Schildt, JV | 1 |
| Gao, D; Guan, Z; Huang, F; Jin, J; Li, K; Luo, G; Wang, X; Wang, Y; Yang, C; Zhang, J; Zhao, Y; Zhao, Z; Zhu, J | 1 |
| Laustrup, H; Lund-Petersen, A; Voss, A | 1 |
| Pipitone, NAM; Salvarani, C; Versari, A | 1 |
| Ajmal, S; Baddour, LM; Chareonthaitawee, P; Farid, S; Kendi, AT; Mahmood, M; O'Horo, JC; Sohail, MR | 1 |
| Dai, Q; Jiang, YX; Jin, XN; Li, F; Li, JC; Sun, Q; Wang, HY; Xu, Y; Zhu, QL; Zhu, ZH | 1 |
| Betancourt Cuellar, SL; Carter, BW; Correa, AM; Hofstetter, WL; Marom, EM; Palacio, DP; Wu, CC | 1 |
| Aschwanden, M; Berger, CT; Daikeler, T; Imfeld, S; Juengling, F; Kyburz, D; Recher, M; Rottenburger, C; Schegk, E; Staub, D | 1 |
| Abe, O; Hayashi, N; Maeda, E; Naganawa, S; Yasaka, K; Yoshikawa, T | 1 |
| Ahlman, MA; Alehashemi, S; Bagheri, AA; Bluemke, DA; Civelek, AC; Cupps, TR; Grayson, PC; Kaplan, MJ; Malayeri, AA; Merkel, PA; Novakovich, E | 1 |
| Anazodo, UC; Finger, E; Günther, M; Kwan, BYM; Pavlosky, W; Prato, FS; St Lawrence, KS; Thiessen, JD; Warrington, JC | 1 |
| Atri, M; Bandos, AI; Gee, MS; Gold, MA; Lee, SI; Mannel, RS | 1 |
| Henderson, RD; Ioannides, ZA; Kubler, P; Langguth, D; Thomas, P | 1 |
| Horai, Y; Ichinose, K; Igawa, T; Kawakami, A; Kurushima, S; Nakamura, H | 1 |
| Bai, HX; Cao, Y; Deng, L; Farwell, MD; Li, H; States, LJ; Sun, J; Tao, Y; Xiao, B; Yang, L; Zhang, P | 1 |
| Basher, RK; Gorla, AKR; Kakkar, N; Mittal, BR; Sen, RK; Sood, A; Vadi, SK | 1 |
| Davidson, DJ; Elojeimy, S; Favinger, JL; Ha, AS; Hippe, DS; Lindberg, AW; Roth, ES | 1 |
| Achmad, A; Bhattarai, A; Heryanto, YD; Higuchi, T; Tsushima, Y; Yudistiro, R | 1 |
| Briganti, A; Castellucci, P; Colicchia, M; Evangelista, L; Fallanca, F; Fanti, S; Ficarra, V; Gallina, A; Incerti, E; Karnes, JR; Lowe, V; Moschini, M; Panareo, S; Picchio, M; Rambaldi, I; Schiavina, R; Zattoni, F | 1 |
| Barnes, A; Booth, HL; Elliott, PM; Garrett, E; Groves, AM; Menezes, LJ; Mohiddin, SA; Patel, RS; Pavlou, M; Porter, JC; Sekhri, N; Wicks, EC | 1 |
| Bektasoglu, HK; Erdogan, EB; Ersoy, YE; Gucin, Z; Guzel, M; Kadioglu, H; Malya, FU; Yildiz, S; Yucel, S | 1 |
| Lederman, HM; Luisi, FAV; Puchnick, A; Regacini, R | 1 |
| Gohda, Y; Hotta, M; Minamimoto, R; Shuno, Y; Yano, H | 1 |
| Dong, W; Jiao, J; Li, J; Li, Q; Mi, H; Song, X | 1 |
| Brousset, P; Franchet, C; Hitzel, A; Martin-Blondel, G; Péricart, S | 1 |
| Chen, S; Fu, H; He, K; Ma, C; Wang, H; Wang, S | 1 |
| Ballarini, T; Caminiti, SP; Cerami, C; Fallanca, F; Gianolli, L; Iannaccone, S; Magnani, G; Perani, D; Presotto, L; Sala, A; Santangelo, R; Vanoli, EG | 1 |
| Ahmed, R; Carter Snead, O; Drake, JM; Go, C; Rubinger, L; Rutka, JT; Widjaja, E | 1 |
| Estall, V; Hruby, G; Kumar, M; Macfarlane, D; Poulsen, M; Pullar, A; Rischin, D; Tripcony, L; Veness, M | 1 |
| Anikin, V; Bush, A; De Sousa, P; Devaraj, A; Granato, F; Haqzad, Y; Iyer, S; Jordan, S; Kostoulas, N; Lim, E; Loubani, M; Love, SM; Marchbank, A; Papagiannopoulos, K; Proli, C; Scarci, M; Sellitri, F; Shackcloth, M | 1 |
| Ben Bouallègue, F; Mariano-Goulart, D; Payoux, P | 1 |
| Azevedo, DC; Bredella, MA; Gill, CM; Martinez-Salazar, EL; Oliveira, AL; Torriani, M | 1 |
| Alberici, A; Borroni, B; Padovani, A; Paghera, B; Paola Caminiti, S; Perani, D; Pilotto, A; Premi, E; Presotto, L; Turrone, R | 1 |
| Choi, H; Jin, KH | 1 |
| Chu, CT; Fan, H; Fu, HL; Li, WH; Ren, G; Wang, TT; Wu, XR | 1 |
| Aguloglu, N; Altindag, S; Can, C; Karaoglan, H; Kepenek, F; Komek, H; Morcali, H | 1 |
| Carnero-Alcázar, M; Carreras, JL; Fernández-Pérez, C; García-Arribas, D; Maroto, L; Olmos, C; Ortega Candil, A; Pérez Castejón, MJ; Pérez-García, CN; Rodríguez Rey, C; Vilacosta, I; Vivas, D | 1 |
| Carp, L; Helsen, N; Stroobants, S; Van den Wyngaert, T | 1 |
| Chondrogiannis, S; Marzola, MC; Rubello, D | 1 |
| Bhosale, PR; Devine, C; Faria, S; Javadi, S; Korivi, BR; Viswanathan, C | 1 |
| Grigsby, PW; Rao, YJ | 1 |
| Alpaugh, RK; Doss, M; Yu, JQ | 1 |
| Chan, SC; Chang, JT; Chang, KP; Fan, KH; Hsu, CL; Huang, BS; Liao, CT; Lin, CY; Ng, SH; Wang, HM; Yeh, CH; Yen, TC; Yen-Ming, T | 1 |
| Dou, KF; Fang, W; Feng, L; He, ZX; Lu, MJ; Wang, J; Wang, L; Yang, MF; Zhao, SH | 1 |
| Alavi, A; Emamzadehfard, S; Gholami, S; Paydary, K; Seraj, SM; Shamchi, SP; Werner, TJ; Zadeh, MZ | 1 |
| Aheer, D; Arora, G; Biswas, A; Garg, A; Hazari, PP; Kumar, R; Mishra, AK; Sharma, A; Sharma, P | 1 |
| Kwak, K; Lee, JM; Park, G; Yun, HJ | 1 |
| Katsuura, T; Kitajima, K; Kurahashi, Y; Odawara, S; Shinohara, H; Yamakado, K | 1 |
| Hatabu, H; Kauczor, HU; Ohno, Y; Seo, JB; van Beek, EJR | 1 |
| Hata, K; Ishihara, S; Kawai, K; Kiyomatsu, T; Morikawa, T; Nozawa, H; Tanaka, T; Watanabe, T | 1 |
| Cuocolo, A; Diomiaiuti, TC; Duro, G; Giugliano, G; Imbriaco, M; Nappi, C; Nicolai, E; Pisani, A; Ponsiglione, A; Riccio, E; Spinelli, L; Trimarco, B | 1 |
| Han, N; Hassan Bakari, K; Lan, X; Qin, C; Sun, X; Wu, Z; Zhang, Y | 1 |
| Babudieri, S; Bagella, P; Fiore, V; Galassi, S; Madeddu, G; Nuvoli, S; Solinas, P; Spanu, A | 1 |
| Alexander, GE; Bauer, RJ; Caselli, RJ; Chen, K; Chen, Y; Lee, W; Locke, DEC; Reiman, EM; Savage, CR; Sharieff, S; Stonnington, CM; Thiyyagura, P | 1 |
| Andreo, F; Centeno, C; López de Castro, P; Martínez-Barenys, C; Mendiluce, L; Ruiz-Manzano, J; Sanz-Santos, J; Serra, P; Torky, M | 1 |
| Balachandar, R; Beg, MF; Ding, GW; Lu, D; Popuri, K | 1 |
| Aguiar, PT; Castro, ACG; Fagundes, TC; Machado, AM; Mafra, A; Mamede, M; P Junior, E; Silva, JA; Silva, LC; Silva, RG | 1 |
| Ohmichi, M; Sasaki, S; Tanaka, T; Terai, Y; Tsuchihashi, H; Yamada, T; Yamamoto, K | 1 |
| Raijmakers, PG; Temmerman, OPP; Verberne, SJ; Vuong, BH | 1 |
| An, H; Chang, C; Chiu, K; Lee, EYP | 1 |
| Altomare, D; Boccardi, M; Festari, C; Frisoni, GB; Gandolfo, F; Nobili, F; Orini, S | 1 |
| Shi, Y; You, J | 1 |
| Duan, D; Jing, X; Li, H; Li, S; Pang, H; You, J | 1 |
| Agosta, F; Altomare, D; Arbizu, J; Boccardi, M; Bouwman, F; Drzezga, A; Festari, C; Nestor, P; Nobili, F; Orini, S; Van Laere, K; Walker, Z | 1 |
| Amanavicius, N; Bharadwaz, A; Kramer, S; Larsen, LP; Morre Pedersen, E; Schlander, S; Sivesgaard, K; Sørensen, M; Tønner Nielsen, D; Viborg Mortensen, F | 1 |
| Abdollahi, A; Adeberg, S; Afshar-Oromieh, A; Bendszus, M; Bougatf, N; Debus, C; Debus, J; Floca, R; Haberkorn, U; Heiland, S; Knoll, M; Rieken, S; Waltenberger, M; Wick, W | 1 |
| Bauerfeind, P; Eshmuminov, D; Lehmann, K; Rordorf, T; Samaras, P; Schneider, PM; Veit-Haibach, P; Vetter, D; Weber, A | 1 |
| Cho, YS; Kim, BT; Lee, KH; Moon, SH; Park, JM; Park, SB; Sun, JM | 1 |
| Baek, S; Han, YM; Kim, ES; Moon, JY; Seo, YL; Yoon, DY; Yun, EJ | 1 |
| Guan, Z; Zhang, X | 1 |
| Jimenez-Hoyuela, JM; Lojo-Ramirez, JA; Martin-Marcuartu, JJ; Pachón-Garrudo, VM | 1 |
| Palmerini, E; Rimondi, E; Staals, EL | 1 |
| Ha, HK; Kim, SJ; Koo, PJ | 1 |
| Asanuma, K; Hagi, T; Matsubara, T; Nakamura, T; Sudo, A; Sugino, Y | 1 |
| Fang, Y; Liu, T; Ma, PQ; Sun, C; Xu, LB; Xu, SF; Yu, SJ; Zhang, WJ; Zhang, XX; Zhao, ZG | 1 |
| Døssing, H; Godballe, C; Lange, NGE; Nguyen, TT; Nielsen, AL; Rohde, M; Thomassen, A | 1 |
| Argemi, X; Bund, C; Herbrecht, R; Imperiale, A; Kessler, R; Leroy-Freschini, B; Treglia, G | 1 |
| Agosta, F; Arbizu, J; Boccardi, M; Bouwman, F; Drzezga, A; Nestor, P; Nobili, F; Walker, Z | 1 |
| Kina, S; Miura, K; Nagano, N; Nagasaka, S; Sato, T; Sugiyama, H; Takeda, Y; Tsujimoto, Y | 1 |
| Cao, Y; Geng, H; Li, K; Shen, M; Zheng, L | 1 |
| Abe, K; Aiba, H; Hayashi, K; Higuchi, T; Igarashi, K; Ikeda, H; Inatani, H; Miwa, S; Mochizuki, T; Shirai, T; Takeuchi, A; Taniguchi, Y; Tsuchiya, H; Yamamoto, N | 1 |
| Dika, E; Diodato, S; Fanti, S; Gardini, A; Lambertini, M; Patrizi, A; Ravaioli, GM; Veronesi, G; Zannetti, G | 1 |
| Balaji, P; Froelich, J; Gencturk, M; Gupta, S; Jha, G; Konety, BR; Soubra, A | 1 |
| Armand, M; Corcia, P; Delage-Corre, M; Duchesne, M; Gachard, N; Jaccard, A; Magy, L; Maisonobe, T; Richard, L; Rizzo, D; Roussellet, O; Vallat, JM; Viala, K | 1 |
| Chua, W; Dan, YY; Goh, Y; Jagmohan, P; Lee, JK; Thian, YL | 1 |
| Hao, CY; Li, ZW; Liu, DN; Wang, HY; Zhao, M; Zhao, W | 1 |
| Bogsrud, TV; Ejlersen, JA; Gormsen, LC; Hansen, IT; Haraldsen, A; Hauge, EM; Hjorthaug, K; Keller, KK; Kramer, S; Nielsen, BD; Stolle, LB; Therkildsen, P | 1 |
| Hou, S; Jia, Q; Lin, X; Meng, Z; Shen, Y; Tan, J; Wang, S | 1 |
| Emoto, S; Hata, K; Hojo, D; Kaneko, M; Kawai, K; Momose, T; Murono, K; Nishikawa, T; Nozawa, H; Otani, K; Sasaki, K; Takahashi, M; Tanaka, T | 1 |
| Chang, SK; Jeong, Y; Jung, IH; Kim, JS; Lee, SW | 1 |
| Fowler, KJ; Fraum, TJ; Hope, TA; Ludwig, DR | 1 |
| Ahn, BC; Jeong, SY; Kim, SJ; Lee, J; Lee, SW; Seo, Y | 1 |
| Chen, L; Guo, J; Liu, X; Wang, Q; Yang, X; Yin, Y | 1 |
| Kim, SJ; Son, GM | 1 |
| Dhawan, V; Eidelberg, D; Ma, Y; Peng, S; Pirtošek, Z; Tomše, P; Trošt, M; Zaletel, K | 1 |
| Li, Q; Li, Y; Liao, S; Liao, X; Liu, Z; Wei, C; Wei, J; Zhong, J | 1 |
| Borel Rinkes, IH; Daamen, LA; Goense, L; Groot, VP; Intven, MPW; Molenaar, IQ; van Santvoort, HC; Wessels, FJ | 1 |
| Chung, JH; Kim, S; Lee, SH; Pahk, K; Yi, E | 1 |
| Amlal, S; Bahloul, A; Marie, PY; Perrin, M; Verger, A | 1 |
| Bonyadlou, S; Brunette, LL; Groshen, S; Ji, L; Lin, YG; Matsuo, K; Mehta, A; Roman, LD; Shuster, D; Sposto, R | 1 |
| Feng, Z; Qi, F; Tan, H; Wang, J; Zhang, R; Zhang, Y | 1 |
| Kan, Y; Liu, J; Wang, W; Wang, Z; Yang, J | 1 |
| Han, S; Lee, JJ; Suh, CH; Woo, S | 1 |
| Byun, BH; Cho, WH; Kim, BI; Koh, JS; Kong, CB; Lee, I; Lim, I; Lim, SM; Song, WS | 1 |
| Barré, L; Fillesoye, F; Gourand, F; Guillouet, S; Hovhannisyan, N; Ibazizene, M; Plancoulaine, B; Toutain, J; Valable, S | 1 |
| Bignardi, S; Comelli, A; Ippolito, M; Petrucci, G; Russo, G; Sabini, MG; Stefano, A; Yezzi, A | 1 |
| Abayaweera, G; Abou-Taleb, HA; AbouElhassan, KM; AbouTaleb, HA; Adair, LS; Adams, E; Addison, O; Addy, I; Akhtar, N; Alten, B; Anesini, J; Añez, R; Angaridis, PA; Aouba, A; Arakawa, K; Aumeeruddy-Elalfi, Z; Bao, LP; Basu, E; Bayraktar, E; Bekkelund, CS; Bell, J; Beraldo, H; Bermúdez, V; Betenbaugh, MJ; Bhattacharya, R; Bienvenu, B; Bolzoni, M; Bootz, F; Borja, JB; Bove, DG; Bowden, ME; Bradsher, C; Brockstedt, D; Brothers, RM; Buschauer, A; Calandriello, L; Caporossi, A; Carba, DB; Carratalà, J; Castella, B; Caviezel, D; Ceccato, R; Charalambidis, G; Charisiadis, A; Chattopadhyay, P; Chen, Q; Chen, W; Chen, Y; Chen, YT; Chen, ZJ; Chen, ZY; Cheng, MA; Cheng, ZB; Cherevko, S; Cheung, IY; Cheung, NV; Chiappini, A; Chiu, YL; Choi, IG; Chough, S; Chung, CY; Cobb, A; Colotto, A; Continentino, MA; Cook, AJMC; Costa, F; Coutsolelos, AG; Cuperus, N; Curtis, BM; Davenport, AJ; de Boysson, H; Dela, F; Deng, XP; Deshayes, S; Dhara, K; Dietrich, D; Dietrich, J; Dilhari, A; Ding, R; Ding, Y; Dirè, S; Dohlmann, TL; Dotsenko, A; Doubrovina, E; Du, K; Du, ZJ; Duvic, M; Eastman, A; Eliakim-Raz, N; Elz, S; Emile, JF; Emmerling, C; Engelhard, MH; Eriksson, JG; Etzold, BJM; Faini, AC; Falsini, B; Farmer, E; Fei, JJ; Ferreira, IP; Föttinger, K; Franconieri, F; Fryda, NJ; Fuentes, I; Galateau-Sallé, F; Ganguly, M; Gani, BA; Gao, X; Gao, XF; Gao, XJ; García-Mendiola, T; Garg, A; Gascon, J; Gayani, B; Gevensleben, H; Gilbert, M; Giudiceandrea, A; Giuliani, N; Gocmen, AY; Goldman, DA; Goltz, D; Gombert, AK; Gomila, A; Goodwin, P; Górnicki, K; Gostin, PF; Graterol, M; Gremillet, C; Grier, S; Grün, AL; Gusakov, A; Halldórsdóttir, HR; Han, L; Han, Z; Hävecker, M; Helge, JW; Heo, K; Hernández, JD; Hindsø, M; Holmen Olofsson, G; Hong, CE; Hong, J; Horenstein, AL; Hosenally, M; Hruz, P; Hsu, HL; Hsu, KC; Hu, SF; Hu, Y; Huang, K; Huang, S; Huang, WH; Humaira, A; Hung, CF; Hung, WS; Huo, XK; Huvinen, E; Idorn, M; Ignatyev, K; Im, WT; Ismaël, IS; Jakobsson, JG; Janaszek-Mańkowska, M; Jeong, GT; Ji, L; Ji, X; Jiang, Y; Jo, IH; Jo, SH; Johnson, AC; Johnson, LE; Kadirvelu, K; Kahnt, A; Kaleta, A; Kamiya, T; Kang, DH; Kang, XH; Kashiwagi, T; Katayama, E; Kawachi, N; Keller, M; Kellermann, L; Khan, T; Khan, ZA; Kharshoum, RM; Khim, JS; Kikuchi, M; Kim, BS; Kim, DS; Kim, DW; Kim, JH; Kim, JJ; Kim, JU; Kim, SK; Kim, WS; Kimura, J; Kiss, C; Knop-Gericke, A; Kobayashi, S; Koivusalo, SB; Kolar, E; Kottegoda, N; Kramer, K; Kristiansen, G; Kruger, AA; Kumar, S; Kumar, V; Kumarage, S; Kursungoz, C; Kushner, BH; Kuwahara, F; Kuzawa, C; Kwon, BO; Landsberg, J; Larsen, S; Lauer, P; Le Luduec, JB; Lee, DW; Lee, H; Lee, HY; Lee, JW; Lee, MJ; Lee, SW; Lefrançois, P; Leibovici, L; Leong, KK; Leong, M; Li, B; Li, D; Li, G; Li, J; Li, YZ; Liang, JH; Liang, X; Liens, A; Ligorio, G; Lin, JD; Lindholm, MG; Liou, MJ; List-Kratochvil, EJW; Litvinov, IV; Liu, F; Liu, S; Liu, Y; Liu, Z; Lohar, S; Lopes, MTP; Lorenzo, E; Lu, X; Lukashuk, L; Lukens, WL; Luo, HR; Luo, L; Luttik, MAH; Ma, Y; MacGowan, A; Mahomoodally, MF; Maissen, S; Malavasi, F; Malhotra, M; Mallik, S; Manna, D; Mans, R; Marangoni, D; Marimpietri, D; Marques, F; Marques, WL; Marsaa, K; Martin Silva, N; Martinez, A; Martínez, MS; Massaia, M; Mayrhofer, KJJ; McDade, T; McNeel, DG; Met, Ö; Micalizio, GC; Modak, S; Morandi, F; Moreau, L; Morla, S; Morrell, AP; Morris, S; Mubarak, Z; Muchlisin, ZA; Munoz, M; Nagao, Y; Nakama, T; Nakamura, H; Nakano, T; Nardi, MV; Nasirian, A; Nelson, MD; Netchiporouk, E; Ni, X; Niess, JH; Nijenhuis, JM; Nikolaou, V; O'Connor, BJ; O'Reilly, RJ; Odobel, F; Ohata, C; Ohyama, B; Olivar, LC; Ordoñez, MG; Ostrovnaya, I; Palmar, J; Panda, S; Pandiyarajan, S; Park, B; Park, H; Park, JH; Park, S; Pasquali, L; Patik, JC; Pearce, CI; Peele, ME; Peng, S; Perera, IC; Petty, JT; Pidko, EA; Pinheiro, CB; Pistoia, V; Pita, M; Planchat, A; Plass, F; Pockes, S; Pradhan, N; Premasudha, P; Pronk, JT; Provost, N; Pujol, M; Qi, P; Qiu, J; Qiu, Z; Quan, J; Quaranta, A; Ra, CH; Rameshan, R; Ranglack, DH; Rausch-Fan, X; Rieger, E; Rivas, JR; Roberts, SS; Rocha, WR; Rodrigues, GLS; Rojas, J; Roy, P; Rozhkova, A; Rufo, S; Rupprechter, G; Saeui, CT; Saha, A; Sakai, M; Salazar, J; Salem, HF; Salgarello, T; Samarakoon, SR; Sandau, C; Sandbeck, DJS; Santos, AF; Santos, VG; Sara, Y; Saslow, SA; Sasseville, D; Sato, S; Sauer, JD; Schlögl, R; Schweiger, MJ; Shashkov, I; Shaw, E; Shen, WQ; Shim, J; Shu, J; Singh, C; Sinha Babu, SP; Sinitsyn, A; Sinitsyna, O; Skadborg, SK; Song, Q; Song, W; Stach-Lempinen, B; Stoddart, M; Stoica, M; Street, SR; Sukwong, P; Sun, CP; Sun, J; Sunwoo, IY; Suresh, S; Szécsényi, Á; Takahashi, T; Takeda, S; Tang, D; Tas, ST; Tebé, C; Teixeira, LR; Teixidor, F; Terrier, B; Teschner, D; Tetzlaff, MT; Theisen, E; Thor Straten, P; Tiitinen, A; Timpel, M; Toccoli, T; Torikai, K; Torres, W; Toscani, D; Trad, S; Tsai, HJ; Tseng, CP; Tucker, WJ; Um, W; Vallejo-Torres, L; van den Broek, M; Van den Heuvel, L; van der Woude, LN; van Maris, AJA; Van Schepdael, A; Vank, C; Verucchi, R; Vigo, JM; Viñas, C; Vogt, TJ; Vuong, C; Wai, H; Wang, B; Wang, D; Wang, H; Wang, JJ; Wang, K; Wang, L; Wang, Q; Wang, YR; Watanabe, S; Watters, AK; Weerasekera, MM; Wei, L; Wheeler, DA; Wiegand, I; Wifling, D; Wijesinghe, GK; Winiczenko, R; Wolker, T; Wu, J; Wu, TC; Wu, YY; Xie, P; Xie, YP; Xu, A; Xu, E; Xu, L; Xu, Z; Yamaguchi, M; Yang, A; Yang, G; Yang, J; Yang, TM; Yang, W; Yang, Y; Yarema, KJ; Yesiltepe, M; Yi, KJ; Yigit, N; Yim, UH; Yin, B; Yu, S; Zengin, G; Zhang, B; Zhang, C; Zhang, GR; Zhang, H; Zhang, J; Zhang, L; Zhang, TY; Zhang, X; Zhang, Y; Zhang, YX; Zhao, H; Zhao, JC; Zhao, Z; Zheng, R; Zhou, W; Zorn Morales, N | 1 |
| Dai, YY; Guan, F; Sa, R; Zhao, HG | 1 |
| Ohmichi, M; Tanaka, T; Terai, Y; Yamada, T; Yamamoto, K | 1 |
| Cui, B; Fan, X; Lu, J; Ma, J; Shang, K; Wang, J; Yang, H; Zhao, G; Zhou, Y | 1 |
| Ando, T; Ichimura, S; Kaneshiro, T; Kiko, T; Kunii, H; Masuda, A; Takeishi, Y; Takenoshita, S; Takizawa, S; Yokokawa, T | 1 |
| Antoniou, GA; Antoniou, SA; Ioannou, CV; Kontopodis, N; Rojoa, D | 1 |
| Abele, J; Biron, V; Cooper, T; Harris, J; Isaac, A; O' Connell, DA; Puttagunta, L; Seikaly, H; Sivarajah, S; Zhang, H | 1 |
| Araki, K; Arima, K; Baba, H; Harimoto, N; Kuwano, H; Shirabe, K; Tetsuya, H; Watanabe, A; Yamashita, Y; Yoshizumi, T | 1 |
| Bagetakos, I; Becker, M; Botsikas, D; Boudabbous, S; Da Cunha Afonso Barisits, AC; Kalovidouri, A; Lam, GT; Mainta, I; Montet, X; Picarra, M | 1 |
| Kao, CH; Lin, CL; Lin, CY | 1 |
| Hoogendam, JP; Roze, JF; Scholten, RJ; Spijker, R; van de Wetering, FT; Veldhuis, WB; Verleye, L; Vlayen, J; Zweemer, RP | 1 |
| Caicedo-Granados, E; Cayci, Z; Gencturk, M; Li, F; Ozturk, K | 1 |
| Bagir, GS; Ertorer, ME; Haydardedeoglu, FE; Kocer, E; Reyhan, M; Torun, N | 1 |
| Alessi, S; Bellomi, M; Colleoni, MA; Iorfida, M; Petralia, G; Pricolo, P; Ruju, F; Zugni, F | 1 |
| de Bree, R; Hoekstra, OS; Pruim, J; van der Laan, BFAM; van der Putten, L; van Dijk, BAC; Wedman, J | 1 |
| Boxer, AL; Cho, H; Choi, JY; Gorno-Tempini, ML; Hansson, O; Janelidze, S; Jögi, J; Kramer, J; La Joie, R; Lyoo, CH; Mattsson, N; Miller, BL; Ohlsson, T; Ossenkoppele, R; Palmqvist, S; Rabinovici, GD; Ryu, YH; Santillo, A; Schöll, M; Smith, R; Strandberg, O; Tsai, R | 1 |
| Aikawa, T; Hayashi, S; Hirata, K; Koyanagawa, K; Magota, K; Manabe, O; Naya, M; Ohira, H; Oyama-Manabe, N; Tamaki, N; Tomiyama, Y; Tsujino, I; Yoshinaga, K | 1 |
| Kang, KW; Kim, I; Koh, Y; Lee, JM; Paeng, JC; Woo, GU; Yoon, SS; Youk, J | 1 |
| Bokemeyer, C; Fisch, M; Hartmann, M; Klutmann, S; Meyer, CP; Oechsle, K; Oing, C; Schriefer, P | 1 |
| Hartzes, AM; Morgan, CJ | 1 |
| Gupta, V; Irrinki, S; Kalra, N; Mittal, BR; Sakaray, YR; Vaiphei, K; Vishnu, KS; Yadav, TD | 1 |
| Aboian, MS; Behr, SC; Copeland, TP; Ding, Y; Flavell, RR; Franc, BL; Hadley, D; Harnish, R; Hawkins, RA; Hernandez Pampaloni, M; Huang, SY; Jenkins, NW; Kawczynski, MG; Lituiev, D; Mari Aparici, C; Nardo, L; Seo, Y; Sohn, JH; Trivedi, H; Zalocusky, KA | 1 |
| Anagnostopoulos, A; Burger, IA; Hasse, B; Huellner, MW; Husmann, L; Ledergerber, B; Rancic, Z; Sah, BR; Stolzmann, P | 1 |
| Guo, Q; Li, B; Sun, H; Wang, X; Zhang, S | 1 |
| Connor, S; Cook, GJ; Dunn, J; Guerrero-Urbano, T; Jeannon, JP; Lei, M; Oakley, R; Pencharz, D; Siddiqui, A; Sriskandan, N; Szyszko, TA; Thavaraj, S | 1 |
| Hirata, K; Iyama, Y; Kidoh, M; Nagayama, Y; Nakagawa, M; Nakaura, T; Namimoto, T; Oda, S; Sakamoto, F; Shiraishi, S; Yamashita, Y | 1 |
| Altmayer, S; Basso Dias, A; Garcez, A; Henz Concatto, N; Hochhegger, B; Irion, K; Marchiori, E; Medeiros, T; Mohammed, TL; Sartori Pacini, G; Verma, N; Watte, G; Zanon, M | 1 |
| Dankbaar, JW; de Boer, M; de Bree, R; de Keizer, B; Peltenburg, B; Philippens, MEP; Terhaard, CHJ; Willems, SM | 1 |
| Fu, L; Li, W; Tian, X | 1 |
| Anemona, L; Buonomo, OC; Caredda, E; Chiaravalloti, A; Marchese, PV; Orsaria, P; Palombi, L; Petrella, G; Portarena, I; Schillaci, O; Titka, B | 1 |
| Cai, X; Dong, J; Huang, T; Li, F; Liu, F; Ma, Y; Xiong, F; Yan, Z; Zhang, Q | 1 |
| Glaudemans, AWJM; Kwee, TC; Pijl, JP; Slart, RHJA; Wouthuyzen-Bakker, M; Yakar, D | 1 |
| Dong, C; Jiang, Y; Lü, X; Wang, Y; Xiao, Z; Xu, P | 1 |
| Kuwabara, H; Tateishi, U; Toda, K; Toriihara, A; Yoshimura, R; Yuasa-Nakagawa, K | 1 |
| Huber, GF; Huellner, MW; Meerwein, CM; Morand, GB; Pizzuto, DA; Stolzmann, P; Vital, D | 1 |
| Cortés-Romera, M; Cos-Domingo, M; Gámez Cenzano, C; Moreno-Llorente, P; Pérez-Maraver, M; Reynés-Llompart, G; Rodríguez-Bel, L; Rossi-Seoane, S; Sabaté-Llobera, A; Vercher Conejero, JL | 1 |
| Goh, BKP; Koh, YX; Srinivasan, N | 1 |
| Gou, B; Liu, G; Liu, J; Liu, X; Wang, Y; You, L; Zhu, X | 1 |
| Kim, K; Kim, SJ; Pak, K | 1 |
| Bang, HY; Chung, HW; Kim, JH; Lee, EJ; Lee, SY; Park, HS; Shim, CS; So, Y; Sung, IK | 1 |
| Belkhir, R; Besson, FL; Blanc, E; Henry, J; Keraen, J; Leguern, V; Mariette, X; Meyer, C; Nocturne, G; Seror, R | 1 |
| Bernard, A; Brown, E; Foote, M; Gandhi, M; Liu, HY; Lock, G; McGrath, M; Milne, R; Panizza, BJ; Porceddu, SV | 1 |
| Calvo, A; Canosa, A; Cerami, C; Chiò, A; Cistaro, A; Fallanca, F; Fania, P; Iaccarino, L; Pagani, M; Pagnini, C; Perani, D; Sala, A; Vanoli, EG | 1 |
| Iino, T; Sato, T; Sato, W; Seki, K; Watanabe, H | 1 |
| Janjigian, YY; Mondaca, S | 1 |
| Anderl-Straub, S; Beer, A; Danek, A; Diehl-Schmid, J; Drzezga, A; Edbauer, D; Fassbender, K; Fliessbach, K; Förstl, H; Goldhardt, O; Grimmer, T; Kornhuber, J; Krause, BJ; Landwehrmeyer, GB; Lauer, M; Levin, J; Licata, A; Ludolph, AC; Lyros, E; Otto, M; Prudlo, J; Schroeter, ML; Spottke, A; Volk, A; Yakushew, I | 1 |
| Aubard, Y; Ceuca, A; Deluche, E; Gauthier, T; Lacorre, A; Legros, M; Margueritte, F; Mbou, VB; Monteil, J; Sallee, C; Tardieu, A | 1 |
| Bom, HS; Cho, SG; Kang, SR; Kim, J; Kwon, SY; Min, JJ; Song, HC; Yoo, SW | 1 |
| Al-Mamgani, A; de Ridder, M; Gouw, ZAR; Hamming-Vrieze, O; Jasperse, B; Navran, A; van den Brekel, MWM; Vogel, WV | 1 |
| Chen, P; Chen, W; Jia, C; Jiang, W; Li, X; Lu, D; Xu, W; Yin, G; Yu, L; Yu, X; Zhang, Y; Zhu, L; Zhu, X | 1 |
| Chiang, GC; Fine, HA; Kovanlikaya, I; Magge, R; Naeger, DM; Pisapia, DJ; Seligman, L | 1 |
| Barriuso, J; Chander, A; Hubner, RA; Lamarca, A; Manoharan, P; McNamara, MG; ÓReilly, D; Valle, JW | 1 |
| Cha, MJ; Chung, MJ; Kim, BT; Kim, HS; Kim, TJ; Kim, TS; Kim, YS; Lee, KS | 1 |
| Bois, JP; Chareonthaitawee, P; Muser, D | 1 |
| Rischpler, C; Woodard, PK | 1 |
| Lin, J; Tang, K; Wang, L; Wu, Y; Zheng, X | 1 |
| Fukushima, T; Gomi, D; Kobayashi, T; Koizumi, T; Oguchi, K; Sekiguchi, N | 1 |
| Harada, H; Hayashi, K; Hino, M; Imai, Y; Ito, K; Kikuchi, M; Shimizu, K; Shinohara, S; Yamashita, D | 1 |
| Jiang, T; Li, W; Shi, HZ; Tong, ZH; Wang, W; Wang, XJ; Wang, Z; Wu, XZ; Xu, LL; Yang, MF; Zhang, YH; Zhang, YY | 1 |
| Cao, L; Ding, CY; Fan, L; Li, JY; Li, TN; Liang, JH; Wang, L; Wu, W; Xia, J; Xu, W; Zhang, YP; Zhu, HY | 1 |
| Altini, C; Bianco, G; Ferrari, C; Lavelli, V; Merenda, N; Niccoli Asabella, A; Pisani, A; Rubini, G; Ungaro, A | 1 |
| Arslan, M; Dag, Y; Simsek, FS | 1 |
| Liu, Y | 3 |
| Fukushi, M; Inoue, K; Kishimoto, S; Minamimoto, R; Mitsumoto, T; Sunaoka, F | 1 |
| Benzo, S; Boyle, J; Chatain, GP; Chittiboina, P; Dieckman, W; Edwards, N; Hayes, CP; Herscovitch, P; Lodish, MB; Lonser, RR; Maric, D; Millo, C; Nieman, LK; Patronas, NJ; Ray Chaudhury, A; Scott, G; Sharma, S; Smirniotopoulos, J; Stratakis, CA | 1 |
| Amorim, BJ; Bernardo, WM; Brito, AET; Esteves, FP; Gomes, GDV; Martello, M; Matushita, CS | 1 |
| Amorim, BJ; Bernardo, WM; Brito, AET; Esteves, F; Gomes, G; Matushita, C | 1 |
| Canevari, C; De Nardi, P; Guarneri, G; Passoni, P; Rosati, R; Slim, N; Tamburini, A | 1 |
| Fujisawa, Y; Koyama, H; Ohno, Y; Sugihara, N; Takenaka, D; Yoshikawa, T; Yui, M | 1 |
| Bley, T; Guggenberger, K | 1 |
| Broccoli, A; Fanti, S; Fonti, C; Lambertini, A; Lodi, F; Nanni, C; Pellegrini, C; Stefoni, V; Zanoni, L; Zinzani, PL | 1 |
| Fangliang, L; Miao, H; Nan, L; Shanyuan, Z; Shaolei, L; Yue, Y; Yumei, L | 1 |
| Eiber, M; Einspieler, I; Haller, B; Henninger, M; Mergen, V; Moog, P; Rummeny, EJ; Schwaiger, M; Thürmel, K; Wendorff, H | 1 |
| Abdel-Halim, CN; Bay, M; Bjørndal, K; Døssing, H; Godballe, C; Jakobsen, J; Madsen, AR; Nielsen, AL; Rosenberg, T; Thomassen, A | 1 |
| Hu, J; Wang, Y; Xue, F; Yan, Y; Zang, Y; Zhang, K | 1 |
| Blankstein, R; Desai, AS; Di Carli, MF; Divakaran, S; Dorbala, S; Ghoshhajra, BB; Givertz, MM; Hedgire, SS; Kwong, RY; Lakdawala, NK; Mehra, MR; Padera, RF; Skali, H; Stewart, GC; Taqueti, VR; Zhou, W | 1 |
| Abgral, R; Benoudiba, F; de Mones, E; Garcia, G; Garrel, R; Mouawad, F; Pondaven, S; Russ, G; Rysman, B; Tronche, S; Zerdoud, S | 1 |
| Eyck, BM; Lagarde, SM; Nieboer, D; Noordman, BJ; Onstenk, BD; Spaander, MCW; Valkema, R; van Lanschot, JJB; Wijnhoven, BPL | 1 |
| Bajaj, N; Bibbo, CF; Blankstein, R; Bravo, PE; Di Carli, MF; Dorbala, S; Groarke, J; Hainer, J; Harrington, M; Hyun, H; Lakdawala, NK; Morgan, V; Padera, RF; Park, MA; Robertson, M; Stewart, GC | 1 |
| Daugaard, H; Falstie-Jensen, T; Gormsen, LC; Lange, J; Ovesen, J; Søballe, K; Sørensen, AK; Vendelbo, MH; Zerahn, B | 1 |
| Ansquer, C; Drui, D; Kraeber-Bodéré, F; Lugat, A; Mirallié, E | 1 |
| Han, Z; Kong, X; Li, H | 1 |
| Narula, J; Narula, N; Zubin Maslov, P | 1 |
| Choi, EK; Kim, SJ; Kim, YK; Park, HL; Yoo, IR | 1 |
| Cheon, M; Choi, JY; Hyun, SH; Kim, H; Kim, J; Lee, KS; Shim, YM; Yoo, J; Zo, JI | 1 |
| Armstrong, C; Donnelly, TD; Kapoor, B; Kiran, M; Kumar, G; Peter, V | 1 |
| Chua, B; Debowski, M; Goodman, S; Jeffree, RL; Lwin, Z; Shaw, TB; Thomas, P | 1 |
| Kim, HH; Kim, SE; Kim, YH; Lee, HY; Lee, KH; Lee, SJ; Lee, WW; Park, DJ; So, Y; Yoon, HJ | 1 |
| Domínguez Ferreras, E; García Vicente, AM; Jiménez Aragón, F; Molino Trinidad, C; Pineda Pineda, MD; Poblete García, VM; Sánchez Pérez, V; Soriano Castrejón, Á; Villa Guzmán, JC | 1 |
| Hayashi, A; Irie, K; Kaneko, K; Masunari, S; Omagari, J; Sadashima, E; Sadashima, S; Yoshida, T | 1 |
| Balogova, S; Huchet, V; Kerrou, K; Michaud, L; Montravers, F; Nataf, V; Talbot, JN | 1 |
| Bellan, E; Bondesan, C; Capirci, C; Chondrogiannis, S; Colletti, PM; Ferretti, A; Gava, M; Grassetto, G; Maffione, AM; Marzola, MC; Rampin, L; Rubello, D | 1 |
| Choi, JY; Hwang, HS; Kim, BT; Kim, H; Kim, S; Kwon, OJ; Lee, HY; Lee, KS; Shim, YM; Yi, CA | 1 |
| Cho, A; Choi, BW; Hong, YJ; Hur, J; Kim, HY; Kim, YJ; Lee, HJ; Lee, JW; Shim, HS | 1 |
| Jadvar, H | 2 |
| Guo, Q; Liu, C; Ma, Q; Xin, J; Xu, W; Yu, S; Zhai, W; Zhao, Z | 1 |
| Achmad, A; Arisaka, Y; Higuchi, T; Kim, M; Miyashita, G; Miyazaki, H; Negishi, A; Tokue, A; Tominaga, H; Tsushima, Y; Yokoo, S | 1 |
| Braun, H; Dörfler, A; Kalender, WA; Kuwert, T; Lell, M; Quick, HH; Uder, M; von Gall, C; Wiesmüller, M; Zeilinger, M; Ziegler, S | 1 |
| Fujimoto, K; Hino, A; Inoue, T; Ishibashi, M; Kaida, H; Kurata, S; Shizukuishi, K; Tateishi, U; Yoneyama, T | 1 |
| Behrendt, FF; Bzyl, J; Mottaghy, FM; Palmowski, K; Palmowski, M; Rix, A; Verburg, FA; Winz, O | 1 |
| Bagrosky, BM; Fenton, LZ; Hayes, KL; Koo, PJ | 1 |
| Bhattacharya, A; Jain, S; Kalra, N; Manohar, K; Mittal, BR; Sharma, A; Varma, S | 1 |
| Ceriani, L; Foppiani, L; Giovanella, L; Piccardo, A; Treglia, G; Trimboli, P; Verburg, FA | 1 |
| Chugani, HT; Jeong, JW; Juhász, C | 1 |
| Fukukura, Y; Jinguji, M; Kajiya, Y; Koriyama, C; Nakabeppu, Y; Nakajo, M; Tanabe, H; Tani, A | 1 |
| Bleeker-Rovers, CP; Janssen, MJ; Kouijzer, IJ; Oyen, WJ; van Dijk, AP; Vos, FJ | 1 |
| Ikari, Y; Ishii, K; Ito, K; Iwatsubo, T; Kato, T; Makishi, Y; Nishio, T; Senda, M; Takahashi, R | 1 |
| Betti, M; Castagnoli, A; Dona, M; Fisicaro, D; Fulcheri, C; Orlandini, LC | 1 |
| Hirami, Y; Maeda, A; Nakata, M; Okita, R; Saisho, S; Shimizu, K; Yasuda, K; Yukawa, T | 1 |
| Inoue, T; Ito, K; Jinnouchi, S; Kaneko, K; Kato, S; Minamimoto, R; Morooka, M; Nakahara, T; Oguchi, K; Ohno, H; Satoh, Y; Senda, M; Shimbo, T; Tamaki, T; Terauchi, T; Tsukamoto, E; Uno, K; Yoshida, T | 1 |
| Bal, A; Bhattacharya, A; Dahyia, D; Kaman, L; Raj, P; Singh, R | 1 |
| Cho, KJ; Joo, YH; Kim, MS; Nam, IC; Park, JO; Yoo, IeR | 2 |
| Hattori, N; Hirata, K; Hosokawa, M; Itoh, K; Manabe, O; Oyama-Manabe, N; Takahashi, H; Tamaki, N | 1 |
| Blickman, JG; Maffione, AM; Rampin, L; Rubello, D | 1 |
| Alzen, G; Berthold, LD; Scholz, D; Steiner, D; Zimmer, KP | 1 |
| Abe, K; Asai, K; Atsumi, K; Baba, S; Hirakawa, M; Honda, H; Isoda, T; Nakamura, K; Ohga, S; Sasaki, T; Shinoto, M; Shioyama, Y; Yoshitake, T | 1 |
| Bal, C; Bandopadhyaya, GP; Gupta, DK; Karunanithi, S; Khangembam, BC; Kumar, A; Kumar, R; Malhotra, A; Sharma, P | 1 |
| Lei, J; Tian, J; Wang, Y; Zhai, Y; Zhang, L | 1 |
| Duo, J; Han, X; Ma, Y; Wang, G; Yang, Y; Zhang, L | 1 |
| Choi, KU; Kim, SJ; Park, SI; Suh, DS; Yoon, MS | 1 |
| Borovicka, J; Müller, J; Plasswilm, L; Putora, PM; Schmidt, F | 1 |
| Jackson, T; Malladi, A; Mercier, G; Subramaniam, RM; Viner, M | 1 |
| Bowsher, J; Das, SK; Lee, JA; McGurk, RJ | 1 |
| Bakhshi, S; Bal, C; Khan, SA; Khangembam, BC; Kumar, R; Malhotra, A; Rastogi, S; Sharma, P; Singh, H; Suman, KC; Thulkar, S | 1 |
| Fu, LP; Li, YG; Liu, CB; Shao, MZ; Tian, JH; Wang, RM; Xu, BX | 1 |
| Hendel, HW; Jensen, BV; Nielsen, D; Skougaard, K | 1 |
| Bonington, A; Bonington, S; Carrington, B; Coutts, G; Hogan, C; Julyan, PJ; Khoo, S; Taylor, B; Westwood, TD | 1 |
| Avierinos, JF; Cammilleri, S; Casalta, JP; Collart, F; Gouriet, F; Habib, G; Laas, O; Mancini, J; Mundler, O; Raoult, D; Riberi, A; Saby, L; Tessonnier, L; Thuny, F | 1 |
| Carreras, JL; Cruz, I; de Villoria, JG; Desco, M; García-Vázquez, V; Lacalle-Aurioles, M; Martino, ME; Navarro, E; Olazarán, J | 1 |
| Hosono, M; Ishikawa, K; Kanamori, S; Koike, R; Nakamatsu, K; Nishikawa, T; Nishimura, Y; Shibata, T; Tachibana, I; Tamura, M | 1 |
| Adam, JA; Adams, HJ; de Keizer, B; de Klerk, JM; Fijnheer, R; Kersten, MJ; Kwee, TC; Nievelstein, RA; Stoker, J; Vermoolen, MA | 1 |
| Baker, S; Clark-Papasavas, C; Cleij, M; Dunn, JT; Howard, R; Kapur, S; Kessler, R; Marsden, P; Reeves, SJ | 1 |
| Hu, JW; Li, Y; Qi, L; Yang, ZQ; Ye, H | 1 |
| Brocken, P; de Geus-Oei, LF; Dekhuijzen, PN; Peters-Bax, L; van der Heijden, HF | 1 |
| Banzo, I; Carril, JM; Del Castillo-Matos, R; Ibáñez-Bravo, S; Jiménez-Bonilla, JF; Martínez-Amador, N; Martínez-Rodríguez, I; Ortega-Nava, F; Quirce, R; Rubio-Vassallo, AS | 1 |
| Braun, JJ; Imperiale, A; Riehm, S | 1 |
| Chander, A; Nash, J; Rees, J; Sanchez-Roa, P | 1 |
| Chen, D; Chen, ZF; Hu, AB; Wang, XY; Zhang, XS | 1 |
| Aravkin, AY; Beatty, JD; Eissa, MJ; Porter, BA; Rogers, JV; Wang, CL | 1 |
| Nakamoto, Y; Nakatani, K; Togashi, K | 1 |
| Alexopoulos, AV; Chen, X; Newey, CR; Wang, ZI; Wong, C; Wu, G | 1 |
| Chen, Y; Liu, B; Qu, B; Tian, J; Wang, H; Xu, B; Zhang, J | 1 |
| de Keizer, B; Minnema, MC | 1 |
| Ahlawat, S; Belzberg, A; Blakeley, J; Fayad, LM; Montgomery, E; Subramaniam, RM | 1 |
| Engelbach, JA; Garbow, JR; Huang, C; Mach, RH; McConathy, J; Piwnica-Worms, D; Rich, KM; Sai, KK; Yuan, L; Zhou, D | 1 |
| Buriánková, E; Flodr, P; Formánek, R; Henzlová, L; Indrák, K; Jarošová, M; Kapitáňová, Z; Mysliveček, M; Papajík, T; Procházka, V; Turcsányi, P; Urbanová, R | 1 |
| Chan Ahn, Y; Cho, SK; Choe, YS; Choi, JY; Kim, BT; Kim, SJ; Kim, WS; Lee, KH; Moon, SH | 1 |
| Byun, BH; Cho, WH; Choi, CW; Jeon, DG; Koh, JS; Kong, CB; Lee, SY; Lim, I; Lim, SM; Song, WS | 1 |
| Cho, KJ; Choi, SH; Kim, JS; Kim, SY; Lee, JH; Nam, SY; Roh, JL; Ryu, IS | 1 |
| Edemir, B; Grabner, A; Kentrup, D; Pavenstädt, H; Reuter, S; Schäfers, M; Schlatter, E; Schnöckel, U; Schober, O; Sirin, Y | 1 |
| Elkhuizen, PH; Koolen, BB; Rutgers, EJ; Valdés Olmos, RA; van der Leij, F; Vogel, WV; Vrancken Peeters, MJ | 1 |
| Inoue, K; Ogata, K; Taniguchi, Y; Terada, Y | 1 |
| Cho, I; Chun, K; Hah, J; Hong, Y; Kong, E | 1 |
| Cho, I; Chun, K; Jang, B; Jeong, J; Kim, S; Kim, T; Kong, E; Song, S | 1 |
| Kim, H; Kim, IJ; Kim, K; Kim, SJ | 1 |
| Backes, WH; Brans, B; Mottaghy, FM; Schrauwen, P; van der Lans, AA; van Marken Lichtenbelt, WD; van Rooijen, BD; Wildberger, JE | 1 |
| Chen, L; Cui, JX; Li, T; Wei, B; Xi, HQ | 1 |
| Fujisawa, Y; Koyama, H; Matsumoto, S; Nishio, M; Ohno, Y; Sugimura, K; Yoshikawa, T | 1 |
| Ito, S; Iwano, S; Kawai, H; Naganawa, S; Ogawa, H; Sakurai, Y | 1 |
| Ebina, Y; Kanda, T; Kitajima, K; Maeda, T; Miyahara, Y; Suenaga, Y; Sugimura, K; Takahashi, S; Ueno, Y; Yamada, H | 1 |
| Chen, SW; Chen, WT; Hsieh, TC; Kao, CH; Lin, TY; Wu, YC; Yen, KY | 1 |
| Aoki, H; Fukumoto, T; Kitajima, K; Kono, A; Matsumoto, I; Okunaga, T; Suenaga, Y; Sugimura, K; Tanaka, K | 1 |
| Ardeshna, K; Bomanji, J; Panagiotidis, E; Pencharz, D; Quigley, AM; Sajjan, R; Syed, R | 1 |
| Driesch, D; Freesmeyer, M; Hofmann, GO; Opfermann, T; Schierz, JH; Stecker, FF; Winkens, T | 1 |
| Agrawal, A; Karapinar, U; Naiboglu, B; Ozer, E; Ozer, HG; Schuller, DE | 1 |
| Hatashita, S; Yamasaki, H | 1 |
| Deller, T; Delso, G; Goldhaber, D; Hüllner, M; Veit-Haibach, P; Wollenweber, SD | 1 |
| Cascini, GL; Console, D; Falcone, C; Parlati, A; Restuccia, A; Rossi, M; Tamburrini, O | 1 |
| Dunsky, KA; Osman, MM; Thornberry, BM; Varvares, MA; Wehrmann, DJ | 1 |
| Evans, PD; Ho, LM; Marin, D; Miller, CM; Paulson, EK; Stinnett, SS; Wong, TZ | 1 |
| Buchbender, C; Gauler, T; Hartung, V; Heusch, P; Heusner, TA; Köhler, J; Lanzman, RS; Nensa, F; Poeppel, TD; Wetter, A; Wittsack, HJ | 1 |
| Jeon, TJ; Kim, JH; Lee, SI; Lee, YC; Ma, DW; Park, H; Youn, YH; Yun, M | 1 |
| Bernard, F; Bernit, E; Berthelot, JM; Colavolpe, C; Costedoat-Chalumeau, N; Ebbo, M; Gobert, D; Godeau, B; Grados, A; Guedj, E; Hamidou, M; Harlé, JR; Haroche, J; Lifermann, F; Mariette, X; Masseau, A; Morel, N; Palat, S; Papo, T; Schleinitz, N; Zaidan, M | 1 |
| Ford, RJ; Kong, FL; Yang, DJ | 1 |
| Baumann, T; Dovi-Akue, PA; Hopt, UT; Langer, M; Rischke, HC; Schäfer, AO | 1 |
| Chu, Q; Hamidian Jahromi, A; Martin, B; Sangster, G; Shi, R; Shokouh-Amiri, H; Takalkar, A; Zibari, G | 1 |
| Bernstine, H; Gafter-Gvili, A; Groshar, D; Leibovici, L; Paul, M; Raanani, P; Ram, R; Shpilberg, O; Tadmor, B; Vidal, L; Yeshurun, M | 1 |
| Warner, RR; Zanzi, I | 1 |
| Antoch, G; Beiderwellen, K; Bockisch, A; Buchbender, C; Forsting, M; Gauler, T; Gomez, B; Heusch, P; Heusner, TA; Köhler, J; Kühl, H; Lanzman, RS; Nensa, F; Schuler, M; Wittsack, HJ | 1 |
| Bussink, J; de Geus-Oei, LF; Kaanders, JH; Oyen, WJ; Peters-Bax, L; Schuurbiers, OC; Troost, EG; Usmanij, EA; van der Heijden, EH | 1 |
| Claassen, D; Ding, Z; Kang, H; Mishra, A; Riddle, WR; Rogers, B; Shokouhi, S | 1 |
| Behrendt, FF; Kuhl, CK; Mottaghy, FM; Palmowski, M; Pietsch, H; Verburg, FA | 1 |
| Israel-Biet, D; Valeyre, D | 1 |
| Diehn, FE; Eckel, LJ; Hunt, CH; Kaufmann, TJ; Mostardi, PM; Rykken, JB; Schwartz, KM; Wald, JT; Wood, CP | 1 |
| Beigelman, C; Boulanger, X; Brun, AL; Ledoux, JB | 1 |
| Kanda, T; Kitajima, K; Konishi, J; Morimoto, K; Nibu, K; Otsuki, N; Saito, M; Sasaki, R; Suenaga, Y; Sugimura, K | 1 |
| Chiu, CT; Hsu, CM; Huang, SW; Jeng, WJ; Su, MY; Yen, TC | 1 |
| Drent, M; Mostard, RL; van Kroonenburgh, MJ | 1 |
| Annunziata, S; Bertagna, F; Caldarella, C; Ceriani, L; Giovanella, L; Muoio, B; Sadeghi, R; Treglia, G; Zakavi, SR | 1 |
| Arai, H; Asada, T; Ikari, Y; Ishii, K; Ito, K; Iwatsubo, T; Kato, T; Nishio, T; Senda, M; Silverman, DH; Sugishita, M; Yamane, T | 1 |
| Costes, N; Gros, A; Guerin, C; Lavenne, F; Le Bars, D; Pouzot, C; Richard, JC | 1 |
| Bejot, R; Bhakoo, KK; Goggi, JL; Moonshi, SS | 1 |
| Aide, N; Berriolo-Riedinger, A; Blagosklonov, O; Brenot-Rossi, I; Bridji, B; Cachin, F; Caignon, JM; Chaumet-Riffaud, P; Collombier, L; Courbon, F; Devillers, A; Doyeux, K; Dubray, B; Fernandez, P; Gremillet, E; Houzard, C; Kolesnikov-Gauthier, H; Modzelewski, R; Olivier, P; Roux, J; Tessonnier, L; Thureau, S; Vera, P; Vervueren, L | 1 |
| Antoch, G; Eicker, S; Floeth, FW; Galldiks, N; Herdmann, J; Langen, KJ; Rhee, S; Steiger, HJ; Stoffels, G | 1 |
| André, M; Bosly, A; Bouazza, S; Costantini, S; Lhommel, R; Michaux, L; Mounier, N; Nols, N; Sonet, A; Van Den Neste, E; Vander Borght, T; Vekemans, MC | 1 |
| Canales, BK; Stone, WZ; Wymer, DC | 1 |
| Inoue, T; Kawahara, N; Kubota, K; Minamimoto, R; Murata, H; Nakanowatari, S; Ohtake, M; Suenaga, J; Tateishi, K; Tateishi, U | 1 |
| Amthauer, H; Erdrich, AS; Furth, C; Grandt, R; Hauptmann, K; Hautzel, H; Hundsdoerfer, P; Kahraman, D; Kobe, C; Ruf, J; Schönberger, S; Steffen, IG; Stiebler, M | 1 |
| Gilhuijs, KG; Koolen, BB; Pengel, KE; Rodenhuis, S; Rutgers, EJ; Valdés Olmos, RA; Vincent, AD; Vogel, WV; Vrancken Peeters, MJ; Wesseling, J | 1 |
| Khoo, JB; Tan, NC; Teo, PT | 1 |
| Beanlands, RS; DaSilva, JN; deKemp, RA; Dumouchel, T; Gollob, MH; Klein, R; Renaud, JM; Thorn, SL; Wells, RG | 1 |
| de Bruyn, M; de Jong, JR; Dierckx, RA; Elsinga, PH; Helfrich, W; Ramakrishnan, NK; Rybczynska, AA; van Waarde, A | 1 |
| Jiang, P; Lu, Y; Wang, N | 1 |
| Afaq, A; Ell, PJ; Endozo, R; Groves, AM; Hutton, BF; Lambrou, T; Lukey, P; Maher, TM; Porter, JC; Screaton, NJ; Shortman, RI; Thomas, BA; Win, T | 1 |
| Case, M; Hake, A; Hochstetler, H; Schuh, K; Sun, J; Trzepacz, PT; Witte, MM; Yu, P | 1 |
| Giovanella, L; Kakhki, VR; Sadeghi, R; Treglia, G | 1 |
| de Wet, C; Deonarine, P; Han, S; Poon, FW | 1 |
| Altenbernd, J; Bockisch, A; Klode, J; Nagarajah, J; Rosenbaum-Krumme, S; Tekin, G; Wieder, HA | 1 |
| Dai, Q; Jiang, YX; Lai, XJ; Zhang, B; Zhao, RN | 1 |
| Henzler, T; Kaiser, CG; Krammer, J; Schnitzer, A; Schoenberg, SO; Wasser, K | 1 |
| Byun, BH; Cho, WH; Choi, CW; Jeon, DG; Kim, BI; Koh, JS; Kong, CB; Lee, SY; Lim, I; Lim, SM; Song, WS | 1 |
| Elshof, LE; Koolen, BB; Loo, CE; Rutgers, EJ; Valdés Olmos, RA; Vogel, WV; Vrancken Peeters, MJ; Wesseling, J | 1 |
| Armbruster, M; Auernhammer, CJ; Haug, A; Ingrisch, M; Nikolaou, K; Paprottka, PM; Reiser, MF; Rist, C; Sommer, WH; Sourbron, S; Zech, CJ | 1 |
| Bourgeois, AC; Bradley, YC; Chang, TT; Embry, S; Hudson, K; Warren, LA | 1 |
| Peller, PJ | 1 |
| Escott, EJ | 1 |
| Beiderwellen, K; Bockisch, A; Buchbender, C; Gomez, B; Hartung, V; Kuehl, H; Lauenstein, TC; Nensa, F; Poeppel, TD | 1 |
| Delank, KS; Dietlein, M; Drzezga, A; Eysel, P; Hungenbach, S; Schmidt, MC | 1 |
| Chen, YK; Chen, YL; Cheng, RH; Tsui, CC; Wang, SC | 1 |
| Wang, J; Zhang, Y; Zhao, C | 1 |
| Fan, W; Li, J; Wang, GH; Zhang, WD; Zhang, WG | 1 |
| Khodzhibekova, MM | 1 |
| Petrun'kin, AM; Tlostanova, MS | 1 |
| Bodet-Milin, C; Brissot, E; Cahu, X; Chevallier, P; Delaunay, J; Guillaume, T; Kraeber-Bodere, F; Lacombe, M; Lestang, E; Malard, F; Mohty, M; Moreau, P | 1 |
| Hosokawa, M; Itoh, K; Kikkawa, T; Kinoshita, Y; Kusumi, T; Nishida, Y; Sakashita, K; Sasaki, S; Takenouchi, T; Uemura, S; Yamada, H | 1 |
| Karapolat, I; Kobak, S; Kumanlioglu, K; Oncel, G; Sertpoyraz, F; Yalcin, M | 1 |
| Booth, K; Hanna, GG; Lynch, T; McAleese, J; McGonigle, N; McGuigan, J; McManus, KG; O'Sullivan, J | 1 |
| Bal, CS; Karunanithi, S; Sahoo, MK | 1 |
| Li, D; Lü, PX | 1 |
| Ahmadi, N; Arora, R; Budoff, M; Conneely, M; Ebrahimi, R; Hajsadeghi, F; Mingos, M | 1 |
| Chung, G; Im, HJ; Kim, CE; Kim, J; Kim, SJ; Kim, YK; Lee, DS | 1 |
| Davison, CM; O'Brien, JT | 1 |
| Akamatsu, G; Baba, S; Mitsumoto, K; Sasaki, M; Taniguchi, T; Tsutsui, Y | 1 |
| Gómez-Rio, M; Jiménez-Heffernan, A; Llamas-Elvira, JM; Ramos-Font, C; Rodríguez-Fernández, A; Sánchez Sánchez, R | 1 |
| Hasanzadeh, M; Kadkhodayan, S; Kakhki, VR; Sadeghi, R; Shahriari, S; Treglia, G; Yousefi, Z; Zakavi, SR | 1 |
| Chen, W; D'Souza, WD; Kim, G; Kligerman, S; Lu, W; Suntharalingam, M; Tan, S; Zhang, H | 1 |
| Adamiak, P; Czepczyński, R; Fularz, M; Jarzabek-Bielecka, G; Kedzia, W; Ruchała, M | 1 |
| Domaracki, P; Grabiec, M; Marszałek, A; Małecki, B; Sadłecki, P; Walentowicz, P; Walentowicz-Sadłecka, M | 1 |
| Bolton, D; Chan, JG; Chang, JH; Clouston, D; Davis, ID; Esler, S; Goh, YP; Gong, SJ; Hiew, CY; Khoo, V; Lee, ST; Lim Joon, D; O'Sullivan, R; Scott, AM; Tochon-Danguy, H; Wada, M | 1 |
| Aksoy, SY; Asa, S; Erkan, ME; Halac, M; Kabasakal, L; Kanmaz, B; Ocak, M; Ozhan, M; Sager, MS; Sönmezoglu, K | 1 |
| Chen, YK; Cheng, RH; Hung, GU; Kao, CH; Su, CT; Tsui, CC; Yeh, CH | 1 |
| Conti, PS; Haldar, JP; Leahy, RM; Li, Q; Lin, Y | 1 |
| An, YS; Jung, YS; Kang, DK; Kim, KS; Kim, TH; Lee, DH; Lee, SJ; Yim, H; Yoon, JK | 1 |
| Lu, Y; Wang, N; Zhai, H | 1 |
| Altini, C; Cappabianca, S; Fanelli, M; Niccoli Asabella, A; Notaristefano, A; Rotondo, A; Rubini, G; Stabile Ianora, AA | 1 |
| Graham, MM | 1 |
| Gönen, M; Lilienstein, J; Maragulia, J; Moskowitz, CH; Ulaner, GA; Zelenetz, AD | 1 |
| Baulieu, F; Benbouzid, F; Cachin, F; Cammilleri, S; Chezal, JM; D'Incan, M; Degoul, F; Gachon, F; Gaudy, C; Gillet, B; Granel-Brocard, F; Grange, JD; Isnardi, V; Kelly, A; Labeille, B; Lacour, JP; Merlin, C; Mestas, D; Meyer, N; Miot-Noirault, E; Payoux, P; Razzouk-Cadet, M; Tychyj, C | 1 |
| Allegri, V; Ambrosini, V; Berselli, A; Cricca, A; Domenico, R; Fanti, S; Martoni, A; Nanni, C; Nicolini, S; Rubello, D; Zucchini, G | 1 |
| Kaneta, T; Morimoto, R; Nakamura, Y; Satoh, F; Takahashi, S; Takanami, K; Takase, K | 1 |
| Fan, M; Liu, S; Liu, Y; Yi, X; Zhang, H | 1 |
| Kim, SK; Kim, YI; Lee, HY; Paeng, JC | 1 |
| Annunziata, S; Bertagna, F; Cafarotti, S; Ceriani, L; Giovanella, L; Lococo, F; Prior, JO; Sadeghi, R; Treglia, G | 2 |
| Bueno, FL; Camargo, RA; Costa, R; de Lima Peixoto, G; Filho, MM; Júnior, JS; Siciliano, RF; Strabelli, TM | 1 |
| Abe, S; Fujita, N; Ito, S; Iwano, S; Kato, K; Naganawa, S; Ota, N; Yamamoto, S; Yamashiro, K | 1 |
| Asano, Y; Iwama, T; Miwa, K; Nomura, Y; Shinoda, J; Takenaka, S; Yano, H; Yonezawa, S | 1 |
| Kim, DU; Kim, H; Kim, IJ; Kim, K; Kim, SJ; Pak, K | 1 |
| Tahari, AK; Wahl, RL | 1 |
| Boada, FE; Davis, DK; Imani, F; Lieberman, FS; Mountz, JM | 1 |
| Chatziioannou, SN; Georgakopoulos, AT; Kafiri, GT; Kallergi, M; Pavlou, SN; Pianou, NK | 1 |
| Aiello, M; Catalano, OA; Luongo, A; Nicolai, E; Pace, L; Salvatore, M; Soricelli, A | 1 |
| Faraggi, M; Garnier, N; Hugonnet, F; Paulmier, B; Serrano, B; Van Der Gucht, A | 1 |
| Birkfellner, W; Goertzen, AL; Kuntner, C; Langer, O; Muellauer, J; Wanek, T; Willimayer, R | 1 |
| Dasgupta, P; Evison, F; Goodfellow, H; Hughes, P; Hughes, S; Khan, MS; O'Brien, T; Rankin, S; Rottenberg, G; Viney, Z | 1 |
| Armbruster, M; Auernhammer, CJ; Ceelen, F; Haug, A; Reiser, MF; Rist, C; Singnurkar, A; Sommer, WH; Sourbron, S; Zech, CJ | 1 |
| Aguiló, R; Arriola, E; Belda-Sanchis, J; Curull, V; Pijuan, L; Rodríguez de Dios, N; Rodríguez-Fuster, A; Sánchez-Font, A; Suárez-Piñera, M; Taus, Á; Vollmer, I; Zuccarino, F | 1 |
| Hatano, E; Hayakawa, N; Higashi, T; Nakamoto, Y; Nakatani, K; Saga, T; Seo, S; Togashi, K; Uemoto, S | 1 |
| Bauerschlag, DO; Behrendt, FF; Hebel, CB; Heinzel, A; Krohn, T; Mottaghy, FM; Verburg, FA | 1 |
| Gao, S; Li, S; Tang, Q; Yang, X | 1 |
| Feng, D; Fulham, M; Kim, J; Kumar, A; Wen, L | 1 |
| Balm, AJ; Hamming-Vrieze, O; Lange, CA; Lodder, WL; Pameijer, FA; Van Den Brekel, MW; Van Velthuysen, ML; Vogel, WV | 1 |
| Bradford, CR; Carey, T; Chepeha, DB; Eisbruch, A; McHugh, JB; Spector, ME; Stenmark, MH; Vainshtein, JM; Wolf, GT; Wong, KK; Worden, FP | 1 |
| Beanlands, RS; Birnie, D; deKemp, RA; Lalonde, M; Ruddy, TD; Wassenaar, R; Wells, RG | 1 |
| Eaton, A; Fazio, M; Hudis, CA; Jhaveri, K; Jochelson, MS; Larson, S; Lilienstein, J; Morris, PG; Patil, S; Ulaner, GA | 1 |
| Inubushi, M; Koizumi, M; Koyama, M; Miwa, K; Murata, T; Nagao, M; Sasaki, M; Wagatsuma, K | 1 |
| Barnes, A; Dickson, JC; O'Meara, C | 1 |
| Brown, JE; Fox, P; Mawlawi, O; Millican, R; Rahim, S; Rohren, EM; Swanston, NM; Taylor, S | 1 |
| Bal, C; Jain, S; Julka, PK; Karunanithi, S; Kumar, R; Malhotra, A; Pal, S; Sharma, P; Thulkar, S | 1 |
| Lodge, MA; Tahari, AK; Wahl, RL | 1 |
| Kim, CK; Park, BK; Park, SY | 1 |
| Bergestuen, DS; Khan, MS; Kim, MK; Oberg, K; Rinke, A; Salazar, R; Thirlwell, C; Toumpanakis, C | 1 |
| Choi, JS; Choi, Y; Han, KH; Kang, WJ; Kim, EK; Kwak, JY; Moon, HJ; Yoon, JH; Youk, JH | 1 |
| Hao, R; Jin, H; Kan, Y; Li, C; Yang, J; Yuan, L | 1 |
| Caldarella, C; Giordano, A; Treglia, G | 1 |
| Cho, A; Choi, YJ; Hwang, HS; Jeong, YH; Kang, WJ; Kim, HJ; Lee, JD; Lee, JH; Yun, M | 1 |
| Matsumura, K; Nakayama, T; Sengoku, T; Takahashi, Y; Usami, M | 1 |
| Ambrosini, V; Colletti, PM; Fanti, S; Marzola, MC; Mascherini, D; Montesi, V; Nanni, C; Pettinato, C; Rossetti, V; Rubello, D; Zompatori, M | 1 |
| Bengel, F; Hinrichs, J; Vogel-Claussen, J; Wacker, F | 1 |
| Schlemmer, HP; Stieltjes, B; Wilhelm, T | 1 |
| Cheng, X; Navab, N; Shi, K; Ziegler, SI | 1 |
| Kebebew, E; Liu, Y; Sadowski, SM; Summers, RM; Weisbrod, AB; Yao, J | 1 |
| Arakawa, Y; Fushimi, Y; Kakigi, T; Kanagaki, M; Mikami, Y; Okada, T; Sakamoto, R; Shimono, T; Takahashi, JC; Togashi, K; Yamamoto, A | 1 |
| Cooley, T; Mercier, G; Subramaniam, RM; Truong, MT; Yu, J | 1 |
| Choi, JY; Choi, YL; Hong, SP; Koo, HH; Lee, SE; Seo, SW; Sung, KS | 1 |
| Coleman, RL; Gershenson, DM; Lucchini, M; Macapinlac, HA; Munsell, MF; Ramirez, PT; Schmeler, KM; Takeuchi, S | 1 |
| Abeyakoon, O; Baltzer, P; Bickel, H; Brader, P; Füger, B; Helbich, T; Magometschnigg, HF; Pinker, K; Polanec, S; Wengert, G | 1 |
| Beuthien-Baumann, B; Buchert, R; Hofheinz, F; Kotzerke, J; Lukas, M; Maus, J; Oehme, L; Schramm, G; Steinbach, J; van den Hoff, J | 1 |
| Evangelista, L; Panunzio, A; Polverosi, R; Pomerri, F; Rubello, D | 1 |
| Ela Bella, AJ; Fan, W; Fu, JH; Lin, P; Luo, KJ; Rong, TH; Yang, H; Zhang, YR | 1 |
| Inoue, T; Jinnouchi, S; Minamimoto, R; Senda, M; Terauchi, T; Yoshida, T | 2 |
| Barber, I; Beek, FJ; Bierings, MB; de Keizer, B; Enríquez, G; Granata, C; Hobbelink, MG; Kwee, TC; Littooij, AS; Nievelstein, RA; Soh, SY; Stoker, J; Vermoolen, MA; Zsíros, J | 1 |
| Avril, N; Bergstrom, D; Brenton, JD; Iannone, R; Lam, R; McNeish, IA; Mozley, PD; Parkinson, C; Rockall, AG; Sala, E; Sarker, SJ | 1 |
| Dols, A; Herholz, K; Kerklaan, BJ; Pijnenburg, YA; Scheltens, P; van Berckel, BN; van der Flier, WM | 1 |
| Burke, L; Henry, MT; Hinchion, J; Kennedy, MP; Maher, MM; McCarthy, J; McCarthy, L; McSweeney, S; Moloney, F; O'Regan, K; Ryan, D | 1 |
| Bush, J; Dizdarevic, S; Keramida, G; Peters, AM; Potts, J | 1 |
| Cheng, D; Coman, D; Hyder, F; McCarthy, T; Rothman, DL; Sanganahalli, BG | 1 |
| Arbizu, J; de Castro, P; Domínguez, I; Gállego Pérez-Larraya, J; Irimia, P; Luquin, MR; Martínez-Vila, E; Ortega-Cubero, S; Pagola, I; Pastor, P; Riverol, M; Viteri, C | 1 |
| Choi, D; Choi, JY; Jang, KM; Kang, TW; Kim, SH; Park, CK | 1 |
| Gollub, MJ; Grewal, RK; Moskowitz, CS; Panu, N; Sohn, M; Thipphavong, S; Zheng, J | 1 |
| Lohrmann, C; Weber, WA | 1 |
| Aaløkken, TM; Bogsrud, TV; Geier, OM; Hagtvedt, T; Holte, H; Lund, KV; Løndalen, AM; Seierstad, T; Smith, HJ | 1 |
| Amtage, F; Buchert, R; Guschlbauer, B; Hellwig, S; Meyer, PT; Niesen, WD; Reinhard, M; Tüscher, O; Weiller, C | 1 |
| Dai, D; Dang, N; Ma, W; Song, X; Wang, J; Xu, W; Zhu, L; Zhu, X | 1 |
| An, N; Chen, Y; Fu, L; Tian, J; Xu, B; Yin, D; Zhang, J | 1 |
| Bentourkia, M; Blanchette, M; Croteau, É; Lebel, R; Lecomte, R; Lepage, M; Poulin, É; Tremblay, L | 2 |
| Brans, B; Demirev, A; Geurts, J; Mottaghy, F; Walenkamp, G; Weijers, R | 1 |
| Tabarin, A | 1 |
| Choi, OH; Jeon, HN; Jo, MS; Kim, GH; Kim, SJ; Suh, DS; Yun, MS | 1 |
| De Ruysscher, D; Doll, C; Duncker-Rohr, V; Eriksen, JG; Grosu, AL; MacManus, M; Mix, M; Nestle, U; Oyen, W; Rücker, G; Vogel, W; Weber, W | 1 |
| Borra, A; Gallamini, A | 1 |
| Bastos, CR; Biz, AN; Caetano, R; Carneiro, MP; Schluckebier, LF; Silva, JW; Silva, RM | 1 |
| Bartenstein, P; Brunner, S; Germano, G; Hacker, M; Lehner, S; Sussebach, C; Todica, A; Uebleis, C; Van Kriekinge, SD | 1 |
| Alavi, A; Blomberg, BA; Buch-Olsen, KM; Diederichsen, AC; Hildebrandt, MG; Høilund-Carlsen, PF; Mickley, H; Simonsen, JA; Takx, RA; Thomassen, A | 1 |
| Hatazawa, J; Hori, M; Hori, Y; Kim, T; Morii, E; Nakamoto, A; Onishi, H; Sakane, M; Tatsumi, M; Tomiyama, N; Tsuboyama, T | 1 |
| Ahlman, MA; Bluemke, DA; Dave, J; Lockshin, BN; Mehta, NN | 1 |
| Baas, IO; Bulten, BF; de Haas, MJ; de Klerk, JM; Rodenburg, CJ; van Ooijen, B | 1 |
| Benveniste, AP; Benveniste, MF; Marom, EM; Mawlawi, OR; Yang, W | 1 |
| Barisione, C; Bossert, I; Camellino, D; Cimmino, M; Cittadini, G; Ghigliotti, G; Marini, C; Massollo, M; Morbelli, S; Palombo, D; Pane, B; Riondato, M; Rousas, N; Sambuceti, G; Spinella, G | 1 |
| Barrington, SF; Biggi, A; Bolis, S; Brice, P; Casasnovas, O; Chauvie, S; Coleman, M; Dann, EJ; Gallamini, A; Gregianin, M; Hofman, MS; Hutchings, M; Kostakoglu, L; Loft, A; Luminari, S; Meignan, M; Mikhaeel, GN; Pulsoni, A; Rigacci, L; Rusconi, C; Salvi, F; Seymour, JF; Trentin, L; Viviani, S; Zaucha, JM | 1 |
| Bluemel, C; Buck, AK; Germer, CT; Herrmann, K; Wiegering, A | 1 |
| Alba, MA; Cid, MC; Corbera-Bellata, M; Depetris, M; Espígol-Frigolé, G; García-Martínez, A; Grau, JM; Hernández-Rodríguez, J; Lomeña, F; Planas-Rigol, E; Prieto-González, S; Tavera-Bahillo, I | 1 |
| Fotopoulos, A; Kyritsis, AP; Sioka, C | 1 |
| Cai, L; Fu, D; Fu, W; Gui, S; Li, J; Li, W; Lu, B; Tang, R; Yang, P; Zhang, H | 1 |
| Chen, S; Cheng, T; Cheung, SK; Chim, CS; Ho, CL; Leung, YL; Liang, R; Wong, KN | 1 |
| Beckert, S; Claussen, CD; Gatidis, S; Klumpp, B; Koenigsrainer, A; Koenigsrainer, I; Mueller, M; Pfannenberg, C; Schwenzer, NF | 1 |
| Arima, K; Imabayashi, E; Ito, K; Matsuda, H; Nakata, Y; Omachi, Y; Sato, N; Shimano, Y | 1 |
| Campbell, A; McCarthy, M; McIvor, J; Siew, T | 1 |
| Bandgar, T; Lele, V; Lila, A; Patt, HP; Shah, N | 1 |
| Berzaczy, D; Dolak, W; Gaiger, A; Hoffmann, M; Jaeger, U; Karanikas, G; Kiesewetter, B; Kletter, K; Lukas, J; Mayerhoefer, ME; Müllauer, L; Pinker-Domenig, K; Porpaczy, E; Prosch, H; Raderer, M; Sillaber, C; Simonitsch-Klupp, I; Skrabs, C; Ubl, P; Weber, M | 1 |
| Al Sannaa, G; Chuang, HH; Khiewvan, B; Lev, D; Macapinlac, HA; McCutcheon, IE; Slopis, JM; Wei, W | 1 |
| Eiber, M; Krause, BJ; Maurer, T | 1 |
| Chiewvit, P; Chiewvit, S; Phongsawat, N; Pooliam, J; Thephamongkhol, K; Ubolnuch, K | 1 |
| Annunziata, S; Bertagna, F; Caldarella, C; Giovanella, L; Sobic-Saranovic, D; Treglia, G | 1 |
| Bando, Y; Harada, M; Ikushima, H; Kubo, M; Matsuzaki, K; Nose, H; Otomi, Y; Otsuka, H; Terazawa, K | 1 |
| Ciancia, G; Cirillo, M; Cozzolino, I; Pane, F; Pettinato, G; Picardi, M; Pugliese, N; Quintarelli, C; Salvatore, C; Zeppa, P | 1 |
| Bellocci, F; Bencardino, G; Calcagni, ML; Giordano, A; Lago, M; Leccisotti, L; Leo, M; Narducci, ML; Pelargonio, G; Perna, F; Stefanelli, A | 1 |
| Castelli, P; Crippa, S; Falconi, M; Laiti, S; Partelli, S; Salgarello, M; Spinelli, AE; Tamburrino, D; Zamboni, G | 1 |
| Gao, XJ; He, ZX; Kang, LM; Li, Y; Lu, MJ; Luo, XL; Wan, JY; Yang, MF; Yang, YJ; Zhang, J; Zhao, SH | 1 |
| Cho, J; Choi, NC; Sharp, GC; Shusharina, N | 1 |
| Domènech-Vilardell, A; Ichise, M; Rasiej, MJ; Taub, RN | 1 |
| Dedeurwaerdere, S; Deleye, S; Staelens, S; Stroobants, S; Verhaeghe, J; wyffels, L | 1 |
| Boly, M; Bruno, MA; Charland-Verville, V; Chatelle, C; Demertzi, A; Gjedde, A; Gosseries, O; Heine, L; Laureys, S; Schnakers, C; Soddu, A; Stender, J; Thibaut, A; Thonnard, M; Vanhaudenhuyse, A | 1 |
| Beuthien-Baumann, B; Gudziol, V; Kitzler, HH; Kotzerke, J; Laniado, M; Maus, J; Platzek, I; Popp, M; Schneider, M; Schramm, G; van den Hoff, J | 1 |
| Hu, K; Huang, T; Liang, X; Nie, D; Sun, T; Tang, G; Tang, X; Wang, H | 1 |
| Duivenvoorden, HJ; Rijkers, AP; Valkema, R; van Eijck, CH | 1 |
| Buvat, I; Chouahnia, K; Cyrta, J; Eder, V; Martinod, E; Morère, JF; Orlhac, F; Pouliquen, C; Soussan, M | 1 |
| Hu, Y; Li, K; Lu, G; Shen, J; Xu, Q; Zhang, Z; Zhu, H | 1 |
| Bergström, GML; Fredén-Lindqvist, J; Hjelmgren, O; Johansson, L; Prahl, U; Schmidt, C | 1 |
| Abu-Rustum, NR; Burger, IA; Goldman, DA; Hricak, H; Kollmeier, MA; Miccò, M; Park, KJ; Sala, E; Vargas, HA | 1 |
| Boerhout, EJ; Castelijns, JA; Comans, EF; de Bree, R; de Graaf, P; Hoekstra, OS; Noij, DP; Oprea-Lager, D; Pieters-van den Bos, IC; Reinhard, R | 1 |
| Ahmadzadehfar, H; Biersack, HJ; Bruhman, J; Ezziddin, S; Meyer, C; Pieper, CC; Sabet, A; Wasmuth, JC | 1 |
| Chang, D; Harris, C; Kauser, A; Lake, ES; Lapsia, S; Subar, D; Wadhwani, S | 1 |
| Chen, YK; Cheng, RH; Chia-Hung, K; Tsui, CC; Wang, SC; Yeh, CL | 1 |
| Cortot, A; Hossein-Foucher, C; Olivier, A; Petyt, G; Scherpereel, A | 1 |
| Li, F; Li, L; Li, Y; Su, M; Tian, R | 1 |
| Blake, P; Chan, D; Fielding, P; Foley, KG; Karran, A; Lewis, WG; Roberts, SA | 1 |
| Ding, XP; Feng, L; Ma, L | 1 |
| Andersen, RV; Braad, PE; Buch-Olsen, KM; Hess, S; Schifter, S | 1 |
| Bartoletti, M; Biffi, M; Bonfiglioli, R; Boriani, G; Diemberger, I; Fanti, S; Graziosi, M; Lorenzini, M; Martignani, C; Nanni, C; Pasquale, F; Rapezzi, C; Tumietto, F; Viale, PL; Ziacchi, M | 1 |
| Goel, R; Jena, A; Negi, P; Renjen, P; Taneja, S | 1 |
| Ghosh, P; Jagust, WJ; Laforce, R; Lehmann, M; Madison, CM; Miller, BL; Rabinovici, GD; Tosun, D; Weiner, MW | 1 |
| Dimitrakopoulou-Strauss, A; Hohenberger, P; Niedermoser, S; Ronellenfitsch, U; Wängler, B | 1 |
| Berstad, AE; Bugge, AS; Johnsrud, K; Kongerud, J; Lund, MB; Naalsund, A | 1 |
| Coolen, J; De Wever, W; Verschakelen, J | 1 |
| Jiawei, X; Ma, C; Shao, M; Wang, H; Wang, X; Wu, Z; Zhao, L | 1 |
| Baum, RP; Hommann, M; Hörsch, D; Kaemmerer, D; Kulkarni, HR; Robiller, F | 1 |
| Benveniste, AP; Benveniste, MF; Marom, EM; Mawlawi, OR; Miranda, RN; Yang, W | 1 |
| Bhosale, P; Frumovitz, M; Garg, N; Meis, JM; Prasad, SR; Surabhi, VR | 1 |
| Alifano, M; Cavazza, A; Cesario, A; Filice, A; Lococo, F; Paci, M; Rapicetta, C; Ricchetti, T; Sgarbi, G; Treglia, G; Versari, A | 1 |
| Xi, K; Xi, S; Xie, X | 1 |
| Kim, C; Kim, J; Kim, YT; Paeng, JC; Ryu, JK | 1 |
| Fujii, H; Fujita, A; Kanazawa, H; Kijima, S; Kimura, Y; Sasaki, T; Shinozaki, T; Sugimoto, H; Utano, K; Utano, Y | 1 |
| Han, K; Hong, IK; Sohn, YM | 1 |
| Li, MM; Li, YY; Liu, L; Ma, XL; Zhang, BL; Zhao, JY | 1 |
| Chae, BJ; Jung, NY; Kang, BJ; Kim, SH; Seo, YY; Yoo, IR | 1 |
| Adang, EM; de Geus-Oei, LF; de Wilt, JH; Netea-Maier, RT; Oyen, WJ; Smit, JW; Vriens, D | 1 |
| Bhattacharya, A; Gayana, S; Jain, S; Mittal, BR; Santhosh, S; Sharma, A | 1 |
| Li, S; Lv, C; Wang, X; Yan, S; Yang, Y; Yu, J; Zhao, B | 1 |
| Ahmadian, A; Berman, J; Brogan, A; Govender, P; Mazzini, M; Mercier, G; Miller, EJ; Ruberg, FL; Sverdlov, AL | 1 |
| Alessandrini, M; Bruno, E; Candidi, M; Chiaravalloti, A; Di Pietro, B; Micarelli, A; Pagani, M; Schillaci, O | 1 |
| Guo, FJ; Hao, Y; He, JP; Li, M; Wang, J | 1 |
| Bouvard, S; Comans, EF; Debets, RM; Huiskamp, G; Leijten, FS; Ryvlin, P; van't Klooster, MA; Zijlmans, M | 1 |
| Bal, C; Jain, TK; Julka, PK; Karunanithi, S; Kumar, R; Parida, GK; Patel, C; Sharma, A; Sharma, P; Thulkar, S | 1 |
| Canbaz Tosun, F; Cıraklı, A; Cıraklı, S; Dabak, N; Dağdemir, A; Elli, M | 1 |
| Adams, HJ; Blase, PE; de Klerk, JM; Dubois, SV; Fijnheer, R; Kwee, TC; Nievelstein, RA | 1 |
| Arya, S; Deshmukh, A; Rane, P | 1 |
| Cheng, C; Hu, S; Liu, Q; Sun, G; Zhang, J; Zuo, C | 1 |
| Feng, B; Fu, Z; Hu, M; Kong, L; Yu, JM; Zhang, GL; Zhang, XL; Zhang, Y; Zhao, F | 1 |
| Brendle, C; Claussen, CD; Gatidis, S; Königsrainer, I; Müller, M; Pfannenberg, AC; Schmidt, H; Schraml, C; Schwenzer, NF | 1 |
| Sadeghi, MM | 1 |
| Allendorf, JD; Chabot, JA; Einersen, P; Epelboym, I; Leung, D; Winner, MD | 1 |
| Choi, SH; Kim, JS; Kim, SY; Lee, HS; Nam, SY; Roh, JL | 1 |
| Andrade, WP; Bitencourt, AG; Chojniak, R; Guimarães, MD; Lima, EN; Marques, EF; Souza, JA | 1 |
| Ashburner, J; Caroli, A; Castiglioni, I; Cerami, C; Della Rosa, PA; Frisoni, G; Friston, K; Gallivanone, F; Gilardi, MC; Perani, D; Prestia, A | 1 |
| Annunziata, S; Caldarella, C; Galiandro, F; Giovanella, L; Pizzuto, DA; Sadeghi, R; Treglia, G | 1 |
| Abele, J; Allegretto, M; Bedard, E; Hunt, I; Maquire, C; Patel, A; Perry, T | 1 |
| Bago-Horvath, Z; Baltzer, P; Bartsch, R; Bickel, H; Bogner, W; Brader, P; Dubsky, P; Gruber, S; Helbich, TH; Karanikas, G; Magometschnigg, H; Pinker, K; Trattnig, S; Weber, M | 1 |
| Lee, CH; Lee, DY; Lee, JJ; Lee, SH; Ryu, JS; Seo, MJ | 1 |
| Hoermann, K; Klohr, S; Li, CY; Sadick, H; Sadick, M; Schoenberg, SO; Weiss, C | 1 |
| Cappelli, A; Castellucci, P; D'Errico, A; Di Fabio, F; Ercolani, G; Giampalma, E; Golfieri, R; Pinna, AD; Pinto, C; Rojas Llimpe, FL; Serra, C | 1 |
| Bousquet, G; Espié, M; Groheux, D; Hindié, E; Marty, M; Merlet, P; Misset, JL; Ohnona, J; Rubello, D; Toubert, ME; Vercellino, L | 1 |
| Freesmeyer, M; Reissig, A; Tauhardt, E; Winkens, T | 1 |
| Balachandran, A; Bassett, RL; Chuang, HH; Habra, MA; Macapinlac, HA; Phan, AT; Takeuchi, S | 1 |
| Adams, H; Grutters, JC; Keijsers, RG; Korenromp, IH | 1 |
| Aydin, M; Erdogan, EB; Ergul, N; Gucin, Z; Kadioglu, H; Muslumanoglu, M; Yildiz, S; Yucel, SB | 1 |
| Driscoll, DO; Halpenny, D; Johnston, C; Keogan, M; Sheehy, N | 1 |
| Bailly, P; Benathan-Tordjmann, J; Daouk, J; Meyer, ME | 1 |
| Grabowska-Derlatka, L; Koperski, L; Królicki, L; Kunikowska, J; Matyskiel, R; Toutounchi, S | 1 |
| Bal, C; Karunanithi, S; Kumar, R; Roy, SG; Sharma, A; Sharma, P; Thulkar, S; Vettiyil, B | 1 |
| Choe, H; Ike, H; Inaba, Y; Kobayashi, N; Miyamae, Y; Saito, T; Yukizawa, Y | 1 |
| Borges, US; da Silva, BB; Gebrim, LH; Lopes-Costa, PV; Pires, AO | 1 |
| Hino-Shishikura, A; Inoue, T; Kawahara, N; Tateishi, K; Tateishi, U; Torii, I | 1 |
| Brownell, AL; Hara, T; Henke, PK; Hucker, WJ; Jaff, MR; Jaffer, FA; Jokivarsi, K; Kessinger, CW; MacNabb, MH; Tawakol, A; Truelove, J; Weissleder, R; Wojtkiewicz, GR | 1 |
| Bae, SK; Jung, SJ; Kim, CK; Kim, TH; Lee, SM; Park, JS; Yoon, HK | 1 |
| Hattori, N; Ito, M; Iwasaki, N; Kamishima, T; Magota, K; Nagahama, K; Nakahara, M; Sudo, H; Takahata, M; Tamaki, N | 1 |
| Benetos, A; Joly, L; Karcher, G; Marie, PY; Poussier, S; Van Der Gucht, A; Verger, A; Watfa, G; Yagdigul, Y | 1 |
| Beuthien-Baumann, B; Kitzler, HH; Kotzerke, J; Laniado, M; Maus, J; Ordemann, R; Platzek, I; Schramm, G; van den Hoff, J | 1 |
| Kowalska, A; Lesiak, J; Młynarczyk, J; Trybek, T | 1 |
| Borms, M; Cocquyt, V; Kruse, V; Maes, A; Pottel, H; Sathekge, M; Van de Wiele, C | 1 |
| Chagawa, K; Hirano, Y; Kido, S; Muramatsu, K; Suga, K; Tachibana, R; Tanaka, S; Xu, R | 1 |
| Bergquist, A; Karlson, BM; Rasmussen, I; Rorsman, F; Sangfelt, P; Sundin, A; Wanders, A | 1 |
| Beiderwellen, K; Buchbender, C; Gomez, B; Heusch, P; Köhler, J; Nensa, F; Reis, H; Ruhlmann, V; Schaarschmidt, B; Sivanesapillai, R | 1 |
| Bagci, U; Bishai, WR; Foster, B; Jain, SK; Kubler, A; Larsson, C; Luna, B; Mollura, DJ | 1 |
| Bertuzzo, D; Calvo, A; Chiò, A; Cistaro, A; De Carli, F; Fania, P; Moglia, C; Morbelli, S; Nobili, F; Öberg, J; Pagani, M; Valentini, MC | 1 |
| Ariyaratnam, P; Beddow, E; Darr, A; Dusmet, M; Granato, F; Greenwood, A; Iyer, S; Kirk, A; Leung, M; Lim, E; Loubani, M; Marchbank, A; Mohamed, S; Naidu, B; Nicholson, AG; Pattenden, HA; Shackcloth, M; West, D | 1 |
| Bergmann, H; Beyer, T; Geist, B; Hacker, M; Hirtl, A; Rausch, I; Schaffarich, M | 1 |
| Gambhir, SS; Iagaru, A; Lutz, AM; Mittra, ES; Mosci, C; Sampath, SC; Willmann, JK | 1 |
| Adler, S; Choyke, PL; Kurdziel, KA; Lindenberg, ML; Logan, J; Mena, E; Shih, J; Turkbey, BI; Wilson, W; Wong, K | 1 |
| Bush, J; Dizdarevic, S; Keramida, G; Peters, AM; Potts, J; Verma, S | 1 |
| Gelfand, MJ; Palumbo, JS; Sharp, SE | 1 |
| Anelli, V; Covello, R; Kayal, R; Manciocco, V; Marucci, L; Mercante, G; Pellini, R; Pichi, B; Sanguineti, G; Sciuto, R; Sperduti, I; Spriano, G; Turri-Zanoni, M; Vidiri, A | 1 |
| Abgral, R; Keromnes, N; Le Roux, PY; Marianowski, R; Palard, X; Potard, G; Robin, P; Rousset, J; Salaun, PY; Valette, G | 1 |
| Bertagna, F; Giovanella, L; Sadeghi, R; Treglia, G | 1 |
| Hiraoka, M; Iizuka, Y; Matsuo, Y; Mizowaki, T; Nakamoto, Y; Togashi, K; Ueki, N; Umeoka, S | 1 |
| Lu, M; Qiu, M; Schindler, TH; Shen, R; Tian, C; Tian, Y; Wei, H; Zhang, X; Zhao, SH | 1 |
| Bartenstein, P; Böning, G; Brunner, S; Hacker, M; Jansen, NL; Kreissl, MC; Lehner, S; Todica, A; Wang, H; Wängler, C; Zacherl, MJ | 1 |
| Bennink, RJ; Fayad, ZA; Kroon, J; Mulder, WJ; Nederveen, AJ; Nieuwdorp, M; Potters, WV; Stroes, ES; Thurlings, RM; van Buul, JD; van der Valk, FM; Verberne, HJ | 1 |
| Li, LF; Liu, NH; Qiu, H; Weng, WW; Xu, Q; Yang, J; Zhang, J; Zhu, YJ | 1 |
| Bernard, C; Coucke, PA; Hatt, M; Hustinx, R; Jodogne, S; Lee, JA; Martinive, P; Van der Rest, C; Visvikis, D; Withofs, N | 1 |
| Deng, J; Shen, N; Tang, J | 1 |
| Allen, PJ; Amtage, F; Eidelberg, D; Feigin, A; Hanspal, E; Heinen, L; Hellwig, S; Leenders, KL; Meyer, PT; Niethammer, M; Poston, KL; Tang, CC; Vonsattel, JP | 1 |
| Chen, MK; Hong, SF; Lai, YS; Lee, KW | 1 |
| Caglar, M; Karabulut, E; Yener, C | 1 |
| Chapman, GJ; Hall, NC; Lee, R; Martin, EW; Murrey, DA; Povoski, SP | 1 |
| Cho, KJ; Joo, YH; Kim, CS; Kim, MS; Kim, SY; Lee, YS; Nam, IC; Park, JO; Yoo, IeR | 1 |
| Guo, HM; Han, JK; Lu, YJ; Lv, K; Wu, ZX; Zhang, K | 1 |
| Choi, WH; Chung, SK; Kim, YK; Lee, KY; Park, HL; Wang, YP; Yoo, IeR | 1 |
| Li, D; Qiao, H; Wang, D; Wang, L; Wang, Y | 1 |
| Assante, R; Cuocolo, A; Dellegrottaglie, S; Gargiulo, P; Marsico, F; Paolillo, S; Perrone Filardi, P; Prastaro, M; Ruggiero, D; Savarese, G; Scala, O; Zampella, E | 1 |
| Botto, H; Girma, A; Hervé, JM; Le Stanc, E; Lebret, T; Letang, N; Neuzillet, Y; Radulescu, C; Rouanne, M; Vilain, D; Yonneau, L | 1 |
| Aldrich, MC; Blume, JD; Deppen, SA; Grogan, EL; Kensinger, CD; Massion, PP; McPheeters, ML; Morgan, AM; Putnam, JB; Walker, RC | 1 |
| Alluri, KC; Chung, CH; Koch, W; Subramaniam, RM; Tahari, AK; Wahl, RL | 1 |
| Bastos, CR; Braga, JU; Caetano, R; da Silva, RM; de Oliveira, IA; Fortes, CP; Pepe, VL; Reis, LG | 1 |
| Ahn, SY; Cheon, GJ; Choi, BI; Han, JK; Joo, I; Lee, ES; Lee, JM; Lee, SJ | 1 |
| Burger, IA; Dinkelborg, L; Friebe, M; Graham, K; Haerle, SK; Hany, TF; Horn-Tutic, M; Kowal, K; Luurtsema, G; Maas, B; Pruim, J; Schaefer, NG; Schibli, R; Stephens, A; von Schulthess, GK; Wiegers, J; Zitzmann-Kolbe, S | 1 |
| Akai, T; Iizuka, H; Sasagawa, Y; Tachibana, O | 1 |
| Bellomi, M; Bertolotti, R; Maisonneuve, P; Paganelli, G; Rampinelli, C; Spaggiari, L; Travaini, LL; Veronesi, G | 1 |
| Cheze Le Rest, C; Fayad, H; Fernandez, P; Lamare, F; Le Pogam, A; Pradier, O; Valette, G; Visvikis, D | 1 |
| Amini, B; Kubicki, SL; Martin, T; Richardson, ML; Rohren, E; Wei, W | 1 |
| Bączyk, M; Czarnywojtek, A; Czepczyński, R; Janicka-Jedyńska, M; Lodyga, M; Ruchała, M; Stangierski, A; Woliński, K; Wyszomirska, A | 1 |
| Delle Fave, G; Falconi, M; Maurizi, A; Panzuto, F; Partelli, S; Polenta, V; Rinzivillo, M; Salgarello, M | 1 |
| Adalet, I; Aykan, F; Has Simsek, D; Kuyumcu, S; Sanlı, Y; Turkmen, C; Unal, S | 1 |
| Beheshti, M; Dinkelborg, L; Haim, S; Kunit, T; Langsteger, W; Loidl, W; Schiller, C; Stephens, A; Zakavi, R | 1 |
| Kalangos, A; Karaca, S; Rager, O; Ratib, O | 1 |
| Chung, MK; Kang, H; Lee, DS; Lee, H | 1 |
| Chondrogiannis, S; Colletti, PM; Fuster, D; Giammarile, F; Grassetto, G; Maffione, AM; Marzola, MC; Musto, A; Rampin, L; Rubello, D | 1 |
| Cho, JH; Cho, KJ; Chun, BJ; Joo, YH; Kim, CS; Kim, MS; Nam, IC; Yoo, IeR | 1 |
| Mikhailidis, DP; Paraskevas, KI; Veith, FJ | 1 |
| Bi, L; Feng, D; Fulham, M; Kim, J | 1 |
| Heinonen, SE; Knuuti, J; Nuutila, P; Roivainen, A; Saraste, A; Saukko, P; Silvola, JM; Uotila, S; Ylä-Herttuala, S | 1 |
| Agarwal, A; Kachnic, LA; Marcus, C; Nene, P; Subramaniam, RM; Xiao, J | 1 |
| Cheng, CL; Chiu, KY; Ho, HC; Li, JR; Lin, WY; Lin, YC; Ou, YC; Su, CK; Tsai, SC | 1 |
| Arnaldi, D; Bossert, I; Bottoni, G; Brugnolo, A; Buschiazzo, A; De Carli, F; Didic, M; Drzezga, A; Frisoni, GB; Galluzzi, S; Guedj, E; Morbelli, S; Nobili, F; Ossenkoppele, R; Pagani, M; Perneczky, R; Picco, A; Sambuceti, G; van Berckel, BN | 1 |
| Biederer, J; Kim, HS; Lee, KS; Ohno, Y; van Beek, EJ | 1 |
| Aoki, D; Banno, K; Iida, M; Irie, H; Kisu, I; Masugi, Y; Murakami, K; Nogami, Y; Okuda, S; Tanaka, K; Tominaga, E | 1 |
| Bonvin, C; Fisch, L; Lalive, P; Lovblad, KO; Müller, HF; Pagano, S; Ratib, O; Sztajzel, R; Viaccoz, A; Vuilleumier, N; Willi, JP | 1 |
| Fukukura, Y; Jinguji, M; Kamimura, K; Nakabeppu, Y; Nakajo, M; Shindo, T; Takumi, K; Yoneyama, T; Yoshiura, T | 1 |
| Bhojwani, D; Choi, JK; Davidoff, AM; Gold, R; Inaba, H; McCarville, MB; Metzger, ML; Sandlund, JT; Sawyer, J; Shulkin, BL | 1 |
| Adams, HJ; de Klerk, JM; Dubois, SV; Fijnheer, R; Kwee, TC; Nievelstein, RA | 1 |
| Cappa, SF; Castiglioni, I; Cerami, C; Della Rosa, PA; Fallanca, F; Gallivanone, F; Garibotto, V; Gianolli, L; Magnani, G; Marcone, A; Nobili, F; Panzacchi, A; Pappatà, S; Perani, D; Vanoli, EG | 1 |
| Beer, AJ; Dinges, J; Eiber, M; Loeffelbein, DJ; Mücke, T; Pickhard, A; Ritschl, LM; Schwaiger, M; Souvatzoglou, M; Wankerl, V | 1 |
| Gottstein, M; Graeter, T; Gruener, B; Haenle, MM; Kaltenbach, TE; Kratzer, W; Mason, RA; Oeztuerk, S | 1 |
| Chang, KJ; Cho, WH; Jeon, DG; Kong, CB; Lee, SY; Lim, I; Lim, SM | 1 |
| Atallah, I; Berta, E; Boyer, E; Karkas, A; Reyt, E; Righini, CA | 1 |
| Bayram, M; Erdoğan, EB; Özçelik, HK; Özkan, D; Sezer, M; Tabak, L; Yakar, A; Yakar, F | 1 |
| Gardin, I; Modzelewski, R; Monnehan, GA; Nkhali, L; Onoma, DP; Ruan, S; Thureau, S; Vera, P | 1 |
| Agarwal, R; Aggarwal, AN; Bal, A; Gupta, D; Gupta, N; Maturu, VN; Mittal, BR | 1 |
| Choi, HJ; Kang, WJ; Kim, GM; Kim, JH; Seo, HJ | 1 |
| Hattori, A; Matsunaga, T; Oh, S; Suzuki, K; Takamochi, K | 1 |
| Hag, AM; Keller, SH; Kjær, A; Knudsen, A; Lebech, AM; Loft, A; Møller, HJ; Ripa, RS; von Benzon, E | 1 |
| Barry, CE; Cai, Y; Carroll, MW; Chen, RY; Cho, SN; Coleman, MT; Dodd, LE; Goldfeder, LC; Hammoud, DA; Herscovitch, P; Jeon, D; Jeong, YJ; Lahouar, S; Lee, JD; Lee, M; Lee, S; Mountz, JM; Paripati, P; Park, SK; Rosenthal, A; Somaiyya, S; Tartakovsky, M; Via, LE; Zahiri, H; Zia, N | 1 |
| Kang, WJ; Kim, BS; Lee, JD | 1 |
| Cabrera-Martín, MN; Carreras, JL; García-Ramos, R; Matías-Guiu, J; Matias-Guiu, JA; Moreno-Ramos, T; Porta-Etessam, J | 1 |
| Acevedo-Báñez, I; Borrego-Dorado, I; García-Gómez, FJ; García-Gutiérrez, M; Martínez-Castillo, R; Tirado-Hospital, JL | 1 |
| Bozza, F; Cervino, AR; Evangelista, L; Ghiotto, C; Michieletto, S; Orvieto, E; Saibene, T | 1 |
| Boonya-ussadorn, T; Choi, WH; Chung, SK; Hyun, J; Kim, SH; Yoo, IeR | 1 |
| Bredella, MA; Chang, CY; Gill, CM; Huang, AJ; Joseph Simeone, F; Taneja, AK; Torriani, M | 1 |
| Baldari, S; Cistaro, A; Fox, J; Kuk, D; Quartuccio, N; Schöder, H; Wexler, LH | 1 |
| Cho, A; Kang, WJ; Kim, YT; Lee, JD; Lee, JH; Lee, JW; Yun, M | 1 |
| Bailly, P; Daouk, J; Jounieaux, V; Kamimura, M; Meyer, ME; Sacksick, D | 1 |
| Daldrup-Link, HE; Donig, J; Link, M; Quon, A; Rosenberg, J; Uslu, L | 1 |
| Ditt, H; Homann, G; Horger, M; Kopp, HG; Mustafa, DF; Nikolaou, K; Spengler, W | 1 |
| Arahata, Y; Fujiwara, K; Fukuyama, H; Ikeda, M; Ishii, K; Ito, K; Kato, T; Maeda, K; Meguro, K; Mitsuyama, Y; Okumura, A; Ouchi, Y; Senda, M; Washimi, Y; Yamamoto, Y | 1 |
| Alokla, K; Kheir, F; Palomino, J | 1 |
| Boellaard, R; Chamuleau, ME; Cillessen, SA; Hoekstra, OS; Hoetjes, N; Jauw, Y; Regelink, JC; Rizvi, SN; van de Ven, PM; Wondergem, MJ; Zijlstra, JM; Zweegman, S | 1 |
| Nakstad, PH | 1 |
| Kubota, K; Mimori, A; Yamashita, H | 1 |
| Hyde, C; Martin, S; Sachpekidis, C; Smailagic, N; Ukoumunne, O; Vacante, M | 1 |
| Kang, H; Kim, E; Kim, H; Kim, YK; Lee, D; Lee, DS; Lee, H; Lee, Y | 1 |
| Frey, S; Hoermann, K; Piniol, R; Sadick, H; Sadick, M; Schoenberg, SO; Weiss, C | 1 |
| Geng, J; Li, X; Nie, F; Zhang, B | 1 |
| Cheng, D; Li, W; Lin, J; Tang, K; Tong, L; Yin, W; Zhao, L; Zheng, S; Zheng, X | 1 |
| Aksu, R; Inal, A; Isikdogan, A; Kaplan, MA; Kucukoner, M; Tasdemir, B; Teke, F; Teke, M; Urakci, Z | 1 |
| Henes, J; la Fougère, C; Nikolaou, K; Pfannenberg, C; Schüle, SC; Xenitidis, T | 1 |
| Barkhof, F; Caroli, A; Carter, SF; Choo, IH; Frisoni, GB; Nordberg, A; Ossenkoppele, R; Prestia, A; Scheltens, P; Schöll, M; Teunissen, CE; Van Berckel, B; van der Flier, WM; Wade, SK; Wall, A | 1 |
| Cabrera-Martín, MN; Carreras, JL; Fernandez-Matarrubia, M; García-Ramos, R; Matías-Guiu, J; Matías-Guiu, JA; Moreno-Ramos, T; Oreja-Guevara, C; Ortega-Candil, A; Pérez-Castejón, MJ; Rodríguez-Rey, C | 1 |
| Napolska, K; Wrzesień, M | 1 |
| Ahmed, FZ; Al-Bahrani, G; Armstrong, I; Arumugam, P; Burns, P; Clarke, B; Cunnington, C; Fullwood, C; Hooper, J; James, J; Mamas, MA; Motwani, M; Qamruddin, A; Sandoe, JA; Tout, D; Zaidi, AM | 1 |
| Blakeley, JO; Chaudhry, M; Chirindel, A; Wahl, R | 1 |
| Bhasin, D; Bhattacharya, A; Gupta, R; Kang, M; Kapoor, R; Mittal, BR; Rana, S; Santhosh, S | 1 |
| Andrianasolo, M; Benyamine, A; Cammilleri, S; Daumas, A; Granel, B; Jean, E; Scafi, M | 1 |
| Li, D; Liu, S; Ming, M; Shi, B; Wang, ZG; Wu, F; Xue, W | 1 |
| Arakawa, Y; Fushimi, Y; Kanagaki, M; Kataoka, M; Minamiguchi, S; Miyamoto, S; Okada, T; Okuchi, S; Takahashi, JC; Togashi, K; Yamamoto, A; Yamauchi, M | 1 |
| Antoniou, A; Ladenson, P; Marcus, C; Rahmim, A; Subramaniam, RM | 1 |
| Aloia, TA; Baiomy, A; Chasen, B; Fox, P; Loyer, EM; Peungjesada, S; Shin, S | 1 |
| Byun, BH; Cho, WH; Chung, SK; Jeon, DG; Kim, SH; Koh, JS; Kong, CB; Lee, SY; Lim, I; Lim, SM; Song, WS | 1 |
| Gatidis, S; la Fougère, C; Nikolaou, K; Schmid, M; Schmidt, H; Schraml, C; Schwenzer, NF | 1 |
| Fan, Y; Fu, ZL; Kang, L; Ma, C; Wang, RF; Xu, XJ; Zhang, JH; Zhang, XC | 1 |
| Bartenstein, P; Chalkidis, RP; Cyran, CC; Fendler, WP; Hacker, M; Herrmann, K; Ilhan, H; Issels, RD; Knösel, T; Lindner, LH | 1 |
| Brouwer, E; Comans, EF; Glaudemans, AW; Lensen, KD; Pereira Arias-Bouda, LM; Slart, RH; Smulders, YM; van der Laken, CJ; Voskuyl, AE; Zwijnenburg, AT | 1 |
| Aldred, VL; Buccheri, V; Cerci, JJ; de Paula, HM; Gonçalves, Mde C; Linardi, Cda C; Siqueira, SA; Zerbini, MC | 1 |
| Boersma, HH; de Haas, HJ; Dierckx, RA; Elsinga, PH; Glaudemans, AW; Golestani, R; Koole, M; Luurtsema, G; Mirfeizi, L; Slart, RH; Tio, RA; Westra, J; Zeebregts, CJ | 1 |
| Huber, GF; Hüllner, M; Kollias, S; Meerwein, CM; Queiroz, M; Veit-Haibach, P | 1 |
| Dong, X; Li, W; Sun, X; Wan, H; Wu, P; Xing, L; Yu, J | 1 |
| McCarville, MB; Navid, F; Ostermeier, A; Shulkin, BL; Snyder, SE | 1 |
| Duong, C; Hicks, RJ; Kaneko, Y; Link, E; Murray, WK | 1 |
| Emri, G; Erdei, I; Fedinecz, N; Galuska, L; Gellén, E; Janka, E; Juhász, I; Lukács, R; Péter, Z; Remenyik, É; Sántha, O | 1 |
| Duan, Y; Fan, T; Guo, Y; Li, J; Shang, D; Shao, Q; Sun, X; Wang, W; Xu, M; Zhang, Y | 1 |
| Chua, S; Cook, GJ; Dearnaley, DP; Horwich, A; Huddart, RA; Sohaib, A | 1 |
| Antoch, G; Buchbender, C; Gomez, B; Grueneisen, J; Heusch, P; Rosenbaum-Krumme, S; Ruhlmann, V; Schaarschmidt, BM; Umutlu, L | 1 |
| Chen, L; Li, Z; Xu, G; Yu, Y; Zhang, H | 1 |
| Akslen, LA; Biermann, M; Brauckhoff, K; Brauckhoff, M; Haugland, HK; Heinecke, A; Kråkenes, J; Varhaug, JE | 1 |
| Balar, AV; Friedman, KP; Huang, WC; Jackson, K; Rosenkrantz, AB | 1 |
| Altinel, D; Cardona, K; Delman, KA; El-Rayes, B; Hawk, N; Kooby, DA; Maithel, SK; Russell, MC; Sarmiento, JM; Schuster, DM; Squires, MH; Staley, CA; Volkan Adsay, N; Winer, JH | 1 |
| Amraoui, S; Amroui, S; Bordachar, P; Bordenave, L; Hindié, E; Mesguich, C; Rivière, A; Tlili, G | 1 |
| Alifano, M; Caillat-Vigneron, N; Farid, K; Petras, S; Poullias, X; Regnard, JF; Servois, V | 1 |
| Erdogan, E; Kanmaz, B; Mut, S; Ozturk, T; Sager, S; Sonmezoglu, K; Teksoz, S; Vatankulu, B | 1 |
| Bernstine, H; Cohen, N; Groshar, D; Kosashvili, Y; Luria, T; Shemesh, S; Sidon, E; Velkes, S | 1 |
| Arisawa, T; Hosoki, T; Kawada, N; Shiroeda, H; Takami, M; Tomita, Y; Uehara, H | 1 |
| Nesterov, DV; Rozengauz, EV | 1 |
| Chen, T; Deng, Z; Jia, L; Li, G; Liu, C; Xiang, X | 1 |
| He, X; Huo, Y; Ma, C; Shao, M; Sun, L | 1 |
| Bankstahl, JP; Bankstahl, M; Kuntner, C; Langer, O; Sauberer, M; Traxl, A; Wanek, T | 1 |
| Kondo, T; Matoba, M; Oota, K; Shimode, Y; Tonami, H; Tuji, H | 1 |
| Aronen, HJ; Auren, J; Huovinen, R; Jambor, I; Kajander, S; Kauppila, E; Kemppainen, J; Kuisma, A; Merisaari, H; Minn, H; Noponen, T; Ramadan, S; Sandell, M; Saunavaara, J; Seppänen, M | 1 |
| Chan, HP; Hu, C; Huang, TC; Peng, NJ; Yu, CC | 1 |
| Han, X; Ji, G; Pei, B; Qiang, Y; Shi, Z; Zhao, J | 1 |
| Bae, KT; Goshima, S; Hirose, Y; Kanematsu, M; Kawada, H; Kawai, N; Kondo, H; Matsunaga, K; Nishibori, H; Noda, Y; Suzui, N; Tanahashi, Y; Watanabe, H | 1 |
| Bolton, D; Chang, JH; Clouston, D; Davis, ID; Esler, S; Goh, YP; Gong, SJ; Hiew, CY; Khoo, V; Lee, ST; Lim Joon, D; O'Sullivan, R; Scott, AM; Wada, M | 1 |
| Dang, Y; Jiang, J; Qiao, Z; Shi, R; Song, W; Sui, X; Wang, Y; Wang, Z; Zhang, B; Zhang, W; Zhang, Y | 1 |
| Abramson, RG; Abramson, VG; Arlinghaus, LR; Chakravarthy, AB; Jones-Jackson, LB; Lambert, KF; Williams, J; Yankeelov, TE | 1 |
| Hamaoka, T; Nirengi, S; Saito, M; Sugie, H; Yoneshiro, T | 1 |
| Carlson, ER; Heidel, RE; Schaefferkoetter, JD | 1 |
| Chang, HT; Chang, TH; Chiu, YL; Chou, CP; Fu, TY; Hu, C; Pan, HB; Peng, NJ | 1 |
| Diehl-Schmid, J; Drzezga, A; Förster, S; Grimmer, T; Meng, C; Mulej Bratec, S; Pasquini, L; Riedl, V; Scherr, M; Schwaiger, M; Shi, K; Sorg, C; Tahmasian, M; Yakushev, I | 1 |
| Han, YJ; Li, HS; Tian, Y; Wang, L; Wang, QS; Wu, HB; Zhou, WL | 1 |
| Buskens, E; de Bock, GH; de Vries, EF; de Vries, EG; Feenstra, T; Glaudemans, AW; Greuter, MJ; Hospers, GA; Koleva-Kolarova, RG; van Kruchten, M; Vermeulen, KM | 1 |
| Chazan, R; Dabrowska, M; Korczynski, P; Krenke, R; Kunikowska, J; Maskey-Warzechowska, M; Orłowski, T; Zukowska, M | 1 |
| Chen, L; Cheng, L; Li, H; Wang, J; Xie, Q; Zhang, L; Zhang, Y | 1 |
| Barber, PV; Booton, R; Califano, R; Crosbie, PA; Evison, M; Martin, J; Summers, Y | 1 |
| Dank, M; Györke, T; Kajáry, K; Kulka, J; Lengyel, Z; Molnár, BÁ; Szentmártoni, G; Tőkés, AM; Tőkés, T; Torgyík, L | 1 |
| Jiang, C; Lei, J; Li, J; Yan, R | 1 |
| Bernard, R; Ceccaldi, M; Didic, M; Felician, O; Gour, N; Guedj, E; Mundler, O; Pécheux, C | 1 |
| Chowdhury, FU; Patel, CN; Scarsbrook, AF; Vaidyanathan, S | 1 |
| Chang, WC; Chen, BB; Chen, CA; Chen, CH; Chen, XJ; Cheng, WF; Chiang, YC; Sheu, BC; Shih, IL; Shih, TT; Torng, PL; Tseng, YH; Wei, LH; Wei, SY; Yen, ML; Yen, RF | 1 |
| Drzezga, A; Förster, S; Kramer, S; Kurz, A; Li, R; Perneczky, R; Yakushev, I | 1 |
| Biersack, HJ; Buermann, J; Essler, M; Gärtner, FC; Skowasch, D | 1 |
| Chin-Lenn, L; McKinnon, JG; Teman, CJ; Urbanellis, P | 1 |
| Akdoğan, V; Canpolat, T; Erkan, AN; Özlüoğlu, LN; Reyhan, M; Yaşar, M; Yılmaz, İ; Yılmazer, C | 1 |
| Alvarez, J; Bilbao, P; Cacicedo, J; Del Hoyo, O; Dolado, A; Espinosa, JM; Fernandez, I; Gaafar, A; Gómez-Suarez, J; Hortelano, E; Pijoan, JI; Sancho, A | 1 |
| Goense, L; Lam, MG; Meijer, GJ; Reitsma, JB; Ruurda, JP; van Hillegersberg, R; van Rossum, PS; van Vulpen, M | 1 |
| Laffon, E; Marthan, R | 1 |
| Kebebew, E; Summers, RM; Wong, KC; Yao, J | 2 |
| Deng, H; Jia, Z; Shen, G; Wang, Q; Zhang, W; Zhou, L | 1 |
| Ahn, BC; Ahn, D; Choi, JH; Kim, H; Na, KJ; Sohn, JH | 1 |
| Chen, L; Hu, W; Wang, Y; Wei, G; Xian, W; Zhang, N | 1 |
| Fletcher, J; Maluccio, M; McCarthy, BP; Riley, AA; Saxena, R; Skill, NJ; Tann, M; Territo, PR | 1 |
| Chang-Hong, L; Dan, S; Qiang, G; Shu-Xia, W | 1 |
| Chen, S; Dong, Y; Ma, C; Wang, S; Zhang, X | 1 |
| Altini, C; Di Palo, A; Fanelli, M; Ferrari, C; Moschetta, M; Niccoli Asabella, A; Rubini, G | 1 |
| Capirci, C; Colletti, PM; Maffione, AM; Marzola, MC; Rubello, D | 1 |
| Koeppe, R; Nan, B; Shu, H | 1 |
| Kang, WJ; Kim, J; Koh, YW; Lee, JH; Shin, NY; Sohn, B | 1 |
| An, DZ; Han, D; Li, BS; Sun, JL; Wang, ZT; Zhang, DK; Zhao, Q | 1 |
| Christian, G; Hungerer, S; Linke, R; Militz, M; Morgenstern, M; Uhde, J | 1 |
| Arbizu, J; de Castro, P; Domínguez-Prado, I; Luquin, MR; Ortega-Cubero, S; Prieto, E; Ribelles, MJ; Riverol, M | 1 |
| Steinke, K; Thomas, PA; Whitley, JM; Zaheer, SN | 1 |
| Higaki, J; Inoue, T; Miki, H; Miyagawa, M; Mochizuki, T; Ogimoto, A; Okayama, H; Yokoyama, R | 1 |
| Fujii, Y; Fukui, I; Kihara, K; Kohno, A; Koizumi, M; Komai, Y; Masuda, H; Sakai, Y; Tanaka, H; Urakami, S; Yamamoto, S; Yonese, J; Yoshida, S; Yuasa, T | 1 |
| Biermann, M; Bjørge, L; Haldorsen, IS; Husby, JA; Magnussen, IJ; Reitan, BC; Salvesen, HB; Salvesen, ØO; Trovik, J | 1 |
| Alanen, K; Grönroos, J; Gullichsen, R; Kajander, S; Kauhanen, S; Kemppainen, J; Nuutila, P; Ovaska, J; Rinta-Kiikka, I; Seppänen, M | 1 |
| Agarwala, S; Bakhshi, S; Bal, C; Bhatnagar, V; Dhull, VS; Kumar, R; Kundu, P; Patel, C; Sharma, P | 1 |
| Kwak, K; Lee, JM; Yun, HJ | 1 |
| Semiglazov, V | 1 |
| Arbizu, J; Chételat, G; Drezgza, A; Garibotto, V; Hesse, S; Lammertsma, AA; Law, I; Morbelli, S; Pagani, M; Pappata', S; Payoux, P; Van De Giessen, E | 1 |
| Cho, A; Kang, WJ; Park, JY; Park, YJ; Song, EH; Song, HT | 1 |
| Bivalacqua, TJ; Blackford, A; Carter, HB; Cho, SY; Cornish, TC; Dannals, RF; Faraj, SF; Gage, KL; Gonzalez-Roibon, N; Guner, G; Han, M; Holt, D; Lodge, MA; Macura, KJ; Mease, RC; Munari, E; Netto, GJ; Partin, AW; Pavlovich, CP; Pomper, MG; Rowe, SP | 1 |
| Hiraishi, H; Nakano, M; Sakamoto, S; Sugaya, H; Sugaya, T; Tominaga, K | 1 |
| Bolen, MA; Brunken, RC; DiFilippo, FP; Obuchowski, NA; Oldan, JD; Shah, SN | 1 |
| Adamiak, P; Czepczyński, R; Fularz, M; Jarząbek-Bielecka, G; Kędzia, W; Rewers, A; Ruchała, M | 1 |
| Prestwich, RJ; Ramasamy, S; Scarsbrook, AF; Sen, M; Slevin, F; Subesinghe, M | 1 |
| Benz, DC; Buechel, RR; Clerc, OF; Fuchs, TA; Gaemperli, O; Gräni, C; Herzog, B; Kaufmann, PA; Liga, R; Mikulicic, F; Pazhenkottil, AP; Possner, M; Stehli, J; Ter Voert, EE; Veit-Haibach, P; Vontobel, J | 1 |
| Basu, S; Pawaskar, AS | 1 |
| Arridge, SR; Atkinson, D; Burgos, N; Cardoso, MJ; Dickson, J; Hutton, BF; Modat, M; Ourselin, S; Schott, JM; Thielemans, K | 1 |
| An, YS; Jeon, GS; Jung, YS; Kang, DK; Kim, TH; You, S | 1 |
| Baek, JH; Cho, SH; Choi, YJ; Kim, DY; Kim, HO; Kim, N; Kim, SY; Koh, MJ; Lee, JH; Yoon, RG | 1 |
| Conti, M; Schaefferkoetter, JD; Townsend, DW; Yan, J | 1 |
| Chen, F; Date, H; Hasegawa, S; Hatano, E; Iwamoto, M; Kawada, K; Nakamoto, Y; Sakai, Y; Toda, K; Togashi, K; Uemoto, S | 1 |
| Ichimura, K; Kaji, M; Kanazawa, S; Mitsuhashi, T; Miyoshi, S; Sato, S; Shinya, T; Soh, J; Tanaka, T; Toyooka, S | 1 |
| Alberini, JL; Bertrand, F; Champion, L; Fourme, E; Gontier, E; Lerebours, F; Wartski, M | 1 |
| Møller, N; Sørensen, M; Trägårdh, M | 1 |
| Ahsanuddin, S; Ashamalla, H; Foster, A; Mattes, MD; Moshchinsky, AB; Rimner, A; Rizk, NP; Weber, WA; Wu, AJ | 1 |
| Altrinetti, V; Bongioanni, F; DeCensi, A; Gennari, A; Gonella, R; Iacozzi, M; Massollo, M; Morbelli, S; Paparo, F; Piccardo, A; Puntoni, M; Sambuceti, G | 1 |
| Chang, CP; Chang, CW; Chang, CY; Cheng, CY; Chu, LS; Liu, RS; Shih, CC; Wang, SJ; Yang, BH | 1 |
| Cook, GJ; Grecchi, E; O'Doherty, J; Tsoumpas, C; Turkheimer, FE; Veronese, M | 1 |
| de Nijs, R; Dyssegaard, A; Feng, L; Fischer, W; Guilloteau, D; Jensen, P; Knudsen, GM; Larsen, VA; Law, I; Mikkelsen, JD; Pinborg, LH; Svarer, C; Thomsen, G | 1 |
| Ishihara, T; Kitajima, K; Kiyota, N; Minamikawa, T; Nibu, K; Otsuki, N; Sasaki, R; Suenaga, Y; Sugimura, K | 1 |
| Baek, JH; Choe, J; Choi, CM; Kim, HJ; Kim, MY | 1 |
| Bird, N; Buscombe, J; Cheow, HK; Eisen, T; Fife, K; Gallagher, FA; Gerety, EL; Heard, S; Hilborne, S; Lawrence, EM; Lomas, DJ; Matakidou, A; Shaw, AS; Soloviev, D; Wason, J; Yan, H | 1 |
| Ayres, KL; Delbeke, D; Hodges, PK; Martin, WH; Price, R; Spottswood, SE; Wang, L | 1 |
| Ahlström, H; Molin, D; Mosavi, F; Selling, J; Wassberg, C | 1 |
| Khong, PL; Tong, DK; Vardhanabhuti, V; Yuan, H | 1 |
| Kassai, Y; Koyama, H; Matsumoto, S; Ohno, Y; Sugimura, K; Takenaka, D; Yoshikawa, T; Yui, M | 1 |
| Antoch, G; Bergmann, C; Buchbender, C; Forsting, M; Heusch, P; Ruhlmann, M; Ruhlmann, V; Schaarschmidt, BM; Schlamann, M; Wetter, A | 1 |
| Fang, W; Lu, M; Ma, X; Wang, L; Xiang, L; Yan, C; Zhao, S | 1 |
| Abdelbaky, A; Cypess, AM; Flynn, A; Li, Q; MacNabb, M; Panagia, M; Samir, A; Scherrer-Crosbie, M; Tawakol, A; Weyman, AE | 1 |
| Alongi, P; Evangelista, L; Gianolli, L; Picchio, M; Saladini, G; Spallino, M; Zattoni, F | 1 |
| Akamatsu, G; Ikari, Y; Maebatake, A; Nishida, H; Nishio, T; Ohnishi, A; Sasaki, M; Senda, M | 1 |
| Abe, K; Baba, S; Honda, H; Kamitani, T; Kawanami, S; Matsuo, Y; Nagao, M; Nakamura, K; Okamoto, T; Sasaki, M; Sunami, S; Yabuuchi, H; Yamamoto, H; Yamasaki, Y; Yonezawa, M | 1 |
| Ishihara, Y; Matsuki, T; Miura, K; Miura, N; Miyoshi, F; Ogawa, T; Ping, B; Shinohara, Y; Shiota, G; Tanabe, Y; Tanaka, N; Tsuno, S; Wang, X; Yamashita, T | 1 |
| Aguadé-Bruix, S; Almirante, B; Castell-Conesa, J; Cuéllar-Calabria, H; Fernández-Hidalgo, N; Ferreira-González, I; Galiñanes, M; Garcia-Dorado, D; González, JJ; Gonzàlez-Alujas, MT; Gracia-Sánchez, L; Maisterra-Santos, O; Oristrell, G; Pizzi, MN; Rodríguez-Palomares, J; Roque, A; Tornos, P | 1 |
| Duncker-Rohr, V; Eschmann, SM; Essler, M; Grosu, AL; Holl, G; König, J; Leifert, A; Miederer, M; Mix, M; Nestle, U; Plotkin, M; Puskas, C; Rischke, HC; Rühl, F; Schimek-Jasch, T; Tosch, M; Vach, W | 1 |
| Beadsmoore, C; MacIver, D; Newman, D; Pawaroo, D | 1 |
| Furuhashi, H; Furukawa, S; Kise, Y; Moriyama, M; Nakamura, S; Ohyama, Y; Okamura, K; Shimizu, M; Takeshita, Y; Weerawanich, W; Yoshiura, K | 1 |
| Borghammer, P; Haraldsen, A; Hjorthaug, K; Højbjerg, JA; Knap, MM; Kramer, SM; Tietze, A; Zacho, HD | 1 |
| English, JF; Sullivan, TJ | 1 |
| Claxton, Z; Fagan, AJ; Harmon, M; Johnston, C; Keogan, M; Malik, V; Meaney, JF; Muldoon, C; O'Toole, D; Ravi, N; Reynolds, JV | 1 |
| Castetbon, V; de Clermont-Galleran, H; de Monès, E; Digue, L; Fernandez, P; Ghafouri, A; Haaser, T; Sagardoy, T | 1 |
| Fukuyama, H; Ito, K; Oishi, N; Ota, K | 1 |
| Asti, M; Cavuto, S; De Berti, G; Erba, PA; Filice, A; Fraternali, A; Froio, A; Iaccarino, C; Iori, M; Pisanello, A; Sghedoni, R; Sollini, M; Versari, A | 1 |
| Adam, G; Derlin, T; Mautner, VF; Salamon, J | 1 |
| Cha, J; Hwang, SH; Jo, K; Kim, D; Lee, N; Yun, M | 1 |
| Kang, JK; Kang, KS; Kim, JS; Kim, KS; Lee, EM; Oh, JS; Park, GY; Seo, MS; Seo, YJ; Son, WC | 1 |
| Balsa-Bretón, MÁ; Guijarro-Armas, G; Merino-Viveros, M; Pavón-Paz, I; Penín-Gonzalez, FJ; Rosado-Sierra, JA | 1 |
| Ardito, A; Arena, V; Basile, V; Brambilla, R; Duregon, E; Massaglia, C; Pelosi, E; Penna, D; Perotti, P; Terzolo, M; Vigna-Taglianti, F; Zaggia, B | 1 |
| Baba, A; Fugo, K; Fukamizu, Y; Hasegawa, R; Ishige, N; Kagayama, S; Kishimoto, T; Koike, N; Motoyoshi, Y; Oshima, Y; Ozaki, A; Shinozaki, F; Shirai, Y; Sugiyama, E; Sugiyama, T; Sunaoshi, T; Tomizawa, M; Toshimitsu, Y; Uchida, Y; Uchiyama, K; Yamamoto, S | 1 |
| de Bree, R; Hoekstra, OS; Leemans, CR; Senft, A; Witte, BI | 1 |
| Alexander, DC; Ourselin, S; Oxtoby, NP; Schott, JM; Young, AL | 1 |
| Dong, J; Li, J; Li, Z; Liu, F; Wang, B; Zhang, Q; Zhou, D; Zhu, D | 1 |
| Arslan, N; Aydin, E; Dadali, Y; Gokcek, A; Okuyucu, K; Ozmen, O; Tatci, E; Yilmaz, U | 1 |
| Burger, IA; Hüllner, M; Queiroz, MA; Samarin, A; Stolzmann, P; Veit-Haibach, P; von Schulthess, G | 1 |
| Jiang, L; Panje, CM; Shi, H; Tan, H; Xiu, Y; Yu, H | 1 |
| Abe, K; Kondo, T; Nakajima, R; Sakai, S; Tanabe, K | 1 |
| Cama, A; Garrè, ML; Mascelli, S; Massollo, M; Milanaccio, C; Morana, G; Nozza, P; Piccardo, A; Puntoni, M; Raso, A; Rossi, A | 1 |
| Chung, YA; Ham, HJ; Jang, KS; Jung, YJ; Lee, J; Lee, JH; Maeng, LS; Park, MS; Park, SI | 1 |
| Kim, SJ; Lee, CH; Pak, K; Yun, MS | 1 |
| Brambilla, D; Fazio, N; Galetta, D; Gasparri, R; Maisonneuve, P; Paganelli, G; Petrella, F; Rezende, GC; Spaggiari, L; Travaini, LL | 1 |
| Jun, S; Kim, H; Nam, HY | 1 |
| Machida, Y; Maeda, S; Matoba, M; Motono, N; Sagawa, M; Tanaka, M; Tonami, H; Ueda, Y; Ueno, M; Usuda, K; Watanabe, N | 1 |
| Joshua, AM; Langer, DL; Metser, U; Singnurkar, A; Wang, J | 1 |
| Berland, Y; Bobot, M; Burtey, S; Cammilleri, S; Dussol, B; Fournier, PE; Ghez, C; Gondouin, B; Jourde-Chiche, N; Legris, T; Sallée, M; Souteyrand, P; Tessonnier, L | 1 |
| Ji, YH; Lv, L; Tian, Y; Wang, QS; Wang, SB; Wu, HB; Zhou, WL | 1 |
| Freesmeyer, M; Kapfhammer, A; Lesser, T; Reissig, A; Steinert, M; Winkens, T | 1 |
| Li, Y; Qin, Y; Tian, M; Wang, D; Wang, X; Yu, L | 1 |
| Chi, K; Daldrup-Link, HE; Gawande, R; Klenk, C; Leung, JT; Luna-Fineman, S; McMillan, A; Owen, D; Quon, A; Sakamoto, KM; Tran, VT | 1 |
| Becker, CD; Becker, M; Bodmer, A; Botsikas, D; Copercini, M; Delattre, BM; Djema, DA; Garibotto, V; Kalovidouri, A; Monnier, S; Montet, X; Ratib, O; Tabouret-Viaud, C | 1 |
| Agrawal, N; Chan, JY; Mydlarz, WK; Qualliotine, JR; Wang, H; Zhou, X | 1 |
| Aliyev, A; Ekmekcioglu, O; Halaç, M; Ozhan, M; Sager, S; Sönmezoğlu, K; Uslu, L; Vatankulu, B; Yilmaz, S | 1 |
| Cho, YS; Choi, JY; Hong, SP; Kim, BT; Lee, KH; Moon, SH; Noh, TS | 1 |
| Bousquet, F; Cathelinaud, O; Fakhry, N; Giovanni, A; Morvan, JB; Rivière, D; Vatin, L; Verdalle, P | 1 |
| Alavi, A; Rubello, D; Yang, H; Zhuang, H | 1 |
| Pei, S; Wei, J; Zhu, X | 1 |
| Albert, NL; Bartenstein, P; Cyran, CC; Fendler, WP; Friederichs, J; Hacker, M; Hungerer, S; Lehner, S; Militz, M; Müller, JP; Wenter, V | 1 |
| Baillet, C; Dewalle-Vignion, AS; Fechter, T; Gardin, I; Gibon, D; Massoptier, L; Modzelewski, R; Nemer, U; Nestle, U; Parcq, C; Schaefer, A; Vera, P; Vermandel, M | 1 |
| Chen, S; Fang, F; Huo, Y; Ma, C; Wang, H; Wang, S; Wu, S; Wu, Z; Ye, Z; Zou, R | 1 |
| Arakawa, J; Fujikawa, A; Kastushika, S; Nagai, T | 1 |
| Kuwert, T; Ritt, P | 1 |
| Alavi, A; Grupe, P; Houshmand, S; Høilund-Carlsen, PF; Salavati, A; Segtnan, EA | 1 |
| Bertolino, A; Dukart, J; Sambataro, F | 1 |
| Chang, S; Kim, SJ | 1 |
| Ali, A; Tawakol, A | 1 |
| Bach-Gansmo, T; Dormagen, JB; Godt, JC; Holtedahl, JE; Johansen, CK; Kløw, NE; Labori, KJ; Schulz, A; Viktil, E | 1 |
| Choi, YJ; Hwang, HS; Kim, MJ; Kwon, MJ; Lee, BH | 1 |
| Jager, PL; Knollema, S; Koopman, D; Slump, CH; Stigt, JA; van Dalen, JA | 1 |
| Emmett, L; Hickey, AJ; Huang, Y; Le, K; Tang, R; Wang, JT; Wang, L | 1 |
| Chang, L; Cheng, MF; Huang, JY; Jou, ST; Ko, CL; Tzen, KY; Yen, RF | 1 |
| Karan, B; Pourbagher, A; Torun, N | 1 |
| Duan, L; Li, J; Qiu, H; Tian, T; Wang, D; Wang, J; Zhang, Q; Zhang, X | 1 |
| Antoch, G; Beiderwellen, K; Bockisch, A; Buchbender, C; Forsting, M; Heusch, P; Kühl, H; Quick, HH; Ruhlmann, V | 1 |
| Itoh, T; Kanda, T; Kitajima, K; Nibu, K; Otsuki, N; Sasaki, R; Suenaga, Y; Sugimura, K | 1 |
| Anwar, B; George, MM; Homer, JJ; Mani, N; Nash, L | 1 |
| Fledelius, J; Frøkiaer, J; Hjorthaug, K; Khalil, AA | 1 |
| Beech, P; Chong, A; Jong, I; Lavender, I; Nandurkar, D; Ramdave, S; Soo, G | 1 |
| Cai, G; Cai, S; Li, D; Li, X; Peng, J; Shi, D; Xu, Y | 1 |
| Kiyohara, H; Nakano, T; Ohno, T; Saito, K; Takagishi, K; Yanagawa, T | 1 |
| Fuchigami, T; Hayasaka, D; Morita, K; Nishi, K; Onouchi, T; Shimada, S; Shiogama, K; Tsutsumi, Y | 1 |
| Arai, Y; Chiba, Y; Hata, M; Komatsu, M; Nishimura, G; Oridate, N; Sano, D; Shiono, O; Taguchi, T; Takahashi, H; Takahashi, M; Yabuki, K | 1 |
| Doi, H; Fukushima, K; Hirota, S; Igarashi, Y; Katsuura, T; Kawanaka, Y; Kitajima, K; Maruyama, K; Miyoshi, Y; Mouri, M; Yamakado, K; Yamano, T | 1 |
| Chen, J; Fang, W; Garcia, EV; Liang, Y; Wang, L; Yang, Y; Zhou, W | 1 |
| Andersen, JD; Lange, MB; Lilholt, HJ; Nielsen, ML; Petersen, LJ; Vyberg, M | 1 |
| Dong, Y; Tian, Y; Wang, LJ; Wang, QS; Wu, HB; Zhou, WL | 1 |
| Gámez, C; Gascon-Bayarri, J; Paipa, A; Povedano, M; Reñé, R; Rico, I; Turon-Sans, J | 1 |
| Balbo-Mussetto, A; Bruna, R; Cirillo, S; De Crescenzo, A; Fornari, A; Gottardi, D; Gueli, A; Lario, CV; Petracchini, M; Saviolo, C; Tarella, C | 1 |
| Bodelle, B; Fischer, S; Grünwald, F; Luboldt, HJ; Luboldt, W; Vogl, TJ; Wiedemann, B | 1 |
| Ahmad, S; Algan, O; Algan, S; Ali, I; Confer, M; Herman, T; Matthiesen, C | 1 |
| Califano, J; Fakhry, C; Marcus, C; Subramaniam, RM; Taghipour, M | 1 |
| Aydin, Y; Eroğlu, A; Genc, B; Kantarci, M; Karaca, L; Ogul, H; Okur, A; Orsal, E; Sade, R | 1 |
| Dolak, W; Giraudo, C; Karanikas, G; Kiesewetter, B; Mayerhoefer, ME; Raderer, M; Simonitsch-Klupp, I; Weber, M | 1 |
| Ishai, A; MacNabb, MH; Scherrer-Crosbie, M; Takx, RA; Tawakol, A; Truong, QA | 1 |
| Fujikawa, S; Kanda, T; Kawai, M; Koga, M; Ogasawara, J; Omoto, M | 1 |
| Bala, G; Blykers, A; Broisat, A; Caveliers, V; Cosyns, B; Descamps, B; Devoogdt, N; Droogmans, S; Fagret, D; Ghezzi, C; Hernot, S; Lahoutte, T; Van Camp, G; Vanhove, C; Xavier, C | 1 |
| Dauchy, FA; de Clermont-Gallerande, H; Dupon, M; Dutertre, A; Dutronc, H; Fernandez, P; Fournier, C; Lawson-Ayayi, S; Vital, JM; Zanotti-Fregonara, P | 1 |
| Guo, Q; Ma, J; Ma, Q; Sun, H; Xin, J; Zhang, S; Zhao, X | 1 |
| Al Bashir, S; Al-Muqbel, KM; Al-Omari, MH; Dagher, NM; Rousan, LA; Yaghan, RJ | 1 |
| Abouzied, ME; Al-Bulushi, NK | 1 |
| Binse, I; Bockisch, A; Rosenbaum-Krumme, SJ; Ruhlmann, M | 1 |
| Huang, G; Li, P; Liu, J; Liu, Q; Song, S; Wang, C; Wang, T | 1 |
| Cheon, GJ; Chung, JK; Goo, JM; Im, HJ; Kang, KW; Kim, EE; Lee, DS; Lee, JS; Paeng, JC | 1 |
| Bochev, P; Chaushev, B; Dancheva, Z; Klisarova, A; Yordanova, T | 1 |
| Datz, L; Pirich, C; Rendl, G; Rettenbacher, L; Rodrigues, M; Stark, H; Studnicka, M | 1 |
| de Jong, VM; Goslings, JC; Schep, NW; Termaat, MF; van Eck-Smit, BL; van Vliet, KE | 1 |
| Boeckx, N; Deroose, CM; Dierickx, D; Gheysens, O; Goffin, KE; Morscio, J; Sagaert, X; Thielemans, S; Tousseyn, T; Verhoef, G; Wlodarska, I | 1 |
| Fukushima, K; Hirota, S; Igarashi, Y; Katsuura, T; Kawanaka, Y; Kitajima, K; Mouri, M; Yamakado, K; Yamamoto, S | 1 |
| Choi, JY; Han, J; Heo, JH; Jang, SJ; Kim, BT; Kim, J; Kim, K; Lee, JY; Shim, YM | 1 |
| Bradley, KM; di Carlo, S; Findlay, JM; Franklin, JM; Gillies, RS; Gleeson, FV; Jones, GE; Maynard, ND; Middleton, MR; Teoh, EJ | 1 |
| Kim, SJ; Pak, K; Park, DY; Shin, S | 1 |
| Cheng, W; Jing, H; Li, Y; Shao, H; Yu, L | 1 |
| Healy, MA; Reddy, RM; Wong, SL; Yin, H | 1 |
| Chan, I; Etemad-Rezai, R; Johnson, C; Landis, M; Louie, AV; Mattonen, SA; Palma, DA; Rodrigues, G; Senan, S; Ward, AD; Yeung, TP | 1 |
| Cho, YS; Choe, YS; Hyun, SH; Kim, BT; Kim, DK; Kim, S; Lee, J; Lee, JK; Lee, KH; Moon, SH | 1 |
| Agrawal, K; Gupta, R; Kaman, L; Kochhar, R; Mittal, BR; Singh, R; Singh, V; Verma, GR; Vineeth Kumar, PM | 1 |
| Chen, K; Guo, X; Li, R; Long, Z; Wu, X; Xu, L; Yao, L; Zhang, J | 1 |
| Adams, HJ; Kwee, TC | 1 |
| Gao, Q; Liang, CH; Shao, D; Tian, XW; Wang, SX | 1 |
| Ceccarini, J; Delva, A; Robberecht, W; Van Damme, P; Van Laere, K; Van Weehaeghe, D | 1 |
| Kuji, I; Ogura, H; Osaki, A; Saeki, T; Sakahara, H; Shigekawa, T; Takeuchi, H; Ueda, S; Ueda, Y; Yamane, T; Yoshizawa, N | 1 |
| Filipiak, KJ; Huczek, Z; Kobylecka, M; Kochman, J; Królicki, L; Kurek, A; Mazurek, K; Mazurek, T; Opolski, G; Zielenkiewicz, M | 1 |
| Adamson, PD; Newby, DE; Williams, MC | 1 |
| Álvarez Cabellos, R; Amo-Salas, M; Espinosa Aunión, R; García Vicente, AM; Jiménez Londoño, GA; Muñoz Sánchez, Mdel M; Pena Pardo, FJ; Relea Calatayud, F; Soriano Castrejón, Á | 1 |
| Kumar, R; Kumar, V; Malhotra, R | 1 |
| Aras, G; Demir, Ö; Erdoğan, MF; Köse, N; Özkan, E; Ünlütürk, U | 1 |
| Arlandini, A; Bertagna, F; Cabria, M; Casazza, S; Catrambone, U; Dib, B; Foppiani, L; Giovanella, L; Massollo, M; Paone, G; Paparo, F; Pastorino, A; Piccardo, A; Puntoni, M; Treglia, G | 1 |
| Bier, G; Eigentler, T; Garbe, C; Hoffmann, V; Kloth, C; Klumpp, B; La Fougère, C; Nikolaou, K; Othman, AE; Pfannenberg, C | 1 |
| Lortholary, O | 1 |
| Chen, Y; Du, R; Shen, Y; Song, F; Tian, M; Wu, S; Zhang, H; Zhang, K; Zhu, Y | 1 |
| Jones, S; Marcus, C; Sarangi, R; Subramaniam, RM; Taghipour, M; Trahan, TJ | 1 |
| Ahlawat, S; Baig, A; Blakeley, JO; Fayad, LM; Jacobs, MA | 1 |
| Doyle-Lindrud, S | 1 |
| Chang, MC; Chang, YT; Chen, BB; Chen, XJ; Cheng, MF; Kuo, TC; Lai, HS; Shih, IL; Shih, TT; Tien, YW; Wu, CH; Yang, SH | 1 |
| Goebel, J; Heusch, P; Nassenstein, K; Nensa, F; Poeppel, TD; Schlosser, T; Schweins, K; Tezgah, E | 1 |
| Azad, GK; Cook, GJ | 1 |
| Sheikhbahaei, S; Subramaniam, RM; Taghipour, M; Wray, R; Wright, JL | 1 |
| Brenot-Rossi, I; Delarbre, B; Houvenaeghel, G; Jalaguier-Coudray, A; Thomassin-Naggara, I; Viens, P; Villard-Mahjoub, R | 1 |
| Matsunaga, N; Shigemoto, Y; Suga, K | 1 |
| Aldelaijan, S; De Blois, F; Devic, S; Faria, S; Lehnert, S; Mohammed, H; Seuntjens, J; Tomic, N | 1 |
| Buck, A; Burgos, N; Cardoso, MJ; Delso, G; Huellner, M; Hutton, BF; Ourselin, S; Sekine, T; Ter Voert, EE; Veit-Haibach, P; Warnock, G | 1 |
| Kakugawa, Y; Matsuda, T; Matsumoto, M; Muramatsu, Y; Saito, H; Saito, Y; Sekiguchi, M; Terauchi, T | 1 |
| Arnulfo, A; Brambilla, M; Buemi, F; Carriero, A; Cassarà, A; Matheoud, R; Sacchetti, GM; Stecco, A | 1 |
| Ahn, SG; Choi, SE; Jeong, J; Jung, WH; Lee, HM; Lee, HW; Lee, MK; Yoo, H | 1 |
| Besson, FL; Chaumet-Riffaud, P; Durand, E; Goujard, C; Lambotte, O; Noel, N; Playe, M; Prigent, A | 1 |
| Barbolosi, D; Bardia, F; Baret, A; Barlesi, F; Ciccolini, J; Muracciole, X; Padovani, L; Taieb, D; Teissonnier, L | 1 |
| Eo, JS; Hong, JH; Jung, US; Kim, S; Lee, JK; Min, KJ | 1 |
| Berti, V; Comis, G; Freddi, I; Polito, C; Pupi, A; Rubello, D; Sorbi, S; Vanzi, E | 1 |
| Akers, SR; Alavi, A; Cheng, G; Rubello, D; Werner, TJ | 1 |
| Allkemper, T; Burg, MC; Heindel, W; Konnert, JR; Noto, B; Riemann, B; Schäfers, M; Stegger, L; Vrachimis, A; Weckesser, M; Wenning, C | 1 |
| Deng, HX; Gao, R; Jia, X; Xue, JJ; Yang, AM; Zhang, FR | 1 |
| Fujii, T; Kuwano, H; Tatsuki, H; Yajima, R | 1 |
| Ameye, L; Delaunoit, T; Deleporte, A; Demolin, G; Flamen, P; Garcia, C; Gauthier, N; Guiot, T; Hendlisz, A; Holbrechts, S; Lhommel, R; Maréchal, R; Van den Eynde, M; Vierasu, I; Woff, E | 1 |
| Couppé, C; Eliasson, P; Friberg, L; Kjær, M; Lonsdale, M; Magnusson, SP; Neergaard, C; Svensson, RB | 1 |
| Koyama, H; Lee, HY; Ohno, Y; Sugimura, K; Yoshikawa, T | 1 |
| Barré, L; Dhilly, M; Guillouet, S; Hovhannisyan, N; Leporrier, M | 1 |
| Boscá, L; Emami, H; Fayad, ZA; Gelfand, J; González-Ramos, S; Martín-Sanz, P; Mojena, M; Morss, A; Paz-García, M; Rosales-Mendoza, CE; Rudd, JH; Singh, P; Swanson, J; Tawakol, A | 1 |
| Ben-Haim, S; Chikman, B; Davidson, T; Eshed, I; Goldstein, J; Goshen, E | 1 |
| Ben-Haim, S; Davidson, T; Epelbaum, R; Garkaby, J; Goshen, E; Israel, O; Primashvili, N; Shapira, R | 1 |
| Alavi, A; Houshmand, S; Peter, J; Rubello, D; Werner, TJ | 1 |
| Baba, S; Hiwatashi, A; Honda, H; Iihara, K; Isoda, T; Iwaki, T; Kikuchi, K; Kitamura, Y; Kuga, D; Mizoguchi, M; Suzuki, SO; Togao, O; Yamashita, K; Yoshimoto, K | 1 |
| Cabello, J; Lukas, M; Nekolla, SG; Pyka, T; Ribeiro, A; Rota Kops, E; Shah, NJ; Yakushev, I; Ziegler, SI | 1 |
| Abdulrezzak, U; Kula, M; Kurt, YK; Tutus, A | 1 |
| Cheson, BD; Cordova, C; Esposito, G; Hill, EM; Nassif, S; Ozdemirli, M; Ujjani, CS; Wang, H | 1 |
| Abildgaard, N; Alavi, A; Christlieb, SB; Gerke, O; Høilund-Carlsen, PF; Kristensen, BW; Larsen, TS; Mylam, KJ; Møller, MB; Nielsen, AL; Olsen, BB; Olsen, KE; Rohde, M; Strandholdt, CN | 1 |
| Boellaard, R; de Langen, AJ; Frings, V; Hoekstra, OS; Hoetjes, N; Kramer, GM; Smit, EF | 1 |
| Berriolo-Riedinger, A; Brunotte, F; Cochet, A; Depardon, E; Dygai-Cochet, I; Fumoleau, P; Humbert, O; Kanoun, S; Lassere, M; Riedinger, JM; Tisserand, S; Toubeau, M; Vrigneaud, JM | 1 |
| Sheikhbahaei, S; Subramaniam, RM; Taghipour, M; Trahan, TJ | 1 |
| McMeekin, H; Pencharz, D; Wagner, T; Wickham, F | 1 |
| Balogova, S; Calzada, M; Cassou-Mounat, T; Devaux, JY; Garderet, L; Huchet, V; Kerrou, K; Mohty, M; Nataf, V; Talbot, JN | 1 |
| Dong, A; Gong, J; Jing, W; Wang, L; Wang, Y; Yang, P; Zhang, X | 1 |
| Castillo, R; Goldman, DA; Gönen, M; Jochelson, MS; Pinker-Domenig, K; Riedl, CC; Ulaner, GA; Wills, J | 1 |
| Li, Y; Liu, K; Ma, Y; Wang, D; Xu, W; Yang, Z | 1 |
| Abdel Rahman, H; Hamoda, A; Hassanein, O; Moussa, E; Omar, W; Raafat, T; Sedky, M; Youssef, A | 1 |
| Brualla González, L; Del Puig Cozar Santiago, M; Ferrer Rebolleda, J; García Hernández, T; Granero Cabañero, D; Roselló Ferrando, J; Sánchez Jurado, R; Vicedo González, A | 1 |
| Alongi, P; Bomanji, J; Fallanca, F; Gianolli, L; Incerti, E; Kayani, I; Picchio, M | 1 |
| Chang, CJ; Chang, WY; Chang, YC; Chao, A; Chou, HH; Hong, JH; Huang, SH; Huang, YE; Lai, CH; Lin, G; Liu, FY; Peng, NJ; Wang, CC; Yang, LY; Yen, TC | 1 |
| Christensen, JB; Holdgaard, PC; Høilund-Carlsen, PF; Madsen, PH | 1 |
| Barthel, H; Fahnert, J; Friedrich, B; Heyde, CE; Jarvers, JS; Kahn, T; Purz, S; Sabri, O; Stumpp, P | 1 |
| Li, W; Liang, F; Zhang, S | 1 |
| Albano, D; Bertagna, F; Bosio, G; Dib, B; Giubbini, R; Piccardo, A | 1 |
| Diehn, M; Dong, X; Gensheimer, MF; Li, R; Loo, BW; Napel, S; Rubin, DL; Wu, J | 1 |
| Chiaravalloti, A; Liguori, C; Mercuri, NB; Pierantozzi, M; Sancesario, G; Sancesario, GM; Schillaci, O; Stefani, A | 1 |
| Al-Muqbel, KM; Yaghan, RJ | 1 |
| Cheng, Y; Gong, J; Guo, B; Huang, L; Ling, X; Shang, J; Tang, Y; Xiao, Z; Xu, H; Zhang, L | 1 |
| Chen, F; Chen, Y; Fang, Y; Han, X; Huang, H; Liu, J; Liu, Q; Ni, B; Shen, L; Shi, Y; Wang, J; Wang, T; Xiao, F; Xu, L; Zhang, M; Zheng, L; Zhong, H; Zhong, L; Zhu, J | 1 |
| Allavena, P; Alloisio, M; Castino, GF; Chiti, A; Cortese, N; Grizzi, F; Lopci, E; Marchesi, F; Marchetti, S; Olivari, L; Pistillo, D; Qehajaj, D; Rahal, D; Roncalli, M; Santoro, A; Toschi, L | 1 |
| Hirata, K; Kasai, K; Kuge, Y; Magota, K; Nishijima, KI; Okamoto, S; Onimaru, R; Shiga, T; Shirato, H; Tamaki, N; Tuchiya, K; Watanabe, S; Yasuda, K | 1 |
| Jinguji, M; Kajiya, Y; Nakajo, M; Tani, A; Yoshiura, T | 1 |
| Chang, JW; Cheng, NM; Chung, HW; Fang, YD; Ho, KC; Hou, MM; Liu, YC; Su, TP; Yang, CT; Yen, TC | 1 |
| Boisgard, R; Buvat, I; Orlhac, F; Soussan, M; Thézé, B | 1 |
| Doot, RK | 1 |
| Cabrera-Martín, MN; Carreras, JL; Galán, L; Guerrero, A; Matías-Guiu, J; Matías-Guiu, JA; Moreno-Ramos, T; Pytel, V; Valles-Salgado, M | 1 |
| Corey, A; El-Deiry, MW; Galt, JR; Hudgins, PA; Kendi, AT; Magliocca, KR; Saba, NF; Schuster, DM; Switchenko, J; Wadsworth, JT | 1 |
| Assal, F; Démonet, JF; Frisoni, GB; Garibotto, V; Giannakopoulos, P; Gold, G; Trombella, S; Zekry, D | 1 |
| Blankstein, R; DiCarli, MF; Dorbala, S; Hulten, EA; Murthy, VL; Osborne, MT; Skali, H; Taqueti, VR | 1 |
| Caubet, O; Laffon, E; Marthan, R; Meunier, V | 1 |
| Bussink, J; de Geus-Oei, LF; Grootjans, W; Le Rest, CC; Oyen, WJ; Tixier, F; van der Vos, CS; Visser, EP; Visvikis, D; Vriens, D | 1 |
| Choi, WH; Han, EJ; Kim, SH; Lee, YS; Park, EK; Park, HL; Song, MJ; Yoo, IR | 1 |
| Chen, RY; Chen, SW; Chen, YH; Chow, NH; Hsieh, TC; Kao, CH; Liang, JA; Lin, YC; Wang, YC; Yang, SN; Yen, KY | 1 |
| Chang, S; Kim, SJ; Koo, PJ; Kwak, JJ | 1 |
| Aarntzen, EH; Bleeker-Rovers, CP; de Geus-Oei, LF; de Rooy, JW; Hosman, AJ; Kouijzer, IJ; Oyen, WJ; Smids, C; Sprong, T; Vos, FJ | 1 |
| Dong, X; Huang, Y; Li, W; Maxim, PG; Sun, L; Sun, X; Wan, H; Xing, L; Yu, J; Zhao, X | 1 |
| Aide, N; Do, P; Hatt, M; Lasnon, C; Lavigne, B; Madelaine, J; Majdoub, M; Visvikis, D | 1 |
| Havariyoun, G | 1 |
| Minamimoto, R | 1 |
| Barkhof, F; Dols, A; Gossink, F; Kerssens, CJ; Krudop, WA; Möller, C; Peters, A; Pijnenburg, YA; Prins, ND; Scheltens, P; Stek, ML; van Berckel, BN; Vijverberg, EG; Wattjes, MP | 1 |
| Carrasquillo, JA; Do, RK; Gonen, M; Pandit-Taskar, N; Shady, W; Sofocleous, CT; Sotirchos, VS | 1 |
| Belohlavek, O; Fencl, P; Harustiak, T; Zemanova, M | 1 |
| Byeon, JS; Hwang, SW; Kim, KJ; Kim, WS; Kwak, MS; Lee, HS; Lee, JM; Myung, SJ; Park, SH; Yang, DH; Yang, SK | 1 |
| Bagnara, MC; Beltrametti, MC; Bruzzi, P; Buschiazzo, A; Calvo, A; Cammarosano, S; Campi, C; Canosa, A; Caponnetto, C; Chiò, A; Cistaro, A; Fania, P; Mancardi, G; Marini, C; Massone, AM; Moglia, C; Morbelli, S; Nobili, FM; Novi, G; Perasso, A; Piana, M; Pomposelli, E; Sambuceti, G; Scialò, C | 1 |
| Achenbach, HJ; Amthauer, H; Apostolova, I; Furth, C; Genseke, P; Kalinski, T; Riedel, S; Rogasch, JM; Schreiber, J; Schultz, M; Steffen, IG; Steinkrüger, FL; Wertzel, H | 1 |
| Benisvy, D; Dufour, M; Gastaud, L; Iannessi, A; Kogay, M; Saada, E; Thariat, J; Thyss, A | 1 |
| Arnaldi, D; Bauckneht, M; Brugnolo, A; Buschiazzo, A; Chincarini, A; Giuliani, A; Morbelli, S; Nobili, F; Öberg, J; Pagani, M; Picco, A; Sambuceti, G | 1 |
| Ahmadian, A; Berman, J; Govender, P; Miller, EJ; Pawar, S; Ruberg, FL | 1 |
| Czuczman, MS; Graf, DA; Lamonica, D; Munteanu, MC | 1 |
| Achenbach, HJ; Amthauer, H; Apostolova, I; Buchert, R; Derlin, T; Ego, K; Furth, C; Hofheinz, F; Kalinski, T; Riedel, S; Schreiber, J; Schultz, M; Steffen, IG; Wertzel, H | 1 |
| Alexandra, JF; Benali, K; Chauchard, M; Coustet, B; Dieude, P; Dossier, A; Goulenok, T; Hyafil, F; Klein, I; Lariviere, D; Papo, T; Pasi, N; Sacre, K | 1 |
| Alberini, JL; Cacheux, W; Fayard, J; Gauthé, M; Lièvre, A; Richard-Molard, M | 1 |
| Ciarmiello, A | 1 |
| Carter, BW; Court, LE; Fried, DV; Ho, L; Hofstetter, WL; Lin, SH; Meijer, GJ; van Rossum, PSN; Zhang, L | 1 |
| Gubała, E; Jarząb, B; Kalemba, M; Kołosza, Z; Krajewska, J; Król, A; Kropin Ska, A; Kukulska, A; Paliczka-Cies Lik, E; Puch, Z | 1 |
| Alagappan, M; Chang, DT; Cui, Y; Koong, AC; Li, R; Pollom, E; Shirato, H; Song, J | 1 |
| Cho, YS; Choe, YS; Im, YH; Kim, BT; Lee, KH; Lim, CH; Moon, SH | 1 |
| Hattori, N; Hirata, K; Kikuchi, Y; Kobayashi, K; Manabe, O; Oyama-Manabe, N; Tamaki, N; Toyonaga, T; Watanabe, S | 1 |
| Asano, Y; Ikegame, Y; Ito, K; Shinoda, J | 1 |
| Akhurst, TJ; Chang, CA; Hicks, RJ; Hofman, MS; Kong, G; Pattison, DA; Tothill, RW | 1 |
| Asakura, K; Endo, M; Hotta, K; Igarashi, K; Imai, K; Ito, S; Kakushima, N; Kawata, N; Matsubayashi, H; Oishi, T; Ono, H; Shimoda, T; Takizawa, K; Tanaka, M; Yamaguchi, Y | 1 |
| Abramson, RG; Abramson, VG; Arlinghaus, LR; Chakravarthy, AB; Gorge, WJ; Knowland, JG; Lattanze, RK; Pendyala, P; Perrin, SR; Rani, SD; Scarantino, CW; Shone, MD; Townsend, DW; Williams, JM; Yankeelov, TE | 1 |
| Bolcaen, J; Boterberg, T; De Vos, F; Deblaere, K; Descamps, B; Goethals, I; Kalala, JP; Lybaert, K; Moerman, L; Van den Broecke, C; Vanhove, C | 1 |
| Accurso, JM; Gupta, V; Jain, MK; Patel, NJ; Vibhute, PG | 1 |
| Adams, HJ; Kwee, TC; Nievelstein, RA | 1 |
| Matsudaira, K; Momose, T; Oka, H; Takahashi, M; Taniguchi, Y | 1 |
| Dasgupta, R; Gelfand, MJ; Kremer, N; Nagarajan, R; Pressey, JG; Sharp, SE; Tiao, GM; Turpin, BK; Wagner, LM; Yin, J | 1 |
| Albano, D; Alongi, P; Baldari, S; Caobelli, F; Gentile, R; Gilardi, MC; Midiri, M; Russo, G; Stefano, A | 1 |
| Blanc, E; de Margerie-Mellon, C; Groheux, D; Lemarignier, C; Merlet, P; Quere, G; Querellou, S; Vercellino, L | 1 |
| Elboğa, U; Kara, A; Şahin, E | 1 |
| de Jager-Leclercq, MG; Hagenaars, JC; Hilbink, M; Hoekstra, CJ; Koning, OH; Moll, FL; Renders, NH; van Petersen, AS; Vlake, AW; Wever, PC | 1 |
| Bitencourt, AG; Chojniak, R; Conrado, JL; Lima, EN; Macedo, BR; Marques, EF | 1 |
| Boellaard, R; de Jong, EE; Dingemans, AC; Groen, HJ; Hoekstra, OS; Lambin, P; Leijenaar, RT; Smit, EF; Troost, EG; van der Noort, V; van Elmpt, W | 1 |
| Bai, R; Li, J; Li, Y; Ma, Y; Shi, H; Wang, C; Xiao, J; Xu, W; Yang, C; Yu, H; Zhang, J | 1 |
| Axelsson, R; Sundin, A; Uhlén, N | 1 |
| Lococo, F; Rufini, V; Treglia, G | 1 |
| Fukukura, Y; Higashi, R; Jinguji, M; Nakabeppu, Y; Nakajo, M; Natsugoe, S; Sasaki, K; Uchikado, Y; Yoshiura, T | 1 |
| Hustinx, R | 1 |
| Ahmed, S; Brindle, N; Chowdhury, FU; Jamieson, S; Motara, H; Olusoga, T; Patel, CN; Pillai, A; Russell, G; Scarsbrook, AF | 1 |
| Alkasab, TK; Kunawudhi, A; Mahmood, U; Wong, AK | 1 |
| Bazan, JG; Duan, F; Graves, EE; Horng, D; Loo, BW; Machtay, M; Siegel, BA; Snyder, BS | 1 |
| Cao, X; Chen, X; Kang, F; Li, Y; Liang, J; Wang, J; Zhan, Y | 1 |
| Higashi, T; Kataoka, TR; Minami, S; Miyake, KK; Nakamoto, Y; Nakatani, K; Saga, T; Terashima, T; Togashi, K; Ueshima, C | 1 |
| Chen, M; Chen, S; Li, N; Li, X; Li, Y; Yin, Y | 1 |
| Briere, TM; Court, LE; Gomez, DR; Liao, Z; Martel, MK; Mohan, R; Niedzielski, JS; Stingo, F; Yang, J | 1 |
| Bom, HS; Cho, SG; Jabin, Z; Jeong, GC; Kang, SR; Kim, J; Kim, YJ; Kwon, SY; Min, JJ; Park, KS; Seon, HJ; Song, HC; Song, M | 1 |
| Conti, M; Schaefferkoetter, JD; Sjöholm, T; Soo, RA; Tam, JK; Tham, I; Townsend, DW; Yan, J | 1 |
| Abdul-Rahman, H; Bauerfeind, P; Eshmuminov, D; Fischer, M; Gubler, C; Lehmann, K; Reiner, C; Schneider, PM; Veit-Haibach, P; Weber, A | 1 |
| Mansi, L; Pace, L; Spadafora, M | 1 |
| Gunter, JL; Jack, CR; Jones, DT; Kantarci, K; Knopman, DS; Lowe, VJ; Machulda, MM; Mielke, MM; Petersen, RC; Reyes, DA; Roberts, RO; Senjem, ML; Therneau, TM; Vemuri, P; Weigand, SD; Wiste, HJ | 1 |
| Cong, L; Gao, T; Hu, L; Wang, S | 1 |
| Hara, T; Ishii, S; Ito, H; Kubo, H; Kuroiwa, D; Miyajima, M; Nanbu, T; Oriuchi, N; Sekino, H; Suenaga, H; Sugawara, S | 1 |
| Asenbaum, U; Furtner, J; Karanikas, G; Mayerhoefer, ME; Nolz, R; Raderer, M; Senn, D; Simonitsch-Klupp, I; Staudenherz, A; Weber, M; Woitek, R | 1 |
| Mena, E; Reddy, S; Sheikhbahaei, S; Solnes, LB; Subramaniam, RM; Wachsmann, J; Yanamadala, A | 1 |
| Copin, D; D'Hulst, L; De Spiegeleer, B; Delcourt, A; Maes, A; Van de Wiele, C; Van Vlaenderen, M | 1 |
| Fayad, ZA; Ishai, A; Joseph, P; Kallend, D; Mani, V; Rudd, JH; Tawakol, A | 1 |
| Chunjie, W; Daohai, X; Lei, T; Li, G; Ruilong, Z; Xiaohong, W | 1 |
| Alanazi, SF; Aljammaz, IJ; Alrumayan, F; Alzimami, KS; Ghannam, MM; Sassi, SA | 1 |
| Bhansali, A; Bhattacharya, A; Khandelwal, N; Mittal, BR; Prakash, M; Rastogi, A; Sharma, S | 1 |
| Gunn, RN; Janisch, R; Khan, S; Matthews, PM; Orchard, TR; Rabiner, EA; Russo, EA; Taylor, SA | 1 |
| Horiki, N; Katsurahara, M; Kobayashi, S; Ogura, M; Ogura, T; Sakuma, H; Suzawa, N | 1 |
| Bertolini, G; Moresco, RM; Moro, M; Pastorino, U; Prisinzano, G; Raccagni, I; Roz, L; Sozzi, G; Tortoreto, M; Valtorta, S | 1 |
| Abulizi, M; Aouizerate, J; Aoun Sebaiti, M; Authier, FJ; Bachoud-Levi, AC; Chalaye, J; Cottereau, AS; Evangelista, E; Gherardi, RK; Guedj, E; Itti, E; Van Der Gucht, A; Verger, A; Yara, S | 1 |
| İbiş, E; Kahraman, A; Konuralp Atakul, B; Koyuncu, K; Ortac, F; Soydal, Ç; Sükür, YE; Taşkın, S | 1 |
| Balar, AV; Friedman, KP; Huang, WC; Jackson, K; Ponzo, F; Raad, RA; Rosenkrantz, AB | 1 |
| Adams, HJA; Kwee, TC | 1 |
| Ciliberto, M; De Crescenzo, F; Ebmeier, KP; Janiri, L; Menghini, D; Treglia, G | 1 |
| Fan, AP; Gold, GE; Kogan, F; McWalter, EJ; Oei, EHG; Quon, A | 1 |
| Alongi, P; Bomanji, JB; Fallanca, F; Gianolli, L; Incerti, E; Kayani, I; Picchio, M | 1 |
| Castelijns, JA; de Bree, R; Hoekstra, OS; René Leemans, C; Senft, A; Yildirim, G | 1 |
| Chiti, A; Costa, G; Lopci, E; Pedicini, V; Poretti, D; Rodari, M; Solbiati, L; Torzilli, G; Viganò, L | 1 |
| Alavi, A; Cheng, G; Lee, PI | 1 |
| Kuang, A; Liu, B; Ma, H; Ren, P; Shen, G; Yang, Y | 1 |
| Gao, Q; Liang, CH; Shao, D; Wang, SX | 1 |
| Brillet, PY; Fain, O; Jacquelin, V; Mekinian, A; Nunes, H; Soussan, M; Valeyre, D | 1 |
| Hadas, M; Halankar, J; Hussey, D; Langer, D; Metser, U; Mohan, R; Tamir, S | 1 |
| Pipitone, N; Salvarani, C; Versari, A | 1 |
| de Jong, BM; Dierckx, RA; Leenders, KL; Meles, SK; Teune, LK | 1 |
| Cavaliere, C; D'Aniello, C; Facchini, G; Fiorica, F | 1 |
| Bassi, C; Butturini, G; Capelli, P; Cingarlini, S; Citton, E; Davì, MV; De Robertis, R; DʼOnofrio, M; Grego, E; Malfatti, V; Malpaga, A; Ortolani, S; Ruzzenente, A; Salgarello, M; Scarpa, A; Tortora, G; Trentin, C; Vallerio, P | 1 |
| Abadi, P; Gerke, O; Godballe, C; Høilund-Carlsen, PF; Johansen, A; Thomassen, A | 1 |
| Barbosa, FG; Burger, IA; Delso, G; Huellner, MW; Mader, CE; Sah, BR; Sekine, T; Stolzmann, P; Ter Voert, EE; Veit-Haibach, P; von Schulthess, GK | 1 |
| Elizalde, A; Fernandez-Montero, A; Garcia-Velloso, MJ; Idoate, MA; Martinez-Regueira, F; Pina, LJ; Prieto, E; Ribelles, MJ; Rodriguez, M; Rodriguez-Spiteri, N; Sancho, L; Santisteban, M | 1 |
| Alexander, S; Amaral, J; Connolly, B; Nihayah, S; Parra, D; Shammas, A; Vali, R | 1 |
| Ali, S; Atri, M; Dehdashti, F; DiSilvestro, P; Gold, M; King, SA; Koh, WJ; Lee, SI; Mannel, RS; Marques, H; Moxley, KM; Pearl, M; Plante, M; Zhang, Z; Zhou, X | 1 |
| Ballarini, T; Bettinardi, V; Caminiti, SP; Gianolli, L; Perani, D; Presotto, L | 1 |
| Hayami, S; Hirono, S; Kawai, M; Kitahata, Y; Kojima, F; Miyazawa, M; Okada, KI; Shimizu, A; Ueno, M; Yamaue, H | 1 |
| la Fougère, C | 1 |
| Grassi, P; Mennitto, A; Procopio, G; Ratta, R; Verzoni, E | 1 |
| Chen, DL; Cheriyan, J; Chilvers, ER; Choudhury, G; Coello, C; Connell, M; Fisk, M; Groves, AM; Gunn, RN; Holman, BF; Hutton, BF; Lee, S; MacNee, W; Mohan, D; Parr, D; Subramanian, D; Tal-Singer, R; Thielemans, K; van Beek, EJ; Vass, L; Wellen, JW; Wilkinson, I; Wilson, FJ | 1 |
| Hofman, MS; Ravi Kumar, AS; Tam, C | 1 |
| Kruse, MJ; Mena, E; Sheikhbahaei, S; Subramaniam, RM; Taghipour, M | 1 |
| Brar, H; Han, K; Langer, D; MacCrostie, P; May, T; Metser, U; Tau, N | 1 |
| Abdulghani, M; Asoglu, R; Chen, W; Dickfeld, TM; Dilsizian, V; Ghzally, Y; Hussein, AA; Niekoop, M; See, V; Shorofsky, SR; Smith, M | 1 |
| Cai, Q; Liang, X; Wen, B; Xie, J; Yang, Q; Yu, J | 1 |
| Altini, C; De Leonardis, F; Fanelli, M; Ferrari, C; Merenda, N; Muggeo, P; Niccoli Asabella, A; Perillo, T; Rubini, G; Santoro, N | 1 |
| Boshomane, T; Lawal, I; Lengana, T; Modiselle, M; Ololade, K; Reyneke, F; Sathekge, M; Vorster, M | 1 |
| Alhilahi, LM; Branstetter, BF; Fakhran, S; Hughes, MA; Rath, TJ; Seungwon, KW; Yankevich, U | 1 |
| Bouazza, F; Covas, A; Deleporte, A; El Nakadi, I; Flamen, P; Garcia, C; Hendlisz, A; Lecocq, C; Liberale, G; Muylle, K | 1 |
| Cho, YY; Jeong, YJ; Jung, JW; Kang, S; Oh, HK; Park, SH | 1 |
| Ma, Y; Wang, Y; Yang, B; Zhao, M | 1 |
| Flors, L; Leiva-Salinas, C; Patrie, JT; Rehm, PK; Schiff, D | 1 |
| Alongi, P; Caminiti, SP; Cerami, C; Comi, G; Gianolli, L; Majno, L; Perani, D; Volontè, MA | 1 |
| Azar, N; Cui, M; Li, Y; Michael, CW; Nakamoto, D | 1 |
| Adens, A; Baillet, C; Beron, A; Huglo, D; Lambert, M; Landy, P; Launay, D; Terriou, L | 1 |
| Deuschl, C; Forsting, M; Gramsch, C; Grueneisen, J; Heusch, P; Mönninghoff, C; Nensa, F; Poeppel, TD; Quick, HH; Sawicki, LM; Schlamann, M; Umutlu, L | 1 |
| Accardo, J; Arnaldi, D; Bauckneht, M; Bongioanni, F; Chincarini, A; De Carli, F; Girtler, N; Giuliani, A; Jonsson, C; Morbelli, S; Nobili, F; Öberg, J; Pagani, M; Sambuceti, G | 1 |
| Broski, SM; Feldman, AL; Habermann, TM; Jevremovic, D; Maurer, MJ; Pham, AQ; Ristow, KM; Wiseman, GA; Witzig, TE | 1 |
| Fatima, N; Zaman, MU | 1 |
| Bassetti, M; Della Siega, P; Di Gregorio, F; Merelli, M; Righi, E; Scarparo, C; Screm, M | 1 |
| Asakura-Yokoe, K; Furukawa, H; Ikuma, H; Uesaka, K | 1 |
| Cheze-Le Rest, C; Jestin-Le Tallec, V; Lozac'h, P; Metges, JP; Teyton, P; Visvikis, D; Volant, A | 1 |
| Corstens, FH; Oyen, WJ; Vogel, WV; Zuijdwijk, MD | 1 |
| Chung, JK; Jeong, JM; Jung, HW; Kim, DG; Lee, DS; Lee, HY; Lee, MC | 1 |
| Ameshima, S; Demura, Y; Ishizaki, T; Mizuno, S; Morikawa, M; Okazawa, H | 1 |
| Fu, Z; Han, A; Kong, FM; Li, D; Li, H; Mu, D; Song, P; Yang, G; Yu, J; Zhang, B; Zhang, W; Zhong, X | 1 |
| Kotani, Y; Koyama, H; Matsumoto, S; Nogami, M; Ohno, Y; Onishi, Y; Sugimura, K; Takenaka, D; Yoshikawa, T | 1 |
| Abe, Y; Asakawa, H; Fukatsu, K; Hama, Y; Ishida, J; Kondo, N; Kondo, T; Mochizuki, H; Omata, J; Tamura, K; Tsuda, H; Ueda, S | 1 |
| Barrio, JR; Nair-Gill, E; Phelps, ME; Radu, CG; Satyamurthy, N; Shelly, SM; Shu, CJ; Witte, ON | 1 |
| Choi, JY; Kim, BT; Lee, WJ; Lim, HK; Park, KW; Park, MJ | 1 |
| Boellaard, R; Fockens, P; Hoekstra, OS; Jager, PL; Omloo, JM; Plukker, JT; Sloof, GW; van Dullemen, HM; van Lanschot, JJ | 1 |
| Doi, R; Hatano, E; Higashi, T; Ikai, I; Iwaisako, K; Mori, A; Nakajima, A; Nakamoto, Y; Seo, S; Tada, M; Tamaki, N; Uemoto, S | 1 |
| Belinc, D; Chen, DT; Eikman, EA; Farma, JM; Malafa, M; Melis, M; Santillan, AA; Walters, J | 1 |
| Hautzel, H; Heinzel, A; Müller, HW; Sander, O; Schneider, M | 1 |
| Choi, JY; Chung, MJ; Kim, BT; Kim, H; Kwon, OJ; Lee, KS; Shin, KM; Yi, CA | 1 |
| Emmering, J; Hoekstra, OS; Krak, NC; Meijer, S; Pinedo, HM; Spreeuwenberg, MD; Twisk, JW; Van der Hoeven, JJ | 1 |
| Arora, A; Deshpande, M; Pathak, S; Purandare, NC; Rangarajan, V; Shah, S; Sharma, AR; Singh, N | 1 |
| Gao, ZR; Jia, Q; Lan, XL; Wei, H; Wu, ZJ; Zhang, YX | 1 |
| Aerts, HJ; Bosmans, G; Buijsen, J; De Ruysscher, D; Dekker, AL; Janssen, MH; Lambin, P; Lammering, G; Lee, JA; Ollers, MC | 1 |
| Colavolpe, C; Conte-Devolx, B; De Micco, C; Henry, JF; Mancini, J; Mundler, O; Palazzo, FF; Sebag, F; Taïeb, D; Tessonnier, L | 1 |
| de Leon, MJ; DeSanti, S; Kemppainen, N; Kim, BC; Li, Y; Mosconi, L; Någren, K; Pirraglia, E; Rinne, JO; Rusinek, H; Tsui, W | 1 |
| Cornfeld, D; Modarresifar, H; Ojha, B; Saif, MW | 1 |
| Eckstein, HH; Essler, M; Krause, BJ; Pelisek, J; Reeps, C; Seidl, S | 1 |
| Aimoni, C; Padovani, D; Paluzzi, A; Pastore, A; Zucchetta, P | 1 |
| Chen, YJ; Lai, CR; Liu, RS; Shen, SH; Shieh, HJ; Sung, PL; Wang, PH; Wen, KC; Yen, MS; Yuan, CC | 1 |
| Daisaki, H; Hamashima, C; Kakinuma, R; Kakizoe, T; Kanou, D; Moriyama, N; Murano, T; Shoda, H; Terauchi, T | 1 |
| Amanuma, M; Arisaka, Y; Endo, K; Higuchi, T; Nakajima, T; Oriuchi, N; Takano, A; Taketomi-Takahashi, A; Tsushima, Y | 1 |
| Fu, Z; Guo, H; Hu, Q; Wang, W; Yu, J; Yuan, S; Zhong, X | 1 |
| Hoshikawa, H; Mitani, T; Mori, N; Nishiyama, Y; Ohkawa, M; Yamamoto, Y | 1 |
| Arena, V; Casoni, R; Douroukas, A; Pelosi, E; Skanjeti, A | 1 |
| Prabhakar, HB; Rabinowitz, CB; Sahani, DV | 1 |
| Comans, EF; de Bree, R; Hoekstra, OS; Kuik, DJ; Langendijk, JA; Leemans, CR; van der Putten, L | 1 |
| Grgic, A; Hellwig, D; Kirsch, CM; Kremp, S; Nestle, U; Schaefer-Schuler, A | 1 |
| Agarwala, S; Bakhshi, S; Kumar, A; Kumar, J; Kumar, R; Seith, A; Sharma, R | 1 |
| Akiyoshi, T; Fujimoto, Y; Koyama, M; Kuroyanagi, H; Matsueda, K; Muto, T; Oya, M; Tanaka, H; Ueno, M; Yamaguchi, T | 1 |
| Hou, M; Li, XN; Liu, J; Liu, YF; Yu, HM; Yu, JM | 1 |
| Nguyen, BD; Pockaj, BA; Roarke, MC | 1 |
| Blake, MA; Colen, RR; Fischman, AJ; King, K; Mueller, PR; Roedl, JB | 1 |
| Brugnolo, A; Dessi, B; Girtler, N; Larsson, SA; Morbelli, S; Nobili, F; Pagani, M; Piccardo, A; Rodriguez, G; Salmaso, D | 1 |
| Blake, MA; Colen, RR; Fischman, AJ; Mueller, PR; Roedl, JB; Sahani, DV | 1 |
| Boscolo, E; Bussoli, L; Gelain, F; Lubin, E; Pizzolato, R; Quaia, E; Tona, G | 1 |
| Boucek, JA; Francis, RJ; Green, AJ; Jones, CG; Khan, N; Turlach, BA | 1 |
| Katz, SC; Shaha, A | 1 |
| Hellwig, D; Kirsch, CM; Kremp, S; Nestle, U; Rübe, C; Schaefer, A | 1 |
| Kasami, M; Uematsu, T; Yuen, S | 1 |
| Fujii, H; Fukushi, M; Hirayama, A; Inoue, K; Ito, M; Kitamura, H; Kurosawa, H; Moriyama, N; Sato, T; Tanaka, T; Tsunoda, Y | 2 |
| Hung, GU; Lee, KW; Liao, PY; Yang, KT; Yang, LH | 1 |
| Hirakawa, K; Ishii, K; Ishiwata, K; Mishina, M; Nariai, T; Ohno, K; Ohta, Y; Senda, M | 1 |
| Chang, CP; Hsieh, HJ; Lee, CY; Lin, KH; Lin, SH; Wang, SJ | 1 |
| Hammack, JE; Jett, JR; Lowe, VJ; Mandrekar, JN; Patel, RR; Subramaniam, RM | 1 |
| Dong, MJ; Lin, XT; Liu, ZF; Ruan, LX; Zhao, J; Zhao, K | 1 |
| Buchert, R | 1 |
| Fukasawa, I; Inaba, N; Kaji, Y; Kitajima, K; Murakami, K; Sugimura, K; Yamasaki, E | 2 |
| Ignatov, V; Ivanov, K; Kolev, N; Madzhov, R; Temelkov, T | 1 |
| Grigsby, PW | 2 |
| Baek, CH; Cho, JK; Choi, J; Choi, JY; Chung, MK; Jeong, HS; Kim, HJ; Ko, YH; Son, YI; Yim, YJ | 1 |
| Bhure, U; Clavien, PA; Hany, TF; Heinrich, S; Pestalozzi, BC; Soyka, J; Strobel, K; Veit-Haibach, P | 1 |
| Kotzerke, J; Zöphel, K | 1 |
| Alavi, A; Kwee, RM; Kwee, TC | 1 |
| Burbar, Z; Claussen, CD; Heiss, WD; Jacob, PK; Jattke, K; Ladebeck, R; Michel, C; Nahmias, C; Pichler, BJ; Schlemmer, HP; Schmand, M; Townsend, D | 1 |
| Krabbe, CA; Pruim, J; Rödiger, LA; Roodenburg, JL; van der Laan, BF | 1 |
| Ben-Sellem, D; Blondet, C; Christmann, D; Constantinesco, A; Forestier, E; Hansmann, Y; Imperiale, A; Mohseni, M; Ojeda, M; Piemont, Y | 1 |
| Choi, CG; Chung, SJ; Kim, JS; Kwon, KY; Lee, MC | 1 |
| Goya, T; Kim, EE; Takeuchi, M; Tateishi, U; Terauchi, T; Tsushima, Y; Uno, H | 1 |
| Abraham, J; Hobbs, G; Kanate, A; Marano, G; Saad, A; Sehbai, A | 1 |
| Chang, J; Feustel, P; Karam, M; Roberts-Klein, S; Shet, N | 1 |
| Dhenain, M; Gurden, H; Lanièce, P; Lefebvre, F; Mastrippolito, R; Pain, F; Routier, AL | 1 |
| Antoch, G; Broelsch, CE; Gerken, G; Grabellus, F; Kaiser, GM; Kuehl, H; Li, J; Müller, SP; Nadalin, S; Paul, A; Radunz, S | 1 |
| Brusa, M; Carnino, R; Cistaro, A; Colombini, E; Ferraris, MM; Gandolfo, S; Giovanella, L; Pentenero, M; Pezzuto, C; Spriano, G; Valentini, MC | 1 |
| Ahmadzadehfar, H; Biersack, HJ; Ezziddin, S; Palmedo, H; Reinhardt, M; Singh, B; Strunk, H; Tüting, T | 1 |
| Guo, HB; Hu, M; Liu, LP; Liu, NB; Xu, XQ; Yang, GR; Yu, JM; Zhang, PL | 1 |
| Didelot, A; Hammers, A; Lothe, A; Mauguière, F; Merlet, I; Ryvlin, P | 1 |
| Bonomo, L; Calcagni, ML; De Gaetano, AM; Giordano, A; Gui, B; Rufini, V; Valentini, AL | 1 |
| Berthelsen, AK; Brenøe, J; Loft, A; Ravn, J; Sørensen, JB | 1 |
| Csiki, Z; Garai, I; Sóvágó, J; Szabados, L; Tóth, C; Tóth, L | 1 |
| Cho, KJ; Choi, SH; Kim, JS; Kim, SY; Lee, JH; Nam, SY; Roh, JL | 1 |
| Hall, NC; Johnson, MA; Martin, EW; Moffatt-Bruce, SD; Povoski, SP; Ross, P; Sharif, S | 1 |
| Bellomi, M; Guarize, J; Leo, F; Maisonneuve, P; Masullo, M; Pelosi, G; Preda, L; Rampinelli, C; Scanagatta, P; Solli, P; Spaggiari, L; Veronesi, G | 1 |
| Britz-Cunningham, SH; Gerbaudo, VH; Millstine, JW | 1 |
| Ahuja, AT; Choi, FP; Lee, YY; Wong, KT | 1 |
| De Gaetano, AM; Fagotti, A; Fanfani, F; Giordano, A; Lorusso, D; Rossitto, C; Scambia, G; Vizzielli, G | 1 |
| Enomoto, K; Hatazawa, J; Higuchi, I; Inohara, H; Inoue, T; Osaki, Y; Tomiyama, Y; Yoshii, T | 1 |
| Escalón, MP; Han, HS; Hsiao, B; Lossos, IS; Serafini, A | 1 |
| Chen, Y; Huang, G; Liu, J; Sun, X; Tong, J; Xue, H; Zhang, C; Zheng, P | 1 |
| Allen, MS; Cassivi, SD; Deschamps, C; Fortes, DL; Lowe, VJ; Nichols, FC; Shen, KR; Wigle, DA | 1 |
| Choe, YH; Choi, JH; Jeon, ES; Lee, IH; Lee, KH | 1 |
| Maurer, AH | 1 |
| Boussion, N; Hammers, A; Kanno, I; Shidahara, M; Suhara, T; Tsoumpas, C; Turkheimer, FE; Visvikis, D | 1 |
| Aloj, L; Lastoria, S; Lauria, A; Marotta, M; Mettivier, G; Montesi, MC; Russo, P | 1 |
| Bar-Shalom, R; Guralnik, L; Israel, O; Kagna, O | 1 |
| Binderup, T; Jensen, MM; Jørgensen, JT; Kjaer, A | 1 |
| Chang, JY; Chang, KY; Chao, J; Yen, Y | 1 |
| El-Kholy, MR; El-Shorbagy, E; Murakami, K; Zytoon, AA | 1 |
| Abe, T; Amemiya, R; Asato, Y; Iijima, T; Kiyoshima, M; Nagai, H; Okumura, T; Saito, H; Sato, M; Shioyama, Y | 1 |
| Lee, SI; Russell, AH | 1 |
| Caprio, MG; Capuano, E; De Falco, T; Imbriaco, M; Limite, G; Pace, L; Salvatore, M | 1 |
| Badiee, S; Chu, B; Coakley, F; Franc, BL; Hawkins, RA; Singer, L; Webb, EM | 1 |
| Iyer, RB; Macapinlac, HA; Vikram, R; Yeung, HD | 1 |
| Balabanova, AA; Berezin, SM; Granov, AM; Iakovleva, EK; Kalashnikov, PA; Pozdniakov, AV; Prozorovskiĭ, KV; Rozengauz, EV; Ryzskova, DV; Shelkoplias, EN; Stanzhevskiĭ, AA; Tiutin, LA; Tlostanova, MS | 1 |
| Chua, ET; Chua, ML; Fong, KW; Gao, F; Khoo, JB; Low, JS; Ng, DC; Ong, SC; Tan, TW; Wee, JT | 1 |
| Azuma, A; Fukuma, E; Ito, K; O'uchi, T; Tanaka, T; Tozaki, M | 1 |
| Agrawal, A; Hall, NC; Martin, EW; Povoski, SP; Ringel, MD | 1 |
| Hamarneh, G; Möller, T; Saad, A; Smith, B | 1 |
| Byun, BH; Cheon, GJ; Choi, CW; Kang, HJ; Kim, KM; Lee, SS; Lim, SM; Na, II; Ryoo, BY; Yang, SH | 1 |
| Horiuchi, C; Inoue, T; Ishiguro, Y; Okudera, K; Taguchi, T; Tsukuda, M | 1 |
| Aozasa, K; Hamada, K; Hatazawa, J; Higuchi, I; Myoui, A; Qiu, Y; Tomita, Y; Ueda, T; Yoshikawa, H; Zhang, B | 1 |
| Daimaru, O; Fukaya, N; Imai, T; Ito, S; Nagata, T; Uchida, H; Yamane, T; Yoshiya, K | 1 |
| Haba, R; Hagiike, M; Izuishi, K; Kaji, M; Kameyama, R; Murota, M; Nishiyama, Y; Takebayashi, R; Yamamoto, Y | 1 |
| Gambhir, SS; Iagaru, AH; McDougall, IR; Mittra, ES; Quon, A | 1 |
| Doi, R; Hatano, E; Higashi, T; Kami, K; Machimoto, T; Masui, T; Ogawa, K; Seo, S; Uemoto, S | 1 |
| Dou, KF; He, ZX; Jain, D; Yang, MF; Yang, YJ | 1 |
| Buist, MR; Comans, EF; Hoekstra, OS; Molthoff, CF; van Baal, MW; van der Veldt, AA | 1 |
| Gaitini, D; Gurman-Balbir, A; Israel, O; Keidar, Z | 1 |
| Conrad, EU; Eary, JF; O'Sullivan, F; O'Sullivan, J | 1 |
| Choi, JI; Kang, KW; Kim, CM; Kim, JH; Kim, SK; Lee, WJ; Nam, BH; Park, JW; Park, KW | 1 |
| Angeletti, G; Avenia, N; Caracò, C; Chiofalo, MG; Colao, A; Faggiano, A; Ferolla, P; Grimaldi, F; Lombardi, G; Mozzillo, N; Pezzullo, L; Santeusanio, F | 1 |
| Choe, G; Chu, K; Chung, CK; Kim, DW; Kim, JY; Lee, CH; Lee, SK; Lee, SY; Park, KI | 1 |
| Jo, MK; Lee, HM; Park, JW | 1 |
| Baurain, JF; Crott, R; Krug, B; Lonneux, M; Pirson, AS; Vander Borght, T | 1 |
| Hasegawa, Y; Hyodo, I; Nakashima, T; Nishio, M; Ogawa, T; Suzuki, H; Suzuki, M; Tamaki, T; Terada, A | 1 |
| Bares, R; Bokemeyer, C; Brenner, W; de Wit, M; Franzius, C; Hartmann, M; Heicappell, R; Kliesch, S; Krege, S; Mueller, S; Oechsle, K; Venz, S; Weissbach, L | 1 |
| Akduman, EI; Nguyen, NC; Oliver, D; Osman, MM; Sayed, MH | 1 |
| Bartolomei, M; Bellomi, M; Carbone, G; De Cicco, C; De Pas, T; Paganelli, G; Pelosi, G; Spaggiari, L; Veronesi, G | 1 |
| Goldsmith, SJ; Vallabhajosula, S | 1 |
| Dumarey, N; Gemmel, F; Welling, M | 1 |
| Love, C; Palestro, CJ | 2 |
| Love, C; Marwin, SE; Palestro, CJ | 1 |
| Conti, PS; Groshen, S; Jadvar, H; Ye, W | 1 |
| Hatazawa, J; Higuchi, I; Inoue, A; Ishikawa, J; Isohashi, K; Kanakura, Y; Nakajo, K; Nakamura, H; Shimosegawa, E; Tatsumi, M | 1 |
| Brouwer, J; de Bree, R; Hoekstra, OS; Leemans, CR; Uyl-de Groot, CA; van Hooren, AC | 1 |
| Goya, T; Honda, Y; Horio, H; Iyama, K; Kaji, M; Koizumi, K; Nakashima, R; Nomori, H; Sakaguchi, K; Shibata, H; Suzuki, T; Takanami, I; Uno, K | 1 |
| Boling, WW; Kraszpulski, M; Lancaster, M; Marano, G; Palade, A; Puce, A | 1 |
| D'souza, MM; Jaimini, A; Mishra, A; Mondal, A; Saw, SK; Sharma, R; Singh, D; Tripathi, M; Tripathi, RP | 1 |
| Doppler, S; Hertl, C; Knell, U; Pichler, R; Szalay, E; Winkler, J | 1 |
| Camargo, RY; Cerci, JJ; Meneghetti, JC; Pereira, MA; Sebastianes, FM; Soares Júnior, J; Tomimori, EK; Zanoni, PH | 1 |
| Bergman, J; Kauhanen, S; Korsoff, P; Minn, H; Nuutila, P; Ovaska, J; Salmela, P; Saltevo, J; Sane, T; Seppänen, M; Välimäki, M | 1 |
| Ameshima, S; Demura, Y; Fujibayashi, Y; Ishizaki, T; Kimura, H; Miyamori, I; Morikawa, M; Okazawa, H; Sasaki, M; Tsuchida, T | 1 |
| Abgral, R; Bizais, Y; Kraeber-Bodéré, F; Le Duc-Pennec, A; Le Roux, PY; Marianovski, R; Potard, G; Pradier, O; Querellou, S; Salaun, PY | 1 |
| Castellon, I; Cholewinski, W; Heiba, SI; Raphael, B | 1 |
| Dupuis, J; Gaulard, P; Haioun, C; Itti, E; Lin, C; Meignan, M; Paone, G | 1 |
| Daum, O; Ferda, J; Ferdová, E; Kreuzberg, B; Mukensnabl, P; Walter, J; Záhlava, J | 1 |
| Becherer, A; Czerny, C; Dawid, M; Dudczak, R; Kletter, K; Mueller-Mang, C; Novotny, C; Peloschek, P; Sailer, J; Weber, M | 1 |
| Berry, H; Gananadha, S; Hazebroek, EJ; Leibman, S; Marx, G; Osgood, L; Pavlakis, N; Shon, IH; Smith, GS | 1 |
| Goyal, P; Hsu, JM; Kellman, RM | 1 |
| Balogh, J; Dahele, M; Ehrlich, L; Silverberg, J; Ung, YC; Wong, CS | 1 |
| Barentsz, JO; Desar, IM; Oyen, WJ; van der Graaf, WT; van Herpen, CM; van Laarhoven, HW | 1 |
| Calonje, E; Dunn, JT; Ferner, RE; O'Doherty, MJ; Warbey, VS | 1 |
| Cho, K; Fukushima, Y; Hakozaki, K; Kanaya, K; Kiriyama, T; Kumita, S; Sakurai, M; Sato, H; Shiiba, M | 1 |
| Bosscha, K; Dassen, AE; Hoekstra, CJ; Lips, DJ; Pruijt, JF | 1 |
| Jeong, YJ; Kim, IJ; Kim, SJ; Kim, YS; Lee, TH | 1 |
| Antoch, G; Beyer, T; Bockisch, A; Dahmen, G; Jablonka, R; Kuehl, H; Rosenbaum, S; Veit-Haibach, P; Vogt, FM | 1 |
| Beheshti, M; Broinger, G; Dralle, H; Kohlfürst, S; Langsteger, W; Nader, M; Pirich, C; Pöcher, S; Vali, R; Waldenberger, P | 1 |
| Auperin, A; Bournaud, C; Busaidy, NL; Corone, C; Ewertz, ME; Jacene, HA; Ladenson, PW; Leboulleux, S; Schlumberger, M; Schroeder, PR; Sherman, SI; Wahl, RL | 1 |
| Bandiera, A; Carretta, A; Casiraghi, M; Ciriaco, P; Libretti, L; Melloni, G; Zannini, P | 1 |
| Eberl, S; Feng, D; Fulham, M; Wen, L; Xia, Y | 1 |
| Dietrich, C; Hartung, E; Ignee, A | 1 |
| Chang, FC; Chang, SY; Chu, PY; Huang, JL; Liu, RS; Tai, SK; Tsai, TL; Wang, YF | 1 |
| Butler-Henderson, K; Campbell, A; Lenzo, NP; McCarthy, M; Yuan, JB | 1 |
| Beheshti, M; Dirisamer, A; Flöry, D; Halpern, BS; Langsteger, W; Mayerhoefer, ME; Wolf, F | 2 |
| Kaji, Y; Kitajima, K; Murakami, K; Sugimura, K; Yamasaki, E | 1 |
| Herbertson, RA; Lee, ST; Scarsbrook, AF; Scott, AM; Tebbutt, N | 1 |
| Brady, MJ; Franklin, KM; Ho, LM; Paulson, EK; Thomas, J; Wong, TZ | 1 |
| Cheng, MF; Hong, RL; Ting, LL; Tzen, KY; Wu, YW; Yen, RF | 1 |
| Baur-Melnyk, A; Becker, CR; Haug, A; Hermann, KA; Reiser, MF; Schmidt, GP; Tiling, R; Utzschneider, S | 1 |
| Bar-Shalom, R; Fruchter, O; Guralnik, L; Israel, O; Kagna, O; Keidar, Z; Solomonov, A; Yigla, M | 1 |
| Aerts, HJ; Boersma, L; Borger, J; De Ruysscher, D; Dehing, C; Dekker, A; Dingemans, AM; Hochstenbag, M; Houben, A; Lambin, P; Ollers, M; Wanders, R | 1 |
| Ferda, J; Ferdová, E; Kreuzberg, B; Matejovic, M; Záhlava, J | 1 |
| Amemiya, R; Asato, Y; Hashimoto, I; Iijima, H; Kaburagi, T; Kaito, K; Kiyoshima, M; Okumura, T; Sato, M; Uchiumi, K | 1 |
| Jacobsson, H; Larsson, S; Wassélius, J | 1 |
| Hosono, M; Kumano, S; Kuwabara, M; Murakami, T; Okada, M; Shimono, T; Shiozaki, H | 1 |
| Adachi, S; Hara, H; Ishii, K; Kida, T; Sakai, H; Suzuki, K; Ueda, O; Yamaguchi, T | 1 |
| Fujimoto, T; Hamada, K; Hashimoto, N; Hatazawa, J; Inoue, A; Myoui, A; Tomita, Y; Yoshikawa, H | 1 |
| Oyen, WJ; Ruers, TJ; Vogel, WV; Wiering, B | 1 |
| Chawla, M; Gupta, SD; Kumar, A; Kumar, R; Malhotra, A; Mehta, SN; Seenu, V | 1 |
| Reske, SN | 2 |
| Chiari, F; Eckel, HE; Gaggl, A; Hausegger, K; Kohlfürst, S; Kresnik, E; Lind, P; Markitz, M; Raunik, W; Salzwimmer, M | 1 |
| Boussion, N; Cheze Le Rest, C; Hatt, M; Visvikis, D | 1 |
| Al-Nahhas, A; Ambrosini, V; Castellucci, P; Cracco, E; Fanti, S; Grassetto, G; Lopci, E; Maffione, AM; Marzola, MC; Massaro, A; Musto, A; Nanni, C; Piva, M; Rampin, L; Rubello, D; Tsamita, CS | 1 |
| Fukuda, H; Hosono, A; Inoue, T; Kaneta, T; Kim, EE; Makimoto, A; Murakami, K; Nakamoto, Y; Suga, T; Tateishi, U; Terauchi, T | 1 |
| Lupi, A; Malfatti, V; Salgarello, M; Zanco, P; Zaroccolo, M | 1 |
| Grunkemeier, GL; Kernstine, KH | 1 |
| Kobayashi, H; Mori, T; Nakashima, R; Nomori, H; Ohba, Y; Shibata, H; Shiraishi, S | 1 |
| Park, KG; Suttie, SA; Welch, AE | 1 |
| Baarslag, HJ; de Haas, MJ; de Jong, PA; de Klerk, JM; Quekel, LG; van Ufford, HM; Wittebol, SH | 1 |
| Guevara, C; Klaeser, B; Krause, T; Mueller, MD; Schmid, RA; Wiskirchen, J | 1 |
| Caldwell, C; Mah, K; Mozeg, D; Yu, H | 1 |
| Araki, T; Ichikawa, T; Kato, S; Matsumoto, K; Motosugi, U; Nambu, A; Nishikawa, K; Okuwaki, H; Saito, A | 1 |
| Bang, YJ; Heo, DS; Im, SA; Kang, WJ; Kim, DW; Kim, TY; Kim, WH; Kim, YJ; Lee, SH; Oh, DY; Sim, SH | 1 |
| Drummond, E; Fay, M; Heriot, AG; Hicks, RJ; Hogg, A; Leong, T; MacKay, J; Milner, A; Ng, M; Ngan, SY; Winton, Ed | 1 |
| Byun, HS; Choi, JY; Jeon, P; Jeon, TY; Kim, HJ; Kim, KH; Kim, ST; Lee, IH | 1 |
| Grutters, JC; Keijsers, RG; Oyen, WJ; Ruven, HJ; van den Bosch, JM; van Velzen-Blad, H; Verzijlbergen, FJ | 1 |
| Chen, K; Guo, H; Reiman, E; Renaut, RA | 1 |
| Fujii, H; Fukuda, H; Kaneta, T; Kitajima, K; Kubota, K; Murakami, K; Nakajima, K; Nakamoto, Y; Satake, M; Senda, M; Tateishi, U; Togashi, K | 1 |
| Andradas, E; Blasco, JA; Escalona, S; Gómez, N; Reza, MM | 1 |
| Brown, G; Houghton, SL; Husband, JE; Potter, KC; Thomas, K | 1 |
| Capacchione, D; Dupuis, J; Haioun, C; Itti, E; Lin, C; Meignan, M; Paone, G; Rahmouni, A | 1 |
| Berovic, M; Booth, H; Dickson, JC; Ell, PJ; Endozo, R; Groves, AM; Kayani, I; Menezes, LJ; Screaton, NJ; Win, T | 1 |
| Kolodny, G; Laham, R; Lehman, S; Palmer, MR; Parker, JA; Varkey, S; Williams, G; Wykrzykowska, J | 1 |
| Jiang, X; Li, B; Xu, H; Zhai, G; Zhang, M | 1 |
| Dick, DW; Gambhir, SS; Goris, ML; Iagaru, A; Mittra, E; Quon, A; Yaghoubi, SS | 1 |
| Blake, MA; Boland, GW; Hahn, PF; Holalkere, NS | 1 |
| Breen, KA; Eustace, SJ; Gleeson, TG; McHugh, J; O'Connell, MJ; O'Gorman, PJ; Shortt, CP | 1 |
| Dunn, J; Fisher, S; MacCabe, C; MacLennan, K; Mehanna, H; Nutting, C; Wong, WL | 1 |
| Ishikawa, S; Kameyama, R; Kimura, N; Nishiyama, Y; Togami, T; Yamamoto, Y | 1 |
| Cheng, KJ; Fan, J; Li, LF; Ling, L; Wang, SQ; Wu, QL; Zhao, K; Zhou, SH | 1 |
| Borbély, K; Fekésházy, A; Lengyel, Z; Magyar, M; Markóczy, Z; Zsiray, M | 1 |
| Clifton, IJ; Muers, MF; Scarsbrook, AF | 1 |
| Araki, T; Ichikawa, T; Kato, S; Matsumoto, K; Nambu, A; Nishikawa, K; Okuwaki, H; Saito, A; Sato, Y | 1 |
| Brett, EM; Desai, SC; Eloy, JA; Fatterpekar, GM; Genden, EM; Kostakoglu, L; Som, PM | 1 |
| Alexander, GE; Bandy, D; Chen, K; Fleisher, AS; Foster, NL; Jagust, WJ; Koeppe, RA; Langbaum, JB; Lee, W; Reiman, EM; Reschke, C; Weiner, MW | 1 |
| Dhawan, V; Eidelberg, D; Ma, Y; Spetsieris, PG | 1 |
| Allen-Auerbach, MS; Benz, MR; Chow, K; Czernin, J; Dry, SM; Eckardt, JJ; Eilber, FC; Elashoff, D; Evilevitch, V; Phelps, ME; Tap, WD; Weber, WA | 1 |
| Fujimoto, T; Fujita, S; Inoue, T; Kamimura, K; Komada, N; Nagamachi, S; Nakajo, M; Nishii, R; Ogita, M; Sakurai, T; Umemura, Y; Wakamatsu, H | 1 |
| Fields, R; McWhorter, A; Mercante, DE; Nuss, D; Pou, AM; Rabalais, AG; Walvekar, R; Wood, C | 1 |
| Chung, JK; Kang, KW; Kwon, HW; Lee, DS; Lee, JW; Lee, MC; Paeng, JC; Suh, KS | 1 |
| Barlier, A; Cammilleri, S; De Micco, C; Enjalbert, A; Fakhry, N; Henry, JF; Morange, I; Mundler, O; Niccoli-Sire, P; Palazzo, FF; Sebag, F; Taïeb, D; Tessonnier, L | 1 |
| Declerck, J; Herholz, K; Markiewicz, PJ; Matthews, JC | 1 |
| Han, SK; Kim, YW; Min, JW; Shim, YS; Um, SW; Yim, JJ; Yoo, CG | 1 |
| Antoch, G; Bockisch, A; Forsting, M; Hahn, S; Hamami, ME; Heusner, TA; Kimmig, KR; Koeninger, A; Kuemmel, S; Otterbach, F; Stahl, A | 1 |
| Antoch, G; Baumeister, R; Bockisch, A; Forsting, M; Hahn, S; Hamami, ME; Heusner, TA; Kim, UH; Stahl, A | 1 |
| Esteva, D; Jiménez Alonso, J; Llamas-Elvira, JM; López de la Torre, M; Muros, MA; Muros, T; Villar, JM | 1 |
| Banti, E; Bianchini, E; Capirci, C; Crepaldi, G; Del Favero, G; Facci, E; Galeotti, F; Gava, M; Marano, G; Panzavolta, R; Pasini, F; Rampin, L; Rubello, D | 1 |
| Laningham, FH; Li, CS; McCarville, MB; Monu, N; Morris, EB; Shulkin, BL; Smeltzer, MP | 1 |
| Chung, JK; Kang, WJ; Kim, BS; Kim, S; Lee, DS; Lee, JW; Lee, MC | 1 |
| Broccoli, P; D'Urso, S; Danieli, R; Fusco, N; Maurici, M; Orlacchio, A; Schillaci, O; Simonetti, G; Yamgoue, M | 1 |
| Horikoshi, T; Ito, H; Kasai, T; Kuniyasu, Y; Motoori, K; Takahashi, F; Takiguchi, Y; Uchiyama, K; Yasufuku, K | 1 |
| Hartman, TE; Krajicek, BJ; Lowe, VJ; Ryu, JH; Vassallo, R | 1 |
| Ardissone, F; Arena, V; Billé, A; Borasio, P; Errico, L; Mancini, M; Pelosi, E; Skanjeti, A | 1 |
| Hatakeyama, K; Kanda, T; Komukai, S; Kosugi, S; Mashima, Y; Matsuki, A; Ohashi, M; Suzuki, T; Umezu, H | 1 |
| Billiet, I; Lesage, K; Maes, A; Pottel, H; Swinnen, G; Vanneste, A; Werbrouck, P | 1 |
| Sherif, A | 1 |
| Chung, MK; Hinrichs, C; Johnson, SC; Mukherjee, L; Singh, V; Xu, G | 1 |
| Bartholomeusz, D; Eglinton, T; Lawrence, M; Luck, A; Varghese, R | 1 |
| Andres, E; Federici, L; Imperiale, A | 1 |
| Carames, MA; Carreras, JL; Clavo, B; Hernandez, MA; Lloret, M; Montz, R; Ponce, P; Robaina, F | 1 |
| Buck, AK; Hasenkamp, E; Hombach, V; Krüger, S; Merk, T; Mottaghy, FM; Pauls, S; Reske, SN; Schumann, C; Wibmer, T | 1 |
| Berthelsen, AK; Engelholm, SA; Høgdall, C; Høgdall, E; Jensen, F; Loft, A; Markova, E; Risum, S; Roed, H | 1 |
| Das, A; Ngamruengphong, S; Nguyen, B; Sharma, VK | 1 |
| Diederich, S; Engeser, P; Junker, K; Passlick, B; Pfluger, T; Pottgen, C; Reck, M | 1 |
| Damjanovich, L; Garai, I; Garami, Z; Hascsi, Z; Lukács, G; Tanyi, M | 1 |
| De Keyzer, F; Dirix, P; Hermans, R; Nuyts, S; Stroobants, S; Vandecaveye, V | 1 |
| Däbritz, J; Foell, D; Frosch, M; Jasper, N; Loeffler, M; Weckesser, M | 1 |
| Han, DL; Jiang, WR; Yu, JM | 1 |
| Cai, L; Chen, QS; Gao, S; Li, DC; Li, YS; Xing, XL | 1 |
| Maguire, GQ; Noz, ME; Ponzo, F | 1 |
| Genden, EM; Kao, J; Kostakoglu, L; Mocherla, B; Packer, S; Park, EE; Som, PM; Vu, HL | 1 |
| Banks, KP; Bradley, YC; Cloran, FJ; Kim, Y; Song, WS | 1 |
| Akhurst, TJ; Dauer, LT; Gollub, MJ; Guillem, JG; Humm, JL; Jhanwar, SC; Kronman, RE; Larson, SM; Margulis, AR; Miller, AR; Montalvo, CV; Paty, PB; Shia, J; Temple, LK; Weiser, MR; Williamson, MJ; Wong, WD | 1 |
| Addeo, P; Bucci, L; Camera, L; D'Antonio, D; Mainenti, PP; Mainolfi, C; Manchia, A; Mancini, M; Maurea, S; Pace, L; Persico, F; Persico, G; Salvatore, M; Speranza, A; Tanga, M | 1 |
| Bolacchi, F; Bruni, C; Calabria, F; Cicciò, C; Guazzaroni, M; Orlacchio, A; Schillaci, O; Simonetti, G; Travascio, L | 1 |
| Albertí, MA; Cano, LM; Fernandez, A; Gamez, C; Martinez-Matos, JA; Martinez-Yélamos, S; Narváez, JA; Vidaller, A | 1 |
| Chan, SC; Chang, JT; Chen, MC; Ko, SF; Liao, CT; Ng, SH; Wai, YY; Wang, HM; Wang, JJ; Yen, TC | 1 |
| Chisholm, EJ; Tolley, NS | 1 |
| Li, M; Liang, Y; Liu, Y; Wu, N; Zhang, WJ; Zhao, P; Zheng, R | 1 |
| Furman, WL; Gelfand, MJ; Salisbury, S; Sharp, SE; Shulkin, BL | 1 |
| Allard, M; Farid, K; Fernandez, P; Guyot, M; Jeandot, R; Sibon, I | 1 |
| Bai, CM; Meng, QL; Ning, XH; Wang, YZ | 1 |
| Ikeda, K; Katahira, K; Kobayashi, H; Mori, T; Nomori, H; Ohba, Y; Shibata, H; Shiraishi, S | 1 |
| Aoyama, N; Koyama, H; Matsumoto, K; Matsumoto, S; Nogami, M; Ohno, Y; Onishi, Y; Sugimura, K; Takenaka, D; Yoshikawa, T | 1 |
| Bellò, M; Beltramo, G; Cassoni, P; Castellano, I; Contu, V; Mistrangelo, M; Morino, M; Munoz, F; Mussa, A; Pelosi, E; Racca, P; Ricardi, U | 1 |
| Aubry, MC; Aughenbaugh, GL; Jett, JR; Nichols Iii, FC; Peller, PJ; Subramaniam, RM; Wilcox, BE | 1 |
| Bartolomei, M; Crosta, C; De Cicco, C; De Roberto, G; Fiori, G; Paganelli, G; Ravizza, D; Santoro, L; Tamayo, D; Trovato, C | 1 |
| Asakura, K; Furukawa, H; Ikuma, H; Uesaka, K | 1 |
| Ata, A; Brepoels, LM; Chundru, S; Douglas-Nikitin, V; Feustel, PJ; Irish, K; Karam, M; Mottaghy, FM; Oliver Wong, CY; Stroobants, SG; Verhoef, GE | 1 |
| Chang, CH; Ding, HJ; Hsieh, TC; Kao, CH; Sun, SS; Wu, HC | 1 |
| Brugnolo, A; Caroli, A; Dessi, B; Frisoni, G; Morbelli, S; Nobili, F; Piccardo, A; Piccini, A; Rodriguez, G; Villavecchia, G | 1 |
| Bomanji, JB; Caplin, M; Conry, BG; Kayani, I; Mahmood, S; Papathanasiou, ND; Prakash, V | 1 |
| Buchmann, I; Freier, K; Haberkorn, U; Hofele, C; Thiele, OC | 1 |
| Amthauer, H; Denecke, T; Furth, C; Hautzel, H; Henze, G; Hundsdoerfer, P; Kobe, C; Misch, D; Ruf, J; Schönberger, S; Steffen, IG; Stöver, B | 1 |
| Akin, O; Ciftci, H; Falay, O; Kutlu, CA; Orki, A; Tasci, AE; Urek, S | 1 |
| Endo, K; Higuchi, T; Horikoshi, H; Nasu, K; Ochiai, R; Oriuchi, N; Watanabe, Y | 1 |
| Blake, MA; Cronin, CG; Fischman, AJ; Holalkere, NS; Kalra, M; Mueller, PR; Sahani, DV; Setty, BN | 1 |
| Balogh, J; Caldwell, C; Khaouam, N; MacKenzie, R; Mah, K; Poon, I; Tirona, R; Yu, H | 1 |
| Aukema, TS; Baas, P; Belderbos, JS; Burgers, SA; Klomp, HM; Teertstra, HJ; Valdés Olmos, RA; van den Heuvel, MM; Vogel, WV | 1 |
| Cheon, GJ; Cho, WH; Jeon, DG; Kim, MS; Koh, JS; Lee, JA; Lee, SY; Oh, DH; Shin, DS; Song, WS; Yoo, JY | 1 |
| Bach-Gansmo, T; Biermann, M; Følling, M; Johnsen, B; Sundin, A; Sørbye, H | 1 |
| Castelijns, JA; de Bree, R; Hoekstra, OS; Leemans, CR | 1 |
| Been, LB; Elsinga, PH; Hoekstra, HJ; Jager, PL; Suurmeijer, AJ; van der Laan, BF | 1 |
| Buda, A; Dell'Anna, T; Guerra, L; Mangili, G; Messa, C; Picchio, M; Signorelli, M; Sironi, S | 1 |
| Feng, R; Ma, L; Meng, X; Yu, JM; Yue, JB; Zhang, HQ | 1 |
| Durski, JM; Georgiou, E; Johnston, PB; Karantanis, D; Lowe, VJ; Mullan, BP; Nathan, MA; Wiseman, GA | 1 |
| Boy, C; Buell, U; Coenen, HH; Eble, MJ; Ehmer, J; Kaiser, HJ; Piroth, MD; Schaefer, WM; Thiele, F | 1 |
| Bastiaannet, E; Brouwers, AH; de Klerk, JM; Hoekstra, HJ; Hoekstra, OS; Koelemij, R; Meijer, S; Oyen, WJ; van der Jagt, EJ; Wobbes, T | 1 |
| Bisdas, S; Chambron-Pinho, N; Mack, M; Middendorp, M; Sader, R; Seitz, O; Vogl, TJ | 1 |
| Poulou, LS; Thanos, L; Ziakas, PD | 1 |
| Carreras-Delgado, JL; Delgado-Bolton, RC; Fernández-Pérez, C; Gambhir, SS; Jiménez-Requena, F; Pérez-Vázquez, JM; Schwimmer, J | 1 |
| Bai, HT; Cai, Q; Gao, YR; Jiang, JL; Wan, LP; Wang, C; Wei, J; Yan, SK; Yang, J; Zhao, JH; Zhao, M; Zhou, LL | 1 |
| Warren, KE | 1 |
| Chang, TC; Chen, MY; Chen, YR; Chou, HH; Hong, JH; Lai, CH; Liu, FY; Ng, KK; Yen, TC | 1 |
| Fujii, H; Fukuda, H; Kanegae, K; Kaneta, T; Kitajima, K; Kubota, K; Murakami, K; Nakajima, K; Nakamoto, Y; Suga, T; Tamaki, N; Tateishi, U | 1 |
| Best, R; Bradshaw, J; Hopwood, M; Jones, G; Katsifis, A; Lim, SM; Merory, J; Rowe, CC; Saling, M; Villemagne, VL; Woodward, M | 1 |
| Bassett, RL; Costelloe, CM; Fitzgerald, NE; Harrell, RK; Madewell, JE; Marom, EM; Mawlawi, OR; Nunez, RF; Raymond, AK | 1 |
| Cha, SH; Kim, KW; Kim, MJ; Lee, JD; Lee, MJ; Park, MS; Yun, MJ | 1 |
| Baik, JH; Chung, SK; Jung, SL; Kang, BJ; O, JH; Park, YH | 1 |
| Desjardins, L; Levy-Gabriel, C; Lumbroso-le Rouic, L; Malhaire, C; Mariani, P; Petras, S; Piperno-Neumann, S; Plancher, C; Salmon, RJ; Servois, V | 1 |
| Bissoli, S; Chierichetti, F; Liessi, G; Pasquali, C; Pedrazzoli, S; Sperti, C | 1 |
| Collange, O; Delon-Martin, C; Dietemann, JL; Kremer, S; Mutschler, V; Namer, IJ; Nicolas-Ong, C; Schenck, M; Schneider, F; Schunck, T | 1 |
| Adam, G; Bannas, P; Derlin, T; Klutmann, S; Lambert, J; Leypoldt, F; Mester, J; Weber, C | 1 |
| Amoura, Z; Archambaud, F; Arnaud, L; Chiras, J; Cluzel, P; Drier, A; Grenier, PA; Haroche, J; Kas, A; Malek, Z; Piette, JC; Toledano, D; Zeitoun, D | 1 |
| Bang, S; Chung, JB; Moon, CM | 1 |
| Carlson, D; Groshen, S; Han, MM; Hawkins, R; Jackson, HA; Mari Aparici, C; Maris, J; Matthay, KK; Quach, A; Taggart, DR; Villablanca, JG; Ye, W | 1 |
| Kim, IJ; Kim, SJ; Kim, YK; Lee, JS; Suh, KT | 1 |
| Bayless, TM; Ginsburg, P; Jacene, HA; Kwon, J; Montgomery, EA; Nguyen, GC; Wahl, RL | 1 |
| Costantini, DL; Done, SJ; Fasih, A; Green, DE; McLarty, K; Reilly, RM; Scollard, DA; Vines, DC | 1 |
| Brooks, RA; Powell, MA | 1 |
| Bold, B; Ishida, R; Okada, N; Omura, K; Piao, Y; Shibuya, H; Tayier, A | 1 |
| Alavi, A; Bertagna, F; Biasiotto, G; Bosio, G; Gabanelli, S; Giubbini, R; Lucchini, S; Merli, G; Puta, E; Rodella, C; Rosenbaum, J; Savelli, G | 1 |
| Huang, G; Liu, J; Liu, T; Pan, L; Song, S; Tang, S; Treven, L; Zhang, C; Zhang, T | 1 |
| Fujita, M; Hosokawa, M; Itoh, K; Shimizu, S; Shirato, H; Takahashi, H | 1 |
| Pietrzykowski, J; Wardyn, KA; Zielonka, TM | 1 |
| Antoch, G; Bockisch, A; Forsting, M; Hahn, S; Hamami, M; Heusner, T; Peng, Z; Zhan, Y; Zhou, X | 1 |
| Martin, P | 1 |
| Chu, HR; Hwang, HS; Kim, JH; Rho, YS; Yoon, DY | 1 |
| Doyeux, K; Edet-Sanson, A; Gardin, I; Hapdey, S; Vauclin, S; Vera, P | 1 |
| Franke, CL; Hofman, PA; Kooi, ME; Korten, AG; Kwee, RM; Meems, BJ; Mess, WH; Prins, MH; Ter Berg, JW; Teule, GJ; van der Geest, RJ; van Engelshoven, JM; van Oostenbrugge, RJ; Wildberger, JE | 1 |
| Goodin, GS; Hudson, MM; Kaste, SC; Krasin, MJ; McCarville, MB; Metzger, M; Shulkin, BL | 1 |
| Bui, C; Castle, VP; Frey, KA; Hutchinson, RJ; Mody, RJ; Shulkin, BL; Yanik, GA | 1 |
| Mercier, G; Peller, P; Sakai, O; Subramaniam, RM; Truong, M | 1 |
| Avril, N; Avril-Sassen, S; Dose-Schwarz, J; Jänicke, F; Lebeau, A; Mahner, S; Schwaiger, M; Tiling, R; Untch, M; Weber, C | 1 |
| Allen-Auerbach, MS; Benz, MR; Czernin, J; Dry, SM; Eilber, FC; Elashoff, D; Phelps, ME; Tap, WD; Weber, WA | 1 |
| Betler, J; Day, E; Kirichenko, A; Miften, M; Mohammadi, S; Parda, D; Reitz, B | 1 |
| English, JR; Kolodny, GM; Palmer, MR; Parker, JA; Werner, MK | 1 |
| Fu, Z; Kong, L; Sun, XD; Xie, P; Yu, JM; Yue, JB; Zhao, HX | 1 |
| Both, M; Gross, WL; Heller, M; Moosig, F; Nölle, B; von Forstner, C | 1 |
| Antoch, G; Bockisch, A; Eberhardt, W; Esser, S; Forsting, M; Gölitz, P; Hamami, M; Heusner, T | 1 |
| Arai, H; Furukawa, K; Furumoto, S; Iwata, R; Kudo, Y; Okamura, N; Tashiro, M; Waragai, M; Yanai, K | 1 |
| Aydin, M; Buyukdereli, G; Disel, U; Erkisi, M; Kara, O; Kelle, AP; Kibar, M; Paydas, S; Reyhan, M; Sahin, B; Unal, I; Yapar, AF; Yapar, Z; Yavuz, S | 1 |
| Braun, JJ; Imperiale, A; Riehm, S; Veillon, F | 1 |
| Amador, R; Galeano, I; Lucas, A; Martín, M; Martínez, JC; Prat, R; Reynés, G | 1 |
| Aukema, TS; Oldenburg, HS; Russell, NS; Rutgers, EJ; Teertstra, HJ; Valdés Olmos, RA; Vogel, WV; Vrancken Peeters, MT; Wesseling, J | 1 |
| Bruna-Muraille, C; Cuif-Job, A; Domange-Testard, A; Jovenin, N; Liehn, JC; Menéroux, B; Papathanassiou, D; Prévost, A | 1 |
| Mikhaeel, NG | 1 |
| Callahan, J; Drummond, E; Drummond, KJ; Grigg, A; Hicks, RJ; Hogg, A; Lau, EW; Ryan, G; Ware, RE | 1 |
| Agool, A; Brouwers, AH; Dijkstra, PU; Krabbe, CA; Phan, TT; Pruim, J; Roodenburg, JL; Scholtens, AM | 1 |
| Arii, K; Fukumoto, M; Horino, T; Kagawa, T; Kobayashi, S; Kumon, Y; Ogawa, Y; Ohnishi, T; Taniguchi, Y; Terada, Y | 1 |
| Furukawa, H; Inokuchi, M; Kawashima, H; Kayahara, M; Kinuya, S; Ohta, T; Taki, J | 1 |
| Higashi, T; Nakamoto, Y; Nakatani, K; Saga, T; Togashi, K | 1 |
| Albrecht, S; Balmer-Majno, S; Brauchli, P; Caspar, C; Cescato-Wenger, C; Hany, T; Klaeser, B; Köberle, D; Nitzsche, E; Pestalozzi, BC; Ruhstaller, T; Schuller, JC; von Moos, R; Widmer, L; Zünd, M | 1 |
| Avitabile, G; Cangiano, A; Caprio, MG; Di Martino, G; Farina, A; Forestieri, P; Imbriaco, M; Pace, L; Salvatore, M; Soscia, F | 1 |
| Baldini, L; Calori, R; Carletto, M; Castellani, M; Dellavedova, L; Gerundini, P; Longari, V; Soligo, D | 1 |
| Abe, K; Baba, S; Hatakenaka, M; Honda, H; Isoda, T; Kaneko, K; Sasaki, M; Yabuuchi, H | 1 |
| Hitachi, S; Ishida, K; Kaneta, T; Katayose, Y; Rikiyama, T; Takahashi, S; Takanami, K; Unno, M; Yamada, S; Yamada, T | 1 |
| Digumarthy, SR; Kalra, MK; Prakash, P; Sharma, A; Shepard, JA | 1 |
| Strobel, K | 1 |
| Bovo, G; De Ponti, E; Di Pisa, G; Gardani, G; Guerra, L; Ippolito, D; Messa, C; Niespolo, R; Sironi, S; Terrevazzi, S | 1 |
| Kam, MH; Lai, J; Phillips, GE; Siu, S; Stevenson, AR; Wong, DC | 1 |
| Fujita, H; Inayama, Y; Ishigatsubo, Y; Sakata, S; Takeuchi, K; Tanaka, M; Tateishi, U; Tomita, N; Watanabe, R | 1 |
| Ananth, L; Barnett, PG; Gould, MK; Nair, VS | 1 |
| Clark, JR; Iyer, NG; Singham, S; Zhu, J | 1 |
| Ament, C; Gonzalez, RG; Hochberg, FH; Kwong, K; Lev, MH; Mullins, ME; Ozsunar, Y; Schaefer, PW | 1 |
| Dhawan, V; Eckert, T; Eidelberg, D; Fahn, S; Feigin, A; Frucht, S; Gudesblatt, M; Lesser, M; Poston, KL; Tang, CC; Vonsattel, JP | 1 |
| Claassen, DO; Josephs, KA; Peller, PJ | 1 |
| Brewer, J; Dale, AM; Fennema-Notestine, C; Fjell, AM; Hagler, DJ; Jennings, RG; Karow, D; McEvoy, LK; Walhovd, KB | 1 |
| Beyer, F; Buerke, B; Gerss, J; Heindel, W; Puesken, M; Scheffe, K; Schober, O; Weckesser, M; Wessling, J | 1 |
| Erturk, SM; Madan, R; Shyn, PB; Silverman, SG; Wu, C | 1 |
| Al-Nahhas, A; Ambrosini, V; Fanti, S; Ferdeghini, M; Gross, MD; Marzola, MC; Massaro, A; Pelizzo, MR; Rubello, D; Toniato, A | 1 |
| Bartel, TB; Bodenner, D; Nalley, C; Stack, BC; Wiebeck, K | 1 |
| Fanti, S; Marzola, MC; Musto, A; Nanni, C; Rampin, L; Rubello, D | 1 |
| Aukema, TS; Gilhuijs, KG; Olmos, RA; Peeters, MJ; Rutgers, EJ; Schot, ME; Straver, ME; Vogel, WV | 1 |
| Bal, CS; Halanaik, D; Kumar, R; Malhotra, A; Reddy, R; Santra, A | 1 |
| Balink, H; Bruyn, G; Bruyn, GA; Collins, J; Gemmel, F | 1 |
| D'Souza, M; Datta, A; Garg, G; Grover, RK; Jaimini, A; Kumar, N; Mishra, AK; Mondal, A; Panwar, P; Sharma, R; Singh, D; Tripathi, M; Varshney, R | 1 |
| Cohen, M; Davila, R; Dehdashti, F; Fialkowski, E; Hussain, H; Moley, JF; Quayle, F; Traugott, AL; Trinkaus, K; Ylagan, L | 1 |
| Heys, SD; Peare, R; Staff, RT | 1 |
| Antoine, M; Balogova, S; Cadranel, J; Gutman, F; Huchet, V; Kerrou, K; Lavolée, A; Mayaud, C; Montravers, F; Nataf, V; Prignon, A; Ruppert, AM; Talbot, JN | 1 |
| Aukema, TS; Bonfrer, JM; Korse, CM; Kroon, BB; Nieweg, OE; Olmos, RA; Vogel, WV; Wouters, MW | 1 |
| Lichauco, JJ; Santos Estrella, PV; Vista, EG | 1 |
| Ang, KK; Cannon, BA; Chao, KS; Chronowski, GM; Frank, SJ; Garden, AS; Ginsberg, LE; Lee, JJ; Lippman, SM; Macapinlac, HA; Moeller, BJ; Morrison, WH; Rana, V; Rosenthal, DI; Schwartz, DL; Sturgis, EM; Weber, RS; Williams, MD | 1 |
| Al-Nahhas, A; Barwick, T; Khan, S; Marzola, MC; Rubello, D; Tan, K; Zerizer, I | 1 |
| Freeman, M; Hendler, A; McSweeney, S; Metser, U; You, J | 1 |
| Kwee, RM | 1 |
| Afshar-Oromieh, A; Böckler, D; Hyhlik-Dürr, A; Kilk, K | 1 |
| Hasegawa, Y; Higashiyama, M; Hosoki, T; Kanzaki, R; Kodama, K; Maeda, J; Okami, J; Takami, M | 1 |
| Berger, F; Issels, R; Reiser, MF; Rist, C; Schlemmer, M; Schramm, N | 1 |
| Bartenstein, P; Hacker, M; Nikolaou, K; Reiser, MF; Rist, C; Rominger, A; Saam, T | 1 |
| Chen, YK; Huang, LW; Lee, SL; Pan, HS | 1 |
| Küçüköz Uzun, A; Ozpaçac, T; Ozülker, F; Ozülker, T | 1 |
| Evans, PM; Partridge, M; Perrin, R; Webb, S | 1 |
| Csiki, I; Delbeke, D; Diaz, R; Duggan, D; Lu, B; McElmurray, J; Spratt, DE | 1 |
| Apostolova, I; Brenner, W; Buchert, R; Dreilich, T; Kabus, S; Klutmann, S; Mester, J; Paulus, T; Plotkin, M; van den Hoff, J; Wiemker, R | 1 |
| Cho, YH; Chung, HW; Kim, JH; Kim, SY; Lee, EJ; Lee, KY; Lee, MH; Lee, SY; Park, HS; So, Y; Sung, IK; Yoo, MW; Yoon, SY | 1 |
| Drubach, LA; Grant, FD; Johnston, PR; Kleinman, PK; Newton, AW; Perez-Rossello, JM | 1 |
| Bainbridge, A; Bandula, S; Bomanji, JB; Daw, S; De Vita, E; Hain, SF; Humphries, PD; Olsen, OE; Prakash, V; Punwani, S; Shankar, A; Stevens, N; Taylor, SA | 1 |
| Alevizaki, M; Datseris, IE; Piaditis, G; Rondogianni, P; Skoura, E; Tolis, G; Tsagarakis, S; Tzanela, M | 1 |
| Deng, C; Feng, D; Huang, G; Liu, JJ; Song, SL; Wang, H; Wen, LF; Wong, CY | 1 |
| Cherry, SR; Li, C; Mitchell, GS | 1 |
| Balogova, S; Giannesini, C; Gutman, F; Huchet, V; Izrael, V; Kerrou, K; Muresan, IP; Nataf, V; Pene, F; Prignon, A; Schlienger, M; Talbot, JN | 1 |
| Albin, RL; Burke, JF; Frey, KA; Gilman, S; Giordani, B; Kilbourn, MR; Koeppe, RA | 1 |
| Canty, JM; deKemp, RA; Fallavollita, JA; Luisi, AJ; Yun, E | 1 |
| Chan, SC; Chang, JT; Chang, KP; Ko, SF; Liao, CT; Lin, CY; Lin, YC; Ng, SH; Wang, HM; Yen, TC | 1 |
| Belleannee, G; Gaye, D; Guyot, M; Nunes, ML; Rault, A; Tabarin, A; Teynie, J; Valli, N | 1 |
| Aristei, C; Falcinelli, L; Palumbo, B; Tarducci, R | 1 |
| Kei, PL; Macapinlac, HA; Stroehlein, JR; Vikram, R; Yeung, HW | 1 |
| Hoshi, K; Tozaki, M | 1 |
| Davison, JM; Grillone, GA; Imsande, HM; Ozonoff, A; Subramaniam, RM | 1 |
| Liozon, E; Ly, KH; Monteil, J; Vidal, E | 1 |
| Chen, L; Chen, W; Dai, YM; Huang, XQ; Jian, W; Li, C; Li, HT; Lin, Y; Lu, M; Xie, B; Xu, CX; Zhang, YK; Zhou, DQ | 1 |
| Aukema, TS; Klop, WM; Kroon, BB; Nieweg, OE; Valdés Olmos, RA; Vogel, WV; Wouters, MW | 1 |
| Campbell, J; Gates, VL; Ho, CL; Lewandowski, RJ; Qing, F; Salem, R; Savin, M; Tang, B; Thie, J; Wong, CY | 1 |
| Horn, J; Lock-Andersen, J; Loft, A; Sjøstrand, H | 1 |
| Borbenyi, Z; Deak, B; Galuska, L; Illes, A; Keresztes, K; Marton, I; Miltenyi, Z; Molnar, Z; Rosta, A; Schneider, T; Simon, Z; Tron, L; Varady, E | 1 |
| Bae, KT; Goshima, S; Hoshi, H; Kako, N; Kanematsu, M; Kondo, H; Watanabe, H; Yamada, T; Yamamoto, N | 1 |
| Brotchi, J; Goldman, S; Levivier, M; Lubansu, A; Massager, N; Pirotte, BJ; Van Bogaert, P; Wikler, D | 2 |
| Chung, DC; Kang, S; Kim, JY; Kim, SK; Lim, MC; Park, JY; Park, SH; Park, SY; Seo, SS; Song, YJ | 1 |
| Mueller-Lisse, UG; Mueller-Lisse, UL | 1 |
| Ahn, MJ; Chung, MJ; Hyun, SH; Kim, BT; Kim, J; Kim, TS; Lee, HY; Lee, KS; Shim, YM; Yi, CA | 1 |
| Manukova, VA; Panchkovskaia, EV; Rudas, MS; Sergienko, VB | 1 |
| Cheng, D; Nair-Gill, E; Radu, CG; Riedinger, M; Wei, XX; Wiltzius, SM; Witte, ON | 1 |
| Blake, MA; Cronin, CG; Prakash, P | 1 |
| Bartolucci, AD; Calabria, F; Mammucari, M; Masala, S; Schillaci, O; Simonetti, G | 1 |
| Crott, R; Krug, B; Pirson, AS; Vander Borght, T | 1 |
| Doi, R; Hatano, E; Higashi, T; Ikai, I; Kitamura, K; Nakamoto, Y; Narita, M; Nitta, T; Seo, S; Taura, K; Uemoto, S; Yamanaka, K; Yasuchika, K | 1 |
| Hong, L; Li, HB; Li, Y; Wang, JL; Wang, Q; Yue, MG | 1 |
| Fayad, ZA; Fuster, V; Klimas, M; Machac, J; Narula, J; Rudd, JH; Strauss, HW; Tahara, N; Tawakol, AA; Virmani, R; Warburton, EA | 1 |
| Dartnell, JA; Lang-Lazdunski, L; Pilling, J | 1 |
| Ball, DL; Brennan, SM; Gregory, DL; Herschtal, A; Hicks, RJ; MacManus, MP; Stillie, A | 1 |
| Imagawa, T; Inoue, T; Kanezawa, N; Okabe, T; Shizukuishi, K; Tateishi, U; Yokota, S | 1 |
| Al-Nahhas, A; Bonciarelli, G; Crepaldi, G; Facci, E; Fornasiero, A; Grassetto, G; Mandoliti, G; Marzola, MC; Minicozzi, AM; Nashimben, O; Otello, D; Pasini, F; Rossi, E; Rubello, D | 1 |
| Koyama, H; Maniwa, Y; Matsumoto, K; Matsumoto, S; Nishimura, Y; Nogami, M; Ohno, Y; Onishi, Y; Sugimura, K; Takenaka, D; Yoshikawa, T | 1 |
| Kumar, R; Shandal, V | 1 |
| Boellaard, R; Comans, EF; Hoekstra, OS; Rizvi, SN; van Tinteren, H | 1 |
| Alkefaji, H; Bruggink, JL; Glaudemans, AW; Meerwaldt, R; Prins, TR; Saleem, BR; Slart, RH; Zeebregts, CJ | 1 |
| de Keyzer, F; Deroose, C; Haustermans, K; Lambrecht, M; Penninckx, F; Roels, S; Sagaert, X; van Cutsem, E; Vandecaveye, V | 1 |
| Kley, K; Oehr, P | 1 |
| Choi, SC; Kim, BI; Kim, BJ; Kim, K; Kim, MH; Kim, Y; Lee, ED; Lee, KH; Park, SI; Ryu, SY | 1 |
| Kochhar, R; Leahy, M; Manoharan, P; Taylor, MB | 1 |
| Ceulemans, G; De Ridder, M; Engels, B; Everaert, H; Hoorens, A; Sermeus, A; Storme, G; Urbain, D; Vanhove, C; Verellen, D; Vermeersch, M | 1 |
| Cameron, D; Fleming, IN; Gilbert, FJ; Miles, KA | 1 |
| Abaleke, S; Chatwin, CR; Ganeshan, B; Miles, KA; Young, RC | 1 |
| Paleri, V; Zammit-Maempel, I | 1 |
| Chen, YK; Hsieh, TC; Kao, CH; Liang, JA; Lin, YY; Sun, SS; Wang, CH; Wu, YC; Yen, KY | 1 |
| Cuganesan, R; Lin, M; Lin, P; Shon, IH; Som, S; Wong, C | 1 |
| Bensimhon, L; Faraggi, M; Hugonnet, F; Latremouille, C; Lavergne, T; Le Heuzey, JY; Lepillier, A; Mainardi, JL; Maunoury, C | 1 |
| Adams, MC; Turkington, TG; Wilson, JM; Wong, TZ | 1 |
| Feeney, J; Gönen, M; Horwitz, S; Schöder, H | 1 |
| Carrie, C; Chabaud, S; Dussart, S; Giammarile, F; Le Pechoux, C; Pommier, P; Touboul, E | 1 |
| Giesel, FL; Haberkorn, U; Kratochwil, C | 1 |
| Allal, BC; Brillouet, S; Canal, P; Caselles, O; Courbon, F; Delord, JP; Filleron, T; Rochaix, P; Thomas, F; Vergez, S | 1 |
| Ahn, BC; Cho, IH; Chun, KA; Jeong, SY; Kang, S; Lee, HJ; Lee, J; Lee, SW; Seo, JH; Won, KS; Zeon, SK | 1 |
| Bamba, Y; Itabashi, M; Kameoka, S | 1 |
| Doki, Y; Eguchi, H; Kim, T; Kitagawa, T; Kobayashi, S; Marubashi, S; Mori, M; Nagano, H; Takeda, Y; Tanemura, M; Tatsumi, M; Tomimaru, Y; Umeshita, K; Wakasa, K | 1 |
| Ahn, JH; Jeong, J; Kim, EK; Kim, JA; Kwak, JY; Ryu, YH; Son, EJ; Youk, JH | 1 |
| Akin, O; Apolo, AB; Bajorin, DF; Milowsky, MI; Riches, J; Schöder, H; Trout, A | 1 |
| Fan, QP; Kuang, AR; Li, FL; Li, L; Miller, JH; Su, MG; Tian, R; Tian, Y | 1 |
| Bhosale, P; Iyer, RB; Levenback, CF; Macapinlac, HA; Peungjesada, S; Rohren, E; Schmeler, K; Wei, W | 1 |
| Duggal, BS; Goyal, BK; Jacob, MJ; Kapur, K; Singh, H | 1 |
| Andersen, A; Bastin, C; Bormans, G; Brooks, DJ; Buckley, C; Farrar, G; Garraux, G; Hasselbalch, S; Ivanoiu, A; Korner, A; Law, I; Minthon, L; Nelissen, N; Owenius, R; Salmon, E; Thurfjell, L; Triau, E; Van Laere, K; Vandenberghe, R | 1 |
| Al-Nahhas, A; Allegri, V; Cacciari, N; De Iaco, P; Fanti, S; Musto, A; Orazi, L; Rosati, M; Rubello, D; Venturoli, S; Zamagni, C | 1 |
| Al Ghuzlan, A; Aupérin, A; Baillot, S; Baudin, E; Bidault, F; Bonniaud, G; Deandreis, D; Leboulleux, S; Lumbroso, J; Poisson, T; Schlumberger, M; Travagli, JP | 1 |
| Bahri, H; Barge, ML; Bayat, S; Cuggia, M; De Guibert, S; Devillers, A; Garin, E; Houot, R; Lamy, T; Le Dortz, L; Le Jeune, F; Rolland, Y | 1 |
| Beauregard, JM; Degrado, TR; Hicks, RJ; Roselt, P; Williams, SG | 1 |
| Brewer, JB; Dale, AM; Fennema-Notestine, C; Hagler, DJ; Hoh, CK; Jennings, RG; Karow, DS; McEvoy, LK | 1 |
| Dubois, F; Dumollard, JM; Martin, C; Prades, JM; Prevot, N; Richard, C; Timoshenko, AP | 1 |
| Gorthi, V; Lee, SH; Moon, YL; Park, SY; Yu, JC | 1 |
| Horiuchi, C; Nishimura, G; Taguchi, T; Tsukuda, M; Yabuki, K | 1 |
| Howman-Giles, R; London, K | 1 |
| Bradley, KM; Gillies, RS; Gleeson, FV; Maynard, ND; Middleton, MR | 1 |
| Maes, A; Pottel, H; Sathekge, MM; Stoltz, A; van de Wiele, C | 1 |
| de Bree, R | 1 |
| Bipat, S; Niekel, MC; Stoker, J | 1 |
| DeCamp, MM; Gangadharan, SP; Kent, MS; Nicotera, SP; Okereke, IC | 1 |
| Schwarz, J | 1 |
| Chaudhry, MA; Lodge, MA; Udall, DN; Wahl, RL | 1 |
| Darling, G; Hwang, D; Mah, K; Maziak, DE; Tirona, R; Tsao, MS; Ung, YC; Wong, CS; Wu, K | 1 |
| Hoekstra, OS; Quarles van Ufford, HM; Riphagen, II; Stroobants, SG; van Tinteren, H | 1 |
| Edemir, B; Gabriëls, G; Kentrup, D; Pavenstädt, H; Reuter, S; Schäfers, M; Schlatter, E; Schnöckel, U; Schober, O; Schröter, R | 1 |
| Cross, S; Dalla-Pozza, L; Howman-Giles, R; London, K; Onikul, E | 1 |
| Baek, JH; Choi, BS; Choi, JW; Jeong, KS; Kim, TY; Kim, WB; Lee, JH; Ryu, JS; Shong, YK | 1 |
| Adang, EM; Comans, EF; de Jong, KP; Dekker, HM; Krabbe, PF; Oyen, WJ; Pruim, J; Roumen, RM; Ruers, TJ; van der Sijp, JR; Wiering, B | 1 |
| Ikeda, T; Ikeda, Y; Iwasa, K; Mastunari, I; Morinaga, A; Noguchi-Shinohara, M; Ono, K; Samuraki, M; Shima, K; Yamada, M; Yanase, D; Yoshita, M | 1 |
| Conron, M; Hutchinson, AF; Irving, LB; Liew, D; Steinfort, DP | 1 |
| Buriánková, E; Dušek, L; Flodr, P; Indrák, K; Jarkovský, J; Koranda, P; Kubová, Z; Kučerová, L; Mysliveček, M; Palová, M; Papajík, T; Procházka, V; Raida, L; Sedová, Z | 1 |
| Klaeser, B; Krause, T | 1 |
| Klarhöfer, M; Lenz, C; Scheffler, K; Sommer, G; Winter, L | 1 |
| Al Ghuzlan, A; Aupérin, A; Baudin, E; Bidault, F; Deandreis, D; Escourrou, C; Leboulleux, S; Lumbroso, J; Schlumberger, M; Travagli, JP | 1 |
| Brianzoni, E; Crisci, R; De Vico, A; Di Leonardo, G; Di Tommaso, S; Divisi, D | 1 |
| Buriánková, E; Havlík, R; Klos, D; Koranda, P; Kysucan, J; Lovecek, M; Neoral, C; Tozzi, I | 1 |
| Bae, SH; Chang, SK; Choi, CS; Gu, DH; Lim, KJ; Park, CH; Seo, YL; Yoon, DY; Yun, EJ | 1 |
| Hur, H; Jeon, HM; Kim, SH; Kim, W; Park, CH; Song, KY | 1 |
| Brambs, HJ; Feuerlein, S; Juchems, MS; Klass, O; Luster, M; Pauls, S; Reske, SN; Schmidt, SA | 1 |
| Bonardel, G; Foehrenbach, H; Gontier, E; Le Floch, H; Mairovitz, A; Margery, J; Marotel, C; Ngampolo, I; Rivière, F; Vaylet, F | 1 |
| Antoch, G; Bockisch, A; Forsting, M; Hahn, S; Hamami, ME; Heusner, TA; Jonkmanns, C; Kuemmel, S; Otterbach, F; Stahl, AR | 1 |
| Choe, JH; Choi, JH; Choi, JY; Hur, SM; Kim, JH; Kim, JS; Kim, S; Kim, SH; Kim, WW; Lee, JE; Lee, SK; Nam, SJ; Yang, JH | 1 |
| Achajew, N; Buchtala, S; Ehrenstein, B; Fleck, M; Haerle, P; Lehmann, P; Lighvani, H; Marienhagen, J | 1 |
| Mori, S; Oguchi, K | 1 |
| Choi, JY; Chung, JH; Jang, HW; Kim, HK; Kim, SW; Lee, JI; Shin, HW; Shin, JH | 1 |
| Kitajima, K; Maeda, T; Ohno, Y; Onishi, Y; Sakamoto, S; Senda, M; Sugimura, K; Suzuki, K; Yoshikawa, T | 1 |
| Däbritz, J; Foell, D; Jasper, N; Loeffler, M; Weckesser, M | 1 |
| Routledge, T; Scarci, M; Sharif, S; Zahid, I | 1 |
| Schönberg, S | 1 |
| Al-Nahhas, A; Alavi, A; Cordiano, C; De Manzoni, G; Grassetto, G; Marzola, MC; Rubello, D | 1 |
| Ballek, E; Grgic, A; Hellwig, D; Hohloch, K; Kirsch, CM; König, J; Nestle, U; Pinkert, J; Puskas, C; Scheidhauer, K; Schubert, J; Truemper, L | 1 |
| Hrdina, C; Pfadenhauer, K; Weinerth, J | 1 |
| Berg, WA; Kalinyak, JE; Larsen, LH; Madsen, KS; Miller, JP; Narayanan, D; Ozonoff, A; Pisano, ED; Schilling, K; Tartar, M | 1 |
| Aerts, J; Giacomelli, F; Grayet, B; Hustinx, R; Jerusalem, G; Mella, C; Mievis, F; Rorive, A; Tancredi, T; Waltregny, D; Withofs, N | 1 |
| Choi, WH; Chung, SK; Kim, SH; O, JH; Yoo, IR | 1 |
| Alkhorayef, MA; Alzimami, KS; Sassi, SA; Spyrou, NM | 1 |
| Cho, A; Cho, HJ; Hur, J; Kang, WJ; Lee, JD; Lee, JH; Yun, M | 1 |
| Bertagna, F; Biasiotto, G; Bosio, G; Giubbini, R; Orlando, E | 1 |
| Schaefer, NG; Soyka, JD; Stahel, RA; Steinert, HC; Veit-Haibach, P | 1 |
| Dong, MJ; Liu, ZF; Wang, GL; Yang, SY; Zhao, K; Zhou, GJ | 1 |
| Doki, Y; Eguchi, H; Hatazawa, J; Hoshino, H; Kim, T; Kobayashi, S; Marubashi, S; Mori, M; Nagano, H; Shimosegawa, E; Takeda, Y; Tanemura, M; Wada, H | 1 |
| Chen, FY; Gu, HY; Jiang, XX; Wu, LM; Xu, JR; Yin, Y | 1 |
| Aizenstein, HJ; Arnold, SE; Barbas, NR; Boeve, BF; Burke, JR; Clark, CM; Dekosky, ST; Farlow, MR; Foster, NL; Gabel, MJ; Heidebrink, JL; Higdon, R; Jagust, WJ; Kawas, CH; Koeppe, RA; Leverenz, JB; Lipton, AM; Peskind, ER; Turner, RS; Womack, KB; Zamrini, EY | 1 |
| Kgomo, M; Maes, A; Pottel, H; Sathekge, M; Stolz, A; Van De Wiele, C | 1 |
| Coya, J; Del Campo-Del Val, L; Gómez-León, N; Hernandez-Maraver, D; Jover-Díaz, R; Pinilla, I; Rodríguez-Vigil, B | 1 |
| Amati, A; Arena, V; Bellò, M; Bisi, G; Douroukas, A; Passera, R; Pelosi, E; Penna, D | 1 |
| Ayuso, JR; Casado, A; Cubedo, R; Del Muro, XG; Fuster, D; Lomeña, F; López-Pousa, A; Martínez-Trufero, J; Maurel, J; Pons, F; Poveda, A | 1 |
| Addeo, P; Becker, CD; Bucher, P; Buchs, NC; Bühler, L; Frossard, JL; Morel, P; Ratib, O; Rosset, A; Roth, AD; Terraz, S; Willi, JP | 1 |
| He, W; Jiang, JJ; Jiang, MS; Xiao, L; Zhang, MJ; Zhu, YH | 1 |
| Conde-Muíño, R; Ferrón, JA; Gómez-Río, M; Llamas-Elvira, JM; Martín-Cano, J; Palma, P; Rodríguez-Fernández, A; Sánchez-Sánchez, R; Segura-Jiménez, I | 1 |
| Jentzmik, F; Müller, J; Schrader, AJ; Schrader, M | 1 |
| Apostolova, I; Brenner, W; Buchert, R; Carlsen, IC; Derlin, T; Opfer, R; Renisch, S | 1 |
| Buck, AK; Frechen, D; Kley, H; Krüger, S; Maschke, S; Mottaghy, FM; Pauls, S; Reske, SN; Wibmer, T | 1 |
| Dudczak, R; Graf, S; Gyöngyösi, M; Karanikas, G; Khorsand, A; Maurer, G; Porenta, G; Schuster, E; Sochor, H | 1 |
| Ahmadzadehfar, H; Biermann, K; Biersack, HJ; Sabet, A | 1 |
| Brower, V | 1 |
| Kim, J; Visioni, A | 1 |
| Aoki, Y; Arai, G; Eguchi, Y; Inoue, G; Ishikawa, T; Kamoda, H; Kishida, S; Koshi, T; Kuniyoshi, K; Miyagi, M; Nakamura, J; Ochiai, N; Ohtori, S; Orita, S; Suzuki, M; Takahashi, K; Takaso, M; Toyone, T; Yamashita, M; Yamauchi, K | 1 |
| Chang, UK; Cho, WI | 1 |
| Chung, DH; Goo, JM; Han, SK; Kang, CH; Kim, YT; Kim, YW; Lee, CH; Lee, SH; Min, JW; Park, CM; Shim, YS; Yim, JJ | 1 |
| De Geus-Oei, LF; Krabbe, PF; Oyen, WJ; Van Der Heijden, HF; Van Laarhoven, HW; Visser, EP; Vriens, D | 1 |
| Christensen, T; Ewertz, M; Fisker, R; Fründ, ET; Grankvist, J; Iyer, V; Larsson, EM; Simonsen, C; Stenbygaard, L | 1 |
| Cermik, TF; Cetin, G; Ciftci, H; Ergül, N; Güner, SI; Sager, S | 1 |
| Bouchelouche, K; Gerke, O; Holt, P; Jensen, TK; Marcussen, N; Riehmann, M; Svolgaard, B | 1 |
| Bi, S; Dong, MJ; Huang, HJ; Li, JJ; Li, LJ; Liu, J; Shen, XM; Sheng, GP; Sheng, JF; Sheng, ZK; Xiang, DR; Yu, HY; Zhao, K | 1 |
| Du Bois, RM; Grutters, JC; Keijsers, RG; Lavalaye, J; Thomeer, M; Van Buul, MM; Van Den Bosch, JM; Verzijlbergen, FJ | 1 |
| Akamoto, S; Hagiike, M; Kakinoki, K; Nishiyama, Y; Okano, K; Suzuki, Y; Usuki, H; Yamamoto, Y | 1 |
| Ahn, BC; Hong, CM; Jeong, SY; Kang, S; Lee, HJ; Lee, J; Lee, SJ; Lee, SW; Song, BI | 1 |
| Kaushik, A; Nguyen, NC; Osman, MM; Wolverson, MK | 1 |
| Araki, T; Ichikawa, T; Kimura, K; Motosugi, U; Sano, K; Satoh, Y; Sou, H | 1 |
| Agko, M; Aybar, PS; Chaudhuri, PK; Higgins, JA; Nazzal, M; Slam, K | 1 |
| Alves, TC; Buchpiguel, CA; Busatto, GF; Curiati, PK; Duran, FL; Menezes, PR; Romano, DC; Scazufca, M; Squarzoni, P; Tamashiro-Duran, JH; Vallada, H | 1 |
| Chan, Q; Gu, J; Khong, PL; Law, W; Liu, RK; Wang, S; Wu, EX; Zhang, J | 1 |
| Fastrez, M; Nogarède, C; Rozenberg, S; Sirtaine, N; Tondeur, M | 1 |
| Ishii, K; Miyamoto, N; Uemura, T; Yoshikawa, T | 1 |
| Lyburn, I; Macdonald, K; Searle, J | 1 |
| Beukema, JC; Havenga, K; Langendijk, JA; Muijs, CT; Pruim, J; van den Bergh, AC; Widder, J | 1 |
| Han, A; Xue, J; Yu, J; Yue, J; Zheng, J; Zhu, D | 1 |
| Blumin, J; Campbell, BH; Maheshwari, M; Massey, BL; Michel, MA; Schultz, CJ; Wang, D; Wilson, JF; Wong, SJ; Zundel, MT | 1 |
| Burbelko, M; Hundt, W; la Fougère, C; Steinbach, S; Tiling, R; Vogtmann, J | 1 |
| Chondrogiannis, S; Conti, G; D'Ambrosio, D; Farace, P; Marzola, P; Merigo, F; Nanni, C; Quarta, C; Rubello, D; Sbarbati, A; Tambalo, S | 1 |
| Ozbek, E; Ozpaçaci, T; Ozülker, F; Ozülker, T | 1 |
| Hong, SH; Kang, EJ; Kim, DW; Kim, SH; Lee, KN | 1 |
| Buecher, B; Deleau, C; des Varannes, SB; Flamant, M; Frampas, E; Galmiche, JP; Kraeber-Bodéré, F; Matysiak-Budnik, T; Rousseau, C | 1 |
| Cheng, C; Dimitrakopoulou-Strauss, A; Haberkorn, U; Pan, L; Strauss, LG | 1 |
| El Fakhri, G; Karp, JS; Scheuermann, J; Surti, S; Trott, CM | 1 |
| Albarghach, N; Corcos, L; Hatt, M; Le Rest, CC; Metges, JP; Pradier, O; Tixier, F; Visvikis, D | 1 |
| Bartlett, NL; Cashen, AF; Dehdashti, F; Homb, A; Luo, J; Siegel, BA | 1 |
| Li, HS; Wang, MF; Wang, QS; Wu, HB; Zhen, X; Zhou, WL | 1 |
| Chang, YT; Cheng, MF; Hsu, C; Liu, KL; Tzen, KY; Wang, HP; Wu, YM; Wu, YW; Yen, RF | 1 |
| Franke, CL; Kooi, ME; Korten, AG; Kwee, RM; Meems, BJ; Mess, WH; Prins, MH; ter Berg, JW; Teule, GJ; Truijman, MT; van Engelshoven, JM; van Oostenbrugge, RJ; Wildberger, JE | 1 |
| Blake, MA; Boland, GW; Dwamena, BA; Goehler, AG; Hahn, PF; Jagtiani Sangwaiya, M; Kalra, MK; Scott, JA | 1 |
| Chevreau, C; Courbon, F; Julian, A; Meyer, N; Payoux, P; Wagner, T; Zerdoud, S | 1 |
| Dalus, K; Holzmannhofer, J; Kronberger, C; Pirich, C; Reitsamer, R; Rendl, G; Rettenbacher, L | 1 |
| Campbell, P; Clark, JR; Depcynzski, B; Ho Shon, I; Lin, M; Lin, P; Wong, V | 1 |
| Choi, JY; Kim, MJ; Kim, SH; Lee, SJ; Rhim, H; Song, I | 1 |
| Buvat, I; Emonts, P; Flamen, P; Garcia, C; Hendlisz, A; Necib, H; Vanderlinden, B; Wagner, A | 1 |
| Bannier, M; Bats, AS; Brenot-Rossi, I; Ferron, G; Gauthier, H; Ghazzar, N; Houvenaeghel, G; Leblanc, E; Lecuru, F; Lumbroso, S; Morice, P; Narducci, F; Querleu, D; Uzan, C; Zerdoud, S | 1 |
| Bal, C; Julka, PK; Kumar, A; Kumar, R; Malhotra, A; Santra, A; Sharma, P | 1 |
| Dai, K; Huang, X; Qu, X; Wu, L; Yan, W | 1 |
| Lee, D; Shim, H; Zhu, A | 1 |
| Doot, RK; Dunnwald, LK; Ellis, GK; Gadi, VK; Gralow, JR; Kurland, BF; Linden, HM; Livingston, RB; Mankoff, DA; Muzi, M; Schubert, EK; Specht, JM | 1 |
| Buijsen, J; Janssen, MH; Lambin, P; Lammering, G; Öllers, MC; Riedl, RG; van den Bogaard, J; van Stiphout, RG | 1 |
| Lang, BH; Law, TT | 1 |
| Gokce, M; Kilicgun, A; Saydam, O; Tanriverdi, O | 1 |
| Brown, JA; Coleman, T; Collins, M; Lightfoot, AJ; Rosevear, HM; Williams, H | 1 |
| Baur-Melnyk, A; Haug, A; Hoffmann, RT; Jakobs, TF; Nikolaou, K; Notohamiprodjo, M; Paprottka, P; Reiser, MF; Rist, C; Schmidt, GP | 1 |
| Bennink, RJ; Busch, OR; Engelbrecht, MR; Gouma, DJ; Ruys, AT; van Gulik, TM; van Westreenen, HL | 1 |
| Bartholomeusz, DF; Nguyen, NQ | 1 |
| Berg, WA; Kalinyak, JE; Madsen, KS; Narayanan, D | 1 |
| Bentivegna, E; Duvillard, P; Gouy, S; Haie-Meder, C; Leboulleux, S; Lumbroso, J; Morice, P; Uzan, C | 1 |
| Fabregat, J; Gamez, C; Lladó, L; Martinez, L; Rafecas, A; Ramos, E; Ruiz, S; Serrano, T; Torras, J; Valls, C | 1 |
| de Geus-Oei, LF; de Wilt, JH; Netea-Maier, RT; Oyen, WJ; van der Wilt, GJ; Vriens, D | 1 |
| Ding, HJ; Hsieh, TC; Kao, CH; Sun, SS; Wang, CH; Wu, YC; Yeh, JJ; Yen, KY | 1 |
| Chen, JH; Hsieh, TC; Kao, CH; Liang, JA; Shum, WY; Su, CC; Yeh, JJ | 1 |
| Liang, W; Meng, J; Xu, S; Zhang, G | 1 |
| Campos, PA; Gil, J; Parrilla, P | 1 |
| Ceriani, L; Giovanella, L; Maffioli, M; Suriano, S | 1 |
| Cho, KJ; Choi, SH; Doo, H; Kim, JS; Kim, SY; Lee, H; Lee, JH; Nam, SY; Roh, JL | 1 |
| Katahira, K; Mori, T; Namimoto, T; Nomori, H; Ohba, Y; Shiraishi, K | 1 |
| Akhurst, TJ; Chessin, DB; Guillem, JG; Larson, SM; Leibold, T; Macapinlac, H; Mazumdar, M; Minsky, BD; Paty, PB; Riedel, E; Saltz, LB; Shia, J; Weiser, MR; Wong, WD; Yeung, HW | 1 |
| Alberini, JL; Bellet, D; Champion, L; Edeline, V; Giraudet, AL; Madar, O; Paulmier, B; Pecking, AP; Poinsignon, A | 1 |
| Cho, N; Chung, JK; Kang, KW; Lyou, CY; Moon, WK; Park, JS | 1 |
| Erasmus, JJ; Truong, MT; Viswanathan, C | 1 |
| Li, M; Liang, Y; Liu, Y; Wu, N; Zhang, W; Zhao, P; Zheng, R | 1 |
| Bailly, P; Daouk, J; El Esper, I; Fin, L; François, G; Jounieaux, V; Leloire, M; Meyer, ME; Morvan, J; Moullart, V; Saidi, L | 1 |
| Brader, P; Fong, Y; Gönen, M; González, L; González, SJ; Strong, VE; Wong, J; Zakowski, M | 1 |
| Buriankova, E; Dusek, L; Flodr, P; Hnatkova, M; Indrak, K; Jarkovsky, J; Koranda, P; Koza, V; Kubova, Z; Malan, A; Myslivecek, M; Papajik, T; Sedova, Z; Skopalova, M; Trneny, M | 1 |
| Fang, L; Hui, P; Hui-Juan, Z; Rui-xue, C; Tao, Y; Xin, C | 1 |
| Hasegawa, C; Ito, H; Kameda, Y; Kondo, T; Murakami, S; Nakayama, H; Oshita, F; Saito, H; Sakuma, Y; Tsuboi, M; Yamada, K; Yokose, T | 1 |
| Krause, BJ; Lordick, F; Ott, K | 1 |
| Bochmann, K; Cyran, CC; Dichgans, M; Habs, M; Hacker, M; Nikolaou, K; Pfefferkorn, T; Raya, JG; Reiser, MF; Rominger, A; Saam, T; Sourbron, S | 1 |
| Chung, WS; Kim, MJ; Kim, YE; Lee, JD; Seo, HJ | 1 |
| Andrade, G; Deppen, S; Grogan, EL; Lambright, ES; Massion, PP; Nesbitt, JC; Putnam, JB; Speroff, T; Walker, R | 1 |
| Hahn, D; Hornegger, J; Kiefer, A; Kuwert, T; Ritt, P; Uder, M | 1 |
| De Neve, W; Deron, P; Duprez, F; Goethals, I; Mertens, K; Rottey, S; Van de Wiele, C; Vermeersch, H | 1 |
| Gámez, C; Mañá, J | 1 |
| Bang, YJ; Chie, EK; Ha, SW; Han, SW; Im, SA; Jang, JY; Kim, SW; Kim, TY; Lee, YG; Oh, DY | 1 |
| Bolton, D; Chang, JH; Clouston, D; Davis, ID; Gong, SJ; Hamilton, CS; Joon, DL; Khoo, V; Lee, ST; Scott, AM | 1 |
| Haerle, SK; Haile, SR; Hany, TF; Schuknecht, B; Stoeckli, SJ; Strobel, K | 1 |
| Abgral, R; Cavarec, MB; Le Duc-Pennec, A; Le Roux, PY; Marianovski, R; Nowak, E; Potard, G; Querellou, S; Salaün, PY; Valette, G | 1 |
| Choi, IS; Choi, WJ; Kang, YH; Lee, SE; Min, HS; Moon, JI; Oh, HH; Ra, YM; Yoon, DS | 1 |
| Guan, DJ; He, ZY; Xu, GZ | 1 |
| Kim, BS; Kim, IJ; Kim, K; Kim, SJ; Pak, K | 2 |
| Chang, CC; Chien, CY; Fang, FM; Huang, SH; Huang, YC; Hung, BT; Lin, WC; Lui, CC; Tu, MC; Wang, PW | 1 |
| Chen, JH; Chen, YK; Kao, CH; Liang, JA; Tsui, CC; Yeh, CL | 1 |
| Bartenstein, P; Czihal, M; Förster, S; Hacker, M; Hoffmann, U; Rominger, A; Tato, F; Weiss, M | 1 |
| Akbulut, Z; Asil, E; Atmaca, AF; Balbay, MD; Caglayan, A; Canda, AE | 1 |
| Alavi, A; Aydin, A; Schuster, S; Shrikanthan, S; Talanow, R | 1 |
| Ahmad, N; Haerle, SK; Hany, TF; Schmid, DT; Stoeckli, SJ | 1 |
| Horiuchi, C; Komatsu, M; Matsuda, H; Mori, M; Niho, T; Nishimura, G; Sakuma, N; Shibata, K; Sugisaki, S; Taguchi, T; Takahashi, M; Tsukuda, M | 1 |
| Bagni, O; Cavallini, M; Familiari, D; Glaudemans, AW; Lenza, A; Prosperi, D; Scopinaro, F; Signore, A; Vitale, V | 1 |
| Alessio, AM; Manchanda, V; Mohr, BC; Parisi, MT; Phillips, GS; Sammer, M | 1 |
| Bornhäuser, M; Ehninger, G; Mohr, B; Paulus, T; Platzbecker, U; Radke, J; Röllig, C; Schaich, M; Stölzel, F; Zöphel, K | 1 |
| Chan, AC; Chan, SC; Cheung, TT; Chok, KS; Fan, ST; Ho, CL; Lo, CM; Ng, KK; Poon, RT; Sharr, WW | 1 |
| Ak, I; Döner, E; Dündar, E; Simsek, FS; Sivrikoz, CM | 1 |
| Cho, SS; Kwon, OD; Na, DL; Seo, SW | 1 |
| Caramella, D; Erba, P; Guidoccio, F; Lazzeri, E; Mariani, G; Perri, M; Volterrani, D | 1 |
| Bao, L; Cheng, X; Li, D; Li, Y; Wang, J; Xu, Z | 2 |
| Eberl, S; Feng, DD; Fulham, M; Wen, L; Xia, Y | 1 |
| Doelken, MT; Doerfler, A; Hammen, T; Huppertz, HJ; Kasper, BS; Kuwert, T; Lukacs, E; Mennecke, A; Rampp, S; Ritt, P; Stefan, H | 1 |
| Ahn, BC; Hong, CM; Jeong, SY; Kang, S; Kim, HW; Lee, HJ; Lee, J; Lee, SW; Song, BI | 1 |
| Kim, CG; Kim, DW; Park, SA | 1 |
| Bhattacharya, A; Das, R; Kashyap, R; Malhotra, P; Manohar, K; Mittal, BR; Varma, N; Varma, S | 1 |
| Higashi, M; Kajiya, Y; Koriyama, C; Matsuda, A; Nakajo, M; Nihara, T; Nioh, T; Shimaoka, S; Shirahama, H; Suenaga, T; Tanaka, S; Tani, A | 1 |
| Barth, T; Muehling, B; Oberhuber, A; Orend, KH; Schelzig, H; Wehrmann, C | 1 |
| Doki, Y; Fujiwara, Y; Hatazawa, J; Higuchi, I; Miyata, H; Takiguchi, S; Yamasaki, M; Yano, M; Yasuda, T | 1 |
| Bajocchi, G; Boiardi, L; Casali, M; Formisano, D; Germanò, G; Magnani, L; Meliconi, R; Pipitone, N; Pulsatelli, L; Salvarani, C; Salvo, D; Versari, A | 1 |
| Yang, WT | 1 |
| Chatburn, L; Mercier, G; Peller, PJ; Sacks, A; Subramaniam, RM; Surasi, DS | 2 |
| Arita, H; Fujita, S; Futami, S; Kawai, K; Kiyohara, S; Kuroki, M; Mizutani, Y; Nagamachi, S; Nakada, H; Nishii, R; Tamura, S; Uchino, N; Wakamatsu, H | 1 |
| English, J; Evans, WC; Gilmore, D | 1 |
| Brunken, R; Culver, DA; Isiguzo, M; Tchou, P; Xu, M | 1 |
| Hand, F; Kell, MR; Robertson, IJ | 1 |
| Balink, H; de Visscher, JG; Dol, J; Krabbe, CA; Roodenburg, JL | 1 |
| Amthauer, H; Becker, M; Ehlert, K; Haberkorn, U; Hasenclever, D; Hundsdörfer, P; Kluge, R; Körholz, D; Kranert, WT; Krausse, A; Kulozik, AE; Mauz-Körholz, C; Purz, S; Rössler, J; Ruschke, K; Sabri, O; Schober, O; Sorge, I; Stiefel, M; Weber, WA | 1 |
| Chiang, S; Dreyer, Z; Margolin, J; Paulino, AC; Teh, BS | 1 |
| Shyn, PB | 1 |
| Chan, WL; Dura, R; Freund, J; Hickey, A; Pohlen, JM; Ramsay, SC; Szeto, ER; Tarlinton, LC; Young, A | 1 |
| Chang, JM; Cho, N; Han, W; Im, SA; Kang, KW; Moon, WK; Noh, DY; Park, IA; Park, SH | 1 |
| Castellani, M; Ceriani, L; De Palma, D; Giovanella, L; Suriano, S; Verburg, FA | 1 |
| Boellaard, R; Cheebsumon, P; Hoekstra, OS; Lammertsma, AA; van Velden, FH; Yaqub, M | 1 |
| Chan, T; Gu, J; Khong, PL; Kwong, YL; Leung, AY; Zhang, J | 1 |
| Barkhof, F; Hazewinkel, M | 1 |
| Choi, WH; Chung, YA; Han, EJ; Lee, SH; Sohn, HS | 1 |
| de Koning, HJ; Groen, HJ; Lammers, JW; Mali, W; Nackaerts, K; Oudkerk, M; Thunnissen, FB; van Klaveren, RJ; van't Westeinde, SC; Vernhout, R; Weenink, C | 1 |
| Adhoute, X; de Clermont, H; Laffon, E; Marthan, R | 1 |
| Lewis, DH; McCue, TJ; Minoshima, S; Toney, LK | 1 |
| Adam, C; Baulac, M; Bouilleret, V; Chassoux, F; Dormont, D; Dupont, S; Semah, F; Thivard, L | 1 |
| Chen, T; Chen, YM; Pan, XF; Shi, YP; Tong, LJ | 1 |
| Deng, SM; Liu, T; Wang, XM; Xu, Y; Yang, HL | 1 |
| Hoekstra, OS; Regelink, JC; Riphagen, II; van Lammeren-Venema, D; Zijlstra, JM; Zweegman, S | 1 |
| Alkhawaldeh, K; Biersack, HJ; Ezziddin, S; Faltten, S | 1 |
| Calabria, F; Crusco, S; Fiaschetti, V; Meschini, A; Nucera, F; Schillaci, O; Simonetti, G | 1 |
| De Haan, HA; Gambhir, SS; Iagaru, AH; Reid, TR; Sze, DY | 1 |
| Francis, R; Morandeau, L; Segard, T | 1 |
| Chen, JH; Jeng, LB; Kao, CH; Liang, JA; Lin, CC; Lin, CY | 1 |
| Chen, JH; Kao, CH; Liang, JA; Lin, CC; Lin, WY; Lu, YY; Wang, HY | 1 |
| Drent, M; Erckens, RJ; Mostard, RL; Nelemans, PJ; van Kroonenburgh, MJ; Verschakelen, JA; Vöö, S; Wijnen, PA | 1 |
| Chiu, NT; Hsiao, YC; Lee, BF; Peng, SL; Wu, PS; Yao, WJ | 1 |
| Calabria, F; Cicciò, C; Danieli, R; Manenti, G; Schillaci, O; Simonetti, G; Squillaci, E; Strigari, L | 1 |
| Gu, HY; Hu, JN; Hua, J; Wu, LM; Xu, JR; Zhu, J | 1 |
| Barst, RJ; Bokhari, J; Bokhari, S; Einstein, AJ; Johnson, LL; Raina, A; Rosenweig, EB; Schulze, PC | 1 |
| Aoyama, N; Itoh, T; Koyama, H; Maniwa, Y; Matsumoto, S; Nishimura, Y; Nishio, M; Nishio, W; Ohno, Y; Onishi, Y; Sugimura, K; Takenaka, D; Yoshikawa, T | 1 |
| Dong, MJ; Liu, ZF; Wang, GL; Yang, SY; Zhao, K | 1 |
| Belloni, B; Essler, M; Haller, B; Hein, R; Krause, BJ; Link, A; Mirceva, V; Souvatzoglou, M; Thaler, M | 1 |
| Aukema, TS; Hoefnagel, CA; Koolen, BB; Loo, CE; Oldenburg, HS; Rodenhuis, S; Rutgers, EJ; Stokkel, MP; Valdés Olmos, RA; van der Hage, JA; Vogel, WV; Vrancken Peeters, MJ | 1 |
| Damjanovich, L; Dinya, T; Galuska, L; Garai, I; Garami, Z; Hascsi, Z; Tanyi, M; Varga, J | 1 |
| Davison, JM; Devaiah, AK; Imsande, HM; Mercier, GA; Ozonoff, AJ; Subramaniam, RM; Truong, MT | 1 |
| Brauner, M; Brillet, PY; Khafagy, A; Mekinian, A; Nicolas, P; Soussan, M; Vessieres, A | 1 |
| Erbay, G; Ibis, E; Kucuk, ON; Ozkan, E; Soydal, C | 1 |
| Fu, Z; Han, D; Mu, D; Xu, G; Yang, W; Yu, J; Zhang, B; Zhao, S; Zhong, X | 1 |
| Anthony, MP; Chan, Q; Chu, KM; Chu, YC; Gong, N; Khong, PL; Lee, HF; Wong, CS | 1 |
| Hu, SL; Shi, W; Xu, JY; Yang, ZY; Zhang, YJ; Zhu, BL | 1 |
| Celik, Y; Erdemoğlu, M; Guzel, AI; Komek, H; Kuyumcuoğlu, U | 1 |
| Boyd, K; Brush, J; Chappell, F; Crawford, F; Dozier, M; Dunlop, M; Fenwick, E; Glanville, J; McIntosh, H; Renehan, A; Weller, D | 1 |
| Huang, G; Liu, J; Wang, Y; Zhang, C | 1 |
| Bomanji, J; Hashemi, M; Iordanidou, L; Markar, SR; Mitchell, I; Read, S; Stoker, D; Vyas, S; Winslet, M | 1 |
| Abdel-Dayem, HM; Attia, I; Boktor, RR; Eltawdy, MH; Mousa, E; Omar, WS; Pitman, AG; Refaat, A | 1 |
| Green, DE; Keller, H; Kudo, G; Vines, DC | 1 |
| Antoch, G; Bockisch, A; Boy, C; Forsting, M; Hahn, S; Heusner, T; Köninger, A; Kümmel, S; Müller, S; Nagarajah, J; Stahl, A | 1 |
| Chung, SK; Kim, SH; Lin, C; Lin, Q; Na, SJ; O, JH; Yoo, IeR | 1 |
| Akita, M; Higashi, R; Hirakawa, T; Hiraoka, S; Hori, K; Kaji, E; Kato, J; Okumura, Y; Saito, S; Suzuki, H; Takahashi, S; Uraoka, T; Yamamoto, K | 1 |
| Kondo, N; Nishimura, G; Tsukuda, M | 1 |
| Fronczewska-Wieniawska, K; Królicki, L; Kuźmińska, M; Niemczyk, K; Osuch-Wójcikiewicz, E | 1 |
| Boersma, HH; Breek, JC; de Boer, JF; Dierckx, RA; Glaudemans, AW; Masteling, MG; Slart, RH; Tietge, UJ; Tio, RA; Zeebregts, CJ | 1 |
| Adam, G; Apostolova, I; Bannas, P; Derlin, T; Groth, M; Klutmann, S; Mester, J | 1 |
| Godballe, C; Grau, C; Johansen, J; Loft, A; Petersen, H | 1 |
| Bernsdorf, M; Graff, J | 1 |
| Buchholz, HG; Fellgiebel, A; Hampel, H; Lang, U; Muller, MJ; Rossmann, H; Schreckenberger, M; Yakushev, I | 1 |
| Adib, S; Béron, A; Dewalle-Vignion, AS; Huglo, D; Lion, G; Petyt, G; Vermandel, M; Verscheure, L; Yeni, N | 1 |
| Abe, M; Endo, M; Hayashi, I; Kaira, K; Kenmotsu, H; Kondo, H; Murakami, H; Naito, T; Nakagawa, K; Nakajima, T; Ohde, Y; Okumura, T; Oriuchi, N; Shukuya, T; Takahashi, T; Yamamoto, N | 1 |
| Hakozaki, K; Iida, S; Ishihara, K; Kiriyama, T; Kumita, S; Murakami, R; Tsuchiya, S; Yanagihara, K; Yoshida, T | 1 |
| Bonomo, L; Giordano, A; Mattoli, MV; Salsano, M; Stefanelli, A; Treglia, G | 1 |
| Berg, S; Blockmans, D; Briel, M; Cid, MC; Daikeler, T; Fuchs, M; Jayne, D; Karageorgaki, Z; Kötter, I; Lamprecht, P; Luqmani, R; Müller-Brand, J; Ng, QK; Prieto-González, S; Raatz, H; Rasch, H; Salvarani, C; Tyndall, A; Walker, UA; Walter, MA; Watts, R | 1 |
| Andersen, MW; Eldjarn, C; Forfang, RM; Hagve, SE; Rootwelt, K | 1 |
| Bissoli, S; Chierichetti, F; Pasquali, C; Pedrazzoli, S; Sperti, C | 1 |
| Muzaffar, R; Osman, MM; Parkar, N; Ruppel, GL; Sachdeva, A; Tran, IT | 1 |
| Arnold, SE; Chen, Y; Detre, JA; Greenberg, JH; Julin, P; Korczykowski, M; Martinez, PM; Musiek, ES; Newberg, AB; Reddin, JS; Wolk, DA | 1 |
| Chen, L; Chen, M; Hu, X; Li, X; Ma, H; Sun, X; Xie, P; Xing, L; Xu, W; Xu, X; Yu, J; Yue, J; Zhang, H; Zhang, L | 1 |
| Cui, L; Gao, J; Guan, Z; Shen, Z; Tian, J; Wang, H; Xu, B; Yao, S | 1 |
| Doot, RK; Kinahan, PE; Kurland, BF; Mankoff, DA | 1 |
| Barger, RL; Nandalur, KR | 1 |
| Bal, C; Jain, SK; Jeph, S; Kumar, R; Malhotra, A; Sharma, DN; Sharma, JB; Sharma, P; Singh, H | 1 |
| Huang, B; Hung, B; Khong, PL; Kwong, DL; Wong, CS; Wong, CY | 1 |
| Ameye, L; Awada, A; Covas, A; Deleporte, A; Emonts, P; Flamen, P; Garcia, C; Golfinopoulos, V; Hendlisz, A; Machiels, G; Paesmans, M; Piccart, M; Toussaint, E; Vanderlinden, B | 1 |
| Bagni, O; Cannas, P; Chiacchiararelli, L; Chiaramida, P; Cianni, R; D'Agostini, A; D'Arienzo, M; Salvatori, R; Scopinaro, F | 1 |
| Barlier, A; Beliard, A; de Micco, C; Gust, L; Henry, JF; Morange, I; Sebag, F; Taieb, D | 1 |
| Cross, S; Dalla-Pozza, L; Graf, N; Howman-Giles, R; Kaspers, G; London, K; Onikul, E; Stege, C | 1 |
| Allen-Auerbach, M; Czernin, J; Dunkelmann, S; Federman, N; Hall, T; Walter, F; Walter, MA | 1 |
| Abdul Rahim, N; Geso, M; Nordin, AJ; Razak, HR | 1 |
| Liao, S; Penney, BC; Pu, Y; Suzuki, K; Zhang, H | 1 |
| Chaiwatanarat, T; Kingpetch, K; Pipatrattana, R; Sirisalipoch, S; Tepmongkol, S | 1 |
| Ell, PJ; Engledow, AH; Groves, AM; Imber, C; Pakzad, F; Skipworth, JR | 1 |
| Duan, FJ; Hua, ZD; Li, SJ; Lv, XD; Song, LP; Tian, YQ; Xie, BQ; Xu, G; Yan, CW; Yang, MF | 1 |
| Kubota, K; Makino, T; Matsuhisa, A; Mizusawa, H; Shibuya, H; Toriihara, A | 1 |
| Allen-Auerbach, M; Czernin, J; Karantanis, D | 1 |
| Beanlands, RS; Birnie, D; DaSilva, JN; de Kemp, RA; Gollob, MH; Guo, A; Ruddy, TD; Tang, AS; Thomson, K; Williams, K | 1 |
| Shah, MA; Smyth, EC | 1 |
| Chang, MC; Chen, JH; Cheng, KY; Kao, CH; Liang, JA; Lin, CC; Yang, KT; Yeh, JJ | 1 |
| Braune, S; Derlin, T; Kluge, S; Klutmann, S; Mester, J; Nierhaus, A; Wichmann, D | 1 |
| Aoki, S; Araki, T; Araya, M; Komiyama, T; Kuriyama, K; Maehata, Y; Marino, K; Nambu, A; Oguri, M; Onishi, H; Saito, R; Satoh, Y; Sawada, E; Tominaga, L | 1 |
| Carpentier, P; Kolesnikov-Gauthier, H | 1 |
| Bajpai, J; Bakhshi, S; Gamnagatti, S; Khan, SA; Kumar, R; Malhotra, A; Rastogi, S; Safaya, R; Sharma, MC; Sreenivas, V | 1 |
| Aoyama, N; Koyama, H; Matsumoto, K; Ohno, Y; Onishi, Y; Sugimura, K; Yoshikawa, T | 1 |
| Berg, WA; Kalinyak, JE; Larsen, LH; Madsen, KS; Narayanan, D; Pisano, ED; Schilling, K; Tartar, M | 1 |
| Cui, ML; He, ZY; Zhao, L; Zhong, XN | 1 |
| Adam, G; Buhk, JH; Derlin, T; Groth, M; Henes, FO; Kooijman, H; Laqmani, A; Regier, M; Schwarz, D | 1 |
| Belião, S; Blocklet, D; Ferreira, A; Goldman, S; Matos, C; Metens, T; Vierasu, I | 1 |
| Chan, T; Khong, PL; Wu, B | 1 |
| Bashir, H; Faruqui, ZS; Maaz, AU; Mahmood, MT; Mian, M; Mufti, KA; Munir, I; Muzahir, S; Nawaz, MK; Siddiqui, N; Uddin, N | 1 |
| Amano, J; Eguchi, T; Hamanaka, K; Kawakami, S; Koizumi, T; Oguchi, K; Shiina, T; Yoshida, K | 1 |
| Altrinetti, V; Bacigalupo, L; Biscaldi, E; Cabria, M; DeCensi, A; Gozza, A; Iacozzi, M; Morbelli, S; Pasa, A; Piccardo, A; Puntoni, M; Villavecchia, G | 1 |
| Salem, SS; Shahin, MA | 1 |
| Agrawal, A; Meacham, R; Naiboğlu, B; Ozer, E; Ryoo, C; Schuller, DE | 1 |
| de Casso, C; Kane, T; Nigam, A; Soni-Jaiswall, A; Visvanathan, V | 1 |
| Ding, Y; Feng, J; Guo, Y; Han, D; Tan, X; Zhang, S | 1 |
| Abrahámová, J; Büchler, T; Fencl, P; Simonová, K | 1 |
| Al Ghuzlan, A; Auperin, A; Baudin, E; Caillou, B; Chami, L; Deandreis, D; Hartl, D; Leboulleux, S; Lumbroso, J; Schlumberger, M; Travagli, JP; Vielh, P | 1 |
| Bae, MS; Chang, JM; Cho, N; Kang, KW; Kim, MY; Moon, WK; Yun, BL | 1 |
| Gao, X; Geng, J; Qin, Y; Tian, M; Wang, D; Yu, L | 1 |
| Ahn, MJ; Ahn, YC; Han, J; Kim, BT; Kim, J; Kwon, OJ; Lee, HY; Lee, KS; Park, J; Park, K; Shim, YM | 1 |
| Grigsby, PW; Yang, F | 2 |
| Beer, AJ; Buck, AK; Dobritz, M; Erkan, M; Friess, H; Herrmann, K; Kleeff, J; Schmid, RM; Schuster, T; Schwaiger, M; Siveke, JT; Wester, HJ | 1 |
| Inoue, M; Kadota, Y; Minami, M; Okumura, M; Ose, N; Sawabata, N; Shintani, Y | 1 |
| Adrada, BE; Buchholz, TA; Carkaci, S; Mawlawi, O; Quraishi, MA; Rohren, E; Wei, W; Yang, W | 1 |
| Chang, MC; Chen, JH; Cheng, KY; Kao, CH; Liang, JA; Yang, KT | 2 |
| de Bruin, WI; Siepel, FJ; Slump, CH; Steenvoorde, P; van Dalen, JA; van Duyn, EB; Wagenaar, NR | 1 |
| Bolacchi, F; Danieli, R; Della Gatta, F; Gaspari, E; Mancini, A; Orlacchio, A; Ragano Caracciolo, C; Schillaci, O; Simonetti, G | 1 |
| Chen, P; Gan, M; Lao, Y; Su, W; Yang, C; Zou, W | 1 |
| Bhattacharya, A; Kashyap, R; Manohar, K; Mittal, BR; Senthil, R; Singh, G | 1 |
| Kimura, H; Kiyono, Y; Maeda, H; Mori, T; Okazawa, H; Tsuchida, T; Tsujikawa, T; Yoshida, Y | 1 |
| Bhang, HE; Pomper, MG | 1 |
| Andersson, M; Bernsdorf, M; Berthelsen, AK; Binderup, T; Graff, J; Kjær, A; Kroman, N; Loft, A; Tange, UB; Teilum, D; Wielenga, VT | 1 |
| Bakir, B; Has, D; Iyibozkurt, C; Mudun, A; Ozel, S; Sanli, Y; Topuz, S; Turkmen, C; Unal, SN; Yavuz, E; Yilmaz, E | 1 |
| Bakhshi, S; Dhawan, D; Kumar, R; Malhotra, A; Radhakrishnan, V; Sharma, P; Thulkar, S; Vishnubhatla, S | 1 |
| Adejolu, M; Huo, L; Rohren, E; Santiago, L; Yang, WT | 1 |
| Goo, JM; Im, HJ; Kang, CH; Kim, JI; Kim, YW; Lee, HJ; Lee, SM; Paeng, JC; Park, CM | 1 |
| Aflalo-Hazan, V; Aparicio, T; Barrau, V; Benamouzig, R; Des Guetz, G; Douard, R; Eder, V; Mehanna, Z; Pop, G; Rust, E; Soussan, M; Wind, P | 1 |
| Bastiaannet, E; Brouwers, AH; Hoekstra, HJ; Hoekstra, OS; Oyen, W; Thompson, JF; Uyl-de Groot, CA; van der Jagt, EJ; van Ooijen, B; Verzijlbergen, F | 1 |
| Araz, M; Ibis, E; Kir, KM; Ozkan, E; Soydal, C | 1 |
| Balan, K; Lever, AM; Seshadri, N; Sonoda, LI | 1 |
| Chowdhury, FU; Culverwell, AD; Scarsbrook, AF | 1 |
| Chen, CF; Huang, YE; Huang, YJ; Lin, MC; Liu, FY; Lu, HI; Wang, PW | 1 |
| Bailly, P; Chatelain, D; Daouk, J; Diouf, M; El Esper, I; Fin, L; Meyer, ME; Morvan, J; Régimbeau, JM; Slama, J | 1 |
| Antoch, G; Bockisch, A; Hahn, S; Hecktor, J; Herrmann, J; Heusner, TA; Kuemmel, S; Lauenstein, T; Nagarajah, J; Otterbach, F; Riegger, C | 1 |
| Bodurtha, A; Down, N; Elavathil, L; George, R; Gulenchyn, KY; Hodgson, N; Holloway, CM; Julian, JA; Levine, MN; Lovrics, P; McCready, D; O'Malley, FP; Perera, F; Pritchard, KI; Shelley, W | 1 |
| Brunetti, A; Cuocolo, A; Esposito, G; Gargiulo, S; Greco, A; Larobina, M; Nekolla, SG; Panico, M; Petretta, M; Petretta, MP | 1 |
| Buckens, CF; van den Bosch, MA; van Hillegersberg, R; van Kessel, CS; van Leeuwen, MS; Verkooijen, HM | 1 |
| Kawanaka, K; Murakami, R; Nakaguchi, Y; Oya, N; Sakamoto, F; Shiraishi, S; Tashiro, K; Tomiguchi, S; Toya, R; Tsujita, N; Yamashita, Y; Yoshida, M | 1 |
| Chen, J; Hu, JN; Hua, J; Liu, MJ; Wu, LM; Xu, JR | 1 |
| Al-Hakami, HA; Anand, S; Black, MJ; Hier, MP; Makis, W; Mlynarek, A; Payne, RJ; Stern, J | 1 |
| Harris, J; Hu, J; Kurien, G; Seikaly, H | 1 |
| D'Asseler, Y; Maes, A; Sathekge, M; Van de Wiele, C; Vorster, M | 1 |
| Chondrogiannis, S; Evangelista, L; Gross, MD; Laird, AM; Marzola, MC; Moubayed, A; Rubello, D; Wong, KK | 1 |
| Daisaki, H; Kinoshita, T; Kubota, K; Macapinlac, HA; Miyake, M; Nagaoka, T; Tateishi, U; Terauchi, T | 1 |
| Gao, X; Tian, M; Yu, L; Zhang, Y | 1 |
| Huang, G; Liu, J; Sun, X; Tong, J; Wang, Y; Zhang, C | 1 |
| Cheng, J; Hu, S; Pan, L; Xu, J; Yang, Z; Ye, D; Zhang, Y | 1 |
| Choi, BI; Eo, JS; Goo, JM; Han, JK; Han, SW; Im, SA; Kim, DH; Kim, SH; Lee, ES; Paeng, JC; Willmann, JK | 1 |
| Chang, CJ; Chiu, PH; Ho, KC; Kuo, WH; Lin, C; Wang, CW; Wu, CY; Wu, YC; Yen, TC; Yu, CT | 1 |
| Barry, M; Crowe, M; Dolan, E; Foran, P; Grant, T; Hannon, N; Kavanagh, E; Kelly, PJ; Marnane, M; McDonnell, C; Merwick, A; Moroney, J; Murphy, S; Noone, I; O'Connell, M; O'Donohoe, M; O'Malley, K; O'Rourke, K; Sheehan, OC | 1 |
| Kwee, SA; Lan, BY; Wong, LL | 1 |
| Bleichrodt, RP; Boerman, OC; de Jong, GM; Dekker, HM; Gotthardt, M; Hendriks, T; Mus, RD; Oyen, WJ; Visser, EP | 1 |
| Edenbrandt, L; Garpered, S; Höglund, P; Jönsson, E; Ly, J; Valind, S; Wollmer, P | 1 |
| Aschoff, P; Bruecher, B; Claussen, CD; Klumpp, BD; Koenigsrainer, A; Kramer, U; Miller, S; Pfannenberg, C; Schwenzer, N | 1 |
| Higashiyama, S; Kawabe, J; Kotani, K; Shiomi, S; Yoshida, A | 1 |
| Bauer, TT; Bittner, RC; Blum, T; Boch, C; Förster, GJ; Kollmeier, J; Misch, D; Tönnies, S | 1 |
| Abe, K; Chikui, T; Goto, Y; Hirano, M; Jinno, T; Kawano, S; Kiyosue, T; Matsubara, R; Nagata, T; Nakamura, S; Oobu, K | 1 |
| Dhawan, V; Eckert, T; Eidelberg, D; Fahn, S; Frucht, S; Poston, KL; Tang, CC; Vonsattel, JP | 1 |
| Cummings, M; de Leon, MJ; Glodzik, L; Goldsmith, SJ; Li, Y; McHugh, P; Mosconi, L; Murray, J; Någren, K; Pirraglia, E; Rinne, JO; Scheinin, N; Tsui, WH; Vallabhajosula, S; Viljanen, T; Williams, S | 1 |
| Han, A; Hu, M; Wang, X; Xue, J; Zheng, J | 1 |
| Farlow, D; Gan, G; Hollands, M; Lam, VW; Laurence, JM; Pleass, HC; Richardson, A; Yao, J | 1 |
| Chakraborty, P; Flynn, JC; Jackson, N; Khoury, B; Markel, DC; Muzik, O; Ren, W; Shi, T | 1 |
| Boon, NA; Chow, MW; Dweck, MR; Fletcher, AM; Jones, C; Joshi, NV; McKillop, G; Newby, DE; Richardson, H; Rudd, JH; van Beek, EJ; White, A; Williams, MC | 1 |
| Adams, KT; Carrasquillo, JA; Chen, CC; Eisenhofer, G; King, KS; Ling, A; Pacak, K; Rao, JU; Timmers, HJ; Wesley, RA; Whatley, M | 1 |
| Colavolpe, C; Dessi, P; Fakhry, N; Giovanni, A; Michel, J; Varoquaux, A | 1 |
| Bolton, WD; Geraldson, CT; Greene, RA; Lagrew, JP; Schammel, CM; Schammel, DP; Stephenson, JE | 1 |
| Ha, HK; Kim, HJ; Kim, JC; Kim, JS; Kwak, JY; Yu, CS | 1 |
| D'Asseler, Y; Gongxeka, H; Maes, A; Sathekge, M; Van de Wiele, C; Vorster, M | 1 |
| Anthony, MP; Khong, PL; Lee, EY; Leung, AY; Loong, F | 1 |
| Bal, C; Kumar, R; Lata, S; Malhotra, A; Naswa, N; Sharma, P; Suman Kc, S | 1 |
| Huh, SH; Jin, SM; Lee, SH; Park, CH; Rho, YS; Yoon, DY | 1 |
| Antoch, G; Forsting, M; Grabellus, F; Hahn, S; Hartung, V; Hecktor, J; Heusner, TA; Kimmig, R; Pöppel, T | 1 |
| Cai, L; Chen, C; Gu, WW; Guo, KY; Wang, YJ; Wu, SJ; Xie, Q; Zou, F | 1 |
| Capanu, M; Coit, DG; Kelsen, DP; Schöder, H; Shah, MA; Smyth, E; Strong, VE | 1 |
| Bong, JJ; Frampton, AE; Habib, NA; Jiao, LR; Kyriakides, C; Martin, JL; Vlavianos, P; Zhang, Y | 1 |
| Bartenstein, P; Dahmen, A; Galle, PR; Goetz, M; Helisch, A; Holtmann, MH; Mudter, J; Neurath, MF; Schreckenberger, M; Uenzen, M | 1 |
| Amrami, KK; Begna, KH; Jerath, NU; Mauermann, ML; Reddy, CG; Ringler, MD; Solomon, BM; Spinner, RJ | 1 |
| Ahn, SD; Chang, SK; Choi, EK; Choi, SH; Kim, JH; Kim, JS; Kim, JY; Kim, SS; Kim, SY; Kim, YS; Lee, SW; Nam, SY; Park, JH; Roh, JL; Shin, HS; Song, SY; Yoon, SM | 1 |
| Alavi, A; Arnold, SE; Newberg, AB; Rovner, BW; Wintering, N | 1 |
| Hoffmeier, A; Maintz, D; Rahbar, K; Schäfers, M; Scheld, HH; Schober, O; Seifarth, H; Spieker, T; Stegger, L; Tiemann, K; Weckesser, M | 1 |
| Allenbach, G; Boubaker, A; Fitting, JW; Letovanec, I; Mihaescu, A; Nicod Lalonde, M; Prior, JO; Ris, HB; Schmidt, S; Stupp, R | 1 |
| Behrendt, FF; Krohn, T; Kuhl, CK; Mottaghy, FM; Palmowski, M; Pietsch, H; Rebière, M; Verburg, FA | 1 |
| Baccega, M; Bellò, M; Cassoni, P; Cravero, F; Filippini, C; Fora, G; Lesca, A; Milanesi, E; Mistrangelo, M; Morino, M; Munoz, FH; Pelosi, E; Racca, P; Ricardi, U; Skanjeti, A | 1 |
| Chowdhury, FU; Gilbert, A; Prestwich, RJ; Scarsbrook, AF; Sen, M; Subesinghe, M | 1 |
| Chung, HH; Chung, JK; Kang, KW; Kang, SB; Kim, JW; Park, NH; Song, YS | 1 |
| Barron, BJ; Dhanasekaran, R; Kim, HS; Lawson, DH; Piduru, SM; Schuster, DM | 1 |
| Holzmannhofer, J; Mc Coy, M; Pirich, C; Rettenbacher, L; Seifen, T; Thaler, C | 1 |
| Herold, CJ; Karanikas, G; Mayerhoefer, ME; Prosch, H; Weber, M | 1 |
| Bentabet, L; Bentourkia, M; Dubeau, F; Mabrouk, R | 1 |
| Han, S; Ng, CY; Pennington, C; Poon, FW; Vaidyanathan, S | 1 |
| Blaufox, MD; Freeman, LM | 1 |
| Erasmus, JJ; Macapinlac, HA | 1 |
| Schillaci, O | 1 |
| Abernethy, AP; Beasley, GM; Broadwater, G; Eikman, EA; Marzban, S; Parsons, C; Salama, AK; Selim, MA; Tyler, DS; Wong, T; Zager, JS | 1 |
| Chen, HH; Chiu, NT; Guo, HR; Lee, BF; Su, WC | 1 |
| Choi, DW; Choi, SH; Heo, JS; Kim, MJ; Ku, BH; Lee, JK; Lee, KH; Lee, KT; Oh, CR | 1 |
| Maldjian, JA; Whitlow, CT | 1 |
| Dimitrakopoulou-Strauss, A; Hohenberger, P; Koczan, D; Pan, L; Strauss, LG | 1 |
| Antoch, G; Bockisch, A; Buchbender, C; Forsting, M; Herbrik, M; Heusner, TA; Treffert, J | 1 |
| Asada, T; Chijiiwa, K; Haruyama, Y; Hotokezaka, M; Nagamachi, S; Uchiyama, S | 1 |
| Berthelsen, AK; Christensen, CB; Costa, JC; Daugaard, G; Graff, J; Loft, A; Møller, AK; Pedersen, KD; Perell, K; Petersen, BL; Skovgaard, LT | 1 |
| Alsac, JM; Boisgard, R; Hervatin, F; Le Guludec, D; Michel, JB; Montravers, F; Sarda-Mantel, L; Tavitian, B | 1 |
| Bae, WK; Kim, YH; Lee, HS; Lee, JW; Lee, SM | 1 |
| Bal, C; Kumar, R; Malhotra, A; Naswa, N; Nazar, AH; Sharma, P; Soundararajan, R | 1 |
| Bao, L; Cheng, X; Li, Y; Liu, B; Wang, J; Xu, Z | 1 |
| Boudousq, V; Collombier, L; Crouzet, J; Kotzki, PO; Lavigne, JP; Lechiche, C; Pouget, JP; Sotto, A | 1 |
| Campbell, PD; Carlson, ER; Long, M; McCoy, JM; Schaefferkoetter, J; Townsend, D | 1 |
| Brach Del Prever, A; Cistaro, A; Fagioli, F; Fania, P; Gastaldo, L; Lopci, E | 1 |
| Kaneko, H; Kano, T; Kubota, K; Mimori, A; Minamimoto, R; Morooka, M; Takahashi, Y; Yamashita, H | 1 |
| Bremerich, J; Forrer, F; Klarhöfer, M; Lardinois, D; Lenz, C; Sommer, G; Wiese, M; Winter, L | 1 |
| Bokacheva, L; Carlin, S; Halliday, J; Kotedia, K; Koutcher, JA; Le, CH; Reese, M; Ricketts, SA | 1 |
| Kato, H; Nakajima, M | 1 |
| Fathinul, F; Lau, WF; Nordin, AJ | 1 |
| Henne-Bruns, D; Hillenbrand, A; Luster, M; Ohlhauser, D; Reske, SN; Weber, T | 1 |
| Adjouadi, M; Bhatt, R; Goryawala, M; Gulec, SA; McGoron, AJ | 1 |
| Edgar, R; Jenkins, L; Parr, DG; Quraishi, N; Stockley, RA; Subramanian, DR | 1 |
| Kim, EK; Kim, HO; Kim, SW; Lee, DH; Ryu, JS; Sohn, BS; Suh, C; Yoon, DH | 1 |
| Bhattacharya, A; Malhotra, P; Manohar, K; Mittal, BR; Raja, S; Varma, S | 1 |
| Beanlands, RS; Mc Ardle, B; Ruddy, TD; Ziadi, MC | 1 |
| Bhattacharya, A; Kashyap, R; Manohar, K; Mittal, BR; Raja, S; Rohit, MK; Singh, B | 1 |
| Hatt, M; Lambin, P; Lammering, G; le Pogam, A; van Stiphout, R; Visvikis, D | 1 |
| Cheng, J; Dai, D; Ma, WC; Song, XY; Xu, WG; Xu, XX; Zhu, L; Zhu, X | 1 |
| Al-Nahhas, A; Cervino, AR; Evangelista, L; Muzzio, PC; Panunzio, A; Polverosi, R; Rubello, D; Vinante, L | 1 |
| Azuma, K; Hattori, S; Hoshino, T; Imamura, Y; Ishibashi, M; Kaida, H; Kawahara, A; Kinoshita, T; Kurata, S; Sadashima, E; Sasada, T; Zaizen, Y | 1 |
| Berradja, K; Boughanmi, N | 1 |
| Gallowitsch, HJ; Malle, P; Sorschag, M | 1 |
| Catalano, P; Sadow, CA; Shinagare, AB; Shyn, PB; Wasser, EJ | 1 |
| Aide, N; Bardet, S; Beauregard, JM; Gervais, R; Guizard, AV; Hicks, RJ; Lasnon, C; Lemoel, G; Milner, A; Paciencia, M; Zalcman, G | 1 |
| Kawakami, Y; Kenzaki, K; Kondo, K; Otsuka, H; Sakiyama, S; Takizawa, H; Tangoku, A; Toba, H | 1 |
| Blake, MA; Catalano, OA; Cronin, CG; Kambadakone, A; McDermott, S; Sahani, D; Scott, J | 1 |
| Albisinni, U; Battista, G; Bazzocchi, A; Brioli, A; Cavo, M; Fanti, S; Nanni, C; Salizzoni, E; Spinnato, P; Zamagni, E | 1 |
| Herzog, H | 1 |
| Li, S; Li, X; Liang, B; Lin, S; Liu, X; Lu, J; Peng, X; Wu, H; Yu, L | 1 |
| Alexoff, D; Benveniste, H; Fowler, JS; Kim, SW; Logan, J; Muench, L; Shea, C; Telang, F; Tomasi, D; Volkow, ND; Wang, GJ; Wong, C | 1 |
| Bleichrodt, RP; Bremers, AJ; de Geus-Oei, LF; Hendriks, T; Oyen, WJ; Teeuwen, PH; van Goor, H | 1 |
| Abe, K; Hiwatashi, A; Honda, H; Iwaki, T; Kikuchi, K; Maruoka, Y; Mizoguchi, M; Suzuki, SO; Togao, O; Yamashita, K; Yoshimoto, K; Yoshiura, T | 1 |
| Chan, SC; Hsu, CL; Liao, CT; Lin, CY; Lin, YJ; Ng, SH; Wang, HM; Yen, TC | 1 |
| Hayashi, A; Hiruta, N; Inaoka, T; Kudo, H; Nakagawa, K; Terada, H; Tokuyama, W | 1 |
| Gerrard, G; Patel, CN; Prestwich, RJ; Scarsbrook, AF; Viner, S | 1 |
| Kochhar, R; Liong, SY; Manoharan, P; Renehan, AG | 1 |
| Akiyama, K; Hoshikawa, H; Inamoto, R; Kishino, T; Mori, N; Mori, T; Nishiyama, Y; Yamamoto, Y | 2 |
| Antoch, G; Bockisch, A; Forsting, M; Hartung, V; Heusner, TA; Kimmig, R; Koeninger, A; Otterbach, F; Riegger, C | 1 |
| Dogan, BE; Turnbull, LW | 1 |
| Baretta, Z; Bezzon, E; Cervino, AR; De Carolis, V; Evangelista, L; Ghiotto, C; Gregianin, M; Muzzio, PC; Pomerri, F; Saladini, G; Vinante, L | 1 |
| Dehdashti, F; DeWees, T; Esthappan, J; Grigsby, PW; Narra, VR; Olsen, JR; Schwarz, JK; Siegel, BA | 1 |
| Baba, Y; Doi, YL; Furuno, T; Kawada, Y; Kitaoka, H; Kubo, T; Matsumura, Y; Okawa, M; Sugiura, T; Yamanaka, S; Yamasaki, N | 1 |
| Allaoua, M; Assal, F; Gutierrez, D; Lövblad, KO; Montandon, ML; Ratib, O; Zaidi, H | 1 |
| Alavi, A; Chen, W; Cheng, G; Torigian, DA; Zhuang, H | 1 |
| Brepoels, L; De Wolf-Peeters, C; Dierickx, D; Dupont, L; Gheysens, O; Herreman, A; Kuypers, D; Morscio, J; Nevens, F; Pirenne, J; Requilé, A; Sagaert, X; Tousseyn, T; Uyttebroeck, A; Van Cleemput, J; Verhoef, G; Verscuren, R; Wlodarska, I | 1 |
| Borrego-Dorado, I; Cuenca-Cuenca, JI; Gómez-Camarero, P; Navarro-González, E; Ortiz-de Tena, A; Ruiz-Franco-Baux, JV; Vázquez-Albertino, RJ | 1 |
| Allende-Riera, A; Cabello-García, D; Cárdenas-Negro, JC; De Sequera-Rahola, M; Martínez-Gimeno, E; Muñoz-Iglesias, J; Ochoa-Figueroa, MA; Uña-Gorospe, J | 1 |
| Harari, PM; Jeraj, R; Nyflot, MJ; Perlman, SB; Yip, S | 1 |
| Beanlands, RS; Cocker, MS; Dekemp, RA; Hammond, RR; Lum, C; Mc Ardle, B; McDonald, MA; Ongaro, DC; Spence, JD; Tardif, JC | 1 |
| de Clermont, H; Laffon, E; Marthan, R | 1 |
| Dote, Y; Fujimoto, S; Okayama, S; Saito, Y; Takeda, Y; Uemura, S | 1 |
| Ahlström, H; Johansson, S; Mosavi, F; Sandberg, DT; Sörensen, J; Turesson, I | 1 |
| Manych, M | 1 |
| Luo, QY; Qiu, ZL; Song, HJ; Xue, YL | 1 |
| Huijbregts, JE; Koopman, M; Lam, MG; Rosenbaum, CE; van den Bosch, MA; Veldhuis, WB | 1 |
| Katayama, T; Kubota, K; Machida, Y; Shibuya, H; Toriihara, A | 1 |
| Hakucho, T; Higashiyama, M; Hosoki, T; Miyake, C; Morimoto, D; Nakanishi, K; Takahashi, Y; Takashima, S; Tomita, Y; Watanabe, S | 1 |
| Ishihara, T; Kurosawa, J; Mikata, R; Miyazaki, M; Otsuka, M; Saito, M; Sakai, Y; Sugiyama, H; Tada, M; Tawada, K; Tsuyuguchi, T; Uchida, Y; Uchiyama, K; Yokosuka, O | 1 |
| Alessandrini, S; Cammilleri, S; Casalta, JP; Cautela, J; Deharo, JC; Giorgi, R; Habib, G; Mundler, O; Raoult, D; Richet, H | 1 |
| Boucher, K; Butterfield, RI; Christian, PE; Hanrahan, C; Hoffman, JM; Kraiss, LW; Lam, UT; Morton, KA; Pendleton, RC; Rondina, MT; Wanner, N; Zimmerman, GA | 1 |
| Ajiki, T; Fukumoto, T; Kotani, J; Ku, Y; Matsumoto, I; Nakao, A; Otsubo, I; Sawa, H; Shinzeki, M; Toyama, H; Ueno, K; Yamada, I; Yoshida, Y | 1 |
| Chen, ZF; Luo, BQ; Rao, LJ; Shi, XC; Wang, XY; Yi, C; Zhang, XS | 1 |
| Aalten, P; Adriaanse, SF; Handels, RL; Hoekstra, OS; Lammertsma, AA; Lemstra, AW; Ossenkoppele, R; Pijnenburg, YA; Prins, ND; Scheltens, P; van Berckel, BN; van Buchem, MA; van der Flier, WM; Verbeek, MM; Verhey, FR; Windhorst, AD; Wolfs, CA | 1 |
| Cho, KJ; Choi, SH; Kim, JS; Kim, SY; Lee, HJ; Lee, JH; Nam, SY; Park, GC; Roh, JL | 1 |
| Han, YM; Hwang, DH; Hwang, HS; Kang, IW; Ko, Y; Lee, ES; Lee, GK | 1 |
| Crane, PK; DeCarli, C; Glymour, MM; Habeck, C; Kim, S; Lee, GJ; Mormino, E; Mukherjee, S; Nho, K; Risacher, S; Saykin, AJ | 1 |
| Abramson, S; Arora, VC; Fleming, S; LaQuaglia, MP; Magnan, H; Price, AP; Sohn, MJ | 1 |
| Casagranda, G; Centonze, M; Donner, D; Erini, M; Pellegrin, A; Rozzanigo, U | 1 |
| Kurabayashi, T; Nakamura, S; Okochi, K; Shibuya, H; Toriihara, A; Watanabe, H | 1 |
| Dank, M; Galgóczy, H; Györke, T; Kulka, J; Lengyel, Z; Somlai, K; Székely, B; Szentmártoni, G; Tőkés, T; Torgyík, L | 1 |
| Chang, HH; Hsu, WM; Huang, SF; Jou, ST; Lee, H; Lee, YL; Liao, YF; Lin, DT; Lin, KH; Liu, YL; Lu, MY; Luo, TY; Shen, LH; Tzen, KY; Wu, PY; Yang, YL | 1 |
| Aygun, N; Gok, B; Hayeri, R; Jallo, G; Wahl, R | 1 |
| Matsunaga, T; Miyasaka, Y; Oh, S; Suzuki, K; Takamochi, K | 1 |
| Al-Ibraheem, A; Beer, AJ; Benz, MR; Buck, AK; Haller, B; Herrmann, K; Juenger, H; Mansour, A; Pomykala, KL; Rudert, M; Scheidhauer, K; Schwaiger, M | 1 |
| Cascini, GL; Catalano, O; Colao, A; Cuccurullo, V; Faggiano, A; Mansi, L; Piunno, A; Scialpi, M | 1 |
| Antoch, G; Beiderwellen, K; Bockisch, A; Buchbender, C; Forsting, M; Hartung-Knemeyer, V; Heusch, P; Heusner, TA; Kühl, H; Lanzman, RS; Wittsack, HJ | 1 |
| Demura, Y; Kimura, H; Morikawa, M; Okazawa, H; Tsuchida, T; Umeda, Y | 1 |
| Ozgul, MA; Sanli, Y; Somay, A; Tamam, M; Yildirim, D | 1 |
| Andersen, FL; Beyer, T; Holm, S; Klausen, TL; Loft, A | 1 |
| Bartenstein, P; Böning, G; Cumming, P; Hacker, M; Lehner, S; Nekolla, SG; Schirrmacher, R; Schwaiger, M; Todica, A; Wängler, C; Weidl, E | 1 |
| Caldarella, C; Giordano, A; Leccisotti, L; Treglia, G | 1 |
| Archie, DS; Freire, AX; Kadaria, D; SultanAli, I; Weiman, DS; Zaman, MK | 1 |
| Ansquer, C; Bodere, F; Bouchot, O; Branchereau, J; Hitier-Berthault, M; Renaudin, K; Rigaud, J | 1 |
| Akdemir, UO; Atasever, T; Benekli, M; Buyukberber, S; Cetin, B; Coskun, U; Senturk, S; Tufan, G; Turan, N | 1 |
| Gao, F; Liu, H; Shi, P | 1 |
| Bailly, C; Bodet-Milin, C; Dupas, B; Eugène, T; Frampas, E; Kraeber-Bodéré, F; Lacombe, M; Moreau, P | 1 |
| Asakawa, I; Hasegawa, M; Inoue, K; Kajitani, C; Katayama, E; Kirita, T; Okamoto, H; Shirone, N; Tamamoto, T; Uto, F | 1 |
| Bailly, C; Bodet-Milin, C; Dupas, B; Eugène, T; Gastinne, T; Kraeber-Bodéré, F; Le Gouill, S | 1 |
| Hwang, SH; Jeon, TJ; Kim, SJ; Kim, TH; Park, CH; Yoo, MR | 1 |
| Batla, A; D'Souza, MM; Dhawan, V; Jaimini, A; Kushwaha, S; Mondal, A; Peng, S; Saw, S; Sharma, R; Tripathi, M | 1 |
| Jin, S; Li, D; Wang, H; Yin, Y | 1 |
| Eid, H; El-Gammal, M; Murakami, K; Zytoon, AA | 1 |
| Chan, SC; Chen, S; Cheung, TT; Chok, KS; Fan, ST; Fung, JY; Ho, CL; Lo, CM; Poon, RT; Sharr, W; Yan Chan, AC; Yau, T | 1 |
| Cho, KJ; Choi, SH; Kim, JS; Kim, JW; Kim, SY; Lee, JH; Nam, SY; Roh, JL | 1 |
| Abolmaali, N; Abramyuk, A; Appold, S; Baumann, M; Zöphel, K | 1 |
| Moreau, P; Touzeau, C | 1 |
| Ahn, BC; Gayed, IW; Kim, HW; Won, KS; Zeon, SK | 1 |
| Göbel, G; Hutterer, M; Jacobs, AH; Jansen, NL; la Fougère, C; McCoy, M; Nowosielski, M; Putzer, D; Schocke, M; Seiz, M; Stockhammer, G; Trinka, E; Virgolini, IJ | 1 |
| Chan, J; Charron, M; Costantini, DL; McQuattie, S; Vali, R | 1 |
| Choi, EK; Choi, WH; Kim, SH; Na, SJ; O, JH; Park, SY; Yoo, IeR | 1 |
| Fang, W; He, J; Wang, L; Xiong, C; Yan, C; Zhang, Y; Zhao, S | 1 |
| Arena, V; Belloro, S; Cistaro, A; Douroukas, A; Leo, G; Longo, G; Pelosi, E; Penna, D; Skanjeti, A; Traverso, A | 1 |
| Beels, L; Brugman, E; D'Asseler, Y; De Spiegeleer, B; Maes, A; Mees, G; Stellamans, K; Van de Wiele, C | 1 |
| Ceccarelli, S; Lacanfora, A; Schillaci, O; Simonetti, G; Travascio, L | 1 |
| Castiglioni, I; Di Grigoli, G; Gallivanone, F; Gilardi, MC; Górriz, JM; Grosso, E; López, M; Moresco, R; Ramírez, J; Salvatore, C; Valtorta, S | 1 |
| Fanti, S; Martoni, AA; Quercia, S; Santini, D; Taffurelli, M; Zamagni, C; Zucchini, G | 1 |
| Fang, W; Guo, J; Wang, JF; Wang, L; Wang, YT; Wei, HX; Yang, MF | 1 |
| Li, J; Wang, G; Wu, P; Wu, Y; Xie, C; Zhang, W | 1 |
| Caroli, A; Chen, K; Frisoni, GB; Herholz, K; Jagust, WJ; Prestia, A; Reiman, E | 1 |
| Bal, C; Bandopadhyaya, GP; Damle, NA; Kumar, L; Kumar, P; Lata, S; Malhotra, A | 1 |
| Kawai, N; Miyake, K; Nishiyama, Y; Okada, M; Tamiya, T; Yamamoto, Y | 1 |
| Baek, KW; Choi, JW; Kim, SJ; Lee, JW; Lee, SM | 1 |
| Antoch, G; Beiderwellen, K; Bockisch, A; Buchbender, C; Forsting, M; Hartung-Knemeyer, V; Heusch, P; Heusner, TA; Lauenstein, TC; Nensa, F | 1 |
| Aparici, CM; Hernandez-Pampaloni, M; Sebro, R | 1 |
| Ancukiewicz, M; Choi, NC; Chun, TT; Fidias, PM; Fischman, AJ; Kradin, RL; Lynch, TJ; Mathisen, DJ; Niemierko, A | 1 |
| Ito, Y; Katoh, C; Kawai, Y; Kitabatake, A; Kohya, T; Kuge, Y; Noriyasu, K; Tamaki, N; Yamada, S; Yoshinaga, K | 1 |
| Detry, R; Gigot, JF; Kartheuser, A; Lonneux, M; Pauwels, S; Reffad, AM | 1 |
| Buck, A; Burger, C; Goerres, G; Lonn, AH; Schoenes, S; Von Schulthess, GK | 1 |
| Carreras, JL; Domper, M; Jiménez, A; Montz, R; Pérez-Castejón, MJ; Ruiz, G; Suárez, M | 1 |
| Akhurst, T; Etchebehere, EC; Gonen, M; Humm, K; Larson, SM; Macapinlac, HA; Scher, HI; Yeung, HW | 1 |
| Koslin, DB | 1 |
| Dunn, WL; Forstrom, LA; Hung, JC; Lowe, VJ; Mullan, BP; Thorson, LM | 1 |
| Belhocine, T; Foidart, J; Hustinx, R; Najjar, F; Quatresooz, P; Rigo, P; Thiry, A | 1 |
| Chou, KL; Chung, YW; Dong, SL; Lee, JS; Liu, RS; Wu, TH | 1 |
| Higashiyama, S; Kawabe, J; Koyama, K; Ochi, H; Okamura, T; Ozawa, N; Yamada, R | 1 |
| Ichihara, K; Kobayashi, H; Kosuda, S; Kusano, S; Watanabe, M | 2 |
| Hosaka, K; Ishii, K; Mori, T; Sakamoto, S; Sasaki, M | 1 |
| Huang, H; Lang, J; Pan, L; Shen, K; Wu, M; Zhu, X | 1 |
| Dehdashti, F; Siegel, BA | 1 |
| Bongers, V; Hobbelink, MG; Hordijk, GJ; van Rijk, PP | 1 |
| Aufschnaiter, M; Heinisch, M; Jörg, L; Langsteger, W; Panholzer, PJ; Rechberger, E; Sega, W; Tausch, C; Wieser, B | 1 |
| Kresnik, E | 1 |
| Peschina, W | 1 |
| Mikosch, P | 1 |
| Jörg, L; Langsteger, W | 1 |
| Kumnig, G | 1 |
| Graf, S; Porenta, G | 1 |
| Fazekas, F; Payer, F | 1 |
| Aronson, N; Flamm, CR; Pisano, ED; Samson, DJ | 1 |
| Beguin, YP; Jerusalem, GH | 1 |
| Coleman, M; Goldsmith, SJ; Kostakoglu, L; Kuji, I; Leonard, JP; Zoe, H | 1 |
| Clavien, PA; Hagge, R; Killius, J; Nelson, RC; Paulson, EK; Rohren, EM; Wong, TZ | 1 |
| Hoffman, MA; Karayalcin, G; Manalili, EY; Mehrotra, B; Palestro, CJ; Rini, JN; Tomas, MB | 1 |
| Akhurst, T; Berlangieri, S; Chan, JG; Hannah, A; McKay, WJ; Price, D; Schelleman, T; Scott, AM; Sizeland, A; Smith, GJ; Tochon-Danguy, H | 1 |
| Arendrup, H; Bangsgaard, R; Carstensen, S; Freiberg, J; Hesse, B; Holm, S; Hove, JD; Kelbaek, H; Kofoed, KF; Rabøl, A | 1 |
| Griffiths, MR; Hicks, RJ; Keith, CJ; Miles, KA; Pitman, AG; Wong, D | 1 |
| Brouwer, J; Comans, EF; de Bree, R; Hoekstra, OS; Leemans, CR; Pruim, J; Regelink, G; Roodenburg, JL; Vaalburg, W; van der Laan, BF; Vissink, A | 1 |
| Asaka, M; Kato, T; Katoh, C; Kondo, S; Kuge, Y; Nambu, T; Nobuta, A; Tamaki, N; Tsukamoto, E | 1 |
| Belhocine, T; De Labrassinne, M; Lahaye, T; Pierard, G; Rigo, P | 1 |
| Bartenstein, P; Brockmann, H; Galle, PR; Helisch, A; Holtmann, M; Neurath, MF; Orth, T; Schreckenberger, M; Schunk, K; Vehling, D | 1 |
| Czernin, J; Fishbein, MC; Phelps, ME; Schiepers, C; Yap, CS | 1 |
| Alavi, A; Chacko, TK; Moussavian, B; Stevenson, K; Zhuang, H | 1 |
| Bachmann, S; Berger, J; Bleckmann, C; Bohuslavizki, KH; Dose, J; Habermann, CR; Jãnicke, F; Jenicke, L | 1 |
| Itoh, Y; Katoh, C; Kubo, N; Kuge, Y; Mabuchi, M; Morita, K; Noriyasu, K; Tamaki, N | 1 |
| Balzarini, J; de Groot, T; De Wolf-Peeters, C; Dupont, P; Mortelmans, L; Spaepen, K; Stroobants, S; Thomas, J; Vandenberghe, P; Verhoef, G | 1 |
| Cheng, KY; Kao, CH; Lin, WY; Tsai, SC; Yen, RF | 1 |
| Pugsley, JM; Vallières, E; Vesselle, H; Wood, DE | 1 |
| Cabrera Villegas, A; Gámez Cenzano, C; García Velloso, MJ | 1 |
| Borrego Dorado, I; Vázquez Albertino, R | 1 |
| Britz-Cunningham, S; Di Carli, MF; Gerbaudo, VH; Mauceri, C; Sugarbaker, DJ; Treves, ST | 1 |
| Chung, CK; Chung, JK; Kim, YK; Lee, DS; Lee, MC; Lee, SK | 1 |
| Chen, T; Hayashi, K; Kaneko, K; Koga, H; Kuwabara, Y; Masuda, K; Nakagawa, M; Nakamura, K; Sasaki, M | 1 |
| Bruns, J; Dobrowolskij, D; Jenicke, L; Niggemeyer, O | 1 |
| Bartenstein, P; Junginger, T; Kneist, W; Menzel, C; Oberholzer, K; Schreckenberger, M | 1 |
| Gorenberg, M; Hallett, WA; O'Doherty, MJ | 1 |
| Alavi, A; Chacko, TK; Feng, Q; Garino, JP; Hickeson, M; Ponzo, F; Stevenson, K; Zhuang, H | 1 |
| Dearling, JL; Flynn, AA; Garlick, PB; Medina, RA; Pedley, RB; Southworth, R | 1 |
| Hisada, K; Kanayama, S; Matsudaira, M; Matsunari, I; Nakajima, K; Nekolla, SG; Takekoshi, N; Taki, J; Tonami, N; Yoneyama, T | 1 |
| Alberer, D; Gallowitsch, HJ; Gasser, J; Gomez, I; Hebenstreit, A; Igerc, I; Kogler, D; Kresnik, E; Kumnig, G; Lind, P; Mikosch, P; Würtz, F | 1 |
| Angelard, B; Kerrou, K; Lacau St Guily, J; Montravers, F; Périé, S; Talbot, JN; Tassart, M | 1 |
| Clark, LA; Clary, BM; Coleman, RE; Gottfried, M; Kalady, MF; Pappas, TN; Rohren, EM; Tyler, DS | 1 |
| Buell, U; Gilsbach, JM; Hans, FJ; Krings, T; Meyer, PT; Möller-Hartmann, W; Reinges, MH; Rohde, V; Sabri, O; Schreckenberger, M; Spetzger, U; Thron, A | 1 |
| Gonen, M; Kraus, DH; Larson, SM; Lin, DT; Patel, SG; Pfister, DG; Schöder, H; Shah, JP; Wolden, S; Wong, RJ | 1 |
| Changlai, SP; Hsia, TC; Kao, CH; Shen, YY; Yen, RF | 1 |
| Dupont, P; Garmyn, M; Gysen, M; Hoe, LV; Mortelmans, L; Stas, M; Stroobants, S; Wever, ID | 1 |
| Brouwers, AH; Mulders, PF; Oyen, WJ; Steffens, MG | 1 |
| Bares, R; Bartusek, G; Dittmann, H; Dohmen, BM; Kehlbach, R; Pritzkow, M; Sarbia, M | 1 |
| Beguin, Y; Fillet, G; Hustinx, R; Jerusalem, G | 2 |
| Buck, A; Goerres, GW; Hany, TF; Steinert, HC; von Schulthess, GK | 1 |
| Boom, RP; Comans, EF; Hoekstra, OS; Lammertsma, AA; Meijer, S; Pijpers, R; Teule, GJ; van der Hoeven, JJ; van Geldere, D | 1 |
| Chung, JK; Jeong, HJ; Jeong, JM; Jung, HW; Kim, CY; Kim, DG; Kim, YK; Lee, DS; Lee, MC | 1 |
| De Winter, F; Dierckx, RA; Kolindou, A; Lambert, B; Noens, L; Van De Wiele, C; Van Den Bossche, B | 1 |
| Abe, A; Kumakura, Y; Momose, T; Nakagawa, K; Ohtomo, K; Oku, S; Watanabe, T | 1 |
| Kirsch, CM; Licht, N; Nestle, U; Schmidt, S; Schnabel, K; Ukena, D; Walter, K | 1 |
| Colombet-Lamau, C; De Beco, V; Grahek, D; Kerrou, K; Mabille, L; Montravers, F; Petegnief, Y; Talbot, JN; Younsi, N; Zerbib, E | 1 |
| Breithardt, G; Bruns, HJ; Hammel, D; Janssen, F; Schäfers, M; Scheld, HH; Schober, O; Stypmann, J; Vahlhaus, C; Wichter, T | 1 |
| Kanai, M; Kawai, Y; Nakamoto, Y; Takabayashi, A; Taki, Y; Tanaka, T | 1 |
| Barrier, A; Houry, S; Huguier, M; Montravers, F; Talbot, JN; Valinas, R | 1 |
| Beuthien-Baumann, B; Bredow, J; Ehninger, G; Fischer, R; Kittner, T; Kropp, J; Naumann, R; Ockert, D | 1 |
| Binns, D; Frydenberg, M; Hicks, R; Hogg, A; Salminen, E | 1 |
| Berner, U; Diehl, M; Döbert, N; Grünwald, F; Menzel, C; Mitrou, P; Mose, S | 1 |
| Heyneman, LE; Patz, EF | 1 |
| Biersack, HJ; Hensel, J; Matthies, A; Palmedo, H; Reinhardt, M; Von Mallek, D | 1 |
| Freiberg, J; Holm, S; Hove, JD; Høst, U; Kelbaek, H; Kofoed, KF | 1 |
| Adam, LE; Alavi, A; Hickeson, M; Lacorte, L; Matthies, A; Yun, M; Zhuang, H | 1 |
| Behrens, S; Koch, H; Kosch, T; Lange, C; Morguet, AJ; Munz, DL; Schultheiss, HP; Selbig, D; Wunderlich, W | 1 |
| Atkins, M; Graeber, GM; Gregory, JL; Gupta, NC; Mullet, D; Rogers, JS; Waheed, U | 1 |
| Clark, PA; Nakamoto, Y; Tatsumi, M; Wahl, RL | 1 |
| Bacharach, SL; Carrasquillo, JA; Carson, JM; Freedman, NM; Kurdziel, K; Libutti, SK; Sellers, D; Sundaram, SK; Whatley, M; Yang, JC | 1 |
| Benatar, NA; Goodey, J; Marsden, PK; O'Doherty, MJ; Smith, MA; Somer, EJ | 1 |
| Kitagawa, Y; Nakamura, M; Nishizawa, S; Ogasawara, T; Sadato, N; Sano, K; Yonekura, Y | 1 |
| Gonen, M; Krug, L; Larson, SM; Pandit, N | 1 |
| Bergström, M; Ekbom, K; Engler, H; Hartvig, P; Långström, B; Lundberg, PO; Nennesmo, I; Nilsson, A; Tsukada, H | 1 |
| Belohlávek, O; Kantorová, I; Liscák, R; Novotný, J; Simonová, G | 1 |
| Di Martino, E; Gagel, B; Hausmann, R; Krombach, GA; Nowak, B; Tietze, L; Westhofen, M; Zimny, M | 1 |
| Husso-Saastamoinen, M; Kuikka, JT; Sohlberg, A | 1 |
| Brinkbaeumer, K; Dresel, S; Hahn, K; Hautmann, H; Kellner, W; Moisseev, A; Poellinger, B; Schmid, RA; Weiss, M | 1 |
| Bares, R; Eschmann, SM; Friedel, G | 1 |
| Bangard, M; Bender, H; Biersack, HJ; Gallkowski, U; Guhlke, S; Reichmann, K; Sartor, J; Willkomm, P | 1 |
| Ando, K; Hosoi, R; Inoue, O; Kobayashi, K; Koike, S; Momosaki, S; Nishimura, T | 1 |
| Fogarty, GB; Hicks, RJ; Peters, LJ; Rischin, D; Scott, C; Stewart, J | 1 |
| Barboriak, DP; Coleman, RE; Provenzale, JM; Rohren, EM | 1 |
| Comans, EF; Herder, GJ; Hoekstra, OS; Joshi, U; Postmus, PE; Smit, EF; Teule, GJ; Van Tinteren, H | 1 |
| Baumert, BG; Dizendorf, EV; Lütolf, UM; Steinert, HC; von Schulthess, GK | 1 |
| Block, S; Buell, U; Kaiser, HJ; Koch, KC; Nowak, B; Schaefer, WM; vom Dahl, J | 1 |
| Steinert, HC; von Schulthess, GK | 1 |
| Bingham, JB | 1 |
| Schwaiger, M | 1 |
| Ackermann, R; Coenen, HH; Hautzel, H; Herzog, H; Krause, BJ; Müller-Gärtner, HW; Müller-Mattheis, V; Roden, W | 1 |
| Alavi, A; Bagg, A; Baker, G; Downs, L; Elstrom, R; Guan, L; Kim, S; Mehrotra, A; Nakhoda, K; Pitsilos, S; Schuster, SJ; Vergilio, JA; Zhuang, H | 1 |
| Graeter, TP; Hellwig, D; Hoffmann, K; Kirsch, CM; Schäfers, HJ; Ukena, D | 1 |
| Siggelkow, W; Zimny, M | 1 |
| Becker, K; Fink, U; Link, T; Ott, K; Schwaiger, M; Siewert, JR; Stahl, A; Weber, WA | 1 |
| Choi, JY; Hong, SB; Hong, SC; Kim, BT; Kim, SE; Kim, SJ; Seo, DW | 1 |
| Antoch, G; Bockisch, A; Brandt-Mainz, K; Görges, R; Müller, S; Stattaus, J | 1 |
| Kossmann, T; Schiesser, M; Stumpe, KD; Trentz, O; Von Schulthess, GK | 1 |
| Buchert, R; Freyhoff, J; Lübeck, M; Lund, CH; Lund, GK; Meinertz, T; Nienaber, CA; Schwaiger, M; Sheehan, FH | 1 |
| Cohade, C; Osman, M; Pannu, HK; Wahl, RL | 1 |
| Dehdashti, F; Grigsby, PW; Miller, TR; Pinkus, E | 1 |
| Kitagawa, Y; Nakamura, M; Nishizawa, S; Ogasawara, T; Sadato, N; Sano, K; Yonekura, Y; Yoshida, M | 1 |
| Ho, CL; Yeung, DW; Yu, SC | 1 |
| Delbeke, D; Pinson, CW | 2 |
| Goldsmith, SJ; Kostakoglu, L | 5 |
| Cohade, C; Leal, JP; Marshall, LT; Nakamoto, Y; Osman, MM; Wahl, RL | 1 |
| Keith, CJ; Miles, KA; Wong, D | 1 |
| Bergh, S; Boerner, AR; Brunkhorst, T; Fricke, E; Hofmann, M; Karstens, JH; Knapp, WH; Machtens, S; Meyer, GJ; van den Hoff, J | 1 |
| Bachmann, LM; Goerres, GW; Mosna-Firlejczyk, K; Steurer, J; von Schulthess, GK | 1 |
| Buecker, A; Buell, U; Kaiser, HJ; Krombach, GA; Kühl, HP; Lipke, CS; Nowak, B; Schaefer, WM | 1 |
| Fogelman, I; Shon, IH | 1 |
| Galen, B; Gourgiotis, L; Guthrie, LC; Patronas, NJ; Reynolds, JC; Sarlis, NJ; Shawker, TH; Skarulis, MC | 1 |
| Flamen, P; Lerut, T | 1 |
| Frick, MP; Karabulut, N; Martin, DR; Yang, M | 1 |
| Becker, W; Grabbe, E; Meller, J; Vosshenrich, R | 1 |
| Bascom, D; Fukui, M; Johnson, JT; McCook, B; Meltzer, C; Snyderman, C; Townsend, DW; Zimmer, LA | 1 |
| Balzarini, J; Bormans, G; De Wolf-Peeters, C; Dupont, P; Mortelmans, L; Spaepen, K; Stroobants, S; Vandenberghe, P; Verhoef, G | 1 |
| Aoki, J; Endo, K; Higuchi, T; Oriuchi, N; Tanada, S; Tian, M; Watanabe, H; Zhang, H | 1 |
| Carlson, KA; Davidson, D; Hutchins, GD; Jung, SH; Schauwecker, DS; Siddiqui, AR; Wagner, JD | 1 |
| Cohade, C; Marshall, LN; Osman, M; Wahl, RN | 1 |
| Bueno, C; Carreras, JL; Lázaro, P; Longo, MI; Montz, R | 1 |
| Maes, A; Mortelmans, L; Mulier, M; Nuyts, J; Stuyck, J; Van Acker, F; Vanquickenborne, B; Verbruggen, A | 1 |
| Bakker, PF; de Klerk, JM; Schlösser, NJ; Stevens, H; van Rijk, PP | 1 |
| Choi, CW; Choi, SC; Kim, MH; Lee, KH; Ryu, SY | 1 |
| Wagner, JD | 1 |
| Brioschi, M; De Cobelli, F; Del Maschio, A; Fazio, F; Gianolli, L; Landoni, C; Matarrese, M; Matei, DV; Messa, C; Picchio, M; Rigatti, P; Rocco, F; Sironi, S | 1 |
| Bomanji, J; Costa, DC; Croasdale, I; Ell, PJ; Gacinovic, S; Lonn, AH; Visvikis, D | 1 |
| Damgaard, K; Daugaard, G; Eigtved, A; Højgaard, L; Lassen, U; Rørth, M | 1 |
| Goerres, GW; Mosna-Firlejczyk, K; Stoeckli, SJ | 1 |
| Hoekstra, OS; Krak, NC; Lammertsma, AA; Twisk, JW; van der Hoeven, JJ; van der Wall, E | 1 |
| Chapman, WC; Delbeke, D; Morris, D; Pinson, CW; Rice, M; Shyr, Y; Washington, MK; Wudel, LJ | 1 |
| Nakamoto, Y; Osman, M; Wahl, RL | 1 |
| Nahmias, C; Niven, E | 1 |
| Feldman, F; Manos, C; van Heertum, R | 1 |
| Asano, E; Chakraborty, PK; Chugani, DC; Chugani, HT; Juhász, C; Mangner, TJ; Muzik, O; Shah, A; Sood, S | 1 |
| Buell, U; Zimmy, M | 1 |
| Buell, U; Cremerius, U; Hochstenbag, M; Lamers, R; Reinartz, P; ten Velde, G; Zimny, M | 1 |
| Endo, K; Higuchi, T; Inoue, T; Khan, N; Oriuchi, N; Sato, N; Tian, M; Zhang, H | 1 |
| Endo, K; Higuchi, T; Koyama, K; Oriuchi, N; Tian, M; Zhang, H | 1 |
| Bax, JJ; Eersels, J; Knapp, FF; Poldermans, D; Sloof, GW; van Lingen, A | 1 |
| Conrad, M; Lehmann, K; Meller, J; Sahlmann, CO; Scheel, A; Siefker, U; Strutz, F; Vosshenrich, R | 1 |
| Aerts, J; Cataldo, D; Duysinx, B; Fassotte, MF; Foidart, J; Hustinx, R; Jerusalem, G; Lemaire, C; Luxen, A; Moreau, P | 1 |
| Ameshima, S; Demura, Y; Ishizaki, T; Miyamori, I; Mizuno, S; Sasaki, M; Totani, Y; Tsuchida, T; Yonekura, Y | 1 |
| Andriole, GL; Dehdashti, F; Fischer, KC; Kibel, AS; Michalski, JM; Miller, TR; Oyama, N; Picus, J; Siegel, BA; Welch, MJ | 1 |
| Guo, J; Higashi, K; Ikeda, R; Matsunari, I; Oguchi, M; Tonami, H; Ueda, Y; Yamamoto, I | 1 |
| Carreras, JL; Cordeiro, CA; Domper, M; Gonzalez, L; Jimenez, A; Montz, HR; Perez Castejon, MJ; Vano, E | 1 |
| Beek, AM; Heussen, N; Hofman, MB; Kühl, HP; Lammertsma, AA; van der Weerdt, AP; van Rossum, AC; Visser, CA; Visser, FC | 1 |
| Mortelmans, L; Spaepen, K; Stroobants, S; Verhoef, G | 1 |
| Fehr, MK; Goerres, GW; Kamel, EM; von Schulthess, GK; Wyss, MT | 1 |
| Laking, GR; Price, PM | 1 |
| Bax, JJ; Boersma, E; Elhendy, A; Geleijnse, ML; Poldermans, D; Roelandt, JR; Schinkel, AF | 1 |
| Barnett, PG; Gould, MK; Maclean, CC; McClellan, MB; Owens, DK; Rydzak, CE; Sanders, GD | 1 |
| Fukuda, H; Ido, T; Kanamaru, R; Kubota, K; Saginoya, T; Takahashi, H; Yamaguchi, K; Yamaura, G; Yamazaki, T; Yoshioka, T | 1 |
| Arulampalam, TH; Costa, DC; Ell, PJ; Francis, DL; Luthra, SK; Taylor, I; Townsend, C; Visvikis, D | 1 |
| Brinkbäumer, K; Dresel, S; Grammerstorff, J; Hahn, K; Pfluger, T; Schmid, R; Schwenzer, K | 1 |
| Chang, CH; Changlai, SP; Kao, A; Shen, YY; Tsai, JJ; Wu, HC | 1 |
| Gallowitsch, HJ; Gasser, J; Igerc, I; Kresnik, E; Kumnig, G; Lind, P; Mikosch, P | 1 |
| Gambhir, SS; Wu, D | 1 |
| Aston, JA; Banati, RB; Cunningham, VJ; Riddell, C; Turkheimer, FE | 1 |
| Alavi, A; Altimari, SM; Chacko, TK; Duarte, PS; Feng, Q; Guan, L; Hickeson, M; Nakhoda, KZ; Reich, P; Sam, JW; Zhuang, H | 1 |
| Drzezga, A; Kurz, A; Lautenschlager, N; Minoshima, S; Riemenschneider, M; Schwaiger, M; Siebner, H; Willoch, F | 1 |
| Alavi, A; Chacko, TK; Moussavian, B; Nakhoda, KZ; Zhuang, H | 1 |
| Beuthien-Baumann, B; Burchert, W; Franke, WG; Handrick, W; Kropp, J; Oehme, L; Pinkert, J; Schackert, G; Schmidt, T | 1 |
| Kim, BT; Kim, K; Kim, TS; Lee, KS; Shim, YM; Yoon, YC | 1 |
| Eyrich, GK; Goerres, GW; Grätz, KW; Schmid, DT; von Schulthess, GK | 1 |
| De Winter, F; Dierckx, R; Gemmel, F; Poffijn, B; Uyttendaele, D; Van De Wiele, C | 1 |
| Belhocine, T; Blockmans, D; Hustinx, R; Mortelmans, L; Vandevivere, J | 1 |
| Gottschild, D; Opfermann, T; Voth, M | 1 |
| Cook, GJ; Husband, JE; Koh, DM | 1 |
| Lowe, VJ | 1 |
| Berchuck, A; Clarke-Pearson, DL; Havrilesky, LJ; Jones, EL; Secord, AA; Wong, TZ | 1 |
| Akhurst, T; Guillem, JG; Larson, SM; Mazumdar, M; Minsky, BD; Moore, HG | 1 |
| Fehr, MK; Goerres, GW; Kaim, AH; Kubik-Huch, RA; Michel, SC; Seifert, B; Steinert, HC; von Schulthess, GK | 1 |
| Goering, UJ; Krahe, T; Kugel, H; Pietrzyk, U; Scharl, A; Scheidhauer, K; Theissen, P; Walter, C | 1 |
| Blum, RH; Hicks, RJ; MacManus, M; Seymour, JF; Wirth, A | 1 |
| Antoine, M; Barranger, E; Grahek, D; Montravers, F; Talbot, JN; Uzan, S | 1 |
| Bax, JJ; Boersma, E; Elhendy, A; Krenning, EP; Maddahi, J; Poldermans, D; Roelandt, JR; Schinkel, A; Valkema, R; van der Wall, EE | 1 |
| Chang, KH; Choi, KY; Chung, CK; Chung, JK; Kim, SK; Kim, YK; Lee, DS; Lee, MC; Lee, SK | 1 |
| Akioka, K; Shirai, N; Takagi, M; Takeuchi, K; Yamagishi, H; Yoshikawa, J; Yoshiyama, M | 1 |
| Beaulieu, S; Dunnwald, LK; Kinahan, P; Lewellen, B; Mankoff, DA; Pham, P; Schubert, EK; Tseng, J | 1 |
| Futatsubashi, M; Kanno, T; Maeda, M; Nakamura, F; Okada, H; Ouchi, Y; Takekuma, M; Torizuka, T; Yoshikawa, E | 1 |
| Leonidas, JC; Palestro, CJ; Rini, JN; Tomas, MB | 1 |
| Aladl, UE; Baum, RP; Dey, D; Przetak, C; Slomka, PJ | 1 |
| Agostini, D; Aide, N; Bensadoun, H; Bottet, P; Bouvard, G; Cappele, O; Comoz, F; Regeasse, A; Sobrio, F | 1 |
| Fujii, S; Fujita, T; Higashi, T; Higuchi, T; Ishimori, T; Kita, M; Konishi, J; Mamede, M; Mukai, T; Nakamoto, Y; Saga, T; Togashi, K; Yura, S | 1 |
| Aide, N; Balogova, S; Colombet, C; De Beco, V; Grahek, D; Jacob, T; Kerrou, K; Montravers, F; Talbot, JN; Younsi, N | 1 |
| Changlai, SP; Chen, WK; Hung, MC; Kao, CH; Wu, HS | 1 |
| Link, T; Peschel, C; Petersen, V; Schmidt, B; Schwaiger, M; Tyndale-Hines, L; Weber, WA | 1 |
| Guller, U; Moch, H; Nitzsche, E; Zuber, M | 1 |
| Drieskens, O; Gysen, M; Mortelmans, L; Stroobants, S; Vandenbosch, G; Vergote, I | 1 |
| Berner, U; Diehl, M; Döbert, N; Grünwald, F; Hamscho, N; Kaufmann, R; Kriener, S; Menzel, C; Rinne, D | 1 |
| Aletti, G; De Cobelli, F; De Marzi, P; Del Maschio, A; Fazio, F; Ferrari, A; Gianolli, L; Landoni, C; Mangili, G; Messa, C; Picchio, M; Sironi, S; Viganò, R; Zangheri, B | 1 |
| Brioschi, M; Fazio, F; Gianolli, L; Gilardi, MC; Landoni, C; Lecchi, M; Picchio, M; Rossetti, C; Savi, A | 1 |
| Weiss, RA | 1 |
| Huang, KM; Hung, RL; Kao, CH; Lui, LT; Pan, MH; Wang, YH; Yen, RF | 1 |
| Akhurst, T; Flores, RM; Gonen, M; Larson, SM; Rusch, VW | 1 |
| Büll, U; Cremerius, U; Hermanns, B; Müller-Rath, R; Mumme, T; Neuss, M; Wirtz, DC | 1 |
| Chun, H; Kim, CK; Krynckyi, BR; Machac, J | 1 |
| Bares, R; Dittmann, H; Dohmen, BM; Eichhorn, K; Eschmann, SM; Horger, M; Machulla, HJ; Paulsen, F; Wehrmann, M | 1 |
| Altman, H; Bar-Shalom, R; Frenkel, A; Gaitini, D; Guralnik, L; Israel, O; Keidar, Z; Kuten, A; Yefremov, N | 1 |
| Bénard, F; Guay, C; Lépine, M; Verreault, J | 1 |
| Carreras, JL; Delgado-Bolton, RC; Fernández-Pérez, C; González-Maté, A | 1 |
| Bauditz, J; Biering, H; Gerl, H; Lochs, H; Pirlich, M; Sandrock, D | 1 |
| Cuocolo, A; Giuliani, A; Mainolfi, C; Maurea, S; Sciaudone, G; Selvaggi, F | 1 |
| Endo, K; Higuchi, T; Oriuchi, N; Tanada, S; Tian, M; Zhang, H | 2 |
| Doi, R; Fujimoto, K; Higashi, T; Imamura, M; Ishimori, T; Konishi, J; Nakamoto, Y; Saga, T | 1 |
| Dietlein, M; Hellwig, D; Kirsch, CM; Schicha, H; Schwaiger, M; Weber, WA | 1 |
| Chang, TC; Hong, JH; Hsueh, S; Kao, PF; Lai, CH; Ng, KK; Tsai, CC; Tsai, CS; Yen, TC | 1 |
| Gao, RL; He, ZX; Jain, D; Liu, XJ; Narula, J; Qin, XW; Shen, R; Shi, RF; Tian, YQ; Wang, SW; Wu, YJ | 1 |
| Cheng, WY; Cui, RX; Li, LY; Li, YF; Zhou, Q; Zhu, ZH | 1 |
| Comber, LA; Griffiths, M; Keith, CJ; Miles, KA | 1 |
| Chen, YK; Kao, CH; Liu, FY; Yen, RF | 1 |
| Larson, SM; Macapinlac, HA; Salmon, AS; Turlakow, A; Yeung, HW | 1 |
| Buck, AK; Glatting, G; Halter, G; Hetzel, M; Kotzerke, J; Mattfeldt, T; Neumaier, B; Reske, SN; Schirrmeister, H; Wurziger, I | 1 |
| Bossuyt, A; Caveliers, V; Everaert, H; Franken, PR; Lahoutte, T; Mertens, J | 1 |
| Fukunaga, H; Higuchi, I; Nishimura, T; Paul, AK; Tatsumi, M; Yasuda, T | 1 |
| Bartalucci, AA; Bass, CS; Bryant, AS; Cerfolio, RJ; Mountz, JM; Ojha, B | 1 |
| Eyrich, GK; Grätz, K; Hugenin, P; Sigg, MB; Steinert, H; Stoeckli, S | 1 |
| Hara, T; Kosaka, N; Kudo, K; Niino, H; Suzuki, T | 1 |
| Csaba, J | 1 |
| Higashi, T; Imamura, M; Ishimori, T; Ishizu, K; Kobayashi, H; Konishi, J; Mamede, M; Nakamoto, Y; Saga, T; Sakahara, H; Sato, N | 1 |
| Bossuyt, A; Caveliers, V; Everaert, H; Franken, PR; Lahoutte, T; Muylle, K; Vanhove, C | 1 |
| Ando, A; Hirai, M; Ishigaki, T; Isobe, S; Ito, K; Izawa, H; Murohara, T; Nanasato, M; Nonokawa, M; Sobue, T; Yokota, M | 1 |
| Alberini, JL; Belhocine, T; Daenen, F; Hustinx, R; Rigo, P | 1 |
| Alavi, A; Chiang, SB; Johnson, GR; Khan, J; Zhuang, H | 1 |
| Endo, K; Higuchi, T; Khan, N; Oriuchi, N; Zhang, H | 1 |
| Chang, TC; Chen, JT; Chou, HH; Hong, JH; Hsueh, S; Huang, KG; Lai, CH; Lin, WJ; Lui, KW; Ma, SY; Ng, KK; See, LC; Tsai, CS; Yen, TC | 1 |
| Antoch, G; Beyer, T; Bockisch, A; Debatin, JF; Freudenberg, LS; Kuehl, H; Marnitz, S; Nemat, AT; Stattaus, J | 1 |
| Borson-Chazot, F; Bournaud, C; Desuzinges, C; Giammarile, F; Hafdi, Z; Houzard, C; Itti, R; Janier, M; Sassolas, G | 1 |
| Dimitrakopoulou-Strauss, A; Herfarth, C; Hinz, U; Lehnert, T; Mechtersheimer, G; Schwarzbach, M; Strauss, LG; Willeke, F | 1 |
| Inoue, Y; Moritan, T; Nagai, R; Ohtomo, K; Yokoyama, I | 2 |
| Endo, K; Mogi, K; Nakasone, Y; Tian, M; Zhang, H | 1 |
| Bleeker-Rovers, CP; Corstens, FH; de Kleijn, EM; Oyen, WJ; van der Meer, JW | 1 |
| Mukherji, SK; Wolf, GT | 1 |
| Conrad, GR; Sinha, P | 1 |
| Bingham, J; Chinyama, C; Hain, SF; O'Doherty, MJ; Smith, MA | 1 |
| Aramburú, I; Brugère, S; Chamorro, H; Coll, C; González, P; Humeres, P; Jofré, J; Kunstmann, S; López, H; Massardo, T; Ramírez, A; Redondo, F; Sierralta, P; Yovanovich, J | 1 |
| Blockmans, D; Buysschaert, I; Knockaert, DC; Mortelmans, L; Vanderschueren, S | 1 |
| Higashi, K; Higuchi, T; Ikeda, R; Kodama, Y; Matsunari, I; Miura, K; Taki, S; Tonami, H; Ueda, Y; Yamamoto, I | 1 |
| Futatsubashi, M; Kanno, T; Kobayashi, M; Nakamura, F; Okada, H; Ouchi, Y; Torizuka, T; Yoshikawa, E | 1 |
| Araki, T; Higashi, K; Higuchi, T; Ikeda, M; Kinuya, S; Nakajima, K; Namura, M; Tagawa, S; Taki, J; Tonami, N; Tsuchiya, T; Yoshida, N | 1 |
| Boers, M; Comans, EF; Diepenhorst, FW; Grijseels, EW; Hoekstra, OS; Postmus, PE; Schreurs, AJ; Smit, EF; Stallaert, RA; Teule, GJ; Uyl-de Groot, CA; van den Bergh, JH; van Mourik, JC; van Tinteren, H; van Velthoven, PC; Verboom, P | 1 |
| Kim, KS; Kim, YJ; Lee, JD; Lee, WJ; Yun, M | 1 |
| Delahaye, N; Gardin, I; Gutman, F; Hitzel, A; Le Guludec, D; Manrique, A; Rakotonirina, H; Véra, P | 1 |
| Mansi, L; Oyen, WJ | 1 |
| Buscombe, J; Signore, A | 1 |
| Albani, JM; Bukowski, RM; Elson, P; Kanvinde, MH; Majhail, NS; Mekhail, TM; Novick, AC; Olencki, TE; Rice, TW; Urbain, JL | 1 |
| Bartenstein, P; Benz, P; Förster, GJ; Jeong, JH; Kunkel, M; Reichert, TE; Wagner, W; Whiteside, TL | 1 |
| Dannenberg, C; Dörffel, W; Hasenclever, D; Hirsch, W; Kluge, R; Körholz, D; Lotz, I; Lüders, H; Sabri, O; Wickmann, L | 1 |
| Bartenstein, P; Grünwald, F; Junginger, T; Kneist, W; Oberholzer, K; Schreckenberger, M | 1 |
| Fukunaga, H; Hata, Y; Higuchi, I; Hujie, Y; Ikeda, M; Ikenaga, M; Kitani, K; Monden, M; Ohue, M; Seki, Y; Sekimoto, M; Takayama, H; Yamamoto, H; Yasui, M | 1 |
| Decristoforo, C; Donnemiller, E; Ensinger, C; Froehlich, F; Gabriel, M; Heute, D; Moncayo, R; von Guggenberg, E | 1 |
| Aubier, M; Charpentier, E; Crestani, B; Delahaye, N; Fery-Lemonnier, E; Girard, P; Le Guludec, D; Lebtahi, R; Rakotonirina, H; Sarda, L; Syrota, A | 1 |
| Aigner, RM; Krippl, P; Schaffler, G; Schwarz, T; Wolf, G | 1 |
| Ametamey, SM; Bode, B; Buck, A; Honer, M; Kaim, AH; Späth, N; Weber, B; Westera, G; Wyss, MT | 1 |
| Chan, JK; Demas, AN; Gould, MK; Kuschner, WG; Maclean, CC; Owens, DK; Rydzak, CE; Shigemitsu, H | 1 |
| Barrington, SF; Chambers, J; Hallett, WA; Nunan, TO; O'Doherty, MJ; Roxburgh, JC | 1 |
| Antoch, G; Beyer, T; Bockisch, A; Debatin, JF; Freudenberg, LS; Görges, R; Jentzen, W; Müller, SP; Nowrousian, MR; Schütt, P | 1 |
| Nakamura, R; Sakamaki, K; Sato, S; Shozushima, M; Terasaki, K; Tsutsumi, R | 1 |
| Boellaard, R; Franssen, EJ; Greuter, HN; Lammertsma, AA; van Lingen, A | 1 |
| Forsthuber, EP; Gallowitsch, HJ; Gasser, J; Gomez, I; Heinisch, M; Kresnik, E; Kumnig, G; Lind, P; Mikosch, P; Umschaden, HW | 1 |
| Haynor, D; Turcotte, E; Vesselle, H; Wiens, L | 1 |
| Essner, R; Faries, MB; Glass, C; Gulec, SA; Kirgan, D; Lee, CC; Morton, DL | 1 |
| Bohdiewicz, PJ; Dworkin, HJ; Gaskill, M; Kondas, D; Wong, CY | 1 |
| Higashi, T; Iida, Y; Ishimori, T; Iwata, M; Kasagi, K; Konishi, J; Matsumoto, K; Misaki, T; Nakamoto, Y; Saga, T | 1 |
| Granov, AM; Kostenikov, NA; Ryzhkova, DV; Savello, VE; Stanzhevskiĭ, AA; Tiushin, LA; Tlostanova, MS | 1 |
| Brouwer, J; Castelijns, JA; Comans, EF; de Bree, R; Hoekstra, OS; Leemans, CR | 1 |
| Kernstine, KH | 1 |
| Coleman, RE; D'Amico, TA; Gonzalez-Stawinski, GV; Harpole, DH; Lemaire, A; Merchant, F; O'Halloran, E | 1 |
| Bellomi, M; Fazio, F; Landoni, C; Leo, F; Leon, M; Pastorino, U; Pelosi, G; Picchio, M; Solli, PG; Spaggiari, L; Veronesi, G | 1 |
| Conti, PS; Jadvar, H; Kherbache, HM; Pinski, JK | 1 |
| Agress, H; Cooper, BZ | 1 |
| Bleeker-Rovers, CP; Bredie, SJ; Corstens, FH; Oyen, WJ; van der Meer, JW | 2 |
| Bieling, P; Garson, C; Goldapple, K; Kennedy, S; Lau, M; Mayberg, H; Segal, Z | 1 |
| Bares, R; Bokemeyer, C; Claussen, CD; Dohmen, BM; Kollmannsberger, C; Oechsle, K; Pfannenberg, AC; Vontheim, R | 1 |
| Chin, BB; Cohade, C; Ewertz, M; Ladenson, P; Patel, P; Wahl, R | 1 |
| Coleman, RE; Gatsonis, CG; Siegel, BA; Wahl, RL | 1 |
| Fukuda, H; Itoh, M; Kubota, K; Ono, S; Qureshy, A; Yamaguchi, K; Yokoyama, J | 1 |
| Boellaard, R; Comans, EF; Hoekstra, OS; Joshi, U; Miller, SD; Pijpers, RJ; Raijmakers, PG; Teule, GJ; van Lingen, A | 1 |
| Eigtved, A; Højgaard, L; Kjaer, A; Lebech, AM | 1 |
| Gayed, I; Iyer, R; Johnson, M; Macapinlac, H; Podoloff, D; Swanston, N; Vu, T | 1 |
| Chen, JT; Chen, WJ; Hsueh, S; Lai, CH; Lai, CR; Lin, WJ; Ma, SY; Ng, KK; See, LC; Yah-Huei, CW; Yen, TC | 1 |
| Buecker, A; Buell, U; Kaiser, HJ; Krombach, GA; Kühl, HP; Lipke, CS; Nowak, B; Reinartz, P; Schaefer, WM | 1 |
| Boerman, OC; Corstens, FH; Edwards, DS; Ellars, CE; Harris, TD; Laverman, P; Oyen, WJ; van Eerd, JE | 1 |
| Delbeke, D; Martin, WH; Scanga, DR | 1 |
| Bares, R; Bokemeyer, C; Claussen, CD; Dohmen, BM; Hartmann, JT; Kollmannsberger, C; Oechsle, K; Pfannenberg, AC; Vonthein, R | 1 |
| Beorlegui, C; Garcia-Velloso, MJ; Pina, L; Regueira, FM; Sola, J; Zornoza, G | 1 |
| Al-Nahhas, AM | 1 |
| Fang, YH; Kao, T; Liu, RS; Wu, LC | 1 |
| Chang, TC; Chou, HH; Hong, JH; Hsueh, S; Huang, KG; Lai, CH; Ng, KK; See, LC; Tsai, CS; Yen, TC | 1 |
| Anderson, CD; Chapman, WC; Chari, RS; Delbeke, D; Pinson, CW; Rice, MH | 1 |
| Chin, BB; Hammoud, D; Patel, P | 1 |
| Amthauer, H; Denecke, T; Felix, R; Gutberlet, M; Hildebrandt, B; Hünerbein, M; Rau, B; Ruf, J; Schlag, PM; Schneider, U; Wust, P | 1 |
| Antoch, G; Bockisch, A; Broelsch, CE; Debatin, JF; Kaiser, GM; Kuehl, H; Metz, KA; Mueller, AB; Mueller, SP; Westermann, S; Zhang, H | 1 |
| Bastiaannet, E; Cobben, DC; Groen, H; Hoekstra, HJ; Jager, PL; Vaalburg, W; van der Graaf, WT | 1 |
| Böhm, B; Geoghegan, J; Gottschild, D; Hellfritzsch, H; Petrovich, A; Scheele, J; Voth, M | 1 |
| Bartsch, P; Belhocine, T; Bury, T; Cataldo, D; Duysinx, B; Louis, R; Nguyen, D | 1 |
| Berbaum, K; Bushnell, D; Kahn, D; Kernstine, K; McLaughlin, K; Menda, Y; Miller, S | 1 |
| Bleeker-Rovers, CP; Jager, G; Oyen, WJ; Tack, CJ; Van Der Meer, JW | 1 |
| Bénard, F; Boucher, L; Lecomte, R; Rodrigue, S | 1 |
| Blank, A; Bokstein, F; Even-Sapir, E; Lerman, H; Lievshitz, G; Metser, U | 1 |
| Asao, T; Endo, K; Katoh, H; Kuwano, H; Mochiki, E; Oriuchi, N | 1 |
| Inoue, T; Ishida, A; Kawano, T; Lee, J; Oka, T; Suzuki, A; Takahashi, N; Tayama, Y; Yokota, S | 1 |
| Cappellari, JO; Geisinger, K; Greven, KM; Keyes, JW; McGuirt, WF; Rogers, JW; Watson, NE; Williams, DW | 1 |
| Abe, K; Hayashi, K; Hiraka, K; Honda, H; Kaneko, K; Koga, H; Kuwabara, Y; Nakagawa, M; Sasaki, M | 1 |
| Becker, K; Beer, A; Brücher, BL; Fink, U; Lordick, F; Schwaiger, M; Siewert, JR; Stein, HJ; Weber, WA; Wieder, HA; Zimmermann, F | 1 |
| Crymes, WB; Demos, H; Gordon, L | 1 |
| Gonen, M; Kraus, D; Larson, SM; Schöder, H; Yeung, HW | 1 |
| Bares, R; Dittmann, H; Dohmen, BM; Fersis, N; Machulla, HJ; Reischl, G; Smyczek-Gargya, B; Vogel, U; Wallwiener, D | 1 |
| Akhurst, TA; Beattie, B; Bornmann, W; Dyke, J; Erdi, Y; Finn, RD; Gunther, I; Humm, JL; Larson, SM; McCarthy, T; Morris, M; Pentlow, K; Scher, H; Squire, O; Welch, M | 1 |
| Chan, SC; Chang, JT; Chang, YC; Ko, SF; Liao, CT; Ng, SH; Wang, HM; Yen, TC | 1 |
| Baer, FM; Schicha, H; Schmidt, M; Schneider, CA; Theissen, P; Voth, E; Wagner, R | 1 |
| Borson-Chazot, F; Bournaud, C; Giammarile, F; Hafdi, Z; Houzard, C; Sassolas, G | 1 |
| Annema, JT; Hoekstra, OS; Rabe, KF; Smit, EF; Versteegh, MI; Veseliç, M | 1 |
| Endo, K; Higuchi, T; Oriuchi, N; Tian, M; Zhang, H | 1 |
| Becherer, A; Bokemeyer, C; De Santis, M; Dittrich, C; Dohmen, BM; Kletter, K; Lang, A; Oechsle, K; Pont, J; Sellner, F; Stoiber, F | 1 |
| Bertoldo, A; Cobelli, C; Sparacino, G | 1 |
| Arulampalam, TH; Ell, PJ; Francis, DL; Taylor, I; Visvikis, D | 1 |
| Barry, B; Baujat, B; Gehanno, P; Lazard, DS; Le Guludec, D | 1 |
| Boán, JF; Redondo, P | 1 |
| Gould, KL; Taegtmeyer, H | 1 |
| Naruke, T; Nomori, H; Ohtsuka, T; Suemasu, K; Uno, K; Watanabe, K | 3 |
| Buck, AK; Glatting, G; Halter, G; Hetzel, M; Liewald, F; Neumaier, B; Reske, SN; Schirrmeister, H; Sunder-Plassmann, L; Wurziger, I | 1 |
| Dirksen, A; Eigtved, A; Fischer, BM; Højgaard, L; Mortensen, J | 1 |
| Chung, JK; Jeong, JM; Kim, SK; Lee, DS; Lee, MC; Lee, YJ | 1 |
| Guo, J; Higashi, K; Ikeda, R; Katsuda, S; Kodama, Y; Matsunari, I; Oguchi, M; Tonami, H; Ueda, Y; Yamamoto, I | 1 |
| Matchar, DB; McCrory, DC; Patwardhan, MB; Rutschmann, OT; Samsa, GP | 1 |
| Chikamatsu, K; Endo, K; Furuya, N; Higuchi, T; Kahn, N; Kamada, H; Ninomiya, H; Oriuchi, N; Takahashi, K | 1 |
| Eimoto, T; Hara, M; Iida, A; Murase, T; Ogino, H; Shibamoto, Y; Shiraki, N; Tamaki, T | 1 |
| Fukuda, H; Hosono, MN; Inoue, Y; Ishii, K; Kondo, S; Matsumura, A; Okamura, T; Takada, Y; Tashiro, M; Wada, Y; Watanabe, Y; Yamada, R | 1 |
| Billheimer, D; Cmelak, AJ; Delbeke, D; Hallahan, DE; Lavely, WC; Martin, WH; Scarfone, C | 1 |
| Chao, K; Erdi, YE; Gonen, M; Larson, SM; Schöder, H; Yeung, HW | 1 |
| Silverman, DH | 1 |
| Biswal, S; Deroose, C; Gambhir, SS; Min, JJ | 1 |
| Eckelman, WC; Esaki, T; Green, MV; Jagoda, E; Ravasi, L; Schmidt, K; Seidel, J; Shimoji, K; Sokoloff, L; Soto-Montenegro, ML | 1 |
| Cobben, DC; de Vries, EF; Elsinga, PH; Hoekstra, HJ; Jager, PL; Maas, B; Suurmeijer, AJ; Vaalburg, W; van Waarde, A | 1 |
| Comtat, C; Kinahan, PE; Lartizien, C | 1 |
| Holmstrom, A; Kelly, RF; Murar, J; Segurola, RJ; Tran, T | 1 |
| Baete, K; Dupont, P; Nuyts, J; Suetens, P; Van Paesschen, W | 1 |
| Beyer, T; Hausegger, K; Igerc, I; Lind, P; Reinprecht, P | 1 |
| Chin, BB; Cohade, C; Nakamoto, Y; Osman, M; Tatsumi, M; Wahl, RL | 1 |
| Diehl, M; Döbert, N; Grünwald, F; Hamscho, N; Menzel, C; Zaplatnikov, K | 1 |
| Gietema, JA; Jager, PL; van der Graaf, WT | 1 |
| Battmann, A; Bauhofer, A; Béhé, M; Behr, TM; Beuter, D; Gotthardt, M; Gratz, S; Höffken, H; Klose, KJ; Pollum, H; Schurrat, T | 1 |
| Hoekstra, OS; Krak, NC; Lammertsma, AA | 1 |
| Aksoy, E; Buck, AK; Glatting, G; Halter, G; Hetzel, M; Liewald, F; Mühling, B; Neumaier, B; Nüssle-Kügele, K; Reske, SN; Schirrmeister, H; Sunder-Plassmann, L | 1 |
| Aigner, RM; Fasching, G; Groell, R; Maier, A; Nicoletti, R; Schaffler, GJ; Schoellnast, H; Smolle-Jüttner, FM; Wolf, G; Woltsche, M | 1 |
| Bender, H; Biersack, HJ; Palmedo, H | 1 |
| Endo, K; Tsushima, Y | 1 |
| Belhocine, T | 1 |
| Akeboshi, M; Hataji, O; Nakatsuka, A; Taguchi, O; Takao, M; Takeda, K; Yamakado, K | 1 |
| Buck, AK; Mattfeldt, T; Reske, SN; Schirrmeister, H | 1 |
| Chung, JK; Jeong, JM; Kang, SB; Kim, MH; Kim, S; Lee, DS; Lee, MC | 1 |
| Brenner, W; Conrad, EU; Eary, JF | 1 |
| Aide, N; Grahek, D; Kerrou, K; Lotz, JP; Montravers, F; Talbot, JN | 1 |
| Chung, JK; Jeong, JM; Kang, WJ; Lee, DS; Lee, MC; So, Y | 1 |
| Brink, I; Vaith, P; Walker, UA; Weiner, SM | 1 |
| Agresti, R; Alessi, A; Bombardieri, E; Crippa, F; Gerali, A | 1 |
| Scheidhauer, K; Seemann, MD; Walter, C | 1 |
| Fazio, F; Gianolli, L; Landoni, C; Messa, C; Picchio, M; Zangheri, B | 1 |
| Chang, KH; Chung, CK; Kim, DW; Kim, KK; Lee, DS; Lee, SK; Yun, CH | 1 |
| Buell, U; Rath, W; Siggelkow, W; Zimny, M | 1 |
| Ishino, S; Kambara, N; Kanoi, T; Kataoka, K; Konishi, J; Motomura, H; Mukai, T; Nohara, R; Ogawa, M; Saito, K; Saji, H | 1 |
| Comans, EF; Golding, RP; Herder, GJ; Hoekstra, OS; Postmus, PE; Smit, EF; Teule, GJ | 1 |
| Brenner, W | 1 |
| Avril, N | 1 |
| André, B; Beckers, C; Foidart, J; Hustinx, R; Kaiser, MJ; Kaye, O; Malaise, MG; Marcelis, S; Mathy, L; Ribbens, C | 1 |
| Friberg, J; Långsjö, J; Minn, H; Någren, K; Nuutila, P; Roivainen, A; Salmi, J; Salonen, A; Välimäki, M; Viljanen, T | 1 |
| Bongaerts, F; Heeren, PA; Jager, PL; Plukker, JT; Sluiter, W; van Dullemen, H | 1 |
| Groen, HJ; Koëter, GH; Kramer, H; Pieterman, RM; Slebos, DJ; Timens, W; Vaalburg, W | 1 |
| Baek, HJ; Cheon, GJ; Cho, KJ; Choi, CW; Chung, JH; Lee, SS; Lim, SM; Park, JH | 1 |
| Aquino, SL; Fischman, AJ; Kwek, BH | 1 |
| Carreras, JL; de Juan, R; Lapeña, L; Montz, R; Peñas, JM; Ruiz-Hernández, G; Samanes, A; Verea, H; Veres, A | 1 |
| Aramburu, I; Brugère, S; Chamorro, H; Coll, C; González, P; Humeres, P; Jofré, MJ; Massardo, T; Sierralta, P; Yovanovich, J | 1 |
| Fujita, T; Higashi, T; Ishimori, T; Ishizu, K; Kato, H; Konishi, J; Mamede, M; Matsumoto, K; Mukai, T; Saga, T; Sato, S; Senda, M; Yamaoka, Y | 1 |
| Coebergh, JW; Hoekstra, OS; van de Poll-Franse, LV; van der Hoeven, JJ; van Oost, FJ; Voogd, AC | 1 |
| Vansteenkiste, JF | 3 |
| Boerdijk, SM; Paans, AM; Pruim, J; Willemsen, AT | 1 |
| Becherer, A; Dudczak, R; Kletter, K; Mitterhauser, M; Niederle, B; Pirich, C; Vierhapper, H; Wadsak, W; Zettinig, G | 1 |
| Underwood, SR | 1 |
| Brink, I; Hentschel, M; Hopt, UT; Imdahl, A; Kleimaier, M | 1 |
| Blumstein, NM; Dankerl, A; Glatting, G; Mottaghy, FM; Reske, SN | 1 |
| Bruschini, L; Bruschini, P; Cosottini, M; Fattori, B; Giorgetti, A; Mariani, G; Nacci, A; Ursino, F; Volterrani, D | 1 |
| Chang, WC; Hung, YC; Kao, CH; Lin, CC; Shen, YY | 1 |
| Hirahara, F; Inoue, T; Kawano, T; Lee, J; Miyagi, E; Nakagami, Y; Shimada, H; Suzuki, A; Takahashi, N; Togo, S | 1 |
| El-Sheemy, M; Eremin, JE; Eremin, O; Griffiths, PA; Jibril, JA; Marshall, C; Mustafa, S; Wheatley, DC | 1 |
| Asano, D; Iida, H; Ishino, S; Kudomi, N; Magata, Y; Mukai, T; Ogawa, M; Saji, H; Shiomi, M; Teramoto, N; Watabe, H | 1 |
| Carrasquillo, JA; Choyke, P; Finkelstein, SE; Galen, B; Hoffman, JM; Rosenberg, SA; Sherry, RM; White, DE | 1 |
| Amthauer, H; Felix, R; Oettle, H; Pelzer, U; Plotkin, M; Ruf, J; Scholman, HJ; Steinmüller, T; Wust, P | 1 |
| Ott, K; Schwaiger, M; Stahl, A; Weber, WA | 1 |
| Brink, I; Digel, W; Ghanem, N; Henke, M; Mix, M; Moser, E; Nitzsche, EU; Ruhland, S; Schumacher, T; Stoelben, E | 1 |
| Ampil, FL; Charrier, A; Connor, P; Ivy, JJ; Monsour, RP; Ramaswamy, MR; Unger, JB | 1 |
| Anaissie, EJ; Barlogie, B; Jones Jackson, LB; Miceli, MH; Talamo, G; Walker, RC | 1 |
| Chen, L; Ding, Y; Shao, M; Tian, J; Wei, B; Yao, S; Yin, D | 1 |
| Austin-Seymour, M; Bhattacharya, M; Ellis, G; Eubank, WB; Gralow, J; Linden, H; Lindsley, S; Livingston, R; Mankoff, D | 1 |
| Lenzo, NP; Moschilla, G; Patrikeos, A | 1 |
| Lalani, T; Schmidt, R; Takasugi, JE; Turcotte, E; Vallières, E; Vesselle, H; Wiens, L; Wood, DE | 1 |
| Oyen, WJ; Ruers, TJ; Wiering, B | 1 |
| Bai, B; Cherry, SR; Leahy, RM; Li, Q; Newport, DF; Siegel, S; Tai, YC; Yang, Y | 1 |
| Helmberger, T; Linke, R; Schroeder, M; Voltz, R | 1 |
| Choi, Y; Choi, YH; Han, KH; Kim, JS; Kim, KS; Kim, SJ; Lee, JD; Lee, JM; Lee, WJ; Lim, SM; Park, JH; Park, YN; Yang, WI; Yoo, N; Yun, M | 1 |
| Fukuchi, M; Kato, H; Kuwano, H; Manda, R; Miyazaki, T; Nakajima, M | 1 |
| de Groot, JW; Jager, PL; Kahraman, T; Links, TP; Plukker, JT | 1 |
| Amthauer, H; Boehmig, M; Felix, R; Hosten, N; Lemke, AJ; Niehues, SM; Rohlfing, T; Rosewicz, S; Stroszczynski, C | 1 |
| Brotchi, J; David, P; Goldman, S; Levivier, M; Massager, N; Pirotte, B; Salmon, I; Vandesteene, A; Wikler, D | 1 |
| Alavi, A; Chiang, S; Fuster, D; Johnson, G; Schuchter, LM; Zhuang, H | 1 |
| Bacharach, SL; Carrasquillo, JA; Carson, JM; Freedman, NM; Libutti, SK; Sellers, D; Sundaram, SK; Whatley, M | 1 |
| Guo, J; Higashi, K; Kodama, Y; Nagao, Y; Oguchi, M; Taki, S; Tonami, H; Ueda, Y; Yamamoto, I; Yokota, H | 1 |
| Adler, L; Bagheri, B; Cone, L; Doss, M; Maurer, AH | 1 |
| Backer, V; Eigtved, A; Enevoldsen, H; Friberg, L; Hansen, H; Mortensen, J; Nielsen, HW; Olesen, KP; Oturai, PS; Stentoft, P | 1 |
| Cook, M; Esaki, T; Green, MV; Ichise, M; Innis, RB; Liow, JS; Modell, KJ; Seidel, J; Sokoloff, L; Toyama, H; Vines, DC | 1 |
| Aro, HT; Jalava, J; Knuuti, J; Koort, JK; Mäkinen, TJ | 1 |
| Alavi, A; Kumar, R; Mitchell, S | 1 |
| Bormans, G; Ceyssens, S; de Groot, T; Flamen, P; Menten, J; Mortelmans, L; Van Calenbergh, F; Van Laere, K | 1 |
| Chung, JK; Im, SH; Jeong, JM; Jung, HW; Kim, DG; Kim, S; Lee, DS; Lee, MC | 1 |
| Bradley, JD; Dehdashti, F; Govindan, R; Mintun, MA; Siegel, BA; Trinkaus, K | 1 |
| Akhurst, T; Bains, MS; Downey, RJ; Gonen, M; Larson, S; Rusch, V; Vincent, A | 1 |
| Cody, HS; Port, ER | 1 |
| Chin, VT; Costello, SP; Court, FG; Kirkwood, ID; Maddern, GJ; Morrison, CP; Teague, BD | 1 |
| AL-Nahhas, A | 1 |
| Bares, R; Besenfelder, H; Bitzer, M; Dittmann, H; Eschmann, SM; Friedel, G; Horger, M; Paulsen, F; Pfannenberg, AC; Reimold, M | 1 |
| Ak, I; Ozalp, S; Vardareli, E; Yalçin, OT; Zor, E | 1 |
| Fukuda, H; Hosaka, K; Ishii, K; Kato, T; Sadato, N; Sakamoto, S; Senda, M; Sugimura, K | 1 |
| Baete, K; Ceyssens, S; De Ceuninck, L; Dupont, P; Gheysens, O; Kelles, A; Nuyts, J; Suetens, P; Van den Eynden, J; Van Laere, K; Van Paesschen, W | 1 |
| Conessa, C; Foehrenbach, H; Hervé, S; Poncet, JL | 1 |
| Dooms, C; Fischer, BM; Mortensen, J; Vansteenkiste, J | 1 |
| Bleeker-Rovers, CP; Corstens, FH; Oyen, WJ; Van Der Meer, JW | 1 |
| Burger, C; Dimitrakopoulou-Strauss, A; Irngartinger, G; Rudi, J; Rühl, A; Strauss, LG; Stremmel, W | 1 |
| Brenner, W; Conrad, EU; Eary, JF; Link, JM; Mankoff, DA; Muzi, M; Vernon, C | 1 |
| Chen, DL; Mintun, MA; Schuster, DP | 1 |
| Antoch, G; Bockisch, A; Ruehm, SG; Vogt, FM | 1 |
| Almog, B; Even-Sapir, E; Fishman, A; Grisaru, D; Lerman, H; Lessing, JB; Levine, C; Metser, U | 1 |
| Brotchi, J; David, P; Goldman, S; Levivier, M; Lipszyc, M; Massager, N; Pirotte, B; Salmon, I; Wikler, D | 1 |
| He, F; Wang, Y; Yu, F | 1 |
| Aquino, SL; Fischman, AJ | 1 |
| Bossuyt, PM; Groen, H; Plukker, JT; Pruim, J; Sloof, GW; van Lanschot, JJ; van Westreenen, HL; Westerterp, M | 1 |
| Alavi, A; Kung, J; Lee, BY; Liebeskind, DS; Newberg, AB | 1 |
| Goldsmith, SJ; Kostakoglu, LA; Palestro, CJ; Somrov, S | 1 |
| Ajani, JA; Correa, AM; Cox, JD; Erasmus, J; Hong, D; Komaki, RR; Lee, HK; Macapinlac, H; Maish, M; Putnam, JB; Rice, DC; Roth, JA; Smythe, WR; Swisher, SG; Thai, L; Vaporciyan, AA; Walsh, GL; Wu, TT | 1 |
| Burrell, SC; Case, MA; Haddad, RI; McCollum, AD; Norris, CM; Posner, MR; Tishler, RB; Van den Abbeele, AD | 1 |
| Beveridge, S; Constable, C; Eberl, S; Fulham, MJ; Henderson, D; Kassiou, M; Lo, SK; Mohamed, A; Zaman, A | 1 |
| Hisada, K; Kanayama, S; Matsudaira, M; Matsunari, I; Nakajima, K; Nekolla, SG; Taki, J; Tonami, N; Yoneyama, T | 2 |
| Corry, J; Hicks, RJ; Hogg, A; Matthews, JP; Peters, LJ; Porceddu, S; Rischin, D; Ware, RE | 1 |
| Endo, K; Higuchi, T; Kamada, H; Khan, N; Ninomiya, H; Oriuchi, N | 1 |
| Ametamey, SM; Buck, A; Gottschalk, J; Honer, M; Kaim, AH; Späth, N; von Schulthess, GK; Weber, B; Wyss, MT | 1 |
| Dence, CS; Gropler, RJ; Herrero, P; Sharp, TL; Welch, MJ | 1 |
| Choudhury, M; Harris, DN; Jones, HA | 1 |
| Ajani, JA; Bresalier, R; Correa, AM; Erasmus, JJ; Komaki, R; Macapinlac, H; Maish, M; Munden, RF; Putnam, JB; Rice, D; Roth, JA; Smythe, WR; Swisher, SG; Vaporciyan, AA; Walsh, GL; Wu, TT | 1 |
| Dudczak, R; Glogar, D; Graf, S; Gyöngyösi, M; Khorsand, A; Kletter, K; Nekolla, SG; Pirich, C; Porenta, G; Sochor, H | 1 |
| Bar-Shalom, R; Ben-Nun, A; Guralnik, L; Haim, N; Israel, O; Keidar, Z; Wollner, M | 1 |
| Chang, TC; Chang, YC; Chao, A; Fan, CC; Fu, YK; Hong, JH; Hsueh, S; Huang, KG; Lai, CH; Lin, CT; Lin, WJ; Ma, SY; Ng, KK; See, LC; Tang, SG; Tsai, CS; Yen, TC | 1 |
| Chan, SC; Chang, YC; Fu, YK; Joseph, CT; Ko, SF; Liao, CT; Lin, WJ; Ng, SH; Wang, HM; Yen, TC | 1 |
| Krohn, KA; Lewellen, B; Lewellen, TK; Link, JM; Mankoff, DA; Minoshima, S; Muzi, M; O'Sullivan, SF; Pham, P; Spence, AM; Swanson, K | 1 |
| Büll, U; Coenen, HH; Dimartino, E; Eble, MJ; Gagel, B; Hamacher, K; Maneschi, P; Pinkawa, M; Reinartz, P; Stanzel, S; Westhofen, M; Zimny, M | 1 |
| Marks, LB; Wong, TZ; Zhou, SM | 1 |
| Coppens, E; El Nakadi, I; Gay, F; Gelin, M; Goldman, S; Liberale, G; Nagy, N; Van Laethem, JL | 1 |
| Caracò, C; Klain, M; Mainolfi, C; Maurea, S; Salvatore, M | 1 |
| Naruke, T; Nomori, H; Ohtsuka, T; Uno, K; Watanabe, K | 1 |
| Gharib, AM; Li, KC; Thomasson, D | 1 |
| Antoch, G; Beyer, T; Bockisch, A; Dahmen, G; Debatin, JF; Freudenberg, LS; Kuehl, H; Mueller, SP; Saoudi, N | 1 |
| Endo, K; Hatori, T; Higuchi, K; Hoshizaki, H; Isobe, N; Kurabayashi, M; Oshima, S; Seki, H; Seki, R; Taniguchi, K; Toyama, T | 1 |
| Hara, M; Iida, A; Itoh, M; Nishio, M; Shibamoto, Y; Shiraki, N; Tamaki, T | 1 |
| Asaka, M; Nakada, K; Takei, T; Tamaki, N; Tsukamoto, E; Yamamoto, F; Zhao, S | 1 |
| Biersack, HJ; Jaeger, U; Palmedo, H; Reichmann, K; Reinhardt, MJ; Rödel, R; Straehler-Pohl, HJ | 1 |
| Rummeny, E; Schwaiger, M; Stollfuss, J; Wieder, H | 1 |
| Antoch, G; Beyer, T; Bockisch, A; Kühl, H; Müller, S; Pink, R; Rosenbaum, S; Veit, P | 1 |
| Steinert, HC | 1 |
| Koshy, M; Paulino, AC; Rusthoven, KE | 1 |
| Becker, CR; Hahn, K; Helmberger, T; Herzog, P; Reiser, MF; Scher, B | 1 |
| Choi, KM; Kim, EJ; Lee, BH; Na, DL; Park, KC | 1 |
| Weissberg, PL | 1 |
| Alavi, A; Dadparvar, S; Dhurairaj, T; Kumar, R; Mavi, A; Potenta, S; Xiu, Y; Yu, JQ; Zhuang, H | 1 |
| Fried, M; Kamel, EM; Padberg, B; Schiesser, M; Schneiter, D; Stoeckli, SJ; Stumpe, KD; Thumshirn, M; Truninger, K; von Schulthess, GK | 1 |
| Habedank, B; Heiss, WD; Herholz, K; Klein, JC; Lenox, M; Nutt, R; Wienhard, K | 1 |
| Daimaru, O; Ito, S; Nagata, T; Uchida, H; Yamane, T; Yoshiya, K | 1 |
| Choe, YS; Choi, JY; Choi, Y; Jang, HJ; Kim, BT; Kim, K; Lee, KH; Lee, KS; Shim, YM | 1 |
| Bhargava, KK; Krauss, ES; Love, C; Marwin, SE; Nichols, KJ; Palestro, CJ; Tomas, MB; Tronco, GG | 1 |
| Barker, D; Dworkin, HJ; Gates, V; Hill, EA; Lewandowski, R; Nagle, C; Qing, F; Salem, R; Wong, CY; Wong, KT | 1 |
| Bekkers, SC; Gorgels, AP; Smedema, JP; Snoep, G; van Kroonenburgh, MJ | 1 |
| Berchem, G; Decker, G; Lasar, Y; Pilloy, W; Snen, M | 1 |
| Haglund, U; Långström, B; Rasmussen, I; Sörensen, J | 1 |
| Babin, E; Bénateau, H; Béquignon, A; Chesnay, E; Comoz, F; Desmonts, C; Goullet de Rugy, M; Hamon, M | 1 |
| Hart, D; Karayalcin, G; Leonidas, JC; Nichols, K; Núñez, R; Palestro, CJ; Rini, JN; Tomas, MB; Tronco, GG | 1 |
| de Castro, S; Drenth, JP; Jansen, JB; Oyen, WJ; van Goor, H; van Kouwen, MC | 1 |
| Biran, T; Chisin, R; Malchi, S; Marciano, R; Weininger, J | 1 |
| Liow, JS; Strother, SC | 1 |
| Bandyopadhyay, D; Chaly, T; Dahl, R; Dhawan, V; Eidelberg, D; Margouleff, D; Robeson, W; Spetsieris, P; Takikawa, S; Zanzi, I | 1 |
| Bartolucci, AA; Bryant, AS; Cerfolio, RJ; Ohja, B; Winokur, TS | 1 |
| Antoch, G; Bockisch, A; Debatin, J; Egelhof, T; Fischer, M; Freudenberg, L; Goehde, S; Gutzeit, A; Hauth, E; Kühl, H | 1 |
| Kulasingam, SL; Matchar, DB; Orlando, LA | 1 |
| Clavien, PA; Hany, TF; Kadry, Z; McCormack, L; Selzner, M; Wildbrett, P | 1 |
| Amthauer, H; Felix, R; Hosten, N; Lemke, AJ; Niehues, SM; Rohlfing, T | 1 |
| Abe, K; Baba, S; Hayashi, K; Honda, H; Kaneko, K; Koga, H; Kuwabara, Y; Sasaki, M | 1 |
| Bruckner, JD; Conrad, EU; Eary, JF; Hawkins, DS; Rubin, BP; Schuetze, SM; Vernon, C | 1 |
| Dehdashti, F; Gibb, RK; Grigsby, PW; Herzog, TJ; Horowitz, NS; Mutch, DG; Powell, MA; Rader, JS; Siegel, BA | 1 |
| Färkkilä, MA; Knuuti, MJ; Luostarinen, ME; Minn, HR; Räsänen, JV; Salo, JA; Sihvo, EI; Viljanen, T | 1 |
| Endo, K; Hikima, A; Mochizuki, H; Morikawa, A; Oriuchi, N | 1 |
| De Wever, W; Ectors, N; Flamen, P; Haustermans, K; Hiele, M; Lerut, T; Van Cutsem, E; Vrieze, O | 1 |
| Cook, G; Flower, MA; Lee, YK; Rowbottom, C; Shahidi, M; Sharma, B; Webb, S | 1 |
| Buck, AK; Glatting, G; Halter, G; Hetzel, M; Kratochwil, C; Mattfeldt, T; Möller, P; Mottaghy, FM; Neumaier, B; Reske, SN; Schirrmeister, H; Wahl, A | 1 |
| Kula, Z; Pietrzak, T; Romanowicz, G; Szefer, J; Zuchora, Z | 1 |
| De Barsy, C; Depas, G; Dresse, MF; Fassotte, MF; Foidart, J; Hoyoux, C; Hustinx, R; Jerusalem, G; Paquet, N; Rigo, P | 1 |
| Hain, SF | 1 |
| Birim, O; Bogers, AJ; Kappetein, AP; Stijnen, T | 1 |
| Chierichetti, F; Decet, G; Liessi, G; Pasquali, C; Pedrazzoli, S; Sperti, C | 1 |
| Chan, SC; Chang, JT; Chang, YC; Fu, YK; Hsu, CH; Lin, KJ; Lin, WJ; Ng, SH; Yen, TC | 1 |
| Anzai, Y; Coltrera, MD; Eary, J; Ford, E; Haynor, D; Kinahan, P; Krohn, K; Laramore, GE; Leblanc, M; Lewellyn, B; Mattes, D; Meyer, J; Phillips, M; Rajendran, J; Schwartz, DL; Virgin, J; Yueh, B | 1 |
| Buatti, JM; Dornfeld, KJ; Funk, GF; Graham, MM; Hoffman, HT; Smith, RB; Yao, M | 1 |
| Brogsitter, C; Burchert, W; Grüning, T; Körfer, R; Lindner, O; Weise, R; Wielepp, P | 1 |
| Dodamane, I; Grewal, RK; Larson, SM; Salaun, PY; Strauss, HW; Yeung, HW | 1 |
| Even-Sapir, E; Kessler, A; Lerman, H; Lievshitz, G; Metser, U; Miller, E; Oren, R | 1 |
| Ishii, G; Murakami, K; Nagai, K; Niho, S; Nishimura, M; Nishiwaki, Y; Suzuki, K; Takamochi, K; Yoshida, J | 1 |
| Bomanji, J; Groves, AM; Kayani, I; Syed, R | 1 |
| Huisman, HJ; Jager, GJ; Karssemeijer, N; Oyen, WJ; van Dalen, JA; Vogel, W | 1 |
| Beal, KP; Yahalom, J; Yeung, HW | 1 |
| Baker, JA; Coleman, RE; Rosen, EL; Soo, MS; Turkington, TG | 1 |
| Deniaud-Alexandre, E; Lerouge, D; Moureau-Zabotto, L; Touboul, E | 1 |
| Aoki, T; Higashi, T; Hiraoka, M; Ishimori, T; Konishi, J; Mamede, M; Mukai, T; Nagata, Y; Nakamoto, Y; Negoro, Y; Saga, T | 1 |
| Junginger, T; Kneist, W | 1 |
| Barghouth, G; Dizendorf, E; Goerres, GW; Hany, TF; Leyvraz, S; Luthi, F; Pestalozzi, B; Schnyder, P; Stupp, R; von Schulthess, GK | 1 |
| Conrad, EU; Eary, JF; Morgan, HD; Schuetze, SM; Vernon, C | 1 |
| Chan, WS; Chu, SK; Coel, M; Tam, YM; Vernon, P; Wong, S; Yau, YY | 1 |
| Higashi, K; Higuchi, T; Hiramatsu, Y; Ishikawa, T; Ito, K; Kuga, G; Matsunari, I; Miura, K; Sakuma, T; Tonami, H; Yamamoto, I | 1 |
| Drenth, JP; Jansen, JB; Nagengast, FM; Oyen, WJ; van Kouwen, MC | 2 |
| Farag, I; Hain, SF; Jones, J; McGurk, M | 1 |
| Chang, TC; Chang, YC; Chou, HH; Hong, JH; Hsueh, S; Lai, CH; Ng, KK; See, LC; Tsai, CS; Yen, TC | 1 |
| Goldman, S; Levivier, M; Massager, N; Wikler, D | 1 |
| Bax, JJ; Boersma, E; Elhendy, A; Poldermans, D; van der Wall, EE | 1 |
| Ito, H; Kawata, T; Kazama, T; Minoshima, S; Motoori, K; Nakano, K; Okamoto, Y; Uchida, Y; Uno, T | 1 |
| Miyabe, K; Nishiyama, Y; Ogawa, T; Ohkawa, M; Satoh, K; Toyama, Y; Yamamoto, Y; Yokoe, K | 1 |
| Antoch, G; Bier, U; Freudenberg, L; Frings, M; Knorn, P; Maschke, M; Timmann, D | 1 |
| Melzer, RA; Müller-Brand, J; Nitzsche, EU; Schindler, C; Tyndall, A; Walter, MA | 1 |
| Cobben, DC; Elsinga, PH; Jager, PL; Plukker, JT; van Dullemen, HM; van Westreenen, HL; Wesseling, J | 1 |
| Chan, SC; Chang, JT; Chang, YC; Fu, YK; Lin, CY; Lin, KJ; Lin, WJ; Ng, SH; Yen, TC | 1 |
| Bianco, JA; Fine, JP; Jaskowiak, CJ; Perlman, SB | 1 |
| Antoch, G; Beyer, T; Bockisch, A; Stattaus, J | 1 |
| Bar-Shalom, R; Israel, O; Keidar, Z; Melamed, E; Militianu, D | 1 |
| Hung, GU; Lin, WY; Tsai, SC | 1 |
| Gambhir, SS; Quon, A | 1 |
| Amberger, CC; Bares, R; Brechtel, K; Dittmann, H; Kötter, I; Overkamp, D | 1 |
| Carlisle, M; Friedland, S; Kaltenbach, T; Segall, G; Soetikno, R; Taur, A | 1 |
| Divgi, C; Pandit-Taskar, N | 1 |
| Matsumoto, K; Minato, K; Sakamoto, S; Senda, M; Tarutani, K; Yamamoto, S | 1 |
| Gong, M; Li, CL; Lü, KJ; Wang, TY; Wei, B; Zou, LF | 1 |
| Bredella, MA; Caputo, G; Hawkins, R; Segall, G; Steinbach, L | 1 |
| Aramaki, T; Endo, M; Furukawa, H; Morimoto, N; Uchida, Y; Uematsu, T; Watanabe, J; Yuen, S; Yukisawa, S | 1 |
| Bares, R; Claussen, C; Claussen, CD; Dammann, F; Eschmann, S; Hoffman, J; Horger, M; Mueller-Berg, M; Schlemmer, H | 1 |
| Havrilesky, LJ; Kulasingam, SL; Matchar, DB; Myers, ER | 1 |
| Alcaide, AB; Bastarrika, G; Campo, A; Cano, D; Cosín, O; Domínguez, P; García-Velloso, MJ; Lozano, MD; Montes, U; Montuenga, L; Pueyo, J; Richter, JA; Seijo, L; Serra, P; Spiteri, N; Torre, W; Vivas, I; Zulueta, JJ | 1 |
| Boellaard, R; Hoekstra, CJ; Hoekstra, OS; Krak, NC; Lammertsma, AA; Twisk, JW | 1 |
| Buell, U; Cremerius, U; Hermanns, B; Mumme, T; Niethard, F-; Reinartz, P; Schaefer, WM; Wirtz, DC | 1 |
| Kida, T; Nakao, R; Suzuki, K | 1 |
| Blaufox, MD; Isasi, CR; Moadel, RM | 1 |
| Maes, A; Mortelmans, L; Moulin-Romsee, G; Silverman, D; Van Laere, K | 1 |
| Fee, WE; Le, QT; Pinto, HA; Ryan, WR | 1 |
| Amthauer, H; Denecke, T; Felix, R; Gutberlet, M; Hildebrandt, B; Hoffmann, KT; Hünerbein, M; Rau, B; Ruf, J; Wust, P | 1 |
| Allen-Auerbach, MS; Czernin, J; Fueger, BJ; Halpern, BS; Hecht, JR; Kim, JH; Phelps, ME; Ratib, O; Weber, WA | 1 |
| Auerbach, MA; Czernin, J; Dahlbom, M; Fueger, BJ; Halpern, BS; Ratib, O; Schiepers, C; Silverman, DH; Weber, WA | 1 |
| Brock, CS; Jones, T; Luthra, SK; Osman, S; Price, PM; Young, H | 1 |
| Fauser, S; Jarius, S; Schulze-Bonhage, A; Talazko, J; Vincent, A; Wagner, K; Ziyeh, S | 1 |
| Bax, JJ; de Boer, J; Jager, PL; Mook, PH; Oudkerk, M; Slart, RH; van der Wall, EE; van Veldhuisen, DJ; Willemsen, AT | 1 |
| Mistry, RC; Pramesh, CS | 1 |
| Altehoefer, C; Ghanem, N; Högerle, S; Kotter, E; Langer, M; Lohrmann, C; Nitzsche, E; Schäfer, O | 1 |
| Becherer, A; Bokemeyer, C; De Santis, M; Dittrich, C; Dohmen, BM; Dudczak, R; Karanikas, G; Kletter, K; Pont, J; Szabó, M | 1 |
| Cheng, EY; Cheson, BD; Guyton, KZ; Hoffman, JM; Johnson, B; Kelloff, GJ; Larson, SM; Mankoff, DA; O'shaughnessy, J; Scher, HI; Schilsky, RL; Shankar, L; Siegel, BA; Sigman, CC; Sullivan, DC | 1 |
| Bosonnet, L; Connor, S; Evans, J; Garvey, CJ; Ghaneh, P; Hughes, M; Jayan, R; Lytras, D; Neoptolemos, JP; Sutton, R; Vinjamuri, S | 1 |
| Bar-Shalom, R; Ben-Nun, A; Frenkel, A; Gaitini, D; Guralnik, L; Israel, O; Keidar, Z; Leiderman, M; Tsalic, M | 1 |
| Liu, Y; Xu, HF; Yuan, MH; Zhang, JH; Zhou, FH; Zhou, RS | 1 |
| Li, LY; Song, ZF; Wang, MZ; Zhu, ZH | 1 |
| Amthauer, H; Felix, R; Lopez Hänninen, E; Oettle, H; Pelzer, U; Plotkin, M; Ruf, J; Stroszczynski, C | 1 |
| Behari, J; Blodgett, TM; Federle, MP; Schoen, RE | 1 |
| Chen, J; Cheong, JH; Hyung, WJ; Kim, J; Lim, JS; Noh, SH; Yun, MJ | 1 |
| Blodgett, TM; Branstetter, BF; Johnson, JT; Meltzer, CC; Raman, S; Snyderman, CH; Zimmer, LA | 1 |
| Borgwardt, L; Carstensen, H; Højgaard, L; Laursen, H; Nowak, M; Schmiegelow, K; Thomsen, C | 1 |
| Akhurst, T; Chu, E; Ditullio, M; Heller, G; Kelly, WK; Larson, SM; Morris, MJ; Scher, HI; Schwartz, L; Siedlecki, K; Slovin, S; Verbel, D | 1 |
| Antoch, G; Bockisch, A; Forsting, M; Kuehl, H; Stergar, H; Veit, P | 1 |
| Bar-Shalom, R; Fischer, D; Frenkel, A; Israel, O; Kagana, O; Keidar, Z; Yefremov, N | 1 |
| Chen, TH; Hong, RL; Pan, MH; Tzen, KY; Yen, RF | 1 |
| Chan, SC; Chang, JT; Chang, YC; Chen, TM; Kang, CJ; Liao, CT; Lin, KJ; Ng, SH; See, LC; Wang, HM; Wu, YF; Yen, TC | 1 |
| Agostini, D; Bouvard, G; Halley, A; Hugentobler, A; Icard, P; Lerochais, JP; Porret, E; Sobrio, F; Zalcman, G | 1 |
| Bley, TA; Brink, I; Hoegerle, S; Klisch, J | 1 |
| Ahn, YC; Bae, DS; Choi, JY; Huh, SJ; Kim, BG; Kim, BH; Lee, J; Lim, DH; Park, W; Park, YJ | 1 |
| Bouman, CA; Kamasak, ME; Morris, ED; Sauer, K | 1 |
| Fanti, S; Nanni, C; Rampin, L; Rubello, D | 1 |
| De Iaco, P; Erba, P; Fanti, S; Farsad, M; Mariani, G; Nanni, C; Rampin, L; Rubello, D; Sansovini, M | 1 |
| Aquino, SL; Gilman, MD | 1 |
| Ng, DC; Ong, SC; Sundram, FX | 1 |
| Andreae, F; Angelberger, P; Dudczak, R; Leimer, M; Li, S; Rodrigues, M; Traub-Weidinger, T; Virgolini, I | 1 |
| Andersen, F; Berthelsen, AK; Holm, S; Højgaard, L; Klausen, TL; Loft, A | 1 |
| Graham, MM; Kubo, A; Nishitani, H; Otsuka, H | 1 |
| Choi, MY; Chung, JK; Jeong, JM; Kim, JH; Lee, DS; Lee, KM; Lee, MC; Park, JG | 1 |
| Endo, K; Higuchi, T; Kanuma, T; Khan, N; Oriuchi, N; Yoshizaki, A | 1 |
| Bax, JJ | 1 |
| Acker, MR; Burrell, SC | 1 |
| Chen, JL; Chen, ZJ; Gao, RL; He, ZX; Hu, FH; Shi, RF; Tian, YQ; Wang, YW; Yang, WX; Yang, YJ; Ye, L; You, SJ | 1 |
| Bomanji, JB; Croasdale, I; Dickson, JC; Ell, PJ; Groves, AM; Hain, SF; Kayani, I; Nagabushan, N; Syed, R; Townsend, C | 1 |
| Feldman, F; Parisien, M; Saxena, C; Van Heertum, R | 1 |
| Ball, DL; Hicks, RJ; Mac Manus, MP; Matthews, JP; Rischin, D; Wirth, A | 1 |
| Brink, I; Ghanem, N; Kelly, T; Langer, M; Moser, E; Schäfer, O; Uhl, M | 1 |
| Ahn, SD; Cho, KJ; Choi, EK; Kim, JH; Kim, SB; Lee, GH; Lee, SW; Park, SI; Ryu, JS; Shin, SS; Song, HY; Song, SY | 1 |
| Delbeke, D; Martin, WH; Roman, CD | 1 |
| Chen, TH; Hong, RL; Pan, MH; Ting, LL; Tzen, KY; Yen, RF | 1 |
| Blake, M; Fischman, AJ; Hahn, PF; Kadavigere, R; Kalva, SP; Sahani, DV; Saini, S | 1 |
| Coleman, JJ; Daggy, J; Davidson, D; Hutchins, G; Logan, T; Love, C; Schauwecker, D; Wagner, JD; Wenck, S | 1 |
| Ide, M; Yasuda, S | 1 |
| Maeda, M; Ozawa, T; Takekuma, M; Torizuka, T; Yasumi, K | 1 |
| Couch, ME; Shockley, WW; Shores, CG; Sutton, DK; Weissler, MC; Zanation, AM | 1 |
| Chan, SC; Chang, JT; Ko, SF; Liao, CT; Ng, SH; Wang, HM; Wong, HF; Yen, TC | 1 |
| Avril, N; Bader, M; Dose Schwarz, J; Hemminger, G; Jänicke, F; Jenicke, L | 1 |
| Biersack, HJ; Bucerius, J; Dumoulin, FL; Gerhardt, T; Jaeger, U; Reinhardt, MJ; Roedel, R; Sauerbruch, T; Strunk, H | 1 |
| Eberhard, S; Gönen, M; Herrmann, K; Hricak, H; Larson, SM; Scardino, P; Scher, HI; Schöder, H | 1 |
| Alinari, L; Baccarani, M; Battista, G; Boschi, S; Canini, R; Castellucci, P; Fanti, S; Farsad, M; Franchi, R; Marengo, M; Monetti, N; Nanni, C; Pettinato, C; Rampin, L; Rubello, D; Stefoni, V; Valentini, D; Zinzani, P | 1 |
| Aro, HT; Jalava, J; Lankinen, P; Mäkinen, TJ; Pöyhönen, T; Roivainen, A | 1 |
| Choi, JY; Chung, MJ; Han, J; Kim, BT; Kim, S; Kwon, OJ; Lee, EJ; Lee, KS; Shim, SS; Shim, YM | 1 |
| Akamoto, S; Izuishi, K; Maeta, H; Nishiyama, Y; Okano, K; Wakabayashi, H; Yachida, S | 1 |
| Arai, T; Ebata, T; Hiromatsu, T; Nagino, M; Nimura, Y; Nishio, H; Oda, K; Yokoyama, Y; Yuasa, N | 1 |
| Krabbe, PF; Oyen, WJ; van Dalen, JA; van den Hoogen, FJ; Vogel, WV; Wensing, BM | 1 |
| Garbow, JR; Laforest, R; Rowland, DJ; Snyder, AZ | 1 |
| Bauerfeind, P; Clavien, PA; Goerres, GW; Hany, TF; Heinrich, S; Pestalozzi, BC; Sagmeister, M; Schäfer, M; von Schulthess, GK | 1 |
| Bissé, E; Brink, I; Engelhardt, R; Epting, T; Yamada, K | 1 |
| Brink, I; Engelhardt, R; Yamada, K | 1 |
| Grosu, AL; Jeremic, B; Molls, M; Picchio, M; Piert, M; Schratzenstaller, U; Schwaiger, M; Weber, WA; Zimmermann, FB | 1 |
| Goshen, E; Oksman, Y; Rotenberg, G; Talmi, YP; Yahalom, R; Zwas, ST | 1 |
| Berkovic, SF; Berlangieri, SU; Byrne, AJ; Ollenberger, GP; Pathmaraj, K; Reutens, DC; Rowe, CC; Scheffer, IE; Scott, AM | 1 |
| Malde, S; Mody, RJ; Pohlen, JA; Shulkin, BL; Strouse, PJ | 1 |
| Bhatnagar, P; Bybel, B; Singh, AD | 1 |
| Dunphy, MP; Freiman, A; Larson, SM; Strauss, HW | 1 |
| Comans, EF; Jager, PL; Plukker, JT; Sloof, GW; van Dullemen, HM; van Lanschot, JJ; van Westreenen, HL; Westerterp, M; Wiggers, T | 1 |
| Hellwig, D; Kirsch, CM; Kremp, S; Nestle, U; Rübe, C; Schaefer-Schuler, A; Sebastian-Welsch, C | 1 |
| Baron, JC; Blaizot, X; Chavoix, C; Giffard, C; Insausti, R; Rauchs, G | 1 |
| Donald Blaufox, M; Isasi, CR; Khandani, AH | 1 |
| Ambrosini, V; Boschi, S; Castellucci, P; Fabbri, M; Fanti, S; Farsad, M; Franchi, R; Nanni, C; Rubello, D | 1 |
| Arslan, N; Dehdashti, F; Siegel, BA | 1 |
| Endo, K; Higuchi, T; Mogi, K; Nakajima, N; Nakasone, Y; Oriuchi, N; Takata, K; Tian, M; Zhang, H | 1 |
| Bipat, S; Bossuyt, PM; Comans, EF; Pijl, ME; Stoker, J; van Leeuwen, MS; Zwinderman, AH | 1 |
| Fischman, AJ; Hahn, PF; Kalva, SP; Mueller, P; Ryan, D; Sahani, DV; Saini, S | 1 |
| Fockens, P; Hoekstra, OS; Jager, PL; Plukker, JT; Reitsma, JB; Sloof, GW; Stoker, J; Van Eck-Smit, BL; van Lanschot, JJ; van Westreenen, HL; Westerterp, M | 1 |
| Beyer, T; Bockisch, A; Difilippo, FP; Kühl, H; Mawlawi, O; Müller, SP; Roberts, F; Rosenbaum, S; Schöder, H; Stattaus, J; Veit, P | 1 |
| Fogelman, I | 1 |
| Amir, R; Becker, S; Liehn, JC; Menéroux, B; Papathanassiou, D | 1 |
| García, JR; Lomeña, F; López, S; Pérez, G; Simó, M; Soler, M | 1 |
| Kubota, T; Nakai, T; Nishimura, T; Okuyama, C; Suzuki, T; Taniike, K; Ushijima, Y; Yamada, K | 1 |
| Bergmann, R; Pietzsch, J | 1 |
| Brokx, HA; Comans, EF; Herder, GJ; Hoekstra, OS; Pasic, A; Postmus, PE; Risse, EK; Sutedja, TG | 1 |
| Gildehaus, FJ; Goetz, C; Herms, J; Holtmannspötter, M; Koch, W; Kreth, FW; Pöpperl, G; Rachinger, W; Tatsch, K; Tonn, JC | 1 |
| Graham, MM; Menda, Y | 1 |
| Graeter, TP; Gröschel, A; Hellwig, AP; Hellwig, D; Kirsch, CM; Nestle, U; Schäfers, HJ; Sybrecht, GW | 1 |
| Czernin, J; Khatibi, B; Phelps, ME; Pio, BS; Silverman, DH; Tran, A | 1 |
| Dresel, S; Hahn, K; Herzog, P; Hungerhuber, E; Reiser, M; Scher, B; Schneede, P; Seitz, M; Tiling, R | 1 |
| Bonab, AA; Carter, EA; Dragotakes, SC; Mariani, G; Pellegrino, D; Pitman, JT | 1 |
| Goodchild, K; Hain, S; Lemon, C; Lodge, MA; Lowe, J; Sanghera, B; Saunders, M; Stott, D; Wong, WL | 1 |
| Monden, T; Nishiyama, Y; Ohkawa, M; Sasakawa, Y; Tsutsui, K; Wakabayashi, H; Yamamoto, Y | 1 |
| Coleman, M; Goldsmith, SJ; Kostakoglu, L; Leonard, JP | 1 |
| Bautz, W; Hornegger, J; Hothorn, T; Kuwert, T; Nömayr, A; Pfahlberg, A; Römer, W | 1 |
| Abe, K; Hayashi, K; Iwasaki, Y; Kosuda, S; Watanabe, S; Yano, F | 1 |
| Chang, TC; Chao, A; Chou, HH; Hsueh, S; Huang, HJ; Lai, CH; Ng, KK; Tsai, CS; Wu, TI; Yen, TC | 1 |
| Atkins, CD | 1 |
| Döbert, N; Engels, K; Grünwald, F; Hamscho, N; Kovács, AF; Menzel, C; Walendzik, H; Yuen Yuen, H | 1 |
| Artioli, D; Castellone, P; Cattaneo, M; Ceresoli, GL; Fazio, F; Gregorc, V; Landoni, C; Messa, C; Picchio, M; Rizzo, G | 1 |
| Hall, FM | 1 |
| Griffiths, MR; Keith, CJ; Miles, KA | 1 |
| Klinkenbijl, JH; Landheer, ML; Oyen, WJ; Steffens, MG; Westenberg, AH | 1 |
| Chugani, DC; Draghici, S; Janisse, J; Juhasz, C; Muzik, O; Pourabdollah, S | 1 |
| Lardinois, D; Moch, H; Roudas, M; Stahel, RA; Steinert, HC; Tutic, M; von Schulthess, GK; Weder, W | 1 |
| Blaufox, MD; Isasi, CR; Jana, S; Milstein, DM; Zhang, T | 1 |
| Sun, Y; Tian, J; Wang, K | 1 |
| Bong, JK; Cheong, JH; Cho, A; Hyung, WJ; Lee, JD; Lim, JS; Noh, SH; Yun, M | 1 |
| Alexopoulus, P; Drzezga, A; Grimmer, T; Kurz, A; Lautenschlager, N; Minoshima, S; Riemenschneider, M; Schwaiger, M; Siebner, H | 1 |
| Chen, WP; Matsunari, I; Minoshima, S; Nishimura, S; Noda, A; Takeda, N; Yajima, K; Yamada, M; Yanase, D | 1 |
| Fink-Bennett, D; Gaskill, M; Hill, J; Margolis, JH; Nagle, C; Parling-Lynch, KJ; Qing, F; Thie, J; Wong, CY; Zakalik, D | 1 |
| Chen, JC; Liu, RS; Su, KH; Wang, SJ; Wu, LC | 1 |
| Alterini, R; Bernardi, F; Bosi, A; Carpaneto, A; Carrai, V; Castagnoli, A; Dini, C; Matteini, M; Nassi, L; Pieroni, C; Rigacci, L | 1 |
| Arenas de Pablo, A; Calero-García, R; García de Barajas, S; García-Lujan, R; Lopez-Encuentra, A; Maldonado, A; Martín de Nicolás, JL; Martín-Escribano, P; Martín-García, I; Pozo, MA; Pozo-Rodríguez, F; Sánchez-Nistal, MA | 1 |
| Cook, G; Sharma, B; Wechalekar, K | 1 |
| Brada, M; Cook, G; Lavrenkov, K; Partridge, M | 1 |
| Baek, CH; Choi, JY; Kim, BT; Kwon, OJ; Lee, KH; Lee, KS; Park, K; Shim, YM | 1 |
| André, B; Beckers, C; Foidart, J; Hustinx, R; Jeukens, X; Kaiser, MJ; Leclercq, P; Malaise, MG; Marcelis, S; Ribbens, C | 1 |
| Fujino, K; Hatazawa, J; Higuchi, I; Kawamata, M; Kitamura, K; Murase, K; Nagayoshi, M; Nakamura, Y; Oku, N; Uenishi, Y | 1 |
| Monden, T; Nishiyama, Y; Ohkawa, M; Sasakawa, Y; Satoh, K; Tsutsui, K; Yamamoto, Y; Yokoe, K | 1 |
| Arzumanov, AA; Granov, AM; Karelin, MI; Kostenikov, NA; Ryzhkova, DV; Shkol'nik, MI; Stanzhevskiĭ, AA; Tlostanova, MS | 1 |
| Endo, K; Higuchi, T; Khan, N; Oriuchi, N | 1 |
| Cohade, C; Fishman, EK; Mourtzikos, KA; Tatsumi, M; Wahl, RL | 1 |
| Bakker, FC; Haarman, HJ; Patka, P; Raijmakers, PG; Scholten, HJ; Termaat, MF | 1 |
| Franc, BL; O'Conner, AR | 1 |
| Brouwer, J; Castelijns, JA; Comans, EF; de Bree, R; Golding, RP; Hoekstra, OS; Leemans, CR; Senft, A | 1 |
| Amit, A; Bar Shalom, R; Beck, D; Israel, O; Kedar, Z; Lavie, O; Lowenstein, L | 1 |
| Alavi, A; Chauhan, A; Kumar, R; Loving, VA; Mitchell, S; Zhuang, H | 1 |
| Bares, R; Budach, W; Dittmann, H; Eschmann, SM; Friedel, G; Hehr, T; Machulla, HJ; Paulsen, F; Reimold, M; Scheiderbauer, J; Vonthein, R | 1 |
| Ishii, K; Minoshima, S | 1 |
| Nobili, FM; Pupi, A | 1 |
| Drenth, JP; Friederich, P; Nagengast, FM; Oyen, WJ; van Goor, H; van Kouwen, MC; van Krieken, JH | 1 |
| Alifano, M; Bellenot, F; Grahek, D; Lemeunier, P; Magdeleinat, P; Molina, T; Perrotin, C; Petino, A; Regnard, JF; Talbot, JN | 1 |
| Gor, DM; Langer, JE; Loevner, LA | 1 |
| Smith, S; Williams, HT | 1 |
| Buda, A; Colombo, M; Fazio, F; Mangioni, C; Messa, C; Moreni, R; Pellegrino, A; Perego, P; Picchio, M; Sironi, S | 1 |
| Akhurst, T; Blumgart, L; Burt, BM; Fong, Y; Jarnagin, W; Kates, TJ; Larson, SM; Mazumdar, M; Riedel, ER; Yeung, H | 1 |
| Butrynski, JE; Conrad, EU; Eary, JF; Hawkins, DS; Rajendran, JG; Schuetze, SM; Vernon, CB | 1 |
| Jager, GJ; Krabbe, PF; Oyen, WJ; Ruers, TJ; Wiering, B | 1 |
| Bachaud, JM; Bègue, M; Caselles, O; Courbon, F; Dygai, I; Gancel, M; Hamelin, D; Laprie, A; Marre, D; Zerdoud, S | 1 |
| Bartenstein, P; Benz, P; Buchholz, HG; Helisch, A; Jeong, JH; Kunkel, M; Reichert, TE; Wagner, W; Whiteside, TL | 1 |
| Franc, BL; Johnson, D; Leong, SP; Mari, C | 1 |
| Gibbs, SD; Gill, SI; Hicks, RJ; Seymour, JF | 1 |
| Arveux, P; Bedenne, L; Bey, P; Bismuth, MJ; Conroy, T; Faivre, J; Guillemin, F; Lejeune, C; Zanni, C | 1 |
| de Langen, AJ; Hoekstra, OS; Paul, MA; Raijmakers, P; Riphagen, I | 1 |
| Alavi, A; Andreadis, C; Chiang, S; Fuster, D; Guan, L; Schuster, S; Zhuang, H | 1 |
| Brink, I; Györke, T; Lange, A; Makó, E; Moser, E; Schäfer, O; Zajic, T | 1 |
| Ayala, A; Carrasquillo, JA; Chen, CC; Del Corral, P; Ilias, I; Mamede, M; Pacak, K; Whatley, M | 1 |
| Aquino, SL; Fan, CM; Fischman, AJ; Halpern, EF; Kuester, LB | 1 |
| Ametamey, SM; Buck, A; Kaufmann, PA; Lacal, JC; Lohmann, C; Lüscher, TF; Matter, CM; Meier, P; Ramirez de Molina, A; Späth, N; von Lukowicz, T; von Schulthess, GK; Weber, B; Wyss, MT | 1 |
| Evenson, AR; Grant, F; Hasselgren, PO; Mitchell, JC; Parangi, S; Parker, JA | 1 |
| Aramaki, T; Furukawa, H; Ikuma, H; Seki, A; Yamagushi, S; Yokoe, K; Yuen, S | 1 |
| Abe, K; Baba, S; Hayashi, K; Honda, H; Koga, H; Kuwabara, Y; Sasaki, M; Takahashi, N | 1 |
| Drummond, EG; Duong, C; Hicks, RJ; Kalff, V; Matthews, JP | 1 |
| Badawi, RD; Dibos, PE; Gilbert, R; Line, BR; Lodge, MA | 1 |
| Avital, S; Even-Sapir, E; Lerman, H; Lievshitz, G; Metser, U; Miller, E | 1 |
| Beyer, T; Bockisch, A; Kühl, H; Martinez, MJ | 1 |
| Brenner, W; Buchert, R; Clausen, M; de Wit, M; Friedrich, RE; Gawad, KA; Hagel, C; Mautner, VF; von Deimling, A | 1 |
| Chang, CP; Chang, CW; Chu, LS; Chu, YK; Hsieh, HJ; Huang, MC; Liao, SQ; Liu, RS; Yang, BH; Yeh, SH; Yen, SH | 1 |
| Battenberg, TF; Buecker, A; Heussen, N; Katoh, M; Krombach, GA; Kühl, HP; Lipke, CS; Nowak, B; Schaefer, WM | 1 |
| Endo, K; Sato, J; Shinozaki, T; Suzuki, H; Suzuki, R; Takagishi, K; Watanabe, H; Yanagawa, T | 1 |
| Kawai, N; Miyake, K; Nagao, S; Nishiyama, Y; Tamiya, T | 1 |
| Graham, MM; Kogame, M; Nishitani, H; Otsuka, H | 1 |
| Binns, D; Conus, N; Cullinane, C; Dorow, DS; Hicks, RJ; McArthur, GA; McCarthy, TJ; Roselt, P | 1 |
| Cangini, D; Canini, R; Castellucci, P; Cavo, M; Fanti, S; Farsad, M; Nanni, C; Salizzoni, E; Tosi, P; Zamagni, E | 1 |
| Cannella, M; Ciarmiello, A; Frati, L; Lastoria, S; Rubinsztein, DC; Simonelli, M; Squitieri, F | 1 |
| Bauer, D; Coenen, HH; Flüss, MO; Hamacher, K; Langen, KJ; Pauleit, D; Risse, J; Stoffels, G; Zimmermann, A | 1 |
| Allen-Auerbach, M; Czernin, J; Park, J; Phelps, M; Yeom, K | 1 |
| Kitamura, K; Matsumoto, K; Mizuta, T; Murase, K; Senda, M; Shimizu, K | 1 |
| Feuerbach, S; Hamer, OW | 1 |
| Erturk, SM; Fujii, H; Ichikawa, T; Ros, PR; Yasuda, S | 1 |
| Campa, J; Finn, R; Forster, G; Humm, J; Larson, S; Ling, C; Polycarpe-Holman, D; Zanzonico, P | 1 |
| Alexoff, DL; Barbarich-Marsteller, NC; Dewey, SL; Fowler, JS; Marsteller, DA; Rubins, DJ; Schiffer, WK | 1 |
| Bar-Shalom, R; Daitzchman, M; Doweck, I; Golz, A; Gordin, A; Israel, O; Keidar, Z; Kuten, A; Yefremov, N | 1 |
| Azhari, H; Bar-Shalom, R; Frenkel, A; Israel, O; Kennedy, JA | 1 |
| Demitriou, H; Duong, CP; Hicks, RJ; Thomas, RJ; Thompson, A; Weih, L; Williams, D | 1 |
| Fukuda, T; Ishii, K; Kono, AK; Miyamoto, N; Mori, E; Sakamoto, S; Sasaki, H | 1 |
| Akhurst, T; Brady, MS; Gonen, M; Hilton, S; Larson, S; Patel, A; Spanknebel, K | 1 |
| Rankin, SC | 2 |
| Cameron, RB; Czernin, J; Fishbein, MC; Phelps, ME; Schiepers, C; Weber, WA; Yap, CS | 1 |
| Bradford, CR; Mukherji, SK | 1 |
| Choti, M; Frassica, D; Gearhart, SL; Rosen, R; Schulick, R; Wahl, R | 1 |
| Bax, JJ; Blanksma, PK; Hisada, K; Kanayama, S; Matsunari, I; Nekolla, SG; Tonami, N; Visser, FC; Yoneyama, T | 1 |
| Piehler, JM | 1 |
| Akhurst, T; Bains, MS; Downey, RJ; Gonen, M; Larson, S; Rizk, N; Rusch, V | 1 |
| Ibaraki, M; Kitamura, K; Miura, S; Okane, K; Satoh, T; Satomi, J; Shimosegawa, E; Sugawara, S; Takahashi, K; Toyoshima, H | 1 |
| Kim, CK; Kim, S; Krynyckyi, BR; Machac, J | 1 |
| Boethius, J; Ericson, K; Wang, SX | 1 |
| Blake, MA; Boland, GW; Fischman, AJ; Halpern, EF; Kalra, MK; Mueller, PR; Slattery, JM | 1 |
| Bieber, T; Biersack, HJ; Bucerius, J; Huber, A; Jaeger, U; Joe, AY; Matthies, A; Reinhardt, MJ; Roedel, R; Strunk, H; Tüting, T | 1 |
| Ben Taib, NO; Brotchi, J; David, P; Dewitte, O; Goldman, S; Lefranc, F; Levivier, M; Massager, N; Pirotte, B; Rorive, S; Wikler, D | 1 |
| Delank, KS; Dietlein, M; Eysel, P; Michael, JW; Schicha, H; Schmidt, M | 1 |
| Abe, S; Ikeda, M; Ishigaki, T; Kato, K; Kobayashi, H; Kubota, T; Nakano, S; Nishino, M; Tadokoro, M | 1 |
| Guo, J; Higashi, K; Katsuda, S; Oguchi, M; Sakuma, T; Takegami, T; Toga, H; Tonami, H; Ueda, Y; Yamamoto, I; Yokota, H | 1 |
| Hashimoto, Y; Kondo, C; Kusakabe, K; Maki, M; Momose, M; Nagai, A; Nishikawa, T; Ohnuki, T; Tsujikawa, T | 1 |
| Aschoff, P; Bares, R; Beyer, T; Brechtel, K; Claussen, CD; Eschmann, SM; Klein, M; Mueller, M; Pfannenberg, AC; Vogel, M | 1 |
| Aquino, SL; Fischman, AJ; Halpern, EF; Kuester, LB; Muse, VV | 1 |
| Bax, JJ; de Boer, J; Dierckx, RA; Irwan, R; Jager, PL; Slart, RH; Sluiter, WJ; van der Wall, EE; van Veldhuisen, DJ | 1 |
| Fukuda, K; Kaneda, T; Kubota, K | 1 |
| Drenth, JP; Laverman, P; Nagengast, FM; Oyen, WJ; van Kouwen, MC; van Krieken, JH | 1 |
| Aschoff, P; Bihl, H; Hagen, R; Schneider, K | 1 |
| Ishii, K; Kawachi, T; Matsuda, H; Mori, E; Mori, T; Sakamoto, S; Sasaki, M; Yamashita, F | 1 |
| Drummond, E; Duong, CP; Hicks, RJ; Leong, T; Michael, M; Thomas, RJ; Weih, L | 1 |
| Bisi, G; Deandreis, D; Douroukas, A; Mancini, M; Pelosi, E; Pennone, M | 1 |
| Ide, M | 1 |
| Gonen, M; Larson, S; Macapinlac, H; Santiago, JF; Yeung, H | 1 |
| Allouache, N; Andrieux, A; Bardet, S; Chajari, MH; Delozier, T; Gervais, R; Henry-Amar, M; Jacob, JH; Laurençon, V; Switsers, O | 1 |
| Dragoiescu, C; Duchateau, CS; Stokkel, MP | 1 |
| Boers, M; Comans, EF; Groen, HJ; Herder, GJ; Hoekstra, OS; Kramer, H; Paul, MA; Postmus, PE; Pruim, J; Smit, EF; Teule, GJ; Uyl-de Groot, CA; van Tinteren, H; Verboom, P; Welling, A | 1 |
| Arai, Y; Hasegawa, T; Moriyama, N; Seki, K; Tateishi, U; Terauchi, T | 1 |
| Dimitrakopoulou-Strauss, A; Eisenhut, M; Georgoulias, V; Haberkorn, U; Herth, F; Koukouraki, S; Mäcke, HR; Strauss, LG | 1 |
| Belohlavek, O; Jaruskova, M | 1 |
| Chung, HH; Kang, KW; Kim, JY; Kim, SK; Kim, TH; Lee, S; Park, SY | 1 |
| Hoekstra, OS; Hooft, L; Huijgens, PC; Lindauer-van der Werf, G; Riphagen, II; Zijlstra, JM | 1 |
| Lee, JD; Nakano, A; Okazawa, H; Shirasaki, H; Ueda, T; Uzui, H; Yonekura, Y | 1 |
| Blocklet, D; del Marmol, V; Dumarey, N; Egrise, D; Goldman, S; Jacobs, F; Remmelink, M; Stallenberg, B; Van Simaeys, G | 1 |
| Abreu, MC; Almeida, P; Balau, F; Ferreira, NC; Fetal, S; Fraga, F; Martins, M; Matela, N; Moura, R; Ortigão, C; Peralta, L; Rato, P; Ribeiro, R; Rodrigues, P; Santos, AI; Trindade, A; Varela, J | 1 |
| Boellaard, R; Börjesson, PK; Castelijns, JA; Comans, EF; de Bree, R; Jauw, YW; Kummer, JA; Lammertsma, AA; Leemans, CR; Roos, JC; van Dongen, GA; Vosjan, MJ | 1 |
| Fischer, BM; Højgaard, L; Klausen, TL; Kristjansen, PE; Ley, CD; Mortensen, J; Olsen, MW | 1 |
| Aschoff, P; Bihl, H; Hagen, R; Hrasky, A; Schneider, K | 1 |
| Inoue, K; Inoue, Y; Koyama, K; Matsuoka, T; Nakamura, K; Okamura, T; Okuma, T; Oyama, Y; Toyoshima, M; Yamamoto, A | 1 |
| Hosono, MN; Inoue, Y; Ishii, K; Kondo, S; Maeda, M; Okamura, T; Tada, T; Takada, Y; Wada, Y; Watanabe, Y | 1 |
| Chen, AY; Halkar, R; Hudgins, PA; Schuster, D; Vilaseca, I | 1 |
| De Oliveira, C; Mota, F | 1 |
| Alavi, A; Hernandez-Pampaloni, M; Takalkar, A; Yu, JQ; Zhuang, H | 1 |
| Chan, SC; Chang, JT; Chang, YC; Chen, YC; Hsu, CL; Liao, CT; Lin, CY; Ng, SH; Wang, HM; Yen, TC | 1 |
| Beorlegui, C; Cervera, M; García-Velloso, MJ; Gil-Rendo, A; Regueira, FM; Zornoza, G | 1 |
| Jonas, R; Koh, S; Mathern, GW; Salamon, N; Sankar, R; Shields, WD; Sutherling, WW; Wu, JY; Yudovin, S | 1 |
| Asselin, MC; Aston, JA; Hinz, R; Turkheimer, FE | 1 |
| Floeth, FW; Hamacher, K; Langen, KJ; Pauleit, D; Reifenberger, G; Rommel, F; Sabel, M; Stoffels, G; Stummer, W | 1 |
| Marres, HA; Merkx, MA; Oyen, WJ; Postema, EJ; van den Hoogen, FJ; Vogel, WV; Wensing, BM | 1 |
| Bourgain, C; Everaert, H; Lamote, J; Makkat, S; Sacré, R; Stadnik, TW | 1 |
| Maublant, J; Naalsund, A | 1 |
| Amanuma, M; Endo, K; Ida, I; Kumano, H; Matsuda, H; Mikuni, M; Oriuchi, N; Oshima, A; Takahashi, K; Yuuki, N | 1 |
| Greer, BE; Rajendran, JG | 1 |
| Dinh, M; Dinh, S; Guntinas-Lichius, O; Mueller, RP; Peter Klussmann, J; Schmidt, M; Semrau, R | 1 |
| Kanno, T; Maeda, M; Nakamura, F; Ogusu, T; Okada, H; Ouchi, Y; Takekuma, M; Torizuka, T; Yoshikawa, E | 1 |
| Carrerea, D; Ferran, N; Gámez, C; Guirao, S; Leon, AF; Lopez, M; Martin-Comin, J; Martinez-Ballarin, I; Ricart, Y; Roca, M | 1 |
| Corstens, FH; Huisman, H; Kaanders, JH; Oyen, WJ; Schinagl, DA; van Dalen, JA; Vogel, WV | 1 |
| Batra, K; Chhabra, A; Makler, PT | 1 |
| Higuchi, T; Izuta, M; Kato, Y; Kojima, R; Kurosaki, H; Maruno, H; Okazaki, A; Oriuchi, N; Tamaki, T; Uki, A | 1 |
| Bissoli, S; Chierichetti, F; Fiore, V; Liessi, G; Pasquali, C; Pedrazzoli, S; Sperti, C | 1 |
| Ali, A; Cyriac, J; Karam, M; Nazeer, T; Novak, L; Nugent, F | 1 |
| Ferrón-Orihuela, JA; Gómez-Río, M; Lardelli-Claret, P; Llamas-Elvira, JM; Medina-Benítez, A; Moral, JV; Ramia-Angel, JM; Ramos-Font, C; Rodríguez-Fernández, A | 1 |
| Hansen, M; Hutchings, M; Loft, A; Ralfkiaer, E; Specht, L | 1 |
| Bombardieri, E | 1 |
| Backhaus, B; Biersack, HJ; Jaeger, U; Matthies, A; Müller, SC; Palmedo, H; Reinhardt, M; von Mallek, D | 1 |
| Brkovich, VS; Hussey, DH; Karnad, AB; McGuff, HS; Miller, FR; Otto, RA | 1 |
| He, Z; Ke, Z; Liu, M; Liu, Y; Zhang, W; Zhang, Y | 1 |
| Chen, W; Cloughesy, T; Czernin, J; Delaloye, S; Kamdar, N; Pope, W; Satyamurthy, N; Schiepers, C; Silverman, DH | 1 |
| Corstens, FH; de Geus-Oei, LF; Koenders, EB; Krabbe, PF; Oyen, WJ; Pruim, J; van Hoorn, BA; Visser, EP; Willemsen, AT | 1 |
| Czernin, J; Fueger, BJ; Halpern, BS; Hildebrandt, I; Phelps, ME; Stout, D; Tran, C; Weber, WA | 1 |
| Andrade, RS; Avril, N; Branstetter, BF; Degirmenci, B; Ferris, RL; Filho, PA; Heron, DE; Seethala, RR | 1 |
| Boellaard, R; Crezee, H; Hoekstra, OS; Hulshof, MC; Omloo, JM; Sloof, GW; ten Kate, FJ; van Lanschot, JJ; Vervenne, WL; Westerterp, M | 1 |
| Aikou, T; Kijima, Y; Natsugoe, S; Owaki, T; Uenosono, Y; Yoshinaka, H; Yoshioka, T | 1 |
| Kohlfürst, S; Lind, P | 1 |
| Francken, AB; Fulham, MJ; Millward, MJ; Thompson, JF | 1 |
| Delbeke, D; Frangoul, HA; Kuttesch, JF; Martin, W; Rhodes, MM; Shankar, S; Whitlock, JA | 1 |
| Plukker, JT; Sloof, GW; Van Lanschot, JJ; Van Westreenen, HL; Westerterp, M | 1 |
| Chang, P; Sun, K; Sun, YE; Tian, JH; Wang, T; Wu, X; Yang, B; Yao, SL; Yu, CH | 1 |
| Bar-Shalom, R; Fogelman, I; Goldberg, A; Israel, O; Keidar, Z; Militianu, D; Nachtigal, A | 1 |
| Fartoux, L; Ganne, N; Grahek, D; Grange, JD; Gutman, F; Kerrou, K; Montravers, F; Poupon, R; Rosmorduc, O; Talbot, JN | 1 |
| Chak, A; Das, A | 1 |
| Bruecker, CW; Eckerle, S; Froehlich, A; Hakim, SG; Hermes, D; Jacobsen, HCh; Lauer, I; Sieg, P | 1 |
| Battmann, A; Bauhofer, A; Béhé, MP; Behr, TM; Beuter, D; Gotthardt, M; Oyen, WJ; Pollum, H; Schipper, M; Schurrat, T | 1 |
| Aflalo-Hazan, V; Frétault, J; Grahek, D; Gutman, F; Kerrou, K; Montravers, F; Raileanu, I; Talbot, JN | 1 |
| Berkhof, J; Buist, MR; Comans, EF; Hoekstra, OS; Hooft, L; Molthoff, CF; van der Veldt, AA; van Diest, PJ | 1 |
| Chang, TC; Hong, JH; Hsueh, S; Huang, HJ; Huang, KG; Lai, CH; Lin, WJ; Ma, SY; Ng, KK; Yen, TC | 1 |
| Higashi, Y; Ishii, K; Miyaishi, M; Mizutani, T; Sasaki, M; Tabata, M | 1 |
| Ak, I; Ozalp, S; Stokkel, MP; Vardareli, E; Yalçin, OT; Zor, E | 1 |
| Duerk, JL; Fei, B; Feyes, DK; Flask, C; Muzic, RF; Oleinick, NL; Wang, H; Wilson, DL | 1 |
| Alavi, A; Kumar, R; Xiu, Y; Zhuang, HM | 1 |
| Jhanwar, YS; Straus, DJ | 1 |
| Al-Nahhas, A; Fanti, S; Nanni, C; Rubello, D | 1 |
| Bares, R; Budach, W; Eschmann, SM; Friedel, G; Hehr, T; Kotzerke, J; Paulsen, F; Reimold, M; Scheiderbauer, J | 1 |
| Amthauer, H; Denecke, T; Furth, C; Henze, G; Lemke, AJ; Misch, D; Plotkin, M; Ruf, J; Steffen, I; Stöver, B; Voelker, T; Vondran, F | 1 |
| Fanti, S; Nanni, C; Rubello, D | 1 |
| Baek, CH; Baek, HJ; Choi, JY; Chung, JH; Jeong, HS; Kim, HJ; Ko, YH; Son, YI | 1 |
| Fujimoto, R; Fujita, T; Hara, T; Higashi, T; Ishizu, K; Kawase, S; Kawashima, H; Lyshchik, A; Nakamoto, Y; Saga, T; Togashi, K | 1 |
| Li, H; Wang, QS; Wang, XL; Zhang, XL | 1 |
| Alavi, A; Cermik, TF; Czerniecki, B; Houseni, M; Mavi, A; Schnall, M; Thiruvenkatasamy, D; Urhan, M; Yu, JQ; Zhuang, H | 1 |
| Chan, SC; Chang, JT; Fan, KH; Liao, CT; Lin, CY; Ng, SH; Wang, HM; Yen, TC | 1 |
| Hurtado-López, LM; Martínez-Duncker, C | 1 |
| Oyen, WJ; van Dalen, JA; Vogel, WV | 1 |
| Amthauer, H; Denecke, T; Gutberlet, M; Hänninen, EL; Hildebrandt, B; Langrehr, J; Miersch, A; Nicolaou, A; Plotkin, M; Ricke, J; Riess, H; Ruf, J; Rühl, R; Stroszczynski, C | 1 |
| Choi, JY; Kim, BT; Kim, H; Kim, J; Kim, S; Kwon, OJ; Lee, KS; Shim, SS; Shim, YM | 1 |
| Akhurst, T; Kijewski, P; Meirelles, GS | 1 |
| Chandra, PS; Huang, J; Koh, S; Mathern, GW; Salamon, N; Vinters, HV; Wu, JY | 1 |
| Waldron, JN | 1 |
| Chan, SC; Chang, JT; Kang, CJ; Ko, SF; Lee, LY; Liao, CT; Ng, SH; Wang, HM; Wong, AM; Yen, TC | 1 |
| Allen, C; Grimes, D; Sullivan, TJ; Valenzuela, AA; Wong, D | 1 |
| Sloof, GW | 1 |
| Pruim, J; Schot, BW; Sluiter, WJ; Vaalburg, W; van Imhoff, GW; Vellenga, E; Zijlstra, JM | 1 |
| Buchert, R; de Wit, M; Raabe, A; Seegers, B | 1 |
| Comans, EF; Hadithi, M; Mallant, M; Mulder, CJ; Oudejans, J; van Waesberghe, JH | 1 |
| Bodenstein, C; Czernin, J; Dubinett, S; Dumont, RA; Herschman, H; Phelps, ME; Seimbille, Y; Su, H; Weber, W | 1 |
| Abe, K; Honda, H; Kaneko, K; Koga, H; Mihara, F; Morioka, T; Ohya, N; Sasaki, M; Sawamoto, H; Yoshiura, T | 1 |
| Hany, TF; Schaefer, NG; Strobel, K; Taverna, C | 1 |
| Comans, EF; de Cock, CC; Knaapen, P; Lammertsma, AA; van Campen, CM; van der Weerdt, AP; Visser, CA; Visser, FC | 1 |
| Duffy, GJ; Gillham, CM; Hollywood, D; Keogan, M; Lucey, JA; Malik, V; Muldoon, C; O'byrne, K; Raouf, AA; Reynolds, JV | 1 |
| Boellaard, R; Hoekstra, O; Oyen, W; Paans, A; Pruim, J; Sloof, G; van Lanschot, J; Visser, E; Westerterp, M | 1 |
| Boisen, K; Bøtker, HE; Bøttcher, M; Hansen, SB; Madsen, MM; Nielsen, TT; Schmitz, O; Søndergaard, HM | 1 |
| Kaji, M; Naruke, T; Nomori, H; Ohtsuka, T; Suemasu, K; Uno, K; Watanabe, K | 1 |
| Chung, JH; Chung, JK; Eo, JS; Jang, SJ; Kim, SE; Lee, MC; Lee, WW; Park, SY; So, Y; Sung, SW | 1 |
| Chung, HH; Chung, JK; Jo, H; Kang, SB; Kang, WJ; Kim, JW; Lee, HP; Park, NH; Song, YS | 1 |
| Christensen, JA; Hartman, TE; Lowe, VJ; Mullan, BP; Nathan, MA; Swensen, SJ | 1 |
| Berthelsen, AK; Daugaard, G; Fischer, BM; Hansen, HH; Langer, SW; Lassen, U; Loft, A; Mortensen, J; Petersen, BI | 1 |
| Bar-Shalom, R; Ben-Haim, S; Guralnik, L; Israel, O; Radan, L | 1 |
| Juergens, KU; Kliesch, S; Stegger, L; Weckesser, M; Wormanns, D | 1 |
| Eubank, WB; Mankoff, DA | 1 |
| Danno, K; Fukunaga, H; Gu, J; Hatazawa, J; Ikeda, M; Monden, M; Nishimura, T; Sekimoto, M; Takemasa, I; Tatsumi, M; Yamamoto, H | 1 |
| Bury, T; Corhay, JL; Duysinx, BC; Hustinx, R; Larock, MP; Louis, R; Nguyen, D | 1 |
| Barberet, M; Deveze, A; Fakhry, N; Giovanni, A; Jacob, T; Mundler, O; Paris, J; Zanaret, M | 1 |
| Chung, HH; Chung, JK; Kang, SB; Kang, WJ; Kim, JW; Lee, HP; Park, NH; Song, YS | 1 |
| Gallowitsch, HJ; Gomez, I; Igerc, I; Kohlfuerst, S; Kresnik, E; Lind, P; Zoller, M | 1 |
| Bettinardi, V; Fazio, F; Galimberti, S; Landoni, C; Mangioni, C; Messa, C; Perego, P; Picchio, M; Signorelli, M; Sironi, S | 1 |
| Baek, CH; Jeong, HS; Ki Chung, M; Kim, BT; Kim, HJ; Kyung Lee, D; Son, YI; Young Choi, J | 1 |
| Choi, SH; Kim, JS; Kim, SY; Lee, JS; Nam, SY; Roh, JL; Ryu, CH | 1 |
| Choi, SH; Kim, JS; Kim, SB; Kim, SY; Lee, JC; Lee, JH; Lee, SW; Nam, SY | 1 |
| Kaanders, JH; Oyen, WJ; Schinagl, DA | 1 |
| Hicks, RJ; Lau, EW; Ware, RE | 1 |
| Corstens, FH; de Geus-Oei, LF; Leer, JW; Oyen, WJ; Punt, CJ; Ruers, TJ | 1 |
| Frizelle, FA; Lolohea, S; Robertson, GM; Watson, AJ | 1 |
| Gambhir, SS; Iagaru, A; McDougall, IR; Quon, A | 1 |
| Cheng, W; Cheng, X; Cui, R; Dang, Y; Fu, Z; Huo, L; Wang, B; Zhu, Z | 1 |
| Ding, HJ; Hsieh, TC; Kao, CH; Lin, CC; Lin, CY; Liu, CS; Sun, SS; Yen, KY | 1 |
| Weian, C; Xiangsong, Z | 1 |
| Deandreis, D; Pelosi, E | 1 |
| Canessa G, J; González E, P; Humeres A, P; Jofré M, MJ; Massardo V, T; Sierralta G, P | 1 |
| Dora, C; Eid, K; Hartmann, A; Stumpe, KDM; Trentz, O; von Schulthess, GK | 1 |
| García-Garzón, JR; Lomeña, F; López-Gandul, S; Pérez-Moure, G; Simó-Perdigó, M; Soler-Peter, M | 1 |
| Brenner, W; Buchert, R; Clausen, M; Schulte, U; von Borczyskowski, D | 1 |
| Ambrosini, V; Castellucci, P; Di Leo, K; Fanti, S; Farsad, M; Franchi, R; Nanni, C; Pession, A; Pettinato, C; Rubello, D; Spinelli, A; Tonelli, R; Trespidi, S | 1 |
| Berrettini, A; De Cicco, C; Fernandez, JR; Galimberti, VE; Intra, M; Luini, A; Paganelli, G; Rotmensz, N; Spano, G; Veronesi, P; Veronesi, U; Viale, G | 1 |
| de Clermont, H; Dilhuydy, MS; Durieux, A; Monteil, J; Pariente, A; Pasticier, G; Ravaud, A | 1 |
| Billotey, C; Broussolle, C; Dumontet, C; Mackey, JR; Sève, P | 1 |
| Hicks, RJ | 1 |
| Aide, N; Bardet, S; Cheze, S; Fruchart, C; Le Stang, N; Leporrier, M; Levaltier, X; Liegard, M; Macro, M; Musafiri, D; Peny, AM; Reman, O; Switsers, O | 1 |
| Ambrosini, V; Battista, G; Canini, R; Castellucci, P; Fanti, S; Farsad, M; Fiorentini, G; Franchi, R; Moretti, A; Nanni, C; Rampin, L; Rubello, D | 1 |
| Alvarez Pérez, RM; Borrego Dorado, I; López Martín, J; Vázquez Albertino, R | 1 |
| Zaret, BL | 1 |
| Ben-Haim, S; Frenkel, A; Israel, O; Kupzov, E; Tamir, A | 1 |
| Bacharach, SL; Carrasquillo, JA; Dieckmann, W; Le Meunier, L; Maass-Moreno, R | 1 |
| Allen, PJ; Brennan, MF; D'Angelica, M; Fong, Y; Larson, SM; Mansour, JC; Pandit-Taskar, N; Schwartz, L | 1 |
| Higashi, T; Nakamoto, Y; Okada, T; Saga, T; Sakamoto, S; Senda, M; Togashi, K | 1 |
| Clément, P; Conessa, C; Foehrenbach, H; Poncet, JL | 1 |
| Meller, J; Sahlmann, CO; Scheel, AK | 1 |
| Jones, RJ; Kasamon, YL; Wahl, RL | 1 |
| Israel, O; Kuten, A | 1 |
| Figlin, R; Weber, WA | 1 |
| Nieweg, O; Valdés Olmos, R | 1 |
| Cho, KJ; Choi, SH; Kim, JS; Kim, SY; Lee, JH; Nam, SY; Roh, JL; Yeo, NK | 1 |
| Allen, MS; Aubry, MC; Daniels, CE; Jett, JR; Lowe, VJ | 1 |
| Grabiec, M; Nowicki, P; Walentowicz, M | 1 |
| Gulec, SA | 2 |
| Allen-Auerbach, M; Czernin, J; Fueger, BJ; Halpern, BS; Lufkin, RB; Yeom, K | 1 |
| Duet, M; Faraggi, M; Lioté, F; Pouchot, J | 1 |
| Cabrera Martín, MN; Calvo Manuel, F; Carreras Delgado, JL; Delgado Bolton, RC; Pasamontes Pingarrón, JA; Scola Yurrita, B | 1 |
| Grewal, RK; Klem, ML; Meyers, PA; Schöder, H; Wexler, LH; Wolden, SL | 1 |
| de Toledo, JS; Roca, I; Sábado, C; Simó, M | 1 |
| Ladenson, PW; Leboulleux, S; Schlumberger, M; Schroeder, PR | 1 |
| Blackstone, EH; Lauer, MS; Murthy, SC; Okereke, IC; Rice, TW | 1 |
| Chen, LB; Jin, ZY; Kong, LY; Miao, Q; Sun, HY; Wang, YN; Zhang, H; Zhang, ZH; Zhou, L | 1 |
| Gong, M; Li, CL; Yang, JG; Zou, LF | 1 |
| Avril, N; Brock, C; Murray, I; Oliver, T; Powles, T | 1 |
| Bova, D; Emami, B; Halama, J; Hong, R; Sethi, A | 1 |
| Camici, PG; John, AS; Leccisotti, L; Mongillo, M; Pennell, DJ | 1 |
| Blumstein, NM; Buck, AK; Glatting, G; Mottaghy, FM; Neumaier, B; Ozdemir, C; Reske, SN; Scharffetter-Kochanek, K; Schubert, R; Sunderkötter, C; Wohlfart, P | 1 |
| Ammann, RW; Clavien, PA; Deplazes, P; Grimm, F; Kadry, Z; Kuenzle, AK; Muellhaupt, B; Renner, EL; Renner-Schneiter, EC; Stumpe, KD; von Schulthess, GK | 1 |
| Bloch, I; Camara, O; Colliot, O; Delso, G; Moreno-Ingelmo, A | 1 |
| Dijkstra, PU; Gravendeel, JP; Krabbe, CA; Pruim, J; Roodenburg, JL; van der Laan, BF; van der Wal, JE | 1 |
| Adam, MJ; Adomat, H; Dragowska, WH; Fadzli, L; Fazli, L; Gleave, M; Green, D; Kartono, A; Koch, CJ; Oliver, T; Ruth, T; Skov, KA; Sy, J; Woo, J; Yapp, DT | 1 |
| Choi, JY; Chung, MJ; Kim, BT; Kim, H; Kim, HY; Kim, YK; Kwon, OJ; Lee, KS; Shim, YM; Yi, CA | 1 |
| Balfe, DM; Ballman, KV; Cerfolio, RJ; Decker, PA; Dehdashti, F; Downey, RJ; Keenan, RJ; Landreneau, RJ; Meyers, BF; Putnam, JB; Reed, CE; Rusch, VW; Siegel, BA | 1 |
| Hirai, T; Katsuragawa, S; Murakami, D; Murakami, R; Nishimura, R; Ota, K; Oya, N; Shiraishi, S; Tomiguchi, S; Uozumi, H; Yamashita, Y | 1 |
| Alavi, A; Basu, S; Iruvuri, S; Mahne, A | 1 |
| Conry, J; Fazilat, S; Gaillard, WD; Pearl, PL; Reeves-Tyer, P; Theodore, WH; Vezina, LG; Weinstein, S | 1 |
| Aide, N; Bardet, S; Delozier, T; Hardouin, A; Heutte, N; Huchet, V; Switsers, O | 1 |
| Coakley, FV; Falk, MS; Franc, B; Hawkins, RA; Kashani-Sabet, M; Truitt, AK | 1 |
| Wooldridge, JE | 1 |
| Baudard, M; Comte, F; Conge, AM; Klein, B; Mariano-Goulart, D; Rossi, JF | 1 |
| Dezortova, M; Hajek, M; Jiru, F; Komarek, V; Krsek, P; Kyncl, M; Marusic, P; Skoch, A; Tichy, M; Zamecnik, J | 1 |
| Choi, SH; Kim, JS; Kim, MR; Kim, SY; Nam, SY; Roh, JL | 1 |
| Drobik, P; Junik, R; Kobus-Błachnio, K; Małkowski, B | 1 |
| Antonelli, L; D'Urso, S; Nicolì, P; Orlacchio, A; Schillaci, O; Sergiacomi, G; Simonetti, G | 1 |
| Anniko, M; Blomquist, E; Ekberg, T; Engström, M; Sörensen, J; Sundin, A | 1 |
| Atsma, DE; Bartunek, J; Bax, JJ; Beeres, SL; Bengel, FM; Hill, JM; Penicka, M; Schalij, MJ; Vanderheyden, M; Wijns, W | 1 |
| Brown, RK; Caoili, EM; Korobkin, M; Mackie, G; Shulkin, BL | 1 |
| Breen, SL; Brock, K; Cummings, B; Dawson, L; De Silva, S; Hendler, A; Keller, A; Kim, J; O'Sullivan, B; Pond, G; Publicover, J; Ringash, J; Waldron, J; Yu, E | 1 |
| Brown, R; Feiglin, D; Hsu, J; Koniarczyk, M; Newman, N; Pohar, S | 1 |
| Enomoto, K; Hamada, K; Hatazawa, J; Higuchi, I; Kakunaga, S; Myoui, A; Tomita, Y; Ueda, T; Yoshikawa, H | 1 |
| Cho, KJ; Choi, SH; Kim, JS; Kim, MR; Kim, SY; Lee, JH; Nam, SY; Roh, JL | 1 |
| Bentzen, SM; Boersma, L; Bosmans, G; Buijsen, J; De Ruysscher, D; Dehing-Oberije, C; Dekker, A; Hochstenbag, M; Houben, R; Lambin, P; van Baardwijk, A; van Kroonenburgh, M; van Suylen, RJ; Wanders, S | 1 |
| Doddamane, I; Gönen, M; Larson, SM; Ong, SC; Patel, SG; Schöder, H; Shah, JP; Shaha, AR; Tabangay-Lim, IM; Tuttle, RM | 1 |
| Deans, AE; Kitazono, MT; Kramer, EL; Maguire, GQ; Moy, L; Murphy-Walcott, AD; Noz, ME; Ponzo, F; Travascio, L | 1 |
| Baandrup, U; Madsen, HH; Palshof, T; Pedersen, U; Pilegaard, HK; Rasmussen, F; Rasmussen, K; Rasmussen, TR; Rehling, M | 1 |
| Fujisaka, M; Fukuoka, J; Ishida, M; Kawano, M; Nishida, H; Shimizu, M; Shojaku, H; Tsubota, M; Watanabe, Y; Yasumura, S | 1 |
| Acikgoz, G; Alavi, A; Cermik, TF; Dadparvar, S; Houseni, M; Mavi, A | 1 |
| Kirby, AM; Mikhaeel, NG | 1 |
| George Mikhaeel, N; Kirby, AM | 1 |
| Alberini, JL; Banal, A; Gontier, E; Le Stanc, E; Pecking, AP; Tainturier, C; Vilain, D; Wartski, M | 1 |
| Bogsrud, TV; Collins, DA; Hay, ID; Karantanis, D; Kasperbauer, JL; Lowe, VJ; Mullan, BP; Nathan, MA; Reading, CC; Strome, SE; Wiseman, GA | 1 |
| Aratake, M; Inoue, T; Oka, T; Saitou, T; Takahashi, A; Takahashi, N; Tayama, Y | 1 |
| Hatazawa, J; Hori, M; Kajimoto, K; Kanai, Y; Kato, H; Kimura, Y; Kitagawa, K; Maruno, M; Oku, N; Tanaka, MR; Yoshimine, T | 1 |
| Arai, K; Endo, K; Hanaoka, H; Higuchi, T; Iida, Y; Ishikita, T; Koyama, K; Miyakubo, M; Mogi, K; Nakasone, Y; Negishi, A; Oriuchi, N; Paudyal, B; Tsushima, Y | 1 |
| Herbertson, RA; Lee, ST; Scott, AM; Tebbutt, N | 1 |
| Beuthien-Baumann, B; Bredow, J; Kotzerke, J; Strumpf, A; Zessin, J | 1 |
| Ben-Haim, M; Even-Sapir, E; Figer, A; Geva, R; Klausner, JM; Lubezky, N; Metser, U; Nakache, R; Shmueli, E | 1 |
| Blankenberg, FG; Inubushi, M; Kuge, Y; Morita, K; Strauss, HW; Tamaki, N; Zhao, S; Zhao, Y | 1 |
| Barber, DC; Conway, J; Dyker, KE; Hanney, MB; Hoggard, N; Ireland, RH; Robinson, MH; Tindale, WB; Wood, SM; Woodhouse, N | 1 |
| Berthelsen, AK; Hillingsoe, J; Kirkegaard, P; Larsen, PN; Loft, A; Mogensen, AM; Rappeport, ED; Rasmussen, A; Thomsen, C; von der Recke, P; Wettergren, A | 1 |
| Alavi, A; Basu, S; Chryssikos, T; Houseni, M; Scot Malay, D; Shah, J; Zhuang, H | 1 |
| Dicken, V; Hoffmann, AL; Karssemeijer, N; Oyen, WJ; Ruers, TJ; van Dalen, JA; Vogel, WV; Wiering, B | 1 |
| Benjamin, RS; Burgess, MA; Charnsangavej, C; Chen, LL; Choi, H; Faria, SC; Macapinlac, HA; Patel, SR; Podoloff, DA | 1 |
| Hanna, WT; Hubner, KF; Long, MJ; Nahmias, C; Townsend, DW; Wahl, LM | 1 |
| Albertotti, C; Anjos, DA; Camargo, EE; Etchebehere, EC; Ramos, CD; Santos, AO | 1 |
| Bundschuh, RA; Essler, M; Martínez, MJ; Martínez-Moeller, A; Nekolla, SG; Schwaiger, M; Ziegler, SI | 1 |
| Akhurst, T; Bhargava, A; Fong, Y; Hricak, H; Klimstra, D; Larson, S; Riedl, CC; Stanziale, SF; Tuorto, S | 1 |
| Czernin, J; Dahlbom, M; de Aburto, MA; Huang, LL; Lin, TW; Marvi, MM; Phelps, ME; Silverman, DH; Tang, M | 1 |
| Cho, KJ; Choi, SH; Kim, JS; Kim, SY; Lee, JH; Nam, SY; Roh, JL; Ryu, CH | 1 |
| Armbruster, C; Feichtinger, H; Gschwantler, M; Kriwanek, S; Kroiss, A; Moeschl, P; Plattner, D; Roka, R; Schueller, J; Singer, E; Weiss, W | 1 |
| Asenbaum, S; Becherer, A; Dudczak, R; Karanikas, G; Kletter, K; Marosi, C; Pötzi, C; Szabo, M | 1 |
| Coleman, RE; Hawk, TC; Turkington, TG; Wong, TZ; Yamamoto, Y | 1 |
| Agrawal, A; Jaiswar, R; Nair, N | 1 |
| Banti, E; Capirci, C; Crepaldi, G; Erba, PA; Fanti, S; Galeotti, F; Gava, M; Mariani, G; Muzzio, PC; Rampin, L; Rubello, D | 1 |
| Bairey, O; Shpilberg, O | 1 |
| Aupérin, A; Avril, MF; Boitier, F; Cavalcanti, A; Kolb, F; Leboulleux, S; Lumbroso, J; Mamelle, G; Masson, F; Maubec, E; Spatz, A; Suciu, V | 1 |
| Buccheri, V; Cerci, JJ; Chaves, AA; Meneghetti, JC; Pracchia, LF; Soares Junior, J | 1 |
| Schöder, H; Smith, CS; Yeung, HW | 1 |
| Adelstein, DJ; Carroll, MA; Esclamado, RM; Lorenz, RR; Rybicki, LA; Saxton, JP; Strome, M; Tan, A; Wood, BG | 1 |
| Abdel-Dayem, H; Altinyay, ME; Castellon, I; Heiba, S; Libes, R; Piperkova, E; Raphael, B; Sandella, N | 1 |
| Alavi, A; Basu, S | 1 |
| Barbet, J; Bodet-Milin, C; Carlier, T; Curtet, C; Kraeber-Bodéré, F; Mirallié, E; Rousseau, C | 1 |
| Fleischer, AC; Hallahan, DE; Huamani, J; Kim, DW; Niermann, KJ; Wilson, WD; Yankeelov, TE | 1 |
| Bandoh, S; Chang, SS; Haba, R; Ishikawa, S; Kanaji, N; Kushida, Y; Nakano, J; Nishiyama, Y; Ohkawa, M; Yamamoto, Y | 1 |
| Huang, LL; Liang, TJ; Nie, YX; Qin, SL; Wang, Q; Wang, Y; Yue, MG; Zhang, CQ; Zhao, YM | 1 |
| Antoch, G; Beyer, T; Bockisch, A; Hauth, EA; Schleucher, R; Stergar, H; Veit-Haibach, P | 1 |
| Al-Nahhas, A; Alavi, A; Ambrosini, V; Fanti, S; Franchi, R; Nanni, C; Pettinato, C; Rubello, D; Spinelli, A; Trespidi, S | 1 |
| Fazio, F; Giovacchini, G; Grimaldi, A; Mansueto, M; Messa, C; Pepe, G; Torbica, A | 1 |
| Belohlavek, O; Fencl, P; Jaruskova, M; Kantorova, I; Simonova, K; Skopalova, M | 1 |
| Kim, EE; Ng, CS; Tamm, EP | 1 |
| Buatti, JM; Chang, K; Graham, MM; Hoffman, HT; Luo, P; Menda, Y; Tan, H; Yao, M | 1 |
| Bloomston, M; Hall, NC; Knopp, MV; Martin, EW; Povoski, SP; Sarikaya, I; Zhang, J | 1 |
| Balink, H; de Visscher, JG; Krabbe, CA | 1 |
| Arnould, L; Berriolo-Riedinger, A; Boichot, C; Brunotte, F; Cochet, A; Coudert, B; Fumoleau, P; Riedinger, JM; Toubeau, M; Touzery, C | 1 |
| Hany, TF; Kurrer, M; Schaefer, NG; Strobel, K; Taverna, C; Wastl, C | 1 |
| Endo, K; Handa, H; Hasegawa, M; Kojima, M; Matsushima, T; Murakami, H; Oriuchi, N; Saitoh, T; Tsukamoto, N; Yokohama, A | 1 |
| Carne, RP; Cook, MJ; Hicks, RJ; Kilpatrick, CJ; Litewka, L; Macgregor, LR; O'Brien, TJ | 1 |
| Abenhardt, W | 1 |
| Bar-Shalom, R; Daitzchman, M; Golz, A; Gordin, A; Israel, O; Keidar, Z | 1 |
| Agrawal, A; Daly, BT; Fleming, AJ; Hall, NC; Paul, CM; Schuller, DE; Smith, SP | 1 |
| Jennings, SG; McHenry, L; Sandrasegaran, K; Schmidt, CM; Skandarajah, A; Tann, M | 1 |
| Al-Nahhas, A; Castellucci, P; Fanti, S; Farsad, M; Fazio, F; Ghi, T; Meriggiola, MC; Messa, C; Nanni, C; Pelusi, G; Perrone, AM; Picchio, M; Rubello, D | 1 |
| Baek, CH; Choi, JY; Chung, MK; Jeong, HS; Kim, HJ; Ko, YH; Son, YI | 1 |
| Fu, Z; Guo, H; Huang, Y; Li, L; Xi, Y; Yang, G; Yu, J; Yuan, S; Zhang, B; Zhang, J; Zhu, H | 1 |
| Fletcher, PT; Foster, NL; Joshi, SC; Powell, S | 1 |
| Daugaard, G; Hain, SF; Harland, SJ; Huddart, RA; Joffe, JK; Kirk, SJ; Logue, J; MacKewn, JE; Mead, GM; O'Doherty, MJ; Padhani, A; Rustin, GJ; Stenning, SP; Vasey, P | 1 |
| Chetty, IJ; Eisbruch, A; Frey, KA; Hayman, JA; Kessler, M; Kong, FM; Lawrence, TS; Normolle, D; Quint, LE; Ten Haken, RK | 1 |
| Abgral, R; Bizais, Y; Couturier, O; Kraeber-Bodéré, F; Querellou, S; Salaun, PY; Valette, G | 1 |
| Dummer, R; Hany, TF; Husarik, DB; Pérez Lago, M; Steinert, HC; Strobel, K | 1 |
| Li, JG; Li, YM; Zhao, TT | 1 |
| Fu, Z; Guo, HB; Li, WW; Liu, TH; Yang, GR; Yang, XH; Yu, JM; Yu, YH; Yuan, SH | 1 |
| Aupérin, A; Bonniaud, G; Bosq, J; Couanet, D; Edeline, V; Fermé, C; Leboulleux, S; Lumbroso, J; Masson, F; Pigneur, F; Ribrag, V; Schlumberger, M; Vanel, D | 1 |
| Bazzi, L; Bellomi, M; Paganelli, G; Radice, D; Rizzo, S; Travaini, LL; Trifirò, G; Zampino, MG | 1 |
| Bley, TA; Frydrychowicz, A; Langer, M; Markl, M; Uhl, M | 1 |
| Bairey, O; Herishanu, Y; Metzer, U; Naparstek, E; Perry, C; Polliack, A; Ruchlemer, R; Sapir, EE; Trejo, L | 1 |
| Houwerzijl, EJ; Koopmans, KP; van Assen, S; van den Dungen, JJ | 1 |
| Dilege, S; Ece, T; Erelel, M; Halac, M; Mudun, A; Sonmezoglu, K; Toker, A; Turkmen, C; Yilmazbayhan, D | 1 |
| Al-Sarraf, N; Aziz, R; Doddakula, K; Gately, K; McGovern, E; Wilson, L; Young, V | 1 |
| Comans, EF; Craanen, ME; Paul, MA; Smit, EF | 1 |
| Becker, K; Fink, U; Herrmann, K; Lordick, F; Ott, K; Schwaiger, M; Siewert, JR; Stahl, A; Weber, WA; Wieder, HA | 1 |
| Honma, Y; Koga, S; Nakano, S; Ogasawara, N | 1 |
| Cunha, ML; Daniel, MM; Funari, MB; Thom, AF; Wagner, J; Yamaga, LY | 1 |
| Auberger, J; Clausen, J; Gastl, G; Kendler, D; Nachbaur, D; Schwaighofer, H; Virgolini, I | 1 |
| Brepoels, L; De Wever, W; De Wolf-Peeters, C; Mortelmans, L; Spaepen, K; Stroobants, S; Thomas, J; Uyttebroeck, A; Vandenberghe, P; Verhoef, G | 2 |
| Armitage, JO; Bishu, S; Bishu, SR; Hankins, JH; Holdeman, KH; Olsasky, SM; Paknikar, S; Quigley, JM; Schmitz, J; Stemm, RA | 1 |
| Armitage, JO; Bishu, S; Bishu, SR; Hankins, JH; Holdeman, KP; Olsasky, SM; Paknikar, S; Quigley, JM; Shostrom, VK; Stem, RA | 1 |
| Arnold, SE; Barbas, NR; Clark, CM; DeCarli, CS; Foster, NL; Heidebrink, JL; Higdon, R; Jagust, WJ; Koeppe, RA; Minoshima, S; Turner, RS | 1 |
| Hayabuchi, N; Hiromatsu, Y; Ishibashi, M; Kaida, H; Kurata, S; Miyake, I; Uchida, M | 1 |
| Kaji, H; Kanegae, K; Kimura, K; Kuge, Y; Nakano, I; Okamoto, S; Shiga, T; Tamaki, N; Zhao, S | 1 |
| Dooms, C; Stroobants, S; Vansteenkiste, J; Wynants, J | 1 |
| Antoch, G; Beyer, T; Bockisch, A; Freudenberg, LS; Rosenbaum, SJ | 1 |
| Adler, LP; Avril, N | 1 |
| Eubank, WB | 1 |
| Schirrmeister, H | 1 |
| Bar-Shalom, R | 1 |
| Macapinlac, HA; Podoloff, DA | 1 |
| Even-Sapir, E; Herishanu, Y; Lerman, H; Lievshitz, G; Metser, U; Perry, C | 1 |
| Alavi, A; Yang, H; Zhuang, H | 1 |
| Alavi, A; Hao Tang, P; Liersch, T; Meller, J; Sahlmann, CO | 1 |
| Walter, MA | 1 |
| Iagaru, A; Kalinyak, JE; McDougall, IR | 1 |
| Fukukura, Y; Jinnouchi, S; Nakajo, M; Tanabe, H; Tateno, R | 1 |
| Choi, SH; Kim, JS; Kim, SY; Lee, JH; Nam, SY; Roh, JL; Yeo, NK | 1 |
| Antoch, G; Beyer, T; Bockisch, A; Dahmen, G; Egelhof, T; Fischer, M; Luczak, C; Rosenbaum, S; Veit-Haibach, P; Wanke, I | 1 |
| Bansilal, S; Farkouh, M; Fayad, ZA; Fuster, V; Machac, J; Myers, KS; Rafique, A; Rudd, JH | 1 |
| Espié, M; Giacchetti, S; Groheux, D; Hindie, E; Misset, JL; Moretti, JL; Toubert, ME; Vercellino, L | 1 |
| Decarli, C; Ellis, W; Jagust, W; Mungas, D; Reed, B | 1 |
| Antonescu, C; Bilsky, MH; Boland, PJ; Healey, JH; Schwab, JH | 1 |
| Bongers, V; Comans, EF; Gundy, CM; Hoekstra, OS; van Lingen, A; Willem Coebergh, J; Zijlstra, JM | 1 |
| Inadama, N; Murayama, H; Nishikido, F; Shibuya, K; Suzuki, T; Tsuda, T; Yamaya, T; Yoshida, E | 1 |
| Fukuda, H | 1 |
| Aide, N; Bardet, S | 1 |
| Goebel, M; Grillhoesl, A; Hofmann, GO; Kirschner, MH; Rosa, F; Tatsch, K | 1 |
| Horiuchi, C; Inoue, T; Kawakami, M; Matsuda, H; Mikami, Y; Nishimura, G; Oka, T; Taguchi, T; Tanigaki, Y; Tsukuda, M; Yoshida, T | 1 |
| Dietl, B; Kölbl, O; Kühnel, T; Marienhagen, J; Schreyer, A | 1 |
| Park, KG; Smith, TA; Suttie, SA | 1 |
| Brambilla, M; Gandolfo, P; Inglese, E; Leva, L; Matheoud, R; Sacchetti, G; Sambuceti, G; Secco, C | 1 |
| Dupuis, J; Haioun, C; Itti, E; Lin, C; Luciani, A; Meignan, M; Paone, G; Petegnief, Y; Rahmouni, A; Talbot, JN | 1 |
| Chan, SC; Chang, JT; Chin, SC; Liao, CT; Lin, CY; Liu, FY; Ng, SH; Wang, HM; Yen, TC | 1 |
| Corstens, FH; de Geus-Oei, LF; Hermsen, R; Krabbe, PF; Oyen, WJ; Pruim, J; Timmer-Bonte, JN; van der Heijden, HF; van Hoorn, BA; Visser, EP; Willemsen, AT | 1 |
| Ito, K; Izumi, S; Kubota, K; Kudo, K; Miyano, S; Sasao, Y; Yukihiro, M | 1 |
| Dehdashti, F; Finkelstein, SE; Grigsby, PW; Hall, BL; Moley, JF; Siegel, BA | 1 |
| Bredella, MA; Fischman, AJ; Hornicek, F; Ouellette, HA; Plamer, WE; Plotkin, SR; Torriani, M; Williams, Z | 1 |
| Hall, NC; Kloos, RT | 1 |
| Crott, R; Krug, B; Pirson, AS; Van Zanten, A; Vander Borght, T | 1 |
| Alavi, A; Kumar, R; Lal, N | 1 |
| Asakura, M; Bandoh, S; Ishikawa, S; Kanaji, N; Kimura, N; Nishiyama, Y; Ohkawa, M; Okuda, M; Yamamoto, Y | 1 |
| Baig, S; Begent, RH; Francis, RJ; Green, AJ | 1 |
| Kontaxakis, G; Pavlopoulos, S; Santos, A; Thireou, T | 1 |
| Collins, CD | 1 |
| Burkill, G; Miles, K | 1 |
| Amthauer, H; Denecke, T; Hänninen, EL; Hildebrandt, B; Langrehr, J; Lehmkuhl, L; Ricke, J; Rühl, R; Steffen, I; Streitparth, F | 1 |
| Calonje, E; Ferner, RE; Golding, JF; Jan, W; O'Doherty, M; Sanjayanathan, V; Smith, M | 1 |
| Alavi, A; Alkhawaldeh, K; Bural, G; Kumar, R | 1 |
| Blumenfeld, H; Buch, K; Novotny, E; Spencer, S; Zubal, IG | 1 |
| An, YS; Lee, PH; Yong, SW; Yoon, JK | 1 |
| Even-Sapir, E; Lerman, H; Metser, U; Miller, E | 1 |
| Chang, TC; Chao, A; Hong, JH; Hsueh, S; Lai, CH; Ng, KK; See, LC; Tsai, CS; Yen, TC | 1 |
| Alavi, A; Basu, S; Cermik, TF; Mavi, A | 1 |
| Corstens, FH; de Geus-Oei, LF; Hermsen, R; Kamm, YJ; Krabbe, PF; Oyen, WJ; Punt, CJ; van Hoorn, BA; van Laarhoven, HW; Visser, EP | 1 |
| Antoch, G; Barkhausen, J; Bockisch, A; Fischer, M; Freudenberg, L; Gutzeit, A; Kuehl, H; Nassenstein, K; Stergar, H; Veit-Haibach, P | 1 |
| Arima, S; Hasegawa, Y; Nakashima, T; Nishio, M; Ogawa, T; Ozawa, T; Suzuki, H; Suzuki, M; Tamaki, T; Terada, A | 1 |
| Berthelsen, AK; Bisgaard, C; Graff, J; Jakobsen, A; Kristiansen, C; Lindebjerg, J; Loft, A | 1 |
| Jia, Q; Wei, H; Wu, ZJ; Zhang, YX | 1 |
| Antoch, G; Bockisch, A; Freudenberg, LS; Frilling, A; Jentzen, W; Kühl, H; Müller, SP | 1 |
| Cho, SS; Kim, JH; Kim, JS; Kim, SE; Kim, YK; Moon, SY | 1 |
| Rödel, R | 1 |
| Reinhardt, MJ | 2 |
| Balan, KK; Gibbs, P; Huguet, EL; Jamieson, NV; Old, S; Praseedom, RK | 1 |
| Bundgaard, T; Buus, S; Grau, C; Hansen, HS; Johansen, J; Keiding, S; Kirkegaard, J; Loft, A; Overgaard, J; Overgaard, M | 1 |
| Badawi, RD; Demetri, GD; Holdsworth, CH; Israel, DA; Kijewski, MF; Manola, JB; Van den Abbeele, AD | 1 |
| Fukuda, H; Iinuma, T; Inoue, T; Ito, K; Jinnouchi, S; Kawamoto, M; Minamimoto, R; Nakashima, R; Nishio, M; Nishizawa, S; Oguchi, K; Okuyama, C; Senda, M; Suzuki, Y; Terauchi, T; Tsukamoto, E; Uno, K; Yoshida, T | 1 |
| Bai, YR; Huang, G; Liu, T; Xu, W; Yan, WL; Ye, M | 1 |
| Daisaki, H; Hamashima, C; Kakugawa, Y; Kozu, T; Moriyama, N; Muramatsu, Y; Saito, D; Saito, H; Shoda, H; Terauchi, T | 1 |
| Giaccone, G | 1 |
| Evans, WK; Gulenchyn, K; Lacchetti, C; Maziak, DE; Smith, CA; Ung, YC; Vanderveen, JA | 1 |
| Bissoli, S; Chierichetti, F; Frison, L; Liessi, G; Pasquali, C; Pedrazzoli, S; Sperti, C | 1 |
| Avila-Rodriguez, MA; Converse, AK; Hampel, JA; Jaskowiak, CJ; McDermott, JC; Nickles, RJ; Selwyn, RG; Thomadsen, BR; Warner, TF | 1 |
| Hotta, T; Nagai, H; Nihashi, T; Terasawa, T | 1 |
| Bauerfeind, I; Baur-Melnyk, A; Haug, A; Heinemann, V; Reiser, MF; Schmidt, GP; Schoenberg, SO | 1 |
| Ishimaru, S; Miura, M; Nishimura, M; Ohira, H; Oyama, N; Sakaue, S; Takei, T; Tamaki, N; Tsujino, I; Tsukamoto, E | 1 |
| Haji, A | 1 |
| Kimura, N; Miki, A; Nishiyama, Y; Ohkawa, M; Sasakawa, Y; Wakabayashi, H; Yamamoto, Y | 1 |
| Abreu-e-Lima, P; El Fakhri, G; Gandler, W; Gerbaudo, VH; Mamede, M; Nosé, V | 1 |
| Asakawa, S; Inoue, T; Lee, J; Miyashita, K; Oka, T; Shizukuishi, K; Takahashi, N | 1 |
| Choi, JY; Kim, BT; Kim, S; Kwon, OJ; Lee, KS; Sung, YM; Yang, SO | 1 |
| Jeong, YJ; Jun, S; Kim, IJ; Kim, JS; Kim, SJ; Kim, YK; Lee, JS; Nam, HY | 1 |
| Alavi, A; Basu, S; Cermik, T; Chen, W; Czerniecki, B; Mavi, A; Schnall, M; Tchou, J | 1 |
| Bender, H; Biersack, HJ; Pleiss, C; Risse, JH | 1 |
| Aulmann, S; Buchmann, I; Haberkorn, U; Hoffner, S; Mack, U; Riedmüller, K | 1 |
| Gómez-Río, M; Llamas-Elvira, JM; López-Ramírez, E; Ramos-Font, C; Rodríguez-Fernández, A | 1 |
| Izuishi, K; Nishiyama, Y; Okano, K; Otani, T; Sano, T; Suzuki, Y; Wakabayashi, H; Yachida, S | 1 |
| Hwang, CY; Kim, JS; Kim, JY; Kim, MH; Lee, SK; Lee, SS; Lee, TY; Seo, DW; Yun, SC | 1 |
| Chung, HH; Chung, JK; Kang, SB; Kang, WJ; Kim, JW; Park, NH; Song, YS | 1 |
| Antoch, G; Bockisch, A; Freudenberg, LS; Frilling, A; Görges, R; Jentzen, W; Kühl, H; Rosenbaum, SJ | 1 |
| Biraben, A; Bouilleret, V; Chassoux, F; Mantzaridez, M; Ribeiro, MJ; Semah, F; Trebossen, R | 1 |
| Bilodeau, PA; Coleman, TA; Gourin, CG; Patel, VS; Watts, TL; Williams, HT | 1 |
| Catalano, L; Del Vecchio, S; Fonti, R; Liuzzi, R; Pace, L; Petruzziello, F; Quarantelli, M; Rotoli, B; Salvatore, B; Salvatore, M; Segreto, S; Sirignano, C | 1 |
| Chen, P; Feng, H; Ma, L; Tan, Y; Tian, J; Wu, W; Xin, J; Yang, X; Yu, L; Zhao, Z | 1 |
| Alazraki, N; Coleman, RE; Fletcher, JW; Gould, M; Kymes, SM; Lee, K; Lowe, VJ; Marn, C; Segall, G; Thet, LA | 1 |
| Ben-Arie, Y; Gaitini, D; Israel, O; Levy, Z; Shalom, RB; Soudack, M | 1 |
| Kim, IJ; Kim, SJ; Kim, YK; Lee, TH | 1 |
| Abdulrahim, N; Brandon, D; Cardarelli, R; Erdman, W; Shie, P | 1 |
| Hinterthaner, M; Stamatis, G | 1 |
| Heijenbrok-Kal, MH; Hunink, MG; Kuipers, EJ; Siersema, PD; van Vliet, EP | 1 |
| Brouwer, J; Castelijns, JA; de Bree, R; Hoekstra, OS; Hooft, L; Leemans, CR; Riphagen, II | 1 |
| Liptay, MJ | 1 |
| Carlos, RC; Cronin, P; Dwamena, BA; Kelly, AM | 1 |
| Bisi, G; Chiappella, A; Deandreis, D; Pelosi, E; Penna, D; Skanjeti, A; Vitolo, U | 1 |
| Dirisamer, A; Haller, J; Heinisch, M; Langsteger, W; Lehner, HP; Schima, W; Weber, M | 1 |
| Czernin, J; Grosu, AL; Weber, WA | 1 |
| Boecker, H; Drzezga, A; Förstl, H; Häussermann, P; Kurz, A; Perneczky, R; Wagenpfeil, S | 1 |
| Gold, MA | 1 |
| Bodet-Milin, C; Campion, L; Dupas, B; Gastinne, T; Goldenberg, DM; Harousseau, JL; Huglo, D; Kraeber-Bodéré, F; Le Gouill, S; Morschhauser, F; Wegener, WA | 1 |
| DU, SD; Huang, JF; Huo, L; Lu, X; Mao, YL; Sang, XT; Yang, ZY; Zhong, SX | 1 |
| Bae, YA; Choe, BK; Chung, MJ; Jeong, SY; Kim, BT; Kim, TS; Lee, KS; Shin, KM | 1 |
| Al-Sarraf, N; Gately, K; Lucey, J; McGovern, E; Wilson, L; Young, V | 1 |
| Breitenstein, S; Hany, TF; Lago, MP; Mende, KA; Soyka, JD; Strobel, K; Tschopp, A; Veit-Haibach, P | 1 |
| Chatziioannou, AF; Feeley, BT; Hsu, WK; Lieberman, JR; Stout, DB; Virk, MS | 1 |
| Beuthien-Baumann, B; Caselli, R; Clerici, F; de Leon, MJ; Diehl-Schmid, J; Drzezga, A; Herholz, K; Holthoff, V; Kalbe, E; Kurz, A; Lucignani, G; Minoshima, S; Mosconi, L; Perneczky, R; Pupi, A; Reiman, EM; Sorbi, S; Tsui, WH | 1 |
| Duclos, A; Giammarile, F; Hau, NH; Ravel, AC; Souquet, PJ | 1 |
| Bellomi, M; Bertolotti, R; Leo, F; Maisonneuve, P; Mulshine, JL; Paganelli, G; Pelosi, G; Preda, L; Scanagatta, P; Solli, P; Spaggiari, L; Veronesi, G | 1 |
| Fukasawa, I; Hagiwara, S; Inaba, N; Kaji, Y; Kitajima, K; Murakami, K; Sugimura, K; Yamasaki, E | 1 |
| Chung, JH; Kim, SE; Lee, WW; Nguyen, XC; Park, SY; So, Y | 1 |
| Maele, GV; Praet, M; Ryck, FD; Tournoy, KG; van Meerbeeck, JP; Vanwalleghem, L; Vermassen, F | 1 |
| Guan, Y; Huang, Z; Lin, X; Liu, P; Xue, F; Zhang, Z; Zuo, C | 1 |
| Bacharach, SL; Badiee, S; Franc, BL; Hadi, M; Hasegawa, BH; Johnson, L; Lam, T; Seo, Y; Teo, BK | 1 |
| Englmeier, KH; Seemann, MD | 1 |
| Dietrich, S; Dimitrakopoulou-Strauss, A; Egerer, G; Haberkorn, U; Ho, AD; Kasper, B; Strauss, LG | 1 |
| Bentho, O; Conant, S; Eldadah, BA; Goldstein, DS; Holmes, C; Imrich, R; Moak, J; Sato, T; Sharabi, Y | 1 |
| Akarriou, M; Brouwer, J; Castelijns, JA; Comans, EF; de Bree, R; Hoekstra, OS; Langendijk, JA; Leemans, CR | 1 |
| Karianakis, G; Poulou, LS; Ziakas, PD | 1 |
| Ahuja, AT; Chan, AT; Kam, MK; King, AD; Leung, SF; Ma, BB; Wong, JK; Yau, YY; Zee, B | 1 |
| Brouwers, AH; de Vries, EG; Elsinga, PH; Jager, PL; Kema, IP; Koopmans, KP; Neels, OC; Sluiter, WJ; Vanghillewe, K | 1 |
| Chen, WP; Matsunari, I; Nishimura, S; Ono, K; Samuraki, M; Shima, K; Takeda, N; Yamada, M; Yanase, D; Yoshita, M | 1 |
| Falay, O; Kutlu, CA | 1 |
| Avril, N; Brenner, W; Dose-Schwarz, J; Habermann, CR; Jenicke, L; Mahner, S; Schirrmacher, S | 1 |
| Ikeda, K; Katahira, K; Kawanaka, K; Mori, T; Nomori, H; Shiraishi, S; Yamashita, Y | 1 |
| Caleo, O; Klain, M; Mancini, M; Maurea, S; Pace, L; Salvatore, B; Salvatore, M; Storto, G | 1 |
| Calcagni, ML; Leccisotti, L; Perotti, G; Rubello, D; Rufini, V; Treglia, G | 1 |
| Abela, GS; Aziz, K; Berger, K; Claycombe, K; Huang, R; Patel, R | 1 |
| Cicone, F; Deron, P; Loose, D; Scopinaro, F; Signore, A; Van de Vyvere, F; Van de Wiele, C; Vermeersch, H | 1 |
| Beyer, T; Bockisch, A; Fitzek, M; Knoess, C; Kracht, L; Kühl, H; Maderwald, S; Pietrzyk, U; Vollmar, S; Wienhard, K | 1 |
| Buchmann, I; Ganten, TM; Haberkorn, U | 1 |
| Ebied, O; El-Kholy, MR; El-Shorbagy, E; Murakami, K; Zytoon, AA | 1 |
| de Bree, R; Golding, RP; Hoekstra, OS; Kuik, DJ; Leemans, CR; Oyen, WJ; Pruim, J; Roodenburg, JL; Senft, A; van den Hoogen, FJ | 1 |
| Imamura, Y; Kotsuji, F; Kurokawa, T; Okazawa, H; Sawamura, Y; Shinagawa, A; Suganuma, N; Tsuchida, T; Tsujikawa, T; Yoshida, Y | 1 |
| Bisi, G; Chiappella, A; Deandreis, D; Gallo, E; Limerutti, G; Mancini, M; Pelosi, E; Penna, D; Pregno, P; Vitolo, U | 1 |
| Hur, J; Ryu, YH; Suh, JS; Yoon, CS; Yun, MJ | 1 |
| Domeki, Y; Fukasawa, I; Inaba, N; Kaji, Y; Kitajima, K; Murakami, K; Suganuma, N; Sugimura, K; Yamasaki, E | 1 |
| Braun, JJ; Constantinesco, A; Imperiale, A; Kessler, R | 1 |
| Fujii, H; Ito, M; Kuwano, H; Saito, N; Tsunoda, Y | 1 |
| Aschoff, P; Brink, I; Claussen, CD; Eschmann, S; Hehr, T; Lichy, MP; Pfannenberg, C; Plathow, C; Schlemmer, HP | 1 |
| Domeki, Y; Kaji, Y; Kitajima, K; Murakami, K; Sugimura, K; Yamasaki, E | 1 |
| Hicks, RJ; Toner, GC | 1 |
| Baillet, G; Cuvier, C; Espie, M; Filmont, JE; Giacchetti, S; Groheux, D; Hennequin, C; Hindie, E; Misset, JL; Moretti, JL; Sarandi, F; Toubert, ME; Vilcoq, JR | 1 |
| Cabrera Martín, MN; Carreras Delgado, JL; Delgado Bolton, RC; Fernández Pérez, C; Pasamontes Pingarrón, JA; Scola Yurrita, B | 1 |
| Amthauer, H; Bares, R; Bokemeyer, C; Brenner, W; Cremerius, U; de Wit, M; Dohmen, BM; Franzius, C; Geworski, L; Hartmann, M; Heicappell, R; Hellwig, D; Kliesch, S; Kotzerke, J; Lehmann, J; Schirrmeister, H; Schlemmer, M; Tatsch, K | 1 |
| Kim, CH; Kim, HS; Kim, WU; Park, YH | 1 |
| Conzett, KB; Dummer, R; Kalff, V; Lago, MP; Schad, K; Seifert, B; Soyka, JD; Steinert, HC; Strobel, K; Veit-Haibach, P | 1 |
| Ball, D; Hicks, R; Hogg, A; Lee, JW; Mac Manus, M | 1 |
| Macapinlac, HA; Schwartz, DL; Weber, RS | 1 |
| Denaxa-Kyza, D; Evangelou, E; Ioannidis, JP; Kyzas, PA | 1 |
| Andrès, E; Blaison, G; Blondet, C; Christmann, D; Constantinesco, A; Federici, L; Goichot, B; Imperiale, A; Pasquali, JL; Pflumio, F; Sibilia, J; Weber, JC | 1 |
| Beyna, T; Domschke, W; Franzius, C; Heindel, W; Juergens, KU; Oei, ML; Pohle, T; Schick, V; Schnekenburger, J; Schober, O; Weckesser, M | 1 |
| Corstens, FH; de Geus-Oei, LF; Kaanders, JH; Kienhorst, L; Oyen, WJ; Philippens, ME; Visser, EP | 1 |
| Bansilal, S; Farkouh, M; Fayad, ZA; Fuster, V; Hargeaves, R; Machac, J; Myers, KS; Pinto, CA; Rafique, A; Rudd, JH; Tong, C | 1 |
| Alexiou, GA; Fotopoulos, AD; Kyritsis, AP; Polyzoidis, KS; Tsiouris, S | 1 |
| Itoh, H; Kimura, H; Kosaka, N; Okazawa, H; Tsuchida, T; Uematsu, H | 1 |
| Inubushi, M; Kanegae, K; Kitagawa, Y; Notani, K; Saitoh, M; Takinami, S; Tamaki, N; Tei, K; Totsuka, Y; Yamazaki, Y | 1 |
| Koyama, H; Maniwa, Y; Nishimura, Y; Nogami, M; Ohbayashi, C; Ohno, Y; Sugimura, K; Takenaka, D | 1 |
| Campbell, MG; Delbeke, D; Martin, WH; Ohana, I; Patton, JA; Sandler, MP; Videlefsky, S | 1 |
| Blessing, C; Carl, M; Feine, U; Fierlbeck, G; Geiger, L; Rassner, G | 1 |
| Goodman, PC; Herndon, J; Lowe, VJ; Patz, EF | 1 |
| Hamoir, E; Luxen, A; Melon, P; Meurisse, M | 1 |
| Delbeke, D; Martin, WH; Meyerowitz, C; Ohana, I; Patton, JA; Sandler, MP; Videlefsky, S | 1 |
| Arnold, W; Avril, N; Herz, M; Kau, RJ; Kruschke, C; Laubenbacher, C; Saumweber, D; Schwaiger, M; Wagner-Manslau, C; Ziegler, S | 1 |
| Anderson, CJ; Connett, JM; Cutler, PD; Dehdashti, F; Meares, CF; Philpott, GW; Schwarz, SW; Siegel, BA; Welch, MJ; Zinn, KR | 1 |
| Austin, JR; Kim, EE; Wong, FC | 1 |
| Khonsari, A; Krisdakumtorn, T; Mandelkern, M; Simpkins, F; Swartz, BW; Vrown, C | 1 |
| Coleman, RE; Duhaylongsod, FG; Lowe, VJ; Patz, EF; Vaughn, AL; Wolfe, WG | 2 |
| Alavi, A; Buchpiguel, C; Chin, BB; Zukerberg, BW | 1 |
| Alexander, C; Berberich, R; Holle, LH; Oberhausen, E; Ruth, T; Sybrecht, GW; Trampert, L; Ukena, D | 1 |
| Dewan, NA; Gobar, LS; Gupta, NC; Reeb, SD; Scott, WJ | 1 |
| Dimitrakopoulou-Strauss, A; Goldschmidt, H; Lorenz, WJ; Maier-Borst, W; Strauss, LG; van Kaick, G | 1 |
| Caldwell, JH; Johnson, PM; Krohn, KA; Martin, GV; Rasey, JS; Revenaugh, JR | 1 |
| Dewan, NA; Gobar, LS; Hauser, LG; Scott, WJ; Sugimoto, JT; Sunderland, JJ | 1 |
| Cappellari, JO; Geisinger, KR; Greven, KM; Keyes, JW; McGuirt, WF; Watson, NE; Williams, DW | 1 |
| Oberhausen, E; Schaefer, A | 1 |
| Hawkins, RA | 1 |
| Berger, HG; Friess, H; Glatting, G; Kocher, F; Reske, SN; Stollfuss, JC | 1 |
| Fujii, M; Imamura, M; Inokuma, T; Kajiyama, T; Konishi, J; Magata, Y; Ohshio, G; Tamaki, N; Torizuka, T; Yonekura, Y | 1 |
| Bassa, P; Endo, K; Inoue, T; Kim, EE; Komaki, R; Podoloff, DA; Wong, FC; Wong, WH; Yang, DJ | 1 |
| Delbeke, D; Hendrix, B; Kessler, RM; Martin, WH; Ohana, I; Patton, JA; Sandler, MP; Weinfeld, Z | 1 |
| Buonocore, E; Cotten, DW; Gould, HR; Hübner, KF; Singh, SK | 1 |
| Foster, NL; Frey, KA; Koeppe, RA; Kuhl, DE; Minoshima, S | 1 |
| Beger, HG; Büchler, MW; Ebert, M; Friess, H; Langhans, J; Reske, SN; Stollfuss, J | 1 |
| Ackermann, RJ; Cotton, L; Ficaro, EP; Macfarlane, DJ; Minn, H; Shreve, PD; Wahl, RL | 1 |
| Aerts, R; Beets, G; De Roo, M; Filez, L; Kerremans, R; Mortelmans, L; Penninckx, F; Schiepers, C | 1 |
| Fink, GR; Heiss, WD; Herholz, K; Ichimiya, A; Jacobs, A; Kessler, J; Mielke, R; Pietrzyk, U | 1 |
| Baer, FM; Schicha, H; Schneider, CA; Sechtem, U; Theissen, P; Voth, E | 1 |
| Delbeke, D; Jennings, MT; Kessler, RM; Lapidus, RL; Maciunas, RJ; Meyerowitz, C; Moots, PL | 1 |
| Biadi, O; Donatelli, F; Fazio, F; Landoni, C; Lucignani, G; Mariani, MA; Mengozzi, G; Palagi, C; Paolini, G; Vanoli, G | 1 |
| Cappelletti, A; Chierchia, SL; Fazio, F; Fragasso, G; Landoni, C; Lucignani, G; Margonato, A; Xuereb, M; Xuereb, RG | 1 |
| Lewis, PJ; Salama, A | 1 |
| Alavi, A; Buchpiguel, CA; Loessner, A | 1 |
| Larson, SM | 1 |
| Dewan, NA; Gupta, NC; Reeb, SD; Schwabe, JL; Scott, WJ; Sugimoto, JT | 1 |
| Coleman, RE; DeLong, DM; Hoffman, JM; Lowe, VJ; Patz, EF | 1 |
| Dussek, J; Gee, T; Griffin, S; Lewis, P; Malsey, M; Marsden, P; Nunan, T | 1 |
| Bushnell, DL; Follett, KA; Kahn, D; Kirchner, PT; Madsen, M; Nathan, MA; Piper, JG | 1 |
| Chen, EQ; Esselstyn, CB; Go, RT; Kohse, LM; Licata, AA; MacIntyre, WJ; Neumann, DR | 1 |
| Gast, T; Hubner, K; Meyer, M; Raja, S | 1 |
| Greenough, RL; Meyer, CR; Orringer, MB; Quint, LE; Wahl, RL; White, RI | 1 |
| Goodman, PC; Harris, LK; Hoffman, JM; Lowe, VJ; Paine, SS; Patz, EF | 1 |
| Bergman, J; Haapanen, A; Haaparanta, M; Härkönen, R; Knuuti, MJ; Nuutila, P; Saraste, M; Savunen, T; Voipio-Pulkki, LM; Wegelius, U | 1 |
| Couson, F; Donath, A; Junod, AF; Lemoine, R; Louis, O; Nicod, L; Slosman, DO; Spiliopoulos, A | 1 |
| Francis, IR; Gritters, LS; Wahl, RL; Zasadny, KR | 1 |
| Comar, D; Fazio, F; Franck, G; Heiss, WD; Herholz, K; Perani, D; Salmon, E | 1 |
| Broussard, WF; Hortobagyi, GN; Kim, EE; Nieweg, OE; Singletary, SE; Tilbury, RS; Wong, WH | 1 |
| Dewan, NA; Frick, MP; Gupta, NC; Phalen, JJ; Redepenning, LS | 1 |
| Adler, LP; al-Kaisi, NK; Crowe, JP; Sunshine, JL | 1 |
| Chin, R; Choplin, RH; Haponik, EF; Hudspeth, AS; Keyes, JW; Reed, JC; Wallenhaupt, S; Ward, R | 1 |
| Delbeke, D; Martin, WH; Patton, JA; Sandler, MP | 2 |
| Campbell, MG; Chapman, WC; Delbeke, D; Pinson, CW; Powers, TA; Sandler, MP; Vitola, JV; Wright, JK | 1 |
| Jones, T; Price, P | 1 |
| Bradfield, H; Gupta, N | 1 |
| Delbeke, D; Knight, SB; Sandler, MP; Stewart, JR | 1 |
| Drane, WE; Mancuso, AA; Mendenhall, WM; Mukherji, SK; Parsons, JT; Stringer, S | 1 |
| Allgayer, B; Avril, N; Bense, S; Dose, J; Graeff, H; Herz, M; Jänicke, F; Laubenbacher, C; Nathrath, W; Pache, H; Römer, W; Schwaiger, M; Ziegler, S | 1 |
| Anzai, Y; Bradford, CR; Carroll, WR; Minoshima, S; Quint, DJ; Wahl, RL; Wolf, GT | 1 |
| Akashi, Y; Fukumura, T; Ichiya, Y; Ishida, T; Kuwabara, Y; Masuda, K; Murayama, S; Sasaki, M; Sugio, K; Yoshida, T | 1 |
| Hoekstra, HJ; Koops, HS; Molenaar, WM; Nieweg, OE; Paans, AM; Pruim, J; Vaalburg, W; van Ginkel, RJ | 1 |
| Browd, SR; Drane, WE; Eikman, EA; Gilmore, RL; Helveston, WR; Mastin, ST; Quisling, RG; Roper, SN | 1 |
| Bassa, P; Buzdar, AU; Hicks, KW; Inoue, T; Kim, EE; Korkmaz, M; Podoloff, DA; Wong, FC; Wong, WH; Yang, DJ | 1 |
| Gunel, E; Gupta, NC; Maloof, J | 1 |
| Ide, M; Kobayashi, S; Mitomi, T; Shohtsu, A; Suzuki, Y; Takagi, S; Yasuda, S | 1 |
| Holle, LH; Lung-Kurt, S; Oberhausen, E; Püschel, W; Schmidt, S; Trampert, L; Villena-Heinsen, CE | 1 |
| deKemp, RA; Nahmias, C | 1 |
| Baer, FM; Deutsch, HJ; Erdmann, E; LaRosée, K; Schicha, H; Schneider, CA; Sechtem, U; Theissen, P; Voth, E | 1 |
| Baer, FM; de Vivie, ER; Deutsch, HJ; Erdmann, E; Horst, M; Schicha, H; Schneider, CA; Sechtem, U; Voth, E | 1 |
| Bury, T; Corhay, JL; D'Harcour, JB; Limet, R; Paulus, P; Radermecker, MF; Rigo, P; Weber, T | 1 |
| Abraham, SA; Alpert, NM; Fischman, AJ; Gewirtz, H; Mukerjee, AK; Picard, MH; Skopicki, HA; Weissman, NJ | 1 |
| Bax, JJ; Boersma, E; Cornel, JH; Fioretti, PM; Reijs, AE; Teule, GJ; van Lingen, A; Visser, CA; Visser, FC | 1 |
| Avril, N; Dose, J; Graeff, H; Herz, M; Jänicke, F; Nathrath, W; Römer, W; Schwaiger, M; Weber, W; Ziegler, S | 1 |
| Strauss, LG | 1 |
| Gambhir, SS; Hoh, CK; Madar, I; Maddahi, J; Phelps, ME | 1 |
| Feine, U; Hanke, JP; Held, J; Lietzenmayer, R; Müller-Schauenburg, W; Wöhrle, H | 1 |
| Bassa, P; Hicks, K; Inoue, T; Kim, EE; Korkmaz, M; Podoloff, DA; Tansey, W; Wong, FC; Wong, WH; Yang, DJ | 1 |
| Garcia, R; Kim, EE; Korkmaz, M; Podoloff, DA; Wong, FC; Wong, WH; Yang, DJ | 1 |
| Altehoefer, C; Buechin, P; Buell, U; Hanrath, P; Messmer, BJ; Sheehan, FH; Uebis, R; vom Dahl, J | 1 |
| Browd, S; Childress, D; Drane, W; Eikman, E; Gilmore, R; Helveston, W; Leonard, C; Mastin, S; Quisling, R; Roper, S | 1 |
| Chen, EQ; Esselstyn, CB; Go, RT; Licata, AA; Maclntyre, WJ; Neumann, DR; Obuchowski, NA | 1 |
| Utech, CI; Winter, PF; Young, CS | 1 |
| Raylman, RR; Wahl, RL | 1 |
| Buonocore, E; Dickey, J; Gould, HR; Hübner, KF; Smith, GT; Stephens, S; Thie, J | 1 |
| Albert, A; Bury, T; Corhay, JL; Dowlati, A; Ghaye, B; Limet, R; Paulus, P; Radermecker, M; Rigo, P; Schoffers, J; Weber, T | 1 |
| Hoekstra, HJ; Kole, AC; Koops, HS; Nieweg, OE; Paans, AM; Pruim, J; Vaalburg, W; van Ginkel, RJ | 1 |
| Ausma, JJ; Borgers, M; Flameng, W; Maes, AF; Mortelmans, LA; Nuyts, JL; Sergeant, P; van de Werf, F | 1 |
| Brancato, R; Fazio, F; Freschi, M; Landoni, C; Lucignani, G; Modorati, G; Trabucchi, G | 1 |
| Allemann, F; Berthold, T; Engel, H; Hauser, M; Steinert, HC; von Schulthess, GK; Weder, W | 1 |
| Cooper, JD; Dehdashti, F; Flanagan, FL; Patterson, GA; Siegel, BA; Sundaresan, SR; Trask, DD | 1 |
| André-Fouet, X; Cinotti, L; Comet, M; Fagret, D; Janier, M; Machecourt, J; Vanzetto, G | 1 |
| Adam, MJ; Celler, A; Champion, P; Coupland, DB; Evans, KG; Finley, RJ; Kwong, JS; Lyster, DM; Müller, NL; Worsley, DF | 1 |
| Beanlands, RS; Coates, G; deKemp, R; Fallen, E; Garnett, ES; Johansen, HL; Nahmias, C; Scheffel, A | 1 |
| Avril, N; Dose, J; Herz, M; Jänicke, F; Kuhn, W; Römer, W; Schwaiger, M; Ziegler, S | 1 |
| Brunken, RC; Chen, EQ; Cook, SA; Go, RT; Khandekar, SP; MacIntyre, WJ; Neumann, DR; Saha, GB; Wong, CY | 1 |
| Freifelder, R; Geagan, MJ; Karp, JS; Kinahan, PE; Lewitt, RM; Muehllehner, G; Shao, L | 1 |
| Bazzicalupo, L; Fiore, F; Gravina, A; Mainolfi, C; Maurea, S; Panico, MR; Salvatore, M; Wang, H | 1 |
| Adler, LP; Al-Kasi, NL; Faulhaber, PF; Schnur, KC; Shenk, RR | 1 |
| Lamki, LM | 1 |
| Coleman, RE; Erasmus, JJ; Goodman, PC; Herndon, J; McAdams, HP; Murray, JG; Patz, EF | 1 |
| Biersack, HJ; Elger, CE; Grünwald, F; Menzel, C | 1 |
| Boobis, AR; Haslett, C; Jones, HA; Krausz, T; Peters, AM; Pride, NB; Sriskandan, S | 1 |
| Adam, G; Bares, R; Buell, U; Cremerius, U; Dohmen, B; Fass, J; Klever, P; Sabri, O; Schumpelick, V; Zimny, M | 1 |
| Bartenstein, P; Daschner, H; Feldmann, HJ; Gross, MW; Kinzel, D; Lumenta, C; Molls, M; Reidel, G; Schwaiger, M; Weber, W; Ziegler, SI | 1 |
| Guhlmann, A; Kotzerke, J; Moog, F; Reske, SN; Storck, M; Sunder-Plassmann, L | 1 |
| Bax, JJ; Boersma, E; Cornel, JH; Elhendy, A; Fioretti, PM; Maat, AP; Roelandt, JR; van Lingen, A; Visser, FC | 1 |
| Bax, JJ; Cornel, JH; Fioretti, PM; Krenning, EP; Poldermans, D; Rambaldi, R; Valkema, R; van Lingen, A; Visser, FC | 1 |
| Baddeley, H; Beaney, R; Chevretton, EB; Davis, J; Hussain, K; Maisey, M; McGurk, M; Tierney, P; Wong, WL | 1 |
| Price, P | 2 |
| Arildsen, RC; Chapman, WC; Delbeke, D; Pinson, CW; Powers, TA; Sandler, MP; Vitola, JV; Wright, JK | 1 |
| Burdon, TA; Hagberg, RC; Pompili, MF; Segall, GM; Stark, P | 1 |
| Bender, H; Biersack, HJ; Kozak, B; Oehr, P; Ruhlmann, J; Schräder, M; Willkomm, P | 1 |
| Bender, H; Biersack, HJ; Grünwald, F; Krebs, D; Mallmann, P; Palmedo, H; Zamora, P | 1 |
| Belani, CP; Ferson, PF; Keenan, RJ; Landreneau, RJ; Luketich, JD; Meltzer, CC; Schauer, PR; Townsend, DW; Urso, GK | 1 |
| Bellemann, ME; Brix, G | 1 |
| Bender, H; Biersack, HJ; Kozak, B; Oehr, P; Robertz-Vaupel, GM; Ruhlmann, J; Schomburg, A; Vaupel, H; Wolter, H | 1 |
| Barrington, SF; Bradbeer, CS; Campbell, M; Lowe, J; O'Doherty, MJ | 1 |
| De Leyn, PR; Dupont, PJ; Mortelmans, LA; Nackaerts, KL; Stroobants, SG; Vansteenkiste, JF; Verschakelen, JA | 1 |
| Boyd, JH; Dunleavy, T; Dunphy, CH; Dunphy, FR; Fletcher, JW; Kim, H; Lowe, VJ; McDonough, E; Minster, J; Varvares, M; Wittry, M | 1 |
| Birnbaum, EH; Dehdashti, F; Flanagan, FL; Fleshman, JW; Kodner, IJ; Ogunbiyi, OA; Philpott, GW; Read, TE; Siegel, BA; Trask, DD | 1 |
| Bury, T; Corhay, JL; Dowlati, A; Ghaye, B; Hustinx, R; Paulus, P; Radermecker, M; Rigo, P | 1 |
| Ferrie, CD; Maisey, MN; Marsden, PK; Robinson, RO | 1 |
| Achten, E; Boon, P; Caemaert, J; De Coo, D; De Reuck, J; Kunnen, M; Santens, P; Van De Kerckhove, T | 1 |
| Büll, U; Cremerius, U; Rath, W; Schröder, W; Wolters, S; Zimny, M | 1 |
| Agresti, R; Bogni, A; Bombardieri, E; Chiesa, C; Crippa, F; De Sanctis, V; Delledonne, V; Greco, M; Leutner, M; Pascali, C; Salvadori, B; Seregni, E | 1 |
| Higashi, K; Nambu, Y; Nishikawa, T; Oguchi, M; Okimura, T; Seki, H; Tonami, H; Ueda, Y; Yamamoto, I; Yuasa, K | 1 |
| Fujiwara, T; Fukuda, H; Ishii, K; Itoh, M; Kitamura, K; Miyake, M; Orihara, H; Satoh, T; Seo, S; Takahashi, S; Tanaka, K; Watanuki, S; Yamamoto, S | 1 |
| Lamonica, D; Myers, LL; Nabi, H; Simpson, GT; Wax, MK | 1 |
| Brecht-Krauss, D; Glatting, G; Guhlmann, A; Kinzl, L; Kotzerke, J; Reske, SN; Suger, G | 1 |
| Abdel-Nabi, H; Carbone, GM; Cronin, VR; Doerr, RJ; Galantowicz, PJ; Lamonica, DM; Spaulding, MB | 1 |
| Coleman, RE; Delbeke, D; Fletcher, JW; Gobar, L; Heiberg, EV; Hubner, K; Karis, J; Kirchner, P; Lawson, M; Lowe, VJ; Patz, EF; Valk, P | 1 |
| Hustinx, R; Paquet, P; Piérard, GE; Rigo, P | 1 |
| Bacharach, SL; Bartlett, ML; Dilsizian, V; Kitsiou, AN; Miller-Davis, C; Srinivasan, G | 1 |
| Glaspy, JA; Hoh, CK; Maddahi, J; Moon, DH; Phelps, ME; Silverman, DH | 1 |
| Bice, AN; Drayer, BP; Fram, EK; Heiserman, JE; Karis, JP; Ricci, PE | 1 |
| Björnsson, EH; Gustafsson, GR; Lamberg, K; Långström, B; Nettelbladt, OS; Sundin, AE; Valind, SO | 1 |
| Baum, RP; Hör, G; Kaufmann, R; Rinne, D | 1 |
| Liu, RS; Soong, BW | 1 |
| Deters, EC; Gross, MD; Kison, PV; Shreve, PD; Steventon, RS; Wahl, RL | 1 |
| Johnson, T; Macfarlane, DJ; Sondak, V; Wahl, RL | 1 |
| Hirano, T; Horikoshi, S; Kurihara, H; Ono, N; Oriuchi, N; Shibasaki, T; Tamura, M; Zama, A | 1 |
| Easton, EJ; Greene, FL; Holder, WD; White, RL; Zuger, JH | 1 |
| Bingham, JB; Fletcher, CD; Lucas, JD; McKee, PH; O'Doherty, MJ; Smith, MA; Wong, JC | 1 |
| Feine, U | 1 |
| Bogaert, J; De Leyn, PR; Demedts, MG; Deneffe, GJ; Dupont, PJ; Lerut, TE; Maes, A; Mortelmans, LA; Nackaerts, KL; Stroobants, SG; Vansteenkiste, JF; Verschakelen, JA | 1 |
| Beger, HG; Diederichs, CG; Glatting, G; Reske, SN; Staib, L | 1 |
| Bury, T; Hustinx, R; Jacquet, N; Jerusalem, G; Paulus, P; Rigo, P | 1 |
| Altenvoerde, G; Kuwert, T; Lerch, H; Matheja, P; Schäfers, M; Schober, O | 1 |
| Beyer, W; Clausen, M; Grimm-Riepe, C; Lübeck, M; Schirren-Bumann, K; Schlüter, B | 1 |
| Wahl, RL | 1 |
| Kimura, H; Kitahara, H; Kuriyama, T; Tatsumi, K; Uchida, Y; Yamada, Y; Yamaguchi, T | 1 |
| Drane, WE; Kiser, JW; Mastin, ST; Nicole, MW | 1 |
| Brown, RS; Fisher, SJ; Torizuka, T; Wahl, RL | 1 |
| Glass, EC; Gupta, RK; Hsueh, EC; Morton, DL; Qi, K; Yee, R | 1 |
| ChangLai, SP; Chieng, PU; Ho, YJ; Kao, CH; Lan, JL | 1 |
| Ah-See, AK; Eremin, O; Heys, SD; Jibril, JA; Miller, ID; Norton, M; Ogston, KN; Sharp, P; Smith, FW; Smith, IC; Whitford, P | 1 |
| Fogelman, I; Jacobson, AF | 1 |
| Barreto, A; Barthelemy, N; Bury, T; Daenen, F; Ghaye, B; Rigo, P | 1 |
| Adams, S; Baum, RP; Bitter, K; Hör, G; Stuckensen, T | 1 |
| AAssar, OS; Caputo, GR; Dillon, WP; Fischbein, NJ; Hawkins, RA; Kaplan, MJ; Price, DC; Singer, MI | 1 |
| Donald, PJ; Manolidis, S; Pounds, TR; Volk, P | 1 |
| Benz, P; Grötz, KA; Kuffner, HD; Kunkel, M; Spitz, J; Wagner, W; Wahlmann, U | 1 |
| Alavi, A; Albelda, SM; Bénard, F; Kaiser, LR; Smith, RJ; Sterman, D | 1 |
| Bax, JJ; Cornel, JH; Elhendy, A; Fioretti, PM; Huitink, JM; Poldermans, D; Roelandt, JR; van Lingen, A; Visser, CA; Visser, FC | 1 |
| Bockisch, A; Brandt-Mainz, K; Müller, SP; Sonnenschein, W | 1 |
| Oakes, TR; Ruth, TJ; Sossi, V | 1 |
| Eary, JF; Eubank, WB; Fisher, ER; Graham, MM; Mankoff, DA; Olshen, AB; Schmiedl, UP; Winter, TC | 1 |
| Collignon, J; Deneufbourg, JM; Hustinx, R; Moreau, P; Paulus, P; Rigo, P; Sambon, A; Vivegnis, D | 1 |
| Cho, BK; Chung, JK; Jung, HW; Kim, CY; Kim, DG; Lee, DS; Paek, SH | 1 |
| Canady, A; Chugani, DC; Chugani, HT; da Silva, EA; Muzik, O; Shah, A; Shah, J; Shen, C; Watson, C | 1 |
| Bishop, H; Gill, H; Graeber, G; Gupta, N; Hurst, J; Stephens, T | 1 |
| Bendriem, B; De Dreuille, O; Foehrenbach, H; Gaillard, JF; L'Her, P; Maszelin, P; Merlet, P; Syrota, A; Vaylet, F | 1 |
| ChangLai, SP; Chieng, PU; Kao, CH; Yen, RF; Yen, TC | 1 |
| Präuer, HW; Römer, W; Schwaiger, M; Treumann, T; Weber, WA; Ziegler, SI | 1 |
| Bicik, I; Buck, A; Huch, RA; Steinert, HC; Trachsel, C; Voellmy, DR; von Schulthess, GK | 1 |
| Allan, K; Ang, LC; Chen, JM; Commins, D; Houle, S; Nedzelski, J; Rowed, D | 1 |
| Branch, MS; Clark, L; Coleman, RE; DeLong, DM; Keogan, MT; McDermott, VG; Tyler, D | 1 |
| Hoh, CK; Schiepers, C | 2 |
| Myers, LL; Wax, MK | 1 |
| Bausart, R; Declerck, P; Delval, D; Jamar, F; Lonneux, M; Moens, R; Pauwels, S; Van Mael, P; Willockx, R; Zreik, H | 1 |
| Hashimoto, M; Hirono, N; Ikejiri, Y; Imamura, T; Ishii, K; Mori, E; Sasaki, M; Shimomura, T; Yamashita, H; Yasuda, M | 1 |
| Drane, WE; Jimenez, LA; Maria, BL; Mastin, ST | 1 |
| Ackermann, R; Fürst, G; Gerharz, CD; Müller-Gärtner, HW; Müller-Mattheis, V; Reinhardt, M; Vosberg, H | 1 |
| Gambhir, SS; Scott, WJ; Shepherd, J | 1 |
| Franzius, C; Schober, O; Sciuk, J | 1 |
| Bruchhaus, H; Hillinger, S; Largiadèr, F; Schmid, RA; Steinert, HC; von Schulthess, GK; Weder, W | 1 |
| Avril, N; Roder, JD; Schwaiger, M; Sendler, A; Siewert, JR | 1 |
| ChangLai, SP; Chieng, PU; Kao, CH; Lan, JL; Liao, KK; Yen, RF | 1 |
| Cronin, BF; Lodge, MA; Lucas, JD; Marsden, PK; O'Doherty, MJ; Smith, MA | 1 |
| Ott, DJ | 1 |
| Lewellen, TK; Miyaoka, RS; Swan, WL | 1 |
| Bishop, HA; Graeber, GM; Gupta, NC; Rogers, JS | 1 |
| Beger, HG; Diederichs, CG; Fröhlich, A; Reske, SN; Staib, L; Vogel, J | 1 |
| Hatazawa, J; Kawamura, M; Orino, K; Sazawa, Y; Suzuki, I | 1 |
| Ishii, Y; Lee, JD; Nakano, A; Shimizu, H; Tsuchida, T; Ueda, T; Yonekura, Y | 1 |
| Lauer, MS; Lytle, BW; Marwick, TH; Secknus, MA; Williams, J; Zuchowski, C | 1 |
| Bachor, R; Hautmann, R; Kotzerke, J; Reske, SN | 1 |
| Graeber, GM; Gupta, NC; Murray, GF | 1 |
| Alazraki, N; Galt, J | 1 |
| Drane, WE; Fenton, JJ; Harman, EM; Mastin, ST; Quesenberry, L | 1 |
| Johkoh, T; Kusuoka, H; Miyoshi, S; Nakamura, H; Nishimura, T; Tatsumi, M; Tomiyama, N; Watanabe, Y; Yutani, K | 1 |
| Abdel-Dayem, HM; Caputo, G; Gates, M; Hines, H; Khanvali, B; Leung, AN; Liebig, JR; Parker, A; Sfakianakis, G; Sollitto, R; Stokkel, MP; Swaney, CM; Wagner, HN; Weber, W; Weir, GJ; Young, C | 1 |
| Higashi, T; Imamura, M; Kogire, M; Konishi, J; Nakamoto, Y; Sakahara, H; Tamaki, N | 1 |
| Dussek, JE; Maisey, MN; O'Doherty, MJ; Saunders, CA | 1 |
| Akioka, K; Ochi, H; Takagi, M; Takeuchi, K; Tanaka, A; Yamagishi, H; Yoshikawa, J | 1 |
| Beauchamp, RD; Chapman, WC; Delbeke, D; Frexes, ME; Leach, SD; Pinson, CW; Richards, WO; Rose, DM; Sandler, MP; Sharp, KW; Wright, JK | 1 |
| Corsi, M; MacMullan, J; Seibyl, J; Spanaki, MV; Spencer, SS; Zubal, IG | 1 |
| Arnold, S; Bartenstein, P; Drzezga, A; Minoshima, S; Noachtar, S; Römer, W; Szecsi, J; Tatsch, K; Weber, W; Winkler, P | 1 |
| Coleman, RE | 3 |
| Castillo, M | 1 |
| Chang, KH; Cheon, JE; Chung, CK; Han, MH; Kim, HD; Kim, IO; Lee, DS; Lee, SK; Won, HJ | 1 |
| Schober, O; Weckesser, M | 1 |
| Block, T; Breul, J; Hartung, R; Hofer, C; Laubenbacher, C; Schwaiger, M | 1 |
| Hanasono, MM; Ku, GH; Kunda, LD; Segall, GM; Terris, DJ | 1 |
| Bausart, R; Bol, A; Borbath, I; Coppens, A; Defrise, M; Lonneux, M; Michel, C; Pauwels, S; Sibomana, M | 1 |
| Hellwig, A; Hellwig, D; Kirsch, CM; Leutz, M; Palm, I; Rentz, K; Sybrecht, GW; Ukena, D | 1 |
| Stokkel, MP; ten Broek, FW; van Rijk, PP | 1 |
| Greven, KM; Joyce, WT; Keyes, JW; McGuirt, WF; Williams, DW | 1 |
| Büll, U; Cremerius, U; Kaiser, HJ; Reinartz, P; Sabri, O; Schreckenberger, M; Zimny, M | 1 |
| Hordijk, GJ; Stokkel, MP; Terhaard, CH; van Rijk, PP | 1 |
| Koh, JH; Pai, M; Park, CH; Suh, JH | 1 |
| Francis, IR; Shapiro, B; Shulkin, BL; Sisson, JC; Thompson, NW | 1 |
| Ishida, H; Kimura, T; Makuuchi, H; Mukai, M; Sadahiro, S; Shohtsu, A; Tajima, T; Tokunaga, N; Yasuda, S | 1 |
| Dworkin, HJ; Wong, CO | 1 |
| Abdul-Karim, FW; Adler, LP; Faulhaber, PF; Miraldi, F; Rodriguez, M; Rose, PG | 1 |
| Becherer, A; Kletter, K | 1 |
| Coleman, RE; Culhane, DK; Erasmus, JJ; Goodman, PC; Herndon, JE; Marom, EM; McAdams, HP; Patz, EF | 1 |
| Avril, N; Schwaiger, M; Weber, WA | 1 |
| Eary, JF | 1 |
| Bohuslavizki, KH; Clausen, M; Klutmann, S; Kröger, S; Mester, J; Sonnemann, U; Thoms, J; Werner, JA | 1 |
| Kotzerke, J; Moog, F; Reske, SN | 1 |
| Graz, KF; Manns, MP; Meier, PN; Mix, H; Petrich, T; van den Hoff, J; Wagner, S; Widjaja, A | 1 |
| Fujii, H; Ide, M; Kubota, M; Shohtsu, A; Tajima, T; Takahashi, W; Umemura, S; Yasuda, S | 1 |
| Delbeke, D | 1 |
| Berlangieri, SU; Clarke, CP; Fitt, GJ; Hennessy, OF; Knight, SR; McKay, WJ; Scott, AM; Tochon-Danguy, HJ | 1 |
| Friedman, DM; Keenan, RJ; Luketich, JD; Meehan, MA; Meltzer, CC; Townsend, DW; Weigel, TL | 1 |
| Hara, T; Kirihara, Y; Kobori, O; Kosaka, N | 1 |
| Alavi, A; Benard, F; Bhatnagar, A; Hustinx, R; Smith, RJ | 1 |
| Beauchamp, RD; Chapman, WC; Delbeke, D; Leach, SD; Pinson, CW; Rose, DM; Shyr, Y; Wright, JK | 1 |
| Fujino, K; Hasegawa, S; Hori, M; Kusuoka, H; Nishimura, T; Uehara, T; Yamaguchi, H | 1 |
| Akhurst, T; Blumgart, LH; Cohen, A; Finn, RD; Fong, Y; Kemeny, N; Larson, SM; Macapinlac, H; Saldinger, PF; Yeung, H | 1 |
| Hordijk, GJ; Moons, KG; Stokkel, MP; ten Broek, FW; van Rijk, PP | 1 |
| Han, M; Hwang, S; Kim, S; Lee, C; Pai, M; Park, CH | 1 |
| Bongers, V; Hordijk, GJ; Stokkel, MP; van Rijk, PP | 1 |
| Carretta, A; Del Maschio, A; Fazio, F; Gilardi, MC; Landoni, C; Lucignani, G; Magnani, P; Messa, C; Rizzo, G; Vanzulli, A; Zannini, P | 1 |
| Aultman, DF; Boykin, KN; Lilien, DL; McDonald, JC; McMillan, RW; Zibari, GB | 1 |
| Alexiou, C; Arnold, W; Kau, RJ; Laubenbacher, C; Schwaiger, M; Werner, M | 1 |
| Bleckmann, C; Bohuslavizki, KH; Buchert, R; Clausen, M; Dose, J; Jänicke, F; Klutmann, S; Mester, J | 1 |
| Barthelemy, N; Bartsch, P; Bury, T; Corhay, JL; Daenen, F; Duysinx, B; Ghaye, B; Rigo, P | 1 |
| Kase, S; Sasaki, M; Sugimachi, K; Sugio, K; Yamazaki, K | 1 |
| Canady, A; Chugani, DC; Chugani, HT; da Silva, EA; Frost, M; Gates, J; Herholz, K; Juhasz, C; Muzik, O; Nagy, F; Ritter, F; Shah, J; von Stockhausen, HM; Watson, C | 1 |
| Collins, BT; Dunphy, FR; Lowe, VJ | 1 |
| Andersson, AP; Dahlstrøm, K; Drzewiecki, KT; Eigtved, A; Friberg, L; Holm, S; Højgaard, L; Jensen, M; Rabøl, A; Sørensen, SS | 1 |
| Higashi, T; Imamura, M; Itoh, K; Konishi, J; Nakamoto, Y; Sakahara, H; Tamaki, N | 1 |
| Hordijk, GJ; Koole, R; Stokkel, MP; ten Broek, FW; van Rijk, PP | 1 |
| Chen, MY; Greven, KM; Keyes, JW; McGuirt, WF; Watson, NE; Williams, DW | 1 |
| Brown, C; Juillard, G; Mandelkern, M; Mark, R; Rege, S; Sadeghi, A; Safa, A; Santiago, S; Tran, L; Weng, E | 1 |
| Hain, SF; Mikhaeel, NG; O'Doherty, MJ; Timothy, AR | 1 |
| Beger, HG; Brambs, HJ; Diederichs, CG; Glasbrenner, B; Glatting, G; Reske, SN; Staib, L; Vogel, J | 1 |
| Bishop, HA; Graeber, GM; Gupta, NC | 1 |
| Acland, KM; O'Doherty, MJ; Russell-Jones, R | 1 |
| Arai, H; Hara, S; Higuchi, M; Higuchi, S; Itoh, M; Okamura, N; Sasaki, H; Shin, RW; Tashiro, M; Trojanowski, JQ | 1 |
| Li, YF; Liu, RS; Ng, HT; Wang, PH; Yuan, CC | 1 |
| Berger, KL; Dehdashti, F; Nicholson, SA; Siegel, BA | 1 |
| Ishii, K; Katayama, Y; Kitamura, S; Mishina, M; Ohyama, M; Senda, M; Tanizaki, N | 1 |
| Al-Amro, A; Bakheet, SM; Larsson, SG; Mahassin, Z; Powe, J; Saleem, M | 1 |
| Alavi, A; Duarte, PS; Pourdehand, M; Shnier, D; Zhuang, H | 1 |
| Avril, N; Dose, J; Graeff, H; Jänicke, F; Kuhn, W; Nährig, J; Römer, W; Sattler, D; Schelling, M; Schwaiger, M; Werner, M | 1 |
| Ah-See, AK; Chilcott, F; Eremin, O; Gilbert, FJ; Heys, SD; Hutcheon, AW; Miller, ID; Payne, S; Sharp, PF; Smith, IC; Waikar, S; Welch, AE; Whitaker, T | 1 |
| Coleman, RE; Gilland, DR; Laymon, CM; Turkington, TG | 1 |
| Belhocine, T; Daenen, F; Focan, C; Honoré, P; Hustinx, R; Rigo, P | 1 |
| Chaiken, L; Hoh, C; Juillard, G; Rege, S; Safa, AA; Withers, HR | 1 |
| Bjornskov, I; Bretlau, P; Eigtved, A; Friberg, L; Grénman, R; Holm, S; Jensen, M; Jyrkkiö, S; Kurki, T; Lapela, M; Lindholm, P; Minn, H; Nuutinen, J; Sand Hansen, H; Solin, O; Sutinen, E | 1 |
| Choi, JY; Kim, BT; Kim, JJ; Kim, SE; Lee, KH; Lee, KS; Shim, YM | 1 |
| Dörffler, W; Haller, U; Köchli, OR; Kubik-Huch, RA; Marincek, B; Seifert, B; Steinert, HC; von Schulthess, GK | 1 |
| Brambs, HJ; Fenchel, S; Flock, F; Grab, D; Kreienberg, R; Nüssle, K; Reske, SN; Rieber, A; Stöhr, I | 1 |
| Farrell, MA; Herndon, JE; McAdams, HP; Patz, EF | 1 |
| Büll, U; Cremerius, U; Di Martino, E; Hausmann, R; Krombach, GA; Nowak, B; Sellhaus, B; Westhofen, M | 1 |
| Bax, JJ; Boersma, E; Elhendy, A; Poldermans, D; Rambaldi, R; Roelandt, JR; Valkema, R; Vletter, W | 1 |
| Boff, GM; Cardaioli, P; Chioin, R; Dalla Volta, S; Della Valentina, P; Thiene, G; Zanco, P | 1 |
| Birnbaum, EH; Dehdashti, F; Fleshman, JW; Kodner, IJ; Ogunbiyi, OA; Read, TE; Siegel, BA; Whiteford, HM; Whiteford, MH; Yee, LF | 1 |
| Ambrose, JA; Cohen, AM; Dangas, G; Feldman, D; Goldman, ME; Machac, J; Meraj, P; Shao, JH; Sharma, SK | 1 |
| Fidler, V; Groen, HJ; Koëter, GH; Meuzelaar, JJ; Mooyaart, EL; Pieterman, RM; Pruim, J; Vaalburg, W; van Putten, JW | 1 |
| Berlangieri, SU; Scott, AM | 1 |
| Czernin, J; Gambhir, SS; Huebner, RH; Park, KC; Phelps, ME; Schwimmer, J; Shepherd, JE | 1 |
| Barrington, SF; Bullock, P; Cox, T; Maisey, M; Pritchard, D; Robinson, RO; Wilmshurst, JM | 1 |
| Bar-Shalom, R; Blaufox, MD; Valdivia, AY | 1 |
| Dussek, J; Hain, SF; Ng, DC; O'Doherty, MJ | 1 |
| Comans, EF; Golding, RP; Hoekman, K; Hoekstra, OS; Teule, GJ; van der Hoeven, JJ | 1 |
| Dazzi, H; Schaffner, A; Stumpe, KD; von Schulthess, GK | 1 |
| Al-Mohammad, A; Norton, MY; Redpath, TW; Waiter, GD; Walton, S; Welch, A | 1 |
| Aoki, J; Endo, K; Inoue, T; Mohara, S; Sano, K; Shinozaki, T; Takagishi, K; Tokunaga, M; Watanabe, H; Yanagawa, T | 1 |
| Czernin, J; Essner, R; Gambhir, SS; Jahan, SA; Park, K; Patel, A; Phelps, ME; Schwimmer, J; Shepherd, JE | 1 |
| Papatheofanis, FJ | 1 |
| Delbeke, D; Leach, SD; Mertz, HR; Sechopoulos, P | 1 |
| Hain, SF; Harper, PG; Huddart, RA; Leslie, MD; O'Doherty, MJ; Timothy, AR | 1 |
| Bormans, G; Coosemans, W; De Leyn, P; De Wever, W; Dupont, P; Ectors, N; Flamen, P; Haustermans, K; Hiele, M; Lerut, A; Mortelmans, L; Peeters, M; Stroobants, S; Van Cutsem, E; Van Raemdonck, D | 1 |
| Bares, R; Buechin, P; Buell, U; Cremerius, U; Fass, J; Sabri, O; Schumpelick, V; Zimny, M | 1 |
| Belli, F; Bombardieri, E; Cascinelli, N; Crippa, F; Gallino, F; Greco, M; Leutner, M; Pilotti, S | 1 |
| Hara, T; Inagaki, K; Kosaka, N; Morita, T | 1 |
| Becerra, A; Carreras, JL; Gómez, MJ; Llamas-Elvira, JM; López de la Torre, M; Muros, MA; Muros, T; Ramírez-Navarro, A; Rodríguez-Fernández, A | 1 |
| Allaoua, M; Barghouth, G; Goerres, GW | 1 |
| Frank, J; Grosse, S; Guhlmann, A; Halter, G; Liewald, F; Storck, M | 1 |
| Kubota, M; Makuuchi, H; Ohta, M; Okumura, A; Saitoh, Y; Shohtsu, A; Suzuki, Y; Tajima, T; Tokuda, Y; Yasuda, S | 1 |
| Beger, HG; Reske, SN; Schirrmeister, H; Staib, L | 1 |
| Avril, N; Bengel, F; Helmberger, H; Roder, JD; Schwaiger, M; Sendler, A; Siewert, JR; Stollfuss, J; Weber, W | 1 |
| Böhmig, M; Hosten, N; Lemke, AJ; Rosewicz, S; Wiedenmann, B | 1 |
| Bangard, M; Bender, H; Biersack, HJ; Decker, P; Grünwald, F; Willkomm, P | 1 |
| Brecht-Krauss, D; Diederichs, CG; Guhlmann, A; Hartwig, E; Heymer, B; Kotzerke, J; Reske, SN; Sarkar, MR; Schulte, M; Von Baer, A | 1 |
| Fazio, F; Landoni, C; Messa, C; Pozzato, C | 1 |
| Anderson, H; Price, P | 1 |
| Bender, H; Biersack, HJ; Grünwald, F; Guhlke, S; Oehr, P; Ruhlmann, J | 1 |
| Picard, JD | 1 |
| Bousson, V; Breau, JL; de Beco, V; Groiselle, C; Hillali, Y; Moretti, JL; Safi, N; Tamgac, F; Valeyre, D; Weinmann, P | 1 |
| Aznar, M; Gagnon, JH; Lisbona, R; Loutfi, A; Murthy, K; Thompson, CJ | 1 |
| Phelps, ME; Silverman, DH | 1 |
| Coleman, RE; Crain, B; Earl, N; Hanson, M; Hoffman, JM; Hulette, C; Welsh-Bohmer, KA | 1 |
| Charron, M; Dachille, MA; Friedman, D; Luketich, JD; Meehan, M; Meltzer, CC; Strollo, D; Townsend, DW; Urso, GK | 1 |
| Dietlein, M; Gandjour, A; Lauterbach, KW; Moka, D; Schicha, H; Theissen, P; Weber, K | 1 |
| Brambs, HJ; Buchmann, I; Klose, T; Leidl, R; Reske, SN | 1 |
| Ahmed, AR; Aoki, J; Endo, K; Inoue, T; Oriuchi, N; Shinozaki, T; Takagishi, K; Tokunaga, M; Tomiyoshi, K; Watanabe, H; Yanagawa, T | 1 |
| Cambier, JP; De Leyn, P; De Wever, W; Flamen, P; Lerut, A; Maes, A; Mortelmans, L; Peeters, M; Van Cutsem, E; Van Raemdonck, D | 1 |
| Coosemans, W; De Leyn, P; De Wever, W; Decker, G; Deneffe, G; Ectors, N; Flamen, P; Hiele, M; Lerut, T; Mortelmans, L; Peeters, M; Van Cutsem, E; Van Raemdonck, D | 1 |
| Patton, JA | 1 |
| Ameshima, S; Demura, Y; Ishizaki, T; Ito, H; Miyamori, I; Mizuno, S; Okamura, S; Totani, Y; Wakabayashi, M; Yonekura, Y | 1 |
| Aronen, HJ; Hänninen, H; Janatuinen, T; Knuuti, J; Lauerma, K; Mäkelä, T; Mäkijärvi, MA; Niemi, P; Toivonen, L; Voipio-Pulkki, LM | 1 |
| Hong, SB; Kim, SE; Roh, SY; Seo, DW | 1 |
| ChangLai, SP; Chieng, PU; Ho, YJ; Hsieh, JF; Kao, CH; Tsai, SC; Yen, RF | 1 |
| Doi, R; Higashi, T; Hosotani, R; Imamura, M; Kogire, M; Konishi, J; Nakamoto, Y; Sakahara, H; Tamaki, N | 1 |
| Biersack, HJ; Grünwald, F | 1 |
| Mechelany-Corone, C; Pecking, AP; Pichon, MF | 1 |
| Drucker, WD; Ghossein, RA; Larson, SM; Robbins, HK; Robbins, RJ; Sharaf, RN; Smith, A; Tuttle, RM | 1 |
| Lai, YH; Liu, IJ; Segall, GM; Terris, MK; Zafar, MB | 1 |
| Case, L; Chin, R; Dunagan, D; Haponik, E; Harkness, B; McCain, T; Oaks, T | 1 |
| Donckier, JE; Pochet, JM; Roelants, V | 1 |
| Albrecht, SR; Allal, AS; Allaoua, M; Becker, M; Dulguerov, P; Goerres, GW; Haenggeli, CA; Lehmann, W; Slosman, DO | 1 |
| Rerkpattanapipat, P | 1 |
| de Klerk, JM; Hordijk, GJ; Stokkel, MP | 1 |
| Alavi, A; Duarte, PS; Fitzgerald, RH; Garino, JP; Maes, A; Pourdehnad, M; Shnier, D; Van Acker, F; Zhuang, H | 1 |
| Macapinlac, HA | 1 |
| Bax, JJ; Boersma, E; Cornel, JH; Elhendy, A; Fioretti, PM; Poldermans, D; Valkema, R; Van Lingen, A; Visser, CA; Visser, FC | 1 |
| Burger, C; Dimitrakopoulou-Strauss, A; Strauss, LG | 1 |
| Kim, BT; Kim, K; Lee, KS; Park, SJ; Shim, YM | 1 |
| Dehdashti, F; Drebin, JA; Linehan, D; Siegel, BA; Strasberg, SM | 1 |
| Czernin, JR; Gambhir, SS; Park, KC; Phelps, ME; Schiepers, C; Schwimmer, J; Shepherd, JE | 1 |
| Brennan, MF | 1 |
| Ehritt-Braun, C; Högerle, S; Ihling, C; Krause, TM; Mix, M; Moser, E; Reinhardt, MJ; Vogelgesang, D | 1 |
| Breuer, R; Chisin, R; Rubinstein, R | 1 |
| Bohuslavizki, KH; Buchert, R; Bumann, D; Clausen, M; de Wit, M; Hossfeld, DK | 1 |
| Miles, KA | 1 |
| Akioka, K; Muro, T; Takeuchi, K; Tani, T; Teragaki, M; Watanabe, H; Yamagishi, H; Yoshikawa, J | 1 |
| Bax, JJ; Boersma, E; Elhendy, A; Poldermans, D; Rahimtoola, SH | 1 |
| Benz, P; Förster, GJ; Grötz, KA; Kunkel, M; Kutzner, J; Rippins, G; Wagner, W; Wahlmann, U | 1 |
| Kuwert, T | 1 |
| Visser, FC | 1 |
| Carette, MF; Cosset, JM; Deniaud-Alexandre, E; Giraud, P; Grahek, D; Housset, M; Julia, F; Montravers, F; Rosenwald, JC; Talbot, JN; Touboul, E | 1 |
| Devillé, WL; Hoekstra, OS; Mijnhout, GS; Teule, GJ; van Tulder, MW | 1 |
| Ho, YJ; Hung, GU; Kao, CH; Shiau, YC; Tsai, SC; Yen, RF | 1 |
| Ahn, IM; Cho, BY; Chung, JK; Hong, SJ; Kim, S; Lee, DS; Lee, E; Lee, MC; So, Y; Yeo, JS; Youn, YK | 1 |
| Bleichrodt, RP; Filez, L; Flamen, P; Hoekstra, OS; Homans, F; Maes, A; Mortelmans, L; Peeters, M; Penninckx, F; Stroobants, S; Van Cutsem, E | 1 |
| Alyafei, S; Endo, K; Inoue, T; Oriuchi, N; Tian, M; Zhang, H | 1 |
| Angelides, S; Dixon, J; Roman, MR; Rossleigh, MA; Walker, BM | 1 |
| DePalatis, LR; Desai, DC; Martin, EW; Soble, D; Zervos, EE | 1 |
| de Vries, EG; Groen, HJ; Jager, PL; Piers, DA; Pieterman, RM; van der Leest, A; van Putten, JW | 1 |
| Burger, C; Dimitrakopoulou-Strauss, A; Heichel, T; Lehnert, T; Mechtersheimer, G; Schwarzbach, M; Strauss, LG; Willeke, F | 1 |
| Aerts, R; D'Hoore, A; Filez, L; Flamen, P; Mortelmans, L; Penninckx, F; Topal, B; Van Cutsem, E | 1 |
| Alavi, A; Liu, Y; Pourdehnad, M; Sinha, P; Yamamoto, AJ; Zhuang, H | 1 |
| Hoegerle, S; Joe, A; Moser, E | 1 |
| Buck, A; Dankerl, A; Reske, SN; Schirrmeister, H | 1 |
| Fujii, H; Ide, M; Makuuchi, H; Mukai, M; Nakasaki, H; Sadahiro, S; Shohtsu, A; Suzuki, Y; Tajima, T; Yasuda, S | 1 |
| Fischer, U; Georgi, P; Hesse, S; Horn, LC; Kluge, R; Kühnel, G; Seese, A | 1 |
| Fujii, S; Higuchi, T; Ishimori, T; Konishi, J; Mamede, M; Mandai, M; Nakamoto, Y; Saga, T; Sakahara, H; Togashi, K | 1 |
| Börner, AR; Hofmann, M; Knapp, WH; Kreipe, HH; Otto, D; Petrich, T; Soudah, B; Weckesser, E; Widjaja, A | 1 |
| Cho, BY; Chung, JK; Jang, JJ; Jeong, JM; Lee, DS; Lee, MC; Lee, YJ; Min, JJ | 1 |
| Cook, GJ | 1 |
| Ito, Y; Katoh, C; Kitabatake, A; Kohya, T; Komuro, K; Kuge, Y; Morita, K; Tamaki, N; Yamada, S; Yoshinaga, K | 1 |
| Klain, M; Mainolfi, C; Maurea, S; Salvatore, M; Ziviello, M | 1 |
| Lawson, MA | 1 |
| Christian, PE; Di Bella, EV; Kadrmas, DJ | 1 |
| Bajzik, G; Dabasi, G; Esik, O; Füzy, M; Kásler, M; Lengyel, Z; Perner, F; Repa, I; Szakáll, S; Szavcsur, P; Szentirmay, Z; Trón, L | 1 |
| Goldstraw, P; Kutlu, CA; Maisey, M; Pastorino, U | 1 |
| Bielack, S; Daldrup-Link, HE; Franzius, C; Jürgens, H; Rummeny, EJ; Schober, O; Sciuk, J | 1 |
| Avril, NE; Becker, K; Busch, R; Dittler, HJ; Fink, U; Helmberger, H; Meisetschläger, G; Ott, K; Schwaiger, M; Siewert, JR; Weber, WA | 1 |
| Barnett, G; Chao, ST; Lee, SY; Raja, S; Suh, JH | 1 |
| Daldrup-Link, HE; Franzius, C; Jürgens, H; Laukamp, D; Link, TM; Rummeny, EJ; Schober, O; Sciuk, J | 1 |
| Alyafei, S; Aoki, J; Endo, K; Inoue, T; Koyama, K; Oriuchi, N; Suzuki, H; Takeuchi, K; Tomaru, Y; Tomiyoshi, K; Yuan, Z | 1 |
| Abdul-Karim, FW; Faulhaber, P; Miraldi, F; Rose, PG | 1 |
| Avril, N; Link, T; Peschel, C; Sandherr, M; Stock, K; von Bubnoff, N; von Schilling, C | 1 |
| Aoki, J; Endo, K; Ichikawa, A; Inoue, T; Koyama, K; Matsubara, K; Oriuchi, N; Sato, N; Suzuki, H; Tomiyoshi, K | 1 |
| Adam, LE; Alavi, A; Alnafisi, N; Herman, C; Kim, W; Yun, M | 1 |
| Bohuslavizki, KH; Buchert, R; Lorenzen, J | 1 |
| Braga, FJ; Flamen, P; Maes, A; Mortelmans, L; Peetermans, W; Vanteenkiste, P | 1 |
| Alavi, A; Ghesani, N; Yamamoto, AJ; Zhuang, H | 1 |
| Cousins, C; deSouza, NM; Dina, R; Fuchsel, F; McIndoe, GA; Mubashar, M; Peters, AM; Soutter, WP; Williams, AD | 1 |
| Brink, I; Hasse, J; Imdahl, A; Jenkner, S; Moser, E; Nitzsche, E; Stoelben, E | 1 |
| Adams, S; Baum, RP; Kovács, AF; Stuckensen, T | 1 |
| Ho, ST; Ho, YJ; Kao, CH; Tsai, SC; Wang, JJ; Yen, RF | 1 |
| Kubota, M; Makuuchi, H; Nasu, S; Ohta, M; Shohtsu, A; Suzuki, Y; Tajima, T; Tokuda, Y; Yasuda, S | 1 |
| Davidson, D; Hutchins, G; Jung, SH; Schauwecker, DS; Wagner, JD; Wenck, S | 1 |
| Altehoefer, C; Ghanem, N; Hoegerle, S; Koehler, G; Moser, E; Nitzsche, E; Scheruebl, H; Waller, CF | 1 |
| Austin-Seymour, MM; Charlop, A; Eary, JF; Ellis, GK; Eubank, WB; Funkhouser, CP; Gralow, JR; Lindsley, KL; Livingston, RB; Mankoff, DA; Shanley, TJ; Takasugi, J; Vesselle, H | 1 |
| Beguin, Y; Fassotte, MF; Fillet, G; Hustinx, R; Jerusalem, G; Najjar, F; Rigo, P | 1 |
| Alavi, A; Alsop, DC; Detre, JA; French, JA; Gonzalez-Atavales, J; Levy-Reis, I; Maldjian, JA; Meyer, PT; Wolf, RL | 1 |
| Bertoldo, A; Cobelli, C; Knuuti, J; Nuutila, P; Oikonen, V; Peltoniemi, P | 1 |
| Bishop, HA; Graeber, GG; Gupta, NC; Hobbs, GR; Tamim, WJ | 1 |
| Gallowitsch, HJ; Gomez, I; Grünbacher, G; Heinisch, M; Kogler, D; Kresnik, E; Kumnig, G; Lind, P; Mikosch, P; Raunik, W; Unterweger, O; Wiesser, S | 1 |
| Gröschel, A; Hellwig, D; Kirsch, CM; Rentz, K; Sybrecht, GW; Ukena, D | 1 |
| Bamberg, M; Hellwig, D; Kirsch, CM; Paulsen, F; Ukena, D | 1 |
| Coche, E; Lonneux, M; Noirhomme, P; Poncelet, AJ; Weynand, B | 1 |
| Coates, G; Nahmias, C; O'Donovan, N; Otero, C; Pelling, M; Skehan, SJ | 1 |
| Becherer, A; Bokemeyer, C; De Santis, M; Dittrich, C; Dohmen, BM; Kletter, K; Oechsle, K; Pont, J; Stoiber, F | 1 |
| Alavi, A; Fraker, DL; Mercier, GA | 1 |
| Choe, KJ; Chung, JK; Kim, TS; Lee, DS; Lee, MC; Moon, WK; Noh, DY; Oh, SK; Youn, YK | 1 |
| Beggs, AD; Curran, KM; Fogelman, I; Hain, SF; Maisey, MN; O'Doherty, MJ | 1 |
| Franc, B; Gauthier-Koelesnikov, H; Helal, BO; Merlet, P; Prigent, A; Schvartz, C; Syrota, A; Toubert, ME | 1 |
| Higashi, K; Katsuda, S; Oguchi, M; Sakuma, T; Seki, H; Taki, S; Taniguchi, M; Tonami, H; Ueda, Y; Yamamoto, I | 1 |
| Gerber, E; Knoll, P; Köhn, H; Kumpan, W; Mirzaei, S; Raderer, M; Schiessel, R; Schratter-Sehn, AU | 1 |
| Schumpelick, V; Zimny, M | 1 |
| Amthauer, H; Felix, R; Schlag, PM; Stroszczynski, C | 1 |
| Fillet, G; Hustinx, R; Jerusalem, G; Najjar, F; Rigo, P | 1 |
| Biemann, S; Buell, U; Nowak, B; Rath, W; Schröder, W; Siggelkow, W; Zimny, M | 1 |
| Chan, F; Chan, WL; Freund, J; McBride, B; Pocock, NA; Sorensen, BJ; Szeto, E | 1 |
| Totsuka, T | 1 |
| Derlon, JM | 1 |
| Chierichetti, F; Ferlin, G; Liessi, G; Pasquali, C; Pedrazzoli, S; Sperti, C | 1 |
| Alavi, A; Alexander, GE; Chang, CY; Chen, W; Clark, CM; Cummings, JL; Czernin, J; de Leon, MJ; Gambhir, SS; Hoffman, JM; Hoh, CK; Jagust, WJ; Kowell, AP; Kung De Aburto, MA; Lu, CS; Mielke, R; Phelps, ME; Pietrini, P; Rapoport, SI; Salmon, E; Schapiro, MB; Silverman, DH; Small, GW; Welsh-Bohmer, KA | 1 |
| Bohuslavizki, KH; Brandt-Mainz, K; Bredow, J; Diehl, M; Dietlein, M; Grünwald, F; Körber, C; Lange, H; Matheja, P; Risse, JH | 1 |
| Alavi, A; Zhuang, H | 1 |
| Bax, JJ; Borghetti, A; De Sutter, J; Elhendy, A; Poldermans, D; Roelandt, JR; Schinkel, AF; Sozzi, FB; Valkema, R; Vourvouri, EC | 1 |
| Haberkorn, U | 1 |
| Buell, U; Foltys, H; Gilsbach, JM; Kemeny, S; Korinth, M; Krings, T; Meyer, PT; Möller-Hartmann, W; Reinges, MH; Rohde, V; Sabri, O; Schreckenberger, M; Spetzger, U; Thron, A | 1 |
| Brinkbäumer, K; Dresel, S; Hahn, K; Pöpperl, G; Schmid, R; Schwenzer, K; Szeimies, U | 1 |
| Broelsch, EC; Clausen, M; Frilling, A; Görges, R; Tecklenborg, K; Weber, F | 1 |
| Arulampalam, T; Boulos, P; Costa, D; Ell, P; Taylor, I; Visvikis, D | 1 |
| Drenth, JP; Nagengast, FM; Oyen, WJ | 1 |
| Elsinga, P; Jager, PL; Plukker, JT; Pruim, J; Que, TH; Vaalburg, W | 1 |
| Alavi, A; Alnafisi, N; Jang, S; Kim, W; Lacorte, L; Yun, M | 1 |
| Avril, N; Breul, J; Hartung, R; Hofer, C; Kübler, H | 1 |
| Bongers, V; Hordijk, GJ; Terhaard, CH; van Rijk, PP | 1 |
| Borbély, K | 1 |
| Swanson, RS | 1 |
| Alexander, HR; Bacharach, SL; Bartlett, DL; Carrasquillo, JA; Choyke, P; Eckelman, WC; Jousse, F; Kranda, K; Libutti, SK; Neumann, RD; Whatley, M | 1 |
| Bombardieri, E; Crippa, F | 1 |
| Baum, RP; Przetak, C | 1 |
| De Landsheere, CM; Degueldre, C; Kulbertus, HE; Lancellotti, P; Melon, PG; Pierard, LA | 1 |
| Akhurst, T; Cai, S; Gonen, M; Larson, SM; Macapinlac, HA; Nuñez, R; Osman, I; Riedel, E; Scher, HI; Yeung, HW | 1 |
| Choi, NC; Fischman, AJ; Lynch, TJ; Mathisen, DJ; Ryu, JS | 1 |
| Biersack, HJ; Gassel, F; Grünwald, F; Risse, JH; Schmitt, O; Schmitz, A | 1 |
| Altenvoerde, G; Becker, W; Köster, G; Lehmann, K; Liersch, T; Meller, J; Meyer, I; Schreiber, K; Siefker, U | 1 |
| Altiok, E; Büll, U; Hanrath, P; Heussen, N; Hoffmann, R; Kaiser, HJ; Kühl, H; Nowak, B | 1 |
| Czernin, J; Figlin, R; Hoh, CK; Phelps, ME; Safaei, A; Seltzer, M; Silverman, DH | 1 |
| Adamson, K; Begent, RH; Buscombe, JR; Green, A; Hilson, AJ; Lieberman, G; MacLean, AB; Reid, WM | 1 |
| Akino, H; Kanamaru, H; Muramoto, S; Okada, K; Oyama, N; Sadato, N; Suzuki, Y; Yamamoto, K; Yonekura, Y | 1 |
| Adler, LP; Siegel, BA; Wahl, RL | 1 |
| Albes, JM; Dohmen, BM; Schott, U; Schülen, E; Wehrmann, M; Ziemer, G | 1 |
| Bares, R; Bokemeyer, C; Claussen, CD; Dohmen, BM; Kanz, L; Kollmannsberger, C; Oechsle, K; Pfannenberg, A | 2 |
| Chung, CK; Chung, JK; Kang, KW; Kim, SK; Kim, YK; Lee, DS; Lee, MC; Lee, SK | 1 |
| Ricart, Y | 1 |
| Cabrera Villegas, A; Gámez Cenzano, C; Martín Urreta, JC | 1 |
| Guller, U; Harder, F; Langer, I; Marti, WR; Moch, H; Nitzsche, EU; Oertli, D; Schirp, U; Torhorst, J; Viehl, CT; Zuber, M | 1 |
| Czernin, J; Filmont, JE; Meta, J; Phelps, ME; Rao, J; Silverman, DH; Valk, PE; Vranjesevic, D | 1 |
| Alberini, JL; Bertrand-Kermorgant, F; Floiras, JL; Goupil, A; Mechelany-Corone, C; Pecking, AP; Pichon, MF | 1 |
| de Man, RA; Krenning, EP; Valkema, R; Verhoef, C; Yzermans, JN | 1 |
| Hoskin, PJ | 1 |
| Bax, JJ; Boersma, E; Elhendy, A; Poldermans, D; van Lingen, A; Visser, CA; Visser, FC | 1 |
| Eichhorn, K; Freitag, P; Gratzl, O; Hofer, S; Maecke, R; Merlo, A; Mueller-Brand, J; Probst, A; Reubi, JC; Schumacher, T; Wasner, M; Zimmerer, S | 1 |
| Binns, DS; Greer, B; Hicks, RJ; Hogg, A; Kalff, V; Ware, RE | 1 |
| Altenvoerde, G; Becker, W; Béhé, M; Behr, TM; Dörner, J; Fischer, U; Grabbe, E; Gratz, S; Meller, J | 1 |
| Bormans, G; De Potter, T; Filez, L; Flamen, P; Maes, A; Mortelmans, L; Penninckx, F; Van Cutsem, E | 1 |
| Beggs, AD; Curran, KM; Hain, SF; O'Doherty, MJ | 1 |
| Beuthien-Baumann, B; Burchert, W; Franke, WG; Hakenberg, OW; Kropp, J; Manseck, A; Tiepolt, C; Tsatalpas, P; Wirth, MP | 1 |
| Coleman, M; Goldsmith, SJ; Kostakoglu, L; Kuji, I; Leonard, JP; Vallabhajosula, S | 1 |
| Endo, K; Inoue, T; Kato, H; Kuwano, H; Miyazaki, T; Nakajima, M; Ojima, H; Oriuchi, N; Tsukada, K; Yoshikawa, M | 1 |
| Hasegawa, S; Hori, M; Maruyama, A; Maruyama, K; Nishimura, T; Paul, AK; Xiuli, M; Yoshioka, J | 1 |
| Pfaltz, M; Schmid, S; Steinert, H; Stoeckli, SJ | 1 |
| Bernd, L; Burger, C; Dimitrakopoulou-Strauss, A; Ewerbeck, V; Heichel, T; Strauss, LG; Wu, H | 1 |
| Hill, AD; O'Higgins, NJ; Prichard, RS; Skehan, SJ | 1 |
| Flamen, P | 1 |
| Adèr, HJ; Boers, M; Comans, EF; De Gast, GC; Hoekstra, OS; Mijnhout, GS; Raijmakers, P; Teule, GJ | 1 |
| Börner, AR; Hofmann, M; Knapp, WH; Otto, D; Petrich, T | 1 |
| Klein, LJ; Lammertsma, AA; van der Weerdt, AP; Visser, CA; Visser, FC | 1 |
| Murata, H; Tamura, K; Tsujii, H; Yoshikawa, K | 1 |
| Bormans, G; Cambier, JP; De Leyn, P; De Wever, W; Ectors, N; Flamen, P; Haustermans, K; Lerut, A; Maes, A; Mortelmans, L; Van Cutsem, E; Van Raemdonck, D | 1 |
| Herndon, JE; Marom, EM; Patz, EF; Sarvis, S | 1 |
| Biro, P; Buck, A; Burger, C; Weber, B | 1 |
| Dietz, A; Eisenhut, M; Haberkorn, U; Henze, M; Mier, W; Mohammed, A; Nollert, J; Rudat, V | 1 |
| Buck, A; Burger, C; Hany, TF; Kamel, E; Lonn, AH; Treyer, V; von Schulthess, GK | 1 |
| Bergmann, L; Bommer, M; Buck, AK; Bunjes, D; Döhner, H; Messer, P; Müller, S; Reske, SN; Schirrmeister, H | 1 |
| Buck, A; Goerres, GW; Hany, TF; Kamel, E; von Schulthess, GK | 1 |
| Croft, DR; Galvin, J; Gross, T; Kern, JA; Kernstine, K; Kirchner, P; McLennan, G; Mullan, B; Peterson, MW; Trapp, J | 1 |
| Chung, CK; Hong, KS; Kim, JY; Lee, DS; Lee, SK | 1 |
| Hikosaka, K; Hosokawa, M; Kato, T; Kohanawa, M; Kuge, Y; Mochizuki, T; Nakada, K; Tamaki, N; Tsukamoto, E; Zhao, S | 1 |
| Byun, SS; Choe, YS; Kim, BT; Lee, KH; Paik, JY | 1 |
| Bax, JJ; Boersma, E; Camici, PG; Fath-Ordoubadi, F; Wijns, W | 1 |
| Futatsubashi, M; Kanno, T; Maeda, M; Nobezawa, S; Okada, H; Ouchi, Y; Takekuma, M; Torizuka, T; Yoshikawa, E | 1 |
| Brown, RS; Goodman, TM; Greenson, JK; Wahl, RL; Zasadny, KR | 1 |
| Brambs, HJ; Fenchel, S; Grab, D; Kotzerke, J; Kreienberg, R; Nuessle, K; Reske, SN; Rieber, A | 1 |
| Gabalski, EC; Gona, JM; Husain, S; Myers, LL; Nabi, H; Wax, MK | 1 |
| Coleman, RE; DeGrado, TR; Liao, RP; Polascik, TJ; Price, DT; Robertson, CN | 1 |
| Fahey, FH | 1 |
| Dagdelen, O; Hahn, K; Jäger, L; Lang, S; Pöpperl, G; Tatsch, K; Tiling, R | 1 |
| Ito, K; Kato, T | 1 |
| Higuchi, T | 1 |
| Bégány, A; Esik, O; Galuska, L; Gilde, K; Hunyadi, J; Ocsai, H; Szakáll, S; Török, L; Trón, L | 1 |
| Ambrus, E; Csernay, L; Farkas, G; Lonovics, J; Papós, M; Pávics, L; Szakáll, S; Takács, T; Trón, L | 1 |
| Avril, N; Dose, J; Rosé, C | 1 |
| Hahn, K; Knesewitsch, P; Manthey, N; Moog, F; Reinhard, P; Tatsch, K | 1 |
| Alavi, A; Cuchiara, A; Hickeson, M; Matthies, A | 1 |
| Cho, BJ; Chung, SK; Haynie, TP; Kim, CG; Kim, EE; Moser, RP; Podoloff, DA; Tilbury, RS; Yang, DJ; Yung, WK | 1 |
| Berman, DS; Friedman, J; Garcia, EV; Kiat, H; Maddahi, J; Van Train, KF | 1 |
579 review(s) available for fluorodeoxyglucose f18 and Sensitivity and Specificity
| Article | Year |
|---|---|
Diagnostic efficacy of combined CT and MRI in detecting nodal metastasis in patients with oral cancer.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Mouth Neoplasms; Sensitivity and Specificity; Tomography, X-Ray Computed | 2022 |
Diagnostic Test Accuracy of 18F-FDG PET or PET/CT for Characterization of Histologic Type of Thymic Epithelial Tumor: A Meta-analysis.
Topics: Diagnostic Tests, Routine; Fluorodeoxyglucose F18; Humans; Neoplasms, Glandular and Epithelial; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Thymus Neoplasms | 2022 |
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neuroectodermal Tumors, Primitive, Peripheral; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma, Ewing; Sensitivity and Specificity; Tomography, X-Ray Computed | 2022 |
Positron emission tomography-computed tomography (PET-CT) in suspected malignant pleural effusion. An updated systematic review and meta-analysis.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Pleural Effusion; Pleural Effusion, Malignant; Pleural Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2021 |
PET/CT and PET/MR Imaging of the Post-treatment Head and Neck: Traps and Tips.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2022 |
Systematic review and meta-analysis of the diagnostic effectiveness of positron emission tomography-computed tomography versus magnetic resonance imaging in the post-treatment surveillance of head and neck squamous cell carcinoma.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck | 2023 |
Diagnostic Performance of 18F-FDG PET/CT for Lymph Node Staging in Penile Cancer.
Topics: Fluorodeoxyglucose F18; Humans; Lymph Nodes; Male; Neoplasm Staging; Penile Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2022 |
Diagnostic performance of MRI, SPECT, and PET in detecting renal cell carcinoma: a systematic review and meta-analysis.
Topics: Adult; Aged; Carcinoma, Renal Cell; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Young Adult | 2022 |
Is Delayed Image of 18F-FDG PET/CT Necessary for Mediastinal Lymph Node Staging in Non-Small Cell Lung Cancer Patients?
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2022 |
Quantifying the contribution of
Topics: Adult; Child; Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2022 |
Does PET scan have any role in the diagnosis of perineural spread associated with the head and neck tumors?
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2022 |
Diagnostic Accuracy of Cardiac MRI versus FDG PET for Cardiac Sarcoidosis: A Systematic Review and Meta-Analysis.
Topics: Adult; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Myocarditis; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Sensitivity and Specificity | 2022 |
Comparison of Preoperative Imaging Modalities for the Assessment of Malignant Potential of Pancreatic Cystic Lesions: A Network Meta-analysis.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Network Meta-Analysis; Pancreatic Cyst; Pancreatic Neoplasms; Positron-Emission Tomography; Sensitivity and Specificity | 2022 |
Diagnostic Test Accuracy of 18 F-FDG PET or PET/CT in Merkel Cell Carcinoma.
Topics: Carcinoma, Merkel Cell; Diagnostic Tests, Routine; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Skin Neoplasms | 2022 |
The increasing indications of FDG-PET/CT in the staging and management of Invasive Bladder Cancer.
Topics: Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Urinary Bladder Neoplasms | 2022 |
The Role of Preoperative Imaging in the Detection of Lateral Lymph Node Metastases in Rectal Cancer: A Systematic Review and Diagnostic Test Meta-analysis.
Topics: Diagnostic Tests, Routine; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Rectal Neoplasms; Sensitivity and Specificity | 2022 |
Comparison of cardiac magnetic resonance imaging and fluorodeoxyglucose positron emission tomography in the assessment of cardiac sarcoidosis: Meta-analysis and systematic review.
Topics: Cardiomyopathies; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Myocarditis; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Sensitivity and Specificity | 2023 |
Diagnostic Performance of PET/MRI in Breast Cancer: A Systematic Review and Bayesian Bivariate Meta-analysis.
Topics: Bayes Theorem; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2023 |
Comparison of the Detection Performance Between FAP and FDG PET/CT in Various Cancers: A Systemic Review and Meta-analysis.
Topics: Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2023 |
Comparison of whole-body 18F-FDG PET/CT and PET/MRI for distant metastases in patients with malignant tumors: a meta-analysis.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2023 |
Diagnostic performance of diffusion-weighted imaging versus 18F-FDG PET/CT in differentiating pulmonary lesions: an updated meta-analysis of comparative studies.
Topics: Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Multiple Pulmonary Nodules; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2023 |
The Diagnostic Value of 18F-FDG PET/CT Scan in Characterizing Adrenal Tumors.
Topics: Adrenal Gland Neoplasms; Adult; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity | 2023 |
Predictive Value of 18 F-FDG PET/CT for Assessment of Tumor Response to Neoadjuvant Chemotherapy in Bladder Cancer.
Topics: Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Urinary Bladder Neoplasms | 2023 |
Lymph nodes primary staging of colorectal cancer in 18F-FDG PET/MRI: a systematic review and meta-analysis.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Magnetic Resonance Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2023 |
Breast Cancer Systemic Staging (Comparison of Computed Tomography, Bone Scan, and 18F-Fluorodeoxyglucose PET/Computed Tomography).
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2023 |
Hepato-Biliary Imaging in an Acute Setting: Is There a Role for Nuclear Medicine?
Topics: Acute Disease; Emergencies; Fluorodeoxyglucose F18; Humans; Nuclear Medicine; Pancreatitis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2023 |
The diagnostic performance of 18 fluorine-fluorodeoxyglucose PET for brain metastases: a systematic review and meta-analysis.
Topics: Brain; Brain Neoplasms; Fluorine; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2023 |
Topics: Acetogenins; Acute Disease; Acute Kidney Injury; Administration, Intravenous; Aged; Albumins; Alcoholism; Aldehyde Dehydrogenase; Aldehyde Dehydrogenase, Mitochondrial; alpha-Glucosidases; Anemia; Animals; Anthozoa; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bacterial; Antigens, Bacterial; Antihypertensive Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Ascites; Asthma; Bacteria; beta-Lactamases; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Binding Sites; Biological Availability; Biomass; Borderline Personality Disorder; Brain; Brucella abortus; Brucella melitensis; Brucellosis; Calcium; Carbapenems; Case-Control Studies; Caseins; Cattle; CD8-Positive T-Lymphocytes; Ceftaroline; Cell Line; Cell Line, Tumor; Cell Physiological Phenomena; Cell Proliferation; Cephalosporins; Chemotherapy, Adjuvant; China; Chitin; Chlorella; Chlorophyll; Chlorophyll A; Chlorophyta; Cholangiocarcinoma; Cisplatin; Conotoxins; Contrast Media; Conus Snail; Cross-Sectional Studies; Cytokines; Decapodiformes; Deoxycytidine; Diagnostic and Statistical Manual of Mental Disorders; Dietary Fiber; Diterpenes; DNA Methylation; Dogs; Double-Blind Method; Drug Design; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Screening Assays, Antitumor; Eicosapentaenoic Acid; Enzyme-Linked Immunosorbent Assay; Epidermis; Escherichia coli; Escherichia coli Infections; Extraintestinal Pathogenic Escherichia coli; Fatty Acids; Fatty Acids, Unsaturated; Fatty Acids, Volatile; Feasibility Studies; Feces; Female; Ferritins; Fluorodeoxyglucose F18; Gastrectomy; Gastrointestinal Microbiome; Gemcitabine; Glomerular Filtration Rate; Glucose; Glycerol; Granulocyte-Macrophage Colony-Stimulating Factor; HeLa Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Hypoxia-Inducible Factor-Proline Dioxygenases; Immunoassay; Immunoglobulin G; India; Infant, Newborn; Infertility; Inflammation; Intensive Care Units; Iron; Iron Deficiencies; Kidney; Lacticaseibacillus rhamnosus; Laurencia; Leukocytes; Lipids; Liver Cirrhosis; Long Interspersed Nucleotide Elements; Longitudinal Studies; Male; Mesenchymal Stem Cells; Methicillin-Resistant Staphylococcus aureus; Mice; Microalgae; Microbial Sensitivity Tests; Microscopy; Middle Aged; Minerals; Molecular Conformation; Molecular Docking Simulation; Molecular Structure; Mycobacterium tuberculosis; Myeloid Cells; Myeloid-Derived Suppressor Cells; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Nephropidae; Nicotinic Antagonists; Nitrogen; Obesity; Oxaliplatin; Paclitaxel; Panax; Pancreatic Neoplasms; Pancreatitis; Personality; Personality Disorders; Personality Inventory; Photobioreactors; Plant Extracts; Plasmalogens; Plasmids; Polymorphism, Genetic; Polynesia; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prebiotics; Predictive Value of Tests; Prognosis; Prolyl-Hydroxylase Inhibitors; Rabbits; Radiopharmaceuticals; Rats; Rats, Wistar; Receptors, Nicotinic; Recombinant Proteins; Retrospective Studies; Rifampin; Risk Factors; RNA, Ribosomal, 16S; Salinity; Seaweed; Sensitivity and Specificity; Sepsis; Sesquiterpenes; Severity of Illness Index; Shock, Septic; Silicones; Single Photon Emission Computed Tomography Computed Tomography; Skin; Snails; Solubility; Solvents; Sputum; Staphylococcal Infections; Stomach Neoplasms; Stramenopiles; Structure-Activity Relationship; Technetium Tc 99m Exametazime; Technology; Terpenes; Tuberculosis; Tuberculosis, Multidrug-Resistant; Urinary Catheters; Urinary Tract Infections; Vascular Endothelial Growth Factor A; Virulence Factors; Water; Wound Healing | 2023 |
Diagnostic performance of noninvasive imaging using computed tomography, magnetic resonance imaging, and positron emission tomography for the detection of ovarian cancer: a meta-analysis.
Topics: Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2023 |
Bone metastases with "false negative" findings on 18F-FDG PET/CT in patients with angiosarcoma: A case series with literature review.
Topics: Adult; Bone Marrow Diseases; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Hemangiosarcoma; Humans; Mastectomy; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2023 |
[
Topics: Anal Canal; Fluorodeoxyglucose F18; Humans; Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2023 |
Comparison of cardiac magnetic resonance imaging and fluorodeoxyglucose positron emission tomography in the assessment of myocardial viability: meta-analysis and systematic review.
Topics: Aged; Female; Fluorodeoxyglucose F18; Heart; Humans; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2023 |
Diagnostic accuracy of whole-body magnetic resonance imaging versus positron emission tomography-computed tomography for the staging of pediatric lymphoma: a systematic review and meta-analysis.
Topics: Child; Fluorodeoxyglucose F18; Humans; Lymphoma; Magnetic Resonance Imaging; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2023 |
Arterial spin labeling (ASL-MRI) versus fluorodeoxyglucose-PET (FDG-PET) in diagnosing dementia: a systematic review and meta-analysis.
Topics: Dementia; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Spin Labels | 2023 |
[Importance of FDG-PET/computed tomography in colorectal cancer].
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2019 |
Fluorodeoxyglucose PET for Monitoring Response to Embolotherapy (Transarterial Chemoembolization) in Primary and Metastatic Liver Tumors.
Topics: Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Female; Fluorodeoxyglucose F18; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Monitoring, Physiologic; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome; Tumor Microenvironment | 2019 |
Advances in Functional Imaging in the Assessment of Head and Neck Cancer.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neuroendocrine Tumors; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Radioactive Tracers; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2019 |
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Ontario; Paraneoplastic Syndromes, Nervous System; Retrospective Studies; Sensitivity and Specificity; Young Adult | 2019 |
Diagnostic performance of FDG PET/CT in critically ill patients with suspected infection: A systematic review and meta-analysis.
Topics: Critical Illness; Fluorodeoxyglucose F18; Humans; Infections; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2020 |
Whole body FDG-PET/CT for the assessment of bone marrow infiltration in patients with newly diagnosed lymphoma.
Topics: Adult; Aged; Biopsy; Bone Marrow; Bone Marrow Examination; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Ilium; Liver; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Whole Body Imaging; Young Adult | 2020 |
Clinical Use of Integrated Positron Emission Tomography-Magnetic Resonance Imaging for Dementia Patients.
Topics: Aged; Brain; Dementia; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2019 |
Diagnostic value of PET/CT versus PET/MRI in gynecological malignancies of the pelvis: A meta-analysis.
Topics: Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Magnetic Resonance Imaging; Pelvis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2020 |
Alternative and New Radiopharmaceutical Agents for Lung Cancer.
Topics: Acetates; Carbon Radioisotopes; Dideoxynucleosides; Fluorodeoxyglucose F18; Gallium Isotopes; Gallium Radioisotopes; Humans; Lung Neoplasms; Methionine; Misonidazole; Neoplasm Staging; Neuroendocrine Tumors; Peptides; Peptides, Cyclic; Positron Emission Tomography Computed Tomography; Quinolines; Radiopharmaceuticals; Sensitivity and Specificity | 2020 |
Meta-Analysis of the Diagnostic Accuracy of Primary Bone and Soft Tissue Sarcomas by 18F-FDG-PET.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Sarcoma; Sensitivity and Specificity; Soft Tissue Neoplasms; Tomography, X-Ray Computed | 2020 |
Molecular Imaging of Pulmonary Inflammation and Infection.
Topics: Citrates; Fluorodeoxyglucose F18; Gallium; Humans; Lung; Lung Diseases; Magnetic Resonance Imaging; Molecular Imaging; Pneumonia; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2020 |
Diagnostic Performance of F-18 Fluorodeoxyglucose Positron Emission Tomography or Positron Emission Tomography/Computed Tomography for Differentiation of Benign and Malignant Vertebral Compression Fractures: A Meta-Analysis.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Fractures, Compression; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Sensitivity and Specificity; Spinal Fractures | 2020 |
18F-FDG PET/CT and whole-body MRI diagnostic performance in M staging for non-small cell lung cancer: a systematic review and meta-analysis.
Topics: Carcinoma, Non-Small-Cell Lung; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Whole Body Imaging | 2020 |
18F-Fluorodeoxyglucose PET/Computed Tomography in the Diagnosis and Monitoring of Giant Cell Arteritis.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2020 |
Use of
Topics: Cost-Benefit Analysis; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Polymyalgia Rheumatica; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2020 |
FDG-PET/CT in Inflammatory Bowel Disease: Is There a Future?
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Inflammatory Bowel Diseases; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2020 |
PET/Computed Tomography in Pulmonary and Thoracic Inflammatory Diseases (Including Cardiac Sarcoidosis): The Current Role and Future Promises.
Topics: Arteritis; Cardiomyopathies; Diagnosis, Differential; Fluorodeoxyglucose F18; Histiocytic Necrotizing Lymphadenitis; Humans; Lupus Erythematosus, Systemic; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Pulmonary Disease, Chronic Obstructive; Radiopharmaceuticals; Sarcoidosis; Sensitivity and Specificity; Thoracic Diseases | 2020 |
FDG-PET/CT in Fever of Unknown Origin, Bacteremia, and Febrile Neutropenia.
Topics: Algorithms; Bacteremia; Diagnosis, Differential; Febrile Neutropenia; Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2020 |
18F-Fluorodeoxyglucose PET/Computed Tomography in Endocarditis.
Topics: Diagnosis, Differential; Endocarditis; Fluorodeoxyglucose F18; Heart Valve Prosthesis; Humans; Positron Emission Tomography Computed Tomography; Prosthesis-Related Infections; Radiopharmaceuticals; Sensitivity and Specificity | 2020 |
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Hip Prosthesis; Humans; Joint Prosthesis; Positron Emission Tomography Computed Tomography; Prosthesis-Related Infections; Radiopharmaceuticals; Sensitivity and Specificity | 2020 |
PET Scan with Fludeoxyglucose/Computed Tomography in Low-Grade Vascular Inflammation.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Inflammation; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Vascular Diseases | 2020 |
Infection and Inflammation Imaging: Beyond FDG.
Topics: Fluorodeoxyglucose F18; Humans; Infections; Inflammation; Molecular Probe Techniques; Organometallic Compounds; Positron-Emission Tomography; Radioisotopes; Radiopharmaceuticals; Receptors, Cell Surface; Sensitivity and Specificity | 2020 |
Novel Quantitative PET Imaging Techniques in Tuberculosis.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tuberculosis | 2020 |
Diffusion-weighted MRI versus FDG-PET/CT for diagnosing pancreatic cancer: an indirect comparison meta-analysis.
Topics: Diagnosis, Differential; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Humans; Pancreas; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2020 |
A two-way comparison of whole-body 18FDG PET-CT and whole-body contrast-enhanced MRI for distant metastasis staging in patients with malignant tumors: a meta-analysis of 13 prospective studies.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Contrast Media; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Whole Body Imaging; Young Adult | 2020 |
Diagnostic Evaluation of 18F-FDG PET/CT Imaging in Recurrent or Residual Urinary Bladder Cancer: A Meta-Analysis.
Topics: Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasm, Residual; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Urinary Bladder Neoplasms | 2020 |
Diagnostic role of F-18 FDG PET/CT for preoperative lymph node staging in thyroid cancer patients; A systematic review and metaanalysis.
Topics: Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Neck; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Thyroid Neoplasms | 2020 |
Diagnostic performance of conventional and advanced imaging modalities for assessing newly diagnosed cervical cancer: systematic review and meta-analysis.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasm Invasiveness; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography; Uterine Cervical Neoplasms | 2020 |
Post-treatment FDG PET/CT predicts progression-free survival in young patients with small round blue cell tumors: Ewing sarcoma and PNET.
Topics: Adolescent; Adult; Bone Neoplasms; Child; Child, Preschool; Cohort Studies; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Neuroectodermal Tumors, Primitive; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Progression-Free Survival; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sarcoma, Ewing; Sensitivity and Specificity; Treatment Outcome; Young Adult | 2020 |
Non-
Topics: Child; Congenital Hyperinsulinism; Diabetes Mellitus, Type 1; Fluorodeoxyglucose F18; Humans; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Urologic Diseases | 2020 |
Imaging of colorectal cancer liver metastases using contrast-enhanced US, multidetector CT, MRI, and FDG PET/CT: a meta-analysis.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Multidetector Computed Tomography; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Ultrasonography; Young Adult | 2021 |
The value of four imaging modalities to distinguish malignant from benign solitary pulmonary nodules: a study based on 73 cohorts incorporating 7956 individuals.
Topics: Cohort Studies; Confidence Intervals; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Likelihood Functions; Magnetic Resonance Imaging; Organotechnetium Compounds; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Solitary Pulmonary Nodule; Somatostatin; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2021 |
PET/CT and MRI for Identifying Axillary Lymph Node Metastases in Breast Cancer Patients: Systematic Review and Meta-Analysis.
Topics: Axilla; Breast Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Sensitivity and Specificity | 2020 |
The value of
Topics: Fluorodeoxyglucose F18; Heart-Assist Devices; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prosthesis-Related Infections; Quality of Life; Radiopharmaceuticals; Sensitivity and Specificity | 2021 |
18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in muscle-invasive bladder cancer.
Topics: Cystectomy; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Muscles; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Urinary Bladder Neoplasms | 2020 |
Hybrid PET/MRI in non-small cell lung cancer (NSCLC) and lung nodules-a literature review.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Magnetic Resonance Imaging; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2021 |
PET imaging in testicular tumours.
Topics: Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Testicular Neoplasms | 2020 |
Performance of
Topics: Early Detection of Cancer; Fluorodeoxyglucose F18; Humans; Neoplasms, Unknown Primary; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Venous Thromboembolism | 2020 |
Comparison of magnetic resonance imaging and 18-fludeoxyglucose positron emission tomography/computed tomography in the diagnostic accuracy of staging in patients with cholangiocarcinoma: A meta-analysis.
Topics: Aged; Bile Duct Neoplasms; Cholangiocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2020 |
Imaging in the Diagnosis of Nonspecific Pyogenic Spondylodiskitis.
Topics: Contrast Media; Discitis; Fluorodeoxyglucose F18; Gadolinium; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2023 |
Direct comparison of diagnostic accuracies of F-18 FDG PET and MRI for detection of bone marrow involvement in lymphoma patients; A meta-analysis.
Topics: Bone Marrow; Bone Marrow Examination; Diffusion Magnetic Resonance Imaging; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphoma; Magnetic Resonance Imaging; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2020 |
Clinical Implementation of Total-Body PET/CT at University of California, Davis.
Topics: California; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Universities; Whole Body Imaging | 2021 |
PET/CT in Surgical Planning for Head and Neck Cancer.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck | 2021 |
Prognostic and predictive values of interim
Topics: Chemoradiotherapy; Disease Progression; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Treatment Outcome | 2021 |
Impact of fluorine-18-fluorodeoxyglucose PET/computed tomography in staging of patients with gallbladder cancer: a systematic review and meta-analysis.
Topics: Fluorodeoxyglucose F18; Gallbladder Neoplasms; Humans; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Sensitivity and Specificity | 2021 |
Diagnostic Role of F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Characterization of Intraductal Papillary Mucinous Neoplasms: An Updated Systematic Review and Meta-analysis.
Topics: Adenocarcinoma, Mucinous; Carcinoma, Pancreatic Ductal; Carcinoma, Papillary; Fluorodeoxyglucose F18; Humans; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2021 |
Diagnostic role of 18F-FDG PET/MRI in the TNM staging of breast cancer: a systematic review and meta-analysis.
Topics: Breast Neoplasms; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2021 |
Diagnostic Performance of Pretreatment 18F-Fluorodeoxyglucose Positron Emission Tomography With or Without Computed Tomography in Patients With Primary Central Nervous System Lymphoma: Updated Systematic Review and Diagnostic Test Accuracy Meta-analyses.
Topics: Central Nervous System Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Neuroimaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity | 2021 |
Diagnostic test accuracies of F-18 FDG PET/CT for prediction of microvascular invasion of hepatocellular carcinoma: A meta-analysis.
Topics: Carcinoma, Hepatocellular; Diagnostic Tests, Routine; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2021 |
Radiologic Evaluation of the Head and Neck Cancer Patient.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2021 |
Practical Considerations When Interpreting FDG PET/CT Imaging for Staging and Treatment Response Assessment in Melanoma Patients.
Topics: Fluorodeoxyglucose F18; Humans; Melanoma; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2021 |
[STAGING CERVICAL CANCER USING PET-CT AND PET-MRI].
Topics: Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2021 |
Prosthetic vascular graft infection: A systematic review and meta-analysis on diagnostic accuracy of 18FDG PET/CT.
Topics: Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity | 2022 |
FDG-PET/CT versus bone marrow biopsy in bone marrow involvement in newly diagnosed paediatric lymphoma: a systematic review and meta-analysis.
Topics: Biopsy; Bone Marrow; Child; Fluorodeoxyglucose F18; Humans; Lymphoma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2021 |
Comparison of Gadolinium-enhanced MRI and 18FDG PET/PET-CT for the diagnosis of brain metastases in lung cancer patients: A meta-analysis of 5 prospective studies.
Topics: Brain Neoplasms; Fluorodeoxyglucose F18; Gadolinium; Humans; Image Enhancement; Lung Neoplasms; Magnetic Resonance Imaging; Multimodal Imaging; Odds Ratio; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; ROC Curve; Sensitivity and Specificity | 2017 |
Correlations of 18F-FDG and 18F-FLT uptake on PET with Ki-67 expression in patients with lung cancer: a meta-analysis.
Topics: Dideoxynucleosides; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Lung Neoplasms; Positron-Emission Tomography; Sensitivity and Specificity | 2018 |
Positron emission tomography/computer tomography in gastrointestinal malignancies: current potential and challenges.
Topics: Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Stomach Neoplasms | 2017 |
PET/Computed Tomography and Precision Medicine: Gastric Cancer.
Topics: Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Precision Medicine; Radiopharmaceuticals; Sensitivity and Specificity; Stomach Neoplasms | 2017 |
The diagnostic value of FDG and amyloid PET in Alzheimer's disease-A systematic review.
Topics: Aged; Alzheimer Disease; Amyloid; Biomarkers; Brain; Female; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2017 |
Performance of F-18 FDG PET/CT for predicting malignant potential of gastrointestinal stromal tumors: A systematic review and meta-analysis.
Topics: Databases, Bibliographic; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity | 2018 |
Usefulness of PET in recognizing and managing vasculitides.
Topics: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Research Design; Retroperitoneal Fibrosis; Sensitivity and Specificity; Vascular Diseases; Vasculitis | 2018 |
Meta-analysis of 18F-FDG PET/CT in the diagnosis of infective endocarditis.
Topics: Endocarditis; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2019 |
Diagnostic Accuracy of Amino Acid and FDG-PET in Differentiating Brain Metastasis Recurrence from Radionecrosis after Radiotherapy: A Systematic Review and Meta-Analysis.
Topics: Brain Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiation Injuries; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity | 2018 |
The diagnostic performance of
Topics: Female; Fluorodeoxyglucose F18; Humans; Male; Methyltyrosines; Neoplasms; Positron-Emission Tomography; Sensitivity and Specificity | 2017 |
FDG-PET/CT for treatment response assessment in head and neck squamous cell carcinoma: a systematic review and meta-analysis of diagnostic performance.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2018 |
Fludeoxyglucose F 18 PET/CT Assessment of Ovarian Cancer.
Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Practice Guidelines as Topic; Radiographic Image Enhancement; Sensitivity and Specificity | 2018 |
FDG-PET Assessment of Other Gynecologic Cancers.
Topics: Aged; Aged, 80 and over; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiographic Image Enhancement; Sensitivity and Specificity; Uterine Neoplasms; Vaginal Neoplasms; Vulvar Neoplasms | 2018 |
The Role of PET Imaging in Gynecologic Radiation Oncology.
Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Middle Aged; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiation Oncology; Radiographic Image Enhancement; Sensitivity and Specificity; Uterine Cervical Neoplasms; Uterine Neoplasms; Vulvar Neoplasms | 2018 |
Normal Variants and Pitfalls Encountered in PET Assessment of Gynecologic Malignancies.
Topics: Adult; Aged; Artifacts; False Positive Reactions; Female; Fluorodeoxyglucose F18; Genital Diseases, Female; Genital Neoplasms, Female; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiographic Image Enhancement; Risk Assessment; Sensitivity and Specificity | 2018 |
The Evolving Role of FDG-PET/CT in the Diagnosis, Staging, and Treatment of Breast Cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Sensitivity and Specificity | 2019 |
MRI for solitary pulmonary nodule and mass assessment: Current state of the art.
Topics: Animals; Contrast Media; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung; Lung Neoplasms; Magnetic Resonance Imaging; Multidetector Computed Tomography; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Sensitivity and Specificity; Solitary Pulmonary Nodule; Thorax | 2018 |
The additional role of 18F-FDG PET/CT in prosthetic valve endocarditis.
Topics: Early Diagnosis; Endocarditis, Bacterial; Fluorodeoxyglucose F18; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Heart Valves; Humans; Positron Emission Tomography Computed Tomography; Prosthesis-Related Infections; Sensitivity and Specificity | 2018 |
The emerging roles of functional imaging in ovarian cancer with peritoneal carcinomatosis.
Topics: Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Ovarian Neoplasms; Ovary; Peritoneal Neoplasms; Peritoneum; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2018 |
Assessing FDG-PET diagnostic accuracy studies to develop recommendations for clinical use in dementia.
Topics: Dementia; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Sensitivity and Specificity | 2018 |
[Expression of Galectin-3 in Differentiated Thyroid Carcinoma and Human Bone Marrow Endothelial Cell Marker and Study and Application of the 18F-Fluordeoxyglucose Imaging].
Topics: Biomarkers, Tumor; Blood Proteins; Bone Marrow; Endothelial Cells; Fluorodeoxyglucose F18; Galectin 3; Galectins; Humans; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms | 2016 |
Automated assessment of FDG-PET for differential diagnosis in patients with neurodegenerative disorders.
Topics: Dementia; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Neurodegenerative Diseases; Positron-Emission Tomography; Sensitivity and Specificity | 2018 |
PET/CT in the diagnosis and prognosis of osteosarcoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Osteosarcoma; Positron Emission Tomography Computed Tomography; Prognosis; Sensitivity and Specificity; Treatment Outcome | 2018 |
Diagnostic Accuracy of F-18 FDG PET/CT for Preoperative Lymph Node Staging in Newly Diagnosed Bladder Cancer Patients: A Systematic Review and Meta-Analysis.
Topics: Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; ROC Curve; Sensitivity and Specificity; Urinary Bladder Neoplasms | 2018 |
PET/MRI for Gastrointestinal Imaging: Current Clinical Status and Future Prospects.
Topics: Early Detection of Cancer; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Gastrointestinal Tract; Humans; Magnetic Resonance Imaging; Neoplasm Staging; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2018 |
F-18 FDG PET for assessment of disease activity of large vessel vasculitis: A systematic review and meta-analysis.
Topics: Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Regression Analysis; Reproducibility of Results; ROC Curve; Sensitivity and Specificity; Vasculitis | 2019 |
Diagnostic value of FDG-PET versus magnetic resonance imaging for detecting spondylitis: a systematic review and meta-analysis.
Topics: Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Odds Ratio; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Spondylitis | 2018 |
Diagnostic accuracy of F-18 FDG PET/CT for characterization of colorectal focal FDG uptake: a systematic review and meta-analysis.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2019 |
18F-FDG PET with or without CT in the diagnosis of extrahepatic metastases or local residual/recurrent hepatocellular carcinoma.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2018 |
The diagnostic performance of CT versus FDG PET-CT for the detection of recurrent pancreatic cancer: a systematic review and meta-analysis.
Topics: Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Pancreas; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2018 |
Contribution of 18F-FDG PET/CT in a case-mix of fever of unknown origin and inflammation of unknown origin: a meta-analysis.
Topics: Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Inflammation; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2019 |
Performance of pre-treatment ¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography for detecting metastasis in ovarian cancer: a systematic review and meta-analysis.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; MEDLINE; Middle Aged; Neoplasm Metastasis; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2018 |
18F-FDG PET in the Diagnosis of Vascular Prosthetic Graft Infection: A Diagnostic Test Accuracy Meta-Analysis.
Topics: Blood Vessel Prosthesis; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prosthesis-Related Infections; Radiopharmaceuticals; Sensitivity and Specificity | 2019 |
Staging/restaging performance of F18-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging in breast cancer: A review and meta-analysis.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2018 |
Positron emission tomography (PET) and magnetic resonance imaging (MRI) for assessing tumour resectability in advanced epithelial ovarian/fallopian tube/primary peritoneal cancer.
Topics: Diffusion Magnetic Resonance Imaging; Fallopian Tube Neoplasms; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Neoplasm, Residual; Ovarian Neoplasms; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Randomized Controlled Trials as Topic; Sensitivity and Specificity; Tomography, X-Ray Computed | 2018 |
[Positron emission tomography in germ cell tumors in men : Possibilities and limitations].
Topics: Fluorodeoxyglucose F18; Humans; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Testicular Neoplasms | 2019 |
Fluorine 18-FDG PET/CT and Diffusion-weighted MRI for Malignant versus Benign Pulmonary Lesions: A Meta-Analysis.
Topics: Diagnosis, Differential; Diagnostic Imaging; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Sensitivity and Specificity | 2019 |
Effectiveness of 18F-FDG PET/CT in the diagnosis, staging and recurrence monitoring of Ewing sarcoma family of tumors: A meta-analysis of 23 studies.
Topics: Adolescent; Adult; Bone Neoplasms; Child; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Odds Ratio; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; ROC Curve; Sarcoma, Ewing; Sensitivity and Specificity; Young Adult | 2018 |
[18F-FDG PET/CT features on paraganglioma of testis with multiple lymph node and lung metastasis: A case report and literature review].
Topics: Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Neoplasm Staging; Paraganglioma; Positron Emission Tomography Computed Tomography; Retrospective Studies; Sensitivity and Specificity; Testicular Neoplasms; Testis | 2018 |
Systematic review of the utility of 18-FDG PET in the preoperative evaluation of IPMNs and cystic lesions of the pancreas.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Pancreas; Pancreatectomy; Pancreatic Cyst; Pancreatic Intraductal Neoplasms; Pancreaticoduodenectomy; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Radiopharmaceuticals; Sensitivity and Specificity | 2019 |
Diagnostic performance of F-18 FDG PET for detection of cardiac sarcoidosis; A systematic review and meta-analysis.
Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Myocarditis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; ROC Curve; Sarcoidosis; Sensitivity and Specificity | 2020 |
Topics: Biliary Tract Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2019 |
PET/CT Evaluation of Cardiac Sarcoidosis.
Topics: Biomedical Technology; Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Myocardial Perfusion Imaging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sarcoidosis; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 2019 |
PET/MR Imaging in Cardiovascular Imaging.
Topics: Cardiomyopathies; Cardiovascular Diseases; Contrast Media; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Angiography; Multimodal Imaging; Myocardial Perfusion Imaging; Myocarditis; Plaque, Atherosclerotic; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 2019 |
Relapsed ovarian cancer - diagnosis using 18F-FDG PET/CT; 4.
Topics: Brazil; Clinical Decision-Making; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2019 |
Cervical cancer - staging and restaging with 18F-FDG PET/CT.
Topics: Brazil; Clinical Decision-Making; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Uterine Cervical Neoplasms | 2019 |
Imaging in Large Vessel Vasculitides.
Topics: Arteries; Computed Tomography Angiography; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Magnetic Resonance Angiography; Positron-Emission Tomography; Sensitivity and Specificity; Takayasu Arteritis; Ultrasonography, Doppler, Duplex; Vasculitis | 2019 |
Diagnostic accuracy of preoperative
Topics: Abdomen; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Pelvis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2019 |
Accuracy of Detecting Residual Disease After Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Systematic Review and Meta-analysis.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Chemoradiotherapy; Endosonography; Esophageal Neoplasms; Esophagoscopy; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Neoplasm, Residual; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2020 |
The diagnostic role of ultrasonography, computed tomography, magnetic resonance imaging, positron emission tomography/computed tomography, and real-time elastography in the differentiation of benign and malignant salivary gland tumors: a meta-analysis.
Topics: Diagnosis, Differential; Elasticity Imaging Techniques; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Salivary Gland Neoplasms; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography | 2019 |
18F-fluorodihydroxyphenylalanine vs other radiopharmaceuticals for imaging neuroendocrine tumours according to their type.
Topics: 3-Iodobenzylguanidine; Bronchial Neoplasms; Carcinoma, Merkel Cell; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lung Neoplasms; Multimodal Imaging; Neoplasm Metastasis; Neuroendocrine Tumors; Octreotide; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Somatostatin; Recurrence; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, Emission-Computed, Single-Photon | 2013 |
Imaging evaluation of prostate cancer with 18F-fluorodeoxyglucose PET/CT: utility and limitations.
Topics: Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Prostatic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
Dual time point 18FDG-PET/CT versus single time point 18FDG-PET/CT for the differential diagnosis of pulmonary nodules: a meta-analysis.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
Comparison of FDG PET/CT and gadolinium-enhanced MRI for the detection of bone metastases in patients with cancer: a meta-analysis.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2013 |
[Evaluation of (18)F-FDG PET/CT in preoperative staging of gastric cancer: a meta-analysis].
Topics: Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Positron-Emission Tomography; Sensitivity and Specificity; Stomach Neoplasms; Tomography, X-Ray Computed | 2013 |
Characterization of the impact to PET quantification and image quality of an anterior array surface coil for PET/MR imaging.
Topics: Equipment Design; Equipment Failure Analysis; Fluorodeoxyglucose F18; Humans; Image Enhancement; Liver Diseases; Magnetic Resonance Imaging; Magnetics; Multimodal Imaging; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Transducers; Whole Body Imaging | 2014 |
Managing lymphoma with non-FDG radiotracers: current clinical and preclinical applications.
Topics: Antibodies, Anti-Idiotypic; Antigens, CD20; Diagnostic Imaging; Fluorodeoxyglucose F18; Humans; Lymphoma; Nuclear Medicine; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 2013 |
Diagnosis of pulmonary sarcoidosis.
Topics: Biopsy; Biopsy, Fine-Needle; Endosonography; Fluorodeoxyglucose F18; Humans; Lung; Positron-Emission Tomography; Sarcoidosis, Pulmonary; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
Imaging of the non-traumatic brachial plexus.
Topics: Brachial Plexus; Brachial Plexus Neuropathies; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Nerve Compression Syndromes; Neurilemmoma; Neurofibroma; Neurologic Examination; Peripheral Nervous System Neoplasms; Positron-Emission Tomography; Radiation Injuries; Reference Values; Sensitivity and Specificity; Syndrome; Thoracic Outlet Syndrome | 2013 |
The role of the PET scan in the management of sarcoidosis.
Topics: Biopsy; Disease Management; Fibrosis; Fluorodeoxyglucose F18; Humans; Lung; Positron-Emission Tomography; Prognosis; Radiography; Sarcoidosis, Pulmonary; Sensitivity and Specificity | 2013 |
Diagnostic performance of Fluorine-18-Fluorodeoxyglucose positron emission tomography for the diagnosis of osteomyelitis related to diabetic foot: a systematic review and a meta-analysis.
Topics: Diabetic Foot; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Osteomyelitis; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
Fluorodeoxyglucose-positron-emission tomography/computed tomography imaging for adrenal masses in patients with lung cancer: review and diagnostic algorithm.
Topics: Adrenal Gland Neoplasms; Algorithms; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Imaging appearances for recurrent nasopharyngeal carcinoma and post-salvage nasopharyngectomy.
Topics: Carcinoma; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Nasopharynx; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2013 |
Is fluorine-18 fluorodeoxyglucose positron emission tomography useful for detecting bladder lesions? A meta-analysis of the literature.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Likelihood Functions; Magnetic Resonance Imaging; Male; Middle Aged; Odds Ratio; Positron-Emission Tomography; Reproducibility of Results; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed; Urinary Bladder Neoplasms | 2014 |
Diagnostic performance of fluorine-18-fluorodeoxyglucose positron emission tomography in patients with Merkel cell carcinoma: a systematic review and meta-analysis.
Topics: Carcinoma, Merkel Cell; Fluorodeoxyglucose F18; Humans; Likelihood Functions; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Skin Neoplasms; Tomography, X-Ray Computed | 2013 |
Role of positron emission tomography/computed tomography in breast cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Precision Medicine; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity | 2013 |
Role of positron emission tomography/computed tomography in bone malignancies.
Topics: Biopsy; Bone Neoplasms; Contrast Media; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Multimodal Imaging; Multiple Myeloma; Neoplasm Staging; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity | 2013 |
Role of positron emission tomography/computed tomography (PET/CT) in head and neck cancer.
Topics: Contrast Media; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity | 2013 |
A meta-analysis on the diagnostic performance of (18)F-FDG and (11)C-methionine PET for differentiating brain tumors.
Topics: Brain Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Methionine; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity | 2014 |
[Application of fluorine-18 fluorodeoxyglucose-positron emission tomography in the diagnosis and therapy of patients with sarcoidosis].
Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal; Biomarkers; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
A comparison of FDG-PET and blood flow SPECT in the diagnosis of neurodegenerative dementias: a systematic review.
Topics: Dementia; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Neurodegenerative Diseases; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 2014 |
Diagnostic performance of fluorine 18 fluorodeoxyglucose positron emission tomography imaging for detection of primary lesion and staging of endometrial cancer patients: systematic review and meta-analysis of the literature.
Topics: Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Positron-Emission Tomography; Sensitivity and Specificity | 2013 |
[Positron emission tomography (PET) in malignant ovarian tumors].
Topics: Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Ovarian Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Women's Health | 2013 |
Is fluorine-18 fluorodeoxyglucose positron emission tomography useful for the thyroid nodules with indeterminate fine needle aspiration biopsy? A meta-analysis of the literature.
Topics: Biopsy, Fine-Needle; Fluorodeoxyglucose F18; Humans; Radionuclide Imaging; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Thyroid Nodule | 2013 |
18 FDG PET and PET-CT for the detection of bone metastases in patients with head and neck cancer. A meta-analysis.
Topics: Bone Neoplasms; Evidence-Based Medicine; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Multimodal Imaging; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
Diagnostic performance of fluorine-18-fluorodeoxyglucose positron emission tomography in the assessment of pleural abnormalities in cancer patients: a systematic review and a meta-analysis.
Topics: Animals; Diagnostic Errors; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Multimodal Imaging; Pleura; Pleural Neoplasms; Positron-Emission Tomography; Sensitivity and Specificity | 2014 |
Diagnostic accuracy of 18F-FDG-PET and PET/CT in the differential diagnosis between malignant and benign pleural lesions: a systematic review and meta-analysis.
Topics: Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Pleural Diseases; Pleural Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
18FDG PET-CT for distant metastases in patients with recurrent head and neck cancer after definitive treatment. A meta-analysis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Salvage Therapy; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2014 |
Combination of cross-sectional and molecular imaging studies in the localization of gastroenteropancreatic neuroendocrine tumors.
Topics: 3-Iodobenzylguanidine; Digestive System Neoplasms; Fluorodeoxyglucose F18; Humans; Intestinal Neoplasms; Magnetic Resonance Imaging; Molecular Imaging; Neuroendocrine Tumors; Pancreatic Neoplasms; Positron-Emission Tomography; Radionuclide Imaging; Receptors, Somatostatin; Sensitivity and Specificity; Stomach Neoplasms; Surveys and Questionnaires; Tomography, X-Ray Computed; Ultrasonography | 2014 |
Diagnostic performance of FDG PET or PET/CT in prosthetic infection after arthroplasty: a meta-analysis.
Topics: Algorithms; Arthroplasty; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Positron-Emission Tomography; Postoperative Complications; Prosthesis-Related Infections; Radiopharmaceuticals; Reproducibility of Results; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Diagnostic performance of dedicated positron emission mammography using fluorine-18-fluorodeoxyglucose in women with suspicious breast lesions: a meta-analysis.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity | 2014 |
[Lung infarction--a diagnostic challenge in the oncologic patient?].
Topics: Angiography; Cardiac-Gated Imaging Techniques; Contrast Media; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Image Enhancement; Imaging, Three-Dimensional; Lung Neoplasms; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Multidetector Computed Tomography; Neoplastic Cells, Circulating; Pneumonia; Positron-Emission Tomography; Prognosis; Pulmonary Infarction; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
Molecular imaging for the characterization of breast tumors.
Topics: Biomarkers, Tumor; Breast Neoplasms; Carcinoma; Estradiol; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Mammography; Molecular Imaging; Multimodal Imaging; Positron-Emission Tomography; Proton Magnetic Resonance Spectroscopy; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 2014 |
What is the clinical value of PET/CT in the diagnosis of pulmonary nodules?
Topics: Biopsy; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Lung; Lung Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2014 |
[Adrenal incidentalomas].
Topics: Adrenal Gland Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Algorithms; Androgens; Cross-Sectional Studies; Diagnosis, Differential; Fluorodeoxyglucose F18; Glucocorticoids; Humans; Incidental Findings; Magnetic Resonance Imaging; Mineralocorticoids; Positron-Emission Tomography; Prognosis; Radiographic Image Enhancement; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Role of PET in lymphoma.
Topics: Antineoplastic Agents; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Large B-Cell, Diffuse; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiotherapy, Conformal; Sensitivity and Specificity; Treatment Outcome | 2014 |
[FDG-PET/CT in staging of breast carcinoma: use in tumour stage III and locoregional recurrent breast carcinoma].
Topics: Aged; Breast Neoplasms; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Benign breast lesions detected by positron emission tomography-computed tomography.
Topics: Aged; Artifacts; Breast Diseases; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Male; Mammography; Middle Aged; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
[Importance of FDG-PET/CT for surgery of rectal cancer].
Topics: Diagnosis, Differential; Disease Progression; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Molecular Imaging; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Rectal Neoplasms; Rectum; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Paraneoplastic immune-mediated neurological effects of systemic cancers.
Topics: Autoantibodies; Fluorodeoxyglucose F18; Humans; Immunotherapy; Neoplasms; Paraneoplastic Syndromes, Nervous System; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity | 2014 |
[Molecular multimodal hybrid imaging in prostate and bladder cancer].
Topics: Biomarkers, Tumor; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Molecular Imaging; Multimodal Imaging; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prostate; Prostatic Neoplasms; Sensitivity and Specificity; Tomography, X-Ray Computed; Urinary Bladder Neoplasms | 2014 |
The role of 18F-FDG-PET and PET/CT in patients with sarcoidosis: an updated evidence-based review.
Topics: Evidence-Based Medicine; Fluorodeoxyglucose F18; Humans; Image Enhancement; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sarcoidosis; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Usefulness of F-18-fluorodeoxyglucose positron emission tomography to confirm suspected pancreatic cancer: a meta-analysis.
Topics: Female; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Invasiveness; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Diagnosis of recurrent uterine cervical cancer: PET versus PET/CT: a systematic review and meta-analysis.
Topics: Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2014 |
Role of imaging in diagnosis, staging and follow-up of lung cancer.
Topics: Early Detection of Cancer; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiography, Thoracic; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
[The relevance of PET/CT for the surgical management of neuroendocrine neoplasms].
Topics: Fluorodeoxyglucose F18; Gallium Radioisotopes; Gene Expression Regulation, Neoplastic; Humans; Molecular Imaging; Multimodal Imaging; Neoplasms, Unknown Primary; Neuroendocrine Tumors; Positron-Emission Tomography; Receptors, Somatostatin; Sensitivity and Specificity; Somatostatin; Tomography, X-Ray Computed | 2014 |
Metastases to the breast from extramammary malignancies - PET/CT findings.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasms, Multiple Primary; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
PET/CT assessment of neuroendocrine tumors of the lung with special emphasis on bronchial carcinoids.
Topics: Bronchial Neoplasms; Carcinoid Tumor; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neuroendocrine Tumors; Octreotide; Organometallic Compounds; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Meta-analysis of (18) fluorodeoxyglucose positron emission tomography-CT for diagnosis of lung malignancies in patients with head and neck squamous cell carcinomas.
Topics: Carcinoma, Squamous Cell; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Positron-Emission Tomography; Prospective Studies; Retrospective Studies; Sensitivity and Specificity | 2015 |
Diagnostic accuracy of 18F-FDG-PET in patients with testicular cancer: a meta-analysis.
Topics: Area Under Curve; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Neoplasms, Germ Cell and Embryonal; Odds Ratio; Positron-Emission Tomography; Radiopharmaceuticals; Seminoma; Sensitivity and Specificity; Testicular Neoplasms; Tomography, X-Ray Computed | 2014 |
Tumor-to-background ratio to predict response to chemotherapy of osteosarcoma better than standard uptake values.
Topics: Antineoplastic Agents; Bone Neoplasms; Chemotherapy, Adjuvant; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Osteosarcoma; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
(18)F-FDG PET and vascular inflammation: time to refine the paradigm?
Topics: Algorithms; Atherosclerosis; Computer Simulation; Evidence-Based Medicine; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Models, Cardiovascular; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Vasculitis | 2015 |
Diagnostic accuracy of fluorine-18-fluorodeoxyglucose positron emission tomography in the evaluation of the primary tumor in patients with cholangiocarcinoma: a meta-analysis.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2014 |
Incidental uptake of 18F-fluorodeoxyglucose in the prostate gland. Systematic review and meta-analysis on prevalence and risk of malignancy.
Topics: Fluorodeoxyglucose F18; Humans; Incidence; Incidental Findings; Male; Prostatic Neoplasms; Radiopharmaceuticals; Reproducibility of Results; Risk Factors; Sensitivity and Specificity | 2014 |
Diagnostic performance of 18F-FDG-PET versus scintigraphy in patients with inflammatory bowel disease: a meta-analysis of prospective literature.
Topics: Fluorodeoxyglucose F18; Humans; Inflammatory Bowel Diseases; Positron-Emission Tomography; Prospective Studies; Sensitivity and Specificity | 2014 |
Meta-analysis of diagnosis of liver metastatic cancers: comparison of (18) FDG PET-CT and gadolinium-enhanced MRI.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2014 |
Nuclear assessment of right ventricle.
Topics: Female; Fluorodeoxyglucose F18; Heart Ventricles; Humans; Male; Myocardial Perfusion Imaging; Positron-Emission Tomography; Radiographic Image Enhancement; Sensitivity and Specificity; Stroke Volume; Ultrasonography; Ventricular Dysfunction, Right; Ventricular Function, Right | 2015 |
Accuracy of FDG-PET to diagnose lung cancer in areas with infectious lung disease: a meta-analysis.
Topics: Diagnosis, Differential; Endemic Diseases; Fluorodeoxyglucose F18; Humans; Infections; Lung Diseases; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity | 2014 |
Accuracy of positron emission tomography and positron emission tomography-CT in the detection of differentiated thyroid cancer recurrence with negative (131) I whole-body scan results: A meta-analysis.
Topics: Adenocarcinoma, Follicular; Carcinoma, Papillary; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, X-Ray Computed; Whole Body Imaging | 2016 |
Role of 18F-FDG PET/CT in the carcinoma of the uterus: a review of literature.
Topics: Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Sensitivity and Specificity; Tomography, X-Ray Computed; Uterine Neoplasms; Uterus | 2014 |
18F-fluorodeoxyglucose uptake in abdominal aortic aneurysms: a useful biomarker of AAA rupture risk.
Topics: Aortic Aneurysm, Abdominal; Biomarkers; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2014 |
FDG PET/CT in the management of colorectal and anal cancers.
Topics: Adult; Aged; Anus Neoplasms; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
PET/CT versus MRI for diagnosis, staging, and follow-up of lung cancer.
Topics: Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome; Whole Body Imaging | 2015 |
Value of 18F-FDG PET and PET/CT for evaluation of pediatric malignancies.
Topics: Adolescent; Brain Neoplasms; Child; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Neoplasm Metastasis; Neoplasm Staging; Neoplasms; Neuroblastoma; Pediatrics; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Wilms Tumor | 2015 |
Clinical value of whole-body PET/CT in patients with active rheumatic diseases.
Topics: Early Diagnosis; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Positron-Emission Tomography; Reproducibility of Results; Rheumatic Diseases; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
¹⁸F-FDG PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
Topics: Aged; Alzheimer Disease; Brain; Cognitive Dysfunction; Dementia; Disease Progression; Early Diagnosis; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2015 |
Primary tumor standardized uptake value predicts survival in head and neck squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Interpretation, Computer-Assisted; Incidence; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Survival Analysis | 2015 |
Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography Hypermetabolism of Vertebral Arteries Revealing Giant Cell Arteritis.
Topics: Aged, 80 and over; Echocardiography, Transesophageal; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Male; Positron-Emission Tomography; Sensitivity and Specificity; Severity of Illness Index; Subclavian Artery; Tomography, X-Ray Computed; Vertebral Artery | 2015 |
Improving patient selection for 18F-FDG PET scanning in the staging of gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma; Carcinoma, Signet Ring Cell; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Immunohistochemistry; Male; Middle Aged; Neoplasm Staging; Observer Variation; Patient Selection; Positron-Emission Tomography; Prospective Studies; Retrospective Studies; Sensitivity and Specificity; Stomach Neoplasms | 2015 |
A meta-analysis comparing 18F-FLT PET with 18F-FDG PET for assessment of brain tumor recurrence.
Topics: Adolescent; Adult; Aged; Brain Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Young Adult | 2015 |
[The current state of radiologic diagnosis in pancreatic cancer].
Topics: Cholangiopancreatography, Endoscopic Retrograde; Cholangiopancreatography, Magnetic Resonance; Diagnosis, Differential; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Performance of FLT-PET for pulmonary lesion diagnosis compared with traditional FDG-PET: A meta-analysis.
Topics: Dideoxynucleosides; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2015 |
Comparison of PET with PET/CT in detecting peritoneal carcinomatosis: a meta-analysis.
Topics: Carcinoma; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Peritoneal Neoplasms; Peritoneum; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
FDG PET/CT in infection and inflammation--current and emerging clinical applications.
Topics: Evidence-Based Medicine; Fluorodeoxyglucose F18; Humans; Infections; Inflammation; Positron-Emission Tomography; Practice Guidelines as Topic; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Diagnostic Performance of ¹⁸F-FDG PET and PET/CT for the Detection of Recurrent Esophageal Cancer After Treatment with Curative Intent: A Systematic Review and Meta-Analysis.
Topics: Biopsy; Esophageal Neoplasms; False Negative Reactions; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Quality Control; Recurrence; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
[Meta-analysis of PET/CT for diagnosis of residual/recurrent nasopharyngeal carcinoma].
Topics: Carcinoma; Fluorodeoxyglucose F18; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Value of (18)F-FDG PET for Predicting Response to Neoadjuvant Therapy in Rectal Cancer: Systematic Review and Meta-Analysis.
Topics: Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Rectal Neoplasms; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Treatment Outcome | 2015 |
A Cochrane review on brain [¹⁸F]FDG PET in dementia: limitations and future perspectives.
Topics: Brain; Cognitive Dysfunction; Dementia; Evidence-Based Medicine; Female; Fluorodeoxyglucose F18; Forecasting; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2015 |
Role of 2-Fluoro-2-Deoxyglucose PET/Computed Tomography in Carcinoma of Unknown Primary.
Topics: Female; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2015 |
Positron Emission Tomography Computed Tomography: A Guide for the General Radiologist.
Topics: Education, Medical, Continuing; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Radiology; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Multimodal Imaging in Neurofibromatosis Type 1-associated Nerve Sheath Tumors.
Topics: Adult; Cell Transformation, Neoplastic; Child; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Nerve Sheath Neoplasms; Neurofibromatosis 1; Peripheral Nervous System Neoplasms; Positron-Emission Tomography; Sensitivity and Specificity; Soft Tissue Neoplasms; Tomography, X-Ray Computed; Whole Body Imaging; Young Adult | 2015 |
Performance of Positron Emission Tomography and Positron Emission Tomography/Computed Tomography Using Fluorine-18-Fluorodeoxyglucose for the Diagnosis, Staging, and Recurrence Assessment of Bone Sarcoma: A Systematic Review and Meta-Analysis.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Osteosarcoma; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
[Role of positron emission tomography and CT with 18F-FDG PET-CT in follow-up of patients treated for head and neck squamous cell carcinoma].
Topics: Carcinoma, Squamous Cell; Early Detection of Cancer; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Comparison of 18F-FDG PET/CT, MRI and SPECT in the diagnosis of local residual/recurrent nasopharyngeal carcinoma: A meta-analysis.
Topics: Carcinoma; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2016 |
Dual-time-point Imaging and Delayed-time-point Fluorodeoxyglucose-PET/Computed Tomography Imaging in Various Clinical Settings.
Topics: Atherosclerosis; Breast Neoplasms; Crohn Disease; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Time Factors; Tomography, X-Ray Computed | 2016 |
FDG PET/CT Imaging of Carotid Atherosclerosis.
Topics: Algorithms; Animals; Carotid Stenosis; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2016 |
Impact of Patient Preparation on the Diagnostic Performance of 18F-FDG PET in Cardiac Sarcoidosis: A Systematic Review and Meta-analysis.
Topics: Anticoagulants; Cardiomyopathies; Fluorodeoxyglucose F18; Heparin; Humans; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Regression Analysis; ROC Curve; Sarcoidosis; Sensitivity and Specificity | 2016 |
The role of 18F-FDG PET/CT in the follow-up of well-differentiated thyroid cancer with negative thyroglobulin but positive and/or elevated antithyroglobulin antibody.
Topics: Autoantibodies; Biomarkers, Tumor; Evidence-Based Medicine; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Positron Emission Tomography Computed Tomography; Reproducibility of Results; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms | 2016 |
Fluorine-18-fluorodeoxyglucose positron emission tomography to evaluate recurrent gastric cancer after surgical resection: a systematic review and meta-analysis.
Topics: Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Recurrence; Sensitivity and Specificity; Stomach Neoplasms | 2016 |
Prognostic value of pretransplant FDG-PET in refractory/relapsed Hodgkin lymphoma treated with autologous stem cell transplantation: systematic review and meta-analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Clinical Trials as Topic; Cohort Studies; Combined Modality Therapy; Disease Progression; Drug Resistance, Neoplasm; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Neoplasm, Residual; Peripheral Blood Stem Cell Transplantation; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Recurrence; Salvage Therapy; Sensitivity and Specificity; Survival Analysis; Transplantation, Autologous; Treatment Outcome | 2016 |
Cardiovascular PET-CT imaging: a new frontier?
Topics: Cardiovascular Diseases; Fluorodeoxyglucose F18; Forecasting; Heart Function Tests; Humans; Image Enhancement; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2016 |
New Positron-Emission Tomography/Computed Tomography Imaging for Bone Metastases
.
Topics: Bone Neoplasms; Choline; Female; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Metastasis; Neoplasms; Positron Emission Tomography Computed Tomography; Radiographic Image Enhancement; Radiopharmaceuticals; Sensitivity and Specificity | 2016 |
Multi-technique imaging of bone metastases: spotlight on PET-CT.
Topics: Bone Neoplasms; Choline; Contrast Media; Evidence-Based Medicine; Fluorodeoxyglucose F18; Humans; Image Enhancement; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Medronate | 2016 |
Contribution of (18)F-FDG PET in the diagnostic assessment of fever of unknown origin (FUO): a stratification-based meta-analysis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Factors; Sensitivity and Specificity; Young Adult | 2016 |
Magnetic Resonance Imaging (MRI) and Positron Emission Tomography (PET)/MRI for Lung Cancer Staging.
Topics: Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Magnetic Resonance Imaging; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2016 |
Clinical utility of F-18 FDG PET-CT in the initial evaluation of lung cancer.
Topics: Early Detection of Cancer; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Factors; Sensitivity and Specificity | 2016 |
[Brain imaging of Alzheimer' disease: state of the art and perspectives for clinicians].
Topics: Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Brain; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Neuroimaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; tau Proteins | 2016 |
Systematic Review on the Additional Value of 18F-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography in Staging Follicular Lymphoma.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2017 |
FDG PET-CT for solitary pulmonary nodule and lung cancer: Literature review.
Topics: Algorithms; Early Detection of Cancer; Fluorodeoxyglucose F18; Incidental Findings; Lung; Lung Neoplasms; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Sensitivity and Specificity; Solitary Pulmonary Nodule | 2016 |
The predictive value of 18F-FDG PET for pathological response of primary tumor in patients with esophageal cancer during or after neoadjuvant chemoradiotherapy: a meta-analysis.
Topics: Carcinoma, Squamous Cell; Chemoradiotherapy; Databases, Factual; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Odds Ratio; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Treatment Outcome | 2016 |
The Value of FDG PET/CT in Treatment Response Assessment, Follow-Up, and Surveillance of Lung Cancer.
Topics: Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Neoplasm Recurrence, Local; Outcome Assessment, Health Care; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Survival Rate; Treatment Outcome | 2017 |
Diagnostic value of 18F-FDG-PET/CT for the evaluation of solitary pulmonary nodules: a systematic review and meta-analysis.
Topics: Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Likelihood Functions; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Solitary Pulmonary Nodule | 2017 |
Is
Topics: Aged; Aging; Blood Glucose; Brain; Case-Control Studies; Depression; Fluorodeoxyglucose F18; Humans; Paroxetine; Positron-Emission Tomography; Selective Serotonin Reuptake Inhibitors; Sensitivity and Specificity; Sleep Deprivation | 2017 |
Diagnostic performance of 18F-FDG PET or PET/CT in restaging renal cell carcinoma: a systematic review and meta-analysis.
Topics: Carcinoma, Renal Cell; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2017 |
Metabolic Imaging in Parkinson Disease.
Topics: Biomarkers; Brain; Brain Mapping; Cognitive Dysfunction; Fluorodeoxyglucose F18; Glucose; Humans; Image Interpretation, Computer-Assisted; Molecular Imaging; Parkinson Disease; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2017 |
Quantification of Lung PET Images: Challenges and Opportunities.
Topics: Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung; Lung Diseases; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Respiratory Function Tests; Sensitivity and Specificity | 2017 |
MRI and FDG-PET/CT based assessment of axillary lymph node metastasis in early breast cancer: a meta-analysis.
Topics: Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2017 |
A meta-analysis to evaluate the diagnostic value of dual-time-point F-fluorodeoxyglucose positron emission tomography/computed tomography for diagnosis of pulmonary nodules.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Odds Ratio; Positron Emission Tomography Computed Tomography; ROC Curve; Sensitivity and Specificity; Solitary Pulmonary Nodule | 2016 |
Recent advances in imaging of pancreatic neoplasms.
Topics: Adenocarcinoma; Diagnostic Imaging; Endoscopy; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Medical Oncology; Pancreatic Neoplasms; Pancreatitis; Positron-Emission Tomography; Radionuclide Imaging; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography | 2008 |
PET-associated incidental neoplasms of the thyroid.
Topics: Biopsy, Needle; Fluorodeoxyglucose F18; Humans; Incidental Findings; Magnetic Resonance Imaging; Neoplasms; Neoplasms, Second Primary; Positron-Emission Tomography; Prognosis; Risk Factors; Sensitivity and Specificity; Thyroid Gland; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed; Ultrasonography | 2008 |
Role of fluorodeoxyglucose-PET versus fluorodeoxyglucose-PET/computed tomography in detection of unknown primary tumor: a meta-analysis of the literature.
Topics: Databases, Bibliographic; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Medical Oncology; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
[Role of sentinel lymph nodes and lymphatic mapping of colorectal cancer].
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Positron-Emission Tomography; Sensitivity and Specificity; Sentinel Lymph Node Biopsy | 2005 |
The prognostic value of PET and PET/CT in cervical cancer.
Topics: Aged; Aged, 80 and over; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Sensitivity and Specificity; Survival Analysis; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2008 |
FDG-PET for diagnosing prosthetic joint infection: systematic review and metaanalysis.
Topics: Fluorodeoxyglucose F18; Humans; Joints; Positron-Emission Tomography; Prosthesis-Related Infections; Sensitivity and Specificity | 2008 |
Imaging of gynecologic malignancies with FDG PET-CT: case examples, physiologic activity, and pitfalls.
Topics: Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Neoplasm Recurrence, Local; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Whole Body Imaging | 2009 |
[Metabolic imaging--PET, PET/CT--in oncologic surgery].
Topics: Breast Neoplasms; Cost-Benefit Analysis; Endocrine Gland Neoplasms; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Head and Neck Neoplasms; Humans; Hungary; Lung Neoplasms; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Surgical Procedures, Operative; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2008 |
Diagnostic value of FDG-PET in recurrent colorectal carcinoma: a meta-analysis.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; ROC Curve; Sensitivity and Specificity | 2009 |
Combined FDG-PET/CT for the detection of unknown primary tumors: systematic review and meta-analysis.
Topics: False Positive Reactions; Fluorodeoxyglucose F18; Humans; Medical Oncology; Neoplasm Metastasis; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiology; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
Modern staging and utility of PET imaging in esophageal cancer management.
Topics: Combined Modality Therapy; Endosonography; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2008 |
Role of PET in the initial staging of cutaneous malignant melanoma: systematic review.
Topics: Fluorodeoxyglucose F18; Humans; Melanoma; Neoplasm Metastasis; Neoplasm Staging; Odds Ratio; Positron-Emission Tomography; Sensitivity and Specificity; Skin Neoplasms | 2008 |
Clinically proven radiopharmaceuticals for infection imaging: mechanisms and applications.
Topics: Animals; Antibodies, Monoclonal; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Immunoglobulin G; Infections; Inflammation; Leukocytes; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2009 |
Future diagnostic agents.
Topics: Animals; Anti-Infective Agents; Antibodies; Bacterial Infections; Cytokines; Fluorodeoxyglucose F18; Fungi; Humans; Immunoglobulin Fragments; Infections; Inflammation; Leukocytes; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity | 2009 |
Nuclear medicine and diabetic foot infections.
Topics: Animals; Anti-Bacterial Agents; Bone and Bones; Diabetic Foot; Fluorodeoxyglucose F18; Humans; Immunoglobulin G; Leukocytes; Nuclear Medicine; Osteomyelitis; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
Nuclear medicine and the infected joint replacement.
Topics: Arthroplasty, Replacement; Bone and Bones; Bone Marrow; Ciprofloxacin; Fluorodeoxyglucose F18; Humans; Indium Radioisotopes; Leukocytes; Nuclear Medicine; Organotechnetium Compounds; Prosthesis Failure; Prosthesis-Related Infections; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity | 2009 |
[Preoperative evaluation of cytologically indeterminate thyroid nodules with 18F-FDG PET].
Topics: Adenoma; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Gland; Thyroid Neoplasms; Thyroid Nodule | 2008 |
Beyond RECIST: molecular and functional imaging techniques for evaluation of response to targeted therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Diagnostic Imaging; Drug Delivery Systems; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Molecular Biology; Neoplasms; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
FDG-PET has no definite role in preoperative imaging in gastric cancer.
Topics: Chemotherapy, Adjuvant; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Neoplasm Staging; Preoperative Care; Radiopharmaceuticals; Sensitivity and Specificity; Stomach Neoplasms; Tomography, Emission-Computed | 2009 |
Established, emerging and future roles of PET/CT in the management of colorectal cancer.
Topics: Colonoscopy; Colorectal Neoplasms; Cost-Benefit Analysis; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Sensitivity and Specificity; Tomography, X-Ray Computed; United Kingdom | 2009 |
Nuclear imaging and cervical cancer.
Topics: Drug Monitoring; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Positron-Emission Tomography; Practice Guidelines as Topic; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Uterine Cervical Neoplasms | 2009 |
Controversies in the management of colorectal liver metastases: role of PET and PET/CT.
Topics: Biopsy, Needle; Catheter Ablation; Chemotherapy, Adjuvant; Colorectal Neoplasms; Cryosurgery; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Hepatectomy; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prognosis; Risk Assessment; Sensitivity and Specificity; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome | 2008 |
[PET and PET-CT of malignant tumors of the exocrine pancreas].
Topics: Adenocarcinoma; Carcinoma, Acinar Cell; Carcinoma, Pancreatic Ductal; Diagnosis, Differential; Disease Progression; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Pancreas; Pancreatic Neoplasms; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
Positron-emission tomography in gynaecologic malignancies.
Topics: Carcinoma; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Positron-Emission Tomography; Sarcoma; Sensitivity and Specificity | 2009 |
Positron emission tomography for monitoring response to neoadjuvant therapy in patients with oesophageal and gastro-oesophageal junction carcinoma.
Topics: Esophageal Neoplasms; Esophagogastric Junction; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Survival Analysis; Treatment Outcome | 2009 |
A systematic review of FDG-PET in breast cancer.
Topics: Breast Neoplasms; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity | 2010 |
Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinoscopy; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
Assessment of response to neoadjuvant therapy in esophageal cancer: an updated systematic review of diagnostic accuracy of endoscopic ultrasonography and fluorodeoxyglucose positron emission tomography.
Topics: Endosonography; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Outcome Assessment, Health Care; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2010 |
[Response judgement - conventional versus new methods].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Cone-Beam Computed Tomography; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Neoadjuvant Therapy; Neoplasm Staging; Patient Care Team; Positron-Emission Tomography; Quality of Life; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Sensitivity and Specificity; Survival Rate; Tomography, Spiral Computed; Treatment Outcome | 2009 |
[Application and future prospect of 18F-FLT PET-CT in guiding delineation of biological target volume].
Topics: Dideoxynucleosides; False Positive Reactions; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Inflammation; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Radiotherapy, Intensity-Modulated; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
[Positron emission tomography in neuroendocrine tumours].
Topics: APUD Cells; Drug and Narcotic Control; Fluorodeoxyglucose F18; Humans; Neuroendocrine Tumors; Norway; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Somatostatin; Sensitivity and Specificity | 2009 |
Advances in imaging in the work-up of head and neck cancer patients.
Topics: Carcinoma, Squamous Cell; Diagnostic Imaging; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Tomography, X-Ray Computed | 2009 |
Unifying the predictive value of pretransplant FDG PET in patients with lymphoma: a review and meta-analysis of published trials.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Positron-Emission Tomography; Preoperative Care; Prevalence; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Stem Cell Transplantation | 2010 |
Meta-analysis of the performance of (18)F-FDG PET in cutaneous melanoma.
Topics: Fluorodeoxyglucose F18; Humans; Incidence; Melanoma; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Skin Neoplasms | 2010 |
Noninvasive assessment of pediatric brain tumors.
Topics: Brain Neoplasms; Child; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity | 2009 |
The role of (18)F-fluorodeoxyglucose positron emission tomography in the diagnosis, staging, and follow-up of cholangiocarcinoma.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity | 2011 |
Novel imaging modalities in gynecologic cancer.
Topics: Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
Usefulness of 18F-FDG PET, combined FDG-PET/CT and EUS in diagnosing primary pancreatic carcinoma: a meta-analysis.
Topics: Endosonography; Fluorodeoxyglucose F18; Humans; Pancreatic Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
[Imaging techniques in the evaluation of primary large vessel vasculitides: Part 2: duplex ultrasound, positron emission tomography, computed tomography, and ophthalmological methods].
Topics: Angiography; Aortic Aneurysm; Aortic Dissection; Arterial Occlusive Diseases; Cone-Beam Computed Tomography; Diagnostic Techniques, Ophthalmological; Emergencies; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Magnetic Resonance Angiography; Optic Neuropathy, Ischemic; Positron-Emission Tomography; Retinal Artery Occlusion; Sensitivity and Specificity; Takayasu Arteritis; Tomography, X-Ray Computed; Ultrasonography, Doppler, Duplex | 2009 |
Interim fluorodeoxyglucose positron emission tomography for early response assessment in diffuse large B cell lymphoma: where are we now?
Topics: Antineoplastic Combined Chemotherapy Protocols; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Outcome Assessment, Health Care; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity | 2009 |
[Nuclear medicine diagnosis of bone metastases].
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Organophosphorus Compounds; Organotechnetium Compounds; Positron-Emission Tomography; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2009 |
Present and future of PET and PET/CT in gynaecologic malignancies.
Topics: Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Forecasting; Genital Diseases, Female; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
FDG PET-CT in the management of primary breast lymphoma.
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
The use of FDG-PET in assessing axillary lymph node status in breast cancer: a systematic review and meta-analysis of the literature.
Topics: Area Under Curve; Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity | 2010 |
Role of FDG-PET and PET/CT in the diagnosis and management of vasculitis.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Vasculitis | 2010 |
Prediction of tumor response to neoadjuvant therapy in patients with esophageal cancer with use of 18F FDG PET: a systematic review.
Topics: Chi-Square Distribution; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity | 2010 |
[Chronic abdominal aortic graft infection : Detection with 18F-FDG-PET/CT].
Topics: Aged; Aorta, Abdominal; Aorta, Thoracic; Aortic Diseases; Aortography; Blood Vessel Prosthesis; Chronic Disease; Cooperative Behavior; Device Removal; Duodenal Diseases; Enterococcus faecalis; Fluorodeoxyglucose F18; Gram-Positive Bacterial Infections; Humans; Iliac Artery; Image Processing, Computer-Assisted; Interdisciplinary Communication; Intestinal Fistula; Klebsiella Infections; Klebsiella pneumoniae; Leriche Syndrome; Male; Positron-Emission Tomography; Postoperative Complications; Prosthesis-Related Infections; Reoperation; Sensitivity and Specificity; Tomography, X-Ray Computed; Vascular Fistula | 2010 |
PET and PET-CT in radiation treatment planning for lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Radiation Dosage; Radiation Injuries; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Sensitivity and Specificity; Tomography, X-Ray Computed | 2010 |
Imaging of advanced renal cell carcinoma.
Topics: Carcinoma, Renal Cell; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Magnetic Resonance Imaging; Male; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Radiographic Image Enhancement; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography, Doppler | 2010 |
Role of PET/CT in ovarian cancer.
Topics: Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2010 |
Imaging atherosclerotic plaque inflammation by fluorodeoxyglucose with positron emission tomography: ready for prime time?
Topics: Animals; Arteries; Atherosclerosis; Biopsy, Needle; Cohort Studies; Coronary Artery Disease; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Immunohistochemistry; Inflammation; Male; Positron-Emission Tomography; Radiographic Image Enhancement; Sensitivity and Specificity; Severity of Illness Index | 2010 |
Imaging in gastrointestinal stromal tumours: current status and future directions.
Topics: Disease Progression; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2010 |
Opportunities for PET to deliver clinical benefit in cancer: breast cancer as a paradigm.
Topics: Biomarkers, Tumor; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
A systematic review of the factors affecting accuracy of SUV measurements.
Topics: Algorithms; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Models, Biological; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2010 |
[PET/CT for diagnostics and therapy stratification of lung cancer].
Topics: Carcinoma, Bronchogenic; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Diagnosis, Differential; Disease Progression; Energy Metabolism; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiographic Image Enhancement; Radiotherapy Planning, Computer-Assisted; Sensitivity and Specificity; Tomography, Spiral Computed; Tomography, X-Ray Computed | 2010 |
Diagnostic imaging of colorectal liver metastases with CT, MR imaging, FDG PET, and/or FDG PET/CT: a meta-analysis of prospective studies including patients who have not previously undergone treatment.
Topics: Colorectal Neoplasms; Contrast Media; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2010 |
[Nuclear medicine imaging in patients with Parkinson's syndrome: an update].
Topics: Animals; Brain; Dihydroxyphenylalanine; Disease Progression; Dopamine; Energy Metabolism; Fluorodeoxyglucose F18; Genetic Predisposition to Disease; Humans; Nerve Degeneration; Neurons; Parkinson Disease; Parkinsonian Disorders; Positron-Emission Tomography; Receptors, Dopamine; Regional Blood Flow; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 2010 |
Added value of baseline 18F-FDG uptake in serial 18F-FDG PET for evaluation of response of solid extracerebral tumors to systemic cytotoxic neoadjuvant treatment: a meta-analysis.
Topics: Antineoplastic Agents; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Neoplasms; Positron-Emission Tomography; Prognosis; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome | 2010 |
Assessing extracranial tumors using diffusion-weighted whole-body MRI.
Topics: Adenoma, Liver Cell; Blood Glucose; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Contrast Media; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Processing, Computer-Assisted; Liver Neoplasms; Lung Neoplasms; Male; Multiple Myeloma; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Prostatic Neoplasms; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2011 |
[What is the role of FDG-PET in thoracic oncology in 2010?].
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2010 |
What is the best way to diagnose and stage malignant pleural mesothelioma?
Topics: Diagnostic Imaging; Evidence-Based Medicine; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Magnetic Resonance Imaging; Male; Mesothelioma; Neoplasm Staging; Pleural Neoplasms; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
Extended staging of oesophageal cancer using FDG-PET - a critical appraisal.
Topics: Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Image Enhancement; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2012 |
Role of ¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography in patients affected by differentiated thyroid carcinoma, high thyroglobulin level, and negative ¹³¹I scan: review of the literature.
Topics: Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thyroglobulin; Thyroid Gland; Thyroid Neoplasms; Tomography, X-Ray Computed; Whole Body Imaging | 2010 |
A meta-analysis of the value of fluorodeoxyglucose-PET/PET-CT in the evaluation of fever of unknown origin.
Topics: Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
18F-FDG PET, combined FDG-PET/CT and MRI for evaluation of bone marrow infiltration in staging of lymphoma: a systematic review and meta-analysis.
Topics: Bone Marrow Neoplasms; Comorbidity; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Magnetic Resonance Imaging; Male; Neoplasm Staging; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2012 |
[Assessment of residual tumours after systemic treatment of metastatic seminoma: ¹⁸F-2-fluoro-2-deoxy-D-glucose positron emission tomography - meta-analysis of diagnostic value].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Seminoma; Sensitivity and Specificity; Testicular Neoplasms; Treatment Outcome; Young Adult | 2011 |
Positron emission tomography for benign and malignant disease.
Topics: Breast Neoplasms; Colorectal Neoplasms; Dermatitis, Contact; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Melanoma; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2011 |
Characterization of adrenal masses by using FDG PET: a systematic review and meta-analysis of diagnostic test performance.
Topics: Adrenal Gland Neoplasms; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity | 2011 |
Positron emission tomography in non-medullary thyroid cancer.
Topics: Biomarkers, Tumor; Early Detection of Cancer; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Population Surveillance; Positron-Emission Tomography; Prognosis; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Thyroid Nodule; Thyrotropin | 2011 |
A meta-analysis of ¹⁸FDG-PET-CT, ¹⁸FDG-PET, MRI and bone scintigraphy for diagnosis of bone metastases in patients with lung cancer.
Topics: Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2012 |
Metabolic positron emission tomography imaging in cancer detection and therapy response.
Topics: Choline; Drug Monitoring; Fluorodeoxyglucose F18; Humans; Molecular Imaging; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tyrosine | 2011 |
The role of 18F-fluorodeoxyglucose positron emission tomography in thyroid neoplasms.
Topics: Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Gland; Thyroid Neoplasms; Thyroid Nodule | 2011 |
The role of [18F]-2-fluoro-2-deoxy-d-glucose-positron emission tomography in thyroid nodules with indeterminate fine-needle aspiration biopsy: systematic review and meta-analysis of the literature.
Topics: Biopsy, Fine-Needle; Carcinoma; Confounding Factors, Epidemiologic; Data Interpretation, Statistical; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Predictive Value of Tests; Prevalence; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Thyroid Nodule; Thyroidectomy | 2011 |
Single photon emission tomography/computed tomography (SPET/CT) and positron emission tomography/computed tomography (PET/CT) to image cancer.
Topics: Adult; Aged; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasms; Neuroendocrine Tumors; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, Emission-Computed, Single-Photon | 2011 |
Positron emission tomography/computed tomography in lung cancer staging, prognosis, and assessment of therapeutic response.
Topics: Carcinoma, Non-Small-Cell Lung; Contrast Media; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Staging; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Whole Body Imaging | 2011 |
[Positron emission tomography - current role in the diagnosis and treatment of upper gastrointestinal carcinomas].
Topics: Adenocarcinoma; Combined Modality Therapy; Dideoxynucleosides; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Sensitivity and Specificity; Stomach Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
Molecular imaging in sarcoidosis.
Topics: Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Sarcoidosis; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
(18)FDG-PET/CT for detecting distant metastases and second primary cancers in patients with head and neck cancer. A meta-analysis.
Topics: Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
F-18 FDG PET for evaluation of bone marrow involvement in non-Hodgkin lymphoma: a meta-analysis.
Topics: Bone Marrow; Evaluation Studies as Topic; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Quality Assurance, Health Care; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
Comparison of 18F-FDG PET/CT with bone scintigraphy for detection of bone metastasis: a meta-analysis.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
Emerging techniques and molecular imaging in breast cancer.
Topics: Adult; Aged; Breast; Breast Neoplasms; Cone-Beam Computed Tomography; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Mammography; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Spectroscopy, Near-Infrared | 2011 |
Value of PET/CT in the management of liver metastases, part 1.
Topics: Biomarkers, Tumor; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Neoplasm Staging; Radiography; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity | 2011 |
Value of PET/CT in the management of primary hepatobiliary tumors, part 2.
Topics: Acetates; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carbon Radioisotopes; Carcinoma, Hepatocellular; Cholangiocarcinoma; Fluorodeoxyglucose F18; Gallbladder Neoplasms; Humans; Liver Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
FDG-PET/CT in the staging of local/regional metastases in breast cancer.
Topics: Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
18F-FDG positron emission tomography: potential utility in the assessment of Crohn's disease.
Topics: Crohn Disease; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Imaging Alzheimer in 2011.
Topics: Alzheimer Disease; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2011 |
Nuclear medicine imaging in dementia: a practical overview for hospitalists.
Topics: Aged; Alzheimer Disease; Amyloid; Dementia; Diagnosis, Computer-Assisted; Diagnosis, Differential; Dopamine Plasma Membrane Transport Proteins; Fluorodeoxyglucose F18; Hospitalists; Humans; Lewy Body Disease; Nuclear Medicine; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 2011 |
Can ¹⁸F-fluorodeoxyglucose positron emission tomography predict responses to neoadjuvant therapy in oesophageal cancer patients? A meta-analysis.
Topics: Adenocarcinoma; Area Under Curve; Confidence Intervals; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Odds Ratio; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity | 2011 |
Diagnosis of bone metastases: a meta-analysis comparing ¹⁸FDG PET, CT, MRI and bone scintigraphy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Child; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2011 |
¹⁸F-fluoro-deoxyglucose positron emission tomography in assessment of myeloma-related bone disease: a systematic review.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multiple Myeloma; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Whole-Body Irradiation | 2012 |
Novel molecular imaging in lung and pleural diseases.
Topics: Female; Fluorodeoxyglucose F18; Gamma Rays; Humans; Lung Diseases; Lung Neoplasms; Male; Molecular Imaging; Pleural Diseases; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2011 |
18F-FDG PET or PET/CT for detecting extrahepatic metastases or recurrent hepatocellular carcinoma: a systematic review and meta-analysis.
Topics: Carcinoma; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Clinical value of FDG PET or PET/CT in urinary bladder cancer: a systemic review and meta-analysis.
Topics: Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Urinary Bladder Neoplasms | 2012 |
18 F-fluorodeoxyglucose positron emission tomography to evaluate recurrent gastric cancer: a systematic review and meta-analysis.
Topics: Contrast Media; Fluorodeoxyglucose F18; Humans; Likelihood Functions; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Stomach Neoplasms; Tomography, X-Ray Computed | 2012 |
A meta-analysis of fluorodeoxyglucose-positron emission tomography versus scintigraphy in the evaluation of suspected osteomyelitis.
Topics: Antibodies, Monoclonal; Bone and Bones; Fluorodeoxyglucose F18; Humans; Leukocytes; Multimodal Imaging; Osteomyelitis; Positron-Emission Tomography; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
The value of FDG positron emission tomography/computerised tomography (PET/CT) in pre-operative staging of colorectal cancer: a systematic review and economic evaluation.
Topics: Cohort Studies; Colorectal Neoplasms; Cost-Benefit Analysis; Fluorodeoxyglucose F18; Humans; Monte Carlo Method; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Preoperative Period; Quality-Adjusted Life Years; Radiopharmaceuticals; Randomized Controlled Trials as Topic; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
Is 18F-FDG PET accurate to predict neoadjuvant therapy response in breast cancer? A meta-analysis.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Neoadjuvant Therapy; Positron-Emission Tomography; Prognosis; Publication Bias; Sensitivity and Specificity; Time Factors; Treatment Outcome | 2012 |
FDG-PET/CT for detection of the unknown primary head and neck tumor.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Multimodal Imaging; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
Diagnostic accuracy of ¹⁸F-FDG-PET and PET/CT in patients with Ewing sarcoma family tumours: a systematic review and a meta-analysis.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Sarcoma, Ewing; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2012 |
Diagnostic performance of dual-time 18F-FDG PET in the diagnosis of pulmonary nodules: a meta-analysis.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Solitary Pulmonary Nodule | 2012 |
Role of ¹⁸F 2-fluoro-2-deoxyglucose positron emission tomography in upper gastrointestinal malignancies.
Topics: Drug Therapy; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Neoplasm Staging; Pancreatic Neoplasms; Peritoneal Neoplasms; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Recurrence; Sensitivity and Specificity; Stomach Neoplasms | 2011 |
Meta-analysis: comparison of F-18 fluorodeoxyglucose-positron emission tomography and bone scintigraphy in the detection of bone metastasis in patients with lung cancer.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity | 2012 |
[FDG-PET and endometrial cancer].
Topics: Endometrial Neoplasms; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Estrogen; Sensitivity and Specificity | 2012 |
(18)FDG-PET/CT for detection of mediastinal nodal metastasis in non-small cell lung cancer: a meta-analysis.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Mediastinal Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity | 2012 |
Diagnostic accuracy of 18 F-FDG and 11 C-PIB-PET for prediction of short-term conversion to Alzheimer's disease in subjects with mild cognitive impairment.
Topics: Aged; Alzheimer Disease; Aniline Compounds; Benzothiazoles; Clinical Trials as Topic; Cognitive Dysfunction; Cross-Sectional Studies; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Thiazoles | 2012 |
18F-FDG PET or PET/CT for detection of metastatic lymph nodes in patients with endometrial cancer: a systematic review and meta-analysis.
Topics: Carcinoma; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Multimodal Imaging; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Cancer imaging: Gene transcription-based imaging and therapeutic systems.
Topics: Diagnostic Imaging; Fluorodeoxyglucose F18; Gene Transfer Techniques; Genes, Reporter; Genetic Therapy; Humans; Neoplasm Micrometastasis; Neoplasms; Organ Specificity; Positron-Emission Tomography; Promoter Regions, Genetic; Sensitivity and Specificity; Transcription, Genetic | 2012 |
False-positive lesions mimicking breast cancer on FDG PET and PET/CT.
Topics: Biopsy; Breast Diseases; Breast Neoplasms; Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Granuloma; Humans; Incidental Findings; Lactation; Mastitis; Multimodal Imaging; Necrosis; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Optimizing the role of FDG PET-CT for potentially operable metastatic colorectal cancer.
Topics: Carcinoembryonic Antigen; Colonography, Computed Tomographic; Colorectal Neoplasms; Cost-Benefit Analysis; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Multimodal Imaging; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Preoperative imaging of colorectal liver metastases after neoadjuvant chemotherapy: a meta-analysis.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Multimodal Imaging; Neoadjuvant Therapy; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Diagnostic value of diffusion-weighted magnetic resonance imaging compared with fluorodeoxyglucose positron emission tomography/computed tomography for pancreatic malignancy: a meta-analysis using a hierarchical regression model.
Topics: Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Pancreatic Neoplasms; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Nuclear medicine imaging in tuberculosis using commercially available radiopharmaceuticals.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Iofetamine; Lung Neoplasms; Magnetic Resonance Imaging; Nuclear Medicine; Organophosphorus Compounds; Organotechnetium Compounds; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Tuberculosis, Pulmonary | 2012 |
How has the management of medullary thyroid carcinoma changed with the advent of 18F-FDG and non-18F-FDG PET radiopharmaceuticals.
Topics: Carcinoma, Medullary; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Proto-Oncogene Mas; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms | 2012 |
18F-FDG-PET evaluation of treatment response to neo-adjuvant therapy in patients with locally advanced rectal cancer: a meta-analysis.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Radiopharmaceuticals; Rectal Neoplasms; Sensitivity and Specificity; Treatment Outcome | 2012 |
Positron emission tomography in hepatobiliary and pancreatic malignancies: a review.
Topics: Carcinoma, Hepatocellular; Cholangiocarcinoma; Digestive System Neoplasms; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2012 |
The role of FDG PET-CT in the therapeutic evaluation for HNSCC patients.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Glucose; Head and Neck Neoplasms; Humans; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
¹⁸F-FDG-PET and ¹⁸F-FDG-PET/CT in the detection of recurrent or metastatic medullary thyroid carcinoma: a systematic review and meta-analysis.
Topics: Carcinoma, Medullary; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, X-Ray Computed | 2012 |
Utility of FDG PET/CT in the assessment of myeloid sarcoma.
Topics: Female; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma, Myeloid; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Low-sensitivity FDG-PET studies: less common lung neoplasms.
Topics: Animals; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Radioactive Tracers; Sensitivity and Specificity | 2012 |
Decreased sensitivity of (18)F-fluorodeoxyglucose imaging in infection and inflammation.
Topics: Diagnostic Imaging; Fluorodeoxyglucose F18; Humans; Infections; Inflammation; Sensitivity and Specificity | 2012 |
Use of dual-point fluorodeoxyglucose imaging to enhance sensitivity and specificity.
Topics: Breast Neoplasms; Digestive System Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Sensitivity and Specificity | 2012 |
Virtual 18F-FDG PET/CT bronchoscopy for lymph node staging in non-small-cell lung cancer patients: present and future applications.
Topics: Bronchoscopy; Carcinoma, Non-Small-Cell Lung; Endoscopy; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
18F-FDG PET/CT and PET for evaluation of pathological response to neoadjuvant chemotherapy in breast cancer: a meta-analysis.
Topics: Adult; Aged; Aged, 80 and over; Area Under Curve; Breast; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Odds Ratio; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2012 |
The efficacy of FDG-PET for the management of esophageal cancer: review article.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
18[F]FDG-PET/CT is a useful molecular marker in evaluating tumour aggressiveness: a revised understanding of an in-vivo FDG-PET imaging that alludes the alteration of cancer biology.
Topics: Biomarkers, Tumor; Cell Dedifferentiation; Early Detection of Cancer; Fluorodeoxyglucose F18; Glycolysis; Humans; Multimodal Imaging; Mutation; Neoplasm Recurrence, Local; Neoplasms; Predictive Value of Tests; Sensitivity and Specificity; Survival Analysis | 2013 |
Molecular imaging of prostate cancer: PET radiotracers.
Topics: Carbon Radioisotopes; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Molecular Imaging; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity | 2012 |
Nuclear perfusion imaging for functional evaluation of patients with known or suspected coronary artery disease: the future is now.
Topics: Coronary Angiography; Coronary Artery Disease; Endothelium, Vascular; Fluorodeoxyglucose F18; Humans; Myocardial Perfusion Imaging; Positron-Emission Tomography; Prognosis; Radiography, Interventional; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Compounds; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon | 2012 |
FDG PET and FDG PET/CT in patients with gastrointestinal stromal tumours.
Topics: Antineoplastic Agents; Benzamides; Blood Glucose; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Indoles; Molecular Targeted Therapy; Multimodal Imaging; Neoplasm Recurrence, Local; Piperazines; Positron-Emission Tomography; Prognosis; Pyrimidines; Pyrroles; Sensitivity and Specificity; Sunitinib; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Utility of positron emission tomography/CT in the evaluation of small bowel pathology.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Intestinal Neoplasms; Intestine, Small; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Imaging of triple-negative breast cancer.
Topics: Breast Neoplasms; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Mammography; Neoadjuvant Therapy; Positron-Emission Tomography; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Sensitivity and Specificity; Ultrasonography, Mammary | 2012 |
Imaging atherosclerosis with hybrid [18F]fluorodeoxyglucose positron emission tomography/computed tomography imaging: what Leonardo da Vinci could not see.
Topics: Atherosclerosis; Fluorodeoxyglucose F18; Humans; Inflammation; Multimodal Imaging; Plaque, Atherosclerotic; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Accuracy of whole-body FDG-PET and FDG-PET/CT in M staging of nasopharyngeal carcinoma: a systematic review and meta-analysis.
Topics: Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Nasopharyngeal Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Factors; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2013 |
Questions and answers: what can be said by diagnostic imaging in neuroendocrine tumors?
Topics: Diagnostic Imaging; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multidetector Computed Tomography; Multimodal Imaging; Neoplasm Proteins; Neuroendocrine Tumors; Nuclear Medicine Department, Hospital; Oligopeptides; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Somatostatin; Sensitivity and Specificity; Somatostatin; Tomography, X-Ray Computed; Ultrasonography | 2012 |
Update on gastrointestinal imaging.
Topics: Cholangiography; Choledochal Cyst; Colonography, Computed Tomographic; Colorectal Neoplasms; Fluorodeoxyglucose F18; Gallstones; Gastrointestinal Diseases; Humans; Magnetic Resonance Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
Evaluation of breast and gynecologic cancers by positron emission tomography.
Topics: Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
Should FDG PET be used to decide whether a patient with an abnormal mammogram or breast finding at physical examination should undergo biopsy?
Topics: Biopsy; Breast; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Mammography; Physical Examination; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
Positron emission tomography in non-Hodgkin's lymphoma (NHL): relationship between tracer uptake and pathological findings, including preliminary experience in the staging of low-grade NHL.
Topics: Carbon Radioisotopes; Cell Division; Disease Progression; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphoma, Non-Hodgkin; Methionine; Neoplasm Staging; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Tissue Distribution; Tomography, Emission-Computed | 2002 |
[Positron emission tomography (PET) in clinical oncology [Part III]].
Topics: Adult; Brain Neoplasms; Breast Neoplasms; Digestive System Neoplasms; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Neoplasms; Ovarian Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, Emission-Computed | 2002 |
[A proposal for the rational use of the PET in oncology].
Topics: Brain Neoplasms; Colorectal Neoplasms; Consensus; Cost-Benefit Analysis; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphoma; Melanoma; Neoplasms; Practice Guidelines as Topic; Radiopharmaceuticals; Sensitivity and Specificity; Solitary Pulmonary Nodule; Spain; Tomography, Emission-Computed | 2002 |
The value of positron emission tomography (PET) imaging in disease staging and therapy assessment.
Topics: Female; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Staging; Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
[Value of [18F]-fluorodeoxyglucose (FDG) positron emission tomography in digestive cancerology].
Topics: Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Neoplasm Recurrence, Local; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
[18F-fluorodeoxyglucose positron emission tomography in the diagnosis of lung cancer].
Topics: Carcinoma, Non-Small-Cell Lung; Cell Division; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
Functional imaging for assessment of therapy.
Topics: Animals; Fluorodeoxyglucose F18; Humans; Mice; Molecular Probes; Neoplasm Staging; Neoplasms; Radiopharmaceuticals; Research; Sensitivity and Specificity; Tomography, Emission-Computed; Treatment Outcome | 2002 |
Positron emission tomography scanning in gynecologic and breast cancers.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Predictive Value of Tests; Prognosis; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
18F-FDG PET evaluation of the response to therapy for lymphoma and for breast, lung, and colorectal carcinoma.
Topics: Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphoma; Male; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Treatment Outcome | 2003 |
Value of whole-body FDG PET in management of lung cancer.
Topics: Drug Therapy, Computer-Assisted; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Reproducibility of Results; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, Emission-Computed; Whole-Body Counting | 2003 |
Positron emission tomography with [(18)F]FDG for therapy response monitoring in lymphoma patients.
Topics: Female; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Predictive Value of Tests; Prognosis; Radioimmunotherapy; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
On the development of rational standards for nuclear response evaluation.
Topics: Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Neoplasms; Radiopharmaceuticals; Reference Standards; Sensitivity and Specificity; Tomography, Emission-Computed; Treatment Outcome | 2003 |
Noninvasive evaluation of ischaemic heart disease: myocardial perfusion imaging or stress echocardiography?
Topics: Echocardiography, Stress; Fluorodeoxyglucose F18; Humans; Myocardial Ischemia; Myocardial Reperfusion; Perfusion; Radiopharmaceuticals; Recovery of Function; Sensitivity and Specificity; Ventricular Dysfunction, Left | 2003 |
Positron emission tomography in diagnosis and management of invasive breast cancer: current status and future perspectives.
Topics: Breast Neoplasms; Diagnosis, Differential; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Positron-Emission Tomography; Practice Patterns, Physicians'; Prognosis; Radiopharmaceuticals; Risk Assessment; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; United States | 2003 |
Imaging of large vessel vasculitis with (18)FDG PET: illusion or reality? A critical review of the literature data.
Topics: Arteries; Arteriosclerosis; Arteritis; Diagnosis, Differential; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Takayasu Arteritis; Tomography, Emission-Computed; Vasculitis | 2003 |
[The value of fluorodeoxyglucose positron emission tomography (FDG-PET) in differentiation of pancreatic lesions].
Topics: Cholangiopancreatography, Endoscopic Retrograde; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Pancreatic Neoplasms; Pancreatitis; Predictive Value of Tests; Radiopharmaceuticals; Recurrence; ROC Curve; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
Positron emission tomography scanning in lung cancer.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; United States | 2003 |
Is positron emission tomography an accurate non-invasive alternative to sentinel lymph node biopsy in breast cancer patients?
Topics: Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Tomography, Emission-Computed | 2003 |
Meta-analysis of the performance of 18F-FDG PET in primary tumor detection in unknown primary tumors.
Topics: False Negative Reactions; Fluorodeoxyglucose F18; Humans; Neoplasms; Neoplasms, Unknown Primary; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
PET scan in occult ectopic ACTH syndrome: a useful tool?
Topics: ACTH Syndrome, Ectopic; Adult; Bronchial Neoplasms; Carcinoid Tumor; Fluorodeoxyglucose F18; Humans; Male; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
Diagnosis of pancreatic cancer using fluorine-18 fluorodeoxyglucose positron emission tomography (FDG PET) --usefulness and limitations in "clinical reality".
Topics: Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Pancreatic Neoplasms; Patient Selection; Practice Patterns, Physicians'; Preoperative Care; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed; Whole-Body Counting | 2003 |
PET in the follow-up of differentiated thyroid cancer.
Topics: Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Neoplasm Recurrence, Local; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms | 2003 |
Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysis.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
PET in the assessment of therapy response in patients with carcinoma of the head and neck and of the esophagus.
Topics: Antineoplastic Agents; Carcinoma; Carcinoma, Squamous Cell; Esophageal Neoplasms; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Practice Patterns, Physicians'; Prognosis; Radiopharmaceuticals; Radiotherapy; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed; Treatment Outcome | 2004 |
FDG PET and alternative imaging in the management of thyroid carcinoma.
Topics: Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Neoplasm Metastasis; Neoplasm Recurrence, Local; Patient Care Management; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, Emission-Computed; Whole-Body Counting | 2003 |
The value of FDG-PET in the detection, grading and response to therapy of soft tissue and bone sarcomas; a systematic review and meta-analysis.
Topics: Adolescent; Adult; Aged; Biopsy, Needle; Bone Neoplasms; Combined Modality Therapy; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Male; Middle Aged; Neoplasm Staging; Randomized Controlled Trials as Topic; Risk Assessment; Sarcoma; Sensitivity and Specificity; Soft Tissue Neoplasms; Survival Analysis; Tomography, Emission-Computed | 2004 |
F-18-fluorodeoxyglucose positron emission tomography leading to a diagnosis of septic thrombophlebitis of the portal vein: description of a case history and review of the literature.
Topics: Aged; Bacterial Infections; Fluorodeoxyglucose F18; Humans; Male; Portal Vein; Radiopharmaceuticals; Sensitivity and Specificity; Thrombophlebitis; Tomography, Emission-Computed | 2004 |
Detection of musculoskeletal infection with 18F-FDG PET: review of the current literature.
Topics: Arthroplasty, Replacement; Chronic Disease; Fluorodeoxyglucose F18; Humans; Infections; Musculoskeletal Diseases; Osteomyelitis; Prosthesis-Related Infections; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2004 |
Alzheimer disease: operating characteristics of PET--a meta-analysis.
Topics: Alzheimer Disease; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Severity of Illness Index; Tomography, Emission-Computed | 2004 |
Brain 18F-FDG PET in the diagnosis of neurodegenerative dementias: comparison with perfusion SPECT and with clinical evaluations lacking nuclear imaging.
Topics: Brain; Dementia; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Neurodegenerative Diseases; Practice Patterns, Physicians'; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2004 |
Advantages and limitations of FDG PET in the follow-up of breast cancer.
Topics: Breast Neoplasms; Clinical Trials as Topic; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Positron-Emission Tomography; Practice Guidelines as Topic; Practice Patterns, Physicians'; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Subtraction Technique; Technology Assessment, Biomedical; Tomography, X-Ray Computed; Treatment Outcome | 2004 |
Measuring response to chemotherapy in locally advanced breast cancer: methodological considerations.
Topics: Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Decision Support Systems, Clinical; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Positron-Emission Tomography; Practice Guidelines as Topic; Practice Patterns, Physicians'; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Treatment Outcome | 2004 |
FDG-PET in monitoring therapy of breast cancer.
Topics: Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Decision Support Systems, Clinical; Drug Therapy; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Staging; Positron-Emission Tomography; Practice Guidelines as Topic; Practice Patterns, Physicians'; Prognosis; Radiopharmaceuticals; Radiotherapy; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Treatment Outcome | 2004 |
Biological characterisation of breast cancer by means of PET.
Topics: Biomarkers, Tumor; Breast Neoplasms; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Positron-Emission Tomography; Proto-Oncogene Mas; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2004 |
FDG-PET for axillary lymph node staging in primary breast cancer.
Topics: Axilla; Breast Neoplasms; Clinical Trials as Topic; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Positron-Emission Tomography; Practice Patterns, Physicians'; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Sentinel Lymph Node Biopsy | 2004 |
FDG PET and other imaging modalities in the primary diagnosis of suspicious breast lesions.
Topics: Breast Neoplasms; Clinical Trials as Topic; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Practice Patterns, Physicians'; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Technetium Tc 99m Sestamibi; Tomography, X-Ray Computed | 2004 |
PET/CT and breast cancer.
Topics: Breast Neoplasms; Clinical Trials as Topic; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Practice Guidelines as Topic; Practice Patterns, Physicians'; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Subtraction Technique; Technology Assessment, Biomedical; Tomography, X-Ray Computed; Treatment Outcome | 2004 |
FDG PET and tumour markers in the diagnosis of recurrent and metastatic breast cancer.
Topics: Biomarkers, Tumor; Breast Neoplasms; Clinical Trials as Topic; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Practice Guidelines as Topic; Practice Patterns, Physicians'; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity | 2004 |
[Significance of PET for ENT-tumors].
Topics: Amino Acids; Blood Glucose; Energy Metabolism; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Molecular Probe Techniques; Neoplasm Proteins; Neoplasm Staging; Otorhinolaryngologic Neoplasms; Prognosis; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
Role of FDG-PET in the diagnosis and treatment of colorectal liver metastases.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Neoplasm Recurrence, Local; Patient Care Planning; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
Dedifferentiated thyroid carcinoma: the imaging role of 18F-FDG PET and non-iodine radiopharmaceuticals.
Topics: Clinical Trials as Topic; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Compounds; Thallium; Thyroid Neoplasms | 2004 |
Positron-emission tomography in prognostic and therapeutic assessment of lung cancer: systematic review.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
[Whole-body tumor staging: MRI or FDG-PET/CT?].
Topics: Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Time Factors; Tomography, X-Ray Computed | 2004 |
Systematic review of the staging performance of 18F-fluorodeoxyglucose positron emission tomography in esophageal cancer.
Topics: Clinical Trials as Topic; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2004 |
Radionuclide imaging of thoracic malignancies.
Topics: Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Male; Neoplasm Staging; Nuclear Medicine; Sensitivity and Specificity; Thoracic Neoplasms; Tomography, Emission-Computed | 2004 |
Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Docetaxel; Endosonography; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Irinotecan; Life Tables; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Positron-Emission Tomography; Preoperative Care; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Radiotherapy, Adjuvant; Retrospective Studies; Sensitivity and Specificity; Survival Analysis; Taxoids; Tomography, X-Ray Computed; Treatment Outcome | 2004 |
The role of fluorodeoxyglucose positron emission tomography in cervical lymph node metastases from an unknown primary tumor.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neck; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2004 |
Meta-analysis: the detection of pancreatic malignancy with positron emission tomography.
Topics: Fluorodeoxyglucose F18; Humans; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2004 |
Meta-analysis of positron emission tomographic and computed tomographic imaging in detecting mediastinal lymph node metastases in nonsmall cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Research Design; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2005 |
[The impact of integrating images of positron emission tomography with computed tomography simulation on radiation therapy planning].
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Neoplasms; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; Sensitivity and Specificity; Tomography, X-Ray Computed | 2004 |
FDG-PET scanning in the diagnosis of gastrointestinal cancers.
Topics: Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2004 |
Pancreatic tumors: role of imaging in the diagnosis, staging, and treatment.
Topics: Adenocarcinoma; Biopsy, Fine-Needle; Cholangiopancreatography, Magnetic Resonance; Diagnostic Imaging; Endosonography; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2004 |
FDG-PET and beyond: molecular breast cancer imaging.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Reference Standards; Sensitivity and Specificity; Sentinel Lymph Node Biopsy | 2005 |
A meta-analysis of FDG-PET for the evaluation of breast cancer recurrence and metastases.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2005 |
Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development.
Topics: Fluorodeoxyglucose F18; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity; Survival Analysis | 2005 |
Imaging of pheochromocytoma and paraganglioma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2005 |
State-of-the-Art FDG-PET imaging of lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2005 |
Utility of 18F-FDG PET in evaluating cancers of lung.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Practice Guidelines as Topic; Practice Patterns, Physicians'; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2005 |
Diagnostic value of MRI in comparison to scintigraphy, PET, MS-CT and PET/CT for the detection of metastases of bone.
Topics: Bone Neoplasms; Contrast Media; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoplasm Metastasis; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2005 |
PET and cancer screening.
Topics: Clinical Trials as Topic; Fluorodeoxyglucose F18; Humans; Incidence; Japan; Mass Screening; Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity | 2005 |
Positron emission tomography for radiation treatment planning.
Topics: Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioma; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Neoplasms; Neoplasms, Unknown Primary; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Prostatic Neoplasms; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; Randomized Controlled Trials as Topic; Sensitivity and Specificity; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2005 |
Positron emission tomography imaging for lymphoma.
Topics: False Positive Reactions; Fluorodeoxyglucose F18; Gallium; Gallium Radioisotopes; Humans; Image Processing, Computer-Assisted; Lymphoma; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2005 |
Colorectal liver metastases: CT, MR imaging, and PET for diagnosis--meta-analysis.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Gadolinium; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, Spiral Computed; Tomography, X-Ray Computed | 2005 |
Esophageal cancer: CT, endoscopic US, and FDG PET for assessment of response to neoadjuvant therapy--systematic review.
Topics: Endosonography; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, Emission-Computed | 2005 |
Small animal positron emission tomography in food sciences.
Topics: Animal Nutritional Physiological Phenomena; Animals; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Food; Models, Animal; Positron-Emission Tomography; Sensitivity and Specificity | 2005 |
Update on 18F-fluorodeoxyglucose/positron emission tomography and positron emission tomography/computed tomography imaging of squamous head and neck cancers.
Topics: Carcinoma, Squamous Cell; Clinical Trials as Topic; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron-Emission Tomography; Practice Guidelines as Topic; Practice Patterns, Physicians'; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2005 |
The role of FDG-PET imaging in the management of lymphoma.
Topics: Bone Marrow; Clinical Trials as Topic; Disease Management; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Imaging, Three-Dimensional; Lymphoma; Lymphoma, Non-Hodgkin; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Recurrence; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Treatment Outcome | 2004 |
PET/CT in oncology--a major advance.
Topics: Artifacts; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2005 |
Positron emission tomography for target volume definition in the treatment of non-small cell lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Movement; Neoplasm Staging; Positron-Emission Tomography; Pulmonary Atelectasis; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2005 |
Review of fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in the follow-up of medullary and anaplastic thyroid carcinomas.
Topics: Carcinoma; Carcinoma, Medullary; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms | 2005 |
The accuracy of diagnostic imaging for the assessment of chronic osteomyelitis: a systematic review and meta-analysis.
Topics: Chronic Disease; Fluorodeoxyglucose F18; Humans; Osteomyelitis; Positron-Emission Tomography; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2005 |
Imaging of cervical lymph nodes in head and neck cancer: the basics.
Topics: Adult; Carcinoma, Squamous Cell; Contrast Media; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Neck; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Palpation; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography | 2006 |
The impact of fluor-18-deoxyglucose-positron emission tomography in the management of colorectal liver metastases.
Topics: Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Hepatectomy; Humans; Liver Neoplasms; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Risk Assessment; Sensitivity and Specificity; Survival Analysis; Treatment Outcome | 2005 |
[The impact of 18F-fluorodeoxyglucose positron emission tomography on the 3D conformal radiotherapy planning in patients with non-small cell lung cancer].
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Radiometry; Radiopharmaceuticals; Radiotherapy, Conformal; Sensitivity and Specificity | 2005 |
The size of mediastinal lymph nodes and its relation with metastatic involvement: a meta-analysis.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Mediastinal Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2006 |
PET imaging for evaluation of metastatic colorectal cancer of the liver.
Topics: Aged; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2006 |
[Recent progress in diagnosis of otorhinolaryngologic diseases: positron emission tomography of head and neck neoplasms].
Topics: Animals; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasm Staging; Otorhinolaryngologic Diseases; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Sensitivity and Specificity; Tomography, X-Ray Computed | 2005 |
The value of FDG-PET in the follow-up of differentiated thyroid cancer: a review of the literature.
Topics: Clinical Trials as Topic; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Practice Guidelines as Topic; Practice Patterns, Physicians'; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thyroid Neoplasms | 2006 |
18F-fluoro-deoxyglucose positron emission tomography for post-treatment evaluation of malignant lymphoma: a systematic review.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Neoplasm, Residual; Positron-Emission Tomography; Sensitivity and Specificity | 2006 |
Patients with locally advanced cervical cancer should not undergo routine pretreatment surgical staging.
Topics: Algorithms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Randomized Controlled Trials as Topic; Sensitivity and Specificity; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2006 |
Expanding role of positron emission tomography in cancer of the uterine cervix.
Topics: Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Sensitivity and Specificity; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2006 |
Application of modern imaging methods in diagnosis of gallbladder cancer.
Topics: Cholecystectomy; Diagnosis, Differential; Early Diagnosis; Fluorodeoxyglucose F18; Gallbladder; Gallbladder Neoplasms; Humans; Incidental Findings; Magnetic Resonance Imaging; Neoplasm Staging; Polyps; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, Spiral Computed; Tomography, X-Ray Computed; Ultrasonography | 2006 |
The added value of metabolic imaging with FDG-PET in oesophageal cancer: prognostic role and prediction of response to treatment.
Topics: Adult; Aged; Aged, 80 and over; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Outcome Assessment, Health Care; Positron-Emission Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome | 2006 |
Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer.
Topics: Adenocarcinoma, Follicular; Biomarkers, Tumor; Biopsy, Fine-Needle; Carcinoma, Papillary; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Iodine Radioisotopes; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Preoperative Care; Radiometry; Radiopharmaceuticals; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Thyroid Nodule; Thyrotropin; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Ultrasonography | 2006 |
Role of positron emission tomography in the (re-)staging of oesophageal cancer.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Clinical Trials as Topic; Endosonography; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2006 |
Reassessment of patients with esophageal cancer after neoadjuvant therapy.
Topics: Biopsy, Fine-Needle; Chemotherapy, Adjuvant; Endosonography; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Adjuvant; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2006 |
The role of PET in lymphoma.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Gallium Radioisotopes; Hodgkin Disease; Humans; Image Processing, Computer-Assisted; Lymphoma, Non-Hodgkin; Medical Oncology; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2006 |
Response monitoring of neoadjuvant therapy using CT, EUS, and FDG-PET.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Clinical Trials as Topic; Endosonography; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2006 |
Current and future use of positron emission tomography (PET) in breast cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Forecasting; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prognosis; Sensitivity and Specificity; Sentinel Lymph Node Biopsy | 2006 |
The role of positron emission tomography in the management of recurrent colorectal cancer: a review.
Topics: Colorectal Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2007 |
The role of 18F-fluoro-deoxy-glucose positron emission tomography (FDG-PET) in the management of patients with colorectal cancer.
Topics: Colorectal Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2007 |
[Role of 18Fluorine-deoxyglucose (FDG) positron emission tomography in the management of lymphomas].
Topics: Adult; Aged; Aged, 80 and over; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity | 2006 |
The role of 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography in disseminated carcinoma of unknown primary site.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Neoplasms, Unknown Primary; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2007 |
[Positron emission tomography in head and neck squamous cell carcinomas].
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Treatment Outcome | 2006 |
Integrating PET and PET/CT into the risk-adapted therapy of lymphoma.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Subtraction Technique; Systems Integration; Technology Assessment, Biomedical; Tomography, X-Ray Computed; Treatment Outcome; Whole Body Imaging | 2007 |
Early detection of cancer recurrence: 18F-FDG PET/CT can make a difference in diagnosis and patient care.
Topics: Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Subtraction Technique; Systems Integration; Technology Assessment, Biomedical; Tomography, X-Ray Computed; Treatment Outcome; Whole Body Imaging | 2007 |
Monitoring cancer treatment with PET/CT: does it make a difference?
Topics: Fluorodeoxyglucose F18; Humans; Neoplasms; Outcome Assessment, Health Care; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Subtraction Technique; Systems Integration; Technology Assessment, Biomedical; Tomography, X-Ray Computed; Treatment Outcome; Whole Body Imaging | 2007 |
Role for positron emission tomography in skeletal diseases.
Topics: Arthritis; Bone Diseases; Bone Diseases, Infectious; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Rheumatic Diseases; Sensitivity and Specificity; Vasculitis | 2007 |
The role of PET in follow-up of patients treated for differentiated epithelial thyroid cancers.
Topics: Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms | 2007 |
Molecular positron emission tomography and PET/CT imaging in urological malignancies.
Topics: Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Male; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Urogenital Neoplasms | 2007 |
Role of imaging in cardiac stem cell therapy.
Topics: Animals; Cardiovascular Diseases; Contrast Media; Diagnostic Imaging; Disease Models, Animal; Dobutamine; Echocardiography, Stress; Female; Fluorodeoxyglucose F18; Genes, Reporter; Humans; Magnetic Resonance Imaging; Male; Myocardial Contraction; Myocardial Infarction; Positron-Emission Tomography; Randomized Controlled Trials as Topic; Sensitivity and Specificity; Stem Cell Transplantation; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Treatment Outcome; Ventricular Function, Left | 2007 |
The role of FDG PET in the management of lymphoma: what is the evidence base?
Topics: Clinical Trials as Topic; Evidence-Based Medicine; Fluorodeoxyglucose F18; Humans; Lymphoma; Positron-Emission Tomography; Practice Guidelines as Topic; Practice Patterns, Physicians'; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2007 |
The role of FDG PET in the management of lymphoma: practical guidelines.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Positron-Emission Tomography; Practice Guidelines as Topic; Practice Patterns, Physicians'; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; United Kingdom | 2007 |
The expanding role of PET technology in the management of patients with colorectal cancer.
Topics: Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Forecasting; Humans; Immunohistochemistry; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Risk Factors; Role; Sensitivity and Specificity; Survival Analysis | 2007 |
Is bone marrow biopsy obligatory in all patients with non-Hodgkin's lymphoma?
Topics: Biopsy, Needle; Bone Marrow; Bone Marrow Examination; Decision Making; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; In Situ Hybridization, Fluorescence; Lymphoma, Non-Hodgkin; Male; Patient Selection; Positron-Emission Tomography; Prognosis; Risk Assessment; Sensitivity and Specificity; Unnecessary Procedures | 2007 |
Imaging of neuroendocrine tumors.
Topics: Carcinoid Tumor; Carcinoma, Neuroendocrine; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Pancreatic Neoplasms; Paraganglioma; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
[The value of PET-CT imaging in malignant tumours of the head and neck].
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2007 |
[MRI in giant cell (temporal) arteritis].
Topics: Arteries; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Image Enhancement; Image Processing, Computer-Assisted; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Positron-Emission Tomography; Sensitivity and Specificity; Temporal Arteries; Ultrasonography, Doppler, Color | 2007 |
Staging of lung cancer.
Topics: False Negative Reactions; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2007 |
PET versus PET/CT dual-modality imaging in evaluation of lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Contrast Media; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Metastasis; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2007 |
F-18 fluorodeoxyglucose-positron emission tomography imaging for primary breast cancer and loco-regional staging.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphatic Metastasis; Mammography; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2007 |
Diagnosis of recurrent and metastatic disease using f-18 fluorodeoxyglucose-positron emission tomography in breast cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity | 2007 |
Detection of bone metastases in breast cancer by positron emission tomography.
Topics: Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2007 |
Normal and abnormal patterns of 18F-fluorodeoxyglucose PET/CT in lymphoma.
Topics: False Negative Reactions; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Lymphoma; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Whole Body Imaging | 2007 |
PET and PET/CT in management of the lymphomas.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
Fluorine-18 fluorodeoxyglucose PET/CT patterns of extranodal involvement in patients with Non-Hodgkin lymphoma and Hodgkin's disease.
Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2007 |
Critical role of 18F-labeled fluorodeoxyglucose PET in the management of patients with arthroplasty.
Topics: Arthroplasty, Replacement; Bone Transplantation; False Negative Reactions; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Postoperative Complications; Prosthesis Failure; Prosthesis-Related Infections; Radiopharmaceuticals; Reoperation; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
Nonprosthesis orthopedic applications of (18)F fluoro-2-deoxy-D-glucose PET in the detection of osteomyelitis.
Topics: Animals; Fluorodeoxyglucose F18; Humans; Osteomyelitis; Radiopharmaceuticals; Recurrence; Sensitivity and Specificity; Tissue Distribution; Tomography, Emission-Computed | 2007 |
[(18)F]fluorodeoxyglucose PET in large vessel vasculitis.
Topics: Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Takayasu Arteritis; Tomography, X-Ray Computed | 2007 |
[Interests and perspectives of PET-CT for breast cancer: review of the literature].
Topics: Bone Neoplasms; Breast Neoplasms; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2007 |
PET probe-guided surgery.
Topics: Clinical Trials as Topic; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Iodine Radioisotopes; Neoplasms; Positron-Emission Tomography; Radioimmunodetection; Radiopharmaceuticals; Sensitivity and Specificity; Surgery, Computer-Assisted | 2007 |
PET imaging in differentiated thyroid cancer: where does it fit and how do we use it?
Topics: Carcinoma, Medullary; Cell Differentiation; Fluorodeoxyglucose F18; Humans; Incidental Findings; Iodine Radioisotopes; Lung Neoplasms; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Thyroid Nodule; Whole Body Imaging | 2007 |
PET/CT in oncology: for which tumours is it the reference standard?
Topics: Breast Neoplasms; Colorectal Neoplasms; Contrast Media; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphoma; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms; Radiopharmaceuticals; Reference Standards; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2007 |
Colorectal cancer: imaging surveillance following resection of primary tumour.
Topics: Biomarkers, Tumor; Carcinoembryonic Antigen; Colonography, Computed Tomographic; Colorectal Neoplasms; Contrast Media; Diagnostic Imaging; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Practice Guidelines as Topic; Radiopharmaceuticals; Sensitivity and Specificity | 2007 |
Gynecologic tumors.
Topics: Female; Fluorodeoxyglucose F18; Humans; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2008 |
Cutaneous melanoma.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Skin Neoplasms; Tomography, X-Ray Computed | 2008 |
FDG-PET, CT, MRI for diagnosis of local residual or recurrent nasopharyngeal carcinoma, which one is the best? A systematic review.
Topics: Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm, Residual; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
18Fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer: a systematic review.
Topics: Carcinoma, Non-Small-Cell Lung; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Mediastinal Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Solitary Pulmonary Nodule; Technology Assessment, Biomedical | 2007 |
18F-FDG PET for posttherapy assessment of Hodgkin's disease and aggressive Non-Hodgkin's lymphoma: a systematic review.
Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2008 |
Management of recurrent colorectal cancer with positron emission tomography.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
Meta-analysis: comparison of F-18 Fluorodeoxyglucose-positron emission tomography and bone scintigraphy in the detection of bone metastases in patients with breast cancer.
Topics: Area Under Curve; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2008 |
[Role of mediastinoscopy and repeat mediastinoscopy today].
Topics: Biopsy, Fine-Needle; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Mediastinoscopy; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2008 |
Staging investigations for oesophageal cancer: a meta-analysis.
Topics: Endosonography; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Systematic review: accuracy of imaging tests in the diagnosis of recurrent laryngeal carcinoma after radiotherapy.
Topics: Carcinoma, Squamous Cell; Confidence Intervals; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Observer Variation; Positron-Emission Tomography; Probability; Risk Assessment; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Sentinel node mapping in lung cancer: the Holy Grail?
Topics: Female; Fluorodeoxyglucose F18; Humans; Intraoperative Care; Lung Neoplasms; Lymph Nodes; Male; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Sentinel Lymph Node Biopsy | 2008 |
Solitary pulmonary nodules: meta-analytic comparison of cross-sectional imaging modalities for diagnosis of malignancy.
Topics: Contrast Media; Diagnostic Imaging; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Organotechnetium Compounds; Predictive Value of Tests; Radiopharmaceuticals; Regression Analysis; ROC Curve; Sensitivity and Specificity; Solitary Pulmonary Nodule; Somatostatin; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2008 |
Technology Insight: advances in molecular imaging and an appraisal of PET/CT scanning.
Topics: Drug Monitoring; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Radiotherapy Planning, Computer-Assisted; Sensitivity and Specificity; Systems Integration; Tomography, X-Ray Computed | 2008 |
PET in cervical cancer--implications for 'staging,' treatment planning, assessment of prognosis, and prediction of response.
Topics: Female; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiography; Radiopharmaceuticals; Sensitivity and Specificity; Uterine Cervical Neoplasms | 2008 |
FDG PET scan strategies and long-term outcomes after first-line therapy in Hodgkin's disease.
Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Longitudinal Studies; Positron-Emission Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Survival Analysis; Survival Rate; Treatment Outcome | 2009 |
Role of PET in medullary thyroid carcinoma.
Topics: Carcinoma, Medullary; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thyroid Neoplasms | 2008 |
[[18F]-FDG-PET in the diagnostics of gastrointestinal tumors].
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholangiocarcinoma; Colonic Neoplasms; Esophageal Neoplasms; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Liver Neoplasms; Meta-Analysis as Topic; Neoplasm Recurrence, Local; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
18F-FDG PET/CT in sarcoidosis management: review and report of 20 cases.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sarcoidosis; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed; Treatment Outcome | 2008 |
PET for sarcomas other than gastrointestinal stromal tumors.
Topics: Biopsy; Dideoxynucleosides; Disease Progression; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Misonidazole; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Radiopharmaceuticals; Sarcoma; Sensitivity and Specificity; Tomography, Emission-Computed; Treatment Outcome | 2008 |
[Systematic review and meta-analysis of diagnostic accuracy of 18F-FDG PET in suspected recurrent head and neck cancer].
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2008 |
18F-fluorodeoxyglucose positron emission tomography to evaluate cervical node metastases in patients with head and neck squamous cell carcinoma: a meta-analysis.
Topics: Confidence Intervals; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Neck; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity | 2008 |
Thallium-201 uptake in lung cancer.
Topics: Breast Neoplasms; Carcinoma, Squamous Cell; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Heart; Humans; Indium Radioisotopes; Iodine Radioisotopes; Lung Neoplasms; Middle Aged; Octreotide; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Thoracic Neoplasms; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1995 |
Positron emission tomography of lung tumors and mediastinal lymph nodes using [18F]fluorodeoxyglucose. The Members of the PET-Lung Tumor Study Group.
Topics: Deoxyglucose; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Predictive Value of Tests; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1994 |
Can positron emission tomography (PET) be used to detect subclinical response to cancer therapy? The EC PET Oncology Concerted Action and the EORTC PET Study Group.
Topics: Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Deoxyglucose; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Fluorodeoxyglucose F18; Humans; Neoplasms; Sensitivity and Specificity; Tomography, Emission-Computed; Treatment Outcome | 1995 |
Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patients.
Topics: Artifacts; Deoxyglucose; False Positive Reactions; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Neoplasms; Sensitivity and Specificity; Tomography, Emission-Computed | 1996 |
[Clinical significance of nuclear medicine in the presurgical diagnosis of epilepsy].
Topics: Brain; Deoxyglucose; Epilepsy; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Sensitivity and Specificity; Technetium; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1997 |
FDG SPECT in the assessment of myocardial viability. Comparison with dobutamine echo.
Topics: Cardiotonic Agents; Deoxyglucose; Dobutamine; Echocardiography; Exercise Test; Fluorodeoxyglucose F18; Glucose; Humans; Hypolipidemic Agents; Myocardial Contraction; Myocardial Infarction; Myocardial Reperfusion; Myocardium; Predictive Value of Tests; Pyrazines; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 1997 |
Fluor-18-deoxyglucose positron emission tomography in differentiated thyroid cancer.
Topics: Cell Differentiation; Female; Fluorodeoxyglucose F18; Humans; Male; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, Emission-Computed | 1998 |
Overview of the current status of PET in breast cancer imaging.
Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Carbon Radioisotopes; Copper; Copper Radioisotopes; Diagnosis, Differential; Estradiol; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Methionine; Neoplasm Metastasis; Neoplasm Staging; Organometallic Compounds; Oxygen Radioisotopes; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Thiosemicarbazones; Tomography, Emission-Computed | 1998 |
[Fluorodeoxyglucose and bronchopulmonary cancer. Initial French results with positron emission tomography].
Topics: Adult; Aged; Carcinoma, Bronchogenic; Equipment Design; Female; Fluorodeoxyglucose F18; France; Humans; Lung Neoplasms; Male; Middle Aged; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, Emission-Computed | 1998 |
Positron emission tomography as a diagnostic tool in oncology.
Topics: Biomarkers, Tumor; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Medical Oncology; Neoplasms; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 1998 |
[Role of 18F-FDG positron emission tomography in surgical evaluation].
Topics: Carcinoma, Bronchogenic; Colorectal Neoplasms; Fluorodeoxyglucose F18; Glycolysis; Humans; Lung Neoplasms; Neoplasms; Pancreatic Neoplasms; Sensitivity and Specificity; Tomography, Emission-Computed | 1998 |
PET imaging using dual-headed gamma cameras: an update.
Topics: Fluorodeoxyglucose F18; Gamma Cameras; Humans; Models, Statistical; Radiometry; Sensitivity and Specificity; Tomography, Emission-Computed | 1999 |
18-FDG imaging in breast cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Metastasis; Neoplasm Staging; Neoplasm, Residual; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1999 |
[Current status of positron emission tomography in diagnosis of abdominal tumors].
Topics: Abdominal Neoplasms; Energy Metabolism; Fluorodeoxyglucose F18; Humans; Sensitivity and Specificity; Tomography, Emission-Computed | 1999 |
FDG imaging without PET.
Topics: Fluorodeoxyglucose F18; Humans; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; United States | 1998 |
18Fluorodeoxyglucose-positron emission tomography in the management of patients with suspected pancreatic cancer.
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Pancreatic Neoplasms; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 1999 |
PET in lung cancer.
Topics: Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, Emission-Computed; Tomography, X-Ray Computed; United States | 1999 |
[FDG-PET in oncology. Methodological principles and clinical applications].
Topics: Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms; Sensitivity and Specificity; Tomography, Emission-Computed | 1999 |
Relevance of positron emission tomography (PET) in oncology.
Topics: Carbon Radioisotopes; Fluorides; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Methionine; Misonidazole; Neoplasm Staging; Neoplasms; Radioisotopes; Radiopharmaceuticals; Sensitivity and Specificity; Thymidine; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1999 |
Nuclear medicine in cancer diagnosis.
Topics: Female; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Staging; Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1999 |
Oncological applications of FDG PET imaging.
Topics: Breast Neoplasms; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms; Pancreatic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 1999 |
18F-fluorodeoxyglucose dual-head positron emission tomography as a procedure for detecting simultaneous primary tumors in cases of head and neck cancer.
Topics: Adult; Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasms, Second Primary; Prospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 1999 |
[Positron emission tomography for detection of lymph node metastases in lung cancer].
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Mediastinum; Sensitivity and Specificity; Tomography, Emission-Computed | 1999 |
Role of nuclear medicine in the evaluation of the solitary pulmonary nodule.
Topics: Aged; Contrast Media; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Intercellular Signaling Peptides and Proteins; Lung Neoplasms; Male; Middle Aged; Peptides; Radiopharmaceuticals; Receptors, Somatostatin; Sensitivity and Specificity; Solitary Pulmonary Nodule; Technetium; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2000 |
A meta-analysis of the literature for whole-body FDG PET detection of recurrent colorectal cancer.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Neoplasm Recurrence, Local; Pelvic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2000 |
Changes in 18F-FDG uptake measured by PET as a pharmacodynamic end-point in anticancer therapy. How far have we got?
Topics: Antineoplastic Agents; Europe; Fluorodeoxyglucose F18; Glucose; Humans; Neoplasms; Pancreatic Neoplasms; Practice Guidelines as Topic; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tissue Distribution; Tomography, Emission-Computed | 2000 |
PET imaging in oncology.
Topics: Colonic Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphoma; Male; Melanoma; Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; United States | 2000 |
[Added value of positron emission tomography with fluoro-18-deoxyglucose as the tracer (FDG-PET) in clinical problem cases in oncology].
Topics: Adult; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2000 |
A review of the literature for whole-body FDG PET in the management of patients with melanoma.
Topics: Confidence Intervals; Cost-Benefit Analysis; Decision Support Techniques; False Negative Reactions; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Melanoma; Neoplasm Recurrence, Local; Neoplasm Staging; Peer Review, Research; Radiopharmaceuticals; Sensitivity and Specificity; Skin Neoplasms; Technology Assessment, Biomedical; Tomography, Emission-Computed; Whole-Body Irradiation | 2000 |
What does positron emission tomography offer oncology?
Topics: Antineoplastic Agents; Fluorodeoxyglucose F18; Gene Expression; History, 20th Century; Humans; Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2000 |
Fluorine-18 fluorodeoxyglucose positron emission tomography in the staging and follow-up of lymphoma: is it time to shift gears?
Topics: Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lymphoma; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2000 |
Sensitivity, specificity, and predictive accuracies of various noninvasive techniques for detecting hibernating myocardium.
Topics: Cardiotonic Agents; Dobutamine; Echocardiography; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Myocardial Stunning; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium; Thallium Radioisotopes; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2001 |
Imaging of cardiac metabolism using radiolabelled glucose, fatty acids and acetate.
Topics: Acetates; Carbon Radioisotopes; Fatty Acids; Fluorodeoxyglucose F18; Heart; Heart Diseases; Humans; Iodine Radioisotopes; Iodobenzenes; Myocardium; Oxygen Consumption; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Ventricular Function, Left | 2001 |
Systematic review of the diagnostic accuracy of (18)F-fluorodeoxyglucose positron emission tomography in melanoma patients.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Melanoma; Odds Ratio; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Skin Neoplasms; Tomography, Emission-Computed | 2001 |
[Meta-analysis of the efficacy of positron emission tomography with F-18-fluorodeoxyglucose in lung tumors. Basis for discussion of the German Consensus Conference on PET in Oncology 2000].
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; MEDLINE; Neoplasm Metastasis; Neoplasm Staging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |
[Fluorodeoxyglucose positron emission tomography (FDG-PET) in the differential diagnosis of pancreatic lesions].
Topics: Cholangiopancreatography, Endoscopic Retrograde; Chronic Disease; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Pancreatic Neoplasms; Pancreatitis; Patient Selection; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Time Factors; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
[Influence of positron emission tomography on surgical therapy planning in recurrent colorectal cancer].
Topics: Adult; Colorectal Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |
[Meta-analysis on the diagnostic efficacy of FDG-PET].
Topics: Coronary Disease; Epilepsy; Fluorodeoxyglucose F18; Humans; Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tissue Survival; Tomography, Emission-Computed | 2001 |
Positron emission tomography in lymphoma: comparison with computed tomography and Gallium-67 single photon emission computed tomography.
Topics: Aged; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lymphoma; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2000 |
Positron emission tomography (PET) of non-small cell lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Cost-Benefit Analysis; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Metastasis; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |
Diagnosis and monitoring of urological tumors using positron emission tomography.
Topics: Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Prostatic Neoplasms; Seminoma; Sensitivity and Specificity; Testicular Neoplasms; Tomography, Emission-Computed; Urinary Bladder Neoplasms; Urogenital Neoplasms | 2001 |
[Functional imaging (PET and SPECT) in epilepsy].
Topics: Animals; Brain; Cerebrovascular Circulation; Epilepsy; Flumazenil; Fluorodeoxyglucose F18; GABA Modulators; Humans; Iodine Radioisotopes; Radiopharmaceuticals; Receptors, Cholinergic; Receptors, GABA; Receptors, GABA-A; Receptors, Histamine H1; Receptors, Opioid; Seizures; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2001 |
PET in lung cancer staging.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |
PET imaging in breast cancer.
Topics: Axilla; Breast Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Treatment Outcome | 2001 |
Evaluation of therapy response in breast and ovarian cancer patients by positron emission tomography (PET).
Topics: Breast Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Ovarian Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Treatment Outcome | 2001 |
[Positron emission tomography (PET) in clinical oncology. Part II].
Topics: Adult; Aged; Colorectal Neoplasms; False Negative Reactions; False Positive Reactions; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphoma; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
Positron emission tomography for staging and management of malignant melanoma.
Topics: Fluorodeoxyglucose F18; Humans; Melanoma; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Skin Neoplasms; Tomography, Emission-Computed | 2002 |
Positron emission tomography in colorectal cancer.
Topics: Adenocarcinoma; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
Imaging in lung cancer: positron emission tomography scan.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Radiopharmaceuticals; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
[Current status of nuclear medicine. Clinical application of FDG-PET for cancer diagnosis. Colorectal cancer].
Topics: Colorectal Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
Positron emission tomography for the diagnosis of breast cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
Comparison of SPECT using technetium-99m agents and thallium-201 and PET for the assessment of myocardial perfusion and viability.
Topics: Coronary Disease; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Heart; Humans; Meta-Analysis as Topic; Nitriles; Organotechnetium Compounds; Oximes; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1990 |
544 trial(s) available for fluorodeoxyglucose f18 and Sensitivity and Specificity
| Article | Year |
|---|---|
Radiological and functional evidence of the bronchial spread of tuberculosis: an observational analysis.
Topics: Anti-Bacterial Agents; Fluorodeoxyglucose F18; HIV Infections; Humans; Inflammation; Positron Emission Tomography Computed Tomography; Prospective Studies; Rifampin; Sensitivity and Specificity; Tuberculosis, Lymph Node; Tuberculosis, Pulmonary; United States | 2021 |
89Zr-panitumumab Combined With 18F-FDG PET Improves Detection and Staging of Head and Neck Squamous Cell Carcinoma.
Topics: Adult; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Panitumumab; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radioisotopes; Radiopharmaceuticals; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Zirconium | 2022 |
Topics: Acetogenins; Acute Disease; Acute Kidney Injury; Administration, Intravenous; Aged; Albumins; Alcoholism; Aldehyde Dehydrogenase; Aldehyde Dehydrogenase, Mitochondrial; alpha-Glucosidases; Anemia; Animals; Anthozoa; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bacterial; Antigens, Bacterial; Antihypertensive Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Ascites; Asthma; Bacteria; beta-Lactamases; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Binding Sites; Biological Availability; Biomass; Borderline Personality Disorder; Brain; Brucella abortus; Brucella melitensis; Brucellosis; Calcium; Carbapenems; Case-Control Studies; Caseins; Cattle; CD8-Positive T-Lymphocytes; Ceftaroline; Cell Line; Cell Line, Tumor; Cell Physiological Phenomena; Cell Proliferation; Cephalosporins; Chemotherapy, Adjuvant; China; Chitin; Chlorella; Chlorophyll; Chlorophyll A; Chlorophyta; Cholangiocarcinoma; Cisplatin; Conotoxins; Contrast Media; Conus Snail; Cross-Sectional Studies; Cytokines; Decapodiformes; Deoxycytidine; Diagnostic and Statistical Manual of Mental Disorders; Dietary Fiber; Diterpenes; DNA Methylation; Dogs; Double-Blind Method; Drug Design; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Screening Assays, Antitumor; Eicosapentaenoic Acid; Enzyme-Linked Immunosorbent Assay; Epidermis; Escherichia coli; Escherichia coli Infections; Extraintestinal Pathogenic Escherichia coli; Fatty Acids; Fatty Acids, Unsaturated; Fatty Acids, Volatile; Feasibility Studies; Feces; Female; Ferritins; Fluorodeoxyglucose F18; Gastrectomy; Gastrointestinal Microbiome; Gemcitabine; Glomerular Filtration Rate; Glucose; Glycerol; Granulocyte-Macrophage Colony-Stimulating Factor; HeLa Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Hypoxia-Inducible Factor-Proline Dioxygenases; Immunoassay; Immunoglobulin G; India; Infant, Newborn; Infertility; Inflammation; Intensive Care Units; Iron; Iron Deficiencies; Kidney; Lacticaseibacillus rhamnosus; Laurencia; Leukocytes; Lipids; Liver Cirrhosis; Long Interspersed Nucleotide Elements; Longitudinal Studies; Male; Mesenchymal Stem Cells; Methicillin-Resistant Staphylococcus aureus; Mice; Microalgae; Microbial Sensitivity Tests; Microscopy; Middle Aged; Minerals; Molecular Conformation; Molecular Docking Simulation; Molecular Structure; Mycobacterium tuberculosis; Myeloid Cells; Myeloid-Derived Suppressor Cells; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Nephropidae; Nicotinic Antagonists; Nitrogen; Obesity; Oxaliplatin; Paclitaxel; Panax; Pancreatic Neoplasms; Pancreatitis; Personality; Personality Disorders; Personality Inventory; Photobioreactors; Plant Extracts; Plasmalogens; Plasmids; Polymorphism, Genetic; Polynesia; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prebiotics; Predictive Value of Tests; Prognosis; Prolyl-Hydroxylase Inhibitors; Rabbits; Radiopharmaceuticals; Rats; Rats, Wistar; Receptors, Nicotinic; Recombinant Proteins; Retrospective Studies; Rifampin; Risk Factors; RNA, Ribosomal, 16S; Salinity; Seaweed; Sensitivity and Specificity; Sepsis; Sesquiterpenes; Severity of Illness Index; Shock, Septic; Silicones; Single Photon Emission Computed Tomography Computed Tomography; Skin; Snails; Solubility; Solvents; Sputum; Staphylococcal Infections; Stomach Neoplasms; Stramenopiles; Structure-Activity Relationship; Technetium Tc 99m Exametazime; Technology; Terpenes; Tuberculosis; Tuberculosis, Multidrug-Resistant; Urinary Catheters; Urinary Tract Infections; Vascular Endothelial Growth Factor A; Virulence Factors; Water; Wound Healing | 2023 |
Prospective Evaluation of Changes in Tumor Size and Tumor Metabolism in Patients with Advanced Gastric Cancer Undergoing Chemotherapy: Association and Clinical Implication.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Male; Metabolic Clearance Rate; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Stomach Neoplasms; Survival Rate; Tumor Burden | 2017 |
Intraoperative Molecular Imaging Combined With Positron Emission Tomography Improves Surgical Management of Peripheral Malignant Pulmonary Nodules.
Topics: Adenocarcinoma; Adult; Aged; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Intraoperative Care; Lung Neoplasms; Male; Middle Aged; Molecular Imaging; Pilot Projects; Pneumonectomy; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Sensitivity and Specificity; Solitary Pulmonary Nodule; Spectroscopy, Near-Infrared | 2017 |
Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography After Concurrent Chemoradiotherapy in Locally Advanced Head-and-Neck Squamous Cell Cancer: The ECLYPS Study.
Topics: Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Outcome Assessment, Health Care; Positron Emission Tomography Computed Tomography; Prognosis; Proportional Hazards Models; Prospective Studies; Reproducibility of Results; Sensitivity and Specificity | 2017 |
Topics: Adult; Aged; Arteries; Biomarkers; Cohort Studies; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Longitudinal Studies; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Sensitivity and Specificity; Takayasu Arteritis | 2018 |
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cardia; Endosonography; Esophagogastric Junction; Feasibility Studies; Female; Fluorodeoxyglucose F18; Gastrectomy; Humans; Male; Middle Aged; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Stomach Neoplasms; Treatment Outcome | 2018 |
Topics: Activities of Daily Living; Acute Disease; Adalimumab; Adaptation, Physiological; Adenosine Triphosphate; Adipose Tissue; Administration, Intravaginal; Adolescent; Adsorption; Adult; Adverse Childhood Experiences; Age Distribution; Age Factors; Aged; Aged, 80 and over; Air Pollution, Indoor; Aldehyde Oxidase; Alginates; Alloys; alpha-Globins; Aluminum Hydroxide; Alveolar Bone Loss; Anaerobiosis; Anesthesia, General; Anesthetics; Animals; Anovulation; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Apoptosis; Bacillus cereus; Bacterial Typing Techniques; Bacteroidetes; Base Composition; Biocompatible Materials; Biofilms; Biological Availability; Biological Transport; Biosensing Techniques; Bipolar Disorder; Blood Glucose; Body Mass Index; Bone Regeneration; Boranes; Brachial Artery; Butyric Acid; Candida albicans; Carbon; Carcinoembryonic Antigen; Cell Differentiation; Cell Line, Tumor; Cell Respiration; Cell Survival; Cells, Cultured; Cerebrovascular Circulation; Charcoal; Child; Child Health; China; Chloride Channels; Chlorides; CHO Cells; Chromatography, Liquid; Chromatography, Micellar Electrokinetic Capillary; Chromium; Chronic Disease; Chronic Periodontitis; Circular Dichroism; Cities; Cohort Studies; Comamonadaceae; Comorbidity; Coronary Artery Disease; Corrosion; Cricetinae; Cricetulus; Cross Infection; Cross-Sectional Studies; Crowding; Culture Media; Cytokines; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetes, Gestational; Diarylheptanoids; Diclofenac; Disability Evaluation; Diterpene Alkaloids; DNA; DNA Mutational Analysis; DNA, Bacterial; Drug Liberation; Drug Resistance, Multiple, Bacterial; Electrochemical Techniques; Electrodes; Electrolytes; Endothelium, Vascular; Enterococcus faecalis; Epithelial Cell Adhesion Molecule; Epithelial Cells; Erbium; Erythropoietin; Ethanol; Ethylenediamines; Fast Foods; Fatty Acids; Female; Fermentation; Ferric Compounds; Fibroblasts; Flavobacteriaceae; Fluorides; Fluorodeoxyglucose F18; Food Microbiology; Formaldehyde; Furaldehyde; Gamma Cameras; Gene Expression; Geologic Sediments; Glucose Tolerance Test; Glycated Hemoglobin; Glycolipids; Glycosylation; Gracilaria; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Guanine; Health Surveys; HeLa Cells; Hemoglobins, Abnormal; Hexosamines; High Fructose Corn Syrup; High-Intensity Interval Training; Hip Fractures; Hippocampus; HLA-B27 Antigen; Hospitalization; Housing; Humans; Hydrogen-Ion Concentration; Hydrolysis; Hydroxides; Hypercapnia; Hypertension; Hypocreales; Hypromellose Derivatives; Image Processing, Computer-Assisted; Incidence; Indole Alkaloids; Indonesia; Inflammation Mediators; Infrared Rays; Insulin Resistance; Intercalating Agents; Ion Transport; Ionophores; Japan; Kinetics; Kluyveromyces; Letrozole; Linear Models; Lipopolysaccharides; Liposomes; Liver; Lung Diseases; Magnesium Hydroxide; Magnetic Resonance Spectroscopy; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mice, Inbred BALB C; Microbial Sensitivity Tests; Microbial Viability; Microscopy, Electron, Transmission; Middle Aged; Mitochondria; Mitochondria, Muscle; Molecular Docking Simulation; Molecular Structure; Muscle, Skeletal; Mutant Proteins; Mutation; Mutation, Missense; Nanocomposites; Nanoparticles; Neoplasm Recurrence, Local; Neoplastic Cells, Circulating; Nucleic Acid Hybridization; Obesity; Occupational Exposure; Oceans and Seas; Odds Ratio; Organometallic Compounds; Osteogenesis; Ovulation Induction; Oxidation-Reduction; Particle Size; Periodontal Ligament; Permeability; Phaseolus; Phenotype; Philippines; Phosphatidylethanolamines; Phospholipids; Photochemical Processes; Phylogeny; Pichia; Pigmentation; Plant Extracts; Polycystic Ovary Syndrome; Polysaccharides; Postprandial Period; Pregnancy; Pregnancy Rate; Prevalence; Product Surveillance, Postmarketing; Progesterone; Progestins; Protein Engineering; Pseudomonas aeruginosa; Psoriasis; Public Facilities; Rats; Rats, Wistar; Receptors, Thyrotropin; Recombinant Proteins; Reproducibility of Results; Republic of Korea; Retrospective Studies; Rhodobacteraceae; Risk; Risk Assessment; Risk Factors; RNA, Ribosomal, 16S; ROC Curve; Saccharomyces cerevisiae; Salinity; Saliva; Seawater; Seaweed; Sensitivity and Specificity; Sequence Analysis, DNA; Sex Factors; Silver Compounds; Smokers; Social Class; Socioeconomic Factors; Soil Microbiology; Solubility; Soy Foods; Spectrometry, Mass, Electrospray Ionization; Spondylitis, Ankylosing; Staphylococcus aureus; Static Electricity; Steroids; Strontium; Sucrose; Surface Properties; Survival Rate; Sweden; Swine; Synapses; Synchrotrons; Tandem Mass Spectrometry; Tannins; Tea; Temperature; Terpenes; Thalidomide; Thermodynamics; Thiadiazoles; Thyroid Cancer, Papillary; Thyroid Neoplasms; Thyroidectomy; Time Factors; Tissue Distribution; Titanium; Toilet Facilities; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Ubiquinone; Urinary Tract Infections; Vaginal Creams, Foams, and Jellies; Venezuela; Vitamin K 2; Waist Circumference; Waste Disposal, Fluid; Wastewater; Water Microbiology; Water Pollutants, Chemical; Whole Body Imaging; X-Ray Diffraction; Young Adult; Ytterbium; Yttrium; Yttrium Radioisotopes; Zinc Compounds | 2018 |
Evaluation of the Usefulness of FDG-PET/CT for Nodal Staging of Breast Cancer.
Topics: Adult; Aged; Aged, 80 and over; Axilla; Breast Neoplasms; Breast Neoplasms, Male; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Mastectomy; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Sensitivity and Specificity | 2018 |
CRH stimulation improves
Topics: ACTH-Secreting Pituitary Adenoma; Adenoma; Adolescent; Adult; Child; Corticotropin-Releasing Hormone; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pituitary ACTH Hypersecretion; Positron-Emission Tomography; Sensitivity and Specificity; Young Adult | 2019 |
Role of 18F-FLT PET/CT in suspected recurrent or residual lymphoma: final results of a pilot prospective trial.
Topics: Adult; Aged; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2019 |
Diagnostic utility of fluorodeoxyglucose positron emission tomography in prosthetic joint infection based on MSIS criteria.
Topics: Aged; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hip Prosthesis; Humans; Male; Middle Aged; Positron-Emission Tomography; Preoperative Care; Prospective Studies; Prosthesis-Related Infections; Radiopharmaceuticals; Sensitivity and Specificity | 2019 |
Regional PET/CT after water gastric inflation for evaluating loco-regional disease of gastric cancer.
Topics: Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Republic of Korea; Risk Assessment; Sensitivity and Specificity; Stomach Neoplasms; Survival Analysis; Survival Rate; Tomography, X-Ray Computed; Water | 2013 |
Response assessment of colorectal liver metastases with contrast enhanced CT/18F-FDG PET.
Topics: Adult; Aged; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Iopamidol; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Spain; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
Coregistered whole body magnetic resonance imaging-positron emission tomography (MRI-PET) versus PET-computed tomography plus brain MRI in staging resectable lung cancer: comparisons of clinical effectiveness in a randomized trial.
Topics: Adult; Aged; Brain; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2013 |
The value of 18F-FDG PET/CT in diagnosing infectious endocarditis.
Topics: Bacteremia; Early Diagnosis; Endocarditis; Female; Fluorodeoxyglucose F18; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
18F-FDOPA PET/CT for detection of recurrence in patients with glioma: prospective comparison with 18F-FDG PET/CT.
Topics: Adolescent; Adult; Brain Neoplasms; Child; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prospective Studies; Recurrence; Reference Standards; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2013 |
The influence of interpreters' professional background and experience on the interpretation of multimodality imaging of pulmonary lesions using 18F-3'-deoxy-fluorothymidine and 18F-fluorodeoxyglucose PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Clinical Competence; Female; Fluorodeoxyglucose F18; Humans; Lung Diseases; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
Comparison of EORTC criteria and PERCIST for PET/CT response evaluation of patients with metastatic colorectal cancer treated with irinotecan and cetuximab.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Camptothecin; Cetuximab; Colorectal Neoplasms; Denmark; Digestive System Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Irinotecan; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Outcome Assessment, Health Care; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Survival Analysis; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
A prospective clinical trial of tumor hypoxia imaging with 18F-fluoromisonidazole positron emission tomography and computed tomography (F-MISO PET/CT) before and during radiation therapy.
Topics: Adult; Aged; Aged, 80 and over; Cell Hypoxia; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Misonidazole; Molecular Imaging; Multimodal Imaging; Neoplasms; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2013 |
Establishing test-retest reliability of an adapted [(18)F]fallypride imaging protocol in older people.
Topics: Aged; Aging; Benzamides; Brain; Brain Mapping; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Positron-Emission Tomography; Protein Binding; Receptors, Dopamine D2; Receptors, Dopamine D3; Reproducibility of Results; Sensitivity and Specificity; Time Factors | 2013 |
Combination of 18F-FDG PET/CT and diffusion-weighted MR imaging as a predictor of histologic response to neoadjuvant chemotherapy: preliminary results in osteosarcoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Diffusion Magnetic Resonance Imaging; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Male; Methotrexate; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Osteosarcoma; Pilot Projects; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2013 |
Supplemental value of diffusion-weighted whole-body imaging with background body signal suppression (DWIBS) technique to whole-body magnetic resonance imaging in detection of bone metastases from thyroid cancer.
Topics: Adult; Aged; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, X-Ray Computed; Treatment Outcome; Whole Body Imaging; Young Adult | 2013 |
Correlation of the apparent diffusion coefficient (ADC) with the standardized uptake value (SUV) in hybrid 18F-FDG PET/MRI in non-small cell lung cancer (NSCLC) lesions: initial results.
Topics: Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Metabolic Clearance Rate; Middle Aged; Multimodal Imaging; Observer Variation; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic | 2013 |
18F-FDG PET early response evaluation of locally advanced non-small cell lung cancer treated with concomitant chemoradiotherapy.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome | 2013 |
Longitudinal progression of cognitive decline correlates with changes in the spatial pattern of brain 18F-FDG PET.
Topics: Aged; Aged, 80 and over; Aging; Brain; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Spatio-Temporal Analysis | 2013 |
The influence of different contrast medium concentrations and injection protocols on quantitative and clinical assessment of FDG-PET/CT in lung cancer.
Topics: Aged; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Injections, Intravenous; Iohexol; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiographic Image Enhancement; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
Interobserver agreement of qualitative analysis and tumor delineation of 18F-fluoromisonidazole and 3'-deoxy-3'-18F-fluorothymidine PET images in lung cancer.
Topics: Adult; Aged; Algorithms; Carcinoma, Non-Small-Cell Lung; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Misonidazole; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tumor Burden | 2013 |
Axillary lymph node characterization in breast cancer patients using magnetic resonance mammography: a prospective comparative study with FDG PET-CT and healthy women.
Topics: Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Mammography; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reference Values; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
Does the pretreatment tumor sampling location correspond with metabolic activity on 18F-FDG PET/CT in breast cancer patients scheduled for neoadjuvant chemotherapy?
Topics: Adult; Aged; Biopsy, Large-Core Needle; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Metabolic Clearance Rate; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Netherlands; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sample Size; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
The significance of alteration 2-[fluorine-18]fluoro-2-deoxy-(D)-glucose uptake in the liver and skeletal muscles of patients with hyperthyroidism.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Hyperthyroidism; Liver; Male; Muscle, Skeletal; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Severity of Illness Index | 2013 |
Diffusion-weighted MRI, 11C-choline PET and 18F-fluorodeoxyglucose PET for predicting the Gleason score in prostate carcinoma.
Topics: Adenocarcinoma; Aged; Biopsy; Carbon Radioisotopes; Choline; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Grading; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Ultrasonography, Interventional | 2014 |
(123)I-BZA2 as a melanin-targeted radiotracer for the identification of melanoma metastases: results and perspectives of a multicenter phase III clinical trial.
Topics: Aged; Benzamides; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Iodine Radioisotopes; Male; Melanins; Melanoma; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Evaluation of PET quantification accuracy in vivo. Comparison of measured FDG concentration in the bladder with urine samples.
Topics: Calibration; Equipment Design; Equipment Failure Analysis; Fluorodeoxyglucose F18; Germany; Humans; Phantoms, Imaging; Positron-Emission Tomography; Radiometry; Radiopharmaceuticals; Reference Values; Reproducibility of Results; Sensitivity and Specificity; Urinary Bladder | 2014 |
Whole-body MRI for initial staging of paediatric lymphoma: prospective comparison to an FDG-PET/CT-based reference standard.
Topics: Adolescent; Child; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Neoplasm Staging; Observer Variation; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Reference Standards; Sensitivity and Specificity; Whole Body Imaging | 2014 |
Hepatic steatosis is associated with increased hepatic FDG uptake.
Topics: Computer Simulation; Fatty Liver; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Liver; Models, Biological; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Up-Regulation | 2014 |
Diffusion-weighted MRI compared to FDG PET/CT for assessment of early treatment response in lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Diffusion Magnetic Resonance Imaging; Doxorubicin; Early Diagnosis; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphoma; Male; Middle Aged; Multimodal Imaging; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome; Vinblastine; Young Adult | 2015 |
Delayed ¹⁸F-fluorodeoxyglucose PET/CT imaging improves quantitation of atherosclerotic plaque inflammation: results from the CAMONA study.
Topics: Adult; Algorithms; Coronary Artery Disease; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Systemic vascular inflammation in abdominal aortic aneurysm patients: a contrast-enhanced PET/CT study.
Topics: Aged; Aortic Aneurysm, Abdominal; Biomarkers; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Systemic Vasculitis; Tomography, X-Ray Computed | 2014 |
Assessment of relapse in patients with peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy using F-18-FDG-PET/CT.
Topics: Antineoplastic Agents; Chemotherapy, Adjuvant; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Hyperthermia, Induced; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Evaluation of diffusion-weighted MRI for pretherapeutic assessment and staging of lymphoma: results of a prospective study in 140 patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lymphoma; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2014 |
Advanced-stage Hodgkin lymphoma: US/chest radiography for detection of relapse in patients in first complete remission--a randomized trial of routine surveillance imaging procedures.
Topics: Adolescent; Adult; Aged; Algorithms; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiation Dosage; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography, Doppler | 2014 |
Cardiovascular implantable electronic device infection: delayed vs standard FDG PET-CT imaging.
Topics: Aged; Defibrillators, Implantable; Endocarditis; Female; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Pacemaker, Artificial; Positron-Emission Tomography; Prosthesis-Related Infections; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Time Factors; Tomography, X-Ray Computed | 2014 |
Fluorine 18 fluorodeoxyglucose PET/CT volume-based indices in locally advanced non-small cell lung cancer: prediction of residual viable tumor after induction chemotherapy.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Induction Chemotherapy; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm, Residual; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden | 2014 |
Utility of 18F-FDG uptake in various regions of Waldeyer's ring to differentiate benign from malignant lesions in the midline roof of the nasopharynx.
Topics: Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution | 2014 |
18F-FDG-PET/CT better localizes active spinal infection than MRI for successful minimally invasive surgery.
Topics: Adult; Aged; Aged, 80 and over; Bacterial Infections; Contrast Media; Discitis; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Image Enhancement; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Male; Middle Aged; Minimally Invasive Surgical Procedures; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Complementarity of visual and voxel-based FDG-PET analysis to detect MCI-like hypometabolic pattern in elderly patients with hypertension and isolated memory complaints.
Topics: Aged; Brain; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Geriatric Assessment; Humans; Hypertension; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Male; Memory Disorders; Middle Aged; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2015 |
Accumulation of (18)F-FDG in the liver in hepatic steatosis.
Topics: Computer Simulation; Fatty Liver; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Liver; Models, Biological; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Up-Regulation | 2014 |
BAY 1075553 PET-CT for Staging and Restaging Prostate Cancer Patients: Comparison with [18F] Fluorocholine PET-CT (Phase I Study).
Topics: Aged; Aged, 80 and over; Bone Marrow; Choline; Fluorodeoxyglucose F18; Glutarates; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Organophosphonates; Positron-Emission Tomography; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Radiometry; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Use of PET-CT for the assessment of treatment results in patients with sarcoidosis.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Outcome Assessment, Health Care; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sarcoidosis; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
HIV infection and arterial inflammation assessed by (18)F-fluorodeoxyglucose (FDG) positron emission tomography (PET): a prospective cross-sectional study.
Topics: Arteritis; Female; Fluorodeoxyglucose F18; HIV Infections; Humans; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution | 2015 |
PET/CT imaging correlates with treatment outcome in patients with multidrug-resistant tuberculosis.
Topics: Adult; Algorithms; Double-Blind Method; Female; Fluorodeoxyglucose F18; Humans; Lung; Male; Metronidazole; Multimodal Imaging; Observer Variation; Positron-Emission Tomography; Prospective Studies; Radiographic Image Interpretation, Computer-Assisted; ROC Curve; Sensitivity and Specificity; Software; Sputum; Tomography, X-Ray Computed; Treatment Outcome; Tuberculosis, Multidrug-Resistant | 2014 |
Positron emission tomography-based evidence of low-amplitude respiratory motion in patients with chronic obstructive pulmonary disease.
Topics: Aged; Aged, 80 and over; Emphysema; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Motion; Multimodal Imaging; Multivariate Analysis; Positron-Emission Tomography; Pulmonary Disease, Chronic Obstructive; Radiopharmaceuticals; Respiration; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
18F-FDG or 3'-deoxy-3'-18F-fluorothymidine to detect transformation of follicular lymphoma.
Topics: Adult; Aged; Area Under Curve; Biomarkers, Tumor; Biopsy; Cell Transformation, Neoplastic; Dideoxynucleosides; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphoma, Follicular; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prospective Studies; Remission Induction; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Lesion regression rate based on RECIST: prediction of treatment outcome in patients with head and neck cancer treated with chemoradiotherapy compared with FDG PET-CT.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chemoradiotherapy; Data Interpretation, Statistical; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Regression Analysis; Reproducibility of Results; Response Evaluation Criteria in Solid Tumors; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
The lower hippocampus global connectivity, the higher its local metabolism in Alzheimer disease.
Topics: Alzheimer Disease; Cognitive Dysfunction; Connectome; Female; Fluorodeoxyglucose F18; Hippocampus; Humans; Male; Middle Aged; Nerve Net; Parietal Lobe; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2015 |
Standardized uptake value and apparent diffusion coefficient of endometrial cancer evaluated with integrated whole-body PET/MR: Correlation with pathological prognostic factors.
Topics: Adult; Aged; Aged, 80 and over; Computer Simulation; Diffusion Magnetic Resonance Imaging; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Metabolic Clearance Rate; Middle Aged; Models, Biological; Multimodal Imaging; Positron-Emission Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Factors; Sensitivity and Specificity; Statistics as Topic; Systems Integration; Whole Body Imaging | 2015 |
18F-FDG PET/CT to Predict Response to Neoadjuvant Chemotherapy and Prognosis in Inflammatory Breast Cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Epirubicin; Fluorodeoxyglucose F18; Fluorouracil; Humans; Image Interpretation, Computer-Assisted; Multimodal Imaging; Neoadjuvant Therapy; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
Improved inter-observer agreement of an expert review panel in an oncology treatment trial--Insights from a structured interventional process.
Topics: Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Double-Blind Method; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Observer Variation; Outcome Assessment, Health Care; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Whole Body MRI in the Staging of Esophageal Cancer--A Prospective Comparison with Whole Body 18F-FDG PET-CT.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
[Use of 18F-FDG-positron emission tomography in presurgical evaluation of nonspecific or suspectious adrenal masses in non-oncologic patients].
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adrenalectomy; Adrenocortical Hyperfunction; Adult; Aged; Area Under Curve; Carcinoma; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Prospective Studies; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity | 2016 |
18F-FDG-PET/MR increases diagnostic confidence in detection of bone metastases compared with 18F-FDG-PET/CT.
Topics: Adult; Aged; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2015 |
Additional Prognostic Value of SUVmax Measured by F-18 FDG PET/CT over Biological Marker Expressions in Surgically Resected Cervical Cancer Patients.
Topics: Adult; Aged; Aged, 80 and over; Antigens, Neoplasm; Biomarkers; Carbonic Anhydrase IX; Carbonic Anhydrases; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2015 |
Current generation time-of-flight (18)F-FDG PET/CT provides higher SUVs for normal adrenal glands, while maintaining an accurate characterization of benign and malignant glands.
Topics: Adrenal Gland Neoplasms; Adrenal Glands; Aged; Biological Transport; Female; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Organ Size; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2016 |
Preparation methods prior to PET/CT scanning that decrease uptake of 18F-FDG by myocardium, brown adipose tissue, and skeletal muscle.
Topics: Adipose Tissue, Brown; Diet, Carbohydrate-Restricted; Diet, High-Fat; Dietary Carbohydrates; Dietary Fats; Dietary Proteins; Fasting; Female; Fluorodeoxyglucose F18; Humans; Male; Metabolic Clearance Rate; Middle Aged; Muscle, Skeletal; Myocardium; Organ Specificity; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution | 2017 |
[(68)Ga]DOTATATE PET/MRI and [(18)F]FDG PET/CT are complementary and superior to diffusion-weighted MR imaging for radioactive-iodine-refractory differentiated thyroid cancer.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Iodine Radioisotopes; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thyroid Neoplasms | 2016 |
Monitoring metabolic response using FDG PET-CT during targeted therapy for metastatic colorectal cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colorectal Neoplasms; Drug Monitoring; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Molecular Targeted Therapy; Niacinamide; Phenylurea Compounds; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Sorafenib; Treatment Outcome | 2016 |
Ruptured human Achilles tendon has elevated metabolic activity up to 1 year after repair.
Topics: Achilles Tendon; Adult; Female; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Male; Positron-Emission Tomography; Radiopharmaceuticals; Recovery of Function; Reproducibility of Results; Rupture; Sensitivity and Specificity; Tenotomy; Tissue Distribution; Treatment Outcome | 2016 |
18F-FDG PET-Derived Tumor Blood Flow Changes After 1 Cycle of Neoadjuvant Chemotherapy Predicts Outcome in Triple-Negative Breast Cancer.
Topics: Adult; Aged; Aged, 80 and over; Angiography; Antineoplastic Agents; Blood Flow Velocity; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoadjuvant Therapy; Neovascularization, Pathologic; Outcome Assessment, Health Care; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome; Triple Negative Breast Neoplasms | 2016 |
Utility of (18)F-FDG PET/CT in patients with advanced squamous cell carcinoma of the uterine cervix receiving concurrent chemoradiotherapy: a parallel study of a prospective randomized trial.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome; Uterine Neoplasms | 2016 |
Comparison of RECIST, EORTC criteria and PERCIST for evaluation of early response to chemotherapy in patients with non-small-cell lung cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Europe; Female; Fluorodeoxyglucose F18; Humans; Internationality; Lung Neoplasms; Male; Middle Aged; Outcome Assessment, Health Care; Positron Emission Tomography Computed Tomography; Practice Guidelines as Topic; Radiopharmaceuticals; Reproducibility of Results; Response Evaluation Criteria in Solid Tumors; Sensitivity and Specificity; Treatment Outcome | 2016 |
The reoxygenation of hypoxia and the reduction of glucose metabolism in head and neck cancer by fractionated radiotherapy with intensity-modulated radiation therapy.
Topics: Adult; Aged; Dose Fractionation, Radiation; Down-Regulation; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Misonidazole; Oxygen; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Conformal; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome; Tumor Hypoxia | 2016 |
A PET/CT approach to spinal cord metabolism in amyotrophic lateral sclerosis.
Topics: Adult; Aged; Aged, 80 and over; Amyotrophic Lateral Sclerosis; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Metabolic Clearance Rate; Middle Aged; Neuroimaging; Organ Specificity; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Spinal Cord; Tissue Distribution | 2016 |
The response of FDG uptake to immunosuppressive treatment on FDG PET/CT imaging for cardiac sarcoidosis.
Topics: Cardiomyopathies; Female; Fluorodeoxyglucose F18; Humans; Immunosuppressive Agents; Male; Metabolic Clearance Rate; Middle Aged; Observer Variation; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Sarcoidosis; Sensitivity and Specificity; Treatment Outcome | 2017 |
18F-FDG PET for Measurement of Response and Prediction of Outcome to Relapsed or Refractory Mantle Cell Lymphoma Therapy with Bendamustine-Rituximab.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Disease-Free Survival; Drug Monitoring; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Mantle-Cell; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Recurrence; Reproducibility of Results; Rituximab; Sensitivity and Specificity; Survival Rate; Treatment Outcome | 2017 |
Towards real-time topical detection and characterization of FDG dose infiltration prior to PET imaging.
Topics: Absorption, Physiological; Breast Neoplasms; Computer Systems; Drug Monitoring; Equipment Design; Equipment Failure Analysis; Female; Fluorodeoxyglucose F18; Humans; Injections; Metabolic Clearance Rate; Radiation Dosage; Radiopharmaceuticals; Reproducibility of Results; Scintillation Counting; Sensitivity and Specificity; Tissue Distribution | 2016 |
[18F]FDG PET/CT-based response assessment of stage IV non-small cell lung cancer treated with paclitaxel-carboplatin-bevacizumab with or without nitroglycerin patches.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carboplatin; Carcinoma, Non-Small-Cell Lung; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Netherlands; Nitroglycerin; Paclitaxel; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Survival Rate; Treatment Outcome; Vasodilator Agents | 2017 |
Volume-based predictive biomarkers of sequential FDG-PET/CT for sunitinib in cancer of unknown primary: identification of the best benefited patients.
Topics: Adult; Antineoplastic Agents; Biomarkers; China; Female; Fluorodeoxyglucose F18; Humans; Indoles; Male; Middle Aged; Neoplasms, Unknown Primary; Outcome Assessment, Health Care; Patient Selection; Positron Emission Tomography Computed Tomography; Prevalence; Prognosis; Pyrroles; Radiopharmaceuticals; Reproducibility of Results; Risk Factors; Sensitivity and Specificity; Sunitinib; Survival Rate; Treatment Outcome; Tumor Burden | 2017 |
Metabolic tumor volume predicts overall survival and local control in patients with stage III non-small cell lung cancer treated in ACRIN 6668/RTOG 0235.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Survival Rate; Treatment Outcome; Tumor Burden; United States | 2017 |
Short-term changes in arterial inflammation predict long-term changes in atherosclerosis progression.
Topics: Arteritis; Carotid Arteries; Carotid Artery Diseases; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2017 |
Do we need FDG-PET/CT to assess atherosclerosis?
Topics: Adult; Aged; Aorta, Thoracic; Aortitis; Atherosclerosis; Causality; Comorbidity; Denmark; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Sodium Fluoride; Survival Rate; Vascular Calcification; Young Adult | 2017 |
Utility of PET/CT to Evaluate Retroperitoneal Lymph Node Metastasis in High-Risk Endometrial Cancer: Results of ACRIN 6671/GOG 0233 Trial.
Topics: Adult; Aged; Aged, 80 and over; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Retroperitoneal Neoplasms; Risk Assessment; Sensitivity and Specificity | 2017 |
Preoperative staging of biliary carcinoma using 18F-fluorodeoxyglucose PET: prospective comparison with PET+CT, MDCT and histopathology.
Topics: Bile Duct Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Patient Selection; Positron-Emission Tomography; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2008 |
Fluorine-18 fluorodeoxyglucose positron emission tomography predicts lymph node metastasis, P-glycoprotein expression, and recurrence after resection in mass-forming intrahepatic cholangiocarcinoma.
Topics: Adult; Aged; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Risk Factors; Sensitivity and Specificity; Tomography, Emission-Computed | 2008 |
2-Deoxy-2[F-18]FDG-PET for detection of recurrent laryngeal carcinoma after radiotherapy: interobserver variability in reporting.
Topics: Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Magnetic Resonance Imaging; Middle Aged; Neoplasm Recurrence, Local; Observer Variation; Positron-Emission Tomography; Sensitivity and Specificity | 2008 |
FDG-PET-based radiotherapy planning in lung cancer: optimum breathing protocol and patient positioning--an intraindividual comparison.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Posture; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Computer-Assisted; Reproducibility of Results; Respiratory Mechanics; Sensitivity and Specificity; Treatment Outcome | 2009 |
Tumour length measured on PET-CT predicts the most appropriate stage-dependent therapeutic approach in oesophageal cancer.
Topics: Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Patient Selection; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2008 |
The influence of I-131 therapy on FDG uptake in differentiated thyroid cancer.
Topics: Adult; Aged; Artifacts; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Metabolic Clearance Rate; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thyroid Neoplasms | 2008 |
Voxel- and ROI-based statistical analyses of PET parameters for guidance in the surgical treatment of intractable mesial temporal lobe epilepsy.
Topics: Adolescent; Adult; Algorithms; Computer Simulation; Epilepsy, Temporal Lobe; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Male; Middle Aged; Models, Biological; Models, Statistical; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Surgery, Computer-Assisted; Treatment Outcome | 2008 |
Contrast-enhanced 18F-FDG PET/CT: 1-stop-shop imaging for assessing the resectability of pancreatic cancer.
Topics: Contrast Media; Fluorodeoxyglucose F18; Humans; Iohexol; Pancreatic Neoplasms; Patient Selection; Positron-Emission Tomography; Preoperative Care; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2008 |
Comparison of 4 modalities for distant metastasis staging in endemic nasopharyngeal carcinoma.
Topics: Adult; Aged; Carcinoma; Diagnostic Imaging; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Metastasis; Neoplasm Staging; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity | 2009 |
The clinical value of [18F]fluoro-dihydroxyphenylalanine positron emission tomography in primary diagnosis, staging, and restaging of neuroendocrine tumors.
Topics: Adrenal Gland Neoplasms; Adult; Carcinoma, Medullary; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Neuroendocrine Tumors; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thyroid Neoplasms | 2009 |
The effectiveness of 18F-FDG PET/CT combined with STIR MRI for diagnosing nodal involvement in the thorax.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Staging; Phantoms, Imaging; Positron-Emission Tomography; Radiography, Thoracic; Sensitivity and Specificity; Thorax; Tomography, X-Ray Computed | 2009 |
Does 18F-FDG PET/CT improve the detection of posttreatment recurrence of head and neck squamous cell carcinoma in patients negative for disease on clinical follow-up?
Topics: Carcinoma, Squamous Cell; False Negative Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
Diagnostic accuracy of contrast-enhanced FDG-PET/CT in primary staging of cutaneous malignant melanoma.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Sensitivity and Specificity; Skin Neoplasms; Time Factors; Tomography, X-Ray Computed | 2009 |
Evaluation of chemotherapy response in osteosarcoma with FDG-PET.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cisplatin; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Ifosfamide; Male; Methotrexate; Middle Aged; Osteosarcoma; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome; Young Adult | 2009 |
The role of 18F-FDG PET/CT in evaluation of early response to neoadjuvant chemotherapy in patients with locally advanced breast cancer.
Topics: Adult; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
PET-CT-guided interventions in the management of FDG-positive lesions in patients suffering from solid malignancies: initial experiences.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Subtraction Technique; Surgery, Computer-Assisted; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2009 |
Prognostic value of interim 18F-FDG PET in patients with diffuse large B-Cell lymphoma: SUV-based assessment at 4 cycles of chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorodeoxyglucose F18; France; Humans; Image Interpretation, Computer-Assisted; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Survival Analysis; Survival Rate; Treatment Outcome; Young Adult | 2009 |
Role of gastric distention with additional water in differentiating locally advanced gastric carcinomas from physiological uptake in the stomach on 18F-fluoro-2-deoxy-D-glucose PET.
Topics: Adult; Aged; Case-Control Studies; Drinking; False Positive Reactions; Female; Fluorodeoxyglucose F18; Gastric Mucosa; Humans; Male; Middle Aged; Positron-Emission Tomography; Sensitivity and Specificity; Stomach; Stomach Neoplasms; Water | 2009 |
Prediction of tumor recurrence by 18F-FDG PET in liver transplantation for hepatocellular carcinoma.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2009 |
18F-FDG PET/CT in mediastinal lymph node staging of non-small-cell lung cancer in a tuberculosis-endemic country: consideration of lymph node calcification and distribution pattern to improve specificity.
Topics: Calcinosis; Carcinoma, Non-Small-Cell Lung; Contrast Media; Endemic Diseases; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Male; Mediastinum; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiography, Thoracic; Sensitivity and Specificity; Tomography, X-Ray Computed; Tuberculosis | 2009 |
Influence of 2-(18F) fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography on recurrent ovarian cancer diagnosis and on selection of patients for secondary cytoreductive surgery.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography; Young Adult | 2009 |
Dose painting in radiotherapy for head and neck squamous cell carcinoma: value of repeated functional imaging with (18)F-FDG PET, (18)F-fluoromisonidazole PET, diffusion-weighted MRI, and dynamic contrast-enhanced MRI.
Topics: Carcinoma, Squamous Cell; Contrast Media; Diffusion Magnetic Resonance Imaging; Dose Fractionation, Radiation; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Computer-Assisted; Radiotherapy, Conformal; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome | 2009 |
Evaluation of the effects of oral water and low-density barium sulphate suspension on bowel appearance on FDG-PET/CT.
Topics: Administration, Oral; Barium Sulfate; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Male; Molecular Weight; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed; Water | 2010 |
Prediction model of chemotherapy response in osteosarcoma by 18F-FDG PET and MRI.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Computer Simulation; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Models, Biological; Osteosarcoma; Outcome Assessment, Health Care; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Treatment Outcome | 2009 |
The 18F-FDG PET cingulate island sign and comparison to 123I-beta-CIT SPECT for diagnosis of dementia with Lewy bodies.
Topics: Aged; Alzheimer Disease; Autopsy; Cocaine; Cohort Studies; Diagnosis, Differential; Dopamine Plasma Membrane Transport Proteins; Female; Fluorodeoxyglucose F18; Gyrus Cinguli; Humans; Image Interpretation, Computer-Assisted; Lewy Body Disease; Male; Positron-Emission Tomography; ROC Curve; Sensitivity and Specificity; Staining and Labeling; Tomography, Emission-Computed, Single-Photon | 2009 |
Prediction of the need for surgical intervention in obstructive Crohn's disease by 18F-FDG PET/CT.
Topics: Adult; Constriction, Pathologic; Crohn Disease; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Hypertrophy; Inflammation; Laboratories; Male; Middle Aged; Muscles; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
F-18 FDG-PET/CT evaluation of patients with differentiated thyroid cancer with negative I-131 total body scan and high thyroglobulin level.
Topics: Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Positron-Emission Tomography; ROC Curve; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Tomography, X-Ray Computed; Whole Body Imaging | 2009 |
Assessment of residual tumour by FDG-PET: conventional imaging and clinical examination following primary chemotherapy of large and locally advanced breast cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Epirubicin; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Fluorouracil; Humans; Magnetic Resonance Imaging; Mammography; Mastectomy; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm, Residual; Paclitaxel; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Ultrasonography, Mammary | 2010 |
Quantitative F18-fluorodeoxyglucose positron emission tomography accurately characterizes peripheral nerve sheath tumors as malignant or benign.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nerve Sheath Neoplasms; Neurilemmoma; Neurofibroma; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2010 |
Limited predictive value of FDG-PET for response assessment in the preoperative treatment of esophageal cancer: results of a prospective multi-center trial (SAKK 75/02).
Topics: Adult; Aged; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Germany; Humans; Male; Middle Aged; Positron-Emission Tomography; Preoperative Care; Prognosis; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Switzerland; Treatment Outcome | 2009 |
Feasibility of FDG PET/CT to monitor the response of axillary lymph node metastases to neoadjuvant chemotherapy in breast cancer patients.
Topics: Adult; Aged; Breast Neoplasms; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2010 |
FDG PET-CT in the management of primary breast lymphoma.
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
Detection of bronchioloalveolar cancer by means of PET/CT and 18F-fluorocholine, and comparison with 18F-fluorodeoxyglucose.
Topics: Adenocarcinoma, Bronchiolo-Alveolar; Aged; Aged, 80 and over; Biological Transport; Choline; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2010 |
Impact of FDG PET/CT on delineation of the gross tumor volume for radiation planning in non-small-cell lung cancer.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Computer-Assisted; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2010 |
Preoperative detection of prostate cancer: a comparison with 11C-choline PET, 18F-fluorodeoxyglucose PET and MR imaging.
Topics: Adenocarcinoma; Aged; Carbon Radioisotopes; Choline; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Preoperative Care; Prognosis; Prostatic Neoplasms; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome | 2010 |
[Positron emission tomography in the diagnosis of atherosclerotic plaques in cancer patients].
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Atherosclerosis; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Sex Factors | 2010 |
The use of FDG-PET/CT and diffusion-weighted magnetic resonance imaging for response prediction before, during and after preoperative chemoradiotherapy for rectal cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Algorithms; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Modality Therapy; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Perioperative Period; Positron-Emission Tomography; Prognosis; Radiotherapy, Adjuvant; Rectal Neoplasms; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
Prediction of response to neoadjuvant radiotherapy in patients with locally advanced rectal cancer by means of sequential 18FDG-PET.
Topics: Adenocarcinoma; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Neoadjuvant Therapy; Positron-Emission Tomography; Preoperative Period; Radiopharmaceuticals; Rectal Neoplasms; Remission Induction; ROC Curve; Sensitivity and Specificity; Treatment Outcome | 2011 |
Impact of (18)F-FDG PET on treatment strategy and 3D radiotherapy planning in non-small cell lung cancer: A prospective multicenter study.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; France; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome | 2010 |
18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial.
Topics: Aged; Alzheimer Disease; Aniline Compounds; Benzothiazoles; Brain; Cognition Disorders; Diagnostic Imaging; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Thiazoles | 2010 |
Added value of positron emission tomography imaging in the surgical treatment of colorectal liver metastases.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Costs and Cost Analysis; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Quality-Adjusted Life Years; Sensitivity and Specificity; Treatment Outcome | 2010 |
Standardised uptake value of 18F-FDG on staging PET/CT in newly diagnosed patients with different subtypes of non-Hodgkin's lymphoma.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; L-Lactate Dehydrogenase; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Sensitivity and Specificity | 2011 |
Breast cancer: comparative effectiveness of positron emission mammography and MR imaging in presurgical planning for the ipsilateral breast.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Mastectomy, Segmental; Middle Aged; Patient Care Planning; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2011 |
¹⁸F-fluoride PET/CT for assessing bone involvement in prostate and breast cancers.
Topics: Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Prostatic Neoplasms; Reference Standards; Sensitivity and Specificity; Technetium Tc 99m Medronate; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2011 |
Value of FDG-PET for monitoring treatment response in patients with advanced GIST refractory to high-dose imatinib. A multicenter GEIS study.
Topics: Adult; Aged; Antineoplastic Agents; Benzamides; Female; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Male; Middle Aged; Piperazines; Positron-Emission Tomography; Pyrimidines; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Spain; Treatment Outcome | 2011 |
The value of metabolic imaging to predict tumour response after chemoradiation in locally advanced rectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Chemotherapy, Adjuvant; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Rectal Neoplasms; Sensitivity and Specificity | 2010 |
Interpretation of positron emission mammography and MRI by experienced breast imaging radiologists: performance and observer reproducibility.
Topics: Adult; Aged; Aged, 80 and over; Area Under Curve; Breast Neoplasms; Clinical Competence; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Inservice Training; Magnetic Resonance Imaging; Middle Aged; Observer Variation; Positron-Emission Tomography; Radiology; Radiopharmaceuticals; Sensitivity and Specificity | 2011 |
18FDG-positron emission tomography/computed tomography (PET/CT) scanning in thyroid nodules with nondiagnostic cytology.
Topics: Adolescent; Adult; Aged; Cytological Techniques; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Histological Techniques; Humans; Male; Middle Aged; Positron-Emission Tomography; Sensitivity and Specificity; Thyroid Neoplasms; Thyroid Nodule; Unnecessary Procedures; Young Adult | 2011 |
¹⁸F-FDG-PET/CT for detection of extramedullary acute myeloid leukemia.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Sarcoma, Myeloid; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
[Disease activity assessment in large vessel vasculitis].
Topics: Biomarkers; Blood Sedimentation; C-Reactive Protein; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Interleukin-6; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Interleukin-6; Sensitivity and Specificity; Severity of Illness Index; Takayasu Arteritis | 2011 |
Diffusion tensor imaging can localize the epileptogenic zone in nonlesional extra-temporal refractory epilepsies when [(18)F]FDG-PET is not contributive.
Topics: Adolescent; Adult; Diffusion Tensor Imaging; Epilepsies, Partial; Epilepsy, Temporal Lobe; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Young Adult | 2011 |
Response to intra-arterial oncolytic virotherapy with the herpes virus NV1020 evaluated by [18F]fluorodeoxyglucose positron emission tomography and computed tomography.
Topics: Adult; Aged; Antineoplastic Agents; Biomarkers, Tumor; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Multimodal Imaging; Oncolytic Virotherapy; Oncolytic Viruses; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Simplexvirus; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Comparison of the diagnostic value of 3-deoxy-3-18F-fluorothymidine and 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the assessment of regional lymph node in thoracic esophageal squamous cell carcinoma: a pilot study.
Topics: Aged; Carcinoma, Squamous Cell; Dideoxynucleosides; Esophageal Neoplasms; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Pilot Projects; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Voxel-level comparison of arterial spin-labeled perfusion MRI and FDG-PET in Alzheimer disease.
Topics: Aged; Alzheimer Disease; Cerebrovascular Circulation; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Angiography; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Sensitivity and Specificity | 2011 |
Value of dual time point F-18 FDG-PET/CT imaging for the evaluation of prognosis and risk factors for recurrence in patients with stage I non-small cell lung cancer treated with stereotactic body radiation therapy.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Radiosurgery; Reproducibility of Results; Risk Factors; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Comparative effectiveness of positron emission mammography and MRI in the contralateral breast of women with newly diagnosed breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Breast Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Mammography; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2012 |
Baseline SUVmax at PET-CT in stage IIIA non-small-cell lung cancer patients undergoing surgery after neoadjuvant therapy: prognostic implication focused on histopathologic subtypes.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Republic of Korea; Risk Assessment; Risk Factors; Sensitivity and Specificity; Statistics as Topic; Survival Analysis; Survival Rate; Tomography, X-Ray Computed | 2012 |
Cost-effectiveness of adding FDG-PET or CT to the diagnostic work-up of patients with stage III melanoma.
Topics: Adult; Aged; Aged, 80 and over; Cost-Benefit Analysis; Female; Fluorodeoxyglucose F18; Hospital Costs; Humans; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Multidetector Computed Tomography; Neoplasm Staging; Netherlands; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Skin Neoplasms | 2012 |
Prospective study of 2-[¹⁸F]fluorodeoxyglucose positron emission tomography in the assessment of regional nodal spread of disease in patients with breast cancer: an Ontario clinical oncology group study.
Topics: Adult; Aged; Aged, 80 and over; Axilla; Biopsy, Needle; Breast Neoplasms; Confidence Intervals; Female; Fluorodeoxyglucose F18; Humans; Logistic Models; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Ontario; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Sensitivity and Specificity; Sentinel Lymph Node Biopsy | 2012 |
Intermodality comparison between 3D perfusion CT and 18F-FDG PET/CT imaging for predicting early tumor response in patients with liver metastasis after chemotherapy: preliminary results of a prospective study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Imaging, Three-Dimensional; Leucovorin; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Organoplatinum Compounds; Perfusion Imaging; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology.
Topics: Aged; Aorta, Thoracic; Biomarkers; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Observer Variation; Positron-Emission Tomography; Prospective Studies; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Severity of Illness Index; Sodium Fluoride; Tomography, X-Ray Computed | 2012 |
Multiphase CT scanning and different intravenous contrast media concentrations in combined F-18-FDG PET/CT: Effect on quantitative and clinical assessment.
Topics: Contrast Media; Dose-Response Relationship, Drug; Female; Fluorodeoxyglucose F18; Humans; Infusions, Intravenous; Iohexol; Male; Middle Aged; Multimodal Imaging; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Delayed response assessment with FDG-PET-CT following (chemo) radiotherapy for locally advanced head and neck squamous cell carcinoma.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Delayed Diagnosis; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Predictive role of post-treatment [18F]FDG PET/CT in patients with uterine cervical cancer.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Outcome Assessment, Health Care; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome; Uterine Neoplasms; Young Adult | 2012 |
Prognostic value of 18f-fluorodeoxyglucose positron emission tomography-computed tomography in predicting survival in patients with unresectable metastatic melanoma to the liver undergoing yttrium-90 radioembolization.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Melanoma; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Survival Analysis; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2012 |
Response of HT29 colorectal xenograft model to cediranib assessed with 18 F-fluoromisonidazole positron emission tomography, dynamic contrast-enhanced and diffusion-weighted MRI.
Topics: Animals; Antineoplastic Agents; Contrast Media; Fluorodeoxyglucose F18; Gadolinium DTPA; HT29 Cells; Humans; Neoplasms, Experimental; Positron-Emission Tomography; Quinazolines; Radiopharmaceuticals; Rats; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome; Xenograft Model Antitumor Assays | 2013 |
Hybrid 18F-FDG PET/CT of colonic anastomosis. A possibility to detect anastomotic leakage?
Topics: Adult; Aged; Aged, 80 and over; Anastomosis, Surgical; Anastomotic Leak; Colorectal Surgery; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Utility of 18F-fluoride PET/CT and 18F-FDG PET/CT in the detection of bony metastases in heightened-risk head and neck cancer patients.
Topics: Bone Neoplasms; Fluorides; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Iodine Radioisotopes; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Risk; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Diagnostic yield of FDG positron-emission tomography/computed tomography in patients with CEID infection: a pilot study.
Topics: Aged; Aged, 80 and over; Defibrillators, Implantable; Endocarditis; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Pacemaker, Artificial; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Prosthesis-Related Infections; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Sepsis; Tomography, X-Ray Computed; Whole Body Imaging | 2013 |
(18)F-FDG PET in the evaluation of acuity of deep vein thrombosis.
Topics: Acute Disease; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Sensitivity and Specificity; Venous Thrombosis | 2012 |
Impact of molecular imaging on the diagnostic process in a memory clinic.
Topics: Aged; Alzheimer Disease; Aniline Compounds; Brain; Carbon Radioisotopes; Dementia; Diagnosis, Differential; Disease Progression; Early Diagnosis; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; France; Frontotemporal Dementia; Humans; Lewy Body Disease; Male; Memory Disorders; Middle Aged; Molecular Imaging; Outpatient Clinics, Hospital; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Thiazoles; Treatment Outcome | 2013 |
The evaluation of FDG-PET imaging for epileptogenic focus localization in patients with MRI positive and MRI negative temporal lobe epilepsy.
Topics: Adolescent; Adult; Brain Mapping; Electroencephalography; Epilepsy, Temporal Lobe; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome | 2013 |
Imaging the early response to chemotherapy in advanced lung cancer with diffusion-weighted magnetic resonance imaging compared to fluorine-18 fluorodeoxyglucose positron emission tomography and computed tomography.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Diffusion Magnetic Resonance Imaging; Early Detection of Cancer; Etoposide; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
18 F-fluorodeoxyglucose positron emission tomography-computed tomography for preoperative lymph node staging in patients undergoing radical cystectomy for bladder cancer: a prospective study.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Cystectomy; Fluorodeoxyglucose F18; Lymph Node Excision; Lymphatic Metastasis; Multimodal Imaging; Neoplasm Staging; Pilot Projects; Positron-Emission Tomography; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Urinary Bladder Neoplasms | 2013 |
Quantitative p retreatment VOI analysis of liver metastases. (99m)Tc-MAA SPECT/CT and FDG PET/CT in relation with treatment response to SIRT.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Aggregated Albumin; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2013 |
Changes in (18)F-fluorothymidine and (18)F-fluorodeoxyglucose positron emission tomography imaging in patients with head and neck cancer treated with chemoradiotherapy.
Topics: Aged; Aged, 80 and over; Chemoradiotherapy; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome | 2013 |
Low-dose dobutamine stress gated SPET for identification of viable myocardium: comparison with stress-rest perfusion SPET and PET.
Topics: Aged; Dobutamine; Exercise Test; Female; Fluorodeoxyglucose F18; Gated Blood-Pool Imaging; Heart; Humans; Male; Myocardial Infarction; Organophosphorus Compounds; Organotechnetium Compounds; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Ultrasonography | 2002 |
Early diagnosis of recurrent breast cancer with FDG-PET in patients with progressive elevation of serum tumor markers.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Breast Neoplasms; Carcinoembryonic Antigen; False Positive Reactions; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Mucin-1; Neoplasm Recurrence, Local; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
Qualitative and quantitative comparison between images obtained with filtered back projection and iterative reconstruction in prostate cancer lesions of (18)F-FDG PET.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Bone Neoplasms; Cervical Vertebrae; Extremities; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Enhancement; Lumbar Vertebrae; Male; Pelvis; Phantoms, Imaging; Prostatic Neoplasms; Radiopharmaceuticals; Reproducibility of Results; Ribs; Sensitivity and Specificity; Soft Tissue Neoplasms; Tomography, Emission-Computed | 2002 |
The usefulness of 18F-FDG PET images obtained 2 hours after intravenous injection in liver tumor.
Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Colorectal Neoplasms; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Injections, Intravenous; Liver Neoplasms; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Time Factors | 2002 |
[F-18 fluorodeoxyglucose positron emission tomography in evaluation of tumors of the ENT area: personal results and review of the literature].
Topics: Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Otorhinolaryngologic Neoplasms; Prognosis; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
F-18 FDG versus Ga-67 for detecting splenic involvement in Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Child; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Splenic Neoplasms; Tomography, Emission-Computed; Whole-Body Counting | 2002 |
Evaluation of 18 F-fluorodeoxyglucose positron emission tomography and computed tomography with histopathologic correlation in the initial staging of head and neck cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Neoplasm Staging; Prognosis; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
Low whole-body insulin sensitivity in patients with ischaemic heart disease is associated with impaired myocardial glucose uptake predictive of poor outcome after revascularisation.
Topics: Aged; Coronary Artery Bypass; Coronary Artery Disease; Female; Fluorodeoxyglucose F18; Glucose; Glucose Clamp Technique; Humans; Insulin Resistance; Male; Middle Aged; Myocardial Contraction; Myocardial Ischemia; Myocardium; Radionuclide Imaging; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Treatment Outcome; Ventricular Dysfunction, Left | 2002 |
Clinical role of (18)F-FDG PET for initial staging of patients with extrahepatic bile duct cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Bile Duct Neoplasms; Bile Ducts, Extrahepatic; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Radiography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
The importance of the location of fluorodeoxyglucose uptake in periprosthetic infection in painful hip prostheses.
Topics: Adult; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Diagnosis, Differential; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hip Joint; Hip Prosthesis; Humans; Male; Middle Aged; Pain, Postoperative; Prosthesis Failure; Prosthesis-Related Infections; Radiopharmaceuticals; Reoperation; Sensitivity and Specificity; Single-Blind Method; Tissue Distribution; Tomography, Emission-Computed | 2002 |
Value and limitation of myocardial fluorodeoxyglucose single photon emission computed tomography using ultra-high energy collimators for assessing myocardial viability.
Topics: Adult; Aged; Aged, 80 and over; Diabetes Mellitus, Type 2; Female; Fluorodeoxyglucose F18; Glucose Clamp Technique; Heart Ventricles; Humans; Male; Middle Aged; Myocardial Ischemia; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Tissue Distribution; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2002 |
Clinical impact of whole body FDG-PET on the staging and therapeutic decision making for malignant lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Citrates; Decision Making; Female; Fluorodeoxyglucose F18; Gallium; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Patient Care Management; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed; Treatment Outcome; Whole-Body Counting | 2002 |
Persistent non-specific FDG uptake on PET imaging following hip arthroplasty.
Topics: Arthroplasty, Replacement, Hip; False Positive Reactions; Female; Femur; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Postoperative Care; Prospective Studies; Prosthesis-Related Infections; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Single-Blind Method; Tissue Distribution; Whole-Body Counting | 2002 |
Myocardial distribution of (18)F-FDG and (99m)Tc-sestamibi on dual-isotope simultaneous acquisition SPET compared with PET.
Topics: Adult; Ammonia; Coronary Artery Disease; Female; Fluorodeoxyglucose F18; Heart Ventricles; Humans; Male; Middle Aged; Nitrogen Radioisotopes; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Technetium Tc 99m Sestamibi; Tissue Distribution; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2002 |
(18)F-FDG positron emission tomography in the early diagnosis of enterocolitis: preliminary results.
Topics: Aged; Enterocolitis; Enterocolitis, Pseudomembranous; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
Comparing whole body 18F-2-deoxyglucose positron emission tomography and technetium-99m methylene diophosphate bone scan to detect bone metastases in patients with non-small cell lung cancer.
Topics: Adult; Aged; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Medronate; Tomography, Emission-Computed; Whole-Body Irradiation | 2002 |
18FDG PET versus high-dose 67Ga scintigraphy for restaging and treatment follow-up of lymphoma patients.
Topics: Adolescent; Adult; Citrates; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gallium; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
FDG-PET after radiotherapy is a good prognostic indicator of rectal cancer.
Topics: Adult; Aged; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Postoperative Period; Preoperative Care; Prognosis; Rectal Neoplasms; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Tomography, Emission-Computed; Treatment Outcome | 2002 |
Variability of insulin-stimulated myocardial glucose uptake in healthy elderly subjects.
Topics: Ammonia; Blood Glucose; Dipyridamole; Fluorodeoxyglucose F18; Glucose; Glucose Clamp Technique; Heart Ventricles; Humans; Hyperemia; Hyperinsulinism; Insulin; Male; Middle Aged; Nitrogen Radioisotopes; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Tomography, Emission-Computed; Ventricular Function, Left | 2002 |
Impact of body habitus on quantitative and qualitative image quality in whole-body FDG-PET.
Topics: Body Mass Index; Body Surface Area; Body Weights and Measures; Female; Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Male; Quality Control; Radiometry; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Sex Factors; Tomography, Emission-Computed; Whole-Body Counting | 2003 |
PET-MR image fusion in soft tissue sarcoma: accuracy, reliability and practicality of interactive point-based and automated mutual information techniques.
Topics: Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Quality Control; Radiopharmaceuticals; Reproducibility of Results; Sarcoma; Sensitivity and Specificity; Subtraction Technique; Tomography, Emission-Computed | 2003 |
FDG-PET for prediction of tumour aggressiveness and response to intra-arterial chemotherapy and radiotherapy in head and neck cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Combined Modality Therapy; Doxorubicin; Female; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed; Treatment Outcome | 2003 |
Prognostic value of [18F]FDG-PET imaging in small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Small Cell; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Single-Blind Method; Survival Analysis; Tomography, Emission-Computed; Treatment Outcome; United States | 2003 |
Multitracer study with positron emission tomography in Creutzfeldt-Jakob disease.
Topics: Adult; Aged; Brain; Carbon Radioisotopes; Cerebrovascular Circulation; Creutzfeldt-Jakob Syndrome; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gliosis; Glucose; Humans; Male; Middle Aged; Monoamine Oxidase Inhibitors; Oxygen Radioisotopes; Radioisotopes; Radiopharmaceuticals; Reference Values; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Tomography, Emission-Computed; Water | 2003 |
Brain metastases after stereotactic radiosurgery using the Leksell gamma knife: can FDG PET help to differentiate radionecrosis from tumour progression?
Topics: Adult; Aged; Brain; Brain Neoplasms; Diagnosis, Differential; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Necrosis; Neoplasm Recurrence, Local; Radiation Injuries; Radiopharmaceuticals; Radiosurgery; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
Staging of recurrent and advanced lung cancer with 18F-FDG PET in a coincidence technique (hybrid PET).
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Carcinoma; Carcinoma, Large Cell; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Pleural Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
Comparison of [18F]FDG-PET and L-3[123I]-iodo-alpha-methyl tyrosine (I-123 IMT)-SPECT in primary lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Methyltyrosines; Middle Aged; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Whole-Body Counting | 2002 |
Impact of whole-body 18F-FDG PET on staging and managing patients for radiation therapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Neoplasms; Palliative Care; Patient Care Management; Prognosis; Radiopharmaceuticals; Radiotherapy; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed; Treatment Outcome; Whole-Body Counting | 2003 |
Comparison of microsphere-equivalent blood flow (15O-water PET) and relative perfusion (99mTc-tetrofosmin SPECT) in myocardium showing metabolism-perfusion mismatch.
Topics: Adult; Aged; Coronary Artery Disease; Coronary Circulation; Female; Fluorodeoxyglucose F18; Heart; Humans; Male; Microspheres; Middle Aged; Myocardium; Organophosphorus Compounds; Organotechnetium Compounds; Oxygen Isotopes; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Water | 2003 |
Extratemporal hypometabolism on FDG PET in temporal lobe epilepsy as a predictor of seizure outcome after temporal lobectomy.
Topics: Adolescent; Adult; Anterior Temporal Lobectomy; Brain Diseases, Metabolic; Cerebral Cortex; Child; Epilepsy, Temporal Lobe; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Postoperative Care; Preoperative Care; Prognosis; Radiation-Protective Agents; Radionuclide Imaging; Reproducibility of Results; Risk Assessment; Seizures; Sensitivity and Specificity; Statistics as Topic; Treatment Outcome | 2003 |
Prospective comparison of 18F-FDG PET with conventional imaging modalities (MRI, CT, and 67Ga scintigraphy) in assessment of combined intraarterial chemotherapy and radiotherapy for head and neck carcinoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Doxorubicin; False Negative Reactions; Female; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Gallium Radioisotopes; Head and Neck Neoplasms; Humans; Injections, Intra-Arterial; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Prospective Studies; Radiopharmaceuticals; Radiotherapy, Adjuvant; Reproducibility of Results; Sensitivity and Specificity; Tomography Scanners, X-Ray Computed; Tomography, Emission-Computed; Treatment Outcome | 2003 |
11C-acetate PET imaging in hepatocellular carcinoma and other liver masses.
Topics: Acetates; Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carbon Radioisotopes; Carcinoma, Hepatocellular; Cholangiocarcinoma; Colonic Neoplasms; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2003 |
Positron emission tomography with 11C-acetate and 18F-FDG in prostate cancer patients.
Topics: Acetates; Aged; Aged, 80 and over; Bone Neoplasms; Carbon; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Prostate-Specific Antigen; Prostatic Neoplasms; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
Validation of an evaluation routine for left ventricular volumes, ejection fraction and wall motion from gated cardiac FDG PET: a comparison with cardiac magnetic resonance imaging.
Topics: Aged; Coronary Artery Disease; Female; Fluorodeoxyglucose F18; Gated Blood-Pool Imaging; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Stroke Volume; Tomography, Emission-Computed; Ventricular Dysfunction, Left | 2003 |
In-111 DTPA-octreotide scintigraphy for disease detection in metastatic thyroid cancer: comparison with F-18 FDG positron emission tomography and extensive conventional radiographic imaging.
Topics: Bone Neoplasms; Carcinoma; Cohort Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Middle Aged; Octreotide; Pentetic Acid; Pleural Neoplasms; Radiography; Radiopharmaceuticals; Sensitivity and Specificity; Skin Neoplasms; Thyroid Neoplasms; Tomography, Emission-Computed | 2003 |
PET-CT: accuracy of PET and CT spatial registration of lung lesions.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
The value of (18)FDG-PET for the detection of infected hip prosthesis.
Topics: Adult; Aged; Arthroplasty, Replacement, Hip; Female; Fluorodeoxyglucose F18; Hip Joint; Hip Prosthesis; Humans; Leukocytes; Male; Middle Aged; Phantoms, Imaging; Prosthesis-Related Infections; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Synovitis; Technetium Tc 99m Exametazime; Technetium Tc 99m Medronate; Tomography, Emission-Computed | 2003 |
Whole-body FDG-PET in patients with stage I non-seminomatous germ cell tumours.
Topics: Adolescent; Adult; Aged; Disease-Free Survival; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Secondary Prevention; Seminoma; Sensitivity and Specificity; Testicular Neoplasms; Tomography, Emission-Computed; Treatment Outcome; Whole-Body Counting | 2003 |
Lymph node metastasis of squamous cell carcinoma from an unknown primary: impact of positron emission tomography.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Cohort Studies; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neck; Neoplasms, Unknown Primary; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
Measuring [(18)F]FDG uptake in breast cancer during chemotherapy: comparison of analytical methods.
Topics: Adult; Aged; Algorithms; Antineoplastic Agents; Breast Neoplasms; Drug Therapy; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Regression Analysis; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome | 2003 |
Absorbed dose to very low birth weight infants from 18F-fluorodeoxyglucose.
Topics: Absorption; Body Weight; Brain; Computer Simulation; Dose-Response Relationship, Radiation; Female; Fluorodeoxyglucose F18; Half-Life; Heart; Humans; Infant, Newborn; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Injections, Intravenous; Kidney; Lung; Male; Models, Biological; Myocardium; Organ Specificity; Pneumonia; Radiation Dosage; Radiometry; Radiopharmaceuticals; Sensitivity and Specificity; Tissue Distribution; Tomography, Emission-Computed; Urinary Bladder | 2003 |
A comparative study of 11C-choline PET and [18F]fluorodeoxyglucose PET in the evaluation of lung cancer.
Topics: Adenocarcinoma; Aged; Carbon Radioisotopes; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Choline; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Radiography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
Assessment of myocardial viability with a positron coincidence gamma camera using fluorodeoxyglucose in comparison with dedicated PET.
Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Gamma Cameras; Heart; Humans; Male; Middle Aged; Myocardial Infarction; Myocardium; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Tissue Survival; Tomography, Emission-Computed | 2003 |
Early diagnosis and follow-up of aortitis with [(18)F]FDG PET and MRI.
Topics: Adult; Aged; Aortitis; Early Diagnosis; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Middle Aged; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed; Treatment Outcome | 2003 |
Whole-body tumor imaging using PET and 2-18F-fluoro-L-tyrosine: preliminary evaluation and comparison with 18F-FDG.
Topics: Aged; Aged, 80 and over; Feasibility Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphoma; Male; Middle Aged; Neoplasms; Organ Specificity; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Tomography, Emission-Computed; Whole-Body Counting | 2003 |
18F-FDG accumulation with PET for differentiation between benign and malignant lesions in the thorax.
Topics: Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Mediastinal Diseases; Mediastinal Neoplasms; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Thallium; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2003 |
11C-acetate PET imaging of prostate cancer: detection of recurrent disease at PSA relapse.
Topics: Acetates; Adenocarcinoma; Aged; Carbon; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Single-Blind Method; Tomography, Emission-Computed | 2003 |
Potential impact of [18F]3'-deoxy-3'-fluorothymidine versus [18F]fluoro-2-deoxy-D-glucose in positron emission tomography for colorectal cancer.
Topics: Aged; Aged, 80 and over; Colorectal Neoplasms; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed; Whole-Body Counting | 2003 |
[18F]FDG imaging of head and neck tumours: comparison of hybrid PET and morphological methods.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Feasibility Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study.
Topics: Aged; Alzheimer Disease; Brain Mapping; Cerebral Cortex; Cognition Disorders; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose; Humans; Longitudinal Studies; Male; Neuropsychological Tests; Prognosis; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Severity of Illness Index; Statistics as Topic; Tomography, Emission-Computed | 2003 |
Persistent vegetative state: evaluation of brain metabolism and brain perfusion with PET and SPECT.
Topics: Adolescent; Adult; Aged; Brain; Cerebrovascular Circulation; Craniocerebral Trauma; Cysteine; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Organotechnetium Compounds; Persistent Vegetative State; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2003 |
Evaluation of fluorodeoxyglucose positron emission tomography in the detection of axillary lymph node metastases in patients with early-stage breast cancer.
Topics: Adult; Aged; Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Preoperative Care; Radiopharmaceuticals; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Tomography, Emission-Computed | 2003 |
Imaging of gynecologic tumors: comparison of (11)C-choline PET with (18)F-FDG PET.
Topics: Adenocarcinoma; Adult; Aged; Carbon Radioisotopes; Carcinoma, Squamous Cell; Carcinosarcoma; Choline; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Radiopharmaceuticals; Reproducibility of Results; Sarcoma; Sarcoma, Clear Cell; Sensitivity and Specificity; Tomography, Emission-Computed; Uterine Neoplasms; Whole-Body Counting | 2003 |
Efficiency of [(18)F]FDG PET in characterising renal cancer and detecting distant metastases: a comparison with CT.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Whole-Body Counting | 2003 |
Positron emission tomography with [(18)F]FDOPA and [(18)F]FDG in the imaging of small cell lung carcinoma: preliminary results.
Topics: Adult; Aged; Carcinoma, Small Cell; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
F18-fluorodeoxyglucose positron emission tomography in detecting metastatic papillary thyroid carcinoma with elevated human serum thyroglobulin levels but negative I-131 whole body scan.
Topics: Adult; Aged; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Radiopharmaceuticals; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Tomography, Emission-Computed; Whole-Body Counting | 2003 |
Positron emission tomography in non-small-cell lung cancer: prediction of response to chemotherapy by quantitative assessment of glucose use.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Confidence Intervals; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Palliative Care; Predictive Value of Tests; Prospective Studies; Sensitivity and Specificity; Survival Analysis; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome | 2003 |
Advanced ovarian carcinoma: usefulness of [(18)F]FDG-PET in combination with CT for lesion detection after primary treatment.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome | 2003 |
[18F]FLT PET for diagnosis and staging of thoracic tumours.
Topics: Adult; Aged; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Neoplasms, Unknown Primary; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thoracic Neoplasms; Tomography, Emission-Computed | 2003 |
Clinical performance of PET/CT in evaluation of cancer: additional value for diagnostic imaging and patient management.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Enhancement; Male; Middle Aged; Neoplasms; Quality Control; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
The impact of image fusion in resolving discrepant findings between FDG-PET and MRI/CT in patients with gynaecological cancers.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Middle Aged; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
Direct imaging of exercise-induced myocardial ischemia with fluorine-18-labeled deoxyglucose and Tc-99m-sestamibi in coronary artery disease.
Topics: Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Diabetes Complications; Diabetes Mellitus; Exercise Test; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocardial Ischemia; Radionuclide Imaging; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 2003 |
Imaging proliferation in lung tumors with PET: 18F-FLT versus 18F-FDG.
Topics: Adult; Aged; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Solitary Pulmonary Nodule; Statistics as Topic; Tomography, Emission-Computed | 2003 |
Gamma camera coincidence imaging with [18F]fluorodeoxyglucose in the pretreatment evaluation of patients with oesophageal cancer.
Topics: Aged; Aged, 80 and over; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms, Squamous Cell; Radiography; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
Optimal scan time for evaluating pancreatic disease with positron emission tomography using F-18-fluorodeoxyglucose.
Topics: False Positive Reactions; Fluorodeoxyglucose F18; Humans; Image Enhancement; Liver Neoplasms; Pancreatic Neoplasms; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Single-Blind Method; Tomography, Emission-Computed | 2003 |
Combined study with FDG PET and Tl SPECT in patients with idiopathic dilated cardiomyopathy.
Topics: Age Factors; Cardiomyopathy, Dilated; Diagnosis, Differential; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Male; Middle Aged; Myocardial Ischemia; Prognosis; Radiation-Protective Agents; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Sex Factors; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2003 |
Whole-body positron emission tomography using fluorodeoxyglucose in patients with metastases of unknown primary tumours (CUP syndrome).
Topics: Adult; Aged; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Radiography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Syndrome; Tomography, Emission-Computed; Whole-Body Counting | 2003 |
Simple quantification of skeletal muscle glucose utilization by static 18F-FDG PET.
Topics: Adult; Aged; Blood Glucose; Female; Femur; Fluorodeoxyglucose F18; Glucose; Glucose Clamp Technique; Humans; Hyperinsulinism; Insulin Resistance; Male; Metabolic Clearance Rate; Middle Aged; Muscle, Skeletal; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Tomography, Emission-Computed | 2003 |
Expression of Glut-1 and Glut-3 in untreated oral squamous cell carcinoma compared with FDG accumulation in a PET study.
Topics: Aged; Biomarkers, Tumor; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Glucose Transporter Type 2; Humans; Male; Middle Aged; Monosaccharide Transport Proteins; Mouth Neoplasms; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Tomography, Emission-Computed | 2004 |
Narrow time-window dual-point 18F-FDG PET for the diagnosis of thoracic malignancy.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Thoracic Neoplasms; Time Factors | 2003 |
Can FDG PET be used to successfully direct preoperative biopsy of soft tissue tumours?
Topics: Adult; Aged; Algorithms; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Preoperative Care; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sarcoma; Sensitivity and Specificity; Soft Tissue Neoplasms; Subtraction Technique; Surgery, Computer-Assisted; Treatment Outcome | 2003 |
An assessment of wall motion, perfusion and glucose metabolism in recent myocardial infarction: a comparison in patients with and without revascularization.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Glucose; Heart Ventricles; Humans; Male; Middle Aged; Movement; Myocardial Infarction; Myocardial Revascularization; Myocardial Stunning; Radionuclide Imaging; Radiopharmaceuticals; Recovery of Function; Reproducibility of Results; Sensitivity and Specificity; Single-Blind Method; Thallium; Treatment Outcome; Ultrasonography; Ventricular Dysfunction, Left | 2003 |
11C-acetate PET imaging of lung cancer: comparison with 18F-FDG PET and 99mTc-MIBI SPET.
Topics: Acetates; Aged; Aged, 80 and over; Carbon; Carcinoma; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed | 2004 |
Early therapy monitoring with FDG-PET in aggressive non-Hodgkin's lymphoma and Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Agents; Drug Monitoring; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed; Treatment Outcome | 2004 |
Cost-effectiveness of FDG-PET in staging non-small cell lung cancer: the PLUS study.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Cost-Benefit Analysis; Female; Fluorodeoxyglucose F18; Health Care Costs; Humans; Lung Neoplasms; Male; Neoplasm Staging; Netherlands; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
Usefulness of 18F-FDG PET in intrahepatic cholangiocarcinoma.
Topics: Adult; Aged; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
Optimisation of the OS-EM algorithm and comparison with FBP for image reconstruction on a dual-head camera: a phantom and a clinical 18F-FDG study.
Topics: Algorithms; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Phantoms, Imaging; Quality Control; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Single-Blind Method; Tomography, Emission-Computed | 2003 |
Detection of recurrent oral squamous cell carcinoma by [18F]-2-fluorodeoxyglucose-positron emission tomography: implications for prognosis and patient management.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Mouth Neoplasms; Neoplasm Recurrence, Local; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Survival Analysis | 2003 |
99mTc-EDDA/HYNIC-TOC and (18)F-FDG in thyroid cancer patients with negative (131)I whole-body scans.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Organotechnetium Compounds; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Somatostatin; Reproducibility of Results; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms | 2004 |
Comparative impact of standard approach, FDG PET and FDG dual-head coincidence gamma camera imaging in preoperative staging of patients with non-small-cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Preoperative Care; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
Pathology results in [18F]fluorodeoxyglucose positron emission tomography of the thyroid gland.
Topics: Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thyroid Gland; Thyroid Neoplasms; Tomography, Emission-Computed | 2003 |
Comparison of sestamibi, thallium, echocardiography and PET for the detection of hibernating myocardium.
Topics: Adult; Aged; Ammonia; Carbon Isotopes; Echocardiography; Exercise Test; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocardial Stunning; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Thallium; Tomography, Emission-Computed, Single-Photon | 2004 |
FDG-PET/CT in re-staging of patients with lymphoma.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Image Enhancement; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Prognosis; Radiography; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Treatment Outcome | 2004 |
The role of fluorine-18 deoxyglucose positron emission tomography in the management of patients with metastatic melanoma: impact on surgical decision making.
Topics: Adult; Aged; Aged, 80 and over; Decision Making, Computer-Assisted; Double-Blind Method; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Middle Aged; Patient Selection; Preoperative Care; Radiography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
Comparison of whole-body 18F-FDG PET, 99mTc-MIBI SPET, and post-therapeutic 131I-Na scintigraphy in the detection of metastatic thyroid cancer.
Topics: Adenocarcinoma, Follicular; Adenocarcinoma, Papillary; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Sodium; Technetium Tc 99m Sestamibi; Thyroid Neoplasms; Treatment Outcome; Whole-Body Counting | 2004 |
Recombinant human thyrotropin stimulation of fluoro-D-glucose positron emission tomography uptake in well-differentiated thyroid carcinoma.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Recombinant Proteins; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Thyrotropin; Tomography, Emission-Computed | 2004 |
Prospective multicenter study of axillary nodal staging by positron emission tomography in breast cancer: a report of the staging breast cancer with PET Study Group.
Topics: Adult; Aged; Aged, 80 and over; Axilla; Breast Neoplasms; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2004 |
FDG-PET delayed imaging for the detection of head and neck cancer recurrence after radio-chemotherapy: comparison with MRI/CT.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Combined Modality Therapy; Drug Therapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed; Treatment Outcome | 2004 |
Initial experience with a prototype dual-crystal (LSO/NaI) dual-head coincidence camera in oncology.
Topics: Adult; Aged; Aged, 80 and over; Equipment Design; Equipment Failure Analysis; Feasibility Studies; Female; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Lutetium; Male; Middle Aged; Neoplasms; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Silicates; Sodium Iodide; Transducers; Whole-Body Counting | 2004 |
Fever of unknown origin: prospective comparison of diagnostic value of 18F-FDG PET and 111In-granulocyte scintigraphy.
Topics: Adult; Aged; Aged, 80 and over; Female; Fever of Unknown Origin; Fluorodeoxyglucose F18; Granulocytes; Humans; Indium Radioisotopes; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2004 |
The role of 18F-FDG PET in staging and early prediction of response to therapy of recurrent gastrointestinal stromal tumors.
Topics: Adult; Aged; Aged, 80 and over; Benzamides; False Positive Reactions; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Imatinib Mesylate; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Piperazines; Prognosis; Pyrimidines; Radiography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Stromal Cells; Tomography, Emission-Computed; Treatment Outcome | 2004 |
18F-FDG uptake in squamous cell carcinoma of the cervix is correlated with glucose transporter 1 expression.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Middle Aged; Monosaccharide Transport Proteins; Neoplasm Recurrence, Local; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Uterine Cervical Neoplasms | 2004 |
Validation of QGS and 4D-MSPECT for quantification of left ventricular volumes and ejection fraction from gated 18F-FDG PET: comparison with cardiac MRI.
Topics: Aged; Aged, 80 and over; Coronary Artery Disease; Female; Fluorodeoxyglucose F18; Gated Blood-Pool Imaging; Heart Ventricles; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Stroke Volume; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2004 |
Estimating the input function non-invasively for FDG-PET quantification with multiple linear regression analysis: simulation and verification with in vivo data.
Topics: Algorithms; Brain; Brain Diseases; Brain Mapping; Computer Simulation; Female; Fluorodeoxyglucose F18; Glucose; Humans; Image Interpretation, Computer-Assisted; Linear Models; Male; Middle Aged; Models, Neurological; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2004 |
Response prediction by FDG-PET after neoadjuvant radiochemotherapy and combined regional hyperthermia of rectal cancer: correlation with endorectal ultrasound and histopathology.
Topics: Adolescent; Adult; Aged; Chemotherapy, Adjuvant; Combined Modality Therapy; Endosonography; Female; Fluorodeoxyglucose F18; Humans; Hyperthermia, Induced; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Rectal Neoplasms; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome | 2004 |
Malignant involvement of the spine: assessment by 18F-FDG PET/CT.
Topics: Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nerve Compression Syndromes; Polyradiculopathy; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Soft Tissue Neoplasms; Spinal Cord Compression; Spinal Neoplasms; Spinal Nerve Roots; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
An analysis of the physiological FDG uptake pattern in the stomach.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Gastric Mucosa; Humans; Image Interpretation, Computer-Assisted; Japan; Male; Middle Aged; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Stomach; Tissue Distribution; Tomography, Emission-Computed | 2003 |
PET with [18F]fluorothymidine for imaging of primary breast cancer: a pilot study.
Topics: Adult; Aged; Breast Neoplasms; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Pilot Projects; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2004 |
Tumor localization of 16beta-18F-fluoro-5alpha-dihydrotestosterone versus 18F-FDG in patients with progressive, metastatic prostate cancer.
Topics: Aged; Bone Neoplasms; Dihydrotestosterone; Fluorodeoxyglucose F18; Humans; Male; Metabolic Clearance Rate; Middle Aged; Prostatic Neoplasms; Radiopharmaceuticals; Receptors, Androgen; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Tomography, Emission-Computed; Whole-Body Counting | 2004 |
Nodal metastases of nasopharyngeal carcinoma: patterns of disease on MRI and FDG PET.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Taiwan | 2004 |
Towards a minimally invasive staging strategy in NSCLC: analysis of PET positive mediastinal lesions by EUS-FNA.
Topics: Adult; Aged; Biopsy, Needle; Carcinoma, Non-Small-Cell Lung; Endosonography; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2004 |
Comparison of 11C-choline PET and FDG PET for the differential diagnosis of malignant tumors.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Brain Neoplasms; Carbon Radioisotopes; Child; Choline; Diagnosis, Differential; Feasibility Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Soft Tissue Neoplasms | 2004 |
"Population" approach improves parameter estimation of kinetic models from dynamic PET data.
Topics: Algorithms; Computer Simulation; Fluorodeoxyglucose F18; Glucose; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Kinetics; Male; Metabolic Clearance Rate; Models, Biological; Muscle, Skeletal; Radioisotope Dilution Technique; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2004 |
[Is coincidence detection emission tomography (CDET) as reliable as positron emission tomography (PET) in head and neck cancer?].
Topics: Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Neoplasms, Unknown Primary; Radiography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
Positron emission tomography of incidentally detected small pulmonary nodules.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Pilot Projects; Pulmonary Disease, Chronic Obstructive; Radiography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, Emission-Computed | 2004 |
Comparison of [18F]fluorodeoxyglucose uptake with glucose transporter-1 expression and proliferation rate in human glioma and non-small-cell lung cancer.
Topics: Biomarkers, Tumor; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Cell Division; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Glioma; Glucose Transporter Type 1; Humans; Lung Neoplasms; Male; Middle Aged; Monosaccharide Transport Proteins; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic | 2004 |
P-glycoprotein expression is associated with FDG uptake and cell differentiation in patients with untreated lung cancer.
Topics: Adenocarcinoma, Bronchiolo-Alveolar; Aged; Aged, 80 and over; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biomarkers, Tumor; Cell Division; Drug Resistance, Multiple; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic | 2004 |
Diagnosis of tumor in the nasal cavity and paranasal sinuses with [11C]choline PET: comparative study with 2-[18F]fluoro-2-deoxy-D-glucose (FDG) PET.
Topics: Adult; Aged; Aged, 80 and over; Carbon Radioisotopes; Choline; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nasal Cavity; Nose Neoplasms; Paranasal Sinus Neoplasms; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2004 |
False-positive and true-negative hilar and mediastinal lymph nodes on FDG-PET--radiological-pathological correlation.
Topics: Aged; Carcinoma; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Tomography, Emission-Computed | 2004 |
Prospective feasibility trial of radiotherapy target definition for head and neck cancer using 3-dimensional PET and CT imaging.
Topics: Adult; Aged; Aged, 80 and over; Feasibility Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Male; Prospective Studies; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; Sensitivity and Specificity; Subtraction Technique; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
Clinical implications of different image reconstruction parameters for interpretation of whole-body PET studies in cancer patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Algorithms; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Male; Middle Aged; Neoplasms; Phantoms, Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed; Whole-Body Counting | 2004 |
Imatinib mesylate for the treatment of gastrointestinal stromal tumours: best monitored with FDG PET.
Topics: Adult; Aged; Antineoplastic Agents; Benzamides; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Imatinib Mesylate; Middle Aged; Piperazines; Positron-Emission Tomography; Prognosis; Pyrimidines; Radiopharmaceuticals; Reproducibility of Results; Sarcoma; Sensitivity and Specificity; Treatment Outcome | 2004 |
18F-FDG PET, somatostatin receptor scintigraphy, and CT in metastatic medullary thyroid carcinoma: a clinical study and an analysis of the literature.
Topics: Adolescent; Adult; Aged; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Somatostatin; Reproducibility of Results; Sensitivity and Specificity; Single-Blind Method; Thyroid Neoplasms; Tomography, X-Ray Computed | 2004 |
Percutaneous radiofrequency ablation of lung neoplasms: initial therapeutic response.
Topics: Aged; Carcinoma; Catheter Ablation; Contrast Media; Digestive System Neoplasms; Feasibility Studies; Female; Fluorodeoxyglucose F18; Fluoroscopy; Follow-Up Studies; Humans; Hypopharyngeal Neoplasms; Iohexol; Leiomyosarcoma; Lung Neoplasms; Male; Radiopharmaceuticals; Sensitivity and Specificity; Survival Analysis; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome; Urinary Bladder Neoplasms | 2004 |
[18F]FDG PET as a substitute for second-look laparotomy in patients with advanced ovarian carcinoma.
Topics: Adult; Aged; Analgesics; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Korea; Laparotomy; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Second-Look Surgery; Sensitivity and Specificity; Tomography, Emission-Computed; Treatment Outcome | 2004 |
FDG PET imaging for grading and prediction of outcome in chondrosarcoma patients.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Chondrosarcoma; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Survival Analysis; Tomography, Emission-Computed; Washington | 2004 |
[18F]FDG in recurrent breast cancer: diagnostic performances, clinical impact and relevance of induced changes in management.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Decision Making; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Patient Care Management; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Tomography, Emission-Computed | 2004 |
Differentiation of mediastinal FDG uptake observed in patients with non-thoracic tumours.
Topics: Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Mediastinum; Middle Aged; Neoplasms, Unknown Primary; Radionuclide Imaging; Reproducibility of Results; Sensitivity and Specificity; Thoracic Neoplasms | 2004 |
Detection of alterations in brain glucose metabolism by positron emission tomography in Takayasu's arteritis.
Topics: Adolescent; Adult; Arteries; Arteriosclerosis; Arteritis; Brain; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Glucose; Humans; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Takayasu Arteritis; Tomography, Emission-Computed; Vasculitis | 2004 |
Assessment of disease activity in rheumatoid arthritis with (18)F-FDG PET.
Topics: Adult; Aged; Arthritis, Rheumatoid; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Severity of Illness Index; Synovitis; Tomography, Emission-Computed; Whole-Body Counting | 2004 |
Imaging of adrenal incidentalomas with PET using (11)C-metomidate and (18)F-FDG.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Carbon Radioisotopes; Etomidate; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Metabolic Clearance Rate; Middle Aged; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2004 |
Detection of distant metastases in esophageal cancer with (18)F-FDG PET.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2004 |
PET for the evaluation of pleural thickening observed on CT.
Topics: Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pleural Neoplasms; Radiography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2004 |
Overexpression of Glut1 in lymphoid follicles correlates with false-positive (18)F-FDG PET results in lung cancer staging.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Diagnostic Errors; False Positive Reactions; Female; Fluorodeoxyglucose F18; Germinal Center; Glucose Transporter Type 1; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Monosaccharide Transport Proteins; Neoplasm Staging; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic | 2004 |
The predictive value of 201Tl rest-redistribution and 18F-fluorodeoxyglucose SPECT for wall motion recovery after recent reperfused myocardial infarction.
Topics: Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Reperfusion; Prognosis; Radiopharmaceuticals; Recovery of Function; Reproducibility of Results; Sensitivity and Specificity; Single-Blind Method; Thallium; Thrombolytic Therapy; Tissue Survival; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Ventricular Dysfunction, Left | 2004 |
What is the most appropriate scan timing for intraoperative detection of malignancy using 18F-FDG-sensitive gamma probe? Preliminary phantom and preoperative patient study.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Image Enhancement; Injections, Intravenous; Intraoperative Care; Middle Aged; Phantoms, Imaging; Pilot Projects; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Stomach Neoplasms; Surgery, Computer-Assisted; Time Factors | 2004 |
Evaluation of F-18 fluorodeoxyglucose (FDG) PET scanning for pulmonary nodules less than 3 cm in diameter, with special reference to the CT images.
Topics: Adenocarcinoma; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; False Negative Reactions; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2004 |
Positron emission tomography imaging of adrenal masses: (18)F-fluorodeoxyglucose and the 11beta-hydroxylase tracer (11)C-metomidate.
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aged; Carbon Radioisotopes; Etomidate; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Steroid 11-beta-Hydroxylase; Tissue Distribution | 2004 |
Usefulness of FDG-PET to detect recurrent cervical cancer based on asymptomatically elevated tumor marker serum levels--a preliminary report.
Topics: Adult; Antigens, Neoplasm; Biomarkers, Tumor; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 2004 |
Value of 18F-FDG PET in the detection of peritoneal carcinomatosis.
Topics: Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Peritoneal Neoplasms; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2004 |
A comparison of 18F-FDG gamma camera PET, mammography and ultrasonography in demonstrating primary disease in locally advanced breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Equipment Failure Analysis; Feasibility Studies; Female; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Mammography; Middle Aged; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Ultrasonography, Mammary | 2004 |
Impact of [18F]FDG-PET on the primary staging of small-cell lung cancer.
Topics: Brain Neoplasms; Carcinoma, Small Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Severity of Illness Index | 2004 |
Diagnosis of infection of implantable central venous catheters by [18F]fluorodeoxyglucose positron emission tomography.
Topics: Adult; Antineoplastic Agents; Catheterization, Central Venous; Cross Infection; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple Myeloma; Pilot Projects; Positron-Emission Tomography; Prosthesis-Related Infections; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thrombophlebitis | 2004 |
The value of vesicant 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET) in gastric malignancies.
Topics: Adenocarcinoma; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Irritants; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Stomach Neoplasms | 2004 |
Analysis of gene expression profiles of hepatocellular carcinomas with regard to 18F-fluorodeoxyglucose uptake pattern on positron emission tomography.
Topics: Adult; Aged; Biomarkers, Tumor; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Proteins; Oligonucleotide Array Sequence Analysis; Organ Specificity; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Severity of Illness Index; Statistics as Topic; Tissue Distribution | 2004 |
Retrospective digital image fusion of multidetector CT and 18F-FDG PET: clinical value in pancreatic lesions--a prospective study with 104 patients.
Topics: Adult; Aged; Aged, 80 and over; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Male; Middle Aged; Neoplasm Staging; Pancreatic Neoplasms; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Signal Processing, Computer-Assisted; Subtraction Technique; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
Comparison of 18F-FDG and 11C-methionine for PET-guided stereotactic brain biopsy of gliomas.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biopsy; Brain Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Methionine; Middle Aged; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Stereotaxic Techniques; Surgery, Computer-Assisted; Tomography, Emission-Computed | 2004 |
Is 18F-FDG PET more accurate than standard diagnostic procedures in the detection of suspected recurrent melanoma?
Topics: Abdominal Neoplasms; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2004 |
Simplified kinetic analysis of tumor 18F-FDG uptake: a dynamic approach.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Kidney Neoplasms; Kinetics; Male; Metabolic Clearance Rate; Middle Aged; Radioisotope Dilution Technique; Radioisotope Renography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2004 |
Characterization of the normal adrenal gland with 18F-FDG PET/CT.
Topics: Adrenal Glands; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lymphoma; Observer Variation; Radiopharmaceuticals; Reference Standards; Reference Values; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
Gamma-camera 18F-FDG PET in diagnosis and staging of patients presenting with suspected lung cancer and comparison with dedicated PET.
Topics: Equipment Failure Analysis; Female; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Single-Blind Method; Tomography, Emission-Computed | 2004 |
18F-FDG uptake and breast density in women with normal breast tissue.
Topics: Adipose Tissue; Adult; Aged; Body Composition; Breast; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Organ Specificity; Radiopharmaceuticals; Reference Values; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Tomography, Emission-Computed | 2004 |
Positron emission tomography in limited-stage small-cell lung cancer: a prospective study.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Small Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Patient Care Planning; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Time Factors; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
The benefit of functional-anatomical imaging with [18F]fluorodeoxyglucose utilizing a dual-head coincidence gamma camera with an integrated X-ray transmission system in non-small cell lung cancer.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Image Enhancement; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2004 |
Validation of anatomical standardization of FDG PET images of normal brain: comparison of SPM and NEUROSTAT.
Topics: Adolescent; Adult; Aged; Algorithms; Brain; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Michigan; Middle Aged; Models, Anatomic; Positron-Emission Tomography; Radiopharmaceuticals; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Software; Subtraction Technique; United Kingdom | 2005 |
Prognostic aspects of 18F-FDG PET kinetics in patients with metastatic colorectal carcinoma receiving FOLFOX chemotherapy.
Topics: Algorithms; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Disease-Free Survival; Fluorodeoxyglucose F18; Fluorouracil; Humans; Image Interpretation, Computer-Assisted; Kinetics; Leucovorin; Organoplatinum Compounds; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Survival Analysis; Treatment Outcome | 2004 |
Comparison of different quantitative approaches to 18F-fluoride PET scans.
Topics: Adolescent; Adult; Aged; Algorithms; Bone and Bones; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Metabolic Clearance Rate; Middle Aged; Models, Biological; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2004 |
The diagnostic accuracy of 18F-fluorodeoxyglucose PET/CT in patients with gynecological malignancies.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Magnetic Resonance Imaging; Middle Aged; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Ultrasonography | 2004 |
Sequential 123I-iododexetimide scans in temporal lobe epilepsy: comparison with neuroimaging scans (MR imaging and 18F-FDG PET imaging).
Topics: Adult; Brain Mapping; Dexetimide; Epilepsy, Temporal Lobe; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 2005 |
Electrocardiographic-gated dual-isotope simultaneous acquisition SPECT using 18F-FDG and 99mTc-sestamibi to assess myocardial viability and function in a single study.
Topics: Adult; Aged; Aged, 80 and over; Electrocardiography; Female; Fluorodeoxyglucose F18; Gated Blood-Pool Imaging; Humans; Image Enhancement; Male; Middle Aged; Myocardial Infarction; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2005 |
In vivo measurement of circulating leucocyte activation in patients following cardiopulmonary bypass.
Topics: Adult; Aged; Algorithms; Cardiopulmonary Bypass; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Inflammation; Leukocyte Count; Leukocytes; Male; Middle Aged; Neutrophil Activation; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2004 |
Electromechanical properties of perfusion/metabolism mismatch: comparison of nonfluoroscopic electroanatomic mapping with 18F-FDG PET.
Topics: Coronary Artery Disease; Electrocardiography; Female; Fluorodeoxyglucose F18; Fluoroscopy; Glucose; Heart Conduction System; Humans; Male; Middle Aged; Myocardial Contraction; Myocardium; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thallium | 2004 |
Defining the priority of using 18F-FDG PET for recurrent cervical cancer.
Topics: Adult; Aged; Aged, 80 and over; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Survival Analysis; Treatment Outcome; Uterine Cervical Neoplasms | 2004 |
Clinical usefulness of 18F-FDG PET in nasopharyngeal carcinoma patients with questionable MRI findings for recurrence.
Topics: Adolescent; Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2004 |
18F-FDG PET of gliomas at delayed intervals: improved distinction between tumor and normal gray matter.
Topics: Adult; Aged; Brain; Brain Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Glioma; Humans; Image Enhancement; Male; Middle Aged; Neurons; Positron-Emission Tomography; Radiopharmaceuticals; Reference Values; Reproducibility of Results; Sensitivity and Specificity | 2004 |
pO(2) Polarography versus positron emission tomography ([(18)F] fluoromisonidazole, [(18)F]-2-fluoro-2'-deoxyglucose). An appraisal of radiotherapeutically relevant hypoxia.
Topics: Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Misonidazole; Oximetry; Oxygen; Oxygen Consumption; Polarography; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2004 |
Using FDG-PET activity as a surrogate for tumor cell density and its effect on equivalent uniform dose calculation.
Topics: Algorithms; Cell Count; Dose-Response Relationship, Radiation; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Radiometry; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Relative Biological Effectiveness; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2004 |
Imaging characterization of non-hypersecreting adrenal masses. Comparison between MR and radionuclide techniques.
Topics: 19-Iodocholesterol; 3-Iodobenzylguanidine; Adenoma; Adrenal Gland Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Magnetic Resonance Imaging; Male; Middle Aged; Pheochromocytoma; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2004 |
Evaluation of myocardial viability following acute myocardial infarction using 201Tl SPECT after thallium-glucose-insulin infusion--comparison with 18F-FDG positron emission tomography.
Topics: Aged; Female; Fluorodeoxyglucose F18; Glucose; Humans; Insulin; Male; Middle Aged; Myocardial Infarction; Positron-Emission Tomography; Potassium; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thallium Radioisotopes; Tissue Survival; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2004 |
18F-FDG PET is superior to 67Ga SPECT in the staging of non-Hodgkin's lymphoma.
Topics: Citrates; Fluorodeoxyglucose F18; Gallium; Humans; Lymphoma, Non-Hodgkin; Neoplasm Staging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 2004 |
Metabolic rates in small brain nuclei determined by high-resolution PET.
Topics: Adult; Aged; Brain; Equipment Failure Analysis; Female; Fluorodeoxyglucose F18; Glucose; Humans; Image Enhancement; Male; Middle Aged; Nerve Net; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution | 2004 |
Decreased 18F-FDG uptake 1 day after initiation of chemotherapy for malignant lymphomas.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome | 2004 |
18F-FDG PET in patients with esophageal squamous cell carcinoma undergoing curative surgery: prognostic implications.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Disease-Free Survival; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Korea; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Survival Analysis; Treatment Outcome | 2004 |
Diagnosing infection in the failed joint replacement: a comparison of coincidence detection 18F-FDG and 111In-labeled leukocyte/99mTc-sulfur colloid marrow imaging.
Topics: Adult; Aged; Aged, 80 and over; Bacterial Infections; Bone Marrow; Female; Fluorodeoxyglucose F18; Hip Prosthesis; Humans; Image Interpretation, Computer-Assisted; Indium Radioisotopes; Knee Prosthesis; Leukocytes; Male; Middle Aged; Prosthesis-Related Infections; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Technetium Tc 99m Sulfur Colloid | 2004 |
Metabolic response after intraarterial 90Y-glass microsphere treatment for colorectal liver metastases: comparison of quantitative and visual analyses by 18F-FDG PET.
Topics: Aged; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Glass; Humans; Liver Function Tests; Liver Neoplasms; Male; Microspheres; Observer Variation; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Trauma Severity Indices; Treatment Outcome; Yttrium Radioisotopes | 2004 |
FDG-PET is able to detect pancreatic carcinoma in chronic pancreatitis.
Topics: Carcinoma; Chronic Disease; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Pancreatitis; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2005 |
Quantitative brain FDG/PET studies using dynamic aortic imaging.
Topics: Algorithms; Aorta, Abdominal; Brain; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 1994 |
Validation of quantitative accuracy of the post-injection transmission-based and transmissionless attenuation correction techniques in neurological FDG-PET.
Topics: Adult; Algorithms; Brain; Epilepsy; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Injections, Intravenous; Male; Middle Aged; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Scattering, Radiation; Sensitivity and Specificity; Subtraction Technique | 2004 |
Prospective evaluation of FDG-PET for detecting pelvic and para-aortic lymph node metastasis in uterine corpus cancer.
Topics: Aorta; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Pelvis; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Uterine Neoplasms | 2004 |
Semiquantitative analysis of interictal glucose metabolism between generalized epilepsy and localization related epilepsy.
Topics: Adolescent; Brain; Child; Child, Preschool; Epilepsies, Partial; Epilepsy, Generalized; Female; Fluorodeoxyglucose F18; Glucose; Humans; Image Interpretation, Computer-Assisted; Male; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution | 2004 |
Is there a role for FGD-PET in radiotherapy planning in esophageal carcinoma?
Topics: Adult; Aged; Carcinoma; Endosonography; Esophageal Neoplasms; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Patient Care Planning; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2004 |
Addition of 18F-FDG-PET scans to radiotherapy planning of thoracic lymphoma.
Topics: Adolescent; Adult; Aged; Dose Fractionation, Radiation; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Observer Variation; Patient Care Planning; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Thoracic Neoplasms; Tomography, X-Ray Computed | 2004 |
Clinical relevance of imaging proliferative activity in lung nodules.
Topics: Adult; Aged; Aged, 80 and over; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Severity of Illness Index; Solitary Pulmonary Nodule | 2005 |
[Evaluation of positron emission tomography by using F-18-fluorodeoxyglucose in diagnosis of recurrent colorectal cancer].
Topics: Adult; Carcinoma; Colon; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Rectum; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2004 |
Measurement of skeletal muscle glucose utilization by dynamic 18F-FDG PET without arterial blood sampling.
Topics: Adult; Aged; Arteries; Diabetes Mellitus; Female; Fluorodeoxyglucose F18; Glucose; Hip; Humans; Image Interpretation, Computer-Assisted; Insulin Resistance; Male; Middle Aged; Muscle, Skeletal; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thorax | 2005 |
Are dual-phase 18F-FDG PET scans necessary in nasopharyngeal carcinoma to assess the primary tumour and loco-regional nodes?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2005 |
18F-FDG PET for detecting myocardial viability: validation of 3D data acquisition.
Topics: Coronary Artery Disease; Female; Fluorodeoxyglucose F18; Heart Ventricles; Humans; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Ventricular Dysfunction, Left | 2005 |
Solid splenic masses: evaluation with 18F-FDG PET/CT.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Splenic Neoplasms; Subtraction Technique; Tomography, X-Ray Computed | 2005 |
Pitfalls in lymph node staging with positron emission tomography in non-small cell lung cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2005 |
18F-FDG and 11C-methionine PET for evaluation of treatment response of lung cancer after stereotactic radiotherapy.
Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Lung Neoplasms; Male; Methionine; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiosurgery; Reproducibility of Results; Sensitivity and Specificity; Solitary Pulmonary Nodule; Treatment Outcome | 2004 |
The value of PET, CT and in-line PET/CT in patients with gastrointestinal stromal tumours: long-term outcome of treatment with imatinib mesylate.
Topics: Adult; Aged; Antineoplastic Agents; Benzamides; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gastrointestinal Neoplasms; Humans; Imatinib Mesylate; Longitudinal Studies; Male; Middle Aged; Piperazines; Positron-Emission Tomography; Prognosis; Pyrimidines; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Survival Analysis; Switzerland; Tomography, X-Ray Computed; Treatment Outcome | 2005 |
Application of intravenous contrast in PET/CT: does it really introduce significant attenuation correction error?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Artifacts; Contrast Media; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Injections, Intravenous; Iopamidol; Male; Middle Aged; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2005 |
Does diabetes mellitus influence the efficacy of FDG-PET in the diagnosis of cervical cancer?
Topics: Adult; Aged; Aged, 80 and over; Artifacts; Diabetes Complications; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Uterine Cervical Neoplasms | 2005 |
Diagnostic value of FDG PET and salivary gland scintigraphy for parotid tumors.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Parotid Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2005 |
FDG PET as a procedure for detecting simultaneous tumours in head and neck cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasms, Multiple Primary; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Whole-Body Counting | 2005 |
Visual and semiquantitative analyses for F-18 fluorodeoxyglucose PET scanning in pulmonary nodules 1 cm to 3 cm in size.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity | 2005 |
The value of [18F]FDG-PET in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Severity of Illness Index; Single-Blind Method; Takayasu Arteritis | 2005 |
Comparison of 18F-FLT PET and 18F-FDG PET in esophageal cancer.
Topics: Aged; Dideoxynucleosides; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2005 |
The value of 18F-FDG PET in the detection of stage M0 carcinoma of the nasopharynx.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Severity of Illness Index; Single-Blind Method; Whole-Body Counting | 2005 |
Optimized intravenous contrast administration for diagnostic whole-body 18F-FDG PET/CT.
Topics: Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Injections, Intravenous; Male; Middle Aged; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed; Whole-Body Counting | 2005 |
The diabetic foot: initial experience with 18F-FDG PET/CT.
Topics: Adult; Aged; Diabetic Foot; Female; Fluorodeoxyglucose F18; Foot; Humans; Male; Middle Aged; Osteomyelitis; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2005 |
Value of delayed 18F-FDG-PET imaging in the detection of hepatocellular carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Injections, Intravenous; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Time Factors | 2005 |
[Large vessel vasculitis as cause of fever of unknown origin (FUO) or systemic inflammation. Diagnosis using 18-F-fluor-2-deoxy-D-glucose positron emission tomography ((18)F-FDG-PET)].
Topics: Adult; Aged; Diagnostic Errors; Female; Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radionuclide Angiography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Systemic Inflammatory Response Syndrome; Vasculitis | 2005 |
Effects of ROI definition and reconstruction method on quantitative outcome and applicability in a response monitoring trial.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Outcome Assessment, Health Care; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; ROC Curve; Sensitivity and Specificity | 2005 |
Comparison of CT, MRI and FDG-PET in response prediction of patients with locally advanced rectal cancer after multimodal preoperative therapy: is there a benefit in using functional imaging?
Topics: Adenocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Rectal Neoplasms; Rectum; Sensitivity and Specificity; Tomography, X-Ray Computed | 2005 |
Optimizing imaging protocols for overweight and obese patients: a lutetium orthosilicate PET/CT study.
Topics: Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Lutetium; Male; Middle Aged; Neoplasms; Obesity; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Severity of Illness Index; Silicates; Subtraction Technique; Tomography, X-Ray Computed | 2005 |
Glucose metabolism in brain tumours can be estimated using [18F]2-fluorodeoxyglucose positron emission tomography and a population-derived input function scaled using a single arterialised venous blood sample.
Topics: Arteries; Brain Neoplasms; Fluorodeoxyglucose F18; Glioma; Glucose; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Reference Values; Reproducibility of Results; Sensitivity and Specificity | 2005 |
Comparison of 99mTc-sestamibi/18FDG DISA SPECT with PET for the detection of viability in patients with coronary artery disease and left ventricular dysfunction.
Topics: Adult; Aged; Aged, 80 and over; Coronary Artery Disease; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Male; Middle Aged; Myocardial Stunning; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2005 |
Detectability of liver metastases in malignant melanoma: prospective comparison of magnetic resonance imaging and positron emission tomography.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Enhancement; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Melanins; Melanoma; Middle Aged; Positron-Emission Tomography; Prospective Studies; Reproducibility of Results; Sensitivity and Specificity | 2005 |
FDG PET is superior to CT in the prediction of viable tumour in post-chemotherapy seminoma residuals.
Topics: Abdomen; Adult; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm, Residual; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiographic Image Enhancement; Radiography, Abdominal; Radiography, Thoracic; Radiopharmaceuticals; Seminoma; Sensitivity and Specificity; Testicular Neoplasms; Thorax; Tomography, Spiral Computed | 2005 |
The additional value of PET/CT over PET in FDG imaging of oesophageal cancer.
Topics: Adult; Aged; Aged, 80 and over; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2005 |
Detection of recurrent pancreatic cancer: comparison of FDG-PET with CT/MRI.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Pancreatic Neoplasms; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2005 |
Increased fluorine-18 2-fluoro-2-deoxy-D-glucose (FDG) uptake in childhood CNS tumors is correlated with malignancy grade: a study with FDG positron emission tomography/magnetic resonance imaging coregistration and image fusion.
Topics: Adolescent; Brain Neoplasms; Child; Child, Preschool; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Infant; Infant, Newborn; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Regional Blood Flow; Sensitivity and Specificity | 2005 |
Detection of residual tumor after radiofrequency ablation of liver metastasis with dual-modality PET/CT: initial results.
Topics: Aged; Catheter Ablation; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Iohexol; Liver; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2006 |
Staging of untreated squamous cell carcinoma of buccal mucosa with 18F-FDG PET: comparison with head and neck CT/MRI and histopathology.
Topics: Adult; Carcinoma, Squamous Cell; Case-Control Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Mouth Mucosa; Mouth Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2005 |
Efficiency of 18F-FDG and 99mTc-depreotide SPECT in the diagnosis of malignancy of solitary pulmonary nodules.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; France; Humans; Lung Neoplasms; Male; Middle Aged; Organotechnetium Compounds; Pilot Projects; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Severity of Illness Index; Solitary Pulmonary Nodule; Somatostatin; Tomography, Emission-Computed, Single-Photon | 2005 |
(18)F-FDG PET/CT in the evaluation of recurrent ovarian cancer: a prospective study on forty-one patients.
Topics: Adult; Aged; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2005 |
Value of 111In-DOTA-lanreotide and 111In-DOTA-DPhe1-Tyr3-octreotide in differentiated thyroid cancer: results of in vitro binding studies and in vivo comparison with 18F-FDG PET.
Topics: Adult; Aged; Cell Line, Tumor; Female; Fluorodeoxyglucose F18; Heterocyclic Compounds; Humans; Male; Metabolic Clearance Rate; Middle Aged; Octreotide; Peptides, Cyclic; Positron-Emission Tomography; Protein Binding; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thyroid Neoplasms | 2005 |
PET/CT with intravenous contrast can be used for PET attenuation correction in cancer patients.
Topics: Adult; Aged; Artifacts; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Injections, Intravenous; Iothalamic Acid; Male; Middle Aged; Neoplasms; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Single-Blind Method; Subtraction Technique; Tomography, X-Ray Computed | 2005 |
Accuracy of cardiac PET imaging using post-injection transmission scan.
Topics: Adult; Aged; Aged, 80 and over; Coronary Artery Disease; Female; Fluorodeoxyglucose F18; Heart; Humans; Image Enhancement; Injections, Intravenous; Male; Middle Aged; Myocardial Infarction; Nitrogen Radioisotopes; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Time Factors; Ventricular Dysfunction, Left | 2005 |
The effect of oral contrast on large bowel activity in FDG-PET/CT.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Artifacts; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Intestine, Large; Male; Metabolic Clearance Rate; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tissue Distribution; Tomography, X-Ray Computed | 2005 |
Diagnostic accuracy of FDG PET imaging for the detection of recurrent or metastatic gynecologic cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2005 |
Oral contrast medium in PET/CT: should you or shouldn't you?
Topics: Abdominal Neoplasms; Administration, Oral; Artifacts; Contrast Media; Diatrizoate Meglumine; Female; Fluorodeoxyglucose F18; Humans; Male; Pelvic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2005 |
Metabolic (FDG-PET) response after radical radiotherapy/chemoradiotherapy for non-small cell lung cancer correlates with patterns of failure.
Topics: Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Survival Analysis | 2005 |
FDG-PET in the prediction of pathologic response after neoadjuvant chemoradiotherapy in locally advanced, resectable esophageal cancer.
Topics: Aged; Chemotherapy, Adjuvant; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy, Adjuvant; Sensitivity and Specificity; Treatment Outcome | 2005 |
Incremental value of fusion imaging with integrated PET-CT in oncology.
Topics: Fluorodeoxyglucose F18; Humans; Image Enhancement; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2005 |
Early restaging whole-body (18)F-FDG PET during induction chemotherapy predicts clinical outcome in patients with locoregionally advanced nasopharyngeal carcinoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Survival Analysis; Survival Rate; Taiwan; Treatment Outcome; Whole Body Imaging | 2005 |
Positron emission tomography with 18F-fluoro-2-deoxyglucose for the detection of recurrent ovarian cancer.
Topics: Adult; Aged; CA-125 Antigen; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2005 |
Early prediction of response to chemotherapy in metastatic breast cancer using sequential 18F-FDG PET.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Cyclophosphamide; Epirubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Paclitaxel; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Treatment Outcome | 2005 |
Detection of Klatskin's tumor in extrahepatic bile duct strictures using delayed 18F-FDG PET/CT: preliminary results for 22 patient studies.
Topics: Adult; Aged; Bile Duct Neoplasms; Female; Fluorodeoxyglucose F18; Hepatic Duct, Common; Humans; Image Interpretation, Computer-Assisted; Klatskin Tumor; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2005 |
Optimised PET reconstruction of the head and neck area: improved diagnostic accuracy.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2005 |
Association of vascular 18F-FDG uptake with vascular calcification.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arteriosclerosis; Calcinosis; Child; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Vascular Diseases | 2005 |
Synchronous primary neoplasms detected on 18F-FDG PET in staging of patients with esophageal cancer.
Topics: Aged; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Incidence; Incidental Findings; Male; Middle Aged; Neoplasm Staging; Neoplasms, Multiple Primary; Netherlands; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity | 2005 |
Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-Small cell lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Patient Selection; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Reproducibility of Results; Sensitivity and Specificity | 2005 |
Focal lung uptake of 18F-fluorodeoxyglucose (18F-FDG) without computed tomography findings.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lung; Middle Aged; Positron-Emission Tomography; Pulmonary Embolism; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2005 |
Hexokinase-II expression in untreated oral squamous cell carcinoma: comparison with FDG PET imaging.
Topics: Adult; Aged; Biomarkers, Tumor; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Hexokinase; Humans; Male; Middle Aged; Mouth Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic | 2005 |
Respiratory motion artefact in the liver dome on FDG PET/CT: comparison of attenuation correction with CT and a caesium external source.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Artifacts; Cesium Radioisotopes; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Liver Neoplasms; Male; Middle Aged; Movement; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Respiratory Mechanics; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2005 |
Pitfalls of FDG-PET for the diagnosis of osteoblastic bone metastases in patients with breast cancer.
Topics: Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Osteoblasts; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Medronate | 2005 |
Diagnostic performance and prognostic impact of FDG-PET in suspected recurrence of surgically treated non-small cell lung cancer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Germany; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Survival Rate; Treatment Outcome | 2006 |
18F-FDG PET/CT for staging of penile cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Penile Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Severity of Illness Index; Subtraction Technique; Tomography, X-Ray Computed | 2005 |
Potential novel application of dual time point SUV measurements as a predictor of survival in head and neck cancer.
Topics: Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Survival Analysis; Survival Rate; United Kingdom | 2005 |
Evaluation of delayed additional FDG PET imaging in patients with pancreatic tumour.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Male; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Time Factors | 2005 |
The prognostic value of FDG PET in head and neck cancer. Correlation with histopathology.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Cisplatin; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Treatment Outcome | 2005 |
Feasibility of [18F]FDG-PET and coregistered CT on clinical target volume definition of advanced non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2005 |
Blood flow-metabolic relationships are dependent on tumour size in non-small cell lung cancer: a study using quantitative contrast-enhanced computer tomography and positron emission tomography.
Topics: Blood Flow Velocity; Contrast Media; Female; Fluorodeoxyglucose F18; Glucose; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Neovascularization, Pathologic; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Severity of Illness Index; Statistics as Topic; Tomography, X-Ray Computed | 2006 |
Application of an objective method for localizing bilateral cortical FDG PET abnormalities to guide the resection of epileptic foci.
Topics: Adolescent; Adult; Algorithms; Brain; Child, Preschool; Epilepsy; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Infant; Male; Pattern Recognition, Automated; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Surgery, Computer-Assisted | 2005 |
Etiology of solitary extrapulmonary positron emission tomography and computed tomography findings in patients with lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2005 |
Lymph node staging of gastric cancer using (18)F-FDG PET: a comparison study with CT.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Gastrectomy; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Stomach Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2005 |
Prediction of individual clinical outcome in MCI by means of genetic assessment and (18)F-FDG PET.
Topics: Aged; Alzheimer Disease; Apolipoproteins E; Cognition Disorders; Female; Fluorodeoxyglucose F18; Genetic Predisposition to Disease; Genetic Testing; Humans; Male; Phenotype; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity | 2005 |
Rapid scanning protocol for brain (18)F-FDG PET: a validation study.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Artificial Intelligence; Brain; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Time Factors | 2005 |
Glucose-normalized standardized uptake value from (18)F-FDG PET in classifying lymphomas.
Topics: Female; Fluorodeoxyglucose F18; Glucose; Hodgkin Disease; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reference Values; Reproducibility of Results; Sensitivity and Specificity; Severity of Illness Index | 2005 |
18FDG-positron emission tomography in post treatment evaluation of residual mass in Hodgkin's lymphoma: long-term results.
Topics: Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm, Residual; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2005 |
Usefulness of noise adaptive non-linear gaussian filter in FDG-PET study.
Topics: Adult; Aged; Algorithms; Computer Simulation; Female; Filtration; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Male; Middle Aged; Models, Biological; Models, Statistical; Neoplasms; Normal Distribution; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Signal Processing, Computer-Assisted; Stochastic Processes | 2005 |
Contribution of whole body FDG-PET to the detection of distant metastasis in pancreatic cancer.
Topics: Adult; Aged; Bone Neoplasms; Carcinoma, Pancreatic Ductal; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Whole-Body Counting | 2005 |
Potential of dual-time-point imaging to improve breast cancer diagnosis with (18)F-FDG PET.
Topics: Adult; Aged; Breast Neoplasms; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Time Factors | 2005 |
Comparison of 18FDG-PET with 99mTc-HMDP scintigraphy for the detection of bone metastases in patients with breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Medronate; Whole Body Imaging | 2005 |
Findings on 18F-FDG PET scans after neoadjuvant chemoradiation provides prognostic stratification in patients with locally advanced rectal carcinoma subsequently treated by radical surgery.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy, Adjuvant; Rectal Neoplasms; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Survival Analysis; Survival Rate; Treatment Outcome | 2006 |
Prognostic relevance of FDG PET in patients with neurofibromatosis type-1 and malignant peripheral nerve sheath tumours.
Topics: Adolescent; Adult; Comorbidity; Female; Fluorodeoxyglucose F18; Germany; Humans; Male; Middle Aged; Nerve Sheath Neoplasms; Neurofibromatosis 1; Outcome Assessment, Health Care; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Survival Rate | 2006 |
PET imaging of brain astrocytoma with 1-11C-acetate.
Topics: Acetates; Adult; Astrocytoma; Brain Neoplasms; Carbon; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2006 |
PET evaluation of fatty tumors in the extremity: possibility of using the standardized uptake value (SUV) to differentiate benign tumors from liposarcoma.
Topics: Adult; Aged; Diagnosis, Differential; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Lipoma; Liposarcoma; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Tyrosine | 2005 |
Evaluation of tumor FDG transport and metabolism in primary central nervous system lymphoma using [18F]fluorodeoxyglucose (FDG) positron emission tomography (PET) kinetic analysis.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biological Transport, Active; Brain Neoplasms; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Kinetics; Lymphoma; Male; Metabolic Clearance Rate; Middle Aged; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Vincristine | 2005 |
The impact of FDG-PET in the management of patients with salivary gland malignancy.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Salivary Gland Neoplasms; Sensitivity and Specificity | 2005 |
Role of 18F-FDG PET/CT in the assessment of bone involvement in newly diagnosed multiple myeloma: preliminary results.
Topics: Adult; Aged; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Myeloma; Pilot Projects; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2006 |
Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington's disease.
Topics: Adult; Atrophy; Brain; Cohort Studies; Female; Fluorodeoxyglucose F18; Glucose Metabolism Disorders; Humans; Huntington Disease; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Nerve Fibers, Myelinated; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity | 2006 |
18F-FET PET compared with 18F-FDG PET and CT in patients with head and neck cancer.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasms, Squamous Cell; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Tyrosine | 2006 |
Standard PET/CT of the chest during shallow breathing is inadequate for comprehensive staging of lung cancer.
Topics: Artifacts; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiography, Thoracic; Radiopharmaceuticals; Reproducibility of Results; Respiratory Mechanics; Sensitivity and Specificity; Solitary Pulmonary Nodule; Subtraction Technique; Thorax | 2006 |
Fluorodeoxyglucose-positron emission tomography/computed tomography imaging in patients with carcinoma of the larynx: diagnostic accuracy and impact on clinical management.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2006 |
Significant clinical impact and prognostic stratification provided by FDG-PET in the staging of oesophageal cancer.
Topics: Adult; Aged; Aged, 80 and over; Australia; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Middle Aged; Outcome Assessment, Health Care; Positron-Emission Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Survival Analysis; Survival Rate; Treatment Outcome | 2006 |
Fully automatic diagnostic system for early- and late-onset mild Alzheimer's disease using FDG PET and 3D-SSP.
Topics: Age of Onset; Aged; Algorithms; Alzheimer Disease; Brain; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Severity of Illness Index | 2006 |
Utility of preoperative [(18)]f fluorodeoxyglucose-positron emission tomography scanning in high-risk melanoma patients.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Middle Aged; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Skin Neoplasms; Tomography, Emission-Computed | 2006 |
Improved staging with pretreatment positron emission tomography/computed tomography in low rectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Rectal Neoplasms; Sensitivity and Specificity; Tomography, X-Ray Computed | 2006 |
Effect of left ventricular function on diagnostic accuracy of FDG SPECT.
Topics: Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocardial Infarction; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Severity of Illness Index; Stroke Volume; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2006 |
18F-FDG accumulation in atherosclerosis: use of CT and MR co-registration of thoracic and carotid arteries.
Topics: Aged; Aged, 80 and over; Atherosclerosis; Carotid Arteries; Fluorodeoxyglucose F18; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Thoracic Arteries; Tomography, X-Ray Computed | 2006 |
Integrated positron emission tomography and magnetic resonance imaging-guided resection of brain tumors: a report of 103 consecutive procedures.
Topics: Adolescent; Adult; Aged; Brain Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Infant; Magnetic Resonance Imaging; Male; Methionine; Middle Aged; Neuronavigation; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2006 |
Low efficacy of 18F-FDG PET for detection of uveal malignant melanoma compared with 123I-IMP SPECT.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Iofetamine; Male; Melanoma; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Uveal Neoplasms | 2006 |
Optimized contrast-enhanced CT protocols for diagnostic whole-body 18F-FDG PET/CT: technical aspects of single-phase versus multiphase CT imaging.
Topics: Artifacts; Biotechnology; Contrast Media; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Iohexol; Male; Middle Aged; Neoplasms; Positron-Emission Tomography; Reproducibility of Results; Respiration; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed; Whole Body Imaging | 2006 |
Accuracy of transmission CT and FDG-PET in the detection of small pulmonary nodules with integrated PET/CT.
Topics: Adolescent; Adult; Child; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Solitary Pulmonary Nodule; Subtraction Technique; Systems Integration; Tomography, X-Ray Computed | 2006 |
Prediction of functional recovery after revascularization in patients with chronic ischaemic left ventricular dysfunction: head-to-head comparison between 99mTc-sestamibi/18F-FDG DISA SPECT and 13N-ammonia/ 18F-FDG PET.
Topics: Aged; Ammonium Chloride; Coronary Artery Bypass; Coronary Artery Disease; Female; Fluorodeoxyglucose F18; Humans; Male; Nitrogen Radioisotopes; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Recovery of Function; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Ventricular Dysfunction, Left | 2006 |
FDG-PET status following chemoradiotherapy provides high management impact and powerful prognostic stratification in oesophageal cancer.
Topics: Adult; Aged; Aged, 80 and over; Australia; Combined Modality Therapy; Drug Therapy; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Middle Aged; Outcome Assessment, Health Care; Positron-Emission Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Radiotherapy; Reproducibility of Results; Sensitivity and Specificity; Survival Analysis; Survival Rate; Treatment Outcome | 2006 |
Cancer screening with FDG-PET.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Incidence; Japan; Male; Middle Aged; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Whole Body Imaging | 2006 |
Clinical impact of fluorine-18 fluorodeoxyglucose positron emission tomography in cancer patients. A comparative study between dedicated camera and dual-head coincidence gamma camera.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Equipment Design; Equipment Failure Analysis; Female; Fluorodeoxyglucose F18; France; Gamma Cameras; Humans; Incidence; Male; Middle Aged; Neoplasms; Positron-Emission Tomography; Practice Patterns, Physicians'; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2006 |
Traditional versus up-front [18F] fluorodeoxyglucose-positron emission tomography staging of non-small-cell lung cancer: a Dutch cooperative randomized study.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Health Care Costs; Humans; Lung Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Time Factors | 2006 |
Disease activity and 18F-FDG uptake in organising pneumonia: semi-quantitative evaluation using computed tomography and positron emission tomography.
Topics: Adult; Cryptogenic Organizing Pneumonia; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Severity of Illness Index; Subtraction Technique; Tomography, X-Ray Computed | 2006 |
Comparative assessment of 18F-fluorodeoxyglucose PET and 99mTc-tetrofosmin SPECT for the prediction of functional recovery in patients with reperfused acute myocardial infarction.
Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Reperfusion; Organophosphorus Compounds; Organotechnetium Compounds; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Recovery of Function; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Ventricular Dysfunction, Left | 2006 |
Fluorine-18-fluorodeoxyglucose positron emission tomography for assessment of patients with unresectable recurrent or metastatic lung cancers after CT-guided radiofrequency ablation: preliminary results.
Topics: Adult; Aged; Aged, 80 and over; Catheter Ablation; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Surgery, Computer-Assisted; Tomography, X-Ray Computed; Treatment Outcome | 2006 |
Advantages and pitfalls of 18F-fluoro-2-deoxy-D-glucose positron emission tomography in detecting locally residual or recurrent nasopharyngeal carcinoma: comparison with magnetic resonance imaging.
Topics: Adult; Brachytherapy; Diagnostic Errors; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity | 2006 |
Breast imaging. Preoperative breast cancer staging: comparison of USPIO-enhanced MR imaging and 18F-fluorodeoxyglucose (FDC) positron emission tomography (PET) imaging for axillary lymph node staging--initial findings.
Topics: Adult; Aged; Axilla; Bayes Theorem; Breast Neoplasms; Contrast Media; Dextrans; Female; Ferrosoferric Oxide; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Image Processing, Computer-Assisted; Iron; Lymph Node Excision; Lymphatic Metastasis; Magnetic Resonance Imaging; Magnetite Nanoparticles; Middle Aged; Neoplasm Staging; Oxides; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2006 |
FDG PET for the assessment of myometrial infiltration in clinical stage I uterine corpus cancer.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Myometrium; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Uterine Neoplasms | 2006 |
Characterization of radiologically indeterminate lung lesions: 99mTc-depreotide SPECT versus 18F-FDG PET.
Topics: Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Organotechnetium Compounds; Positron-Emission Tomography; Prospective Studies; Radiography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Somatostatin; Tomography, Emission-Computed, Single-Photon | 2006 |
Prognostic value of FDG-PET in patients with ovarian carcinoma following surgical treatment.
Topics: Female; Fluorodeoxyglucose F18; Humans; Incidence; Japan; Longitudinal Studies; Ovarian Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Survival; Survival Rate; Treatment Outcome | 2006 |
Different histopathological subtypes of Hodgkin lymphoma show significantly different levels of FDG uptake.
Topics: Adult; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymph Nodes; Male; Middle Aged; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Sensitivity and Specificity | 2006 |
The added value of metabolic imaging with FDG-PET in oesophageal cancer: prognostic role and prediction of response to treatment.
Topics: Adult; Aged; Aged, 80 and over; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Outcome Assessment, Health Care; Positron-Emission Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome | 2006 |
18F-FDOPA PET imaging of brain tumors: comparison study with 18F-FDG PET and evaluation of diagnostic accuracy.
Topics: Adult; Aged; Brain Neoplasms; California; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2006 |
Comparison of image-derived and arterial input functions for estimating the rate of glucose metabolism in therapy-monitoring 18F-FDG PET studies.
Topics: Adult; Aged; Arteries; Blood Glucose; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Neoplasms; Outcome Assessment, Health Care; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Therapy, Computer-Assisted; Treatment Outcome | 2006 |
FDG-PET and CT patterns of bone metastases and their relationship to previously administered anti-cancer therapy.
Topics: Adult; Aged; Antineoplastic Agents; Bone and Bones; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2006 |
Necessity of a uniform start for scanning after FDG injection in brain PET study.
Topics: Adult; Artifacts; Brain; Fluorodeoxyglucose F18; Humans; Image Enhancement; Injections, Intraventricular; Male; Metabolic Clearance Rate; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Time Factors | 2006 |
Correlative imaging strategies implementing CT, MRI, and PET for staging of childhood Hodgkin disease.
Topics: Adolescent; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2006 |
Dual time point 18F-FDG PET imaging detects breast cancer with high sensitivity and correlates well with histologic subtypes.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Radiographic Image Enhancement; Radiographic Image Interpretation, Computer-Assisted; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Subtraction Technique | 2006 |
Differential roles of 18F-FDG PET in patients with locoregional advanced nasopharyngeal carcinoma after primary curative therapy: response evaluation and impact on management.
Topics: Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Outcome Assessment, Health Care; Positron-Emission Tomography; Practice Patterns, Physicians'; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2006 |
Early FDG-PET assessment in combination with clinical risk scores determines prognosis in recurring lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Remission Induction; Risk Factors; Sensitivity and Specificity; Survival Rate; Transplantation, Autologous; Treatment Outcome | 2007 |
Pre-surgical identification of epileptogenic areas in temporal lobe epilepsy by 123I-iomazenil SPECT: a comparison with IMP SPECT and FDG PET.
Topics: Adolescent; Adult; Epilepsy, Temporal Lobe; Female; Flumazenil; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Iofetamine; Male; Positron-Emission Tomography; Preoperative Care; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 2006 |
Role of [18F]FDG PET/CT in the assessment of suspected recurrent ovarian cancer: correlation with clinical or histological findings.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Population Surveillance; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Subtraction Technique; Systems Integration; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
Post-therapy surveillance of patients with uterine cancers: value of integrated FDG PET/CT in the detection of recurrence.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Population Surveillance; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Systems Integration; Tomography, X-Ray Computed; Treatment Outcome; Uterine Neoplasms | 2007 |
Changing patterns of abnormal vascular wall F-18 fluorodeoxyglucose uptake on follow-up PET/CT studies.
Topics: Aged; Aged, 80 and over; Calcinosis; Coronary Artery Disease; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tissue Distribution; Tomography, X-Ray Computed | 2006 |
PET for staging in rhabdomyosarcoma: an evaluation of PET as an adjunct to current staging tools.
Topics: Adolescent; Adult; Child; Child, Preschool; Evaluation Studies as Topic; Female; Fluorodeoxyglucose F18; Humans; Infant; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Rhabdomyosarcoma; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
The utility of positron emission tomography in staging of potentially operable carcinoma of the thoracic esophagus: results of the American College of Surgeons Oncology Group Z0060 trial.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Biopsy, Needle; Carcinoma; Confidence Intervals; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Risk Assessment; Sensitivity and Specificity; Sex Factors; Survival Rate; Thoracotomy | 2007 |
Interpretation, accuracy and management implications of FDG PET/CT in cutaneous malignant melanoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Skin Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
Importance of [18F]fluorodeoxyglucose-positron emission tomography scanning for the monitoring of responses to immunotherapy in follicular lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cancer Vaccines; Combined Modality Therapy; Dendritic Cells; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Immunotherapy; Lymphoma, Follicular; Male; Middle Aged; Neoplasm, Residual; Prognosis; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Survival Rate; Tissue Distribution; Tomography, X-Ray Computed | 2007 |
Nonrigid image registration for head and neck cancer radiotherapy treatment planning with PET/CT.
Topics: Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2007 |
Potential role of FDG PET in the setting of diabetic neuro-osteoarthropathy: can it differentiate uncomplicated Charcot's neuroarthropathy from osteomyelitis and soft-tissue infection?
Topics: Adult; Aged; Arthropathy, Neurogenic; Diabetic Foot; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Osteomyelitis; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Soft Tissue Infections | 2007 |
A novel iterative method for lesion delineation and volumetric quantification with FDG PET.
Topics: Aged; Calibration; Colorectal Neoplasms; Feasibility Studies; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Liver Neoplasms; Middle Aged; Models, Biological; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tumor Burden | 2007 |
Time course of early response to chemotherapy in non-small cell lung cancer patients with 18F-FDG PET/CT.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Carboplatin; Carcinoma, Non-Small-Cell Lung; Docetaxel; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Taxoids; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
18F-FDG PET/CT delayed images after diuretic for restaging invasive bladder cancer.
Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Urinary Bladder Neoplasms | 2007 |
18F-FDG PET scanning correlates with tissue markers of poor prognosis and predicts mortality for patients after liver resection for colorectal metastases.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Hepatectomy; Humans; Incidence; Liver Neoplasms; Male; Middle Aged; New York; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Survival Rate; Treatment Outcome | 2007 |
[11C] methionine and [18F] fluorodeoxyglucose PET in the follow-up of glioblastoma multiforme.
Topics: Brain Neoplasms; Carbon Radioisotopes; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glioblastoma; Humans; Kaplan-Meier Estimate; Magnetic Resonance Imaging; Male; Methionine; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Survival Rate | 2007 |
Sequential FDG-PET/CT reliably predicts response of locally advanced rectal cancer to neo-adjuvant chemo-radiation therapy.
Topics: Adult; Aged; Aged, 80 and over; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy, Adjuvant; Rectal Neoplasms; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
Prospective comparison of two gamma probes for intraoperative detection of 18F-FDG: in vitro assessment and clinical evaluation in differentiated thyroid cancer patients with iodine-negative recurrence.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Intraoperative Care; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Surgery, Computer-Assisted; Thyroid Neoplasms; Treatment Outcome | 2007 |
[18F]FDG-PET predicts complete pathological response of breast cancer to neoadjuvant chemotherapy.
Topics: Antineoplastic Agents; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome | 2007 |
Diagnostic accuracy of 18F-FDG PET/CT in characterizing ovarian lesions and staging ovarian cancer: correlation with transvaginal ultrasonography, computed tomography, and histology.
Topics: Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Staging; Ovarian Diseases; Ovarian Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography, Doppler, Color | 2007 |
18fluorodeoxyglucose positron emission tomography in the prediction of relapse in patients with high-risk, clinical stage I nonseminomatous germ cell tumors: preliminary report of MRC Trial TE22--the NCRI Testis Tumour Clinical Study Group.
Topics: Adolescent; Adult; Biopsy, Needle; Chemotherapy, Adjuvant; Combined Modality Therapy; Disease-Free Survival; Fluorodeoxyglucose F18; Germinoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Orchiectomy; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Risk Assessment; Salvage Therapy; Sensitivity and Specificity; Survival Analysis; Testicular Neoplasms | 2007 |
The additional value of FDG PET imaging for distinguishing N0 or N1 from N2 stage in preoperative staging of non-small cell lung cancer in region where the prevalence of inflammatory lung disease is high.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prevalence; Prognosis; Radiography; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity | 2007 |
Chemotherapy response evaluation with 18F-FDG PET in patients with non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Netherlands; Positron-Emission Tomography; Prognosis; Reproducibility of Results; Sensitivity and Specificity; Survival Analysis; Survival Rate; Treatment Outcome | 2007 |
Cervical lymph node metastases of unknown origin: primary tumor detection with whole-body positron emission tomography/computed tomography.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neck; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
CT and PET: early prognostic indicators of response to imatinib mesylate in patients with gastrointestinal stromal tumor.
Topics: Antineoplastic Agents; Benzamides; Female; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Male; Pilot Projects; Piperazines; Positron-Emission Tomography; Prognosis; Pyrimidines; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome; United States | 2007 |
Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for d
Topics: Adult; Aged; Breast Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasms, Hormone-Dependent; Positron-Emission Tomography; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Sensitivity and Specificity; Tomography, Emission-Computed | 2008 |
Role of 18F-fluorodeoxyglucose positron emission tomography imaging in surgery for pancreatic cancer.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Sensitivity and Specificity | 2008 |
Basal ganglia involvement in temporal lobe epilepsy: a functional and morphologic study.
Topics: Adolescent; Adult; Basal Ganglia; Basal Ganglia Diseases; Dihydroxyphenylalanine; Dopamine; Down-Regulation; Energy Metabolism; Epilepsy, Temporal Lobe; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Neostriatum; Neural Pathways; Positron-Emission Tomography; Predictive Value of Tests; Sensitivity and Specificity; Substantia Nigra | 2008 |
Evaluation of response to fractionated radioimmunotherapy with 90Y-epratuzumab in non-Hodgkin's lymphoma by 18F-fluorodeoxyglucose positron emission tomography.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antigens, Neoplasm; Disease Progression; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radioimmunotherapy; Radiopharmaceuticals; Salvage Therapy; Sensitivity and Specificity; Sialic Acid Binding Ig-like Lectin 2; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2008 |
The yield of endoscopic ultrasound in lung cancer staging: does lymph node size matter?
Topics: Adult; Aged; Aged, 80 and over; Biopsy, Fine-Needle; Endosonography; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Early prediction of therapy outcome in patients with high-risk soft tissue sarcoma using positron emission tomography.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Etoposide; Female; Fluorodeoxyglucose F18; Humans; Ifosfamide; Male; Middle Aged; Outcome Assessment, Health Care; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sarcoma; Sensitivity and Specificity; Treatment Outcome | 2008 |
Positron emission tomography/computed tomography and whole-body magnetic resonance imaging in staging of advanced nonsmall cell lung cancer--initial results.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Contrast Media; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Enhancement; Iohexol; Lung; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Observer Variation; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2008 |
[18F]-FDG-PET in clinical stage I/II non-seminomatous germ cell tumours: results of the German multicentre trial.
Topics: Adolescent; Adult; Fluorodeoxyglucose F18; Germany; Humans; Lymph Node Excision; Lymph Nodes; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Risk Assessment; Sensitivity and Specificity; Testicular Neoplasms; Tomography, X-Ray Computed | 2008 |
Clinical influence of 18F-fluorodeoxyglucose positron emission tomography on the management of primary tumours of the thymus.
Topics: Adult; Aged; Aged, 80 and over; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thymus Neoplasms | 2008 |
Diagnostic impact of 18F-FDG PET-CT evaluating solid pancreatic lesions versus endosonography, endoscopic retrograde cholangio-pancreatography with intraductal ultrasonography and abdominal ultrasound.
Topics: Adult; Aged; Aged, 80 and over; Cholangiopancreatography, Endoscopic Retrograde; Endoscopy, Digestive System; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed; Ultrasonography | 2008 |
RadioimmunoPET: detection of colorectal carcinoma with positron-emitting copper-64-labeled monoclonal antibody.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Animals; Colorectal Neoplasms; Copper Radioisotopes; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Predictive Value of Tests; Radiation Dosage; Radioimmunodetection; Rats; Rats, Sprague-Dawley; Sensitivity and Specificity; Tomography, Emission-Computed | 1995 |
HMPAO SPET and FDG PET in Alzheimer's disease and vascular dementia: comparison of perfusion and metabolic pattern.
Topics: Aged; Aging; Alzheimer Disease; Brain; Cerebrovascular Circulation; Dementia, Vascular; Deoxyglucose; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Male; Organotechnetium Compounds; Oximes; ROC Curve; Sensitivity and Specificity; Technetium Tc 99m Exametazime; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1994 |
Semiquantitative and visual analysis of FDG-PET images in pulmonary abnormalities.
Topics: Deoxyglucose; Diagnosis, Differential; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung; Lung Neoplasms; Prospective Studies; ROC Curve; Sensitivity and Specificity; Tomography, Emission-Computed | 1994 |
Whole-body 18F-fluorodeoxyglucose positron emission tomography in preoperative evaluation of lung cancer.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Deoxyglucose; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasm Staging; Preoperative Care; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 1994 |
Positron emission tomography to stage suspected metastatic colorectal carcinoma to the liver.
Topics: Colorectal Neoplasms; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1996 |
[Cancer detection with whole-body FDG PET images without attenuation correction].
Topics: Adult; Aged; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms; Sensitivity and Specificity; Tomography, Emission-Computed | 1996 |
Predictive value of low dose dobutamine transesophageal echocardiography and fluorine-18 fluorodeoxyglucose positron emission tomography for recovery of regional left ventricular function after successful revascularization.
Topics: Adrenergic beta-Agonists; Deoxyglucose; Dobutamine; Echocardiography, Transesophageal; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Heart; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Predictive Value of Tests; Prospective Studies; Sensitivity and Specificity; Time Factors; Tomography, Emission-Computed; Ventricular Dysfunction, Left; Ventricular Function, Left | 1996 |
Dissociation of neutrophil emigration and metabolic activity in lobar pneumonia and bronchiectasis.
Topics: Adult; Aged; Bronchiectasis; Cell Movement; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glucose; Granulocytes; Humans; Iodine Radioisotopes; Male; Middle Aged; Neutrophils; Pneumonia, Pneumococcal; Sensitivity and Specificity; Tomography, Emission-Computed | 1997 |
Prediction of improvement of ventricular function after revascularization. 18F-fluorodeoxyglucose single-photon emission computed tomography vs low-dose dobutamine echocardiography.
Topics: Analysis of Variance; Cardiotonic Agents; Chi-Square Distribution; Coronary Artery Bypass; Deoxyglucose; Dobutamine; Echocardiography; Female; Fluorodeoxyglucose F18; Humans; Male; Myocardial Revascularization; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 1997 |
Prospective investigation of positron emission tomography in lung nodules.
Topics: Aged; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, Emission-Computed | 1998 |
Primary staging and follow-up of high risk melanoma patients with whole-body 18F-fluorodeoxyglucose positron emission tomography: results of a prospective study of 100 patients.
Topics: Adult; Aged; Aged, 80 and over; False Negative Reactions; False Positive Reactions; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Melanoma; Middle Aged; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Risk Factors; Sensitivity and Specificity; Tomography, Emission-Computed; Whole-Body Counting | 1998 |
Clinical evaluation of whole-body 18F-fluorodeoxyglucose positron emission tomography in the detection of liver metastases.
Topics: Adult; Aged; Carcinoma; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Ultrasonography | 1998 |
Controlled prospective study of positron emission tomography using the glucose analogue [18f]fluorodeoxyglucose in the evaluation of pulmonary nodules.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Bronchoscopy; Carcinoma, Bronchogenic; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, Emission-Computed | 1998 |
Comparative efficacy of positron emission tomography with FDG and computed tomographic scanning in preoperative staging of non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Preoperative Care; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1999 |
Assessment of pulmonary lesions with 18F-fluorodeoxyglucose positron imaging using coincidence mode gamma cameras.
Topics: Case-Control Studies; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 1999 |
18Fluorodeoxyglucose-positron emission tomography in the management of patients with suspected pancreatic cancer.
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Pancreatic Neoplasms; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 1999 |
Fluorine-18-fluorodeoxyglucose positron emission tomography is useless for the detection of local recurrence after radical prostatectomy.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Cicatrix; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prostatectomy; Prostatic Neoplasms; Sensitivity and Specificity; Tomography, Emission-Computed | 1999 |
F-18 fluorodeoxyglucose positron emission tomography in the non-invasive staging of non-small cell lung cancer.
Topics: Adult; Aged; Carcinoma in Situ; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1999 |
18F-fluorodeoxyglucose dual-head positron emission tomography as a procedure for detecting simultaneous primary tumors in cases of head and neck cancer.
Topics: Adult; Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasms, Second Primary; Prospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 1999 |
Value of FDG-PET in detecting residual or recurrent nonsmall cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Chi-Square Distribution; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1999 |
FDG PET evaluation of head and neck cancer: value of imaging the thorax.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Evaluation Studies as Topic; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Radiopharmaceuticals; Sensitivity and Specificity; Thoracic Neoplasms; Tomography, Emission-Computed | 2000 |
Accuracy and clinical impact of mediastinal lymph node staging with FDG-PET imaging in potentially resectable lung cancer.
Topics: Adult; Aged; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Mediastinal Neoplasms; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2000 |
Glucose hypometabolism and neuropathological correlates in brains of dementia with Lewy bodies.
Topics: Aged; Alleles; Alzheimer Disease; Apolipoprotein E4; Apolipoproteins E; Brain; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Gene Frequency; Gliosis; Glucose; Humans; Immunohistochemistry; Lewy Bodies; Lewy Body Disease; Male; Nerve Tissue Proteins; Occipital Lobe; Sensitivity and Specificity; Synucleins; tau Proteins; Tomography, Emission-Computed; Ubiquitins; Visual Cortex | 2000 |
[18FDG-PET imaging of pancreatic adenocarcinoma].
Topics: Adenocarcinoma; Aged; Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2000 |
Classification of asymptomatic adnexal masses by ultrasound, magnetic resonance imaging, and positron emission tomography.
Topics: Adnexal Diseases; Adolescent; Adult; Aged; Aged, 80 and over; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Ovarian Neoplasms; Sensitivity and Specificity; Tomography, Emission-Computed; Ultrasonography, Doppler | 2000 |
Preoperative staging of non-small-cell lung cancer with positron-emission tomography.
Topics: Adult; Aged; Biopsy, Needle; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Staging; Prospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Ultrasonography | 2000 |
Fluorodeoxyglucose positron emission tomography in the evaluation of germ cell tumours at relapse.
Topics: Adolescent; Adult; alpha-Fetoproteins; Biomarkers, Tumor; Chorionic Gonadotropin, beta Subunit, Human; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Germinoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Radiopharmaceuticals; Retrospective Studies; Seminoma; Sensitivity and Specificity; Teratoma; Testicular Neoplasms; Tomography, Emission-Computed | 2000 |
Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Metastasis; Neoplasm Staging; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography | 2000 |
Fluorodeoxyglucose positron emission tomography and the prognosis of pancreatic carcinoma.
Topics: Adenocarcinoma; Aged; Analysis of Variance; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multivariate Analysis; Pancreatic Neoplasms; Probability; Prognosis; Sensitivity and Specificity; Severity of Illness Index; Survival Rate; Tomography, Emission-Computed | 2000 |
Utility of fluorine-18-fluorodeoxyglucose positron emission tomography in differentiated thyroid carcinoma with negative radioiodine scans and elevated serum thyroglobulin levels.
Topics: Adenocarcinoma, Follicular; Adult; Aged; Carcinoma, Papillary; Catheter Ablation; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Middle Aged; Radiopharmaceuticals; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Thyroidectomy; Tomography, Emission-Computed | 2000 |
Delayed (18)F-fluoro-2-deoxy-D-glucose positron emission tomography scan for differentiation between malignant and benign lesions in the pancreas.
Topics: Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreas; Pancreatic Neoplasms; Reproducibility of Results; Sensitivity and Specificity; Time Factors; Tomography, Emission-Computed | 2000 |
Survival of patients evaluated by FDG-PET before hepatic resection for metastatic colorectal carcinoma: a prospective database study.
Topics: Aged; Carcinoma; Colorectal Neoplasms; Databases, Factual; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Missouri; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Survival Rate; Tomography, Emission-Computed | 2001 |
18FDG-PET following treatment as valid predictor for disease-free survival in Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Sedimentation; Child; Child, Preschool; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Predictive Value of Tests; Radiopharmaceuticals; Radiotherapy; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
Prediction of functional recovery in patients with myocardial infarction after revascularization--comparison of low-dose dobutamine stress echocardiography with fluorine-18 fluorodeoxyglucose positron emission tomography.
Topics: Aged; Cell Survival; Dobutamine; Echocardiography; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Myocardium; Predictive Value of Tests; Prognosis; Sensitivity and Specificity; Tomography, Emission-Computed; Treatment Outcome; Ventricular Dysfunction, Left | 2001 |
Angiography effectively supports the diagnosis of hepatic metastases in medullary thyroid carcinoma.
Topics: Adult; Aged; Angiography; Calcitonin; Carcinoma, Medullary; Diagnosis, Differential; Diarrhea; Female; Fluorodeoxyglucose F18; Flushing; Humans; Liver; Liver Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, Emission-Computed | 2001 |
Detection of malignant tumors: whole-body PET with fluorine 18 alpha-methyl tyrosine versus FDG--preliminary study.
Topics: Adult; Aged; Aged, 80 and over; alpha-Methyltyrosine; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Methyltyrosines; Middle Aged; Neoplasms; Probability; Reference Values; Sensitivity and Specificity; Tomography, Emission-Computed; Whole-Body Irradiation | 2001 |
Comparing 18-fluoro-2-deoxyglucose positron emission tomography with a combination of technetium 99m tetrofosmin single photon emission computed tomography and computed tomography to detect recurrent or persistent nasopharyngeal carcinomas after radiother
Topics: Adolescent; Adult; Aged; Carcinoma; Diagnosis, Differential; Drug Resistance, Neoplasm; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Organophosphorus Compounds; Organotechnetium Compounds; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2001 |
18fluorodeoxyglucose positron emission tomography to detect mediastinal or internal mammary metastases in breast cancer.
Topics: Adult; Aged; Biopsy; Breast Neoplasms; Breast Neoplasms, Male; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Staging; Prevalence; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) for the staging of low-grade non-Hodgkin's lymphoma (NHL).
Topics: Adult; Aged; Bone Marrow; Colon; False Negative Reactions; Fluorodeoxyglucose F18; Humans; Liver; Lung; Lymph Nodes; Lymphoma, Non-Hodgkin; Middle Aged; Neoplasm Staging; Sensitivity and Specificity; Spleen; Tomography, Emission-Computed | 2001 |
Predictive impact of 2-18fluoro-2-deoxy-D-glucose positron emission tomography for residual postchemotherapy masses in patients with bulky seminoma.
Topics: Adult; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm, Residual; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Seminoma; Sensitivity and Specificity; Testicular Neoplasms; Tomography, Emission-Computed | 2001 |
Fluorodeoxyglucose positron emission tomography for detection of recurrent or metastatic breast cancer.
Topics: Adult; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |
2-[Fluorine-18]-fluoro-2-deoxy-d-glucose positron emission tomography in the diagnosis of recurrent ovarian cancer.
Topics: CA-125 Antigen; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |
FDG-PET in staging and restaging non-small cell lung cancer after neoadjuvant chemoradiotherapy: correlation with histopathology.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Lung Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Treatment Outcome; Vinblastine | 2002 |
Fluorine-18 fluorodeoxyglucose positron emission tomography findings in spondylodiscitis: preliminary results.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Discitis; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |
11C-acetate PET imaging of prostate cancer.
Topics: Acetates; Adenocarcinoma; Aged; Aged, 80 and over; Bone Neoplasms; Carbon; Carbon Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Prostatic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
Early prediction of treatment response to high-dose salvage chemotherapy in patients with relapsed germ cell cancer using [(18)F]FDG PET.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Predictive Value of Tests; Prognosis; Prospective Studies; Radiopharmaceuticals; Salvage Therapy; Seminoma; Sensitivity and Specificity; Testicular Neoplasms; Tomography, Emission-Computed; Treatment Outcome | 2002 |
Feasibility, safety and image quality of cardiac FDG studies during hyperinsulinaemic-euglycaemic clamping.
Topics: Aged; Blood Glucose; Coronary Disease; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Feasibility Studies; Female; Fluorodeoxyglucose F18; Glucose Clamp Technique; Heart; Humans; Insulin; Male; Middle Aged; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 2002 |
Local injection of the 90Y-labelled peptidic vector DOTATOC to control gliomas of WHO grades II and III: an extended pilot study.
Topics: Adult; Aged; Brachytherapy; Brain Neoplasms; Dose-Response Relationship, Radiation; Feasibility Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glioma; Humans; Injections, Intralesional; Magnetic Resonance Imaging; Male; Middle Aged; Octreotide; Pilot Projects; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Adjuvant; Receptors, Somatostatin; Sensitivity and Specificity; Treatment Outcome; World Health Organization; Yttrium Radioisotopes | 2002 |
18F-FDG hybrid PET in patients with suspected spondylitis.
Topics: Adult; Aged; Biopsy, Needle; Citrates; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Gallium; Humans; Lumbar Vertebrae; Magnetic Resonance Imaging; Male; Middle Aged; Prospective Studies; Radiography; Radiopharmaceuticals; Sensitivity and Specificity; Spondylitis; Technetium Tc 99m Medronate; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2002 |
Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography and Ga-67 scintigraphy in evaluation of lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
Myocardial viability assessment with gated SPECT Tc-99m tetrofosmin % wall thickening: comparison with F-18 FDG-PET.
Topics: Aged; Cell Survival; Coronary Artery Disease; Exercise Test; Female; Fluorodeoxyglucose F18; Gated Blood-Pool Imaging; Heart; Humans; Hypertrophy, Left Ventricular; Male; Middle Aged; Myocardial Infarction; Myocardium; Organophosphorus Compounds; Organotechnetium Compounds; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2002 |
Reproducibility and clinical value of 18F-fluorodeoxyglucose positron emission tomography in recurrent melanoma.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Melanoma; Middle Aged; Neoplasm Recurrence, Local; Observer Variation; Patient Care; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Skin Neoplasms; Statistics as Topic; Surveys and Questionnaires; Tomography, Emission-Computed; Whole-Body Counting | 2002 |
Influence of rhTSH on [(18)F]fluorodeoxyglucose uptake by differentiated thyroid carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Recombinant Proteins; Sensitivity and Specificity; Thyroid Neoplasms; Thyrotropin; Thyroxine | 2002 |
Use of arterialised venous instead of arterial blood for measurement of myocardial glucose metabolism during euglycaemic-hyperinsulinaemic clamping.
Topics: Arm; Blood Glucose; Female; Fluorodeoxyglucose F18; Glucose; Glucose Clamp Technique; Heart; Hot Temperature; Humans; Insulin; Male; Middle Aged; Myocardium; Radial Artery; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Veins | 2002 |
Pretreatment evaluation of carcinomas of the hypopharynx and larynx with 18F-fluorodeoxyglucose, 123I-alpha-methyl-L-tyrosine and 99mTc-hexakis-2-methoxyisobutylisonitrile.
Topics: alpha-Methyltyrosine; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Iodine Radioisotopes; Laryngeal Neoplasms; Male; Middle Aged; Prospective Studies; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 2002 |
CT vs 68Ge attenuation correction in a combined PET/CT system: evaluation of the effect of lowering the CT tube current.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Calibration; Female; Fluorodeoxyglucose F18; Germanium; Humans; Image Enhancement; Male; Middle Aged; Neoplasm Staging; Neoplasms; Radiographic Image Enhancement; Radioisotopes; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
Initial results in the assessment of multiple myeloma using 18F-FDG PET.
Topics: Adult; Aged; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Multiple Myeloma; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Single-Blind Method; Tomography, Emission-Computed | 2002 |
Accuracy of PET in predicting functional recovery after revascularisation in patients with chronic ischaemic dysfunction: head-to-head comparison between blood flow, glucose utilisation and water-perfusable tissue fraction.
Topics: Adult; Aged; Chronic Disease; Coronary Circulation; Coronary Vessels; Female; Fluorodeoxyglucose F18; Heart; Humans; Male; Middle Aged; Myocardial Ischemia; Myocardial Revascularization; Oxygen Radioisotopes; Postoperative Period; Radiopharmaceuticals; Recovery of Function; Reproducibility of Results; ROC Curve; Sensitivity and Specificity; Stroke Volume; Tomography, Emission-Computed; Treatment Outcome; Ventricular Dysfunction, Left; Water | 2002 |
Ovarian cancer recurrence: role of whole-body positron emission tomography using 2-[fluorine-18]-fluoro-2-deoxy- D-glucose.
Topics: Adenocarcinoma; Adenocarcinoma, Clear Cell; Adenocarcinoma, Mucinous; Adult; Aged; CA-125 Antigen; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Granulosa Cell Tumor; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Postoperative Care; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed; Whole-Body Counting | 2002 |
Expression of hexokinase II and Glut-1 in untreated human breast cancer.
Topics: Adult; Aged; Biomarkers, Tumor; Biopsy; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Excitatory Amino Acid Transporter 2; Fluorodeoxyglucose F18; Hexokinase; Humans; Middle Aged; Neoplasm Staging; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Single-Blind Method | 2002 |
The use of [18 F]fluorodeoxyglucose positron emission tomography to differentiate between synovitis, loosening and infection of hip and knee prostheses.
Topics: Adult; Aged; Aged, 80 and over; Arthralgia; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Hip Joint; Hip Prosthesis; Humans; Knee Joint; Knee Prosthesis; Male; Middle Aged; Prosthesis Failure; Prosthesis-Related Infections; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Synovitis; Tomography, Emission-Computed | 2002 |
3009 other study(ies) available for fluorodeoxyglucose f18 and Sensitivity and Specificity
| Article | Year |
|---|---|
Benefit of [18F]-FDG PET/CT for treatment-naïve nasopharyngeal carcinoma.
Topics: Epstein-Barr Virus Infections; Fluorodeoxyglucose F18; Herpesvirus 4, Human; Humans; Lymph Nodes; Lymphatic Metastasis; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Sensitivity and Specificity | 2022 |
Comparison of nodal staging between CT, MRI, and [
Topics: Adult; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2022 |
Whole-body hybrid positron emission tomography imaging yields clinically relevant information in the staging and restaging of sinonasal tumors.
Topics: Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoplasm Staging; Neoplasms, Second Primary; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2021 |
An [18F]FDG-PET/CT deep learning method for fully automated detection of pathological mediastinal lymph nodes in lung cancer patients.
Topics: Artificial Intelligence; Deep Learning; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity | 2022 |
Changes of [
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Bayes Theorem; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2021 |
Comparison of 68Ga-DOTANOC and 18F-FDG PET-CT Scans in the Evaluation of Primary Tumors and Lymph Node Metastasis in Patients With Rectal Neuroendocrine Tumors.
Topics: Adult; Aged; China; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neuroendocrine Tumors; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Rectal Neoplasms; Sensitivity and Specificity | 2021 |
Diagnostic performance of the FDG-PET/CT in patients with resected mucinous colorectal liver metastases.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2021 |
Clinical Usefulness of [18F]-Fluoro-2-Deoxy-d-Glucose-Positron Emission Tomography/Computed Tomography for Distinguishing Between Autoimmune Pancreatitis and Pancreatic Cancer.
Topics: Aged; Autoimmune Pancreatitis; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multivariate Analysis; Pancreas; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity | 2021 |
Pulmonary Sarcomatoid Carcinoma With Epiglottis and Ileum Metastasis Detected by 18F-FDG PET/CT.
Topics: Carcinoma; Carcinoma, Non-Small-Cell Lung; Epiglottis; Fluorodeoxyglucose F18; Humans; Ileum; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2022 |
Impact of PET/CT among patients with suspected mycotic aortic aneurysms.
Topics: Aged; Aged, 80 and over; Aneurysm, Infected; Aortic Aneurysm; Disease Management; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Sensitivity and Specificity | 2021 |
Analysis of the Mechanism of Breast Metastasis Based on Image Recognition and Ultrasound Diagnosis.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2021 |
Prognostic value of metabolic activity of the psoas muscle evaluated by preoperative
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; Humans; Insulin Resistance; Liver; Mastectomy; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Preoperative Care; Prognosis; Proportional Hazards Models; Psoas Muscles; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Treatment Outcome; Triple Negative Breast Neoplasms | 2021 |
Diagnosis of bone metastases in breast cancer: Lesion-based sensitivity of dual-time-point FDG-PET/CT compared to low-dose CT and bone scintigraphy.
Topics: Bone and Bones; Bone Neoplasms; Breast; Breast Neoplasms; Diagnostic Tests, Routine; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radionuclide Imaging; Sensitivity and Specificity; Tomography, X-Ray Computed | 2021 |
Comparative accuracy and cost-effectiveness of dynamic contrast-enhanced CT and positron emission tomography in the characterisation of solitary pulmonary nodules.
Topics: Cost-Benefit Analysis; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2022 |
Usefulness of brain FDG PET/CT imaging in pediatric patients with suspected autoimmune encephalitis from a prospective study.
Topics: Adolescent; Brain; Child; Encephalitis; Female; Fluorodeoxyglucose F18; Hashimoto Disease; Humans; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity | 2022 |
IgA Nephropathy in a Patient With Metastatic Carcinoma of Unknown Primary: Findings on 18F-FDG PET/MRI.
Topics: Adult; Carcinoma; Fluorodeoxyglucose F18; Glomerulonephritis, IGA; Humans; Magnetic Resonance Imaging; Male; Neoplasms, Unknown Primary; Radiopharmaceuticals; Sensitivity and Specificity | 2022 |
Diagnostic value of
Topics: Adult; Child; Fluorodeoxyglucose F18; Humans; Nerve Sheath Neoplasms; Neurofibromatosis 1; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2022 |
Hybrid PET/MRI in Staging Endometrial Cancer: Diagnostic and Predictive Value in a Prospective Cohort.
Topics: Aged; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity | 2022 |
Port-Site Metastases in Incidentally Detected Carcinoma Gall Bladder: Role of 18F-FDG PET/CT and Patient Outcome.
Topics: Carcinoma; Fluorodeoxyglucose F18; Gallbladder Neoplasms; Humans; Liver Neoplasms; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2022 |
Feasibility of [18F]FDG PET/MRI with Early-Delayed and Extended PET as One-Stop Imaging for Staging and Predicting Metastasis in Rectal Cancer.
Topics: Feasibility Studies; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Rectal Neoplasms; Sensitivity and Specificity | 2022 |
Impact of
Topics: Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Muscles; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Urinary Bladder Neoplasms | 2022 |
First-in-human assessment of the novel LAT1 targeting PET probe
Topics: Adult; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioblastoma; Glioma; Humans; Large Neutral Amino Acid-Transporter 1; Male; Molecular Probes; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution | 2022 |
The diagnostic accuracy and clinical impact of FDG-PET/CT follow-up for patients on adjuvant immunotherapy for high-risk malignant melanoma.
Topics: Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Immunotherapy; Melanoma; Melanoma, Cutaneous Malignant; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Skin Neoplasms | 2022 |
Sensitivity of [18F]FDG PET/CT and classification of the primary tumor site in patients with carcinoma of unknown primary.
Topics: Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasms, Unknown Primary; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2022 |
Positron Emission Tomography/Magnetic Resonance Imaging (PET/MRI) Versus the Standard of Care Imaging in the Diagnosis of Peritoneal Carcinomatosis.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Standard of Care | 2023 |
Solitary Lymph Node Metastasis From a Malignant Peripheral Nerve Sheath Tumor of the Thoracic Vertebra Revealed on FDG PET/CT.
Topics: Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Staging; Neurofibrosarcoma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Sensitivity and Specificity; Thoracic Vertebrae | 2022 |
Diagnosis and staging of cardiac masses: additional value of CMR with
Topics: Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2022 |
Retroperitoneal venous malformation mimicking a nodal metastasis in oesophageal cancer on staging F18-FDG PET/CT.
Topics: Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2022 |
Head and Neck Cancer and PET/Computed Tomography.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2022 |
18F-FSPG PET imaging for the evaluation of indeterminate pulmonary nodules.
Topics: Fluorodeoxyglucose F18; Glutamic Acid; Humans; Lung Neoplasms; Multiple Pulmonary Nodules; Pilot Projects; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2022 |
"The Benefit Of Positron Emission Tomography/Computed Tomography In Stage I And Stage II Melanomas With High-Risk Decisiondx-Melanoma Scores".
Topics: Dichlorodiphenyl Dichloroethylene; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Testicular Neoplasms | 2022 |
Diagnostic Value of Nodal Staging of Lung Cancer With Usual Interstitial Pneumonia Using PET.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Idiopathic Pulmonary Fibrosis; Lung Neoplasms; Lymph Nodes; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity | 2022 |
Simultaneous
Topics: Arthritis, Infectious; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Feasibility Studies; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Prospective Studies; Prosthesis-Related Infections; Sensitivity and Specificity | 2022 |
Diagnostic Accuracy of FDG PET for the Identification of Vascular Graft Infection.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Treatment Outcome; Vascular Diseases | 2022 |
Precision Medicine: Can 18F-FDG PET Detect Cardiotoxicity Phenotypes?
Topics: Cardiotoxicity; Fluorodeoxyglucose F18; Humans; Phenotype; Positron-Emission Tomography; Precision Medicine; Radiopharmaceuticals; Sensitivity and Specificity | 2022 |
Routine contrast-enhanced CT is insufficient for TNM-staging of duodenal adenocarcinoma.
Topics: Adenocarcinoma; Cohort Studies; Duodenal Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2022 |
18 F-FDOPA and MRI Findings in a Case of Multiple Sclerosis.
Topics: Adult; Brain Neoplasms; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multiple Sclerosis; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2022 |
Value of rest
Topics: Angina, Unstable; Coronary Artery Disease; East Asian People; Fluorodeoxyglucose F18; Humans; Prospective Studies; Sensitivity and Specificity | 2023 |
Value of diffusion MRI versus [18F]FDG PET/CT in detection of cervical nodal metastases in differentiated thyroid cancer patients.
Topics: Adenocarcinoma; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms | 2022 |
The Clinical Diagnostic Value of F-FDG PET/CT Combined with MRI in Pancreatic Cancer.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2022 |
Rare form of metastasis: lung cancer metastases to inguinal hernia sac detected by 18F-FDG PET/CT.
Topics: Fluorodeoxyglucose F18; Hernia, Inguinal; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2022 |
Correlation between MAMMI-PET findings and anatomopathological outcomes in breast cancer patients.
Topics: Adult; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2022 |
Diagnostic Accuracy of a Convolutional Neural Network Assessment of Solitary Pulmonary Nodules Compared With PET With CT Imaging and Dynamic Contrast-Enhanced CT Imaging Using Unenhanced and Contrast-Enhanced CT Imaging.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neural Networks, Computer; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2023 |
Automatic detection of primary and metastatic lesions on cervicothoracic region and whole-body bone using a uniform machine-learnable approach for [18F]-FDG-PET/CT image analysis.
Topics: Fluorodeoxyglucose F18; Image Processing, Computer-Assisted; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2022 |
Diagnostic performance of F-18 FDG PET/CT in recurrent adenocarcinoma gallbladder and its impact on post-recurrence survival.
Topics: Adenocarcinoma; Biomarkers, Tumor; Cicatrix; Fluorodeoxyglucose F18; Gallbladder; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2023 |
Role of 18F-FDG PET/CT for detection of recurrence and metastases in renal cell carcinoma-are we underusing PET/CT?
Topics: Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2022 |
Diagnostic Significance of 18F-FDG PET/CT Imaging Coupled with Magnetic Resonance Imaging of the Entire Body for Bone Metastases.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Whole Body Imaging | 2022 |
Comparison of 18F-FDG PET/CT and ultrasound in staging of patients with malignant melanoma.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Melanoma, Cutaneous Malignant; Middle Aged; Neoplasm Staging; Polyesters; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Suppuration | 2022 |
Clinical Value of Diffusion-Weighted Whole-Body Imaging with Background Body Signal Suppression (DWIBS) for Staging of Patients with Suspected Head and Neck Cancer.
Topics: Aged; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Multimodal Imaging; Sensitivity and Specificity; Whole Body Imaging | 2022 |
Diagnostic efficacy of positron emission computerized tomography scans in suspicious laryngeal findings postorgan preservation treatment.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Larynx; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck | 2023 |
Benefit of [
Topics: Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Salvage Therapy; Sensitivity and Specificity | 2023 |
FDG PET-CT as an important diagnostic tool and prognostic marker in suspected recurrent cervical carcinoma after radiotherapy: comparison with MRI.
Topics: Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Uterine Cervical Neoplasms | 2022 |
PET/MR versus PET/CT for locoregional staging of oropharyngeal squamous cell cancer.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Neoplasm Staging; Neoplasms, Squamous Cell; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck | 2023 |
Staging of breast cancer in pregnancy with ultralow dose [18F]-FDG-PET/CT.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Pregnancy; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2023 |
Added value of semi-quantitative analysis of [18F]FDG PET/CT for the diagnosis of device-related infections in patients with a left ventricular assist device.
Topics: Fluorodeoxyglucose F18; Heart-Assist Devices; Humans; Positron Emission Tomography Computed Tomography; Prosthesis-Related Infections; Quality of Life; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2023 |
Comparison of PET-CT and MRI for evaluation of axillary lymph nodes in early breast cancer patients.
Topics: Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Retrospective Studies; Sensitivity and Specificity; Sentinel Lymph Node Biopsy | 2022 |
Automated lung cancer assessment on 18F-PET/CT using Retina U-Net and anatomical region segmentation.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2023 |
Clinical value of fluorine-18-fluorodeoxyglucose PET/MRI for liver metastasis in colorectal cancer: a prospective study.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Sensitivity and Specificity | 2023 |
Cervical Lymph Node Metastasis From Recurrent Glioblastoma Detected by MRI and 2-[18F]FDG PET/CT.
Topics: Female; Fluorodeoxyglucose F18; Glioblastoma; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2023 |
Assessment of bone lesions with 18 F-FDG PET/MRI in patients with nasopharyngeal carcinoma.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2023 |
Whole-body three-dimensional short tau inversion recovery and T1-weighted in/opposed phase MRI in the detection of neuroblastoma bone marrow metastasis: comparative study with PET/CT utilising bone marrow biopsy as the reference standard.
Topics: Biopsy; Bone Marrow; Bone Marrow Neoplasms; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neuroblastoma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Reference Standards; Sensitivity and Specificity; Whole Body Imaging | 2023 |
Prediction of Malignant Thyroid Nodules Using 18 F-FDG PET/CT-Based Radiomics Features in Thyroid Incidentalomas.
Topics: Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Nodule | 2023 |
Bone Metastases Detection in Patients with Breast Cancer: Does Bone Scintigraphy Add Information to PET/CT?
Topics: Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Sensitivity and Specificity | 2023 |
Benign pancreatic lesion on 18F-FDG PET-MRI: A case report.
Topics: Adult; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Pancreas; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2023 |
The Role of Axillary SUV
Topics: Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Tomography, X-Ray Computed | 2023 |
Role of 18F-FDG PET/CT in evaluating lymph node status in patients with head and neck squamous cell carcinoma.
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck | 2023 |
Diagnostic performance of FDG PET/MRI for cervical lymph node metastasis in patients with clinically N0 head and neck cancer.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck | 2023 |
Impact of Follow-up 18F-FDG PET on the Management in Patients With Lung Cancer: A Meta-analysis: Erratum.
Topics: Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2023 |
Value of Myocardial Contrast Echocardiography in Detecting Coronary Microcirculatory Dysfunction in Ischemia With Non-obstructive Coronary Artery Disease.
Topics: Contrast Media; Coronary Artery Disease; Coronary Circulation; Echocardiography; Fluorodeoxyglucose F18; Humans; Ischemia; Microcirculation; Predictive Value of Tests; Sensitivity and Specificity | 2023 |
Accuracy of nodal staging by 18F-FDG-PET/CT in limited disease small-cell lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Retrospective Studies; Sensitivity and Specificity; Small Cell Lung Carcinoma; Tomography, X-Ray Computed | 2023 |
A PET-CT score for discriminating malignant from benign pleural effusions.
Topics: Cardiomegaly; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Pleural Effusion; Pleural Effusion, Malignant; Positron Emission Tomography Computed Tomography; Prospective Studies; Sensitivity and Specificity | 2023 |
The value of [18F]FDG PET/CT examination in the detection and differentiation of recurrent ovarian cancer.
Topics: Female; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2023 |
Accuracy of pre-operative 18-fluoride fluorodeoxyglucose positron emission tomography (FDG-PET) in predicting lymph node involvement in colon cancer.
Topics: Australia; Colonic Neoplasms; Fluorides; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphadenopathy; Lymphatic Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2023 |
Assessing the role of positron emission tomography and bone scintigraphy in imaging of pleuropulmonary blastoma (PPB): A report from the International PPB/DICER1 Registry.
Topics: Bone Neoplasms; Child, Preschool; DEAD-box RNA Helicases; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radionuclide Imaging; Radiopharmaceuticals; Registries; Retrospective Studies; Ribonuclease III; Sensitivity and Specificity | 2023 |
[Value of PET imaging in head and neck cancer].
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2023 |
Solitary Axillary Lymph Node Metastasis From Bladder Cancer Detected by FDG PET/CT.
Topics: Aged; Axilla; Carcinoma, Transitional Cell; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Urinary Bladder Neoplasms | 2023 |
Evaluation of post-chemotherapy residual seminomatous masses by 18F-fluorodeoxyglucose PET/CT using tumor-to-liver ratio - conundrum or solution?
Topics: Fluorodeoxyglucose F18; Humans; Liver; Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2023 |
Potential of preoperative fluorodeoxyglucose-positron emission tomography/computed tomography to diagnose contralateral lymph node metastases in patients with oral cancer.
Topics: Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Mouth Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2023 |
Diagnostic value of 18 F-fluoro-2-deoxyglucose positron emission tomography/computed tomography imaging in acral melanoma-predominant Asian patients.
Topics: Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Melanoma; Melanoma, Cutaneous Malignant; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Skin Neoplasms | 2023 |
Value of [18F]FDG PET/CT in Diagnosis and Management of Spondylodiscitis.
Topics: Discitis; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Osteomyelitis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2023 |
Diagnostic accuracy of SSR-PET/CT compared to histopathology in the identification of liver metastases from well-differentiated neuroendocrine tumors.
Topics: Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Neuroendocrine Tumors; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Somatostatin; Sensitivity and Specificity | 2023 |
Evaluation of 18-FDG PET diagnostic capabilities for cancer screening in heart transplant patients, a retrospective study.
Topics: Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Heart Transplantation; Humans; Male; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2023 |
PET/CT scan improves detection of metastatic disease compared with CT scan alone in women with high-grade neuroendocrine cervical cancer: a NeCTuR study.
Topics: Carcinoma, Neuroendocrine; Cervix Uteri; Female; Fluorodeoxyglucose F18; Humans; Neoplasms, Second Primary; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2023 |
Lytic Bony Lesions On 18 F-FDG PET-CT Versus 99m Tc MDP Bone Scan.
Topics: Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2023 |
The predictive value, sensitivity, specificity, and accuracy of PET CT in the evaluation of axillary metastases in breast cancer.
Topics: Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2023 |
MRI and PET/CT in the assessment of lymph node metastases in head and neck cancer.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2023 |
Value of 12-lead electrocardiogram to predict myocardial scar on FDG PET in heart failure patients.
Topics: Aged; Cicatrix; Electrocardiography; Female; Fluorodeoxyglucose F18; Heart Failure; Humans; Male; Middle Aged; Myocardial Ischemia; Nitrogen Radioisotopes; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity | 2021 |
[18F]FDG positron emission tomography and ultrasound in the diagnosis of giant cell arteritis: congruent or complementary imaging methods?
Topics: Aged; Aged, 80 and over; Aorta; Axillary Artery; Carotid Artery, Common; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Male; Middle Aged; Popliteal Artery; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Subclavian Artery; Temporal Arteries; Ultrasonography; Vertebral Artery | 2020 |
The Role of 18F-Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography in the Diagnosis of Postoperative Hardware-Related Spinal Infections.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Postoperative Complications; Prosthesis-Related Infections; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Spine | 2019 |
Second-look PET-CT following an initial incomplete PET-CT response to (chemo)radiotherapy for head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Retrospective Studies; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck | 2020 |
The Utility of 18F-fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography in Cutaneous B-Cell Lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Skin; Skin Neoplasms; Young Adult | 2019 |
The value of
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; CA-19-9 Antigen; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Micrometastasis; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2019 |
PET-MR Imaging and MR Texture Analysis in the Diagnosis of Pancreatic Cysts: A Prospective Preliminary Study.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Pancreatic Cyst; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity | 2020 |
Prognostic value of
Topics: Animals; Brain; Disease Models, Animal; Feasibility Studies; Fluorodeoxyglucose F18; Glucose; Humans; Male; Positron-Emission Tomography; Post-Cardiac Arrest Syndrome; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Sensitivity and Specificity; Specific Pathogen-Free Organisms | 2019 |
Granulomatous hepatitis masquerading as metastases on FDG PET/CT.
Topics: Fluorodeoxyglucose F18; Hepatitis; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2020 |
Role of 18F-FDG PET/CT in restaging and follow-up of patients with GIST.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gastrointestinal Stromal Tumors; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity | 2020 |
[The chemotherapy response evaluated by (99m)Tc-HTOC, (18)F-FDG PET-CT and whole body bone scan for a case of childen with neuroblastoma].
Topics: Bone and Bones; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Neuroblastoma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Medronate; Whole Body Imaging | 2019 |
The value of PET/CT in determining lymph node metastasis of endometrial cancer.
Topics: Adult; Aged; Aged, 80 and over; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Pelvis; Positron Emission Tomography Computed Tomography; Retrospective Studies; Sensitivity and Specificity | 2019 |
The accuracy of hippocampal volumetry and glucose metabolism for the diagnosis of patients with suspected Alzheimer's disease, using automatic quantitative clinical tools.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cognitive Dysfunction; Early Diagnosis; Female; Fluorodeoxyglucose F18; Glucose; Hippocampus; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiographic Image Interpretation, Computer-Assisted; Retrospective Studies; Sensitivity and Specificity | 2019 |
Diagnosis of cardiac sarcoidosis despite negative findings on serial late gadolinium enhancement with cardiac magnetic resonance imaging/
Topics: Adult; Biopsy; Cardiomyopathies; Fluorodeoxyglucose F18; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radiography, Thoracic; Radiopharmaceuticals; Sarcoidosis; Sensitivity and Specificity | 2020 |
Biomechanical characteristics of isolated carotid atherosclerotic plaques assessed by ultrasonography.
Topics: Aged; Atherosclerosis; Carotid Arteries; Carotid Intima-Media Thickness; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Linear Models; Male; Middle Aged; Plaque, Atherosclerotic; Positron Emission Tomography Computed Tomography; Pulse Wave Analysis; ROC Curve; Sensitivity and Specificity | 2019 |
Diagnostic accuracy of ultrasound for detecting large-vessel giant cell arteritis using FDG PET/CT as the reference.
Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prospective Studies; Sensitivity and Specificity; Temporal Arteries; Ultrasonography | 2020 |
Diffusion-weighted MRI for initial staging in Hodgkin`s lymphoma: comparison with FDG PET.
Topics: Aged; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Magnetic Resonance Imaging; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity | 2020 |
Diagnostic performance of 18F-2-fluoro-2-deoxy-D-glucose PET/computerized tomography in identifying bone marrow infiltration in new patients with diffuse large B-cell lymphoma and Hodgkin lymphoma.
Topics: Adult; Aged; Bone Marrow Neoplasms; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Ilium; Lymphoma, B-Cell; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Young Adult | 2020 |
Incremental value of FDG-PET/CT to monitor treatment response in infectious spondylodiscitis.
Topics: Aged; Anti-Bacterial Agents; Discitis; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2020 |
Preoperative PET-CT is useful for predicting recurrent extrahepatic metastasis of hepatocellular carcinoma after resection.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Preoperative Care; Proportional Hazards Models; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity | 2020 |
Predicting Response to Neoadjuvant Chemotherapy Using 18F FDG PET-CT in Patients with Locally Advanced Breast Cancer.
Topics: Antineoplastic Agents; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2020 |
Performance of Positron Emission Tomography-Computed Tomography and Bone Marrow Biopsy in Detecting Bone Marrow Infiltration in Lymphoma Cases
Topics: Adult; Aged; Biopsy; Bone Marrow; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Young Adult | 2020 |
Combined DCE-MRI- and FDG-PET enable histopathological grading prediction in a rat model of hepatocellular carcinoma.
Topics: Animals; Carcinoma, Hepatocellular; Contrast Media; Disease Models, Animal; Fluorodeoxyglucose F18; Image Enhancement; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Neoplasm Grading; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Wistar; Sensitivity and Specificity; Tumor Burden | 2020 |
Discrepancies between positron emission tomography/magnetic resonance imaging and positron emission tomography/computed tomography in a cohort of oncological patients.
Topics: Adult; Aged; Aged, 80 and over; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Young Adult | 2020 |
[Positron emission tomography in infective endocarditis associated with intracardiac devices and prosthetic valves].
Topics: Adult; Aged; Aged, 80 and over; Defibrillators, Implantable; Endocarditis; Female; Fluorodeoxyglucose F18; Heart Valve Prosthesis; Humans; Male; Middle Aged; Pacemaker, Artificial; Positron Emission Tomography Computed Tomography; Prosthesis-Related Infections; Reference Values; Reproducibility of Results; Sensitivity and Specificity; Statistics, Nonparametric; Young Adult | 2020 |
Accuracy of
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Mouth Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2020 |
Radiogenomic Models Using Machine Learning Techniques to Predict EGFR Mutations in Non-Small Cell Lung Cancer.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; ErbB Receptors; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Imaging Genomics; Lung; Lung Neoplasms; Machine Learning; Male; Mutation; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity | 2021 |
False positive finding from malignancy-like lesions on FDG PET/CT: case report of tuberculosis patients.
Topics: Antitubercular Agents; Biopsy; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Sensitivity and Specificity; Treatment Outcome; Tuberculosis | 2020 |
Pilot Study of [
Topics: Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Muscles; Neoplasm Staging; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Urinary Bladder Neoplasms | 2020 |
Prediction of the human papillomavirus status in patients with oropharyngeal squamous cell carcinoma by FDG-PET imaging dataset using deep learning analysis: A hypothesis-generating study.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Cohort Studies; Datasets as Topic; Deep Learning; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Oropharyngeal Neoplasms; Oropharynx; Papillomavirus Infections; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2020 |
The Multicenter Italian Trial Assesses the Performance of FDG-PET /CT Related to Pre-Test Cancer Risk in Patients with Solitary Pulmonary Nodules and Introduces a Segmental Thoracic Diagnostic Strategy.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Italy; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiation Exposure; Radiopharmaceuticals; Retrospective Studies; Risk Assessment; Sensitivity and Specificity; Solitary Pulmonary Nodule | 2020 |
A prospective comparative study of ultrasonography, contrast-enhanced MRI and 18F-FDG PET/CT for preoperative detection of axillary lymph node metastasis in breast cancer patients.
Topics: Adult; Aged; Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography | 2020 |
A prospective comparative study of contrast-enhanced CT, contrast-enhanced MRI and 18F-FDG PET/CT in the preoperative staging of colorectal cancer patients.
Topics: Aged; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2020 |
Predicting MCI progression with FDG-PET and cognitive scores: a longitudinal study.
Topics: Algorithms; Alzheimer Disease; Brain; Cognitive Dysfunction; Disease Progression; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Mental Status and Dementia Tests; Positron-Emission Tomography; Prognosis; Sensitivity and Specificity | 2020 |
18-FDG PET-CT should be included in preoperative staging of gall bladder cancer.
Topics: Aged; Bone Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Gallbladder Neoplasms; Humans; Liver Neoplasms; Lymph Nodes; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Omentum; Palliative Care; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Survival; Tomography, X-Ray Computed | 2020 |
Diagnostic Accuracy of PET/CT and Contrast Enhanced CT in Patients With Suspected Infected Aortic Aneurysms.
Topics: Aged; Aged, 80 and over; Aneurysm, Infected; Aorta; Aortic Aneurysm; Contrast Media; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Reference Standards; Retrospective Studies; Sensitivity and Specificity | 2020 |
The role of FDG-PET-CT is limited in initial staging of nodal metastasis for thin cutaneous melanoma.
Topics: Biopsy; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Melanoma; Melanoma, Cutaneous Malignant; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Skin Neoplasms | 2021 |
The impact of atlas-based MR attenuation correction on the diagnosis of FDG-PET/MR for Alzheimer's diseases- A simulation study combining multi-center data and ADNI-data.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Cognitive Dysfunction; Computer Simulation; Datasets as Topic; Diagnosis, Differential; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Neuroimaging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2020 |
Investigating the Reliability of Fluorodeoxyglucose 18 Positive Emission Tomography-Computed Tomography Detection of Regional Lymph Node Metastasis in Head and Neck Malignancy.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2020 |
Follow up imaging of oral, oropharyngeal and hypopharyngeal cancer patients: Comparison of PET-CT and MRI post treatment.
Topics: Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Hypopharyngeal Neoplasms; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2020 |
Deep learning analysis using FDG-PET to predict treatment outcome in patients with oral cavity squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Deep Learning; Diagnosis, Computer-Assisted; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome; Tumor Burden | 2020 |
Is FDG-PET/CT used correctly in the combined approach for nodal staging in NSCLC patients?
Topics: Adult; Aged; Biopsy, Fine-Needle; Carcinoma, Non-Small-Cell Lung; Endosonography; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2020 |
Diagnostic Accuracy and Confidence of [18F] FDG PET/MRI in comparison with PET or MRI alone in Head and Neck Cancer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2020 |
Visual PET/CT scoring of mesenteric fdg uptake to differentiate between tuberculous peritonitis and peritoneal carcinomatosis.
Topics: Fluorodeoxyglucose F18; Humans; Peritoneal Neoplasms; Peritonitis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2020 |
Prospective evaluation of the impact of human papilloma virus status and small node size on the diagnostic accuracy of 18F-fluorodeoxyglucose positron emission tomography/computed tomography for primary head and neck squamous cell carcinoma.
Topics: Alphapapillomavirus; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Papillomaviridae; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck | 2020 |
[PET/CT with 18F-fluorodeoxyglucose and 11C-methionine after autologous stem cell transplantation in multiple myeloma patients].
Topics: Carbon Radioisotopes; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Humans; Methionine; Multiple Myeloma; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Transplantation, Autologous | 2019 |
68Ga-DOTATOC PET for Treatment Efficacy Evaluation of Cardiac Sarcoidosis.
Topics: Adult; Aged; Cardiomyopathies; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Octreotide; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Sarcoidosis; Sensitivity and Specificity; Treatment Outcome | 2020 |
Can FDG-PET replace biopsy for the evaluation of residual tumor in pediatric mature B-cell non-Hodgkin lymphoma?
Topics: Adolescent; Biopsy; Child; Child, Preschool; Cross-Sectional Studies; Egypt; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Male; Neoplasm Recurrence, Local; Neoplasm, Residual; Positron Emission Tomography Computed Tomography; Retrospective Studies; Sensitivity and Specificity | 2020 |
Accuracy of peritoneal carcinomatosis extent diagnosis by initial FDG PET CT in epithelial ovarian cancer: A multicentre study of the FRANCOGYN research group.
Topics: Adult; Aged; Aged, 80 and over; CA-125 Antigen; Carcinoma; Carcinoma, Ovarian Epithelial; Female; Fluorodeoxyglucose F18; France; Humans; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Ovarian Neoplasms; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Survival Rate | 2020 |
Will FAPI PET/CT Replace FDG PET/CT in the Next Decade? Counterpoint-No, Not So Fast!
Topics: Biomarkers; Endopeptidases; Fluorodeoxyglucose F18; Gelatinases; Humans; Membrane Proteins; Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Serine Endopeptidases | 2021 |
Will FAPI PET/CT Replace FDG PET/CT in the Next Decade? Point-An Important Diagnostic, Phenotypic, and Biomarker Role.
Topics: Biomarkers; Endopeptidases; Fluorodeoxyglucose F18; Gelatinases; Humans; Membrane Proteins; Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Serine Endopeptidases | 2021 |
One-by-One Comparison of Lymph Nodes Between 18F-FDG Uptake and Pathological Diagnosis in Esophageal Cancer.
Topics: Aged; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Sensitivity and Specificity | 2020 |
MM2-type sporadic Creutzfeldt-Jakob disease: new diagnostic criteria for MM2-cortical type.
Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Cerebral Cortex; Cerebrovascular Circulation; Creutzfeldt-Jakob Syndrome; Cysteine; Diffusion Magnetic Resonance Imaging; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Iofetamine; Male; Middle Aged; Organotechnetium Compounds; Prion Proteins; PrPSc Proteins; Radiopharmaceuticals; Sensitivity and Specificity; Thalamus; Tomography, Emission-Computed, Single-Photon | 2020 |
The impact of 18F-FDG PET/CT in the clinical management of patients with lymph node metastasis of unknown primary origin.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Neoplasms, Unknown Primary; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2021 |
Multi-slice representational learning of convolutional neural network for Alzheimer's disease classification using positron emission tomography.
Topics: Alzheimer Disease; Cognition; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Neural Networks, Computer; Positron Emission Tomography Computed Tomography; Sensitivity and Specificity | 2020 |
Can 18F-FDG PET/MRI Be Used as a Diagnostic Tool in Early Neuro-Behçet Disease?
Topics: Behcet Syndrome; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2021 |
FDG-PET/CT in high-risk primary breast cancer-a prospective study of stage migration and clinical impact.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity | 2021 |
Prognostic impact of preoperative FDG-PET positive lymph nodes in lung cancer.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2021 |
Diagnostic performance of
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Multiple Myeloma; Osteolysis; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiography; Reproducibility of Results; Sensitivity and Specificity; Smoldering Multiple Myeloma | 2021 |
18F-FBPA PET in Sarcoidosis: Comparison to Inflammation-Related Uptake on FDG PET.
Topics: Aged; Biological Transport; Fluorodeoxyglucose F18; Humans; Inflammation; Large Neutral Amino Acid-Transporter 1; Male; Positron-Emission Tomography; Sarcoidosis; Sensitivity and Specificity | 2020 |
Diagnostic accuracy for the epileptogenic zone detection in focal epilepsy could be higher in FDG-PET/MRI than in FDG-PET/CT.
Topics: Epilepsies, Partial; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity | 2021 |
Use of
Topics: Adult; Aged; Chemoradiotherapy; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Female; Fluorodeoxyglucose F18; Humans; India; Male; Middle Aged; Neoadjuvant Therapy; Polymerase Chain Reaction; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Survival Rate | 2021 |
A Comparison of the Diagnostic Value of Positron Emission Tomography/Computed Tomography and Ultrasound for the Detection of Metastatic Axillary Nodal Disease in Treatment-Naive Breast Cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2020 |
Complete pathological response (pCR) in gastroesophageal cancer: Correlation with metabolic response.
Topics: Adenocarcinoma; Aged; Carcinoma, Squamous Cell; Chemoradiotherapy, Adjuvant; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Preoperative Care; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Treatment Outcome; Watchful Waiting | 2020 |
Diagnostic Accuracy of Amyloid versus
Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Autopsy; Brain; DNA-Binding Proteins; Female; Fluorodeoxyglucose F18; Frontotemporal Dementia; Frontotemporal Lobar Degeneration; Humans; Male; Middle Aged; Pick Disease of the Brain; Plaque, Amyloid; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; tau Proteins; Thiazoles | 2021 |
Machine learning-based diagnostic method of pre-therapeutic
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Machine Learning; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2021 |
A Pioneering Paper That Provided a Tool for Accurate, Observer-Independent Analysis of
Topics: Brain; Dementia; Fluorodeoxyglucose F18; Humans; Publications; Sensitivity and Specificity | 2020 |
Value of 18F-FDG PET/CT in patients with hepatic metastatic carcinoma of unknown primary.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Case-Control Studies; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Unknown Primary; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2020 |
Glucose-Functionalized Liposomes for Reducing False Positives in Cancer Diagnosis.
Topics: Animals; Fluorodeoxyglucose F18; Glucose; Liposomes; Mice; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2021 |
RADIOISOTOPE DIAGNOSTIC ALGORITHM FOR THE RELAPSE AND METASTASES DETECTION IN THE IODINE-NEGATIVE DIFFERENTIATED THYROID CANCER.
Topics: Algorithms; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Neoplasm Metastasis; Neoplasm Recurrence, Local; Organotechnetium Compounds; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Sodium Pertechnetate Tc 99m; Survival Analysis; Technetium Tc 99m Dimercaptosuccinic Acid; Thyroid Gland; Thyroid Neoplasms; Ukraine; Whole-Body Counting | 2020 |
Efficacy of 11C-2β-carbomethoxy-3β-(4-fluorophenyl) tropane positron emission tomography combined with 18F-fluorodeoxyglucose positron emission tomography in the diagnosis of early Parkinson disease: A protocol for systematic review and meta analysis.
Topics: Fluorodeoxyglucose F18; Humans; Meta-Analysis as Topic; Multimodal Imaging; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Randomized Controlled Trials as Topic; Research Design; Sensitivity and Specificity; Severity of Illness Index; Systematic Review as Topic; Tropanes | 2020 |
Metastatic cervical lymph nodes from incidental thyroid cancer mimicking lymphomatous involvement on 18F-FDG PET/CT images.
Topics: Fluorodeoxyglucose F18; Humans; Lymph Nodes; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Sensitivity and Specificity; Thyroid Neoplasms | 2021 |
Total-body dynamic PET/CT of micro-metastatic lymph node in a patient with lung cancer.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Positron Emission Tomography Computed Tomography; Sensitivity and Specificity | 2021 |
Performance of Long-Term CT and PET/CT Surveillance for Detection of Distant Recurrence in Patients with Resected Stage IIIA-D Melanoma.
Topics: Australia; Fluorodeoxyglucose F18; Humans; Melanoma; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2021 |
Performance evaluation of the mouse version of the LabPET II PET scanner.
Topics: Animals; Brain; Calibration; Electronics; Equipment Design; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Mice; Phantoms, Imaging; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity; Whole Body Imaging | 2021 |
PET/MRI assessment of lung nodules in primary abdominal malignancies: sensitivity and outcome analysis.
Topics: Abdominal Neoplasms; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Magnetic Resonance Imaging; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2021 |
A machine learning-based radiomics model for the prediction of axillary lymph-node metastasis in breast cancer.
Topics: Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Machine Learning; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2021 |
Diagnostic performance of 18F-FDG PET/CT for the detection of occult primary tumors in squamous cell carcinoma of unknown primary in the head and neck: a single-center retrospective study.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Positron Emission Tomography Computed Tomography; Retrospective Studies; Sensitivity and Specificity | 2021 |
Digital PET/CT allows for shorter acquisition protocols or reduced radiopharmaceutical dose in [
Topics: Body Weight; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Signal-To-Noise Ratio | 2021 |
Improving accuracy of 18F-fluorodeoxyglucose PET computed tomography to diagnose nodal involvement in non-small cell lung cancer: utility of using various predictive models.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Sensitivity and Specificity | 2021 |
Topics: Aorta; Blood Vessel Prosthesis; Blood Vessel Prosthesis Implantation; Blood Vessels; Cardiac Surgical Procedures; Fluorodeoxyglucose F18; Fracture Fixation, Internal; Humans; Mediastinitis; Omentum; Positron Emission Tomography Computed Tomography; Postoperative Hemorrhage; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Recurrence; Sensitivity and Specificity; Sternum; Therapeutic Irrigation; Vascular Grafting; Wound Healing | 2021 |
Initial experience with positron emission tomography/computed tomography in addition to computed tomography and magnetic resonance imaging in preoperative risk assessment of endometrial cancer patients.
Topics: Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Risk Assessment; Sensitivity and Specificity; Tomography, X-Ray Computed | 2021 |
The value of endobronchial ultrasound-guided transbronchial needle aspiration, 18-fluorodeoxyglucose positron emission tomography/computed tomography, and ultrasonography imaging techniques in the diagnosis of mediastinal and/or hilar malignant, anthracot
Topics: Aged; Anthracosis; Diagnosis, Differential; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphadenopathy; Male; Mediastinum; Middle Aged; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Retrospective Studies; Sensitivity and Specificity; Ultrasonography | 2021 |
Role of dual-point 18F-FDG-PET/CT in the diagnosis of pancreatic adenocarcinoma, in patients with and without concomitant chronic pancreatitis: Comparison with CECT and EUS.
Topics: Adenocarcinoma; Carcinoma, Pancreatic Ductal; Fluorodeoxyglucose F18; Humans; Male; Pancreatic Neoplasms; Pancreatitis, Chronic; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2021 |
What Is the Comparative Ability of 18F-FDG PET/CT, 99mTc-MDP Skeletal Scintigraphy, and Whole-body MRI as a Staging Investigation to Detect Skeletal Metastases in Patients with Osteosarcoma and Ewing Sarcoma?
Topics: Adolescent; Adult; Bone Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Neoplasm Metastasis; Neoplasm Staging; Osteosarcoma; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sarcoma, Ewing; Sensitivity and Specificity; Technetium Tc 99m Medronate; Whole Body Imaging; Young Adult | 2021 |
Positron emission tomography in clinically suspected myocarditis - STREAM study design.
Topics: Aftercare; Cohort Studies; Fluorodeoxyglucose F18; Humans; Myocarditis; Patient Discharge; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity | 2021 |
Breast cancer detection by dedicated breast positron emission tomography according to the World Health Organization classification of breast tumors.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Whole Body Imaging; World Health Organization | 2021 |
FDG-PET-CT/MRI in head and neck squamous cell carcinoma: Impact on pretherapeutic N classification, detection of distant metastases, and second primary tumors.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Neoplasms, Second Primary; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck | 2021 |
Complicated pubovesical fistula on PET/CT and MRI.
Topics: Fistula; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Sensitivity and Specificity | 2021 |
Detection and staging of recurrent or metastatic nasopharyngeal carcinoma in the era of FDG PET/MR.
Topics: Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2022 |
Breast Metastasis of Primary Peritoneal Carcinoma Demonstrated on FDG PET/CT.
Topics: Breast Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2021 |
A comparison between 18F-FDG PET/CT and classical physical examination package for cancer screening in asymptomatic Chinese patients.
Topics: China; Early Detection of Cancer; Fluorodeoxyglucose F18; Humans; Neoplasms; Physical Examination; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2021 |
Evaluation of the Diagnostic Performance of Positron Emission Tomography/Magnetic Resonance for the Diagnosis of Liver Metastases.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2021 |
Role of dual-time point
Topics: Bile Duct Neoplasms; Fluorodeoxyglucose F18; Humans; Klatskin Tumor; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2021 |
FDG-PET/CT in intensive care patients with bloodstream infection.
Topics: Adult; Aged; Aged, 80 and over; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies; Sensitivity and Specificity; Sepsis | 2021 |
[Use of PET/CT for staging of Ewing's sarcoma. Report of one case].
Topics: Adolescent; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma, Ewing; Sensitivity and Specificity; Tomography, X-Ray Computed | 2020 |
Limited utility of novel serological biomarkers in patients newly suspected of having giant cell arteritis.
Topics: Adrenal Cortex Hormones; Aged; Biomarkers; Biopsy; C-Reactive Protein; Enzyme-Linked Immunosorbent Assay; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Interferon-gamma; Interleukin-12; Interleukin-6; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Procalcitonin; Sensitivity and Specificity; Serum Amyloid P-Component; Vascular Endothelial Growth Factor A; von Willebrand Factor | 2021 |
The Diagnostic Value of FDG-PET/CT for Urachal Cancer.
Topics: Carcinoma, Transitional Cell; Electrons; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Urinary Bladder Neoplasms | 2021 |
Accuracy of 18-F Fluorodeoxyglucose Positron Emission Tomographic/Computed Tomographic Imaging in Primary Staging of Squamous Cell Carcinoma of the Oral Cavity.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Mouth; Mouth Neoplasms; Neck; Neck Dissection; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Young Adult | 2021 |
FDG-PET/CT for pretherapeutic lymph node staging in non-small cell lung cancer: A tailored approach to the ESTS/ESMO guideline workflow.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Expressed Sequence Tags; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Male; Mediastinum; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Practice Guidelines as Topic; Prospective Studies; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Workflow | 2021 |
Value of accurate diagnosis for metastatic supraclavicular lymph nodes in breast cancer: assessment with neck US, CT, and 18F-FDG PET/CT.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography | 2021 |
Role of FDG PET/CT for detection of primary tumor in patients with extracervical metastases from carcinoma of unknown primary.
Topics: Aged; Carcinoma; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2021 |
[Temporal pole encephalocele, a surgical treatable cause of drug-resistant epilepsy].
Topics: Adult; Drug Resistant Epilepsy; Electroencephalography; Encephalocele; Epilepsies, Partial; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Male; Neuroimaging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2021 |
The additional diagnostic impact of positron emission tomography-computed tomography for lymph node metastasis from colorectal cancer: A prospective lymph node level analysis.
Topics: Adenocarcinoma; Aged; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity | 2021 |
Comparison of different diagnostic imaging techniques for the detection of bone invasion in oral cancers.
Topics: Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Mandible; Mouth Neoplasms; Neoplasm Invasiveness; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2021 |
CT texture analysis of tonsil cancer: Discrimination from normal palatine tonsils.
Topics: Aged; Area Under Curve; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Palatine Tonsil; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tonsillar Neoplasms | 2021 |
Value of [18F]FDG PET-CT in the follow-up of surgically treated oral tongue squamous cell carcinoma: single centre cohort analysis on 87 patients.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Tongue Neoplasms | 2021 |
Diagnostic performance of
Topics: Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Rectal Neoplasms; Retrospective Studies; Sensitivity and Specificity | 2021 |
Supporting imaging modalities for improving diagnosis of prosthesis endocarditis: preliminary results of a single-center experience with 18F-FDG-PET/CT.
Topics: Aged; Endocarditis; Female; Fluorodeoxyglucose F18; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Humans; Male; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity | 2017 |
Arterial spin labeling-based Z-maps have high specificity and positive predictive value for neurodegenerative dementia compared to FDG-PET.
Topics: Aged; Alzheimer Disease; Arteries; Brain; Female; Fluorodeoxyglucose F18; Frontotemporal Dementia; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Sensitivity and Specificity; Spin Labels | 2017 |
[Combined use of thin-section CT and
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Solitary Pulmonary Nodule | 2017 |
Use of FDG PET/CT in identification of bone marrow involvement in diffuse large B cell lymphoma and follicular lymphoma: comparison with iliac crest bone marrow biopsy.
Topics: Adult; Aged; Biopsy; Bone Marrow; Bone Marrow Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Ilium; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Young Adult | 2017 |
Abnormal metabolic brain network associated with Parkinson's disease: replication on a new European sample.
Topics: Aged; Brain; Case-Control Studies; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2017 |
FDG PET/CT as theranostic imaging in diagnosis of non-small cell lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung; Lung Neoplasms; Neoplasm Staging; Outcome Assessment, Health Care; Positron Emission Tomography Computed Tomography; Prognosis; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Survival Analysis; Theranostic Nanomedicine | 2017 |
Parameters of simultaneous 18F-FDG-PET/MRI predict tumor stage and several histopathological features in uterine cervical cancer.
Topics: Adult; Aged; Biomarkers; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Neoplasm Grading; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity; Uterine Cervical Neoplasms | 2017 |
The value of pre- and post-neoadjuvant chemotherapy F-18 FDG PET/CT scans in breast cancer: comparison with MRI.
Topics: Breast; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Treatment Outcome | 2018 |
Performance of 18F-FDG PET/CT in the Characterization of Adrenal Masses in Noncancer Patients: A Prospective Study.
Topics: Adrenal Gland Neoplasms; Adrenal Glands; Aged; Area Under Curve; Biopsy, Needle; Cohort Studies; Female; Fluorodeoxyglucose F18; France; Humans; Image Processing, Computer-Assisted; Immunohistochemistry; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prospective Studies; ROC Curve; Sensitivity and Specificity; Statistics, Nonparametric | 2017 |
Carcinoembryonic antigen directed PET-CECT scanning for postoperative surveillance of colorectal cancer.
Topics: Adult; Aged; Carcinoembryonic Antigen; Colectomy; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Postoperative Complications; Postoperative Period; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Young Adult | 2017 |
[
Topics: Comorbidity; Disease-Free Survival; Fluorodeoxyglucose F18; France; Humans; Idiopathic Pulmonary Fibrosis; Incidence; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Factors; Sensitivity and Specificity; Smoking; Survival Rate | 2017 |
Changes in the distributions of fluorine-18-labelled fluoro-2-deoxy-d-glucose accumulation into tongue-related muscles after dissection in patients with tongue cancer.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Muscle, Skeletal; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tongue Neoplasms | 2017 |
Detection of residual head and neck squamous cell carcinoma after (chemo)radiotherapy: a pilot study assessing the value of diffusion-weighted magnetic resonance imaging as an adjunct to PET-CT using
Topics: Adult; Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm, Residual; Pilot Projects; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2017 |
Metabolic volume performs better than SUVmax in the detection of left ventricular assist device driveline infection.
Topics: Female; Fluorodeoxyglucose F18; Heart-Assist Devices; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prosthesis-Related Infections; Radiopharmaceuticals; Sensitivity and Specificity | 2017 |
F-18 FDG and F-18 Tau PET in posterior cortical atrophy.
Topics: Alzheimer Disease; Atrophy; Cerebral Cortex; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; tau Proteins | 2017 |
Risk stratification of diffuse large B-cell lymphoma with interim PET-CT based on different cutoff Deauville scores.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Image Processing, Computer-Assisted; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prednisone; Prognosis; Reference Values; Rituximab; Sensitivity and Specificity; Treatment Outcome; Vincristine | 2018 |
Multiparametric voxel-based analyses of standardized uptake values and apparent diffusion coefficients of soft-tissue tumours with a positron emission tomography/magnetic resonance system: Preliminary results.
Topics: Adult; Aged; Diffusion Magnetic Resonance Imaging; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Grading; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; ROC Curve; Sarcoma; Sensitivity and Specificity; Soft Tissue Neoplasms; Tumor Burden | 2017 |
Can the combined administration of labelled fluoro-2 deoxy d glucose and insulin or chrome increase the diagnostic sensitivity of Positron Emission Tomography (PET)?
Topics: Fluorodeoxyglucose F18; Glycolysis; Humans; Insulin; Models, Theoretical; Neoplasms; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity | 2017 |
High FDG uptake on PET is associated with negative cell-to-cell adhesion molecule E-cadherin expression in lung adenocarcinoma.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antigens, CD; Biomarkers, Tumor; Cadherins; Cell Adhesion Molecules; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2017 |
18 F-FDG PET/MR imaging in patients with suspected liver lesions: Value of liver-specific contrast agent Gadobenate dimeglumine.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Hepatocellular; Cholangiocarcinoma; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Melanoma; Middle Aged; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2017 |
Prognostic value of positron emission tomography/computed tomography for adjuvant chemotherapy of colon cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cohort Studies; Colectomy; Colonic Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Kaplan-Meier Estimate; Leucovorin; Male; Middle Aged; Multivariate Analysis; Neoplasm Invasiveness; Neoplasm Staging; Organoplatinum Compounds; Positron Emission Tomography Computed Tomography; Prognosis; Proportional Hazards Models; Republic of Korea; Retrospective Studies; Risk Assessment; ROC Curve; Sensitivity and Specificity; Survival Analysis; Treatment Outcome | 2018 |
Fluorodeoxyglucose-positron emission tomography/computed tomography performs better than contrast-enhanced computed tomography for metastasis evaluation in the initial staging of pancreatic adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Contrast Media; Fluorodeoxyglucose F18; Humans; Image Enhancement; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2017 |
Diagnostic importance of 18F-FDG PET/CT parameters and total lesion glycolysis in differentiating between benign and malignant adrenal lesions.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Computer Simulation; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Image Interpretation, Computer-Assisted; Male; Metabolic Clearance Rate; Middle Aged; Models, Biological; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tissue Distribution | 2017 |
Positron emission tomography/computed tomography (PET/CT) and CT for N staging of non-small cell lung cancer.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2017 |
Analysis of metastatic involvement in bone using anatomical and functional information from 18F-FDG PET/CT.
Topics: Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Models, Biological; Models, Statistical; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2017 |
Clinical usefulness of F-18 FDG PET in lymphoepithelioma-like gastric carcinoma.
Topics: Aged; Epstein-Barr Virus Infections; Female; Fluorodeoxyglucose F18; Gastrectomy; Herpesvirus 4, Human; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Stomach Neoplasms | 2017 |
Oligometastatic Stomach Carcinoma From Lung Squamous Cell Carcinoma Detected by 18F-FDG PET/CT.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Sensitivity and Specificity; Stomach Neoplasms | 2017 |
68Ga-DOTATOC and 18F-FDG PET/CT for identifying the primary lesions of suspected and metastatic neuroendocrine tumors: A prospective study in Taiwan.
Topics: Adult; Aged; Aged, 80 and over; Area Under Curve; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neuroendocrine Tumors; Octreotide; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Taiwan; Young Adult | 2018 |
Re: 18F-FDG PET/CT Versus Contrast-Enhanced CT for Staging and Prognostic Prediction in Patients With Salivary Gland Carcinomas.
Topics: Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Salivary Glands; Sensitivity and Specificity; Tomography, X-Ray Computed | 2017 |
18F-fluoro-deoxy-glucose positron emission tomography combined with computed tomography can reliably rule-out infection and cancer in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis suspected of disease relapse.
Topics: Aged; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Infections; Male; Middle Aged; Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Recurrence; Retrospective Studies; Sensitivity and Specificity; Whole Body Imaging | 2017 |
Detection of Lymph Node Metastasis in Patients with Bladder Cancer using Maximum Standardised Uptake Value and
Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hospitals, High-Volume; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Preoperative Period; Reference Standards; Sensitivity and Specificity; Treatment Outcome; Urinary Bladder Neoplasms | 2019 |
Low Accuracy of Computed Tomography and Positron Emission Tomography to Detect Lung and Lymph Node Metastases of Colorectal Cancer.
Topics: Aged; Colorectal Neoplasms; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2017 |
The value of 18F-FDG PET/CT imaging in breast cancer staging.
Topics: Adult; Aged; Aged, 80 and over; Axilla; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Retrospective Studies; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Tomography, Emission-Computed; Young Adult | 2018 |
Predictive value of
Topics: Aged; Aorta; Aortic Diseases; Computed Tomography Angiography; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hematoma; Humans; Image Processing, Computer-Assisted; Inflammation; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; ROC Curve; Sensitivity and Specificity; Vena Cava, Superior | 2019 |
18F-FDG-PET/CT for the detection of disease in patients with head and neck cancer treated with radiotherapy.
Topics: Adult; Aged; Aged, 80 and over; Area Under Curve; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Neoplasm, Residual; Positron Emission Tomography Computed Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck | 2017 |
A new diagnostic marker for differentiating multicentric gliomas from multiple intracranial diffuse large B-cell lymphomas on 18F-FDG PET images.
Topics: Adult; Aged; Brain Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Glioma; Humans; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity | 2017 |
Regarding "Survival Outcomes in Asymptomatic Patients with Normal Conventional Imaging but Raised Carcinoembryonic Antigen Levels in Colorectal Cancer Following Positron Emission Tomography-Computed Tomography Imaging".
Topics: Carcinoembryonic Antigen; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2017 |
Amide proton transfer-weighted imaging to differentiate malignant from benign pulmonary lesions: Comparison with diffusion-weighted imaging and FDG-PET/CT.
Topics: Aged; Aged, 80 and over; Diagnosis, Differential; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Multiple Pulmonary Nodules; Positron Emission Tomography Computed Tomography; Prospective Studies; Protons; Radiopharmaceuticals; Sensitivity and Specificity; Solitary Pulmonary Nodule | 2018 |
Efficacy of PET/CT to exclude leiomyoma in patients with lesions suspicious for uterine sarcoma on MRI.
Topics: Adult; Aged; Area Under Curve; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Leiomyoma; Magnetic Resonance Imaging; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reference Values; Retrospective Studies; Sarcoma; Sensitivity and Specificity; Uterine Neoplasms | 2017 |
Diagnostic classification of solitary pulmonary nodules using dual time
Topics: Area Under Curve; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Granuloma; Humans; Lung Neoplasms; Machine Learning; Male; Positron Emission Tomography Computed Tomography; Reproducibility of Results; ROC Curve; Sensitivity and Specificity; Solitary Pulmonary Nodule | 2017 |
Usefulness of esophagogastroduodenoscopy and
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Early Detection of Cancer; Endoscopy, Digestive System; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Mouth Neoplasms; Neoplasms, Multiple Primary; Positron Emission Tomography Computed Tomography; Sensitivity and Specificity | 2017 |
Utility of (18) F-FDG PET/CT and CECT in conjunction with serum CA 19-9 for detecting recurrent pancreatic adenocarcinoma.
Topics: Adenocarcinoma; Aged; Biomarkers, Tumor; CA-19-9 Antigen; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Triiodobenzoic Acids | 2018 |
Longer-Term Investigation of the Value of 18F-FDG-PET and Magnetic Resonance Imaging for Predicting the Conversion of Mild Cognitive Impairment to Alzheimer's Disease: A Multicenter Study.
Topics: Aged; Alzheimer Disease; Brain; Cognitive Dysfunction; Disease Progression; Educational Status; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Logistic Models; Magnetic Resonance Imaging; Male; Multivariate Analysis; Neuropsychological Tests; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity | 2017 |
18F-FDG PET/CT in preoperative staging of vulvar cancer patients: is it really effective?
Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Groin; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Pelvis; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Preoperative Care; Radiopharmaceuticals; Sensitivity and Specificity; Vulvar Neoplasms | 2017 |
Heterogeneity of myocardial 2-[18F]fluoro-2-deoxy-D-glucose uptake is a typical feature in cardiac sarcoidosis: a study of 231 patients.
Topics: Analysis of Variance; Cardiomyopathies; Cohort Studies; Female; Finland; Fluorodeoxyglucose F18; Follow-Up Studies; Hospitals, University; Humans; Lymph Nodes; Male; Myocardial Perfusion Imaging; Positron Emission Tomography Computed Tomography; Reference Values; Retrospective Studies; Sarcoidosis; Sensitivity and Specificity; Severity of Illness Index | 2018 |
The value of
Topics: Adult; Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Retroperitoneal Fibrosis; Sensitivity and Specificity | 2018 |
PET-CT findings in patients with polymyalgia rheumatica without symptoms of cranial ischaemia.
Topics: Aged; Aged, 80 and over; C-Reactive Protein; Denmark; Female; Fluorodeoxyglucose F18; Hip; Humans; Male; Middle Aged; Polymyalgia Rheumatica; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Shoulder; Spine | 2017 |
Clinical Values of Combined Diffused Optical Tomography and PET-CT in the Diagnosis of Breast Cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Sensitivity and Specificity; Tomography, Optical | 2017 |
Topics: Adenocarcinoma; Aged; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2018 |
[18F]FDG positron emission tomography in patients presenting with suspicion of giant cell arteritis-lessons from a vasculitis clinic.
Topics: Aged; Aged, 80 and over; Ambulatory Care Facilities; Biopsy, Needle; Cohort Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Giant Cell Arteritis; Hospitals, University; Humans; Immunohistochemistry; Male; Positron Emission Tomography Computed Tomography; Retrospective Studies; Risk Assessment; ROC Curve; Sensitivity and Specificity; Statistics, Nonparametric; Switzerland; Time Factors; Visual Acuity | 2018 |
Role of delayed-time-point imaging during abdominal and pelvic cancer screening using FDG-PET/CT in the general population.
Topics: Abdominal Neoplasms; Adult; Aged; Aged, 80 and over; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pelvic Neoplasms; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Time Factors | 2017 |
Using simultaneous PET/MRI to compare the accuracy of diagnosing frontotemporal dementia by arterial spin labelling MRI and FDG-PET.
Topics: Aged; Brain; Female; Fluorodeoxyglucose F18; Frontotemporal Dementia; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Observer Variation; Pilot Projects; Positron-Emission Tomography; Sensitivity and Specificity; Spin Labels | 2018 |
Identification of Distant Metastatic Disease in Uterine Cervical and Endometrial Cancers with FDG PET/CT: Analysis from the ACRIN 6671/GOG 0233 Multicenter Trial.
Topics: Adult; Aged; Aged, 80 and over; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Societies, Medical; United States; Uterine Neoplasms | 2018 |
The utility of FDG-PET in complex neurological conditions.
Topics: Adult; Encephalitis; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neurologic Examination; Polymyalgia Rheumatica; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Vasculitis | 2017 |
[Coexistence of Takayasu's arteritis and inflammatory colitis detected by fluorodeoxyglucose positron emission tomography].
Topics: Adult; Colitis; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Inflammatory Bowel Diseases; Positron-Emission Tomography; Prednisolone; Radiopharmaceuticals; Sensitivity and Specificity; Takayasu Arteritis; Treatment Outcome; Vulnerable Populations | 2017 |
18F-FDG PET/CT in Diagnostic and Prognostic Evaluation of Patients With Suspected Recurrence of Chondrosarcoma.
Topics: Adolescent; Adult; Aged; Bone Neoplasms; Chondrosarcoma; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Survival Rate; Young Adult | 2018 |
Soft Tissue Sarcoma Response to Two Cycles of Neoadjuvant Chemotherapy: A Multireader Analysis of MRI Findings and Agreement with RECIST Criteria and Change in SUVmax.
Topics: Adult; Aged; Chemotherapy, Adjuvant; Child; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoadjuvant Therapy; Observer Variation; Positron-Emission Tomography; Response Evaluation Criteria in Solid Tumors; Retrospective Studies; Sarcoma; Sensitivity and Specificity; Soft Tissue Neoplasms; Treatment Outcome | 2018 |
Comparison between the diagnostic accuracies of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and conventional imaging in recurrent urothelial carcinomas: a retrospective, multicenter study.
Topics: Aged; Carcinoma, Transitional Cell; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Italy; Magnetic Resonance Imaging; Male; Minnesota; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Urinary Bladder Neoplasms | 2018 |
Diagnostic accuracy and prognostic value of simultaneous hybrid 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging in cardiac sarcoidosis.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Cardiomyopathies; Cause of Death; Cohort Studies; Death, Sudden, Cardiac; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Proportional Hazards Models; Prospective Studies; Sarcoidosis; Sensitivity and Specificity; Survival Analysis; Young Adult | 2018 |
The role of PET and MRI in evaluating the feasibility of skin-sparing mastectomy following neoadjuvant therapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Breast Neoplasms; Cyclophosphamide; Docetaxel; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Mastectomy; Middle Aged; Minimally Invasive Surgical Procedures; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Taxoids | 2018 |
Can diffusion-weighted whole-body MRI replace contrast-enhanced CT for initial staging of Hodgkin lymphoma in children and adolescents?
Topics: Adolescent; Child; Child, Preschool; Contrast Media; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging; Young Adult | 2018 |
Diagnostic performance of
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Pelvis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Rectal Neoplasms; Sensitivity and Specificity | 2018 |
Relationship between collateral circulation and myocardial viability of
Topics: Collateral Circulation; Coronary Angiography; Coronary Artery Disease; Female; Fluorodeoxyglucose F18; Heart; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Myocardium; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Rest; Sensitivity and Specificity; Severity of Illness Index | 2018 |
18F-Fluorodeoxyglucose positron emission tomography computed tomography detection threshold in follicular lymphoma: A case report.
Topics: Adrenal Cortex Hormones; Aged; Diagnosis, Differential; Fluorodeoxyglucose F18; Germinal Center; Humans; Lymphoma, Follicular; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2017 |
PET/CT predicts bone marrow involvement in paediatric non-Hodgkin lymphoma and may preclude the need for bone marrow biopsy in selected patients.
Topics: Adolescent; Adult; Biopsy; Bone Marrow; Bone Marrow Neoplasms; Cell Differentiation; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Lumbar Vertebrae; Lymphoma, Non-Hodgkin; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Young Adult | 2018 |
FDG-PET and CSF biomarker accuracy in prediction of conversion to different dementias in a large multicentre MCI cohort.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Brain; Cognitive Dysfunction; Disease Progression; Female; Fluorodeoxyglucose F18; Frontotemporal Dementia; Humans; Male; Middle Aged; Neuropsychological Tests; Phosphorylation; Positron-Emission Tomography; Prognosis; Sensitivity and Specificity; tau Proteins | 2018 |
Utility of additional dedicated high-resolution 3T MRI in children with medically refractory focal epilepsy.
Topics: Brain; Child; Drug Resistant Epilepsy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Magnetoencephalography; Male; Malformations of Cortical Development; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Seizures; Sensitivity and Specificity; Treatment Outcome | 2018 |
Prospective analysis of the utility of 18-FDG PET in Merkel cell carcinoma of the skin: A Trans Tasman Radiation Oncology Group Study, TROG 09:03.
Topics: Aged; Carcinoma, Merkel Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Skin Neoplasms; Survival Rate | 2018 |
A diagnostic cohort study on the accuracy of 18-fluorodeoxyglucose (
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Thymoma; Thymus Neoplasms; United Kingdom | 2018 |
Joint Assessment of Quantitative 18F-Florbetapir and 18F-FDG Regional Uptake Using Baseline Data from the ADNI.
Topics: Aged; Alzheimer Disease; Aniline Compounds; Brain; Brain Mapping; Cognitive Dysfunction; Cross-Sectional Studies; Disease Progression; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity | 2018 |
Sex differences in pericardial adipose tissue assessed by PET/CT and association with cardiometabolic risk.
Topics: Adipose Tissue; Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; Cardiovascular Diseases; Female; Fluorodeoxyglucose F18; Humans; Insulin Resistance; Male; Metabolic Syndrome; Middle Aged; Obesity; Overweight; Pericardium; Positron Emission Tomography Computed Tomography; Prevalence; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Sensitivity and Specificity; Sex Factors | 2018 |
Single-subject SPM FDG-PET patterns predict risk of dementia progression in Parkinson disease.
Topics: Aged; Brain; Dementia; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Models, Statistical; Parkinson Disease; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Risk Assessment; Sensitivity and Specificity | 2018 |
Predicting cognitive decline with deep learning of brain metabolism and amyloid imaging.
Topics: Aged; Alzheimer Disease; Amyloid; Aniline Compounds; Brain; Cognitive Dysfunction; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Male; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Support Vector Machine | 2018 |
Characterization of tubo-ovarian abscess mimicking adnexal masses: Comparison between contrast-enhanced CT,
Topics: Abscess; Adnexa Uteri; Adnexal Diseases; Adolescent; Adult; Aged; Contrast Media; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2018 |
The Effect on Survival and Mortality of the Highest SUVmax Value on Metastatic Foci in Postoperative Kidney Tumors.
Topics: Adult; Aged; Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Kidney Neoplasms; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postoperative Period; Predictive Value of Tests; Preoperative Care; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Tumor Burden | 2018 |
Usefulness of positron emission tomography/computed tomography in patients with valve-tube graft infection.
Topics: Adult; Aged; Aged, 80 and over; Aortic Valve; Blood Vessel Prosthesis; Endocarditis; Female; Fluorodeoxyglucose F18; Heart Valve Prosthesis; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prospective Studies; Prosthesis-Related Infections; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Spain; Vascular Grafting | 2018 |
Clinical utility of simultaneous whole-body
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nasopharyngeal Carcinoma; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2018 |
Relationship of myocardial hibernation, scar, and angiographic collateral flow in ischemic cardiomyopathy with coronary chronic total occlusion.
Topics: Aged; Cardiomyopathies; Contrast Media; Coronary Angiography; Coronary Occlusion; Female; Fluorodeoxyglucose F18; Gadolinium; Heart; Heart Failure; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Myocardial Ischemia; Myocardial Perfusion Imaging; Myocardium; Positron Emission Tomography Computed Tomography; Retrospective Studies; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 2019 |
99mTc-Methionine Hybrid SPECT/CT for Detection of Recurrent Glioma: Comparison With 18F-FDG PET/CT and Contrast-Enhanced MRI.
Topics: Adult; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioma; Humans; Magnetic Resonance Imaging; Male; Methionine; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Single Photon Emission Computed Tomography Computed Tomography; Technetium | 2018 |
Multi-Modality Sparse Representation for Alzheimer's Disease Classification.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cognitive Dysfunction; Fluorodeoxyglucose F18; Hippocampus; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Pattern Recognition, Automated; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Support Vector Machine | 2018 |
Tumor response to neoadjuvant chemotherapy in patients with esophageal cancer assessed with CT and FDG-PET/CT - RECIST 1.1 vs. PERCIST 1.0.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Fluorouracil; Glycolysis; Humans; Infusions, Intravenous; Male; Middle Aged; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Response Evaluation Criteria in Solid Tumors; Sensitivity and Specificity; Treatment Outcome; Tumor Burden | 2018 |
Diagnostic value of FDG-PET/CT for lateral pelvic lymph node metastasis in rectal cancer treated with preoperative chemoradiotherapy.
Topics: Adult; Aged; Chemoradiotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Pelvis; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Preoperative Care; Radiopharmaceuticals; Rectal Neoplasms; Rectum; Sensitivity and Specificity | 2018 |
Early Cardiac Involvement Affects Left Ventricular Longitudinal Function in Females Carrying α-Galactosidase A Mutation: Role of Hybrid Positron Emission Tomography and Magnetic Resonance Imaging and Speckle-Tracking Echocardiography.
Topics: Adult; Aged; alpha-Galactosidase; Biomarkers; Cardiac-Gated Imaging Techniques; Contrast Media; Echocardiography, Doppler; Fabry Disease; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Mutation; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Troponin; Ventricular Dysfunction, Left | 2018 |
Value of
Topics: Adult; Aged; Aged, 80 and over; Ascites; Biomarkers, Tumor; CA-125 Antigen; Carcinoembryonic Antigen; Enzyme-Linked Immunosorbent Assay; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Sex Factors; Survival Analysis | 2018 |
Predicting Imminent Progression to Clinically Significant Memory Decline Using Volumetric MRI and FDG PET.
Topics: Aged; Alzheimer Disease; Apolipoproteins E; Brain; Cognitive Dysfunction; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity | 2018 |
Systematic Compared With Targeted Staging With Endobronchial Ultrasound in Patients With Lung Cancer.
Topics: Adult; Aged; Bronchoscopy; Carcinoma, Non-Small-Cell Lung; Cohort Studies; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Node Excision; Lymph Nodes; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Retrospective Studies; Sensitivity and Specificity; Spain | 2018 |
Multimodal and Multiscale Deep Neural Networks for the Early Diagnosis of Alzheimer's Disease using structural MR and FDG-PET images.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Case-Control Studies; Cognitive Dysfunction; Deep Learning; Early Diagnosis; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neural Networks, Computer; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2018 |
Individualized threshold for tumor segmentation in 18F-FDG PET/CT imaging: The key for response evaluation of neoadjuvant chemoradiation therapy in patients with rectal cancer?
Topics: Adenocarcinoma; Adult; Aged; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Rectal Neoplasms; Retrospective Studies; Sensitivity and Specificity; Treatment Outcome; Tumor Burden | 2018 |
Which is better for predicting pelvic lymph node metastases in patients with cervical cancer: Fluorodeoxyglucose-positron emission tomography/computed tomography or a sentinel node biopsy? A retrospective observational study.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Pelvic Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Uterine Cervical Neoplasms | 2018 |
Fluorodeoxyglucose positron emission tomography imaging for diagnosing periprosthetic hip infection: the importance of diagnostic criteria.
Topics: Aged; Aged, 80 and over; Cohort Studies; Female; Fluorodeoxyglucose F18; Hip Joint; Hip Prosthesis; Humans; Male; Middle Aged; Positron-Emission Tomography; Prosthesis-Related Infections; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2018 |
[Application of (18)F-fluorodeoxyglucose Metabolic Imaging in Diagnosis and Treatment of Cervical Cancer].
Topics: Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Pelvis; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Single Photon Emission Computed Tomography Computed Tomography; Uterine Cervical Neoplasms | 2016 |
Diagnostic accuracy of CE-CT, MRI and FDG PET/CT for detecting colorectal cancer liver metastases in patients considered eligible for hepatic resection and/or local ablation.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prospective Studies; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2018 |
Impact of
Topics: Adult; Aged; Brain Neoplasms; Disease Progression; Female; Fluorodeoxyglucose F18; Glioma; Heavy Ion Radiotherapy; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiotherapy, Computer-Assisted; Retrospective Studies; Sensitivity and Specificity; Survival Analysis; Tumor Burden | 2018 |
Role of 18F-FDG PET/CT in patients without known primary malignancy with skeletal lesions suspicious for cancer metastasis.
Topics: Aged; Bone and Bones; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2018 |
Detection of loco-regional recurrence in malignant head and neck tumors: a comparison of CT, MRI, and FDG PET-CT.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2019 |
Diagnosis of vasculitis with
Topics: Adrenal Cortex Hormones; Fever of Unknown Origin; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Vasculitis | 2019 |
A Mass With High Uptake of Fluorodeoxyglucose on Positron Emission Tomography.
Topics: Adolescent; Ankle Joint; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity; Synovitis, Pigmented Villonodular | 2018 |
Is FDG-PET/CT Useful for Diagnosing Pulmonary Metastasis in Patients with Soft Tissue Sarcoma?
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Reproducibility of Results; Retrospective Studies; Sarcoma; Sensitivity and Specificity; Tomography, X-Ray Computed | 2018 |
[The role of preoperative (18)F-FDG PET-CT in lymphatic metastasis diagnosis of cutaneous malignant melanoma on extremities and trunk].
Topics: Extremities; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Melanoma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Skin Neoplasms; Torso | 2018 |
PET/CT and prediction of thyroid cancer in patients with follicular neoplasm or atypia.
Topics: Adult; Aged; Aged, 80 and over; Biopsy, Fine-Needle; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Sensitivity and Specificity; Thyroid Neoplasms; Thyroid Nodule; Ultrasonography; Young Adult | 2018 |
18F-FDG PET/CT for invasive fungal infection in immunocompromised patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Immunocompromised Host; Invasive Fungal Infections; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Young Adult | 2018 |
European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain
Topics: Brain; Cognitive Dysfunction; Consensus; Dementia; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Neurodegenerative Diseases; Nuclear Medicine; Positron-Emission Tomography; Sensitivity and Specificity | 2018 |
Clinically simplified screening methods to evaluate maximum standard uptake value from F-18-FDG-PET/CT in patients with non-small-cell lung cancer.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Databases, Factual; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies; ROC Curve; Sensitivity and Specificity | 2018 |
Computed Tomographic Studies of Noncalcified Nodules Related to Neuroendocrine Lung Tumor Using 68Gallium-Tagged Somatostatin Variant for Improvement in Diagnosis: A Non-Experimental, Non-Randomized, Cross-Sectional Study.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; Gallium; Heterocyclic Compounds, 1-Ring; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Receptors, Somatostatin; Sensitivity and Specificity; Somatostatin; Tomography, X-Ray Computed | 2018 |
Efficacy and Limitations of F-18-fluoro-2-deoxy-D-glucose Positron Emission Tomography to Differentiate Between Malignant and Benign Bone and Soft Tissue Tumors.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Sensitivity and Specificity; Soft Tissue Neoplasms; Young Adult | 2018 |
Considerations on 18FDG PET/CT and sentinel lymph node biopsy in AJCC stages I and II of melanoma.
Topics: Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Melanoma; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Skin Neoplasms | 2020 |
FDG-PET/CT for Assessing the Response to Neoadjuvant Chemotherapy in Bladder Cancer Patients.
Topics: Adult; Aged; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Prognosis; Sensitivity and Specificity; Treatment Outcome; Urinary Bladder Neoplasms | 2018 |
Pathology of Nerve Biopsy and Diagnostic Yield of PCR-Based Clonality Testing in Neurolymphomatosis.
Topics: Aged; Aged, 80 and over; Antigens, CD; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Immunomodulation; Male; Middle Aged; Neural Conduction; Neurolymphomatosis; Peripheral Nerves; Polymerase Chain Reaction; Positron-Emission Tomography; Predictive Value of Tests; Retrospective Studies; Sensitivity and Specificity | 2018 |
Diagnostic utility of whole body CT scanning in patients with unexplained weight loss.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Predictive Value of Tests; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Weight Loss; Whole Body Imaging; Young Adult | 2018 |
Use of 18F-FDG-PET/CT for Retroperitoneal/Intra-Abdominal Soft Tissue Sarcomas.
Topics: Abdominal Cavity; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Positron Emission Tomography Computed Tomography; Prognosis; Retroperitoneal Neoplasms; Sarcoma; Sensitivity and Specificity | 2018 |
Simple dichotomous assessment of cranial artery inflammation by conventional 18F-FDG PET/CT shows high accuracy for the diagnosis of giant cell arteritis: a case-control study.
Topics: Aged; Case-Control Studies; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Inflammation; Male; Observer Variation; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2019 |
Combination of positron emission tomography/computed tomography and chest thin-layer high-resolution computed tomography for evaluation of pulmonary nodules: Correlation with imaging features, maximum standardized uptake value, and pathology.
Topics: Adult; Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Multiple Pulmonary Nodules; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Solitary Pulmonary Nodule; Thorax; Tomography, X-Ray Computed; Young Adult | 2018 |
Efficacy of 18-fluoro deoxy glucose-positron emission tomography computed tomography for the detection of colonic neoplasia proximal to obstructing colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Colectomy; Colon; Colonic Neoplasms; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Intestinal Obstruction; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Preoperative Care; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Treatment Outcome | 2018 |
Clinical significance of the post-radiotherapy
Topics: Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Staging; Neoplasm, Residual; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Time Factors; Young Adult | 2019 |
The effects of image reconstruction algorithms on topographic characteristics, diagnostic performance and clinical correlation of metabolic brain networks in Parkinson's disease.
Topics: Algorithms; Brain; Cohort Studies; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Neural Pathways; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2018 |
Metabolic tumor heterogeneity analysis by F-18 FDG PET/CT predicts mediastinal lymph node metastasis in non-small cell lung cancer patients with clinically suspected N2.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity | 2018 |
Central Nervous System Myelomatosis Delineated by High-Resolution Brain Images From Fully Digital 18F-FDG PET.
Topics: Brain; Central Nervous System Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple Myeloma; Positron-Emission Tomography; Sensitivity and Specificity | 2018 |
Predictive Value of FDG PET/CT to Detect Lymph Node Metastases in Cervical Cancer.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Retrospective Studies; Sensitivity and Specificity; Uterine Cervical Neoplasms | 2018 |
Diagnostic value of fluorine-18 deoxyglucose positron emission tomography/computed tomography in deep sternal wound infection.
Topics: Adult; Aged; Aged, 80 and over; Candidiasis; Female; Fluorodeoxyglucose F18; Humans; Klebsiella Infections; Male; Mediastinitis; Middle Aged; Osteomyelitis; Positron Emission Tomography Computed Tomography; Prospective Studies; Pseudomonas Infections; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Staphylococcal Infections; Sternum; Surgical Wound Infection; Thoracic Surgical Procedures; Tietze's Syndrome | 2018 |
Comparison of 99mTc-methyl diphosphonate bone scintigraphy and 18F-fluorodeoxyglucose positron emission tomography/computed tomography to predict histologic response to neoadjuvant chemotherapy in patients with osteosarcoma.
Topics: Adolescent; Adult; Area Under Curve; Bone Neoplasms; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Male; Neoadjuvant Therapy; Osteosarcoma; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Technetium Tc 99m Medronate; Treatment Outcome; Young Adult | 2018 |
[
Topics: Animals; Central Nervous System Neoplasms; Disease Models, Animal; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioblastoma; Heterografts; Histocytochemistry; Humans; Image Processing, Computer-Assisted; Lymphoma; Magnetic Resonance Imaging; Neoplasm Transplantation; Positron-Emission Tomography; Radiopharmaceuticals; Rats, Nude; Sensitivity and Specificity; Vidarabine | 2018 |
A smart and operator independent system to delineate tumours in Positron Emission Tomography scans.
Topics: Algorithms; Brain Neoplasms; Diagnosis, Computer-Assisted; False Positive Reactions; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Neoplasm Metastasis; Neoplasms; Observer Variation; Pattern Recognition, Automated; Phantoms, Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiotherapy Planning, Computer-Assisted; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Software; Tomography, X-Ray Computed | 2018 |
The role of dual time point PET/CT for distinguishing malignant from benign focal 18F-FDG uptake duodenal lesions.
Topics: Adult; Aged; Aged, 80 and over; Area Under Curve; Diagnosis, Differential; Duodenal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reference Values; Reproducibility of Results; Sensitivity and Specificity; Time Factors | 2018 |
The diagnostic accuracy of fluorodeoxyglucose-positron emission tomography/computed tomography and sentinel node biopsy in the prediction of pelvic lymph node metastasis in patients with endometrial cancer: A retrospective observational study.
Topics: Aged; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Pelvis; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Sentinel Lymph Node Biopsy | 2018 |
Clinical Value of Hybrid TOF-PET/MR Imaging-Based Multiparametric Imaging in Localizing Seizure Focus in Patients with MRI-Negative Temporal Lobe Epilepsy.
Topics: Adult; Epilepsy, Temporal Lobe; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neuroimaging; Positron-Emission Tomography; Sensitivity and Specificity | 2018 |
Takayasu arteritis detected by PET/MRI with
Topics: Adolescent; Electrocardiography; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Takayasu Arteritis | 2020 |
Association of Fludeoxyglucose F 18-Labeled Positron Emission Tomography and Computed Tomography With the Detection of Oropharyngeal Cancer Recurrence.
Topics: Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Oropharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Treatment Outcome | 2018 |
A new strategy based on fluorodeoxyglucose-positron emission tomography for managing liver metastasis from colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Colorectal Neoplasms; Decision Support Techniques; Fluorodeoxyglucose F18; Hepatectomy; Humans; Liver Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2018 |
What is the diagnostic performance of 18-FDG-PET/MR compared to PET/CT for the N- and M- staging of breast cancer?
Topics: Adult; Aged; Axilla; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity | 2019 |
Utility of FDG PET/CT in the Characterization of Sinonasal Neoplasms: Analysis of Standardized Uptake Value Parameters.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Paranasal Sinus Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Young Adult | 2018 |
Hounsfield unit value has null effect on thyroid nodules at 18F-FDG PET/CT scans.
Topics: Adult; Aged; Biopsy, Fine-Needle; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Thyroid Gland; Thyroid Neoplasms; Thyroid Nodule; Thyroidectomy | 2018 |
The added value of whole-body magnetic resonance imaging in the management of patients with advanced breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast; Breast Neoplasms; Disease Progression; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Patient Selection; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Treatment Outcome; Whole Body Imaging | 2018 |
Is C-11 Methionine PET an alternative to 18-F FDG-PET for identifying recurrent laryngeal cancer after radiotherapy?
Topics: Aged; Carcinoma; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Male; Methionine; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2019 |
Discriminative Accuracy of [18F]flortaucipir Positron Emission Tomography for Alzheimer Disease vs Other Neurodegenerative Disorders.
Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Area Under Curve; Carbolines; Cerebral Cortex; Cognitive Dysfunction; Cross-Sectional Studies; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neurodegenerative Diseases; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2018 |
Use of
Topics: Adult; Aged; Algorithms; Area Under Curve; Diagnosis, Computer-Assisted; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Multivariate Analysis; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sarcoidosis; Sensitivity and Specificity | 2019 |
FDG PET for Evaluation of Bone Marrow Status in T-Cell Lymphoma.
Topics: Adult; Aged; Bone Marrow; Bone Marrow Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, T-Cell; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2019 |
Meta-analysis for diagnostic tests.
Topics: Diagnostic Tests, Routine; Fluorodeoxyglucose F18; Humans; ROC Curve; Sensitivity and Specificity; Vasculitis | 2019 |
Radio-pathological Correlation of 18F-FDG PET in Characterizing Gallbladder Wall Thickening.
Topics: Adolescent; Adult; Aged; Cholecystectomy; Cholecystitis; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Gallbladder; Gallbladder Neoplasms; Humans; Lymph Nodes; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography; Young Adult | 2019 |
A Deep Learning Model to Predict a Diagnosis of Alzheimer Disease by Using
Topics: Aged; Aged, 80 and over; Algorithms; Alzheimer Disease; Cognitive Dysfunction; Deep Learning; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity | 2019 |
Comparing diagnostic accuracy of
Topics: Aged; Blood Vessel Prosthesis; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Observer Variation; Positron Emission Tomography Computed Tomography; Postoperative Complications; Predictive Value of Tests; Prospective Studies; Prosthesis-Related Infections; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Veins | 2019 |
Amide proton transfer imaging to evaluate the grading of squamous cell carcinoma of the cervix: A comparative study using
Topics: Amides; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Observer Variation; Positron-Emission Tomography; Prospective Studies; Protons; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2019 |
Palatine tonsil SUVmax on FDG PET-CT as a discriminator between benign and malignant tonsils in patients with and without head and neck squamous cell carcinoma of unknown primary.
Topics: Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Palatine Tonsil; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck | 2019 |
A multiparametric MRI-based machine learning to distinguish between uterine sarcoma and benign leiomyoma: comparison with
Topics: Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Leiomyoma; Machine Learning; Magnetic Resonance Imaging; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sarcoma; Sensitivity and Specificity; Uterine Neoplasms; Uterus; Young Adult | 2019 |
Prediction of ultrasound guided fine needle aspiration cytology results by FDG PET-CT for lymph node metastases in head and neck squamous cell carcinoma patients.
Topics: Adult; Cytodiagnosis; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Retrospective Studies; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck | 2018 |
18F-FDG PET-CT in Unknown-Source of Elevated Serum Carcinoembryonic Antigen (CEA) Level.
Topics: Adult; Aged; Carcinoembryonic Antigen; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2018 |
FDG-PET/CT for Detecting an Infection Focus in Patients With Bloodstream Infection: Factors Affecting Diagnostic Yield.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies; Sensitivity and Specificity | 2019 |
Prognostic value of metabolic tumor burden calculated using dual-time-point 18F-fluorodeoxyglucose positron emission tomography/CT in patients with oropharyngeal or hypopharyngeal cancer.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Hypopharyngeal Neoplasms; Male; Oropharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Progression-Free Survival; Radiopharmaceuticals; Sensitivity and Specificity; Tumor Burden | 2019 |
Use of MRI and FDG-PET/CT to predict fixation of advanced hypopharyngeal squamous cell carcinoma to prevertebral space.
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Invasiveness; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Spine | 2019 |
Diagnostic Accuracy of 18F-FDG PET/CT in Patients With Biochemical Evidence of Recurrent, Residual, or Metastatic Medullary Thyroid Carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Calcitonin; Carcinoembryonic Antigen; Carcinoma, Neuroendocrine; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm, Residual; Positron Emission Tomography Computed Tomography; Recurrence; Retrospective Studies; Sensitivity and Specificity; Thyroid Neoplasms; Young Adult | 2019 |
Clinical Value of Positron Emission Tomography-Computed Tomography Combined with Ultrasound in Detection of Primary Tumors in Patients with Malignant Ascites.
Topics: Ascites; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Ultrasonography | 2019 |
FDG PET/CT to predict the curability of endoscopic resection for early gastric cancer.
Topics: Adult; Aged; Aged, 80 and over; Area Under Curve; Endoscopic Mucosal Resection; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Stomach Neoplasms | 2019 |
Usefulness of
Topics: Aged; Case-Control Studies; Female; Fluorodeoxyglucose F18; Humans; Lung; Lymph Nodes; Lymphoma; Male; Middle Aged; Parotid Gland; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Sjogren's Syndrome | 2019 |
Utility of a repeat PET/CT scan in HPV-associated Oropharyngeal Cancer following incomplete nodal response from (chemo)radiotherapy.
Topics: Adult; Aged; Aged, 80 and over; Chemoradiotherapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Neoplasm Recurrence, Local; Oropharyngeal Neoplasms; Papillomaviridae; Papillomavirus Infections; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Young Adult | 2019 |
Testing the diagnostic accuracy of [18F]FDG-PET in discriminating spinal- and bulbar-onset amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Medulla Oblongata; Middle Aged; Motor Cortex; Sensitivity and Specificity; Spine | 2019 |
Visualization of arterial wall vascularization using superb microvascular imaging in active-stage Takayasu arteritis.
Topics: Adult; Carotid Artery, Common; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Magnetic Resonance Angiography; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Sensitivity and Specificity; Severity of Illness Index; Takayasu Arteritis; Ultrasonography | 2019 |
Application of positron emission tomography imaging to personalize esophagogastric cancer care.
Topics: Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Positron-Emission Tomography; Precision Medicine; Radiopharmaceuticals; Sensitivity and Specificity; Stomach Neoplasms; Treatment Outcome | 2019 |
FDG-PET underscores the key role of the thalamus in frontotemporal lobar degeneration caused by C9ORF72 mutations.
Topics: Aged; C9orf72 Protein; Cerebellum; Female; Fluorodeoxyglucose F18; Frontotemporal Lobar Degeneration; Humans; Male; Middle Aged; Mutation; Positron-Emission Tomography; Sensitivity and Specificity; Thalamus | 2019 |
Para-aortic Lymph Node Invasion in High-risk Endometrial Cancer: Performance of
Topics: Adult; Aged; Aorta; Area Under Curve; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2019 |
Association between FDG uptake in the right ventricular myocardium and cancer therapy-induced cardiotoxicity.
Topics: Adult; Aged; Aged, 80 and over; Anthracyclines; Breast Neoplasms; Cardiotoxicity; Echocardiography; Female; Fluorodeoxyglucose F18; Heart Ventricles; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Regression Analysis; ROC Curve; Sensitivity and Specificity; Trastuzumab; Ventricular Dysfunction, Right | 2020 |
FDG-PET/CT improves detection of residual disease and reduces the need for examination under anaesthesia in oropharyngeal cancer patients treated with (chemo-)radiation.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm, Residual; Oropharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Treatment Outcome | 2019 |
Correlation between EGFR mutation status and F
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; ErbB Receptors; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Mutation; Non-Smokers; Positron Emission Tomography Computed Tomography; Radiographic Image Interpretation, Computer-Assisted; Regression Analysis; Retrospective Studies; ROC Curve; Sensitivity and Specificity | 2019 |
Integrated PET-MRI for Glioma Surveillance: Perfusion-Metabolism Discordance Rate and Association With Molecular Profiling.
Topics: Adult; Aged; Brain Neoplasms; Disease Progression; Female; Fluorodeoxyglucose F18; Glioma; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Grading; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tumor Burden | 2019 |
Solitary Nodular Invasive Mucinous Adenocarcinoma of the Lung: Imaging Diagnosis Using the Morphologic-Metabolic Dissociation Sign.
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2019 |
The value of 18F-FDG PET/CT in the diagnosis of different size of solitary pulmonary nodules.
Topics: Diagnosis, Differential; Dimensional Measurement Accuracy; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tumor Burden | 2019 |
Fluorine-18-fluorodeoxyglucose-positron emission tomography evaluation in metastatic bone lesions in lung cancer: Possible prediction of pain and skeletal-related events.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Cancer Pain; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Sensitivity and Specificity; Small Cell Lung Carcinoma | 2019 |
Clinical Value of Fused PET/MRI for Surgical Planning in Patients With Oral/Oropharyngeal Carcinoma.
Topics: Aged; Aged, 80 and over; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Mandibular Neoplasms; Middle Aged; Mouth Neoplasms; Multimodal Imaging; Neoplasm Invasiveness; Oropharyngeal Neoplasms; Patient Care Planning; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2020 |
Development and validation of the PET-CT score for diagnosis of malignant pleural effusion.
Topics: Adult; Aged; Aged, 80 and over; Area Under Curve; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Likelihood Functions; Lung; Lung Neoplasms; Male; Middle Aged; Observer Variation; Pleural Effusion, Malignant; Positron Emission Tomography Computed Tomography; Prospective Studies; Reproducibility of Results; Sensitivity and Specificity; Solitary Pulmonary Nodule; Young Adult | 2019 |
Prognostic Value of Baseline and Interim Total Metabolic Tumor Volume and Total Lesion Glycolysis Measured on 18F-FDG PET-CT in Patients with Follicular Lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Area Under Curve; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lymphoma, Follicular; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; ROC Curve; Sensitivity and Specificity; Survival Analysis; Tumor Burden | 2019 |
[Role of 18F-FDG PET/CT in comparison with CECT for whole-body assessment of patients with esophageal cancer.]
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2019 |
An exceptional group of non-small cell lung cancer difficult to diagnose: Evaluation of lipid-poor adrenal lesions.
Topics: Adrenal Gland Neoplasms; Aged; Biopsy; Blood Glucose; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Female; Fluorodeoxyglucose F18; Humans; Lipids; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Retrospective Studies; ROC Curve; Sensitivity and Specificity | 2019 |
FDG PET/CT for metastatic squamous cell carcinoma of unknown primary of the head and neck.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Neoplasms, Unknown Primary; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2019 |
The clinical utility of phase-based respiratory gated PET imaging based on visual feedback with a head-mounted display system.
Topics: Aged; Biliary Tract Neoplasms; Equipment Design; Feedback, Sensory; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Multimodal Imaging; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Respiratory-Gated Imaging Techniques; Retrospective Studies; Sensitivity and Specificity; User-Computer Interface | 2019 |
Prognostic value of fluorodeoxyglucose positron emission tomography/computed tomography and inguinal sentinel lymph node biopsy in patients with anal cancer.
Topics: Aged; Anus Neoplasms; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Inguinal Canal; Lymph Node Excision; Lymphatic Metastasis; Lymphoscintigraphy; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Sentinel Lymph Node Biopsy | 2019 |
Solitary pulmonary nodule: Comparison of quantitative capability for differentiation and management among dynamic CE-perfusion MRI at 3 T system, dynamic CE-perfusion ADCT and FDG-PET/CT.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Perfusion Imaging; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, Spiral Computed; Tomography, X-Ray Computed | 2019 |
Occult mediastinal lymph node metastasis in FDG-PET/CT node-negative lung adenocarcinoma patients: Risk factors and histopathological study.
Topics: Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Neoplasm Staging; Pneumonectomy; Positron Emission Tomography Computed Tomography; Retrospective Studies; Sensitivity and Specificity; Tumor Burden | 2019 |
Three-dimensional fat-saturated T1-weighted Cartesian volumetric interpolated breath-hold examination (VIBE) for the diagnosis of aortitis in patients with suspected large vessel vasculitis: a comparative study with
Topics: Aged; Aortitis; Breath Holding; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Vasculitis | 2019 |
Risk of Malignancy in FDG-Avid Thyroid Incidentalomas on PET/CT: A Prospective Study.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Biopsy, Fine-Needle; Denmark; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prospective Studies; Risk; Sensitivity and Specificity; Thyroid Neoplasms; Thyroid Nodule; Ultrasonography | 2019 |
Diagnostic Accuracy of Advanced Imaging in Cardiac Sarcoidosis.
Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Heart Transplantation; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sarcoidosis; Sensitivity and Specificity | 2019 |
Cystic form of cervical lymphadenopathy. Guidelines of the French Society of Otorhinolaryngology - Head and Neck Surgery (SFORL). Part 1: Diagnostic procedures for lymphadenopathy in case of cervical mass with cystic aspect.
Topics: Adult; Biopsy, Fine-Needle; Diagnosis, Differential; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image-Guided Biopsy; Lymphadenopathy; Magnetic Resonance Imaging; Nasopharyngeal Neoplasms; Oropharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Sensitivity and Specificity; Thyroid Cancer, Papillary; Thyroid Neoplasms; Tomography, X-Ray Computed; Ultrasonography | 2019 |
Feasibility of somatostatin receptor-targeted imaging for detection of myocardial inflammation: A pilot study.
Topics: Aged; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocarditis; Organometallic Compounds; Pilot Projects; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Receptors, Somatostatin; Sarcoidosis; Sensitivity and Specificity | 2021 |
18F FDG-PET/CT has poor diagnostic accuracy in diagnosing shoulder PJI.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Joint Diseases; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prosthesis-Related Infections; Radiopharmaceuticals; Sensitivity and Specificity; Shoulder Joint; Shoulder Prosthesis | 2019 |
18F-FDOPA PET Compared With 123I-Metaiodobenzylguanidine Scintigraphy and 18F-FDG PET in Secreting Sporadic Pheochromocytoma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Male; Pheochromocytoma; Positron Emission Tomography Computed Tomography; Sensitivity and Specificity; Young Adult | 2019 |
Somatostatin receptor imaging in active cardiac sarcoidosis: Would less be enough?
Topics: Fluorodeoxyglucose F18; Humans; Myocarditis; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Receptors, Somatostatin; Sarcoidosis; Sensitivity and Specificity | 2021 |
The clinical value of F-18 FDG PET/CT in differentiating malignant from benign lesions in pneumoconiosis patients.
Topics: Adult; Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Hyperplasia; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Neoplasm Staging; Pneumoconiosis; Positron Emission Tomography Computed Tomography; Pulmonary Fibrosis; Retrospective Studies; ROC Curve; Sensitivity and Specificity | 2020 |
Diagnostic Performance of ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/CT for Chronic Empyema-Associated Malignancy.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Empyema; Female; Fistula; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity | 2019 |
Diagnostic performance of 18F-fluorodeoxyglucose positron emission tomography in the evaluation of glioma.
Topics: Adult; Aged; Brain Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Grading; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2019 |
Assessment of FDG retention differences between the FDG-avid benign pulmonary lesion and primary lung cancer using dual-time-point FDG-PET imaging.
Topics: Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Metabolic Clearance Rate; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tissue Distribution; Tuberculosis, Pulmonary | 2013 |
Fifteen different 18F-FDG PET/CT qualitative and quantitative parameters investigated as pathological response predictors of locally advanced rectal cancer treated by neoadjuvant chemoradiation therapy.
Topics: Adult; Aged; Aged, 80 and over; Area Under Curve; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Male; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Radionuclide Imaging; Radiopharmaceuticals; Rectal Neoplasms; Reproducibility of Results; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Treatment Outcome | 2013 |
NSCLC subtype prediction using cytologic fluid specimens from needle aspiration biopsies.
Topics: Aged; Antigens, Neoplasm; Area Under Curve; Biomarkers, Tumor; Biopsy, Needle; Body Fluids; Carcinoembryonic Antigen; Carcinoma, Non-Small-Cell Lung; Cytodiagnosis; Female; Fluorodeoxyglucose F18; Humans; Keratin-19; Lung Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity | 2013 |
Value of ¹⁸F-FDG PET/CT in the diagnosis of primary gastric cancer via stomach distension.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Diatrizoate Meglumine; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Stomach; Stomach Neoplasms; Tomography, X-Ray Computed | 2013 |
Clinical significance of ¹⁸F-α-methyl tyrosine PET/CT for the detection of bone marrow invasion in patients with oral squamous cell carcinoma: comparison with ¹⁸F-FDG PET/CT and MRI.
Topics: Aged; Aged, 80 and over; Bone Marrow Neoplasms; Carcinoma, Squamous Cell; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Mouth Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Tyrosine | 2013 |
Integrated whole-body PET/MR hybrid imaging: clinical experience.
Topics: Adult; Aged; Artifacts; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasms; Observer Variation; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging; Young Adult | 2013 |
Assessment of atherosclerosis in oncologic patients using ¹⁸F-fluoride PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Atherosclerosis; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Organ Specificity; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Tomography, X-Ray Computed | 2013 |
Accuracy of a clinical PET/CT vs. a preclinical μPET system for monitoring treatment effects in tumour xenografts.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Cell Line, Tumor; Drug Monitoring; Equipment Design; Equipment Failure Analysis; Female; Fluorodeoxyglucose F18; Indoles; Mice; Mice, Nude; Multimodal Imaging; Neoplasms, Experimental; Positron-Emission Tomography; Pyrroles; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Sunitinib; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
18F-FDG PET/CT evaluation of children and young adults with suspected spinal fusion hardware infection.
Topics: Adolescent; Child; Female; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Osteitis; Positron-Emission Tomography; Prosthesis-Related Infections; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Scoliosis; Sensitivity and Specificity; Spinal Fusion; Tomography, X-Ray Computed; Young Adult | 2013 |
F-18 FDG-PET/CT in evaluation of patients with fever of unknown origin.
Topics: Aged; Female; Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
Thyroglobulin levels and thyroglobulin doubling time independently predict a positive 18F-FDG PET/CT scan in patients with biochemical recurrence of differentiated thyroid carcinoma.
Topics: Adolescent; Adult; Aged; Cost-Benefit Analysis; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Iodine Radioisotopes; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Predictive Value of Tests; Radiopharmaceuticals; Recurrence; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Thyroxine; Time Factors | 2013 |
Localization of function-specific segments of the primary motor pathway in children with Sturge-Weber syndrome: a multimodal imaging analysis.
Topics: Child; Connectome; Diffusion Tensor Imaging; Efferent Pathways; Female; Fluorodeoxyglucose F18; Humans; Male; Motor Cortex; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Somatosensory Cortex; Sturge-Weber Syndrome | 2013 |
Diagnosis of metastases from postoperative differentiated thyroid cancer: comparison between FDG and FLT PET/CT studies.
Topics: Adult; Aged; Chi-Square Distribution; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Sensitivity and Specificity; Statistics, Nonparametric; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed; Whole Body Imaging | 2013 |
Equal sensitivity of early and late scans after injection of FDG for the detection of Alzheimer pattern: an analysis of 3D PET data from J-ADNI, a multi-center study.
Topics: Aged; Alzheimer Disease; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Imaging, Three-Dimensional; Injections, Intravenous; Japan; Male; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Factors; Sensitivity and Specificity | 2013 |
Improvement in clinical evaluation of PET/CT images with high resolution algorithms.
Topics: Algorithms; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Male; Middle Aged; Multimodal Imaging; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
Role of 2-[18F]fluoro-2-deoxyglucose positron emission tomography in preoperative management of solid-type small-sized lung cancer.
Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Preoperative Period; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden | 2013 |
Observer variation study of the assessment and diagnosis of incidental colonic FDG uptake.
Topics: Adult; Aged; Aged, 80 and over; Colon; Colonic Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Japan; Male; Middle Aged; Observer Variation; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity | 2013 |
Sensitivity and specificity of FDG PET-CT scan in detecting lymph node metastasis in operable periampullary tumours in correlation with the final histopathology after curative surgery.
Topics: Adult; Aged; Aged, 80 and over; Ampulla of Vater; Common Bile Duct Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
Extracapsular spread in hypopharyngeal squamous cell carcinoma: diagnostic value of FDG PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Kaplan-Meier Estimate; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neck Dissection; Neoplasm Invasiveness; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
Diagnostic accuracy of lymph node metastasis depends on metabolic activity of the primary lesion in thoracic squamous esophageal cancer.
Topics: Adult; Aged; Aged, 80 and over; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasms, Squamous Cell; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Thorax; Tomography, X-Ray Computed | 2013 |
Invited editorial: Response to therapy assessment of colorectal liver metastasis.
Topics: Adult; Aged; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Iopamidol; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Spain; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
Imaging of chronic inflammatory bowel disease with 18F-FDG PET in children and adolescents.
Topics: Adolescent; Child; Colitis, Ulcerative; Crohn Disease; Endoscopy, Gastrointestinal; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Intestines; Male; Positron-Emission Tomography; Sensitivity and Specificity; Stomach; Tomography, X-Ray Computed | 2013 |
Prediction of outcome with FDG-PET in definitive chemoradiotherapy for esophageal cancer.
Topics: Adult; Aged; Aged, 80 and over; Chemoradiotherapy; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Japan; Male; Middle Aged; Positron-Emission Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Risk Assessment; Sensitivity and Specificity; Survival Rate; Treatment Outcome | 2013 |
Correlation between biological marker expression and F-fluorodeoxyglucose uptake in cervical cancer measured by positron emission tomography.
Topics: Adult; Aged; Biomarkers, Tumor; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Proteins; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Uterine Cervical Neoplasms | 2013 |
Relevance of incidental colorectal FDG-PET/CT-enhanced lesions.
Topics: Aged; Aged, 80 and over; Colonoscopy; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
PET/CT mediastinal and liver FDG uptake: effects of biological and procedural factors.
Topics: Age Distribution; Aging; Body Mass Index; Boston; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Mediastinal Neoplasms; Metabolic Clearance Rate; Middle Aged; Multimodal Imaging; Organ Specificity; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Sex Distribution; Tissue Distribution | 2013 |
Combining multiple FDG-PET radiotherapy target segmentation methods to reduce the effect of variable performance of individual segmentation methods.
Topics: Algorithms; Fluorodeoxyglucose F18; Image Enhancement; Image Interpretation, Computer-Assisted; Neoplasms; Pattern Recognition, Automated; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Image-Guided; Reproducibility of Results; Sensitivity and Specificity | 2013 |
Diagnostic accuracy of 18F-FDG PET/CT for detecting recurrence in patients with primary skeletal Ewing sarcoma.
Topics: Adolescent; Adult; Bone Neoplasms; Child; Female; Fluorodeoxyglucose F18; Humans; In Vitro Techniques; Male; Middle Aged; Positron-Emission Tomography; Recurrence; Retrospective Studies; Sarcoma, Ewing; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2013 |
Utility of FDG-PETCT and magnetic resonance spectroscopy in differentiating between cerebral lymphoma and non-malignant CNS lesions in HIV-infected patients.
Topics: Adult; Biomarkers; Brain Diseases; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; HIV Infections; Humans; Lymphoma, AIDS-Related; Magnetic Resonance Spectroscopy; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; United Kingdom | 2013 |
Positron emission tomography/computed tomography for diagnosis of prosthetic valve endocarditis: increased valvular 18F-fluorodeoxyglucose uptake as a novel major criterion.
Topics: Aged; Chi-Square Distribution; Cohort Studies; Endocarditis; Female; Fluorodeoxyglucose F18; Heart Valve Prosthesis; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Prospective Studies; Prosthesis-Related Infections; Sensitivity and Specificity; Statistics, Nonparametric; Tomography, X-Ray Computed | 2013 |
Comparison of different methods of spatial normalization of FDG-PET brain images in the voxel-wise analysis of MCI patients and controls.
Topics: Aged; Brain; Case-Control Studies; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Positron-Emission Tomography; Sensitivity and Specificity | 2013 |
Whole-body MRI for the detection of bone marrow involvement in lymphoma: prospective study in 116 patients and comparison with FDG-PET.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biopsy; Bone Marrow; Bone Marrow Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Whole Body Imaging; Young Adult | 2013 |
Application of (18)F-FDG PET/CT imaging in diagnosing bladder tumor metastasis lesions.
Topics: Adult; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Urinary Bladder Neoplasms | 2013 |
High performance of F-fluorodeoxyglucose positron emission tomography and contrast-enhanced CT in a rapid outpatient diagnostic program for patients with suspected lung cancer.
Topics: Aged; Ambulatory Care; Carcinoma, Non-Small-Cell Lung; Cohort Studies; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Small Cell Lung Carcinoma; Tomography, X-Ray Computed | 2014 |
Diagnosis of recurrence and assessment of post-recurrence survival in patients with extracranial non-small cell lung cancer evaluated by 18F-FDG PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
Interest of [18F]FDG PET/CT for treatment efficacy assessment in aggressive phenotype of sarcoidosis with special emphasis on sinonasal involvement.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Nose Diseases; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sarcoidosis; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
FDG PET in the early diagnosis of large-vessel vasculitis.
Topics: Diffusion; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Remission Induction; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Vasculitis | 2013 |
Value of ¹⁸F-FDG-PET/CT in the detection of recurrent hepatocellular carcinoma after hepatectomy or radiofrequency ablation: a comparative study with contrast-enhanced ultrasound.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Catheter Ablation; Female; Fluorodeoxyglucose F18; Hepatectomy; Humans; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography | 2013 |
(18)F-FDG PET/CT-positive internal mammary lymph nodes: pathologic correlation by ultrasound-guided fine-needle aspiration and assessment of associated risk factors.
Topics: Breast Neoplasms; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Statistics as Topic; Tomography, X-Ray Computed; Washington | 2013 |
FDG-PET/CT assessment of misty mesentery: feasibility for distinguishing viable mesenteric malignancy from stable conditions.
Topics: Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Japan; Male; Mesentery; Middle Aged; Multimodal Imaging; Peritoneal Neoplasms; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Factors; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
Optimizing SPECT SISCOM analysis to localize seizure-onset zone by using varying z scores.
Topics: Adolescent; Adult; Aged; Algorithms; Brain Mapping; Child; Child, Preschool; Cysteine; Electroencephalography; Electronic Data Processing; Epilepsy; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Organotechnetium Compounds; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Young Adult | 2013 |
Evaluation of ¹⁸F-FDG and ¹⁸F-FLT for monitoring therapeutic responses of colorectal cancer cells to radiotherapy.
Topics: Apoptosis; Cell Line, Tumor; Cell Survival; Colorectal Neoplasms; Dideoxynucleosides; Dose-Response Relationship, Radiation; Fluorodeoxyglucose F18; Humans; Metabolic Clearance Rate; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy, Image-Guided; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome | 2013 |
False-positive PET scan after bone marrow biopsy.
Topics: Aged; Biopsy; Bone Marrow; Fluorodeoxyglucose F18; Humans; Male; Multiple Myeloma; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
Schwannoma in neurofibromatosis type 1: a pitfall for detecting malignancy by metabolic imaging.
Topics: Diagnosis, Differential; Diagnostic Errors; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasms, Multiple Primary; Neurofibromatosis 1; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Soft Tissue Neoplasms | 2013 |
18F-AFETP, 18F-FET, and 18F-FDG imaging of mouse DBT gliomas.
Topics: Alanine; Animals; Brain Neoplasms; Cell Line, Tumor; Fluorodeoxyglucose F18; Glioma; Male; Metabolic Clearance Rate; Mice; Mice, Inbred BALB C; Organ Specificity; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Triazoles; Tyrosine | 2013 |
2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography examination in patients with chronic lymphocytic leukemia may reveal Richter transformation.
Topics: Adult; Aged; Disease Progression; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Anaplastic; Male; Middle Aged; Multimodal Imaging; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Prospective Studies; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
The role of 18F-FDG PET/CT for initial staging of nasal type natural killer/T-cell lymphoma: a comparison with conventional staging methods.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Lymphoma, T-Cell; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Nose Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2013 |
Prognostic value of preoperative metabolic tumor volume and total lesion glycolysis measured by 18F-FDG PET/CT in salivary gland carcinomas.
Topics: Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Preoperative Care; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Salivary Gland Neoplasms; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden; Young Adult | 2013 |
PET with 18F-FDG-labeled T lymphocytes for diagnosis of acute rat renal allograft rejection.
Topics: Animals; Cell Tracking; Fluorodeoxyglucose F18; Graft Rejection; Kidney Transplantation; Male; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Inbred Lew; Reproducibility of Results; Sensitivity and Specificity; T-Lymphocytes | 2013 |
Accuracy of 18F-FDG PET/CT for primary tumor visualization and staging in T1 breast cancer.
Topics: Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Clinical implication of FDG-PET/CT in monitoring disease activity in IgG4-related disease.
Topics: Aged; Blood Protein Disorders; Fluorodeoxyglucose F18; Humans; Immunoglobulin G; Male; Monitoring, Physiologic; Multimodal Imaging; Nephritis, Interstitial; Positron-Emission Tomography; Sensitivity and Specificity; Severity of Illness Index; Tomography, X-Ray Computed | 2013 |
18F-FDG PET/CT findings in patients with Kikuchi disease.
Topics: Adolescent; Adult; Aged; Child; Female; Fluorodeoxyglucose F18; Histiocytic Necrotizing Lymphadenitis; Humans; Lymph Nodes; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2013 |
Evaluation of hybrid PET/CT gastrography in gastric cancer.
Topics: Adult; Aged; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Observer Variation; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Republic of Korea; Risk Factors; Sensitivity and Specificity; Stomach Neoplasms; Tomography, X-Ray Computed | 2013 |
Thyroid incidentalomas on FDG PET/CT in patients with non-thyroid cancer - a large retrospective monocentric study.
Topics: Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Republic of Korea; Retrospective Studies; Risk Factors; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, X-Ray Computed | 2013 |
Imaging cold-activated brown adipose tissue using dynamic T2*-weighted magnetic resonance imaging and 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography.
Topics: Adipose Tissue, Brown; Adolescent; Adult; Cold Temperature; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Male; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Young Adult | 2013 |
Comparison of quantitatively analyzed dynamic area-detector CT using various mathematic methods with FDG PET/CT in management of solitary pulmonary nodules.
Topics: Aged; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Positron-Emission Tomography; Prospective Studies; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Reproducibility of Results; ROC Curve; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2013 |
Value of fusion of PET and MRI for staging of endometrial cancer: comparison with ¹⁸F-FDG contrast-enhanced PET/CT and dynamic contrast-enhanced pelvic MRI.
Topics: Adult; Aged; Aged, 80 and over; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoplasm Staging; Pelvis; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2013 |
Preoperative 18F-FDG PET/CT and high-risk HPV in patients with oropharyngeal squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Alphapapillomavirus; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Human papillomavirus 16; Humans; In Situ Hybridization; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Middle Aged; Oropharyngeal Neoplasms; Papillomavirus Infections; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed; Tongue Neoplasms; Tonsillar Neoplasms | 2014 |
Which FDG/PET parameters of the primary tumors in colon or sigmoid cancer provide the best correlation with the pathological findings?
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Biopsy; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Tumor Burden | 2013 |
Respiratory-gated ¹⁸F-FDG PET/CT for the diagnosis of liver metastasis.
Topics: Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Respiratory-Gated Imaging Techniques; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2013 |
(18)F-fluorodeoxyglucose positron emission tomography/computed tomography in diagnosis of post-transplant lymphoproliferative disorder.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Female; Fluorodeoxyglucose F18; Humans; Lymphoproliferative Disorders; Male; Middle Aged; Organ Transplantation; Positron-Emission Tomography; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2014 |
Early dynamic 18F-FDG PET/CT to diagnose chronic osteomyelitis following lower extremity fractures. A pilot study.
Topics: Early Diagnosis; Female; Fluorodeoxyglucose F18; Fractures, Bone; Humans; Image Enhancement; Leg Injuries; Male; Middle Aged; Multimodal Imaging; Osteomyelitis; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Clinicopathological determinants of positron emission tomography computed tomography fluorodeoxyglucose standardised uptake value in head and neck carcinoma.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck | 2013 |
Diagnosed mild cognitive impairment due to Alzheimer's disease with PET biomarkers of beta amyloid and neuronal dysfunction.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Biomarkers; Cerebral Cortex; Cognitive Dysfunction; Disease Progression; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Thiazoles | 2013 |
Whole-body MRI and PET/CT in multiple myeloma patients during staging and after treatment: personal experience in a longitudinal study.
Topics: Aftercare; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Multiple Myeloma; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2013 |
PET-CT and the detection of the asymptomatic recurrence or second primary lesions in the treated head and neck cancer patient.
Topics: Adult; Aged; Cohort Studies; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Positron-Emission Tomography; Retrospective Studies; Risk Assessment; Sensitivity and Specificity; Severity of Illness Index; Survival Analysis; Tomography, X-Ray Computed | 2013 |
FDG-PET/CT characterization of adrenal nodules: diagnostic accuracy and interreader agreement using quantitative and qualitative methods.
Topics: Adrenal Gland Neoplasms; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
Hybrid [¹⁸F]-FDG PET/MRI including non-Gaussian diffusion-weighted imaging (DWI): preliminary results in non-small cell lung cancer (NSCLC).
Topics: Carcinoma, Non-Small-Cell Lung; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Normal Distribution; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2013 |
¹⁸F-fluorodeoxyglucose positron emission tomography-computed tomography for the evaluation of bone metastasis in patients with gastric cancer.
Topics: Bone and Bones; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Stomach Neoplasms; Tomography, X-Ray Computed | 2013 |
Usefulness of 2-[18F]-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography for staging and evaluation of treatment response in IgG4-related disease: a retrospective multicenter study.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Female; Fluorodeoxyglucose F18; Humans; Immunoglobulin G; Immunosuppressive Agents; Male; Middle Aged; Multiple Organ Failure; Positron-Emission Tomography; Prednisone; Retrospective Studies; Rituximab; Sensitivity and Specificity; Severity of Illness Index; Steroids; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
[Fusion of Continuously Moving Table MRI and PET Improves Lesion Detection in Recurrent Rectal Cancer].
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Enhancement; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Rectal Neoplasms; Rectum; Retrospective Studies; Sensitivity and Specificity | 2015 |
Accuracy of multi-detector computed tomography, fluorodeoxyglucose positron emission tomography-CT, and CA 19-9 levels in detecting recurrent pancreatic adenocarcinoma.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; CA-19-9 Antigen; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multidetector Computed Tomography; Neoplasm Recurrence, Local; Pancreatic Neoplasms; Positron-Emission Tomography; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
The role of ¹⁸F-FDG PET/CT for the diagnosis of infections in patients with hematological malignancies and persistent febrile neutropenia.
Topics: Adult; Aged; Aged, 80 and over; Female; Fever; Fluorodeoxyglucose F18; Follow-Up Studies; Hematologic Neoplasms; Humans; Male; Middle Aged; Neutropenia; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Reference Standards; Sensitivity and Specificity; Tertiary Care Centers; Tomography, X-Ray Computed; Young Adult | 2013 |
Observations on the effects of lithium on carcinoid tumors.
Topics: Bone Neoplasms; Carcinoid Tumor; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Lithium Compounds; Liver Neoplasms; Male; Mood Disorders; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity; Young Adult | 2013 |
Intramedullary spinal cord metastases: visibility on PET and correlation with MRI features.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Single-Blind Method; Spinal Cord Neoplasms; Statistics as Topic | 2014 |
Value of retrospective image fusion of ¹⁸F-FDG PET and MRI for preoperative staging of head and neck cancer: comparison with PET/CT and contrast-enhanced neck MRI.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
A comparison of positron emission tomography and colonoscopy for the detection of advanced colorectal neoplasms in subjects undergoing a health check-up.
Topics: Adult; Aged; Aged, 80 and over; Colonoscopy; Colorectal Neoplasms; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2013 |
Visual-statistical interpretation of (18)F-FDG-PET images for characteristic Alzheimer patterns in a multicenter study: inter-rater concordance and relationship to automated quantitative evaluation.
Topics: Algorithms; Alzheimer Disease; Artificial Intelligence; Cognitive Dysfunction; Data Interpretation, Statistical; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Japan; Male; Middle Aged; Observer Variation; Pattern Recognition, Automated; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2014 |
Noninvasive quantitative assessment of pulmonary blood flow with 18F-FDG PET.
Topics: Acute Lung Injury; Animals; Computer Simulation; Female; Fluorodeoxyglucose F18; Image Enhancement; Image Interpretation, Computer-Assisted; Models, Biological; Perfusion Imaging; Positron-Emission Tomography; Pulmonary Artery; Pulmonary Circulation; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Swine | 2013 |
Stratification of 18F-labeled PET imaging agents for the assessment of antiangiogenic therapy responses in tumors.
Topics: Angiogenesis Inhibitors; Animals; Axitinib; Cell Line, Tumor; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Imidazoles; Indazoles; Isotope Labeling; Mice; Neoplasms, Experimental; Peptides, Cyclic; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome | 2013 |
Hypermetabolism in 18F-FDG PET predicts favorable outcome following decompressive surgery in patients with degenerative cervical myelopathy.
Topics: Aged; Aged, 80 and over; Cervical Vertebrae; Decompression, Surgical; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Spinal Cord Compression; Spinal Stenosis; Treatment Outcome | 2013 |
Quantitative and qualitative analysis of metabolic response at interim positron emission tomography scan combined with International Prognostic Index is highly predictive of outcome in diffuse large B-cell lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
(62)Cu-diacetyl-bis (N(4)-methylthiosemicarbazone) PET in human gliomas: comparative study with [(18)F]fluorodeoxyglucose and L-methyl-[(11)C]methionine PET.
Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Coordination Complexes; Copper Radioisotopes; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Methionine; Middle Aged; Organometallic Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thiosemicarbazones; Young Adult | 2014 |
Interim PET response criteria in paediatric non-Hodgkin's lymphoma. Results from a retrospective multicenter reading.
Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Germany; Humans; Lymphoma, Non-Hodgkin; Male; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Treatment Outcome; Young Adult | 2013 |
Sequential (18)F-FDG PET/CT for early prediction of complete pathological response in breast and axilla during neoadjuvant chemotherapy.
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Positron-Emission Tomography; Receptor, ErbB-2; Receptors, Estrogen; Retrospective Studies; Sensitivity and Specificity; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Triple Negative Breast Neoplasms | 2014 |
Repeatable noninvasive measurement of mouse myocardial glucose uptake with 18F-FDG: evaluation of tracer kinetics in a type 1 diabetes model.
Topics: Animals; Diabetes Mellitus, Type 1; Fluorodeoxyglucose F18; Heart; Male; Metabolic Clearance Rate; Mice; Myocardium; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2013 |
In vivo responses of human A375M melanoma to a σ ligand: 18F-FDG PET imaging.
Topics: Animals; Antineoplastic Agents; Carbazoles; Cell Line, Tumor; Fluorodeoxyglucose F18; Humans; Melanoma; Metabolic Clearance Rate; Mice; Mice, Nude; Organ Specificity; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, sigma; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Treatment Outcome | 2013 |
Areas of normal pulmonary parenchyma on HRCT exhibit increased FDG PET signal in IPF patients.
Topics: Aged; Aged, 80 and over; Case-Control Studies; Female; Fluorodeoxyglucose F18; Humans; Idiopathic Pulmonary Fibrosis; Lung; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Comparison of neuroimaging modalities for the prediction of conversion from mild cognitive impairment to Alzheimer's dementia.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid; Aniline Compounds; Apolipoproteins E; Brain; Cognitive Dysfunction; Cohort Studies; Disease Progression; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Forecasting; Genotype; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuroimaging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Temporal Lobe; Thiazoles | 2014 |
The role of 18F-fluoro-2-deoxyglucose positron emission tomography/computed tomography in the management of patients with carcinoma of unknown primary.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Staging; Neoplasms, Unknown Primary; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Scotland; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
18FDG-PET to assess recurrence and long term survival in patients with malignant melanoma.
Topics: Biomarkers, Tumor; Female; Fluorodeoxyglucose F18; Germany; Humans; Male; Melanoma; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Factors; S100 Calcium Binding Protein beta Subunit; Sensitivity and Specificity; Skin Neoplasms; Survival Analysis; Survivors; Tomography, X-Ray Computed | 2013 |
[Diagnostic values of ultrasound and (18)F-fluoro-2-deoxy-D-glucose-positron emission tomography/computerized tomography for patients with suspected thyroid carcinoma and lymph node metastasis].
Topics: Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, X-Ray Computed; Ultrasonography; Young Adult | 2013 |
Comparison of (18)F-FDG PET/CT and (99 m)Tc-MDP bone scintigraphy for detection of bone metastasis in osteosarcoma.
Topics: Adolescent; Adult; Bone Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Osteosarcoma; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Medronate; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2013 |
Evaluation of neuroendocrine liver metastases: a comparison of dynamic contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography.
Topics: Contrast Media; Coordination Complexes; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neuroendocrine Tumors; Octreotide; Organometallic Compounds; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Depiction and characterization of liver lesions in whole body [¹⁸F]-FDG PET/MRI.
Topics: Adult; Aged; Algorithms; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Whole Body Imaging; Young Adult | 2013 |
18F-fluorodeoxyglucose uptake pattern in patients with suspected spondylodiscitis.
Topics: Adult; Aged; Aged, 80 and over; Discitis; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Spine; Young Adult | 2013 |
[The compared study in detecting the recurrence and metastases of breast cancer patients post treatment between (18)F-FDG PET/CT and conventional workup].
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
[Predictive value of positron emission tomography with 18F-FDG in the diagnosis and staging of patients with Hodgkin's lymphoma].
Topics: Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
[Sensitivity of PET with 18F-fluorodesoxyglucose in the diagnosis of neuroendocrine tumors of the lungs].
Topics: Adult; Aged; Carcinoid Tumor; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Neuroendocrine Tumors; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Small Cell Lung Carcinoma | 2013 |
18F-FDG PET/CT for the assessment of gastrointestinal GVHD: results of a pilot study.
Topics: Adult; Aged; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Gastrointestinal Diseases; Graft vs Host Disease; Hematologic Diseases; Humans; Male; Middle Aged; Multimodal Imaging; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Transplantation Conditioning; Young Adult | 2014 |
Diagnostic value of ¹⁸F-FDG PET/CT for lymph node metastasis of esophageal squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Demonstrating disease activity in patients with rheumatoid arthritis. Is 18F FDG PET a sensitive method?
Topics: Arthritis, Rheumatoid; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Severity of Illness Index | 2013 |
The mediastinal staging accuracy of 18F-Fluorodeoxyglycose positron emission tomography/computed tomography in non-small cell lung cancer with variable time intervals to surgery.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Time Factors; Tomography, X-Ray Computed | 2013 |
Pulmonary alveolar microlithiasis: imaging characteristics of planar and SPECT/CT bone scan versus 18F-FDG and 18F-sodium fluoride PET/CT scanning.
Topics: Calcinosis; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Genetic Diseases, Inborn; Humans; Lung Diseases; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Rare Diseases; Sensitivity and Specificity; Sodium Fluoride; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2013 |
Accurate detection of metabolically active "brown" and "white" adipose tissues with computed tomography.
Topics: Adipose Tissue, Brown; Adipose Tissue, White; Adult; Female; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
Identifying neuropathic pain using (18)F-FDG micro-PET: a multivariate pattern analysis.
Topics: Animals; Brain; Fluorodeoxyglucose F18; Image Enhancement; Image Interpretation, Computer-Assisted; Male; Multivariate Analysis; Neuralgia; Pattern Recognition, Automated; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Sensitivity and Specificity | 2014 |
Influences of point-spread function and time-of-flight reconstructions on standardized uptake value of lymph node metastases in FDG-PET.
Topics: Algorithms; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lymphatic Metastasis; Models, Biological; Models, Statistical; Positron-Emission Tomography; Radiopharmaceuticals; Reference Values; Reproducibility of Results; Sensitivity and Specificity | 2014 |
Ability of FDG-PET/CT in the detection of gallbladder cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Carcinoid Tumor; Carcinoma, Adenosquamous; Female; Fluorodeoxyglucose F18; Gallbladder Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Modeling pathologic response of esophageal cancer to chemoradiation therapy using spatial-temporal 18F-FDG PET features, clinical parameters, and demographics.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Chemoradiotherapy, Adjuvant; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Logistic Models; Male; Middle Aged; Models, Biological; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden | 2014 |
[SUVmax measured by 18F FDG PET/CT in the primary tumor in relation to clinical and pathological features of endometrial cancer].
Topics: Adult; Aged; Aged, 80 and over; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Poland; Predictive Value of Tests; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Tumor Burden; Women's Health | 2013 |
FDG and FDG-labelled leucocyte PET/CT in the imaging of prosthetic joint infection.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Joint Prosthesis; Leukocytes; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prosthesis-Related Infections; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
A new method for detecting urinary bladder cancer by using FDG PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Image Processing, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Tumor Burden; Urinary Bladder Neoplasms | 2014 |
Sparsity Constrained Mixture Modeling for the Estimation of Kinetic Parameters in Dynamic PET.
Topics: Algorithms; Colonic Neoplasms; Computer Simulation; Contrast Media; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Kinetics; Metabolic Clearance Rate; Models, Biological; Models, Statistical; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity | 2014 |
Diagnostic performance of 18F-FDG PET/CT, ultrasonography and MRI. Detection of axillary lymph node metastasis in breast cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Axilla; Breast Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography, Mammary | 2014 |
Current clinical use of 18FDG-PET/CT in patients with thoracic and systemic sarcoidosis.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Comparative effectiveness research for molecular imaging.
Topics: Comparative Effectiveness Research; Fluorodeoxyglucose F18; Humans; Molecular Imaging; Neoplasms; Positron-Emission Tomography; Precision Medicine; Radiopharmaceuticals; Sensitivity and Specificity | 2012 |
False-Positive [18F]fluorodeoxyglucose-avid lymph nodes on positron emission tomography-computed tomography after allogeneic but not autologous stem-cell transplantation in patients with lymphoma.
Topics: Adolescent; Adult; Aged; Child; Disease-Free Survival; False Positive Reactions; Female; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Humans; Lymph Nodes; Lymphoma; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Lymphoma, T-Cell; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Transplantation, Autologous; Transplantation, Homologous | 2014 |
18F-FDG PET/CT impact on testicular tumours clinical management.
Topics: Adolescent; Adult; Aged; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Seminoma; Sensitivity and Specificity; Testicular Neoplasms; Tomography, X-Ray Computed | 2014 |
Characterization of lipid-rich adrenal tumors by FDG PET/CT: Are they hormone-secreting or not?
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aged; Aldosterone; Cortisone; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Multimodal Imaging; Myelolipoma; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Comparison of F-18-FDG PET/CT findings between pancreatic solid pseudopapillary tumor and pancreatic ductal adenocarcinoma.
Topics: Adult; Aged; Carcinoma, Pancreatic Ductal; Carcinoma, Papillary; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Pacemaker-related infection detected by (18)F-fluorodeoxyglucose positron emission tomography-computed tomography.
Topics: Anemia; Diagnosis, Differential; Endocarditis, Non-Infective; Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pacemaker, Artificial; Positron-Emission Tomography; Radiopharmaceuticals; Reoperation; Sensitivity and Specificity; Weight Loss | 2014 |
Comparison of ¹⁸F-fluoride PET/CT, ¹⁸F-FDG PET/CT and bone scintigraphy (planar and SPECT) in detection of bone metastases of differentiated thyroid cancer: a pilot study.
Topics: Adenocarcinoma, Follicular; Aged; Bone and Bones; Bone Neoplasms; Carcinoma, Papillary; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Pilot Projects; Positron-Emission Tomography; Sensitivity and Specificity; Thyroid Neoplasms; Thyroidectomy; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2014 |
Comparison of (11)C-methionine, (11)C-choline, and (18)F-fluorodeoxyglucose-PET for distinguishing glioma recurrence from radiation necrosis.
Topics: Adult; Aged; Area Under Curve; Brain; Brain Neoplasms; Carbon Isotopes; Choline; Combined Modality Therapy; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioma; Humans; Magnetic Resonance Imaging; Male; Methionine; Middle Aged; Necrosis; Neoplasm Recurrence, Local; Neuroimaging; Positron-Emission Tomography; Radiation Injuries; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Tissue Distribution | 2014 |
Splenic FDG uptake predicts poor prognosis in patients with unresectable cholangiocarcinoma.
Topics: Adult; Aged; Aged, 80 and over; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Republic of Korea; Risk Assessment; Sensitivity and Specificity; Spleen; Survival Rate | 2014 |
Quantitative FDG PET/CT in the community: experience from interpretation of outside oncologic PET/CT exams in referred cancer patients.
Topics: Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Referral and Consultation; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tertiary Care Centers; Tomography, X-Ray Computed | 2014 |
Molecular and metabolic pattern classification for detection of brain glioma progression.
Topics: Adult; Aged; Biomarkers, Tumor; Brain Neoplasms; Diagnosis, Computer-Assisted; Female; Fluorodeoxyglucose F18; Glioma; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Molecular Imaging; Positron-Emission Tomography; Protons; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Support Vector Machine | 2014 |
Recurrent thyroid cancer diagnosis: ROC study of the effect of a high-resolution head and neck 18F-FDG PET/CT scan.
Topics: Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; ROC Curve; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, X-Ray Computed | 2014 |
Comparison of whole-body PET/CT and PET/MRI in breast cancer patients: lesion detection and quantitation of 18F-deoxyglucose uptake in lesions and in normal organ tissues.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Metabolic Clearance Rate; Middle Aged; Molecular Imaging; Multimodal Imaging; Organ Specificity; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Tomography, X-Ray Computed; Whole Body Imaging | 2014 |
Impact of a new respiratory amplitude-based gating technique in evaluation of upper abdominal PET lesions.
Topics: Abdomen; Abdominal Neoplasms; Adolescent; Adult; Aged; Aged, 80 and over; Algorithms; Artifacts; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Motion; Positron-Emission Tomography; Radiographic Image Enhancement; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Reproducibility of Results; Respiratory-Gated Imaging Techniques; Sensitivity and Specificity; Young Adult | 2014 |
18F, 11C and 68Ga in small animal PET imaging. Evaluation of partial volume correction methods.
Topics: Algorithms; Animals; Artifacts; Brain; Carbon Radioisotopes; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Image Enhancement; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Sensitivity and Specificity | 2013 |
Role of fluorodeoxyglucose positron emission tomography (FDG PET)-computed tomography (CT) in the staging of bladder cancer.
Topics: Abdomen; Adult; Aged; Aged, 80 and over; Cost-Benefit Analysis; Cystectomy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Patient Selection; Pelvis; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Thorax; Tomography, X-Ray Computed; Urinary Bladder Neoplasms | 2014 |
Diagnostic accuracy of dynamic gadoxetic-acid-enhanced MRI and PET/CT compared in patients with liver metastases from neuroendocrine neoplasms.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neuroendocrine Tumors; Organometallic Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Impact of 18F-FDG PET/CT in the treatment of patients with non-small cell lung cancer.
Topics: Adenocarcinoma; Carcinoma, Non-Small-Cell Lung; Decision Making; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Mediastinum; Multimodal Imaging; Neoplasm Staging; Pneumonectomy; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Clinical utility and limitations of FDG PET in detecting recurrent hepatocellular carcinoma in postoperative patients.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Postoperative Period; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2014 |
Negative 18F-2-fluorodeoxyglucose PET/CT predicts good cancer specific survival in patients with a suspicion of recurrent ovarian cancer.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Germany; Humans; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron-Emission Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Risk Assessment; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
A graph-based approach for the retrieval of multi-modality medical images.
Topics: Algorithms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Detection of extranodal spread in head and neck cancer with [18F]FDG PET and MRI: improved accuracy?
Topics: Aged; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reference Standards; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity | 2015 |
Reliability of post-chemoradiotherapy F-18-FDG PET/CT for prediction of locoregional failure in human papillomavirus-associated oropharyngeal cancer.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Oropharyngeal Neoplasms; Papillomaviridae; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
SPECT gated blood pool phase analysis of lateral wall motion for prediction of CRT response.
Topics: Aged; Area Under Curve; Cardiac Resynchronization Therapy; Cicatrix; Female; Fluorodeoxyglucose F18; Heart Failure; Heart Ventricles; Humans; Male; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; ROC Curve; Rubidium Radioisotopes; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2014 |
Prognostic value of quantitative fluorodeoxyglucose measurements in newly diagnosed metastatic breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tumor Burden | 2013 |
FDG uptake heterogeneity evaluated by fractal analysis improves the differential diagnosis of pulmonary nodules.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Models, Biological; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2014 |
A comparison of CT- and MR-based attenuation correction in neurological PET.
Topics: Adult; Aged; Cerebellum; Cerebral Cortex; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Correlation of PUV and SUV in the extremities while using PEM as a high-resolution positron emission scanner.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Extremities; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Young Adult | 2014 |
Diagnostic accuracy of ¹⁸F-FDG PET/CT for detection of suspected recurrence in patients with oesophageal carcinoma.
Topics: Adult; Aged; Carcinoma; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Respiratory-gated PET/CT versus delayed images for the quantitative evaluation of lower pulmonary and hepatic lesions.
Topics: Adult; Aged; Aged, 80 and over; Artifacts; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Respiratory-Gated Imaging Techniques; Retrospective Studies; Sensitivity and Specificity; Time Factors; Tomography, X-Ray Computed; Whole Body Imaging | 2014 |
The value of adding (18)F-FDG PET/CT to adrenal protocol CT for characterizing adrenal metastasis (≥ 10 mm) in oncologic patients.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Iohexol; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
A risk-adapted approach using US features and FNA results in the management of thyroid incidentalomas identified by 18F-FDG PET.
Topics: Adenocarcinoma, Follicular; Age Factors; Aged; Algorithms; Biomarkers, Tumor; Biopsy, Fine-Needle; Diagnosis, Differential; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Positron-Emission Tomography; Risk Adjustment; Risk Factors; Sensitivity and Specificity; Sex Factors; Thyroid Gland; Thyroid Neoplasms; Thyroid Nodule; Tomography, X-Ray Computed; Tumor Burden; Ultrasonography | 2014 |
(18)F-FDG PET as a single imaging modality in pediatric neuroblastoma: comparison with abdomen CT and bone scintigraphy.
Topics: Bone and Bones; Bone Neoplasms; Child, Preschool; Female; Fluorodeoxyglucose F18; Ganglioneuroblastoma; Humans; Image Interpretation, Computer-Assisted; Infant; Infant, Newborn; Lymph Nodes; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Neuroblastoma; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Diagnostic accuracy of FDG-PET cancer screening in asymptomatic individuals: use of record linkage from the Osaka Cancer Registry.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Japan; Magnetic Resonance Imaging; Male; Mass Screening; Middle Aged; Multimodal Imaging; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Registries; Sensitivity and Specificity; Whole Body Imaging; Young Adult | 2014 |
Performance of FDG PET/ceCT in the evaluation of patients with lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Whole-body-MR-diffusion weighted imaging in oncology.
Topics: Adult; Aged; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasms; Positron-Emission Tomography; Reference Values; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2013 |
Direct parametric image reconstruction of rapid multi-tracer PET.
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Computer Simulation; Contrast Media; Dideoxynucleosides; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Mice; Models, Biological; Neoplasms, Experimental; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity | 2013 |
Multimodal image driven patient specific tumor growth modeling.
Topics: Algorithms; Cell Proliferation; Computer Simulation; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Models, Biological; Multimodal Imaging; Pancreatic Neoplasms; Patient-Centered Care; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Tumor Burden | 2013 |
Quantitative imaging values of CT, MR, and FDG-PET to differentiate pineal parenchymal tumors and germinomas: are they useful?
Topics: Adolescent; Adult; Brain Neoplasms; Child; Child, Preschool; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Germinoma; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Infant; Magnetic Resonance Imaging; Male; Middle Aged; Pineal Gland; Pinealoma; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Sex Factors; Tomography, X-Ray Computed; Young Adult | 2014 |
Head and neck squamous cell cancer (stages III and IV) induction chemotherapy assessment: value of FDG volumetric imaging parameters.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Squamous Cell; Computer Simulation; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Induction Chemotherapy; Male; Middle Aged; Models, Biological; Neoplasm Staging; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome; Tumor Burden | 2014 |
Prognostic value of 18F-FDG PET/CT in patients with soft tissue sarcoma: comparisons between metabolic parameters.
Topics: Adult; Biomarkers, Tumor; Female; Fluorodeoxyglucose F18; Humans; Incidence; Male; Middle Aged; Positron-Emission Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Republic of Korea; Sarcoma; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed; Young Adult | 2014 |
Utility of 18F-FDG PET/CT in follow-up of patients with low-grade serous carcinoma of the ovary.
Topics: Adolescent; Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2014 |
Indeterminate lung nodules in cancer patients: pretest probability of malignancy and the role of 18F-FDG PET/CT.
Topics: Aged; Data Interpretation, Statistical; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2014 |
Maximum standardized uptake value on PET/CT in preoperative assessment of lymph node metastasis from thoracic esophageal squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2014 |
Performance profile of a FDG-PET cancer screening program for detecting gastric cancer: results from a nationwide Japanese survey.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Gastroscopy; Humans; Japan; Male; Mass Screening; Middle Aged; Neoplasm Staging; Pepsinogen A; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Stomach Neoplasms | 2014 |
Repeatability of quantitative FDG-PET/CT and contrast-enhanced CT in recurrent ovarian carcinoma: test-retest measurements for tumor FDG uptake, diameter, and volume.
Topics: Adult; Aged; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Tumor Burden | 2014 |
The added value of 18-fluorodeoxyglucose-positron emission tomography in the diagnosis of the behavioral variant of frontotemporal dementia.
Topics: Cerebrospinal Fluid; Diagnosis, Differential; Electroencephalography; Female; Fluorodeoxyglucose F18; Frontotemporal Dementia; Humans; Male; Middle Aged; Neuroimaging; Neuropsychological Tests; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2014 |
Increasing the accuracy of 18F-FDG PET/CT interpretation of "mildly positive" mediastinal nodes in the staging of non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Multimodal Imaging; Neoplasm Staging; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Mapping phosphorylation rate of fluoro-deoxy-glucose in rat brain by (19)F chemical shift imaging.
Topics: Algorithms; Animals; Brain; Fluorodeoxyglucose F18; Glucose-6-Phosphate; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Metabolic Clearance Rate; Molecular Imaging; Phosphorylation; Phosphotransferases; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Inbred Lew; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution | 2014 |
Clinical and neuroimaging characteristics of 14 patients with prionopathy: a descriptive study.
Topics: Adult; Aged; Brain; Creutzfeldt-Jakob Syndrome; Dementia; Diagnosis, Differential; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Insomnia, Fatal Familial; Male; Middle Aged; Neuroimaging; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity | 2015 |
Inflammatory myofibroblastic tumours of the liver: gadoxetic acid-enhanced and diffusion-weighted MRI findings with 18F-FDG PET/CT and clinical significance of regression on follow-up.
Topics: Adult; Aged; Contrast Media; Diagnosis, Differential; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gadolinium DTPA; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2014 |
Diagnostic accuracy of ¹⁸F-FDG PET/CT for detection of advanced colorectal adenoma.
Topics: Adenoma; Adult; Aged; Aged, 80 and over; Colonic Polyps; Colonoscopy; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Transcranial sonography and [18F]fluorodeoxyglucose positron emission tomography for the differential diagnosis of parkinsonism: a head-to-head comparison.
Topics: Aged; Brain; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple System Atrophy; Parkinsonian Disorders; Radionuclide Imaging; Sensitivity and Specificity; Supranuclear Palsy, Progressive; Ultrasonography, Doppler, Transcranial | 2014 |
[The diagnostic value of (18)F-FDG PET-CT imaging in patients with primary extranodal lymphoma].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2014 |
Does the novel integrated PET/MRI offer the same diagnostic performance as PET/CT for oncological indications?
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Optimization of the reference region method for dual pharmacokinetic modeling using Gd-DTPA/MRI and (18) F-FDG/PET.
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Contrast Media; Fluorodeoxyglucose F18; Gadolinium DTPA; Glioblastoma; Image Enhancement; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Models, Biological; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Rats, Inbred F344; Reference Values; Reproducibility of Results; Sensitivity and Specificity | 2015 |
Comparison of [18 F]FDG PET/CT and MRI in the diagnosis of active osteomyelitis.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Osteomyelitis; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2014 |
Correlation between expression of biological markers and [F]fluorodeoxyglucose uptake in endometrial cancer.
Topics: Adult; Aged; Biomarkers, Tumor; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Proteins; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic | 2014 |
Influence of experience and qualification on PET-based target volume delineation. When there is no expert--ask your colleague.
Topics: Algorithms; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Clinical Competence; Combined Modality Therapy; Cooperative Behavior; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Interdisciplinary Communication; Lung Neoplasms; Male; Observer Variation; Positron-Emission Tomography; Professional Competence; Radiotherapy Planning, Computer-Assisted; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed; Tumor Burden | 2014 |
[Cost analysis of18F-FDG PET-CT from the perspective of the Brazilian Unified National Health System as healthcare provider: a study in a public healthcare center in Rio de Janeiro, Brazil].
Topics: Brazil; Cost-Benefit Analysis; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; National Health Programs; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Influence of SPECT attenuation correction on the quantification of hibernating myocardium as derived from combined myocardial perfusion SPECT and ¹⁸F-FDG PET.
Topics: Aged; Algorithms; Artifacts; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Male; Middle Aged; Multimodal Imaging; Myocardial Perfusion Imaging; Myocardial Stunning; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 2014 |
Assessment of combination of contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography for evaluation of ovarian masses.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Female; Fluorodeoxyglucose F18; Gadolinium; Heterocyclic Compounds; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Organometallic Compounds; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Vascular inflammation in psoriasis localizes to the arterial wall using a novel imaging technique.
Topics: Aorta, Thoracic; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Angiography; Male; Multimodal Imaging; Positron-Emission Tomography; Psoriasis; Sensitivity and Specificity; Tomography, X-Ray Computed; Vasculitis | 2014 |
The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the Deauville five-point scale.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Treatment Outcome; Young Adult | 2014 |
Positron emission tomography assessment of large vessel inflammation in patients with newly diagnosed, biopsy-proven giant cell arteritis: a prospective, case-control study.
Topics: Acute-Phase Proteins; Aged; Aged, 80 and over; Aorta; Area Under Curve; Arteries; Axillary Artery; Biopsy; Carotid Arteries; Case-Control Studies; Female; Femoral Artery; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Iliac Artery; Interleukin-6; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Subclavian Artery; Temporal Arteries; Tomography, X-Ray Computed | 2014 |
[Comparison of ¹⁸F-FDG PET/CT and large-scale DWI for evaluation of non-Hodgkin lymphoma bone marrow infiltration].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Marrow; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2014 |
11C-acetate PET/CT for metabolic characterization of multiple myeloma: a comparative study with 18F-FDG PET/CT.
Topics: Acetates; Adult; Aged; Aged, 80 and over; Carbon; Case-Control Studies; Female; Fluorodeoxyglucose F18; Glucose; Humans; Lipid Metabolism; Male; Middle Aged; Multimodal Imaging; Multiple Myeloma; Paraproteinemias; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Risk; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden | 2014 |
Concordance between (99m)Tc-ECD SPECT and 18F-FDG PET interpretations in patients with cognitive disorders diagnosed according to NIA-AA criteria.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Cognition Disorders; Cysteine; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Observer Variation; Organotechnetium Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 2014 |
FDG PET in early stage cutaneous malignant melanoma.
Topics: Early Detection of Cancer; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Melanoma; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Skin Neoplasms | 2014 |
Utility of hCRH-stimulated (18) F-FDG PET-CT scan in localisation of pituitary microadenoma in Cushing's disease.
Topics: ACTH-Secreting Pituitary Adenoma; Adenoma; Adolescent; Adult; Child; Corticotropin-Releasing Hormone; Cushing Syndrome; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2014 |
The value of ¹⁸F-FDG PET/CT in the management of malignant peripheral nerve sheath tumors.
Topics: Adolescent; Adult; Aged; Child; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Male; Middle Aged; Multimodal Imaging; Neurilemmoma; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden; Young Adult | 2014 |
Comparison of 18F-FDG Pet/CT and CT: diagnosis performance in lymphoma patient after treatment.
Topics: Adolescent; Adult; Aged; Child; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2014 |
Comparing the performance of visual estimation and standard uptake value of F-18 fluorodeoxyglucose positron emission tomography/computed tomography for detecting malignancy in pancreatic tumors other than invasive ductal carcinoma.
Topics: Adenoma; Adult; Aged; Cystadenoma, Serous; Diagnosis, Differential; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neuroendocrine Tumors; Pancreas; Pancreatic Neoplasms; Positron-Emission Tomography; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
The role of (18)fluoro-deoxyglucose positron emission tomography/computed tomography in resectable pancreatic cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; CA-19-9 Antigen; Chemoradiotherapy, Adjuvant; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography | 2014 |
Abnormalities of myocardial perfusion and glucose metabolism in patients with isolated left ventricular non-compaction.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Coronary Artery Disease; Female; Fluorodeoxyglucose F18; Heart Defects, Congenital; Humans; Hyperglycemia; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Stroke Volume; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Young Adult | 2014 |
Correlation of (18)F-FDG avid volumes on pre-radiation therapy and post-radiation therapy FDG PET scans in recurrent lung cancer.
Topics: Aged; Aged, 80 and over; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Glucose; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Paclitaxel; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy, Conformal; Sensitivity and Specificity; Small Cell Lung Carcinoma; Tomography, X-Ray Computed | 2014 |
Clinical utility of 18F-FDG positron emission tomography in malignant peritoneal mesothelioma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Peritoneal Neoplasms; Positron-Emission Tomography; Recurrence; Retrospective Studies; Sensitivity and Specificity; Treatment Outcome; Young Adult | 2016 |
Towards a reproducible protocol for repetitive and semi-quantitative rat brain imaging with (18) F-FDG: exemplified in a memantine pharmacological challenge.
Topics: Animals; Brain; Computer Simulation; Fasting; Fluorodeoxyglucose F18; Image Enhancement; Male; Memantine; Metabolic Clearance Rate; Models, Biological; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Sensitivity and Specificity | 2014 |
Diagnostic precision of PET imaging and functional MRI in disorders of consciousness: a clinical validation study.
Topics: Adolescent; Adult; Belgium; Consciousness Disorders; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Young Adult | 2014 |
FDG PET/MR for lymph node staging in head and neck cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck | 2014 |
Comparative uptake of ¹⁸F-FEN-DPAZn2, ¹⁸F-FECH, ¹⁸F-fluoride, and ¹⁸F-FDG in fibrosarcoma and aseptic inflammation.
Topics: Animals; Bacterial Infections; Cell Line, Tumor; Choline; Diagnosis, Differential; Female; Fibrosarcoma; Fluorides; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Inflammation; Male; Metabolic Clearance Rate; Mice; Organ Specificity; Organometallic Compounds; Picolinic Acids; Radionuclide Imaging; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Turpentine | 2014 |
Small-worldness and gender differences of large scale brain metabolic covariance networks in young adults: a FDG PET study of 400 subjects.
Topics: Adult; Brain; China; Computer Simulation; Dominance, Cerebral; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Models, Neurological; Models, Statistical; Nerve Net; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Sex Factors; Tissue Distribution; Young Adult | 2015 |
A study of plaque vascularization and inflammation using quantitative contrast-enhanced US and PET/CT.
Topics: Aged; Carotid Artery Diseases; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Male; Metabolic Clearance Rate; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography | 2014 |
Combined pre-treatment MRI and 18F-FDG PET/CT parameters as prognostic biomarkers in patients with cervical cancer.
Topics: Adult; Aged; Biomarkers, Tumor; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed; Uterine Cervical Neoplasms; Young Adult | 2014 |
Whole-body-MR imaging including DWIBS in the work-up of patients with head and neck squamous cell carcinoma: a feasibility study.
Topics: Aged; Carcinoma, Squamous Cell; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed; Whole Body Imaging | 2014 |
Survival in patients with hepatocellular carcinoma treated with 90Y-microsphere radioembolization. Prediction by 18F-FDG PET.
Topics: Adult; Aged; Aged, 80 and over; Brachytherapy; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Survival Rate; Yttrium Radioisotopes | 2014 |
The influence of FDG PET-CT on the detection of extrahepatic disease in patients being considered for resection of colorectal liver metastasis.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Precancerous Conditions; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Higher predictive value of tumour and node [18F]-FDG PET metabolic volume and TLG in advanced lung cancer under chemotherapy.
Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Paclitaxel; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Treatment Outcome; Tumor Burden | 2014 |
Risk factors for N2 metastasis in patients with non-small-cell lung cancer: multivariate analyses of 18F-FDG PET/CT data.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; China; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Multivariate Analysis; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Risk Assessment; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2014 |
Prognostic significance of novel ¹⁸F-FDG PET/CT defined tumour variables in patients with oesophageal cancer.
Topics: Adult; Aged; Carcinoma; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed | 2014 |
18F-FDG-PET/CT in fever of unknown origin: clinical value.
Topics: Adult; Aged; Female; Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2014 |
Role of ¹⁸F-FDG PET/CT in the diagnosis of infective endocarditis in patients with an implanted cardiac device: a prospective study.
Topics: Aged; Defibrillators, Implantable; Endocarditis, Bacterial; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Reliability of semiquantitative ¹⁸F-FDG PET parameters derived from simultaneous brain PET/MRI: a feasibility study.
Topics: Adolescent; Adult; Aged; Algorithms; Brain Diseases; Computer Simulation; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Models, Biological; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2014 |
Parallel ICA of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Benzothiazoles; Biomarkers; Brain; Data Interpretation, Statistical; Female; Fluorodeoxyglucose F18; Glucose; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Principal Component Analysis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thiazoles | 2014 |
[Importance of PET for surgery of gastrointestinal stromal tumors].
Topics: Combined Modality Therapy; Energy Metabolism; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Molecular Imaging; Neoadjuvant Therapy; Positron-Emission Tomography; Prognosis; Sensitivity and Specificity; Tumor Burden | 2014 |
PET-CT in the assessment of lung cancer at Rikshospitalet from 2007-2011.
Topics: Aged; Algorithms; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Male; Mediastinum; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
18F-FDG SPECT/CT in the diagnosis of differentiated thyroid carcinoma with elevated thyroglobulin and negative iodine-131 scans.
Topics: False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Iodine Radioisotopes; Male; Middle Aged; Multimodal Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
Aggressive angiomyxomas: a comprehensive imaging review with clinical and histopathologic correlation.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Myxoma; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Tomography, X-Ray Computed; Urogenital Neoplasms | 2014 |
Is there any role of positron emission tomography computed tomography for predicting resectability of gallbladder cancer?
Topics: Adult; Aged; Aged, 80 and over; Cholecystography; Female; Fluorodeoxyglucose F18; Gallbladder; Gallbladder Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Routine use of dual time ¹⁸F-FDG PET for staging of preoperative lung cancer: does it affect clinical management?
Topics: Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung; Lung Neoplasms; Male; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Time Factors | 2014 |
Role of [18F]fluorodeoxyglucose positron emission tomography-computed tomography, sonography, and sonographically guided fine-needle aspiration biopsy in the diagnosis of axillary lymph nodes in patients with breast cancer: comparison of diagnostic perfor
Topics: Adult; Aged; Axilla; Breast Neoplasms; Carcinoma, Ductal, Breast; Endoscopic Ultrasound-Guided Fine Needle Aspiration; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Tomography, X-Ray Computed; Ultrasonography, Mammary | 2014 |
Clinical significance of FDG-PET/CT at the postoperative surveillance in the breast cancer patients.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Breast; Breast Neoplasms; Breast Neoplasms, Male; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Humans; Male; Mammography; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Postoperative Care; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography, Mammary; Young Adult | 2016 |
Cost-effectiveness of FDG-PET/CT for cytologically indeterminate thyroid nodules: a decision analytic approach.
Topics: Adult; Cost-Benefit Analysis; Decision Support Techniques; Decision Trees; Fluorodeoxyglucose F18; Health Care Costs; Humans; Markov Chains; Models, Econometric; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms; Thyroid Nodule; Tomography, X-Ray Computed | 2014 |
F-18 FDG PET/CT in the evaluation of Takayasu arteritis: an experience from the tropics.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; India; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Takayasu Arteritis; Tomography, X-Ray Computed; Tropical Climate | 2014 |
Overestimated value of (18)F-FDG PET/CT to diagnose pulmonary nodules: Analysis of 298 patients.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Risk Factors; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2014 |
Quantitative interpretation of FDG PET/CT with myocardial perfusion imaging increases diagnostic information in the evaluation of cardiac sarcoidosis.
Topics: Female; Fluorodeoxyglucose F18; Heart Diseases; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Male; Middle Aged; Multimodal Imaging; Myocardial Perfusion Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sarcoidosis; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Cortico-subcortical metabolic correlates of olfactory processing in healthy resting subjects.
Topics: Brain; Brain Mapping; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Multimodal Imaging; Nerve Net; Olfactory Perception; Positron-Emission Tomography; Radiopharmaceuticals; Reference Values; Reproducibility of Results; Rest; Sensitivity and Specificity; Statistics as Topic; Tomography, X-Ray Computed | 2014 |
Can we increase the yield of FDG-PET in the preoperative work-up for epilepsy surgery?
Topics: Adolescent; Adult; Brain; Child; Electrodes, Implanted; Electroencephalography; Epilepsies, Partial; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Reproducibility of Results; Seizures; Sensitivity and Specificity; Signal Processing, Computer-Assisted; Young Adult | 2014 |
Diagnostic accuracy of integrated (18)F-FDG PET/CT for restaging patients with malignant germ cell tumours.
Topics: Adolescent; Adult; Aged; Biomarkers, Tumor; Child; Child, Preschool; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Infant; Iohexol; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Evaluation of primary bone lymphoma and the importance of positron emission tomography.
Topics: Adolescent; Biopsy; Bone Neoplasms; Chemoradiotherapy; Child; Femoral Neoplasms; Fibula; Fluorodeoxyglucose F18; Humans; Ilium; Lymphoma, Non-Hodgkin; Male; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Remission Induction; Reproducibility of Results; Sensitivity and Specificity | 2014 |
Utility of quantitative FDG-PET/CT for the detection of bone marrow involvement in follicular lymphoma: a histopathological correlation study.
Topics: Adult; Aged; Aged, 80 and over; Bone Marrow Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Male; Middle Aged; Multimodal Imaging; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Tomography, X-Ray Computed | 2014 |
Oral cavity squamous cell carcinoma: role of pretreatment imaging and its influence on management.
Topics: Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Mouth Neoplasms; Multidetector Computed Tomography; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Tomography, Emission-Computed; Tumor Burden | 2014 |
The role of 18F-FDG PET/CT in differentiating malignant from benign portal vein thrombosis.
Topics: Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasms; Portal Vein; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed; Venous Thrombosis; Young Adult | 2014 |
Value of ¹⁸F-FDG PET-CT in surveillance of postoperative colorectal cancer patients with various carcinoembryonic antigen concentrations.
Topics: Adult; Aged; Carcinoembryonic Antigen; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Postoperative Period; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Measurement of apparent diffusion coefficient with simultaneous MR/positron emission tomography in patients with peritoneal carcinomatosis: comparison with 18F-FDG-PET.
Topics: Adult; Aged; Carcinoma; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Ovarian Neoplasms; Peritoneal Neoplasms; Positron-Emission Tomography; Prospective Studies; Sensitivity and Specificity | 2014 |
Positron emission tomography (PET) has limited utility in the staging of pancreatic adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Linear Models; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Clinical values for abnormal ¹⁸F-FDG uptake in the head and neck region of patients with head and neck squamous cell carcinoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biopsy; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity | 2014 |
Can 18F-FDG PET improve the evaluation of suspicious breast lesions on MRI?
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
A standardized [18F]-FDG-PET template for spatial normalization in statistical parametric mapping of dementia.
Topics: Aged; Aged, 80 and over; Brain; Brain Mapping; Case-Control Studies; Cognitive Dysfunction; Dementia; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Sensitivity and Specificity | 2014 |
Should We Routinely Investigate Incidental Head and Neck Findings on 18-Fluorodeoxyglucose Positron Emission Tomography in Patients Being Staged for Non-small Cell Lung Cancer? A Retrospective Analysis.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Incidental Findings; Lung Neoplasms; Male; Neoplasms, Second Primary; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2015 |
Improved differentiation of benign and malignant breast tumors with multiparametric 18fluorodeoxyglucose positron emission tomography magnetic resonance imaging: a feasibility study.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Neoplasm Grading; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Tumor Burden | 2014 |
Performance of (18)F-FDG PET/CT as a postoperative surveillance imaging modality for asymptomatic advanced gastric cancer patients.
Topics: Adult; Aged; Anastomosis, Surgical; False Positive Reactions; Female; Fluorodeoxyglucose F18; Gastrectomy; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Stomach Neoplasms; Tomography, X-Ray Computed | 2014 |
Effect of time-of-flight technique on the diagnostic performance of 18F-FDG PET/CT for assessment of lymph node metastases in head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2014 |
Imaging in resectable colorectal liver metastasis patients with or without preoperative chemotherapy: results of the PROMETEO-01 study.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Chemotherapy, Adjuvant; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Induction Chemotherapy; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity | 2014 |
¹⁸F-FDG-PET/CT in staging, restaging, and treatment response assessment of male breast cancer.
Topics: Adult; Aged; Breast Neoplasms, Male; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome; Whole Body Imaging | 2014 |
Early detection of disease progression after palliative chemotherapy in NSCLC patients by (18)F-FDG-PET.
Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Germany; Humans; Incidence; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Palliative Care; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Risk Assessment; Risk Factors; Sensitivity and Specificity | 2014 |
Impact of ¹⁸F-FDG PET/CT on the management of adrenocortical carcinoma: analysis of 106 patients.
Topics: Adolescent; Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Adult; Aged; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2014 |
FDG PET for gauging of sarcoid disease activity.
Topics: Fluorodeoxyglucose F18; Granuloma; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Respiratory Function Tests; Sarcoidosis; Sarcoidosis, Pulmonary; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Assessment of multifocality and axillary nodal involvement in early-stage breast cancer patients using 18F-FDG PET/CT compared to contrast-enhanced and diffusion-weighted magnetic resonance imaging and sentinel node biopsy.
Topics: Adult; Aged; Axilla; Breast Neoplasms; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Tomography, X-Ray Computed | 2015 |
18F-FDG-PET/CT is of limited value in primary staging of early stage cervical cancer.
Topics: Adult; Aged; Aged, 80 and over; Cervix Uteri; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Staging; Pelvis; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Uterine Cervical Neoplasms; Young Adult | 2015 |
Cerebral arterial inflow assessment with 18F-FDG PET: methodology and feasibility.
Topics: Aged; Blood Flow Velocity; Brain; Cerebral Arteries; Cerebrovascular Circulation; Computer Simulation; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Models, Cardiovascular; Models, Neurological; Perfusion Imaging; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2014 |
What parameters from 18F-FDG PET/CT are useful in evaluation of adrenal lesions?
Topics: Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Use of 18F-FDG PET/CT imaging for evaluation of patients with primary splenic lymphoma.
Topics: Adolescent; Adult; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Splenic Neoplasms; Tomography, X-Ray Computed | 2014 |
(18)F-fluorodeoxy glucose and (18)F fluoride PET for detection of inflammation focus in periprosthetic hip joint infection cases.
Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Hip Joint; Hip Prosthesis; Humans; Inflammation; Male; Middle Aged; Prospective Studies; Prosthesis-Related Infections; Radionuclide Imaging; Sensitivity and Specificity | 2015 |
Evaluation of bone metastases from breast cancer by bone scintigraphy and positron emission tomography/computed tomography imaging.
Topics: Bone Neoplasms; Breast Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Medronate; Tomography, X-Ray Computed | 2014 |
Multimodal approach to detect osseous involvement in meningioma: additional value of (18)F-fluoride PET/CT for conventional imaging.
Topics: Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Meningioma; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
18F-fluorodeoxyglucose positron emission tomography/computed tomography enables the detection of recurrent same-site deep vein thrombosis by illuminating recently formed, neutrophil-rich thrombus.
Topics: Animals; Case-Control Studies; Cohort Studies; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Humans; Ligation; Male; Mice; Mice, Inbred C57BL; Middle Aged; Multimodal Imaging; Neutropenia; Neutrophils; Positron-Emission Tomography; Recurrence; Retrospective Studies; Sensitivity and Specificity; Thrombosis; Time Factors; Tomography, X-Ray Computed; Venous Thrombosis | 2014 |
Value of 18F-FDG PET/CT for early prediction of pathologic response (by residual cancer burden criteria) of locally advanced breast cancer to neoadjuvant chemotherapy.
Topics: Adult; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Neoplasm Grading; Neoplasm, Residual; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
FDG PET/MR for the assessment of lymph node involvement in lymphoma: initial results and role of diffusion-weighted MR.
Topics: Adolescent; Adult; Aged; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphoma; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Young Adult | 2014 |
The role of 18F-Fluorodeoxyglucose Positron Emission Tomography in patients with suspected recurrence or metastatic differentiated thyroid carcinoma with elevated serum thyroglobulin and negative I-131 whole body scan.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Recurrence; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Tomography, X-Ray Computed; Whole Body Imaging | 2014 |
CA 15.3 measurements for separating FDG PET/CT positive from negative findings in breast carcinoma recurrence. Factors influencing the area under the ROC curve.
Topics: Adult; Aged; Biomarkers, Tumor; Breast Neoplasms; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Mucin-1; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Risk Assessment; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Texture analysis on (18)F-FDG PET/CT images to differentiate malignant and benign bone and soft-tissue lesions.
Topics: Area Under Curve; Bone and Bones; Bone Neoplasms; Diagnosis, Computer-Assisted; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Soft Tissue Neoplasms; Support Vector Machine; Tomography, X-Ray Computed | 2014 |
Monitoring dominant strictures in primary sclerosing cholangitis with brush cytology and FDG-PET.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Cholangitis, Sclerosing; Constriction, Pathologic; Cytological Techniques; Disease Progression; Feasibility Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Transplantation; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Sensitivity and Specificity | 2014 |
Diagnostic accuracy of whole-body PET/MRI and whole-body PET/CT for TNM staging in oncology.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reference Standards; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2015 |
In vivo prediction of tuberculosis-associated cavity formation in rabbits.
Topics: Animals; Dental Pulp Cavity; Fluorodeoxyglucose F18; Positron-Emission Tomography; Rabbits; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Tooth Diseases; Tuberculosis | 2015 |
Functional pattern of brain FDG-PET in amyotrophic lateral sclerosis.
Topics: Adult; Aged; Aged, 80 and over; Amyotrophic Lateral Sclerosis; Brain; Case-Control Studies; Discriminant Analysis; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neural Pathways; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Young Adult | 2014 |
Test performance of PET-CT for mediastinal lymph node staging of pulmonary carcinoid tumours.
Topics: Aged; Carcinoid Tumor; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Variation of system performance, quality control standards and adherence to international FDG-PET/CT imaging guidelines. A national survey of PET/CT operations in Austria.
Topics: Austria; Fluorodeoxyglucose F18; Guideline Adherence; Health Care Surveys; Internationality; Multimodal Imaging; Nuclear Medicine; Positron-Emission Tomography; Practice Guidelines as Topic; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Detection of osseous metastasis by 18F-NaF/18F-FDG PET/CT versus CT alone.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Sodium Fluoride; Tomography, X-Ray Computed | 2015 |
A pilot study of the value of 18F-fluoro-deoxy-thymidine PET/CT in predicting viable lymphoma in residual 18F-FDG avid masses after completion of therapy.
Topics: Adult; Aged; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Multimodal Imaging; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Selective CT for PET/CT: dose reduction in Langerhans cell histiocytosis.
Topics: Adolescent; Adult; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Histiocytosis, Langerhans-Cell; Humans; Infant; Male; Positron-Emission Tomography; Radiation Dosage; Radiation Protection; Radiographic Image Enhancement; Radiometry; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2015 |
Planned neck dissection after chemoradiotherapy in advanced oropharyngeal squamous cell cancer: the role of US, MRI and FDG-PET/TC scans to assess residual neck disease.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neck Dissection; Neoplasm, Residual; Oropharyngeal Neoplasms; Patient Care Planning; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography, Doppler, Color | 2014 |
Diagnostic performance of FDG PET/CT to detect subclinical HNSCC recurrence 6 months after the end of treatment.
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2015 |
Prediction of clinical outcome after stereotactic body radiotherapy for non-small cell lung cancer using diffusion-weighted MRI and (18)F-FDG PET.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Radiosurgery; Reproducibility of Results; Sensitivity and Specificity | 2014 |
The impacts of severe perfusion defects, akinetic/dyskinetic segments, and viable myocardium on the accuracy of volumes and LVEF measured by gated ⁹⁹mTc-MIBI SPECT and gated ¹⁸F-FDG PET in patients with left ventricular aneurysm: cardiac magnetic resonanc
Topics: Cardiac-Gated Single-Photon Emission Computer-Assisted Tomography; Coronary Artery Disease; Female; Fluorodeoxyglucose F18; Heart Aneurysm; Humans; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Stroke Volume; Technetium Tc 99m Sestamibi; Ventricular Dysfunction, Left | 2014 |
In-vivo monitoring of erythropoietin treatment after myocardial infarction in mice with [⁶⁸Ga]Annexin A5 and [¹⁸F]FDG PET.
Topics: Animals; Annexin A5; Cardiotonic Agents; Drug Monitoring; Erythropoietin; Fluorodeoxyglucose F18; Male; Mice; Mice, Inbred C57BL; Myocardial Infarction; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome | 2014 |
In vivo imaging of enhanced leukocyte accumulation in atherosclerotic lesions in humans.
Topics: Case-Control Studies; Cell Movement; Confidence Intervals; Coronary Artery Disease; Female; Fluorodeoxyglucose F18; Humans; Leukocytes, Mononuclear; Male; Middle Aged; Multimodal Imaging; Observer Variation; Positron-Emission Tomography; Sensitivity and Specificity; Severity of Illness Index; Statistics, Nonparametric; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Transplantation, Autologous | 2014 |
FDG PET/CT for rectal carcinoma radiotherapy treatment planning: comparison of functional volume delineation algorithms and clinical challenges.
Topics: Adult; Algorithms; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Male; Multimodal Imaging; Observer Variation; Pattern Recognition, Automated; Positron-Emission Tomography; Radiotherapy, Image-Guided; Rectal Neoplasms; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden | 2014 |
A disease-specific metabolic brain network associated with corticobasal degeneration.
Topics: Aged; Aged, 80 and over; Basal Ganglia Diseases; Cerebral Cortex; Cerebrum; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Metabolic Networks and Pathways; Middle Aged; Multiple System Atrophy; Nerve Net; Neurodegenerative Diseases; Parkinsonian Disorders; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity; Supranuclear Palsy, Progressive | 2014 |
Efficiency of three-dimensional Doppler ultrasonography in assessing nodal metastasis of head and neck cancer.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Comparative Effectiveness Research; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Imaging, Three-Dimensional; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Neck; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography, Doppler, Color | 2015 |
Value of CT, FDG PET-CT and serum tumor markers in staging recurrent colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Tumor Burden; Young Adult | 2015 |
Comparison of two threshold detection criteria methodologies for determination of probe positivity for intraoperative in situ identification of presumed abnormal 18F-FDG-avid tissue sites during radioguided oncologic surgery.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Intraoperative Care; Male; Middle Aged; Models, Statistical; Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Surgery, Computer-Assisted | 2014 |
Association between the standardized uptake value and high-risk HPV in hypopharyngeal squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Cohort Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Papillomavirus Infections; Positron-Emission Tomography; Preoperative Care; Proportional Hazards Models; Retrospective Studies; Risk Assessment; ROC Curve; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Survival Analysis | 2014 |
Role of 18F-FDG PET/CT in detecting pelvic lymph-node metastases in patients with early-stage uterine cervical cancer: comparison with MRI findings.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoplasm Staging; Pelvis; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2014 |
Prognostic value of SUVmax and metabolic tumor volume on 18F-FDG PET/CT in early stage non-small cell lung cancer patients without LN metastasis.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Lymphatic Metastasis; Male; Metabolic Clearance Rate; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Tumor Burden | 2014 |
The effect of tumor size on the imaging diagnosis: a study based on simulation.
Topics: Computer Simulation; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Metabolic Clearance Rate; Models, Biological; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tumor Burden | 2014 |
Potential impact of 18F-FDG PET/CT on patients selection for neoadjuvant chemotherapy before radical cystectomy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Contrast Media; Cystectomy; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Urinary Bladder Neoplasms | 2014 |
Prognostic value of FDG PET metabolic tumor volume in human papillomavirus-positive stage III and IV oropharyngeal squamous cell carcinoma.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Oropharyngeal Neoplasms; Papillomaviridae; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Survival Rate; Tumor Burden | 2014 |
Prediction of microvascular invasion of hepatocellular carcinoma using gadoxetic acid-enhanced MR and (18)F-FDG PET/CT.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Image Enhancement; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Microvessels; Middle Aged; Multimodal Imaging; Neoplasm Invasiveness; Neovascularization, Pathologic; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
First clinical results of (D)-18F-Fluoromethyltyrosine (BAY 86-9596) PET/CT in patients with non-small cell lung cancer and head and neck squamous cell carcinoma.
Topics: Adult; Aged; Biopsy; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; False Positive Reactions; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Inflammation; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Prospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Tyrosine | 2014 |
Diagnostic value of interleukin-10 in cerebrospinal fluid for diffuse large B-cell lymphoma of the central nervous system.
Topics: Adult; Aged; Aged, 80 and over; Area Under Curve; Biomarkers; Brain Diseases; Central Nervous System Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Interleukin-10; Interleukin-6; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Interleukin-2; ROC Curve; Sensitivity and Specificity | 2015 |
Positron emission tomography in the diagnostic work-up of screening-detected lung nodules.
Topics: Aged; Area Under Curve; Early Detection of Cancer; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Mass Screening; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; ROC Curve; Sensitivity and Specificity; Smoking; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2015 |
Influence of partial volume correction in staging of head and neck squamous cell carcinoma using PET/CT.
Topics: Aged; Algorithms; Artifacts; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed; Tumor Burden | 2014 |
The acetabular fossa hot spot on 18F-FDG PET/CT: epidemiology, natural history, and proposed etiology.
Topics: Acetabulum; Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Incidence; Joint Diseases; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Tomography, X-Ray Computed; United States; Young Adult | 2015 |
The usefulness of standardized uptake value in differentiation between benign and malignant thyroid lesions detected incidentally in 18F-FDG PET/CT examination.
Topics: Biological Transport; Biopsy, Fine-Needle; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Reference Standards; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, X-Ray Computed | 2014 |
The role of combined Ga-DOTANOC and (18)FDG PET/CT in the management of patients with pancreatic neuroendocrine tumors.
Topics: Aged; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Male; Middle Aged; Neuroendocrine Tumors; Organometallic Compounds; Pancreatic Neoplasms; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Can complementary 68Ga-DOTATATE and 18F-FDG PET/CT establish the missing link between histopathology and therapeutic approach in gastroenteropancreatic neuroendocrine tumors?
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Intestinal Neoplasms; Ki-67 Antigen; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neuroendocrine Tumors; Organometallic Compounds; Pancreatic Neoplasms; Positron-Emission Tomography; Prospective Studies; Sensitivity and Specificity; Stomach Neoplasms; Tomography, X-Ray Computed | 2014 |
Long-term results confirmed that 18F-FDG-PET/CT was an excellent diagnostic modality for early detection of vascular grafts infection.
Topics: Adult; Aged; Aged, 80 and over; Blood Vessel Prosthesis; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prosthesis-Related Infections; Radiopharmaceuticals; Sensitivity and Specificity | 2018 |
Hole detection in metabolic connectivity of Alzheimer's disease using kappa-Laplacian.
Topics: Algorithms; Alzheimer Disease; Artificial Intelligence; Brain; Cognitive Dysfunction; Connectome; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2014 |
Efficacy of 18F-fluorodeoxyglucose positron emission tomography/CT imaging for extracapsular spread of laryngeal squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2016 |
Multi-stage thresholded region classification for whole-body PET-CT lymphoma studies.
Topics: Computer Simulation; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lymphoma; Models, Biological; Multimodal Imaging; Pattern Recognition, Automated; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2014 |
[18F]fluorodeoxyglucose uptake in atherosclerotic plaques is associated with reduced coronary flow reserve in mice.
Topics: Animals; Aortitis; Computer Simulation; Coronary Artery Disease; Female; Fluorodeoxyglucose F18; Fractional Flow Reserve, Myocardial; Image Interpretation, Computer-Assisted; Male; Metabolic Clearance Rate; Mice; Mice, Inbred C57BL; Mice, Knockout; Models, Cardiovascular; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2014 |
Reduction of bladder activity on FDG PET/CT scan in patients with urinary bladder carcinoma. A prospective study with a patient-friendly protocol.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Metabolic Clearance Rate; Middle Aged; Multimodal Imaging; Patient Satisfaction; Patient-Centered Care; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Urinary Bladder; Urinary Bladder Neoplasms; Urination | 2015 |
Visual versus semi-quantitative analysis of 18F-FDG-PET in amnestic MCI: an European Alzheimer's Disease Consortium (EADC) project.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cognitive Dysfunction; Europe; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Psychiatric Status Rating Scales; Sensitivity and Specificity | 2015 |
The efficacy of preoperative positron emission tomography-computed tomography (PET-CT) for detection of lymph node metastasis in cervical and endometrial cancer: clinical and pathological factors influencing it.
Topics: Adult; Aged; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2015 |
18FDG-PET-CT: an imaging biomarker of high-risk carotid plaques. Correlation to symptoms and microembolic signals.
Topics: Aged; Aged, 80 and over; Area Under Curve; Carotid Stenosis; Female; Fluorodeoxyglucose F18; Humans; Intracranial Embolism; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Risk Factors; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography, Doppler, Transcranial | 2014 |
Diagnostic performances of FDG-PET/CT and diffusion-weighted imaging indices for differentiating benign pheochromocytoma from other benign adrenal tumors.
Topics: Adolescent; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2015 |
The role of FDG-PET/CT in the evaluation of residual disease in paediatric non-Hodgkin lymphoma.
Topics: Adolescent; Biopsy; Child; Child, Preschool; Disease Progression; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Multimodal Imaging; Neoplasm, Residual; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2015 |
Direct comparison of visual and quantitative bone marrow FDG-PET/CT findings with bone marrow biopsy results in diffuse large B-cell lymphoma: does bone marrow FDG-PET/CT live up to its promise?
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Bone Marrow; Female; Fluorodeoxyglucose F18; Humans; Ilium; Imaging, Three-Dimensional; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Validation of an optimized SPM procedure for FDG-PET in dementia diagnosis in a clinical setting.
Topics: Aged; Aged, 80 and over; Brain; Data Interpretation, Statistical; Diagnosis, Computer-Assisted; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neurodegenerative Diseases; Positron-Emission Tomography; Sensitivity and Specificity | 2014 |
Diagnostic value of retrospective PET-MRI fusion in head-and-neck cancer.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Reproducibility of Results; Retrospective Studies; ROC Curve; Sensitivity and Specificity | 2014 |
Determination of vitality of liver lesions by alveolar echinococcosis. Comparison of parametric contrast enhanced ultrasound (SonoVue®) with quantified 18F-FDG-PET-CT.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cohort Studies; Contrast Media; Echinococcosis, Hepatic; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Phospholipids; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Severity of Illness Index; Sulfur Hexafluoride; Tissue Survival; Tomography, X-Ray Computed; Ultrasonography; Young Adult | 2015 |
Usefulness of increased 18F-FDG uptake for detecting local recurrence in patients with extremity osteosarcoma treated with surgical resection and endoprosthetic replacement.
Topics: Adolescent; Bone Neoplasms; Extremities; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Multimodal Imaging; Neoplasm Recurrence, Local; Osteosarcoma; Positron-Emission Tomography; Prostheses and Implants; Prosthesis Implantation; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
The role of tonsillectomy in the initial diagnostic work-up of head and neck squamous cell carcinoma of unknown primary.
Topics: Aged; Aged, 80 and over; Biopsy; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Diseases; Male; Middle Aged; Neoplasm Invasiveness; Neoplasms, Unknown Primary; Palatine Tonsil; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Tonsillectomy | 2014 |
Segmentation of heterogeneous or small FDG PET positive tissue based on a 3D-locally adaptive random walk algorithm.
Topics: Algorithms; Data Interpretation, Statistical; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Neoplasms; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2014 |
Dual-time point whole-body 18F-fluorodeoxyglucose PET/CT imaging in undiagnosed mediastinal lymphadenopathy: a prospective study of 117 patients with sarcoidosis and TB.
Topics: Aged; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Diseases; Male; Mediastinum; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Sarcoidosis, Pulmonary; Sensitivity and Specificity; Tomography, X-Ray Computed; Tuberculosis, Pulmonary; Whole Body Imaging | 2014 |
Detection of breast cancer in an FDG-PET cancer screening program: results of a nationwide Japanese survey.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Japan; Mammography; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Surveys and Questionnaires; Tomography, X-Ray Computed; Young Adult | 2015 |
¹⁸F-FDG PET/CT in hepatocellular carcinoma: detection of bone metastasis and prediction of prognosis.
Topics: Adult; Aged; Bone and Bones; Bone Neoplasms; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Retrospective Studies; Sensitivity and Specificity; Survival Analysis; Tomography, X-Ray Computed | 2015 |
Prognostic Significance of the Standardized Uptake Value on Positron Emission Tomography in Patients with Multiple Clinical-N0 Lung Cancers.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2015 |
Differentiation of an adrenal mass in patients with non-small cell lung cancer by means of a normal range of adrenal standardized uptake values on FDG PET/CT.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Carcinoma, Non-Small-Cell Lung; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Liver; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Organ Size; Positron-Emission Tomography; Radiopharmaceuticals; Reference Values; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Clinical course of primary progressive aphasia: clinical and FDG-PET patterns.
Topics: Aged; Aged, 80 and over; Aphasia, Primary Progressive; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Sensitivity and Specificity; Statistics, Nonparametric; Survival Analysis; Time Factors | 2015 |
[Usefulness of (18)FDG PET-CT scan as a diagnostic tool of fever of unknown origin].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Diagnosis, Differential; Female; Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Infections; Inflammation; Male; Middle Aged; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2015 |
Staging of locally advanced breast cancer and the prediction of response to neoadjuvant chemotherapy: complementary role of scintimammography and 18F-FDG PET/CT.
Topics: Adult; Aged; Breast Neoplasms; Chemotherapy, Adjuvant; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Fluorodeoxyglucose F18; Humans; Mammography; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Treatment Outcome; Whole Body Imaging | 2017 |
18F-FDG PET/CT findings in endometrial cancer patients: the correlation between SUVmax and clinicopathologic features.
Topics: Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Menopause; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Comparison of the diagnostic accuracy of 99 m-Tc-MDP bone scintigraphy and 18 F-FDG PET/CT for the detection of skeletal metastases.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Child; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Medronate; Tomography, X-Ray Computed | 2016 |
Pediatric bone sarcoma: diagnostic performance of ¹⁸F-FDG PET/CT versus conventional imaging for initial staging and follow-up.
Topics: Adolescent; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Multimodal Imaging; Neoplasm Staging; Observer Variation; Osteosarcoma; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
The performance of contrast-enhanced FDG PET/CT for the differential diagnosis of unexpected ovarian mass lesions in patients with nongynecologic cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Case-Control Studies; Colorectal Neoplasms; Contrast Media; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Improved detection of bone metastases from lung cancer in the thoracic cage using 5- and 1-mm axial images versus a new CT software generating rib unfolding images: comparison with standard ¹⁸F-FDG-PET/CT.
Topics: Aged; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Ribs; Sensitivity and Specificity; Software; Tomography, X-Ray Computed | 2015 |
Prediction of Outcomes in Mild Cognitive Impairment by Using 18F-FDG-PET: A Multicenter Study.
Topics: Aged; Alzheimer Disease; Brain; Cognitive Dysfunction; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Logistic Models; Longitudinal Studies; Magnetic Resonance Imaging; Male; Mental Status Schedule; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Retrospective Studies; Sensitivity and Specificity | 2015 |
The value of endobronchial ultrasound transbronchial needle aspiration in normal positron emission tomography in lung cancer.
Topics: Endoscopic Ultrasound-Guided Fine Needle Aspiration; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2015 |
Gender differences in the human brain.
Topics: Brain; China; Female; Fluorodeoxyglucose F18; Humans; Male; Nerve Net; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Sex Factors; Tissue Distribution; Young Adult | 2015 |
Optimal likelihood-ratio multiple testing with application to Alzheimer's disease and questionable dementia.
Topics: Alzheimer Disease; Brain; Computer Simulation; Dementia; Fluorodeoxyglucose F18; Frontal Lobe; Hippocampus; Humans; Likelihood Functions; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity | 2015 |
18F-fluorodeoxyglucose uptake level-based lymph node staging in oropharyngeal squamous cell cancer--role of molecular marker expression on diagnostic outcome.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Molecular Diagnostic Techniques; Multimodal Imaging; Neoplasm Staging; Oropharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Characterization of solitary pulmonary nodules with 18F-FDG PET/CT relative activity distribution analysis.
Topics: Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; ROC Curve; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2015 |
Significance of hormone receptor status in comparison of 18F -FDG-PET/CT and 99mTc-MDP bone scintigraphy for evaluating bone metastases in patients with breast cancer: single center experience.
Topics: Adult; Aged; Aged, 80 and over; Bone and Bones; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Technetium Tc 99m Medronate; Tomography, X-Ray Computed | 2015 |
[Relapsing polychondritis. Primary and follow-up diagnostics with (18)F-FDG-PET/CT].
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Enhancement; Multimodal Imaging; Polychondritis, Relapsing; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Prediction of AD dementia by biomarkers following the NIA-AA and IWG diagnostic criteria in MCI patients from three European memory clinics.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Amyloidosis; Atrophy; Biomarkers; Disease Progression; Fluorodeoxyglucose F18; Hippocampus; Humans; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Sensitivity and Specificity; tau Proteins | 2015 |
Visual and statistical analysis of ¹⁸F-FDG PET in primary progressive aphasia.
Topics: Aged; Aged, 80 and over; Aphasia, Primary Progressive; Data Interpretation, Statistical; Female; Fluorodeoxyglucose F18; Humans; Male; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2015 |
Investigation of radiation protection of medical staff performing medical diagnostic examinations by using PET/CT technique.
Topics: Fluorodeoxyglucose F18; Health Personnel; Humans; Multimodal Imaging; Occupational Exposure; Poland; Positron-Emission Tomography; Radiation Dosage; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Thermoluminescent Dosimetry; Tomography, X-Ray Computed; Whole-Body Counting | 2015 |
Early diagnosis of cardiac implantable electronic device generator pocket infection using ¹⁸F-FDG-PET/CT.
Topics: Aged; Aged, 80 and over; Defibrillators, Implantable; Device Removal; Early Diagnosis; Echocardiography; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prospective Studies; Prosthesis-Related Infections; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
18F-FDG PET/CT qualitative and quantitative evaluation in neurofibromatosis type 1 patients for detection of malignant transformation: comparison of early to delayed imaging with and without liver activity normalization.
Topics: Adolescent; Adult; Aged; Child; Female; Fluorodeoxyglucose F18; Humans; Liver; Male; Middle Aged; Nerve Sheath Neoplasms; Neurofibromatosis 1; Positron-Emission Tomography; Predictive Value of Tests; Reproducibility of Results; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Time Factors; Tomography, X-Ray Computed; Young Adult | 2015 |
Diagnostic accuracy of F-18 FDG PET/CECT vs. CECT for detecting recurrence of periampullary carcinoma and its prognostic significance.
Topics: Bile Duct Neoplasms; Bile Ducts; Carcinoma; Cholangiography; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiographic Image Enhancement; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Survival Analysis; Tomography, X-Ray Computed | 2015 |
The applications of corrected standardized uptake values in the diagnosis of peripheral lung lesions.
Topics: Fluorodeoxyglucose F18; Humans; Lung Diseases; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2015 |
Grading meningioma: a comparative study of thallium-SPECT and FDG-PET.
Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Meningeal Neoplasms; Meningioma; Middle Aged; Neoplasm Grading; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon | 2015 |
Fluorodeoxyglucose positron emission tomography/computerized tomography in differentiated thyroid cancer management: Importance of clinical justification and value in predicting survival.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Risk Assessment; Sensitivity and Specificity; Survival Analysis; Thyroid Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
(18)F-FDG Uptake at the Surgical Margin after Hepatic Resection: Patterns of Uptake and Differential Diagnosis.
Topics: Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Liver Diseases; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Prediction of response to neoadjuvant chemotherapy in osteosarcoma using dual-phase (18)F-FDG PET/CT.
Topics: Adolescent; Bone Neoplasms; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Neoadjuvant Therapy; Osteosarcoma; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2015 |
Multiparametric analysis of bone marrow in cancer patients using simultaneous PET/MR imaging: Correlation of fat fraction, diffusivity, metabolic activity, and anthropometric data.
Topics: Adipose Tissue; Adiposity; Adolescent; Adult; Aged; Aged, 80 and over; Anthropometry; Body Weight; Bone Marrow; Child; Child, Preschool; Contrast Media; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasms; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity; Young Adult | 2015 |
[Diagnostic value of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in fever of unknown origin].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Asian People; Child; Child, Preschool; Diagnosis, Differential; Female; Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2015 |
Evaluation of several FDG PET parameters for prediction of soft tissue tumour grade at primary diagnosis and recurrence.
Topics: Female; Fluorodeoxyglucose F18; Humans; Liver; Male; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sarcoma; Sensitivity and Specificity; Soft Tissue Neoplasms | 2015 |
Large-vessel vasculitis: interobserver agreement and diagnostic accuracy of 18F-FDG-PET/CT.
Topics: Aged; Arteries; Atherosclerosis; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Inflammation; Male; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Vasculitis | 2015 |
Dealing with bone marrow biopsies in the staging of classical Hodgkin lymphoma: an old issue revisited in the (18)F-fluorodeoxyglucose-positron emission tomography era.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biopsy; Bone Marrow; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Immunohistochemistry; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Young Adult | 2015 |
Feasibility of [18F]-RGD for ex vivo imaging of atherosclerosis in detection of αvβ3 integrin expression.
Topics: Aged; Aged, 80 and over; Biomarkers; Carotid Artery Diseases; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Integrin alphaVbeta3; Male; Middle Aged; Molecular Diagnostic Techniques; Molecular Imaging; Oligopeptides; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2015 |
Post-treatment surveillance of head and neck cancer: pitfalls in the interpretation of FDG PET-CT/MRI.
Topics: Adult; Aged; Aged, 80 and over; Disease Progression; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Population Surveillance; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Intra-tumour 18F-FDG uptake heterogeneity decreases the reliability on target volume definition with positron emission tomography/computed tomography imaging.
Topics: Adult; Aged; Artifacts; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Tumor Burden | 2015 |
FDG PET/CT imaging of desmoplastic small round cell tumor: findings at staging, during treatment and at follow-up.
Topics: Adolescent; Adult; Child; Child, Preschool; Desmoplastic Small Round Cell Tumor; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2015 |
Diagnostic accuracy of (18)F-FDG-PET/CT in early and late stages of high-risk cutaneous malignant melanoma.
Topics: Adult; Aged; Aged, 80 and over; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Sensitivity and Specificity; Skin Neoplasms; Tomography, X-Ray Computed; Young Adult | 2015 |
Comparison of primary tumour volumes delineated on four-dimensional computed tomography maximum intensity projection and (18) F-fluorodeoxyglucose positron emission tomography computed tomography images of non-small cell lung cancer.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Four-Dimensional Computed Tomography; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tumor Burden | 2015 |
The role of 18F-FDG PET/CT in the management of testicular cancers.
Topics: Adult; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Neoplasms, Germ Cell and Embryonal; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Seminoma; Sensitivity and Specificity; Testicular Neoplasms; Tomography, X-Ray Computed | 2015 |
Does 18F-FDG PET/MRI reduce the number of indeterminate abdominal incidentalomas compared with 18F-FDG PET/CT?
Topics: Abdominal Neoplasms; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Incidental Findings; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2015 |
Post-PET ultrasound improves specificity of 18F-FDG-PET for recurrent differentiated thyroid cancer while maintaining sensitivity.
Topics: Adult; Aged; Biopsy, Fine-Needle; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Multimodal Imaging; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Ultrasonography | 2015 |
Comparison of Coregistration Accuracy of Pelvic Structures Between Sequential and Simultaneous Imaging During Hybrid PET/MRI in Patients with Bladder Cancer.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Pelvis; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Urinary Bladder Neoplasms | 2015 |
Octreoscan Versus FDG-PET for Neuroendocrine Tumor Staging: A Biological Approach.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Indium Radioisotopes; Male; Middle Aged; Neoplasm Grading; Neuroendocrine Tumors; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Somatostatin; Survival Rate; Tomography, X-Ray Computed; Young Adult | 2015 |
High performances of (18)F-fluorodeoxyglucose PET-CT in cardiac implantable device infections: A study of 40 patients.
Topics: Adult; Aged; Aged, 80 and over; Defibrillators, Implantable; Endocarditis; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Male; Middle Aged; Multimodal Imaging; Pacemaker, Artificial; Positron-Emission Tomography; Prosthesis-Related Infections; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2015 |
Respiratory-gated imaging in metabolic evaluation of small solitary pulmonary nodules: 18F-FDG PET/CT and correlation with histology.
Topics: Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Four-Dimensional Computed Tomography; Humans; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2015 |
Comparison of F-18 FDG-PET/CT and Tc-99m MIBI in the preoperative evaluation of cold thyroid nodules in the same patient group.
Topics: Adult; Aged; Biopsy, Fine-Needle; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Preoperative Care; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Thyroid Nodule; Thyroidectomy | 2015 |
The value of 18-FDG PET/CT in the diagnosis and management of implant-related infections of the tibia: a case series.
Topics: Adult; Female; Fluorodeoxyglucose F18; Fracture Fixation, Internal; Humans; Israel; Male; Middle Aged; Positron-Emission Tomography; Postoperative Complications; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Surgical Wound Infection; Tibial Fractures; Tomography, X-Ray Computed | 2015 |
Usefulness of dual-phase 18F-FDG PET/CT for diagnosing small pancreatic tumors.
Topics: Adult; Aged; Carcinoma, Pancreatic Ductal; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed; Tumor Burden | 2015 |
[Comparative analysis of integrated (99m)Tc-MIBI-SPECT/localizable CT and integrated ¹⁸F-FDG-PET/CT for differential diagnosis of solitary pulmonary nodules].
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Solitary Pulmonary Nodule; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2015 |
A comparative study of 18F-FDG PET/CT and ultrasonography in the diagnosis of breast cancer and axillary lymph node metastasis.
Topics: Adult; Aged; Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Ultrasonography; Young Adult | 2017 |
[(18)F]FDG is not transported by P-glycoprotein and breast cancer resistance protein at the rodent blood-brain barrier.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport, Active; Blood-Brain Barrier; Female; Fluorodeoxyglucose F18; Metabolic Clearance Rate; Mice; Mice, Knockout; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Sensitivity and Specificity; Species Specificity; Tissue Distribution | 2015 |
Prospective evaluation of planar bone scintigraphy, SPECT, SPECT/CT, 18F-NaF PET/CT and whole body 1.5T MRI, including DWI, for the detection of bone metastases in high risk breast and prostate cancer patients: SKELETA clinical trial.
Topics: Bone and Bones; Bone Neoplasms; Breast Neoplasms; Diphosphonates; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Prostatic Neoplasms; Radionuclide Imaging; Sensitivity and Specificity; Technetium Compounds | 2016 |
Added value of using a cocktail of F-18 sodium fluoride and F-18 fluorodeoxyglucose in positron emission tomography/computed tomography for detecting bony metastasis: a case report.
Topics: Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Sensitivity and Specificity; Sodium Fluoride; Tomography, X-Ray Computed | 2015 |
A new method of detecting pulmonary nodules with PET/CT based on an improved watershed algorithm.
Topics: Algorithms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Support Vector Machine; Tomography, X-Ray Computed | 2015 |
18-F fluorodeoxyglucose uptake in positron emission tomography as a pathological grade predictor for renal clear cell carcinomas.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Grading; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Comparison of [(11)C]choline Positron Emission Tomography With T2- and Diffusion-Weighted Magnetic Resonance Imaging for Delineating Malignant Intraprostatic Lesions.
Topics: Adult; Aged; Analysis of Variance; Carbon Radioisotopes; Choline; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Radiopharmaceuticals; Reference Standards; Sensitivity and Specificity; Tumor Burden | 2015 |
Prone Versus Supine Breast FDG-PET/CT for Assessing Locoregional Disease Distribution in Locally Advanced Breast Cancer.
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Invasiveness; Patient Positioning; Positron-Emission Tomography; Prone Position; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Supine Position; Tomography, X-Ray Computed | 2015 |
Human brown adipose tissue assessed by simple, noninvasive near-infrared time-resolved spectroscopy.
Topics: Adipose Tissue, Brown; Adolescent; Adult; Body Composition; Fluorodeoxyglucose F18; Hemoglobins; Humans; Male; Mitochondria; Positron-Emission Tomography; Sensitivity and Specificity; Specific Gravity; Spectroscopy, Near-Infrared; Temperature; Time Factors; Tomography, X-Ray Computed; Young Adult | 2015 |
Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?
Topics: Aged; Aged, 80 and over; Area Under Curve; Carcinoma, Squamous Cell; Cell Proliferation; Cohort Studies; Dideoxynucleosides; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Multimodal Imaging; Neck Dissection; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
FDG-PET/CT detection of very early breast cancer in women with breast microcalcification lesions found in mammography screening.
Topics: Aged; Breast Neoplasms; Calcinosis; Comorbidity; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Mammography; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Factors; Sensitivity and Specificity; Taiwan; Tomography, X-Ray Computed; Whole Body Imaging | 2015 |
Adenocarcinoma with BAC features presented as the nonsolid nodule is prone to be false-negative on 18F-FDG PET/CT.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2015 |
The value of PET/CT with FES or FDG tracers in metastatic breast cancer: a computer simulation study in ER-positive patients.
Topics: Biopsy; Breast Neoplasms; Computer Simulation; Diagnostic Imaging; Estradiol; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Estrogen; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Diagnostic accuracy of contrast-enhanced computed tomography and positron emission tomography with 18-FDG in identifying malignant solitary pulmonary nodules.
Topics: Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2015 |
A comparative study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and (99m)Tc-MDP whole-body bone scanning for imaging osteolytic bone metastases.
Topics: Adult; Aged; Bone Neoplasms; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Osteolysis; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Medronate; Tomography, X-Ray Computed; Whole Body Imaging | 2015 |
Can EBUS-TBNA provide an accurate diagnosis in patients found to have enlarged or FDG-avid lymph nodes during surveillance of previously treated lung cancer? A retrospective study.
Topics: Adenocarcinoma; Aged; Bronchoscopy; Carcinoma, Squamous Cell; Databases, Factual; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Male; Middle Aged; Neoplasm Recurrence, Local; Predictive Value of Tests; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Small Cell Lung Carcinoma | 2015 |
Response evaluation after primary systemic therapy of Her2 positive breast cancer – an observational cross-sectional study.
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Cross-Sectional Studies; Docetaxel; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Receptor, ErbB-2; Sensitivity and Specificity; Taxoids; Tomography, X-Ray Computed; Trastuzumab | 2015 |
Rhinal hypometabolism on FDG PET in healthy APO-E4 carriers: impact on memory function and metabolic networks.
Topics: Adult; Aged; Alzheimer Disease; Apolipoprotein E4; Cerebral Cortex; Female; Fluorodeoxyglucose F18; Genetic Predisposition to Disease; Heterozygote; Humans; Male; Memory; Metabolic Networks and Pathways; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2015 |
Gaussian Mixture Models and Model Selection for [18F] Fluorodeoxyglucose Positron Emission Tomography Classification in Alzheimer's Disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Female; Fluorodeoxyglucose F18; Humans; Male; Models, Theoretical; Normal Distribution; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2014 |
[The role of PET in lung cancer staging].
Topics: Disease Progression; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Kikuchi-Fujimoto lymphadenitis imitating metastatic melanoma on positron emission tomography: a case report.
Topics: Adult; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Histiocytic Necrotizing Lymphadenitis; Humans; Melanoma; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Skin Neoplasms; Tomography, X-Ray Computed | 2015 |
Positron emission tomography evaluation of sinonasal inverted papilloma and related conditions: a prospective clinical study.
Topics: Adolescent; Adult; Aged; Carcinoma, Squamous Cell; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Nasal Polyps; Nose Neoplasms; Papilloma, Inverted; Paranasal Sinus Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2015 |
Should PET/CT be implemented in the routine imaging work-up of locally advanced head and neck squamous cell carcinoma? A prospective analysis.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
The total amount of uptake may affect the input function: a theoretic approach about 18F-FDG PET imaging.
Topics: Computer Simulation; Contrast Media; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Mediastinal Neoplasms; Metabolic Clearance Rate; Middle Aged; Models, Biological; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution | 2015 |
Tumor growth prediction with reaction-diffusion and hyperelastic biomechanical model by physiological data fusion.
Topics: Algorithms; Biomechanical Phenomena; Contrast Media; Fluorodeoxyglucose F18; Humans; Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Feasibility of FDG-PET/CT for the initial diagnosis of papillary thyroid cancer.
Topics: Adult; Aged; Carcinoma, Papillary; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Diseases; Thyroid Neoplasms | 2016 |
[Value of FDG PET-CT associated with pathology in diagnosing residual tumor in patients with nasopharyngeal carcinoma after radiotherapy].
Topics: Carcinoma; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm, Residual; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Evaluation of 11C-acetate and 18F-FDG PET/CT in mouse multidrug resistance gene-2 deficient mouse model of hepatocellular carcinoma.
Topics: Acetates; Animals; ATP Binding Cassette Transporter, Subfamily B; ATP-Binding Cassette Sub-Family B Member 4; Carbon; Carcinoma, Hepatocellular; Disease Models, Animal; Fluorodeoxyglucose F18; Liver Neoplasms; Mice; Mice, Knockout; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Preliminary discussion on the value of (18)F-FDG PET/CT in the diagnosis and early staging of non-mycosis fungoides/Sézary's syndrome cutaneous malignant lymphomas.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphoma; Male; Middle Aged; Multimodal Imaging; Mycosis Fungoides; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Sezary Syndrome; Skin; Skin Neoplasms; Tomography, X-Ray Computed; Young Adult | 2015 |
18F-FDG PET/CT is useful in initial staging, restaging for pediatric rhabdomyosarcoma.
Topics: Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prostate; Radiopharmaceuticals; Retrospective Studies; Rhabdomyosarcoma, Alveolar; Rhabdomyosarcoma, Embryonal; Sensitivity and Specificity | 2017 |
18F-FDG PET/CT role in staging of gastric carcinomas: comparison with conventional contrast enhancement computed tomography.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Stomach; Stomach Neoplasms; Tomography, X-Ray Computed | 2015 |
Multiple testing for neuroimaging via hidden Markov random field.
Topics: Algorithms; Alzheimer Disease; Cognitive Dysfunction; Computer Simulation; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Markov Chains; Models, Statistical; Neuroimaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2015 |
Is there an additive value of 18 F-FDG PET-CT to CT/MRI for detecting nodal metastasis in oropharyngeal squamous cell carcinoma patients with palpably negative neck?
Topics: Carcinoma, Squamous Cell; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Neck; Oropharyngeal Neoplasms; Palpation; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2016 |
Intratumoral Heterogeneity of Subcutaneous Nodules in a Never-Smoker Woman of Lung Squamous Cell Carcinoma Detected on 18F-Fluorodeoxyglucose Positron Emission Tomography and Computed Tomography: A Case Report.
Topics: Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
FDG PET/CT dataset for navigation on femoral bone: a feasibility study.
Topics: Animals; Cadaver; Computer Simulation; Datasets as Topic; Feasibility Studies; Femur; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Models, Biological; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Surgery, Computer-Assisted; Swine | 2015 |
Metabolic patterns in prion diseases: an FDG PET voxel-based analysis.
Topics: Adult; Aged; Brain; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Male; Middle Aged; Molecular Imaging; Positron-Emission Tomography; Prion Diseases; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2015 |
Would you bet on PET? Evaluation of the significance of positive PET scan results post-microwave ablation for non-small cell lung cancer.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Catheter Ablation; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Microwaves; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome | 2015 |
Quantitative analysis of myocardial 18F-fluorodeoxyglucose uptake by PET/CT for detection of cardiac sarcoidosis.
Topics: Aged; Cardiomyopathies; Dimensional Measurement Accuracy; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Myocardium; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Sarcoidosis; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Clinical Value of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Upper Tract Urothelial Carcinoma: Impact on Detection of Metastases and Patient Management.
Topics: Adult; Aged; Aged, 80 and over; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Surveys and Questionnaires; Urinary Bladder Neoplasms; Urothelium | 2016 |
Metabolic Tumor Volume on 18F-FDG PET/CT Improves Preoperative Identification of High-Risk Endometrial Carcinoma Patients.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Biopsy; Carcinoma; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Myometrium; Neoplasm Invasiveness; Neoplasm Metastasis; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed; Tumor Burden | 2015 |
Accuracy of 18F-FDG PET/CT, Multidetector CT, and MR Imaging in the Diagnosis of Pancreatic Cysts: A Prospective Single-Center Study.
Topics: Adult; Aged; Cholangiopancreatography, Endoscopic Retrograde; Contrast Media; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multidetector Computed Tomography; Pancreatic Cyst; Pancreatic Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Diagnostic value of 18F-FDG PET/CT in paediatric neuroblastoma: comparison with 131I-MIBG scintigraphy.
Topics: 3-Iodobenzylguanidine; Child; Female; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Neuroblastoma; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Multimodal Discrimination of Alzheimer's Disease Based on Regional Cortical Atrophy and Hypometabolism.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Glucose; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2015 |
RECIST for Response (Clinical and Imaging) in Neoadjuvant Clinical Trials in Operable Breast Cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Mammography; Neoadjuvant Therapy; Positron-Emission Tomography; Reproducibility of Results; Response Evaluation Criteria in Solid Tumors; Sensitivity and Specificity; Triple Negative Breast Neoplasms | 2015 |
(18)F-fluoride PET imaging in a nude rat model of bone metastasis from breast cancer: Comparison with (18)F-FDG and bioluminescence imaging.
Topics: Animals; Bone Neoplasms; Breast Neoplasms; Cell Line, Tumor; Disease Models, Animal; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Luminescent Measurements; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Nude; Reproducibility of Results; Sensitivity and Specificity | 2015 |
¹⁸F-DCFBC PET/CT for PSMA-Based Detection and Characterization of Primary Prostate Cancer.
Topics: Aged; Antigens, Surface; Biomarkers, Tumor; Biopsy; Cysteine; Fluorodeoxyglucose F18; Glutamate Carboxypeptidase II; Humans; Hypertrophy; Immunohistochemistry; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Prostatectomy; Prostatic Neoplasms; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Feasibility of detecting small intestinal disease by FDG-PET/CT.
Topics: Aged; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Intestinal Diseases; Intestine, Small; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Do myocardial PET-MR and PET-CT FDG images provide comparable information?
Topics: Adolescent; Adult; Aged; Cardiac Imaging Techniques; Computer Simulation; Female; Fluorodeoxyglucose F18; Heart; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Male; Middle Aged; Models, Cardiovascular; Myocardium; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Young Adult | 2016 |
Utility of PET/CT in the diagnosis of recurrent ovarian cancer depending on CA 125 serum level.
Topics: Adult; Aged; Biomarkers, Tumor; CA-125 Antigen; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Assessment of outcomes with delayed (18)F-FDG PET-CT response assessment in head and neck squamous cell carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
MR-based attenuation correction for cardiac FDG PET on a hybrid PET/MRI scanner: comparison with standard CT attenuation correction.
Topics: Adult; Aged; Algorithms; Artifacts; Cardiac Imaging Techniques; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Myocardium; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Multi-contrast attenuation map synthesis for PET/MR scanners: assessment on FDG and Florbetapir PET tracers.
Topics: Aniline Compounds; Brain; Ethylene Glycols; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Multimodal Imaging; Positron-Emission Tomography; Radioactive Tracers; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Evaluation of lymph node status after neoadjuvant chemotherapy in breast cancer patients: comparison of diagnostic performance of ultrasound, MRI and ¹⁸F-FDG PET/CT.
Topics: Breast Neoplasms; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography, Mammary | 2015 |
Histogram Analysis of Apparent Diffusion Coefficients for Occult Tonsil Cancer in Patients with Cervical Nodal Metastasis from an Unknown Primary Site at Presentation.
Topics: Adult; Aged; Biopsy; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Tonsillar Neoplasms; Tonsillectomy | 2016 |
Initial assessment of image quality for low-dose PET: evaluation of lesion detectability.
Topics: Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Mycobacterium tuberculosis; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Signal-To-Noise Ratio; Tuberculosis, Pulmonary | 2015 |
Relationship Between 18F-FDG PET/CT Scans and KRAS Mutations in Metastatic Colorectal Cancer.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Fluorodeoxyglucose F18; Genetic Markers; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Mutation; Polymorphism, Single Nucleotide; Positron-Emission Tomography; Proto-Oncogene Proteins; Proto-Oncogene Proteins p21(ras); Radiopharmaceuticals; ras Proteins; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Predicting pleural invasion using HRCT and 18F-FDG PET/CT in lung adenocarcinoma with pleural contact.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Invasiveness; Pleura; Pleural Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Methodologic Considerations for Quantitative 18F-FDG PET/CT Studies of Hepatic Glucose Metabolism in Healthy Subjects.
Topics: Algorithms; Feasibility Studies; Female; Fluorodeoxyglucose F18; Glucose; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Information Storage and Retrieval; Liver; Male; Metabolic Clearance Rate; Middle Aged; Models, Biological; Models, Statistical; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reference Values; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Ratio of Lymph Node to Primary Tumor SUV on PET/CT Accurately Predicts Nodal Malignancy in Non-Small-Cell Lung Cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
18F-FDG PET/CT is a prognostic biomarker in patients affected by bone metastases from breast cancer in comparison with 18F-NaF PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Sodium Fluoride; Survival Rate; Tomography, X-Ray Computed | 2015 |
Added Value of Dual-Time-Point 18F-FDG PET/CT With Delayed Imaging for Detecting Aortic Graft Infection: An Observational Study.
Topics: Aged; Aged, 80 and over; Aorta; Blood Vessel Prosthesis; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Prosthesis-Related Infections; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Multimodal Partial-Volume Correction: Application to 18F-Fluoride PET/CT Bone Metastases Studies.
Topics: Artifacts; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Image Enhancement; Imaging, Three-Dimensional; Multimodal Imaging; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
TSPO Imaging in Glioblastoma Multiforme: A Direct Comparison Between 123I-CLINDE SPECT, 18F-FET PET, and Gadolinium-Enhanced MR Imaging.
Topics: Aged; Biomarkers, Tumor; Brain Neoplasms; Bridged Bicyclo Compounds, Heterocyclic; Female; Fluorodeoxyglucose F18; Gadolinium; Glioblastoma; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Molecular Imaging; Radiopharmaceuticals; Receptors, GABA; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Tomography, Emission-Computed; Tyrosine | 2015 |
FDG-PET/contrast-enhanced CT as a post-treatment tool in head and neck squamous cell carcinoma: comparison with FDG-PET/non-contrast-enhanced CT and contrast-enhanced CT.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Contrast Media; Face; Female; Fluorodeoxyglucose F18; Head; Head and Neck Neoplasms; Humans; Image Enhancement; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2016 |
Ultrasonography-Guided Core Biopsy of Supraclavicular Lymph Nodes for Diagnosis of Metastasis and Identification of Epidermal Growth Factor Receptor (EGFR) Mutation in Advanced Lung Cancer.
Topics: Adult; Aged; Aged, 80 and over; ErbB Receptors; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neck; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography, Interventional | 2015 |
Prospective study evaluating the relative sensitivity of 18F-NaF PET/CT for detecting skeletal metastases from renal cell carcinoma in comparison to multidetector CT and 99mTc-MDP bone scintigraphy, using an adaptive trial design.
Topics: Aged; Bone Neoplasms; Carcinoma, Papillary; Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kidney Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radionuclide Imaging; Research Design; Sensitivity and Specificity; Technetium Tc 99m Medronate; Tomography, X-Ray Computed | 2015 |
Dose Optimization of the Administered Activity in Pediatric Bone Scintigraphy: Validation of the North American Consensus Guidelines.
Topics: Adolescent; Bone Diseases; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Guideline Adherence; Humans; Image Enhancement; Infant; Male; Medical Oncology; North America; Pediatrics; Positron-Emission Tomography; Practice Guidelines as Topic; Radiation Dosage; Radiation Protection; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tennessee | 2015 |
Whole-body diffusion-weighted MRI and (18)F-FDG PET/CT can discriminate between different lymphoma subtypes.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Diagnosis, Differential; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging; Young Adult | 2015 |
Pancreatic Tumor Growth Prediction with Multiplicative Growth and Image-Derived Motion.
Topics: Algorithms; Artificial Intelligence; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Male; Middle Aged; Motion; Multimodal Imaging; Neuroendocrine Tumors; Pancreatic Neoplasms; Pattern Recognition, Automated; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed; Tumor Burden | 2015 |
Factors that affect PERCIST-defined test-retest comparability: an exploration of feasibility in routine clinical practice.
Topics: Adult; Aged; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Diffusion-weighted MR imaging using FASE sequence for 3T MR system: Preliminary comparison of capability for N-stage assessment by means of diffusion-weighted MR imaging using EPI sequence, STIR FASE imaging and FDG PET/CT for non-small cell lung cancer p
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Diffusion Magnetic Resonance Imaging; Echo-Planar Imaging; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Locoregional tumour evaluation of squamous cell carcinoma in the head and neck area: a comparison between MRI, PET/CT and integrated PET/MRI.
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Recurrence; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2016 |
The characterization and prognostic significance of right ventricular glucose metabolism in non-ischemic dilated cardiomyopathy.
Topics: Biomarkers; Cardiomyopathy, Dilated; Female; Fluorodeoxyglucose F18; Glucose; Heart Ventricles; Humans; Male; Metabolic Clearance Rate; Middle Aged; Positron-Emission Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Factors; Sensitivity and Specificity; Survival Rate; Tissue Distribution | 2016 |
Contrast-Enhanced Ultrasound: A Novel Noninvasive, Nonionizing Method for the Detection of Brown Adipose Tissue in Humans.
Topics: Adipose Tissue, Brown; Adult; Blood Flow Velocity; Cohort Studies; Cold Temperature; Contrast Media; Fluorodeoxyglucose F18; Healthy Volunteers; Hemodynamics; Humans; Male; Positron-Emission Tomography; Sensitivity and Specificity; Ultrasonography, Doppler; Young Adult | 2015 |
Recurrent renal cell carcinoma: clinical and prognostic value of FDG PET/CT.
Topics: Aged; Carcinoma, Renal Cell; Decision Making; Decision Support Systems, Clinical; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Kidney Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2016 |
Influence of Statistical Fluctuation on Reproducibility and Accuracy of SUVmax and SUVpeak: A Phantom Study.
Topics: Computer Simulation; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Models, Biological; Models, Statistical; Neoplasms; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Whole Body Imaging | 2015 |
Anterior mediastinal solid tumours in adults: characterisation using dynamic contrast-enhanced MRI, diffusion-weighted MRI, and FDG-PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Magnetic Resonance Imaging; Male; Mediastinal Neoplasms; Middle Aged; Multimodal Imaging; Neoplasms, Germ Cell and Embryonal; Neoplasms, Glandular and Epithelial; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Thymoma; Thymus Neoplasms; Tomography, X-Ray Computed; Young Adult | 2015 |
Comparative study of ¹⁸F-FDG-PET/CT imaging and serum hTERT mRNA quantification in cancer diagnosis.
Topics: Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms; Positron-Emission Tomography; Prospective Studies; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sensitivity and Specificity; Telomerase; Tomography, X-Ray Computed | 2015 |
Improving the Diagnosis of Infective Endocarditis in Prosthetic Valves and Intracardiac Devices With 18F-Fluordeoxyglucose Positron Emission Tomography/Computed Tomography Angiography: Initial Results at an Infective Endocarditis Referral Center.
Topics: Aged; Angiography; Arrhythmias, Cardiac; Defibrillators, Implantable; Echocardiography; Endocarditis; Female; Fluorodeoxyglucose F18; Heart Valve Diseases; Heart Valve Prosthesis; Humans; Male; Middle Aged; Pacemaker, Artificial; Positron-Emission Tomography; Postoperative Complications; Predictive Value of Tests; Prospective Studies; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Effectiveness of imaging modalities for screening IgG4-related dacryoadenitis and sialadenitis (Mikulicz's disease) and for differentiating it from Sjögren's syndrome (SS), with an emphasis on sonography.
Topics: Dacryocystitis; Diagnosis, Differential; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Humans; Immunoglobulin G; Magnetic Resonance Imaging; Male; Middle Aged; Mikulicz' Disease; Positron-Emission Tomography; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Sialadenitis; Sjogren's Syndrome; Tomography, X-Ray Computed; Ultrasonography | 2015 |
Accuracy of 18F-FDG PET-CT in triaging lung cancer patients with suspected brain metastases for MRI.
Topics: Aged; Aged, 80 and over; Brain Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Observer Variation; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
The Role of FDG-PET in the Diagnosis and Staging of Ocular Adnexal Lymphoproliferative Disease.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Orbital Diseases; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Accuracy of (18) FDG PET-CT for treatment evaluation 3 months after completion of chemoradiotherapy for head and neck squamous cell carcinoma: 2-year minimum follow-up.
Topics: Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Positron Emission Tomography Computed Tomography; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2016 |
Effects of imaging modalities, brain atlases and feature selection on prediction of Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Atlases as Topic; Brain; Cognitive Dysfunction; Cohort Studies; Datasets as Topic; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Support Vector Machine | 2015 |
Diagnostic performances of [18F]fluorocholine positron emission tomography in brain tumors.
Topics: Adult; Aged; Brain Neoplasms; Choline; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2018 |
Risk Stratification of Thyroid Incidentalomas Found on PET/CT: The Value of Iodine Content on Noncontrast Computed Tomography.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Middle Aged; Retrospective Studies; Risk; Risk Assessment; Sensitivity and Specificity; Thyroid Gland; Thyroid Neoplasms; Tomography, X-Ray Computed | 2015 |
Preserved Hippocampal Glucose Metabolism on 18F-FDG PET after Transplantation of Human Umbilical Cord Blood-derived Mesenchymal Stem Cells in Chronic Epileptic Rats.
Topics: Animals; Chronic Disease; Cord Blood Stem Cell Transplantation; Epilepsy, Temporal Lobe; Fluorodeoxyglucose F18; Hippocampus; Male; Mesenchymal Stem Cell Transplantation; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Treatment Outcome | 2015 |
18F-FDG PET/CT in the post-operative monitoring of patients with adrenocortical carcinoma.
Topics: Abdominal Neoplasms; Adolescent; Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Carcinoma; Adult; Aged; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Postoperative Period; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2015 |
Diffusion-weighted whole-body imaging with background body signal suppression/T2 image fusion and positron emission tomography/computed tomography of upper gastrointestinal cancers.
Topics: Aged; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Upper Gastrointestinal Tract; Whole Body Imaging | 2015 |
Screening for distant metastases in head and neck cancer patients using FDG-PET and chest CT: validation of an algorithm.
Topics: Adult; Aged; Algorithms; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2016 |
A simulation system for biomarker evolution in neurodegenerative disease.
Topics: Alzheimer Disease; Biomarkers; Brain; Computer Simulation; Disease Progression; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Longitudinal Studies; Models, Neurological; Nerve Tissue Proteins; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution | 2015 |
Use of FDG PET/CT in Patients with Pancoast Tumors: Does It Add Any Contribution to Patient Management?
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Pancoast Syndrome; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed; Tumor Burden | 2015 |
Role of 18F-FDG PET/CT Imaging in Intrahepatic Cholangiocarcinoma.
Topics: Adult; Aged; Aged, 80 and over; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biomarkers, Tumor; Carcinoma, Hepatocellular; Cholangiocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Klatskin Tumor; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2016 |
Clinical role of early dynamic FDG-PET/CT for the evaluation of renal cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity | 2016 |
Diagnostic and prognostic value of 18F-DOPA PET and 1H-MR spectroscopy in pediatric supratentorial infiltrative gliomas: a comparative study.
Topics: Adolescent; Brain; Child; Child, Preschool; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Glioma; Humans; Kaplan-Meier Estimate; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Prognosis; Proton Magnetic Resonance Spectroscopy; Retrospective Studies; Sensitivity and Specificity; Supratentorial Neoplasms | 2015 |
Evaluation of 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in rat models with hepatocellular carcinoma with liver cirrhosis.
Topics: Animals; Carcinoma, Hepatocellular; Diethylnitrosamine; Feasibility Studies; Fluorodeoxyglucose F18; Liver Cirrhosis; Liver Neoplasms; Male; Metabolic Clearance Rate; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Tomography, X-Ray Computed | 2015 |
Fluorodeoxyglucose positron emission tomography in pulmonary carcinoid tumors.
Topics: Adolescent; Adult; Aged; Carcinoid Tumor; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gene Expression Regulation, Neoplastic; Humans; Ki-67 Antigen; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Preoperative Period; Prognosis; Retrospective Studies; Sensitivity and Specificity; Young Adult | 2015 |
A new method for segmentation of FDG PET metabolic tumour volume using the peritumoural halo layer and a 10-step colour scale. A study in patients with papillary thyroid carcinoma.
Topics: Adult; Aged; Algorithms; Carcinoma; Carcinoma, Papillary; Color; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Male; Middle Aged; Observer Variation; Pattern Recognition, Automated; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Severity of Illness Index; Thyroid Cancer, Papillary; Thyroid Neoplasms; Tumor Burden | 2015 |
Diagnostic Performance of Diffusion-Weighted Imaging for Multiple Hilar and Mediastinal Lymph Nodes with FDG Accumulation.
Topics: Aged; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Diseases; Lymphatic Metastasis; Lymphoma; Male; Mediastinum; Middle Aged; Multimodal Imaging; Pneumoconiosis; Positron-Emission Tomography; Prospective Studies; Sarcoidosis; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
18F-FDG-PET/CT in the Staging and Management of Melanoma: A Prospective Multicenter Ontario PET Registry Study.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Middle Aged; Multimodal Imaging; Neoplasm Staging; Ontario; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Registries; Sensitivity and Specificity; Tomography, X-Ray Computed | 2016 |
Diagnostic performance of [(18)F]fluorodeoxyglucose positron emission tomography-computed tomography in cyst infection in patients with autosomal dominant polycystic kidney disease.
Topics: Adult; Aged; Cysts; Female; Fluorodeoxyglucose F18; France; Hospitals, Teaching; Humans; Infections; Magnetic Resonance Imaging; Male; Middle Aged; Polycystic Kidney, Autosomal Dominant; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Staining and Labeling; Tomography, X-Ray Computed | 2016 |
18F-FDG PET/CT in differentiating malignant from benign origins of obstructive jaundice.
Topics: Aged; Bile Ducts; Carcinoma; Cholecystitis; Choledocholithiasis; Constriction, Pathologic; Digestive System Neoplasms; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Jaundice, Obstructive; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Pancreatitis; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Enhancing 18F-FDG-PET/CT analysis in lung cancer patients. Is CT-CT image fusion helpful in predicting pleural involvement? A pilot study.
Topics: Aged; Aged, 80 and over; Feasibility Studies; Fluorodeoxyglucose F18; Humans; Image Enhancement; Lung Neoplasms; Middle Aged; Multimodal Imaging; Neoplasm Invasiveness; Observer Variation; Pilot Projects; Pleural Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
[Correlation between metabolic tumor volume (MTV) and microvessel density (MVD) and blood-borne metastasis in colorectal carcinoma].
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Microvessels; Multimodal Imaging; Neoplasm Staging; Neoplastic Cells, Circulating; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Progressing Toward a Cohesive Pediatric 18F-FDG PET/MR Protocol: Is Administration of Gadolinium Chelates Necessary?
Topics: Adolescent; Chelating Agents; Child; Child, Preschool; Contrast Media; Female; Fluorodeoxyglucose F18; Gadolinium; Humans; Infant; Magnetic Resonance Imaging; Male; Multimodal Imaging; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Young Adult | 2016 |
Clinical utility of 18F-FDG-PET/MR for preoperative breast cancer staging.
Topics: Adult; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity | 2016 |
Comparing staging by positron emission tomography with contrast-enhanced computed tomography and by pathology in head and neck squamous cell carcinoma.
Topics: Adult; Aged; Biopsy, Needle; Carcinoma, Squamous Cell; Cohort Studies; Contrast Media; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Immunohistochemistry; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Radiographic Image Enhancement; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Comparison of FDG and FDG-labeled leukocytes PET/CT in diagnosis of infection.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; Fluorodeoxyglucose F18; Humans; Image Enhancement; Leukocytes; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Staining and Labeling; Tomography, X-Ray Computed; Young Adult | 2015 |
Hepatic FDG uptake is associated with future cardiovascular events in asymptomatic individuals with non-alcoholic fatty liver disease.
Topics: Adult; Aged; Asymptomatic Diseases; Biomarkers; Causality; Comorbidity; Coronary Artery Disease; Female; Fluorodeoxyglucose F18; Humans; Liver; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Positron Emission Tomography Computed Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Republic of Korea; Risk Assessment; Risk Factors; Sensitivity and Specificity | 2017 |
Mild-to-moderate hyperglycemia will not decrease the sensitivity of 18F-FDG PET imaging in the detection of pedal osteomyelitis in diabetic patients.
Topics: Adult; Aged; Aged, 80 and over; Diabetic Foot; Female; Fluorodeoxyglucose F18; Humans; Hyperglycemia; Male; Middle Aged; Osteomyelitis; Positron-Emission Tomography; Sensitivity and Specificity | 2016 |
The diagnostic value of [(18)F]FDG PET for the detection of chronic osteomyelitis and implant-associated infection.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Orthopedic Procedures; Osteomyelitis; Positron-Emission Tomography; Prosthesis-Related Infections; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2016 |
Impact of consensus contours from multiple PET segmentation methods on the accuracy of functional volume delineation.
Topics: Algorithms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Lymphoma; Male; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2016 |
(18)F-FDG Uptake Characteristics in Differentiating Benign from Malignant Nasopharyngeal Lesions in Children.
Topics: Child; Child, Preschool; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Infant; Infant, Newborn; Male; Metabolic Clearance Rate; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution | 2015 |
Left ventricular asynchrony in early isolated cardiac sarcoidosis.
Topics: Adult; Cardiomyopathies; Coronary Angiography; Early Diagnosis; Fluorodeoxyglucose F18; Gadolinium; Glucocorticoids; Humans; Magnetic Resonance Imaging, Cine; Male; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Sarcoidosis; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome; Ventricular Dysfunction, Left | 2016 |
PET/MRI and PET/CT: is there room for both at the top of the food chain?
Topics: Fluorodeoxyglucose F18; Food Chain; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2016 |
Accurate Prediction of Conversion to Alzheimer's Disease using Imaging, Genetic, and Neuropsychological Biomarkers.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Apolipoproteins E; Area Under Curve; Brain; Cognitive Dysfunction; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity | 2016 |
Limited Prognostic Value of SUV max Measured by F-18 FDG PET/CT in Newly Diagnosed Small Cell Lung Cancer Patients.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Carcinoma, Non-Small-Cell Lung; Computer Simulation; Disease-Free Survival; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Models, Biological; Multimodal Imaging; Positron-Emission Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Republic of Korea; Risk Assessment; Risk Factors; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed | 2015 |
Diagnostic performance of CT, MRI and PET/CT in patients with suspected colorectal liver metastases: the superiority of MRI.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Contrast Media; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Liver Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2016 |
Relationship between Preoperative ¹⁸F-Fluorodeoxyglucose Uptake and Epidermal Growth Factor Receptor Status in Primary Colorectal Cancer.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; ErbB Receptors; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiography; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity | 2016 |
Search of Unknown Fever Focus Using PET in Critically Ill Children With Complicated Underlying Diseases.
Topics: Adolescent; Child; Child, Preschool; Comorbidity; Critical Illness; Diagnosis, Differential; Female; Fever of Unknown Origin; Fluorodeoxyglucose F18; Hospitals, University; Humans; Infant; Intensive Care Units, Pediatric; Length of Stay; Male; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2016 |
Diffusion-weighted imaging and (18) F-fluorodeoxyglucose positron emission tomography/computed tomography in breast cancer: Correlation of the apparent diffusion coefficient and maximum standardized uptake values with prognostic factors.
Topics: Adult; Aged; Breast Neoplasms; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Mammography; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2016 |
The significance of pre-therapeutic F-18-FDG PET-CT in lymphoma-associated hemophagocytic lymphohistiocytosis when pathological evidence is unavailable.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Fluorodeoxyglucose F18; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Kaplan-Meier Estimate; Lymphohistiocytosis, Hemophagocytic; Lymphoma; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome; Vincristine | 2016 |
Potential influence of Gadolinium contrast on image segmentation in MR-based attenuation correction with Dixon sequences in whole-body 18F-FDG PET/MR.
Topics: Adult; Aged; Contrast Media; Female; Fluorodeoxyglucose F18; Gadolinium; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Whole Body Imaging | 2016 |
[(18)F]-FDG PET/CT imaging for detection of nodal metastases in patients with squamous cell carcinoma of the pharynx and larynx: comparison with CT.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neck; Neoplasms, Second Primary; Pharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2016 |
Role of 18-Fludeoxyglucose positron emission tomography-computed tomography and subsequent panendoscopy in head and neck squamous cell carcinoma of unknown primary.
Topics: Carcinoma, Squamous Cell; Endoscopy; False Positive Reactions; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Neoplasms, Unknown Primary; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Tongue Neoplasms | 2016 |
Using positron emission tomography (PET) response criteria in solid tumours (PERCIST) 1.0 for evaluation of 2'-deoxy-2'-[18F] fluoro-D-glucose-PET/CT scans to predict survival early during treatment of locally advanced non-small cell lung cancer (NSCLC).
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Denmark; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Risk Assessment; Sensitivity and Specificity; Survival Rate; Treatment Outcome | 2016 |
Ultrasound stratification of the FDG-avid thyroid nodule.
Topics: Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Risk Assessment; Sensitivity and Specificity; Thyroid Gland; Thyroid Nodule; Tomography, X-Ray Computed; Ultrasonography | 2016 |
The preoperative SUVmax for (18)F-FDG uptake predicts survival in patients with colorectal cancer.
Topics: Adult; Aged; Colorectal Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Monitoring bone and soft-tissue tumors after carbon-ion radiotherapy using ¹⁸F-FDG positron emission tomography: a retrospective cohort study.
Topics: Adult; Aged; Aged, 80 and over; Area Under Curve; Bone Neoplasms; Cohort Studies; Female; Fluorodeoxyglucose F18; Heavy Ion Radiotherapy; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Soft Tissue Neoplasms | 2015 |
18F-FDG PET imaging for identifying the dynamics of intestinal disease caused by SFTSV infection in a mouse model.
Topics: Animals; Antibodies, Viral; Bunyaviridae Infections; Chlorocebus aethiops; Disease Models, Animal; Fluorodeoxyglucose F18; Host-Pathogen Interactions; Humans; Intestinal Diseases; Mice; Multimodal Imaging; Phlebovirus; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Vero Cells | 2016 |
Imaging strategy for response evaluation to chemoradiotherapy of the nodal disease in patients with head and neck squamous cell carcinoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biopsy, Fine-Needle; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography; Young Adult | 2016 |
Diagnostic and prognostic value of (18)F-FDG PET/CT for axillary lymph node staging in patients with breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2016 |
Right ventricular dyssynchrony in pulmonary hypertension: Phase analysis using FDG-PET imaging.
Topics: Adult; Algorithms; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Hypertension, Pulmonary; Image Enhancement; Image Interpretation, Computer-Assisted; Male; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Ventricular Dysfunction, Right | 2017 |
Diagnostic accuracy of imaging methods for the diagnosis of skeletal malignancies: A retrospective analysis against a pathology-proven reference.
Topics: Adult; Bone and Bones; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2016 |
Usefulness and pitfalls of F-18-FDG PET/CT for diagnosing extramedullary acute leukemia.
Topics: Acute Disease; Adolescent; Adult; Aged; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Leukemia; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging; Young Adult | 2016 |
Cognitive impairment in ALS patients and validation of the Spanish version of the ALS-CBS test.
Topics: Adult; Aged; Aged, 80 and over; Amyotrophic Lateral Sclerosis; Cognition Disorders; Female; Fluorodeoxyglucose F18; Humans; Logistic Models; Magnetic Resonance Imaging; Male; Mental Status Schedule; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Psychomotor Disorders; Retrospective Studies; Sensitivity and Specificity; Severity of Illness Index; Translating | 2016 |
Whole-body MRI with diffusion-weighted imaging: a valuable alternative to contrast-enhanced CT for initial staging of aggressive lymphoma.
Topics: Adult; Aged; Biopsy; Contrast Media; Diagnosis, Differential; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Iohexol; Lymphoma; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2016 |
Focal colorectal uptake in (18)FDG-PET/CT: maximum standard uptake value as a trigger in a semi-automated screening setting.
Topics: Adult; Aged; Aged, 80 and over; Colon; Colonoscopy; Colorectal Neoplasms; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2016 |
Quantitative evaluation of correlation of dose and FDG-PET uptake value with clinical chest wall complications in patients with lung cancer treated with stereotactic body radiation therapy.
Topics: Adult; Aged; Aged, 80 and over; Chest Pain; Dose-Response Relationship, Radiation; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiation Dosage; Radiation Injuries; Radiopharmaceuticals; Radiosurgery; Reproducibility of Results; Retrospective Studies; Rib Fractures; Sensitivity and Specificity; Statistics as Topic; Thoracic Wall; Treatment Outcome | 2015 |
The value of follow-up FDG-PET/CT in the management and prognosis of patients with HPV-positive oropharyngeal squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Comorbidity; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Maryland; Middle Aged; Oropharyngeal Neoplasms; Papillomavirus Infections; Positron Emission Tomography Computed Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Survival Rate | 2015 |
The Comparison of Computed Tomography Perfusion, Contrast-Enhanced Computed Tomography and Positron-Emission Tomography/Computed Tomography for the Detection of Primary Esophageal Carcinoma.
Topics: Adult; Aged; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2016 |
18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
Topics: Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Image Interpretation, Computer-Assisted; Lymphatic Metastasis; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2016 |
Supraclavicular Brown Adipose Tissue 18F-FDG Uptake and Cardiovascular Disease.
Topics: Adipose Tissue, Brown; Adult; Aged; Boston; Clavicle; Coronary Artery Disease; Disease-Free Survival; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Tissue Distribution | 2016 |
[Systemic vasculitic neuropathy diagnosed by means of (18)F-FDG PET CT].
Topics: Adult; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Peripheral Nervous System Diseases; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Systemic Vasculitis | 2016 |
Targeting of vascular cell adhesion molecule-1 by 18F-labelled nanobodies for PET/CT imaging of inflamed atherosclerotic plaques.
Topics: Analysis of Variance; Animals; Apolipoproteins E; Atherosclerosis; Disease Models, Animal; Endothelial Cells; Female; Fluorodeoxyglucose F18; In Vitro Techniques; Inflammation; Mice; Mice, Inbred C57BL; Plaque, Atherosclerotic; Positron Emission Tomography Computed Tomography; Random Allocation; Sensitivity and Specificity; Single-Domain Antibodies; Vascular Cell Adhesion Molecule-1 | 2016 |
Interest of [(18)F]fluorodeoxyglucose positron emission tomography/computed tomography for the diagnosis of relapse in patients with spinal infection: a prospective study.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Meningitis; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prospective Studies; Recurrence; Sensitivity and Specificity; Spinal Diseases | 2016 |
Accuracy of PET/MR image coregistration of cervical lesions.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Uterine Cervical Neoplasms; Whole Body Imaging | 2016 |
Clinical relevance of 18F-FDG-negative osteoblastic metastatic bone lesions noted on PET/CT in breast cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Osteolysis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2016 |
Comparison of 18F-FDG PET/CT scan and 99mTc-MDP bone scintigraphy in detecting bone metastasis in head and neck tumors.
Topics: Adolescent; Adult; Aged; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Enhancement; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Technetium Tc 99m Medronate; Young Adult | 2016 |
Initial [18F]FDG PET/CT in high-risk DTC patients. A three-year follow-up.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Germany; Humans; Longitudinal Studies; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Radiotherapy, Adjuvant; Remission Induction; Reproducibility of Results; Retrospective Studies; Risk Factors; Sensitivity and Specificity; Survival Rate; Thyroid Neoplasms; Treatment Outcome; Young Adult | 2016 |
Feasibility of simultaneous 18F-FDG PET/MRI for the quantitative volumetric and metabolic measurements of abdominal fat tissues using fat segmentation.
Topics: Abdominal Fat; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Observer Variation; Organ Size; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2016 |
Dual-time point 18FDG-PET/CT imaging may be useful in assessing local recurrent disease in high grade bone and soft tissue sarcoma.
Topics: Adult; Aged; Bone Neoplasms; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Grading; Neoplasm Recurrence, Local; Positron-Emission Tomography; Sarcoma; Sensitivity and Specificity; Time Factors; Tomography, X-Ray Computed | 2016 |
Diagnostic performance of [18F] FDG PET-CT compared to bone scintigraphy for the detection of bone metastases in lung cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Bone and Bones; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Sensitivity and Specificity | 2016 |
Physiological uptake values of 18F-FDG in long bones of the lower extremity on PET/CT imaging.
Topics: Adult; Age Factors; Bone Diseases; Female; Femur; Fluorodeoxyglucose F18; Humans; Lower Extremity; Male; Middle Aged; Organ Specificity; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Sex Factors; Tibia; Tissue Distribution | 2016 |
Detection of bone marrow involvement in newly diagnosed post-transplant lymphoproliferative disorder: (18)F-fluorodeoxyglucose positron emission tomography/computed tomography versus bone marrow biopsy.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Marrow; Bone Marrow Cells; Child; Female; Fluorodeoxyglucose F18; Humans; Immunophenotyping; Male; Middle Aged; Myeloproliferative Disorders; Neoplasm Staging; Organ Transplantation; Positron Emission Tomography Computed Tomography; Sensitivity and Specificity; Young Adult | 2016 |
FDG-PET/CT as a post-treatment restaging tool in urothelial carcinoma: Comparison with contrast-enhanced CT.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiographic Image Enhancement; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome; Urologic Neoplasms; Urothelium | 2016 |
Prognostic significance of volume-based 18F-FDG PET/CT parameter in patients with surgically resected non-small cell lung cancer. Comparison with immunohistochemical biomarkers.
Topics: Aged; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Republic of Korea; Risk Assessment; Sensitivity and Specificity; Survival Rate; Treatment Outcome; Tumor Burden | 2016 |
Restaging oesophageal cancer after neoadjuvant therapy with (18)F-FDG PET-CT: identifying interval metastases and predicting incurable disease at surgery.
Topics: Adult; Aged; Chemotherapy, Adjuvant; Decision Theory; Disease Progression; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Risk Assessment; Sensitivity and Specificity; Tomography, X-Ray Computed | 2016 |
Tumor Heterogeneity Assessed by 18F-FDG PET/CT Is Not Significantly Associated with Nodal Metastasis in Breast Cancer Patients.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tumor Burden | 2016 |
Use of 18F-FDG PET Scan and Ultrasound-guided Biopsy in the Diagnosis of Hepatic Carcinomas.
Topics: Adult; Aged; Bile Duct Neoplasms; Carcinoma, Hepatocellular; Cholangiocarcinoma; Cohort Studies; Female; Fluorodeoxyglucose F18; Hepatectomy; Humans; Image-Guided Biopsy; Liver; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Tumor Burden; Ultrasonography | 2015 |
Use of Positron Emission Tomography to Detect Recurrence and Associations With Survival in Patients With Lung and Esophageal Cancers.
Topics: Aged; Aged, 80 and over; Cohort Studies; Confounding Factors, Epidemiologic; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Medical Overuse; Medicare; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; SEER Program; Sensitivity and Specificity; Survival Analysis; United States | 2016 |
Detection of Local Cancer Recurrence After Stereotactic Ablative Radiation Therapy for Lung Cancer: Physician Performance Versus Radiomic Assessment.
Topics: Aged; Aged, 80 and over; Area Under Curve; Carcinoma, Non-Small-Cell Lung; Clinical Competence; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Observer Variation; Positron-Emission Tomography; Radiation Oncology; Radiology; Radiopharmaceuticals; Radiosurgery; Response Evaluation Criteria in Solid Tumors; ROC Curve; Sensitivity and Specificity; Time Factors; Tomography, X-Ray Computed | 2016 |
Utility of FDG PET/CT for Differential Diagnosis of Patients Clinically Suspected of IgG4-Related Disease.
Topics: Adult; Aged; Aged, 80 and over; Autoimmune Diseases; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Immunoglobulin G; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2016 |
FLT PET/CT Is Better Than FDG PET/CT in Differentiating Benign From Malignant Pancreatobiliary Lesions.
Topics: Adult; Aged; Biliary Tract Neoplasms; Biopsy, Fine-Needle; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2016 |
Prediction of Progressive Mild Cognitive Impairment by Multi-Modal Neuroimaging Biomarkers.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aniline Compounds; Biomarkers; Brain; Cognitive Dysfunction; Disease Progression; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Predictive Value of Tests; Psychiatric Status Rating Scales; Sensitivity and Specificity | 2016 |
Prospective Validation of 18F-FDG Brain PET Discriminant Analysis Methods in the Diagnosis of Amyotrophic Lateral Sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Brain; Computer Simulation; Data Interpretation, Statistical; Discriminant Analysis; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Male; Middle Aged; Models, Statistical; Pattern Recognition, Automated; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2016 |
Near-Infrared Diffuse Optical Imaging for Early Prediction of Breast Cancer Response to Neoadjuvant Chemotherapy: A Comparative Study Using 18F-FDG PET/CT.
Topics: Adult; Aged; Antineoplastic Agents; Biomarkers, Tumor; Breast Neoplasms; Chemotherapy, Adjuvant; Drug Monitoring; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Hemoglobins; Humans; Middle Aged; Molecular Imaging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Spectroscopy, Near-Infrared; Tomography, Optical; Treatment Outcome | 2016 |
PET/CT evaluation of
Topics: Aged; Biomarkers; Coronary Artery Disease; Female; Fluorodeoxyglucose F18; Humans; Intra-Abdominal Fat; Male; Myocardial Perfusion Imaging; Panniculitis; Positron Emission Tomography Computed Tomography; Prognosis; Reproducibility of Results; Risk Factors; Sensitivity and Specificity | 2017 |
Prognostic Role of Early and End-of-Neoadjuvant Treatment 18F-FDG PET/CT in Patients With Breast Cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Lymph Nodes; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity | 2016 |
Potential clinical implication of (18) F-FDG PET/CT in diagnosis of periprosthetic infection and its comparison with (18) F-Fluoride PET/CT.
Topics: Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Prospective Studies; Prosthesis-Related Infections; Sensitivity and Specificity | 2016 |
Clinical significance of thyroid incidentalomas identified by 18F-FDG PET/CT: correlation of ultrasonograpy findings with cytology results.
Topics: Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Incidental Findings; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Reproducibility of Results; Sensitivity and Specificity; Thyroid Neoplasms; Ultrasonography | 2016 |
Thyroid nodules with indeterminate cytology: prospective comparison between 18F-FDG-PET/CT, multiparametric neck ultrasonography, 99mTc-MIBI scintigraphy and histology.
Topics: Aged; Cytodiagnosis; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neck; Positron-Emission Tomography; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Thyroid Nodule; Tomography, X-Ray Computed; Ultrasonography | 2016 |
CT imaging of bone and bone marrow infiltration in malignant melanoma--Challenges and limitations for clinical staging in comparison to 18FDG-PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Bone and Bones; Bone Marrow; Bone Marrow Neoplasms; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2016 |
[Visceral mycoses].
Topics: Fluorodeoxyglucose F18; Foot Diseases; France; Humans; Immunocompromised Host; Mycetoma; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Urban Population | 2015 |
PET Mapping of Neurofunctional Changes in a Posttraumatic Stress Disorder Model.
Topics: Animals; Brain Mapping; Fluorodeoxyglucose F18; Image Interpretation, Computer-Assisted; Male; Nerve Net; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Sensitivity and Specificity; Stress Disorders, Post-Traumatic | 2016 |
The value of fourth and subsequent post-treatment 18F-FDG PET/CT scans in the management of patients with non-Hodgkin's lymphoma.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Treatment Outcome | 2016 |
Multiparametric whole-body anatomic, functional, and metabolic imaging characteristics of peripheral lesions in patients with schwannomatosis.
Topics: Adult; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Molecular Imaging; Multimodal Imaging; Neurilemmoma; Neurofibromatoses; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Skin Neoplasms; Whole Body Imaging | 2016 |
PET/MRI in pancreatic and periampullary cancer: correlating diffusion-weighted imaging, MR spectroscopy and glucose metabolic activity with clinical stage and prognosis.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Diffusion Magnetic Resonance Imaging; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glucose; Humans; Magnetic Resonance Spectroscopy; Male; Metabolic Clearance Rate; Middle Aged; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Factors; Sensitivity and Specificity; Taiwan; Young Adult | 2016 |
Evaluation of a low-carbohydrate diet-based preparation protocol without fasting for cardiac PET/MR imaging.
Topics: Adult; Cardiac Imaging Techniques; Diet, Carbohydrate-Restricted; Dietary Proteins; Fasting; Female; Fluorodeoxyglucose F18; Heart; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Myocardium; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2017 |
FDG Avidity and Tumor Burden: Survival Outcomes for Patients With Recurrent Breast Cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed; Tumor Burden | 2016 |
Contribution of FDG PET/CT for the Optimization of the Management of Additional Lesions Detected on Local Staging Breast MRI.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2016 |
F-18-FDG-avid lymph node metastasis along preferential lymphatic drainage pathways from the tumor-bearing lung lobe on F-18-FDG PET/CT in patients with non-small-cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Drainage; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies; Sensitivity and Specificity | 2016 |
FDG-PET-based differential uptake volume histograms: a possible approach towards definition of biological target volumes.
Topics: Algorithms; Carcinoma, Non-Small-Cell Lung; Computer Simulation; Data Interpretation, Statistical; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Lung Neoplasms; Models, Biological; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tumor Burden | 2016 |
Multi-Atlas-Based Attenuation Correction for Brain 18F-FDG PET Imaging Using a Time-of-Flight PET/MR Scanner: Comparison with Clinical Single-Atlas- and CT-Based Attenuation Correction.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Artifacts; Brain; Brain Neoplasms; Fluorodeoxyglucose F18; Humans; Image Enhancement; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2016 |
Sensitivity of 2-[
Topics: Adult; Aged; Aged, 80 and over; Colonoscopy; Colorectal Neoplasms; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Invasiveness; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Single-Blind Method | 2016 |
Comparison of retrospective PET and MRI-DWI (PET/MRI-DWI) image fusion with PET/CT and MRI-DWI in detection of cervical and endometrial cancer lymph node metastases.
Topics: Adult; Aged; Contrast Media; Diffusion Magnetic Resonance Imaging; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Uterine Cervical Neoplasms | 2016 |
The Prognostic Impact of Early Change in 18F-FDG PET SUV After Neoadjuvant Chemotherapy in Patients with Locally Advanced Breast Cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Breast Neoplasms; Chemotherapy, Adjuvant; Drug Monitoring; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm, Residual; Positron-Emission Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Republic of Korea; Retrospective Studies; Risk Factors; Sensitivity and Specificity; Survival Rate; Treatment Outcome | 2016 |
An alternative parameter for early forecasting clinical response in NSCLC patients during radiotherapy: proof of concept study.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Carcinoma, Non-Small-Cell Lung; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Pilot Projects; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome | 2016 |
Prognostic value of total lesion glycolysis measured by 18F-FDG PET/CT in patients with locally advanced cervical cancer.
Topics: Adult; Aged; Aged, 80 and over; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Longitudinal Studies; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Treatment Outcome; Uterine Cervical Neoplasms | 2016 |
Cerebral metabolic rate of glucose quantification with the aortic image-derived input function and Patlak method: numerical and patient data evaluation.
Topics: Algorithms; Aorta; Brain; Computer Simulation; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Male; Models, Biological; Models, Statistical; Positron-Emission Tomography; Radiopharmaceuticals; Regression Analysis; Reproducibility of Results; Sensitivity and Specificity | 2016 |
18F-FDG uptake and clearance in patients with compromised renal function.
Topics: Aged; Aged, 80 and over; Computer Simulation; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Kidney Diseases; Male; Metabolic Clearance Rate; Middle Aged; Models, Biological; Positron-Emission Tomography; Radioisotope Dilution Technique; Radioisotope Renography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2016 |
[Diagnostic efficacy of 99Tcm-MIBI SPECT/CT and 18F-FDG coincidence SPECT/CT for solitary pulmonary nodules: a comparative study].
Topics: Area Under Curve; Fluorodeoxyglucose F18; Humans; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Solitary Pulmonary Nodule; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2016 |
Prediction of Extracapsular Invasion at Metastatic Sentinel Nodes and Non-sentinel Lymph Nodal Metastases by FDG-PET in Cases with Breast Cancer.
Topics: Adult; Aged; Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Sentinel Lymph Node Biopsy | 2016 |
Comparative Analysis between [(18)F]Fludarabine-PET and [(18)F]FDG-PET in a Murine Model of Inflammation.
Topics: Animals; Fluorodeoxyglucose F18; Inflammation; Mice; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tissue Distribution; Vidarabine | 2016 |
GM-CSF Enhances Macrophage Glycolytic Activity In Vitro and Improves Detection of Inflammation In Vivo.
Topics: Animals; Arteritis; Cells, Cultured; Fluorodeoxyglucose F18; Glycolysis; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Image Enhancement; Macrophages; Male; Mice; Positron-Emission Tomography; Rabbits; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2016 |
Incidental detection of elastofibroma dorsi on PET-CT: initial findings and changes in tumor size and standardized uptake value on serial scans.
Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Scapula; Sensitivity and Specificity; Soft Tissue Neoplasms; Tumor Burden | 2016 |
Metabolic assessment of Merkel cell carcinoma: the role of 18F-FDG PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Merkel Cell; Computer Simulation; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Metabolic Clearance Rate; Middle Aged; Models, Biological; Molecular Imaging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Skin Neoplasms | 2016 |
Novel assessment of global metabolism by 18F-FDG-PET for localizing affected lobe in temporal lobe epilepsy.
Topics: Adult; Brain; Brain Diseases, Metabolic; Epilepsy, Temporal Lobe; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution | 2016 |
Diagnostic utility of intravoxel incoherent motion mr imaging in differentiating primary central nervous system lymphoma from glioblastoma multiforme.
Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Glioblastoma; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Lymphoma; Magnetic Resonance Imaging; Male; Middle Aged; Motion; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Young Adult | 2016 |
Comparison between MRI-based attenuation correction methods for brain PET in dementia patients.
Topics: Aged; Alzheimer Disease; Artifacts; Brain; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2016 |
Combined imaging with 68Ga-DOTA-TATE and 18F-FDG PET/CT on the basis of volumetric parameters in neuroendocrine tumors.
Topics: Adult; Aged; Drug Combinations; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Male; Middle Aged; Neuroendocrine Tumors; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tumor Burden | 2016 |
(18) F-FDG PET-CT and trephine biopsy assessment of bone marrow involvement in lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Bone Marrow; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies; Sensitivity and Specificity; Young Adult | 2016 |
Dual time-point FDG PET/CT and FDG uptake and related enzymes in lymphadenopathies: preliminary results.
Topics: Adolescent; Adult; Aged; Algorithms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Glucose-6-Phosphatase; Hexokinase; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Lymphoma; Male; Middle Aged; Pilot Projects; Positron Emission Tomography Computed Tomography; Reproducibility of Results; Sensitivity and Specificity; Tumor Burden; Young Adult | 2016 |
Repeatability of Quantitative Whole-Body 18F-FDG PET/CT Uptake Measures as Function of Uptake Interval and Lesion Selection in Non-Small Cell Lung Cancer Patients.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Male; Metabolic Clearance Rate; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Whole Body Imaging | 2016 |
Value of fourth and subsequent post-therapy follow-up 18F-FDG PET/CT scans in patients with breast cancer.
Topics: Breast Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Maryland; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Risk Factors; Sensitivity and Specificity; Survival Rate; Treatment Outcome | 2016 |
Radiation dose of 18F-FDG to lactating breasts, its effect on the effective dose and a more accurate effective dose from 18F-FDG.
Topics: Absorption, Radiation; Adult; Breast; Computer Simulation; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lactation; Models, Biological; Positron Emission Tomography Computed Tomography; Radiation Dosage; Radiation Exposure; Radiometry; Radiopharmaceuticals; Relative Biological Effectiveness; Reproducibility of Results; Sensitivity and Specificity | 2016 |
18F-fluorocholine versus 18F-fluorodeoxyglucose for PET/CT imaging in patients with suspected relapsing or progressive multiple myeloma: a pilot study.
Topics: Aged; Aged, 80 and over; Choline; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple Myeloma; Pilot Projects; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Recurrence; Reproducibility of Results; Sensitivity and Specificity | 2016 |
Primary Uterine Peripheral T-cell Lymphoma: A Case Report of MRI and 18F-FDG PET/CT Findings.
Topics: Adult; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Image-Guided Biopsy; Lymphoma, T-Cell, Peripheral; Magnetic Resonance Imaging; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Sensitivity and Specificity; Uterine Neoplasms; Uterus | 2016 |
(18)F-FDG-PET/CT for systemic staging of newly diagnosed triple-negative breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Staging; New York; Positron Emission Tomography Computed Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Survival Rate; Triple Negative Breast Neoplasms | 2016 |
(18)F-FDG PET/CT can correct the clinical stages and predict pathological parameters before operation in cervical cancer.
Topics: Adult; Aged; Cervix Uteri; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Preoperative Care; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tumor Burden; Uterine Cervical Neoplasms | 2016 |
Role of FDG-PET scan in the management of pediatric mature B cell non-Hodgkin's lymphoma. CCHE experience.
Topics: Adolescent; Burkitt Lymphoma; Cancer Care Facilities; Child; Child, Preschool; Egypt; Female; Fluorodeoxyglucose F18; Hospitals, Pediatric; Humans; Infant; Lymphoma, Large B-Cell, Diffuse; Male; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2016 |
Performance evaluation of a high resolution dedicated breast PET scanner.
Topics: Breast; Breast Diseases; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Models, Anatomic; Phantoms, Imaging; Positron-Emission Tomography; Prone Position; Radiopharmaceuticals; Sensitivity and Specificity | 2016 |
Diagnostic accuracy of FDG PET/CT for clinical evaluation at the end of treatment of HL and NHL: a comparison of the Deauville Criteria (DC) and the International Harmonization Project Criteria (IHPC).
Topics: Adolescent; Adult; Aged, 80 and over; Child; Female; Fluorodeoxyglucose F18; Humans; Italy; Lymphoma; Male; Middle Aged; Outcome Assessment, Health Care; Positron Emission Tomography Computed Tomography; Practice Guidelines as Topic; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Survival Rate; United Kingdom; Young Adult | 2016 |
Use of Simultaneous 18F-FDG PET/MRI for the Detection of Spondylodiskitis.
Topics: Aged; Aged, 80 and over; Discitis; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2016 |
Clinical value of fluorine-18 2-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in penile cancer.
Topics: Adult; Aged; Biopsy; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Penile Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Surveys and Questionnaires; Tomography, X-Ray Computed | 2016 |
18F-FDG-PET/CT in Patients Affected by Differentiated Thyroid Carcinoma with Positive Thyroglobulin Level and Negative 131I Whole Body Scan. It's Value Confirmed by a Bicentric Experience.
Topics: Biomarkers, Tumor; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Thyroidectomy; Whole Body Imaging | 2016 |
Robust Intratumor Partitioning to Identify High-Risk Subregions in Lung Cancer: A Pilot Study.
Topics: Aged; Aged, 80 and over; California; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Margins of Excision; Middle Aged; Positron Emission Tomography Computed Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Radiotherapy, Image-Guided; Reproducibility of Results; Retrospective Studies; Risk Assessment; Sensitivity and Specificity; Survival Analysis; Tumor Burden | 2016 |
Cerebrospinal fluid lactate levels and brain [18F]FDG PET hypometabolism within the default mode network in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Brain; Brain Diseases, Metabolic; Fluorodeoxyglucose F18; Glucose; Humans; Lactic Acid; Metabolic Clearance Rate; Nerve Net; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution | 2016 |
Effectiveness of 18F-FDG-PET/CT vs Bone Scintigraphy in Treatment Response Assessment of Bone Metastases in Breast Cancer.
Topics: Adult; Aged; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Osteoblasts; Osteolysis; Positron Emission Tomography Computed Tomography; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Treatment Outcome | 2016 |
Correlation of pretreatment 18F-FDG uptake with clinicopathological factors and prognosis in patients with newly diagnosed diffuse large B-cell lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prednisone; Prevalence; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Risk Factors; Sensitivity and Specificity; Statistics as Topic; Survival Rate; Treatment Outcome; Vincristine; Young Adult | 2016 |
Correlation of metabolic information on FDG-PET with tissue expression of immune markers in patients with non-small cell lung cancer (NSCLC) who are candidates for upfront surgery.
Topics: Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Cytokines; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Immunologic Factors; Lung Neoplasms; Male; Middle Aged; Molecular Imaging; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic | 2016 |
FLT-PET/CT diagnosis of primary and metastatic nodal lesions of gastric cancer: comparison with FDG-PET/CT.
Topics: Dideoxynucleosides; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Stomach Neoplasms | 2016 |
TLG-S criteria are superior to both EORTC and PERCIST for predicting outcomes in patients with metastatic lung adenocarcinoma treated with erlotinib.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Erlotinib Hydrochloride; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Outcome Assessment, Health Care; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Response Evaluation Criteria in Solid Tumors; Sensitivity and Specificity; Survival Rate; Treatment Outcome | 2016 |
Multiscale Texture Analysis: From 18F-FDG PET Images to Histologic Images.
Topics: Animals; Biopsy; Cell Line, Tumor; Fluorodeoxyglucose F18; Image Interpretation, Computer-Assisted; Mice; Neoplasms, Experimental; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2016 |
Getting the Most out of 18F-FDG PET Scans: The Predictive Value of 18F-FDG PET-Derived Blood Flow Estimates for Breast Cancer.
Topics: Breast Neoplasms; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2016 |
Amyloid- and FDG-PET imaging in amyotrophic lateral sclerosis.
Topics: Amyloid; Amyotrophic Lateral Sclerosis; Aniline Compounds; Brain; Brain Diseases, Metabolic; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Molecular Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Stilbenes | 2016 |
Is There a Role for PET/CT Parameters to Characterize Benign, Malignant, and Metastatic Parotid Tumors?
Topics: Aged; Biomarkers, Tumor; Carcinoma, Squamous Cell; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Parotid Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tumor Burden | 2016 |
Patient preparation for cardiac fluorine-18 fluorodeoxyglucose positron emission tomography imaging of inflammation.
Topics: Cardiac Imaging Techniques; Diet, Carbohydrate-Restricted; Fasting; Fluorodeoxyglucose F18; Humans; Image Enhancement; Myocarditis; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2017 |
Early Assessment of Treatment Response in Takayasu Arteritis: An 18FDG PET Procedure.
Topics: Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Takayasu Arteritis | 2016 |
The Impact of Optimal Respiratory Gating and Image Noise on Evaluation of Intratumor Heterogeneity on 18F-FDG PET Imaging of Lung Cancer.
Topics: Aged; Aged, 80 and over; Algorithms; Artifacts; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiographic Image Enhancement; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Reproducibility of Results; Respiratory Mechanics; Respiratory-Gated Imaging Techniques; Sensitivity and Specificity; Signal-To-Noise Ratio | 2016 |
Clinical usefulness of post-treatment FDG PET/CT in patients with ovarian malignancy.
Topics: Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Sensitivity and Specificity; Survival Analysis; Young Adult | 2016 |
Immunohistochemical overexpression of hypoxia-induced factor 1α associated with slow reduction in
Topics: Adult; Aged; Biomarkers, Tumor; Female; Fluorodeoxyglucose F18; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Metabolic Clearance Rate; Middle Aged; Neoplasm Staging; Pharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Up-Regulation | 2016 |
Interim Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography to Predict Pathologic Response to Preoperative Chemoradiotherapy and Prognosis in Patients With Locally Advanced Rectal Cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Area Under Curve; Chemoradiotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Kaplan-Meier Estimate; Male; Middle Aged; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Prognosis; Radioisotopes; Rectal Neoplasms; ROC Curve; Sensitivity and Specificity; Treatment Outcome | 2016 |
A comparison of the diagnostic value of MRI and
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Discitis; Epidural Abscess; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies; Sensitivity and Specificity; Spine; Young Adult | 2017 |
Early Change in Metabolic Tumor Heterogeneity during Chemoradiotherapy and Its Prognostic Value for Patients with Locally Advanced Non-Small Cell Lung Cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; ROC Curve; Sensitivity and Specificity; Time Factors; Treatment Outcome | 2016 |
Topics: Adult; Aged; Aged, 80 and over; Europe; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Lung Neoplasms; Male; Middle Aged; Pattern Recognition, Automated; Positron Emission Tomography Computed Tomography; Practice Guidelines as Topic; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tumor Burden | 2016 |
Commentary to 'Evaluation of a new motion correction algorithm in PET/CT: combining the entire acquired PET data to create a single three-dimensional motion-corrected PET/CT image'.
Topics: Aged; Algorithms; Artifacts; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Imaging, Three-Dimensional; Male; Movement; Neoplasms; Positron Emission Tomography Computed Tomography; Reproducibility of Results; Sensitivity and Specificity | 2016 |
Response to 'Commentary to "Evaluation of a new motion correction algorithm in PET/CT: combining the entire acquired PET data to create a single three-dimensional motion-corrected PET/CT image."'.
Topics: Aged; Algorithms; Artifacts; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Imaging, Three-Dimensional; Male; Movement; Neoplasms; Positron Emission Tomography Computed Tomography; Reproducibility of Results; Sensitivity and Specificity | 2016 |
Diagnostic Accuracy of MRI and Additional [18F]FDG-PET for Behavioral Variant Frontotemporal Dementia in Patients with Late Onset Behavioral Changes.
Topics: Age of Onset; Aged; Atrophy; Brain; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Frontotemporal Dementia; Humans; Magnetic Resonance Imaging; Male; Mental Disorders; Middle Aged; Neuroimaging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity | 2016 |
Surrogate Imaging Biomarkers of Response of Colorectal Liver Metastases After Salvage Radioembolization Using 90Y-Loaded Resin Microspheres.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Response Evaluation Criteria in Solid Tumors; Retrospective Studies; Salvage Therapy; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed; Yttrium Radioisotopes | 2016 |
FDG-PET/CT lymph node staging after neoadjuvant chemotherapy in patients with adenocarcinoma of the esophageal-gastric junction.
Topics: Adenocarcinoma; Adult; Aged; Chemotherapy, Adjuvant; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity | 2016 |
Fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography for the detection of proximal synchronous lesions in patients with obstructive colorectal cancer.
Topics: Adenoma; Aged; Colectomy; Colon; Colonoscopy; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Intestinal Obstruction; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2017 |
Standardized visual reading of F18-FDG-PET in patients with non-small cell lung cancer scheduled for preoperative thoracic lymph node staging.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Liver; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Neoplasm Grading; Neoplasm Staging; Observer Variation; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2016 |
[Is FDG TEP CT practice changing in the management of sarcomas in adults?].
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sarcoma; Sensitivity and Specificity | 2016 |
Predicting the transition from normal aging to Alzheimer's disease: A statistical mechanistic evaluation of FDG-PET data.
Topics: Aged; Aging; Alzheimer Disease; Biomarkers; Brain; Cognitive Dysfunction; Computer Simulation; Data Interpretation, Statistical; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Models, Statistical; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2016 |
The asphericity of the metabolic tumour volume in NSCLC: correlation with histopathology and molecular markers.
Topics: Aged; Aged, 80 and over; Algorithms; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tumor Burden | 2016 |
Positron emission tomography and computed tomography angiography for the diagnosis of giant cell arteritis: A real-life prospective study.
Topics: Aged; Aged, 80 and over; C-Reactive Protein; Computed Tomography Angiography; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity | 2016 |
Prognostic impact of tumour burden assessed by metabolic tumour volume on FDG PET/CT in anal canal cancer.
Topics: Adult; Aged; Aged, 80 and over; Anus Neoplasms; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; France; Humans; Longitudinal Studies; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Risk Assessment; Risk Factors; Sensitivity and Specificity; Survival Rate; Treatment Outcome; Tumor Burden | 2017 |
How reliable is
Topics: Brain Diseases, Metabolic; Corpus Striatum; Early Diagnosis; Female; Fluorodeoxyglucose F18; Humans; Huntington Disease; Male; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2016 |
The value of
Topics: Adenocarcinoma; Antineoplastic Agents; Chemoradiotherapy, Adjuvant; Disease-Free Survival; Early Detection of Cancer; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Induction Chemotherapy; Longitudinal Studies; Male; Middle Aged; Positron-Emission Tomography; Preoperative Care; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Survival Rate; Texas; Treatment Outcome | 2017 |
The role of FDG-PET in localization of recurrent lesions of differentiated thyroid cancer (DTC) in patients with asymptomatic hyperthyroglobulinemia in a real clinical practice.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Young Adult | 2016 |
Quantitative Analysis of (18)F-Fluorodeoxyglucose Positron Emission Tomography Identifies Novel Prognostic Imaging Biomarkers in Locally Advanced Pancreatic Cancer Patients Treated With Stereotactic Body Radiation Therapy.
Topics: Adult; Aged; Biomarkers; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Radiosurgery; Radiotherapy Dosage; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Survival Analysis; Treatment Outcome | 2016 |
Relation between primary tumor FDG avidity and site of first distant metastasis in patients with breast cancer.
Topics: Adult; Breast Neoplasms; Chi-Square Distribution; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Palliative Care; Positron Emission Tomography Computed Tomography; Prognosis; Sensitivity and Specificity; Survival Rate | 2016 |
The usefulness of (18)F-FDG PET/CT for assessing methotrexate-associated lymphoproliferative disorder (MTX-LPD).
Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Tumor Burden | 2016 |
Differences in Brain Metabolic Impairment between Chronic Mild/Moderate TBI Patients with and without Visible Brain Lesions Based on MRI.
Topics: Adult; Brain; Brain Injuries, Traumatic; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Severity of Illness Index | 2016 |
(68)Ga-DOTATATE and (18)F-FDG PET/CT in Paraganglioma and Pheochromocytoma: utility, patterns and heterogeneity.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Organometallic Compounds; Paraganglioma; Pheochromocytoma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2016 |
Can positron emission tomography detect colorectal adenomas and cancers?
Topics: Adenoma; Adult; Aged; Aged, 80 and over; Colonoscopy; Colorectal Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multivariate Analysis; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Young Adult | 2017 |
Kinetic Modeling and Graphical Analysis of 18F-Fluoromethylcholine (FCho), 18F-Fluoroethyltyrosine (FET) and 18F-Fluorodeoxyglucose (FDG) PET for the Fiscrimination between High-Grade Glioma and Radiation Necrosis in Rats.
Topics: Animals; Brain; Cell Line, Tumor; Choline; Diagnosis, Differential; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Glioblastoma; Humans; Kinetics; Necrosis; Neoplasm Grading; Positron-Emission Tomography; Radiation Injuries; Radiopharmaceuticals; Rats, Inbred F344; Reproducibility of Results; Sensitivity and Specificity; Tyrosine | 2016 |
A Large Cohort Study of 18F Fluoro-Deoxy-Glucose Uptake in Normal Spinal Cord: Quantitative Assessment of the Contamination From Adjacent Vertebral Marrow Uptake and Validity of Normalizing the Cord Uptake Against the Lumbar Thecal Sac.
Topics: Age Distribution; Aging; Bone Marrow; Cohort Studies; Dura Mater; Female; Florida; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lumbar Vertebrae; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reference Values; Reproducibility of Results; Sensitivity and Specificity; Sex Distribution; Spinal Cord | 2017 |
Potential use of (18)F-FDG-PET/CT to visualize hypermetabolism associated with muscle pain in patients with adult spinal deformity: a case report.
Topics: Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Metabolic Clearance Rate; Middle Aged; Myalgia; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Scoliosis; Sensitivity and Specificity | 2016 |
Detection of lymph node metastases in pediatric and adolescent/young adult sarcoma: Sentinel lymph node biopsy versus fludeoxyglucose positron emission tomography imaging-A prospective trial.
Topics: Adolescent; Adult; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Infant; Lymph Node Excision; Lymphatic Metastasis; Lymphoscintigraphy; Male; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Sarcoma; Sensitivity and Specificity; Sentinel Lymph Node; Sentinel Lymph Node Biopsy; Tomography, X-Ray Computed; Young Adult | 2017 |
Recurrent bladder carcinoma: clinical and prognostic role of 18 F-FDG PET/CT.
Topics: Aged; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Italy; Male; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Factors; Sensitivity and Specificity; Survival Rate; Urinary Bladder Neoplasms | 2017 |
Contribution of nonattenuation-corrected images on FDG-PET/CT in the assessment of solitary pulmonary nodules.
Topics: Adult; Aged; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Solitary Pulmonary Nodule | 2016 |
Value of 18F-FDG PET/CT in diagnosing chronic Q fever in patients with central vascular disease.
Topics: Aortic Aneurysm, Abdominal; Aortic Diseases; Blood Vessel Prosthesis; Coxiella burnetii; DNA, Bacterial; Fluorodeoxyglucose F18; Humans; Iliac Artery; Polymerase Chain Reaction; Positron Emission Tomography Computed Tomography; Prospective Studies; Prosthesis-Related Infections; Q Fever; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Vascular Diseases | 2016 |
Can positron emission mammography help to identify clinically significant breast cancer in women with suspicious calcifications on mammography?
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Breast Neoplasms; Calcinosis; Carcinoma, Intraductal, Noninfiltrating; Early Detection of Cancer; Female; Fibroadenoma; Fluorodeoxyglucose F18; Humans; Mammography; Middle Aged; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity | 2017 |
18F-FDG PET/CT Diagnosis of Bronchopulmonary Carcinoids Versus Pulmonary Hamartomas: Reply.
Topics: Carcinoid Tumor; Fluorodeoxyglucose F18; Hamartoma; Humans; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2017 |
Re: 18F-FDG PET/CT Diagnosis of Bronchopulmonary Carcinoids Versus Pulmonary Hamartomas.
Topics: Carcinoid Tumor; Fluorodeoxyglucose F18; Hamartoma; Humans; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2017 |
Texture analysis of
Topics: Aged; Aged, 80 and over; Algorithms; Chemoradiotherapy; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Male; Middle Aged; Outcome Assessment, Health Care; Pattern Recognition, Automated; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Treatment Outcome; Tumor Burden | 2017 |
How to scan who: the delicate balance between selecting the patient and selecting the imaging protocol.
Topics: Cost-Benefit Analysis; Europe; Fluorodeoxyglucose F18; Lung Neoplasms; Medical Oncology; Nuclear Medicine; Patient Selection; Positron Emission Tomography Computed Tomography; Practice Guidelines as Topic; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Solitary Pulmonary Nodule | 2017 |
Clinical impact and diagnostic accuracy of 2-[
Topics: Adult; Aged; Alzheimer Disease; Cognitive Dysfunction; Comorbidity; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prevalence; Reproducibility of Results; Risk Factors; Sensitivity and Specificity; Tertiary Care Centers; United Kingdom | 2017 |
Accuracy of FDG-PET/CT for Detection of Incidental Pre-Malignant and Malignant Colonic Lesions - Correlation with Colonoscopic and Histopathologic Findings.
Topics: Adenocarcinoma; Adenoma; Colon; Colonic Neoplasms; Colonic Polyps; Colonoscopy; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Middle Aged; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2016 |
Removing Noises Induced by Gamma Radiation in Cerenkov Luminescence Imaging Using a Temporal Median Filter.
Topics: Algorithms; Animals; Filtration; Fluorodeoxyglucose F18; Gamma Rays; Image Enhancement; Luminescent Measurements; Mice; Molecular Imaging; Phantoms, Imaging; Radiation Dosage; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Signal-To-Noise Ratio | 2016 |
Clinical, Morphologic, and Pathologic Features Associated With Increased FDG Uptake in Schwannoma.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 3; Humans; Male; Middle Aged; Neurilemmoma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution | 2016 |
Limited diagnostic value of Dual-Time-Point (18)F-FDG PET/CT imaging for classifying solitary pulmonary nodules in granuloma-endemic regions both at visual and quantitative analyses.
Topics: Adult; Contrast Media; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Granuloma; Humans; Lung Neoplasms; Male; Middle Aged; Observer Variation; Positron Emission Tomography Computed Tomography; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Solitary Pulmonary Nodule | 2016 |
(18)F-Fluorodeoxyglucose Positron Emission Tomography Can Quantify and Predict Esophageal Injury During Radiation Therapy.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Esophagitis; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiation Injuries; Radiopharmaceuticals; Radiotherapy, Conformal; Radiotherapy, Image-Guided; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Treatment Outcome | 2016 |
Prediction of coronary artery calcium progression by FDG uptake of large arteries in asymptomatic individuals.
Topics: Algorithms; Asymptomatic Diseases; Computer Simulation; Coronary Artery Disease; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Models, Cardiovascular; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Vascular Calcification | 2017 |
Quantitative Accuracy and Lesion Detectability of Low-Dose
Topics: Adult; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Lung Neoplasms; Male; Middle Aged; Observer Variation; Positron-Emission Tomography; Radiation Dosage; Radiation Exposure; Radiation Protection; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2017 |
Topics: Adenocarcinoma; Contrast Media; Endosonography; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Preoperative Period; Radiopharmaceuticals; Sensitivity and Specificity; Stomach Neoplasms | 2017 |
Segmental
Topics: Cost-Benefit Analysis; Europe; Fluorodeoxyglucose F18; Lung Neoplasms; Medical Oncology; Nuclear Medicine; Positron Emission Tomography Computed Tomography; Practice Guidelines as Topic; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Solitary Pulmonary Nodule | 2017 |
Defining imaging biomarker cut points for brain aging and Alzheimer's disease.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Aging; Alzheimer Disease; Amyloidosis; Aniline Compounds; Brain; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Sensitivity and Specificity; Thiazoles | 2017 |
Optimized workflow and imaging protocols for whole-body oncologic PET/MRI.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Multimodal Imaging; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Whole Body Imaging; Workflow | 2016 |
Evaluation of [18F]-FDG-Based Hybrid Imaging Combinations for Assessment of Bone Marrow Involvement in Lymphoma at Initial Staging.
Topics: Adult; Aged; Aged, 80 and over; Bone Marrow; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphoma; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Whole Body Imaging; Young Adult | 2016 |
Metabolic and morphological measurements of subcutaneous and visceral fat and their relationship with disease stage and overall survival in newly diagnosed pancreatic adenocarcinoma : Metabolic and morphological fat measurements in pancreatic adenocarcino
Topics: Abdominal Fat; Adenocarcinoma; Adult; Aged; Aged, 80 and over; Biomarkers; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Intra-Abdominal Fat; Male; Middle Aged; Neoplasm Staging; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Factors; Sensitivity and Specificity; Subcutaneous Fat; Survival Rate | 2017 |
Quantitative imaging characteristics of zirconium-89 on Gemini Time-Of-Flight PET/CT.
Topics: Antibodies, Monoclonal; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Half-Life; Humans; Phantoms, Imaging; Positron Emission Tomography Computed Tomography; Radioisotopes; Radiopharmaceuticals; Scattering, Radiation; Sensitivity and Specificity; Zirconium | 2016 |
Utility of PET/CT with fluorine-18-fluorodeoxyglucose-labeled autologous leukocytes for diagnosing diabetic foot osteomyelitis in patients with Charcot's neuroarthropathy.
Topics: Aged; Charcot-Marie-Tooth Disease; Diabetic Foot; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Leukocytes; Magnetic Resonance Imaging; Male; Middle Aged; Osteomyelitis; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity | 2016 |
Role of 18F-fluorodeoxyglucose Positron Emission Tomography in the Monitoring of Inflammatory Activity in Crohn's Disease.
Topics: Adult; Crohn Disease; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Severity of Illness Index; Treatment Outcome; Young Adult | 2016 |
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Gastric Mucosa; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; ROC Curve; Sensitivity and Specificity | 2016 |
Metabolic Evaluation of Non-Small Cell Lung Cancer Patient-Derived Xenograft Models Using 18F-FDG PET: A Potential Tool for Early Therapy Response.
Topics: Animals; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Female; Fluorodeoxyglucose F18; Glucose; Humans; Lung Neoplasms; Male; Mice, Nude; Mice, SCID; Molecular Imaging; Outcome and Process Assessment, Health Care; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome; Tumor Cells, Cultured | 2017 |
Brain
Topics: Adolescent; Adult; Aged; Brain; Brain Diseases, Metabolic; Chronic Disease; Cognition Disorders; Fasciitis; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Myositis; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Young Adult | 2017 |
Preoperative 18F-Fluorodeoxyglucose Positron Emission Tomography/CT in Prediction of Uterine Risk Factors and Lymph Node Metastasis: An Analysis of 111 Endometrioid Endometrial Cancer Patients.
Topics: Adult; Aged; Carcinoma, Endometrioid; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Myometrium; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Preoperative Period; Prospective Studies; Radiopharmaceuticals; Risk Assessment; Risk Factors; Sensitivity and Specificity | 2017 |
Prospective Pilot Study to Evaluate the Incremental Value of PET Information in Patients With Bladder Cancer Undergoing 18F-FDG Simultaneous PET/MRI.
Topics: Aged; Carcinoma, Transitional Cell; Diuresis; Diuretics; Female; Fluorodeoxyglucose F18; Furosemide; Humans; Lymph Nodes; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Pelvis; Peritoneal Neoplasms; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Urinary Bladder Neoplasms | 2017 |
Critical considerations on the predictive value of end-of-treatment FDG-PET in lymphoma.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Outcome Assessment, Health Care; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome | 2017 |
PET/MRI of metabolic activity in osteoarthritis: A feasibility study.
Topics: Adult; Biomarkers; Bone Diseases, Metabolic; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Multimodal Imaging; Osteoarthritis, Knee; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution | 2017 |
Reply to letter of Adams and Kwee: Critical considerations on the predictive value of end-of-treatment FDG/PET in lymphoma.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Outcome Assessment, Health Care; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome | 2017 |
The adverse impact of surveillance intervals on the sensitivity of FDG-PET/CT for the detection of distant metastases in head and neck cancer patients.
Topics: Adult; Aftercare; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Time Factors | 2017 |
Positron Emission Tomography-Computed Tomography for Patients with Recurrent Colorectal Liver Metastases: Impact on Restaging and Treatment Planning.
Topics: Bone Neoplasms; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasm Staging; Patient Care Planning; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Recurrence; Sensitivity and Specificity; Survival Rate | 2017 |
The role of serial FDG PET for assessing therapeutic response in patients with cardiac sarcoidosis.
Topics: Cardiomyopathies; Drug Monitoring; Female; Fluorodeoxyglucose F18; Humans; Immunosuppressive Agents; Longitudinal Studies; Male; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sarcoidosis; Sensitivity and Specificity; Subtraction Technique; Treatment Outcome | 2017 |
Discussion of 18F-FDG PET/CT imaging characteristics and diagnostic values of angioimmunoblastic T-cell lymphoma.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Immunoblastic Lymphadenopathy; Lymphoma, T-Cell; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity | 2017 |
FDG-PET/CT in the prediction of pulmonary function improvement in nonspecific interstitial pneumonia. A Pilot Study.
Topics: Adult; Aged; Aged, 80 and over; Area Under Curve; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Forced Expiratory Volume; Forecasting; Humans; Lung; Lung Diseases, Interstitial; Male; Middle Aged; Pilot Projects; Positron Emission Tomography Computed Tomography; Pulmonary Fibrosis; Radiographic Image Enhancement; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed; Total Lung Capacity; Treatment Outcome; Vital Capacity | 2016 |
Effect of chemotherapy on the impact of FDG-PET/CT in selection of patients for surgical resection of colorectal liver metastases: single center analysis of PET-CAM randomized trial.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Colorectal Neoplasms; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Young Adult | 2017 |
Letter to the Editor - Unenhanced whole-body MRI versus PET-CT for the detection of prostate cancer metastases after primary treatment.
Topics: Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2016 |
Role of Combined 68Ga-DOTATOC and 18F-FDG Positron Emission Tomography/Computed Tomography in the Diagnostic Workup of Pancreas Neuroendocrine Tumors: Implications for Managing Surgical Decisions.
Topics: Adult; Aged; Aged, 80 and over; Decision Making; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neuroendocrine Tumors; Octreotide; Organometallic Compounds; Pancreas; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Preoperative Period; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity | 2017 |
Topics: Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphocele; Lymphoma; Male; Middle Aged; Necrosis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Young Adult | 2017 |
PET/MR Outperforms PET/CT in Suspected Occult Tumors.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasms, Unknown Primary; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2017 |
MRI fused with prone FDG PET/CT improves the primary tumour staging of patients with breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Predictive Value of Tests; Prone Position; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2017 |
Correlation of PET/CT and Image-Guided Biopsies of Pediatric Malignancies.
Topics: Adolescent; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Image-Guided Biopsy; Male; Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Statistics as Topic | 2017 |
Validation of
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Databases, Factual; Early Diagnosis; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Public-Private Sector Partnerships; Reproducibility of Results; Sensitivity and Specificity | 2017 |
Value of apparent diffusion coefficient prior to neoadjuvant therapy is a predictor of histologic response in patients with borderline resectable pancreatic carcinoma.
Topics: Aged; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Male; Neoadjuvant Therapy; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Treatment Outcome | 2017 |
Topics: Algorithms; Amyotrophic Lateral Sclerosis; Data Interpretation, Statistical; Discriminant Analysis; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Pattern Recognition, Automated; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Support Vector Machine | 2017 |
Does F-18 FDG-PET still play a role in metastatic renal cell carcinoma?
Topics: Biomarkers, Tumor; Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Neoplasm Grading; Neoplasm Staging; Patient Selection; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity | 2017 |
FDG PET in follicular lymphoma: more than a staging test?
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2017 |
Post-treatment 18F-FDG-PET/CT versus contrast-enhanced CT in patients with oropharyngeal squamous cell carcinoma: comparative effectiveness study.
Topics: Carcinoma, Squamous Cell; Contrast Media; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Oropharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Sensitivity and Specificity | 2017 |
Detection of extra-regional tumour recurrence with
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Salvage Therapy; Sensitivity and Specificity | 2017 |
Hibernating substrate of ventricular tachycardia: a three-dimensional metabolic and electro-anatomic assessment.
Topics: Aged; Body Surface Potential Mapping; Female; Fluorodeoxyglucose F18; Heart Conduction System; Humans; Imaging, Three-Dimensional; Male; Myocardial Stunning; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity; Tachycardia, Ventricular | 2017 |
Pediatric Hodgkin Lymphoma: Predictive value of interim 18F-FDG PET/CT in therapy response assessment.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Child; Child, Preschool; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Infant; Male; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Treatment Outcome | 2017 |
Topics: Adult; Age Distribution; Asymptomatic Diseases; Female; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Factors; Sensitivity and Specificity; Sex Distribution; Skin Neoplasms; South Africa | 2017 |
PET/CT for Head and Neck Squamous Cell Carcinoma: Should We Routinely Include the Head and Abdomen?
Topics: Abdominal Neoplasms; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Middle Aged; Pennsylvania; Positron Emission Tomography Computed Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Factors; Sensitivity and Specificity; Skull Neoplasms; Squamous Cell Carcinoma of Head and Neck | 2017 |
Accuracy of FDG-PET/CT in Colorectal Peritoneal Carcinomatosis: Potential Tool for Evaluation of Chemotherapeutic Response.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Drug Therapy; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoadjuvant Therapy; Outcome Assessment, Health Care; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity | 2017 |
Correlation of hypoxia inducible transcription factor in breast cancer and SUVmax of F-18 FDG PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Breast Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Middle Aged; Molecular Imaging; Positron Emission Tomography Computed Tomography; Prevalence; Radiopharmaceuticals; Republic of Korea; Risk Factors; Sensitivity and Specificity; Survival Rate; Tumor Hypoxia | 2017 |
The role of 18F-FDG PET/CT in staging and restaging primary bone lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Young Adult | 2017 |
FDG PET/MR Imaging Coregistration Helps Predict Survival in Patients with Glioblastoma and Radiologic Progression after Standard of Care Treatment.
Topics: Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Risk Assessment; Sensitivity and Specificity; Survival Analysis; Virginia | 2017 |
Evaluation of an optimized [
Topics: Aged; Aged, 80 and over; Basal Ganglia Diseases; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neurodegenerative Diseases; Parkinsonian Disorders; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2017 |
Cytological evaluation by fine needle aspiration biopsy of incidental focal increased fluorodeoxyglucose uptake in thyroid on positron emission tomography scan.
Topics: Adenoma; Adult; Aged, 80 and over; Biopsy, Fine-Needle; Carcinoma; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Nodule | 2017 |
[Usefulness of nuclear medicine in Erdheim-Chester disease: A Lille experience].
Topics: Adult; Aged; Aged, 80 and over; Bone and Bones; Erdheim-Chester Disease; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Nuclear Medicine; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Retrospective Studies; Sensitivity and Specificity; Young Adult | 2017 |
Diagnostic impact of integrated 18F-FDG PET/MRI in cerebral staging of patients with non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2017 |
Progressive Disintegration of Brain Networking from Normal Aging to Alzheimer Disease: Analysis of Independent Components of
Topics: Aged; Aged, 80 and over; Aging; Alzheimer Disease; Brain; Cognitive Dysfunction; Connectome; Disease Progression; Fluorodeoxyglucose F18; Humans; Middle Aged; Nerve Net; Positron-Emission Tomography; Principal Component Analysis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Severity of Illness Index | 2017 |
Accuracy of 18-F FDG PET/CT to detect bone marrow clearance in patients with peripheral T-cell lymphoma - tissue remains the issue.
Topics: Biopsy; Bone Marrow; Fluorodeoxyglucose F18; Humans; Lymphoma, T-Cell, Peripheral; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2017 |
18FDG PET/CT: A Sensitive Tool That Needs Better Users' Understanding.
Topics: Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2017 |
Higher fluorine-18 fluorodeoxyglucose positron emission tomography (FDG-PET) uptake in tuberculous compared to bacterial spondylodiscitis.
Topics: Bacterial Infections; Case-Control Studies; Diagnosis, Differential; Discitis; Female; Fluorodeoxyglucose F18; Humans; Intervertebral Disc; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tuberculosis | 2017 |
Prognostic value of initial fluorodeoxyglucose-PET in esophageal cancer: a prospective study.
Topics: Adult; Aged; Aged, 80 and over; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; France; Humans; Male; Middle Aged; Positron-Emission Tomography; Prevalence; Prognosis; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Survival Analysis; Survival Rate | 2008 |
Utility of fluorodeoxyglucose-PET in patients with differentiated thyroid carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms | 2008 |
Comparison of FDG-PET findings of brain metastasis from non-small-cell lung cancer and small-cell lung cancer.
Topics: Aged; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Whole-Body Counting | 2008 |
FDG positron emission tomography imaging of drug-induced pneumonitis.
Topics: Aged; Anxiety Disorders; Brain Neoplasms; Breast Neoplasms; Dibenzothiazepines; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Pneumonia; Positron-Emission Tomography; Quetiapine Fumarate; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2008 |
Using 18F-fluorodeoxyglucose positron emission tomography to estimate the length of gross tumor in patients with squamous cell carcinoma of the esophagus.
Topics: Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2009 |
Non-small cell lung cancer: whole-body MR examination for M-stage assessment--utility for whole-body diffusion-weighted imaging compared with integrated FDG PET/CT.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Carcinoma, Non-Small-Cell Lung; Contrast Media; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Gadolinium; Heterocyclic Compounds; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Organometallic Compounds; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2008 |
Utility of 18F-fluoro-deoxyglucose emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in combination with ultrasonography for axillary staging in primary breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Axilla; Breast Neoplasms; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Probability; Prognosis; Prospective Studies; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Statistics, Nonparametric; Survival Analysis; Tomography, X-Ray Computed; Ultrasonography, Doppler | 2008 |
Molecular imaging of lymphoid organs and immune activation by positron emission tomography with a new [18F]-labeled 2'-deoxycytidine analog.
Topics: Animals; Deoxycytidine; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Lymphoscintigraphy; Mice; Mice, Inbred C57BL; Mice, Inbred MRL lpr; Positron-Emission Tomography; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Tissue Distribution | 2008 |
Detecting recurrence of gastric cancer: the value of FDG PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Stomach Neoplasms; Tomography, X-Ray Computed | 2009 |
Importance of fluorodeoxyglucose-positron emission tomography (FDG-PET) and endoscopic ultrasonography parameters in predicting survival following surgery for esophageal cancer.
Topics: Adult; Aged; Biopsy, Needle; Cohort Studies; Disease-Free Survival; Endosonography; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Immunohistochemistry; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Patient Selection; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Probability; Proportional Hazards Models; Prospective Studies; Risk Assessment; Sensitivity and Specificity; Survival Analysis; Treatment Outcome | 2008 |
PET/CT fusion scan enhances CT staging in patients with pancreatic neoplasms.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Assessment of large-vessel involvement in giant cell arteritis with 18F-FDG PET: introducing an ROC-analysis-based cutoff ratio.
Topics: Aged; Aorta, Thoracic; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Liver; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity | 2008 |
Non-small cell lung cancer staging: efficacy comparison of integrated PET/CT versus 3.0-T whole-body MR imaging.
Topics: Carcinoma, Non-Small-Cell Lung; Contrast Media; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Whole Body Imaging | 2008 |
Preoperative [18F] FDG-PET after chemotherapy in locally advanced breast cancer: prognostic value as compared with histopathology.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Breast Neoplasms; Cohort Studies; Combined Modality Therapy; Confidence Intervals; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Mastectomy, Segmental; Middle Aged; Multivariate Analysis; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prognosis; Retrospective Studies; Risk Assessment; Sensitivity and Specificity; Survival Analysis; Treatment Outcome | 2008 |
Percutaneous endoscopic gastrostomy site metastases in head and neck cancer: use of FDG PET-CT.
Topics: Aged; Female; Fluorodeoxyglucose F18; Gastroscopy; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
The value of dual time point (18)F-FDG PET imaging for the differentiation between malignant and benign lesions.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Digestive System Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Tumor delineation based on time-activity curve differences assessed with dynamic fluorodeoxyglucose positron emission tomography-computed tomography in rectal cancer patients.
Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Movement; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Rectal Neoplasms; Rectum; Sensitivity and Specificity; Tomography, X-Ray Computed; Tumor Burden | 2009 |
Does 18F-FDG PET/CT add diagnostic accuracy in incidentally identified non-secreting adrenal tumours?
Topics: Adrenal Gland Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Middle Aged; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Aging; Alzheimer Disease; Aniline Compounds; Benzothiazoles; Brain; Cognition Disorders; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Regression Analysis; Sensitivity and Specificity; Thiazoles | 2008 |
18F-FDG positron emission tomography CT (FDG PET-CT) in the management of pancreatic cancer: initial experience in 12 patients.
Topics: Adult; Aged; Biopsy, Fine-Needle; Diagnosis, Differential; Endosonography; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Injections, Intravenous; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Pancreatic Neoplasms; Pilot Projects; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Increased 18F-fluorodeoxyglucose uptake in abdominal aortic aneurysms in positron emission/computed tomography is associated with inflammation, aortic wall instability, and acute symptoms.
Topics: Acute Disease; Aged; Aneurysm, Ruptured; Aortic Aneurysm, Abdominal; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Inflammation; Male; Middle Aged; Pilot Projects; Positron-Emission Tomography; Preoperative Care; Probability; Reference Values; Risk Assessment; Sensitivity and Specificity; Severity of Illness Index; Statistics, Nonparametric | 2008 |
18-FDG PET in the diagnosis of laterocervical metastases from occult carcinoma.
Topics: Aged; Aged, 80 and over; Biopsy, Fine-Needle; Cohort Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Enhancement; Immunohistochemistry; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neck; Neck Dissection; Neoplasm Staging; Neoplasms, Unknown Primary; Positron-Emission Tomography; Prospective Studies; Risk Assessment; Sensitivity and Specificity | 2009 |
Whole-body positron emission tomography with 18F-fluorodeoxyglucose is an effective method to detect extra-pelvic recurrence in uterine sarcomas.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Pelvis; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Sarcoma; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Uterine Neoplasms; Whole Body Imaging | 2008 |
Evaluation of whole-body cancer screening using 18F-2-deoxy-2-fluoro-D-glucose positron emission tomography: a preliminary report.
Topics: Female; Fluorodeoxyglucose F18; Humans; Male; Mass Screening; Middle Aged; Neoplasms; Pilot Projects; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Whole Body Imaging | 2008 |
Detection of metastatic lesions from malignant pheochromocytoma and paraganglioma with diffusion-weighted magnetic resonance imaging: comparison with 18F-FDG positron emission tomography and 123I-MIBG scintigraphy.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity | 2008 |
Dual-time-point FDG PET for the evaluation of locoregional lymph nodes in thoracic esophageal squamous cell cancer.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thoracic Neoplasms | 2009 |
Evaluation of the therapeutic effects and recurrence for head and neck cancer after chemoradiotherapy by FDG-PET.
Topics: Adolescent; Adult; Aged; Carcinoma; Child; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Otorhinolaryngologic Neoplasms; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2009 |
Dual-phase FDG-PET: delayed acquisition improves hepatic detectability of pathological uptake.
Topics: Algorithms; Female; Fluorodeoxyglucose F18; Fourier Analysis; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiography, Abdominal; Radiopharmaceuticals; Sensitivity and Specificity; Statistics, Nonparametric; Time Factors; Tomography, X-Ray Computed | 2008 |
Whole-body MR imaging with the use of parallel imaging for detection of skeletal metastases in pediatric patients with small-cell neoplasms: comparison with skeletal scintigraphy and FDG PET/CT.
Topics: Adolescent; Bone Neoplasms; Carcinoma, Small Cell; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Infant; Magnetic Resonance Imaging; Male; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2008 |
Comparison of preoperative whole-body positron emission tomography with MDCT in patients with primary colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Colonic Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Rectal Neoplasms; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
Evaluation of gross tumor size using CT, 18F-FDG PET, integrated 18F-FDG PET/CT and pathological analysis in non-small cell lung cancer.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Lung Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Systems Integration; Tomography, X-Ray Computed | 2009 |
Desmoplastic melanoma: true positive and false negative findings on F-18 FDG-PET/CT.
Topics: Aged, 80 and over; False Negative Reactions; Female; Fibroma, Desmoplastic; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Melanoma; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2008 |
Visual PET/CT scoring for nonspecific 18F-FDG uptake in the differentiation of early malignant and benign esophageal lesions.
Topics: Aged; Area Under Curve; Chi-Square Distribution; Diagnosis, Differential; Esophageal Diseases; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Precancerous Conditions; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2008 |
Principal component analysis of FDG PET in amnestic MCI.
Topics: Aged; Alzheimer Disease; Amnesia; Case-Control Studies; Discriminant Analysis; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Memory; Positron-Emission Tomography; Principal Component Analysis; Sensitivity and Specificity | 2008 |
Integrated fluorine-18 fluorodeoxyglucose (18F-FDG) PET/CT compared to standard contrast-enhanced CT for characterization and staging of pulmonary tumors eligible for surgical resection.
Topics: Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Assessment of tumour response with (18)F-fluorodeoxyglucose positron emission tomography using three-dimensional measures compared to SUVmax--a phantom study.
Topics: Algorithms; Fluorodeoxyglucose F18; Image Enhancement; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Neoplasms; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2008 |
A contrast-oriented algorithm for FDG-PET-based delineation of tumour volumes for the radiotherapy of lung cancer: derivation from phantom measurements and validation in patient data.
Topics: Algorithms; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Phantoms, Imaging; Positron-Emission Tomography; Radiotherapy Planning, Computer-Assisted; Sensitivity and Specificity; Tumor Burden | 2008 |
Comparison of FDG PET and MRI for evaluating the tumor extent of breast cancer and the impact of FDG PET on the systemic staging and prognosis of patients who are candidates for breast-conserving therapy.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Carcinoma, Lobular; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2009 |
Improvement of the diagnostic accuracy of lymph node metastases of colorectal cancer in 18F-FDG-PET/CT by optimizing the iteration number for the image reconstruction.
Topics: Algorithms; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2008 |
The feasibility of 11C-methionine-PET in diagnosis of solitary lung nodules/masses when compared with 18F-FDG-PET.
Topics: Adult; Aged; Aged, 80 and over; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Methionine; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Solitary Pulmonary Nodule | 2008 |
Occult malignancy in patients with suspected paraneoplastic neurologic syndromes: value of positron emission tomography in diagnosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Neoplasm; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Paraneoplastic Syndromes, Nervous System; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2008 |
On the effect of sample size of the normal database on statistical power of single subject analysis.
Topics: Alzheimer Disease; Area Under Curve; Brain; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Models, Statistical; Radionuclide Imaging; Radiopharmaceuticals; Reference Values; Reproducibility of Results; Sample Size; Sensitivity and Specificity | 2008 |
Diagnostic accuracy of integrated FDG-PET/contrast-enhanced CT in staging ovarian cancer: comparison with enhanced CT.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2008 |
Tumor volume assessment by 18F-FDG PET/CT in patients with oral cavity cancer with dental artifacts on CT or MR images.
Topics: Adult; Aged; Artifacts; Dental Implants; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Mouth Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
High intraindividual variability of global myocardial 18F-FDG uptake over time.
Topics: Fasting; Female; Fluorodeoxyglucose F18; Heart; Heart Diseases; Humans; Image Interpretation, Computer-Assisted; Male; Metabolic Clearance Rate; Middle Aged; Myocardium; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2008 |
Simultaneous MR/PET imaging of the human brain: feasibility study.
Topics: Brain; Feasibility Studies; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Radiography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique | 2008 |
FDG-PET and detection of distant metastases and simultaneous tumors in head and neck squamous cell carcinoma: a comparison with chest radiography and chest CT.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasms, Second Primary; Positron-Emission Tomography; Radiography, Thoracic; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2009 |
Unusual abdominal localization of cat scratch disease mimicking malignancy on F-18 FDG PET/CT examination.
Topics: Abdomen; Angiomatosis, Bacillary; Cat-Scratch Disease; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Radiography, Abdominal; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Diagnostic value of brain MRI and 18F-FDG PET in the differentiation of Parkinsonian-type multiple system atrophy from Parkinson's disease.
Topics: Adult; Aged; Cerebellum; Diffusion Magnetic Resonance Imaging; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Multiple System Atrophy; Parkinson Disease; Pons; Positron-Emission Tomography; Putamen; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Single-Blind Method | 2008 |
Diagnostic performance of PET/CT in differentiation of malignant and benign non-solid solitary pulmonary nodules.
Topics: Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2008 |
Correlation among [18F]fluorodeoxyglucose positron emission tomography/computed tomography, cancer antigen 27.29, and circulating tumor cell testing in metastatic breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Antigens, Tumor-Associated, Carbohydrate; Biomarkers, Tumor; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplastic Cells, Circulating; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Bilateral hilar foci on 18F-FDG PET scan in patients without lung cancer: variables associated with benign and malignant etiology.
Topics: Adult; Aged; Aged, 80 and over; Artifacts; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2008 |
A method based on Monte Carlo simulations and voxelized anatomical atlases to evaluate and correct uncertainties on radiotracer accumulation quantitation in beta microprobe studies in the rat brain.
Topics: Animals; Brain; Carbon Radioisotopes; Electrons; Fluorodeoxyglucose F18; Models, Anatomic; Monte Carlo Method; Oxygen Radioisotopes; Raclopride; Radioisotopes; Rats; Sensitivity and Specificity; Uncertainty | 2008 |
Preoperative assessment of hilar cholangiocarcinoma by dual-modality PET/CT.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Accuracy of 18F-FDG-PET/CT for staging of oral squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Italy; Male; Middle Aged; Mouth Neoplasms; Neck Dissection; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Preoperative 18F-FDG-PET/CT imaging and sentinel node biopsy in the detection of regional lymph node metastases in malignant melanoma.
Topics: Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Positron-Emission Tomography; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Skin Neoplasms; Tomography, X-Ray Computed | 2008 |
[Significance of dual-time-point 18F-FDG PET imaging in evaluation of hilar and mediastinal lymph node metastasis in non-small-cell lung cancer].
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Positron-Emission Tomography; Sensitivity and Specificity; Time Factors | 2008 |
PET imaging of brain 5-HT1A receptors in the preoperative evaluation of temporal lobe epilepsy.
Topics: Adolescent; Adult; Aminopyridines; Brain; Case-Control Studies; Electroencephalography; Epilepsy, Temporal Lobe; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Piperazines; Positron-Emission Tomography; Preoperative Care; Prospective Studies; Protein Binding; Radiopharmaceuticals; Receptor, Serotonin, 5-HT1A; Receptors, Dopamine D3; Sensitivity and Specificity; Temporal Lobe; Treatment Outcome | 2008 |
Preoperative staging of mesothelioma by 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography fused imaging and mediastinoscopy compared to pathological findings after extrapleural pneumonectomy.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinoscopy; Mesothelioma; Middle Aged; Neoplasm Staging; Pneumonectomy; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Unnecessary Procedures | 2008 |
Utility of combined (18)F-fluorodeoxyglucose-positron emission tomography and computed tomography in patients with cervical metastases from unknown primary tumors.
Topics: Adult; Aged; Cohort Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2009 |
A novel approach to positron emission tomography in lung cancer.
Topics: Aged, 80 and over; Biopsy, Needle; Fluorodeoxyglucose F18; Follow-Up Studies; Gamma Cameras; Humans; Lung Neoplasms; Lymph Nodes; Male; Neoplasm Staging; Pneumonectomy; Positron-Emission Tomography; Postoperative Care; Preoperative Care; Sensitivity and Specificity; Thoracotomy; Treatment Outcome; Whole Body Imaging | 2008 |
Difficulties encountered managing nodules detected during a computed tomography lung cancer screening program.
Topics: Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2008 |
Improved discrimination of benign and malignant lesions on FDG PET/CT, using comparative activity ratios to brain, basal ganglia, or cerebellum.
Topics: Brain; Brain Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Current role of radionuclide imaging in differentiated thyroid cancer.
Topics: Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Risk Factors; Sensitivity and Specificity; Thyroid Neoplasms; Thyroidectomy; Treatment Outcome | 2008 |
A treatment selection protocol for recurrent ovarian cancer patients: the role of FDG-PET/CT and staging laparoscopy.
Topics: Adult; Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Laparoscopy; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Patient Selection; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
The role of CT and ¹⁸F-FDG PET in managing the neck in node-positive head and neck cancer after chemoradiotherapy.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neck; Neck Dissection; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
High incidence of false-positive PET scans in patients with aggressive non-Hodgkin's lymphoma treated with rituximab-containing regimens.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Prednisone; Recurrence; Retrospective Studies; Rituximab; Sensitivity and Specificity; Survival Analysis; Vincristine; Young Adult | 2009 |
The sensitivity of 18F-fluorodeoxyglucose positron emission tomography in the evaluation of metastatic pulmonary nodules.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Logistic Models; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Comparison of multidetector CT with F-18-FDG-PET and SPECT in the assessment of myocardial viability in patients with myocardial infarction: a preliminary study.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Stunning; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2009 |
Combined imaging modalities: PET/CT and SPECT/CT.
Topics: Fluorodeoxyglucose F18; Half-Life; Humans; Image Processing, Computer-Assisted; Neoplasms; Nuclear Medicine; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Technetium; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Whole-Body Irradiation | 2008 |
Functional and structural synergy for resolution recovery and partial volume correction in brain PET.
Topics: Algorithms; Alzheimer Disease; Artifacts; Brain; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2009 |
18F-FDG positron autoradiography with a particle counting silicon pixel detector.
Topics: Animals; Autoradiography; Brain; Cluster Analysis; Electrons; Fluorodeoxyglucose F18; Linear Models; Male; Rats; Sensitivity and Specificity; Silicon; Software | 2008 |
Noninvasive diagnosis of solitary pulmonary lesions in cancer patients based on 2-fluoro-2-deoxy-D-glucose avidity on positron emission tomography/computed tomography.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Solitary Pulmonary Nodule | 2008 |
Tumor volume in subcutaneous mouse xenografts measured by microCT is more accurate and reproducible than determined by 18F-FDG-microPET or external caliper.
Topics: Adenocarcinoma; Animals; Breast Neoplasms; Fluorodeoxyglucose F18; Humans; Mice; Mice, Nude; Physical Examination; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Dual time point FDG-PET/CT imaging... Potential tool for diagnosis of breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Middle Aged; Neoplasm Invasiveness; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
FDG PET/CT findings of thymic carcinoid and bronchial carcinoid in a patient with multiple neuroendocrine neoplasia type1.
Topics: Adult; Bronchial Neoplasms; Carcinoid Tumor; Fluorodeoxyglucose F18; Genetic Markers; Humans; Lymphatic Metastasis; Male; Multiple Endocrine Neoplasia Type 1; Positron-Emission Tomography; Proto-Oncogene Proteins; Sensitivity and Specificity; Thymus Neoplasms; Tomography, X-Ray Computed; Whole Body Imaging | 2008 |
Performance of 18F-FDG PET/CT in endometrial cancer.
Topics: Adult; Aged; Aorta; Aortography; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Pelvis; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Dual-time-point 18F-FDG PET/CT versus dynamic breast MRI of suspicious breast lesions.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Spectroscopy; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Role of IV iodinated contrast material in 18F-FDG PET/CT of liver metastases.
Topics: Colorectal Neoplasms; Contrast Media; Fluorodeoxyglucose F18; Image Enhancement; Iopamidol; Liver Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Utility of PET/CT in differentiating benign from malignant adrenal nodules in patients with cancer.
Topics: Adrenal Gland Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2008 |
[Current possibilities of radiodiagnosis in liver tumors].
Topics: Adult; Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography | 2008 |
Ductal carcinoma in situ: correlation between FDG-PET/CT and histopathology.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Combined use of perioperative TSH-stimulated (18)F-FDG PET/CT imaging and gamma probe radioguided surgery to localize and verify resection of iodine scan-negative recurrent thyroid carcinoma.
Topics: Carcinoma, Papillary; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Gamma Rays; Humans; Image Processing, Computer-Assisted; Iodine Radioisotopes; Middle Aged; Neck Dissection; Neoplasm Recurrence, Local; Neoplasm, Residual; Positron-Emission Tomography; Radiotherapy, Adjuvant; Sensitivity and Specificity; Surgery, Computer-Assisted; Thyroid Neoplasms; Thyrotropin; Tomography, X-Ray Computed; Young Adult | 2008 |
Kinetic modeling based probabilistic segmentation for molecular images.
Topics: Algorithms; Artificial Intelligence; Brain; Computer Simulation; Fluorodeoxyglucose F18; Image Enhancement; Image Interpretation, Computer-Assisted; Kinetics; Models, Biological; Models, Statistical; Molecular Probe Techniques; Pattern Recognition, Automated; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2008 |
Clinical significance of 18F-FDG uptake by primary sites in patients with diffuse large B cell lymphoma in the head and neck: a pilot study.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Incidence; Korea; Lymphoma, B-Cell; Neoplasm Recurrence, Local; Pilot Projects; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Risk Assessment; Risk Factors; Sensitivity and Specificity; Survival Analysis; Survival Rate | 2008 |
Correlation between FDG-PET findings and GLUT1 expression in salivary gland pleomorphic adenomas.
Topics: Adenoma, Pleomorphic; Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Salivary Gland Neoplasms; Sensitivity and Specificity; Statistics as Topic; Young Adult | 2008 |
18F-FDG-PET of musculoskeletal tumors: a correlation with the expression of glucose transporter 1 and hexokinase II.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Child; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Hexokinase; Humans; Male; Middle Aged; Muscle Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Young Adult | 2008 |
Drug-induced pneumonitis detected earlier by 18F-FDG-PET than by high-resolution CT: a case report with non-Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Pneumonia; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Vincristine | 2008 |
Detection of gastric cancer using 18F-FLT PET: comparison with 18F-FDG PET.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Cell Proliferation; Dideoxynucleosides; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Ki-67 Antigen; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Stomach Neoplasms | 2009 |
18F-FDG PET/CT evaluation of patients with ovarian carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Metastasis; Ovarian Neoplasms; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Contribution of 18F-fluorodeoxyglucose positron emission tomography to the diagnosis of early pancreatic carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Chi-Square Distribution; Early Diagnosis; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Statistics, Nonparametric; Treatment Outcome | 2008 |
Myocardial 18F-FDG uptake after exercise-induced myocardial ischemia in patients with coronary artery disease.
Topics: Coronary Artery Disease; Exercise Test; Female; Fluorodeoxyglucose F18; Humans; Male; Metabolic Clearance Rate; Middle Aged; Myocardial Ischemia; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2008 |
Clarifying the diagnosis of clinically suspected recurrence of cervical cancer: impact of 18F-FDG PET.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Risk Assessment; Risk Factors; Sensitivity and Specificity; Survival Analysis; Survival Rate; Uterine Cervical Neoplasms | 2008 |
Fever of unknown origin: the role of 18F-FDG PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Female; Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed; Young Adult | 2008 |
Spatial heterogeneity in sarcoma 18F-FDG uptake as a predictor of patient outcome.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Outcome Assessment, Health Care; Prevalence; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sarcoma; Sensitivity and Specificity; Survival Analysis; Survival Rate; United States | 2008 |
A prospective evaluation of 18F-FDG and 11C-acetate PET/CT for detection of primary and metastatic hepatocellular carcinoma.
Topics: Acetates; Adult; Carbon; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Incidence; Korea; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Subtraction Technique; Survival Analysis; Survival Rate; Tomography, X-Ray Computed | 2008 |
Secretive and proliferative tumor profile helps to select the best imaging technique to identify postoperative persistent or relapsing medullary thyroid cancer.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Calcitonin; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Postoperative Complications; Predictive Value of Tests; Radiopharmaceuticals; Receptors, Somatostatin; Retrospective Studies; Sensitivity and Specificity; Thyroid Neoplasms | 2009 |
Predictors of surgical outcome and pathologic considerations in focal cortical dysplasia.
Topics: Adolescent; Adult; Cerebral Cortex; Child; Child, Preschool; Cohort Studies; Electroencephalography; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Malformations of Cortical Development; Neurosurgical Procedures; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Seizures; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Young Adult | 2009 |
Significance of 18F-fluorodeoxyglucose positron-emission tomography/computed tomography for the postoperative surveillance of advanced renal cell carcinoma.
Topics: Adult; Aged; Carcinoma, Renal Cell; Epidemiologic Methods; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
Limitations of FDG-PET and FDG-PET with computed tomography for detecting synchronous cancer in pharyngeal cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Endoscopy, Digestive System; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Neoplasm Staging; Neoplasms, Multiple Primary; Pharyngeal Neoplasms; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Stomach Neoplasms; Tomography, X-Ray Computed | 2008 |
[18F]Fluorodeoxyglucose positron emission tomography in nonseminomatous germ cell tumors after chemotherapy: the German multicenter positron emission tomography study group.
Topics: Adolescent; Adult; Biomarkers, Tumor; Cell Survival; Cisplatin; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm, Residual; Neoplasms, Germ Cell and Embryonal; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Retroperitoneal Neoplasms; Sensitivity and Specificity; Testicular Neoplasms; Tomography, X-Ray Computed | 2008 |
Increased 18F-FDG uptake in the posterior ocular bulb is associated with brain metastasis: a retrospective study.
Topics: Brain Neoplasms; Eye Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution | 2008 |
Imaging of lung hamartomas by multidetector computed tomography and positron emission tomography.
Topics: Adult; Aged; Cohort Studies; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Hamartoma; Humans; Lung Diseases; Male; Middle Aged; Pneumonectomy; Positron-Emission Tomography; Retrospective Studies; Risk Assessment; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, X-Ray Computed; Treatment Outcome | 2008 |
[F-18]-fluorodeoxyglucose PET-CT of the normal prostate gland.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Prostate; Radiopharmaceuticals; Reference Values; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tissue Distribution; Tomography, X-Ray Computed; Young Adult | 2008 |
18F-FDG-PET in patients with malignant lymphoma having long-term follow-up: staging and restaging, and evaluation of treatment response and recurrence.
Topics: Adolescent; Adult; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Longitudinal Studies; Lymphoma; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome; Young Adult | 2008 |
The cost-effectiveness of 18FDG-PET in selecting patients with suspicion of recurrent laryngeal carcinoma after radiotherapy for direct laryngoscopy.
Topics: Aged; Aged, 80 and over; Cost-Benefit Analysis; Female; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Laryngoscopy; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2009 |
11C-Acetate can be used in place of 18F-fluorodeoxyglucose for positron emission tomography imaging of non-small cell lung cancer with higher sensitivity for well-differentiated adenocarcinoma.
Topics: Acetates; Adenocarcinoma; Carbon; Carbon Radioisotopes; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cell Differentiation; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Fluorodeoxyglucose-positron emission tomographic imaging for the diagnosis of mesial temporal lobe epilepsy.
Topics: Adolescent; Adult; Epilepsy, Temporal Lobe; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Young Adult | 2008 |
Prospective evaluation of CECT and 18F-FDG-PET/CT in detection of hepatic metastases.
Topics: Adolescent; Adult; Aged; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiography, Abdominal; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed; Young Adult | 2009 |
[SPECT and FDG-PET in diagnostics of neurolues].
Topics: Adult; Basal Ganglia; Blood Glucose; Brain; Cysteine; Dementia; Diagnosis, Differential; Diseases in Twins; Fluorodeoxyglucose F18; Frontal Lobe; Humans; Male; Middle Aged; Neurosyphilis; Organotechnetium Compounds; Positron-Emission Tomography; Sensitivity and Specificity; Syphilis, Cardiovascular; Syphilis, Congenital; Tomography, Emission-Computed, Single-Photon | 2008 |
Value of precise localization of recurrent multiple myeloma with F-18 FDG PET/CT.
Topics: Adult; Fluorodeoxyglucose F18; Humans; Male; Multiple Myeloma; Positron-Emission Tomography; Recurrence; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
Bone marrow involvement in diffuse large B-cell lymphoma: correlation between FDG-PET uptake and type of cellular infiltrate.
Topics: Adult; Aged; Aged, 80 and over; Bone Marrow; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Medical Oncology; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Prognosis; Sensitivity and Specificity | 2009 |
(18)F-FDG-PET/CT of orofacial tumors, a value of whole-body imaging approach.
Topics: Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed; Whole Body Imaging | 2010 |
Diagnostic imaging in Merkel cell carcinoma: lessons to learn from 16 cases with correlation of sonography, CT, MRI and PET.
Topics: Aged; Aged, 80 and over; Carcinoma, Merkel Cell; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Skin Neoplasms; Statistics as Topic; Tomography, X-Ray Computed | 2010 |
The utility of FDG-PET in the preoperative staging of esophageal cancer.
Topics: Adult; Aged; Aged, 80 and over; Cohort Studies; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prospective Studies; Risk Assessment; Sensitivity and Specificity; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome | 2008 |
Effect of 18F-fluorodeoxyglucose positron emission tomography on the management of patients with head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cohort Studies; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neck Dissection; Neoplasm Staging; Positron-Emission Tomography; Postoperative Care; Preoperative Care; Radiotherapy, Adjuvant; Sensitivity and Specificity; Survival Analysis; Treatment Outcome | 2008 |
18F-fluorodeoxyglucose positron emission tomography-computed tomography for suspected recurrent papillary thyroid cancer: early experience at Sunnybrook Health Sciences Centre.
Topics: Adult; Aged; Biomarkers; Cancer Care Facilities; Carcinoma, Papillary; Cohort Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Ontario; Positron-Emission Tomography; Reproducibility of Results; Retrospective Studies; Risk Assessment; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Thyroidectomy; Time Factors; Treatment Outcome; Young Adult | 2008 |
[18F]FDG PET/CT in the diagnosis of malignant peripheral nerve sheath tumours in neurofibromatosis type-1.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Fluorodeoxyglucose F18; Humans; Middle Aged; Nerve Sheath Neoplasms; Neurofibromatosis 1; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
Validation of fast-RAMLA in clinical PET.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Male; Middle Aged; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Whole Body Imaging | 2008 |
Characterization of pulmonary lesions with low F-18 FDG uptake using double phase F-18 FDG PET/CT: comparison of visual and quantitative analyses.
Topics: Adult; Aged; Aged, 80 and over; Area Under Curve; Female; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2009 |
The value of 18F-DOPA PET-CT in patients with medullary thyroid carcinoma: comparison with 18F-FDG PET-CT.
Topics: Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Thyroid Neoplasms; Tomography, X-Ray Computed | 2009 |
Assessment of the incremental value of recombinant thyrotropin stimulation before 2-[18F]-Fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography imaging to localize residual differentiated thyroid cancer.
Topics: Adenocarcinoma, Follicular; Adult; Aged; Fluorodeoxyglucose F18; Genetic Variation; Humans; Middle Aged; Neoplasm Metastasis; Neoplasm, Residual; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Recombinant Proteins; Sensitivity and Specificity; Thyroid Neoplasms; Thyroidectomy; Thyrotropin; Tomography, X-Ray Computed | 2009 |
Transbronchial needle aspiration in lung cancer patients suitable for operation with positive mediastinal positron emission tomography.
Topics: Aged; Biopsy, Fine-Needle; Carcinoma, Non-Small-Cell Lung; Cohort Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Immunohistochemistry; Lung Neoplasms; Male; Mediastinoscopy; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Pneumonectomy; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Prospective Studies; Risk Assessment; Sensitivity and Specificity; Treatment Outcome | 2009 |
Genetic algorithm-based PCA eigenvector selection and weighting for automated identification of dementia using FDG-PET imaging.
Topics: Algorithms; Alzheimer Disease; Brain; Dementia; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Positron-Emission Tomography; Principal Component Analysis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2008 |
The use of contrast-enhanced ultrasound in patients with GIST metastases that are negative in CT and PET.
Topics: Adult; Antineoplastic Agents; Benzamides; Contrast Media; Female; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Neoplasm Metastasis; Piperazines; Positron-Emission Tomography; Pyrimidines; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography | 2008 |
Positron emission tomography in surveillance of head and neck squamous cell carcinoma after definitive chemoradiotherapy.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neck; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
18F-fluorodeoxyglucose positron emission tomography imaging in brain tumours: the Western Australia positron emission tomography/cyclotron service experience.
Topics: Adult; Aged; Brain Neoplasms; Cyclotrons; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Young Adult | 2008 |
Integrated contrast-enhanced diagnostic whole-body PET/CT as a first-line restaging modality in patients with suspected metastatic recurrence of breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Systems Integration; Tomography, X-Ray Computed; Triiodobenzoic Acids; Whole Body Imaging | 2010 |
Accuracy of integrated FDG-PET/contrast-enhanced CT in detecting pelvic and paraaortic lymph node metastasis in patients with uterine cancer.
Topics: Adult; Aged; Aorta; Aortography; Carcinoma; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Pelvis; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Systems Integration; Tomography, X-Ray Computed; Uterine Neoplasms | 2009 |
Adrenal nodules at FDG PET/CT in patients known to have or suspected of having lung cancer: a proposal for an efficient diagnostic algorithm.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Algorithms; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity | 2009 |
Usefulness of 201TL SPECT/CT relative to 18F-FDG PET/CT in detecting recurrent skull base nasopharyngeal carcinoma.
Topics: Adult; Aged; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Logistic Models; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Probability; Prospective Studies; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Skull Base; Tomography, Emission-Computed, Single-Photon | 2009 |
Whole-body MRI at 1.5 T and 3 T compared with FDG-PET-CT for the detection of tumour recurrence in patients with colorectal cancer.
Topics: Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2009 |
The value of FDG-PET/CT in assessing single pulmonary nodules in patients at high risk of lung cancer.
Topics: Aged; Aged, 80 and over; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiation Dosage; Retrospective Studies; Risk; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2009 |
Increased (18)F-deoxyglucose uptake in the lung during the first weeks of radiotherapy is correlated with subsequent Radiation-Induced Lung Toxicity (RILT): a prospective pilot study.
Topics: Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Pilot Projects; Predictive Value of Tests; Prospective Studies; Radiation Injuries; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2009 |
Performance of integrated FDG-PET/contrast-enhanced CT in the staging and restaging of colorectal cancer: comparison with PET and enhanced CT.
Topics: Aged; Aged, 80 and over; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Systems Integration; Tomography, X-Ray Computed | 2010 |
Fever of unknown origin: a value of (18)F-FDG-PET/CT with integrated full diagnostic isotropic CT imaging.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Algorithms; Contrast Media; Diagnosis, Differential; Female; Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2010 |
Usefulness of FDG-PET/CT in the detection of pancreatic metastases from lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2009 |
Time-to-time correlation of high-risk atherosclerotic lesions identified with [(18)F]-FDG-PET/CT.
Topics: Atherosclerosis; Calcinosis; Female; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Subtraction Technique; Time Factors; Tomography, X-Ray Computed | 2009 |
Integrated FDG-PET/CT compared with intravenous contrast-enhanced CT for evaluation of metastatic regional lymph nodes in patients with resectable early stage esophageal cancer.
Topics: Aged; Contrast Media; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Injections, Intravenous; Iopamidol; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Systems Integration; Tomography, X-Ray Computed | 2009 |
Usefulness of a breath-holding acquisition method in PET/CT for pulmonary lesions.
Topics: Aged, 80 and over; Artifacts; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Respiratory Mechanics; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2009 |
[Positron-emission tomography (PET) and PET/CT in head and neck cancer - recommendations of an interdisciplinary consensus conference].
Topics: Blood Glucose; Chemotherapy, Adjuvant; Combined Modality Therapy; Consensus; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphatic Metastasis; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Otorhinolaryngologic Neoplasms; Patient Care Team; Positron-Emission Tomography; Radiotherapy Planning, Computer-Assisted; Radiotherapy, High-Energy; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
Incorporation of wavelet-based denoising in iterative deconvolution for partial volume correction in whole-body PET imaging.
Topics: Algorithms; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Positron-Emission Tomography; Sensitivity and Specificity; Whole Body Imaging | 2009 |
Comparative study of FDG PET/CT and conventional imaging in the staging of rhabdomyosarcoma.
Topics: Adolescent; Adult; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Rhabdomyosarcoma; Sensitivity and Specificity; Soft Tissue Neoplasms; Tomography, X-Ray Computed; Young Adult | 2009 |
The effect of 18F-FDG-PET/CT respiratory gating on detected metabolic activity in lung lesions.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Respiratory-Gated Imaging Techniques; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
Invited commentary.
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2009 |
Evaluation of semiquantitative assessments of fluorodeoxyglucose uptake on positron emission tomography scans for the diagnosis of pulmonary malignancies 1 to 3 cm in size.
Topics: Adenocarcinoma; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tissue Distribution | 2009 |
CT and 18F-FDG PET for noninvasive detection of splenic involvement in patients with malignant lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Lymphoma; Male; Middle Aged; Neoplasm Staging; Patient Selection; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Splenic Neoplasms; Tomography, X-Ray Computed | 2009 |
Coregistered FDG PET/CT-based textural characterization of head and neck cancer for radiation treatment planning.
Topics: Algorithms; Area Under Curve; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Pattern Recognition, Automated; Positron-Emission Tomography; Radiotherapy Planning, Computer-Assisted; Reproducibility of Results; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
Thin-section CT of the mediastinum in preoperative N-staging of non-small cell lung cancer: comparison with FDG PET.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Iohexol; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Spiral Computed | 2010 |
The role of PET/CT in detection of gastric cancer recurrence.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Stomach Neoplasms; Tomography, X-Ray Computed | 2009 |
The impact of 18-fluorodeoxyglucose positron emission tomography on the staging, management and outcome of anal cancer.
Topics: Adult; Aged; Aged, 80 and over; Anus Neoplasms; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Sensitivity and Specificity | 2009 |
18F-FDG PET/CT findings of sinonasal inverted papilloma with or without coexistent malignancy: comparison with MR imaging findings in eight patients.
Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nose Neoplasms; Papilloma, Inverted; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2009 |
18F-FDG PET, genotype-corrected ACE and sIL-2R in newly diagnosed sarcoidosis.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Genotype; Humans; Male; Middle Aged; Peptidyl-Dipeptidase A; Positron-Emission Tomography; Receptors, Interleukin-2; Retrospective Studies; Sarcoidosis; Sensitivity and Specificity; Solubility | 2009 |
FDG-PET parametric imaging by total variation minimization.
Topics: Algorithms; Brain; Computer Simulation; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Models, Neurological; Models, Statistical; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2009 |
Clinical value of whole-body FDG-PET for recurrent gastric cancer: a multicenter study.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Sensitivity and Specificity; Stomach Neoplasms; Tomography, X-Ray Computed; Whole-Body Counting | 2009 |
Diagnostic accuracy of serial CT/magnetic resonance imaging review vs. positron emission tomography/CT in colorectal cancer patients with suspected and known recurrence.
Topics: Carcinoembryonic Antigen; Colorectal Neoplasms; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
Idiopathic pulmonary fibrosis and diffuse parenchymal lung disease: implications from initial experience with 18F-FDG PET/CT.
Topics: Aged; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Diseases, Interstitial; Male; Pilot Projects; Positron-Emission Tomography; Pulmonary Fibrosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique | 2009 |
Imaging of inflamed and vulnerable plaque in coronary arteries with 18F-FDG PET/CT in patients with suppression of myocardial uptake using a low-carbohydrate, high-fat preparation.
Topics: Arteritis; Coronary Artery Disease; Diet, Carbohydrate-Restricted; Dietary Fats; Fluorodeoxyglucose F18; Humans; Image Enhancement; Myocardium; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
The Role of 18F-FDG PET/CT in the evaluation of Ascites of Undetermined Origin.
Topics: Adult; Aged; Aged, 80 and over; Ascites; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed; Young Adult | 2009 |
Novel strategy for a cocktail 18F-fluoride and 18F-FDG PET/CT scan for evaluation of malignancy: results of the pilot-phase study.
Topics: Adult; Aged; Animals; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Male; Mice; Middle Aged; Neoplasms; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed; Young Adult | 2009 |
PET/CT for the characterization of adrenal masses in patients with cancer: qualitative versus quantitative accuracy in 150 consecutive patients.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Contrast Media; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
Whole-Body MRI versus PET in assessment of multiple myeloma disease activity.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Myeloma; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Whole Body Imaging | 2009 |
Advanced head and neck cancer: is there a role for fluorodeoxyglucose PET/computed tomography?
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm, Residual; Positron-Emission Tomography; Recurrence; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
Dual time point FDG PET for evaluation of malignant pleural mesothelioma.
Topics: Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Mesothelioma; Middle Aged; Positron-Emission Tomography; Sensitivity and Specificity; Time Factors | 2009 |
Clinical significance of FDG single-photon emission computed tomography: Computed tomography in the diagnosis of head and neck cancers and study of its mechanism.
Topics: Adult; Aged; Biomarkers, Tumor; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Glucose Transporter Type 3; Head and Neck Neoplasms; Humans; Image Interpretation, Computer-Assisted; Image Processing, Computer-Assisted; Immunoenzyme Techniques; Magnetic Resonance Imaging; Male; Middle Aged; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2008 |
[The advantage of Positron Emission Tomography combined with Computer Tomography (PET-CT) in the diagnosis of lung cancer (experience with 408 patients)].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Hungary; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinoscopy; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Thoracotomy; Tomography, X-Ray Computed | 2009 |
No lung cancer at resection of PET positive lesions: an audit of the lung cancer multidisciplinary team.
Topics: Adult; Aged; Aged, 80 and over; Bronchoscopy; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Patient Care Team; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2009 |
Relationship between maximum standardized uptake value (SUVmax) of lung cancer and lymph node metastasis on FDG-PET.
Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity | 2009 |
The significance and management of incidental [18F]fluorodeoxyglucose-positron-emission tomography uptake in the thyroid gland in patients with cancer.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thyroid Gland; Thyroid Neoplasms; Young Adult | 2009 |
Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's Disease Neuroimaging Initiative (ADNI).
Topics: Aged; Alzheimer Disease; Cerebral Cortex; Cognition Disorders; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reference Values; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic | 2009 |
Differential diagnosis of parkinsonian syndromes using PCA-based functional imaging features.
Topics: Adult; Algorithms; Artificial Intelligence; Brain; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Male; Middle Aged; Parkinson Disease; Pattern Recognition, Automated; Principal Component Analysis; Radiography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2009 |
FDG-PET/CT imaging predicts histopathologic treatment responses after the initial cycle of neoadjuvant chemotherapy in high-grade soft-tissue sarcomas.
Topics: Adult; Aged; Aged, 80 and over; Deoxycytidine; Doxorubicin; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gemcitabine; Humans; Ifosfamide; Male; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Prospective Studies; Sarcoma; Sensitivity and Specificity; Soft Tissue Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
Positron emission tomography-computed tomography surveillance for the node-positive neck after chemoradiotherapy.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Combined Modality Therapy; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Enhancement; Image Processing, Computer-Assisted; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Otorhinolaryngologic Neoplasms; Positron-Emission Tomography; Radiotherapy, Conformal; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
18F-FDG avidity of pheochromocytomas and paragangliomas: a new molecular imaging signature?
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Molecular Probe Techniques; Paraganglioma; Pheochromocytoma; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Succinate Dehydrogenase; Tissue Distribution | 2009 |
Robustness of multivariate image analysis assessed by resampling techniques and applied to FDG-PET scans of patients with Alzheimer's disease.
Topics: Algorithms; Alzheimer Disease; Brain; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Male; Middle Aged; Multivariate Analysis; Positron-Emission Tomography; Principal Component Analysis; Radiopharmaceuticals; Reproducibility of Results; Sample Size; Sensitivity and Specificity; Young Adult | 2009 |
The role of whole-body FDG PET/CT, Tc 99m MDP bone scintigraphy, and serum alkaline phosphatase in detecting bone metastasis in patients with newly diagnosed lung cancer.
Topics: Aged; Alkaline Phosphatase; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Medical Records; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Technetium Tc 99m Medronate; Tomography, X-Ray Computed; Whole Body Imaging | 2009 |
Diagnostic value of full-dose FDG PET/CT for axillary lymph node staging in breast cancer patients.
Topics: Adult; Aged; Axilla; Breast Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Tomography, X-Ray Computed | 2009 |
Gastrointestinal 18F-FDG accumulation on PET without a corresponding CT abnormality is not an early indicator of cancer development.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Diagnostic Errors; False Positive Reactions; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed; Whole Body Imaging; Young Adult | 2009 |
Clinical and pathological factors related to 18F-FDG-PET positivity in the diagnosis of recurrence and/or metastasis in patients with differentiated thyroid cancer.
Topics: Adolescent; Adult; Aged; Child; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Young Adult | 2009 |
The role of dual-time combined 18-fluorodeoxyglucose positron emission tomography and computed tomography in the staging and restaging workup of locally advanced rectal cancer, treated with preoperative chemoradiation therapy and radical surgery.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Rectal Neoplasms; Remission Induction; Sensitivity and Specificity; Statistics, Nonparametric; Tomography, X-Ray Computed | 2009 |
PET-CT of the normal spinal cord in children.
Topics: Adolescent; Child; Child, Preschool; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Radionuclide Imaging; Radiopharmaceuticals; Reference Values; Reproducibility of Results; Sensitivity and Specificity; Spinal Cord; Subtraction Technique; Tomography, X-Ray Computed | 2009 |
Role of PET/CT in the detection of liver metastases from colorectal cancer.
Topics: Aged; Carcinoma; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Hepatectomy; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
Dual-time point scanning of integrated FDG PET/CT for the evaluation of mediastinal and hilar lymph nodes in non-small cell lung cancer diagnosed as operable by contrast-enhanced CT.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Male; Mediastinum; Middle Aged; Moon; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2010 |
Abnormal fluorodeoxyglucose PET in pulmonary Langerhans cell histiocytosis.
Topics: Adult; Cohort Studies; Female; Fluorodeoxyglucose F18; Histiocytosis, Langerhans-Cell; Humans; Male; Middle Aged; Positron-Emission Tomography; Probability; Radiographic Image Interpretation, Computer-Assisted; Retrospective Studies; Risk Assessment; Sensitivity and Specificity; Severity of Illness Index | 2009 |
Schwannoma of the esophagus: a case exhibiting high 18F-fluorodeoxyglucose uptake in positron emission tomography imaging.
Topics: Aged; Anastomosis, Surgical; Biopsy, Needle; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Immunohistochemistry; Neoplasm Staging; Neurilemmoma; Positron-Emission Tomography; Risk Assessment; Sensitivity and Specificity; Thoracotomy; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
FDG-PET/CT for the preoperative lymph node staging of invasive bladder cancer.
Topics: Aged; Aged, 80 and over; Belgium; Cystectomy; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome; Urinary Bladder Neoplasms | 2010 |
Editorial comment on: FDG-PET/CT for the preoperative lymph node staging of invasive bladder cancer.
Topics: Cystectomy; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Urinary Bladder Neoplasms | 2010 |
Spatially augmented LPboosting for AD classification with evaluations on the ADNI dataset.
Topics: Aged; Algorithms; Alzheimer Disease; Brain; Databases, Factual; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Male; Neuropsychological Tests; Organ Size; Positron-Emission Tomography; Psychiatric Status Rating Scales; ROC Curve; Sensitivity and Specificity | 2009 |
Positron-emission tomography/computed tomography (PET/CT) in the initial staging of primary rectal cancer.
Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Rectal Neoplasms; Retrospective Studies; Sensitivity and Specificity; Time Factors; Tomography, X-Ray Computed | 2010 |
Value of 18 FDG-PET/CT in clinical practice in patients with fever of unknown origin and unexplained prolonged inflammatory syndrome.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Algorithms; Contrast Media; Diagnosis, Differential; Female; Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2010 |
Modification of glucose metabolism in radiation-induced brain injury areas using cervical spinal cord stimulation.
Topics: Adult; Afferent Pathways; Aged; Brain; Brain Damage, Chronic; Brain Mapping; Brain Neoplasms; Cerebrovascular Circulation; Cervical Vertebrae; Electric Stimulation; Energy Metabolism; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiation Injuries; Radiotherapy; Sensitivity and Specificity; Spinal Cord | 2009 |
Detection of bone metastases in patients with lung cancer: 99mTc-MDP planar bone scintigraphy, 18F-fluoride PET or 18F-FDG PET/CT.
Topics: Bone and Bones; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Fluorides; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Technetium Tc 99m Medronate; Tomography, X-Ray Computed | 2009 |
[The role of preoperative investigation with 18-FDG-PET/CT in primary operable breast cancer].
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Patient Selection; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Tomography, X-Ray Computed | 2009 |
Diagnostic value of [(18)F]-FDG PET/CT in children with fever of unknown origin or unexplained signs of inflammation.
Topics: Adolescent; Child; Child, Preschool; Female; Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Infant; Inflammation; Male; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2010 |
[Value of 18F-FDG and 11C-MET PET-CT in differentiation of brain ringlike-enhanced neoplastic and non-neoplastic lesions on MRI imaging].
Topics: Acetates; Adolescent; Adult; Aged; Brain Abscess; Brain Neoplasms; Carbon; Carbon Radioisotopes; Child; Craniopharyngioma; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Glioblastoma; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Young Adult | 2009 |
Prone breast dual-time-point PET/CT compared with MRI for determining breast cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Spectroscopy; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
The diagnostic and prognostic utility of positron emission tomography/computed tomography-based follow-up after radiotherapy for head and neck cancer.
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Positron-Emission Tomography; Prognosis; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
Limitations of dual time point PET in the assessment of lung nodules with low FDG avidity.
Topics: Diagnosis, Differential; False Negative Reactions; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Solitary Pulmonary Nodule | 2010 |
Feasibility of ex vivo FDG PET of the colon.
Topics: Aged; Aged, 80 and over; Colon; Colonic Polyps; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2009 |
Detection of colo-rectal liver metastases: prospective comparison of contrast enhanced US, multidetector CT, PET/CT, and 1.5 Tesla MR with extracellular and reticulo-endothelial cell specific contrast agents.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Contrast Media; Dextrans; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Iohexol; Liver Neoplasms; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography | 2010 |
Accuracy of early and delayed FDG PET-CT and of contrast-enhanced CT in the evaluation of lung nodules: a preliminary study on 30 patients.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, Emission-Computed; Tomography, X-Ray Computed; Whole Body Imaging | 2009 |
18F-FDG PET/CT in the evaluation of POEMS syndrome.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Paraneoplastic Syndromes; POEMS Syndrome; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed; Whole Body Imaging | 2010 |
Pretreatment evaluation of distant-site status in patients with nasopharyngeal carcinoma: accuracy of whole-body MRI at 3-Tesla and FDG-PET-CT.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed; Whole Body Imaging; Young Adult | 2009 |
Evaluation of 18fluoro-2-deoxyglucose positron emission tomography in iodine scan negative, differentiated thyroid cancer recurrence.
Topics: Adult; Aged; Biomarkers, Tumor; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Whole Body Imaging; Young Adult | 2009 |
[Value of (18)F-FDG PET-CT in the preoperative N staging of non-small cell lung cancer].
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Preoperative Period; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
123I-MIBG scintigraphy and 18F-FDG PET in neuroblastoma.
Topics: 3-Iodobenzylguanidine; Child, Preschool; Fluorodeoxyglucose F18; Humans; Male; Neuroblastoma; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2009 |
Delayed acquisition and hyperglycemia improve brain metastasis detection on F-18 FDG PET.
Topics: Brain Neoplasms; Fluorodeoxyglucose F18; Humans; Hyperglycemia; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Sensitivity and Specificity; Time Factors | 2009 |
Application of 18F-fluorodeoxyglucose positron emission tomography in diagnosis of malignant diseases.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Young Adult | 2009 |
Is diffusion-weighted magnetic resonance imaging superior to positron emission tomography with fludeoxyglucose F 18 in imaging non-small cell lung cancer?
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2009 |
Detection of bone metastases in non-small cell lung cancer patients: comparison of whole-body diffusion-weighted imaging (DWI), whole-body MR imaging without and with DWI, whole-body FDG-PET/CT, and bone scintigraphy.
Topics: Aged, 80 and over; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Contrast Media; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Gadolinium; Heterocyclic Compounds; History, 18th Century; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2009 |
Comparison of positron emission tomography scanning and sentinel node biopsy in the detection of inguinal node metastases in patients with anal cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Carcinoma, Squamous Cell; Combined Modality Therapy; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Inguinal Canal; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Sentinel Lymph Node Biopsy | 2010 |
Utility of integrated computed tomography-positron emission tomography for selection of operable malignant pleural mesothelioma.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Mesothelioma; Middle Aged; Neoplasm Staging; Pleural Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
Positron emission tomography for the detection of colorectal adenomas.
Topics: Adenoma; Adult; Aged; Aged, 80 and over; Colonoscopy; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity | 2010 |
Prognostic importance of standardized uptake value on F-18 fluorodeoxyglucose-positron emission tomography in biliary tract carcinoma.
Topics: Aged; Aged, 80 and over; Biliary Tract Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Sex Factors | 2009 |
FDG positron emission tomography/computed tomography scan may identify mantle cell lymphoma patients with unusually favorable outcome.
Topics: Belgium; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Mantle-Cell; Male; Positron-Emission Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Risk Assessment; Risk Factors; Sensitivity and Specificity; Survival Analysis; Survival Rate; Tomography, X-Ray Computed; United States | 2009 |
Preliminary study of detecting urothelial malignancy with FDG PET in Taiwanese ESRD patients.
Topics: Female; Fluorodeoxyglucose F18; Humans; Kidney Failure, Chronic; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Urologic Neoplasms | 2009 |
Mapping brain morphological and functional conversion patterns in amnestic MCI: a voxel-based MRI and FDG-PET study.
Topics: Aged; Aged, 80 and over; Amnesia; Brain; Brain Mapping; Cognition Disorders; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique | 2010 |
Comparison of (68)Ga-DOTATATE and (18)F-fluorodeoxyglucose PET/CT in the detection of recurrent medullary thyroid carcinoma.
Topics: Adult; Aged; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Organometallic Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Thyroid Gland; Thyroid Neoplasms; Tomography, X-Ray Computed | 2010 |
High 2-[18F]fluoro-2-deoxy-d-glucose (18FDG) uptake measured by positron emission tomography is associated with reduced overall survival in patients with oral squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Survival Analysis | 2009 |
Early and late therapy response assessment with [18F]fluorodeoxyglucose positron emission tomography in pediatric Hodgkin's lymphoma: analysis of a prospective multicenter trial.
Topics: Adolescent; Child; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Outcome Assessment, Health Care; Positron-Emission Tomography; Prospective Studies; Reproducibility of Results; Sensitivity and Specificity; Time Factors | 2009 |
The role of positron emission tomography/computed tomography in the diagnosis of pleural diseases.
Topics: Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Male; Mesothelioma; Middle Aged; Pleural Diseases; Pleural Effusion; Pleural Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Thoracic Surgery, Video-Assisted; Thoracotomy; Tomography, X-Ray Computed; Tuberculosis, Pleural | 2009 |
[Utility of FDG-PET and diffusion weighted MRI for the management of cancer patients and medical cancer checkup].
Topics: Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Humans; Mass Screening; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2008 |
Automated radiation targeting in head-and-neck cancer using region-based texture analysis of PET and CT images.
Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Oropharyngeal Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Sensitivity and Specificity; Tomography, X-Ray Computed; Tongue Neoplasms; Tonsillar Neoplasms | 2009 |
Evaluation of (18)F-FDG PET-CT for differentiation of pulmonary pathology in an approach of outpatient fast track assessment.
Topics: Carcinoma, Non-Small-Cell Lung; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Small Cell Lung Carcinoma; Tomography, X-Ray Computed | 2009 |
[18F]FLT-PET and [18F]FDG-PET in the evaluation of radiotherapy for laryngeal cancer.
Topics: Aged; Aged, 80 and over; Dideoxynucleosides; Feasibility Studies; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity | 2009 |
Role of the integrated FDG PET/CT in the surgical management of patients with high risk clinical early stage endometrial cancer: detection of pelvic nodal metastases.
Topics: Aged; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Pelvis; Positron-Emission Tomography; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity | 2009 |
Prognostic value of serial [18F]fluorodeoxyglucose PET-CT uptake in stage III patients with non-small cell lung cancer treated by concurrent chemoradiotherapy.
Topics: Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; China; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Radiotherapy, Adjuvant; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Subtraction Technique; Survival Analysis; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
18F-FDG PET and PET/CT in Burkitt's lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Burkitt Lymphoma; Child; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed; Young Adult | 2010 |
The quantification of dynamic FET PET imaging and correlation with the clinical outcome in patients with glioblastoma.
Topics: Brain Neoplasms; Fluorodeoxyglucose F18; Glioblastoma; Humans; Image Interpretation, Computer-Assisted; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Treatment Outcome | 2009 |
Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography and computed tomography in patients with melanoma with palpable lymph node metastases: diagnostic accuracy and impact on treatment.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
18F-Fluorodeoxyglucose-PET/CT to evaluate tumor, nodal disease, and gross tumor volume of oropharyngeal and oral cavity cancer: comparison with MR imaging and validation with surgical specimen.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Mouth Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Oropharyngeal Neoplasms; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
[The role of FDG-PET in staging of lymphoma and evaluation of therapeutic efficiency].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphoma; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Young Adult | 2009 |
Detection of hematogenous bone metastasis in cervical cancer: 18F-fluorodeoxyglucose-positron emission tomography versus computed tomography and magnetic resonance imaging.
Topics: Aged; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Neoplastic Cells, Circulating; Positron-Emission Tomography; Predictive Value of Tests; Retrospective Studies; Risk Factors; Sensitivity and Specificity; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2009 |
Clinical impact of whole body FDG-PET for recurrent biliary cancer: a multicenter study.
Topics: Aged; Aged, 80 and over; Biliary Tract Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Recurrence; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2009 |
Tumor necrosis in osteosarcoma: inclusion of the point of greatest metabolic activity from F-18 FDG PET/CT in the histopathologic analysis.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Image Interpretation, Computer-Assisted; Necrosis; Osteosarcoma; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Survival Analysis; Survival Rate; Texas; Tomography, X-Ray Computed | 2010 |
Paraaortic lymph node metastasis in patients with intra-abdominal malignancies: CT vs PET.
Topics: Abdominal Neoplasms; Adult; Aged; Aorta; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Tomography, X-Ray Computed | 2009 |
Incidental thyroid uptake on F-18 FDG PET/CT: correlation with ultrasonography and pathology.
Topics: Adult; Biological Transport; Diagnosis, Differential; Disease; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Thyroid Gland; Tomography, X-Ray Computed; Ultrasonography | 2009 |
Preoperative staging of liver metastases from uveal melanoma by magnetic resonance imaging (MRI) and fluorodeoxyglucose-positron emission tomography (FDG-PET).
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Melanoma; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Uveal Neoplasms | 2010 |
Tumor relapse after pancreatic cancer resection is detected earlier by 18-FDG PET than by CT.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Pancreatectomy; Pancreatic Neoplasms; Pancreaticoduodenectomy; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed | 2010 |
Usefulness of functional MRI associated with PET scan and evoked potentials in the evaluation of brain functions after severe brain injury: preliminary results.
Topics: Adult; Aged; Brain Damage, Chronic; Cerebral Cortex; Cerebral Hemorrhage; Coma, Post-Head Injury; Electroencephalography; Energy Metabolism; Evoked Potentials; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Hypoxia, Brain; Image Enhancement; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Myocardial Infarction; Oxygen Consumption; Persistent Vegetative State; Positron-Emission Tomography; Prognosis; Sensitivity and Specificity; Young Adult | 2010 |
18F-FDG-PET/CT in the diagnosis of paraneoplastic neurological syndromes: a retrospective analysis.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nervous System Diseases; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed; Young Adult | 2010 |
18F-fluorodeoxyglucose-positron emission tomography scanning is more useful in followup than in the initial assessment of patients with Erdheim-Chester disease.
Topics: Adult; Aged; Cohort Studies; Erdheim-Chester Disease; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Observer Variation; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Severity of Illness Index; Whole Body Imaging | 2009 |
Comparison of iodine-123 metaiodobenzylguanidine (MIBG) scan and [18F]fluorodeoxyglucose positron emission tomography to evaluate response after iodine-131 MIBG therapy for relapsed neuroblastoma.
Topics: 3-Iodobenzylguanidine; Adolescent; Child; Child, Preschool; Clinical Trials, Phase I as Topic; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Neoplasm Recurrence, Local; Neuroblastoma; Outcome Assessment, Health Care; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
Prediction of residual disease of spine infection using F-18 FDG PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Back Pain; Bacterial Infections; Female; Fever; Fluorodeoxyglucose F18; Gait Disorders, Neurologic; Humans; Intervertebral Disc; Male; Middle Aged; Osteomyelitis; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Recurrence; Sensitivity and Specificity; Spinal Cord Compression; Spinal Diseases; Spine; Tomography, X-Ray Computed; Tuberculosis, Spinal; Young Adult | 2009 |
18F-FDG small-animal PET/CT differentiates trastuzumab-responsive from unresponsive human breast cancer xenografts in athymic mice.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Breast Neoplasms; Cell Line, Tumor; Cell Transformation, Neoplastic; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Genes, erbB-2; Humans; Immunohistochemistry; Mice; Mice, Nude; Positron-Emission Tomography; Sensitivity and Specificity; Tissue Distribution; Tomography, X-Ray Computed; Trastuzumab; Treatment Outcome | 2009 |
Evaluation of 18F-FDG PET/CT for diagnosing cervical nodal metastases in patients with oral cavity or oropharynx carcinoma.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Neck Dissection; Oropharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
Can hybrid FDG-PET/CT detect subclinical lymph node metastasis of esophageal cancer appropriately and contribute to radiation treatment planning? A comparison of image-based and pathological findings.
Topics: Aged; Carcinoma, Squamous Cell; Endosonography; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Patient Selection; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
[PET-CT in evaluation of pulmonary nodule--case report].
Topics: Adenocarcinoma, Clear Cell; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Lung Diseases; Lung Neoplasms; Middle Aged; Neoplasms, Second Primary; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2009 |
Computer-aided detection (CAD) and assessment of malignant lesions in the liver and lung using a novel PET/CT software tool: initial results.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Diagnosis, Computer-Assisted; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Liver; Liver Neoplasms; Lung; Lung Neoplasms; Male; Middle Aged; Molecular Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Software; Tomography, X-Ray Computed; Tumor Burden | 2010 |
Is there a role for bone scan in Hodgkin lymphoma in the age of 18F-fluorodeoxyglucose positron emission tomography?
Topics: Bone and Bones; Bone Neoplasms; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
Additional diagnostic value of (18)F-FDG PET-CT in detecting retropharyngeal nodal metastases.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Retroperitoneal Neoplasms; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
Development of a generic thresholding algorithm for the delineation of 18FDG-PET-positive tissue: application to the comparison of three thresholding models.
Topics: Algorithms; Artificial Intelligence; Computer Simulation; Differential Threshold; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Models, Biological; Neoplasms; Pattern Recognition, Automated; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2009 |
Multimodality imaging of carotid artery plaques: 18F-fluoro-2-deoxyglucose positron emission tomography, computed tomography, and magnetic resonance imaging.
Topics: Aged; Aged, 80 and over; Calcinosis; Carotid Arteries; Carotid Stenosis; Female; Fibrosis; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lipids; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Sensitivity and Specificity; Statistics as Topic; Tomography, X-Ray Computed | 2009 |
Bone and [18F]fluorodeoxyglucose positron-emission tomography/computed tomography scanning for the assessment of osseous involvement in Hodgkin lymphoma in children and young adults.
Topics: Adolescent; Bone and Bones; Bone Neoplasms; Child; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Positron-Emission Tomography; Prognosis; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2009 |
FDG PET imaging of childhood sarcomas.
Topics: Adolescent; Biopsy; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Neoplasm Staging; Neuroectodermal Tumors, Primitive; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Rhabdomyosarcoma; Sarcoma, Ewing; Sensitivity and Specificity; Single-Blind Method; Tomography, X-Ray Computed; Young Adult | 2010 |
Fluorodeoxyglucose-positron-emission tomography imaging of head and neck squamous cell cancer.
Topics: Biopsy, Fine-Needle; Carcinoma, Squamous Cell; Disease Progression; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Neoplasms, Multiple Primary; Neoplasms, Unknown Primary; Otorhinolaryngologic Neoplasms; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed; Tumor Burden; Ultrasonography | 2010 |
A region growing method for tumor volume segmentation on PET images for rectal and anal cancer patients.
Topics: Algorithms; Anus Neoplasms; Artificial Intelligence; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Pattern Recognition, Automated; Positron-Emission Tomography; Radiopharmaceuticals; Rectal Neoplasms; Reproducibility of Results; Sensitivity and Specificity | 2009 |
Respiratory gating enhances imaging of pulmonary nodules and measurement of tracer uptake in FDG PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Processing, Computer-Assisted; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Respiratory-Gated Imaging Techniques; Sensitivity and Specificity; Solitary Pulmonary Nodule; Statistics, Nonparametric; Tomography, X-Ray Computed | 2009 |
Prognostic value of 18F-FDG PET-CT metabolic index for nasopharyngeal carcinoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Dose Fractionation, Radiation; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Nasopharyngeal Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Radiotherapy, Adjuvant; Radiotherapy, Intensity-Modulated; Retrospective Studies; ROC Curve; Sample Size; Sensitivity and Specificity; Tomography, X-Ray Computed | 2010 |
"One-stop-shop" staging: should we prefer FDG-PET/CT or MRI for the detection of bone metastases?
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Melanoma; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Skin Neoplasms; Tomography, X-Ray Computed | 2011 |
Amyloid PET in mild cognitive impairment and Alzheimer's disease with BF-227: comparison to FDG-PET.
Topics: Aged; Alzheimer Disease; Amyloid; Benzoxazoles; Brain; Brain Mapping; Carbon Radioisotopes; Cognition Disorders; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Plaque, Amyloid; Positron-Emission Tomography; ROC Curve; Sensitivity and Specificity; Thiazoles | 2010 |
The value of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in carcinoma of an unknown primary: diagnosis and follow-up.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Neoplasms, Unknown Primary; Positron-Emission Tomography; Sensitivity and Specificity; Survival Analysis; Tomography, X-Ray Computed; Young Adult | 2010 |
Imaging in sinonasal sarcoidosis: CT, MRI, 67Gallium scintigraphy and 18F-FDG PET/CT features.
Topics: Adult; Aged; Blood Glucose; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Nose Deformities, Acquired; Nose Diseases; Paranasal Sinus Diseases; Positron-Emission Tomography; Prognosis; Radionuclide Imaging; Recurrence; Sarcoidosis; Sensitivity and Specificity; Tomography, Spiral Computed; Tomography, X-Ray Computed | 2010 |
Relative value of magnetic resonance spectroscopy, magnetic resonance perfusion, and 2-(18F) fluoro-2-deoxy-D-glucose positron emission tomography for detection of recurrence or grade increase in gliomas.
Topics: Adolescent; Adult; Aged; Brain; Brain Neoplasms; Diagnosis, Differential; Disease Progression; False Positive Reactions; Female; Fluorodeoxyglucose F18; Gadolinium; Glioma; Humans; Magnetic Resonance Angiography; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiotherapy; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity | 2010 |
The role of FDG PET/CT in patients with locoregional breast cancer recurrence: a comparison to conventional imaging techniques.
Topics: Adult; Aged; Breast Neoplasms; Chi-Square Distribution; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Middle Aged; Neoplasm Recurrence, Local; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Whole Body Imaging | 2010 |
[Comparison between PET(-FDG) and computed tomography in the staging of lung cancer. Consequences for operability in 94 patients].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
Comparative PET study using F-18 FET and F-18 FDG for the evaluation of patients with suspected brain tumour.
Topics: Adult; Aged; Brain; Brain Neoplasms; Diagnosis, Differential; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Glioma; Humans; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radioisotopes; Reproducibility of Results; Sensitivity and Specificity; Tyrosine; Young Adult | 2010 |
18F-FDG PET in squamous cell carcinoma of the oral cavity and oropharynx: a study on inter- and intraobserver agreement.
Topics: Carboplatin; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Nuclear Medicine; Observer Variation; Oropharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2010 |
Positron emission tomography/computed tomography: a clinical tool for evaluation of enthesitis in patients with spondyloarthritides.
Topics: Aged; Arthritis, Rheumatoid; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Spondylarthritis; Tendinopathy; Tomography, X-Ray Computed | 2010 |
[The role of / 18FDG PET/CT for the initial staging and therapy in primary breast cancer].
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
The potential clinical value of FDG-PET for recurrent renal cell carcinoma.
Topics: Aged; Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Survival Rate | 2011 |
Dual-time-point [18F]-FDG PET/CT in the diagnostic evaluation of suspicious breast lesions.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Mammography; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2010 |
The prognostic value of F-18 fluorodeoxyglucose bone marrow uptake in patients with recent diagnosis of multiple myeloma: a comparative study with Tc-99m sestamibi.
Topics: Aged; Bone Marrow; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Multiple Myeloma; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 2010 |
Detection of residual lymph node metastases in high-risk papillary thyroid cancer patients receiving adjuvant I-131 therapy: the usefulness of F-18 FDG PET/CT.
Topics: Adult; Aged; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy, Adjuvant; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Subtraction Technique; Thyroid Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
F-18 FDG PET/CT findings in two patients with hepatic angiomyolipoma with and without intratumoral hemorrhage.
Topics: Aged; Angiomyolipoma; Female; Fluorodeoxyglucose F18; Hemorrhage; Humans; Liver Neoplasms; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2010 |
FDG PET/CT in assessment of pulmonary lymphangitic carcinomatosis.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Iopamidol; Lung Neoplasms; Lymphangitis; Male; Middle Aged; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Sensitivity and Specificity | 2010 |
Change in glucose metabolism measured by 18F-FDG PET/CT as a predictor of histopathologic response to neoadjuvant treatment in rectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Blood Glucose; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Neoadjuvant Therapy; Observer Variation; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Rectal Neoplasms; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
Comparison of magnetic resonance imaging-fluorodeoxy- glucose positron emission tomography fusion with pathological staging in rectal cancer.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Rectal Neoplasms; Retrospective Studies; Sensitivity and Specificity | 2010 |
SUVmax in FDG-PET at the biopsy site correlates with the proliferation potential of tumor cells in non-Hodgkin lymphoma.
Topics: Biopsy; Cell Proliferation; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Lymph Nodes; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Prognosis; Reproducibility of Results; Sensitivity and Specificity | 2010 |
PET scan 18F-fluorodeoxyglucose uptake and prognosis in patients with resected clinical stage IA non-small cell lung cancer.
Topics: Adenocarcinoma; Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Prospective Studies; Retrospective Studies; Sensitivity and Specificity | 2010 |
Role of pretreatment 18FDG-PET/CT in surgical decision-making for head and neck cancers.
Topics: Aged; Aged, 80 and over; Biopsy, Needle; Carcinoma, Squamous Cell; Cohort Studies; Decision Making; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Immunohistochemistry; Lymph Node Excision; Lymph Nodes; Male; Middle Aged; Neck Dissection; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Retrospective Studies; Sensitivity and Specificity | 2010 |
Glioma recurrence versus radiation necrosis? A pilot comparison of arterial spin-labeled, dynamic susceptibility contrast enhanced MRI, and FDG-PET imaging.
Topics: Adult; Aged; Brain Injuries; Brain Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Gadolinium; Glioma; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Necrosis; Neoplasm Recurrence, Local; Pilot Projects; Positron-Emission Tomography; Radiation Injuries; Radiopharmaceuticals; Radiotherapy; Reproducibility of Results; Sensitivity and Specificity; Spin Labels; Young Adult | 2010 |
Differential diagnosis of parkinsonism: a metabolic imaging study using pattern analysis.
Topics: Aged; Brain; Brain Mapping; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Parkinsonian Disorders; Pattern Recognition, Automated; Positron-Emission Tomography; Predictive Value of Tests; Psychiatric Status Rating Scales; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity | 2010 |
The stripe of primary lateral sclerosis: focal primary motor cortex hypometabolism seen on fluorodeoxyglucose F18 positron emission tomography.
Topics: Aged; Brain Mapping; Diagnosis, Differential; Disease Progression; Energy Metabolism; Female; Fluorodeoxyglucose F18; Gait Disorders, Neurologic; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Motor Cortex; Motor Neuron Disease; Paresis; Positron-Emission Tomography; Predictive Value of Tests; Pseudobulbar Palsy; Pyramidal Tracts; Retrospective Studies; Sensitivity and Specificity | 2010 |
Combining MR imaging, positron-emission tomography, and CSF biomarkers in the diagnosis and prognosis of Alzheimer disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Databases, Factual; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hippocampus; Humans; Logistic Models; Magnetic Resonance Imaging; Male; Middle Aged; Peptide Fragments; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; ROC Curve; Sensitivity and Specificity; tau Proteins | 2010 |
Prediction of lymph node metastases in NSCLC. Three dimensional anatomical parameters do not substitute FDG-PET-CT.
Topics: Aged; Automation; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiography; Retrospective Studies; ROC Curve; Sensitivity and Specificity | 2010 |
PET/CT pattern analysis for surgical staple line recurrence in patients with colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Sutures; Tomography, X-Ray Computed | 2010 |
Dual PET/CT with (18)F-DOPA and (18)F-FDG in metastatic medullary thyroid carcinoma and rapidly increasing calcitonin levels: Comparison with conventional imaging.
Topics: Adult; Aged; Biomarkers, Tumor; Calcitonin; Carcinoma, Medullary; Chi-Square Distribution; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Sensitivity and Specificity; Statistics, Nonparametric; Thyroid Neoplasms; Thyroidectomy | 2010 |
Intraoperative radiation exposure with the use of (18)F-FDG-guided thyroid cancer surgery.
Topics: Fluorodeoxyglucose F18; Humans; Intraoperative Period; Minimally Invasive Surgical Procedures; Occupational Exposure; Pilot Projects; Positron-Emission Tomography; Radiation Monitoring; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Thyroid Neoplasms; Treatment Outcome | 2010 |
F-18 FDG PET/CT in the diagnosis of fever of unknown origin.
Topics: Adult; Aged; Aged, 80 and over; Bacterial Infections; Diagnosis, Differential; Female; Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
Comparative evaluation of F-18 FDOPA, F-18 FDG, and F-18 FLT-PET/CT for metabolic imaging of low grade gliomas.
Topics: Adolescent; Adult; Brain Neoplasms; Child; Child, Preschool; Dideoxynucleosides; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed; Young Adult | 2009 |
Exclusion of malignancy in thyroid nodules with indeterminate fine-needle aspiration cytology after negative 18F-fluorodeoxyglucose positron emission tomography: interim analysis.
Topics: Adult; Aged; Biopsy, Fine-Needle; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Nodule; Thyroidectomy; Tomography, X-Ray Computed; Ultrasonography | 2010 |
Utility of FDG PET/CT and brain MRI in melanoma patients with increased serum S-100B level during follow-up.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Brain Neoplasms; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Melanoma; Middle Aged; Nerve Growth Factors; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; S100 Calcium Binding Protein beta Subunit; S100 Proteins; Sensitivity and Specificity; Skin Neoplasms; Tomography, X-Ray Computed; Whole Body Imaging | 2010 |
Flourine-18 flourodeoxyglucose positron emission tomography as a non-invasive test of disease activity in Takayasu's arteritis--a report of four cases.
Topics: Adult; Anticoagulants; Asthma; Constriction, Pathologic; Diagnosis, Differential; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Immunosuppressive Agents; Middle Aged; Positron-Emission Tomography; Sensitivity and Specificity; Takayasu Arteritis; Tuberculosis, Pulmonary | 2010 |
Prospective imaging assessment of mortality risk after head-and-neck radiotherapy.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Dose Fractionation, Radiation; Female; Fluorodeoxyglucose F18; Human papillomavirus 16; Humans; Laryngeal Neoplasms; Male; Middle Aged; Multivariate Analysis; Pharyngeal Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy, Intensity-Modulated; Risk Assessment; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2010 |
Assessment of tumor recurrence in patients with colorectal cancer and elevated carcinoembryonic antigen level: FDG PET/CT versus contrast-enhanced 64-MDCT of the chest and abdomen.
Topics: Adult; Aged; Aged, 80 and over; Carcinoembryonic Antigen; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Radiographic Image Interpretation, Computer-Assisted; Radiography, Abdominal; Radiography, Thoracic; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2010 |
Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Pneumonectomy; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
[Combined functional and morphological imaging of sarcomas: significance for diagnostics and therapy monitoring].
Topics: Adult; Fluorodeoxyglucose F18; Germany; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sarcoma; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
[PET/CT imaging of atherosclerotic blood vessel alterations].
Topics: Aged; Aged, 80 and over; Atherosclerosis; Female; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2010 |
Combined positron emission tomography-computed tomography and tumor markers for detecting recurrent ovarian cancer.
Topics: Adenocarcinoma; Adult; Aged; Biomarkers, Tumor; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
Comparison of (18)F-FDG-PET/CT with (99m)Tc-MDP bone scintigraphy for the detection of bone metastases in cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Bone and Bones; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Technetium Tc 99m Medronate; Tomography, X-Ray Computed | 2010 |
The use of PET images for radiotherapy treatment planning: an error analysis using radiobiological endpoints.
Topics: Endpoint Determination; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Computer-Assisted; Reproducibility of Results; Sensitivity and Specificity | 2010 |
Combined correction of recovery effect and motion blur for SUV quantification of solitary pulmonary nodules in FDG PET/CT.
Topics: Aged; Algorithms; Artifacts; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Lung Neoplasms; Male; Motion; Phantoms, Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2010 |
High FDG uptake in PET/CT predicts worse prognosis in patients with metastatic gastric adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Metastasis; Palliative Care; Positron-Emission Tomography; Proportional Hazards Models; Reproducibility of Results; Sensitivity and Specificity; Stomach Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
Skeletal trauma in child abuse: detection with 18F-NaF PET.
Topics: Child Abuse; Female; Fluorodeoxyglucose F18; Fractures, Bone; Humans; Image Interpretation, Computer-Assisted; Infant; Infant, Newborn; Male; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Sodium Fluoride | 2010 |
Pediatric and adolescent lymphoma: comparison of whole-body STIR half-Fourier RARE MR imaging with an enhanced PET/CT reference for initial staging.
Topics: Adolescent; Child; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Iohexol; Lymphatic Metastasis; Lymphoma; Magnetic Resonance Imaging; Male; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Reference Standards; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2010 |
Role of [(18)F]FDG-PET/CT in the detection of occult recurrent medullary thyroid cancer.
Topics: Adult; Aged; Calcitonin; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Recurrence; Retrospective Studies; Sensitivity and Specificity; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed; Young Adult | 2010 |
18F-FDG PET/CT-related metabolic parameters and their value in early prediction of chemotherapy response in a VX2 tumor model.
Topics: Animals; Antineoplastic Agents; Cisplatin; Computer Simulation; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Liver Neoplasms, Experimental; Metabolic Clearance Rate; Models, Biological; Positron-Emission Tomography; Rabbits; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tissue Distribution; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
Cerenkov luminescence tomography for small-animal imaging.
Topics: Animals; Cell Line, Tumor; Computer-Aided Design; Equipment Design; Equipment Failure Analysis; Fluorodeoxyglucose F18; Humans; Luminescent Measurements; Melanoma; Mice; Mice, Nude; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Whole Body Imaging | 2010 |
[Fluoroethylthyrosine 18F PET in the detection of brain tumours].
Topics: Adult; Aged; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioblastoma; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Oligodendroglioma; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Tyrosine | 2010 |
Comparing fludeoxyglucose F18-PET assessment of regional cerebral glucose metabolism and [11C]dihydrotetrabenazine-PET in evaluation of early dementia and mild cognitive impairment.
Topics: Age of Onset; Aged; Aged, 80 and over; Binding, Competitive; Brain Mapping; Carbon Radioisotopes; Cerebral Cortex; Cerebrovascular Circulation; Cognition Disorders; Dementia; Early Diagnosis; Energy Metabolism; Female; Fluorodeoxyglucose F18; Glucose; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tetrabenazine | 2010 |
An abbreviated hyperinsulinemic-euglycemic clamp results in similar myocardial glucose utilization in both diabetic and non-diabetic patients with ischemic cardiomyopathy.
Topics: Aged; Cardiomyopathies; Diabetes Complications; Female; Fluorodeoxyglucose F18; Glucose Clamp Technique; Humans; Male; Middle Aged; Myocardial Ischemia; Myocardial Perfusion Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2010 |
Comprehensive imaging of residual/ recurrent nasopharyngeal carcinoma using whole-body MRI at 3 T compared with FDG-PET-CT.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm, Residual; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed; Whole Body Imaging; Young Adult | 2010 |
18F-FDG PET for the identification of adrenocortical carcinomas among indeterminate adrenal tumors at computed tomography scanning.
Topics: Adrenal Cortex Neoplasms; Adrenal Gland Neoplasms; Adrenocortical Adenoma; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2010 |
Incidental finding of focal FDG uptake in the bowel during PET/CT: CT features and correlation with histopathologic results.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Incidence; Incidental Findings; Intestinal Diseases; Intestinal Mucosa; Intestines; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Subtraction Technique; Texas; Tomography, X-Ray Computed; Young Adult | 2010 |
1H MR spectroscopy of invasive ductal carcinoma: correlations with FDG PET and histologic prognostic factors.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Humans; Japan; Magnetic Resonance Spectroscopy; Middle Aged; Positron-Emission Tomography; Prevalence; Prognosis; Protons; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic | 2010 |
Squamous cell carcinoma of the palatine tonsils: FDG standardized uptake value ratio as a biomarker to differentiate tonsillar carcinoma from physiologic uptake.
Topics: Adult; Aged; Aged, 80 and over; Area Under Curve; Biomarkers; Carcinoma, Squamous Cell; Contrast Media; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Palatine Tonsil; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, Spiral Computed; Tonsillar Neoplasms; Triiodobenzoic Acids | 2010 |
[Vasculitis assessment with [18F]FDG positron emission tomography].
Topics: Aortitis; Arteritis; Diagnosis, Differential; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Takayasu Arteritis; Vasculitis | 2010 |
Whole-body diffusion-weighted imaging vs. FDG-PET for the detection of non-small-cell lung cancer. How do they measure up?
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Whole Body Imaging | 2010 |
Utility of preoperative 18F-FDG PET/CT and brain MRI in melanoma patients with palpable lymph node metastases.
Topics: Aged; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Melanoma; Middle Aged; Positron-Emission Tomography; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
Fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography predicts extrahepatic metastatic potential of colorectal metastasis: a practical guide for yttrium-90 microsphere liver-directed therapy.
Topics: Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Microspheres; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tissue Distribution; Tomography, X-Ray Computed; Tumor Cells, Cultured; Yttrium Radioisotopes | 2010 |
[PET scanning for malignant melanoma and positive sentinel node diagnostics].
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Skin Neoplasms | 2010 |
Prognostic value of FDG-PET in Hodgkin lymphoma for posttreatment evaluation. Long term follow-up results.
Topics: Adolescent; Adult; Aged; Cohort Studies; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Remission Induction; Retrospective Studies; Sensitivity and Specificity; Survival Rate; Time Factors; Treatment Outcome; Young Adult | 2010 |
Clinical interest of integrating positron emission tomography imaging in the workup of 55 children with incidentally diagnosed brain lesions.
Topics: Adolescent; Brain Diseases; Brain Neoplasms; Carbon Radioisotopes; Child; Child, Preschool; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Incidental Findings; Infant; Magnetic Resonance Imaging; Male; Methionine; Positron-Emission Tomography; Sensitivity and Specificity | 2010 |
Clinical impact of integrating positron emission tomography during surgery in 85 children with brain tumors.
Topics: Adolescent; Belgium; Brain Neoplasms; Carbon Radioisotopes; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Incidental Findings; Infant; Magnetic Resonance Imaging; Male; Methionine; Neuronavigation; Positron-Emission Tomography; Postoperative Complications; Reoperation; Retrospective Studies; Sensitivity and Specificity | 2010 |
Pelvic lymph node status assessed by 18F-fluorodeoxyglucose positron emission tomography predicts low-risk group for distant recurrence in locally advanced cervical cancer: a prospective study.
Topics: Adult; Aged; Antigens, Neoplasm; Biomarkers, Tumor; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Logistic Models; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Neoplasm Staging; Pelvis; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Risk; Sensitivity and Specificity; Serpins; Uterine Cervical Neoplasms; Young Adult | 2011 |
Volume-based parameter of 18)F-FDG PET/CT in malignant pleural mesothelioma: prediction of therapeutic response and prognostic implications.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Mesothelioma; Middle Aged; Neoplasms, Glandular and Epithelial; Pleural Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed | 2010 |
PET probes for distinct metabolic pathways have different cell specificities during immune responses in mice.
Topics: Animals; Cell Proliferation; Cells; Cellular Structures; Fluorodeoxyglucose F18; Immune System Phenomena; Male; Metabolic Networks and Pathways; Mice; Mice, Inbred C57BL; Mice, SCID; Positron-Emission Tomography; Sensitivity and Specificity | 2010 |
Metabolic and clinical assessment of efficacy of cryoablation therapy on skeletal masses by 18F-FDG positron emission tomography/computed tomography (PET/CT) and visual analogue scale (VAS): initial experience.
Topics: Aged; Bone Neoplasms; Cryosurgery; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pain; Pain Measurement; Pilot Projects; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
The diagnostic accuracy of 18F-FDG PET in cutaneous malignant melanoma.
Topics: Fluorodeoxyglucose F18; Humans; Melanoma; Positron-Emission Tomography; Sensitivity and Specificity; Skin Neoplasms | 2010 |
Prognostic value of (18)F-fluorodeoxyglucose positron emission tomography in patients with extrahepatic bile duct cancer.
Topics: Adult; Aged; Aged, 80 and over; Bile Duct Neoplasms; Bile Ducts, Extrahepatic; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Sensitivity and Specificity; Survival Rate | 2011 |
[Value of (18)F-FDG imaging and serum tumor markers in the diagnosis of recurrent endometrial carcinoma].
Topics: Adenocarcinoma; Adult; Aged; Biomarkers, Tumor; CA-125 Antigen; Cystadenocarcinoma, Serous; DNA-Binding Proteins; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Transcription Factors | 2010 |
Integrated positron emission tomography-computed tomography does not accurately stage intrathoracic disease of patients undergoing trimodality therapy for malignant pleural mesothelioma.
Topics: Aged; Biopsy; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Male; Mediastinoscopy; Mesothelioma; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Pleural Neoplasms; Pleurodesis; Pneumonectomy; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Radiotherapy, Adjuvant; Reproducibility of Results; Sensitivity and Specificity; Talc; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
Impact of 18F-fluorodeoxyglucose positron emission tomography in the staging and treatment response assessment of extra-pulmonary small-cell cancer.
Topics: Carcinoma, Small Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome | 2010 |
PET assessment of disease activity in children with juvenile idiopathic arthritis.
Topics: Adolescent; Arthritis, Juvenile; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Infant; Male; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Synovial Membrane | 2010 |
18F-FDG-PET/CT in patients with breast cancer and rising Ca 15-3 with negative conventional imaging: a multicentre study.
Topics: Adult; Aged; Biomarkers, Tumor; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Italy; Middle Aged; Mucin-1; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
Non-small cell carcinoma: comparison of postoperative intra- and extrathoracic recurrence assessment capability of qualitatively and/or quantitatively assessed FDG-PET/CT and standard radiological examinations.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Magnetic Resonance Imaging; Male; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2011 |
Significance of 18F-fluorodeoxyglucose positron-emission tomography/computed tomography for the postoperative surveillance of advanced renal cell carcinoma.
Topics: Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2010 |
Two decades at the cross-roads of biology, physics and epidemiology: lessons learned in [18F-]FDG positron emission tomography in oncology.
Topics: Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Practice Guidelines as Topic; Radiopharmaceuticals; Sensitivity and Specificity | 2010 |
Accuracy of FDG-PET-CT in the diagnostic work-up of vascular prosthetic graft infection.
Topics: Aged; Blood Vessel Prosthesis; Blood Vessel Prosthesis Implantation; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Observer Variation; Positron-Emission Tomography; Predictive Value of Tests; Prosthesis-Related Infections; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2010 |
Usefulness of combined FDG-PET with CT or tumour markers in lung cancer diagnosis.
Topics: Biomarkers, Tumor; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Medical Oncology; Neoplasm Metastasis; Positron-Emission Tomography; Predictive Value of Tests; Retrospective Studies; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2010 |
Detection of recurrence by 18F-FDG PET in patients with endometrial cancer showing no evidence of disease.
Topics: Adult; Aged; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Retrospective Studies; Sensitivity and Specificity | 2010 |
Texture analysis of non-small cell lung cancer on unenhanced computed tomography: initial evidence for a relationship with tumour glucose metabolism and stage.
Topics: Aged; Algorithms; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Linear Models; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Pilot Projects; Positron-Emission Tomography; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity | 2010 |
Pretreatment positron emission tomography with [18F]fluorodeoxyglucose for head and neck squamous cancer.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Multicenter Studies as Topic; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity | 2010 |
Exposing the evil in the dark: the usefulness of delayed-phase FDG PET scan to enhance the detectability of tiny residual skull base osteosarcoma initially concealed by adjacent high physiological brain activity.
Topics: Brain; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm, Residual; Osteosarcoma; Positron-Emission Tomography; Sensitivity and Specificity; Skull Base Neoplasms; Time Factors; Tomography, X-Ray Computed | 2010 |
The prevalence and clinical significance of (18) F-2-fluoro-2-deoxy-D-glucose (FDG) uptake in the thyroid gland on PET or PET-CT in patients with lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Neoplasm Staging; Outcome Assessment, Health Care; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Thyroid Gland; Thyroid Neoplasms; Tomography, X-Ray Computed | 2011 |
Whole body [(18) F]fluorodeoxyglucose positron emission tomography imaging for the diagnosis of pacemaker or implantable cardioverter defibrillator infection: a preliminary prospective study.
Topics: Bacteria; Bacterial Infections; Defibrillators, Implantable; Diagnostic Errors; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Postoperative Complications; Predictive Value of Tests; Prospective Studies; Sensitivity and Specificity; Whole Body Imaging | 2011 |
Characterization of T-cell lymphomas by FDG PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, T-Cell; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2010 |
Preclinical and clinical evidence that Deoxy-2-[18F]fluoro-D-glucose positron emission tomography with computed tomography is a reliable tool for the detection of early molecular responses to erlotinib in head and neck cancer.
Topics: Aged; Animals; Blotting, Western; Cell Line, Tumor; Erlotinib Hydrochloride; Female; Fluorescent Antibody Technique; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Mice; Mice, Nude; Middle Aged; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Phosphorylation; Positron-Emission Tomography; Protein Kinase Inhibitors; Quinazolines; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome; Xenograft Model Antitumor Assays | 2010 |
Incidental pituitary uptake on whole-body 18F-FDG PET/CT: a multicentre study.
Topics: Adenoma; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Incidence; Korea; Male; Middle Aged; Pituitary Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2010 |
Management of local recurrence of colorectal cancer: the role of PET/CT.
Topics: Adult; Aged; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2011 |
Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography in differential diagnosis of benign and malignant intraductal papillary-mucinous neoplasm of the pancreas.
Topics: Adenoma; Adult; Aged; Aged, 80 and over; Carcinoma in Situ; Carcinoma, Pancreatic Ductal; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Japan; Male; Middle Aged; Neoplasms, Cystic, Mucinous, and Serous; Pancreatectomy; Pancreatic Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2010 |
The role of ultrasonography and FDG-PET in axillary lymph node staging of breast cancer.
Topics: Adult; Aged; Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Ultrasonography, Mammary | 2010 |
Clinical value of fluorine-18 2-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in bladder cancer.
Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Patient Care Planning; Positron-Emission Tomography; Sensitivity and Specificity; Surveys and Questionnaires; Tomography, Emission-Computed; Urinary Bladder Neoplasms | 2010 |
Recognition of fibrous dysplasia of bone mimicking skeletal metastasis on 18F-FDG PET/CT imaging.
Topics: Adolescent; Adult; Aged; Bone Neoplasms; Diagnosis, Differential; Female; Fibrous Dysplasia of Bone; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed; Young Adult | 2011 |
Clinical utility of positron emission tomography/computed tomography in the evaluation of suspected recurrent ovarian cancer in the setting of normal CA-125 levels.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; CA-125 Antigen; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reference Values; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2010 |
Value of PET-CT in avoiding multimodality therapy in operable cervical cancer.
Topics: Adult; Aged; Aged, 80 and over; Biopsy, Needle; Chemotherapy, Adjuvant; Chi-Square Distribution; Cohort Studies; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Hysterectomy; Immunohistochemistry; Lymph Nodes; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Radiotherapy, Adjuvant; Sensitivity and Specificity; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2010 |
FDG-PET/CT in advanced ovarian cancer staging: value and pitfalls in detecting lesions in different abdominal and pelvic quadrants compared with laparoscopy.
Topics: Aged; Diagnosis, Differential; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Laparoscopy; Middle Aged; Multimodal Imaging; Neoplasm Staging; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
18F-fluorodeoxyglucose positron emission tomography and computed tomography in anaplastic thyroid cancer.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Tomography, X-Ray Computed; Whole Body Imaging | 2010 |
Diagnostic and prognostic impact of 18F-FDG PET/CT in follicular lymphoma.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Immunologic Factors; Lymphoma, Follicular; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
Pilot comparison of F-fluorocholine and F-fluorodeoxyglucose PET/CT with conventional imaging in prostate cancer.
Topics: Aged; Choline; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Staging; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Prostate; Prostatic Neoplasms; Radiographic Image Enhancement; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2010 |
Relative capability of MR imaging and FDG PET to depict changes associated with prodromal and early Alzheimer disease.
Topics: Aged; Alzheimer Disease; Case-Control Studies; Chi-Square Distribution; Early Diagnosis; Female; Fluorodeoxyglucose F18; Hippocampus; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Monte Carlo Method; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity | 2010 |
Preoperative combined 18-fluorodeoxyglucose positron emission tomography and computed tomography imaging in head and neck cancer: does it really improve initial N staging?
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Neoplasm Staging; Oropharyngeal Neoplasms; Polymerase Chain Reaction; Sensitivity and Specificity; Tomography, X-Ray Computed | 2010 |
Evaluation of shoulder disorders by 2-[F-18]-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography.
Topics: Aged; Bursitis; Female; Fluorodeoxyglucose F18; Humans; Joint Diseases; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Rotator Cuff; Rotator Cuff Injuries; Sensitivity and Specificity; Shoulder Joint; Tomography, X-Ray Computed | 2010 |
Role of 18F-FDG PET in detecting primary site in the patient with primary unknown carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Carcinoma, Squamous Cell; Diagnostic Imaging; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Neoplasms, Unknown Primary; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Statistics, Nonparametric; Survival Rate | 2010 |
Methodological issues in the evaluation of FDG PET/CT accuracy in pediatric lymphoma.
Topics: Child; Fluorodeoxyglucose F18; Humans; Lymphoma; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2010 |
Additional benefit of ¹⁸F-fluorodeoxyglucose integrated positron emission tomography/computed tomography in the staging of oesophageal cancer.
Topics: Adult; Aged; Aged, 80 and over; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2011 |
Dual time-point FDG PET-CT for differentiating benign from malignant solitary pulmonary nodules in a TB endemic area.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiography; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tuberculosis, Pulmonary | 2010 |
The real additional value of FDG-PET in detecting the occult primary tumour in patients with cervical lymph node metastases of unknown primary tumour.
Topics: Biopsy; Carcinoma, Squamous Cell; Diagnostic Imaging; Endoscopy; False Negative Reactions; False Positive Reactions; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2010 |
[(18)F]Fluorodeoxyglucose positron emission tomography-computerized tomography and lung cancer: a significant referral bias exists.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Referral and Consultation; Selection Bias; Sensitivity and Specificity; Survival Analysis | 2011 |
Characterization of a perirectal artifact in 18F-FDG PET/CT.
Topics: Artifacts; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Rectal Neoplasms; Rectum; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed; Urinary Bladder | 2010 |
Autocontouring and manual contouring: which is the better method for target delineation using 18F-FDG PET/CT in non-small cell lung cancer?
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Pattern Recognition, Automated; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2010 |
Potential of noninvasive serial assessment of acute renal allograft rejection by 18F-FDG PET to monitor treatment efficiency.
Topics: Acute Disease; Animals; Feasibility Studies; Fluorodeoxyglucose F18; Graft Rejection; Kidney Transplantation; Male; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Rats; Rats, Inbred Lew; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome | 2010 |
18F-FDG PET/CT in paediatric lymphoma: comparison with conventional imaging.
Topics: Adolescent; Child; Child, Preschool; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
Diagnostic accuracy of ultrasound and 18-F-FDG PET or PET/CT for patients with suspected recurrent papillary thyroid carcinoma.
Topics: Adolescent; Adult; Aged; Carcinoma; Carcinoma, Papillary; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Thyroid Cancer, Papillary; Thyroid Gland; Thyroid Neoplasms; Tomography, X-Ray Computed; Ultrasonography, Doppler, Color; Young Adult | 2010 |
A comparison of the diagnostic sensitivity of MRI, CBF-SPECT, FDG-PET and cerebrospinal fluid biomarkers for detecting Alzheimer's disease in a memory clinic.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Atrophy; Biomarkers; Cerebrospinal Fluid; Early Diagnosis; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Peptide Fragments; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Sensitivity and Specificity; Severity of Illness Index; Single-Blind Method; tau Proteins; Temporal Lobe; Tomography, Emission-Computed, Single-Photon | 2010 |
Cost-benefit of minimally invasive staging of non-small cell lung cancer: a decision tree sensitivity analysis.
Topics: Australia; Biopsy, Fine-Needle; Carcinoma, Non-Small-Cell Lung; Cost-Benefit Analysis; Decision Trees; Endosonography; Fluorodeoxyglucose F18; Health Care Costs; Humans; Lung Neoplasms; Mediastinoscopy; Neoplasm Staging; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2010 |
[The role of PET imaging in patients with lymphoma].
Topics: Antineoplastic Agents; Disease Progression; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphoma; Neoplasm Staging; Neoplasm, Residual; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2010 |
Fluorodesoxyglucose uptake in the remaining adrenal glands during the follow-up of patients with adrenocortical carcinoma: do not consider it as malignancy.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenalectomy; Adrenocortical Carcinoma; Adult; Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Time Factors | 2011 |
18-fluorine fluorodeoxyglucose positron emission tomography with computerized tomography versus computerized tomography alone for the management of solitary lung nodules with diameters inferior to 1.5 cm.
Topics: Adult; Aged; Bronchoscopy; Female; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2010 |
[Benefit of PET/CT in the preoperative staging in pancreatic carcinomas].
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2010 |
CT, MR, (18)F-FDG PET/CT, and their combined use for the assessment of mandibular invasion by squamous cell carcinomas of the oral cavity.
Topics: Carcinoma, Squamous Cell; Contrast Media; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Image Enhancement; Iohexol; Magnetic Resonance Imaging; Male; Mandible; Mandibular Neoplasms; Middle Aged; Mouth Neoplasms; Neoplasm Invasiveness; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2010 |
The efficacy of preoperative PET/CT for prediction of curability in surgery for locally advanced gastric carcinoma.
Topics: Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gastrectomy; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Stomach Neoplasms; Tomography, X-Ray Computed | 2010 |
Diffusion-weighted MR imaging in comparison to integrated [¹⁸F]-FDG PET/CT for N-staging in patients with lung cancer.
Topics: Aged; Aged, 80 and over; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Systems Integration; Tomography, X-Ray Computed | 2012 |
Diagnostic accuracy of fused positron emission tomography/magnetic resonance mammography: initial results.
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Mammography; Middle Aged; Radiopharmaceuticals; Reference Standards; Sensitivity and Specificity; Tomography, Emission-Computed | 2011 |
Radioguided surgery using an intraoperative PET probe for tumor localization and verification of complete resection in differentiated thyroid cancer: a pilot study.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms | 2011 |
18F-FDG PET as a diagnostic procedure in large vessel vasculitis-a controlled, blinded re-examination of routine PET scans.
Topics: Aged; Area Under Curve; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Research Design; ROC Curve; Sensitivity and Specificity; Vasculitis | 2011 |
Application of (18)F-fluorodeoxyglucose positron emission tomography to detection of proximal lesions of obstructive colorectal cancer.
Topics: Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Intestinal Obstruction; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Statistics, Nonparametric | 2010 |
Localization of medullary thyroid carcinoma after surgery using (11)C-methionine PET/CT: comparison with (18)F-FDG PET/CT.
Topics: Adult; Aged; Calcitonin; Carbon Radioisotopes; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Humans; Male; Methionine; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Sensitivity and Specificity; Thyroid Neoplasms; Thyroidectomy | 2010 |
FDG-PET/CT imaging of elastofibroma dorsi.
Topics: Aged; Female; Fibroma; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Soft Tissue Neoplasms; Tomography, X-Ray Computed | 2011 |
Noninvasive assessment of pediatric inflammatory bowel disease with ¹⁸F-fluorodeoxyglucose-positron emission tomography and computed tomography.
Topics: Adolescent; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Inflammatory Bowel Diseases; Male; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 2011 |
[Tumor diagnosis with PET-CT. Are false hopes raised in cancer patients? (interview by Ute Kempf)].
Topics: Breast Neoplasms; Carcinoma, Bronchogenic; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Insurance Coverage; Lung Neoplasms; Male; National Health Programs; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prostatic Neoplasms; Sensitivity and Specificity; Tomography, X-Ray Computed; Unnecessary Procedures | 2010 |
Retrospective web-based multicenter evaluation of ¹⁸F-FDG-PET and CT derived predictive factors. Radioimmunotherapy with yttrium-90-ibritumomab tiuxetan in follicular non Hodgkin's lymphoma.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Female; Fluorodeoxyglucose F18; Humans; Internet; Lymphoma, Follicular; Male; Middle Aged; Prognosis; Radioimmunotherapy; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
Vertebral arteries: a target for FDG-PET imaging in giant cell arteritis? Clinical, ultrasonographic and PET study in 46 patients.
Topics: Aged; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Ultrasonography; Vertebral Artery | 2011 |
The value of dual-time-point 18F-FDG PET/CT for identifying axillary lymph node metastasis in breast cancer patients.
Topics: Adult; Aged; Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Tomography, X-Ray Computed; Young Adult | 2011 |
Preliminary Monte Carlo study of (18)F-FDG SPECT imaging with LaBr(3):Ce Crystal-based Gamma Cameras.
Topics: Algorithms; Bromides; Computer Simulation; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Lanthanum; Light; Monte Carlo Method; Positron-Emission Tomography; Radiation; Sensitivity and Specificity; Software; Time Factors; Tomography, Emission-Computed, Single-Photon | 2010 |
Usefulness of FDG PET/CT in determining benign from malignant endobronchial obstruction.
Topics: Adult; Aged; Aged, 80 and over; Constriction, Pathologic; Contrast Media; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Probability; Pulmonary Atelectasis; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
Continued pemetrexed and platin-based chemotherapy in patients with malignant pleural mesothelioma (MPM): value of 18F-FDG-PET/CT.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Fluorodeoxyglucose F18; Glutamates; Guanine; Humans; Male; Mesothelioma; Middle Aged; Pemetrexed; Pleural Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Diagnostic value of FDG-PET for lymph node metastasis and outcome of surgery for biliary cancer.
Topics: Adult; Aged; Aged, 80 and over; Biliary Tract Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2011 |
Validation of consensus panel diagnosis in dementia.
Topics: Alzheimer Disease; Consensus; Fluorodeoxyglucose F18; Frontotemporal Dementia; Humans; Positron-Emission Tomography; Predictive Value of Tests; Reproducibility of Results; Sensitivity and Specificity | 2010 |
FDG uptake in lymph-nodes of HIV+ and tuberculosis patients: implications for cancer staging.
Topics: Adult; Female; Fluorodeoxyglucose F18; HIV Infections; Humans; Male; Middle Aged; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tuberculosis | 2010 |
Diagnostic value of CT, PET and combined PET/CT performed with low-dose unenhanced CT and full-dose enhanced CT in the initial staging of lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Contrast Media; Diatrizoate Meglumine; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiation Dosage; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2011 |
Bone marrow disease detection with FDG-PET/CT and bone marrow biopsy during the staging of malignant lymphoma: results from a large multicentre study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biopsy; Bone Marrow; Bone Marrow Neoplasms; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
Value of contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography in detection and presurgical assessment of pancreatic cancer: a prospective study.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Chi-Square Distribution; Contrast Media; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Male; Middle Aged; Neoplasm Staging; Pancreatic Neoplasms; Pilot Projects; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Switzerland; Tomography, X-Ray Computed; Young Adult | 2011 |
Lymph node uptake of 18F-fluorodeoxyglucose detected with positron emission tomography/computed tomography mimicking malignant lymphoma in a patient with Kikuchi disease.
Topics: Adolescent; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Histiocytic Necrotizing Lymphadenitis; Humans; Lymph Nodes; Lymphoma; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2010 |
FDG PET/CT in cancer therapy monitoring: computer-assisted analysis of baseline together with up to two follow-ups.
Topics: Adult; Aged; Algorithms; Artificial Intelligence; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Information Storage and Retrieval; Male; Middle Aged; Neoplasms; Pattern Recognition, Automated; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
Brain metastasis in lung cancer. Comparison of cerebral MRI and 18F-FDG-PET/CT for diagnosis in the initial staging.
Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Germany; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
Assessment of left ventricular volumes, ejection fraction and mass. Comparison of model-based analysis of ECG-gated (⁹⁹m)Tc-SPECT and ¹⁸F-FDG-PET.
Topics: Cardiac-Gated Imaging Techniques; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Organ Size; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Stroke Volume; Technetium; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2011 |
A letter regarding diagnostic accuracy of ultrasound and 18-F-FDG PET or PET/CT for patients with suspected recurrent papillary thyroid carcinoma.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, X-Ray Computed; Ultrasonography | 2011 |
Beyond FDG: Many Molecular Imaging Agents Are in Development.
Topics: Biomarkers, Tumor; Breast Neoplasms; Dihydrotestosterone; Drug Design; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Male; Neoplasms; Nuclear Medicine; Positron-Emission Tomography; Prostatic Neoplasms; Radiology; Radiopharmaceuticals; Receptor, ErbB-2; Receptors, Androgen; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
18F-fluorodeoxyglucose-PET for patients with suspected spondylitis showing Modic change.
Topics: Adult; Aged; Aged, 80 and over; Cohort Studies; Diagnosis, Differential; Discitis; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Osteomyelitis; Positron-Emission Tomography; Prospective Studies; Sensitivity and Specificity; Spondylitis | 2010 |
Comparison of MR imaging and FDG-PET/CT in the differential diagnosis of benign and malignant vertebral compression fractures.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Female; Fluorodeoxyglucose F18; Fractures, Compression; Fractures, Spontaneous; Humans; Image Processing, Computer-Assisted; Lumbar Vertebrae; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; ROC Curve; Sensitivity and Specificity; Spinal Fractures; Spinal Neoplasms; Thoracic Vertebrae; Tomography, X-Ray Computed; Young Adult | 2011 |
Impact of parenchymal tuberculosis sequelae on mediastinal lymph node staging in patients with lung cancer.
Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Latent Tuberculosis; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
Comparison of two region of interest definition methods for metabolic response evaluation with [¹⁸F]FDG-PET.
Topics: Adult; Aged; Antineoplastic Agents; Computer Simulation; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Middle Aged; Models, Biological; Neoplasms; Netherlands; Positron-Emission Tomography; Prevalence; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Survival Analysis; Survival Rate; Treatment Outcome | 2010 |
MRI and PET/CT of patients with bone metastases from breast carcinoma.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Breast Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Mammography; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
The value of FDG PET/CT in the initial staging and bone marrow involvement of patients with multiple myeloma.
Topics: Adult; Aged; Aged, 80 and over; Bone Marrow; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple Myeloma; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2011 |
Preoperative lymph-node staging of invasive urothelial bladder cancer with 18F-fluorodeoxyglucose positron emission tomography/computed axial tomography and magnetic resonance imaging: correlation with histopathology.
Topics: Adenocarcinoma; Aged; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prognosis; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Urinary Bladder Neoplasms; Urothelium | 2011 |
Diagnostic value of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in patients with fever of unknown origin.
Topics: Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
Imaging the inflammatory activity of sarcoidosis: sensitivity and inter observer agreement of (67)Ga imaging and (18)F-FDG PET.
Topics: Adult; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Male; Middle Aged; Observer Variation; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sarcoidosis; Sarcoidosis, Pulmonary; Sensitivity and Specificity | 2011 |
18F-fluorodeoxyglucose positron emission tomography in the diagnosis of small pancreatic cancer.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Medical Oncology; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Quality of Life; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
Can (18)F-FDG PET/CT predict recurrence in patients with cutaneous malignant melanoma?
Topics: Female; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Skin Neoplasms; Subtraction Technique; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
Is there a common SUV threshold in oncological FDG PET/CT, at least for some common indications? A retrospective study.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Reference Standards; Retrospective Studies; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2011 |
Diagnosis of peritoneal dissemination: comparison of 18F-FDG PET/CT, diffusion-weighted MRI, and contrast-enhanced MDCT.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Peritoneal Neoplasms; Peritoneum; Positron-Emission Tomography; Predictive Value of Tests; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
Retroperitoneal extraskeletal osteosarcomas.
Topics: Aged; Bone Neoplasms; CA-125 Antigen; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Osteosarcoma; Positron-Emission Tomography; Radiopharmaceuticals; Retroperitoneal Neoplasms; Sensitivity and Specificity; Tomography, X-Ray Computed | 2010 |
Age-related metabolic profiles in cognitively healthy elders: results from a voxel-based [18F]fluorodeoxyglucose-positron-emission tomography study with partial volume effects correction.
Topics: Aged; Aging; Algorithms; Brain; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Male; Positron-Emission Tomography; Radiopharmaceuticals; Reference Values; Reproducibility of Results; Sensitivity and Specificity | 2011 |
Dynamic contrast-enhanced MRI of primary rectal cancer: quantitative correlation with positron emission tomography/computed tomography.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Contrast Media; Female; Fluorodeoxyglucose F18; Heterocyclic Compounds; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Rectal Neoplasms; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
Evaluation of 18FDG PET-CT in the diagnosis of endometriosis: a prospective study.
Topics: Adult; Endometriosis; Female; Fluorodeoxyglucose F18; Humans; Laparoscopy; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Severity of Illness Index; Tomography, X-Ray Computed; Young Adult | 2011 |
Computer-assisted system for diagnosis of Alzheimer disease using data base- independent estimation and fluorodeoxyglucose- positron-emission tomography and 3D-stereotactic surface projection.
Topics: Aged; Algorithms; Alzheimer Disease; Artificial Intelligence; Brain; Cluster Analysis; Computer Graphics; Computer Simulation; Databases, Factual; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Information Storage and Retrieval; Male; Models, Biological; Models, Statistical; Numerical Analysis, Computer-Assisted; Pattern Recognition, Automated; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Signal Processing, Computer-Assisted; Subtraction Technique; User-Computer Interface | 2011 |
The role of dual time point FDG PET imaging in the evaluation of solitary pulmonary nodules with an initial standard uptake value less than 2.5.
Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Solitary Pulmonary Nodule; Surveys and Questionnaires | 2011 |
18F-FLT-PET for detection of rectal cancer.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Male; Middle Aged; Pilot Projects; Positron-Emission Tomography; Rectal Neoplasms; Sensitivity and Specificity; Tomography, X-Ray Computed; Tumor Burden | 2011 |
Clinical value of (18)F-FDG PET/CT in postoperative monitoring for patients with colorectal carcinoma.
Topics: Adolescent; Adult; Aged; Bone Neoplasms; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Monitoring, Physiologic; Neoplasm Recurrence, Local; Peritoneal Neoplasms; Positron-Emission Tomography; Postoperative Care; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2011 |
Comparison of physical examination and fluorodeoxyglucose positron emission tomography/computed tomography 4-6 months after radiotherapy to assess residual head-and-neck cancer.
Topics: Adult; Aged; Aged, 80 and over; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm, Residual; Physical Examination; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Failure; Young Adult | 2011 |
Evaluation of contrast medium enhancement and [(18)F]-FDG uptake of liver metastasis in PET/CT prior to therapy.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2012 |
Potential role of combined FDG PET/CT & contrast enhancement MRI in a rectal carcinoma model with nodal metastases characterized by a poor FDG-avidity.
Topics: Adenocarcinoma; Animals; Contrast Media; Fluorodeoxyglucose F18; HT29 Cells; Humans; Image Enhancement; Lymphatic Metastasis; Magnetic Resonance Imaging; Mice; Mice, Nude; Rectal Neoplasms; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2012 |
A prospective diagnostic accuracy study of F-18 fluorodeoxyglucose-positron emission tomography/computed tomography in the evaluation of indeterminate renal masses.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Papillary; Carcinoma, Renal Cell; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2011 |
Hounsfield units upon PET/CT are useful in evaluating metastatic regional lymph nodes in patients with oesophageal squamous cell carcinoma.
Topics: Aged; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Clinical impact of fluorodeoxyglucose-positron emission tomography scan/computed tomography in comparison with computed tomography on the detection of colorectal cancer recurrence.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
Shortened acquisition protocols for the quantitative assessment of the 2-tissue-compartment model using dynamic PET/CT 18F-FDG studies.
Topics: Algorithms; Computer Simulation; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Models, Biological; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Time Factors; Tomography, X-Ray Computed | 2011 |
Improvement in lesion detection with whole-body oncologic time-of-flight PET.
Topics: Algorithms; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Whole Body Imaging | 2011 |
Intratumor heterogeneity characterized by textural features on baseline 18F-FDG PET images predicts response to concomitant radiochemotherapy in esophageal cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Combined Modality Therapy; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy, Conformal; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome | 2011 |
18F-FDG PET/CT for early response assessment in diffuse large B-cell lymphoma: poor predictive value of international harmonization project interpretation.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Lymphoma, B-Cell; Male; Middle Aged; Positron-Emission Tomography; Prednisone; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome; Vincristine | 2011 |
Preliminary study of 11C-choline PET/CT for T staging of locally advanced nasopharyngeal carcinoma: comparison with 18F-FDG PET/CT.
Topics: Adult; Aged; Carbon Radioisotopes; Choline; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Invasiveness; Neoplasm Staging; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2011 |
Diagnostic value of 18F-FDG-PET/CT in indeterminate infiltrative hepatic lesions in an endemic area of viral hepatitis.
Topics: Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Diagnostic Imaging; Endemic Diseases; Female; Fluorodeoxyglucose F18; Hepatitis, Viral, Human; Humans; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Taiwan; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2011 |
Potential of integrated [18F] fluorodeoxyglucose positron-emission tomography/CT in identifying vulnerable carotid plaques.
Topics: Aged; Carotid Stenosis; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Stroke; Subtraction Technique; Tomography, X-Ray Computed | 2011 |
Fluorodeoxyglucose positron emission tomography fails to detect distant metastases at initial staging of melanoma patients with metastatic involvement of sentinel lymph node.
Topics: Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Melanoma; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Skin Neoplasms | 2011 |
Lymphoscintigraphy in breast cancer patients after neoadjuvant chemotherapy. Diagnostic value and the work-up of sentinel node negative patients.
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Carcinoma; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Sentinel Lymph Node Biopsy | 2011 |
Value of diffusion-weighted imaging in the detection of viable tumour after neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer: comparison with T2 weighted and PET/CT imaging.
Topics: Adult; Aged; Aged, 80 and over; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Positron-Emission Tomography; Radiopharmaceuticals; Rectal Neoplasms; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Detection and characterization of tumor changes in 18F-FDG PET patient monitoring using parametric imaging.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Carcinoma; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Male; Middle Aged; Pattern Recognition, Automated; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Young Adult | 2011 |
Accuracy of 18-fluoro-2-deoxy-D-glucose positron emission tomography in the pretherapeutic detection of occult para-aortic node involvement in patients with a locally advanced cervical carcinoma.
Topics: Adenocarcinoma; Adenocarcinoma, Clear Cell; Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Child; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome; Uterine Cervical Neoplasms; Young Adult | 2011 |
F-18 FDG PET-CT in patients with recurrent glioma: comparison with contrast enhanced MRI.
Topics: Adolescent; Adult; Aged; Biopsy; Brain Neoplasms; Child; Contrast Media; Female; Fluorodeoxyglucose F18; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Grading; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
PET tumor metabolism in locally advanced breast cancer patients undergoing neoadjuvant chemotherapy: value of static versus kinetic measures of fluorodeoxyglucose uptake.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Kinetics; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Outcome Assessment, Health Care; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Survival Analysis | 2011 |
PET-based treatment response evaluation in rectal cancer: prediction and validation.
Topics: Chemoradiotherapy; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Rectal Neoplasms; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed; Tumor Burden | 2012 |
Accuracy of positron emission tomography in mediastinal node assessment in coal workers with lung cancer.
Topics: Adenocarcinoma; Aged; Anthracosis; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Coal; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinoscopy; Mediastinum; Middle Aged; Multimodal Imaging; Neoplasm Staging; Pleural Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Turkey | 2012 |
Utility of ¹⁸F-FDG PET/CT in identifying penile squamous cell carcinoma metastatic lymph nodes.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Multimodal Imaging; Penile Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
FDG-PET-CT and whole-body MRI for triage in patients planned for radioembolisation therapy.
Topics: Adult; Aged; Algorithms; Angiography; Contrast Media; Embolization, Therapeutic; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Image Interpretation, Computer-Assisted; Iohexol; Liver Neoplasms; Magnetic Resonance Imaging; Male; Microspheres; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Software; Technetium Tc 99m Aggregated Albumin; Tomography, X-Ray Computed; Treatment Outcome; Triage; Whole Body Imaging; Yttrium Radioisotopes | 2012 |
FDG-positron emission tomography/computed tomography and standardized uptake value in the primary diagnosis and staging of hilar cholangiocarcinoma.
Topics: Adult; Aged; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Netherlands; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
18F-FDG-PET/CT in the assessment of pancreatic cancer: is the contrast or a better-designed trial needed?
Topics: Biopsy; Contrast Media; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Radiopharmaceuticals; Research Design; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
[The accuracy of FDG-PET/CT in early-stage cervical and vaginal cancers].
Topics: Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Hysterectomy; Lymph Node Excision; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Sensitivity and Specificity; Uterine Cervical Neoplasms; Vaginal Neoplasms; Young Adult | 2011 |
Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT?
Topics: Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prognosis; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed | 2011 |
Clinically unrecognized pulmonary aspiration during gastrointestinal endoscopy with sedation: a potential pitfall interfering the performance of 18F-FDG PET for cancer screening.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia; Artifacts; Endoscopy, Gastrointestinal; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Incidental Findings; Lung Diseases; Male; Mass Screening; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2011 |
Clinical usefulness of dual-time FDG PET-CT in assessment of esophageal squamous cell carcinoma.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2012 |
How to comprehend the meaning of ADC value on DWI sequence.
Topics: Aged; Aged, 80 and over; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Systems Integration; Tomography, X-Ray Computed | 2012 |
Reply to: Use of FDG PET/CT for peritoneal carcinomatosis before hyperthermic intraperitoneal chemotherapy: some considerations.
Topics: Fluorodeoxyglucose F18; Humans; Hyperthermia, Induced; Peritoneal Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
Combined [18F]fluorodeoxyglucose positron emission tomography and computed tomography for detecting contralateral neck metastases in patients with head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
Diffusion-weighted magnetic resonance for pulmonary nodules: 1.5 vs. 3 Tesla.
Topics: Diagnosis, Differential; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Humans; Japan; Lung Diseases; Lung Neoplasms; Multiple Pulmonary Nodules; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Solitary Pulmonary Nodule; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
Evaluation of ¹⁸F-FDG-PET for early detection of suboptimal response of rectal cancer to preoperative chemoradiotherapy: a prospective analysis.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Humans; Leucovorin; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Rectal Neoplasms; Sensitivity and Specificity; Survival Rate; Treatment Outcome | 2011 |
The assessment of breast cancer response to neoadjuvant chemotherapy: comparison of magnetic resonance imaging and 18F-fluorodeoxyglucose positron emission tomography.
Topics: Adult; Aged; Breast; Breast Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Image Enhancement; Magnetic Resonance Imaging; Middle Aged; Neoadjuvant Therapy; Observer Variation; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Treatment Outcome | 2011 |
Regional nodal staging with 18F-FDG PET-CT in non-small cell lung cancer: Additional diagnostic value of CT attenuation and dual-time-point imaging.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Respiratory-gated 18F-FDG PET imaging in lung cancer: effects on sensitivity and specificity.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multiple Pulmonary Nodules; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Respiration; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
Novel handheld PET probes provide intraoperative localization of PET-avid lymph nodes.
Topics: Animals; Fluorodeoxyglucose F18; Lymph Nodes; Lymphatic Metastasis; Mesothelioma; Positron-Emission Tomography; Predictive Value of Tests; Radiography; Radiopharmaceuticals; Rats; Rats, Nude; ROC Curve; Sensitivity and Specificity; Transplantation, Heterologous | 2011 |
Determining the extent and stage of disease in patients with newly diagnosed non-Hodgkin's lymphoma using 18F-FDG-PET/CT.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
Value of [18F] fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in diagnosis and localization of Cushing's disease.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Pituitary ACTH Hypersecretion; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2011 |
Prognostic value of preoperative FDG-PET in stage IA lung adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2012 |
Quantification of supra-aortic arterial wall inflammation in patients with arteritis using high resolution dynamic contrast-enhanced magnetic resonance imaging: initial results in correlation to [18F]-FDG PET/CT.
Topics: Aged; Arteritis; C-Reactive Protein; Carotid Arteries; Confidence Intervals; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity; Statistics, Nonparametric; Tomography, X-Ray Computed; Vertebral Artery | 2011 |
Gadoxetate disodium-enhanced magnetic resonance imaging versus contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of colorectal liver metastases.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Statistics as Topic; Tomography, X-Ray Computed | 2011 |
Accuracy of FDG-PET to diagnose lung cancer in a region of endemic granulomatous disease.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Diagnosis, Differential; Endemic Diseases; Female; Fluorodeoxyglucose F18; Granuloma; Humans; Likelihood Functions; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tennessee | 2011 |
Anatomical accuracy of abdominal lesion localization. Retrospective automatic rigid image registration between FDG-PET and MRI.
Topics: Abdominal Neoplasms; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Subtraction Technique | 2011 |
Metabolic tumour volume. Prognostic value in locally advanced squamous cell carcinoma of the head and neck.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Imaging, Three-Dimensional; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2011 |
Diagnostic performance of contrast enhanced CT and 18F-FDG PET/CT in suspicious recurrence of biliary tract cancer after curative resection.
Topics: Adult; Aged; Biliary Tract Neoplasms; Biomarkers, Tumor; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
Histopathological correlation of (11)C-choline PET scans for target volume definition in radical prostate radiotherapy.
Topics: Aged; Analysis of Variance; Choline; Combined Modality Therapy; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prostatectomy; Prostatic Neoplasms; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
Initial staging of the neck in head and neck squamous cell carcinoma: a comparison of CT, PET/CT, and ultrasound-guided fine-needle aspiration cytology.
Topics: Adult; Aged; Aged, 80 and over; Biopsy, Fine-Needle; Carcinoma, Squamous Cell; Cohort Studies; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Immunohistochemistry; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neck; Neck Dissection; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography | 2012 |
Prognostic value of fluorine-18 fluorodeoxyglucose positron-emission tomography imaging in patients with head and neck squamous cell carcinoma.
Topics: Aged; Analysis of Variance; Biopsy, Needle; Carcinoma, Squamous Cell; Cohort Studies; Disease Progression; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Male; Middle Aged; Multimodal Imaging; Multivariate Analysis; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Statistics, Nonparametric; Survival Analysis; Tomography, X-Ray Computed | 2012 |
The peak-standardized uptake value (P-SUV) by preoperative positron emission tomography-computed tomography (PET-CT) is a useful indicator of lymph node metastasis in gastric cancer.
Topics: Adenocarcinoma; Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gastrectomy; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Stomach Neoplasms; Survival Rate; Tomography, X-Ray Computed | 2011 |
Predictive value of F-18 FDG PET/CT for malignant pleural effusion in non-small cell lung cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Pleural Effusion; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2011 |
A comparative study of fused FDG PET/MRI, PET/CT, MRI, and CT imaging for assessing surrounding tissue invasion of advanced buccal squamous cell carcinoma.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Demography; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Mouth Neoplasms; Neoplasm Invasiveness; Neoplasm Staging; Observer Variation; Positron-Emission Tomography; Predictive Value of Tests; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
Patterns of extracranial involvement in newly diagnosed giant cell arteritis assessed by physical examination, colour coded duplex sonography and FDG-PET.
Topics: Aged; Aged, 80 and over; Case-Control Studies; Extremities; Female; Fluorodeoxyglucose F18; Germany; Giant Cell Arteritis; Humans; Male; Middle Aged; Physical Examination; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Ultrasonography, Doppler, Color | 2011 |
Is positron emission tomography reliable to predict post-chemotherapy retroperitoneal lymph node involvement in advanced germ cell tumors of the testis?
Topics: Adult; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retroperitoneal Space; Sensitivity and Specificity; Testicular Neoplasms; Young Adult | 2011 |
Fluorodeoxyglucose-positron-emission tomography findings in mantle cell lymphoma.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Mantle-Cell; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiography; Sensitivity and Specificity | 2011 |
The value of (18)F-FDG PET/CT for the detection of distant metastases in high-risk patients with head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, Spiral Computed | 2011 |
Efficacy of fluoro-2-deoxy-D-glucose positron emission tomography to evaluate responses to concurrent chemoradiotherapy for head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2011 |
Can sequential 18F-FDG PET/CT replace WBC imaging in the diabetic foot?
Topics: Aged; Aged, 80 and over; Diabetic Foot; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Leukocytes; Male; Middle Aged; Osteomyelitis; Positron-Emission Tomography; Sensitivity and Specificity; Soft Tissue Infections; Technetium Tc 99m Exametazime; Time Factors; Tomography, X-Ray Computed | 2011 |
Evaluation of optimal acquisition duration or injected activity for pediatric 18F-FDG PET/CT.
Topics: Adolescent; Body Weight; Child; Child, Preschool; Fluorodeoxyglucose F18; Humans; Infant; Injections; Male; Neoplasms; Positron-Emission Tomography; Radiation Dosage; Sensitivity and Specificity; Time Factors; Tomography, X-Ray Computed; Young Adult | 2011 |
Can positron emission tomography with the dual tracers [11 C]acetate and [18 F]fludeoxyglucose predict microvascular invasion in hepatocellular carcinoma?
Topics: Acetates; Adult; Aged; Aged, 80 and over; Carbon; Carcinoma, Hepatocellular; Chi-Square Distribution; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Hepatectomy; Hong Kong; Humans; Liver Neoplasms; Liver Transplantation; Male; Microvessels; Middle Aged; Neoplasm Invasiveness; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Survival Analysis; Survival Rate; Time Factors; Treatment Outcome | 2011 |
Is mediastinoscopy still the gold standard to evaluate mediastinal lymph nodes in patients with non-small cell lung carcinoma?
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinoscopy; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome; Turkey | 2012 |
Effect of illiteracy on neuropsychological tests and glucose metabolism of brain in later life.
Topics: Aged; Brain; Cognition; Educational Status; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Neuropsychological Tests; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2012 |
Adrenal masses in patients with cancer: PET/CT characterization with combined CT histogram and standardized uptake value PET analysis.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Algorithms; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2011 |
Dual-modality brain PET-CT image segmentation based on adaptive use of functional and anatomical information.
Topics: Adolescent; Adult; Aged; Algorithms; Brain; Brain Neoplasms; Child; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Male; Middle Aged; Pattern Recognition, Automated; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed; Young Adult | 2012 |
Multimodality approach in cryptogenic epilepsy with focus on morphometric 3T MRI.
Topics: Adolescent; Adult; Algorithms; Contrast Media; Electroencephalography; Epilepsy; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Magnetoencephalography; Male; Middle Aged; Neuroimaging; Radiopharmaceuticals; Sensitivity and Specificity; Software; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2012 |
Preoperative risk stratification using (18)F-FDG PET/CT in women with endometrial cancer.
Topics: Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Preoperative Care; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2011 |
Detecting the recurrence of gastric cancer after curative resection: comparison of FDG PET/CT and contrast-enhanced abdominal CT.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Stomach Neoplasms; Tomography, X-Ray Computed | 2011 |
Can fluorodeoxyglucose positron emission tomography/computed tomography avoid negative iliac crest biopsies in evaluation of marrow involvement by lymphoma at time of initial staging?
Topics: Algorithms; Biopsy; Bone Marrow; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Ilium; Lymphoma, Non-Hodgkin; Male; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
Clinical significance of primary lesion FDG uptake for choice between oesophagectomy and endoscopic submucosal dissection for resectable oesophageal squamous cell carcinomas.
Topics: Aged; Endoscopy; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Humans; Male; Medical Oncology; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography | 2011 |
Comparison of clinical and surgical-pathological staging in IIIA non-small cell lung cancer patients.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Mediastinoscopy; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
The impact of ¹⁸F-fluorodeoxyglucose positron emission tomography positive lymph nodes on postoperative recurrence and survival in resectable thoracic esophageal squamous cell carcinoma.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Postoperative Period; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Survival Rate; Thoracic Neoplasms | 2012 |
Comparison of diagnostic and prognostic capabilities of ¹⁸F-FDG-PET/CT, ¹³¹I-scintigraphy, and diffusion-weighted magnetic resonance imaging for postoperative thyroid cancer.
Topics: Adenocarcinoma, Follicular; Adenocarcinoma, Papillary; Adult; Aged; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed | 2011 |
The role of PET and PET/CT in managing the care of lymphoma patients.
Topics: Adult; Citrates; Female; Fluorodeoxyglucose F18; Gallium; Humans; Lymphoma; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Remission Induction; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
Metabolism-perfusion imaging to predict disease activity in cardiac sarcoidosis.
Topics: Cardiomyopathies; Diagnosis, Differential; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Myocardium; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis; Sensitivity and Specificity; Severity of Illness Index | 2011 |
Performance of 18F-FDG PET/contrast-enhanced CT in the staging of squamous cell carcinoma of the oral cavity and oropharynx.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Mouth Neoplasms; Multimodal Imaging; Neoplasm Staging; Oropharyngeal Neoplasms; Positron-Emission Tomography; Radiographic Image Enhancement; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
[18F]Fluorodeoxyglucose positron emission tomography for detection of bone marrow involvement in children and adolescents with Hodgkin's lymphoma.
Topics: Adolescent; Biopsy; Bone Marrow Neoplasms; Child; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Neoplasm Staging; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity | 2011 |
Impact of PET-CT on involved field radiotherapy design for pediatric Hodgkin lymphoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Adjuvant; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2012 |
Dual-time-point (18)F-FDG-PET/CT imaging in the assessment of suspected malignancy.
Topics: Adult; Aged; Aged, 80 and over; Chi-Square Distribution; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Multimodal Imaging; Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2011 |
Comparison of diffusion-weighted MR imaging and FDG PET/CT to predict pathological complete response to neoadjuvant chemotherapy in patients with breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neoadjuvant Therapy; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Remission Induction; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2012 |
Relationship between serum thyroglobulin and 18FDG-PET/CT in 131I-negative differentiated thyroid carcinomas.
Topics: Adenocarcinoma, Follicular; Adult; Aged; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Tomography, X-Ray Computed; Young Adult | 2012 |
Impact of [¹⁸F]FDG PET imaging parameters on automatic tumour delineation: need for improved tumour delineation methodology.
Topics: Algorithms; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Neoplasms; Pattern Recognition, Automated; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2011 |
Whole-body diffusion-weighted imaging: the added value to whole-body MRI at initial diagnosis of lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Chi-Square Distribution; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Lymphoma; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2011 |
Clinical value of integrated [18F]fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in the preoperative assessment of papillary thyroid carcinoma: comparison with sonography.
Topics: Adult; Aged; Carcinoma; Carcinoma, Papillary; Chi-Square Distribution; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Preoperative Period; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Cancer, Papillary; Thyroid Neoplasms; Tomography, X-Ray Computed; Ultrasonography | 2011 |
The role of the ¹⁸f-fluorodeoxyglucose-positron emission tomography scan in the Nederlands Leuvens Longkanker screenings Onderzoek lung cancer screening trial.
Topics: Adenocarcinoma; Aged; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Mass Screening; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prognosis; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Small Cell Lung Carcinoma; Survival Rate | 2011 |
Is liver SUV stable over time in ¹⁸F-FDG PET imaging?
Topics: Adult; Aged; Aged, 80 and over; Computer Simulation; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Liver; Male; Middle Aged; Models, Biological; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2011 |
The value of F-18 FDG PET in patients with primary sclerosing cholangitis and cholangiocarcinoma using visual and semiquantitative analysis.
Topics: Adult; Aged; Aged, 80 and over; Cholangiocarcinoma; Cholangitis, Sclerosing; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiography; ROC Curve; Sensitivity and Specificity; Whole Body Imaging | 2011 |
MR-PET fusion imaging in evaluating adnexal lesions: a preliminary study.
Topics: Adnexal Diseases; Adult; Aged; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2011 |
Inflammatory activity assessment by F18 FDG-PET/CT in persistent symptomatic sarcoidosis.
Topics: Adult; Aged; Biomarkers; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Lung Diseases; Male; Middle Aged; Multimodal Imaging; Neopterin; Netherlands; Peptidyl-Dipeptidase A; Positron-Emission Tomography; Predictive Value of Tests; Quality of Life; Radiopharmaceuticals; Receptors, Interleukin-2; Reproducibility of Results; Retrospective Studies; Sarcoidosis; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging; Young Adult | 2011 |
The use of dual-phase 18F-FDG PET in characterizing thyroid incidentalomas.
Topics: Adult; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Precancerous Conditions; Predictive Value of Tests; Prevalence; Radiopharmaceuticals; Retrospective Studies; Risk Assessment; ROC Curve; Sensitivity and Specificity; Thyroid Neoplasms; Thyroid Nodule; Tomography, X-Ray Computed | 2011 |
Role of combined DWIBS/3D-CE-T1w whole-body MRI in tumor staging: Comparison with PET-CT.
Topics: Adult; Aged; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2012 |
PET imaging may provide a novel biomarker and understanding of right ventricular dysfunction in patients with idiopathic pulmonary arterial hypertension.
Topics: Adolescent; Adult; Biomarkers; Cohort Studies; Contrast Media; Diagnostic Imaging; Disease Progression; Echocardiography, Doppler, Color; Electrocardiography; Familial Primary Pulmonary Hypertension; Female; Fluorodeoxyglucose F18; Humans; Hypertension, Pulmonary; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Retrospective Studies; Sensitivity and Specificity; Severity of Illness Index; Survival Rate; Ventricular Dysfunction, Right; Young Adult | 2011 |
N stage disease in patients with non-small cell lung cancer: efficacy of quantitative and qualitative assessment with STIR turbo spin-echo imaging, diffusion-weighted MR imaging, and fluorodeoxyglucose PET/CT.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
Prognostic value of [18F]-fluoro-deoxy-glucose PET/CT, S100 or MIA for assessment of cancer-associated mortality in patients with high risk melanoma.
Topics: Adult; Aged; Aged, 80 and over; Extracellular Matrix Proteins; Female; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Middle Aged; Neoplasm Proteins; Positron-Emission Tomography; Retrospective Studies; S100 Proteins; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
18F-FDG PET/CT as a staging procedure in primary stage II and III breast cancer: comparison with conventional imaging techniques.
Topics: Adult; Aged; Breast Neoplasms; Diagnostic Imaging; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2012 |
The value of 18-FDG PET/CT in early-stage breast cancer compared to traditional diagnostic modalities with an emphasis on changes in disease stage designation and treatment plan.
Topics: Adult; Aged; Axilla; Breast Neoplasms; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Hungary; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Use of 18F-FDG PET/CT as a predictive biomarker of outcome in patients with head-and-neck non-squamous cell carcinoma.
Topics: Biomarkers, Tumor; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed; Triiodobenzoic Acids | 2011 |
Patterns of pulmonary tuberculosis on FDG-PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Tuberculosis, Pulmonary | 2012 |
Impact of ¹⁸F-FDG PET/CT for detecting recurrence of medullary thyroid carcinoma.
Topics: Adult; Aged; Calcitonin; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Humans; Lung; Lymph Nodes; Male; Mediastinum; Middle Aged; Multimodal Imaging; Neck; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Retrospective Studies; Sensitivity and Specificity; Thyroid Gland; Thyroid Neoplasms; Tomography, X-Ray Computed; Young Adult | 2011 |
Correlation of measurements from diffusion weighted MR imaging and FDG PET/CT in GIST patients: ADC versus SUV.
Topics: Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Tomography, X-Ray Computed | 2012 |
The clinical value of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in postoperative patients with gastrointestinal mucinous adenocarcinoma.
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gastrointestinal Neoplasms; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Peritoneum; Positron-Emission Tomography; Postoperative Period; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
18F-FDG PET-CT and USG/CT in benign and malignant ovarian tumors with postoperative histopathological correlation.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Staging; Ovarian Diseases; Ovarian Neoplasms; Poland; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography, Doppler, Color | 2011 |
The role of integrated F-18-FDG-PET scanning in the detection of M1 disease in oesophageal adenocarcinoma and impact on clinical management.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Colonic Neoplasms; Combined Modality Therapy; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Positron-Emission Tomography; Prostatic Neoplasms; Sensitivity and Specificity | 2011 |
A preliminary report on the impact of ¹⁸F-FDG PET/CT in the management of paediatric head and neck cancer.
Topics: Adolescent; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Pediatrics; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Evaluation of mouse tail-vein injections both qualitatively and quantitatively on small-animal PET tail scans.
Topics: Animals; Fluorodeoxyglucose F18; Injections, Intravenous; Mice; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tail; Whole Body Imaging | 2011 |
Comparison of FDG-PET/CT and bone scintigraphy for detection of bone metastases in breast cancer.
Topics: Adult; Aged; Bone and Bones; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2011 |
Diagnostic accuracy of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in differentiated thyroid cancer patients with elevated thyroglobulin and negative (131)I whole body scan: evaluation by thyroglobulin level.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Recurrence; Retrospective Studies; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Tomography, X-Ray Computed; Whole Body Imaging | 2012 |
Detectability of colorectal neoplasia with fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Colonoscopy; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2012 |
Diagnostic sensitivity of ¹⁸fluorodeoxyglucose positron emission tomography for detecting synchronous multiple primary cancers in head and neck cancer patients.
Topics: Early Diagnosis; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Staging; Neoplasms, Multiple Primary; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity | 2012 |
[Usefulness of 18F-FDG PET/CT examination in the diagnosis of head and neck cancer--preliminary results].
Topics: Adult; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Poland; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2011 |
High-resolution imaging of human atherosclerotic carotid plaques with micro 18F-FDG PET scanning exploring plaque vulnerability.
Topics: Aged; Aged, 80 and over; Carotid Stenosis; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2011 |
Can (18)F-FDG-PET/CT be generally recommended in patients with differentiated thyroid carcinoma and elevated thyroglobulin levels but negative I-131 whole body scan?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Multimodal Imaging; Neck; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Tomography, X-Ray Computed; Ultrasonography; Whole Body Imaging; Young Adult | 2012 |
[Indications for the use of PET or PET/CT in patients with breast cancer].
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2011 |
Stage-dependent agreement between cerebrospinal fluid proteins and FDG-PET findings in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Apolipoprotein E4; Area Under Curve; Biomarkers; Cerebrospinal Fluid Proteins; Cognition Disorders; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neuropsychological Tests; Peptide Fragments; Positron-Emission Tomography; Psychiatric Status Rating Scales; Retrospective Studies; Sensitivity and Specificity; tau Proteins | 2012 |
Evaluation of PET volume segmentation methods: comparisons with expert manual delineations.
Topics: Algorithms; Fluorodeoxyglucose F18; Fuzzy Logic; Humans; Image Processing, Computer-Assisted; Lymphoma, Non-Hodgkin; Observer Variation; Pattern Recognition, Automated; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2012 |
18F-FDG uptake on PET in primary mediastinal non-thymic neoplasm: a clinicopathological study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Mediastinal Neoplasms; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thymus Neoplasms; Tissue Distribution; Young Adult | 2012 |
FDG-PET/CT in the diagnosis of recurrent breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
The impact of 18F-FDG PET on the management of patients with suspected large vessel vasculitis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arteritis; Case-Control Studies; Female; Fluorodeoxyglucose F18; Humans; Immunosuppressive Agents; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Regression Analysis; Reproducibility of Results; Rheumatology; Sensitivity and Specificity; Takayasu Arteritis; Vasculitis | 2012 |
Experiences with citrate rather than heparin as an anticoagulant for ¹⁸F-FDG labeling of leukocytes.
Topics: Anticoagulants; Cells, Cultured; Citric Acid; Fluorodeoxyglucose F18; Heparin; Humans; Image Enhancement; Isotope Labeling; Leukocytes; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity | 2011 |
Comparison of International Consensus Guidelines versus 18-FDG PET in detecting malignancy of intraductal papillary mucinous neoplasms of the pancreas.
Topics: Adenocarcinoma, Mucinous; Adenocarcinoma, Papillary; Adult; Aged; Aged, 80 and over; Biopsy; Carcinoma, Pancreatic Ductal; Contrast Media; Female; Fluorodeoxyglucose F18; Guideline Adherence; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Multidetector Computed Tomography; Pancreas; Pancreatic Neoplasms; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
Does ¹⁸F-FDG uptake by respiratory muscles on PET/CT correlate with chronic obstructive pulmonary disease?
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Pulmonary Disease, Chronic Obstructive; Reproducibility of Results; Respiratory Muscles; Sensitivity and Specificity; Statistics as Topic; Tomography, X-Ray Computed | 2011 |
Mediastinal lymph nodes staging by 18F-FDG PET/CT for early stage non-small cell lung cancer: a multicenter study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Characterization of adrenal metastatic cancer using FDG PET/CT.
Topics: Adrenal Gland Neoplasms; Adrenal Glands; Aged; Carcinoma; China; Cohort Studies; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Hyperplasia; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Risk; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Design considerations for using PET as a response measure in single site and multicenter clinical trials.
Topics: Endpoint Determination; Fluorodeoxyglucose F18; Humans; Multicenter Studies as Topic; Positron-Emission Tomography; Radiopharmaceuticals; Randomized Controlled Trials as Topic; Reproducibility of Results; Research Design; Sample Size; Sensitivity and Specificity | 2012 |
Role of FDG PET-CT in detecting recurrence in patients with uterine sarcoma: comparison with conventional imaging.
Topics: Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sarcoma; Sensitivity and Specificity; Tomography, X-Ray Computed; Uterine Neoplasms | 2012 |
Dynamic PET-CT studies for characterizing nasopharyngeal carcinoma metabolism: comparison of analytical methods.
Topics: Adult; Aged; Algorithms; Blood Glucose; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Serial FDG-PET/CT for early outcome prediction in patients with metastatic colorectal cancer undergoing chemotherapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multimodal Imaging; Multivariate Analysis; Neoplasm Metastasis; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome; Whole Body Imaging; Young Adult | 2012 |
90Y-PET for the assessment of microsphere biodistribution after selective internal radiotherapy.
Topics: Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Liver; Liver Neoplasms; Male; Microspheres; Middle Aged; Organotechnetium Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Yttrium Radioisotopes | 2012 |
Preoperative 18F-FDG uptake is strongly correlated with malignancy, Weiss score, and molecular markers of aggressiveness in adrenal cortical tumors.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2012 |
18F-FDG PET/CT compared to conventional imaging modalities in pediatric primary bone tumors.
Topics: Adolescent; Australia; Bone Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Infant; Male; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Is there a need for dedicated bone imaging in addition to 18F-FDG PET/CT imaging in pediatric sarcoma patients?
Topics: Adolescent; Bone Neoplasms; Child; Child, Preschool; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Multimodal Imaging; Positron-Emission Tomography; Radionuclide Imaging; Retrospective Studies; Sarcoma; Sensitivity and Specificity; Soft Tissue Neoplasms; Technetium Tc 99m Medronate; Tomography, X-Ray Computed | 2012 |
Imaging characteristics of extrapulmonary tuberculosis lesions on dual time point imaging (DTPI) of FDG PET/CT.
Topics: Adolescent; Adult; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed; Tuberculosis; Tuberculosis, Pulmonary; Young Adult | 2011 |
Prognostic value of the quantitative metabolic volumetric measurement on 18F-FDG PET/CT in Stage IV nonsurgical small-cell lung cancer.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Illinois; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Survival Analysis; Survival Rate; Tomography, X-Ray Computed | 2012 |
Utility of 8F-FDG PET/CT in well differentiated thyroid carcinoma with high serum antithyroglobulin antibody.
Topics: Adenocarcinoma; Adult; Autoantibodies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Injections, Intravenous; Iodine Radioisotopes; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed; Whole Body Imaging | 2011 |
The role of 18FDG PET/CT in the management of colorectal liver metastases.
Topics: Adult; Aged; Colorectal Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hepatectomy; Humans; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
The role of myocardial viability assessed by perfusion/F-18 FDG imaging in children with anomalous origin of the left coronary artery from the pulmonary artery.
Topics: Arterio-Arterial Fistula; Child; Child, Preschool; Coronary Vessel Anomalies; Coronary Vessels; Female; Fluorodeoxyglucose F18; Humans; Infant; Male; Myocardial Perfusion Imaging; Myocardial Stunning; Pulmonary Artery; Radiography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2012 |
Utility of F-18 FDG PET/CT in screening for paraneoplastic neurological syndromes.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Mass Screening; Paraneoplastic Syndromes, Nervous System; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Relationship among glycolytic phenotype, grade, and histological subtype in ovarian carcinoma.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Reduced septal glucose metabolism predicts response to cardiac resynchronization therapy.
Topics: Aged; Cardiac Resynchronization Therapy; Cardiomyopathies; Female; Fluorodeoxyglucose F18; Heart Septum; Humans; Male; Patient Selection; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome | 2012 |
Diagnostic value of positron emission tomography combined with computed tomography for evaluating patients with septic shock of unknown origin.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Intensive Care Units; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Shock, Septic; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Prediction of chemotherapy response by PET-CT in osteosarcoma: correlation with histologic necrosis.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Necrosis; Neoadjuvant Therapy; Osteosarcoma; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2011 |
Diffusion-weighted MRI versus 18F-FDG PET/CT: performance as predictors of tumor treatment response and patient survival in patients with non-small cell lung cancer receiving chemoradiotherapy.
Topics: Adult; Aged; Biopsy; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Contrast Media; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Diffusion weighted MRI and 18F-FDG PET/CT in non-small cell lung cancer (NSCLC): does the apparent diffusion coefficient (ADC) correlate with tracer uptake (SUV)?
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Metabolic Clearance Rate; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
MR imaging versus PET/CT for evaluation of pancreatic lesions.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Observer Variation; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Automatic detection and classification of nasopharyngeal carcinoma on PET/CT with support vector machine.
Topics: Contrast Media; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Multimodal Imaging; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Support Vector Machine; Tomography, X-Ray Computed | 2012 |
Clinical utility of ¹⁸F FDG-PET/CT in the detection of bone marrow disease in Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Bone Marrow Neoplasms; Child; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2012 |
Utility of 18F-fluorodeoxyglucose positron emission tomography for distinguishing between the histological types of early stage thymic epithelial tumours.
Topics: Adult; Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Thymectomy; Thymus Neoplasms; Tomography, X-Ray Computed | 2012 |
Detection of metastatic bone lesions in breast cancer patients: fused (18)F-Fluoride-PET/MDCT has higher accuracy than MDCT. Preliminary experience.
Topics: Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
¹⁸F-Fluorodeoxyglucose positron emission tomography/computed tomography finds answers in cancer patients with increasing tumor markers and negative or equivocal conventional imaging modalities.
Topics: Adult; Aged; Biomarkers, Tumor; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2012 |
The value of PET/CT to assess clinically negative necks.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Multimodal Imaging; Neck; Neck Dissection; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2012 |
Predictive value of positron emission tomography-computed tomography image fusion in the diagnosis of head and neck cancer: does it really improve staging and management?
Topics: Biopsy; Carcinoma; Clinical Competence; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Incidental Findings; Lymphatic Metastasis; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Unknown Primary; Observer Variation; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
[Positron emission tomography in the diagnosis and monitoring of patients with nonseminomatous germ cell tumours].
Topics: Fluorodeoxyglucose F18; Humans; Male; Neoplasms, Germ Cell and Embryonal; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Testicular Neoplasms | 2011 |
Is (18)F-fluorodeoxyglucose-PET/CT useful for the presurgical characterization of thyroid nodules with indeterminate fine needle aspiration cytology?
Topics: Adenocarcinoma, Follicular; Adult; Aged; Biopsy, Fine-Needle; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Sensitivity and Specificity; Thyroid Neoplasms; Thyroid Nodule; Tomography, X-Ray Computed; Ultrasonography | 2012 |
Mammography and ultrasonography evaluation of unexpected focal 18F-FDG uptakes in breast on PET/CT.
Topics: Adult; Breast; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Mammography; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography, Mammary | 2012 |
The method and efficacy of 18F-fluorodeoxyglucose positron emission tomography/computed tomography for diagnosing the lymphatic metastasis of colorectal carcinoma.
Topics: Adult; Aged; Carcinoma; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Subtraction Technique; Tomography, X-Ray Computed | 2012 |
Delineation of FDG-PET tumors from heterogeneous background using spectral clustering.
Topics: Algorithms; Artifacts; Artificial Intelligence; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Neoplasms; Pattern Recognition, Automated; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2012 |
Comparison of 3'-deoxy-3'-[¹⁸F]fluorothymidine positron emission tomography (FLT PET) and FDG PET/CT for the detection and characterization of pancreatic tumours.
Topics: Adult; Aged; Aged, 80 and over; Cohort Studies; Contrast Media; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Lymph node metastasis diagnosis using positron emission tomography with 2-[18F] fluoro-2-deoxy-D-glucose as a tracer and computed tomography in surgical cases of non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Pneumonectomy; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Semiquantitative analysis of maximum standardized uptake values of regional lymph nodes in inflammatory breast cancer: is there a reliable threshold for differentiating benign from malignant?
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reference Values; Reproducibility of Results; Sensitivity and Specificity | 2012 |
Targeted lymph node biopsy in mediastinoscopy using 3D FDG-PET/CT movies: a feasibility study.
Topics: Aged; Biopsy; Carcinoma, Non-Small-Cell Lung; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Lung Neoplasms; Lymph Nodes; Male; Mediastinoscopy; Mediastinum; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Surgery, Computer-Assisted; Tomography, X-Ray Computed | 2012 |
Role of [18F]-FDG-PET/MDCT in evaluating early response in patients with Hodgkin's lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome; Vinblastine | 2012 |
Quantification of Kryptofix 2.2.2 in [18F]fluorine-labelled radiopharmaceuticals by rapid-resolution liquid chromatography.
Topics: Bridged Bicyclo Compounds, Heterocyclic; Chromatography, High Pressure Liquid; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2012 |
Clinical utility of F-18 FDG PET/CT in recurrent breast carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2012 |
Oestrogen-related tumour phenotype: positron emission tomography characterisation with ¹⁸F-FDG and ¹⁸F-FES.
Topics: Aged; Breast Neoplasms; Contrast Media; Endometrial Neoplasms; Estrogens; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Middle Aged; Neoplasms, Hormone-Dependent; Phenotype; Positron-Emission Tomography; Sensitivity and Specificity | 2012 |
Preoperative PET/CT in early-stage breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Diagnostic value of PET/CT is similar to that of conventional MRI and even better for detecting small peritoneal implants in patients with recurrent ovarian cancer.
Topics: Abdominal Neoplasms; Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Ovarian Neoplasms; Pelvic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Pediatric nonlymphoblastic non-Hodgkin lymphoma: baseline, interim, and posttreatment PET/CT versus contrast-enhanced CT for evaluation--a prospective study.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Contrast Media; Diatrizoate; Female; Fluorodeoxyglucose F18; Humans; Iopamidol; Kaplan-Meier Estimate; Lymphoma, Non-Hodgkin; Male; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Accuracy and predictive features of FDG-PET/CT and CT for diagnosis of lymph node metastasis of T1 non-small-cell lung cancer manifesting as a subsolid nodule.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Comparison of FDG-PET/CT and MR with diffusion-weighted imaging for assessing peritoneal carcinomatosis from gastrointestinal malignancy.
Topics: Adult; Aged; Aged, 80 and over; Diffusion Magnetic Resonance Imaging; Early Diagnosis; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2012 |
The role of 18F-FDG PET/CT in detecting colorectal cancer recurrence in patients with elevated CEA levels.
Topics: Aged; Carcinoembryonic Antigen; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2012 |
Superiority of 18F-FDG PET compared to 111In-labelled leucocyte scintigraphy in the evaluation of fever of unknown origin.
Topics: Adult; Aged; Aged, 80 and over; Female; Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Indium Radioisotopes; Male; Middle Aged; Parvovirus; Positron-Emission Tomography; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Staining and Labeling | 2012 |
Solitary pulmonary nodules differentiated by dynamic F-18 FDG PET in a region with high prevalence of granulomatous disease.
Topics: Adult; Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Granuloma; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Solitary Pulmonary Nodule | 2012 |
Improved imaging of intrahepatic colorectal metastases with 18F-fluorodeoxyglucose respiratory-gated positron emission tomography.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Respiratory-Gated Imaging Techniques; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Whole-body FDG PET/CT is more accurate than conventional imaging for staging primary breast cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2012 |
Reproducibility and accuracy of non-invasive measurement of infarct size in mice with high-resolution PET/CT.
Topics: Algorithms; Animals; Female; Fluorodeoxyglucose F18; Image Enhancement; Image Interpretation, Computer-Assisted; Male; Mice; Mice, Inbred C57BL; Multimodal Imaging; Myocardial Infarction; Pattern Recognition, Automated; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
FDG-PET/CT-based gross tumor volume contouring for radiation therapy planning: an experimental phantom study.
Topics: Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Neoplasms; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Image-Guided; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed; Tumor Burden | 2012 |
Head and neck incidentalomas on positron emission tomographic scanning: ignore or investigate?
Topics: Adult; Aged; Aged, 80 and over; Cooperative Behavior; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Incidental Findings; Interdisciplinary Communication; Male; Middle Aged; Multimodal Imaging; Otorhinolaryngologic Neoplasms; Positron-Emission Tomography; Referral and Consultation; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2011 |
Cost-effectiveness of positron emission tomography/computed tomography in the management of advanced head and neck cancer.
Topics: Aged; Alberta; Carcinoma, Squamous Cell; Cohort Studies; Contrast Media; Cost-Benefit Analysis; Disease Progression; Female; Fluorodeoxyglucose F18; Hospital Costs; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Otorhinolaryngologic Neoplasms; Palliative Care; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2011 |
Neoadjuvant chemotherapy in breast cancer: prediction of pathologic response with PET/CT and dynamic contrast-enhanced MR imaging--prospective assessment.
Topics: Adult; Aged; Analysis of Variance; Area Under Curve; Biopsy, Needle; Breast Neoplasms; Contrast Media; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Logistic Models; Magnetic Resonance Imaging; Microcirculation; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Correlations between SUVmax and expression of GLUT1 and growth factors inducing lymphangiogenesis.
Topics: Aged; Carcinoma; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Intercellular Signaling Peptides and Proteins; Lymphangiogenesis; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Subtraction Technique; Tomography, X-Ray Computed | 2012 |
Clinical value of whole body fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in the detection of metastatic bladder cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma; Carcinoma, Small Cell; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiographic Image Interpretation, Computer-Assisted; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Urinary Bladder Neoplasms | 2012 |
Node/aorta and node/liver SUV ratios from (18)F-FDG PET/CT may improve the detection of occult mediastinal lymph node metastases in patients with non-small cell lung carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Aorta; Aortography; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Liver; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Carotid plaque inflammation on 18F-fluorodeoxyglucose positron emission tomography predicts early stroke recurrence.
Topics: Aged; Carotid Stenosis; Early Diagnosis; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Inflammation; Male; Multimodal Imaging; Plaque, Atherosclerotic; Positron-Emission Tomography; Proportional Hazards Models; Radiopharmaceuticals; Recurrence; ROC Curve; Sensitivity and Specificity; Stroke; Tomography, X-Ray Computed | 2012 |
18F-2-deoxy-2-fluoro-D-glucose positron emission tomography, computed tomography, and magnetic resonance imaging for the detection of experimental colorectal liver metastases.
Topics: Animals; Artifacts; Colorectal Neoplasms; Fluorodeoxyglucose F18; Image Processing, Computer-Assisted; Liver Neoplasms; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Rats; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Semi-automatic analysis of standard uptake values in serial PET/CT studies in patients with lung cancer and lymphoma.
Topics: Algorithms; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Lung Neoplasms; Lymphoma; Male; Metabolic Clearance Rate; Middle Aged; Pattern Recognition, Automated; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2012 |
Preoperative assessment of peritoneal carcinomatosis: intraindividual comparison of 18F-FDG PET/CT and MRI.
Topics: Carcinoma; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Peritoneal Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
[Staging with 18F-FDG-PET/CT influences stage-specific survival in advanced non-small cell lung cancer (NSCLC)].
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Germany; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Survival Analysis; Survival Rate; Tomography, X-Ray Computed | 2012 |
Clinical significance of combined assessment of the maximum standardized uptake value of F-18 FDG PET with nodal size in the diagnosis of cervical lymph node metastasis of oral squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Neck; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution | 2012 |
Network correlates of disease severity in multiple system atrophy.
Topics: Biomarkers; Brain; Case-Control Studies; Female; Fluorodeoxyglucose F18; Functional Neuroimaging; Humans; Male; Middle Aged; Models, Statistical; Multiple System Atrophy; Parkinson Disease; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Severity of Illness Index | 2012 |
Amyloid and metabolic positron emission tomography imaging of cognitively normal adults with Alzheimer's parents.
Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Amyloid; Aniline Compounds; Brain; Brain Mapping; Cognition Disorders; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Psychiatric Status Rating Scales; Sensitivity and Specificity; Thiazoles | 2013 |
Clinical value of 18F-FDG PET-CT in detecting primary tumor for patients with carcinoma of unknown primary.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma; Carcinoma, Squamous Cell; Digestive System Neoplasms; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Hemangiosarcoma; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Neoplasms, Unknown Primary; Ovarian Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Prostatic Neoplasms; Retrospective Studies; Sensitivity and Specificity; Stomach Neoplasms; Tomography, X-Ray Computed; Urologic Neoplasms | 2012 |
Impact of F18-fluorodeoxyglycose positron emission tomography/computed tomography on the management of resectable pancreatic tumours.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Cystadenoma, Serous; Decision Support Techniques; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Neuroendocrine Tumors; Pancreatectomy; Pancreatic Neoplasms; Pancreatitis; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Differentiation of septic and aseptic loosening by PET with both 11C-PK11195 and 18F-FDG in rat models.
Topics: Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antineoplastic Agents; Arthroplasty, Replacement, Knee; Carbon Radioisotopes; Carrier Proteins; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Foreign-Body Reaction; Hindlimb; Isoquinolines; Knee Prosthesis; Pilot Projects; Positron-Emission Tomography; Prosthesis Failure; Prosthesis-Related Infections; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Sensitivity and Specificity; Staphylococcal Infections | 2012 |
Staging and functional characterization of pheochromocytoma and paraganglioma by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Screening for distant metastases before salvage surgery in patients with recurrent head and neck squamous cell carcinoma: a retrospective case series comparing thoraco-abdominal CT, positron emission tomography and abdominal ultrasound.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Endoscopy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Liver Function Tests; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Salvage Therapy; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Factors associated with positive F-18 flurodeoxyglucose positron emission tomography before thyroidectomy in patients with papillary thyroid carcinoma.
Topics: Adult; Carcinoma; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neck; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Thyroid Cancer, Papillary; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed; Ultrasonography | 2012 |
Use of positron emission tomography in initial staging of nonsmall cell lung carcinoma: a regional teaching hospital experience.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Neoplasms, Squamous Cell; Positron-Emission Tomography; Predictive Value of Tests; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Diagnostic value of FDG-PET/CT for lymph node metastasis of colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Chi-Square Distribution; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Tuberculous lymphadenitis: FDG PET and CT findings in responsive and nonresponsive disease.
Topics: Adult; Female; Fluorodeoxyglucose F18; HIV Infections; Humans; Lymph Nodes; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome; Tuberculosis, Lymph Node | 2012 |
Prospective evaluation of 68Ga-DOTA-NOC PET-CT in patients with recurrent medullary thyroid carcinoma: comparison with 18F-FDG PET-CT.
Topics: Adult; Aged; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Male; Middle Aged; Multimodal Imaging; Neck; Neoplasm Recurrence, Local; Organometallic Compounds; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, X-Ray Computed | 2012 |
Diagnostic value of only 18F-fluorodeocyglucose positron emission tomography/computed tomography-positive lymph nodes in head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Interpretation, Computer-Assisted; Lymph Node Excision; Lymph Nodes; Male; Middle Aged; Multimodal Imaging; Neck Dissection; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Diagnostic accuracy of dual-time-point 18F-FDG PET/CT for the detection of axillary lymph node metastases in breast cancer patients.
Topics: Adult; Aged; Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
¹⁸F-FDG uptake by spleen helps rapidly predict the dose level after total body irradiation in a Tibetan minipig model.
Topics: Animals; Biological Assay; Body Burden; Fluorodeoxyglucose F18; Multimodal Imaging; Positron-Emission Tomography; Radiation Dosage; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Spleen; Swine; Swine, Miniature; Tomography, X-Ray Computed; Whole-Body Counting | 2012 |
A prospective evaluation of the utility of 2-deoxy-2-[(18) F]fluoro-D-glucose positron emission tomography and computed tomography in staging locally advanced gastric cancer.
Topics: Adult; Aged; Aged, 80 and over; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Laparoscopy; Male; Middle Aged; Models, Economic; Multimodal Imaging; Neoplasm Micrometastasis; Neoplasm Staging; Patient Care; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Stomach Neoplasms; Tomography, X-Ray Computed | 2012 |
18F-fluorodeoxyglucose positron emission tomography in management of pancreatic cystic tumors.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Cyst; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity | 2012 |
18F-Fluorodeoxyglucose positron-emission tomography (PET) can be used to assess inflammation non-invasively in Crohn's disease.
Topics: Adult; Colonoscopy; Crohn Disease; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Young Adult | 2012 |
Conversion of arterial input functions for dual pharmacokinetic modeling using Gd-DTPA/MRI and 18F-FDG/PET.
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Computer Simulation; Contrast Media; Fluorodeoxyglucose F18; Gadolinium DTPA; Glioblastoma; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Models, Biological; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Inbred F344; Reproducibility of Results; Sensitivity and Specificity | 2013 |
Neuroleukemiosis: an unusual cause of peripheral neuropathy.
Topics: Acute Disease; Aged; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid; Leukemic Infiltration; Male; Middle Aged; Peripheral Nerves; Peripheral Nervous System Diseases; Positron-Emission Tomography; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Time Factors | 2012 |
Diagnostic value of neck node status using 18F-FDG PET for salivary duct carcinoma of the major salivary glands.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Salivary Ducts; Salivary Gland Neoplasms; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Initial clinical comparison of 18F-florbetapir and 18F-FDG PET in patients with Alzheimer disease and controls.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aniline Compounds; Ethylene Glycols; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Severity of Illness Index | 2012 |
Differentiation of malignant and benign cardiac tumors using 18F-FDG PET/CT.
Topics: Adult; Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Glucose; Heart Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
¹⁸F-fluorodeoxyglucose PET/CT findings in pleural effusions of patients with known cancer. A cytopathological correlation.
Topics: Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasms; Pleural Effusion; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Role of positron emission tomography-computed tomography in the management of anal cancer.
Topics: Adult; Aged; Anal Canal; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Digital Rectal Examination; False Positive Reactions; Female; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Humans; Inguinal Canal; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Proctoscopy; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Tomography, X-Ray Computed | 2012 |
Prolonged back pain attributed to suspected spondylodiscitis. The value of ¹⁸F-FDG PET/CT imaging in the diagnostic work-up of patients.
Topics: Back Pain; Chronic Pain; Discitis; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Assessment of pulmonary melanoma metastases with 18F-FDG PET/CT: which PET-negative patients require additional tests for definitive staging?
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Medical Oncology; Melanoma; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity; Skin Neoplasms; Tomography, X-Ray Computed | 2012 |
Extraction of time activity curves from gated FDG-PET images for small animals' heart studies.
Topics: Animals; Cardiac-Gated Imaging Techniques; Computer Simulation; Fluorodeoxyglucose F18; Glucose; Heart; Image Interpretation, Computer-Assisted; Male; Metabolic Clearance Rate; Models, Cardiovascular; Myocardium; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Inbred F344; Reproducibility of Results; Sensitivity and Specificity | 2012 |
18F-FDG PET-CT in the evaluation of paraneoplastic syndromes: experience at a regional oncology centre.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Paraneoplastic Syndromes; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Young Adult | 2012 |
Letter from the Editors: low-sensitivity FDG-PET studies.
Topics: Fluorodeoxyglucose F18; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Sensitivity and Specificity | 2012 |
A multicenter prospective evaluation of the clinical utility of F-18 FDG-PET/CT in patients with AJCC stage IIIB or IIIC extremity melanoma.
Topics: Adult; Aged; Disease Progression; Disease-Free Survival; Extremities; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Multimodal Imaging; Neoplasm Staging; Population Surveillance; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Skin Neoplasms; Survival Analysis; Tomography, X-Ray Computed | 2012 |
Prognostic value of whole-body total lesion glycolysis at pretreatment FDG PET/CT in non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Carcinoma, Non-Small-Cell Lung; Disease Progression; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed; Whole Body Imaging | 2012 |
The value of positron emission tomography/computed tomography for evaluating metastatic disease in patients with pancreatic cancer.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Carcinoma, Pancreatic Ductal; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multidetector Computed Tomography; Multimodal Imaging; Neoplasm Invasiveness; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Republic of Korea; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2012 |
Whither the hippocampus? FDG-PET hippocampal hypometabolism in Alzheimer disease revisited.
Topics: Aged; Alzheimer Disease; Female; Fluorodeoxyglucose F18; Hippocampus; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2012 |
Correlation of dynamic PET and gene array data in patients with gastrointestinal stromal tumors.
Topics: Adult; Biomarkers, Tumor; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Gene Expression Profiling; Humans; Male; Middle Aged; Neoplasm Proteins; Positron-Emission Tomography; Protein Array Analysis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic | 2012 |
Role of the standardized uptake value of 18-fluorodeoxyglucose positron emission tomography-computed tomography in detecting the primary tumor and lymph node metastasis in colorectal cancers.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Multidetector Computed Tomography; Multimodal Imaging; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Tumor Burden | 2012 |
A prospective comparison of 18F-FDG PET/CT and CT as diagnostic tools to identify the primary tumor site in patients with extracervical carcinoma of unknown primary site.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Unknown Primary; Positron-Emission Tomography; Prospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2012 |
Comparison of 18F-fluoro-deoxy-glucose, 18F-fluoro-methyl-choline, and 18F-DPA714 for positron-emission tomography imaging of leukocyte accumulation in the aortic wall of experimental abdominal aneurysms.
Topics: Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Autoradiography; Chemotaxis, Leukocyte; Choline; Disease Models, Animal; Fluorodeoxyglucose F18; Guinea Pigs; Leukocytes; Positron-Emission Tomography; Predictive Value of Tests; Pyrazoles; Pyrimidines; Radiopharmaceuticals; Rats; Rats, Inbred Lew; Sensitivity and Specificity; Transplantation, Heterologous | 2012 |
Comparison of diagnostic ability between (99m)Tc-MDP bone scan and (18)F-FDG PET/CT for bone metastasis in patients with small cell lung cancer.
Topics: Aged; Bone and Bones; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Small Cell Lung Carcinoma; Technetium Tc 99m Medronate; Tomography, X-Ray Computed | 2012 |
Spectrum of 18F-FDG PET/CT findings in patients presenting with fever of unknown origin.
Topics: Causality; Comorbidity; Fever of Unknown Origin; Fluorodeoxyglucose F18; Global Health; Humans; Infections; Inflammation; Multimodal Imaging; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Place of (18)F-FDG-PET with computed tomography in the diagnostic algorithm of patients with fever of unknown origin.
Topics: Adult; Aged; Algorithms; Female; Fever of Unknown Origin; Fluorodeoxyglucose F18; France; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
The use of multiple time point dynamic positron emission tomography/computed tomography in patients with oral/head and neck cancer does not predictably identify metastatic cervical lymph nodes.
Topics: Carcinoma, Squamous Cell; Child; Cohort Studies; Female; Fluorodeoxyglucose F18; Forecasting; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neck; Neck Dissection; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Time Factors; Tomography, X-Ray Computed | 2013 |
The role of 18F-FDG PET/CT in the metabolic characterization of lung nodules in pediatric patients with bone sarcoma.
Topics: Adolescent; Adult; Bone Neoplasms; Child; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Multimodal Imaging; Osteosarcoma; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sarcoma, Ewing; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2012 |
Similarities and differences in fluorodeoxyglucose positron emission tomography/computed tomography findings in spondyloarthropathy, polymyalgia rheumatica and rheumatoid arthritis.
Topics: Adult; Aged; Aged, 80 and over; Arthritis, Rheumatoid; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Joints; Male; Middle Aged; Multimodal Imaging; Multivariate Analysis; Polymyalgia Rheumatica; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Spondylarthropathies; Tomography, X-Ray Computed | 2013 |
Preoperative staging of non-small-cell lung cancer: comparison of whole-body diffusion-weighted magnetic resonance imaging and 18F-fluorodeoxyglucose-positron emission tomography/computed tomography.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Period; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2012 |
Impact of FDG-PET computed tomography for surgery of recurrent or persistent differentiated thyroid carcinoma.
Topics: Adenocarcinoma, Follicular; Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm, Residual; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reoperation; Sensitivity and Specificity; Thyroid Cancer, Papillary; Thyroid Neoplasms; Tomography, X-Ray Computed; Young Adult | 2012 |
An algorithm for PET tumor volume and activity quantification: without specifying camera's point spread function (PSF).
Topics: Algorithms; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Liver Neoplasms; Pattern Recognition, Automated; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2012 |
Assessment of pulmonary neutrophilic inflammation in emphysema by quantitative positron emission tomography.
Topics: Aged; alpha 1-Antitrypsin Deficiency; Bronchitis; Cohort Studies; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; Forced Expiratory Volume; Humans; Inflammation Mediators; Male; Middle Aged; Multimodal Imaging; Neutrophil Activation; Positron-Emission Tomography; Pulmonary Disease, Chronic Obstructive; Reference Values; Respiratory Function Tests; Sensitivity and Specificity; Severity of Illness Index; Statistics, Nonparametric; Tomography, X-Ray Computed; United Kingdom | 2012 |
A segmentation framework towards automatic generation of boost subvolumes for FDG-PET tumors: a digital phantom study.
Topics: Algorithms; Computer Simulation; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Models, Biological; Neoplasms; Pattern Recognition, Automated; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2012 |
The role of integrated 18F-FDG PET-CT as a staging tool for limited-stage small cell lung cancer: a retrospective study.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Small Cell Lung Carcinoma; Systems Integration; Tomography, X-Ray Computed | 2012 |
Comparison of various criteria in interpreting end of therapy F-18 labeled fluorodeoxyglucose positron emission tomography/computed tomography in patients with aggressive non-Hodgkin lymphoma.
Topics: Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2013 |
Comparison of nitrate augmented Tc-99m tetrofosmin gated SPECT imaging with FDG PET imaging for the assessment of myocardial viability in patients with severe left ventricular dysfunction.
Topics: Adult; Aged; Cardiac-Gated Single-Photon Emission Computer-Assisted Tomography; Coronary Artery Disease; Female; Fluorodeoxyglucose F18; Heart; Humans; Male; Middle Aged; Myocardial Infarction; Nitrates; Organophosphorus Compounds; Organotechnetium Compounds; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Ventricular Dysfunction, Left | 2012 |
Early prediction of pathological response in locally advanced rectal cancer based on sequential 18F-FDG PET.
Topics: Adult; Aged; Aged, 80 and over; Chemoradiotherapy; Combined Modality Therapy; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Period; Prognosis; Rectal Neoplasms; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Time Factors; Treatment Outcome | 2013 |
[Value of dual-time-point (18)F-fluorodeoxyglucose integrated positron emission and computed tomography in differentiation of malignant from benign gastrointestinal diseases].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Colitis; Colorectal Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gastritis; Gastrointestinal Diseases; Gastrointestinal Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Proctitis; Proctocolitis; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Stomach Neoplasms; Tomography, X-Ray Computed | 2012 |
Indeterminate pulmonary nodules on CT images in breast cancer patient: the additional value of 18F-FDG PET/CT.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Mammography; Multimodal Imaging; Multiple Pulmonary Nodules; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Prognostic significance of total lesion glycolysis in patients with advanced non-small cell lung cancer receiving chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Republic of Korea; Retrospective Studies; Sensitivity and Specificity; Survival Analysis; Survival Rate; Treatment Outcome | 2012 |
Assessment of brain glucose metabolism with input function determined from brain PET images by means of Bayesian ICA and MCMC methods.
Topics: Adult; Algorithms; Bayes Theorem; Brain; Computer Simulation; Female; Fluorodeoxyglucose F18; Glucose; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Male; Models, Biological; Models, Statistical; Positron-Emission Tomography; Principal Component Analysis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2012 |
Incidence, appropriateness, and consequences of recommendations for additional imaging tests in oncological PET/CT reports.
Topics: Adult; Aged; Aged, 80 and over; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Incidence; Male; Middle Aged; Multimodal Imaging; Neoplasms; Positron-Emission Tomography; Quality Control; Radiation Dosage; Retrospective Studies; Risk Assessment; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
Impact of point spread function reconstruction on thoracic lymph node staging with 18F-FDG PET/CT in non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Thorax; Tomography, X-Ray Computed | 2012 |
18F-fluorodeoxyglucose positron emission tomography/computed tomography is useful in postoperative follow-up of asymptomatic non-small-cell lung cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Asymptomatic Diseases; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Pneumonectomy; Positron-Emission Tomography; Postoperative Care; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Survival Analysis; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Contrast enhanced MRI and ¹⁸F-FDG PET-CT in the assessment of multiple myeloma: a comparison of results in different phases of the disease.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Disease Progression; Female; Fluorodeoxyglucose F18; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Multiple Myeloma; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
PET/MRI: challenges, solutions and perspectives.
Topics: Alzheimer Disease; Animals; Brain; Carbon Radioisotopes; Contrast Media; Diffusion Magnetic Resonance Imaging; Efficiency; Electron Spin Resonance Spectroscopy; Equipment Design; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Models, Animal; Multimodal Imaging; Positron-Emission Tomography; Raclopride; Rats; Sensitivity and Specificity; Software; Tomography, X-Ray Computed; Whole Body Imaging; Young Adult | 2012 |
[Efficiency comparison between PET/CT and conventional work-up for evaluating distant metastasis of nasopharyngeal carcinoma].
Topics: Aged; Carcinoma; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography | 2012 |
Acute alcohol intoxication decreases glucose metabolism but increases acetate uptake in the human brain.
Topics: Acetates; Adolescent; Adult; Alcoholic Intoxication; Brain; Carbon; Child; Ethanol; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Young Adult | 2013 |
Differentiating primary CNS lymphoma from glioblastoma multiforme: assessment using arterial spin labeling, diffusion-weighted imaging, and ¹⁸F-fluorodeoxyglucose positron emission tomography.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brain Neoplasms; Child; Diagnosis, Differential; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Glioblastoma; Humans; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Spin Labels; Young Adult | 2013 |
Round cell liposarcoma arising in the left foot: MRI and PET findings.
Topics: Aorta, Abdominal; Bone Neoplasms; Fluorodeoxyglucose F18; Foot; Humans; Liposarcoma; Liposarcoma, Myxoid; Lymph Node Excision; Magnetic Resonance Imaging; Male; Metatarsal Bones; Middle Aged; Neoplasm Grading; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Soft Tissue Neoplasms; Tarsal Bones | 2012 |
Increasing the yield of recombinant thyroid-stimulating hormone-stimulated 2-(18-fluoride)-flu-2-deoxy-D-glucose positron emission tomography-CT in patients with differentiated thyroid carcinoma.
Topics: Adenocarcinoma, Follicular; Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Recombinant Proteins; Retrospective Studies; Sensitivity and Specificity; Thyroglobulin; Thyroid Cancer, Papillary; Thyroid Neoplasms; Thyrotropin Alfa; Tomography, X-Ray Computed; Young Adult | 2012 |
Utility of 18-fluorodeoxyglucose positron emission/computed tomography in the management of recurrent colorectal cancer.
Topics: Carcinoembryonic Antigen; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Comparison of ( 18 ) F-FLT PET and ( 18 ) F-FDG PET for detection of cervical lymph node metastases in head and neck cancers.
Topics: Adult; Aged; Aged, 80 and over; Combined Modality Therapy; Dideoxynucleosides; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Otorhinolaryngologic Neoplasms; Positron-Emission Tomography; Prospective Studies; Sensitivity and Specificity; Statistics as Topic; Tomography, X-Ray Computed | 2012 |
Comparison of the diagnostic value of FDG-PET/CT and axillary ultrasound for the detection of lymph node metastases in breast cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Axilla; Breast Neoplasms; Breast Neoplasms, Male; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography | 2012 |
Comparison of 18F-FDG positron emission tomography/computed tomography and computed tomography in patients with already-treated breast cancer: diagnostic and prognostic implications.
Topics: Breast Neoplasms; Breast Neoplasms, Male; Female; Fluorodeoxyglucose F18; Humans; Italy; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Factors; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Tumor volume and subvolume concordance between FDG-PET/CT and diffusion-weighted MRI for squamous cell carcinoma of the cervix.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Tumor Burden; Uterine Cervical Neoplasms | 2013 |
Usefulness of high-sensitive cardiac troponin T for evaluating the activity of cardiac sarcoidosis.
Topics: Aged; Biomarkers; Cardiomyopathies; Echocardiography; Electrocardiography; Female; Fluorodeoxyglucose F18; Glucocorticoids; Humans; Male; Middle Aged; Muramidase; Natriuretic Peptide, Brain; Peptidyl-Dipeptidase A; Positron-Emission Tomography; Predictive Value of Tests; Retrospective Studies; Sarcoidosis; Sensitivity and Specificity; Stroke Volume; Troponin T; Ventricular Function, Left | 2012 |
Anatomically guided voxel-based partial volume effect correction in brain PET: impact of MRI segmentation.
Topics: Aged; Aged, 80 and over; Algorithms; Artifacts; Brain; Dementia; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique | 2012 |
Comparison of FDG-PET, MRI and CT for post radiofrequency ablation evaluation of hepatic tumors.
Topics: Ablation Techniques; Adult; Aged; Cost-Benefit Analysis; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiofrequency Therapy; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
The accuracy of positron emission tomography in the detection of posttransplant lymphoproliferative disorder.
Topics: Adult; Biopsy; Female; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Humans; Lymphoproliferative Disorders; Male; Middle Aged; Organ Transplantation; Positron-Emission Tomography; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Time Factors | 2013 |
[Evaluation of efficacy and clinical impact of 18F-FDG-PET in the diagnosis of recurrent medullary thyroid cancer with increased calcitonin and negative imaging test].
Topics: Biomarkers, Tumor; Bone Neoplasms; Calcitonin; Carcinoma, Medullary; Disease Progression; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multiple Endocrine Neoplasia Type 2a; Multiple Endocrine Neoplasia Type 2b; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Thyroid Neoplasms; Thyroidectomy | 2012 |
Utility of low dose (18)F-FDG PET-CT in patients with suspected colorectal carcinoma recurrence in conventional diagnostic methods.
Topics: Adenocarcinoma; Aged; Biomarkers, Tumor; Brain Neoplasms; Carcinoembryonic Antigen; Chemoradiotherapy; Colorectal Neoplasms; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Spiral Computed; Tomography, X-Ray Computed | 2012 |
Correlation of PET images of metabolism, proliferation and hypoxia to characterize tumor phenotype in patients with cancer of the oropharynx.
Topics: Adult; Aged; Brain Neoplasms; Cell Hypoxia; Cell Proliferation; Coordination Complexes; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Organometallic Compounds; Oropharyngeal Neoplasms; Phenotype; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Thiosemicarbazones; Tomography, X-Ray Computed | 2012 |
Variability of ¹⁸F-FDG-positive lung lesion volume by thresholding.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Lung Neoplasms; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tumor Burden | 2013 |
Primary cardiac lymphoma: echocardiography and F-18-fluorodeoxyglucose positron emission tomography in selection of a biopsy site.
Topics: Echocardiography; Fluorodeoxyglucose F18; Heart Neoplasms; Humans; Image-Guided Biopsy; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2013 |
Whole-body diffusion-weighted MRI compared with (18)F-NaF PET/CT for detection of bone metastases in patients with high-risk prostate carcinoma.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Chi-Square Distribution; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prospective Studies; Prostatic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2012 |
[Non small cell lung carcinoma - evaluation of tumor heterogeneity using CT texture analysis].
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Lung; Lung Neoplasms; Male; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed | 2012 |
Comparison of the diagnostic and prognostic values of 99mTc-MDP-planar bone scintigraphy, 131I-SPECT/CT and 18F-FDG-PET/CT for the detection of bone metastases from differentiated thyroid cancer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone and Bones; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Retrospective Studies; Sensitivity and Specificity; Survival Analysis; Technetium Tc 99m Medronate; Thyroid Neoplasms; Tomography, X-Ray Computed; Young Adult | 2012 |
Added value of FDG-PET imaging in the diagnostic workup for yttrium-90 radioembolisation in patients with colorectal cancer liver metastases.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome; Yttrium Radioisotopes | 2013 |
Diagnostic performance of fluorodeoxyglucose-positron emission tomography/computed tomography combined with ultrasonography-guided fine needle aspiration cytology for identifying axillary lymph node status in patients with breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Axilla; Biomarkers, Tumor; Biopsy, Fine-Needle; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Tomography, X-Ray Computed; Ultrasonography, Mammary | 2013 |
F18-FDG PET-CT analyses of small peripheral adenocarcinoma of the lung.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
Use of F-18 fluorodeoxyglucose positron emission tomography with dual-phase imaging to identify intraductal papillary mucinous neoplasm.
Topics: Adenocarcinoma, Mucinous; Aged; Aged, 80 and over; Carcinoma, Pancreatic Ductal; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
Feasibility of (18)F-fluorodeoxyglucose positron-emission tomography for preoperative evaluation of biliary tract cancer.
Topics: Adult; Aged; Aged, 80 and over; Biliary Tract Neoplasms; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2012 |
[Diagnostic value of (18)F-labeled NaF positron emission tomography-computed tomography imaging in the detection of bone metastases in patients with lung cancer before treatment].
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Utility of quantitative 18 F-fluorodeoxyglucose uptake measurement to identify occult tonsillar carcinoma in patients with cervical metastasis of unknown primary tumours: a retrospective case-control study.
Topics: Carcinoma, Squamous Cell; Case-Control Studies; Chi-Square Distribution; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neck; Neoplasm Staging; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Statistics, Nonparametric; Tomography, X-Ray Computed; Tonsillar Neoplasms | 2013 |
Role of 18F-FDG PET/CT in the diagnosis of clinically suspected Marjolin ulcer.
Topics: Adult; Aged; Burns; Carcinoma, Squamous Cell; Chronic Disease; Contracture; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Skin Diseases; Skin Neoplasms; Skin Ulcer; Tomography, X-Ray Computed | 2012 |
Relationship between baseline brain metabolism measured using [¹⁸F]FDG PET and memory and executive function in prodromal and early Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Brain; Cognition Disorders; Early Diagnosis; Executive Function; Female; Fluorodeoxyglucose F18; Humans; Male; Memory; Memory Disorders; Positron-Emission Tomography; Prodromal Symptoms; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Tissue Distribution | 2012 |
Characteristic imaging features of desmoplastic small round cell tumour.
Topics: Adolescent; Adult; Bone Neoplasms; Child; Desmoplastic Small Round Cell Tumor; Digestive System Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Muscle Neoplasms; Neoplasm Metastasis; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Urinary Bladder Neoplasms; Young Adult | 2013 |
[Diagnosis of large-vessel vasculitis using [18F]-FDG PET-CT].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Immunosuppressive Agents; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Vasculitis | 2013 |
Optimal timing of post-treatment [18F]fluorodeoxyglucose-PET/CT for patients with head and neck malignancy.
Topics: Aged; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Recurrence; Retrospective Studies; Sensitivity and Specificity; Time Factors; Tomography, X-Ray Computed | 2013 |
[The role of FDG-PET-CT in the evaluation of primary systemic therapy in breast cancer: links between metabolic and pathological remission].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Axilla; Biomarkers, Tumor; Breast Neoplasms; Cell Proliferation; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Remission Induction; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Characterization of neuroblastic tumors using 18F-FDOPA PET.
Topics: 3-Iodobenzylguanidine; Biological Transport; Carboxy-Lyases; Catecholamines; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Infant; Male; Neuroblastoma; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Vanilmandelic Acid | 2013 |
The maximum standardized uptake value of fluorodeoxyglucose positron emission tomography of the primary tumour is a good predictor of pathological nodal involvement in clinical N0 non-small-cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multivariate Analysis; Positron-Emission Tomography; Sensitivity and Specificity | 2013 |
(18) F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of recurrent bone and soft tissue sarcoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Sarcoma; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2013 |
Does positron emission tomography data acquisition impact simultaneous diffusion-weighted imaging in a whole-body PET/MRI system?
Topics: Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Whole Body Imaging | 2013 |
Virtual bronchoscopy using FDG-PET/CT images for the evaluation of lung cancer.
Topics: Adult; Aged; Biopsy; Bronchoalveolar Lavage; Bronchoscopy; Chi-Square Distribution; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Multidetector Computed Tomography; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Turkey | 2012 |
Clinical evaluation of PET image reconstruction using a spatial resolution model.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Algorithms; Computer Simulation; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Male; Middle Aged; Models, Biological; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Whole Body Imaging; Young Adult | 2013 |
Positron emission tomography in the assessment of left ventricular function in healthy rats: a comparison of four imaging methods.
Topics: Animals; Female; Fluorodeoxyglucose F18; Heart Ventricles; Image Enhancement; Image Interpretation, Computer-Assisted; Organometallic Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Reference Values; Reproducibility of Results; Sensitivity and Specificity; Serum Albumin; Ventricular Function, Left | 2013 |
Which is the optimal acquisition time for FDG PET/CT imaging in patients with infective endocarditis?
Topics: Endocarditis; Fluorodeoxyglucose F18; Heart Valve Prosthesis; Humans; Image Enhancement; Male; Multimodal Imaging; Positron-Emission Tomography; Prosthesis-Related Infections; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Time Factors; Tomography, X-Ray Computed | 2013 |
Dual time point positron emission tomography/computed tomography scan in evaluation of intrathoracic lesions in an area endemic for histoplasmosis and with high prevalence of sarcoidosis.
Topics: Aged; Diagnosis, Differential; Endemic Diseases; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Histoplasmosis; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prevalence; Retrospective Studies; Sarcoidosis; Sensitivity and Specificity; Thoracic Neoplasms; Tomography, X-Ray Computed; United States; United States Department of Veterans Affairs | 2013 |
The role of positron emission tomography with 18F-fluorodeoxyglucose in nodal staging of clinical and radiological N₀ head and neck cancers.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neck Dissection; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
Patient-adaptive lesion metabolism analysis by dynamic PET images.
Topics: Adult; Algorithms; Computer Simulation; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Male; Metabolic Clearance Rate; Models, Biological; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thoracic Neoplasms; Tissue Distribution | 2012 |
FDG-PET in the evaluation of myeloma in 2012.
Topics: Bone Marrow; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multiple Myeloma; Plasmacytoma; Positron-Emission Tomography; Sensitivity and Specificity | 2013 |
Efficacy of FDG-PET for defining gross tumor volume of head and neck cancer.
Topics: Carcinoma, Squamous Cell; Computer Simulation; Contrast Media; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Imaging, Three-Dimensional; Male; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
The role of FDG-PET scanning in assessing lymphoma in 2012.
Topics: Antineoplastic Combined Chemotherapy Protocols; Fluorodeoxyglucose F18; France; Hodgkin Disease; Humans; Immunotherapy; Lymphoma; Lymphoma, B-Cell; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Prognosis; Sensitivity and Specificity; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
Dynamic contrast-enhanced CT to assess metabolic response in patients with advanced non-small cell lung cancer and stable disease after chemotherapy or chemoradiotherapy.
Topics: Adult; Aged; Aged, 80 and over; Area Under Curve; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Contrast Media; Drug Therapy; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Odds Ratio; Positron-Emission Tomography; Prospective Studies; Sensitivity and Specificity; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
Differential diagnosis of parkinsonian syndromes using F-18 fluorodeoxyglucose positron emission tomography.
Topics: Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; India; Male; Middle Aged; Observer Variation; Parkinsonian Disorders; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity | 2013 |
Registration of PET and CT images based on multiresolution gradient of mutual information demons algorithm for positioning esophageal cancer patients.
Topics: Algorithms; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Pattern Recognition, Automated; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Image-Guided; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2013 |
High impact of FDG-PET/CT in diagnostic strategies for ovarian cancer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Ovarian Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Statistics, Nonparametric; Tomography, X-Ray Computed | 2013 |
11C-acetate and 18F-FDG PET/CT for clinical staging and selection of patients with hepatocellular carcinoma for liver transplantation on the basis of Milan criteria: surgeon's perspective.
Topics: Adult; Aged; Carbon Radioisotopes; Carcinoma, Hepatocellular; Contrast Media; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Male; Medical Oncology; Middle Aged; Neoplasm Staging; Nuclear Medicine; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
Evaluation of 18F-FDG PET/CT and CT/MRI with histopathologic correlation in patients undergoing central compartment neck dissection for squamous cell carcinoma of the larynx, hypopharynx, and esophagus.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Cohort Studies; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neck Dissection; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
Modification of staging and treatment of head and neck cancer by FDG-PET/CT prior to radiotherapy.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Otorhinolaryngologic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
Multiple myeloma imaging.
Topics: Bone and Bones; Fluorodeoxyglucose F18; France; Humans; Magnetic Resonance Imaging; Multiple Myeloma; Positron-Emission Tomography; Prognosis; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
Peritoneal carcinomatosis in patients with ovarian cancer: enhanced CT versus 18F-FDG PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Ovarian Neoplasms; Peritoneal Neoplasms; Positron-Emission Tomography; Radiography, Abdominal; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
[18F]-fluoro-ethyl-L-tyrosine PET: a valuable diagnostic tool in neuro-oncology, but not all that glitters is glioma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Blood-Brain Barrier; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glioma; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Grading; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tyrosine; Young Adult | 2013 |
Dual-time-point FDG PET/CT for the evaluation of pediatric tumors.
Topics: Adolescent; Child; Child, Preschool; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Infant; Male; Multimodal Imaging; Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
The clinical value of dual-time point 18F-FDG PET/CT for differentiating extrahepatic cholangiocarcinoma from benign disease.
Topics: Aged; Bile Duct Neoplasms; Cholangiocarcinoma; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Time Factors; Tomography, X-Ray Computed | 2013 |
Evaluation of right ventricular volume and ejection fraction by gated (18)F-FDG PET in patients with pulmonary hypertension: comparison with cardiac MRI and CT.
Topics: Adult; Cardiac-Gated Imaging Techniques; Female; Fluorodeoxyglucose F18; Humans; Hypertension, Pulmonary; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Stroke Volume; Tomography, X-Ray Computed; Ventricular Dysfunction, Right | 2013 |
PET in the clinical work-up of patients with spondylodiscitis: a new tool for the clinician?
Topics: Discitis; Female; Fluorodeoxyglucose F18; Humans; Intervertebral Disc; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2012 |
Rare lymphoid malignancies of the breast: report of two cases illustrating potential diagnostic techniques.
Topics: Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Mammography; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography, Mammary | 2012 |
A Decision Support System for the assisted diagnosis of brain tumors: a feasibility study for ¹⁸F-FDG PET preclinical studies.
Topics: Algorithms; Brain Neoplasms; Decision Support Systems, Clinical; Disease Progression; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Principal Component Analysis; Sensitivity and Specificity | 2012 |
Potential utility of early metabolic response by 18F-2-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in a selected group of breast cancer patients receiving preoperative chemotherapy.
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Middle Aged; Multimodal Imaging; Outcome Assessment, Health Care; Positron-Emission Tomography; Preoperative Period; Prognosis; Receptor, ErbB-2; Receptors, Estrogen; Remission Induction; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
Phase analysis by gated F-18 FDG PET/CT for left ventricular dyssynchrony assessment: a comparison with gated Tc-99m sestamibi SPECT.
Topics: Algorithms; Cardiac-Gated Imaging Techniques; Coronary Artery Disease; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Software; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Ventricular Dysfunction, Left | 2013 |
Clinical value of whole-body F-18 fluorodeoxyglucose positron emission tomography/computed tomography in patients with carcinoma of unknown primary.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; China; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasms, Unknown Primary; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Whole Body Imaging; Young Adult | 2013 |
Diagnostic accuracy of markers for prodromal Alzheimer's disease in independent clinical series.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Cognition Disorders; Databases, Factual; Disease Progression; Female; Fluorodeoxyglucose F18; Hippocampus; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Peptide Fragments; Positron-Emission Tomography; Sensitivity and Specificity; Statistics, Nonparametric; Time Factors | 2013 |
The role of 18F-fluoride PET-CT in the detection of bone metastases in patients with breast, lung and prostate carcinoma: a comparison with FDG PET/CT and 99mTc-MDP bone scan.
Topics: Adult; Aged; Brain Neoplasms; Breast Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Medronate; Tomography, X-Ray Computed | 2013 |
[Usefulness and limitation of FDG-PET in the diagnosis of primary central nervous system lymphoma].
Topics: Aged; Aged, 80 and over; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2013 |
Clinical utility of fluoride-18 positron emission tomography/CT in temporomandibular disorder with osteoarthritis: comparisons with 99mTc-MDP bone scan.
Topics: Adult; Area Under Curve; Cervical Vertebrae; Female; Fluorodeoxyglucose F18; Humans; Joint Dislocations; Male; Muscle, Skeletal; Osteoarthritis; Parietal Bone; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Technetium Tc 99m Medronate; Temporal Bone; Temporomandibular Joint; Temporomandibular Joint Disc; Temporomandibular Joint Disorders | 2013 |
Standardized uptake values for [¹⁸F] FDG in normal organ tissues: comparison of whole-body PET/CT and PET/MRI.
Topics: Female; Fluorodeoxyglucose F18; Germany; Humans; Magnetic Resonance Imaging; Male; Metabolic Clearance Rate; Middle Aged; Multimodal Imaging; Organ Specificity; Positron-Emission Tomography; Radiopharmaceuticals; Reference Values; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Tomography, X-Ray Computed; Whole Body Imaging | 2013 |
FDG PET/CT evaluation of pathologically proven pulmonary lesions in an area of high endemic granulomatous disease.
Topics: Aged; Aged, 80 and over; California; Coccidioidomycosis; Endemic Diseases; Female; Fluorodeoxyglucose F18; Granuloma, Respiratory Tract; Humans; Incidence; Lung; Lung Diseases, Fungal; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
Potential of 18F-FDG PET toward personalized radiotherapy or chemoradiotherapy in lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Glucose; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Probability; Prospective Studies; Regression Analysis; Sensitivity and Specificity; Treatment Outcome | 2013 |
FDG-PET improves the staging and selection of patients with recurrent colorectal cancer.
Topics: Colorectal Neoplasms; Endoscopy; False Negative Reactions; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Patient Selection; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole-Body Counting | 2002 |
PET attenuation coefficients from CT images: experimental evaluation of the transformation of CT into PET 511-keV attenuation coefficients.
Topics: Calibration; Fluorodeoxyglucose F18; Humans; Image Enhancement; Models, Biological; Neoplasms; Phantoms, Imaging; Protons; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
Biodistribution and dosimetry of [(18)F]fluorodeoxyglucose labelled leukocytes in normal human subjects.
Topics: Fluorodeoxyglucose F18; Humans; Isotope Labeling; Leukocytes; Metabolic Clearance Rate; Radiation Dosage; Radiopharmaceuticals; Reference Values; Sensitivity and Specificity; Tissue Distribution; Tomography, Emission-Computed; Whole-Body Counting | 2002 |
Fluorodeoxyglucose positron emission tomography and somatostatin receptor scintigraphy for diagnosing and staging carcinoid tumours: correlations with the pathological indexes p53 and Ki-67.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoid Tumor; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Octreotide; Pentetic Acid; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Single-Blind Method; Statistics as Topic; Tumor Suppressor Protein p53 | 2002 |
Dynamic evaluation of absorbed dose to the bladder wall with a balloon-bladder phantom during a study using [(18)F]fluorodeoxyglucose positron emission imaging.
Topics: Adult; Aged; Computer Simulation; Fluorodeoxyglucose F18; Humans; Male; Models, Biological; Phantoms, Imaging; Radiation Dosage; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Sensitivity and Specificity; Tomography, Emission-Computed; Urinary Bladder; Urination | 2002 |
Decision-tree sensitivity analysis for cost-effectiveness of whole-body FDG PET in the management of patients with non-small-cell lung carcinoma in Japan.
Topics: Algorithms; Carcinoma, Non-Small-Cell Lung; Cost-Benefit Analysis; Decision Trees; Fluorodeoxyglucose F18; Humans; Japan; Life Expectancy; Lung Neoplasms; Radiography; Radiopharmaceuticals; Sensitivity and Specificity; Survival Analysis; Tomography, Emission-Computed; Whole-Body Counting | 2002 |
Variation in FDG uptakes in different regions in normal human brain as a function of the time (30 and 60 minutes) after injection of FDG.
Topics: Aged; Brain; Female; Fluorodeoxyglucose F18; Humans; Injections, Intravenous; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Time Factors; Tissue Distribution | 2002 |
[Role of positron emission tomography in detecting recurrent epithelial ovarian carcinoma].
Topics: CA-125 Antigen; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Neoplasm Recurrence, Local; Ovarian Neoplasms; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
Cost-effectiveness of dual-head 18F-fluorodeoxyglucose PET for the detection of recurrent laryngeal cancer.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Cost-Benefit Analysis; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Laryngeal Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Squamous Cell; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
[The value of F-18 fluorodeoxyglucose in positron emission tomography diagnosis of breast carcinoma].
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
[F-18 fluorodeoxyglucose positron emission tomography in lung lesions].
Topics: Carcinoma, Bronchogenic; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cost-Benefit Analysis; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Staging; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
[F-18 fluorodeoxyglucose positron emission tomography in malignant lymphoma].
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Neoplasm Staging; Neoplasm, Residual; Sensitivity and Specificity; Tomography, Emission-Computed; Treatment Outcome | 2002 |
[F-18 fluorodeoxyglucose positron emission tomography in colorectal carcinoma].
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Lung Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Sensitivity and Specificity; Tomography, Emission-Computed; Treatment Outcome | 2002 |
[Value of F-18 fluorodeoxyglucose positron emission tomography in thyroid carcinoma].
Topics: Adenocarcinoma, Follicular; Adenoma; Carcinoma, Papillary; Diagnosis, Differential; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Prognosis; Sensitivity and Specificity; Survival Rate; Thyroid Neoplasms; Tomography, Emission-Computed | 2002 |
[F-18 fluorodeoxyglucose for diagnosis of myocardial viability: applications in clinical practice].
Topics: Fluorodeoxyglucose F18; Heart Failure; Heart Transplantation; Humans; Myocardial Infarction; Myocardial Revascularization; Myocardial Stunning; Prognosis; Sensitivity and Specificity; Tissue Survival; Tomography, Emission-Computed | 2002 |
[F-18 fluorodeoxyglucose positron emission tomography in neurology].
Topics: Brain; Brain Diseases; Brain Neoplasms; Diagnosis, Differential; Energy Metabolism; Epilepsy; Fluorodeoxyglucose F18; Humans; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
PET predicts prognosis after 1 cycle of chemotherapy in aggressive lymphoma and Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Time Factors; Tomography, Emission-Computed; Treatment Outcome | 2002 |
FDG positron emission tomography to manage patients with an occult primary carcinoma and metastasis outside the cervical lymph nodes.
Topics: Blue Cross Blue Shield Insurance Plans; Carcinoma; Device Approval; Fluorodeoxyglucose F18; Humans; Insurance Coverage; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Neoplasms, Unknown Primary; Outcome Assessment, Health Care; Radiopharmaceuticals; Sensitivity and Specificity; Technology Assessment, Biomedical; Tomography, Emission-Computed; United States; United States Food and Drug Administration | 2002 |
The role of F-18 FDG positron emission tomography in preoperative assessment of the liver in patients being considered for curative resection of hepatic metastases from colorectal cancer.
Topics: Adult; Aged; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Preoperative Care; Radiopharmaceuticals; Reference Standards; Retrospective Studies; Sensitivity and Specificity; Single-Blind Method; Tomography, Emission-Computed; Ultrasonography | 2002 |
Solitary pulmonary nodules: accuracy and cost-effectiveness of sodium iodide FDG-PET using Australian data.
Topics: Aged; Australia; Cohort Studies; Cost Savings; Cost-Benefit Analysis; Decision Trees; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, Emission-Computed | 2002 |
Detection of unknown primary tumours and distant metastases in patients with cervical metastases: value of FDG-PET versus conventional modalities.
Topics: Adenocarcinoma; Carcinoma; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasms, Unknown Primary; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
Staging of regional nodes in AJCC stage I and II melanoma: 18FDG PET imaging versus sentinel node detection.
Topics: Adult; Aged; Disease Progression; Extremities; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Injections, Intravenous; Lymph Nodes; Male; Melanoma; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Radiopharmaceuticals; Recurrence; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Tomography, Emission-Computed | 2002 |
Noninvasive assessment of Crohn's disease activity: a comparison of 18F-fluorodeoxyglucose positron emission tomography, hydromagnetic resonance imaging, and granulocyte scintigraphy with labeled antibodies.
Topics: Adult; Antibodies, Monoclonal; Antigens, Neoplasm; Cell Adhesion Molecules; Colonoscopy; Crohn Disease; Female; Fluorodeoxyglucose F18; Granulocytes; Humans; Magnetic Resonance Imaging; Male; Membrane Glycoproteins; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 2002 |
FDG-PET imaging in lung cancer: how sensitive is it for bronchioloalveolar carcinoma?
Topics: Adenocarcinoma, Bronchiolo-Alveolar; Adult; Aged; Aged, 80 and over; Biological Transport; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
Comparison of fluorodeoxyglucose positron emission tomography and "conventional diagnostic procedures" for the detection of distant metastases in breast cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Diagnostic Imaging; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Single-Blind Method; Tomography, Emission-Computed | 2002 |
Early restaging positron emission tomography with ( 18)F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Doxorubicin; Evaluation Studies as Topic; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Monitoring, Physiologic; Multivariate Analysis; Neoplasm Staging; Predictive Value of Tests; Prednisolone; Probability; Prognosis; Prospective Studies; Sensitivity and Specificity; Survival Rate; Time Factors; Tomography, Emission-Computed; Treatment Outcome; Vincristine | 2002 |
Fluorine-18 FDG-PET in detecting local recurrence and distant metastases in breast cancer--Taiwanese experiences.
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
The impact of fluorodeoxyglucose F 18 positron-emission tomography on the surgical staging of non-small cell lung cancer.
Topics: Biopsy; Carcinoma, Non-Small-Cell Lung; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Magnetic Resonance Imaging; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Washington | 2002 |
Assessment of malignant pleural mesothelioma with (18)F-FDG dual-head gamma-camera coincidence imaging: comparison with histopathology.
Topics: Algorithms; Female; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Image Processing, Computer-Assisted; Male; Mediastinal Neoplasms; Mesothelioma; Middle Aged; Pleura; Pleural Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
(18)F-FDG PET in localization of frontal lobe epilepsy: comparison of visual and SPM analysis.
Topics: Adult; Case-Control Studies; Epilepsy, Frontal Lobe; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Models, Statistical; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
[F-18 FDG positron emission tomography in diagnosis and follow-up of patients with musculoskeletal tumors].
Topics: Adolescent; Adult; Aged; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Postoperative Complications; Radiotherapy, Adjuvant; Sensitivity and Specificity; Soft Tissue Neoplasms; Tomography, Emission-Computed | 2002 |
[Positron emission tomography for the preoperative staging of esophageal carcinoma].
Topics: Carcinoma; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
Does diabetes affect [(18)F]FDG standardised uptake values in lung cancer?
Topics: Adult; Aged; Aged, 80 and over; Blood Glucose; Diabetes Complications; Diabetes Mellitus; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Quality Control; Radionuclide Imaging; Radiopharmaceuticals; Reference Standards; Reference Values; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Statistics as Topic; Tissue Distribution | 2002 |
Dissociation of glucose tracer uptake and glucose transporter distribution in the regionally ischaemic isolated rat heart: application of a new autoradiographic technique.
Topics: Animals; Autoradiography; Carbon Radioisotopes; Cerebrovascular Circulation; Deoxyglucose; Fluorodeoxyglucose F18; Glucose; Glucose Transporter Type 1; Glucose Transporter Type 2; Heart Ventricles; In Vitro Techniques; Male; Monosaccharide Transport Proteins; Myocardial Ischemia; Myocardial Reperfusion; Myocardium; Quality Control; Radiopharmaceuticals; Rats; Rats, Wistar; Reference Values; Reproducibility of Results; Sensitivity and Specificity | 2002 |
Fluorodeoxyglucose imaging using a coincidence gamma camera to detect head and neck squamous cell carcinoma and response to chemotherapy.
Topics: Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Gamma Cameras; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neck; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
Clinical utility of positron emission tomography in the diagnosis and management of periampullary neoplasms.
Topics: Adenocarcinoma; Ampulla of Vater; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
Functional MRI and 18F FDG-positron emission tomography for presurgical planning: comparison with electrical cortical stimulation.
Topics: Adult; Aged; Artifacts; Brain Mapping; Brain Neoplasms; Cerebral Cortex; Electric Stimulation; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Muscle, Skeletal; Oxygen; Sensitivity and Specificity; Stereotaxic Techniques; Tomography, Emission-Computed | 2002 |
Diagnostic and prognostic value of [(18)F]fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
18-FDG PET scan in the staging of recurrent melanoma: additional value and therapeutic impact.
Topics: Adult; Aged; Aged, 80 and over; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Neoplasms; Radiopharmaceuticals; Recurrence; Sensitivity and Specificity; Skin Neoplasms; Time Factors; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
Re: Clinical role of f-18 fluorodeoxyglucose positron emission tomography for detection and management of renal cell carcinoma.
Topics: Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Neoplasm Recurrence, Local; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
Early changes in [18F]FLT uptake after chemotherapy: an experimental study.
Topics: Antineoplastic Agents; Artifacts; Carcinoma, Squamous Cell; Cell Survival; Cisplatin; Deoxycytidine; Dideoxynucleosides; Dose-Response Relationship, Drug; Esophageal Neoplasms; Fluorodeoxyglucose F18; Fluorouracil; Gemcitabine; Humans; Methotrexate; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Tumor Cells, Cultured | 2002 |
PET diagnostic accuracy: improvement with in-line PET-CT system: initial results.
Topics: Abdominal Neoplasms; Adult; Aged; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Microcomputers; Middle Aged; Neoplasm Staging; Neoplasms; Otorhinolaryngologic Neoplasms; Sensitivity and Specificity; Software; Tomography, Emission-Computed; Tomography, Spiral Computed | 2002 |
Determinants of diagnostic performance of [F-18]fluorodeoxyglucose positron emission tomography for axillary staging in breast cancer.
Topics: Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Tomography, Emission-Computed | 2002 |
Usefulness of whole-body (18)F-FDG PET in patients with suspected metastatic brain tumors.
Topics: Brain Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
[Optimization of radiotherapy planning for non-small cell lung cancer (NSCLC) using 18FDG-PET].
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Radiopharmaceuticals; Radiotherapy, Computer-Assisted; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
Direct epicardial mapping can differentiate hibernating from scarred myocardium: a validation study with 18F-FDG-PET.
Topics: Aged; Body Surface Potential Mapping; Coronary Angiography; Coronary Artery Bypass; Coronary Circulation; Coronary Disease; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Stunning; Pericardium; Predictive Value of Tests; ROC Curve; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2002 |
Usefulness of FDG-positron emission tomography in diagnosing peritoneal recurrence of colorectal cancer.
Topics: Aged; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Peritoneal Neoplasms; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
[18 F-fluorodeoxyglucose positron emission tomography for characterization and initial staging of pancreatic tumors].
Topics: Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Pancreatic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
Simultaneous occurrence of Hodgkin's lymphoma and eosinophilic granuloma: a potential pitfall in positron emission tomography imaging.
Topics: Adult; Eosinophilic Granuloma; Eosinophils; Fluorodeoxyglucose F18; Histiocytosis, Langerhans-Cell; Hodgkin Disease; Humans; Islets of Langerhans; Lymphoma; Male; Middle Aged; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
Investigations with FDG-PET scanning in prostate cancer show limited value for clinical practice.
Topics: Adenocarcinoma; Biomarkers, Tumor; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Neoplasm Proteins; Neoplasm Staging; Prostate-Specific Antigen; Prostatic Neoplasms; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
Positron emission tomography for the staging of Hodgkin's lymphoma--increasing the body of evidence in favor of the method.
Topics: Adolescent; Adult; Aged; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymph Nodes; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Ultrasonography | 2002 |
PET imaging in patients with bronchioloalveolar cell carcinoma.
Topics: Adenocarcinoma, Bronchiolo-Alveolar; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Radiopharmaceuticals; Registries; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
Breast cancer imaging with PET and SPECT agents: an in vivo comparison.
Topics: Animals; Breast Neoplasms; Fluorodeoxyglucose F18; Metabolic Clearance Rate; Muscle, Skeletal; Neoplasm Transplantation; Radiometry; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Dimercaptosuccinic Acid; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2002 |
Use of a corrected standardized uptake value based on the lesion size on CT permits accurate characterization of lung nodules on FDG-PET.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Male; Middle Aged; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Solitary Pulmonary Nodule; Subtraction Technique; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
[Differentiation between vital heart muscle tissue and infarct scar using magnetocardiography].
Topics: Adult; Aged; Algorithms; Cicatrix; Diagnosis, Differential; Electrocardiography; Equipment Design; Female; Fluorodeoxyglucose F18; Humans; Magnetics; Male; Middle Aged; Myocardial Infarction; Sensitivity and Specificity; Signal Processing, Computer-Assisted; Tissue Survival; Tomography, Emission-Computed | 2002 |
Clinical role of F-18 fluorodeoxyglucose positron emission tomography imaging in patients with lung cancer and suspected malignant pleural effusion.
Topics: Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Pleural Effusion; Pleural Effusion, Malignant; Pleural Neoplasms; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
Comparison of SUV and Patlak slope for monitoring of cancer therapy using serial PET scans.
Topics: Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Interleukin-2; Kidney Neoplasms; Male; Radiopharmaceuticals; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed; Treatment Outcome | 2003 |
[Relevance of colour-duplex echography for detection and therapy of recurrences in the follow-up of head and neck cancer].
Topics: Adenocarcinoma; Carcinoma, Adenoid Cystic; Carcinoma, Squamous Cell; Combined Modality Therapy; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Leiomyosarcoma; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Otorhinolaryngologic Neoplasms; Sensitivity and Specificity; Survival Rate; Tomography, Emission-Computed; Tomography, X-Ray Computed; Ultrasonography, Doppler, Color | 2002 |
PET imaging using a triple-head gamma camera.
Topics: Adult; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Oligodendroglioma; Phantoms, Imaging; Radiopharmaceuticals; Sarcoidosis; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
Enhancement of the relative uptake of 18F-FDG in mouse fibrosarcoma by rolipram.
Topics: Animals; Brain; Fibrosarcoma; Fluorodeoxyglucose F18; Heart; Hindlimb; Image Enhancement; Male; Mice; Mice, Inbred C3H; Muscle, Skeletal; Myocardium; Neoplasm Transplantation; Plasma; Radionuclide Imaging; Radiopharmaceuticals; Rolipram; Sensitivity and Specificity; Tissue Distribution | 2002 |
The usefulness of fluorine 18-labelled deoxyglucose positron emission tomography in the investigation of patients with cervical lymphadenopathy from an unknown primary tumor.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Male; Middle Aged; Neoplasms, Unknown Primary; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
Screening for cerebral metastases with FDG PET in patients undergoing whole-body staging of non-central nervous system malignancy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brain Neoplasms; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Regression Analysis; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
Prospective use of serial questionnaires to evaluate the therapeutic efficacy of 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) in suspected lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Clinical Protocols; Cohort Studies; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Surveys and Questionnaires; Tomography, Emission-Computed | 2003 |
Initial clinical experience using a new integrated in-line PET/CT system.
Topics: Aged; Brain Neoplasms; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
Where can FDG-PET contribute most to anatomical imaging problems?
Topics: Brain Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
[The (11C) acetate positron emission tomography in prostatic carcinoma. New prospects in metabolic imaging].
Topics: Acetates; Adenocarcinoma; Amino Acids; Biopsy; Carbon Radioisotopes; Choline; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prostate; Prostatic Neoplasms; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
Utility of FDG-PET scanning in lymphoma by WHO classification.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Radiopharmaceuticals; Recurrence; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
Mediastinal lymph node staging in suspected lung cancer: comparison of positron emission tomography with F-18-fluorodeoxyglucose and mediastinoscopy.
Topics: Carcinoma, Bronchogenic; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Male; Mediastinoscopy; Mediastinum; Middle Aged; Neoplasm Staging; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
FDG PET imaging of locally advanced gastric carcinomas: correlation with endoscopic and histopathological findings.
Topics: Fluorodeoxyglucose F18; Follow-Up Studies; Gastroscopy; Humans; Male; Middle Aged; Observer Variation; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Reference Values; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Single-Blind Method; Statistics as Topic; Stomach Neoplasms; Survival Analysis; Survival Rate | 2003 |
Diagnosis in medullary thyroid cancer with [18F]FDG-PET and improvement using a combined PET/CT scanner.
Topics: Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoplasm Metastasis; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms; Thyroidectomy; Tomography, Emission-Computed; Tomography, X-Ray Computed; Whole-Body Irradiation | 2003 |
Detection of metallic implant-associated infections with FDG PET in patients with trauma: correlation with microbiologic results.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone and Bones; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Metals; Middle Aged; Prospective Studies; Prosthesis-Related Infections; Radiopharmaceuticals; Reproducibility of Results; ROC Curve; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
Prediction of left ventricular functional recovery by dobutamine echocardiography, F-18 deoxyglucose or 99mTc sestamibi nuclear imaging in patients with chronic myocardial infarction.
Topics: Aged; Echocardiography, Stress; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction; Myocardial Revascularization; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Recovery of Function; Reproducibility of Results; ROC Curve; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2002 |
Uptake in supraclavicular area fat ("USA-Fat"): description on 18F-FDG PET/CT.
Topics: Adipose Tissue; Adolescent; Adult; Aged; Aged, 80 and over; Child; Clavicle; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Muscle, Skeletal; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Soft Tissue Neoplasms; Subtraction Technique; Tissue Distribution; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
Improved prognostic value of 18F-FDG PET using a simple visual analysis of tumor characteristics in patients with cervical cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Middle Aged; Observer Variation; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Severity of Illness Index; Single-Blind Method; Survival Analysis; Tomography, Emission-Computed; Treatment Outcome; Uterine Cervical Neoplasms | 2003 |
11C-acetate: a new tracer for the evaluation of hepatocellular carcinoma.
Topics: Acetates; Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carbon Radioisotopes; Carcinoma, Hepatocellular; Cholangiocarcinoma; Colonic Neoplasms; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2003 |
Clinically significant inaccurate localization of lesions with PET/CT: frequency in 300 patients.
Topics: Adult; Aged; Breast Neoplasms; Colonic Neoplasms; Diagnostic Errors; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Germanium; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasms; Radioisotopes; Radiopharmaceuticals; Rectal Neoplasms; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Subtraction Technique; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
Pancreatic cancer: preliminary experience with sodium iodide fluorodeoxyglucose positron emission tomography in Australia.
Topics: Fluorodeoxyglucose F18; Humans; Pancreatic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Sodium Iodide; Tomography, Emission-Computed | 2003 |
Assessment of clinical utility of 18F-FDG PET in patients with head and neck cancer: a probability analysis.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Models, Biological; Models, Statistical; Neoplasm Recurrence, Local; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Switzerland; Tomography, Emission-Computed | 2003 |
F-18 FDG positron emission tomography and benign fractures.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Diagnosis, Differential; False Positive Reactions; Fluorodeoxyglucose F18; Fractures, Bone; Humans; Male; Middle Aged; Radiopharmaceuticals; Rib Fractures; Sensitivity and Specificity; Spinal Fractures; Tomography, Emission-Computed | 2003 |
Role of FDG-PET scan in staging of cancer of the esophagus and gastroesophageal junction.
Topics: Esophageal Neoplasms; Esophagogastric Junction; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
Comparison of MR and PET imaging for the evaluation of liver metastases.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Aged, 80 and over; Child; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Melanoma; Middle Aged; Retrospective Studies; Sarcoma; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
Value of F-18 FDG hybrid camera PET and MRI in early takayasu aortitis.
Topics: Aged; Aorta; Aorta, Thoracic; Aortitis; Arteries; Diagnosis, Differential; Female; Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Male; Middle Aged; Muscle, Smooth, Vascular; Prospective Studies; Sensitivity and Specificity; Takayasu Arteritis; Tomography, Emission-Computed | 2003 |
Combined positron emission tomography/computed tomography imaging of recurrent thyroid cancer.
Topics: Adult; Aged; Calcitonin; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Thyroidectomy; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
[(18)F]FDG PET monitoring of tumour response to chemotherapy: does [(18)F]FDG uptake correlate with the viable tumour cell fraction?
Topics: Animals; Antineoplastic Agents, Alkylating; Apoptosis; Burkitt Lymphoma; Cell Division; Cyclophosphamide; Drug Therapy; Female; Fluorodeoxyglucose F18; Humans; Male; Mice; Mice, SCID; Neoplasm Transplantation; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Treatment Outcome | 2003 |
11C-choline PET for the detection of bone and soft tissue tumours in comparison with FDG PET.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biological Transport; Bone Diseases; Bone Neoplasms; Carbon Radioisotopes; Child; Choline; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Radiopharmaceuticals; Regression Analysis; Reproducibility of Results; Sensitivity and Specificity; Soft Tissue Neoplasms; Tomography, Emission-Computed | 2003 |
Melanoma patients evaluated by four different positron emission tomography reconstruction techniques.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymph Nodes; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Skin Neoplasms; Tomography, Emission-Computed | 2003 |
Fluorodeoxyglucose-positron emission tomography imaging versus sentinel node biopsy in the primary staging of melanoma patients.
Topics: Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Skin Neoplasms; Tomography, Emission-Computed | 2003 |
Use of a dual-head coincidence camera and 18F-FDG for detection and nodal staging of non-small cell lung cancer: accuracy as determined by 2 independent observers.
Topics: Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Observer Variation; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
Detection of early recurrence with 18F-FDG PET in patients with cervical cancer.
Topics: Adult; Aged; Carcinoma; Carcinoma, Squamous Cell; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 2003 |
PET detection of melanoma metastases in lymph nodes.
Topics: Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Melanoma; Radiopharmaceuticals; Sensitivity and Specificity; Skin Neoplasms; Tomography, Emission-Computed | 2003 |
Value of [11C]choline-positron emission tomography for re-staging prostate cancer: a comparison with [18F]fluorodeoxyglucose-positron emission tomography.
Topics: Aged; Aged, 80 and over; Biomarkers, Tumor; Carbon Radioisotopes; Choline; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Prostate; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
CT-based attenuation correction in the calculation of semi-quantitative indices of [18F]FDG uptake in PET.
Topics: Algorithms; Artifacts; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Liver Neoplasms; Lung Neoplasms; Mediastinal Neoplasms; Neoplasms; Quality Control; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
The role of [18F]fluorodeoxyglucose positron emission tomography imaging in the evaluation of hepatocellular carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Biopsy; Carcinoma, Hepatocellular; Decision Trees; Female; Fluorodeoxyglucose F18; Hepatectomy; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Necrosis; Neoplasm Recurrence, Local; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
Prevalence and patterns of bone metastases detected with positron emission tomography using F-18 FDG.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Child; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Male; Maryland; Middle Aged; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
18FDG PET scanning of benign and malignant musculoskeletal lesions.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Child; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Radiopharmaceuticals; Sarcoma; Sensitivity and Specificity; Soft Tissue Neoplasms; Tomography, Emission-Computed | 2003 |
Alpha-methyl-L-tryptophan PET detects epileptogenic cortex in children with intractable epilepsy.
Topics: Adolescent; Child; Child, Preschool; Electroencephalography; Energy Metabolism; Epilepsy; Female; Fluorodeoxyglucose F18; Humans; Infant; Magnetic Resonance Imaging; Male; Neocortex; Radiopharmaceuticals; Sensitivity and Specificity; Serotonin; Tomography, Emission-Computed; Treatment Outcome; Tryptophan | 2003 |
Value of 18-F-deoxyglucose (FDG) positron emission tomography (PET) for the diagnosis of pancreatic cancer.
Topics: Fluorodeoxyglucose F18; Humans; Pancreatic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
Mediastinal staging of lung cancer with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography and a dual-head coincidence gamma camera.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Large Cell; Carcinoma, Squamous Cell; Feasibility Studies; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Lung Neoplasms; Lymph Nodes; Mediastinum; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
Nuclear imaging is more sensitive for the detection of viable myocardium than dobutamine echocardiography.
Topics: Coronary Artery Disease; Dobutamine; Echocardiography; Fatty Acids; Fluorodeoxyglucose F18; Glucose; Heart Ventricles; Humans; Iodobenzenes; Middle Aged; Myocardium; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thallium; Tissue Survival; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2003 |
Patient surface radiation doses at two PET imaging facilities.
Topics: Adult; Breast; Female; Fluorodeoxyglucose F18; Gonads; Heart; Humans; Liver; Male; Myocardium; Organ Specificity; Ovary; Radiation Dosage; Radiometry; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Safety; Sensitivity and Specificity; Skin; Thermoluminescent Dosimetry | 2003 |
Myocardial viability in chronic ischemic heart disease: comparison of contrast-enhanced magnetic resonance imaging with (18)F-fluorodeoxyglucose positron emission tomography.
Topics: Adult; Aged; Aged, 80 and over; Chronic Disease; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Myocardial Ischemia; Radiopharmaceuticals; Research Design; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
[18F]-Fluorodeoxyglucose positron emission tomography in patients with suspected recurrence of breast cancer.
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Mucin-1; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
Cost-effectiveness of alternative management strategies for patients with solitary pulmonary nodules.
Topics: Algorithms; Biopsy, Needle; Cost-Benefit Analysis; Decision Support Techniques; Fluorodeoxyglucose F18; Humans; Probability; Quality-Adjusted Life Years; Radiopharmaceuticals; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
Evaluation of 18F-FDG PET in patients with advanced, metastatic, or recurrent gastric cancer.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Sensitivity and Specificity; Stomach Neoplasms; Tomography, Emission-Computed | 2003 |
Detecting metastatic pelvic lymph nodes by 18F-2-deoxyglucose positron emission tomography in patients with prostate-specific antigen relapse after treatment for localized prostate cancer.
Topics: Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Pelvis; Predictive Value of Tests; Prostate-Specific Antigen; Prostatic Neoplasms; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
F-18 fluorodeoxyglucose positron-emission tomography in the diagnosis of tumor recurrence and metastases in the follow-up of patients with breast carcinoma: a comparison to conventional imaging.
Topics: Biomarkers, Tumor; Breast Neoplasms; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
A linear wavelet filter for parametric imaging with dynamic PET.
Topics: Aged; Algorithms; Alzheimer Disease; Brain; Computer Simulation; Fluorodeoxyglucose F18; Humans; Image Enhancement; Linear Models; Male; Models, Biological; Phantoms, Imaging; Raclopride; Radioisotopes; Reproducibility of Results; Sensitivity and Specificity; Signal Processing, Computer-Assisted; Stochastic Processes; Tomography, Emission-Computed | 2003 |
Rapid normalization of osseous FDG uptake following traumatic or surgical fractures.
Topics: Adult; Aged; Aged, 80 and over; Bone and Bones; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Fractures, Bone; Humans; Male; Metabolic Clearance Rate; Middle Aged; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Time Factors; Tomography, Emission-Computed | 2003 |
Applications of fluorodeoxyglucose positron emission tomography in the diagnosis of infection.
Topics: Adult; Chronic Disease; Diagnosis, Differential; Female; Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Infections; Male; Middle Aged; Osteomyelitis; Predictive Value of Tests; Prosthesis-Related Infections; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Soft Tissue Infections; Tomography, Emission-Computed | 2003 |
Metastasis to regional lymph nodes in patients with esophageal squamous cell carcinoma: CT versus FDG PET for presurgical detection prospective study.
Topics: Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
Impact of whole body positron emission tomography on initial staging and therapy in patients with squamous cell carcinoma of the oral cavity.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Mouth Neoplasms; Neoplasm Metastasis; Neoplasm Staging; Neoplasms, Multiple Primary; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
18-Fluorine fluorodeoxyglucose positron emission tomography for the diagnosis of infection in the postoperative spine.
Topics: Adolescent; Adult; Aged; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Lumbar Vertebrae; Male; Middle Aged; Orthopedic Fixation Devices; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Spinal Diseases; Surgical Wound Infection; Tomography, Emission-Computed | 2003 |
New horizons in oncologic imaging.
Topics: Carcinoma, Non-Small-Cell Lung; Contrast Media; Ferric Compounds; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Magnetics; Male; Medical Oncology; Nanotechnology; Neoplasm Staging; Prostatic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
The role of PET scanning in the detection of recurrent cervical cancer.
Topics: Adult; Aged; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 2003 |
A case-controlled study of 18-fluorodeoxyglucose positron emission tomography in the detection of pelvic recurrence in previously irradiated rectal cancer patients.
Topics: Case-Control Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Recurrence, Local; Pelvic Neoplasms; Predictive Value of Tests; Radiopharmaceuticals; Rectal Neoplasms; Sensitivity and Specificity; Tomography, Emission-Computed; Treatment Outcome | 2003 |
Follow-up of women with breast cancer: comparison between MRI and FDG PET.
Topics: Breast Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
Clinical and diagnostic value of preoperative MR mammography and FDG-PET in suspicious breast lesions.
Topics: Breast; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Middle Aged; Preoperative Care; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
Frequent impact of [18F]fluorodeoxyglucose positron emission tomography on the staging and management of patients with indolent non-Hodgkin's lymphoma.
Topics: False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
Preoperative comparison of different noninvasive strategies for predicting improvement in left ventricular function after coronary artery bypass grafting.
Topics: Aged; Coronary Artery Bypass; Echocardiography, Stress; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Postoperative Period; Predictive Value of Tests; Radionuclide Ventriculography; Radiopharmaceuticals; Sensitivity and Specificity; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2003 |
Differential features of metabolic abnormalities between medial and lateral temporal lobe epilepsy: quantitative analysis of (18)F-FDG PET using SPM.
Topics: Adult; Brain Diseases, Metabolic; Brain Mapping; Diagnosis, Differential; Epilepsy, Temporal Lobe; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Radiopharmaceuticals; Reference Values; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Temporal Lobe; Tissue Distribution; Tomography, Emission-Computed | 2003 |
Identification of cardiac sarcoidosis with (13)N-NH(3)/(18)F-FDG PET.
Topics: Adult; Aged; Ammonia; Carbon Isotopes; Cardiomyopathies; Female; Fluorodeoxyglucose F18; Heart; Humans; Male; Middle Aged; Myocardium; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sarcoidosis; Sensitivity and Specificity; Tissue Distribution; Tomography, Emission-Computed | 2003 |
SUV varies with time after injection in (18)F-FDG PET of breast cancer: characterization and method to adjust for time differences.
Topics: Adult; Aged; Breast; Breast Neoplasms; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Metabolic Clearance Rate; Middle Aged; Quality Control; Radiopharmaceuticals; Regression Analysis; Retrospective Studies; Sensitivity and Specificity; Time Factors; Tomography, Emission-Computed | 2003 |
18F-FDG PET versus CT for evaluating the spleen during initial staging of lymphoma.
Topics: Adolescent; Adult; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Single-Blind Method; Spleen; Splenic Neoplasms; Tomography, Emission-Computed; Tomography, Spiral Computed | 2003 |
Automated 3-dimensional registration of stand-alone (18)F-FDG whole-body PET with CT.
Topics: Algorithms; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Lung; Male; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Subtraction Technique; Tomography, Emission-Computed; Tomography, X-Ray Computed; Whole-Body Counting | 2003 |
Clinical value of FDG-PET in the follow up of post-operative patients with endometrial cancer.
Topics: Adult; Aged; Aged, 80 and over; Disease-Free Survival; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Neoplasm Recurrence, Local; Postoperative Care; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Treatment Outcome | 2003 |
Positron emission tomography with FDG in the detection of peritoneal and retroperitoneal metastases of ovarian cancer.
Topics: Adult; Aged; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Peritoneal Neoplasms; Prospective Studies; Retroperitoneal Neoplasms; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
Paraneoplastic syndromes: detection of malignant tumors using [(18)F]FDG-PET.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms; Paraneoplastic Syndromes; Radiography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
Evaluation of the clinical performances of a large NaI(Tl) crystal 3D PET scanner.
Topics: Adult; Aged; Equipment Failure Analysis; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Middle Aged; Neoplasms; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Sodium Iodide; Tomography, Emission-Computed; Transducers | 2003 |
The oncologists' and radiologists' PET.
Topics: Cost-Benefit Analysis; Decision Making; Fluorodeoxyglucose F18; Health Policy; Humans; Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
18-fluoro-2-deoxyglucose positron emission tomography in detecting residual/recurrent nasopharyngeal carcinomas and comparison with magnetic resonance imaging.
Topics: Adolescent; Adult; Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm, Residual; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
Positron emission tomography defines metastatic disease but not locoregional disease in patients with malignant pleural mesothelioma.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Carcinoma; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Magnetic Resonance Imaging; Male; Mesothelioma; Middle Aged; Neoplasm Staging; New York; Pleural Neoplasms; Predictive Value of Tests; Radiopharmaceuticals; Sarcoma; Sensitivity and Specificity; Statistics as Topic; Thoracic Cavity; Thoracic Surgical Procedures; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome | 2003 |
[FDG PET as an early nuclear medical diagnostic tool for aseptic wear-induced loosening of hip joint endoprostheses--a report of two cases].
Topics: Acetabulum; Aged; Blood Glucose; Early Diagnosis; Female; Femur; Fluorodeoxyglucose F18; Hip Prosthesis; Humans; Male; Middle Aged; Postoperative Complications; Prosthesis Failure; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
The usefulness of a repeat study for differentiating between bowel activity and local tumor recurrence on FDG PET scans.
Topics: Colon; Diagnosis, Differential; Enema; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Quality Control; Rectal Neoplasms; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
Prognostic value of PET using 18F-FDG in Hodgkin's disease for posttreatment evaluation.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Prognosis; Radiography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Treatment Outcome | 2003 |
FGD-PET in the follow-up of recurrent colorectal cancer.
Topics: Adult; Aged; Colorectal Neoplasms; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Predictive Value of Tests; Sensitivity and Specificity; Tomography, Emission-Computed; Treatment Outcome | 2003 |
Detection of lung cancer with positron coincidence gamma camera using fluorodeoxyglucose in comparison with dedicated PET.
Topics: Adult; Aged; Aged, 80 and over; Electrons; Feasibility Studies; Female; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Lung Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
[PET with (18)F-fluorodeoxyglucose for staging of non-small cell lung cancer].
Topics: Carcinoma, Non-Small-Cell Lung; Cost-Benefit Analysis; Databases, Factual; Evidence-Based Medicine; Fluorodeoxyglucose F18; Germany; Humans; Lung Neoplasms; Neoplasm Staging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
[Evaluation of positron emission tomography in diagnosing and staging of lung cancer].
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
Solitary pulmonary nodules: impact of quantitative contrast-enhanced CT on the cost-effectiveness of FDG-PET.
Topics: Cost-Benefit Analysis; Decision Trees; Fluorodeoxyglucose F18; Humans; Radiographic Image Enhancement; Radiopharmaceuticals; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, Emission-Computed; Tomography, X-Ray Computed; United Kingdom | 2003 |
Compare FDG-PET and Tc-99m tetrofosmin SPECT to detect metastatic thyroid carcinoma.
Topics: Adult; Aged; Carcinoma, Papillary, Follicular; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Iodine Radioisotopes; Male; Middle Aged; Organophosphorus Compounds; Organotechnetium Compounds; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2003 |
Peritoneal carcinomatosis: role of (18)F-FDG PET.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Carcinoma; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms, Mesothelial; Ovarian Neoplasms; Peritoneal Neoplasms; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Stomach Neoplasms | 2003 |
Comparative biodistribution of iodinated amino acids in rats: selection of the optimal analog for oncologic imaging outside the brain.
Topics: Amino Acids; Animals; Brain Neoplasms; Fluorodeoxyglucose F18; Inflammation; Iodine Radioisotopes; Methyltyrosines; Neoplasm Transplantation; Organ Specificity; Radionuclide Imaging; Radiopharmaceuticals; Rats; Reproducibility of Results; Rhabdomyosarcoma; Sensitivity and Specificity; Tissue Distribution; Turpentine; Whole-Body Counting | 2003 |
The role of FDG-PET scan in staging patients with nonsmall cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinoscopy; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
Staging of head and neck tumors: [18F]fluorodeoxyglucose positron emission tomography compared with physical examination and conventional imaging modalities.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chi-Square Distribution; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymph Nodes; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
Uptake rates of 18F-fluorodeoxyglucose and 11C-choline in lung cancer and pulmonary tuberculosis: a positron emission tomography study.
Topics: Aged; Aged, 80 and over; Blood Glucose; Carbon Radioisotopes; Choline; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, Emission-Computed; Tuberculosis, Pulmonary | 2003 |
Positron emission tomography in presurgical localization of epileptic foci.
Topics: Adolescent; Adult; Brain; Carbon Radioisotopes; Electroencephalography; Epilepsy; Female; Flumazenil; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Preoperative Care; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Treatment Outcome | 2003 |
Optimal dose of 18F-FDG required for whole-body PET using an LSO PET camera.
Topics: Dose-Response Relationship, Drug; Equipment Failure Analysis; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Lutetium; Male; Middle Aged; Neoplasms; Quality Control; Radiation Protection; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Silicates; Tomography, Emission-Computed; Whole-Body Counting | 2003 |
Roles of positron emission tomography with fluorine-18-deoxyglucose in the detection of local recurrent and distant metastatic sarcoma.
Topics: Adolescent; Adult; Aged; Child; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sarcoma; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome | 2003 |
Value of dual-phase 2-fluoro-2-deoxy-d-glucose positron emission tomography in cervical cancer.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2003 |
Non-small cell lung cancer: dual-modality PET/CT in preoperative staging.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
Is [18F]-2-fluoro-2-deoxy-d-glucose (FDG) scintigraphy with non-dedicated positron emission tomography useful in the diagnostic management of suspected metastatic thyroid carcinoma in patients with no detectable radioiodine uptake?
Topics: Adenocarcinoma, Follicular; Adenoma, Oxyphilic; Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Prospective Studies; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Thyroidectomy; Tomography, Emission-Computed | 2003 |
[Biologic characterization of soft tissue sarcomes by positron emission tomography (initial results)].
Topics: Amino Acid Transport System A; Aminoisobutyric Acids; Blood Glucose; Carbon Radioisotopes; Fluorodeoxyglucose F18; Humans; Infusions, Intravenous; Neoplasm Proteins; Oxygen Radioisotopes; Regional Blood Flow; Sarcoma; Sensitivity and Specificity; Soft Tissue Neoplasms; Tomography, Emission-Computed | 1998 |
Clinical value of FDG PET in patients with fever of unknown origin and patients suspected of focal infection or inflammation.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; False Negative Reactions; False Positive Reactions; Female; Fever of Unknown Origin; Fluorodeoxyglucose F18; Focal Infection; Humans; Inflammation; Male; Middle Aged; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 2004 |
Evaluation of head and neck squamous cell carcinoma after treatment.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2003 |
Comment on Meller et al.: Value of F-18 FDG hybrid camera PET and MRI in early Takayasu aortitis.
Topics: Aged; Aorta; Aorta, Thoracic; Arteries; Diagnosis, Differential; Female; Fever of Unknown Origin; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Image Enhancement; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Male; Middle Aged; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Takayasu Arteritis; Temporal Arteries; Tomography, Emission-Computed; Ultrasonography | 2004 |
Discrepant uptake between fluorine-18 fluorodeoxy glucose and Tc-99m sestamibi in bronchioloalveolar cell carcinoma.
Topics: Adenocarcinoma, Bronchiolo-Alveolar; Aged; Diagnosis, Differential; False Negative Reactions; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Radiography; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 2003 |
FDG-PET in infectious and inflammatory disease.
Topics: Diagnosis, Differential; Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Infections; Inflammation; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
FDG-PET in infectious and inflammatory disease.
Topics: Diagnosis, Differential; Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Infections; Inflammation; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
F-18 fluorodeoxyglucose positron emission tomography in the evaluation of distant metastases from renal cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
Importance of F18-fluorodeoxy-D-2-glucose positron emission tomography (FDG-PET) for staging and therapy control of Hodgkin's lymphoma in childhood and adolescence - consequences for the GPOH-HD 2003 protocol.
Topics: Adolescent; Blood Glucose; Child; Combined Modality Therapy; Disease-Free Survival; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Neoplasm Staging; Neoplasm, Residual; Prognosis; Radiotherapy, Adjuvant; Sensitivity and Specificity; Tomography, Emission-Computed; Treatment Outcome; Whole-Body Counting | 2003 |
[Positron emission tomography for preoperative lymph node diagnosis in esophageal carcinoma].
Topics: Adenocarcinoma; Aged; Biopsy; Carcinoma, Squamous Cell; Esophageal Neoplasms; Esophagectomy; Esophagus; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Patient Care Planning; Prospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
[A case of curative resection of local recurrence after abdominosacral resection of recurrent rectal cancer based on the diagnosis of PET/CT fusion images].
Topics: Aged; Diagnosis, Differential; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Recurrence, Local; Radiopharmaceuticals; Rectal Neoplasms; Rectum; Sacrococcygeal Region; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
18F-choline in experimental soft tissue infection assessed with autoradiography and high-resolution PET.
Topics: Animals; Autoradiography; Choline; Fluorodeoxyglucose F18; Metabolic Clearance Rate; Muscle, Skeletal; Myositis; Neoplasms; Organ Specificity; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Sensitivity and Specificity; Soft Tissue Infections; Staphylococcal Infections; Tissue Distribution | 2004 |
Augmentation effects of lymphocyte activation by antigen-presenting macrophages on FDG uptake.
Topics: Adult; Animals; Antigen-Presenting Cells; Cells, Cultured; Fluorodeoxyglucose F18; Humans; Lymphocyte Activation; Macrophages; Male; Mice; Mice, Inbred C57BL; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Spleen | 2003 |
Measurement of 18F-FDG concentrations in blood samples: comparison of direct calibration and standard solution methods.
Topics: Blood Chemical Analysis; Calibration; Fluorodeoxyglucose F18; Humans; Radioisotope Dilution Technique; Radiometry; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2003 |
Comparison of FDG-PET and dynamic contrast-enhanced MRI in the evaluation of suggestive breast lesions.
Topics: Adenocarcinoma; Adult; Aged; Breast Diseases; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
Application of a neural network to improve nodal staging accuracy with 18F-FDG PET in non-small cell lung cancer.
Topics: Aged; Artificial Intelligence; Carcinoma, Non-Small-Cell Lung; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Neural Networks, Computer; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2003 |
High predictive value of F-18 FDG PET patterns of the spine for metastases or benign lesions with good agreement between readers.
Topics: Breast Neoplasms; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Observer Variation; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Spinal Neoplasms; Tomography, Emission-Computed | 2003 |
[The role of positron emission tomography with C18-Fluorodeoxyglucose in clinical oncology].
Topics: Brain Neoplasms; Breast Neoplasms; Carbon Radioisotopes; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphoma; Male; Medical Oncology; Neoplasms; Outcome Assessment, Health Care; Pancreatic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Testicular Neoplasms; Tomography, Emission-Computed | 2003 |
Positron emission tomography using [18F]fluorodeoxyglucose (FDG-PET) in the clinically negative neck: is it likely to be superior?
Topics: Adult; Aged; Biopsy, Needle; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Immunohistochemistry; Lymph Nodes; Magnetic Resonance Imaging; Male; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Pharyngeal Neoplasms; Positron-Emission Tomography; Risk Assessment; Sampling Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2004 |
Positron emission tomography with 2-[18f]fluoro-2-deoxy-D-glucose: can it be used to accurately stage the mediastinum in non-small cell lung cancer as an alternative to mediastinoscopy?
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mediastinoscopy; Neoplasm Staging; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
A comparative analysis of positron emission tomography and mediastinoscopy in staging non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinoscopy; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
Fluorodeoxyglucose positron emission tomography improves preoperative staging of resectable lung metastasis.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
Diagnostic role of [F-18]-FDG positron emission tomography in restaging renal cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
Detection of clinically unexpected malignant and premalignant tumors with whole-body FDG PET: histopathologic comparison.
Topics: Aged; Aged, 80 and over; Biopsy; Blood Glucose; Energy Metabolism; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Incidental Findings; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Neoplasms, Multiple Primary; Precancerous Conditions; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
Fluorine 18 fluorodeoxyglucose positron emission tomography in the diagnosis and follow-up of three patients with vasculitis.
Topics: Aged; Aortitis; Blood Glucose; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Granulomatosis with Polyangiitis; Humans; Immunosuppressive Agents; Male; Polyarteritis Nodosa; Prednisone; Sensitivity and Specificity; Tomography, Emission-Computed; Vasculitis | 2004 |
Modulation of cortical-limbic pathways in major depression: treatment-specific effects of cognitive behavior therapy.
Topics: Adult; Ambulatory Care; Antidepressive Agents, Second-Generation; Blood Glucose; Brain Mapping; Cerebral Cortex; Cognitive Behavioral Therapy; Depressive Disorder, Major; Energy Metabolism; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Frontal Lobe; Humans; Limbic System; Male; Middle Aged; Nerve Net; Neural Pathways; Outcome and Process Assessment, Health Care; Paroxetine; Personality Inventory; Prefrontal Cortex; Sensitivity and Specificity; Tomography, Emission-Computed | 2004 |
F-18-fluorodeoxyglucose positron emission tomography in diagnosis and follow-up of patients with different types of vasculitis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Female; Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Netherlands; Prednisone; Sensitivity and Specificity; Tomography, Emission-Computed; Vasculitis | 2003 |
[Early prediction of treatment response to high-dose chemotherapy in patients with relapsed germ cell tumors using [18F]FDG-PET, CT or MRI, and tumor marker].
Topics: Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Chorionic Gonadotropin, beta Subunit, Human; Fluorodeoxyglucose F18; Follow-Up Studies; Germany; Germinoma; Humans; Karnofsky Performance Status; Logistic Models; Magnetic Resonance Imaging; Male; Middle Aged; Multicenter Studies as Topic; Neoplasm Recurrence, Local; Patient Selection; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Seminoma; Sensitivity and Specificity; Testicular Neoplasms; Time Factors; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
Imaging of experimental colitis with a radiolabeled leukotriene B4 antagonist.
Topics: Animals; Biphenyl Compounds; Colitis; Female; Fluorodeoxyglucose F18; Granulocytes; Isotope Labeling; Leukotriene B4; Neutrophils; Oligopeptides; Organ Specificity; Pyridines; Rabbits; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Exametazime; Tetrazoles; Tissue Distribution; Whole-Body Counting | 2004 |
Value of FDG PET imaging in the management of patients with thyroid, neuroendocrine, and neural crest tumors.
Topics: Fluorodeoxyglucose F18; Neoplasm Recurrence, Local; Nervous System Neoplasms; Neural Crest; Neuroendocrine Tumors; Patient Care Management; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, Emission-Computed | 2004 |
The role of [(18)F] FDG-PET, CT/MRI and tumor marker kinetics in the evaluation of post chemotherapy residual masses in metastatic germ cell tumors--prospects for management.
Topics: Adult; Biomarkers, Tumor; Fluorodeoxyglucose F18; Germinoma; Humans; Magnetic Resonance Imaging; Middle Aged; Neoplasm, Residual; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2004 |
18F-FDG PET complemented with sentinel lymph node biopsy in the detection of axillary involvement in breast cancer.
Topics: Adult; Aged; Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Radiopharmaceuticals; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Tomography, Emission-Computed | 2004 |
Restaging of recurrent cervical carcinoma with dual-phase [18F]fluoro-2-deoxy-D-glucose positron emission tomography.
Topics: Adult; Aged; Aged, 80 and over; Biopsy, Needle; Confidence Intervals; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Probability; Prospective Studies; Risk Assessment; Salvage Therapy; Sensitivity and Specificity; Survival Analysis; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome; Uterine Cervical Neoplasms | 2004 |
Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma.
Topics: Adult; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Female; Fluorodeoxyglucose F18; Gallbladder Neoplasms; Humans; Male; Middle Aged; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2004 |
Combined positron emission tomography - computed tomography improves specificity for thyroid carcinoma by identifying vocal cord activity after laryngeal nerve paralysis.
Topics: Carcinoma, Papillary; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Male; Middle Aged; Neck; Neoplasm Recurrence, Local; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed; Vocal Cord Paralysis; Vocal Cords | 2003 |
PET scans superior to CT for detection of colon cancer spread.
Topics: Colonic Neoplasms; Fluorodeoxyglucose F18; Humans; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
Intraoperative radiation therapy in liver tissue in a pig model: monitoring with dual-modality PET/CT.
Topics: Anastomosis, Roux-en-Y; Animals; Bile Ducts, Extrahepatic; Brachytherapy; Combined Modality Therapy; Dilatation, Pathologic; Energy Metabolism; Female; Fluorodeoxyglucose F18; Hepatic Artery; Hepatic Duct, Common; Image Interpretation, Computer-Assisted; Jejunum; Liver; Liver Regeneration; Necrosis; Particle Accelerators; Portal Vein; Radiation Injuries, Experimental; Sensitivity and Specificity; Swine; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
Impact of positron emission tomography on strategy in liver resection for primary and secondary liver tumors.
Topics: Adenoma, Liver Cell; Breast Neoplasms; Carcinoma, Hepatocellular; Colorectal Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Male; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2004 |
Evaluation of pleural disease with 18-fluorodeoxyglucose positron emission tomography imaging.
Topics: Adult; Aged; Aged, 80 and over; Biopsy, Needle; Confidence Intervals; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Male; Middle Aged; Pleural Diseases; Pleural Effusion; Pleural Neoplasms; Predictive Value of Tests; Prospective Studies; Sensitivity and Specificity; Severity of Illness Index; Tomography, Emission-Computed | 2004 |
The utility of 99mTc depreotide compared with F-18 fluorodeoxyglucose positron emission tomography and surgical staging in patients with suspected non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Biopsy, Needle; Carcinoma, Non-Small-Cell Lung; Cohort Studies; Confidence Intervals; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Probability; Prospective Studies; Sensitivity and Specificity; Technetium Tc 99m Pentetate; Tomography, Emission-Computed | 2004 |
Respiratory gating for 3-dimensional PET of the thorax: feasibility and initial results.
Topics: Adult; Artifacts; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Male; Phantoms, Imaging; Radiopharmaceuticals; Respiration; Sensitivity and Specificity; Thorax; Tomography, Emission-Computed | 2004 |
Evaluation of 18F-2-deoxy-2-fluoro-D-glucose positron emission tomography for gastric cancer.
Topics: Adult; Aged; Aged, 80 and over; Biopsy, Needle; Female; Fluorodeoxyglucose F18; Gastrectomy; Humans; Immunohistochemistry; Lymph Nodes; Male; Middle Aged; Monitoring, Physiologic; Neoplasm Staging; Postoperative Period; Probability; Risk Assessment; Sensitivity and Specificity; Statistics, Nonparametric; Stomach Neoplasms; Survival Analysis; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome | 2004 |
The clinical relevance of thymic fluorodeoxyglucose uptake in pediatric patients after chemotherapy.
Topics: Adolescent; Child; Child, Preschool; Diagnosis, Differential; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Humans; Infant; Infant, Newborn; Male; Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Thymus Gland; Thymus Neoplasms | 2004 |
Can post-RT neck dissection be omitted for patients with head-and-neck cancer who have a negative PET scan after definitive radiation therapy?
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Neck Dissection; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
Time course of tumor metabolic activity during chemoradiotherapy of esophageal squamous cell carcinoma and response to treatment.
Topics: Aged; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Combined Modality Therapy; Disease-Free Survival; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Preoperative Care; Prognosis; Prospective Studies; Radiotherapy, Adjuvant; Risk Assessment; Sensitivity and Specificity; Survival Analysis; Tomography, Emission-Computed; Treatment Outcome | 2004 |
Head and neck cancer: clinical usefulness and accuracy of PET/CT image fusion.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Image Interpretation, Computer-Assisted; Lymph Nodes; Male; Middle Aged; Muscle, Skeletal; Patient Care; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
F-18-FDG uptake is a reliable predictory of functional recovery of akinetic but viable infarct regions as defined by magnetic resonance imaging before and after revascularization.
Topics: Adult; Aged; Coronary Angiography; Dobutamine; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction; Myocardial Revascularization; Myocardium; Predictive Value of Tests; Radiopharmaceuticals; Recovery of Function; Sensitivity and Specificity; Tissue Survival; Tomography, Emission-Computed; Ventricular Function, Left | 2004 |
Diagnostic management of suspected metastatic thyroid carcinoma: clinical value of octreotide scintigraphy in patients with negative high-dose radioiodine scans.
Topics: Adult; Aged; Biopsy, Fine-Needle; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Indium Radioisotopes; Iodine Radioisotopes; Male; Middle Aged; Octreotide; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Somatostatin; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Tomography, Emission-Computed; Whole-Body Counting | 2004 |
2-18fluoro-deoxy-D-glucose positron emission tomography is a reliable predictor for viable tumor in postchemotherapy seminoma: an update of the prospective multicentric SEMPET trial.
Topics: Austria; Clinical Trials as Topic; Fluorodeoxyglucose F18; Follow-Up Studies; Germany; Humans; Male; Neoplasm, Residual; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Seminoma; Sensitivity and Specificity; Testicular Neoplasms; Tomography, Emission-Computed | 2004 |
FDG-PET for the pre-operative evaluation of colorectal liver metastases.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Hepatectomy; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, Spiral Computed | 2004 |
Lymph node false-positive FDG-PET after recent surgery in primary melanoma.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Male; Melanoma; Middle Aged; Neoplasm Recurrence, Local; Sensitivity and Specificity; Skin Neoplasms; Tomography, Emission-Computed | 2004 |
Myocardial ischemia, fluorodeoxyglucose, and severity of coronary artery stenosis: the complexities of metabolic remodeling in hibernating myocardium.
Topics: Coronary Stenosis; Energy Metabolism; Exercise Test; Fasting; Fluorodeoxyglucose F18; Humans; Myocardial Ischemia; Myocardial Stunning; Myocardium; Radiopharmaceuticals; Sampling Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2004 |
The size of metastatic foci and lymph nodes yielding false-negative and false-positive lymph node staging with positron emission tomography in patients with lung cancer.
Topics: Adenocarcinoma; Aged; Carcinoma, Adenosquamous; Carcinoma, Large Cell; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Carcinosarcoma; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
[18F] 3-deoxy-3'-fluorothymidine positron emission tomography: alternative or diagnostic adjunct to 2-[18f]-fluoro-2-deoxy-D-glucose positron emission tomography in the workup of suspicious central focal lesions?
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Bronchogenic; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; False Positive Reactions; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Male; Middle Aged; Neoplasm Staging; Neoplasms, Multiple Primary; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2004 |
Use of FDG-microPET for detection of small nodules in a rabbit model of pulmonary metastatic cancer.
Topics: Animals; Carcinoma; Cell Line, Tumor; Disease Models, Animal; Fluorodeoxyglucose F18; Lung Neoplasms; Rabbits; Radiography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, Emission-Computed | 2004 |
Tetraphenylphosphonium as a novel molecular probe for imaging tumors.
Topics: Animals; Cell Line, Tumor; Diagnosis, Differential; Fluorodeoxyglucose F18; Inflammation; Male; Mice; Mice, Nude; Molecular Probes; Neoplasms; Onium Compounds; Organ Specificity; Organophosphorus Compounds; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Tomography, Emission-Computed; Tuberculosis, Cutaneous | 2004 |
Measurement of cerebral glucose metabolic rates in the anesthetized rat by dynamic scanning with 18F-FDG, the ATLAS small animal PET scanner, and arterial blood sampling.
Topics: Anesthesia; Animals; Blood Glucose; Brain; Brain Mapping; Equipment Failure Analysis; Fluorodeoxyglucose F18; Glucose; Male; Metabolic Clearance Rate; Radioisotope Dilution Technique; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Tomography, Emission-Computed | 2004 |
Selectivity of 18F-FLT and 18F-FDG for differentiating tumor from inflammation in a rodent model.
Topics: Animals; Diagnosis, Differential; Dideoxynucleosides; Disease Models, Animal; Fluorodeoxyglucose F18; Glioma; Inflammation; Male; Metabolic Clearance Rate; Organ Specificity; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Wistar; Reproducibility of Results; Rodentia; Sensitivity and Specificity; Tissue Distribution; Turpentine | 2004 |
A lesion detection observer study comparing 2-dimensional versus fully 3-dimensional whole-body PET imaging protocols.
Topics: Algorithms; Computer Simulation; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Models, Biological; Neoplasms; Observer Variation; Phantoms, Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed; Whole-Body Counting | 2004 |
Accuracy and cost-effectiveness of [18F]-2-fluoro-deoxy-D-glucose-positron emission tomography scan in potentially resectable non-small cell lung cancer.
Topics: Algorithms; Carcinoma, Non-Small-Cell Lung; Cost-Benefit Analysis; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Mediastinoscopy; Neoplasm Staging; Predictive Value of Tests; Retrospective Studies; Sensitivity and Specificity; Thoracotomy; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
Anatomical-based FDG-PET reconstruction for the detection of hypo-metabolic regions in epilepsy.
Topics: Algorithms; Brain; Brain Mapping; Epilepsy; Fluorodeoxyglucose F18; Glucose; Humans; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Phantoms, Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, Emission-Computed | 2004 |
PET/CT: artifacts caused by bowel motion.
Topics: Abdominal Neoplasms; Artifacts; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Intestinal Mucosa; Intestines; Male; Middle Aged; Movement; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Subtraction Technique; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
The influence of thyroglobulin on functional imaging in differentiated thyroid cancer.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lymphatic Metastasis; Male; Middle Aged; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Thyrotropin; Tomography, Emission-Computed; Whole-Body Counting | 2004 |
Lymph node staging in lung cancer using [18F]FDG-PET.
Topics: Adenocarcinoma; Adult; Aged; Carcinoid Tumor; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
Non-small cell lung cancer: evaluation of pleural abnormalities on CT scans with 18F FDG PET.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Contrast Media; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Pleural Diseases; Pleural Neoplasms; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
Analysis models to assess cost effectiveness of the four strategies for the work-up of solitary pulmonary nodules.
Topics: Cost-Benefit Analysis; Decision Trees; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mass Screening; Prevalence; Radiopharmaceuticals; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
18FDG imaging of giant cell arteritis: usefulness of whole-body plus brain PET.
Topics: Adolescent; Adult; Arteries; Arteriosclerosis; Arteritis; Brain; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Glucose; Humans; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Takayasu Arteritis; Tomography, Emission-Computed; Vasculitis | 2004 |
Parietal lobe epilepsy: the semiology, yield of diagnostic workup, and surgical outcome.
Topics: Adolescent; Adult; Brain Mapping; Child; Electroencephalography; Epilepsy; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Neocortex; Parietal Lobe; Preoperative Care; Prognosis; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2004 |
A catheter-based radiation detector for endovascular detection of atheromatous plaques.
Topics: Animals; Carotid Stenosis; Catheterization; Coronary Artery Disease; Equipment Design; Equipment Failure Analysis; Fluorodeoxyglucose F18; Humans; Phantoms, Imaging; Radiation Dosage; Radiometry; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Scintillation Counting; Sensitivity and Specificity | 2004 |
The performance of( 18)F-fluorodeoxyglucose positron emission tomography in small solitary pulmonary nodules.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Single-Blind Method; Solitary Pulmonary Nodule | 2004 |
18F-FDG PET in rheumatoid arthritis: there still is a long way to go.
Topics: Arthritis, Rheumatoid; Fluorodeoxyglucose F18; Humans; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Severity of Illness Index; Synovitis; Tomography, Emission-Computed | 2004 |
GLUT1 expression in tissue and (18)F-FDG uptake.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Diagnostic Errors; False Positive Reactions; Female; Fluorodeoxyglucose F18; Germinal Center; Glucose Transporter Type 1; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Monosaccharide Transport Proteins; Neoplasm Staging; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic | 2004 |
Fluorodeoxyglucose positron emission tomography and CT after talc pleurodesis.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Pleural Effusion, Malignant; Pleurodesis; Retrospective Studies; Risk Assessment; Sensitivity and Specificity; Talc; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome | 2004 |
[Positron emission tomography using 18-FDG-PET in radiologically indeterminate pulmonary lesions].
Topics: Adult; Aged; Diagnosis, Differential; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Predictive Value of Tests; Radiography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, Emission-Computed | 2004 |
Staging in patients with locoregionally recurrent breast cancer: current practice and prospects for positron emission tomography.
Topics: Adult; Aged; Breast Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Surveys and Questionnaires; Tomography, Emission-Computed | 2004 |
Nodules, CT-scans and PET-scans: a good partnership.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
Source of impaired image quality in 3D whole-body FDG PET scanning.
Topics: Artifacts; Dose-Response Relationship, Drug; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Imaging, Three-Dimensional; Lutetium; Male; Middle Aged; Neoplasms; Positron-Emission Tomography; Quality Control; Radiation Protection; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Silicates; Whole-Body Counting | 2004 |
Imaging techniques in the assessment of myocardial hibernation.
Topics: Adult; Aged; Ammonia; Carbon Radioisotopes; Exercise Test; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocardial Stunning; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Thallium; Tomography, Emission-Computed, Single-Photon; Ultrasonography | 2004 |
Impact of FDG-PET for staging of oesophageal cancer.
Topics: Adult; Aged; Aged, 80 and over; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2004 |
Positron emission tomography (PET) in the staging of head neck cancer: comparison between PET and CT.
Topics: Aged; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
(18)F-FDG accumulation in atherosclerotic plaques: immunohistochemical and PET imaging study.
Topics: Animals; Aorta, Abdominal; Aorta, Thoracic; Arteriosclerosis; Fluorodeoxyglucose F18; Macrophages; Rabbits; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2004 |
A prospective analysis of positron emission tomography and conventional imaging for detection of stage IV metastatic melanoma in patients undergoing metastasectomy.
Topics: Adult; Diagnostic Imaging; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Neoplasm Metastasis; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2004 |
Role of F18-FDG PET for monitoring of radiochemotherapy -- estimation of detectable number of tumour cells.
Topics: Cell Count; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Pancreatic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Treatment Outcome | 2004 |
Comparison of different SUV-based methods for monitoring cytotoxic therapy with FDG PET.
Topics: Algorithms; Antineoplastic Agents; Cisplatin; Fluorodeoxyglucose F18; Image Interpretation, Computer-Assisted; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Statistics as Topic; Stomach Neoplasms; Treatment Outcome | 2004 |
Detection of recurrent cervical cancer by whole-body FDG PET scan in asymptomatic and symptomatic women.
Topics: Adult; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Uterine Cervical Neoplasms; Whole-Body Counting | 2004 |
Impact of FDG PET on defining the extent of disease and on the treatment of patients with recurrent or metastatic breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Chi-Square Distribution; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 2004 |
Diffuse splenic metastases from seminoma visualized on FDG PET.
Topics: Adult; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Staging; Radiopharmaceuticals; Seminoma; Sensitivity and Specificity; Splenic Neoplasms; Testicular Neoplasms; Tomography, Emission-Computed | 2004 |
Relationship between non-small cell lung cancer fluorodeoxyglucose uptake at positron emission tomography and surgical stage with relevance to patient prognosis.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Prognosis; Sensitivity and Specificity; Tomography, Emission-Computed | 2004 |
Optimization and performance evaluation of the microPET II scanner for in vivo small-animal imaging.
Topics: Animals; Bone and Bones; Brain; Equipment Design; Equipment Failure Analysis; Fluorodeoxyglucose F18; Glucose; Mice; Miniaturization; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Reproducibility of Results; Sensitivity and Specificity; Whole-Body Counting | 2004 |
Antibody-positive paraneoplastic neurologic syndromes: value of CT and PET for tumor diagnosis.
Topics: Adenocarcinoma; Adult; Aged; Antibody Specificity; Autoantibodies; Autoimmune Diseases of the Nervous System; Carcinoma; Carcinoma, Small Cell; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms, Unknown Primary; Neuroblastoma; Neurons; Ovarian Neoplasms; Paraneoplastic Polyneuropathy; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Spiral Computed | 2004 |
Value of positron emission tomography in the diagnosis of recurrent oesophageal carcinoma.
Topics: Adult; Aged; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 2004 |
Impact of 18F-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in patients with biochemical evidence of recurrent or residual medullary thyroid cancer.
Topics: Adolescent; Adult; Aged; Biomarkers, Tumor; Chi-Square Distribution; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms; Thyroidectomy; Tomography, Emission-Computed | 2004 |
In vitro proton magnetic resonance spectroscopic lactate and choline measurements, 18F-FDG uptake, and prognosis in patients with lung adenocarcinoma.
Topics: Adenocarcinoma; Aged; Choline; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Japan; Lactic Acid; Lung Neoplasms; Magnetic Resonance Spectroscopy; Male; Middle Aged; Prognosis; Protons; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Statistics as Topic; Survival Analysis | 2004 |
Absolute quantification of regional cerebral glucose utilization in mice by 18F-FDG small animal PET scanning and 2-14C-DG autoradiography.
Topics: Anesthetics; Animals; Autoradiography; Brain; Brain Mapping; Carbon Radioisotopes; Deoxyglucose; Feasibility Studies; Fluorodeoxyglucose F18; Glucose; Image Interpretation, Computer-Assisted; Male; Metabolic Clearance Rate; Mice; Mice, Inbred BALB C; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Tomography, Emission-Computed | 2004 |
Comparative 18F-FDG PET of experimental Staphylococcus aureus osteomyelitis and normal bone healing.
Topics: Animals; Diagnosis, Differential; Disease Models, Animal; Fluorodeoxyglucose F18; Male; Osteomyelitis; Rabbits; Radiopharmaceuticals; Reference Values; Reproducibility of Results; Sensitivity and Specificity; Staphylococcal Infections; Tibia; Tomography, Emission-Computed; Wound Healing | 2004 |
Direct comparison of 18F-FDG and 11C-methionine PET in suspected recurrence of glioma: sensitivity, inter-observer variability and prognostic value.
Topics: Adolescent; Adult; Aged; Belgium; Brain Neoplasms; Child; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Methionine; Middle Aged; Neoplasm Recurrence, Local; Observer Variation; Positron-Emission Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Risk Assessment; Risk Factors; Sensitivity and Specificity; Survival Analysis | 2005 |
11C-methionine PET as a prognostic marker in patients with glioma: comparison with 18F-FDG PET.
Topics: Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioma; Humans; Korea; Male; Methionine; Middle Aged; Positron-Emission Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Risk Assessment; Risk Factors; Sensitivity and Specificity; Survival Analysis | 2005 |
Preoperative F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value predicts survival after lung cancer resection.
Topics: Adult; Aged; Carcinoid Tumor; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Predictive Value of Tests; Preoperative Care; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Survival Analysis; Tomography, Emission-Computed | 2004 |
Don't give up your gamma probe.
Topics: Axilla; Biopsy; Breast Neoplasms; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2004 |
Role of FDG-PET in surgical management of patients with colorectal liver metastases.
Topics: Aged; Carcinoembryonic Antigen; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Treatment Outcome | 2004 |
Uptake of 2-[18F]fluoro-2-deoxy-D-glucose in uterine leiomyoma: imaging of four patients by coincidence positron emission tomography.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Leiomyoma; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Uterine Neoplasms | 2004 |
Evaluation of anatomy based reconstruction for partial volume correction in brain FDG-PET.
Topics: Adult; Algorithms; Anterior Temporal Lobectomy; Blood Glucose; Brain; Brain Mapping; Epilepsy, Temporal Lobe; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Likelihood Functions; Mathematical Computing; Monte Carlo Method; Phantoms, Imaging; Positron-Emission Tomography; Postoperative Complications; Sensitivity and Specificity | 2004 |
FDG-PET scan in local follow-up of irradiated head and neck squamous cell carcinomas.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Male; Middle Aged; Oropharyngeal Neoplasms; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2004 |
Fever of unknown origin: prospective comparison of diagnostic value of (18)F-FDG PET and (111)In-granulocyte scintigraphy.
Topics: Adult; Aged; Aged, 80 and over; Female; Fever of Unknown Origin; Fluorodeoxyglucose F18; Granulocytes; Humans; Indium Radioisotopes; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2004 |
Comparison of methods to quantitate 18F-FDG uptake with PET during experimental acute lung injury.
Topics: Animals; Computer Simulation; Disease Models, Animal; Dogs; Fluorodeoxyglucose F18; Image Interpretation, Computer-Assisted; Kinetics; Models, Biological; Radioisotope Dilution Technique; Radiopharmaceuticals; Reproducibility of Results; Respiratory Distress Syndrome; Sensitivity and Specificity; Tomography, Emission-Computed | 2004 |
Combined use of 18F-fluorodeoxyglucose and 11C-methionine in 45 positron emission tomography-guided stereotactic brain biopsies.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biopsy; Brain; Brain Diseases; Brain Neoplasms; Carbon Radioisotopes; Cerebral Cortex; Child; Child, Preschool; Diagnosis, Differential; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Methionine; Middle Aged; Neuronavigation; Prognosis; Sensitivity and Specificity; Stereotaxic Techniques; Tomography, Emission-Computed | 2004 |
[18F-FDG PET in the diagnosis of head and neck tumor].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2004 |
Does whole-body 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography have an advantage over thoracic positron emission tomography for staging patients with lung cancer?
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Retrospective Studies; Sensitivity and Specificity; Solitary Pulmonary Nodule; Thoracic Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed; Whole-Body Counting | 2004 |
FDG-PET findings in patients with suspected encephalitis.
Topics: Adolescent; Adult; Aged; Brain; Encephalitis; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Single-Blind Method | 2004 |
2-Fluoro-2-deoxy-D-glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Combined Modality Therapy; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Preoperative Care; Prognosis; Radiopharmaceuticals; Remission Induction; Retrospective Studies; Risk Factors; Sensitivity and Specificity; Survival Rate; Tomography, Emission-Computed | 2004 |
Positron emission tomography with 18F-fluorodeoxyglucose to predict pathologic response after induction chemotherapy and definitive chemoradiotherapy in head and neck cancer.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymph Nodes; Male; Middle Aged; Neck; Neoplasm Staging; Neoplasm, Residual; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Adjuvant; Sensitivity and Specificity; Treatment Outcome | 2004 |
Usefulness of fluorine-18 fluorodeoxyglucose positron emission tomography in patients with a residual structural abnormality after definitive treatment for squamous cell carcinoma of the head and neck.
Topics: Aged; Carcinoma, Squamous Cell; Cohort Studies; Combined Modality Therapy; Confidence Intervals; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Lymph Nodes; Male; Middle Aged; Neoplasm Staging; Neoplasm, Residual; Positron-Emission Tomography; Prospective Studies; Risk Assessment; Sensitivity and Specificity; Survival Analysis; Tomography, X-Ray Computed | 2004 |
Positron emission tomographic imaging with 11C-choline in differential diagnosis of head and neck tumors: comparison with 18F-FDG PET.
Topics: Adult; Aged; Aged, 80 and over; Carbon Radioisotopes; Choline; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2004 |
Influence of ceftriaxone treatment on FDG uptake--an in vivo [18F]-fluorodeoxyglucose imaging study in soft tissue infections in rats.
Topics: Animals; Anti-Bacterial Agents; Ceftriaxone; Fluorodeoxyglucose F18; Male; Metabolic Clearance Rate; Myositis; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Sensitivity and Specificity; Soft Tissue Infections; Staphylococcal Infections; Treatment Outcome | 2004 |
Impact of reversible trapping of tracer and the presence of blood metabolites on measurements of myocardial glucose utilization performed by PET and 18F-fluorodeoxyglucose using the Patlak method.
Topics: Algorithms; Animals; Blood Glucose; Dogs; Fluorodeoxyglucose F18; Glucose; Heart; Image Interpretation, Computer-Assisted; Metabolic Clearance Rate; Myocardium; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2004 |
PET/CT using 18F-FDG in suspected lung cancer recurrence: diagnostic value and impact on patient management.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed; Treatment Outcome | 2004 |
The role of PET scan in the preoperative management of oesophageal cancer.
Topics: Adult; Aged; Aged, 80 and over; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
[False negative cases of F-18 fluorodeoxyglucose-positron emission tomography (FDG-PET) imaging in small lung cancer less than 3 cm in size].
Topics: Adenocarcinoma; Aged; Carcinoma, Small Cell; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Sensitivity and Specificity; Tomography, Emission-Computed | 2004 |
Molecular imaging of hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Diagnosis, Differential; Fluorodeoxyglucose F18; Gene Expression Profiling; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; RNA, Messenger; Sensitivity and Specificity | 2004 |
Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: comparison with CT and PET.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2004 |
A problem in diagnosing N3 disease using FDG-PET in patients with lung cancer--high false positive rate with visual assessment.
Topics: Aged; Carcinoma; Diagnostic Errors; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity | 2004 |
[PET/CT imaging in head and neck tumors].
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Processing, Computer-Assisted; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Unknown Primary; Otorhinolaryngologic Neoplasms; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2004 |
[PET/CT for colorectal and hepatic tumors].
Topics: Adult; Aged; Colon; Colorectal Neoplasms; Disease Progression; Equipment Design; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Processing, Computer-Assisted; Liver; Liver Neoplasms; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Rectum; Sensitivity and Specificity; Tomography, X-Ray Computed | 2004 |
[Principles of PET/CT and clinical application].
Topics: Artifacts; Energy Metabolism; Equipment Design; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Processing, Computer-Assisted; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2004 |
[PET/CT in lymphoma patients].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Artifacts; Child; Child, Preschool; Equipment Design; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Image Enhancement; Image Processing, Computer-Assisted; Lymphoma; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2004 |
[PET-CT interventional tumour therapy].
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Equipment Design; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Processing, Computer-Assisted; Male; Middle Aged; Neoplasm Staging; Neoplasms; Palliative Care; Positron-Emission Tomography; Radiology, Interventional; Sensitivity and Specificity; Therapy, Computer-Assisted; Tomography, X-Ray Computed | 2004 |
A sensitive way to demonstrate subtle optic ataxia.
Topics: Ataxia; Brain; Brain Mapping; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Ophthalmoplegia; Positron-Emission Tomography; Psychomotor Performance; Sensitivity and Specificity; Visual Perception | 2004 |
Noninvasive imaging of atherosclerosis: the biology behind the pictures.
Topics: Arteriosclerosis; Calcinosis; Fluorodeoxyglucose F18; Humans; Radiography; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2004 |
18F-FDG PET for evaluation of the treatment response in patients with gastrointestinal tract lymphomas.
Topics: Adult; Aged; Antineoplastic Agents; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Lymphoma; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Treatment Outcome | 2004 |
Significance of incidental 18F-FDG accumulations in the gastrointestinal tract in PET/CT: correlation with endoscopic and histopathologic results.
Topics: Aged; Aged, 80 and over; Endoscopy, Digestive System; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Gastrointestinal Tract; Humans; Incidental Findings; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Subtraction Technique; Tomography, X-Ray Computed | 2004 |
Diagnostic Value of PET in Cardiac Sarcoidosis.
Topics: Adult; Aged; Cardiomyopathies; Citrates; Female; Fluorodeoxyglucose F18; Gallium; Heart; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Myocardium; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sarcoidosis; Sensitivity and Specificity; Thallium; Tissue Distribution; Tomography, Emission-Computed | 2004 |
[Early detection of synchronous thyroid carcinoma and malignant melanoma by fluorodeoxyglucose positron emission tomography].
Topics: Fluorodeoxyglucose F18; Humans; Male; Melanoma; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Skin Neoplasms; Thyroid Neoplasms | 2003 |
Is positron emission tomography using 18F-fluorodeoxyglucose and 11C-acetate valuable in diagnosing indeterminate pancreatic masses?
Topics: Adenocarcinoma; Carbon Radioisotopes; Chronic Disease; Diagnosis, Differential; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Pancreatic Neoplasms; Pancreatitis; Positron-Emission Tomography; Sensitivity and Specificity | 2004 |
[Interest of PET/CT scan fusion to assess mandible involvement in oral cavity and oro pharyngeal carcinomas].
Topics: Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Mandibular Neoplasms; Middle Aged; Mouth; Oropharyngeal Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2004 |
Coincidence-detection FDG-PET versus gallium in children and young adults with newly diagnosed Hodgkin's disease.
Topics: Adolescent; Adult; Child; Child, Preschool; False Positive Reactions; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Hodgkin Disease; Humans; Image Interpretation, Computer-Assisted; Male; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Spleen; Tomography, Emission-Computed, Single-Photon | 2005 |
Measurements of occupational exposure for a technologist performing 18F FDG PET scans.
Topics: Adult; Body Burden; Equipment Failure Analysis; Fluorodeoxyglucose F18; Humans; Male; Medical Laboratory Personnel; Nuclear Medicine; Occupational Exposure; Positron-Emission Tomography; Radiation Dosage; Radiation Protection; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Thermoluminescent Dosimetry | 2004 |
Noise and signal decoupling in maximum-likelihood reconstructions and Metz filters for PET brain images.
Topics: Algorithms; Artifacts; Brain; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Likelihood Functions; Models, Biological; Models, Statistical; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Scattering, Radiation; Sensitivity and Specificity; Stochastic Processes | 1994 |
Repeat FDG-PET after neoadjuvant therapy is a predictor of pathologic response in patients with non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Prognosis; Radiotherapy; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2004 |
Unknown primary tumors: detection with dual-modality PET/CT--initial experience.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2005 |
Does the novel PET/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver?
Topics: Colorectal Neoplasms; Contrast Media; Databases, Factual; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Triiodobenzoic Acids | 2004 |
[Clinical use of digital retrospective image fusion of CT, MRI, FDG-PET and SPECT -- fields of indications and results].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Posture; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Software; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2004 |
Use of positron emission tomography in localized extremity soft tissue sarcoma treated with neoadjuvant chemotherapy.
Topics: Adolescent; Adult; Aged; Chemotherapy, Adjuvant; Child; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lower Extremity; Male; Middle Aged; Multivariate Analysis; Neoadjuvant Therapy; Neoplasm Staging; Orthopedic Procedures; Positron-Emission Tomography; Probability; Prospective Studies; Risk Assessment; Sarcoma; Sensitivity and Specificity; Soft Tissue Neoplasms; Survival Analysis; Treatment Outcome; Upper Extremity | 2005 |
Adenocarcinoma of the esophagus and the esophagogastric junction: positron emission tomography improves staging and prediction of survival in distant but not in locoregional disease.
Topics: Adenocarcinoma; Endosonography; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2004 |
18F-FDG PET in children with lymphomas.
Topics: Adolescent; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Treatment Outcome | 2005 |
Positron emission tomography in cancer of the head and neck.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity | 2005 |
F-18-fluorodeoxyglucose positron emission tomography in differentiating malignant from benign pancreatic cysts: a prospective study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Pancreatic Ductal; Cystadenocarcinoma; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Pancreatic Cyst; Pancreatic Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Spiral Computed | 2005 |
FDG-PET/CT imaging for preradiotherapy staging of head-and-neck squamous cell carcinoma.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2005 |
Can post-RT FDG PET accurately predict the pathologic status in neck dissection after radiation for locally advanced head and neck cancer? In regard to Rogers et al. (Int J Radiat Oncol Biol Phys 2004;58:694-697).
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Neck Dissection; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Treatment Outcome | 2005 |
An analysis of the 18F-FDG uptake pattern in the stomach.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Gastric Mucosa; Humans; Male; Middle Aged; New York; Positron-Emission Tomography; Radiopharmaceuticals; Reference Values; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Stomach | 2005 |
FDG-PET for lymph node staging in NSCLC: a major step forward, but beware of the pitfalls.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2005 |
Combined F-18 FDG positron emission tomography/computed tomography in the diagnosis of colonic polyps: the potential and limitations of the technique.
Topics: Adenoma; Aged; Cecal Neoplasms; Colonic Polyps; Fluorodeoxyglucose F18; Humans; Image Enhancement; Incidental Findings; Male; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2005 |
Accuracy of rigid CT-FDG-PET image registration of the liver.
Topics: Fluorodeoxyglucose F18; Humans; Liver; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2004 |
FDG-PET scanning for detection and staging of extranodal marginal zone lymphomas of the MALT type: a report of 42 cases.
Topics: Adult; Aged; Aged, 80 and over; Databases, Factual; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2005 |
Detection of primary breast carcinoma with a dedicated, large-field-of-view FDG PET mammography device: initial experience.
Topics: Adenocarcinoma; Adult; Aged; Biopsy; Breast Diseases; Breast Neoplasms; Calcinosis; Carcinoma in Situ; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Humans; Mammography; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Sensitivity and Specificity | 2005 |
Comment on the publication 'Impact of FDG-PET for staging of oesophageal cancer' by A. Imdahl et al.
Topics: Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Positron-Emission Tomography; Sensitivity and Specificity | 2005 |
Fluorodeoxyglucose positron emission tomography scanning: basic principles and imaging of adult soft-tissue sarcomas.
Topics: Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Proportional Hazards Models; Radiopharmaceuticals; Sarcoma; Sensitivity and Specificity; Soft Tissue Neoplasms; Tomography, Emission-Computed; Treatment Outcome | 2004 |
18F-FDG uptake by primary tumor as a predictor of intratumoral lymphatic vessel invasion and lymph node involvement in non-small cell lung cancer: analysis of a multicenter study.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Japan; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Risk Assessment; Risk Factors; Sensitivity and Specificity; Statistics as Topic | 2005 |
Positron emission tomography (PET) in the management of oro-pharyngeal cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; False Negative Reactions; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Oropharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2005 |
Modern multimodal neuroimaging for radiosurgery: the example of PET scan integration.
Topics: Adenoma; Brain; Brain Neoplasms; Contrast Media; Energy Metabolism; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Image Enhancement; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Neuronavigation; Phantoms, Imaging; Pituitary Neoplasms; Positron-Emission Tomography; Quality Control; Radiosurgery; Sensitivity and Specificity; Tomography, X-Ray Computed | 2004 |
Assessment of myocardial viability by nuclear imaging techniques.
Topics: Animals; Cardiomyopathies; Diabetes Complications; Disease Models, Animal; Echocardiography, Stress; Fluorodeoxyglucose F18; Heart; Humans; Myocardial Contraction; Myocardial Ischemia; Myocardial Revascularization; Myocardial Stunning; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Sensitivity and Specificity; Stroke Volume; Swine; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left; Ventricular Function, Left | 2005 |
Strategies in detection of the primary tumour in anti-Yo associated paraneoplastic cerebellar degeneration.
Topics: Adenocarcinoma; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Magnetic Resonance Imaging; Middle Aged; Neoplasms, Unknown Primary; Paraneoplastic Cerebellar Degeneration; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Whole-Body Counting | 2005 |
Influence of reconstruction iterations on 18F-FDG PET/CT standardized uptake values.
Topics: Algorithms; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Male; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2005 |
18-Fluorodeoxyglucose positron emission tomography has limited sensitivity for colonic adenoma and early stage colon cancer.
Topics: Adenoma; Aged; Colonic Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Precancerous Conditions; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity | 2005 |
PET: too much of a good thing? Does the plethora of choices impact on patient management?
Topics: Clinical Trials as Topic; Fluorodeoxyglucose F18; Humans; Pancreatic Neoplasms; Positron-Emission Tomography; Practice Guidelines as Topic; Practice Patterns, Physicians'; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Survival Analysis | 2005 |
An intra-operative positron probe with background rejection capability for FDG-guided surgery.
Topics: Background Radiation; Equipment Design; Equipment Failure Analysis; Fluorodeoxyglucose F18; Humans; Neoplasms; Phantoms, Imaging; Positron-Emission Tomography; Radiation Dosage; Radiometry; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Surgery, Computer-Assisted; Transducers | 2005 |
[The role of 18F fluorodeoxyglucose triple-head coincidence imaging in the diagnosis of suspected lung cancer].
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 2005 |
Value of FDG PET in the assessment of patients with multiple myeloma.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Myeloma; Neoplasm Staging; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2005 |
Comparison of FDG PET and SPECT for detection of bone metastases in breast cancer.
Topics: Adult; Aged; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 2005 |
Rational diagnosis of squamous cell carcinoma of the head and neck region: comparative evaluation of CT, MRI, and 18FDG PET.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Pharyngeal Neoplasms; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2005 |
FDG-PET for management of cervical and ovarian cancer.
Topics: CA-125 Antigen; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Uterine Cervical Neoplasms | 2005 |
Early lung cancer detection using spiral computed tomography and positron emission tomography.
Topics: Adult; Age Distribution; Cohort Studies; Early Diagnosis; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Mass Screening; Middle Aged; Positron-Emission Tomography; Prevalence; Risk Assessment; Sensitivity and Specificity; Sex Distribution; Smoking; Spain; Spirometry; Tomography, Spiral Computed | 2005 |
Radionuclide imaging of the painful hip arthroplasty: positron-emission tomography versus triple-phase bone scanning.
Topics: Adult; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Granuloma, Foreign-Body; Humans; Male; Middle Aged; Positron-Emission Tomography; Prosthesis Failure; Prosthesis-Related Infections; Radiopharmaceuticals; Reoperation; Sensitivity and Specificity | 2005 |
Factors affecting quality control of [18F]FDG injection: bacterial endotoxins test, aluminum ions test and HPLC analysis for FDG and CIDG.
Topics: Aluminum; Chromatography, High Pressure Liquid; Chromatography, Ion Exchange; Deoxyglucose; Endotoxins; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Hydrogen-Ion Concentration; Quality Control; Sensitivity and Specificity | 2005 |
Cost-effectiveness of 18F-fluorodeoxyglucose positron emission tomography in the assessment of early dementia from a Belgian and European perspective.
Topics: Algorithms; Case-Control Studies; Cost-Benefit Analysis; Dementia; Europe; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Predictive Value of Tests; Reproducibility of Results; Sensitivity and Specificity | 2005 |
Positron-emission tomography for surveillance of head and neck cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm, Residual; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Radiotherapy, Adjuvant; Retrospective Studies; Sensitivity and Specificity; Time Factors; Treatment Outcome | 2005 |
Comparison between 18F-FDG PET, in-line PET/CT, and software fusion for restaging of recurrent colorectal cancer.
Topics: Algorithms; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Software; Subtraction Technique; Tomography, X-Ray Computed | 2005 |
FDG-PET and MRI in potassium channel antibody-associated non-paraneoplastic limbic encephalitis: correlation with clinical course and neuropsychology.
Topics: Adult; Amnesia; Female; Fluorodeoxyglucose F18; Functional Laterality; Humans; Limbic Encephalitis; Magnetic Resonance Imaging; Positron-Emission Tomography; Potassium Channels; Prognosis; Radiography; Radiopharmaceuticals; Seizures; Sensitivity and Specificity; Temporal Lobe | 2005 |
Role of PET scan in management of oesophageal cancer.
Topics: Esophageal Neoplasms; Esophagogastric Junction; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Metastasis; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2005 |
Positron emission tomography does not add to computed tomography for the diagnosis and staging of pancreatic cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Pancreatic Ductal; Chronic Disease; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Pancreatitis; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2005 |
[The application of 18F-fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2005 |
[Application of positron emission tomography in diagnosis and staging for lung cancer].
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Sensitivity and Specificity | 2005 |
Functional imaging of a colon polyp.
Topics: Adenoma; Colonic Neoplasms; Colonic Polyps; Colonoscopy; Diagnosis, Differential; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2005 |
Improvement in preoperative staging of gastric adenocarcinoma with positron emission tomography.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Signet Ring Cell; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Peritoneal Neoplasms; Positron-Emission Tomography; Preoperative Care; Prognosis; Radiography; Radiopharmaceuticals; Sensitivity and Specificity; Stomach Neoplasms | 2005 |
Head and neck malignancy: is PET/CT more accurate than PET or CT alone?
Topics: Adult; Aged; Aged, 80 and over; Artifacts; Blood Glucose; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Sensitivity and Specificity | 2005 |
Fluorodeoxyglucose positron emission tomography as an outcome measure for castrate metastatic prostate cancer treated with antimicrotubule chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Fluorodeoxyglucose F18; Humans; Male; Microtubules; Neoplasm Metastasis; Orchiectomy; Positron-Emission Tomography; Prostate-Specific Antigen; Prostatic Neoplasms; Sensitivity and Specificity; Treatment Outcome | 2005 |
PET/CT detection of unexpected gastrointestinal foci of 18F-FDG uptake: incidence, localization patterns, and clinical significance.
Topics: Adult; Aged; Aged, 80 and over; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Incidence; Incidental Findings; Israel; Middle Aged; Positron-Emission Tomography; Precancerous Conditions; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Subtraction Technique; Tissue Distribution; Tomography, X-Ray Computed | 2005 |
Whole-body 18F-FDG PET in recurrent or metastatic nasopharyngeal carcinoma.
Topics: Adolescent; Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Risk Assessment; Risk Factors; Sensitivity and Specificity; Treatment Outcome; Whole-Body Counting | 2005 |
The usefulness of MRI and PET imaging for the detection of parametrial involvement and lymph node metastasis in patients with cervical cancer.
Topics: Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Uterine Cervical Neoplasms | 2005 |
Direct reconstruction of kinetic parameter images from dynamic PET data.
Topics: Algorithms; Animals; Artificial Intelligence; Brain; Brain Mapping; Computer Simulation; Fluorodeoxyglucose F18; Image Enhancement; Image Interpretation, Computer-Assisted; Information Storage and Retrieval; Kinetics; Metabolic Clearance Rate; Models, Neurological; Models, Statistical; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution | 2005 |
Value of PET-CT fusion imaging in avoiding potential pitfalls in the interpretation of 18F-FDG accumulation in the distal oesophagus.
Topics: Artifacts; Diagnostic Errors; Esophageal Neoplasms; Esophagus; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2005 |
Initial experience in use of fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography in thyroid carcinoma patients with elevated serum thyroglobulin but negative iodine-131 whole body scans.
Topics: Adenoma, Oxyphilic; Adult; Aged; Aged, 80 and over; Carcinoma, Papillary; Carcinoma, Papillary, Follicular; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms | 2005 |
Correlation between serum CEA level and metabolic volume as determined by FDG PET in postoperative patients with recurrent colorectal cancer.
Topics: Biomarkers, Tumor; Carcinoembryonic Antigen; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Severity of Illness Index; Statistics as Topic; Tissue Distribution | 2005 |
FDG imaging should be considered the preferred technique for accurate assessment of myocardial viability: for.
Topics: Coronary Artery Disease; Fluorodeoxyglucose F18; Heart Diseases; Humans; Image Processing, Computer-Assisted; Myocardium; Perfusion; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity | 2005 |
2-(18F)-fluoro-2-deoxy-D-glucose positron emission tomography detects clinical relevant adenomas of the colon: a prospective study.
Topics: Adenoma; Colonic Neoplasms; Colonoscopy; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity | 2005 |
[Head to head comparison of dobutamine alone and combined with nitrate stress echocardiography and 99mTc-MIBI/18FDG myocardial SPECT image for diagnosis of viable myocardium in patients with severe left ventricular dysfunction].
Topics: Adult; Dobutamine; Echocardiography; Female; Fluorodeoxyglucose F18; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 2005 |
18FDG-PET applications for cartilage neoplasms.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Cartilage Diseases; Child; Chondroma; Chondrosarcoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Osteochondroma; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2005 |
Detection of liver metastases from adenocarcinoma of the colon and pancreas: comparison of mangafodipir trisodium-enhanced liver MRI and whole-body FDG PET.
Topics: Adenocarcinoma; Adult; Aged; Colonic Neoplasms; Contrast Media; Edetic Acid; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Manganese; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Pyridoxal Phosphate; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2005 |
Inefficacy of F-18 fluorodeoxy-D-glucose-positron emission tomography scans for initial evaluation in early-stage cutaneous melanoma.
Topics: Adult; Aged; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Skin Neoplasms; Tomography, Emission-Computed | 2005 |
Use, accuracy, and implications for patient management of [18F]-2-fluorodeoxyglucose-positron emission/computerized tomography for head and neck tumors.
Topics: Brain; Cohort Studies; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Regression Analysis; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2005 |
18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Mouth Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2005 |
2-[18F]fluoro-2-deoxyglucose positron emission tomography for the detection of disease in patients with prostate-specific antigen relapse after radical prostatectomy.
Topics: Aged; Bone Neoplasms; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Retrospective Studies; Sensitivity and Specificity | 2005 |
Potential pitfalls of 18F-FDG PET in a large series of patients treated for malignant lymphoma: prevalence and scan interpretation.
Topics: Artifacts; Diagnostic Errors; Fluorodeoxyglucose F18; Humans; Lymphoma; Observer Variation; Positron-Emission Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Treatment Outcome | 2005 |
Comparison of 18F-FDG and 68Ga PET imaging in the assessment of experimental osteomyelitis due to Staphylococcus aureus.
Topics: Animals; Citrates; Disease Models, Animal; Fluorodeoxyglucose F18; Gallium; Male; Metabolic Clearance Rate; Osteomyelitis; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Sensitivity and Specificity; Staphylococcal Infections | 2005 |
Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging.
Topics: Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2005 |
Significance of fluorodeoxyglucose PET imaging in the diagnosis of malignancies in patients with biliary stricture.
Topics: Aged; Bile; Biliary Tract Neoplasms; Cholestasis; Cytological Techniques; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2005 |
Intense PET signal in the degenerative necrosis superimposed on chronic pancreatitis.
Topics: Aged; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Necrosis; Pancreas; Pancreatic Neoplasms; Pancreaticoduodenectomy; Pancreatitis, Chronic; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity | 2005 |
Registration of [18F]FDG microPET and small-animal MRI.
Topics: Animals; Female; Fluorodeoxyglucose F18; Magnetic Resonance Imaging; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Stereotaxic Techniques; Surgery, Computer-Assisted; Tumor Cells, Cultured | 2005 |
Positron emission tomography/computed tomography influences on the management of resectable pancreatic cancer and its cost-effectiveness.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Cost-Benefit Analysis; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Sensitivity and Specificity; Tomography, X-Ray Computed | 2005 |
Factors influencing [F-18] 2-fluoro-2-deoxy-D-glucose (F-18 FDG) uptake in melanoma cells: the role of proliferation rate, viability, glucose transporter expression and hexokinase activity.
Topics: Animals; Biological Availability; Cell Proliferation; Cell Survival; Fluorodeoxyglucose F18; Glucose; Hexokinase; Humans; Melanocytes; Melanoma; Mice; Monosaccharide Transport Proteins; Positron-Emission Tomography; Risk Factors; Sensitivity and Specificity; Species Specificity; Tumor Cells, Cultured | 2005 |
Factors influencing [F-18] 2-fluoro-2-deoxy-D-glucose (F-18 FDG) accumulation in melanoma cells: is FDG a substrate of multidrug resistance (MDR)?
Topics: Antineoplastic Combined Chemotherapy Protocols; Biological Availability; Blotting, Western; Drug Interactions; Drug Resistance, Multiple; Fluorodeoxyglucose F18; Humans; Melanocytes; Melanoma; Positron-Emission Tomography; Probability; Reference Values; Risk Assessment; Sensitivity and Specificity; Tumor Cells, Cultured | 2005 |
The role of gamma-PET in the evaluation of patients with recurrent squamous cell cancer of the head and neck.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Gamma Cameras; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2005 |
Assessment of the role of FDG PET in the diagnosis and management of children with refractory epilepsy.
Topics: Anticonvulsants; Australia; Child; Child, Preschool; Epilepsy; Female; Fluorodeoxyglucose F18; Humans; Infant; Male; Positron-Emission Tomography; Preoperative Care; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Treatment Failure; Treatment Outcome | 2005 |
FDG PET for the study of primary hepatic malignancies in children.
Topics: Child, Preschool; Female; Fluorodeoxyglucose F18; Hepatoblastoma; Humans; Infant; Liver Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals; Rhabdomyosarcoma, Embryonal; Sensitivity and Specificity | 2006 |
Visualization of primary uveal melanoma with PET/CT scan.
Topics: Fluorodeoxyglucose F18; Humans; Melanoma; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Uveal Neoplasms | 2006 |
Imaging visual recognition memory network by PET in the baboon: perirhinal cortex heterogeneity and plasticity after perirhinal lesion.
Topics: Animals; Behavior, Animal; Brain Mapping; Disease Models, Animal; Fluorodeoxyglucose F18; Male; Memory Disorders; Neuronal Plasticity; Papio; Parahippocampal Gyrus; Pattern Recognition, Visual; Positron-Emission Tomography; Sensitivity and Specificity | 2006 |
Intra-individual variability of cardiac uptake on serial whole-body 18F-FDG PET.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Heart; Humans; Male; Middle Aged; Myocardium; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tissue Distribution; United States; Whole-Body Counting | 2005 |
FDG uptake in colonic villous adenomas.
Topics: Adenoma, Villous; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity | 2005 |
Detection of liver metastases from gastrointestinal cancer: comparision of high resolution MnDPDP enhanced MRI and FDG-PET.
Topics: Adenocarcinoma; Adult; Aged; Contrast Media; Edetic Acid; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Pyridoxal Phosphate; Radiopharmaceuticals; Sensitivity and Specificity | 2005 |
Respiration artifacts in whole-body (18)F-FDG PET/CT studies with combined PET/CT tomographs employing spiral CT technology with 1 to 16 detector rows.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Artifacts; Biotechnology; Equipment Failure Analysis; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Male; Middle Aged; Movement; Positron-Emission Tomography; Radiography, Abdominal; Radiography, Thoracic; Radiopharmaceuticals; Reproducibility of Results; Respiratory Mechanics; Retrospective Studies; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed; Transducers | 2005 |
Osteoblastic bone metastases in breast cancer: is not seeing believing?
Topics: Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Osteoblasts; Positron-Emission Tomography; Practice Guidelines as Topic; Practice Patterns, Physicians'; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Medronate | 2005 |
Relative roles of bone scintigraphy and positron emission tomography in assessing the treatment response of bone metastases.
Topics: Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Medronate; Treatment Outcome | 2005 |
Detection and staging of preinvasive lesions and occult lung cancer in the central airways with 18F-fluorodeoxyglucose positron emission tomography: a pilot study.
Topics: Aged; Bronchoscopy; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Neoplasms, Squamous Cell; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity | 2005 |
Positron emission tomography with O-(2-[18F]fluoroethyl)-l-tyrosine versus magnetic resonance imaging in the diagnosis of recurrent gliomas.
Topics: Adult; Aged; Brain Neoplasms; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Glioma; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Recurrence; Retrospective Studies; Sensitivity and Specificity | 2005 |
18F-FDG PET for staging breast cancer in patients with inner-quadrant versus outer-quadrant tumors: comparison with long-term clinical outcome.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Risk Assessment; Risk Factors; Sensitivity and Specificity; Severity of Illness Index | 2005 |
Inflammation and infection: imaging properties of 18F-FDG-labeled white blood cells versus 18F-FDG.
Topics: Animals; Escherichia coli Infections; Fluorodeoxyglucose F18; Inflammation; Leukocytes; Male; Metabolic Clearance Rate; Pseudomonas Infections; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution | 2005 |
[Anatomical accuracy of lesion localization. Retrospective interactive rigid image registration between 18F-FDG-PET and X-ray CT].
Topics: Fluorodeoxyglucose F18; Humans; Neoplasms; Observer Variation; Positron-Emission Tomography; Radioisotopes; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2005 |
Should mediastinoscopy actually be incorporated into the FDG PET strategy for patients with non-small cell lung carcinoma?
Topics: Carcinoma, Non-Small-Cell Lung; Cost-Benefit Analysis; Fluorodeoxyglucose F18; Health Care Costs; Humans; Japan; Lung Neoplasms; Lymphatic Metastasis; Mediastinoscopy; Mediastinum; Models, Economic; Positron-Emission Tomography; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Tomography, X-Ray Computed | 2005 |
18F-FDG PET in the management of endometrial cancer.
Topics: Adult; Aged; Aged, 80 and over; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Whole Body Imaging | 2006 |
Overestimation of the prognostic significance of SUV measurement by positron emission tomography for non-small-cell lung cancer.
Topics: Biomarkers; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Sensitivity and Specificity; Survival Analysis | 2005 |
[Head and neck neoplasms--combination PET/CT is better than a single approach].
Topics: Controlled Clinical Trials as Topic; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Enhancement; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2005 |
Imaging bone metastases in breast cancer.
Topics: Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 2005 |
Value of fluorodeoxyglucose positron emission tomography in women with breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2005 |
FDG-PET and CT characterization of adrenal lesions in cancer patients.
Topics: Adrenal Gland Neoplasms; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Male; Middle Aged; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2006 |
[Application of 18FDG-PET in the diagnosis of lung cancer].
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |
Quantification method in [18F]fluorodeoxyglucose brain positron emission tomography using independent component analysis.
Topics: Algorithms; Artificial Intelligence; Brain; Computer Simulation; Fluorodeoxyglucose F18; Image Enhancement; Image Interpretation, Computer-Assisted; Information Storage and Retrieval; Models, Biological; Models, Neurological; Phantoms, Imaging; Positron-Emission Tomography; Principal Component Analysis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2005 |
Accuracy of helical computed tomography and [18F] fluorodeoxyglucose positron emission tomography for identifying lymph node mediastinal metastases in potentially resectable non-small-cell lung cancer.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinum; Observer Variation; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Single-Blind Method; Tomography, Spiral Computed | 2005 |
Improved detection of second primary cancer using integrated [18F] fluorodeoxyglucose positron emission tomography and computed tomography for initial tumor staging.
Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Neoplasms; Neoplasms, Second Primary; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2005 |
(18)F-FDG PET imaging of rheumatoid knee synovitis correlates with dynamic magnetic resonance and sonographic assessments as well as with the serum level of metalloproteinase-3.
Topics: Adult; Arthritis, Rheumatoid; Fluorodeoxyglucose F18; Humans; Knee Joint; Magnetic Resonance Imaging; Matrix Metalloproteinase 3; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Synovitis; Ultrasonography | 2006 |
[Positron emission tomography in oncourology].
Topics: Adolescent; Adult; Aged; Carcinoma, Embryonal; Carcinoma, Renal Cell; Choriocarcinoma; Data Interpretation, Statistical; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Kidney; Kidney Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Prostate; Prostate-Specific Antigen; Prostatic Hyperplasia; Prostatic Neoplasms; Radiopharmaceuticals; Seminoma; Sensitivity and Specificity; Testicular Neoplasms; Testis | 2005 |
Initial experience with FDG-PET/CT in the evaluation of breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2006 |
FDG PET imaging in the evaluation of post-transplant lymphoproliferative disorder following renal transplantation.
Topics: Adolescent; Adult; Biopsy; Child; Female; Fluorodeoxyglucose F18; Humans; Immunosuppressive Agents; Kidney Transplantation; Lymphoproliferative Disorders; Male; Positron-Emission Tomography; Postoperative Complications; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole-Body Counting | 2005 |
Screening for distant metastases in patients with head and neck cancer: is there a role for (18)FDG-PET?
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasms, Second Primary; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity | 2006 |
The role of hybrid PET/CT in the evaluation of patients with cervical cancer.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography; Uterine Cervical Neoplasms; Whole Body Imaging | 2006 |
Is standardised (18)F-FDG uptake value an outcome predictor in patients with stage III non-small cell lung cancer?
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Incidence; Lung Neoplasms; Middle Aged; Outcome Assessment, Health Care; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Reference Values; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Survival Analysis; Survival Rate | 2006 |
PET is better than perfusion SPECT for early diagnosis of Alzheimer's disease -- for.
Topics: Alzheimer Disease; Disease Progression; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technology Assessment, Biomedical; Tomography, Emission-Computed, Single-Photon | 2005 |
PET is better than perfusion SPECT for early diagnosis of Alzheimer's disease -- against.
Topics: Alzheimer Disease; Disease Progression; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technology Assessment, Biomedical; Tomography, Emission-Computed, Single-Photon | 2005 |
Ability of FDG-PET to detect all cancers in patients with familial adenomatous polyposis, and impact on clinical management.
Topics: Adenomatous Polyposis Coli; Adult; Colonic Neoplasms; Delivery of Health Care; Duodenal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Precancerous Conditions; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2006 |
[Results of FDG-PET scanning in the pre-operative staging of broncho-pulmonary tumors].
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2005 |
FDG PET and SPECT of bone metastases in breast cancer.
Topics: Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 2005 |
Lymph node metastasis in patients with clinical early-stage cervical cancer: detection with integrated FDG PET/CT.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Prospective Studies; Radiography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 2006 |
Recent chemotherapy reduces the sensitivity of [18F]fluorodeoxyglucose positron emission tomography in the detection of colorectal metastases.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Colorectal Neoplasms; Combined Modality Therapy; Digestive System Surgical Procedures; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Multivariate Analysis; Positron-Emission Tomography; Prospective Studies; Regression Analysis; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome | 2005 |
[18F]Fluorodeoxyglucose positron emission tomography predicts outcome for Ewing sarcoma family of tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Disease-Free Survival; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiotherapy, Adjuvant; Reproducibility of Results; Sarcoma, Ewing; Sensitivity and Specificity; Surgical Procedures, Operative; Treatment Outcome | 2005 |
Clinical and prognostic value of [(18)F]FDG-PET for surveillance of oral squamous cell carcinoma after surgical salvage therapy.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Middle Aged; Mouth Neoplasms; Positron-Emission Tomography; Postoperative Care; Prognosis; Radiopharmaceuticals; Salvage Therapy; Sensitivity and Specificity; Survival Analysis | 2006 |
The role of a positron- and high-energy gamma photon probe in intraoperative localization of recurrent melanoma.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Intraoperative Care; Male; Melanoma; Neoplasm Recurrence, Local; Photons; Pilot Projects; Positron-Emission Tomography; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Surgery, Computer-Assisted; Treatment Outcome | 2005 |
Primary skeletal muscle marginal zone lymphoma with persistent tissue tropism and PET-avidity.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Fluorodeoxyglucose F18; Humans; Lymphoma; Magnetic Resonance Imaging; Male; Middle Aged; Muscle Neoplasms; Muscle, Skeletal; Positron-Emission Tomography; Prednisone; Recurrence; Remission Induction; Sensitivity and Specificity; Vincristine | 2006 |
Use of a decision analysis model to assess the cost-effectiveness of 18F-FDG PET in the management of metachronous liver metastases of colorectal cancer.
Topics: Colorectal Neoplasms; Cost-Benefit Analysis; Decision Support Techniques; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Neoplasm Metastasis; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Sensitivity and Specificity; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2005 |
Can [18F]fluorodeoxyglucose positron emission tomography imaging complement biopsy results from the iliac crest for the detection of bone marrow involvement in patients with malignant lymphoma?
Topics: Biopsy, Needle; Bone Marrow; Female; Fluorodeoxyglucose F18; Humans; Ilium; Lymphoma; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity | 2006 |
Impact of FDG PET for staging of Ewing sarcomas and primitive neuroectodermal tumours.
Topics: Adolescent; Adult; Bone Neoplasms; Child; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neuroectodermal Tumors; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sarcoma, Ewing; Sensitivity and Specificity | 2006 |
Discordant localization of 2-[18F]-fluoro-2-deoxy-D-glucose in 6-[18F]-fluorodopamine- and [(123)I]-metaiodobenzylguanidine-negative metastatic pheochromocytoma sites.
Topics: 3-Iodobenzylguanidine; Adult; Dopamine; False Negative Reactions; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity | 2006 |
Lipomatous hypertrophy of the interatrial septum: prevalence and features on fusion 18F fluorodeoxyglucose positron emission tomography/CT.
Topics: Aged; Aged, 80 and over; Cohort Studies; Female; Fluorodeoxyglucose F18; Heart Atria; Heart Neoplasms; Heart Septum; Humans; Hypertrophy, Left Ventricular; Image Processing, Computer-Assisted; Lipoma; Male; Middle Aged; Positron-Emission Tomography; Prevalence; Retrospective Studies; Sensitivity and Specificity; Severity of Illness Index; Tomography, Spiral Computed | 2005 |
18F-choline images murine atherosclerotic plaques ex vivo.
Topics: Animals; Aorta; Apolipoproteins E; Atherosclerosis; Autoradiography; Choline; Choline Kinase; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2006 |
Preoperative evaluation of thyroid nodules with 18FDG-PET/CT.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Nodule; Thyroidectomy; Tomography, X-Ray Computed | 2005 |
Positron emission tomography scanning is not superior to whole body multidetector helical computed tomography in the preoperative staging of colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Spiral Computed; Whole Body Imaging | 2006 |
Comparison of 2-dimensional and 3-dimensional acquisition for 18F-FDG PET oncology studies performed on an LSO-based scanner.
Topics: Equipment Design; Equipment Failure Analysis; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Lutetium; Male; Medical Oncology; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Silicates; Whole Body Imaging | 2006 |
18F-FDG PET/CT in the evaluation of adrenal masses.
Topics: Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Infant; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2006 |
Whole-body 18F-FDG PET/CT in the presence of truncation artifacts.
Topics: Algorithms; Artifacts; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2006 |
MRI better than FDG-PET at detecting liver tumors.
Topics: Colonic Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Neoplasm Staging; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Survival Rate | 2005 |
Assessment of reversible myocardial dysfunction in chronic ischaemic heart disease: comparison of contrast-enhanced cardiovascular magnetic resonance and a combined positron emission tomography-single photon emission computed tomography imaging protocol.
Topics: Chronic Disease; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Angiography; Male; Middle Aged; Myocardial Ischemia; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 2006 |
Multi-tracer small animal PET imaging of the tumour response to the novel pan-Erb-B inhibitor CI-1033.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Dideoxynucleosides; ErbB Receptors; Fluorodeoxyglucose F18; Humans; Mice; Morpholines; Positron-Emission Tomography; Prognosis; Protein-Tyrosine Kinases; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome; Tumor Cells, Cultured | 2006 |
[Optimization of basic adjustable data-acquisition parameters for continuous three-dimensional whole-body FDG-PET].
Topics: Electronic Data Processing; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Imaging, Three-Dimensional; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2006 |
How useful is integrated PET and CT for the management of pancreatic cancer?
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Cost-Benefit Analysis; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Sensitivity and Specificity; Tomography, X-Ray Computed | 2006 |
Animal-specific positioning molds for registration of repeat imaging studies: comparative microPET imaging of F18-labeled fluoro-deoxyglucose and fluoro-misonidazole in rodent tumors.
Topics: Animals; Carcinoma, Squamous Cell; Equipment Design; Equipment Failure Analysis; Fluorodeoxyglucose F18; Humans; Male; Misonidazole; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Rats; Reproducibility of Results; Restraint, Physical; Sensitivity and Specificity; Species Specificity; Subtraction Technique | 2006 |
Reproducibility of intraperitoneal 2-deoxy-2-[18F]-fluoro-D-glucose cerebral uptake in rodents through time.
Topics: Animals; Brain; Female; Fluorodeoxyglucose F18; Injections, Intraperitoneal; Kinetics; Male; Metabolic Clearance Rate; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Sensitivity and Specificity; Sex Factors | 2006 |
Super-resolution in PET imaging.
Topics: Algorithms; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Lung Neoplasms; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2006 |
Staging of non-small cell lung cancer (NSCLC).
Topics: Adrenal Gland Neoplasms; Carcinoma, Non-Small-Cell Lung; Diagnostic Imaging; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2006 |
Evaluation of thoracic tumors with 18F-fluorothymidine and 18F-fluorodeoxyglucose-positron emission tomography.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Ki-67 Antigen; Lung Neoplasms; Lymphatic Metastasis; Male; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Thoracic Neoplasms | 2006 |
Controversies: is there a role for positron-emission tomographic CT in the initial staging of head and neck squamous cell carcinoma?
Topics: Biopsy; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Enhancement; Image Processing, Computer-Assisted; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2006 |
Invited commentary.
Topics: Adenocarcinoma; Esophageal Neoplasms; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Neoplasm Staging; Positron-Emission Tomography; Sensitivity and Specificity; Survival Analysis | 2006 |
Preoperative 18[F]-fluorodeoxyglucose positron emission tomography standardized uptake values predict survival after esophageal adenocarcinoma resection.
Topics: Adenocarcinoma; Biological Transport; Esophageal Neoplasms; Fluorodeoxyglucose F18; Follow-Up Studies; Gastrectomy; Humans; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Survival Analysis; Tomography, X-Ray Computed | 2006 |
Concomitant paravertebral FDG uptake helps differentiate supraclavicular and suprarenal brown fat uptake from malignant uptake when CT coregistration is not available.
Topics: Adipose Tissue, Brown; Clavicle; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Kidney; Male; Middle Aged; Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Spine; Subtraction Technique; Tomography, X-Ray Computed | 2006 |
FDG-PET on irradiated brain tumor: ten years' summary.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brain; Brain Neoplasms; Carcinoma; Child; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Survival Analysis | 2006 |
Adrenal lesions: characterization with fused PET/CT image in patients with proved or suspected malignancy--initial experience.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 2006 |
Diagnostic performance of whole body dual modality 18F-FDG PET/CT imaging for N- and M-staging of malignant melanoma: experience with 250 consecutive patients.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Skin Neoplasms; Tomography, X-Ray Computed | 2006 |
The implications of 18F-FDG PET for the diagnosis of endoprosthetic loosening and infection in hip and knee arthroplasty: results from a prospective, blinded study.
Topics: Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Equipment Failure Analysis; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Foreign-Body Reaction; Hip Joint; Hip Prosthesis; Humans; Knee Joint; Knee Prosthesis; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Prosthesis Failure; Prosthesis-Related Infections; Radiopharmaceuticals; Reoperation; Sensitivity and Specificity; Single-Blind Method | 2006 |
Microvessel density: correlation with 18F-FDG uptake and prognostic impact in lung adenocarcinomas.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Japan; Lung Neoplasms; Male; Microcirculation; Middle Aged; Neovascularization, Pathologic; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic | 2006 |
Accuracy of PET for diagnosis of solid pulmonary lesions with 18F-FDG uptake below the standardized uptake value of 2.5.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Solitary Pulmonary Nodule | 2006 |
Noninvasive monitoring of colonic carcinogenesis: feasibility of [(18)F]FDG-PET in the azoxymethane model.
Topics: Adenocarcinoma; Animals; Azoxymethane; Colonic Neoplasms; Disease Models, Animal; Feasibility Studies; Fluorodeoxyglucose F18; Male; Metabolic Clearance Rate; Organ Specificity; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Inbred F344; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution | 2006 |
[The integrated PET/CT: technological advance in diagnostics of head and neck recurrencies and CUP?].
Topics: Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasms, Unknown Primary; Palpation; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Time Factors; Tomography, X-Ray Computed | 2006 |
Comparison of the diagnostic performance of FDG-PET and VBM-MRI in very mild Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Brain; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Severity of Illness Index | 2006 |
Role of whole body positron emission tomography/computed tomography scan with 18F-fluorodeoxyglucose in patients with biopsy proven tumor metastases from unknown primary site.
Topics: Adult; Aged; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Italy; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed; Whole Body Imaging | 2006 |
A retrospective analysis of the impact of 18F-FDG PET scans on clinical management of 133 breast cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Incidence; Middle Aged; Positron-Emission Tomography; Practice Patterns, Physicians'; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Risk Assessment; Risk Factors; Sensitivity and Specificity; United States | 2006 |
Quantitative assessment of SSTR2 expression in patients with non-small cell lung cancer using(68)Ga-DOTATOC PET and comparison with (18)F-FDG PET.
Topics: Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Proteins; Octreotide; Organometallic Compounds; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Somatostatin; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution | 2006 |
Role of FDG-PET and PET/CT in the diagnosis of prolonged febrile states.
Topics: Chronic Disease; Fever; Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Prosthesis-Related Infections; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2006 |
Clinical impact of FDG-PET imaging in post-therapy surveillance of uterine cervical cancer: from diagnosis to prognosis.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Palliative Care; Pelvic Exenteration; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Salvage Therapy; Sensitivity and Specificity; Uterine Cervical Neoplasms | 2006 |
Imaging infection with 18F-FDG-labeled leukocyte PET/CT: initial experience in 21 patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arthritis, Infectious; Bacterial Infections; Behcet Syndrome; Diabetic Foot; Endocarditis, Bacterial; Female; Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Leukocytes; Male; Middle Aged; Pancreatic Pseudocyst; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2006 |
Clear-PEM: a dedicated PET camera for improved breast cancer detection.
Topics: Breast Neoplasms; Equipment Design; Equipment Failure Analysis; Female; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Image Enhancement; Phantoms, Imaging; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2005 |
Performance of immuno-positron emission tomography with zirconium-89-labeled chimeric monoclonal antibody U36 in the detection of lymph node metastases in head and neck cancer patients.
Topics: Aged; Antibodies, Monoclonal; Carcinoma, Squamous Cell; False Positive Reactions; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Isotope Labeling; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Positron-Emission Tomography; Radioisotopes; Sensitivity and Specificity; Zirconium | 2006 |
How few cancer cells can be detected by positron emission tomography? A frequent question addressed by an in vitro study.
Topics: Carcinoma, Small Cell; Cell Count; Cell Line, Tumor; Fluorodeoxyglucose F18; Glioblastoma; Humans; Lung Neoplasms; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity | 2006 |
[Significance of PET and integrated PET/CT in the diagnostics of occult primary tumors].
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Nasopharynx; Neoplasms, Unknown Primary; Otorhinolaryngologic Neoplasms; Palatine Tonsil; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed; Tonsillectomy | 2006 |
Usefulness of FDG-microPET for early evaluation of therapeutic effects on VX2 rabbit carcinoma.
Topics: Animals; Carcinoma; Fluorodeoxyglucose F18; Hyperthermia, Induced; Neoplasms, Experimental; Positron-Emission Tomography; Prognosis; Rabbits; Radiopharmaceuticals; Radiotherapy; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome | 2006 |
PET-CT vs contrast-enhanced CT: what is the role for each after chemoradiation for advanced oropharyngeal cancer?
Topics: Adult; Aged; Carcinoma, Squamous Cell; Contrast Media; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Male; Middle Aged; Neck; Neoplasm, Residual; Oropharyngeal Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Radiotherapy, Adjuvant; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2006 |
F-18 FDG-PET imaging and correlation with CT in staging and follow-up of pediatric lymphomas.
Topics: Adolescent; Adult; Biopsy; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Lymph Nodes; Lymphoma, Non-Hodgkin; Male; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2006 |
Fluorodeoxyglucose positron emission tomography with sentinel lymph node biopsy for evaluation of axillary involvement in breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Axilla; Breast Neoplasms; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Regression Analysis; Sensitivity and Specificity; Sentinel Lymph Node Biopsy | 2006 |
Magnetic source imaging localizes epileptogenic zone in children with tuberous sclerosis complex.
Topics: Child; Child, Preschool; Electroencephalography; Epilepsy; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Infant; Magnetic Resonance Imaging; Magnetoencephalography; Positron-Emission Tomography; Sensitivity and Specificity; Tuberous Sclerosis; Videotape Recording | 2006 |
Multi-resolution Bayesian regression in PET dynamic studies using wavelets.
Topics: Bayes Theorem; Brain; Computer Simulation; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Kinetics; Models, Neurological; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Regression Analysis; Sensitivity and Specificity | 2006 |
18F-FET PET differentiation of ring-enhancing brain lesions.
Topics: Adult; Aged; Biopsy; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2006 |
FDG-PET in the clinically negative neck in oral squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Biopsy, Needle; Carcinoma, Squamous Cell; Cytodiagnosis; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Neck; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Sensitivity and Specificity | 2006 |
The solitary pulmonary nodule--is it malignant or benign? Diagnostic performance of Tc-depreotide SPECT.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Organotechnetium Compounds; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Solitary Pulmonary Nodule; Somatostatin | 2006 |
Brain metabolic changes associated with predispotion to onset of major depressive disorder and adjustment disorder in cancer patients--a preliminary PET study.
Topics: Adjustment Disorders; Adolescent; Adult; Aged; Blood Glucose; Brain; Cerebral Cortex; Depressive Disorder, Major; Disease Progression; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Male; Middle Aged; Neoplasms; Nerve Net; Personality Inventory; Positron-Emission Tomography; Sensitivity and Specificity | 2007 |
Diagnostic work-up and outcome of cervical metastases from an unknown primary.
Topics: Adult; Aged; Aged, 80 and over; Biopsy, Needle; Combined Modality Therapy; Disease-Free Survival; Endoscopy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neck Dissection; Neoplasms, Unknown Primary; Otorhinolaryngologic Neoplasms; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2006 |
Correction of an image size difference between positron emission tomography (PET) and computed tomography (CT) improves image fusion of dedicated PET and CT.
Topics: Algorithms; Artifacts; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Information Storage and Retrieval; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2006 |
Obscured bone metastases after administration of hematopoietic factor on FDG-PET.
Topics: Artifacts; Bone and Bones; Bone Neoplasms; Cholangiocarcinoma; Diagnostic Errors; False Negative Reactions; Female; Fluorodeoxyglucose F18; Granulocyte Colony-Stimulating Factor; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2006 |
Clinical usefulness of 18-fluorodeoxyglucose positron emission tomography in the management of patients with nonpancreatic periampullary neoplasms.
Topics: Adult; Aged; Aged, 80 and over; Ampulla of Vater; Bile Duct Neoplasms; Duodenal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Laparotomy; Male; Middle Aged; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Risk Assessment; Sensitivity and Specificity | 2006 |
Role of fluorine-18 fluoro-deoxyglucose positron emission tomography scan in the evaluation and follow-up of patients with low-grade lymphomas.
Topics: Fluorodeoxyglucose F18; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, B-Cell; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity | 2006 |
[Technical limits of PET/CT with 18FDG in prostate cancer].
Topics: Adenocarcinoma; Biopsy, Needle; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Processing, Computer-Assisted; Lymph Nodes; Male; Neoplasm Staging; Positron-Emission Tomography; Prostate; Prostatic Neoplasms; Sensitivity and Specificity; Tomography, X-Ray Computed | 2006 |
The role of positron emission tomography scans in the management of the N-positive neck in head and neck squamous cell carcinoma after chemoradiotherapy.
Topics: Aged; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Sensitivity and Specificity | 2006 |
[Diagnostic value of 18F-fDG Pet/CT in the detection of the cervical lymph nodes metastasis].
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity | 2006 |
Impact of animal handling on the results of 18F-FDG PET studies in mice.
Topics: Animal Husbandry; Animals; Artifacts; Behavior, Animal; Environment; Fluorodeoxyglucose F18; Male; Metabolic Clearance Rate; Mice; Motor Activity; Organ Specificity; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Whole Body Imaging | 2006 |
Posttreatment assessment of response using FDG-PET/CT for patients treated with definitive radiation therapy for head and neck cancers.
Topics: Adult; Aged; Carcinoma, Squamous Cell; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm, Residual; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2006 |
Monitoring of response to pre-operative chemoradiation in combination with hyperthermia in oesophageal cancer by FDG-PET.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Combined Modality Therapy; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Hyperthermia, Induced; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Positron-Emission Tomography; Preoperative Care; Prognosis; Prospective Studies; Radiotherapy; Sensitivity and Specificity; Treatment Outcome | 2006 |
Ductal carcinoma in-situ of the breast detected by [F-18] fluorodeoxyglucose positron emission tomography.
Topics: Biopsy, Needle; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Immunohistochemistry; Japan; Mastectomy, Segmental; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Risk Assessment; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Treatment Outcome | 2006 |
Detection of metastatic disease in patients with uveal melanoma using positron emission tomography.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Uveal Neoplasms | 2006 |
Utility of FDG-PET/CT in follow-up of children treated for Hodgkin and non-Hodgkin lymphoma.
Topics: Adolescent; Child; Child, Preschool; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Positron-Emission Tomography; Recurrence; Retrospective Studies; Sensitivity and Specificity | 2006 |
[Fluorine-18 fluorodeoxyglucose-positron emission tomography imaging of carcinoma of cardia or fundus of stomach].
Topics: Adult; Aged; Aged, 80 and over; Cardia; Female; Fluorodeoxyglucose F18; Gastric Fundus; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Stomach Neoplasms | 2006 |
PET/CT in patients with hepatocellular carcinoma using [(18)F]fluorocholine: preliminary comparison with [(18)F]FDG PET/CT.
Topics: Carcinoma, Hepatocellular; Choline; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2006 |
The value of FDG-PET and bone scintigraphy with SPECT in the primary diagnosis and follow-up of patients with chronic osteomyelitis of the mandible.
Topics: Adult; Aged; Aged, 80 and over; Chronic Disease; False Negative Reactions; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Mandible; Middle Aged; Osteomyelitis; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Time Factors; Tomography, Emission-Computed, Single-Photon | 2006 |
Improved tumour detection by gastrin receptor scintigraphy in patients with metastasised medullary thyroid carcinoma.
Topics: Adult; Biomarkers, Tumor; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Male; Middle Aged; Neoplasm Proteins; Radionuclide Imaging; Radiopharmaceuticals; Receptor, Cholecystokinin B; Receptors, Somatostatin; Reproducibility of Results; Sensitivity and Specificity; Thyroid Neoplasms | 2006 |
[18F-FDG PET and bone scintigraphy to search for bone metastasis of lung cancer].
Topics: Aged; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Technetium Tc 99m Medronate | 2006 |
Microvessel density and p53 in detecting cervical cancer by FDG PET in cases of suspected recurrence.
Topics: Adult; Aged; Animals; Biomarkers; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Microvessels; Middle Aged; Patient Selection; Positron-Emission Tomography; Recurrence; Regression Analysis; Sensitivity and Specificity; Tumor Suppressor Protein p53; Uterine Cervical Neoplasms | 2006 |
Comparative benefits and limitations of 18F-FDG PET and CT-MRI in documented or suspected recurrent cervical cancer.
Topics: Antigens, Neoplasm; Documentation; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Recurrence; Salvage Therapy; Sensitivity and Specificity; Serpins; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2006 |
F18-FDG coincidence-PET in patients with suspected gynecological malignancy.
Topics: Adenocarcinoma; Adnexal Diseases; Adult; Aged; Aged, 80 and over; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Gamma Cameras; Genital Neoplasms, Female; Humans; Laparotomy; Leiomyoma; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography | 2006 |
Deformable and rigid registration of MRI and microPET images for photodynamic therapy of cancer in mice.
Topics: Animals; Automation; Disease Models, Animal; Fluorodeoxyglucose F18; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Kidney; Magnetic Resonance Imaging; Mice; Neoplasms; Photochemotherapy; Positron-Emission Tomography; Radiography; Reproducibility of Results; Sensitivity and Specificity; Time Factors; Urinary Bladder; Whole-Body Counting | 2006 |
18F-fluorodeoxyglucose-positron emission tomography in evaluation of primary cutaneous lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Neoplasm Staging; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Skin Neoplasms; Tomography, X-Ray Computed | 2006 |
Clinical PET in oncology: not only FDG.
Topics: Acetates; Carbon Radioisotopes; Choline; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Medical Oncology; Methionine; Neoplasms; Organometallic Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2006 |
Impact of staging with 18F-FDG-PET on outcome of patients with stage III non-small cell lung cancer: PET identifies potential survivors.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Incidence; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Outcome Assessment, Health Care; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Survival Rate; Treatment Outcome | 2007 |
18F-DOPA PET/CT and neuroendocrine tumours.
Topics: Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Neuroendocrine Tumors; Positron-Emission Tomography; Practice Guidelines as Topic; Practice Patterns, Physicians'; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2006 |
Integrated 18F-FDG PET/CT for the initial evaluation of cervical node level of patients with papillary thyroid carcinoma: comparison with ultrasound and contrast-enhanced CT.
Topics: Adolescent; Adult; Aged; Carcinoma, Papillary; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lymph Nodes; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, X-Ray Computed; Ultrasonography | 2006 |
Diagnostic accuracy of bone metastases detection in cancer patients: comparison between bone scintigraphy and whole-body FDG-PET.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Technetium Tc 99m Medronate; Whole Body Imaging | 2006 |
Clinical value of pre-and postoperative 18F-FDG PET/CT in patients undergoing liver transplantation for hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Neoplasm Recurrence, Local; Perioperative Care; Positron-Emission Tomography; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, Spiral Computed | 2006 |
18F-FDG PET of thyroid nodules with inconclusive cytologic results.
Topics: Adult; Aged; Algorithms; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Invasiveness; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thyroid Neoplasms; Thyroidectomy | 2006 |
Adequate evaluation of image registration in hybrid PET/CT.
Topics: Artifacts; Biotechnology; Contrast Media; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Iohexol; Male; Middle Aged; Neoplasms; Positron-Emission Tomography; Reproducibility of Results; Respiration; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed; Whole Body Imaging | 2006 |
Evaluation of patients with liver metastases from colorectal cancer for locally ablative treatment with laser induced thermotherapy. Impact of PET with 18F-fluorodeoxyglucose on therapeutic decisions.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Hyperthermia, Induced; Lasers; Liver Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2006 |
Stage T1 non-small cell lung cancer: preoperative mediastinal nodal staging with integrated FDG PET/CT--a prospective study.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2006 |
Correlation of PET/CT standardized uptake value measurements between dedicated workstations and a PACS-integrated workstation system.
Topics: Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Radiology Information Systems; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; User-Computer Interface | 2007 |
FDG-PET/MRI coregistration and diffusion-tensor imaging distinguish epileptogenic tubers and cortex in patients with tuberous sclerosis complex: a preliminary report.
Topics: Brain Mapping; Cerebral Cortex; Child, Preschool; Cohort Studies; Diffusion Magnetic Resonance Imaging; Epilepsy; Female; Fluorodeoxyglucose F18; Humans; Magnetoencephalography; Male; Positron-Emission Tomography; Preoperative Care; Retrospective Studies; Sensitivity and Specificity; Treatment Outcome; Tuberous Sclerosis | 2006 |
Fluorodeoxyglucose positron emission tomography for the preoperative staging of oral cavity cancers: only one piece of the puzzle.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymphatic Metastasis; Mouth Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity | 2006 |
Prospective study of [18F]fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Mouth Neoplasms; Neck; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2006 |
Positron emission tomography in the detection and staging of ocular adnexal lymphoproliferative disease.
Topics: Adult; Aged; Conjunctival Neoplasms; Eye Neoplasms; Eyelid Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lacrimal Apparatus Diseases; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Orbital Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2006 |
Potential time benefit in the assessment of recurrent rat rhabdomyosarcoma using positron emission tomography (PET) with (18)fluorodeoxyglucose depends on therapy-specific growth delay.
Topics: Animals; Feasibility Studies; Fluorodeoxyglucose F18; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Reproducibility of Results; Rhabdomyosarcoma; Sensitivity and Specificity; Time Factors | 2006 |
18F-FDG PET versus CT for the detection of enteropathy-associated T-cell lymphoma in refractory celiac disease.
Topics: Adult; Aged; Aged, 80 and over; Atrophy; Celiac Disease; Duodenum; Female; Fluorodeoxyglucose F18; Humans; Intestinal Mucosa; Intestinal Neoplasms; Longitudinal Studies; Lymphatic Diseases; Lymphoma, T-Cell; Male; Middle Aged; Positron-Emission Tomography; Radiography, Abdominal; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2006 |
Monitoring tumor glucose utilization by positron emission tomography for the prediction of treatment response to epidermal growth factor receptor kinase inhibitors.
Topics: Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; ErbB Receptors; Fluorodeoxyglucose F18; Gefitinib; Glucose; Humans; Lung Neoplasms; Mice; Mice, SCID; Neoplasm Staging; Positron-Emission Tomography; Quinazolines; Sensitivity and Specificity; Treatment Outcome; Tumor Cells, Cultured | 2006 |
Bone involvement in patients with lymphoma: the role of FDG-PET/CT.
Topics: Adolescent; Adult; Bone Marrow Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2007 |
FDG PET as a predictor of response to resynchronisation therapy in patients with ischaemic cardiomyopathy.
Topics: Aged; Cardiac Pacing, Artificial; Cardiomyopathies; Female; Fluorodeoxyglucose F18; Humans; Male; Myocardial Ischemia; Patient Selection; Positron-Emission Tomography; Prognosis; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Treatment Outcome | 2007 |
(18)FDG uptake during induction chemoradiation for oesophageal cancer fails to predict histomorphological tumour response.
Topics: Adult; Aged; Esophageal Neoplasms; Esophagus; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Prognosis; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2006 |
Quantification of FDG PET studies using standardised uptake values in multi-centre trials: effects of image reconstruction, resolution and ROI definition parameters.
Topics: Algorithms; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Multicenter Studies as Topic; Netherlands; Positron-Emission Tomography; Radiopharmaceuticals; Reference Standards; Reproducibility of Results; Sensitivity and Specificity | 2007 |
Evaluation of iterative reconstruction (OSEM) versus filtered back-projection for the assessment of myocardial glucose uptake and myocardial perfusion using dynamic PET.
Topics: Algorithms; Female; Fluorodeoxyglucose F18; Heart; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Myocardium; Perfusion; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2007 |
Prognostic significance of [(18)F]fluorodeoxyglucose uptake on positron emission tomography in patients with pathologic stage I lung adenocarcinoma.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Aged, 80 and over; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Positron-Emission Tomography; Prognosis; Sensitivity and Specificity | 2006 |
Consideration of serum glucose levels during malignant mediastinal lymph node detection in non-small-cell lung cancer by FDG-PET.
Topics: Blood Glucose; Carcinoma, Non-Small-Cell Lung; Diabetes Complications; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Mediastinum; Radionuclide Imaging; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity | 2006 |
Clinical impact of integrated PET/CT on the management of suspected cervical cancer recurrence.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2007 |
Characterization of the solitary pulmonary nodule: 18F-FDG PET versus nodule-enhancement CT.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiography; Radiopharmaceuticals; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, Emission-Computed | 2006 |
A prospective study of PET/CT in initial staging of small-cell lung cancer: comparison with CT, bone scintigraphy and bone marrow analysis.
Topics: Aged; Bone Marrow; Bone Neoplasms; Carcinoma, Small Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
The role of FDG-PET/CT in suspected recurrence of breast cancer.
Topics: Adult; Aged; Biomarkers, Tumor; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2006 |
Unexpected finding of elevated glucose uptake in fibrous dysplasia mimicking malignancy: contradicting metabolism and morphology in combined PET/CT.
Topics: Adult; Blood Glucose; Carcinoma, Embryonal; Combined Modality Therapy; Diagnosis, Differential; Femoral Neoplasms; Fibrous Dysplasia, Polyostotic; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Neoplasm Recurrence, Local; Positron-Emission Tomography; Postoperative Complications; Sensitivity and Specificity; Testicular Neoplasms; Tomography, X-Ray Computed | 2007 |
Correlation of GLUT-1 overexpression, tumor size, and depth of invasion with 18F-2-fluoro-2-deoxy-D-glucose uptake by positron emission tomography in colorectal cancer.
Topics: Adenocarcinoma; Aged; Biomarkers, Tumor; Colorectal Neoplasms; Disease Progression; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Glucose Transporter Type 1; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Invasiveness; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity | 2006 |
18F-FDG PET imaging in assessing exudative pleural effusions.
Topics: Exudates and Transudates; Female; Fluorodeoxyglucose F18; Humans; In Vitro Techniques; Male; Middle Aged; Pleural Effusion; Pleural Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2006 |
[Contribution of 18FDG PET/CT post treatment surveillance of head and neck squamous cell carcinoma].
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Clinical Protocols; Data Interpretation, Statistical; Endoscopy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Time Factors; Tomography, X-Ray Computed | 2006 |
Combined PET/CT in the follow-up of differentiated thyroid carcinoma: what is the impact of each modality?
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Neoplasm Recurrence, Local; Population Surveillance; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Subtraction Technique; Systems Integration; Thyroid Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
Use of integrated 18F-FDG PET/CT to improve the accuracy of initial cervical nodal evaluation in patients with head and neck squamous cell carcinoma.
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Middle Aged; Neck; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
Clinical significance of intrathoracic lesions detected by 18F-fluorodeoxyglucose positron emission tomography in the management of patients with head and neck cancer.
Topics: Adolescent; Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
F-18 FDG-PET as a routine surveillance tool for the detection of recurrent head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Time Factors | 2007 |
From anatomical to biological target volumes: the role of PET in radiation treatment planning.
Topics: Cell Hypoxia; Clinical Trials as Topic; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Misonidazole; Neoplasms; Observer Variation; Patient Care Planning; Positron-Emission Tomography; Radiation Tolerance; Radiopharmaceuticals; Radiotherapy; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Tumor Burden | 2006 |
PET/CT: will it change the way that we use CT in cancer imaging?
Topics: Adenocarcinoma; Biomarkers, Tumor; Carcinoembryonic Antigen; Case Management; Colorectal Neoplasms; Diagnostic Errors; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Lymphatic Metastasis; Neoplasm Metastasis; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Prevalence; Probability; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2006 |
PET in face and neck tumours.
Topics: Facial Neoplasms; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Second Primary; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2006 |
FDG-PET in colorectal cancer.
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Biomarkers, Tumor; Carcinoembryonic Antigen; Clinical Trials as Topic; Colorectal Neoplasms; Combined Modality Therapy; Cost-Benefit Analysis; Fluorodeoxyglucose F18; Fluorouracil; Humans; Liver Neoplasms; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Treatment Outcome | 2006 |
F-18 FDG PET/CT evaluation of osseous and soft tissue sarcomas.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Soft Tissue Neoplasms; Subtraction Technique; Tomography, X-Ray Computed | 2006 |
Endometrial and ovarian F-18 FDG uptake in serial PET studies and the value of delayed imaging for differentiation.
Topics: Adolescent; Adult; Aged; Drug Administration Schedule; Endometrium; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Menopause; Middle Aged; Organ Specificity; Ovary; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Time Factors; Tissue Distribution | 2006 |
Positive correlation between standardized uptake values of FDG uptake in the stomach and the value of the C-13 urea breath test.
Topics: Breath Tests; Carbon Isotopes; Female; Fluorodeoxyglucose F18; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Organ Specificity; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Statistics as Topic; Stomach; Urea | 2006 |
Differentiation of recurrent astrocytoma from radiation necrosis: a pilot study with 13N-NH3 PET.
Topics: Adult; Astrocytoma; Brain Diseases; Brain Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Necrosis; Neoplasm Recurrence, Local; Nitrogen Radioisotopes; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2007 |
Diagnostic value of 18F-FDG PET/CT in trauma patients with suspected chronic osteomyelitis.
Topics: Adult; Aged; Bone and Bones; Chronic Disease; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Osteomyelitis; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
Intravenous furosemide injection during 18F-FDG PET acquisition.
Topics: Abdominal Neoplasms; Diuretics; Drug Combinations; Female; Fluorodeoxyglucose F18; Furosemide; Humans; Image Enhancement; Injections, Intravenous; Male; Middle Aged; Pelvic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2006 |
Occurrence of an artifact in brain 18F-FDG PET with calculated attenuation correction.
Topics: Artifacts; Brain; Diagnostic Errors; Epilepsy; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Infant; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2006 |
FDG small animal PET permits early detection of malignant cells in a xenograft murine model.
Topics: Animals; Cell Line, Tumor; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Mice; Mice, Nude; Neoplasm Transplantation; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Rhabdomyosarcoma; Sensitivity and Specificity; Time Factors | 2007 |
A comparative study on the value of FDG-PET and sentinel node biopsy to identify occult axillary metastases.
Topics: Adult; Aged; Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Sentinel Lymph Node Biopsy | 2007 |
PET scans for decision-making in metastatic renal cell carcinoma: a single-institution evaluation.
Topics: Adult; Aged; Carcinoma, Renal Cell; Decision Making; Female; Fluorodeoxyglucose F18; Humans; Immunotherapy; Kidney Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity | 2006 |
Ga-67 SPECT: ave atque vale! Or have we bid a premature farewell to a trusted friend?
Topics: Bone and Bones; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Image Processing, Computer-Assisted; Lymphoma; Male; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 2006 |
Prognostic value of early 18 fluorodeoxyglucose positron emission tomography and gallium-67 scintigraphy in aggressive lymphoma: a prospective comparative study.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 2006 |
18F-FDG PET/CT in the assessment of carcinoma of unknown primary origin.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2006 |
[Evaluation of efficacy and clinical impact of FDG-PET on patients with suspicion of recurrent cutaneous melanoma].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Breast Neoplasms; Case Management; Combined Modality Therapy; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasms, Second Primary; Positron-Emission Tomography; Predictive Value of Tests; Prevalence; Prostatic Neoplasms; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Skin Neoplasms; Unnecessary Procedures | 2006 |
Fluorodeoxyglucose and calcium uptake in the vascular wall: clinically relevant or sugar-coated pill?
Topics: Atherosclerosis; Calcinosis; Calcium; Fluorodeoxyglucose F18; Humans; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2006 |
PET/CT imaging: effect of respiratory motion on apparent myocardial uptake.
Topics: Adult; Artifacts; Fluorodeoxyglucose F18; Heart; Humans; Movement; Myocardium; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Respiratory Mechanics; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2006 |
The utility of F-18 fluorodeoxyglucose whole body PET imaging for determining malignancy in cystic lesions of the pancreas.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Cystadenoma, Serous; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2006 |
Clinical value of manual fusion of PET and CT images in patients with suspected recurrent colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2007 |
18F-FDG PET and PET/CT in fever of unknown origin.
Topics: Aged; Cell Line, Tumor; Clinical Trials as Topic; Fever of Unknown Origin; Fluorodeoxyglucose F18; Glucose; Glucose Transporter Type 1; Glucose Transporter Type 2; Humans; Inflammation; Insulin; Positron-Emission Tomography; Sensitivity and Specificity; Temperature; Tomography, X-Ray Computed | 2007 |
Routine use of FDG-PET scans in melanoma patients with positive sentinel node biopsy.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Skin Neoplasms; Whole Body Imaging | 2007 |
Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Case-Control Studies; Cell Line, Tumor; Clinical Protocols; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Proportional Hazards Models; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
The utility of fluorodeoxyglucose positron emission tomography in the evaluation of carcinoid tumors presenting as pulmonary nodules.
Topics: Adult; Aged; Biopsy; Carcinoid Tumor; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Solitary Pulmonary Nodule | 2007 |
[The value of FDG PET/CT, ultrasound and CT in diagnosing recurrent ovarian carcinoma].
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Poland; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Women's Health | 2006 |
A surgical perspective on positron emission tomography.
Topics: Breast Neoplasms; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Image Enhancement; Melanoma; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Thyroid Neoplasms; Tomography, X-Ray Computed | 2007 |
Evaluation of suspected local recurrence in head and neck cancer: a comparison between PET and PET/CT for biopsy proven lesions.
Topics: Adult; Aged; Biopsy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Research Design; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
[Comparison between 18F-FDG PET and conventional imaging techniques (CT SCAN and MRI) in the diagnosis of head and neck tumor suspicion of recurrence].
Topics: Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2006 |
PET/CT in paediatrics: it is time to increase its use!
Topics: Biopsy; Child; Diagnostic Imaging; Fluorodeoxyglucose F18; Humans; Neuroblastoma; Pediatrics; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
[18F]Fluorodeoxyglucose uptake by positron emission tomography for diagnosis of suspected lung cancer: impact of verification bias.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Neoplasm Staging; Outcome Assessment, Health Care; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2007 |
Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging and comparison with single-photon emission computed tomography.
Topics: Female; Fluorodeoxyglucose F18; Heart; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Myocardial Ischemia; Myocardium; Sensitivity and Specificity; Stroke Volume; Tomography, Emission-Computed, Single-Photon | 2006 |
[The diagnostic value of FDG coincidence imaging combined with serum tumor marker assays for pulmonary lesions].
Topics: Adult; Aged; Aged, 80 and over; Antigens, Neoplasm; Biomarkers, Tumor; Carcinoembryonic Antigen; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Keratin-19; Keratins; Lung Neoplasms; Male; Middle Aged; Phosphopyruvate Hydratase; Plasma Cell Granuloma, Pulmonary; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tuberculosis, Pulmonary | 2006 |
Correlation of PET standard uptake value and CT window-level thresholds for target delineation in CT-based radiation treatment planning.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Observer Variation; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
Myocardial pre-synaptic sympathetic function correlates with glucose uptake in the failing human heart.
Topics: Aged; Coronary Angiography; Coronary Artery Disease; Fluorodeoxyglucose F18; Glucose; Heart; Heart Failure; Humans; Insulin Resistance; Magnetic Resonance Imaging; Male; Middle Aged; Myocardium; Myocytes, Cardiac; Norepinephrine; Positron-Emission Tomography; Sensitivity and Specificity; Ventricular Dysfunction, Left | 2007 |
Direct comparison of [18F]FDG PET/CT with PET alone and with side-by-side PET and CT in patients with malignant melanoma.
Topics: Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Medical Oncology; Melanoma; Middle Aged; Neoplasm Metastasis; Nerve Growth Factors; Positron-Emission Tomography; Reproducibility of Results; Risk; ROC Curve; S100 Calcium Binding Protein beta Subunit; S100 Proteins; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2007 |
F-18-fluorodeoxyglucose (FDG) positron-emission tomography of Echinococcus multilocularis liver lesions: prospective evaluation of its value for diagnosis and follow-up during benzimidazole therapy.
Topics: Adult; Aged; Animals; Anthelmintics; Benzimidazoles; Diagnosis, Differential; Echinococcosis, Hepatic; Echinococcus multilocularis; Female; Fluorodeoxyglucose F18; Humans; Liver; Male; Middle Aged; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Sensitivity and Specificity | 2007 |
Explicit incorporation of prior anatomical information into a nonrigid registration of thoracic and abdominal CT and 18-FDG whole-body emission PET images.
Topics: Algorithms; Artificial Intelligence; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Information Storage and Retrieval; Positron-Emission Tomography; Radiography, Abdominal; Radiography, Thoracic; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed; Whole Body Imaging | 2007 |
FDG PET in oral and oropharyngeal cancer. Value for confirmation of N0 neck and detection of occult metastases.
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Oropharyngeal Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity | 2008 |
Non-invasive evaluation of tumour hypoxia in the Shionogi tumour model for prostate cancer with 18F-EF5 and positron emission tomography.
Topics: Androgen Antagonists; Androgens; Animals; Flow Cytometry; Fluorodeoxyglucose F18; Humans; Hypoxia; Male; Mice; Oxygen; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity | 2007 |
Mediastinal nodal staging of nonsmall cell lung cancer using integrated 18F-FDG PET/CT in a tuberculosis-endemic country: diagnostic efficacy in 674 patients.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Sensitivity and Specificity; Tuberculosis, Pulmonary | 2007 |
Impact of FDG-PET/CT imaging on nodal staging for head-and-neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Neoplasm Staging; Observer Variation; Positron-Emission Tomography; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
Potential clinical role of fluorodeoxyglucose-positron emission tomography in assessing primary or secondary lymphomas of the parotid gland.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Parotid Neoplasms; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 2007 |
Prognosis of children with partial epilepsy: MRI and serial 18FDG-PET.
Topics: Child; Child, Preschool; Epilepsies, Partial; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Infant; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2007 |
Influence of CA 15-3 blood level and doubling time on diagnostic performances of 18F-FDG PET in breast cancer patients with occult recurrence.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Metabolic Clearance Rate; Middle Aged; Mucin-1; Neoplasm Proteins; Neoplasm Recurrence, Local; Patient Selection; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity | 2007 |
Can a positive positron emission tomography scan be positive news?
Topics: Cancer Vaccines; Combined Modality Therapy; Dendritic Cells; Fluorodeoxyglucose F18; Humans; Immunotherapy; Lymphoma, Follicular; Neoplasm, Residual; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity | 2007 |
(1)H MR spectroscopic imaging in patients with MRI-negative extratemporal epilepsy: correlation with ictal onset zone and histopathology.
Topics: Adolescent; Adult; Aspartic Acid; Brain Mapping; Child; Choline; Creatine; Electroencephalography; Epilepsies, Partial; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 2007 |
18F-fluorodeoxyglucose-positron emission tomography and bone scintigraphy for detecting bone metastases in patients with malignancies of the upper aerodigestive tract.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Child; Cohort Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Statistics, Nonparametric; Technetium Tc 99m Medronate; Whole Body Imaging; Whole-Body Counting | 2008 |
The role of positron emission tomography (PET) in diagnostics of gastroenteropancreatic neuroendocrine tumours (GEP NET).
Topics: Fluorodeoxyglucose F18; Humans; Neuroendocrine Tumors; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity | 2006 |
Solitary pulmonary nodules: morphological and metabolic characterisation by FDG-PET-MDCT.
Topics: Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiographic Image Enhancement; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2007 |
Clinical impact of positron emission tomography (PET) with (18F)fluorodeoxyglucose (FDG) in head and neck tumours.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2007 |
Differentiating adrenal adenomas from nonadenomas using (18)F-FDG PET/CT: quantitative and qualitative evaluation.
Topics: Adrenal Gland Neoplasms; Adrenocortical Adenoma; Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2007 |
Intraobserver and interobserver variability in GTV delineation on FDG-PET-CT images of head and neck cancers.
Topics: Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Enhancement; Imaging, Three-Dimensional; Male; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2007 |
What does PET imaging add to conventional staging of head and neck cancer patients?
Topics: Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Neck Dissection; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
Evaluation of delayed 18F-FDG PET in differential diagnosis for malignant soft-tissue tumors.
Topics: Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Soft Tissue Neoplasms; Time Factors | 2006 |
Utility of 18F-fluorodeoxyglucose positron emission tomography in the preoperative staging of squamous cell carcinoma of the oropharynx.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Oropharyngeal Neoplasms; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
PET-CT-based auto-contouring in non-small-cell lung cancer correlates with pathology and reduces interobserver variability in the delineation of the primary tumor and involved nodal volumes.
Topics: Artificial Intelligence; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Imaging, Three-Dimensional; Lung Neoplasms; Male; Observer Variation; Pattern Recognition, Automated; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2007 |
Diagnostic accuracy of 18F-FDG PET in restaging patients with medullary thyroid carcinoma and elevated calcitonin levels.
Topics: Aged; Biomarkers, Tumor; Calcitonin; Carcinoma, Medullary; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Sensitivity and Specificity; Thyroid Neoplasms | 2007 |
Improving specificity of breast MRI using prone PET and fused MRI and PET 3D volume datasets.
Topics: Adult; Breast Neoplasms; Equipment Design; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
The value of HRCT and Tc-depreotide in the evaluation of pulmonary lesions.
Topics: Adult; Aged; Aged, 80 and over; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Organotechnetium Compounds; Radionuclide Imaging; Receptors, Somatostatin; Sensitivity and Specificity; Somatostatin; Tomography, X-Ray Computed | 2006 |
Positron emission tomography for predicting malignancy of sinonasal inverted papilloma.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Papilloma, Inverted; Paranasal Sinus Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2007 |
FDG PET in detecting primary and recurrent malignant salivary gland tumors.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Salivary Gland Neoplasms; Sensitivity and Specificity | 2007 |
In search of an unknown primary tumour presenting with cervical metastases: performance of hybrid FDG-PET-CT.
Topics: Adult; Aged; Aged, 80 and over; Cervical Vertebrae; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Enhancement; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2007 |
The value of quantifying 18F-FDG uptake in thyroid nodules found incidentally on whole-body PET-CT.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Incidental Findings; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Thyroid Nodule; Tomography, X-Ray Computed; Whole Body Imaging | 2007 |
Clinical evaluation of the effect of attenuation correction technique on 18F-fluoride PET images.
Topics: Adult; Aged; Aged, 80 and over; Artifacts; Bone and Bones; Bone Diseases; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2007 |
Crossed cerebellar diaschisis: a positron emission tomography study with L-[methyl-11C]methionine and 2-deoxy-2-[18F]fluoro-D-glucose.
Topics: Adult; Aged; Brain Neoplasms; Cerebellar Diseases; Cerebellum; Female; Fluorodeoxyglucose F18; Humans; Male; Methionine; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2007 |
Diagnosis of maxillofacial tumor with L-3-[18f]-fluoro-alpha-methyltyrosine (FMT) PET: a comparative study with FDG-PET.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Facial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Jaw Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tyrosine | 2007 |
Diagnostic impact of PET with 18F-FDG, 18F-DOPA and 3-O-methyl-6-[18F]fluoro-DOPA in recurrent or metastatic medullary thyroid carcinoma.
Topics: Adult; Aged; Carcinoma, Medullary; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thyroid Neoplasms | 2007 |
The role and limitations of 18-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) scan and computerized tomography (CT) in restaging patients with hepatic colorectal metastases following neoadjuvant chemotherapy: comparison with operative and
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Hepatectomy; Humans; Liver Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
Comparison of 99mTc-annexin A5 with 18F-FDG for the detection of atherosclerosis in ApoE-/- mice.
Topics: Animals; Annexin A5; Apolipoproteins E; Atherosclerosis; Disease Models, Animal; Fluorodeoxyglucose F18; Mice; Mice, Knockout; Organotechnetium Compounds; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2007 |
Contrast-enhanced FDG-PET/CT vs. SPIO-enhanced MRI vs. FDG-PET vs. CT in patients with liver metastases from colorectal cancer: a prospective study with intraoperative confirmation.
Topics: Abdominal Neoplasms; Adult; Aged; Colonic Neoplasms; Contrast Media; Dextrans; Female; Ferrosoferric Oxide; Fluorodeoxyglucose F18; Humans; Image Enhancement; Iron; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Middle Aged; Oxides; Peritoneal Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Rectal Neoplasms; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria.
Topics: Antineoplastic Agents; Benzamides; Disease Progression; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Multivariate Analysis; Neoplasm Metastasis; Piperazines; Positron-Emission Tomography; Protein-Tyrosine Kinases; Pyrimidines; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
Postacquisition detection of tumor motion in the lung and upper abdomen using list-mode PET data: a feasibility study.
Topics: Abdominal Neoplasms; Algorithms; Artifacts; Feasibility Studies; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Lung Neoplasms; Movement; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2007 |
Predicting seizure-free status for temporal lobe epilepsy patients undergoing surgery: prognostic value of quantifying maximal metabolic asymmetry extending over a specified proportion of the temporal lobe.
Topics: Adult; Algorithms; Brain; Epilepsy, Temporal Lobe; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Male; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome | 2007 |
Utility of FDG PET in patients with squamous cell carcinomas of the oral cavity.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Cohort Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Probability; Proportional Hazards Models; Retrospective Studies; Risk Assessment; Sensitivity and Specificity; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome | 2008 |
Differential diagnosis of benign and malign pancreatic masses with 18F-fluordeoxyglucose-positron emission tomography recorded with a dual-head coincidence gamma camera.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Male; Middle Aged; Pancreatic Diseases; Pancreatic Neoplasms; Pancreatitis, Chronic; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2007 |
Head and neck cancer: dedicated FDG PET/CT protocol for detection--phantom and initial clinical studies.
Topics: Adult; Aged; Biopsy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
Substitution of oral (18)F-FDG for intravenous (18)F-FDG in PET scanning.
Topics: Administration, Oral; Adolescent; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Injections, Intravenous; Male; Middle Aged; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2007 |
F-18 fluorodeoxy-D-glucose positron emission tomography scan in the initial evaluation of patients with a primary melanoma thicker than 4 mm.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Skin Neoplasms | 2007 |
Metabolic test with fluorine-18-fluorodeoxyglucose in staging and detection of residual tumor or recurrence in Hodgkin lymphoma.
Topics: Adolescent; Adult; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Neoplasm, Residual; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 2007 |
Thymic extension in the superior mediastinum in patients with thymic hyperplasia: potential cause of false-positive findings on 18F-FDG PET/CT.
Topics: Adolescent; Adult; Child; Child, Preschool; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Infant; Infant, Newborn; Male; Mediastinum; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Subtraction Technique; Thymus Gland; Thymus Neoplasms; Tomography, X-Ray Computed | 2007 |
Ability of positron emission tomography to detect residual neck node disease in patients with head and neck squamous cell carcinoma after definitive chemoradiotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Neck Dissection; Neoplasm Staging; Neoplasm, Residual; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Radiotherapy Dosage; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity | 2007 |
Impact of PET/CT in comparison with same day contrast enhanced CT in breast cancer management.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
Partial volume correction of standardized uptake values and the dual time point in FDG-PET imaging: should these be routinely employed in assessing patients with cancer?
Topics: Artifacts; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2007 |
Measuring tumor perfusion in control and treated murine tumors: correlation of microbubble contrast-enhanced sonography to dynamic contrast-enhanced magnetic resonance imaging and fluorodeoxyglucose positron emission tomography.
Topics: Animals; Cell Line, Tumor; Contrast Media; Fluorocarbons; Fluorodeoxyglucose F18; Magnetic Resonance Imaging; Mice; Mice, Inbred C57BL; Neoplasms, Experimental; Neovascularization, Pathologic; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Ultrasonography | 2007 |
Correlation of 18F-FLT and 18F-FDG uptake on PET with Ki-67 immunohistochemistry in non-small cell lung cancer.
Topics: Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic | 2007 |
[18F-FDG imaging by coincidence circuit SPECT with low-dose CT in preoperative assessment of pulmonary lesions].
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Pneumonia; Preoperative Care; Radiation Dosage; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Tuberculosis, Pulmonary | 2006 |
FDG-PET/CT in restaging of patients with recurrent breast cancer: possible impact on staging and therapy.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Stomach Neoplasms; Tomography, X-Ray Computed | 2007 |
Retro-orbital injection is an effective route for radiopharmaceutical administration in mice during small-animal PET studies.
Topics: Animals; Carbon Radioisotopes; Choline; Female; Fluorodeoxyglucose F18; Image Enhancement; Injections, Intravenous; Metabolic Clearance Rate; Mice; Mice, Inbred ICR; Organ Specificity; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Whole Body Imaging | 2007 |
Cost-effectiveness analysis in the clinical management of patients with known or suspected lung cancer: [18F]fluorodeoxyglucose PET and CT comparison.
Topics: Cost-Benefit Analysis; Female; Fluorodeoxyglucose F18; Health Care Costs; Humans; Italy; Lung Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
Prognostic and diagnostic accuracy of [18F]FDG-PET/CT in 190 patients with carcinoma of unknown primary.
Topics: Adult; Aged; Czech Republic; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Positron-Emission Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Subtraction Technique; Survival Analysis; Survival Rate; Tomography, X-Ray Computed | 2007 |
Pathology and FDG PET correlation of residual lymph nodes in head and neck cancer after radiation treatment.
Topics: Adult; Aged; Biopsy, Fine-Needle; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2007 |
FDG-PET scan in patients with clinically and/or radiologically suspicious colorectal cancer recurrence but normal CEA.
Topics: Adult; Aged; Aged, 80 and over; Carcinoembryonic Antigen; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2007 |
Hodgkin disease: diagnostic value of FDG PET/CT after first-line therapy--is biopsy of FDG-avid lesions still needed?
Topics: Adolescent; Adult; Aged; Biopsy; Child; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Recurrence; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
The usefulness of (18)F-fluorodeoxyglucose positron emission tomography ((18)F-FDG-PET) and a comparison of (18)F-FDG-pet with (67)gallium scintigraphy in the evaluation of lymphoma: relation to histologic subtypes based on the World Health Organization c
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Gallium Radioisotopes; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; World Health Organization | 2007 |
'MRI-negative PET-positive' temporal lobe epilepsy (TLE) and mesial TLE differ with quantitative MRI and PET: a case control study.
Topics: Adult; Brain; Epilepsy, Temporal Lobe; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2007 |
FDG-PET: an important tool in the diagnosis of lung cancer.
Topics: Abdomen; Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
The role of FDG-PET/CT imaging in head and neck malignant conditions: impact on diagnostic accuracy and patient care.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biopsy, Fine-Needle; Carcinoma, Squamous Cell; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Patient Care Planning; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2007 |
Impact of [18F]-2-fluorodeoxyglucose-positron emission tomography/computed tomography on previously untreated head and neck cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Cohort Studies; Cost-Benefit Analysis; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Infusions, Intravenous; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
Positron-emission tomography and computed tomography of cystic pancreatic masses.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Cyst; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
Role of 18F-FDG PET/CT in management of high-grade salivary gland malignancies.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiographic Image Enhancement; Radiopharmaceuticals; Salivary Gland Neoplasms; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
Diagnostic and prognostic value of 18F-FDG PET/CT for patients with suspected recurrence from squamous cell carcinoma of the esophagus.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
Quantifying metabolic asymmetry modulo structure in Alzheimer's disease.
Topics: Algorithms; Alzheimer Disease; Brain; Brain Mapping; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2007 |
A pilot study of [18F]fluorodeoxyglucose positron emission tomography scans during and after radiation-based therapy in patients with non small-cell lung cancer.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Confidence Intervals; Dose Fractionation, Radiation; Dose-Response Relationship, Radiation; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Probability; Radiotherapy, Conformal; Risk Factors; Sensitivity and Specificity; Survival Analysis; Treatment Outcome | 2007 |
Does 18fluoro-fluorodeoxyglucose positron emission tomography improve recurrence detection in patients treated for head and neck squamous cell carcinoma with negative clinical follow-up?
Topics: Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Whole Body Imaging | 2007 |
High-risk melanoma: accuracy of FDG PET/CT with added CT morphologic information for detection of metastases.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Skin Neoplasms; Tomography, X-Ray Computed | 2007 |
[Performance of 18F-FDG PET/CT in the detection of primary breast cancer and staging of the regional lymph nodes].
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fibroadenoma; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
[FDG PET/CT versus PET alone for pre-surgical detection of lymph node metastasis in esophageal carcinoma].
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
Prospective study of bone marrow infiltration in aggressive lymphoma by three independent methods: whole-body MRI, PET/CT and bone marrow biopsy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Marrow Neoplasms; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Middle Aged; Prednisone; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Vincristine; Whole Body Imaging | 2008 |
Role of multidetector CT and FDG-PET/CT in the diagnosis of local and distant recurrence of resected rectal cancer.
Topics: Female; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Radiopharmaceuticals; Rectal Neoplasms; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2007 |
Diagnostic accuracy of PET/CT in patients with extranodal marginal zone MALT lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Data Collection; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Positron-Emission Tomography; Recurrence; Sensitivity and Specificity; Tissue Distribution; Tomography, Emission-Computed | 2007 |
Vascular graft infection due to chronic Q fever diagnosed with fusion positron emission tomography/computed tomography.
Topics: Anti-Bacterial Agents; Aortic Aneurysm, Abdominal; Blood Vessel Prosthesis; Blood Vessel Prosthesis Implantation; Chronic Disease; Combined Modality Therapy; Device Removal; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prosthesis-Related Infections; Q Fever; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
Factors causing inaccurate staging of mediastinal nodal involvement in non-small cell lung cancer patients staged by positron emission tomography.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Logistic Models; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2007 |
Endoscopic ultrasound guided fine-needle aspiration and 18FDG-positron emission tomography in the evaluation of patients with non-small cell lung cancer.
Topics: Aged; Biopsy, Fine-Needle; Carcinoma, Non-Small-Cell Lung; Endosonography; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Ultrasonography, Interventional | 2007 |
Prediction of tumor response by FDG-PET: comparison of the accuracy of single and sequential studies in patients with adenocarcinomas of the esophagogastric junction.
Topics: Adenocarcinoma; Aged; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome | 2007 |
[FDG-PET (positron emission tomography) in the detection of primary breast cancer and lymph node involvement].
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Sentinel Lymph Node Biopsy | 2007 |
[Diagnostic value of positron emission tomography/computed tomography with fluorine-18 fluordeoxyglucose in patients with differentiated thyroid gland carcinoma, high thyroglobulin serum levels and negative iodine whole body scan].
Topics: Adolescent; Adult; Aged; Biomarkers, Tumor; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Tomography, X-Ray Computed; Whole Body Imaging | 2007 |
Fluorine-18-fluorodeoxyglucose positron emission tomography as a novel noninvasive diagnostic tool for gastrointestinal graft-versus-host disease.
Topics: Bone Marrow Transplantation; Female; Fluorodeoxyglucose F18; Gastrointestinal Diseases; Graft vs Host Disease; Humans; Leukemia, Myeloid; Middle Aged; Positron-Emission Tomography; Sensitivity and Specificity | 2007 |
Aggressive and indolent non-Hodgkin's lymphoma: response assessment by integrated international workshop criteria.
Topics: Adolescent; Adult; Aged; Burkitt Lymphoma; Fluorodeoxyglucose F18; Humans; International Cooperation; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Positron-Emission Tomography; Practice Guidelines as Topic; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
F-18-fluoro-deoxy-glucose positron emission tomography in the assessment of peripheral T-cell lymphomas.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, T-Cell, Cutaneous; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
Hodgkin lymphoma: Response assessment by revised International Workshop Criteria.
Topics: Adolescent; Adult; Aged; Child; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; International Cooperation; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Positron-Emission Tomography; Practice Guidelines as Topic; Predictive Value of Tests; Radiopharmaceuticals; Remission Induction; Retrospective Studies; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
Predictive value and diagnostic accuracy of F-18-fluoro-deoxy-glucose positron emission tomography treated grade 1 and 2 follicular lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Disease-Free Survival; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Remission Induction; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease.
Topics: Adult; Aged; Alzheimer Disease; Brain; Dementia; Diagnosis, Differential; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2007 |
Diffuse and diffuse-plus-focal uptake in the thyroid gland identified by using FDG-PET: prevalence of thyroid cancer and Hashimoto's thyroiditis.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Hashimoto Disease; Humans; Japan; Male; Middle Aged; Positron-Emission Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Thyroid Gland; Thyroid Neoplasms; Tissue Distribution | 2007 |
Comparison of MET-PET and FDG-PET for differentiation between benign lesions and lung cancer in pneumoconiosis.
Topics: Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Methionine; Middle Aged; Pneumoconiosis; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2007 |
F-18 FDG PET/CT in the management of thyroid cancer.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Subtraction Technique; Thyroglobulin; Thyroid Neoplasms; Thyrotropin; Tomography, X-Ray Computed | 2007 |
The efficacy of whole-body FDG-PET or PET/CT for autoimmune pancreatitis and associated extrapancreatic autoimmune lesions.
Topics: Aged; Autoimmune Diseases; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatitis; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed; Whole Body Imaging | 2007 |
Combined 18F-fluorodeoxyglucose-positron emission tomography and computed tomography as a primary screening method for detecting second primary cancers and distant metastases in patients with head and neck cancer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Second Primary; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
TNM staging with FDG-PET/CT in patients with primary head and neck cancer.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
(18)Fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: implications for atherosclerosis therapy trials.
Topics: Aged; Aortic Diseases; Atherosclerosis; Carotid Artery Diseases; Diabetic Angiopathies; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Inflammation; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2007 |
What does fluorodeoxyglucose PET imaging add to a clinical diagnosis of dementia?
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Brain Mapping; Cognition Disorders; Female; Fluorodeoxyglucose F18; Humans; Male; Neurologic Examination; Positron-Emission Tomography; Predictive Value of Tests; Sensitivity and Specificity | 2007 |
Spinal metastases from myxoid liposarcoma warrant screening with magnetic resonance imaging.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Liposarcoma, Myxoid; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Soft Tissue Neoplasms; Spinal Neoplasms; Survival Rate | 2007 |
FDG PET in lymphoma: the need for standardization of interpretation. An observer variation study.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Netherlands; Observer Variation; Physicians; Positron-Emission Tomography; Professional Competence; Radiopharmaceuticals; Reference Standards; Reproducibility of Results; Sensitivity and Specificity | 2007 |
Annihilation photon acollinearity in PET: volunteer and phantom FDG studies.
Topics: Algorithms; Artifacts; Computer Simulation; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Models, Biological; Models, Statistical; Phantoms, Imaging; Photons; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2007 |
[Clinical significance of integrated PET/CT in the diagnosis of thoracic cancers].
Topics: Carcinoma, Squamous Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
Would patient selection based on both calcitonin blood level and doubling time improve 18F-FDG PET sensitivity in restaging of medullary thyroid cancer?
Topics: Calcitonin; Carcinoma, Medullary; False Positive Reactions; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Patient Selection; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms | 2007 |
[Diagnosis of chronic osteitis of the bones in the extremities. Relative value of F-18 FDG-PET].
Topics: Adult; Aged; Arm Injuries; Bacterial Infections; Bacteriological Techniques; Biopsy; Blood Glucose; Bone and Bones; Chronic Disease; Female; Fluorodeoxyglucose F18; Fractures, Open; Humans; Leg Injuries; Magnetic Resonance Imaging; Male; Middle Aged; Osteitis; Positron-Emission Tomography; Postoperative Complications; Predictive Value of Tests; Reoperation; Sensitivity and Specificity; Surgical Wound Infection; Tomography, X-Ray Computed | 2007 |
Early assessment of clinical response to concurrent chemoradiotherapy in head and neck carcinoma using fluoro-2-deoxy-d-glucose positron emission tomography.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Blood Glucose; Carcinoma, Squamous Cell; Cell Survival; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Neoplasm, Residual; Otorhinolaryngologic Neoplasms; Positron-Emission Tomography; Prognosis; Radiotherapy Dosage; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2008 |
The impact of FDG-PET/CT on the management of head and neck tumours: the radiotherapist's perspective.
Topics: Carcinoma, Squamous Cell; Data Interpretation, Statistical; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Medical Staff, Hospital; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
[18F]2-fluoro-2-deoxy-D-glucose incorporation by AGS gastric adenocarcinoma cells in vitro during response to epirubicin, cisplatin and 5-fluorouracil.
Topics: Adenocarcinoma; Annexin A5; Antineoplastic Combined Chemotherapy Protocols; Cell Cycle; Cell Survival; Cisplatin; Dose-Response Relationship, Drug; Epirubicin; Flow Cytometry; Fluorodeoxyglucose F18; Fluorouracil; Humans; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Stomach Neoplasms; Tumor Cells, Cultured | 2007 |
Spatial and temporal heterogeneity of regional myocardial uptake in patients without heart disease under fasting conditions on repeated whole-body 18F-FDG PET/CT.
Topics: Fasting; Female; Fluorodeoxyglucose F18; Heart; Heart Diseases; Humans; Image Interpretation, Computer-Assisted; Male; Metabolic Clearance Rate; Middle Aged; Myocardium; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Tomography, X-Ray Computed; Whole Body Imaging | 2007 |
Early 18F-FDG PET for prediction of prognosis in patients with diffuse large B-cell lymphoma: SUV-based assessment versus visual analysis.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; France; Humans; Image Interpretation, Computer-Assisted; Lymphoma, B-Cell; Male; Middle Aged; Observer Variation; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Survival Analysis; Survival Rate | 2007 |
18F-FDG PET can replace conventional work-up in primary M staging of nonkeratinizing nasopharyngeal carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2007 |
FDG-PET/CT finding of high uptake in pulmonary alveolar microlithiasis.
Topics: Fluorodeoxyglucose F18; Humans; Lithiasis; Male; Middle Aged; Pneumonia; Positron-Emission Tomography; Pulmonary Alveoli; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
Combined [18F]Fluorodeoxyglucose positron emission tomography and computed tomography (FDG-PET/CT) for detection of recurrent, 131I-negative thyroid cancer.
Topics: Decision Making; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Tomography, X-Ray Computed; Whole Body Imaging | 2008 |
Value of PET in the assessment of patients with neurofibromatosis type 1.
Topics: Adolescent; Adult; Aged; Carbon Isotopes; Female; Fluorodeoxyglucose F18; Humans; Male; Methionine; Middle Aged; Neurofibromatosis 1; Peripheral Nervous System Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Whole Body Imaging | 2007 |
Activity-based costing evaluation of [18F]-fludeoxyglucose production.
Topics: Costs and Cost Analysis; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiation Dosage; Sensitivity and Specificity; Social Control, Formal; Time Factors | 2008 |
18F-FDG PET in detecting primary breast cancer.
Topics: Adult; Breast Neoplasms; Equipment Design; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
Comparison of (18)F-FLT PET and (18)F-FDG PET for preoperative staging in non-small cell lung cancer.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2008 |
Semiautomatic volume of interest drawing for (18)F-FDG image analysis-method and preliminary results.
Topics: Algorithms; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Male; Middle Aged; Neoplasms; Pattern Recognition, Automated; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2008 |
Analysis and interpretation of dynamic FDG PET oncological studies using data reduction techniques.
Topics: Algorithms; Artificial Intelligence; Data Interpretation, Statistical; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Neoplasms; Positron-Emission Tomography; Principal Component Analysis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2007 |
Assessment of local control after laser-induced thermotherapy of liver metastases from colorectal cancer: contribution of FDG-PET in patients with clinical suspicion of progressive disease.
Topics: Adult; Aged; Catheter Ablation; Colorectal Neoplasms; Diagnostic Errors; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Hyperthermia, Induced; Laser Therapy; Liver Neoplasms; Male; Middle Aged; Neoplasm, Residual; Positron-Emission Tomography; ROC Curve; Sensitivity and Specificity | 2007 |
[18F]2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET) as a diagnostic tool for neurofibromatosis 1 (NF1) associated malignant peripheral nerve sheath tumours (MPNSTs): a long-term clinical study.
Topics: Adolescent; Adult; Age Factors; Aged; Biopsy, Needle; Child; Child, Preschool; Cohort Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Immunohistochemistry; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Nerve Sheath Neoplasms; Neurofibroma, Plexiform; Neurofibromatosis 1; Positron-Emission Tomography; Probability; Risk Assessment; Sensitivity and Specificity; Sex Factors; Tomography, X-Ray Computed | 2008 |
Impact of dual-time-point (18)F-FDG PET imaging and partial volume correction in the assessment of solitary pulmonary nodules.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Solitary Pulmonary Nodule | 2008 |
Evaluating the accuracy of perfusion/metabolism (SPET/PET) ratio in seizure localization.
Topics: Brain; Female; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Seizures; Sensitivity and Specificity; Technetium Tc 99m Exametazime; Tomography, Emission-Computed, Single-Photon | 2008 |
A comparison of cerebral glucose metabolism in Parkinson's disease, Parkinson's disease dementia and dementia with Lewy bodies.
Topics: Aged; Aged, 80 and over; Brain Mapping; Cerebral Cortex; Dementia; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Functional Laterality; Glucose; Humans; Image Processing, Computer-Assisted; Lewy Body Disease; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Predictive Value of Tests; Sensitivity and Specificity | 2007 |
Benign nonphysiologic lesions with increased 18F-FDG uptake on PET/CT: characterization and incidence.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Infant; Israel; Male; Middle Aged; Neoplasms; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Risk Assessment; Risk Factors; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
Standardized uptake value in para-aortic lymph nodes is a significant prognostic factor in patients with primary advanced squamous cervical cancer.
Topics: Adult; Aged; Aorta; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Survival Analysis; Survival Rate; Taiwan; Uterine Cervical Neoplasms | 2008 |
Impact of FDG PET on the preoperative staging of newly diagnosed breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2008 |
Chemotherapy response evaluation with FDG-PET in patients with colorectal cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Combined Modality Therapy; Disease-Free Survival; Evaluation Studies as Topic; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Probability; Prospective Studies; Risk Assessment; Sensitivity and Specificity; Survival Analysis; Treatment Outcome | 2008 |
[Detection of FDG-PET and FDG-PET/CT in head and neck squamous cell carcinoma].
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
PET/CT and histopathologic response to preoperative chemoradiation therapy in locally advanced rectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Chemotherapy, Adjuvant; Combined Modality Therapy; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Iohexol; Male; Middle Aged; Neoplasm Recurrence, Local; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Radiotherapy, Adjuvant; Rectal Neoplasms; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome | 2008 |
[The role of whole body 2-[fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in the management of unknown primary tumors].
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Positron-Emission Tomography; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
Dual-modality FDG-PET/CT in follow-up of patients with recurrent iodine-negative differentiated thyroid cancer.
Topics: Adult; Aged; Aged, 80 and over; Confidence Intervals; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Predictive Value of Tests; Radiography; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms | 2007 |
Cerebral glucose metabolism in oculopalatal tremor.
Topics: Adult; Aged; Brain; Fluorodeoxyglucose F18; Functional Laterality; Glucose; Humans; Male; Middle Aged; Myoclonus; Neural Pathways; Olivary Nucleus; Pons; Positron-Emission Tomography; Predictive Value of Tests; Sensitivity and Specificity; Thalamus; Tremor | 2008 |
PET/CT imaging in head and neck tumors.
Topics: Contrast Media; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
F18-FDG-PET evaluation of patients for resection of colorectal liver metastases.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Medical Oncology; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome; Whole Body Imaging | 2007 |
Prospective study of 18FDG-PET in the detection and management of patients with lymph node metastases to the neck from an unknown primary tumor. Results from the DAHANCA-13 study.
Topics: Adult; Aged; Carcinoma; Endoscopy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Neoplasms; Neoplasms, Unknown Primary; Positron-Emission Tomography; Practice Guidelines as Topic; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Radiotherapy, Adjuvant; Sensitivity and Specificity | 2008 |
Performance profile of FDG-PET and PET/CT for cancer screening on the basis of a Japanese Nationwide Survey.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; False Positive Reactions; Female; Fluorodeoxyglucose F18; Health Care Surveys; Humans; Image Processing, Computer-Assisted; Japan; Male; Middle Aged; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Program Evaluation; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
Evaluation of 18F-2-deoxy-2-fluoro-glucose positron emission tomography for gastric cancer screening in asymptomatic individuals undergoing endoscopy.
Topics: Aged; Endoscopy, Gastrointestinal; Female; Fluorodeoxyglucose F18; Humans; Male; Mass Screening; Middle Aged; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity; Stomach Neoplasms | 2007 |
18Fluorodeoxyglucose positron emission tomography, a standard diagnostic tool in lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Mediastinal Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Solitary Pulmonary Nodule; Technology Assessment, Biomedical | 2007 |
18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.
Topics: Adenocarcinoma, Mucinous; Adenocarcinoma, Papillary; Adult; Aged; Aged, 80 and over; Carcinoma, Pancreatic Ductal; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Pancreatic Neoplasms; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2007 |
18F-labeled resin microspheres as surrogates for 90Y resin microspheres used in the treatment of hepatic tumors: a radiolabeling and PET validation study.
Topics: Animals; Carcinoma, Hepatocellular; Embolization, Therapeutic; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Microspheres; Positron-Emission Tomography; Rabbits; Radiopharmaceuticals; Radiotherapy Dosage; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Sensitivity and Specificity; Yttrium Radioisotopes | 2007 |
Comprehensive imaging of tumor recurrence in breast cancer patients using whole-body MRI at 1.5 and 3 T compared to FDG-PET-CT.
Topics: Adult; Aged; Breast Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Iohexol; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Whole Body Imaging | 2008 |
Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis.
Topics: Adult; Aged; Cardiomyopathies; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sarcoidosis; Sensitivity and Specificity; Subtraction Technique | 2008 |
Comparison of early and delayed FDG PET for evaluation of biliary stricture.
Topics: Aged; Aged, 80 and over; Bile Duct Diseases; Biliary Tract Neoplasms; Constriction, Pathologic; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Time Factors | 2007 |
Pre-operative estimation of esophageal tumor metabolic length in FDG-PET images with surgical pathology confirmation.
Topics: Aged; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Phantoms, Imaging; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity | 2007 |
SUV correction for injection errors in FDG-PET examination.
Topics: Algorithms; Diagnostic Errors; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Injections, Intra-Arterial; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2007 |
Nonpalpable supraclavicular lymph nodes in lung cancer patients: preoperative characterization with 18F-FDG PET/CT.
Topics: Adult; Aged; Biopsy, Needle; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neck; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Double-phase 18F-FDG PET-CT for determination of pulmonary tuberculoma activity.
Topics: Acute Disease; Adult; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed; Tuberculosis, Pulmonary | 2008 |
Role of FDG-PET in the assessment of survival prognosis in melanoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Recurrence; Reproducibility of Results; Sensitivity and Specificity; Sex Factors; Time Factors; Tomography, Spiral Computed | 2007 |
Comparison of 99mtechnetium-pertechnetate and 123iodide SPECT with FDG-PET in patients suspicious for breast cancer.
Topics: Adult; Aged; Breast Neoplasms; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prone Position; Sensitivity and Specificity; Sodium Pertechnetate Tc 99m; Supine Position; Thoracic Neoplasms; Tomography, Emission-Computed, Single-Photon | 2007 |
Diagnostic accuracy of 201Thallium-SPECT and 18F-FDG-PET in the clinical assessment of glioma recurrence.
Topics: Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thallium; Tomography, Emission-Computed, Single-Photon | 2008 |
Clinical role of 18F-FDG PET-CT in suspected and potentially operable cholangiocarcinoma: a prospective study compared with conventional imaging.
Topics: Adult; Aged; Bile Duct Neoplasms; Bile Ducts, Extrahepatic; Bile Ducts, Intrahepatic; Biopsy; Cholangiocarcinoma; Cholangiopancreatography, Magnetic Resonance; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphatic Metastasis; Magnetic Resonance Angiography; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
The clinical impact of [(18)F]FDG PET/CT for the management of recurrent endometrial cancer: correlation with clinical and histological findings.
Topics: Adult; Aged; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Outcome Assessment, Health Care; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Tomography, X-Ray Computed; Treatment Outcome | 2008 |
Combined metabolic and morphologic imaging in thyroid carcinoma patients with elevated serum thyroglobulin and negative cervical ultrasonography: role of 124I-PET/CT and FDG-PET.
Topics: Adult; Aged; Aged, 80 and over; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Tomography, X-Ray Computed | 2008 |
Identification of distant metastases with positron-emission tomography-computed tomography in patients with previously untreated head and neck cancer.
Topics: Carcinoma, Squamous Cell; Contrast Media; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Lung Neoplasms; Male; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Oropharyngeal Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiography, Thoracic; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Spiral Computed | 2008 |
18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma.
Topics: Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Multiple Myeloma; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, X-Ray Computed | 2008 |
A multicenter clinical trial on the diagnostic value of dual-tracer PET/CT in pulmonary lesions using 3'-deoxy-3'-18F-fluorothymidine and 18F-FDG.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; China; Dideoxynucleosides; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Solitary Pulmonary Nodule; Subtraction Technique; Tomography, X-Ray Computed | 2008 |
A comparison of the diagnostic accuracy of 18F-FDG PET and CT in the characterization of solitary pulmonary nodules.
Topics: Algorithms; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2008 |
Utility of sonographically guided biopsy in metabolically suspected recurrent lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Neoplasm Recurrence, Local; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Ultrasonography, Interventional | 2008 |
Clinical implication of F-18 FDG PET/CT for differentiated thyroid cancer in patients with negative diagnostic iodine-123 scan and elevated thyroglobulin.
Topics: Adult; Aged; Biomarkers, Tumor; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Tomography, X-Ray Computed | 2009 |
FDG-PET in the detection of bone marrow disease in Hodgkin's disease and aggressive non-Hodgkin's lymphoma and its impact on clinical management.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biopsy, Needle; Bone Marrow; Bone Marrow Neoplasms; Child; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity | 2008 |
Detection of histologically proven peritoneal carcinomatosis with fused 18F-FDG-PET/MDCT.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2009 |
Diagnosis supporting algorithm for lymph node metastases from colorectal carcinoma on 18F-FDG PET/CT.
Topics: Algorithms; Colorectal Neoplasms; Data Interpretation, Statistical; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2008 |
Right prefrontal hypometabolism predicts delusions in dementia with Lewy bodies.
Topics: Aged; Cognition Disorders; Delusions; Energy Metabolism; Female; Fluorodeoxyglucose F18; Functional Laterality; Hallucinations; Humans; Lewy Body Disease; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prefrontal Cortex; Regression Analysis; Sensitivity and Specificity | 2009 |
[The values of (11)C-acetate and (18)F-fluorodeoxyglucose positron emission tomography in diagnosis of indefinite liver masses].
Topics: Acetates; Adult; Aged; Carbon Radioisotopes; Female; Fluorodeoxyglucose F18; Humans; Liver; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Sensitivity and Specificity | 2007 |
Efficacy of PET/CT in the characterization of solid or partly solid solitary pulmonary nodules.
Topics: Diagnostic Errors; Female; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Retrospective Studies; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2008 |
Mediastinal lymph node staging by means of positron emission tomography is less sensitive in elderly patients with non-small-cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinoscopy; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Staging pathways in recurrent colorectal carcinoma: is contrast-enhanced 18F-FDG PET/CT the diagnostic tool of choice?
Topics: Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Characterization of osteolytic, osteoblastic, and mixed lesions in a prostate cancer mouse model using 18F-FDG and 18F-fluoride PET/CT.
Topics: Animals; Cell Line, Tumor; Disease Models, Animal; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Mice; Mice, SCID; Osteolysis; Prostatic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution | 2008 |
Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's disease, and other dementias.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cognition Disorders; Dementia; Europe; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; United States | 2008 |
[FDG-PET-CT and the diagnosis of malignancy of pulmonary nodules and mass lesions].
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Lung cancer screening with low-dose computed tomography: a non-invasive diagnostic protocol for baseline lung nodules.
Topics: Aged; Chi-Square Distribution; Contrast Media; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Incidence; Lung Neoplasms; Male; Mass Screening; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiation Dosage; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Sensitivity and Specificity; Statistics, Nonparametric; Tomography, X-Ray Computed | 2008 |
Performance of FDG-PET/CT in the diagnosis of recurrent endometrial cancer.
Topics: Adult; Aged; Aged, 80 and over; Endometrial Neoplasms; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
High correlations between primary tumours and loco-regional metastatic lymph nodes in non-small-cell lung cancer with respect to glucose transporter type 1-mediated 2-deoxy-2-F18-fluoro-D-glucose uptake.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2008 |
Misdiagnoses of 11C-choline combined with 18F-FDG PET imaging in brain tumours.
Topics: Adolescent; Adult; Aged; Brain Neoplasms; Carbon Radioisotopes; Child; Choline; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2008 |
Correcting tumour SUV for enhanced bone marrow uptake: retrospective 18F-FDG PET/CT studies.
Topics: Adult; Aged; Aged, 80 and over; Bone Marrow; Bone Marrow Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Multimodal virtual bronchoscopy using PET/CT images.
Topics: Bronchoscopes; Carcinoma, Non-Small-Cell Lung; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Lung Neoplasms; Lymphatic Metastasis; Positron-Emission Tomography; Sensitivity and Specificity; Software; Tomography, X-Ray Computed; User-Computer Interface | 2008 |
Biomarkers to detect central dopamine deficiency and distinguish Parkinson disease from multiple system atrophy.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Biomarkers; Brain; Dihydroxyphenylalanine; Dopamine; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Heart Septum; Humans; Male; Multiple System Atrophy; Parkinson Disease; Positron-Emission Tomography; Sensitivity and Specificity | 2008 |
Improved detection of recurrent laryngeal tumor after radiotherapy using (18)FDG-PET as initial method.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Laryngoscopy; Male; Middle Aged; Neoplasm Recurrence, Local; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2008 |
[Annex V: 18-fluorodeoxyglucose positron emission tomography in the management of differentiated thyroid cancers].
Topics: Contraindications; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Pregnancy; Prognosis; Sensitivity and Specificity; Thyroid Neoplasms | 2007 |
The impact of 18F-FDG PET/CT on assessment of nasopharyngeal carcinoma at diagnosis.
Topics: Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2008 |
Improved staging of patients with carcinoid and islet cell tumors with 18F-dihydroxy-phenyl-alanine and 11C-5-hydroxy-tryptophan positron emission tomography.
Topics: 5-Hydroxytryptophan; Adenoma, Islet Cell; Adult; Aged; Carbon Radioisotopes; Carcinoid Tumor; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Somatostatin; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Effect of sample size for normal database on diagnostic performance of brain FDG PET for the detection of Alzheimer's disease using automated image analysis.
Topics: Aged; Alzheimer Disease; Artificial Intelligence; Databases, Factual; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Pattern Recognition, Automated; Positron-Emission Tomography; Radiopharmaceuticals; Reference Values; Reproducibility of Results; Sample Size; Sensitivity and Specificity | 2008 |
Mediastinal mapping with positron emission tomography/computed tomography.
Topics: Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lymph Nodes; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Comparison between positron emission tomography using 2-[fluorine-18]fluoro-2-deoxy-D-glucose, conventional imaging and computed tomography for staging of breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Diagnostic Imaging; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2008 |
Diffusion-weighted magnetic resonance imaging for diagnosing malignant pulmonary nodules/masses: comparison with positron emission tomography.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Diagnostic Imaging; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Prospective Studies; ROC Curve; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2008 |
Postsurgical diagnostic evaluation of patients with differentiated thyroid carcinoma: comparison of ultrasound, iodine-131 scintigraphy and PET with fluorine-18 fluorodeoxyglucose.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Positron-Emission Tomography; Postoperative Period; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms; Thyroidectomy; Ultrasonography | 2008 |
Noninvasive detection and localization of vulnerable plaque and arterial thrombosis with computed tomography angiography/positron emission tomography.
Topics: Animals; Aortic Diseases; Atherosclerosis; C-Reactive Protein; Cholesterol, Dietary; Fluorodeoxyglucose F18; Macrophages; Male; Plasminogen Activator Inhibitor 1; Positron-Emission Tomography; Rabbits; Radiopharmaceuticals; Sensitivity and Specificity; Thrombosis; Tomography, X-Ray Computed; Vasculitis | 2008 |
Prognostic value of FDG uptake by the bone marrow in squamous cell carcinoma of the head and neck.
Topics: Belgium; Bone Marrow; Carcinoma, Squamous Cell; Comorbidity; Disease-Free Survival; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Survival; Survival Rate | 2008 |
Multi-modality imaging of uveal melanomas using combined PET/CT, high-resolution PET and MR imaging.
Topics: Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Melanoma; Positron-Emission Tomography; Radiography; Radioisotopes; Sensitivity and Specificity; Uveal Neoplasms; Whole-Body Irradiation | 2008 |
Breast cancer with low FDG uptake: characterization by means of dual-time point FDG-PET/CT.
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
Screening for distant metastases in head and neck cancer patients by chest CT or whole body FDG-PET: a prospective multicenter trial.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis; Prospective Studies; Radiography, Thoracic; Radiopharmaceuticals; Risk Factors; ROC Curve; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Whole Body Imaging | 2008 |
Comparison of 18F-FDG PET and MRI in assessment of uterine smooth muscle tumors.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Myometrium; Positron-Emission Tomography; Sensitivity and Specificity; Smooth Muscle Tumor | 2008 |
Role of whole-body [18F] fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) and conventional techniques in the staging of patients with Hodgkin and aggressive non Hodgkin lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Comparative study of fluorodeoxyglucose positron emission tomography and magnetic resonance imaging for the detection of spinal bone marrow infiltration in untreated patients with multiple myeloma.
Topics: Aged; Algorithms; Bone Marrow; Contrast Media; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Myeloma; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Spinal Neoplasms | 2008 |
Performance of integrated FDG-PET/contrast-enhanced CT in the diagnosis of recurrent ovarian cancer: comparison with integrated FDG-PET/non-contrast-enhanced CT and enhanced CT.
Topics: Adult; Aged; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Iopamidol; Male; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Systems Integration; Tomography, X-Ray Computed | 2008 |
Preoperative diagnosis of lymph node metastases of colorectal cancer by FDG-PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Colonic Neoplasms; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Rectal Neoplasms; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Performance of FDG-PET/CT for diagnosis of recurrent uterine cervical cancer.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Male; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2008 |
Effect of (18)F-FDG PET/CT imaging in patients with clinical Stage II and III breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
18Fluorine fluorodeoxyglucose-positron emission tomography/computed tomography in dermatomyositis.
Topics: Dermatomyositis; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Chemotherapy response assessment in stage IV melanoma patients-comparison of 18F-FDG-PET/CT, CT, brain MRI, and tumormarker S-100B.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Biomarkers, Tumor; Brain; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Melanoma; Middle Aged; Nerve Growth Factors; Outcome Assessment, Health Care; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; S100 Calcium Binding Protein beta Subunit; S100 Proteins; Sensitivity and Specificity; Subtraction Technique; Survival Analysis; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome | 2008 |
FDG-PET staging of head and neck cancer--can improved imaging lead to improved treatment?
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Neck; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Value of (18)F-FDG-PET/CT in patients with fever of unknown origin and unexplained prolonged inflammatory syndrome: a single centre analysis experience.
Topics: Adult; Aged; Female; Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Syndrome; Tomography, X-Ray Computed | 2010 |
Comparison of tumor volumes derived from glucose metabolic rate maps and SUV maps in dynamic 18F-FDG PET.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Glucose; Humans; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Lung Neoplasms; Male; Metabolic Clearance Rate; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2008 |
Atherosclerosis inflammation imaging with 18F-FDG PET: carotid, iliac, and femoral uptake reproducibility, quantification methods, and recommendations.
Topics: Arteritis; Atherosclerosis; Carotid Arteries; Female; Femoral Artery; Fluorodeoxyglucose F18; Humans; Iliac Artery; Image Interpretation, Computer-Assisted; Male; Middle Aged; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2008 |
99mTc-Tetrofosmin SPECT for the detection of glioma recurrence.
Topics: Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thallium; Tomography, Emission-Computed, Single-Photon | 2008 |
18F-FDG PET of common enhancing malignant brain tumors.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Algorithms; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2008 |
Accuracy of 18F-FDG PET/CT in detecting pelvic and paraaortic lymph node metastasis in patients with endometrial cancer.
Topics: Adult; Aged; Aorta; Aortography; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Pelvis; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Assessment of cervical lymph node metastases using FDG-PET in patients with head and neck cancer.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Clinical Protocols; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Dynamic MRI, dynamic multidetector-row computed tomography (MDCT), and coregistered 2-[fluorine-18]-fluoro-2-deoxy-D-glucose-positron emission tomography (FDG-PET)/CT: comparative study of capability for management of pulmonary nodules.
Topics: Adult; Aged; Aged, 80 and over; Bacterial Infections; Carcinoma; Diagnosis, Differential; Feasibility Studies; Female; Fluorodeoxyglucose F18; Hamartoma; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Observer Variation; Pneumonia; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2008 |
Rest myocardial perfusion/metabolism imaging using simultaneous dual-isotope acquisition SPECT with technetium-99m-MIBI/fluorine-18-FDG.
Topics: Deoxyglucose; Feasibility Studies; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Heart; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Myocardial Ischemia; Myocardium; Phantoms, Imaging; Predictive Value of Tests; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 1995 |
Positron emission tomography and ultrasonography. A comparative retrospective study assessing the diagnostic validity in lymph node metastases of malignant melanoma.
Topics: Adolescent; Adult; Aged; Cicatrix; Costs and Cost Analysis; Deoxyglucose; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Staging; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Ultrasonography | 1995 |
Thoracic nodal staging with PET imaging with 18FDG in patients with bronchogenic carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Bronchogenic; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Sensitivity and Specificity; Thorax; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1995 |
Fluorine-18-fluorodeoxyglucose positron emission tomography for preoperative parathyroid imaging in primary hyperparathyroidism.
Topics: Adenoma; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Hyperparathyroidism; Male; Middle Aged; Parathyroid Neoplasms; Preoperative Care; Prospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 1995 |
Evaluation of myocardial ischemia using a rest metabolism/stress perfusion protocol with fluorine-18 deoxyglucose/technetium-99m MIBI and dual-isotope simultaneous-acquisition single-photon emission computed tomography.
Topics: Coronary Angiography; Coronary Disease; Deoxyglucose; Dipyridamole; Exercise Test; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Heart; Humans; Male; Middle Aged; Myocardial Ischemia; Myocardium; Predictive Value of Tests; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents | 1995 |
Comparison of fluorine-18-fluorodeoxyglucose PET, MRI and endoscopy for staging head and neck squamous-cell carcinomas.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Deoxyglucose; Endoscopy; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Oropharyngeal Neoplasms; Predictive Value of Tests; Sensitivity and Specificity; Tomography, Emission-Computed | 1995 |
Positron emission tomography in the detection of residual laryngeal carcinoma.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Deoxyglucose; Edema; Fibrosis; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Humans; Laryngeal Diseases; Laryngeal Neoplasms; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Neoplasm, Residual; Predictive Value of Tests; Radiotherapy Dosage; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1995 |
Improved sensitivity of 18FDG-positron emission tomography scans in frontal and "frontal plus" epilepsy.
Topics: Adult; Deoxyglucose; Diagnosis, Differential; Electroencephalography; Epilepsy, Frontal Lobe; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Frontal Lobe; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Parietal Lobe; Sensitivity and Specificity; Temporal Lobe; Tomography, Emission-Computed | 1995 |
Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography (FDG PET).
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Biopsy; Carcinoma; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Likelihood Functions; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Predictive Value of Tests; Prospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 1995 |
[18FDG in the primary staging of lung tumors. Results with a gamma camera and a 511 keV collimator].
Topics: Adult; Aged; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gamma Rays; Glycolysis; Humans; Lung Neoplasms; Middle Aged; Neoplasm Staging; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 1995 |
PET-FDG imaging and transthoracic needle lung aspiration biopsy in evaluation of pulmonary lesions. A comparative risk-benefit analysis.
Topics: Adult; Aged; Aged, 80 and over; Biopsy, Needle; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Retrospective Studies; Risk Assessment; Sensitivity and Specificity; Tomography, Emission-Computed | 1995 |
Evaluation of tumour metabolism and multidrug resistance in patients with treated malignant lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Deoxyglucose; Drug Resistance, Multiple; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Neoplasm, Residual; Oxygen Radioisotopes; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Time Factors; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Water | 1995 |
Comparison of fluorine-18-fluorodeoxyglucose and tritiated fluoromisonidazole uptake during low-flow ischemia.
Topics: Animals; Coronary Circulation; Deoxyglucose; Dogs; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Heart; Misonidazole; Myocardial Ischemia; Radionuclide Imaging; Sensitivity and Specificity; Tritium | 1995 |
Detection of scalene lymph node metastases from lung cancer. Positron emission tomography.
Topics: Carcinoma, Non-Small-Cell Lung; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Sensitivity and Specificity; Tomography, Emission-Computed | 1995 |
A comparative diagnostic study of head and neck nodal metastases using positron emission tomography.
Topics: Carcinoma, Squamous Cell; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Lymphatic Metastasis; Neck; Neoplasm Staging; Pharyngeal Neoplasms; Prospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1995 |
[Performance of a multispect 2 gamma camera for imaging 511-keV gamma rays].
Topics: Deoxyglucose; Electrons; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gamma Rays; Humans; Models, Structural; Neoplasms; Nitrilotriacetic Acid; Organometallic Compounds; Organophosphonates; Organophosphorus Compounds; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 1995 |
Pancreatic tumors: imaging with PET.
Topics: Adenocarcinoma; Carbon Radioisotopes; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Levodopa; Neuroendocrine Tumors; Pancreatic Neoplasms; Sensitivity and Specificity; Serotonin; Tomography, Emission-Computed | 1995 |
2-(fluorine-18)-fluoro-2-deoxy-D-glucose PET in detection of pancreatic cancer: value of quantitative image interpretation.
Topics: Adenocarcinoma; Adult; Chronic Disease; Deoxyglucose; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Pancreatic Neoplasms; Pancreatitis; Predictive Value of Tests; ROC Curve; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1995 |
Evaluation of pancreatic tumors with positron emission tomography and F-18 fluorodeoxyglucose: comparison with CT and US.
Topics: Adenocarcinoma; Deoxyglucose; Evaluation Studies as Topic; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Predictive Value of Tests; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Ultrasonography | 1995 |
Detecting recurrent or residual lung cancer with FDG-PET.
Topics: Adult; Aged; Aged, 80 and over; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Sensitivity and Specificity; Tomography, Emission-Computed | 1995 |
FDG-SPECT: correlation with FDG-PET.
Topics: Adult; Aged; Brain; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Heart; Humans; Male; Middle Aged; Neoplasms; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1995 |
Characterization of chest masses by FDG positron emission tomography.
Topics: Deoxyglucose; Diagnosis, Differential; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Retrospective Studies; Sensitivity and Specificity; Thoracic Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1995 |
A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET.
Topics: Aged; Alzheimer Disease; Brain; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Sensitivity and Specificity; Stereotaxic Techniques; Tomography, Emission-Computed | 1995 |
Diagnosis of pancreatic cancer by 2[18F]-fluoro-2-deoxy-D-glucose positron emission tomography.
Topics: Adult; Aged; Chronic Disease; Deoxyglucose; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Pancreatitis; Prospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 1995 |
Triple-head SPECT with 2-[fluorine-18]fluoro-2-deoxy-D-glucose (FDG): initial evaluation in oncology and comparison with FDG PET.
Topics: Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Models, Structural; Neoplasms; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1995 |
Clinical value of whole-body positron emission tomography with [18F]fluorodeoxyglucose in recurrent colorectal cancer.
Topics: Aged; Colorectal Neoplasms; Deoxyglucose; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1994 |
Comparison of low-dose dobutamine-gradient-echo magnetic resonance imaging and positron emission tomography with [18F]fluorodeoxyglucose in patients with chronic coronary artery disease. A functional and morphological approach to the detection of residual
Topics: Coronary Angiography; Coronary Disease; Deoxyglucose; Dobutamine; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Heart; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction; Predictive Value of Tests; Prospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 1995 |
Optimal cutoff levels of F-18 fluorodeoxyglucose uptake in the differentiation of low-grade from high-grade brain tumors with PET.
Topics: Adult; Brain; Brain Neoplasms; Deoxyglucose; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioma; Humans; Magnetic Resonance Imaging; Male; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1995 |
Identification of hibernating myocardium: a comparison between dobutamine echocardiography and study of perfusion and metabolism in patients with severe left ventricular dysfunction.
Topics: Coronary Disease; Deoxyglucose; Dobutamine; Echocardiography; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Heart; Humans; Male; Middle Aged; Myocardium; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 1995 |
Specificity and sensitivity of exercise-induced ST segment elevation for detection of residual viability: comparison with fluorodeoxyglucose and positron emission tomography.
Topics: Coronary Angiography; Coronary Circulation; Deoxyglucose; Electrocardiography; Exercise Test; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Heart; Humans; Male; Middle Aged; Myocardial Infarction; Myocardium; Predictive Value of Tests; Prospective Studies; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1995 |
Uptake of fluorine-18-fluorodeoxyglucose in sarcoidosis.
Topics: Adult; Deoxyglucose; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Diseases; Lymphoma; Male; Middle Aged; Sarcoidosis; Sensitivity and Specificity; Tomography, Emission-Computed | 1994 |
Is there a role for FDG PET imaging in the management of patients with sarcoidosis?
Topics: Citrates; Citric Acid; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lymph Nodes; Lymphoma; Sarcoidosis; Sarcoidosis, Pulmonary; Sensitivity and Specificity; Tomography, Emission-Computed | 1994 |
Cancer or inflammation? A Holy Grail for nuclear medicine.
Topics: Citrates; Citric Acid; Deoxyglucose; Diagnosis, Differential; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Inflammation; Lymphoma; Neoplasms; Sarcoidosis; Sensitivity and Specificity; Tomography, Emission-Computed | 1994 |
Diagnosis of recurrent brain tumor: value of 201Tl SPECT vs 18F-fluorodeoxyglucose PET.
Topics: Adult; Brain Neoplasms; Deoxyglucose; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Sensitivity and Specificity; Thallium Radioisotopes; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1994 |
Primary hyperparathyroidism: preoperative parathyroid imaging with regional body FDG PET.
Topics: Adenoma; Adult; Aged; Contrast Media; Deoxyglucose; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Hyperparathyroidism; Hyperplasia; Male; Middle Aged; Parathyroid Glands; Parathyroid Neoplasms; Parathyroidectomy; Sensitivity and Specificity; Tomography, Emission-Computed | 1994 |
Increased F-18 FDG accumulation in an acute fracture.
Topics: Adult; Bone Neoplasms; Clavicle; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Fractures, Bone; Humans; Image Processing, Computer-Assisted; Male; Scapula; Sensitivity and Specificity; Time Factors; Tomography, Emission-Computed | 1994 |
Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation.
Topics: Carcinoma, Non-Small-Cell Lung; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1994 |
Persistent or recurrent bronchogenic carcinoma: detection with PET and 2-[F-18]-2-deoxy-D-glucose.
Topics: Carcinoma, Bronchogenic; Deoxyglucose; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Pulmonary Fibrosis; Sensitivity and Specificity; Tomography, Emission-Computed | 1994 |
Myocardial viability: fluorine-18-deoxyglucose positron emission tomography in prediction of wall motion recovery after revascularization.
Topics: Angioplasty, Balloon, Coronary; Coronary Artery Bypass; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Heart; Humans; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction; Myocardium; Postoperative Period; Predictive Value of Tests; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Ultrasonography | 1994 |
Satellite PET and lung cancer: a prospective study in surgical patients.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Deoxyglucose; Female; Fluorodeoxyglucose F18; Hospitals, Satellite; Humans; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 1993 |
Initial assessment of positron emission tomography using 2-fluorine-18-fluoro-2-deoxy-D-glucose in the imaging of malignant melanoma.
Topics: Deoxyglucose; Feasibility Studies; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Pilot Projects; Sensitivity and Specificity; Skin Neoplasms; Tomography, Emission-Computed | 1993 |
Comparability of FDG PET studies in probable Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Brain; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Reproducibility of Results; ROC Curve; Sensitivity and Specificity; Tomography, Emission-Computed | 1993 |
Positron emission tomography with fluorine-18-deoxyglucose in the detection and staging of breast cancer.
Topics: Adenocarcinoma; Adult; Breast; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Sensitivity and Specificity; Tomography, Emission-Computed | 1993 |
Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules. Potential role in evaluation and management.
Topics: Aged; Deoxyglucose; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, Emission-Computed | 1993 |
Evaluation of breast masses and axillary lymph nodes with [F-18] 2-deoxy-2-fluoro-D-glucose PET.
Topics: Adult; Aged; Aged, 80 and over; Axilla; Breast Neoplasms; Deoxyglucose; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Sensitivity and Specificity; Tomography, Emission-Computed | 1993 |
Mediastinal staging of non-small-cell lung cancer with positron emission tomography.
Topics: Aged; Carcinoma, Small Cell; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Prospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1995 |
Lung tumor growth correlates with glucose metabolism measured by fluoride-18 fluorodeoxyglucose positron emission tomography.
Topics: Aged; Biopsy; Case-Control Studies; Deoxyglucose; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Glucose; Humans; Lung Neoplasms; Male; Middle Aged; Sensitivity and Specificity; Time Factors; Tomography, Emission-Computed | 1995 |
Detection of malignancies with SPECT versus PET, with 2-[fluorine-18]fluoro-2-deoxy-D-glucose.
Topics: Adult; Aged; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms; Phantoms, Imaging; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1996 |
Role of positron emission tomography scanning in evaluating gastrointestinal neoplasms.
Topics: Colorectal Neoplasms; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Pancreatic Neoplasms; Sensitivity and Specificity; Tomography, Emission-Computed | 1996 |
Evaluation of pulmonary lesions with FDG-PET. Comparison of findings in patients with and without a history of prior malignancy.
Topics: Adult; Aged; Aged, 80 and over; Deoxyglucose; False Positive Reactions; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Granuloma; Humans; Lung Diseases; Lung Neoplasms; Male; Mesothelioma; Middle Aged; Neurilemmoma; Pneumonia; Predictive Value of Tests; Radiography; Radionuclide Imaging; Sensitivity and Specificity; Tuberculosis, Pulmonary | 1996 |
Occult primary tumors of the head and neck: detection with 2-[F-18] fluoro-2-deoxy-D-glucose SPECT.
Topics: Biopsy; Carcinoma, Squamous Cell; Contrast Media; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasms, Unknown Primary; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 1996 |
Metabolic characterization of breast tumors with positron emission tomography using F-18 fluorodeoxyglucose.
Topics: Breast Neoplasms; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Middle Aged; Prospective Studies; ROC Curve; Sensitivity and Specificity; Tomography, Emission-Computed | 1996 |
Recurrence of head and neck cancer after surgery or irradiation: prospective comparison of 2-deoxy-2-[F-18]fluoro-D-glucose PET and MR imaging diagnoses.
Topics: Aged; Aged, 80 and over; Contrast Media; Deoxyglucose; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Mouth Neoplasms; Neoplasm Recurrence, Local; Prospective Studies; ROC Curve; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1996 |
The usefulness of FDG positron emission tomography for the detection of mediastinal lymph node metastases in patients with non-small cell lung cancer: a comparative study with X-ray computed tomography.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Deoxyglucose; Evaluation Studies as Topic; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinum; Predictive Value of Tests; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1996 |
Fluorine-18-fluorodeoxyglucose PET imaging of soft-tissue sarcoma.
Topics: Deoxyglucose; Diagnosis, Differential; Evaluation Studies as Topic; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Sarcoma; Sensitivity and Specificity; Soft Tissue Neoplasms; Tomography, Emission-Computed | 1996 |
Prospective localization of epileptogenic foci: comparison of PET and SPECT with site of surgery and clinical outcome.
Topics: Adult; Deoxyglucose; Epilepsies, Partial; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Organotechnetium Compounds; Oximes; Predictive Value of Tests; Prospective Studies; Psychosurgery; Retrospective Studies; Sensitivity and Specificity; Technetium Tc 99m Exametazime; Temporal Lobe; Time Factors; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 1996 |
Evaluation of preoperative chemotherapy using PET with fluorine-18-fluorodeoxyglucose in breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Combined Modality Therapy; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Mammography; Middle Aged; Neoplasm, Residual; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Ultrasonography, Mammary | 1996 |
Probability of malignancy in solitary pulmonary nodules using fluorine-18-FDG and PET.
Topics: Adult; Aged; Aged, 80 and over; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Likelihood Functions; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Odds Ratio; Predictive Value of Tests; Probability; Risk Factors; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, Emission-Computed | 1996 |
Investigations of breast tumors with fluorine-18-fluorodeoxyglucose and SPECT.
Topics: Breast Neoplasms; Deoxyglucose; Feasibility Studies; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Metastasis; Prospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 1996 |
Automated determination of the left ventricular long axis in cardiac positron tomography.
Topics: Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Heart; Heart Ventricles; Humans; Image Processing, Computer-Assisted; Myocardial Infarction; Phantoms, Imaging; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 1996 |
Comparison of dobutamine transesophageal echocardiography and dobutamine magnetic resonance imaging for detection of residual myocardial viability.
Topics: Adrenergic beta-Agonists; Adult; Aged; Deoxyglucose; Dobutamine; Echocardiography, Transesophageal; Electrocardiography; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gated Blood-Pool Imaging; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction; Reproducibility of Results; Sensitivity and Specificity; Stroke Volume; Tissue Survival; Tomography, Emission-Computed; Ventricular Function, Left | 1996 |
[Positron emission tomography in the evaluation of intrathoracic lymphatic extension of non-small cell bronchial cancer. A preliminary study of 30 patients].
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Magnetic Resonance Imaging; Male; Mediastinoscopy; Mediastinum; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Predictive Value of Tests; Prospective Studies; Sensitivity and Specificity; Thoracotomy; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1996 |
Factors influencing regional myocardial contractile response to inotropic stimulation. Analysis in humans with stable ischemic heart disease.
Topics: Adenosine; Adrenergic beta-Agonists; Aged; Ammonia; Carbon Isotopes; Coronary Artery Bypass; Coronary Circulation; Coronary Disease; Deoxyglucose; Dobutamine; Echocardiography; False Negative Reactions; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction; Myocardial Ischemia; Sensitivity and Specificity; Tomography, Emission-Computed | 1996 |
Prediction of recovery of myocardial dysfunction after revascularization. Comparison of fluorine-18 fluorodeoxyglucose/thallium-201 SPECT, thallium-201 stress-reinjection SPECT and dobutamine echocardiography.
Topics: Adult; Aged; Deoxyglucose; Dobutamine; Echocardiography; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocardial Contraction; Myocardial Revascularization; Predictive Value of Tests; Sensitivity and Specificity; Thallium Radioisotopes; Tissue Survival; Tomography, Emission-Computed, Single-Photon | 1996 |
Assessment of axillary lymph node involvement in breast cancer patients with positron emission tomography using radiolabeled 2-(fluorine-18)-fluoro-2-deoxy-D-glucose.
Topics: Adult; Aged; Axilla; Breast Neoplasms; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Predictive Value of Tests; Sensitivity and Specificity; Tomography, Emission-Computed | 1996 |
Decision tree sensitivity analysis for cost-effectiveness of FDG-PET in the staging and management of non-small-cell lung carcinoma.
Topics: Carcinoma, Non-Small-Cell Lung; Cost-Benefit Analysis; Decision Trees; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Life Expectancy; Lung Neoplasms; Male; Neoplasm Staging; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1996 |
Fluorine-18-FDG and iodine-131-iodide uptake in thyroid cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Follicular; Carcinoma, Papillary; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Prospective Studies; Sensitivity and Specificity; Thyroid Neoplasms; Thyroidectomy; Tomography, Emission-Computed | 1996 |
Comparison of fluorine-18-fluorodeoxyglucose and carbon-11-methionine PET in detection of malignant tumors.
Topics: Adult; Aged; Bone Neoplasms; Breast Neoplasms; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Methionine; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Sensitivity and Specificity; Soft Tissue Neoplasms; Tomography, Emission-Computed | 1996 |
Comparison of fluorine-18-FDG PET and technetium-99m-MIBI SPECT in evaluation of musculoskeletal sarcomas.
Topics: Adult; Bone Neoplasms; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Muscle Neoplasms; Neoplasm Recurrence, Local; Neoplasm, Residual; Sarcoma; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1996 |
Recovery of regional left ventricular dysfunction after coronary revascularization. Impact of myocardial viability assessed by nuclear imaging and vessel patency at follow-up angiography.
Topics: Aged; Cell Survival; Coronary Angiography; Coronary Artery Bypass; Deoxyglucose; Diagnostic Imaging; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Heart; Humans; Male; Middle Aged; Myocardial Contraction; Myocardium; Postoperative Period; Predictive Value of Tests; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 1996 |
Intractable temporal lobe epilepsy: comparison of positron emission tomography with qualitative and quantitative MR.
Topics: Adolescent; Adult; Age of Onset; Deoxyglucose; Epilepsy, Temporal Lobe; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Hippocampus; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Preoperative Care; Sensitivity and Specificity; Time Factors; Tomography, Emission-Computed; Treatment Outcome | 1996 |
Comparison of FDG-PET and sestamibi-SPECT in primary hyperparathyroidism.
Topics: Adenoma; Adult; Aged; Aged, 80 and over; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Hyperparathyroidism; Hyperplasia; Male; Middle Aged; Parathyroid Glands; Parathyroid Neoplasms; Prospective Studies; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1996 |
Prospective evaluation of fluorine-18 fluorodeoxyclucose positron emission tomography in breast cancer for staging of the axilla related to surgery and immunocytochemistry.
Topics: Axilla; Breast Neoplasms; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Prospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 1996 |
Evaluation of ion-implanted-silicon detectors for use in intraoperative positron-sensitive probes.
Topics: Beta Particles; Deoxyglucose; Electrons; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Intraoperative Period; Neoplasms; Radiation Dosage; Radiometry; Radionuclide Imaging; Sensitivity and Specificity; Silicon | 1996 |
Differentiating benign from malignant lung lesions using "quantitative" parameters of FDG PET images.
Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Cost-Benefit Analysis; Deoxyglucose; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Injections, Intravenous; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1996 |
Staging of the mediastinum: value of positron emission tomography imaging in non-small cell lung cancer.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Mediastinum; Neoplasm Staging; Predictive Value of Tests; Preoperative Care; Prospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1996 |
Detection of local recurrence of soft-tissue sarcoma with positron emission tomography using [18F]fluorodeoxyglucose.
Topics: Adult; Aged; Aged, 80 and over; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Reproducibility of Results; Sarcoma; Sensitivity and Specificity; Statistics, Nonparametric; Tomography, Emission-Computed | 1997 |
Assessment of myocardial viability in chronic coronary artery disease using technetium-99m sestamibi SPECT. Correlation with histologic and positron emission tomographic studies and functional follow-up.
Topics: Ammonia; Coronary Angiography; Coronary Artery Bypass; Coronary Disease; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gated Blood-Pool Imaging; Heart; Humans; Male; Middle Aged; Myocardial Contraction; Myocardium; Nitrogen Radioisotopes; Predictive Value of Tests; Prospective Studies; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1997 |
Glucose metabolism and pathological findings in uveal melanoma: preliminary results.
Topics: Adult; Aged; Aged, 80 and over; Cell Division; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Male; Melanoma; Middle Aged; Prognosis; Sensitivity and Specificity; Tomography, Emission-Computed; Uveal Neoplasms | 1996 |
Non-small cell lung cancer: nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling.
Topics: Adult; Aged; Biopsy; Carcinoma, Non-Small-Cell Lung; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1997 |
Staging of esophageal cancer with 18F-fluorodeoxyglucose positron emission tomography.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Deoxyglucose; Esophageal Neoplasms; Esophagus; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1997 |
Metabolic myocardial viability assessment with iodine 123-16-iodo-3-methylhexadecanoic acid in recent myocardial infarction: comparison with thallium-201 and fluorine-18 fluorodeoxyglucose.
Topics: Deoxyglucose; Exercise Test; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Heart; Humans; Iodine Radioisotopes; Middle Aged; Myocardial Infarction; Palmitic Acids; Predictive Value of Tests; ROC Curve; Sensitivity and Specificity; Thallium Radioisotopes; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1997 |
Pulmonary nodules: differential diagnosis using 18F-fluorodeoxyglucose single-photon emission computed tomography.
Topics: Deoxyglucose; Diagnosis, Differential; Feasibility Studies; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Radiography; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, Emission-Computed, Single-Photon | 1997 |
Can nitrogen-13 ammonia kinetic modeling define myocardial viability independent of fluorine-18 fluorodeoxyglucose?
Topics: Aged; Cell Survival; Coronary Circulation; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Heart; Humans; Male; Middle Aged; Myocardial Infarction; Nitrogen Radioisotopes; Sensitivity and Specificity; Tomography, Emission-Computed | 1997 |
[Metabolic characterization of ovarian tumors with positron-emission tomography and F-18 fluorodeoxyglucose].
Topics: Adult; Aged; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Prospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 1997 |
Myocardial viability studies using fluorine-18-FDG SPECT: a comparison with fluorine-18-FDG PET.
Topics: Coronary Circulation; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Heart; Humans; Rubidium Radioisotopes; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1997 |
Three-dimensional imaging characteristics of the HEAD PENN-PET scanner.
Topics: Brain; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Infant; Phantoms, Imaging; Sensitivity and Specificity; Tomography, Emission-Computed | 1997 |
Tc-99m MIBI scintigraphy in patients with lung cancer. Comparison with CT and fluorine-18 FDG PET imaging.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 1997 |
Axillary lymph node metastases: screening with [F-18]2-deoxy-2-fluoro-D-glucose (FDG) PET.
Topics: Adult; Aged; Axilla; Breast Neoplasms; Deoxyglucose; False Negative Reactions; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Sensitivity and Specificity; Tomography, Emission-Computed | 1997 |
Positron emission tomography, bronchogenic carcinoma, and the adrenals.
Topics: Adrenal Gland Diseases; Adrenal Gland Neoplasms; Carcinoma, Bronchogenic; Deoxyglucose; Diagnosis, Differential; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1997 |
Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-fluorodeoxyglucose positron emission tomography.
Topics: Adrenal Gland Diseases; Adrenal Gland Neoplasms; Adrenal Glands; Biopsy, Needle; Carcinoma, Bronchogenic; Deoxyglucose; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Radiography; Sensitivity and Specificity; Tomography, Emission-Computed | 1997 |
Fluorine-18 fluorodeoxyglucose positron emission tomography in the differential diagnosis of pancreatic carcinoma: a report of 106 cases.
Topics: Adenocarcinoma; Blood Glucose; Chronic Disease; Deoxyglucose; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Pancreatitis; Predictive Value of Tests; Sensitivity and Specificity; Tomography, Emission-Computed | 1997 |
Fluorine-18-FDG PET and iodine-123-IMT SPECT in the evaluation of brain tumors.
Topics: Astrocytoma; Brain; Brain Neoplasms; Deoxyglucose; Evaluation Studies as Topic; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioblastoma; Humans; Iodine Radioisotopes; Male; Methyltyrosines; Middle Aged; Neoplasm Recurrence, Local; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1997 |
Lymph node staging in non-small cell lung cancer: evaluation by [18F]FDG positron emission tomography (PET).
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Male; Middle Aged; Neoplasm Staging; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1997 |
A prospective study of PET-FDG imaging for the assessment of head and neck squamous cell carcinoma.
Topics: Aged; Carcinoma, Squamous Cell; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1997 |
Is there a future for PET in oncology?
Topics: Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Medical Oncology; Neoplasms; Sensitivity and Specificity; Tomography, Emission-Computed | 1997 |
Staging recurrent metastatic colorectal carcinoma with PET.
Topics: Adenocarcinoma; Algorithms; Colorectal Neoplasms; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Portography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1997 |
Characterization of pulmonary nodules and mediastinal staging of bronchogenic carcinoma with F-18 fluorodeoxyglucose positron emission tomography.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Bronchogenic; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Neoplasm Staging; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1997 |
[PET scan in general practice for diagnosis of breast carcinoma].
Topics: Adult; Aged; Aged, 80 and over; Blood Glucose; Breast; Breast Neoplasms; Deoxyglucose; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 1997 |
Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography and technetium-99m methoxyisobutylisonitrile scintimammography in the detection of breast tumours.
Topics: Axilla; Breast Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1997 |
Role of positron emission tomography in staging esophageal cancer.
Topics: Adenocarcinoma; Bone Neoplasms; Carcinoma, Squamous Cell; Deoxyglucose; Esophageal Neoplasms; False Negative Reactions; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Laparoscopy; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Staging; Patient Care Planning; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Thoracoscopy; Tomography, Emission-Computed; Tomography, X-Ray Computed; Video Recording | 1997 |
NMR studies of brain 13C-glucose uptake and metabolism: present status.
Topics: Animals; Animals, Domestic; Blood Glucose; Energy Metabolism; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Spectroscopy; Sensitivity and Specificity | 1997 |
Fluorodeoxyglucose whole-body positron emission tomography in colorectal cancer patients studied in routine daily practice.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Sensitivity and Specificity; Tomography, Emission-Computed | 1997 |
PET scanning and the human immunodeficiency virus-positive patient.
Topics: Adult; AIDS-Related Opportunistic Infections; Brain; Brain Neoplasms; Carbon Radioisotopes; Female; Fever of Unknown Origin; Fluorine Radioisotopes; Fluorodeoxyglucose F18; HIV Infections; Humans; Lymphoma, AIDS-Related; Male; Methionine; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Toxoplasmosis, Cerebral | 1997 |
Mediastinal lymph node staging with FDG-PET scan in patients with potentially operable non-small cell lung cancer: a prospective analysis of 50 cases. Leuven Lung Cancer Group.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Mediastinum; Middle Aged; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1997 |
Evaluation of chemotherapy response in patients with advanced head and neck cancer using [F-18]fluorodeoxyglucose positron emission tomography.
Topics: Animals; Antineoplastic Agents; Biopsy; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 1997 |
Detection of recurrent and metastatic colorectal cancer: comparison of positron emission tomography and computed tomography.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1997 |
Whole-body 18FDG positron emission tomography in the staging of non-small cell lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1997 |
Visual and semiquantitative analysis of cortical FDG-PET scans in childhood epileptic encephalopathies.
Topics: Brain; Case-Control Studies; Child; Child, Preschool; Epilepsy; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Infant; Observer Variation; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 1997 |
Single-voxel proton MR spectroscopy and positron emission tomography for lateralization of refractory temporal lobe epilepsy.
Topics: Adolescent; Adult; Electroencephalography; Epilepsy, Temporal Lobe; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Sensitivity and Specificity; Temporal Lobe; Tomography, Emission-Computed | 1998 |
[18F-fluorodeoxyglucose PET in ovarian carcinoma: methodology and preliminary results].
Topics: Adult; Aged; Cystadenocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Radiopharmaceuticals; Recurrence; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 1997 |
Prospective evaluation of fluorine-18-FDG PET in presurgical staging of the axilla in breast cancer.
Topics: Axilla; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Preoperative Care; Prospective Studies; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, Emission-Computed | 1998 |
Comparison of fluorine-18-FDG PET and thallium-201 SPECT in evaluation of lung cancer.
Topics: Adenocarcinoma; Aged; Carcinoma, Squamous Cell; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Radiopharmaceuticals; Sensitivity and Specificity; Thallium Radioisotopes; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1998 |
Performance evaluation of a large axial field-of-view PET scanner: SET-2400W.
Topics: Bone Neoplasms; Equipment Design; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Phantoms, Imaging; Scattering, Radiation; Sensitivity and Specificity; Tissue Distribution; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 1997 |
Positron emission tomography in the evaluation of the N0 neck.
Topics: Carcinoma, Squamous Cell; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Incidence; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neck; Neoplasm Staging; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 1998 |
Chronic osteomyelitis: detection with FDG PET and correlation with histopathologic findings.
Topics: Bone and Bones; Chronic Disease; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Osteomyelitis; Prospective Studies; Radioimmunodetection; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Soft Tissue Infections; Staphylococcal Infections; Technetium Tc 99m Medronate; Tomography, Emission-Computed | 1998 |
Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: correlation with histopathologic and CT findings.
Topics: Adenocarcinoma; Aged; Colorectal Neoplasms; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Neoplasm Staging; Predictive Value of Tests; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1998 |
Malignant melanoma staging using whole-body positron emission tomography.
Topics: Aged; Animals; Female; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Skin Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1998 |
[18F]fluorodeoxyglucose single photon emission computed tomography: can it replace PET and thallium SPECT for the assessment of myocardial viability?
Topics: Adult; Aged; Coronary Disease; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocardium; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Stroke Volume; Thallium Radioisotopes; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 1998 |
Accuracy of whole-body fluorine-18-FDG PET for the detection of recurrent or metastatic breast carcinoma.
Topics: Bone Neoplasms; Breast Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Middle Aged; Neoplasm Recurrence, Local; Predictive Value of Tests; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, Emission-Computed | 1998 |
Differentiating recurrent tumor from radiation necrosis: time for re-evaluation of positron emission tomography?
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Necrosis; Neoplasm Recurrence, Local; Radiation Injuries; Radiography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 1998 |
Combined fluorine-18-FDG and carbon-11-methionine PET for diagnosis of tumors in lung and mediastinum.
Topics: Aged; Carbon Radioisotopes; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Mediastinal Neoplasms; Methionine; Middle Aged; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1998 |
Positron emission tomography in asymptomatic gene carriers of Machado-Joseph disease.
Topics: Adolescent; Adult; Biomarkers; Brain; Brain Chemistry; Case-Control Studies; Discriminant Analysis; Fluorodeoxyglucose F18; Heterozygote; Humans; Machado-Joseph Disease; Middle Aged; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 1998 |
Oncologic diagnosis with 2-[fluorine-18]fluoro-2-deoxy-D-glucose imaging: dual-head coincidence gamma camera versus positron emission tomographic scanner.
Topics: Abdomen; Abdominal Neoplasms; Adenocarcinoma; Axilla; Bone Marrow; Bone Neoplasms; False Positive Reactions; Female; Fluorodeoxyglucose F18; Gamma Cameras; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Neck; Observer Variation; Radiopharmaceuticals; Sensitivity and Specificity; Single-Blind Method; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1998 |
Prospective evaluation of 2-[18F]-2-deoxy-D-glucose positron emission tomography in staging of regional lymph nodes in patients with cutaneous malignant melanoma.
Topics: Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Melanoma; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Skin Neoplasms; Tomography, Emission-Computed | 1998 |
Assessment of malignancy of glioma by positron emission tomography with 18F-fluorodeoxyglucose and single photon emission computed tomography with thallium-201 chloride.
Topics: Astrocytoma; Blood Glucose; Brain Neoplasms; Cell Division; Fluorodeoxyglucose F18; Glioblastoma; Glioma; Humans; Magnetic Resonance Imaging; Oligodendroglioma; Sensitivity and Specificity; Survival Rate; Thallium; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 1998 |
Effectiveness of positron emission tomography for the detection of melanoma metastases.
Topics: Diagnostic Errors; Fluorodeoxyglucose F18; Humans; Melanoma; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Skin Neoplasms; Tomography, Emission-Computed | 1998 |
Evaluation of fluorodeoxyglucose positron emission tomography in the management of soft-tissue sarcomas.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Evaluation Studies as Topic; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Retrospective Studies; Sarcoma; Sensitivity and Specificity; Soft Tissue Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed; Whole-Body Counting | 1998 |
Lymph node staging in non-small-cell lung cancer with FDG-PET scan: a prospective study on 690 lymph node stations from 68 patients.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Middle Aged; Neoplasm Staging; Odds Ratio; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1998 |
FDG PET: elevated plasma glucose reduces both uptake and detection rate of pancreatic malignancies.
Topics: Blood Glucose; Chronic Disease; Diabetes Complications; Fluorodeoxyglucose F18; Humans; Pancreatic Neoplasms; Pancreatitis; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, Emission-Computed | 1998 |
Positron emission tomography with F-18-deoxyglucose in patients with differentiated thyroid carcinoma, elevated thyroglobulin levels, and negative iodine scans.
Topics: Adenocarcinoma, Follicular; Adult; Aged; Biomarkers, Tumor; Carcinoma, Papillary; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Thyrotropin; Tomography, Emission-Computed | 1998 |
Histological verification of positive fluorine-18 fluorodeoxyglucose findings in patients with differentiated thyroid cancer.
Topics: Adenocarcinoma, Follicular; Adult; Aged; Biomarkers, Tumor; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Tomography, Emission-Computed | 1998 |
Fluorine-18-fluorodeoxyglucose and carbon-11-methionine evaluation of lymphadenopathy in sarcoidosis.
Topics: Adult; Bronchoalveolar Lavage Fluid; Carbon Radioisotopes; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Gallium Radioisotopes; Humans; Lymphatic Diseases; Male; Mediastinum; Methionine; Middle Aged; Prognosis; Radiopharmaceuticals; Sarcoidosis, Pulmonary; Sensitivity and Specificity; Time Factors; Tomography, Emission-Computed | 1998 |
Prediction of myocardial viability: Tl-201 versus sestamibi versus teboroxime compared with FDG uptake.
Topics: Coronary Circulation; Female; Fluorodeoxyglucose F18; Forecasting; Heart; Heart Transplantation; Humans; Male; Middle Aged; Myocardial Ischemia; Myocardial Reperfusion; Myocardial Stunning; Myocardium; Organotechnetium Compounds; Oximes; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Tissue Survival | 1998 |
Effect of insulin on uptake of FDG by experimental mammary carcinoma in diabetic rats.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Female; Fluorodeoxyglucose F18; Insulin; Mammary Neoplasms, Experimental; Neoplasm Transplantation; Rats; Rats, Inbred Lew; Sensitivity and Specificity; Tissue Distribution; Tomography, Emission-Computed | 1998 |
Positron emission tomography plus serum TA90 immune complex assay for detection of occult metastatic melanoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antigens, Neoplasm; Biomarkers, Tumor; Enzyme-Linked Immunosorbent Assay; Female; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Middle Aged; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Skin Neoplasms; Tomography, Emission-Computed | 1998 |
Regional cerebral blood flow and glucose metabolism in Sjögren's syndrome.
Topics: Adult; Brain; Brain Diseases; Cerebrovascular Circulation; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Magnetic Resonance Imaging; Middle Aged; Radiopharmaceuticals; Sensitivity and Specificity; Sjogren's Syndrome; Technetium Tc 99m Exametazime; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1998 |
Staging of the axilla in breast cancer: accurate in vivo assessment using positron emission tomography with 2-(fluorine-18)-fluoro-2-deoxy-D-glucose.
Topics: Adult; Aged; Aged, 80 and over; Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 1998 |
Bone scanning in clinical oncology: does it have a future?
Topics: Bone and Bones; Bone Neoplasms; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Medical Oncology; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Medronate; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1998 |
Fluorine-18 deoxyglucose positron emission tomography for the detection of bone metastases in patients with non-small cell lung cancer.
Topics: Aged; Bone and Bones; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Medronate; Tomography, Emission-Computed | 1998 |
Prospective comparison of 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer.
Topics: Carcinoma, Squamous Cell; Diagnostic Imaging; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 1998 |
Clinical utility of positron emission tomography with 18F-fluorodeoxyglucose in detecting residual/recurrent squamous cell carcinoma of the head and neck.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Cohort Studies; Evaluation Studies as Topic; False Negative Reactions; False Positive Reactions; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Mouth Neoplasms; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm, Residual; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Tongue Neoplasms; Tonsillar Neoplasms | 1998 |
The use of positron emission tomography scanning in occult and recurrent head and neck cancer.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1998 |
[Value of (F18)-2-fluorodeoxyglucose PET scanning in staging mouth cavity carcinoma. Comparative evaluation of PET findings before and after preoperative radiochemotherapy with histological and computerized tomography findings].
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Neoadjuvant Therapy; Neoplasm Staging; Prospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome | 1998 |
Metabolic imaging of malignant pleural mesothelioma with fluorodeoxyglucose positron emission tomography.
Topics: Biopsy; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Mesothelioma; Middle Aged; Pleural Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Thoracoscopy; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1998 |
Comparison of fluorine-18-FDG with rest-redistribution thallium-201 SPECT to delineate viable myocardium and predict functional recovery after revascularization.
Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Artery Bypass; Echocardiography; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Heart; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Myocardial Stunning; Predictive Value of Tests; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 1998 |
Technetium-99m-furifosmin in the follow-up of differentiated thyroid carcinoma.
Topics: Carcinoma, Papillary; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Organophosphorus Compounds; Organotechnetium Compounds; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1998 |
[Decision tree sensitivity analysis for cost-effectiveness of chest FDG-PET in patients with a pulmonary tumor (non-small cell carcinoma)].
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Cost-Benefit Analysis; Decision Trees; Fluorodeoxyglucose F18; Hospitalization; Humans; Lung Neoplasms; Middle Aged; Radiopharmaceuticals; Sensitivity and Specificity; Thorax; Tomography, Emission-Computed | 1998 |
A phantom study evaluating the quantitative aspect of 3D PET imaging of the brain.
Topics: Algorithms; Biophysical Phenomena; Biophysics; Brain; Fluorodeoxyglucose F18; Humans; Phantoms, Imaging; Scattering, Radiation; Sensitivity and Specificity; Tomography, Emission-Computed | 1998 |
Imaging of oncologic patients: benefit of combined CT and FDG PET in the diagnosis of malignancy.
Topics: Abdominal Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Thoracic Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1998 |
18FDG-PET for the assessment of primary head and neck tumors: clinical, computed tomography, and histopathological correlation in 38 patients.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Radiography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 1998 |
Whole-body [18F]FDG PET in the management of metastatic brain tumours.
Topics: Adult; Aged; Blood Glucose; Brain Edema; Brain Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neurologic Examination; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1998 |
Objective method for localization of cortical asymmetries using positron emission tomography to aid surgical resection of epileptic foci.
Topics: Adolescent; Adult; Cerebral Cortex; Child; Child, Preschool; Electrodes, Implanted; Electroencephalography; Epilepsy; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Infant; Magnetic Resonance Imaging; Male; Middle Aged; Patient Care Planning; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Therapy, Computer-Assisted; Tomography, Emission-Computed; Treatment Outcome | 1998 |
Dynamic positron emission tomography with F-18 fluorodeoxyglucose imaging in differentiation of benign from malignant lung/mediastinal lesions.
Topics: Adenocarcinoma; Adult; Aged; Biopsy, Needle; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Follow-Up Studies; Granuloma; Humans; Lung Diseases; Lung Neoplasms; Mediastinal Diseases; Mediastinal Neoplasms; Middle Aged; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 1998 |
Detection of recurrent or persistent nasopharyngeal carcinomas after radiotherapy with 18-fluoro-2-deoxyglucose positron emission tomography and comparison with computed tomography.
Topics: Adolescent; Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1998 |
Planar coincidence scintigraphy and PET in staging malignant melanoma.
Topics: Adult; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Melanoma; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Skin Neoplasms; Tomography, Emission-Computed | 1998 |
A study of vestibular schwannomas using positron emission tomography and monoclonal antibody Ki-67.
Topics: Adult; Aged; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Ki-67 Antigen; Magnetic Resonance Imaging; Middle Aged; Mitotic Index; Neuroma, Acoustic; Pilot Projects; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 1998 |
Diagnosis of pancreatic carcinoma: role of FDG PET.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 1998 |
Positron emission tomography in the evaluation of the negative neck in patients with oral cavity cancer.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Mouth Neoplasms; Neck; Neoplasm Staging; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1998 |
Can dual-headed 18F-FDG SPET imaging reliably supersede PET in clinical oncology? A comparative study in lung and gastrointestinal tract cancer.
Topics: Colorectal Neoplasms; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gamma Cameras; Gastrointestinal Neoplasms; Humans; Lung Neoplasms; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Pancreatic Neoplasms; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1998 |
Lack of association of apolipoprotein E epsilon4 allele dose with cerebral glucose metabolism in Alzheimer disease.
Topics: Aged; Alleles; Alzheimer Disease; Apolipoprotein E4; Apolipoproteins E; Blood Glucose; Brain; Brain Mapping; Energy Metabolism; Female; Fluorodeoxyglucose F18; Genotype; Humans; Male; Middle Aged; Sensitivity and Specificity; Tomography, Emission-Computed | 1998 |
Comparative value of thallium and glucose SPECT imaging in childhood brain tumors.
Topics: Brain Neoplasms; Child; False Negative Reactions; Fluorodeoxyglucose F18; Humans; Necrosis; Neoplasm Recurrence, Local; Neoplasm, Residual; Predictive Value of Tests; Radiation Injuries; Radiopharmaceuticals; Sensitivity and Specificity; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon | 1998 |
[Positron emission tomography with [18 F]-2-fluoro-2-deoxy-D-glucose (18FDG-PET) in diagnosis of retroperitoneal lymph node metastases of testicular tumors].
Topics: Adult; Biomarkers, Tumor; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Prognosis; Retroperitoneal Neoplasms; Seminoma; Sensitivity and Specificity; Testicular Neoplasms; Tomography, Emission-Computed | 1998 |
Cost-effectiveness of FDG-PET for staging non-small cell lung cancer: a decision analysis.
Topics: Carcinoma, Non-Small-Cell Lung; Cost-Benefit Analysis; Costs and Cost Analysis; Decision Trees; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Life Expectancy; Lung Neoplasms; Medicare; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; United States | 1998 |
[Detection of unexpected extrathoracic metastases in preoperative staging of non-small-cell bronchial carcinoma (NSCLC) with positron emission tomography (PET)].
Topics: Blood Glucose; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Metastasis; Neoplasm Staging; Prognosis; Sensitivity and Specificity; Tomography, Emission-Computed | 1998 |
[Can the extent of pancreatic tumors be evaluated reliably enough by positron emission tomography (PET)].
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Chronic Disease; Fluorodeoxyglucose F18; Gastrinoma; Humans; Pancreas; Pancreatic Neoplasms; Pancreatitis; Sensitivity and Specificity; Tomography, Emission-Computed | 1998 |
The role of FDG-PET, HMPAO-SPET and MRI in the detection of brain involvement in patients with systemic lupus erythematosus.
Topics: Adult; Antibodies, Anticardiolipin; Brain; Female; Fluorodeoxyglucose F18; Humans; Lupus Erythematosus, Systemic; Magnetic Resonance Imaging; Middle Aged; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Exametazime; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1999 |
A PET study of 18FDG uptake in soft tissue masses.
Topics: Case-Control Studies; Connective Tissue Diseases; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Radiopharmaceuticals; Sarcoma; Sensitivity and Specificity; Soft Tissue Neoplasms; Time Factors; Tomography, Emission-Computed | 1999 |
Whole-body PET proves superior to CT for staging primary colorectal carcinoma.
Topics: Aged; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1999 |
FDG PET and dual-head gamma camera positron coincidence detection imaging of suspected malignancies and brain disorders.
Topics: Adult; Aged; Brain; Brain Diseases; Dementia; Female; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 1999 |
Detection of liver metastases from pancreatic cancer using FDG PET.
Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Pancreatic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1999 |
[Efficacy of F-18 fluorodeoxyglucose positron emission tomography (FDG-PET) scans in diagnosis of pulmonary nodules].
Topics: Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphoma; Male; Middle Aged; Sensitivity and Specificity; Tomography, Emission-Computed | 1998 |
Reciprocal ST-segment depression associated with exercise-induced ST-segment elevation indicates residual viability after myocardial infarction.
Topics: Aged; Ammonia; Coronary Angiography; Coronary Circulation; Electrocardiography; Exercise Test; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Nitrogen Radioisotopes; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 1999 |
Functional status and quality of life in patients with heart failure undergoing coronary bypass surgery after assessment of myocardial viability.
Topics: Aged; Cardiotonic Agents; Coronary Artery Bypass; Dobutamine; Echocardiography; Exercise Test; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Heart Failure; Humans; Male; Myocardial Ischemia; Prognosis; Prospective Studies; Quality of Life; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, Emission-Computed; Ventricular Dysfunction, Left; Ventricular Function, Left | 1999 |
[Lymph node staging of bladder neck carcinoma with positron emission tomography].
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Sensitivity and Specificity; Tomography, Emission-Computed; Urinary Bladder Neoplasms | 1999 |
Positron emission tomographic imaging with fluorodeoxyglucose isefficacious in evaluating malignant pulmonary disease.
Topics: Aged; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1999 |
FDG SPECT in patients with lung masses.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 1999 |
Feasibility of fluorodeoxyglucose dual-head gamma camera coincidence imaging in the evaluation of lung cancer: comparison with FDG PET.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Feasibility Studies; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 1999 |
Contribution of PET in the detection of liver metastases from pancreatic tumours.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Male; Middle Aged; Pancreatic Neoplasms; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1999 |
Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the staging of lung cancer.
Topics: Adult; Aged; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1999 |
Exercise four hour redistribution thallium-201 single photon emission computed tomography and exercise induced ST segment elevation in detecting the viable myocardium in patients with acute myocardial infarction.
Topics: Adult; Aged; Electrocardiography; Exercise Test; Female; Fluorodeoxyglucose F18; Heart; Humans; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction; Nitrogen Radioisotopes; Predictive Value of Tests; Sensitivity and Specificity; Statistics, Nonparametric; Thallium Radioisotopes; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1999 |
Sensitivity and specificity of quantitative difference SPECT analysis in seizure localization.
Topics: Adult; Brain; Cerebrovascular Circulation; Electroencephalography; Epilepsies, Partial; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Radiopharmaceuticals; Sensitivity and Specificity; Subtraction Technique; Technetium Tc 99m Exametazime; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1999 |
18F-FDG PET studies in patients with extratemporal and temporal epilepsy: evaluation of an observer-independent analysis.
Topics: Adolescent; Adult; Electroencephalography; Epilepsy; Epilepsy, Temporal Lobe; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Observer Variation; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 1999 |
Imaging intractable epilepsy: how many tests are enough?
Topics: Diagnostic Imaging; Electroencephalography; Epilepsy; Fluorodeoxyglucose F18; Hippocampus; Humans; Magnetic Resonance Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Exametazime; Temporal Lobe; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1999 |
Comparison of MR imaging with PET and ictal SPECT in 118 patients with intractable epilepsy.
Topics: Adolescent; Adult; Brain; Child; Electroencephalography; Epilepsy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Technetium Tc 99m Exametazime; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Videotape Recording | 1999 |
[PET in oncology: standardization and specificity].
Topics: Fluorodeoxyglucose F18; Humans; Neoplasms; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 1999 |
Uses and limitations of FDG positron emission tomography in patients with head and neck cancer.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Neoplasm, Residual; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome | 1999 |
Attenuation correction in whole-body FDG oncological studies: the role of statistical reconstruction.
Topics: Adult; Aged; Algorithms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Neoplasms; Observer Variation; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Time Factors; Tomography, Emission-Computed | 1999 |
[Brain metastases of lung cancer: diagnostic accuracy of positron emission tomography with fluorodeoxyglucose (FDG-PET)].
Topics: Adult; Aged; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Sensitivity and Specificity; Tomography, Emission-Computed | 1999 |
Preoperative assessment of cervical lymph nodes in head and neck cancer with fluorine-18 fluorodeoxyglucose using a dual-head coincidence camera: a pilot study.
Topics: Carcinoma, Squamous Cell; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neck; Neoplasm Staging; Pilot Projects; Preoperative Care; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 1999 |
Occult primary tumors of the head and neck: lack of benefit from positron emission tomography imaging with 2-[F-18]fluoro-2-deoxy-D-glucose.
Topics: Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Neoplasms, Unknown Primary; Sensitivity and Specificity; Tomography, Emission-Computed | 1999 |
F-18-FDG positron imaging in oncological patients: gamma camera coincidence detection versus dedicated PET.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Gamma Cameras; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphoma; Middle Aged; Neoplasms; Phantoms, Imaging; Radiopharmaceuticals; Recurrence; Sensitivity and Specificity; Tomography, Emission-Computed | 1999 |
The detection of local recurrent head and neck cancer with fluorine-18 fluorodeoxyglucose dual-head positron emission tomography.
Topics: Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Time Factors; Tomography, Emission-Computed | 1999 |
Fluorine-18 fluorodeoxyglucose imaging using dual-head coincidence positron emission tomography without attenuation correction in patients with head and neck cancer.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Gamma Cameras; Head; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neck; Neoplasm Recurrence, Local; Neoplasm, Residual; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 1999 |
Pheochromocytomas: imaging with 2-[fluorine-18]fluoro-2-deoxy-D-glucose PET.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pheochromocytoma; Prognosis; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1999 |
Peritoneal recurrence of colon cancer detected by positron emission tomography: report of a case.
Topics: Aged; Colonic Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Peritoneal Neoplasms; Sensitivity and Specificity; Tomography, Emission-Computed | 1999 |
Role of FDG PET in metastatic thyroid cancer.
Topics: Autoantibodies; False Negative Reactions; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lymphatic Metastasis; Neoplasm Metastasis; Radiopharmaceuticals; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Tomography, Emission-Computed | 1999 |
Positron emission tomography for evaluating para-aortic nodal metastasis in locally advanced cervical cancer before surgical staging: a surgicopathologic study.
Topics: Aorta; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymphatic Metastasis; Pelvis; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 1999 |
Staging non-small cell lung cancer with whole-body PET.
Topics: Adult; Aged; Aged, 80 and over; Bone and Bones; Bone Neoplasms; Brain; Brain Neoplasms; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Whole-Body Counting | 1999 |
[F-18 FDG PET for detection of occult primary tumor in patients with lymphatic metastases of the neck region].
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Unknown Primary; Otorhinolaryngologic Neoplasms; Sensitivity and Specificity; Tomography, Emission-Computed | 1999 |
FDG PET can replace bone scintigraphy in primary staging of malignant lymphoma.
Topics: Adolescent; Adult; Aged; Biopsy; Bone and Bones; Bone Marrow; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 1999 |
Positron emission tomography and cholangiocarcinoma in primary sclerosing cholangitis.
Topics: Adult; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Cholangitis, Sclerosing; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1999 |
A small breast cancer detected by PET.
Topics: Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 1999 |
Evaluation of distant metastases in esophageal cancer: 100 consecutive positron emission tomography scans.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Minimally Invasive Surgical Procedures; Neoplasm Metastasis; Neoplasm Staging; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1999 |
Positron emission tomography of esophageal carcinoma using (11)C-choline and (18)F-fluorodeoxyglucose: a novel method of preoperative lymph node staging.
Topics: Aged; Aged, 80 and over; Carbon Radioisotopes; Choline; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Male; Middle Aged; Neoplasm Staging; Sensitivity and Specificity; Time Factors; Tomography, Emission-Computed | 1999 |
Can the standardized uptake value characterize primary brain tumors on FDG-PET?
Topics: Adult; Brain; Brain Neoplasms; Case-Control Studies; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Male; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity | 1999 |
Optimal interpretation of FDG PET in the diagnosis, staging and management of pancreatic carcinoma.
Topics: Adenocarcinoma; Blood Glucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Pancreatic Neoplasms; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1999 |
Validity of 18F-fluorodeoxyglucose imaging with a dual-head coincidence gamma camera for detection of myocardial viability.
Topics: Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Stunning; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1999 |
Utility of 18F-FDG positron emission tomography scanning on selection of patients for resection of hepatic colorectal metastases.
Topics: Adult; Aged; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Hepatectomy; Humans; Liver Neoplasms; Male; Middle Aged; Patient Selection; Peritoneal Neoplasms; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 1999 |
The clinical usefulness of F-18 FDG coincidence PET without attenuation correction and without whole-body scanning mode in pulmonary lesions comparison with CT, MRI, and clinical findings.
Topics: Aged; Biopsy, Needle; False Positive Reactions; Female; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Spinal Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1999 |
FDG positron emission tomography in head and neck cancer: pitfall or pathology?
Topics: Adult; Aged; Artifacts; Blood Glucose; Diagnosis, Differential; Fasting; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Iatrogenic Disease; Image Processing, Computer-Assisted; Middle Aged; Muscle Contraction; Muscle, Skeletal; Neoplasm Recurrence, Local; Neoplasm Staging; Papilloma; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Wound Healing | 1999 |
FDG/PET and spiral CT image fusion for medistinal lymph node assessment of non-small cell lung cancer patients.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Neoplasm Staging; Observer Variation; Prognosis; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1999 |
The use of FDG-positron emission tomography for the evaluation of colorectal metastases of the liver.
Topics: Adult; Aged; Carcinoma; Colonic Neoplasms; Contraindications; False Positive Reactions; Female; Fluorodeoxyglucose F18; Hepatectomy; Humans; Laparotomy; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Patient Care Planning; Radiopharmaceuticals; Rectal Neoplasms; Reoperation; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1999 |
Lymph node detection of head and neck squamous cell carcinomas by positron emission tomography with fluorodeoxyglucose F 18 in a routine clinical setting.
Topics: Academic Medical Centers; Adult; Aged; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Node Excision; Lymph Nodes; Magnetic Resonance Imaging; Male; Middle Aged; Neck; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1999 |
Effect of attenuation correction on lesion detectability in FDG PET of breast cancer.
Topics: Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Lymphatic Metastasis; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 1999 |
Intracranial EEG versus flumazenil and glucose PET in children with extratemporal lobe epilepsy.
Topics: Adolescent; Blood Glucose; Brain; Child; Child, Preschool; Electroencephalography; Epilepsy; Female; Flumazenil; Fluorodeoxyglucose F18; Humans; Male; ROC Curve; Sensitivity and Specificity; Tomography, Emission-Computed | 2000 |
Initial evaluation of pulmonary abnormalities: CT-guided fine-needle aspiration biopsy and fluoride-18 fluorodeoxyglucose positron emission tomography correlation.
Topics: Biopsy, Needle; Carcinoma; Carcinoma, Bronchogenic; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Retrospective Studies; Sensitivity and Specificity; Thoracic Neoplasms; Tomography, Emission-Computed | 2000 |
Use of fluorine-18 fluorodeoxyglucose positron emission tomography in the detection of silent metastases from malignant melanoma.
Topics: Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Skin Neoplasms; Tomography, Emission-Computed | 2000 |
Evaluation of pancreatic islet cell tumors by fluorine-18 fluorodeoxyglucose positron emission tomography: comparison with other modalities.
Topics: Adenoma, Islet Cell; Adult; Aged; Diagnostic Imaging; Feasibility Studies; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2000 |
Preoperative evaluation of patients with primary head and neck cancer using dual-head 18fluorodeoxyglucose positron emission tomography.
Topics: Carcinoma, Squamous Cell; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Second Primary; Predictive Value of Tests; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Ultrasonography | 2000 |
18-FDG-PET for the assessment of residual masses on CT following treatment of lymphomas.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm, Residual; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2000 |
Values and limitations of 18F-fluorodeoxyglucose-positron-emission tomography with preoperative evaluation of patients with pancreatic masses.
Topics: Area Under Curve; Blood Glucose; Cholangiopancreatography, Endoscopic Retrograde; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Middle Aged; Pancreatic Diseases; Pancreatic Neoplasms; Preoperative Care; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2000 |
Comparative efficacy of positron emission tomography with fluorodeoxyglucose in evaluation of small (<1 cm), intermediate (1 to 3 cm), and large (>3 cm) lymph node lesions.
Topics: Adult; Aged; Aged, 80 and over; Blood Glucose; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Neoplasm Staging; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2000 |
The value of positron emission tomography scanning in the detection of subclinical metastatic melanoma.
Topics: Female; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Skin Neoplasms; Tomography, Emission-Computed | 2000 |
Whole-body PET with (fluorine-18)-2-deoxyglucose for detecting recurrent primary serous peritoneal carcinoma: An initial report.
Topics: Adult; CA-125 Antigen; Cystadenocarcinoma, Papillary; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Peritoneal Neoplasms; Prospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2000 |
FDG PET evaluation of mucinous neoplasms: correlation of FDG uptake with histopathologic features.
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 2000 |
Semi-automatic ROI placement system for analysis of brain PET images based on elastic model: application to diagnosis of Alzheimer's disease.
Topics: Adult; Aged; Alzheimer Disease; Case-Control Studies; Fluorodeoxyglucose F18; Humans; Middle Aged; Sensitivity and Specificity; Software; Tomography, Emission-Computed | 2000 |
F-18 fluorodeoxyglucose chest uptake in lung inflammation and infection.
Topics: Adult; Aged; Breast Neoplasms; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Respiratory Tract Infections; Sensitivity and Specificity; Tomography, Emission-Computed | 2000 |
Exclusion of chronic osteomyelitis with F-18 fluorodeoxyglucose positron emission tomographic imaging.
Topics: Adult; Aged; Chronic Disease; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Osteomyelitis; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2000 |
Positron emission tomography using [(18)F]Fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Cyclophosphamide; Epirubicin; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Paclitaxel; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, Emission-Computed | 2000 |
Positron emission tomography using [(18)F]-fluorodeoxy-D-glucose to predict the pathologic response of breast cancer to primary chemotherapy.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Axilla; Biopsy; Breast Neoplasms; Cyclophosphamide; Docetaxel; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Paclitaxel; Prednisolone; Radiopharmaceuticals; Sensitivity and Specificity; Taxoids; Tomography, Emission-Computed; Vincristine | 2000 |
Transmission scanning system for a gamma camera coincidence scanner.
Topics: Cesium Radioisotopes; Female; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Image Processing, Computer-Assisted; Male; Phantoms, Imaging; Radiopharmaceuticals; Sensitivity and Specificity | 2000 |
Positron emission tomography: an independent indicator of radiocurability in head and neck carcinomas.
Topics: Adult; Aged; Aged, 80 and over; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Predictive Value of Tests; Prognosis; Risk Assessment; Sensitivity and Specificity; Tomography, Emission-Computed | 2000 |
Experience in qualitative and quantitative FDG PET in follow-up of patients with suspected recurrence from head and neck cancer.
Topics: Adult; Aged; Denmark; Diagnosis, Differential; Female; Finland; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2000 |
Improved detection of individual nodal involvement in squamous cell carcinoma of the esophagus by FDG PET.
Topics: Aged; Carcinoma, Squamous Cell; Endosonography; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2000 |
Value of (18F)-FDG positron emission tomography, computed tomography, and magnetic resonance imaging in diagnosing primary and recurrent ovarian carcinoma.
Topics: Adult; Aged; Carcinoma; Colonic Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Laparotomy; Magnetic Resonance Imaging; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Peritoneal Neoplasms; Prospective Studies; Radiography, Abdominal; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Whole-Body Counting | 2000 |
Non-small cell lung cancer: FDG PET for nodal staging in patients with stage I disease.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Radiography, Thoracic; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2000 |
[Results of pretherapeutic lymph node diagnosis in head and neck tumors. Clinical value of 18-FDG positron emission tomography (PET)].
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Evaluation Studies as Topic; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymph Node Excision; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Palpation; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Time Factors; Tomography, Emission-Computed; Tomography, X-Ray Computed; Ultrasonography | 2000 |
Doppler tissue velocity sampling improves diagnostic accuracy during dobutamine stress echocardiography for the assessment of viable myocardium in patients with severe left ventricular dysfunction.
Topics: Dobutamine; Echocardiography, Doppler, Pulsed; Exercise Test; Female; Fluorodeoxyglucose F18; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Contraction; Observer Variation; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Severity of Illness Index; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2000 |
Positron emission tomography is a useful tool in differentiating idiopathic from ischemic dilated cardiomyopathy.
Topics: Adult; Aged; Ammonia; Cardiomyopathy, Dilated; Coronary Circulation; Coronary Disease; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nitrogen Isotopes; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2000 |
Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocarcinoma of the colon and rectum.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Colonic Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Recurrence, Local; Radiopharmaceuticals; Rectal Neoplasms; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 2000 |
Evaluation of myocardial viability in asymptomatic patients early after infarction with perfusion/metabolism single-photon-emission computed tomographic imaging and dobutamine echocardiography.
Topics: Cardiotonic Agents; Dobutamine; Echocardiography; Exercise Test; Female; Fluorodeoxyglucose F18; Humans; Injections, Intravenous; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction; Myocardial Revascularization; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 2000 |
Metabolic staging of lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Mediastinal Neoplasms; Neoplasm Staging; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2000 |
Positron emission tomography in imaging spinal cord tumors.
Topics: Adolescent; Adult; Carbon Radioisotopes; Child; Child, Preschool; Combined Modality Therapy; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Infant; Magnetic Resonance Imaging; Male; Methionine; Middle Aged; Neoplasm, Residual; Radiotherapy, Adjuvant; Sensitivity and Specificity; Spinal Cord; Spinal Cord Neoplasms; Tomography, Emission-Computed | 2000 |
Prognostic value of FDG PET imaging in malignant pleural mesothelioma.
Topics: Biopsy; Fluorodeoxyglucose F18; Humans; Male; Mesothelioma; Middle Aged; Pleural Neoplasms; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2000 |
Infection imaging using whole-body FDG-PET.
Topics: Adult; Aged; Aged, 80 and over; Bone Diseases, Infectious; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Radiopharmaceuticals; Sensitivity and Specificity; Soft Tissue Infections; Tomography, Emission-Computed | 2000 |
Regional myocardial wall thickening assessed at rest by ECG gated (18)F-FDG positron emission tomography and by magnetic resonance imaging.
Topics: Adult; Aged; Coronary Disease; Electrocardiography; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging, Cine; Middle Aged; Myocardium; Pilot Projects; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2000 |
Glucose metabolic analysis of musculoskeletal tumours using 18fluorine-FDG PET as an aid to preoperative planning.
Topics: Adolescent; Adult; Aged; Bone Neoplasms; Child; Female; Fluorodeoxyglucose F18; Glucose-6-Phosphate Isomerase; Humans; Male; Middle Aged; Musculoskeletal Diseases; Radionuclide Imaging; Radiopharmaceuticals; Reverse Transcriptase Polymerase Chain Reaction; Sarcoma; Sensitivity and Specificity; Soft Tissue Neoplasms | 2000 |
Utility evaluations for Markov states of lung cancer for PET-based disease management.
Topics: Aged; Analysis of Variance; Carcinoma, Non-Small-Cell Lung; Cohort Studies; Decision Making; Decision Support Techniques; Fluorodeoxyglucose F18; Health Status Indicators; Humans; Lung Neoplasms; Markov Chains; Mediastinoscopy; Middle Aged; Neoplasm Staging; Outcome Assessment, Health Care; Patient Participation; Quality of Life; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2000 |
EUS, PET, and CT scanning for evaluation of pancreatic adenocarcinoma.
Topics: Adenocarcinoma; Biopsy, Needle; Diagnosis, Differential; Endosonography; Fluorodeoxyglucose F18; Humans; Neoplasm Invasiveness; Neoplasm Staging; Pancreatic Neoplasms; Prospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2000 |
Which kinds of lymph node metastases can FDG PET detect? A clinical study in melanoma.
Topics: Adult; Aged; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Melanoma; Middle Aged; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Skin Neoplasms; Tomography, Emission-Computed | 2000 |
Sensitive detection of mediastinal lymph node metastasis of lung cancer with 11C-choline PET.
Topics: Adult; Aged; Carbon Radioisotopes; Carcinoma, Non-Small-Cell Lung; Choline; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Phantoms, Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2000 |
[Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) in ORL and pulmonary oncology].
Topics: Fluorodeoxyglucose F18; Glucose; Humans; Lung Neoplasms; Lymph Nodes; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Unknown Primary; Otorhinolaryngologic Neoplasms; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2000 |
FDG positron emission tomography in the diagnosis of peripheral pulmonary focal lesions.
Topics: Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Radiopharmaceuticals; Risk Factors; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2000 |
Comparative efficacy of positron emission tomography and ultrasonography in preoperative evaluation of axillary lymph node metastases in breast cancer.
Topics: Adult; Aged; Axilla; Breast Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Mastectomy; Middle Aged; Neoplasm Staging; Neoplasms, Multiple Primary; Preoperative Care; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Ultrasonography | 2000 |
Is (18)F-fluorodeoxyglucose positron emission tomography in recurrent colorectal cancer a contribution to surgical decision making?
Topics: Abdominal Neoplasms; Adult; Aged; Aged, 80 and over; Carcinoembryonic Antigen; Colonic Neoplasms; Decision Making; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Patient Care Planning; Radiopharmaceuticals; Rectal Neoplasms; Sensitivity and Specificity; Thoracic Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed; Ultrasonography | 2000 |
Preoperative evaluation of pancreatic masses with positron emission tomography using 18F-fluorodeoxyglucose: diagnostic limitations.
Topics: Adenocarcinoma; Adult; Aged; Chronic Disease; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Pancreatic Neoplasms; Pancreatitis; Prospective Studies; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Ultrasonography | 2000 |
Combined imaging techniques for pancreatic cancer.
Topics: Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Pancreatectomy; Pancreatic Neoplasms; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2000 |
FDG PET and immunoscintigraphy with 99mTc-labeled antibody fragments for detection of the recurrence of colorectal carcinoma.
Topics: Antibodies, Monoclonal; Bone Neoplasms; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Organotechnetium Compounds; Predictive Value of Tests; Radioimmunodetection; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2000 |
Grading of tumors and tumorlike lesions of bone: evaluation by FDG PET.
Topics: Adult; Bone and Bones; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sarcoma; Sensitivity and Specificity; Tomography, Emission-Computed | 2000 |
Is there a role for FDG PET in the diagnosis of musculoskeletal neoplasms?
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Muscle Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2000 |
Clinical PET in oncology.
Topics: Artifacts; Blood Glucose; Cooperative Behavior; Cyclotrons; False Positive Reactions; Female; Fluorodeoxyglucose F18; Germany; Humans; Inflammation; Lymphatic Metastasis; Male; Medical Oncology; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms; Nuclear Medicine; Organ Specificity; Practice Guidelines as Topic; Private Practice; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Universities | 2000 |
[Positron emission tomography in tumor pathology].
Topics: Europe; Fluorodeoxyglucose F18; Humans; Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2000 |
Assessment of malignancy in pulmonary lesions: FDG dual-head coincidence gamma camera imaging in association with serum tumor marker measurement.
Topics: Adult; Aged; Aged, 80 and over; Antigens, Neoplasm; Biomarkers, Tumor; Carcinoembryonic Antigen; Female; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Keratin-19; Keratins; Lung Neoplasms; Male; Middle Aged; Phosphopyruvate Hydratase; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity | 2000 |
Results of preliminary clinical trials of the positron emission mammography system PEM-I: a dedicated breast imaging system producing glucose metabolic images using FDG.
Topics: Adult; Aged; Breast; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Glucose; Humans; Mammography; Middle Aged; Pilot Projects; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2000 |
Evaluating dementia using PET: how do we put into clinical perspective what we know to date?
Topics: Alzheimer Disease; Brain; Dementia; Fluorodeoxyglucose F18; Humans; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2000 |
FDG PET imaging in patients with pathologically verified dementia.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Dementia; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Parietal Lobe; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Temporal Lobe; Tomography, Emission-Computed | 2000 |
Whole-body FDG positron emission tomographic imaging for staging esophageal cancer comparison with computed tomography.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Minimally Invasive Surgical Procedures; Neoplasm Staging; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Thoracic Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2000 |
Cost-effectiveness of FDG-PET for the management of solitary pulmonary nodules: a decision analysis based on cost reimbursement in Germany.
Topics: Biopsy, Needle; Cohort Studies; Cost Savings; Cost-Benefit Analysis; Decision Support Techniques; Fluorodeoxyglucose F18; Germany; Humans; Insurance, Health, Reimbursement; Life Expectancy; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Radiopharmaceuticals; Risk Factors; Sensitivity and Specificity; Solitary Pulmonary Nodule; Survival Rate; Tomography, Emission-Computed | 2000 |
Primary staging of lymphomas: cost-effectiveness of FDG-PET versus computed tomography.
Topics: Adolescent; Adult; Aged; Cost-Benefit Analysis; Europe; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2000 |
PET imaging of musculoskeletal tumours with fluorine-18 alpha-methyltyrosine: comparison with fluorine-18 fluorodeoxyglucose PET.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Child; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Muscle Neoplasms; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tyrosine | 2000 |
The utility of positron emission tomography for the diagnosis and staging of recurrent esophageal cancer.
Topics: Adenocarcinoma; Aged; Carcinoma, Squamous Cell; Endosonography; Esophageal Neoplasms; Esophagectomy; Esophagostomy; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gastrectomy; Gastrostomy; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Sensitivity and Specificity; Survival Analysis; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2000 |
Histopathologic validation of lymph node staging with FDG-PET scan in cancer of the esophagus and gastroesophageal junction: A prospective study based on primary surgery with extensive lymphadenectomy.
Topics: Adult; Aged; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Stomach Neoplasms; Tomography, Emission-Computed | 2000 |
Instrumentation for coincidence imaging with multihead scintillation cameras.
Topics: Algorithms; Equipment Design; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Image Processing, Computer-Assisted; Phantoms, Imaging; Quality Assurance, Health Care; Radiopharmaceuticals; Scintillation Counting; Sensitivity and Specificity; Tomography, Emission-Computed | 2000 |
[Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the clinical diagnosis of lung cancer].
Topics: Bone and Bones; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2000 |
Multimodality MR imaging assessment of myocardial viability: combination of first-pass and late contrast enhancement to wall motion dynamics and comparison with FDG PET-initial experience.
Topics: Aged; Cardiotonic Agents; Coronary Disease; Dobutamine; Female; Fluorodeoxyglucose F18; Heart Function Tests; Humans; Hypertrophy, Left Ventricular; Magnetic Resonance Imaging; Male; Middle Aged; Myocardial Contraction; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Ventricular Function, Left; Ventriculography, First-Pass | 2000 |
Correlation of temporal lobe glucose metabolism with the Wada memory test.
Topics: Adolescent; Adult; Amobarbital; Child; Epilepsy, Temporal Lobe; Female; Fluorodeoxyglucose F18; Functional Laterality; Glucose; Humans; Male; Memory; Middle Aged; Sensitivity and Specificity; Temporal Lobe; Tomography, Emission-Computed | 2000 |
Comparison of 18-fluoro-2-deoxyglucose positron emission tomography and computed tomography in detection of cervical lymph node metastases of nasopharyngeal carcinoma.
Topics: Adult; Aged; Biopsy; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Nasopharyngeal Neoplasms; Neck; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2000 |
FDG PET in thyroid cancer: thyroxine or not?
Topics: Fluorodeoxyglucose F18; Humans; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms; Thyrotropin; Thyroxine; Tomography, Emission-Computed | 2000 |
[1959-1999: from serum markers to 18-FDG in oncology. The experience of the René-Huguenin Center].
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Breast Neoplasms; CA-125 Antigen; CA-19-9 Antigen; Carcinoembryonic Antigen; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Mucin-1; Neoplasm Proteins; Ovarian Neoplasms; Predictive Value of Tests; Sensitivity and Specificity; Tomography, Emission-Computed | 2000 |
Preparation by recombinant human thyrotropin or thyroid hormone withdrawal are comparable for the detection of residual differentiated thyroid carcinoma.
Topics: Adult; Cohort Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Staging; Neoplasm, Residual; Radiopharmaceuticals; Recombinant Proteins; Recurrence; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Thyroid Hormones; Thyroid Neoplasms; Thyroidectomy; Thyrotropin; Tomography, Emission-Computed | 2001 |
Fluorodeoxyglucose positron emission tomography studies in diagnosis and staging of clinically organ-confined prostate cancer.
Topics: Aged; Aged, 80 and over; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Prostate; Prostatic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |
Staging by positron emission tomography predicts survival in patients with non-small cell lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Survival Analysis; Tomography, Emission-Computed | 2001 |
Staging of non-small-cell lung cancer with positron-emission tomography.
Topics: Carcinoid Tumor; Carcinoma, Non-Small-Cell Lung; False Negative Reactions; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mediastinal Neoplasms; Neoplasm Staging; Sensitivity and Specificity; Tomography, Emission-Computed | 2000 |
Direct comparison of F-18-FDG PET and ultrasound in the follow-up of patients with squamous cell cancer of the head and neck.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Predictive Value of Tests; Radiography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed; Ultrasonography | 2000 |
Low-dose dobutamine imagings predicting regional improvement in left ventricular function after revascularization.
Topics: Adrenergic beta-Agonists; Contrast Media; Diagnostic Imaging; Dobutamine; Echocardiography; Fluorodeoxyglucose F18; Gated Blood-Pool Imaging; Humans; Magnetic Resonance Imaging, Cine; Myocardial Revascularization; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Ventricular Function, Left | 2000 |
Fluorodeoxyglucose positron emission tomography, a new technique for increasing the detection rate of coincident thyroid cancer in head and neck oncology.
Topics: Adult; Aged; Blood Glucose; Carcinoma, Squamous Cell; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Multiple Primary; Neoplasms, Unknown Primary; Otorhinolaryngologic Neoplasms; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, Emission-Computed | 2000 |
The promising role of 18F-FDG PET in detecting infected lower limb prosthesis implants.
Topics: Adult; Aged; Aged, 80 and over; Fluorodeoxyglucose F18; Hip Prosthesis; Humans; Knee Prosthesis; Middle Aged; Prosthesis-Related Infections; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |
Clinical usefulness of FDG PET in differentiated thyroid cancer.
Topics: Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, Emission-Computed | 2001 |
Relationship between preoperative viability and postoperative improvement in LVEF and heart failure symptoms.
Topics: Cardiomyopathy, Dilated; Case-Control Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocardial Revascularization; Myocardial Stunning; Predictive Value of Tests; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Stroke Volume; Tomography, Emission-Computed, Single-Photon; Ventricular Function, Left | 2001 |
Quantitative PET studies in pretreated melanoma patients: a comparison of 6-[18F]fluoro-L-dopa with 18F-FDG and (15)O-water using compartment and noncompartment analysis.
Topics: Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Melanoma; Models, Theoretical; Oxygen Radioisotopes; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |
Evaluation of lymph node metastases in squamous cell carcinoma of the esophagus with positron emission tomography.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
Decision analysis for the cost-effective management of recurrent colorectal cancer.
Topics: Colorectal Neoplasms; Cost-Benefit Analysis; Decision Trees; Direct Service Costs; Fluorodeoxyglucose F18; Humans; Life Expectancy; Liver Neoplasms; Models, Theoretical; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Survival Analysis; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
PET scanning in malignancy: infant, adolescent or mature citizen?
Topics: Cost-Benefit Analysis; Decision Trees; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Technology Assessment, Biomedical; Tomography, Emission-Computed | 2001 |
Metastatic lymph nodes in patients with cervical cancer: detection with MR imaging and FDG PET.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 2001 |
[Contribution of PET using FDG in the diagnosis of lung cancer--first results].
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
An approach to demonstrating cost-effectiveness of diagnostic imaging modalities in Australia illustrated by positron emission tomography.
Topics: Australia; Cardiovascular Diseases; Cost Savings; Cost-Benefit Analysis; Decision Trees; Fluorodeoxyglucose F18; Humans; Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |
[Therapy monitoring with 2-(18F)-FDG positron emission tomography after neoadjuvant radiation treatment of mouth carcinoma].
Topics: Adult; Aged; Blood Glucose; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Mouth Neoplasms; Neoadjuvant Therapy; Neoplasm Staging; Sensitivity and Specificity; Tomography, Emission-Computed; Treatment Outcome | 2001 |
[Value of positron emission tomography in treatment of lymphoma patients].
Topics: Blood Glucose; Combined Modality Therapy; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Neoplasm, Residual; Sensitivity and Specificity; Survival Rate; Tomography, Emission-Computed; Treatment Outcome | 2001 |
CT and (18)F-deoxyglucose (FDG) image fusion for optimization of conformal radiotherapy of lung cancers.
Topics: Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasm Staging; Phantoms, Imaging; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy, Conformal; Reproducibility of Results; Sensitivity and Specificity; Technology, Radiologic; Tomography, X-Ray Computed | 2001 |
Differentiation of radiographically indeterminate solitary pulmonary nodules with.
Topics: Adult; Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, Emission-Computed | 2001 |
F-18-fluorodeoxyglucose positron emission tomography as a presurgical evaluation modality for I-131 scan-negative thyroid carcinoma patients with local recurrence in cervical lymph nodes.
Topics: Adult; Aged; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Indium Radioisotopes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Preoperative Care; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms; Thyroidectomy; Tomography, Emission-Computed | 2001 |
Unexplained rising carcinoembryonic antigen (CEA) in the postoperative surveillance of colorectal cancer: the utility of positron emission tomography (PET).
Topics: Adult; Aged; Carcinoembryonic Antigen; Colorectal Neoplasms; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Postoperative Care; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |
Tumour detectability in 2-dimensional and 3-dimensional positron emission tomography using the SET-2400W: a phantom study.
Topics: Animals; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Neoplasms; Neoplasms, Muscle Tissue; Phantoms, Imaging; Rabbits; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |
Staging and managing lung tumors using F-18 FDG coincidence detection.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
18F-labeled fluorodeoxyglucose positron emission tomography-guided surgery for recurrent colorectal cancer: a feasibility study.
Topics: Beta Particles; Colorectal Neoplasms; Feasibility Studies; Fluorodeoxyglucose F18; Gamma Rays; Half-Life; Humans; Intraoperative Period; Neoplasm Recurrence, Local; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |
L-3-[123I]iodo-alpha-methyl-tyrosine SPECT in non-small cell lung cancer: preliminary observations.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinum; Methyltyrosines; Middle Aged; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2001 |
Dynamic PET 18F-FDG studies in patients with primary and recurrent soft-tissue sarcomas: impact on diagnosis and correlation with grading.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Radiopharmaceuticals; Sarcoma; Sensitivity and Specificity; Soft Tissue Neoplasms; Tomography, Emission-Computed | 2001 |
Clinical value of whole-body emission tomography in potentially curable colorectal liver metastases.
Topics: Adult; Aged; Colorectal Neoplasms; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Patient Selection; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Survival Rate; Tomography, Emission-Computed; Whole-Body Irradiation | 2001 |
Similar pelvic abnormalities on FDG positron emission tomography of different origins.
Topics: Adult; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Pelvic Neoplasms; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |
Cervical lymph node sarcoidosis as a pitfall in F-18 FDG positron emission tomography.
Topics: Aged; Diagnosis, Differential; Ear, External; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Melanoma; Neck; Radiopharmaceuticals; Sarcoidosis; Sensitivity and Specificity; Skin Neoplasms; Tomography, Emission-Computed | 2001 |
Elevated FDG uptake in the lactating human breast.
Topics: Adult; Breast; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lactation; Melanoma; Neoplasm Staging; Sensitivity and Specificity; Skin Neoplasms; Tomography, Emission-Computed | 2001 |
Evaluation of a surgical gamma probe for detection of 18F-FDG.
Topics: Fluorodeoxyglucose F18; Gamma Cameras; Humans; Intraoperative Period; Radiopharmaceuticals; Sensitivity and Specificity; Surgical Equipment | 2000 |
[18F-FDG positron-emission-tomography in cervical carcinoma: preliminary findings].
Topics: Adult; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Hysterectomy; Lymph Node Excision; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 2001 |
Clinical value of positron emission tomography with FDG for recurrent ovarian cancer.
Topics: Case-Control Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |
[Follow-up of differentiated thyroid cancer patients using rhTSH--preliminary results].
Topics: Adult; Aged; Feasibility Studies; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Iodine Radioisotopes; Middle Aged; Neoplasm Staging; Radionuclide Imaging; Radiopharmaceuticals; Recombinant Proteins; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Thyroidectomy; Thyrotropin; Thyroxine; Triiodothyronine | 2001 |
Relationship between expression of the sodium/iodide symporter and 131I uptake in recurrent lesions of differentiated thyroid carcinoma.
Topics: Adenocarcinoma, Follicular; Adolescent; Adult; Aged; Bone Neoplasms; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Iodine Radioisotopes; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Symporters; Thyroid Neoplasms; Tomography, Emission-Computed | 2001 |
The clinical use of PET--where are we now?
Topics: Cardiomyopathies; Cost-Benefit Analysis; Fluorodeoxyglucose F18; Half-Life; Humans; Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |
Low-dose dobutamine electrocardiograph-gated myocardial SPECT for identifying viable myocardium: comparison with dobutamine stress echocardiography and PET.
Topics: Aged; Dobutamine; Echocardiography; Electrocardiography; Exercise Test; Female; Fluorodeoxyglucose F18; Gated Blood-Pool Imaging; Heart; Humans; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction; Organophosphorus Compounds; Organotechnetium Compounds; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents; Ventricular Function, Left | 2001 |
The diagnostic role of radionuclide imaging in evaluation of patients with nonhypersecreting adrenal masses.
Topics: 19-Iodocholesterol; 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity | 2001 |
Role of molecular imaging in management of nonhypersecreting adrenal masses.
Topics: 19-Iodocholesterol; 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Fluorodeoxyglucose F18; Humans; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity | 2001 |
Feasibility of dual-isotope coincidence/single-photon imaging of the myocardium.
Topics: Feasibility Studies; Fluorodeoxyglucose F18; Heart; Humans; Image Processing, Computer-Assisted; Phantoms, Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2001 |
Early experience with PET scanning in thoracic tumours.
Topics: Adult; Aged; Blood Glucose; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Neoplasms, Multiple Primary; Sensitivity and Specificity; Thoracic Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
FDG-PET for detection of pulmonary metastases from malignant primary bone tumors: comparison with spiral CT.
Topics: Adolescent; Adult; Bone and Bones; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Osteosarcoma; Radiography, Thoracic; Radiopharmaceuticals; Retrospective Studies; Sarcoma, Ewing; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |
Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Drug Monitoring; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorodeoxyglucose F18; Humans; Leucovorin; Male; Middle Aged; Patient Selection; Preoperative Care; Prognosis; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Statistics, Nonparametric; Survival Rate; Tomography, Emission-Computed | 2001 |
The sensitivity and specificity of FDG PET in distinguishing recurrent brain tumor from radionecrosis in patients treated with stereotactic radiosurgery.
Topics: Adolescent; Adult; Aged; Brain Neoplasms; Child; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Necrosis; Radiography; Radiosurgery; Recurrence; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |
Whole-body MR imaging for detection of bone metastases in children and young adults: comparison with skeletal scintigraphy and FDG PET.
Topics: Adolescent; Adult; Bone Neoplasms; Child; Child, Preschool; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Infant; Magnetic Resonance Imaging; Male; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |
Positive emission tomography for evaluating a complete clinical response in patients with ovarian or peritoneal carcinoma: correlation with second-look laparotomy.
Topics: Adenocarcinoma, Mucinous; Adenofibroma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; CA-125 Antigen; Carcinoma, Endometrioid; Female; Fluorodeoxyglucose F18; Humans; Laparotomy; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Peritoneal Neoplasms; Radiopharmaceuticals; Reoperation; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |
Pitfalls in imaging Hodgkin's disease with computed tomography and positron emission tomography using fluorine-18-fluorodeoxyglucose.
Topics: Adult; Animals; Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Glucose; Hodgkin Disease; Humans; Immunocompromised Host; Neoplasm Recurrence, Local; Radiopharmaceuticals; Sensitivity and Specificity; Serologic Tests; Splenic Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed; Toxoplasma; Toxoplasmosis | 2001 |
Usefulness of dual-head coincidence gamma camera with thick NaI crystals for nuclear oncology: comparison with dedicated PET camera and conventional gamma camera with thin NaI crystals.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Male; Middle Aged; Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Sodium Iodide; Technetium Tc 99m Medronate; Tomography, Emission-Computed | 2001 |
F-18 FDG uptake in a patient with psoriatic arthritis: imaging correlation with patient symptoms.
Topics: Antineoplastic Agents; Arthritis, Psoriatic; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Middle Aged; Radiopharmaceuticals; Sensitivity and Specificity; Severity of Illness Index; Tomography, Emission-Computed | 2001 |
Apthoid stomatitis caused by vasculitis: focus detection and follow-up by whole-body FDG positron emission tomography.
Topics: Fluorodeoxyglucose F18; Humans; Leg; Male; Middle Aged; Radiopharmaceuticals; Sensitivity and Specificity; Stomatitis, Aphthous; Tomography, Emission-Computed; Vasculitis; Whole-Body Counting | 2001 |
Neural tuberculosis detected by F-18 FDG positron emission tomography.
Topics: Antitubercular Agents; Fever of Unknown Origin; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Radiopharmaceuticals; Sensitivity and Specificity; Sputum; Tomography, Emission-Computed; Tuberculin Test; Tuberculosis, Central Nervous System | 2001 |
Detection of choriocarcinoma in the lung by FDG positron emission tomography.
Topics: Adult; Choriocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |
Detection of pelvic lymph node metastases in gynecologic malignancy: a comparison of CT, MR imaging, and positron emission tomography.
Topics: Adult; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Lymph Node Excision; Lymphatic Metastasis; Magnetic Resonance Imaging; Pelvis; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
Validation of FDG positron emission tomography for differentiation of unknown pulmonary lesions.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Large Cell; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |
Staging of the neck in patients with oral cavity squamous cell carcinomas: a prospective comparison of PET, ultrasound, CT and MRI.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Diagnostic Imaging; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Neoplasms, Second Primary; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Ultrasonography | 2000 |
Whole body PET for the evaluation of bony metastases in patients with breast cancer: comparison with 99Tcm-MDP bone scintigraphy.
Topics: Adult; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Technetium Tc 99m Medronate; Tomography, Emission-Computed | 2001 |
FDG-PET sensitivity for melanoma lymph node metastases is dependent on tumor volume.
Topics: Fluorodeoxyglucose F18; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Melanoma; Radiography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |
Whole-body 18F dopa PET for detection of gastrointestinal carcinoid tumors.
Topics: Adult; Aged; Carcinoid Tumor; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Receptors, Somatostatin; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
Detection of mesial temporal lobe hypoperfusion in patients with temporal lobe epilepsy by use of arterial spin labeled perfusion MR imaging.
Topics: Adult; Dominance, Cerebral; Energy Metabolism; Epilepsy, Temporal Lobe; Female; Fluorodeoxyglucose F18; Hippocampus; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Psychosurgery; Reference Values; Regional Blood Flow; Retrospective Studies; Sensitivity and Specificity; Temporal Lobe; Tomography, Emission-Computed | 2001 |
Kinetic modeling of [(18)F]FDG in skeletal muscle by PET: a four-compartment five-rate-constant model.
Topics: Adult; Biological Transport; Blood Flow Velocity; Cell Membrane; Extracellular Space; Fluorodeoxyglucose F18; Glucose Clamp Technique; Glucose-6-Phosphatase; Humans; Insulin; Kinetics; Male; Mathematics; Models, Biological; Muscle, Skeletal; Phosphorylation; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |
Mediastinal lymph node sampling following positron emission tomography with fluorodeoxyglucose imaging in lung cancer staging.
Topics: Carcinoma, Non-Small-Cell Lung; False Negative Reactions; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Neoplasm Staging; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |
Evaluation of head and neck cancer with 18F-FDG PET: a comparison with conventional methods.
Topics: Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Otorhinolaryngologic Neoplasms; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
[Accuracy of positron emission tomography with fluorine-18-fluoro-deoxyglucose].
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
PET-FDG scan enhances but does not replace preoperative surgical staging in non-small cell lung carcinoma.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinoscopy; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
Visual and semiquantitative analysis of 18F-fluorodeoxyglucose positron emission tomography using a partial-ring tomograph without attenuation correction to differentiate benign and malignant pulmonary nodules.
Topics: Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |
FDG positron emission tomography in isolated limb perfusion therapy in patients with locally advanced melanoma: preliminary results.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Chemotherapy, Cancer, Regional Perfusion; Drug Therapy, Combination; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Likelihood Functions; Male; Melanoma; Melphalan; Middle Aged; Neoplasm Metastasis; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tumor Necrosis Factor-alpha; Whole-Body Counting | 2001 |
FDG-PET as a "metabolic biopsy" tool in thoracic lesions with indeterminate biopsy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
Clinical impact of (18)F-FDG PET in thyroid carcinoma patients with elevated thyroglobulin levels and negative (131)I scanning results after therapy.
Topics: Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Tomography, Emission-Computed | 2001 |
Comparison of [(18)F]FDG PET and (201)Tl SPECT in evaluation of pulmonary nodules.
Topics: Adenocarcinoma; Adenocarcinoma, Bronchiolo-Alveolar; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Sensitivity and Specificity; Thallium Radioisotopes; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2001 |
[Determination of therapy management in rectal carcinoma by staging with 18-FDG-PET].
Topics: Adenocarcinoma; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Middle Aged; Radiopharmaceuticals; Rectal Neoplasms; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Ultrasonography | 2001 |
Positron emission tomography (PET) for staging low-grade non-Hodgkin's lymphomas (NHL).
Topics: Adult; Aged; Bone Marrow; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Liver; Lung; Lymph Nodes; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Spleen; Tomography, Emission-Computed | 2001 |
Coincidence detection FDG PET in the management of oncological patients: attenuation correction versus non-attenuation correction.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Gamma Cameras; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Neoplasms; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thoracic Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
[Diagnosis and prognosis in neuro-oncology: contribution of positron emission tomography].
Topics: Brain Neoplasms; Carbon Radioisotopes; Diagnosis, Differential; Fluorodeoxyglucose F18; Follow-Up Studies; Glioma; Humans; Methionine; Neoplasm Recurrence, Local; Prognosis; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |
Value of 18-fluorodeoxyglucose positron emission tomography in the management of patients with cystic tumors of the pancreas.
Topics: Adult; Aged; Aged, 80 and over; Cysts; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome.
Topics: Aged; Brain; Dementia; Disease Progression; Female; Fluorodeoxyglucose F18; Glucose; Humans; Likelihood Functions; Male; Middle Aged; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |
Fluorine-18 fluorodeoxyglucose positron emission tomography in medullary thyroid cancer: results of a multicentre study.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
Finding infection--help from PET.
Topics: Fluorodeoxyglucose F18; Glucose; Humans; Infections; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |
Improved identification of viable myocardium using second harmonic imaging during dobutamine stress echocardiography.
Topics: Cardiotonic Agents; Dobutamine; Echocardiography, Stress; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocardium; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2001 |
FDG PET for evaluating breast cancer.
Topics: Blue Cross Blue Shield Insurance Plans; Breast Neoplasms; Device Approval; Drug Approval; Evidence-Based Medicine; Female; Fluorodeoxyglucose F18; Humans; Radiopharmaceuticals; Recurrence; Sensitivity and Specificity; Technology Assessment, Biomedical; Tomography, Emission-Computed; United States; United States Food and Drug Administration | 2001 |
Metabolic and electrophysiological validation of functional MRI.
Topics: Adult; Aged; Artifacts; Bias; Brain Mapping; Brain Neoplasms; Electrodiagnosis; Electrophysiology; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Magnetics; Male; Middle Aged; Preoperative Care; Psychomotor Performance; Radiopharmaceuticals; Sensitivity and Specificity; Signal Processing, Computer-Assisted; Stereotaxic Techniques; Tomography, Emission-Computed | 2001 |
[[F-18]FDG imaging of head and neck tumors: comparison of hybrid PET, dedicated PET and CT].
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Radiopharmaceuticals; Recurrence; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
Preoperative diagnostic value of [(18)F] fluorodeoxyglucose positron emission tomography in patients with radioiodine-negative recurrent well-differentiated thyroid carcinoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; Child; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Thyroidectomy; Tomography, Emission-Computed | 2001 |
The impact of FDG-PET on the management algorithm for recurrent colorectal cancer.
Topics: Aged; Algorithms; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Recurrence, Local; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
Evaluation of (pre-)malignant colonic abnormalities: endoscopic validation of FDG-PET findings.
Topics: Adenoma; Adenomatous Polyps; Cohort Studies; Colonic Neoplasms; Colonic Polyps; Colonoscopy; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Precancerous Conditions; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |
Carbon-11 choline or FDG-PET for staging of oesophageal cancer?
Topics: Carbon Radioisotopes; Choline; Esophageal Neoplasms; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Time Factors; Tomography, Emission-Computed | 2001 |
18F-FDG PET in characterizing adrenal lesions detected on CT or MRI.
Topics: Adrenal Gland Diseases; Adrenal Gland Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
F-18-fluoro-deoxy-glucose positron-emission tomography scanning in detection of local recurrence after radiotherapy for laryngeal/ pharyngeal cancer.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Laryngoscopy; Male; Middle Aged; Neoplasm Recurrence, Local; Pharyngeal Neoplasms; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |
Is an FDG-PET scan the new imaging standard for colon cancer?
Topics: Carcinoembryonic Antigen; Colonic Neoplasms; Fluorodeoxyglucose F18; Humans; Laparotomy; Radiopharmaceuticals; Recurrence; Second-Look Surgery; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |
A prospective study of 2-[18F] fluoro-2-deoxy-D-glucose/positron emission tomography scan, 99mTc-labeled arcitumomab (CEA-scan), and blind second-look laparotomy for detecting colon cancer recurrence in patients with increasing carcinoembryonic antigen le
Topics: Adult; Aged; Antibodies, Monoclonal; Colonic Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Laparotomy; Male; Middle Aged; Organotechnetium Compounds; Prospective Studies; Radiopharmaceuticals; Recurrence; Second-Look Surgery; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |
Identification of viable myocardium early after acute myocardial infarction using closed-loop arbutamine echocardiography: comparison with positron emission tomography.
Topics: Adrenergic beta-Agonists; Catecholamines; Echocardiography; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |
Combined 18F-FDG and 11C-methionine PET scans in patients with newly progressive metastatic prostate cancer.
Topics: Adenocarcinoma; Aged; Bone Neoplasms; Carbon Radioisotopes; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Methionine; Middle Aged; Prospective Studies; Prostatic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Soft Tissue Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
Chronic bacterial osteomyelitis: prospective comparison of (18)F-FDG imaging with a dual-head coincidence camera and (111)In-labelled autologous leucocyte scintigraphy.
Topics: Adult; Aged; Bacterial Infections; Chronic Disease; Female; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Indium Radioisotopes; Leukocytes; Male; Middle Aged; Osteomyelitis; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
Is quantitation necessary for oncological PET studies? For.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
Strain rate measurement by doppler echocardiography allows improved assessment of myocardial viability inpatients with depressed left ventricular function.
Topics: Aged; Coronary Stenosis; Dobutamine; Echocardiography, Doppler; Echocardiography, Stress; Female; Fluorodeoxyglucose F18; Heart; Humans; Image Enhancement; Male; Middle Aged; Myocardium; Predictive Value of Tests; Reproducibility of Results; ROC Curve; Sampling Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Ventricular Dysfunction, Left | 2002 |
The usefulness of F-18 deoxyglucose whole-body positron emission tomography (PET) for re-staging of renal cell cancer.
Topics: Adult; Aged; Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
The clinical application of a dual head gamma camera with coincidence detection in 20 women with suspected ovarian cancer.
Topics: Adult; Aged; Aged, 80 and over; CA-125 Antigen; Female; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Middle Aged; Ovarian Neoplasms; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity | 2001 |
FDG positron emission tomography detection of pelvic nodal metastases in gynecologic cancer.
Topics: Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
Value of positron emission tomography for lung cancer staging.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
Diagnostic performance of [18F]FDG-PET and ictal [99mTc]-HMPAO SPECT in occipital lobe epilepsy.
Topics: Adolescent; Adult; Cerebral Cortex; Diagnosis, Differential; Electroencephalography; Epilepsies, Partial; Female; Fluorodeoxyglucose F18; Functional Laterality; Humans; Magnetic Resonance Imaging; Male; Occipital Lobe; Regional Blood Flow; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Exametazime; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2001 |
[67-Gallium citrate gammagraphy in the study of lymphomas].
Topics: Citrates; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Gallium; Gallium Radioisotopes; Humans; Lymphoma; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2002 |
Selective axillary surgery in breast cancer patients based on positron emission tomography with 18F-fluoro-2-deoxy-D-glucose: not yet!
Topics: Aged; Aged, 80 and over; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymphatic Metastasis; Middle Aged; Neoplasm Metastasis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
Whole-body (18)F-FDG PET and conventional imaging for predicting outcome in previously treated breast cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Ultrasonography, Mammary | 2002 |
Detection of occult disease in breast cancer using fluorodeoxyglucose camera-based positron emission tomography.
Topics: Adult; Aged; Biomarkers, Tumor; Biopsy; Breast Neoplasms; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Mucin-1; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Time Factors; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
Fluorine-18 FDG imaging in hepatocellular carcinoma using positron coincidence detection and single photon emission computed tomography.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Pilot Projects; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2002 |
FDG PET in the management of lymphoma: a clinical perspective.
Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Neoplasm Staging; Predictive Value of Tests; Radiography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
Evaluation of high-risk melanoma: comparison of [18F]FDG PET and high-dose 67Ga SPET.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Citrates; False Positive Reactions; Female; Fluorodeoxyglucose F18; Gallium; Humans; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Skin Neoplasms; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Whole-Body Counting | 2002 |
Whole-body PET with FDG for the diagnosis of recurrent gastric cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Carcinoma, Signet Ring Cell; Databases, Factual; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Radiography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Single-Blind Method; Stomach Neoplasms; Survival Analysis; Tomography, Emission-Computed; Whole-Body Counting | 2002 |
FDG-PET as a "metabolic biopsy" tool in non-lung lesions with indeterminate biopsy.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Laparoscopy; Male; Middle Aged; Neoplasms; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Spinal Puncture; Tomography, Emission-Computed | 2002 |
Diagnostic value of 18F-FDG positron emission tomography for detection and treatment control of malignant germ cell tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Fluorodeoxyglucose F18; Germinoma; Humans; Male; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Testicular Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma.
Topics: Adult; Aged; Carcinoma; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
Is there a role for positron emission tomography with 18F-fluorodeoxyglucose in the initial staging of nodal negative oral and oropharyngeal squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Oropharyngeal Neoplasms; Prospective Studies; Radiography; Radiopharmaceuticals; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Tomography, Emission-Computed | 2002 |
The role of quantitative (18)F-FDG PET studies for the differentiation of malignant and benign bone lesions.
Topics: Bayes Theorem; Bone Diseases; Bone Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
[Diagnosis of esophageal cancer using positron emission tomography].
Topics: Endosonography; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
Positron emission tomography for assessment of the response to induction radiochemotherapy in locally advanced oesophageal cancer.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Combined Modality Therapy; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Remission Induction; Risk Factors; Sensitivity and Specificity; Survival Rate; Tomography, Emission-Computed | 2002 |
T1 lung cancers: sensitivity of diagnosis with fluorodeoxyglucose PET.
Topics: Adult; Aged; Aged, 80 and over; Chi-Square Distribution; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Registries; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
A femoral arteriovenous shunt facilitates arterial whole blood sampling in animals.
Topics: Animals; Arteriovenous Shunt, Surgical; Blood; Blood Pressure; Blood Specimen Collection; Femoral Artery; Femoral Vein; Fluorodeoxyglucose F18; Humans; Male; Radionuclide Imaging; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Reproducibility of Results; Sensitivity and Specificity | 2002 |
Head and neck imaging with PET and PET/CT: artefacts from dental metallic implants.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Artifacts; Dental Restoration, Permanent; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
FDG-PET imaging and the diagnosis of non-small cell lung cancer in a region of high histoplasmosis prevalence.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Histoplasmosis; Humans; Iowa; Lung Neoplasms; Male; Middle Aged; Predictive Value of Tests; Prevalence; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography with conventional assessment by computed tomography scans and serum tumor markers for the evaluation of residual masses in patients with nonseminomatous germ cell carcinoma.
Topics: Adult; Biomarkers, Tumor; Fluorodeoxyglucose F18; Follow-Up Studies; Germinoma; Humans; Magnetic Resonance Imaging; Middle Aged; Neoplasm, Residual; Prognosis; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
Pre-surgical evaluation and surgical outcome of 41 patients with non-lesional neocortical epilepsy.
Topics: Adolescent; Adult; Child; Electroencephalography; Epilepsy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Neocortex; Radiopharmaceuticals; Sensitivity and Specificity; Technetium; Time Factors; Tomography, Emission-Computed; Treatment Outcome | 2002 |
Fluorodeoxyglucose uptake and glucose transporter expression in experimental inflammatory lesions and malignant tumours: effects of insulin and glucose loading.
Topics: Animals; Fluorodeoxyglucose F18; Glucose; Hypoglycemic Agents; Inflammation; Insulin; Liver Neoplasms, Experimental; Male; Monosaccharide Transport Proteins; Rabbits; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Wistar; Sensitivity and Specificity; Staphylococcal Infections | 2002 |
Use of insulin to improve [18 F]fluorodeoxyglucose labelling and retention for in vivo positron emission tomography imaging of monocyte trafficking.
Topics: Animals; Fluorodeoxyglucose F18; Glucose-6-Phosphatase; Humans; Hypoglycemic Agents; In Vitro Techniques; Insulin; Liver; Lymphocytes; Male; Models, Animal; Monocytes; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Sensitivity and Specificity; Time Factors; Tomography, Emission-Computed | 2002 |
Asymptomatic adnexal masses: correlation of FDG PET and histopathologic findings.
Topics: Adnexal Diseases; Adult; Aged; Aged, 80 and over; Confidence Intervals; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Ovarian Neoplasms; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Ultrasonography | 2002 |
Oncological diagnosis using positron coincidence gamma camera with fluorodeoxyglucose in comparison with dedicated PET.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Male; Middle Aged; Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
Positron emission tomography in the evaluation of synchronous lung lesions in patients with untreated head and neck cancer.
Topics: Adult; Aged; Bronchoscopy; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms, Multiple Primary; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
Comparison of [18 F]fluorocholine and [18 F]fluorodeoxyglucose for positron emission tomography of androgen dependent and androgen independent prostate cancer.
Topics: Animals; Choline; Fluorine Compounds; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Metabolic Clearance Rate; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Prostate; Prostatic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tissue Distribution; Tomography, Emission-Computed; Tumor Cells, Cultured | 2002 |
Data acquisition in PET imaging.
Topics: Algorithms; Brain; Data Collection; Data Display; Education, Continuing; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
[Correlation of FDG-PET and MRI/CT with histopathology in primary diagnosis, lymph node staging and diagnosis of recurrency of head and neck cancer].
Topics: Adult; Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Unknown Primary; Otorhinolaryngologic Neoplasms; Prognosis; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
[Current status of nuclear medicine. Clinical application of FDG-PET for cancer diagnosis. Malignant lymphoma].
Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
[The role of PET scan in the diagnosis of malignant melanoma].
Topics: Adult; Aged; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Middle Aged; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Skin Neoplasms; Tomography, Emission-Computed | 2002 |
[The role of FDG-PET scan in the diagnosis of pancreatic carcinoma].
Topics: Adult; CA-19-9 Antigen; Carcinoma; Cholangiopancreatography, Endoscopic Retrograde; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Pancreatitis; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Ultrasonography | 2002 |
Dual time point 18F-FDG PET for the evaluation of pulmonary nodules.
Topics: Adenocarcinoma; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Radiopharmaceuticals; Sensitivity and Specificity; Solitary Pulmonary Nodule; Time Factors; Tomography, Emission-Computed | 2002 |
Differentiation of residual or recurrent tumors from post-treatment changes with F-18 FDG PET.
Topics: Abdominal Neoplasms; Brain; Brain Neoplasms; Deoxyglucose; Diagnosis, Differential; Diagnostic Techniques, Surgical; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Magnetic Resonance Imaging; Necrosis; Neoplasm Recurrence, Local; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1992 |